<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>CEREB Pathology - Combined Tests</title>
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
  <style>
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
</style>
  <style>
  body {
    font-family: Arial, sans-serif;
    padding: 0;
    margin: 0;
  }

  button {
    margin: 5px;
    padding: 10px 15px;
    background: #ffffff;
    border: 1px solid #2d3748;
    border-radius: 4px;
    cursor: pointer;
    color: #000000;
    position: relative;
    top: 5px;
    font-size: 14px;
    transition: background 0.2s ease, color 0.2s ease, transform 0.1s ease;
  }

  button:hover {
    background: #f3f4f6;
    color: #000000;
    transform: translateY(-1px);
  }

  body, html {
            margin: 0;
            padding: 0;
            height: 100%;
            overflow: hidden;
        }
        .iframe-container {
            position: fixed;
            top: 0;
            left: 0;
            right: 0;
            bottom: 0;
            overflow: auto;
            -webkit-overflow-scrolling: touch;
        }
        .iframe-container iframe {
            width: 100%;
            height: 100%;
            border: none;
            display: block;
        }
    
    /* Mobile optimization */
    

  /* Dropdown styling */
  .dropdown-wrapper {
    position: absolute;
    top: 20px;
    right: 20px;
    z-index: 1100;
  }

  .dropdown-toggle {
    background: #2c5281;
    color: white;
    border: none;
    font-size: 14px;
    padding: 10px 18px;
    border-radius: 6px;
    font-weight: bold;
    letter-spacing: 0.5px;
  }

  .dropdown-toggle:hover {
    background: #24466c;
  }

  .dropdown-menu {
  display: none;
  position: absolute;
  right: 0;              /* keep aligned to right edge of toggle */
  margin-top: 6px;
  background: white;
  border: 1px solid #cbd5e0;
  border-radius: 8px;
  max-height: 350px;
  overflow-y: auto;
  box-shadow: 0 6px 16px rgba(0, 0, 0, 0.15);
  min-width: 250px;
  max-width: 90vw;       /* prevent it from going outside screen */
  word-wrap: break-word; /* wrap long names */
  white-space: normal;   /* allow text to wrap */
  animation: fadeIn 0.2s ease-in-out;
}

.dropdown-menu button {
  display: block;
  width: 100%;
  text-align: left;
  margin: 0;
  padding: 10px 15px;
  border-radius: 0;
  background: transparent;
  color: #2d3748;
  border: none;
  border-bottom: 1px solid #edf2f7;
  font-size: 13px;
  white-space: normal;   /* allow wrapping inside button */
  word-break: break-word;
}


  img {
    max-width: 100%;
    max-height: 400px;
    width: auto;
    height: auto;
    display: block;
    margin: 10px auto;
  }

  body > section:last-child {
    margin-bottom: 0 !important;
  }
  
</style>
  <script>
  function showTest(id) {
    document.querySelectorAll('.iframe-container').forEach(div => div.style.display = 'none');
    document.getElementById(id).style.display = 'block';
    document.getElementById('dropdownMenu').style.display = 'none';
    window.scrollTo(0, 0);
  }

  function toggleDropdown() {
    const menu = document.getElementById('dropdownMenu');
    menu.style.display = menu.style.display === 'block' ? 'none' : 'block';
  }

  document.addEventListener('click', function (event) {
    const toggle = document.getElementById('dropdownToggle');
    const menu = document.getElementById('dropdownMenu');
    if (!toggle.contains(event.target) && !menu.contains(event.target)) {
      menu.style.display = 'none';
    }
  });
</script>
<script src="../../../access-control.js"></script>
  <script src="../../../block.js"></script>
  <script src="../../../error-handler/link-checker.js"></script>
  <script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-5920367457745298"
     crossorigin="anonymous"></script>
</head>
<body>
<script>
      // Initialize access control for protected page
      if (!accessControl.initProtectedPage()) {
        throw new Error('Access denied - redirecting to index.html');
      }
    </script>
  <button onclick="history.back()" style="position: absolute; top: 20px; left: 20px; background: transparent; color: white; border: none; padding: 10px; cursor: pointer; z-index: 1001; font-size: 20px;">
  <i class="fas fa-arrow-left"></i>
</button>

<div class="dropdown-wrapper">
  <button class="dropdown-toggle" id="dropdownToggle" onclick="toggleDropdown()">â˜° INDEX</button>
  <div class="dropdown-menu" id="dropdownMenu">
<button onclick="showTest('test1')">CNS</button>
<button onclick="showTest('test2')">Cardiovascular System</button>
<button onclick="showTest('test3')">Cell Injury</button>
<button onclick="showTest('test4')">Endocrinology</button>
<button onclick="showTest('test5')">Gastrointestinal System</button>
<button onclick="showTest('test6')">Heamatology</button>
<button onclick="showTest('test7')">Immunity</button>
<button onclick="showTest('test8')">Inflammation</button>
<button onclick="showTest('test9')">Liver</button>
<button onclick="showTest('test10')">Male and Female Genital Tract</button>
<button onclick="showTest('test11')">Neoplasia</button>
<button onclick="showTest('test12')">Renal System</button>
<button onclick="showTest('test13')">Respiratory System</button>
</div>
  </div>
  
<div id="test1" class="iframe-container" style="display:block;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Cns&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Cns&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                33 Questions | 132 Total Marks | 43 min Duration | ~78.18 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A 45-year-old patient sustains a traumatic injury resulting in damage to nervous tissue. The subsequent healing process involves the formation of scar tissue at the site of injury. Which of the following cell types is primarily responsible for the formation of scar tissue during the repair of nervous tissue?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Neuroglia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fibroblasts&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Axons&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Microglia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Neuroglia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Neuroglia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Fibroblasts are the primary cell type responsible for scar formation in peripheral tissues , but not typically within the CNS, as they produce collagen and other extracellular matrix components leading to the formation of connective tissue scars.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Fibroblasts&lt;/li&gt;&lt;li&gt;â€¢ primary cell type&lt;/li&gt;&lt;li&gt;â€¢ scar formation in peripheral tissues&lt;/li&gt;&lt;li&gt;â€¢ Option C: Axons do not form scar tissue but can be i nvolved in the regeneration process in the peripheral nervous system under certain conditions.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Axons&lt;/li&gt;&lt;li&gt;â€¢ nvolved in the regeneration process&lt;/li&gt;&lt;li&gt;â€¢ peripheral nervous system&lt;/li&gt;&lt;li&gt;â€¢ Option D: Microglia are the resident macrophages of the CNS , involved in the immune response and clean-up after injury but are not the primary cells responsible for scar tissue formation.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Microglia&lt;/li&gt;&lt;li&gt;â€¢ resident macrophages of the CNS&lt;/li&gt;&lt;li&gt;â€¢ immune response&lt;/li&gt;&lt;li&gt;â€¢ clean-up after injury&lt;/li&gt;&lt;li&gt;â€¢ primary cells&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The cell type primarily responsible for the formation of scar tissue during the repair of nervous tissue is Neuroglia , as astrocytes , a type of glial cell , play a crucial role in the gliosis process that leads to scar formation in the CNS .&lt;/li&gt;&lt;li&gt;âž¤ cell type&lt;/li&gt;&lt;li&gt;âž¤ formation of scar tissue&lt;/li&gt;&lt;li&gt;âž¤ repair of nervous tissue is Neuroglia&lt;/li&gt;&lt;li&gt;âž¤ astrocytes&lt;/li&gt;&lt;li&gt;âž¤ glial cell&lt;/li&gt;&lt;li&gt;âž¤ gliosis process&lt;/li&gt;&lt;li&gt;âž¤ scar formation in the CNS&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th 1255&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th 1255&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old patient presents with headaches and visual disturbances. Imaging reveals a suprasellar mass consistent with a craniopharyngioma. The patient is concerned about the potential spread of the tumor. Which of the following brain tumors is least likely to spread via cerebrospinal fluid (CSF)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Germ cell tumors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Medulloblastoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CNS Lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Craniopharyngioma&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Craniopharyngioma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Craniopharyngioma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Germ cell tumors, particularly those occurring in the brain , can disseminate via the CSF due to their typical midline location, which facilitates spread through the ventricular system.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Germ cell tumors,&lt;/li&gt;&lt;li&gt;â€¢ occurring in the brain&lt;/li&gt;&lt;li&gt;â€¢ Option B: Medulloblastoma is a highly malignant primary brain tumor that often spreads via the CSF , characteristically leading to drop metastasis at the cauda equina.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Medulloblastoma&lt;/li&gt;&lt;li&gt;â€¢ highly malignant primary brain tumor&lt;/li&gt;&lt;li&gt;â€¢ spreads via the CSF&lt;/li&gt;&lt;li&gt;â€¢ Option C: CNS lymphoma , although primarily a parenchymal brain tumor , can occasionally disseminate in the CSF , particularly in the setting of leptomeningeal disease.&lt;/li&gt;&lt;li&gt;â€¢ Option C: CNS lymphoma&lt;/li&gt;&lt;li&gt;â€¢ parenchymal brain tumor&lt;/li&gt;&lt;li&gt;â€¢ disseminate in the CSF&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Craniopharyngioma is the brain tumor that is least likely to spread via cerebrospinal fluid , as it typically presents with local growth and does not commonly disseminate through the CSF pathways.&lt;/li&gt;&lt;li&gt;âž¤ Craniopharyngioma&lt;/li&gt;&lt;li&gt;âž¤ brain tumor&lt;/li&gt;&lt;li&gt;âž¤ least likely to spread via cerebrospinal fluid&lt;/li&gt;&lt;li&gt;âž¤ presents with local growth&lt;/li&gt;&lt;li&gt;âž¤ Brain tumors spreading via CSF are&lt;/li&gt;&lt;li&gt;âž¤ Brain tumors spreading via CSF are&lt;/li&gt;&lt;li&gt;âž¤ Ependymoma Medulloblastoma Choroid plexus carcinoma Astrocytoma Germinoma Pineoblastoma CNS Lymphoma.&lt;/li&gt;&lt;li&gt;âž¤ Ependymoma&lt;/li&gt;&lt;li&gt;âž¤ Medulloblastoma&lt;/li&gt;&lt;li&gt;âž¤ Choroid plexus carcinoma&lt;/li&gt;&lt;li&gt;âž¤ Astrocytoma&lt;/li&gt;&lt;li&gt;âž¤ Germinoma&lt;/li&gt;&lt;li&gt;âž¤ Pineoblastoma&lt;/li&gt;&lt;li&gt;âž¤ CNS Lymphoma.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/ 1293&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th/ 1293&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 75-year-old patient presents to the neurology clinic with a progressive decline in memory and cognitive function over the past few years. The family reports episodes of visual hallucinations and fluctuations in alertness. Cognitive testing demonstrates impaired memory recall and difficulty with executive functions. An MRI of the brain shows atrophy in the temporal and parietal lobes. Biopsy of brain tissue was done. Which of the following features is not typically associated with the pathology of this patient&#x27;s condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Neurofibrillary tangles&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Senile neuritic plaques&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amyloid angiopathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lewy bodies&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lewy bodies&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Lewy bodies&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: Neurofibrillary tangles : These are twisted tangles of tau protein within nerve cells.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Neurofibrillary tangles&lt;/li&gt;&lt;li&gt;â€¢ twisted tangles&lt;/li&gt;&lt;li&gt;â€¢ tau protein&lt;/li&gt;&lt;li&gt;â€¢ Option B: Senile (neuritic) plaques : These are abnormal clusters of beta-amyloid protein that accumulate between nerve cells .&lt;/li&gt;&lt;li&gt;â€¢ Option B: Senile (neuritic) plaques&lt;/li&gt;&lt;li&gt;â€¢ abnormal clusters&lt;/li&gt;&lt;li&gt;â€¢ beta-amyloid protein&lt;/li&gt;&lt;li&gt;â€¢ accumulate between nerve cells&lt;/li&gt;&lt;li&gt;â€¢ Option C: Amyloid angiopathy : It involves the deposition of amyloid protein in blood vessel walls .&lt;/li&gt;&lt;li&gt;â€¢ Option C: Amyloid angiopathy&lt;/li&gt;&lt;li&gt;â€¢ deposition of amyloid protein&lt;/li&gt;&lt;li&gt;â€¢ blood vessel walls&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lewy bodies are not typically associated with the pathology of Alzheimer&#x27;s disease , which is characterized by neurofibrillary tangles , senile neuritic plaques , and amyloid angiopathy .&lt;/li&gt;&lt;li&gt;âž¤ Lewy bodies&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ pathology of Alzheimer&#x27;s disease&lt;/li&gt;&lt;li&gt;âž¤ neurofibrillary tangles&lt;/li&gt;&lt;li&gt;âž¤ senile neuritic plaques&lt;/li&gt;&lt;li&gt;âž¤ amyloid angiopathy&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 1275&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 1275&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old patient presents with unilateral sensorineural hearing loss and persistent tinnitus. Physical examination reveals a non-tender mass in the vicinity of cranial nerve VIII. An MRI indicates a well-circumscribed mass in the internal acoustic meatus, and a subsequent biopsy is performed. Histologically, the tissue demonstrates distinct regions of cellularity with areas showing dense proliferation of spindle cells, while others show less density. There is also evidence of nuclear palisading. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Schwannoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Leukemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Angiofibroma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Schwannoma&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/10/picture1_GWIBY0y.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Schwannoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B: Lymphoma : Lymphomas are neoplasms of the lymphatic system and would present histologically with an infiltration of lymphoid cells , which does not correspond to the nuclear palisading and alternating cellularity described in the stem.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Lymphoma&lt;/li&gt;&lt;li&gt;â€¢ neoplasms of the lymphatic system&lt;/li&gt;&lt;li&gt;â€¢ present histologically&lt;/li&gt;&lt;li&gt;â€¢ infiltration of lymphoid cells&lt;/li&gt;&lt;li&gt;â€¢ Option C: Leukemia : This is a hematopoietic stem cell malignancy primarily affecting the bone marrow and blood . Histology of a solid mass would not reveal the characteristic findings of leukemia , such as blasts or excessive leukocytes .&lt;/li&gt;&lt;li&gt;â€¢ Option C: Leukemia&lt;/li&gt;&lt;li&gt;â€¢ hematopoietic stem cell malignancy&lt;/li&gt;&lt;li&gt;â€¢ affecting the bone marrow&lt;/li&gt;&lt;li&gt;â€¢ blood&lt;/li&gt;&lt;li&gt;â€¢ Histology&lt;/li&gt;&lt;li&gt;â€¢ solid mass&lt;/li&gt;&lt;li&gt;â€¢ not reveal the characteristic findings of leukemia&lt;/li&gt;&lt;li&gt;â€¢ blasts or excessive leukocytes&lt;/li&gt;&lt;li&gt;â€¢ Option D: Angiofibroma : Angiofibroma, often a benign tumor of adolescent males , would show a stromal and vascular component histologically , which is not described in the biopsy findings of the question stem.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Angiofibroma&lt;/li&gt;&lt;li&gt;â€¢ benign tumor of adolescent males&lt;/li&gt;&lt;li&gt;â€¢ stromal&lt;/li&gt;&lt;li&gt;â€¢ vascular component histologically&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The characteristic histological features of schwannomas are Antoni A areas , with hypercellular tissue and nuclear palisading , and Antoni B areas , which are less cellular .&lt;/li&gt;&lt;li&gt;âž¤ histological features&lt;/li&gt;&lt;li&gt;âž¤ schwannomas&lt;/li&gt;&lt;li&gt;âž¤ Antoni A areas&lt;/li&gt;&lt;li&gt;âž¤ hypercellular tissue&lt;/li&gt;&lt;li&gt;âž¤ nuclear palisading&lt;/li&gt;&lt;li&gt;âž¤ Antoni B areas&lt;/li&gt;&lt;li&gt;âž¤ less cellular&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/e p1237&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th/e p1237&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old patient presents with a gradual decline in memory and cognitive function over the past few years. Family members report increasing forgetfulness and difficulty with daily tasks. Neurological examination reveals no tremors or rigidity but does show signs of impaired memory recall. An MRI of the brain demonstrates atrophy in the temporal and parietal lobes. Biopsy of brain tissue reveals n eurofibrillary tangles. Which condition is the patient likely to be suffering?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Parkinsonism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alzheimerâ€™s disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Multiple sclerosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Perivenous encephalomyelitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Alzheimerâ€™s disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Alzheimerâ€™s disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: Parkinson&#x27;s disease is characterized by the presence of Lewy bodies , not neurofibrillary tangles.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Parkinson&#x27;s&lt;/li&gt;&lt;li&gt;â€¢ presence of Lewy bodies&lt;/li&gt;&lt;li&gt;â€¢ Option C: Multiple sclerosis involves demyelination of nerve fibers and is not typically associated with neurofibrillary tangles.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Multiple sclerosis&lt;/li&gt;&lt;li&gt;â€¢ demyelination of nerve fibers&lt;/li&gt;&lt;li&gt;â€¢ Option D: Perivenous encephalomyelitis : It may refer to inflammation around blood vessels in the brain and spinal cord , but without more specific information, it&#x27;s challenging to associate it with neurofibrillary tangles.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Perivenous encephalomyelitis&lt;/li&gt;&lt;li&gt;â€¢ inflammation around blood vessels&lt;/li&gt;&lt;li&gt;â€¢ brain and spinal cord&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Alzheimer&#x27;s disease is characterized by the presence of neurofibrillary tangles composed of tau protein within nerve cells , which are a hallmark of the disease&#x27;s neuropathology.&lt;/li&gt;&lt;li&gt;âž¤ Alzheimer&#x27;s disease&lt;/li&gt;&lt;li&gt;âž¤ presence of neurofibrillary tangles&lt;/li&gt;&lt;li&gt;âž¤ tau protein&lt;/li&gt;&lt;li&gt;âž¤ nerve cells&lt;/li&gt;&lt;li&gt;âž¤ disease&#x27;s neuropathology.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 1278&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 1278&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Dementia in an old man with senile plaques is usually associated with:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alzheimerâ€™s disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Picks disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Parkinsonâ€™s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Alzheimerâ€™s disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Alzheimerâ€™s disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B: Pick&#x27;s disease: Also known as frontotemporal dementia , is characterized by the presence of abnormal tau protein in nerve cells , but it is not typically associated with senile plaques .&lt;/li&gt;&lt;li&gt;â€¢ Option B: Pick&#x27;s disease:&lt;/li&gt;&lt;li&gt;â€¢ frontotemporal dementia&lt;/li&gt;&lt;li&gt;â€¢ presence of abnormal tau protein&lt;/li&gt;&lt;li&gt;â€¢ nerve cells&lt;/li&gt;&lt;li&gt;â€¢ senile plaques&lt;/li&gt;&lt;li&gt;â€¢ Option C: Parkinson&#x27;s disease: It primarily involves motor symptoms such as tremors , rigidity, and bradykinesia . It is not directly associated with senile plaques.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Parkinson&#x27;s disease:&lt;/li&gt;&lt;li&gt;â€¢ motor symptoms such as tremors&lt;/li&gt;&lt;li&gt;â€¢ rigidity, and bradykinesia&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins 10 th / 1275&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Robbins 10 th / 1275&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old man with a history of progressive memory loss and cognitive decline over the past 5 years is brought to the physician by his family due to concerns about his worsening ability to perform daily tasks. The patient&#x27;s Mini-Mental State Examination score has declined significantly since the last visit. An MRI of the brain shows widespread atrophy with particular emphasis in the temporal and parietal lobes. Histological examination of a biopsy specimen from the cerebral cortex reveals extracellular amyloid deposits and intraneuronal hyperphosphorylated tau protein aggregates. Which of the following additional histopathological findings would be least likely to support the likely disease in the patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Presence of granulovacuolar degeneration in hippocampal neurons&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Abundant deposition of alpha-synuclein within neurons&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Extensive amyloid deposition in the walls of cerebral blood vessels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Accumulation of Hirano bodies in the hippocampus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Abundant deposition of alpha-synuclein within neurons&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Abundant deposition of alpha-synuclein within neurons&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Granulovacuolar degeneration is characterized by small fluid-filled cavities containing granular debris found in the hippocampal neurons and is often seen in Alzheimer&#x27;s disease .&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Granulovacuolar degeneration&lt;/li&gt;&lt;li&gt;â€¢ small fluid-filled cavities&lt;/li&gt;&lt;li&gt;â€¢ granular debris&lt;/li&gt;&lt;li&gt;â€¢ hippocampal neurons&lt;/li&gt;&lt;li&gt;â€¢ Alzheimer&#x27;s disease&lt;/li&gt;&lt;li&gt;â€¢ Option C: Cerebral amyloid angiopathy involves the deposition of amyloid-beta protein in the walls of small to medium-sized arteries in the central nervous system and is commonly associated with Alzheimer&#x27;s disease.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Cerebral amyloid angiopathy&lt;/li&gt;&lt;li&gt;â€¢ deposition of amyloid-beta protein&lt;/li&gt;&lt;li&gt;â€¢ walls of small to medium-sized arteries&lt;/li&gt;&lt;li&gt;â€¢ central nervous system&lt;/li&gt;&lt;li&gt;â€¢ Option D: Hirano bodies are intracellular inclusions found in the astrocytic processes that are often associated with Alzheimer&#x27;s disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Hirano bodies&lt;/li&gt;&lt;li&gt;â€¢ intracellular inclusions&lt;/li&gt;&lt;li&gt;â€¢ astrocytic processes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The least likely histopathological finding to support the diagnosis of Alzheimer&#x27;s disease is abundant deposition of alpha-synuclein within neurons , as this is indicative of disorders such as Parkinson&#x27;s disease and Lewy body dementia , rather than Alzheimer&#x27;s disease.&lt;/li&gt;&lt;li&gt;âž¤ least likely histopathological finding&lt;/li&gt;&lt;li&gt;âž¤ diagnosis of Alzheimer&#x27;s disease&lt;/li&gt;&lt;li&gt;âž¤ abundant deposition of alpha-synuclein within neurons&lt;/li&gt;&lt;li&gt;âž¤ Parkinson&#x27;s disease&lt;/li&gt;&lt;li&gt;âž¤ Lewy body dementia&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1275&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1275&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Tau protein are associated with all except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Parkinsonism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alzheimerâ€™s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Frontotemporal lobar degeneration&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Huntingtonâ€™s disease&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Huntingtonâ€™s disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/27/screenshot-2024-04-27-175112.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Huntingtonâ€™s disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old patient presents with a progressive decline in memory and cognitive function. Genetic testing reveals a polymorphism in the APOE gene, specifically the Îµ4 allele. This gene is implicated in the risk and susceptibility to late-onset Alzheimer&#x27;s disease. Which chromosome harbours the APOE gene associated with Alzheimer&#x27;s disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;6&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;12&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;19&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 19&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) 19&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The APOE gene associated with Alzheimer&#x27;s disease is located on chromosome 19 . This locus has a significant impact on the likelihood of developing Alzheimer&#x27;s disease , particularly the Îµ4 allele .&lt;/li&gt;&lt;li&gt;âž¤ APOE gene&lt;/li&gt;&lt;li&gt;âž¤ Alzheimer&#x27;s disease&lt;/li&gt;&lt;li&gt;âž¤ chromosome 19&lt;/li&gt;&lt;li&gt;âž¤ locus&lt;/li&gt;&lt;li&gt;âž¤ impact on the likelihood&lt;/li&gt;&lt;li&gt;âž¤ Alzheimer&#x27;s disease&lt;/li&gt;&lt;li&gt;âž¤ Îµ4 allele&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1285&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1285&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following receptor on neuronal membrane that induces development of glioma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CD45&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CD133&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CD33&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CD24&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. CD133&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) CD133&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: CD45 is a common leukocyte antigen and is not specifically associated with glioma development.&lt;/li&gt;&lt;li&gt;â€¢ Option A: CD45&lt;/li&gt;&lt;li&gt;â€¢ common leukocyte antigen&lt;/li&gt;&lt;li&gt;â€¢ Option C: CD33 is a cell surface marker associated with myeloid cells and is not directly related to glioma development.&lt;/li&gt;&lt;li&gt;â€¢ Option C: CD33&lt;/li&gt;&lt;li&gt;â€¢ cell surface marker&lt;/li&gt;&lt;li&gt;â€¢ myeloid cells&lt;/li&gt;&lt;li&gt;â€¢ Option D: CD24 is a cell adhesion molecule and has been associated with various cellular processes , but it is not a primary marker for glioma development.&lt;/li&gt;&lt;li&gt;â€¢ Option D: CD24&lt;/li&gt;&lt;li&gt;â€¢ cell adhesion molecule&lt;/li&gt;&lt;li&gt;â€¢ various cellular processes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ CD133 is a marker associated with neural stem cells and is implicated in the tumorigenic properties of glioma stem cells , which contribute to the development of gliomas.&lt;/li&gt;&lt;li&gt;âž¤ CD133&lt;/li&gt;&lt;li&gt;âž¤ marker associated with neural stem cells&lt;/li&gt;&lt;li&gt;âž¤ tumorigenic properties of glioma stem cells&lt;/li&gt;&lt;li&gt;âž¤ development of gliomas.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old patient undergoes imaging for suspected pituitary adenoma. The radiological report indicates a pituitary mass. The pituitary adenomas are regarded as macroadenomas when their size is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;gt; 1 cm&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;&amp;gt; 1.5 cm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;&amp;gt; 2 cm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;&amp;gt; 2.5 cm&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. &gt; 1 cm&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) &amp;gt; 1 cm&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which is not a neuronal tumor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ependymoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Neuroblastoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gangliocytoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ganglioglioma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Ependymoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Ependymoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Neuroblastoma is a malignant tumor derived from primitive neuroblasts , which are cells in the sympathetic nervous system, and it is indeed a neuronal tumor.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Neuroblastoma&lt;/li&gt;&lt;li&gt;â€¢ malignant tumor&lt;/li&gt;&lt;li&gt;â€¢ primitive neuroblasts&lt;/li&gt;&lt;li&gt;â€¢ Option C: Gangliocytoma is a rare , benign tumor composed of mature neurons , and it is classified as a neuronal tumor.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Gangliocytoma&lt;/li&gt;&lt;li&gt;â€¢ rare&lt;/li&gt;&lt;li&gt;â€¢ benign tumor&lt;/li&gt;&lt;li&gt;â€¢ mature neurons&lt;/li&gt;&lt;li&gt;â€¢ Option D: Ganglioglioma is a tumor that contains both neoplastic neurons and glial cells , which classifies it as a mixed neuronal-glial tumor.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Ganglioglioma&lt;/li&gt;&lt;li&gt;â€¢ tumor&lt;/li&gt;&lt;li&gt;â€¢ contains both neoplastic neurons&lt;/li&gt;&lt;li&gt;â€¢ glial cells&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ependymoma is not a neuronal tumor ; it is a glial tumor arising from the ependymal cells of the ventricular system .&lt;/li&gt;&lt;li&gt;âž¤ Ependymoma&lt;/li&gt;&lt;li&gt;âž¤ not a neuronal tumor&lt;/li&gt;&lt;li&gt;âž¤ glial tumor&lt;/li&gt;&lt;li&gt;âž¤ ependymal cells&lt;/li&gt;&lt;li&gt;âž¤ ventricular system&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 1296&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 1296&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old patient presents with new-onset headaches, visual disturbances, and seizures. Brain imaging reveals multiple metastatic lesions. Which primary malignancy is most commonly associated with brain metastases in adults?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Stomach&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ovary&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oral cavity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lung&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lung&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Lung&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: While stomach cancer can metastasize to various organs , it is not the most common source of brain metastases in adults.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ stomach&lt;/li&gt;&lt;li&gt;â€¢ cancer&lt;/li&gt;&lt;li&gt;â€¢ metastasize to various organs&lt;/li&gt;&lt;li&gt;â€¢ Option B: Ovarian cancer typically spreads to peritoneal surfaces and although it can metastasize widely , it is not the most frequent cause of brain metastases.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Ovarian&lt;/li&gt;&lt;li&gt;â€¢ cancer&lt;/li&gt;&lt;li&gt;â€¢ spreads to peritoneal surfaces&lt;/li&gt;&lt;li&gt;â€¢ metastasize widely&lt;/li&gt;&lt;li&gt;â€¢ Option C: Oral cavity cancers tend to spread locally and to regional lymph nodes ; they less commonly metastasize to the brain.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Oral cavity&lt;/li&gt;&lt;li&gt;â€¢ cancers&lt;/li&gt;&lt;li&gt;â€¢ spread locally&lt;/li&gt;&lt;li&gt;â€¢ regional lymph nodes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lung cancer is the primary malignancy most commonly associated with brain metastases in adults , reflecting both its prevalence and its biological behaviour of spreading to the brain.&lt;/li&gt;&lt;li&gt;âž¤ Lung cancer&lt;/li&gt;&lt;li&gt;âž¤ primary malignancy&lt;/li&gt;&lt;li&gt;âž¤ brain metastases in adults&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 1301&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 1301&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not true about medulloblastoma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Radiosensitive tumor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Spreads through CSF&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Surgical treatment not done&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Occurs in young age group&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Surgical treatment not done&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Surgical treatment not done&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Medulloblastoma is a radiosensitive tumor and radiation therapy is often part of the treatment plan.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Medulloblastoma&lt;/li&gt;&lt;li&gt;â€¢ radiosensitive tumor&lt;/li&gt;&lt;li&gt;â€¢ radiation therapy&lt;/li&gt;&lt;li&gt;â€¢ Option B: Medulloblastoma commonly spreads through the cerebrospinal fluid (CSF), leading to leptomeningeal dissemination .&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Medulloblastoma&lt;/li&gt;&lt;li&gt;â€¢ spreads through the cerebrospinal fluid&lt;/li&gt;&lt;li&gt;â€¢ leptomeningeal dissemination&lt;/li&gt;&lt;li&gt;â€¢ Option D: Medulloblastoma predominantly occurs in the pediatric age group .&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Medulloblastoma&lt;/li&gt;&lt;li&gt;â€¢ pediatric age group&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Surgical treatment is indeed performed for medulloblastoma and it is an important part of the management strategy for this type of tumor .&lt;/li&gt;&lt;li&gt;âž¤ Surgical treatment&lt;/li&gt;&lt;li&gt;âž¤ performed for medulloblastoma&lt;/li&gt;&lt;li&gt;âž¤ management strategy&lt;/li&gt;&lt;li&gt;âž¤ tumor&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 1298&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 1298&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old patient presents with neurological symptoms, and imaging reveals multiple intracranial lesions. Considering all tumor types, which is the most common cause of intracranial tumors in adults?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Astrocytoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Medulloblastoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Meningioma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Secondaries&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Secondaries&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Secondaries&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Astrocytoma , which includes glioblastoma multiforme , is a type of primary brain tumor originating from astrocytes . They are one of the most common primary brain tumors in adults but not the most common cause of intracranial tumors when all tumor types are considered.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Astrocytoma&lt;/li&gt;&lt;li&gt;â€¢ glioblastoma multiforme&lt;/li&gt;&lt;li&gt;â€¢ primary brain tumor originating from astrocytes&lt;/li&gt;&lt;li&gt;â€¢ most common primary brain tumors&lt;/li&gt;&lt;li&gt;â€¢ adults&lt;/li&gt;&lt;li&gt;â€¢ Option B: Medulloblastoma is a common brain tumor in children and is rarely the cause of intracranial tumors in adults , as its occurrence decreases significantly with age.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Medulloblastoma&lt;/li&gt;&lt;li&gt;â€¢ common brain tumor in children&lt;/li&gt;&lt;li&gt;â€¢ rarely the cause of intracranial tumors in adults&lt;/li&gt;&lt;li&gt;â€¢ Option C: Meningiomas are common , usually benign , primary brain tumors arising from the meninges and are more prevalent in adults , particularly in women . However, they are not the most common cause of all intracranial tumors in adults.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Meningiomas&lt;/li&gt;&lt;li&gt;â€¢ common&lt;/li&gt;&lt;li&gt;â€¢ benign&lt;/li&gt;&lt;li&gt;â€¢ primary brain tumors&lt;/li&gt;&lt;li&gt;â€¢ meninges&lt;/li&gt;&lt;li&gt;â€¢ more prevalent in adults&lt;/li&gt;&lt;li&gt;â€¢ women&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Secondaries are the most common cause of intracranial tumors in adults , with metastases to the brain from other primary cancers occurring more frequently than primary brain tumors .&lt;/li&gt;&lt;li&gt;âž¤ Secondaries&lt;/li&gt;&lt;li&gt;âž¤ most common cause of intracranial tumors&lt;/li&gt;&lt;li&gt;âž¤ adults&lt;/li&gt;&lt;li&gt;âž¤ metastases&lt;/li&gt;&lt;li&gt;âž¤ brain&lt;/li&gt;&lt;li&gt;âž¤ primary cancers&lt;/li&gt;&lt;li&gt;âž¤ primary brain tumors&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old male presents with a resting tremor, bradykinesia, and rigidity. On examination, there is a characteristic \&quot;pill-rolling\&quot; tremor observed. The patient also exhibits postural instability. Which neurotransmitter is primarily affected in the pathophysiology of Parkinson&#x27;s disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Serotonin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acetylcholine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;GABA (Gamma-aminobutyric acid)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dopamine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Dopamine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A: Changes in serotonin levels are more associated with mood disorders .&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Changes&lt;/li&gt;&lt;li&gt;â€¢ serotonin levels&lt;/li&gt;&lt;li&gt;â€¢ mood disorders&lt;/li&gt;&lt;li&gt;â€¢ Option B: While imbalances in acetylcholine and dopamine play a role in movement disorders , the primary deficit in Parkinson&#x27;s disease is related to dopamine deficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ imbalances in acetylcholine&lt;/li&gt;&lt;li&gt;â€¢ dopamine&lt;/li&gt;&lt;li&gt;â€¢ movement disorders&lt;/li&gt;&lt;li&gt;â€¢ Option C: GABA is an inhibitory neurotransmitter , and alterations in GABAergic transmission are not the primary cause of Parkinson&#x27;s disease.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ GABA&lt;/li&gt;&lt;li&gt;â€¢ inhibitory neurotransmitter&lt;/li&gt;&lt;li&gt;â€¢ alterations in GABAergic transmission&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The neurotransmitter primarily affected in the pathophysiology of Parkinson&#x27;s disease is Dopamine , which is depleted due to degeneration of dopaminergic neurons in the substantia nigra , leading to characteristic symptoms like resting tremor , bradykinesia, and rigidity .&lt;/li&gt;&lt;li&gt;âž¤ neurotransmitter primarily affected in the pathophysiology&lt;/li&gt;&lt;li&gt;âž¤ Parkinson&#x27;s disease&lt;/li&gt;&lt;li&gt;âž¤ Dopamine&lt;/li&gt;&lt;li&gt;âž¤ depleted&lt;/li&gt;&lt;li&gt;âž¤ degeneration of dopaminergic neurons&lt;/li&gt;&lt;li&gt;âž¤ substantia nigra&lt;/li&gt;&lt;li&gt;âž¤ resting tremor&lt;/li&gt;&lt;li&gt;âž¤ bradykinesia,&lt;/li&gt;&lt;li&gt;âž¤ rigidity&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1293&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1293&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Glial fibrillary proteins are present in:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Astrocytoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Meduloblastoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ependymoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Astrocytoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Astrocytoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Medulloblastoma is a type of primitive neuroectodermal tumor that arises in the cerebellum and is not typically associated with GFAP, as it does not arise from glial cells.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Medulloblastoma&lt;/li&gt;&lt;li&gt;â€¢ type of primitive neuroectodermal tumor&lt;/li&gt;&lt;li&gt;â€¢ arises in the cerebellum&lt;/li&gt;&lt;li&gt;â€¢ Option C: Ependymoma originates from ependymal cells of the ventricular system , and while ependymal cells are glial cells , they are not characterized by GFAP expression in the same way astrocytes are.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Ependymoma&lt;/li&gt;&lt;li&gt;â€¢ ependymal cells&lt;/li&gt;&lt;li&gt;â€¢ ventricular system&lt;/li&gt;&lt;li&gt;â€¢ ependymal cells are glial cells&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Glial fibrillary acidic protein (GFAP) is a marker for astrocytes and is present in astrocytoma which is a tumor arising from these glial cells .&lt;/li&gt;&lt;li&gt;âž¤ Glial fibrillary acidic protein&lt;/li&gt;&lt;li&gt;âž¤ marker for astrocytes&lt;/li&gt;&lt;li&gt;âž¤ present in astrocytoma&lt;/li&gt;&lt;li&gt;âž¤ tumor arising from these glial cells&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1293&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1293&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Enamel like superstructure is seen in which of the following neurological lesion?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Craniopharyngioma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pituitary tumour&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Astrocytoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ependymonas&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Craniopharyngioma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Craniopharyngioma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B: Pituitary tumors typically do not present with enamel-like superstructures.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Pituitary tumors&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ enamel-like superstructures.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Astrocytomas are gliomas , and their appearance does not typically include enamel-like structures.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Astrocytomas&lt;/li&gt;&lt;li&gt;â€¢ gliomas&lt;/li&gt;&lt;li&gt;â€¢ Option D: Ependymonas do not have the presence of enamel-like structure .&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Ependymonas&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ presence of enamel-like structure&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ An enamel-like superstructure is characteristic of craniopharyngioma , a tumor that arises from Rathkeâ€™s pouch remnants and can show calcifications that resemble enamel .&lt;/li&gt;&lt;li&gt;âž¤ enamel-like superstructure&lt;/li&gt;&lt;li&gt;âž¤ craniopharyngioma&lt;/li&gt;&lt;li&gt;âž¤ tumor&lt;/li&gt;&lt;li&gt;âž¤ arises from Rathkeâ€™s pouch remnants&lt;/li&gt;&lt;li&gt;âž¤ show calcifications&lt;/li&gt;&lt;li&gt;âž¤ resemble enamel&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1293&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1293&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Pseudorosettes are seen in all except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Neuroblastoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Retinoblastoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Medulloblastoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thecoma&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Thecoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Thecoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: Neuroblastoma is a pediatric tumor of the sympathetic nervous system and commonly displays pseudorosettes , where tumor cells are arranged around a fibrillary matrix but lack a true lumen.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Neuroblastoma&lt;/li&gt;&lt;li&gt;â€¢ pediatric tumor&lt;/li&gt;&lt;li&gt;â€¢ sympathetic nervous system&lt;/li&gt;&lt;li&gt;â€¢ displays pseudorosettes&lt;/li&gt;&lt;li&gt;â€¢ Option B: Retinoblastoma , a malignant tumor of retinal cells , also can exhibit pseudorosette formation , where cells circle around a central area of necrosis or fibrillar material rather than a lumen.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Retinoblastoma&lt;/li&gt;&lt;li&gt;â€¢ malignant tumor&lt;/li&gt;&lt;li&gt;â€¢ retinal cells&lt;/li&gt;&lt;li&gt;â€¢ exhibit pseudorosette formation&lt;/li&gt;&lt;li&gt;â€¢ cells circle around&lt;/li&gt;&lt;li&gt;â€¢ central area&lt;/li&gt;&lt;li&gt;â€¢ necrosis&lt;/li&gt;&lt;li&gt;â€¢ fibrillar material&lt;/li&gt;&lt;li&gt;â€¢ Option C: Medulloblastoma is a primitive neuroectodermal tumor of the cerebellum in children and is characterized by the presence of pseudorosettes where the cells form perivascular patterns mimicking rosettes .&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Medulloblastoma&lt;/li&gt;&lt;li&gt;â€¢ primitive neuroectodermal tumor&lt;/li&gt;&lt;li&gt;â€¢ cerebellum in children&lt;/li&gt;&lt;li&gt;â€¢ presence of pseudorosettes&lt;/li&gt;&lt;li&gt;â€¢ cells form perivascular patterns mimicking rosettes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pseudorosettes are typically seen in neuroblastoma , retinoblastoma , and medulloblastoma , but not in thecoma , which is an ovarian tumor.&lt;/li&gt;&lt;li&gt;âž¤ Pseudorosettes&lt;/li&gt;&lt;li&gt;âž¤ neuroblastoma&lt;/li&gt;&lt;li&gt;âž¤ retinoblastoma&lt;/li&gt;&lt;li&gt;âž¤ medulloblastoma&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 1293&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 1293&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Most common primary intracranial malignancy is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glioblastoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ependymoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Choroid angioma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pinealoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Glioblastoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Glioblastoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Ependymoma is a relatively rare glial tumor that arises from ependymal cells lining the ventricles or the central canal of the spinal cord and is more common in children and young adults .&lt;/li&gt;&lt;li&gt;â€¢ Option B: Ependymoma&lt;/li&gt;&lt;li&gt;â€¢ rare glial tumor&lt;/li&gt;&lt;li&gt;â€¢ arises from ependymal cells lining&lt;/li&gt;&lt;li&gt;â€¢ ventricles or the central canal&lt;/li&gt;&lt;li&gt;â€¢ spinal cord&lt;/li&gt;&lt;li&gt;â€¢ children and young adults&lt;/li&gt;&lt;li&gt;â€¢ Option C: Choroid angioma , also known as cavernous hemangioma , is a vascular malformation rather than a true neoplasm and is not considered a common cause of intracranial malignancy.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Choroid angioma&lt;/li&gt;&lt;li&gt;â€¢ cavernous hemangioma&lt;/li&gt;&lt;li&gt;â€¢ vascular malformation&lt;/li&gt;&lt;li&gt;â€¢ true neoplasm&lt;/li&gt;&lt;li&gt;â€¢ Option D: Pinealoma, or pineal gland tumor , is a rare type of brain tumor arising from the cells of the pineal gland ; these can be benign or malignant but are not the most common brain tumors.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Pinealoma,&lt;/li&gt;&lt;li&gt;â€¢ pineal gland tumor&lt;/li&gt;&lt;li&gt;â€¢ rare type of brain tumor arising&lt;/li&gt;&lt;li&gt;â€¢ cells of the pineal gland&lt;/li&gt;&lt;li&gt;â€¢ benign or malignant&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Glioblastoma is the most common intracranial malignancy , a highly aggressive and rapidly progressing tumor arising from astrocytes .&lt;/li&gt;&lt;li&gt;âž¤ Glioblastoma&lt;/li&gt;&lt;li&gt;âž¤ most common intracranial malignancy&lt;/li&gt;&lt;li&gt;âž¤ highly aggressive&lt;/li&gt;&lt;li&gt;âž¤ rapidly progressing tumor arising from astrocytes&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1294&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1294&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old female presents with a history of progressively worsening headaches and focal neurological deficits. Brain imaging reveals an enhancing mass which on histopathological examination confirms the diagnosis of meningioma. Which subtype of meningioma is associated with the worst prognosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Syncytial&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fibroblastic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anaplastic&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Atypical&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Anaplastic&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Anaplastic&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Syncytial meningiomas are characterized by densely packed cells with minimal intervening connective tissue .&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Syncytial&lt;/li&gt;&lt;li&gt;â€¢ meningiomas&lt;/li&gt;&lt;li&gt;â€¢ densely packed cells&lt;/li&gt;&lt;li&gt;â€¢ minimal intervening connective tissue&lt;/li&gt;&lt;li&gt;â€¢ Option B: Fibroblastic meningiomas are composed of spindle-shaped cells resembling fibroblasts.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Fibroblastic&lt;/li&gt;&lt;li&gt;â€¢ meningiomas&lt;/li&gt;&lt;li&gt;â€¢ spindle-shaped cells&lt;/li&gt;&lt;li&gt;â€¢ Option D: Atypical meningiomas are intermediate in terms of aggressiveness between benign and anaplastic meningiomas .&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Atypical&lt;/li&gt;&lt;li&gt;â€¢ meningiomas&lt;/li&gt;&lt;li&gt;â€¢ intermediate&lt;/li&gt;&lt;li&gt;â€¢ aggressiveness between benign&lt;/li&gt;&lt;li&gt;â€¢ anaplastic meningiomas&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Anaplastic meningioma is associated with the worst prognosis among the meningioma subtypes due to its high degree of cellular atypia and increased mitotic activity .&lt;/li&gt;&lt;li&gt;âž¤ Anaplastic meningioma&lt;/li&gt;&lt;li&gt;âž¤ worst prognosis&lt;/li&gt;&lt;li&gt;âž¤ meningioma subtypes&lt;/li&gt;&lt;li&gt;âž¤ high degree of cellular atypia&lt;/li&gt;&lt;li&gt;âž¤ increased mitotic activity&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th /1301&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th /1301&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is affected in patients with Alzheimerâ€™s disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Parietal and frontal lobe&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Parietal and temporal lobe&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Temporal and occipital lobe&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Parietal and occipital lobe&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Parietal and temporal lobe&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Parietal and temporal lobe&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: While the parietal and frontal lobes may be affected later in Alzheimerâ€™s disease , they are not typically the regions most affected early in the disease process.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ parietal and frontal lobes&lt;/li&gt;&lt;li&gt;â€¢ affected later in Alzheimerâ€™s disease&lt;/li&gt;&lt;li&gt;â€¢ Option C: Temporal lobe involvement is a hallmark of Alzheimer&#x27;s disease , but the occipital lobe is generally spared until the later stages of the disease.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Temporal lobe&lt;/li&gt;&lt;li&gt;â€¢ hallmark of Alzheimer&#x27;s disease&lt;/li&gt;&lt;li&gt;â€¢ Option D: The occipital lobe , involved in visual processing , is typically less affected than the parietal and temporal lobes in Alzheimerâ€™s disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ occipital lobe&lt;/li&gt;&lt;li&gt;â€¢ visual processing&lt;/li&gt;&lt;li&gt;â€¢ less affected&lt;/li&gt;&lt;li&gt;â€¢ parietal and temporal lobes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In Alzheimerâ€™s disease , atrophy is most pronounced in the parietal and temporal lobes , which includes the hippocampus , one of the earliest and most severely affected areas.&lt;/li&gt;&lt;li&gt;âž¤ Alzheimerâ€™s disease&lt;/li&gt;&lt;li&gt;âž¤ atrophy&lt;/li&gt;&lt;li&gt;âž¤ pronounced in the parietal&lt;/li&gt;&lt;li&gt;âž¤ temporal lobes&lt;/li&gt;&lt;li&gt;âž¤ hippocampus&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbin 10 th / 1275&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbin 10 th / 1275&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old male presents with gait problems. On examination, a key pathological feature in the substantia nigra neurons is observed, characterized by abnormal protein aggregates primarily composed of alpha-synuclein. Which of the following conditions is most likely responsible for the presence of these intracellular inclusions?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alzheimer disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Parkinson disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Huntington disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pick disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Parkinson disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Parkinson disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: While Alzheimer&#x27;s disease may involve abnormal protein aggregates , including beta-amyloid plaques and neurofibrillary tangles , Lewy bodies are not characteristic of Alzheimer&#x27;s disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Alzheimer&#x27;s disease&lt;/li&gt;&lt;li&gt;â€¢ involve abnormal protein aggregates&lt;/li&gt;&lt;li&gt;â€¢ beta-amyloid plaques&lt;/li&gt;&lt;li&gt;â€¢ neurofibrillary tangles&lt;/li&gt;&lt;li&gt;â€¢ Option C : Huntington&#x27;s disease is characterized by the presence of huntingtin protein aggregates but not Lewy bodies.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Huntington&#x27;s disease&lt;/li&gt;&lt;li&gt;â€¢ presence of huntingtin protein aggregates&lt;/li&gt;&lt;li&gt;â€¢ Option D: Pick&#x27;s disease is associated with frontotemporal lobar degeneration and is characterized by Pick bodies , not Lewy bodies.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Pick&#x27;s disease&lt;/li&gt;&lt;li&gt;â€¢ frontotemporal lobar degeneration&lt;/li&gt;&lt;li&gt;â€¢ Pick bodies&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Parkinson disease is most likely responsible for the presence of these intracellular inclusions , as Lewy bodies composed of alpha-synuclein are a hallmark of this condition.&lt;/li&gt;&lt;li&gt;âž¤ Parkinson disease&lt;/li&gt;&lt;li&gt;âž¤ presence of these intracellular inclusions&lt;/li&gt;&lt;li&gt;âž¤ Lewy bodies composed of alpha-synuclein&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1282&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1282&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Tuberous sclerosis is associated with all except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ash leaf macule&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Shagreen patch&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Schwannoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Adenoma sebaceum&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Schwannoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Schwannoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Ash leaf macules are hypopigmented lesions typically found in tuberous sclerosis . They are one of the earliest dermatological signs of the disease and can be observed with a Wood&#x27;s lamp examination.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Ash leaf macules&lt;/li&gt;&lt;li&gt;â€¢ hypopigmented lesions&lt;/li&gt;&lt;li&gt;â€¢ tuberous sclerosis&lt;/li&gt;&lt;li&gt;â€¢ Option B: Shagreen patches are areas of thick , leathery skin found typically on the lower back ; they are connective tissue nevi associated with tuberous sclerosis .&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Shagreen patches&lt;/li&gt;&lt;li&gt;â€¢ areas of thick&lt;/li&gt;&lt;li&gt;â€¢ leathery skin&lt;/li&gt;&lt;li&gt;â€¢ lower back&lt;/li&gt;&lt;li&gt;â€¢ connective tissue nevi&lt;/li&gt;&lt;li&gt;â€¢ tuberous sclerosis&lt;/li&gt;&lt;li&gt;â€¢ Option D: Adenoma sebaceum , which is a misnomer for facial angiofibromas , manifests as small red or pink papules , commonly found on the face , particularly the nose and cheeks , in tuberous sclerosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Adenoma sebaceum&lt;/li&gt;&lt;li&gt;â€¢ misnomer&lt;/li&gt;&lt;li&gt;â€¢ facial angiofibromas&lt;/li&gt;&lt;li&gt;â€¢ small red or pink papules&lt;/li&gt;&lt;li&gt;â€¢ face&lt;/li&gt;&lt;li&gt;â€¢ nose and cheeks&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Schwannoma is not associated with tuberous sclerosis ; rather, it is commonly associated with neurofibromatosis , another phakomatosis .&lt;/li&gt;&lt;li&gt;âž¤ Schwannoma&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ tuberous sclerosis&lt;/li&gt;&lt;li&gt;âž¤ associated with neurofibromatosis&lt;/li&gt;&lt;li&gt;âž¤ phakomatosis&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th 1302&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th 1302&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is seen in schwannnoma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Spindle cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Storiform pattern&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Target cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Antoni A and B pattern&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Antoni A and B pattern&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Antoni A and B pattern&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Spindle cells are indeed a component of schwannomas but are not specific to them as they can be seen in a variety of other neoplastic and reactive processes.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Spindle cells&lt;/li&gt;&lt;li&gt;â€¢ component of schwannomas&lt;/li&gt;&lt;li&gt;â€¢ not specific to them&lt;/li&gt;&lt;li&gt;â€¢ Option B. Storiform pattern , characterized by a cartwheel or mat-like arrangement of cells , is not typical for schwannoma. It&#x27;s more commonly seen in dermatofibroma or malignant fibrous histiocytoma.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Storiform pattern&lt;/li&gt;&lt;li&gt;â€¢ cartwheel or mat-like arrangement of cells&lt;/li&gt;&lt;li&gt;â€¢ Option C. Target cells are a type of red blood cell with a bullseye appearance typically associated with conditions like liver disease or hemoglobinopathies , not schwannomas.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Target cells&lt;/li&gt;&lt;li&gt;â€¢ red blood cell&lt;/li&gt;&lt;li&gt;â€¢ bullseye appearance&lt;/li&gt;&lt;li&gt;â€¢ liver disease&lt;/li&gt;&lt;li&gt;â€¢ hemoglobinopathies&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Schwannomas are characterized by their distinctive Antoni A and B patterns on histology , which helps distinguish them from other soft tissue tumors . While spindle cells are a feature of schwannomas , the presence of the Antoni A and B patterns is more pathognomonic . Storiform patterns and target cells are associated with different pathologies and are not seen in schwannomas.&lt;/li&gt;&lt;li&gt;â€¢ Schwannomas&lt;/li&gt;&lt;li&gt;â€¢ distinctive Antoni A&lt;/li&gt;&lt;li&gt;â€¢ B patterns on histology&lt;/li&gt;&lt;li&gt;â€¢ distinguish&lt;/li&gt;&lt;li&gt;â€¢ soft tissue tumors&lt;/li&gt;&lt;li&gt;â€¢ spindle cells&lt;/li&gt;&lt;li&gt;â€¢ schwannomas&lt;/li&gt;&lt;li&gt;â€¢ presence of the Antoni A&lt;/li&gt;&lt;li&gt;â€¢ B patterns&lt;/li&gt;&lt;li&gt;â€¢ more pathognomonic&lt;/li&gt;&lt;li&gt;â€¢ Storiform patterns&lt;/li&gt;&lt;li&gt;â€¢ target cells&lt;/li&gt;&lt;li&gt;â€¢ different pathologies&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins 10 th 1302&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Robbins 10 th 1302&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 7-year-old child presents with symptoms of vomiting, headache, and unsteady gait. Brain imaging reveals the diagnosis of a medulloblastoma. Which of the following is the commonest for this tumor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Medulla&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cerebellum&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cerebrum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pineal gland&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Cerebellum&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Cerebellum&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a pediatric patient diagnosed with a primitive neuroectodermal tumor of the cerebellum (medulloblastoma) , known for its aggressive nature and potential for metastasis, which anatomical site would be the most vigilant for the detection of metastatic spread?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lung&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Liver&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Spleen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CNS&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. CNS&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) CNS&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Medulloblastoma most commonly metastasizes within the central nervous system (CNS) , spreading through the CSF to create \&quot;drop metastases\&quot; particularly at the cauda equina .&lt;/li&gt;&lt;li&gt;âž¤ Medulloblastoma&lt;/li&gt;&lt;li&gt;âž¤ metastasizes&lt;/li&gt;&lt;li&gt;âž¤ central nervous system&lt;/li&gt;&lt;li&gt;âž¤ spreading&lt;/li&gt;&lt;li&gt;âž¤ CSF to create \&quot;drop metastases\&quot;&lt;/li&gt;&lt;li&gt;âž¤ cauda equina&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1298&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1298&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 9-year-old child presents with headaches and ataxia. Imaging reveals a cerebellar tumor with characteristic histological features, including the presence of eosinophilic, corkscrew-shaped protein aggregates known as Rosenthal fibers. Which of the following tumors is most likely responsible for these histopathological findings?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pilocytic astrocytoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glioblastoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Medulloblastoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ependymoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Pilocytic astrocytoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Pilocytic astrocytoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Glioblastomas are high-grade tumors that can have various cellular morphologies but do not typically have Rosenthal fibers as a defining characteristic.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Glioblastomas&lt;/li&gt;&lt;li&gt;â€¢ high-grade tumors&lt;/li&gt;&lt;li&gt;â€¢ various cellular morphologies&lt;/li&gt;&lt;li&gt;â€¢ Option C: Medulloblastomas are highly malignant primitive neuroectodermal tumors commonly found in the cerebellum of children but are not associated with Rosenthal fibers.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Medulloblastomas&lt;/li&gt;&lt;li&gt;â€¢ highly malignant primitive neuroectodermal tumors&lt;/li&gt;&lt;li&gt;â€¢ cerebellum&lt;/li&gt;&lt;li&gt;â€¢ children&lt;/li&gt;&lt;li&gt;â€¢ Option D: Ependymomas arise from the ependymal cells of the ventricular system and can occur in the cerebellum , but they are not characterized by the presence of Rosenthal fibers.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Ependymomas&lt;/li&gt;&lt;li&gt;â€¢ arise&lt;/li&gt;&lt;li&gt;â€¢ ependymal cells&lt;/li&gt;&lt;li&gt;â€¢ ventricular system&lt;/li&gt;&lt;li&gt;â€¢ cerebellum&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pilocytic astrocytoma is most likely responsible for the histopathological findings of eosinophilic , corkscrew-shaped Rosenthal fibers .&lt;/li&gt;&lt;li&gt;âž¤ Pilocytic astrocytoma&lt;/li&gt;&lt;li&gt;âž¤ histopathological&lt;/li&gt;&lt;li&gt;âž¤ eosinophilic&lt;/li&gt;&lt;li&gt;âž¤ corkscrew-shaped Rosenthal fibers&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1293&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1293&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Verocay bodies are seen in:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Meningioma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hemangioma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glioma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Schwannoma&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Schwannoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Schwannoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Meningiomas may exhibit whorled patterns and psammoma bodies , Verocay bodies are not a feature of meningiomas.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Meningiomas&lt;/li&gt;&lt;li&gt;â€¢ whorled patterns&lt;/li&gt;&lt;li&gt;â€¢ psammoma bodies&lt;/li&gt;&lt;li&gt;â€¢ Option B: Hemangiomas are benign tumors derived from blood vessels and can occur in various tissues including the skin and internal organs . They do not display Verocay bodies.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Hemangiomas&lt;/li&gt;&lt;li&gt;â€¢ benign tumors&lt;/li&gt;&lt;li&gt;â€¢ blood vessels&lt;/li&gt;&lt;li&gt;â€¢ various tissues&lt;/li&gt;&lt;li&gt;â€¢ skin and internal organs&lt;/li&gt;&lt;li&gt;â€¢ Option C: Gliomas are tumors arising from glial cells in the central nervous system , including astrocytes , oligodendrocytes , and ependymal cells . They do not have Verocay bodies.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Gliomas&lt;/li&gt;&lt;li&gt;â€¢ tumors&lt;/li&gt;&lt;li&gt;â€¢ glial cells&lt;/li&gt;&lt;li&gt;â€¢ central nervous system&lt;/li&gt;&lt;li&gt;â€¢ astrocytes&lt;/li&gt;&lt;li&gt;â€¢ oligodendrocytes&lt;/li&gt;&lt;li&gt;â€¢ ependymal cells&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Verocay bodies are seen in schwannomas and are characterized by palisading nuclei creating nuclear-free zones within the densely cellular Antoni A areas of the tumor .&lt;/li&gt;&lt;li&gt;âž¤ Verocay bodies&lt;/li&gt;&lt;li&gt;âž¤ schwannomas&lt;/li&gt;&lt;li&gt;âž¤ palisading nuclei&lt;/li&gt;&lt;li&gt;âž¤ nuclear-free zones&lt;/li&gt;&lt;li&gt;âž¤ densely cellular Antoni A areas of the tumor&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1302&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1302&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In reviewing brain imaging studies of various neoplasms, a physician notes the frequent occurrence of intratumoral calcifications. Such calcifications, though not exclusive, are most characteristically associated with which of the following types of primary brain tumors?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ependymoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Medulloblastoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oligodendroglioma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glioblastoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Oligodendroglioma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Oligodendroglioma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Ependymomas, tumors arising from ependymal cells lining the ventricular system , can have various imaging features, but they are not specifically known for frequent calcification.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Ependymomas,&lt;/li&gt;&lt;li&gt;â€¢ ependymal cells lining&lt;/li&gt;&lt;li&gt;â€¢ ventricular system&lt;/li&gt;&lt;li&gt;â€¢ Option B: Medulloblastomas , which are malignant childhood tumors of the cerebellum , may show calcification, but it is not as common or pronounced as in oligodendrogliomas.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Medulloblastomas&lt;/li&gt;&lt;li&gt;â€¢ malignant childhood tumors&lt;/li&gt;&lt;li&gt;â€¢ cerebellum&lt;/li&gt;&lt;li&gt;â€¢ Option D: Glioblastomas are highly aggressive brain tumors that may occasionally show areas of calcification ; however, calcifications are more characteristic and frequent in oligodendrogliomas.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Glioblastomas&lt;/li&gt;&lt;li&gt;â€¢ highly aggressive brain tumors&lt;/li&gt;&lt;li&gt;â€¢ areas of calcification&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Oligodendroglioma is the tumor most commonly associated with calcification in adult patients , a feature that can be visualized on imaging studies .&lt;/li&gt;&lt;li&gt;âž¤ Oligodendroglioma&lt;/li&gt;&lt;li&gt;âž¤ tumor most commonly associated&lt;/li&gt;&lt;li&gt;âž¤ calcification in adult patients&lt;/li&gt;&lt;li&gt;âž¤ visualized on imaging studies&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1295&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1295&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which chromosome mutation is associated with medulloblastoma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chromosome 16&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chromosome 17&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chromosome 18&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chromosome 19&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Chromosome 17&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Chromosome 17&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The chromosomal abnormalities associated with medulloblastomas , is seen due to mutations or deletions on chromosome 17 .&lt;/li&gt;&lt;li&gt;âž¤ chromosomal abnormalities&lt;/li&gt;&lt;li&gt;âž¤ medulloblastomas&lt;/li&gt;&lt;li&gt;âž¤ mutations or deletions on chromosome 17&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1298&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1298&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67-year-old male with a history of smoking and a recent diagnosis of small-cell lung carcinoma presents with a chief complaint of increasing weakness, particularly in the proximal muscles of his limbs. He reports that the weakness improves with repeated use of the muscles. Electromyography reveals a decremental response in muscle action potential amplitude with low-frequency stimulation, which improves with high-frequency stimulation. Mechanism of muscle weakness in Lambert-Eaton syndrome is which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Diminished calcium in the sarcoplasmic reticulum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Antibody against the sarcoplasmic reticulum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Accelerated uptake of the neurotransmitter at the nerve-muscle junction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Antibody against presynaptic channels at the nerve-muscle junction&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Antibody against presynaptic channels at the nerve-muscle junction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Diminished calcium in the sarcoplasmic reticulum would affect muscle contraction but is not the mechanism of muscle weakness seen in Lambert-Eaton syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Diminished calcium in the sarcoplasmic reticulum&lt;/li&gt;&lt;li&gt;â€¢ affect muscle contraction&lt;/li&gt;&lt;li&gt;â€¢ not the mechanism of muscle weakness&lt;/li&gt;&lt;li&gt;â€¢ Option B: An antibody against the sarcoplasmic reticulum is not associated with Lambert-Eaton syndrome . Antibodies in LEMS are directed against voltage-gated calcium channels on the presynaptic nerve terminal, not against the sarcoplasmic reticulum.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ antibody against the sarcoplasmic reticulum&lt;/li&gt;&lt;li&gt;â€¢ not associated with Lambert-Eaton syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option C: Accelerated uptake of neurotransmitter at the nerve-muscle junction would likely lead to a decrease in available neurotransmitter for muscle contraction , but this is not the pathophysiology of Lambert-Eaton syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Accelerated uptake of neurotransmitter at the nerve-muscle junction&lt;/li&gt;&lt;li&gt;â€¢ decrease in available neurotransmitter&lt;/li&gt;&lt;li&gt;â€¢ muscle contraction&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Muscle weakness in Lambert-Eaton syndrome is due to antibodies against presynaptic voltage-gated calcium channels at the nerve-muscle junction , impairing acetylcholine release.&lt;/li&gt;&lt;li&gt;âž¤ Muscle weakness&lt;/li&gt;&lt;li&gt;âž¤ Lambert-Eaton syndrome&lt;/li&gt;&lt;li&gt;âž¤ antibodies against presynaptic voltage-gated calcium channels&lt;/li&gt;&lt;li&gt;âž¤ nerve-muscle junction&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1226&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1226&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A neuropathologist is examining the brain from a patient with HIV, and, in the cerebral parenchyma, he identifies multinucleated cells. The virus is inducing a change in what type of cell to produce these giant cells?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Neurons&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Astrocytes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oligodendroglial cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Microglial cells&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Microglial cells&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Microglial cells&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: Neurons are not typically the target cells for HIV replication .&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Neurons&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ target cells for HIV replication&lt;/li&gt;&lt;li&gt;â€¢ Option B: Astrocytes are not the primary target cells for HIV replication ; microglial cells play a more significant role.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Astrocytes&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ primary target cells for HIV replication&lt;/li&gt;&lt;li&gt;â€¢ Option C: Oligodendroglial cells are not the primary target cells for HIV ; microglial cells are more commonly infected.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Oligodendroglial cells&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ primary target cells for HIV&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In HIV encephalitis , specifically microglial cells contribute in the formation of multinucleated giant cells within the cerebral parenchyma .&lt;/li&gt;&lt;li&gt;âž¤ HIV encephalitis&lt;/li&gt;&lt;li&gt;âž¤ microglial cells&lt;/li&gt;&lt;li&gt;âž¤ formation of multinucleated giant cells&lt;/li&gt;&lt;li&gt;âž¤ cerebral parenchyma&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 1267&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 1267&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 43 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test2" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Cardiovascular System&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Cardiovascular System&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                65 Questions | 260 Total Marks | 75 min Duration | ~69.23 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;All the following drugs are used for treatment of congestive heart failure except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Nesiritide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sacubitril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Trimetazidine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metoprolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Trimetazidine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/screenshot-2024-05-08-094413.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Trimetazidine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Nesiritide: Nesiritide is a recombinant B-type natriuretic peptide that has vasodilatory effects and is used in the management of acute decompensated heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Nesiritide:&lt;/li&gt;&lt;li&gt;â€¢ recombinant B-type natriuretic peptide&lt;/li&gt;&lt;li&gt;â€¢ vasodilatory effects&lt;/li&gt;&lt;li&gt;â€¢ acute decompensated heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sacubitril: When combined with valsartan (a neprilysin inhibitor and an angiotensin II receptor blocker, respectively), sacubitril is used to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sacubitril:&lt;/li&gt;&lt;li&gt;â€¢ combined with valsartan&lt;/li&gt;&lt;li&gt;â€¢ neprilysin inhibitor and an angiotensin II receptor blocker,&lt;/li&gt;&lt;li&gt;â€¢ reduce the risk of cardiovascular death&lt;/li&gt;&lt;li&gt;â€¢ hospitalization for heart failure in patients&lt;/li&gt;&lt;li&gt;â€¢ chronic heart&lt;/li&gt;&lt;li&gt;â€¢ failure.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metoprolol: Metoprolol is a beta-blocker that is used in the management of CHF. It reduces myocardial oxygen demand and can improve survival in patients with heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metoprolol:&lt;/li&gt;&lt;li&gt;â€¢ beta-blocker&lt;/li&gt;&lt;li&gt;â€¢ CHF.&lt;/li&gt;&lt;li&gt;â€¢ reduces myocardial oxygen demand&lt;/li&gt;&lt;li&gt;â€¢ improve survival in patients with heart failure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Angiotensin receptor blocker which blocks thromboxane A2 receptor is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Losartan&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Telmisartan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Candesartan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Olmesartan&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Losartan&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Losartan&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Telmisartan: Incorrect because Telmisartan is known as a partial agonist of peroxisome proliferator-activated receptor gamma (PPAR-Î³), which differentiates it from Losartan and does not confer the ability to block the thromboxane A2 receptor.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Telmisartan:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Telmisartan is known as a partial agonist of peroxisome proliferator-activated receptor&lt;/li&gt;&lt;li&gt;â€¢ gamma (PPAR-Î³),&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ block the thromboxane A2 receptor.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Candesartan: Incorrect as Candesartan is an inactive ester prodrug that does not possess the ability to block the thromboxane A2 receptor. It is hydrolyzed to its active form within the body, which acts selectively on the angiotensin receptor.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Candesartan:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Candesartan&lt;/li&gt;&lt;li&gt;â€¢ inactive ester&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ block the&lt;/li&gt;&lt;li&gt;â€¢ thromboxane A2 receptor.&lt;/li&gt;&lt;li&gt;â€¢ hydrolyzed&lt;/li&gt;&lt;li&gt;â€¢ its active form&lt;/li&gt;&lt;li&gt;â€¢ acts selectively&lt;/li&gt;&lt;li&gt;â€¢ angiotensin receptor.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Olmesartan: Incorrect for this question since Olmesartan, while also being an inactive ester prodrug hydrolyzed to its active form , does not block the thromboxane A2 receptor. It is cleared by renal elimination and biliary excretion and does not require dose adjustment in patients with mild-to-moderate renal or hepatic impairment.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Olmesartan:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Olmesartan,&lt;/li&gt;&lt;li&gt;â€¢ inactive ester prodrug hydrolyzed&lt;/li&gt;&lt;li&gt;â€¢ active form&lt;/li&gt;&lt;li&gt;â€¢ does not block the thromboxane A2 receptor.&lt;/li&gt;&lt;li&gt;â€¢ cleared by renal elimination&lt;/li&gt;&lt;li&gt;â€¢ biliary excretion&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ mild-to-moderate renal or hepatic impairment.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Losartan is unique among angiotensin receptor blockers in that it also competitively antagonizes the thromboxane A2 receptor, contributing to its antiplatelet effects.&lt;/li&gt;&lt;li&gt;â€¢ Losartan&lt;/li&gt;&lt;li&gt;â€¢ angiotensin receptor blockers&lt;/li&gt;&lt;li&gt;â€¢ competitively antagonizes&lt;/li&gt;&lt;li&gt;â€¢ thromboxane A2 receptor,&lt;/li&gt;&lt;li&gt;â€¢ antiplatelet effects.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient is taking atorvastatin for dyslipidemia. Which of these drugs should be avoided in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Clarithromycin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oxycodone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rivaroxaban&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Adalimumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Clarithromycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Clarithromycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Oxycodone: Incorrect because oxycodone, an opioid analgesic, does not significantly interact with the CYP3A4 enzyme in a way that would affect the metabolism of atorvastatin to a clinically relevant extent.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Oxycodone:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ opioid analgesic,&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ CYP3A4 enzyme&lt;/li&gt;&lt;li&gt;â€¢ metabolism of atorvastatin to a clinically relevant extent.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Rivaroxaban: Incorrect as rivaroxaban, an anticoagulant , is not metabolized by CYP3A4 in a way that would interfere with atorvastatin metabolism.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Rivaroxaban:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ rivaroxaban,&lt;/li&gt;&lt;li&gt;â€¢ anticoagulant&lt;/li&gt;&lt;li&gt;â€¢ not metabolized by CYP3A4&lt;/li&gt;&lt;li&gt;â€¢ atorvastatin metabolism.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Adalimumab: Incorrect because adalimumab , an immunosuppressive drug used to treat autoimmune diseases, does not interact with the CYP3A4 enzyme and thus would not affect atorvastatin levels.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Adalimumab:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ adalimumab&lt;/li&gt;&lt;li&gt;â€¢ immunosuppressive drug&lt;/li&gt;&lt;li&gt;â€¢ autoimmune diseases, does not&lt;/li&gt;&lt;li&gt;â€¢ CYP3A4 enzyme&lt;/li&gt;&lt;li&gt;â€¢ would not&lt;/li&gt;&lt;li&gt;â€¢ atorvastatin levels.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ When prescribing statins, avoid concomitant use with drugs that inhibit CYP3A4, such as clarithromycin, to prevent an increase in their plasma levels which could lead to myopathy. Other notable CYP3A4 inhibitors to avoid include amiodarone, gemfibrozil, HIV protease inhibitors (such as saquinavir, ritonavir), and itraconazole.&lt;/li&gt;&lt;li&gt;â€¢ statins,&lt;/li&gt;&lt;li&gt;â€¢ avoid&lt;/li&gt;&lt;li&gt;â€¢ inhibit CYP3A4,&lt;/li&gt;&lt;li&gt;â€¢ clarithromycin,&lt;/li&gt;&lt;li&gt;â€¢ increase&lt;/li&gt;&lt;li&gt;â€¢ plasma levels&lt;/li&gt;&lt;li&gt;â€¢ lead to myopathy.&lt;/li&gt;&lt;li&gt;â€¢ CYP3A4 inhibitors&lt;/li&gt;&lt;li&gt;â€¢ amiodarone, gemfibrozil, HIV&lt;/li&gt;&lt;li&gt;â€¢ protease inhibitors (such as saquinavir, ritonavir), and itraconazole.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statement is True regarding Sacubitril?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is a drug that can act by inhibiting angiotensin converting enzyme&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is a drug used in combination with valsartan for congestive heart failure&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypokalemia is an adverse effect of sacubitril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sacubitril is combined with ramipril for treatment of hypertension&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It is a drug used in combination with valsartan for congestive heart failure&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) It is a drug used in combination with valsartan for congestive heart failure&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Incorrect because sacubitril is not an angiotensin converting enzyme (ACE) inhibitor , which typically have names ending in -pril.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ sacubitril is not an angiotensin converting enzyme (ACE) inhibitor&lt;/li&gt;&lt;li&gt;â€¢ Option C. Incorrect as hypokalemia is not a side effect associated with sacubitril. It is more commonly associated with traditional diuretics rather than neprilysin inhibitors.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ hypokalemia&lt;/li&gt;&lt;li&gt;â€¢ not a side effect&lt;/li&gt;&lt;li&gt;â€¢ sacubitril.&lt;/li&gt;&lt;li&gt;â€¢ more&lt;/li&gt;&lt;li&gt;â€¢ traditional&lt;/li&gt;&lt;li&gt;â€¢ diuretics&lt;/li&gt;&lt;li&gt;â€¢ neprilysin inhibitors.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Incorrect because sacubitril is combined with valsartan, not ramipril , and the combination is used for heart failure, not specifically for hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ sacubitril is combined with valsartan, not ramipril&lt;/li&gt;&lt;li&gt;â€¢ heart failure,&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Sacubitril is a neprilysin inhibitor used in combination with valsartan as an ARNI for the treatment of heart failure to reduce the risk of cardiovascular death and heart failure hospitalization , particularly in patients with reduced ejection fraction.&lt;/li&gt;&lt;li&gt;â€¢ Sacubitril is a neprilysin inhibitor&lt;/li&gt;&lt;li&gt;â€¢ with valsartan&lt;/li&gt;&lt;li&gt;â€¢ ARNI for the treatment of heart failure&lt;/li&gt;&lt;li&gt;â€¢ reduce the risk&lt;/li&gt;&lt;li&gt;â€¢ cardiovascular death and heart failure hospitalization&lt;/li&gt;&lt;li&gt;â€¢ reduced ejection fraction.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs is an oral renin inhibitor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Candesartan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aliskiren&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Quinapril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Benazepril&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Aliskiren&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Aliskiren&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Candesartan: Candesartan is an angiotensin II receptor blocker (ARB) . It works by blocking the action of angiotensin II at its receptor, preventing angiotensin II from causing vasoconstriction and aldosterone release, which in turn lowers blood pressure. It does not inhibit renin directly.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Candesartan:&lt;/li&gt;&lt;li&gt;â€¢ angiotensin II receptor blocker (ARB)&lt;/li&gt;&lt;li&gt;â€¢ blocking the action of angiotensin II&lt;/li&gt;&lt;li&gt;â€¢ preventing angiotensin II&lt;/li&gt;&lt;li&gt;â€¢ vasoconstriction and aldosterone&lt;/li&gt;&lt;li&gt;â€¢ lowers blood pressure.&lt;/li&gt;&lt;li&gt;â€¢ does not inhibit renin&lt;/li&gt;&lt;li&gt;â€¢ Option C. Quinapril: Quinapril is an angiotensin-converting enzyme (ACE) inhibitor . It inhibits the enzyme responsible for converting angiotensin I to angiotensin II, a potent vasoconstrictor. By reducing the levels of angiotensin II, it lowers blood pressure. Quinapril acts later in the RAAS pathway compared to aliskiren and does not directly inhibit renin.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Quinapril:&lt;/li&gt;&lt;li&gt;â€¢ angiotensin-converting enzyme (ACE) inhibitor&lt;/li&gt;&lt;li&gt;â€¢ converting&lt;/li&gt;&lt;li&gt;â€¢ angiotensin I to angiotensin II,&lt;/li&gt;&lt;li&gt;â€¢ potent vasoconstrictor.&lt;/li&gt;&lt;li&gt;â€¢ reducing&lt;/li&gt;&lt;li&gt;â€¢ angiotensin II,&lt;/li&gt;&lt;li&gt;â€¢ lowers blood pressure.&lt;/li&gt;&lt;li&gt;â€¢ RAAS pathway&lt;/li&gt;&lt;li&gt;â€¢ to aliskiren&lt;/li&gt;&lt;li&gt;â€¢ does not directly inhibit renin.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Benazepril: Benazepril is also an ACE inhibitor, similar to quinapril. It lowers blood pressure by inhibiting the conversion of angiotensin I to angiotensin II, thereby reducing vasoconstriction and aldosterone-mediated volume expansion . Like quinapril, benazepril does not act by inhibiting renin.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Benazepril:&lt;/li&gt;&lt;li&gt;â€¢ ACE inhibitor,&lt;/li&gt;&lt;li&gt;â€¢ quinapril.&lt;/li&gt;&lt;li&gt;â€¢ lowers blood pressure&lt;/li&gt;&lt;li&gt;â€¢ inhibiting&lt;/li&gt;&lt;li&gt;â€¢ conversion of&lt;/li&gt;&lt;li&gt;â€¢ angiotensin I to angiotensin II,&lt;/li&gt;&lt;li&gt;â€¢ reducing vasoconstriction&lt;/li&gt;&lt;li&gt;â€¢ aldosterone-mediated volume expansion&lt;/li&gt;&lt;li&gt;â€¢ quinapril,&lt;/li&gt;&lt;li&gt;â€¢ benazepril does not&lt;/li&gt;&lt;li&gt;â€¢ inhibiting renin.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The objective is to understand the mechanisms of action of various drugs used in the management of hypertension, focusing on their roles within the renin-angiotensin-aldosterone system. Recognizing the unique action of aliskiren as a renin inhibitor, in contrast to ARBs and ACE inhibitors that act downstream, is essential for effective hypertension management.&lt;/li&gt;&lt;li&gt;âž¤ mechanisms of action&lt;/li&gt;&lt;li&gt;âž¤ management of hypertension,&lt;/li&gt;&lt;li&gt;âž¤ renin-angiotensin-aldosterone system.&lt;/li&gt;&lt;li&gt;âž¤ aliskiren as a renin inhibitor,&lt;/li&gt;&lt;li&gt;âž¤ contrast to ARBs and ACE inhibitors&lt;/li&gt;&lt;li&gt;âž¤ act downstream,&lt;/li&gt;&lt;li&gt;âž¤ hypertension management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the drug of choice for digoxin induced ventricular tachyarrhythmias?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Quinidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amiodarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lignocaine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phenytoin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lignocaine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Lignocaine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Quinidine: Quinidine is an antiarrhythmic that can increase serum digoxin levels and is contraindicated in digoxin-induced arrhythmias because it may exacerbate toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Quinidine:&lt;/li&gt;&lt;li&gt;â€¢ antiarrhythmic&lt;/li&gt;&lt;li&gt;â€¢ increase serum digoxin levels&lt;/li&gt;&lt;li&gt;â€¢ contraindicated in digoxin-induced arrhythmias&lt;/li&gt;&lt;li&gt;â€¢ exacerbate toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Amiodarone: While amiodarone is a versatile antiarrhythmic agent used in various types of arrhythmias , it can interact with digoxin and increase its levels , potentially worsening toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Amiodarone:&lt;/li&gt;&lt;li&gt;â€¢ versatile antiarrhythmic agent&lt;/li&gt;&lt;li&gt;â€¢ various types of arrhythmias&lt;/li&gt;&lt;li&gt;â€¢ interact&lt;/li&gt;&lt;li&gt;â€¢ digoxin and increase its levels&lt;/li&gt;&lt;li&gt;â€¢ worsening toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Phenytoin: Phenytoin is effective for ventricular arrhythmias, especially in the context of acute myocardial infarction, but it is not the first choice for digoxin-induced arrhythmias. It can be used if lignocaine is not available or contraindicated.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Phenytoin:&lt;/li&gt;&lt;li&gt;â€¢ ventricular arrhythmias,&lt;/li&gt;&lt;li&gt;â€¢ acute myocardial infarction,&lt;/li&gt;&lt;li&gt;â€¢ not the first choice for digoxin-induced arrhythmias.&lt;/li&gt;&lt;li&gt;â€¢ can be used&lt;/li&gt;&lt;li&gt;â€¢ lignocaine is not available or contraindicated.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational goal is to understand the appropriate management of digoxin-induced ventricular tachyarrhythmias . Recognizing lignocaine as the drug of choice in this scenario is critical for effectively addressing the cardiac toxicity associated with digoxin overdose , minimizing the risk of further cardiac complications.&lt;/li&gt;&lt;li&gt;âž¤ appropriate management of digoxin-induced ventricular tachyarrhythmias&lt;/li&gt;&lt;li&gt;âž¤ lignocaine&lt;/li&gt;&lt;li&gt;âž¤ drug of choice&lt;/li&gt;&lt;li&gt;âž¤ critical for effectively addressing the cardiac toxicity&lt;/li&gt;&lt;li&gt;âž¤ digoxin&lt;/li&gt;&lt;li&gt;âž¤ overdose&lt;/li&gt;&lt;li&gt;âž¤ minimizing the risk&lt;/li&gt;&lt;li&gt;âž¤ cardiac complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Ivabradine is a drug that has been used in clinical practice for few years now. It is indicated for the management of which of the following diseases?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Stable angina&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prerenal azotemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alzheimerâ€™s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Smoking cessation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Stable angina&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Stable angina&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prerenal azotemia: Incorrect as prerenal azotemia is related to kidney function and ivabradine does not have a role in its treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prerenal azotemia:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ prerenal azotemia&lt;/li&gt;&lt;li&gt;â€¢ kidney function&lt;/li&gt;&lt;li&gt;â€¢ ivabradine does not&lt;/li&gt;&lt;li&gt;â€¢ treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Alzheimerâ€™s disease: Incorrect because Alzheimerâ€™s disease is a neurodegenerative condition and ivabradine is not indicated for its treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Alzheimerâ€™s disease:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ neurodegenerative condition&lt;/li&gt;&lt;li&gt;â€¢ ivabradine is not&lt;/li&gt;&lt;li&gt;â€¢ treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Smoking cessation: Incorrect as ivabradine is not used in smoking cessation ; it is a cardiac medication used for heart rate control.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Smoking cessation:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ ivabradine&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ smoking cessation&lt;/li&gt;&lt;li&gt;â€¢ cardiac medication&lt;/li&gt;&lt;li&gt;â€¢ heart rate&lt;/li&gt;&lt;li&gt;â€¢ control.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Ivabradine is indicated for the management of stable angina and congestive heart failure . It works by inhibiting the funny current in the SA node , leading to a reduction in heart rate, which is a key therapeutic target in managing these conditions.&lt;/li&gt;&lt;li&gt;â€¢ Ivabradine&lt;/li&gt;&lt;li&gt;â€¢ management of stable angina and congestive heart failure&lt;/li&gt;&lt;li&gt;â€¢ inhibiting the funny current&lt;/li&gt;&lt;li&gt;â€¢ SA node&lt;/li&gt;&lt;li&gt;â€¢ reduction in heart rate,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drug is used in CHF for relief of congestive symptoms and restoration of cardiac performance but does not possess inotropic action?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Digoxin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dobutamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amrinone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metoprolol&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Metoprolol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Metoprolol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Digoxin: Digoxin has a positive inotropic effect , increasing the force of cardiac contractions , and is used in CHF to improve symptoms and cardiac performance. It does not fit the criteria as it possesses inotropic action.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Digoxin:&lt;/li&gt;&lt;li&gt;â€¢ positive inotropic effect&lt;/li&gt;&lt;li&gt;â€¢ increasing the force of cardiac contractions&lt;/li&gt;&lt;li&gt;â€¢ CHF to improve&lt;/li&gt;&lt;li&gt;â€¢ symptoms and cardiac performance.&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ inotropic action.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dobutamine: Dobutamine is a beta-1 adrenergic agonist with positive inotropic effects , used primarily in acute heart failure to increase cardiac output. It directly increases the force of heart contractions.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dobutamine:&lt;/li&gt;&lt;li&gt;â€¢ beta-1 adrenergic agonist&lt;/li&gt;&lt;li&gt;â€¢ positive inotropic effects&lt;/li&gt;&lt;li&gt;â€¢ acute heart&lt;/li&gt;&lt;li&gt;â€¢ failure&lt;/li&gt;&lt;li&gt;â€¢ increase cardiac output.&lt;/li&gt;&lt;li&gt;â€¢ increases the force of heart contractions.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Amrinone: Amrinone is a phosphodiesterase inhibitor with positive inotropic and vasodilatory effects , used to improve cardiac output in heart failure patients. Like dobutamine and digoxin, it increases the force of cardiac contractions.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Amrinone:&lt;/li&gt;&lt;li&gt;â€¢ phosphodiesterase inhibitor&lt;/li&gt;&lt;li&gt;â€¢ positive inotropic and vasodilatory effects&lt;/li&gt;&lt;li&gt;â€¢ improve&lt;/li&gt;&lt;li&gt;â€¢ cardiac output&lt;/li&gt;&lt;li&gt;â€¢ dobutamine and digoxin,&lt;/li&gt;&lt;li&gt;â€¢ increases the force of cardiac contractions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational goal is to understand the role of different classes of drugs in the management of CHF, particularly distinguishing those with and without inotropic action. Metoprolol&#x27;s use in CHF illustrates the importance of managing heart rate and reducing myocardial oxygen demand as part of a strategy to improve cardiac performance without directly increasing the force of contraction&lt;/li&gt;&lt;li&gt;âž¤ different classes of drugs&lt;/li&gt;&lt;li&gt;âž¤ CHF,&lt;/li&gt;&lt;li&gt;âž¤ distinguishing&lt;/li&gt;&lt;li&gt;âž¤ with and without inotropic action.&lt;/li&gt;&lt;li&gt;âž¤ Metoprolol&#x27;s&lt;/li&gt;&lt;li&gt;âž¤ CHF illustrates&lt;/li&gt;&lt;li&gt;âž¤ heart rate and reducing&lt;/li&gt;&lt;li&gt;âž¤ myocardial oxygen demand&lt;/li&gt;&lt;li&gt;âž¤ improve cardiac performance&lt;/li&gt;&lt;li&gt;âž¤ without directly increasing the force of contraction&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drug can be used for treatment of euvolemic hyponatremia in patient with advanced congestive heart failure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tolvaptan&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nesiritide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hydrocortisone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metoprolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Tolvaptan&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Tolvaptan&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Nesiritide: Incorrect as nesiritide is a recombinant B-type natriuretic peptide used as a b decompensated heart failure, not specifically for euvolemic hyponatremia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Nesiritide:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ recombinant B-type natriuretic peptide&lt;/li&gt;&lt;li&gt;â€¢ b&lt;/li&gt;&lt;li&gt;â€¢ euvolemic hyponatremia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hydrocortisone: Incorrect because hydrocortisone is a corticosteroid and does not address the underlying mechanisms of euvolemic hyponatremia in CHF.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hydrocortisone:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ hydrocortisone&lt;/li&gt;&lt;li&gt;â€¢ corticosteroid&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ euvolemic hyponatremia in CHF.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metoprolol: Incorrect as metoprolol is a beta-blocker used in the management of CHF and hypertension , but it is not used to directly treat euvolemic hyponatremia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metoprolol:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ metoprolol is a beta-blocker&lt;/li&gt;&lt;li&gt;â€¢ CHF and hypertension&lt;/li&gt;&lt;li&gt;â€¢ not used&lt;/li&gt;&lt;li&gt;â€¢ euvolemic hyponatremia.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ In patients with advanced congestive heart failure presenting with euvolemic hyponatremia, tolvaptan is used to correct water retention and hyponatremia associated with SIADH by antagonizing the vasopressin V2 receptors and increasing water excretion.&lt;/li&gt;&lt;li&gt;â€¢ advanced congestive heart failure&lt;/li&gt;&lt;li&gt;â€¢ euvolemic hyponatremia, tolvaptan&lt;/li&gt;&lt;li&gt;â€¢ correct water&lt;/li&gt;&lt;li&gt;â€¢ retention and hyponatremia associated with SIADH&lt;/li&gt;&lt;li&gt;â€¢ antagonizing the vasopressin V2 receptors&lt;/li&gt;&lt;li&gt;â€¢ increasing water excretion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Propranolol can be used in all of the following conditions except.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thyrotoxicosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Variant angina&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Migraine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypertension&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Variant angina&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/88.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Variant angina&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Thyrotoxicosis: Propranolol is used in thyrotoxicosis to provide symptomatic relief from hyperthyroid symptoms such as tachycardia, anxiety, and tremors . It can also inhibit peripheral conversion of T4 to T3.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Thyrotoxicosis:&lt;/li&gt;&lt;li&gt;â€¢ Propranolol&lt;/li&gt;&lt;li&gt;â€¢ thyrotoxicosis&lt;/li&gt;&lt;li&gt;â€¢ symptomatic relief&lt;/li&gt;&lt;li&gt;â€¢ hyperthyroid symptoms&lt;/li&gt;&lt;li&gt;â€¢ tachycardia, anxiety, and tremors&lt;/li&gt;&lt;li&gt;â€¢ inhibit peripheral conversion of T4 to T3.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Migraine: Propranolol is used as a prophylactic treatment for migraine . It helps reduce the frequency and severity of migraine attacks.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Migraine:&lt;/li&gt;&lt;li&gt;â€¢ Propranolol&lt;/li&gt;&lt;li&gt;â€¢ prophylactic treatment for migraine&lt;/li&gt;&lt;li&gt;â€¢ reduce the frequency&lt;/li&gt;&lt;li&gt;â€¢ severity of&lt;/li&gt;&lt;li&gt;â€¢ migraine attacks.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypertension: Propranolol can be used in the management of hypertension . It lowers blood pressure by reducing cardiac output and inhibiting renin release from the kidneys.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypertension:&lt;/li&gt;&lt;li&gt;â€¢ Propranolol&lt;/li&gt;&lt;li&gt;â€¢ hypertension&lt;/li&gt;&lt;li&gt;â€¢ lowers blood pressure&lt;/li&gt;&lt;li&gt;â€¢ reducing cardiac&lt;/li&gt;&lt;li&gt;â€¢ output&lt;/li&gt;&lt;li&gt;â€¢ inhibiting&lt;/li&gt;&lt;li&gt;â€¢ renin&lt;/li&gt;&lt;li&gt;â€¢ kidneys.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational goal is to understand the therapeutic uses and contraindications of propranolol, a non-selective beta-blocke r. Recognizing that propranolol is contraindicated in variant angina due to its potential to worsen coronary artery spasms highlights the importance of considering the specific clinical context when selecting beta-blockers for treatment.&lt;/li&gt;&lt;li&gt;âž¤ therapeutic uses&lt;/li&gt;&lt;li&gt;âž¤ contraindications of propranolol,&lt;/li&gt;&lt;li&gt;âž¤ non-selective beta-blocke&lt;/li&gt;&lt;li&gt;âž¤ propranolol is contraindicated in variant angina&lt;/li&gt;&lt;li&gt;âž¤ potential to worsen coronary artery spasms&lt;/li&gt;&lt;li&gt;âž¤ Indications of Î²-Blockers:&lt;/li&gt;&lt;li&gt;âž¤ Indications of Î²-Blockers:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following are adverse effects of amiodarone except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pulmonary fibrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Corneal microdeposits&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Photosensitivity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tachycardia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Tachycardia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Tachycardia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pulmonary fibrosis: This is a serious and well-recognized side effect of amiodarone, especially with long-term use.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pulmonary fibrosis:&lt;/li&gt;&lt;li&gt;â€¢ serious and well-recognized side effect of amiodarone,&lt;/li&gt;&lt;li&gt;â€¢ long-term use.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Corneal microdeposits: Common and typically reversible upon discontinuation of the drug.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Corneal microdeposits:&lt;/li&gt;&lt;li&gt;â€¢ Common&lt;/li&gt;&lt;li&gt;â€¢ reversible upon discontinuation of the drug.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Photosensitivity: This adverse effect can occur in patients taking amiodarone , leading to increased risk of sunburn and skin pigmentation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Photosensitivity:&lt;/li&gt;&lt;li&gt;â€¢ adverse effect&lt;/li&gt;&lt;li&gt;â€¢ , leading to increased risk of sunburn and skin&lt;/li&gt;&lt;li&gt;â€¢ pigmentation.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Amiodarone is a class III anti-arrhythmic drug associated with several adverse effects including pulmonary fibrosis, corneal microdeposits, and photosensitivity, but not tachycardia; in fact, it more commonly causes bradycardia.&lt;/li&gt;&lt;li&gt;â€¢ Amiodarone&lt;/li&gt;&lt;li&gt;â€¢ class III anti-arrhythmic drug&lt;/li&gt;&lt;li&gt;â€¢ several adverse effects&lt;/li&gt;&lt;li&gt;â€¢ pulmonary fibrosis, corneal&lt;/li&gt;&lt;li&gt;â€¢ microdeposits, and photosensitivity,&lt;/li&gt;&lt;li&gt;â€¢ in fact, it more commonly causes bradycardia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not true about the mechanism of action of digitalis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It binds to the intracellular face of Na + K + ATPase enzyme&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;There is rise in intracellular Na +&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It has positive ionotropic action&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inotropic action of digoxin is independent of cardiac innervation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. It binds to the intracellular face of Na + K + ATPase enzyme&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) It binds to the intracellular face of Na+ K+ ATPase enzyme.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. There is a rise in intracellular Na+: This statement is true; the inhibition of Na+/K+ ATPase by digitalis leads to increased intracellular sodium.&lt;/li&gt;&lt;li&gt;â€¢ Option B. There is a rise in intracellular Na+:&lt;/li&gt;&lt;li&gt;â€¢ true;&lt;/li&gt;&lt;li&gt;â€¢ inhibition of Na+/K+ ATPase&lt;/li&gt;&lt;li&gt;â€¢ digitalis&lt;/li&gt;&lt;li&gt;â€¢ increased&lt;/li&gt;&lt;li&gt;â€¢ intracellular sodium.&lt;/li&gt;&lt;li&gt;â€¢ Option C. It has positive inotropic action: This is true; digitalis increases the force of cardiac muscle contraction.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. It has positive inotropic action:&lt;/li&gt;&lt;li&gt;â€¢ true;&lt;/li&gt;&lt;li&gt;â€¢ increases the force of cardiac muscle contraction.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Inotropic action of digoxin is independent of cardiac innervation: This is also true; digitalis exerts its effects directly on the cardiac muscle cells, not through the nervous system. Though, it can decrease the AV conduction via vagus like action but this action is responsible for its use in atrial fibrillation , not as an inotropic drug.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Inotropic action of digoxin is independent of cardiac innervation:&lt;/li&gt;&lt;li&gt;â€¢ true;&lt;/li&gt;&lt;li&gt;â€¢ cardiac muscle cells, not&lt;/li&gt;&lt;li&gt;â€¢ nervous system.&lt;/li&gt;&lt;li&gt;â€¢ can decrease the AV conduction&lt;/li&gt;&lt;li&gt;â€¢ vagus&lt;/li&gt;&lt;li&gt;â€¢ use in atrial fibrillation&lt;/li&gt;&lt;li&gt;â€¢ not as an inotropic drug.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Digitalis binds to the extracellular face of the Na+/K+ ATPase enzyme , leading to increased intracellular calcium, and in turn, positive inotropic action, which enhances cardiac contractility.&lt;/li&gt;&lt;li&gt;â€¢ Digitalis binds&lt;/li&gt;&lt;li&gt;â€¢ extracellular face of the Na+/K+ ATPase enzyme&lt;/li&gt;&lt;li&gt;â€¢ increased intracellular calcium,&lt;/li&gt;&lt;li&gt;â€¢ positive inotropic action,&lt;/li&gt;&lt;li&gt;â€¢ cardiac contractility.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Fenoldopam is used in the management of?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypertensive emergencies&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Congestive heart failure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Migraine prophylaxis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tachyarrhythmias&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Hypertensive emergencies&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Hypertensive emergencies&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Congestive heart failure: Fenoldopam is not typically used in the management of congestive heart failure (CHF). Drugs commonly used in CHF include ACE inhibitors, beta-blockers, diuretics, and aldosterone antagonists , which work by different mechanisms to reduce the workload on the heart and improve cardiac output .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Congestive heart failure:&lt;/li&gt;&lt;li&gt;â€¢ Fenoldopam&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ congestive heart failure (CHF).&lt;/li&gt;&lt;li&gt;â€¢ CHF include ACE inhibitors, beta-blockers, diuretics, and aldosterone antagonists&lt;/li&gt;&lt;li&gt;â€¢ reduce the workload on the heart&lt;/li&gt;&lt;li&gt;â€¢ improve cardiac output&lt;/li&gt;&lt;li&gt;â€¢ Option C. Migraine prophylaxis: Fenoldopam is not used for migraine prophylaxis . Medications for migraine prevention include beta-blockers (such as propranolol), calcium channel blockers, antidepressants, and antiepileptic drugs , which have different mechanisms of action aimed at reducing the frequency and severity of migraine attacks .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Migraine prophylaxis:&lt;/li&gt;&lt;li&gt;â€¢ Fenoldopam&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ migraine prophylaxis&lt;/li&gt;&lt;li&gt;â€¢ beta-blockers (such as propranolol), calcium channel blockers, antidepressants, and antiepileptic drugs&lt;/li&gt;&lt;li&gt;â€¢ reducing the frequency and severity of migraine attacks&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tachyarrhythmias: Fenoldopam is not indicated for the treatment of tachyarrhythmias. Drugs used to manage tachyarrhythmias include beta-blockers, calcium channel blockers, antiarrhythmic agents, and sometimes digoxin , depending on the type and cause of the arrhythmia. These medications work by modulating cardiac electrical activity to normalize heart rhythm .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tachyarrhythmias:&lt;/li&gt;&lt;li&gt;â€¢ Fenoldopam&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ tachyarrhythmias. Drugs used&lt;/li&gt;&lt;li&gt;â€¢ beta-blockers, calcium channel blockers, antiarrhythmic agents, and sometimes digoxin&lt;/li&gt;&lt;li&gt;â€¢ type and cause of the arrhythmia.&lt;/li&gt;&lt;li&gt;â€¢ modulating cardiac electrical activity&lt;/li&gt;&lt;li&gt;â€¢ normalize heart rhythm&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational goal is to understand the specific indications for fenoldopam, particularly its role in managing hypertensive emergencies due to its vasodilatory effects and positive impact on renal perfusion . Additionally, recognizing that fenoldopam is not indicated for congestive heart failure, migraine prophylaxis, or tachyarrhythmias underscores the importance of selecting appropriate medications based on the clinical condition being treated.&lt;/li&gt;&lt;li&gt;âž¤ specific indications for fenoldopam,&lt;/li&gt;&lt;li&gt;âž¤ managing hypertensive emergencies&lt;/li&gt;&lt;li&gt;âž¤ its vasodilatory effects&lt;/li&gt;&lt;li&gt;âž¤ renal perfusion&lt;/li&gt;&lt;li&gt;âž¤ fenoldopam is not&lt;/li&gt;&lt;li&gt;âž¤ congestive heart failure, migraine prophylaxis, or tachyarrhythmias&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A new antiarrhythmic drug is found to be effective against both atrial and ventricular arrhythmias. Its effect on action potential is shown in the Figure. The effect of this new drug is most like:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lignocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Propanolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Encainide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Quinidine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Quinidine&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/25/image-2-min.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Quinidine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lignocaine: Lignocaine (Lidocaine) is a Class IB antiarrhythmic drug that primarily works by shortening the action potential duration by blocking sodium channels , particularly in ischemic or depolarized cells . It does not prolong the action potential plateau.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lignocaine:&lt;/li&gt;&lt;li&gt;â€¢ Class IB antiarrhythmic drug&lt;/li&gt;&lt;li&gt;â€¢ shortening the action potential&lt;/li&gt;&lt;li&gt;â€¢ blocking sodium channels&lt;/li&gt;&lt;li&gt;â€¢ ischemic or depolarized cells&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ action&lt;/li&gt;&lt;li&gt;â€¢ potential plateau.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Propranolol: Propranolol is a Class II antiarrhythmic , which is a beta-blocker that reduces sympathetic nervous system activity. It does not have a direct effect on the action potential duration or plateau phase.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Propranolol:&lt;/li&gt;&lt;li&gt;â€¢ Class II antiarrhythmic&lt;/li&gt;&lt;li&gt;â€¢ beta-blocker&lt;/li&gt;&lt;li&gt;â€¢ sympathetic nervous system&lt;/li&gt;&lt;li&gt;â€¢ activity.&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ action potential duration or plateau phase.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Encainide: Encainide , which is no longer widely used, was a Class IC antiarrhythmic drug that significantly slows conduction by blocking sodium channels but does not typically prolong the action potential duration.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Encainide:&lt;/li&gt;&lt;li&gt;â€¢ Encainide&lt;/li&gt;&lt;li&gt;â€¢ no longer widely used,&lt;/li&gt;&lt;li&gt;â€¢ Class IC antiarrhythmic drug&lt;/li&gt;&lt;li&gt;â€¢ blocking sodium channels&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ action potential duration.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational goal is to recognize the electrophysiologic effects of antiarrhythmic drugs on the cardiac action potential. Understanding how these drugs affect the action potential can provide insights into their therapeutic uses and potential arrhythmogenic risks. Quinidine&#x27;s effect of prolonging the action potential duration is useful in the treatment of both atrial and ventricular arrhythmias, but it also carries the risk of proarrhythmia, underlining the need for careful patient selection and monitoring.&lt;/li&gt;&lt;li&gt;âž¤ electrophysiologic effects of antiarrhythmic drugs&lt;/li&gt;&lt;li&gt;âž¤ action potential&lt;/li&gt;&lt;li&gt;âž¤ therapeutic uses and potential&lt;/li&gt;&lt;li&gt;âž¤ arrhythmogenic risks. Quinidine&#x27;s&lt;/li&gt;&lt;li&gt;âž¤ prolonging the action potential duration&lt;/li&gt;&lt;li&gt;âž¤ both atrial and&lt;/li&gt;&lt;li&gt;âž¤ ventricular arrhythmias,&lt;/li&gt;&lt;li&gt;âž¤ risk of proarrhythmia,&lt;/li&gt;&lt;li&gt;âž¤ careful patient selection&lt;/li&gt;&lt;li&gt;âž¤ monitoring.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man presents with NYHA Class III breathlessness with a serum creatinine of 2.5 mg/dL and potassium level of 5.5 mEq/L. Which of the following drug is contraindicated?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Carvedilol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Spironolactone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nitroglycerine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Digoxin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Spironolactone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Spironolactone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Carvedilol: Incorrect as beta blockers like carvedilol are indicated in CHF and can reduce mortality. They should be started at a very low dose and gradually titrated to the target dose.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Carvedilol:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ carvedilol&lt;/li&gt;&lt;li&gt;â€¢ indicated in CHF and can reduce mortality.&lt;/li&gt;&lt;li&gt;â€¢ started&lt;/li&gt;&lt;li&gt;â€¢ at a very low dose&lt;/li&gt;&lt;li&gt;â€¢ to&lt;/li&gt;&lt;li&gt;â€¢ target dose.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Nitroglycerine: Incorrect because nitroglycerine is a vasodilator that can help reduce the workload of the heart and provide symptomatic relief in CHF.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Nitroglycerine:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ nitroglycerine is a vasodilator&lt;/li&gt;&lt;li&gt;â€¢ reduce the workload of the heart&lt;/li&gt;&lt;li&gt;â€¢ symptomatic relief in CHF.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Digoxin: Incorrect as digoxin is an oral inotropic agent that can be used in chronic CHF to improve symptoms and possibly exercise capacity. Although it is excreted by kidneys but it can be used in renal failure after dose adjustment.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Digoxin:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ oral inotropic agent&lt;/li&gt;&lt;li&gt;â€¢ chronic CHF&lt;/li&gt;&lt;li&gt;â€¢ improve&lt;/li&gt;&lt;li&gt;â€¢ exercise capacity.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ In patients with CHF and compromised renal function or elevated serum potassium levels , potassium-sparing diuretics like spironolactone should b e avoided due to the increased risk of severe hyperkalemia.&lt;/li&gt;&lt;li&gt;â€¢ CHF and compromised renal function&lt;/li&gt;&lt;li&gt;â€¢ elevated serum potassium levels&lt;/li&gt;&lt;li&gt;â€¢ potassium-sparing diuretics&lt;/li&gt;&lt;li&gt;â€¢ spironolactone&lt;/li&gt;&lt;li&gt;â€¢ e avoided&lt;/li&gt;&lt;li&gt;â€¢ increased risk of severe hyperkalemia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Trimetazidine is a drug approved for the treatment of angina pectoris. Its mechanism of action is assumed to be:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bradycardiac agent&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rho kinase inhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;K channel opener&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inhibiting mitochondrial LC3- KAT&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Inhibiting mitochondrial LC3- KAT&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Inhibiting mitochondrial LC3-KAT&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Incorrect because ivabradine is the bradycardiac agent used for angina , which acts by blocking the funny current in the SA node , not trimetazidine.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ ivabradine is the bradycardiac agent&lt;/li&gt;&lt;li&gt;â€¢ for angina&lt;/li&gt;&lt;li&gt;â€¢ acts by blocking the funny current in the SA&lt;/li&gt;&lt;li&gt;â€¢ node&lt;/li&gt;&lt;li&gt;â€¢ Option B. Incorrect as fasudil is the rho kinase inhibitor utilized for angina pectoris , not trimetazidine.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ fasudil&lt;/li&gt;&lt;li&gt;â€¢ rho kinase inhibitor utilized for angina pectoris&lt;/li&gt;&lt;li&gt;â€¢ Option C. Incorrect because nicorandil is the K channel opener (which also has nitric oxide releasing properties ) that is used for angina pectoris, rather than trimetazidine.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ nicorandil is the K channel opener&lt;/li&gt;&lt;li&gt;â€¢ nitric oxide releasing properties&lt;/li&gt;&lt;li&gt;â€¢ used for&lt;/li&gt;&lt;li&gt;â€¢ angina pectoris,&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Trimetazidine is an antianginal medication that reduces the frequency of angina attacks and increases exercise capacity through a mechanism that likely involves the inhibition of mitochondrial LC3-KAT, leading to a shift from fatty acid to glucose metabolism in the myocardium and resulting in a reduced oxygen demand.&lt;/li&gt;&lt;li&gt;â€¢ Trimetazidine&lt;/li&gt;&lt;li&gt;â€¢ antianginal medication&lt;/li&gt;&lt;li&gt;â€¢ reduces the frequency of angina attacks&lt;/li&gt;&lt;li&gt;â€¢ increases exercise capacity&lt;/li&gt;&lt;li&gt;â€¢ inhibition of mitochondrial LC3-KAT,&lt;/li&gt;&lt;li&gt;â€¢ fatty acid to glucose metabolism&lt;/li&gt;&lt;li&gt;â€¢ myocardium and resulting&lt;/li&gt;&lt;li&gt;â€¢ reduced oxygen demand.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following are seen in digitalis toxicity except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ventricular bigeminy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Paroxysmal atrial tachycardia with fast ventricular rate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Regularization of atrial fibrillation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bidirectional ventricular tachycardia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Paroxysmal atrial tachycardia with fast ventricular rate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Paroxysmal atrial tachycardia with fast ventricular rate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ventricular bigeminy: Seen with digitalis toxicity as it causes increased ventricular ectopy.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ventricular bigeminy:&lt;/li&gt;&lt;li&gt;â€¢ digitalis toxicity&lt;/li&gt;&lt;li&gt;â€¢ increased ventricular ectopy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Regularization of atrial fibrillation: Suggestive of digitalis toxicity where there is an AV block with a regular ventricular rate.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Regularization of atrial fibrillation:&lt;/li&gt;&lt;li&gt;â€¢ digitalis toxicity&lt;/li&gt;&lt;li&gt;â€¢ AV block&lt;/li&gt;&lt;li&gt;â€¢ regular ventricular&lt;/li&gt;&lt;li&gt;â€¢ rate.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bidirectional ventricular tachycardia: Associated with digitalis toxicity and can manifest in the context of severe structural heart disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Bidirectional ventricular tachycardia:&lt;/li&gt;&lt;li&gt;â€¢ digitalis toxicity&lt;/li&gt;&lt;li&gt;â€¢ severe structural&lt;/li&gt;&lt;li&gt;â€¢ heart disease.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ In digitalis toxicity, you would expect to see arrhythmias such as ventricular bigeminy, regularization of AF due to AV block, and bidirectional ventricular tachycardia, but not paroxysmal atrial tachycardia with a fast ventricular rate&lt;/li&gt;&lt;li&gt;â€¢ digitalis toxicity,&lt;/li&gt;&lt;li&gt;â€¢ arrhythmias such as ventricular bigeminy, regularization of AF due to AV block,&lt;/li&gt;&lt;li&gt;â€¢ bidirectional ventricular tachycardia,&lt;/li&gt;&lt;li&gt;â€¢ not paroxysmal atrial tachycardia&lt;/li&gt;&lt;li&gt;â€¢ fast ventricular rate&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All are true about starting beta-blocker therapy in a patient with congestive heart failure except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;They should be started with optimum doses&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;They should gradually increase over the weeks&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Special precautions should be taken in cases of NYHA class III and IV&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Carvedilol and metoprolol are the preferred drugs&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. They should be started with optimum doses&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) They should be started with optimum doses.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Gradually increasing the dose over weeks is correct , as this allows for the patientâ€™s tolerance to the drug to build and minimizes the risk of adverse effects.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Gradually increasing the dose over weeks&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ patientâ€™s tolerance to the drug&lt;/li&gt;&lt;li&gt;â€¢ minimizes&lt;/li&gt;&lt;li&gt;â€¢ risk of adverse effects.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Special precautions with NYHA class III and IV patients are necessary due to their increased risk of fluid overload and worsening heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Special precautions with NYHA class III and IV patients&lt;/li&gt;&lt;li&gt;â€¢ increased risk of fluid overload&lt;/li&gt;&lt;li&gt;â€¢ worsening heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Carvedilol and metoprolol are indeed the preferred beta-blockers for treating congestive heart failure due to their proven benefits in this patient population.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Carvedilol and metoprolol&lt;/li&gt;&lt;li&gt;â€¢ preferred beta-blockers&lt;/li&gt;&lt;li&gt;â€¢ congestive heart failure&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ When initiating beta-blocker therapy in congestive heart failure , it is essential to start with very low doses and titrate gradually to minimize risks , especially in patients with more advanced disease (NYHA class III and IV).&lt;/li&gt;&lt;li&gt;â€¢ beta-blocker&lt;/li&gt;&lt;li&gt;â€¢ congestive heart failure&lt;/li&gt;&lt;li&gt;â€¢ start with very low doses and titrate&lt;/li&gt;&lt;li&gt;â€¢ minimize risks&lt;/li&gt;&lt;li&gt;â€¢ more advanced disease (NYHA class III and IV).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following statements about nesiritide are true except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is a BNP analogue&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It can be used in decompensated CHF&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It can be administered orally&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It causes loss of Na + in the urine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It can be administered orally&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) It can be administered orally&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. It is a BNP analogue: This statement is true. Nesiritide is a synthetic version of BNP that is used in the management of acute decompensated heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option A. It is a BNP analogue:&lt;/li&gt;&lt;li&gt;â€¢ true. Nesiritide&lt;/li&gt;&lt;li&gt;â€¢ synthetic&lt;/li&gt;&lt;li&gt;â€¢ BNP&lt;/li&gt;&lt;li&gt;â€¢ acute decompensated heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option B. It can be used in decompensated CHF: This statement is true . Nesiritide is indicated for the treatment of acute decompensated congestive heart failure (CHF), where it works by causing vasodilation and natriuresis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. It can be used in decompensated CHF:&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;li&gt;â€¢ Nesiritide&lt;/li&gt;&lt;li&gt;â€¢ treatment of acute&lt;/li&gt;&lt;li&gt;â€¢ decompensated congestive heart failure (CHF),&lt;/li&gt;&lt;li&gt;â€¢ vasodilation and natriuresis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. It causes loss of Na+ in the urine: This statement is true . Nesiritide promotes natriuresis, which is the excretion of sodium in the urine , contributing to its beneficial effects in heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option D. It causes loss of Na+ in the urine:&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;li&gt;â€¢ natriuresis,&lt;/li&gt;&lt;li&gt;â€¢ excretion of sodium&lt;/li&gt;&lt;li&gt;â€¢ urine&lt;/li&gt;&lt;li&gt;â€¢ beneficial effects in heart failure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational goal is to understand the administration and effects of nesiritide in the treatment of acute decompensated heart failure . Nesiritide must be administered intravenously due to its peptide nature and the gastrointestinal degradation of oral peptides&lt;/li&gt;&lt;li&gt;âž¤ administration and effects of nesiritide&lt;/li&gt;&lt;li&gt;âž¤ acute decompensated heart&lt;/li&gt;&lt;li&gt;âž¤ failure&lt;/li&gt;&lt;li&gt;âž¤ administered intravenously&lt;/li&gt;&lt;li&gt;âž¤ peptide&lt;/li&gt;&lt;li&gt;âž¤ gastrointestinal degradation of oral peptides&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about diazoxide is false?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It acts by causing prolonged opening of ATP dependent K + channels in beta cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It can cause severe hypoglycemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It can be used to treat patients with insulinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is used as an antihypertensive agent&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It can cause severe hypoglycemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) It can cause severe hypoglycemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. This statement is true as diazoxide does cause prolonged opening of ATP-dependent K+ channels in pancreatic beta cells, leading to decreased insulin release.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ true as diazoxide&lt;/li&gt;&lt;li&gt;â€¢ prolonged opening of ATP-dependent K+ channels&lt;/li&gt;&lt;li&gt;â€¢ decreased insulin release.&lt;/li&gt;&lt;li&gt;â€¢ Option C. True because diazoxide is used in the treatment of insulinoma due to its ability to suppress insulin secretion .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ True&lt;/li&gt;&lt;li&gt;â€¢ diazoxide&lt;/li&gt;&lt;li&gt;â€¢ insulinoma&lt;/li&gt;&lt;li&gt;â€¢ ability to suppress insulin secretion&lt;/li&gt;&lt;li&gt;â€¢ Option D. True since diazoxide has a vasodilatory effect due to its action on potassium channels in blood vessels, making it useful as an antihypertensive agent.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ True&lt;/li&gt;&lt;li&gt;â€¢ diazoxide&lt;/li&gt;&lt;li&gt;â€¢ vasodilatory effect&lt;/li&gt;&lt;li&gt;â€¢ potassium channels in blood vessels,&lt;/li&gt;&lt;li&gt;â€¢ antihypertensive agent.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Diazoxide causes hyperglycemia , not hypoglycemia, by i nhibiting insulin release through the opening of K+ channels in pancreatic beta cells and is used in the treatment of insulinoma and as an antihypertensive agent due to its vasodilatory action.&lt;/li&gt;&lt;li&gt;â€¢ Diazoxide&lt;/li&gt;&lt;li&gt;â€¢ hyperglycemia&lt;/li&gt;&lt;li&gt;â€¢ nhibiting insulin release&lt;/li&gt;&lt;li&gt;â€¢ opening of K+ channels in pancreatic&lt;/li&gt;&lt;li&gt;â€¢ beta cells&lt;/li&gt;&lt;li&gt;â€¢ insulinoma&lt;/li&gt;&lt;li&gt;â€¢ antihypertensive agent&lt;/li&gt;&lt;li&gt;â€¢ vasodilatory action.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Alpha methyldopa is primarily used for treatment of:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pregnancy induced hypertension&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Renovascular hypertension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;First line agent in hypertension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Refractory hypertension&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Pregnancy induced hypertension&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Pregnancy induced hypertension&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Renovascular hypertension: Incorrect as alpha methyldopa is not the first choice of treatment for renovascular hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Renovascular hypertension:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ alpha methyldopa&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ renovascular&lt;/li&gt;&lt;li&gt;â€¢ hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option C. First line agent in hypertension: Incorrect because alpha methyldopa is not commonly used as a first-line treatment for essential hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option C. First line agent in hypertension:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ alpha methyldopa&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ first-line treatment for&lt;/li&gt;&lt;li&gt;â€¢ essential hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Refractory hypertension: Incorrect as alpha methyldopa is not typically reserved for refractory hypertension but could be used if other options are unsuitable.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Refractory hypertension:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ alpha methyldopa&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ refractory hypertension&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Alpha methyldopa is mainly used for the treatment of hypertension in pregnancy due to its efficacy and safety profile, acting through central mechanisms by stimulating alpha-2 adrenergic receptors.&lt;/li&gt;&lt;li&gt;â€¢ Alpha methyldopa&lt;/li&gt;&lt;li&gt;â€¢ hypertension in pregnancy&lt;/li&gt;&lt;li&gt;â€¢ efficacy and safety profile,&lt;/li&gt;&lt;li&gt;â€¢ central mechanisms by stimulating alpha-2 adrenergic receptors.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about hydralazine is not true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It causes direct relaxation of the blood vessels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It causes dilatation of both arteries and veins&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Postural hypotension is not a common problem&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It increases plasma renin activity&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It causes dilatation of both arteries and veins&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) It causes dilatation of both arteries and veins&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Correct as hydrala zine does cause direct relaxation of blood vessels, particularly arterioles.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Correct&lt;/li&gt;&lt;li&gt;â€¢ hydrala&lt;/li&gt;&lt;li&gt;â€¢ direct relaxation of blood vessels,&lt;/li&gt;&lt;li&gt;â€¢ arterioles.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Correct because postural hypotension is not a common problem with hydralazine, as it does not significantly dilate veins.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Correct&lt;/li&gt;&lt;li&gt;â€¢ postural hypotension&lt;/li&gt;&lt;li&gt;â€¢ not a&lt;/li&gt;&lt;li&gt;â€¢ hydralazine,&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ dilate veins.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Correct as vasodilators like hydralazine can cause an increase in plasma renin activity due to compensatory mechanisms following a decrease in blood pressure , such as increased sympathetic activity.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Correct as vasodilators like hydralazine&lt;/li&gt;&lt;li&gt;â€¢ increase in plasma renin activity&lt;/li&gt;&lt;li&gt;â€¢ compensatory mechanisms&lt;/li&gt;&lt;li&gt;â€¢ decrease in blood pressure&lt;/li&gt;&lt;li&gt;â€¢ increased sympathetic activity.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Hydralazine is an antihypertensive agent that predominantly causes arteriolar dilation, resulting in decreased blood pressure without significantly affecting veins or causing postural hypotension.&lt;/li&gt;&lt;li&gt;â€¢ Hydralazine&lt;/li&gt;&lt;li&gt;â€¢ antihypertensive agent&lt;/li&gt;&lt;li&gt;â€¢ arteriolar dilation,&lt;/li&gt;&lt;li&gt;â€¢ decreased blood pressure&lt;/li&gt;&lt;li&gt;â€¢ without&lt;/li&gt;&lt;li&gt;â€¢ veins or causing postural hypotension.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following statements are true about the use of clonidine in the treatment of hypertension except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It acts by causing a reduction in central sympathetic outflow&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It increases LDL-cholesterol on prolonged use&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sedation and xerostomia are common side effects of clonidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It can be combined with vasodilators&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It increases LDL-cholesterol on prolonged use&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) It increases LDL-cholesterol on prolonged use&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Correct as clonidine decreases central sympathetic outflow due to its alpha-2 agonist action.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Correct&lt;/li&gt;&lt;li&gt;â€¢ clonidine decreases central sympathetic outflow&lt;/li&gt;&lt;li&gt;â€¢ alpha-2 agonist action.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Correct since sedation and xerostomia are well-documented side effects of clonidine.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Correct&lt;/li&gt;&lt;li&gt;â€¢ sedation and xerostomia are well-documented side effects of clonidine.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Correct because clonidine can be combined with vasodilators to treat hypertension effectively.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Correct&lt;/li&gt;&lt;li&gt;â€¢ clonidine can be combined with vasodilators&lt;/li&gt;&lt;li&gt;â€¢ hypertension effectively.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Clonidine, an alpha-2 agonist , is used in the treatment of hypertension, primarily by reducing central sympathetic outflow and not by increasing LDL-cholesterol; it actually tends to have a beneficial effect on cholesterol profiles.&lt;/li&gt;&lt;li&gt;â€¢ Clonidine, an alpha-2 agonist&lt;/li&gt;&lt;li&gt;â€¢ hypertension,&lt;/li&gt;&lt;li&gt;â€¢ reducing central sympathetic outflow&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ increasing LDL-cholesterol;&lt;/li&gt;&lt;li&gt;â€¢ beneficial effect on cholesterol profiles.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient was taking verapamil for PSVT prophylaxis. He was given propranolol for treatment of essential tremors. This combination can result in:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atrial fibrillation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bradycardia with AV block&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Torsades de pointes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tachycardia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Bradycardia with AV block&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Bradycardia with AV block&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atrial fibrillation is not the most likely outcome of adding verapamil to propranolol therapy, although verapamil is sometimes used to control ventricular rate in patients with atrial fibrillation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atrial fibrillation&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ outcome&lt;/li&gt;&lt;li&gt;â€¢ verapamil to propranolol&lt;/li&gt;&lt;li&gt;â€¢ verapamil is&lt;/li&gt;&lt;li&gt;â€¢ to control ventricular rate&lt;/li&gt;&lt;li&gt;â€¢ atrial fibrillation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Torsadesâ€™ de pointes is a specific type of ventricular tachycardia often associated with a prolonged QT interval , which is not a typical side effect of either propranolol or verapamil.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Torsadesâ€™&lt;/li&gt;&lt;li&gt;â€¢ specific type of ventricular tachycardia&lt;/li&gt;&lt;li&gt;â€¢ prolonged QT interval&lt;/li&gt;&lt;li&gt;â€¢ not a typical side effect&lt;/li&gt;&lt;li&gt;â€¢ propranolol or verapamil.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tachycardia , or increased heart rate , would be unlikely as both drug s work to slow the heart rate.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tachycardia&lt;/li&gt;&lt;li&gt;â€¢ increased heart rate&lt;/li&gt;&lt;li&gt;â€¢ unlikely as both drug&lt;/li&gt;&lt;li&gt;â€¢ slow the heart rate.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objectives:&lt;/li&gt;&lt;li&gt;âž¤ Therefore, the most appropriate answer in the context of this clinical scenario is B. Bradycardia with AV block, considering the pharmacological actions of both propranolol and verapamil and the symptoms reported by the patient.&lt;/li&gt;&lt;li&gt;âž¤ B. Bradycardia&lt;/li&gt;&lt;li&gt;âž¤ AV block,&lt;/li&gt;&lt;li&gt;âž¤ pharmacological actions of both propranolol and verapamil&lt;/li&gt;&lt;li&gt;âž¤ symptoms&lt;/li&gt;&lt;li&gt;âž¤ Ref: KDT 8th/160&lt;/li&gt;&lt;li&gt;âž¤ Ref: KDT 8th/160&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Sodium nitroprusside acts by stimulation of?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Guanylyl cyclase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Phosphokinase 1,2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phospholipase A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phospholipase B&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Guanylyl cyclase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Guanylyl cyclase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Phosphokinase 1,2: There is no enzyme specifically named phosphokinase 1,2. This option does not relate to the known mechanism of action of sodium nitroprusside.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Phosphokinase 1,2:&lt;/li&gt;&lt;li&gt;â€¢ no&lt;/li&gt;&lt;li&gt;â€¢ phosphokinase 1,2.&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ Option C. Phospholipase A: Phospholipase A is an enzyme that hydrolyzes phospholipids to produce fatty acids and lysophospholipids . It is not directly involved in the mechanism of action of sodium nitroprusside.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Phospholipase A:&lt;/li&gt;&lt;li&gt;â€¢ Phospholipase A is an enzyme&lt;/li&gt;&lt;li&gt;â€¢ hydrolyzes phospholipids&lt;/li&gt;&lt;li&gt;â€¢ fatty acids&lt;/li&gt;&lt;li&gt;â€¢ lysophospholipids&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ mechanism of action of sodium nitroprusside.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Phospholipase B: Phospholipase B also acts on phospholipids but is not related to the vasodilatory action of sodium nitroprusside.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Phospholipase B:&lt;/li&gt;&lt;li&gt;â€¢ acts on phospholipids&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ vasodilatory action of sodium&lt;/li&gt;&lt;li&gt;â€¢ nitroprusside.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational goal is to understand the pharmacodynamics of sodium nitroprusside , a potent vasodilator. By knowing that its mechanism involves th e stimulation of guanylyl cyclase and the subsequent increase in cGMP, healthcare professionals can better anticipate its effects and necessary precautions, such as monitoring for signs of cyanide toxicity due to its metabolism. Understanding the differences in mechanisms among various vasodilators is crucial for selecting the appropriate agent in clinical scenarios.&lt;/li&gt;&lt;li&gt;âž¤ pharmacodynamics of sodium nitroprusside&lt;/li&gt;&lt;li&gt;âž¤ potent vasodilator.&lt;/li&gt;&lt;li&gt;âž¤ e stimulation of guanylyl cyclase&lt;/li&gt;&lt;li&gt;âž¤ increase in cGMP,&lt;/li&gt;&lt;li&gt;âž¤ monitoring for signs of cyanide toxicity&lt;/li&gt;&lt;li&gt;âž¤ differences in mechanisms&lt;/li&gt;&lt;li&gt;âž¤ vasodilators&lt;/li&gt;&lt;li&gt;âž¤ selecting the appropriate agent&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old woman with a history of ischemic cardiomyopathy and left ventricular ejection fraction of 35%. She is NYHA class II in terms of symptoms. She is on lisinopril, carvedilol, and spironolactone. Her blood pressure is 102/82 mmHg, and heart rate is 80 bpm. Which of the following additional medications will further reduce her risk of hospitalization due to heart failure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aliskiren&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Digoxin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ivabradine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Valsartan&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ivabradine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Ivabradine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aliskiren: Aliskiren is a direct renin inhibitor and is used to treat hypertension. While it can reduce blood pressure and has been studied in heart failure , it is not specifically indicated to reduce mortality in heart failure patients , particularly when already on optimal therapy with an ACE inhibitor, beta-blocker, and aldosterone antagonist.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aliskiren:&lt;/li&gt;&lt;li&gt;â€¢ direct renin inhibitor&lt;/li&gt;&lt;li&gt;â€¢ hypertension.&lt;/li&gt;&lt;li&gt;â€¢ reduce blood pressure&lt;/li&gt;&lt;li&gt;â€¢ heart failure&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ reduce mortality in heart failure patients&lt;/li&gt;&lt;li&gt;â€¢ ACE inhibitor, beta-blocker, and aldosterone antagonist.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Digoxin: Digoxin may help improve symptoms and reduce hospitalizations by increasing contractility and controlling heart rate, but it has not been shown to reduce mortality in heart failure patients.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Digoxin:&lt;/li&gt;&lt;li&gt;â€¢ improve&lt;/li&gt;&lt;li&gt;â€¢ reduce hospitalizations&lt;/li&gt;&lt;li&gt;â€¢ increasing contractility and controlling heart rate,&lt;/li&gt;&lt;li&gt;â€¢ has not&lt;/li&gt;&lt;li&gt;â€¢ reduce mortality in heart failure patients.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Valsartan: The patient is already on lisinopril, an ACE inhibitor, which provides the mortality benefit of inhibiting the renin-angiotensin-aldosterone system (RAAS). Adding another RAAS inhibitor like valsartan, an ARB, without removing the ACE inhibitor is not typically recommended due to increased risk of adverse effects without additional mortality benefit.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Valsartan:&lt;/li&gt;&lt;li&gt;â€¢ lisinopril, an ACE inhibitor,&lt;/li&gt;&lt;li&gt;â€¢ mortality benefit of inhibiting the renin-angiotensin-aldosterone system (RAAS).&lt;/li&gt;&lt;li&gt;â€¢ valsartan, an ARB, without removing the ACE inhibitor&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ increased risk of adverse effects without additional mortality benefit.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ivabradine can be used in certain heart failure patients with a high heart rate despite optimal standard therapy to further reduce the risk of heart failure-related morbidity. It is important to recognize the therapeutic benefits and limitations of additional heart failure treatments in the context of a patient&#x27;s overall medical regimen and clinical status.&lt;/li&gt;&lt;li&gt;âž¤ Ivabradine&lt;/li&gt;&lt;li&gt;âž¤ certain heart failure&lt;/li&gt;&lt;li&gt;âž¤ high heart rate&lt;/li&gt;&lt;li&gt;âž¤ reduce the risk of heart failure-related morbidity.&lt;/li&gt;&lt;li&gt;âž¤ recognize the therapeutic benefits&lt;/li&gt;&lt;li&gt;âž¤ limitations of&lt;/li&gt;&lt;li&gt;âž¤ additional heart failure&lt;/li&gt;&lt;li&gt;âž¤ Ref : CMDT 2022 Pg 410&lt;/li&gt;&lt;li&gt;âž¤ Ref : CMDT 2022 Pg 410&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following medications has been shown to reduce mortality in heart failure with reduced ejection fraction?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Digoxin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metoprolol succinate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dobutamine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Metoprolol succinate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Metoprolol succinate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Digoxin: While digoxin can improve symptoms and reduce hospitalizations by increasing the force of cardiac c ontractions and controlling heart rate in patients with heart failure, it has not been shown to reduce mortality in these patients.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Digoxin:&lt;/li&gt;&lt;li&gt;â€¢ improve symptoms and reduce hospitalizations by increasing the force of cardiac c&lt;/li&gt;&lt;li&gt;â€¢ controlling heart rate&lt;/li&gt;&lt;li&gt;â€¢ heart failure,&lt;/li&gt;&lt;li&gt;â€¢ has not been shown to reduce mortality&lt;/li&gt;&lt;li&gt;â€¢ Option B. Furosemide: Furosemide is a loop diuretic that is used to reduce symptoms of congestion in heart failure by promoting the excretion of sodium and water . However, it does not have a direct effect on reducing mortality in heart failure with reduced ejection fraction.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Furosemide:&lt;/li&gt;&lt;li&gt;â€¢ loop diuretic&lt;/li&gt;&lt;li&gt;â€¢ reduce symptoms of congestion in heart failure&lt;/li&gt;&lt;li&gt;â€¢ excretion of sodium and water&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ direct effect on reducing mortality in heart failure&lt;/li&gt;&lt;li&gt;â€¢ reduced&lt;/li&gt;&lt;li&gt;â€¢ ejection fraction.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Dobutamine: Dobutamine is a beta-1 agonist used in acute heart failure to increase cardiac output . It is generally used for short-term support in hospitalized patients and is not shown to reduce long-term mortality in chronic heart failure ; its long-term use can actually be harmful due to increased cardiac oxygen demand and potential for arrhythmia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Dobutamine:&lt;/li&gt;&lt;li&gt;â€¢ beta-1 agonist&lt;/li&gt;&lt;li&gt;â€¢ acute heart failure to increase cardiac output&lt;/li&gt;&lt;li&gt;â€¢ short-term support in hospitalized patients&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ reduce long-term mortality in chronic heart failure&lt;/li&gt;&lt;li&gt;â€¢ harmful due to increased cardiac oxygen demand&lt;/li&gt;&lt;li&gt;â€¢ arrhythmia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational goal is to understand the role of different classes of drugs in the treatment of heart failure with reduced ejection fraction, particularly those that have been demonstrated to reduce mortality.&lt;/li&gt;&lt;li&gt;âž¤ different classes of drugs&lt;/li&gt;&lt;li&gt;âž¤ heart failure&lt;/li&gt;&lt;li&gt;âž¤ reduced ejection&lt;/li&gt;&lt;li&gt;âž¤ fraction,&lt;/li&gt;&lt;li&gt;âž¤ have been demonstrated to reduce mortality.&lt;/li&gt;&lt;li&gt;âž¤ Drugs reducing mortality in CHF include:&lt;/li&gt;&lt;li&gt;âž¤ Drugs reducing mortality in CHF include:&lt;/li&gt;&lt;li&gt;âž¤ Beta blockers ACE inhibitors ARBs Aldosterone antagonists Ivabradine Hydralazine + Isosorbide dinitrate&lt;/li&gt;&lt;li&gt;âž¤ Beta blockers&lt;/li&gt;&lt;li&gt;âž¤ ACE inhibitors&lt;/li&gt;&lt;li&gt;âž¤ ARBs&lt;/li&gt;&lt;li&gt;âž¤ Aldosterone antagonists&lt;/li&gt;&lt;li&gt;âž¤ Ivabradine&lt;/li&gt;&lt;li&gt;âž¤ Hydralazine + Isosorbide dinitrate&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The primary mechanism of action of nitrates in a patient of classical angina is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Coronary vasodilation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decrease heart rate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreased afterload&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Decreases preload&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Decreases preload&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Decreases preload&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Coronary Vasodilation : Nitrates do cause some coronary vasodilation, but this is not their primary action in treating classical angina. Endothelium independent coronary vasodilation is the primary mechanism of nitrates in treatment of variant angina. In a typical vascular system, the endothelium plays a crucial role in regulating blood vessel tone and blood flow . It does this by releasing substances like nitric oxide (NO), which promote vasodilation. However, nitrates work independently of the endothelial cells. They are converted into nitric oxide (NO) within the smooth muscle cells. This NO then activates an enzyme called guanylate cyclase , which increases the levels of cyclic guanosine monophosphate (cGMP). The increase in cGMP leads to relaxation of the smooth muscle cells , resulting in vasodilatio n. This mechanism is particularly important in conditions like variant angina, where there are episodes of coronary artery spasm . Nitrate s can effectively relax the smooth muscle in the coronary arteries, reducing the spasm and thus alleviating the angina pain . This action is independent of the endothelium, which may not be functioning optimally in all individuals with coronary artery disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Coronary Vasodilation&lt;/li&gt;&lt;li&gt;â€¢ Nitrates do&lt;/li&gt;&lt;li&gt;â€¢ coronary vasodilation,&lt;/li&gt;&lt;li&gt;â€¢ not their primary action&lt;/li&gt;&lt;li&gt;â€¢ classical angina.&lt;/li&gt;&lt;li&gt;â€¢ Endothelium independent coronary vasodilation&lt;/li&gt;&lt;li&gt;â€¢ primary&lt;/li&gt;&lt;li&gt;â€¢ nitrates&lt;/li&gt;&lt;li&gt;â€¢ variant&lt;/li&gt;&lt;li&gt;â€¢ angina.&lt;/li&gt;&lt;li&gt;â€¢ endothelium&lt;/li&gt;&lt;li&gt;â€¢ regulating blood vessel tone and blood flow&lt;/li&gt;&lt;li&gt;â€¢ nitric oxide (NO),&lt;/li&gt;&lt;li&gt;â€¢ promote vasodilation.&lt;/li&gt;&lt;li&gt;â€¢ nitrates work independently of the endothelial&lt;/li&gt;&lt;li&gt;â€¢ cells.&lt;/li&gt;&lt;li&gt;â€¢ converted into nitric oxide (NO)&lt;/li&gt;&lt;li&gt;â€¢ within&lt;/li&gt;&lt;li&gt;â€¢ smooth muscle cells.&lt;/li&gt;&lt;li&gt;â€¢ NO&lt;/li&gt;&lt;li&gt;â€¢ guanylate cyclase&lt;/li&gt;&lt;li&gt;â€¢ increases the levels of cyclic guanosine monophosphate (cGMP).&lt;/li&gt;&lt;li&gt;â€¢ increase in cGMP&lt;/li&gt;&lt;li&gt;â€¢ smooth muscle cells&lt;/li&gt;&lt;li&gt;â€¢ vasodilatio&lt;/li&gt;&lt;li&gt;â€¢ variant angina,&lt;/li&gt;&lt;li&gt;â€¢ episodes of coronary artery spasm&lt;/li&gt;&lt;li&gt;â€¢ Nitrate&lt;/li&gt;&lt;li&gt;â€¢ relax the smooth muscle&lt;/li&gt;&lt;li&gt;â€¢ coronary arteries,&lt;/li&gt;&lt;li&gt;â€¢ reducing the spasm&lt;/li&gt;&lt;li&gt;â€¢ alleviating the angina pain&lt;/li&gt;&lt;li&gt;â€¢ independent&lt;/li&gt;&lt;li&gt;â€¢ endothelium,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ functioning optimally&lt;/li&gt;&lt;li&gt;â€¢ coronary artery disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Decrease Heart Rate : Nitrates do not have a significant effect on heart rate. Drugs that primarily decrease heart rate , such as beta-blockers , are used separately for this purpose in the management of angina.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Decrease Heart Rate&lt;/li&gt;&lt;li&gt;â€¢ do not&lt;/li&gt;&lt;li&gt;â€¢ heart rate.&lt;/li&gt;&lt;li&gt;â€¢ primarily decrease heart rate&lt;/li&gt;&lt;li&gt;â€¢ beta-blockers&lt;/li&gt;&lt;li&gt;â€¢ Option C. Decrease Afterload : While nitrates can have a minor effect on afterload due to systemic vasodilation , decreasing afterload is not their primary mechanism of action in treating angina . Medications like ACE inhibitors or angiotensin receptor blockers are more effective for this purpose.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Decrease Afterload&lt;/li&gt;&lt;li&gt;â€¢ nitrates&lt;/li&gt;&lt;li&gt;â€¢ minor effect on afterload&lt;/li&gt;&lt;li&gt;â€¢ systemic vasodilation&lt;/li&gt;&lt;li&gt;â€¢ decreasing&lt;/li&gt;&lt;li&gt;â€¢ afterload&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ treating angina&lt;/li&gt;&lt;li&gt;â€¢ ACE inhibitors or angiotensin receptor&lt;/li&gt;&lt;li&gt;â€¢ blockers&lt;/li&gt;&lt;li&gt;â€¢ more&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ The mechanism of action of nitrates in classical angina is decrease in preload. The mechanism of action of nitrates i n variant angina is endothelium independent coronary vasodilation.&lt;/li&gt;&lt;li&gt;â€¢ The mechanism of action of nitrates in classical angina is decrease in preload.&lt;/li&gt;&lt;li&gt;â€¢ mechanism of action of nitrates&lt;/li&gt;&lt;li&gt;â€¢ classical angina is decrease in preload.&lt;/li&gt;&lt;li&gt;â€¢ The mechanism of action of nitrates i n variant angina is endothelium independent coronary vasodilation.&lt;/li&gt;&lt;li&gt;â€¢ mechanism of action of nitrates&lt;/li&gt;&lt;li&gt;â€¢ n variant angina&lt;/li&gt;&lt;li&gt;â€¢ endothelium independent coronary vasodilation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 56-year-old patient with essential hypertension on ACE inhibitors for 6 months developed chronic refractory dry cough. What would be the correct action to be taken?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reduce the dose of ACE inhibitor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Add anti- tussive for treatment of cough&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Change to Angiotensin receptor blocker (ARB)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Order for a CT scan of chest&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Change to Angiotensin receptor blocker (ARB)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Change to Angiotensin receptor blocker (ARB)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reduce the dose of ACE inhibitor: Reducing the dose of the ACE inhibitor would not alleviate the cough since the adverse effect is not dose-related and the patient has already developed sensitivity to the drug.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reduce the dose of ACE inhibitor:&lt;/li&gt;&lt;li&gt;â€¢ would not alleviate the cough&lt;/li&gt;&lt;li&gt;â€¢ Option B. Add anti-tussive for the treatment of cough: An anti-tussive would not address the underlying cause of the cough, which in this case is due to the ACE inhibitors.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Add anti-tussive for the treatment of cough:&lt;/li&gt;&lt;li&gt;â€¢ would not&lt;/li&gt;&lt;li&gt;â€¢ cause of the cough,&lt;/li&gt;&lt;li&gt;â€¢ due to the ACE inhibitors.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Order for a CT scan of the chest: A CT scan would be an unnecessary investigation and an additional cost burden for the patient, given that the cause of the chronic cough is already known to be drug-related and not indicative of an underlying pulmonary pathology.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Order for a CT scan of the chest:&lt;/li&gt;&lt;li&gt;â€¢ unnecessary investigation&lt;/li&gt;&lt;li&gt;â€¢ chronic cough is already known to be drug-related&lt;/li&gt;&lt;li&gt;â€¢ not indicative of an underlying&lt;/li&gt;&lt;li&gt;â€¢ pulmonary pathology.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ For a patient who develops a chronic dry cough while on ACE inhibitors, changing to an Angiotensin receptor blocker (ARB) is the correct course of action, a s ARBs do not cause this side effect.&lt;/li&gt;&lt;li&gt;â€¢ chronic dry cough while on ACE inhibitors,&lt;/li&gt;&lt;li&gt;â€¢ Angiotensin receptor blocker (ARB)&lt;/li&gt;&lt;li&gt;â€¢ correct course of action,&lt;/li&gt;&lt;li&gt;â€¢ s ARBs do not&lt;/li&gt;&lt;li&gt;â€¢ side effect.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs can result in prolongation of QT interval in ECG?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Quinidine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lignocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ciprofloxacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Quinidine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/screenshot-2024-05-08-113043.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Quinidine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lignocaine: Lignocaine (also known as lidocaine) is a class Ib anti-arrhythmic drug that predominantly blocks Na+ channels and is less likely to cause QT prolongation as its action is more specific to the fast sodium channels and it actually tends to shorten the action potential duration.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lignocaine:&lt;/li&gt;&lt;li&gt;â€¢ class Ib anti-arrhythmic drug&lt;/li&gt;&lt;li&gt;â€¢ blocks Na+ channels&lt;/li&gt;&lt;li&gt;â€¢ less&lt;/li&gt;&lt;li&gt;â€¢ QT prolongation&lt;/li&gt;&lt;li&gt;â€¢ more specific to the fast sodium channels&lt;/li&gt;&lt;li&gt;â€¢ shorten the action potential duration.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ciprofloxacin: Ciprofloxacin is a fluoroquinolone antibiotic . Although fluoroquinolones like sparfloxacin, levofloxacin, and moxifloxacin are associated with QT prolongation, ciprofloxacin is less implicated in causing this adverse effect when compared to other drugs in its class.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ciprofloxacin:&lt;/li&gt;&lt;li&gt;â€¢ fluoroquinolone antibiotic&lt;/li&gt;&lt;li&gt;â€¢ sparfloxacin, levofloxacin, and&lt;/li&gt;&lt;li&gt;â€¢ moxifloxacin&lt;/li&gt;&lt;li&gt;â€¢ QT prolongation, ciprofloxacin is less&lt;/li&gt;&lt;li&gt;â€¢ adverse effect&lt;/li&gt;&lt;li&gt;â€¢ Option D. Propranolol: Propranolol is a non-selective beta-blocker and is not commonly associated with QT prolongation . It acts on the beta-adrenergic receptors and can affect heart rate and contractility but not typically the QT interval.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Propranolol:&lt;/li&gt;&lt;li&gt;â€¢ non-selective beta-blocker&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ QT prolongation&lt;/li&gt;&lt;li&gt;â€¢ beta-adrenergic receptors&lt;/li&gt;&lt;li&gt;â€¢ heart rate and contractility&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ QT interval.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Quinidine, a class Ia anti-arrhythmic drug , can cause QT interval prolongation on an ECG due to its blockade of potassium channels, which affects the repolarization phase of the cardiac action potential.&lt;/li&gt;&lt;li&gt;â€¢ Quinidine,&lt;/li&gt;&lt;li&gt;â€¢ class Ia anti-arrhythmic drug&lt;/li&gt;&lt;li&gt;â€¢ QT interval prolongation on an ECG&lt;/li&gt;&lt;li&gt;â€¢ blockade of potassium channels,&lt;/li&gt;&lt;li&gt;â€¢ repolarization phase of the cardiac action potential.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Preferred drug for the treatment of uncomplicated grade 2 hypertension in a 48-year-old man is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chlorthalidone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Triamterene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Spironolactone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Chlorthalidone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/screenshot-2024-05-08-114419.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Chlorthalidone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Triamterene: Triamterene is a potassium-sparing diuretic that is not typically used as first-line treatment for hypertension. It is often used in combination with other diuretics to prevent hypokalemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Triamterene:&lt;/li&gt;&lt;li&gt;â€¢ potassium-sparing diuretic&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ first-line treatment for hypertension.&lt;/li&gt;&lt;li&gt;â€¢ used in combination&lt;/li&gt;&lt;li&gt;â€¢ diuretics to prevent hypokalemia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Spironolactone: Spironolactone is another potassium-sparing diuretic that also blocks the effects of aldosterone . While it can be used for hypertension , it is usually reserved for cases that are resistant to other treatments or for specific conditions like primary hyperaldosteronism.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Spironolactone:&lt;/li&gt;&lt;li&gt;â€¢ potassium-sparing diuretic&lt;/li&gt;&lt;li&gt;â€¢ blocks the effects of aldosterone&lt;/li&gt;&lt;li&gt;â€¢ hypertension&lt;/li&gt;&lt;li&gt;â€¢ resistant to other treatments&lt;/li&gt;&lt;li&gt;â€¢ specific conditions like&lt;/li&gt;&lt;li&gt;â€¢ primary hyperaldosteronism.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Furosemide: Furosemide is a loop diuretic that is primarily used for the treatment of edema associated with heart failure or renal disease. It is not typically used as first-line treatment for uncomplicated hypertension due to its shorter duration of action and greater risk for electrolyte imbalances.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Furosemide:&lt;/li&gt;&lt;li&gt;â€¢ loop diuretic&lt;/li&gt;&lt;li&gt;â€¢ edema associated with heart failure&lt;/li&gt;&lt;li&gt;â€¢ renal disease.&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ first-line treatment for uncomplicated hypertension&lt;/li&gt;&lt;li&gt;â€¢ shorter duration of action and&lt;/li&gt;&lt;li&gt;â€¢ electrolyte imbalances.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational goal is to identify the preferred initial treatment options for hypertension. Thiazide-like diuretics such as chlorthalidone are recommended as first-line therapy for most patients with hypertension due to their effectiveness in lowering blood pressure and reducing the risk of cardiovascular events.&lt;/li&gt;&lt;li&gt;âž¤ initial treatment&lt;/li&gt;&lt;li&gt;âž¤ hypertension.&lt;/li&gt;&lt;li&gt;âž¤ chlorthalidone are recommended as first-line therapy&lt;/li&gt;&lt;li&gt;âž¤ hypertension&lt;/li&gt;&lt;li&gt;âž¤ lowering&lt;/li&gt;&lt;li&gt;âž¤ blood pressure and reducing the risk of cardiovascular events.&lt;/li&gt;&lt;li&gt;âž¤ FIRST LINE DRUGS FOR DIFFERENT PATIENTS WITH HYPERTENSION&lt;/li&gt;&lt;li&gt;âž¤ FIRST LINE DRUGS FOR DIFFERENT PATIENTS WITH HYPERTENSION&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Nitrates are an important group of vasodilators used for angina and hypertension. These drugs primarily act by:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Activation of guanylyl cyclase and decrease in cGMP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Activation of guanylyl cyclase and increase in cGMP&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Activation of guanylyl cyclase and decrease in cAMP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Activation of guanylyl cyclase and increase in cAMP&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Activation of guanylyl cyclase and increase in cGMP&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Activation of guanylyl cyclase and increase in cGMP&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational goal is to understand the mechanism of action of nitrates in the treatment of angina and hypertension. Knowledge that nitrates increase cGMP levels through the activation of guanylyl cyclase is fundamental in understanding how these drugs induce vasodilation and relieve symptoms associated with ischemic heart disease . This mechanism is also the basis for the use of nitrates in other conditions where vasodilation is beneficial.&lt;/li&gt;&lt;li&gt;âž¤ mechanism of action of nitrates&lt;/li&gt;&lt;li&gt;âž¤ angina and hypertension.&lt;/li&gt;&lt;li&gt;âž¤ nitrates increase cGMP levels&lt;/li&gt;&lt;li&gt;âž¤ activation of guanylyl cyclase&lt;/li&gt;&lt;li&gt;âž¤ vasodilation&lt;/li&gt;&lt;li&gt;âž¤ relieve symptoms associated with ischemic heart disease&lt;/li&gt;&lt;li&gt;âž¤ use of&lt;/li&gt;&lt;li&gt;âž¤ nitrates&lt;/li&gt;&lt;li&gt;âž¤ vasodilation is beneficial.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Why does adenosine have a short half-life?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Spontaneous hydrolysis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rapid metabolism by enzymes in the liver&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Uptake in RBC and endothelial cells&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Renal excretion&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Uptake in RBC and endothelial cells&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Uptake in RBC and endothelial cells&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Spontaneous hydrolysis: While spontaneous hydrolysis can occur, it is not the primary reason for adenosine&#x27;s short half-life in vivo.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Spontaneous hydrolysis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Rapid metabolism by enzymes in the liver: Although liver enzymes play a role in drug metabolism, in the case of adenosine, the rapid uptake and metabolism by RBCs and endothelial cells are more significant.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Rapid metabolism by enzymes in the liver:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Renal excretion: While renal excretion does remove substances from the blood, adenosine&#x27;s short half-life is due more to cellular uptake and metabolism than to excretion by the kidneys.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Renal excretion:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Adenosine has a short half-life due to rapid uptake and intracellular metabolism in RBCs and endothelial cells, where it is phosphorylated to AMP or deaminated to eventually form uric acid. Adenosine is also the drug of choice (DOC) for the treatment of paroxysmal supraventricular tachycardia (PSVT).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs act as K channel opener?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Spironolactone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amiloride&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nicorandil&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Methyldopa&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Nicorandil&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Nicorandil&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Spironolactone: Spironolactone is a potassium-sparing diuretic that works at the level of the distal convoluted tubule in the kidneys but does not act as a K channel opener in the cardiovascular system.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Spironolactone:&lt;/li&gt;&lt;li&gt;â€¢ potassium-sparing diuretic&lt;/li&gt;&lt;li&gt;â€¢ at the level of the distal convoluted tubule&lt;/li&gt;&lt;li&gt;â€¢ does not act&lt;/li&gt;&lt;li&gt;â€¢ K channel opener&lt;/li&gt;&lt;li&gt;â€¢ Option B. Amiloride: Amiloride is also a potassium-sparing diuretic that affects ion channels in the kidneys , but again, it does not open potassium channels in vascular smooth muscle.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Amiloride:&lt;/li&gt;&lt;li&gt;â€¢ potassium-sparing diuretic&lt;/li&gt;&lt;li&gt;â€¢ ion channels in the kidneys&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ open potassium channels&lt;/li&gt;&lt;li&gt;â€¢ Option D. Methyldopa: Methyldopa is an antihypertensive medication that acts centrally as an alpha-2 agonist to lower blood pressure . It does not have K channel opening properties.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Methyldopa:&lt;/li&gt;&lt;li&gt;â€¢ antihypertensive medication&lt;/li&gt;&lt;li&gt;â€¢ acts centrally as an alpha-2 agonist&lt;/li&gt;&lt;li&gt;â€¢ lower blood&lt;/li&gt;&lt;li&gt;â€¢ pressure&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ K channel opening properties.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Nicorandil acts as a K channel opener and has nitrate-like properties, making it effective in the treatment of angina pectoris due to its ability to reduce myocardial oxygen demand and increase blood flow to the ischemic heart muscle.&lt;/li&gt;&lt;li&gt;âž¤ Nicorandil&lt;/li&gt;&lt;li&gt;âž¤ K channel opener and has nitrate-like properties,&lt;/li&gt;&lt;li&gt;âž¤ treatment of angina pectoris&lt;/li&gt;&lt;li&gt;âž¤ reduce myocardial oxygen demand&lt;/li&gt;&lt;li&gt;âž¤ increase blood flow to the ischemic heart muscle.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old female treated with an antihypertensive drug and presented with the following features shown in figure. Likely agent is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Methyl Dopa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Minoxidil&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Captopril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fenoldopam&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Minoxidil&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/25/41.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Minoxidil&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Methyldopa: Methyldopa is an antihypertensive medication that can cause side effects such as drowsiness and dry mouth but is not commonly associated with hirsutism.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Methyldopa:&lt;/li&gt;&lt;li&gt;â€¢ antihypertensive medication&lt;/li&gt;&lt;li&gt;â€¢ drowsiness and dry mouth&lt;/li&gt;&lt;li&gt;â€¢ Option C. Captopril: Captopril is an ACE inhibitor used to treat high blood pressure and heart failure . It can cause a persistent dry cough, taste changes, and in rare cases, angioedema, but not hirsutism.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Captopril:&lt;/li&gt;&lt;li&gt;â€¢ ACE inhibitor&lt;/li&gt;&lt;li&gt;â€¢ high blood pressure and heart failure&lt;/li&gt;&lt;li&gt;â€¢ dry&lt;/li&gt;&lt;li&gt;â€¢ cough, taste changes,&lt;/li&gt;&lt;li&gt;â€¢ angioedema,&lt;/li&gt;&lt;li&gt;â€¢ Option D. Fenoldopam: Fenoldopam is a vasodilator used in hypertensive emergen cies, acting as a dopamine D1 receptor agonist . It does not have hirsutism listed as a side effect.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Fenoldopam:&lt;/li&gt;&lt;li&gt;â€¢ vasodilator&lt;/li&gt;&lt;li&gt;â€¢ hypertensive emergen&lt;/li&gt;&lt;li&gt;â€¢ dopamine D1 receptor agonist&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational goal is to recognize the important drugs causing hirsutism. These include:&lt;/li&gt;&lt;li&gt;âž¤ important drugs&lt;/li&gt;&lt;li&gt;âž¤ hirsutism.&lt;/li&gt;&lt;li&gt;âž¤ Minoxidil Cyclosporine Phenytoin Androgens&lt;/li&gt;&lt;li&gt;âž¤ Minoxidil&lt;/li&gt;&lt;li&gt;âž¤ Minoxidil&lt;/li&gt;&lt;li&gt;âž¤ Cyclosporine&lt;/li&gt;&lt;li&gt;âž¤ Cyclosporine&lt;/li&gt;&lt;li&gt;âž¤ Phenytoin&lt;/li&gt;&lt;li&gt;âž¤ Phenytoin&lt;/li&gt;&lt;li&gt;âž¤ Androgens&lt;/li&gt;&lt;li&gt;âž¤ Androgens&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55 yr. old male presented to emergency with severe acute chest pain, radiating to left shoulder and back in the last 20 minutes. It was associated with sweating. ECG is shown in the figure. Which of the following drug should be given to the patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amiodarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Adenosine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tenecteplase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Verapamil&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Tenecteplase&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/25/42.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Tenecteplase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Amiodarone: Amiodarone is an antiarrhythmic medication that is not indicated as an initial treatment for acute myocardial infarction unless there are accompanying life-threatening arrhythmias.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Amiodarone:&lt;/li&gt;&lt;li&gt;â€¢ antiarrhythmic medication&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ acute&lt;/li&gt;&lt;li&gt;â€¢ myocardial infarction&lt;/li&gt;&lt;li&gt;â€¢ life-threatening arrhythmias.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Adenosine: Adenosine is typically used in the treatment of certain forms of supraventricular tachycardia and not in the setting of acute myocardial infarction.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Adenosine:&lt;/li&gt;&lt;li&gt;â€¢ used&lt;/li&gt;&lt;li&gt;â€¢ supraventricular tachycardia&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ acute myocardial infarction.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Verapamil: Verapamil is a calcium channel blocker that is generally contraindicated in the setting of acute myocardial infarction, especially with evidence of STEMI, as it can further depress myocardial contractility and lead to hemodynamic deterioration.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Verapamil:&lt;/li&gt;&lt;li&gt;â€¢ calcium channel blocker&lt;/li&gt;&lt;li&gt;â€¢ contraindicated&lt;/li&gt;&lt;li&gt;â€¢ acute myocardial&lt;/li&gt;&lt;li&gt;â€¢ infarction,&lt;/li&gt;&lt;li&gt;â€¢ STEMI,&lt;/li&gt;&lt;li&gt;â€¢ depress myocardial contractility&lt;/li&gt;&lt;li&gt;â€¢ lead to hemodynamic&lt;/li&gt;&lt;li&gt;â€¢ deterioration.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The objective is to recognize the appropriate use of thrombolytic therapy in the treatment of STEMI when PCI is not immediately available. Prompt initiation of thrombolytic therapy can significantly improve outcomes in STEMI by restoring coronary blood flow and minimizing myocardial damage.&lt;/li&gt;&lt;li&gt;âž¤ appropriate use of thrombolytic therapy&lt;/li&gt;&lt;li&gt;âž¤ STEMI when PCI is not immediately&lt;/li&gt;&lt;li&gt;âž¤ available.&lt;/li&gt;&lt;li&gt;âž¤ Prompt&lt;/li&gt;&lt;li&gt;âž¤ thrombolytic therapy&lt;/li&gt;&lt;li&gt;âž¤ improve outcomes in STEMI&lt;/li&gt;&lt;li&gt;âž¤ coronary blood flow&lt;/li&gt;&lt;li&gt;âž¤ minimizing myocardial damage.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Drug obtained from plant (shown in the Figure) is used for treatment of? Myocardial infarction Malaria Congestive heart failure Arrhythmias&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;a &amp;amp; b&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;b &amp;amp; c&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;c &amp;amp; d&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;b &amp;amp; d&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. b &amp; d&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/picture4_rOVLeTF.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) b &amp;amp; d&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Myocardial infarction: Neither quinine nor quinidine is primarily used for the treatment of myocardial infarction.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Myocardial infarction:&lt;/li&gt;&lt;li&gt;â€¢ quinine nor quinidine&lt;/li&gt;&lt;li&gt;â€¢ myocardial infarction.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Malaria: Quinine , obtained from the cinchona bark , is indeed used for the treatment of malaria.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Malaria:&lt;/li&gt;&lt;li&gt;â€¢ Quinine&lt;/li&gt;&lt;li&gt;â€¢ cinchona bark&lt;/li&gt;&lt;li&gt;â€¢ treatment of malaria.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Congestive heart failure: Neither quinine nor quinidine is a first-line treatment for congestive heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Congestive heart failure:&lt;/li&gt;&lt;li&gt;â€¢ Neither quinine nor quinidine&lt;/li&gt;&lt;li&gt;â€¢ first-line&lt;/li&gt;&lt;li&gt;â€¢ congestive heart failure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Quinine and quinidine, drugs derived from the cinchona plant, are used in the treatment of malaria and cardiac arrhythmias, respectively, illustrating the importance of plant-based compounds in the development of medications.&lt;/li&gt;&lt;li&gt;âž¤ Quinine and quinidine,&lt;/li&gt;&lt;li&gt;âž¤ cinchona plant,&lt;/li&gt;&lt;li&gt;âž¤ malaria and cardiac arrhythmias,&lt;/li&gt;&lt;li&gt;âž¤ importance of plant-based compounds&lt;/li&gt;&lt;li&gt;âž¤ development of medications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs is used for reversal of cerebral vasospasm and infarct following subarachnoid hemorrhage?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Nimodipine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amlodipine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diltiazem&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Verapamil&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Nimodipine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Nimodipine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Amlodipine: While amlodipine is also a calcium channel blocker , it is not specifically indicated for cerebral vasospasm. It is more commonly used for hypertension and coronary artery disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Amlodipine:&lt;/li&gt;&lt;li&gt;â€¢ calcium channel blocker&lt;/li&gt;&lt;li&gt;â€¢ cerebral vasospasm.&lt;/li&gt;&lt;li&gt;â€¢ hypertension and coronary artery disease.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Diltiazem: Diltiazem is another calcium channel blocker with a broader cardiovascular effect profile and is not the drug of choice for cerebral vasospasm.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Diltiazem:&lt;/li&gt;&lt;li&gt;â€¢ calcium channel blocker&lt;/li&gt;&lt;li&gt;â€¢ broader cardiovascular effect profile&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ cerebral vasospasm.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Verapamil: Verapamil is a non-selective calcium channel blocker and is not specifically recommended for the treatment of cerebral vasospasm following subarachnoid hemorrhage.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Verapamil:&lt;/li&gt;&lt;li&gt;â€¢ non-selective calcium channel blocker&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ cerebral vasospasm&lt;/li&gt;&lt;li&gt;â€¢ subarachnoid hemorrhage.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Nimodipine is used for the reversal of cerebral vasospasm and reducing mortality after subarachnoid hemorrhage, due to its s elective action on cerebral blood vessels.&lt;/li&gt;&lt;li&gt;âž¤ Nimodipine&lt;/li&gt;&lt;li&gt;âž¤ reversal of cerebral vasospasm and reducing mortality&lt;/li&gt;&lt;li&gt;âž¤ subarachnoid hemorrhage,&lt;/li&gt;&lt;li&gt;âž¤ elective action on cerebral blood vessels.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Antihypertensive drugs act by all the following mechanism except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Na + - K + - ATPase inhibition&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alpha adrenergic blockade&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Beta adrenergic blockade&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Potassium channel opener&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Na + - K + - ATPase inhibition&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Na+- K+- ATPase inhibition&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Na+- K+- ATPase inhibition mechanism is associated with digitalis drugs for CHF and not with the treatment of hypertension, whereas alpha and beta adrenergic blockade and potassium channel opening are valid mechanisms for antihypertensive drugs.&lt;/li&gt;&lt;li&gt;âž¤ Na+- K+- ATPase inhibition&lt;/li&gt;&lt;li&gt;âž¤ digitalis drugs for CHF&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ hypertension,&lt;/li&gt;&lt;li&gt;âž¤ alpha and beta adrenergic blockade and potassium channel opening&lt;/li&gt;&lt;li&gt;âž¤ antihypertensive drugs.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a patient with concomitant diabetes, anti-hypertensive agent of choice is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thiazides&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Beta adrenergic blocker&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ACE inhibitor&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diazoxide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. ACE inhibitor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) ACE inhibitor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Thiazides: Thiazide diuretics are effective antihypertensive agents but can affect carbohydrate metabolism and are not the first choice in patients with diabetes , as they can potentially worsen glycemic control.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Thiazides:&lt;/li&gt;&lt;li&gt;â€¢ antihypertensive&lt;/li&gt;&lt;li&gt;â€¢ affect carbohydrate metabolism&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ first choice in patients with diabetes&lt;/li&gt;&lt;li&gt;â€¢ worsen glycemic control.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Beta adrenergic blocker: Beta-blockers can mask symptoms of hypoglycemia and may also affect lipid metabolism. Although they are effective for blood pressure control, they are not typically the first-line choice in diabetic patients unless there are other compelling indications such as heart failure or post-myocardial infarction.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Beta adrenergic blocker:&lt;/li&gt;&lt;li&gt;â€¢ can mask&lt;/li&gt;&lt;li&gt;â€¢ hypoglycemia&lt;/li&gt;&lt;li&gt;â€¢ lipid metabolism.&lt;/li&gt;&lt;li&gt;â€¢ effective for blood pressure control,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ first-line choice in diabetic patients&lt;/li&gt;&lt;li&gt;â€¢ other compelling indications such as heart failure or post-myocardial infarction.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Diazoxide: Diazoxide is a vasodilator that can actually increase blood sugar levels by inhibiting insulin release from the pancreas . It is not used for routine treatment of hypertension and is certainly not the drug of choice in patients with diabetes.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Diazoxide:&lt;/li&gt;&lt;li&gt;â€¢ vasodilator&lt;/li&gt;&lt;li&gt;â€¢ increase blood sugar levels&lt;/li&gt;&lt;li&gt;â€¢ inhibiting insulin release&lt;/li&gt;&lt;li&gt;â€¢ pancreas&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ hypertension&lt;/li&gt;&lt;li&gt;â€¢ not the drug of choice in patients with diabetes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational goal is to understand the appropriate choice of antihypertensive medication in patients with diabetes . ACE inhibitors offer renal protection and do not worsen glycemic control, making them a superior option for this patient population. Other properties of ACE inhibitors are also important for entrance exams.&lt;/li&gt;&lt;li&gt;âž¤ appropriate choice of antihypertensive medication in patients with diabetes&lt;/li&gt;&lt;li&gt;âž¤ ACE&lt;/li&gt;&lt;li&gt;âž¤ inhibitors offer renal protection&lt;/li&gt;&lt;li&gt;âž¤ do not&lt;/li&gt;&lt;li&gt;âž¤ glycemic control,&lt;/li&gt;&lt;li&gt;âž¤ Properties of ACE inhibitors&lt;/li&gt;&lt;li&gt;âž¤ Properties of ACE inhibitors&lt;/li&gt;&lt;li&gt;âž¤ C - C ough&lt;/li&gt;&lt;li&gt;âž¤ C&lt;/li&gt;&lt;li&gt;âž¤ C&lt;/li&gt;&lt;li&gt;âž¤ A - A ngioedema&lt;/li&gt;&lt;li&gt;âž¤ A&lt;/li&gt;&lt;li&gt;âž¤ A&lt;/li&gt;&lt;li&gt;âž¤ P - P rodrugs (except captopril and Lisinopril)&lt;/li&gt;&lt;li&gt;âž¤ P&lt;/li&gt;&lt;li&gt;âž¤ P&lt;/li&gt;&lt;li&gt;âž¤ T - T aste disturbances&lt;/li&gt;&lt;li&gt;âž¤ T&lt;/li&gt;&lt;li&gt;âž¤ T&lt;/li&gt;&lt;li&gt;âž¤ O - O rthostatic hypotension (when combined with diuretics)&lt;/li&gt;&lt;li&gt;âž¤ O&lt;/li&gt;&lt;li&gt;âž¤ O&lt;/li&gt;&lt;li&gt;âž¤ P - P regnancy (contra- indicated)&lt;/li&gt;&lt;li&gt;âž¤ P&lt;/li&gt;&lt;li&gt;âž¤ P&lt;/li&gt;&lt;li&gt;âž¤ R - bilateral R enal artery stenosis (contra-indicated)&lt;/li&gt;&lt;li&gt;âž¤ R&lt;/li&gt;&lt;li&gt;âž¤ R&lt;/li&gt;&lt;li&gt;âž¤ I - I ncreased K+ (contra-indicated)&lt;/li&gt;&lt;li&gt;âž¤ I&lt;/li&gt;&lt;li&gt;âž¤ I&lt;/li&gt;&lt;li&gt;âž¤ L - L ower the risk of diabetic nephropathy (Preferred drug in diabetic patients with hypertension)&lt;/li&gt;&lt;li&gt;âž¤ L&lt;/li&gt;&lt;li&gt;âž¤ L&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is a Rho kinase inhibitor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fasudil&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ranolazine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Trimetazidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ivabradine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Fasudil&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Fasudil&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ranolazine: Ranolazine is an anti-anginal medication. It works by inhibiting the late phase of the sodium current in the cardiac myocytes , thus reducing intracellular calcium overload and myocardial oxygen consumption. It does not act as a Rho kinase inhibitor.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ranolazine:&lt;/li&gt;&lt;li&gt;â€¢ anti-anginal medication.&lt;/li&gt;&lt;li&gt;â€¢ inhibiting the late phase of the sodium&lt;/li&gt;&lt;li&gt;â€¢ cardiac myocytes&lt;/li&gt;&lt;li&gt;â€¢ reducing intracellular calcium overload&lt;/li&gt;&lt;li&gt;â€¢ myocardial oxygen consumption.&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ Rho kinase&lt;/li&gt;&lt;li&gt;â€¢ inhibitor.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Trimetazidine: Trimetazidine is an anti-ischemic (anti-anginal) metabolic agent that improves myocardial glucose utilization through inhibition of fatty acid metabolism. This action helps to maintain energy production in ischemic heart cells. Trimetazidine is not a Rho kinase inhibitor.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Trimetazidine:&lt;/li&gt;&lt;li&gt;â€¢ anti-ischemic (anti-anginal) metabolic agent&lt;/li&gt;&lt;li&gt;â€¢ improves myocardial glucose&lt;/li&gt;&lt;li&gt;â€¢ inhibition of fatty acid metabolism.&lt;/li&gt;&lt;li&gt;â€¢ maintain energy production in ischemic heart cells.&lt;/li&gt;&lt;li&gt;â€¢ Trimetazidine is not a Rho kinase inhibitor.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ivabradine: Ivabradine is a heart rate-reducing agent that works by inhibiting the If (funny) channel in the sinoatrial node of the heart , leading to a reduction in heart rate and myocardial oxygen demand. It is used for the treatment of chronic heart failure and stable angina pectoris in patients who cannot take beta-blockers . Ivabradine is not a Rho kinase inhibitor.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ivabradine:&lt;/li&gt;&lt;li&gt;â€¢ heart rate-reducing agent&lt;/li&gt;&lt;li&gt;â€¢ inhibiting the If (funny) channel in the sinoatrial node&lt;/li&gt;&lt;li&gt;â€¢ of the heart&lt;/li&gt;&lt;li&gt;â€¢ reduction in heart rate and myocardial oxygen demand.&lt;/li&gt;&lt;li&gt;â€¢ chronic heart failure&lt;/li&gt;&lt;li&gt;â€¢ stable angina pectoris&lt;/li&gt;&lt;li&gt;â€¢ cannot take beta-blockers&lt;/li&gt;&lt;li&gt;â€¢ Ivabradine is not a Rho kinase inhibitor.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational goal is to understand the different mechanisms of action of various anti-anginal drugs. Fasudil as a Rho kinase inhibitor contrasts with ranolazine, trimetazidine, and ivabradine, which have different mechanisms.&lt;/li&gt;&lt;li&gt;âž¤ different mechanisms of action&lt;/li&gt;&lt;li&gt;âž¤ anti-anginal drugs. Fasudil as a Rho kinase&lt;/li&gt;&lt;li&gt;âž¤ inhibitor contrasts&lt;/li&gt;&lt;li&gt;âž¤ ranolazine, trimetazidine, and ivabradine,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the antiarrhythmic agent with the following mechanism of action?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Flecainide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tocainide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Procainamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ibutilide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Flecainide&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/14/whatsapp-image-2024-02-14-at-35057-pm.jpeg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/25/image-3-1.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Flecainide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Tocainide: Tocainide is a Class IB antiarrhythmic agent. Class IB drugs tend to shorten the action potential duration rather than having no change in repolarization.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Tocainide:&lt;/li&gt;&lt;li&gt;â€¢ Class IB antiarrhythmic agent.&lt;/li&gt;&lt;li&gt;â€¢ shorten the action potential&lt;/li&gt;&lt;li&gt;â€¢ no change in repolarization.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Procainamide: Procainamide is a Class IA antiarrhythmic agent that not only blocks sodium channels but also has a moderate effect on repolarization, leading to a slight prolongation of the action potential, which is not depicted in the graph.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Procainamide:&lt;/li&gt;&lt;li&gt;â€¢ a Class IA antiarrhythmic agent&lt;/li&gt;&lt;li&gt;â€¢ not only blocks sodium channels&lt;/li&gt;&lt;li&gt;â€¢ moderate effect on repolarization,&lt;/li&gt;&lt;li&gt;â€¢ slight prolongation of the action potential,&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ibutilide: Ibutilide is a Class III antiarrhythmic drug that acts by prolonging repolarization through potassium channel blockade, which would lengthen the action potential, contrary to what is shown in the graph.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ibutilide:&lt;/li&gt;&lt;li&gt;â€¢ Class III antiarrhythmic drug&lt;/li&gt;&lt;li&gt;â€¢ prolonging repolarization&lt;/li&gt;&lt;li&gt;â€¢ potassium channel&lt;/li&gt;&lt;li&gt;â€¢ blockade,&lt;/li&gt;&lt;li&gt;â€¢ lengthen the action potential,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational goal is to recognize the electrophysiologic profiles of different classes of antiarrhythmic drugs. Class IC antiarrhythmics like flecainide are characterized by their potent sodium channel-blocking effects with minimal impact on the duration of the action potential. Understanding these properties is important for the appropriate selection and use of antiarrhythmic drugs in clinical practice.&lt;/li&gt;&lt;li&gt;âž¤ electrophysiologic profiles&lt;/li&gt;&lt;li&gt;âž¤ different classes of antiarrhythmic drugs.&lt;/li&gt;&lt;li&gt;âž¤ Class IC&lt;/li&gt;&lt;li&gt;âž¤ antiarrhythmics like flecainide&lt;/li&gt;&lt;li&gt;âž¤ potent sodium channel-blocking effects&lt;/li&gt;&lt;li&gt;âž¤ minimal impact&lt;/li&gt;&lt;li&gt;âž¤ duration of the action potential.&lt;/li&gt;&lt;li&gt;âž¤ appropriate selection and use of antiarrhythmic drugs in clinical practice.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT true about the use of Î² blockers in CHF?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;These should be started at a very low dose and slowly titrated upwards&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carvedilol is the most widely used Î² blocker&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;These are drug of choice in acute decompensated heart failure&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;These can reduce mortality in CHF patients&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. These are drug of choice in acute decompensated heart failure&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) These are drug of choice in acute decompensated heart failure&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. These should be started at a very low dose and slowly titrated upwards: This is correct and a key principle in the chronic management of CHF . Beta blockers need to be started at low doses to avoid abrupt changes in cardiac function and allow for patient tolerance.&lt;/li&gt;&lt;li&gt;â€¢ Option A. These should be started at a very low dose and slowly titrated upwards:&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ chronic&lt;/li&gt;&lt;li&gt;â€¢ CHF&lt;/li&gt;&lt;li&gt;â€¢ low doses to avoid abrupt changes in cardiac function&lt;/li&gt;&lt;li&gt;â€¢ Option B. Carvedilol is the most widely used Î² blocker: While carvedilol is one of the commonly used beta blockers in CHF, saying it is \&quot; the most widely used \&quot; may not be true in all settings, as metoprolol and bisoprolol are also commonly prescribed. However, this statement is generally accepted in practice.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Carvedilol is the most widely used Î² blocker:&lt;/li&gt;&lt;li&gt;â€¢ carvedilol&lt;/li&gt;&lt;li&gt;â€¢ beta blockers in CHF,&lt;/li&gt;&lt;li&gt;â€¢ the most widely used&lt;/li&gt;&lt;li&gt;â€¢ not be true in all settings,&lt;/li&gt;&lt;li&gt;â€¢ metoprolol and bisoprolol&lt;/li&gt;&lt;li&gt;â€¢ also commonly prescribed.&lt;/li&gt;&lt;li&gt;â€¢ Option D. These can reduce mortality in CHF patients: This is true . Beta blockers have been shown to decrease mortality in chronic CHF by improving left ventricular function , reducing arrhythmias, and limiting cardiac remodeling.&lt;/li&gt;&lt;li&gt;â€¢ Option D. These can reduce mortality in CHF patients:&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;li&gt;â€¢ Beta blockers&lt;/li&gt;&lt;li&gt;â€¢ decrease mortality in chronic&lt;/li&gt;&lt;li&gt;â€¢ CHF&lt;/li&gt;&lt;li&gt;â€¢ improving left ventricular function&lt;/li&gt;&lt;li&gt;â€¢ reducing arrhythmias, and limiting cardiac remodeling.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Beta blockers should not be used as the drug of choice in acute decompensated heart failure but are essential for the management of chronic CHF , where they have been shown to reduce mortality and morbidity.&lt;/li&gt;&lt;li&gt;âž¤ Beta blockers&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ drug of choice&lt;/li&gt;&lt;li&gt;âž¤ acute decompensated heart failure&lt;/li&gt;&lt;li&gt;âž¤ chronic CHF&lt;/li&gt;&lt;li&gt;âž¤ reduce mortality and morbidity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following drugs can cause gynecomastia except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Digoxin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amiloride&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cimetidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ketoconazole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Amiloride&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Amiloride&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Digoxin: Digoxin, a cardiac glycoside, has been associated with gynecomastia as a rare adverse effect, possibly due to its estrogen-like effects and alterations in hormone metabolism.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Digoxin:&lt;/li&gt;&lt;li&gt;â€¢ Digoxin,&lt;/li&gt;&lt;li&gt;â€¢ cardiac glycoside,&lt;/li&gt;&lt;li&gt;â€¢ gynecomastia&lt;/li&gt;&lt;li&gt;â€¢ adverse effect,&lt;/li&gt;&lt;li&gt;â€¢ estrogen-like effects and alterations in hormone metabolism.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cimetidine: Cimetidine, a histamine H2 receptor antagonist , can cause gynecomastia by blocking androgen receptors and increasing prolactin secretion.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cimetidine:&lt;/li&gt;&lt;li&gt;â€¢ histamine H2 receptor antagonist&lt;/li&gt;&lt;li&gt;â€¢ gynecomastia&lt;/li&gt;&lt;li&gt;â€¢ blocking androgen receptors&lt;/li&gt;&lt;li&gt;â€¢ increasing prolactin secretion.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ketoconazole: Ketoconazole, an antifungal agent, can inhibit testosterone synthesis by blocking cytochrome P450 enzymes, leading to elevated estrogen levels and resulting in gynecomastia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ketoconazole:&lt;/li&gt;&lt;li&gt;â€¢ an antifungal agent,&lt;/li&gt;&lt;li&gt;â€¢ inhibit testosterone synthesis&lt;/li&gt;&lt;li&gt;â€¢ blocking cytochrome P450&lt;/li&gt;&lt;li&gt;â€¢ elevated estrogen levels&lt;/li&gt;&lt;li&gt;â€¢ gynecomastia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational goal is to recognize medications associated with the development of gynecomastia a s an adverse effect.&lt;/li&gt;&lt;li&gt;âž¤ recognize medications associated with the development of gynecomastia a&lt;/li&gt;&lt;li&gt;âž¤ IMPORTANT DRUGS CAUSING GYNAECOMASTIA:&lt;/li&gt;&lt;li&gt;âž¤ IMPORTANT DRUGS CAUSING GYNAECOMASTIA:&lt;/li&gt;&lt;li&gt;âž¤ DI: DI goxin&lt;/li&gt;&lt;li&gt;âž¤ DI: DI&lt;/li&gt;&lt;li&gt;âž¤ S: S pironolactone&lt;/li&gt;&lt;li&gt;âž¤ S: S&lt;/li&gt;&lt;li&gt;âž¤ C: C imetidine, K etoconazole&lt;/li&gt;&lt;li&gt;âž¤ C: C&lt;/li&gt;&lt;li&gt;âž¤ K&lt;/li&gt;&lt;li&gt;âž¤ O: O estrogens&lt;/li&gt;&lt;li&gt;âž¤ O: O&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drug precipitates digoxin toxicity by inhibiting the efflux proteins (P-glycoprotein) of digoxin?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Calcium gluconate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Quinidine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tricyclic antidepressants&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Quinidine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Quinidine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Calcium gluconate: Calcium gluconate is not known to inhibit P-gp and does not precipitate digoxin toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Calcium gluconate:&lt;/li&gt;&lt;li&gt;â€¢ not known&lt;/li&gt;&lt;li&gt;â€¢ inhibit P-gp&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ digoxin toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Propranolol: Propranolol is a beta-blocker and d oes not inhibit P-gp. It may increase the risk of digoxin toxicity through additive negative chronotropic and dromotropic effects.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Propranolol:&lt;/li&gt;&lt;li&gt;â€¢ beta-blocker&lt;/li&gt;&lt;li&gt;â€¢ oes not inhibit P-gp.&lt;/li&gt;&lt;li&gt;â€¢ increase the risk of digoxin toxicity&lt;/li&gt;&lt;li&gt;â€¢ negative chronotropic and dromotropic effects.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tricyclic antidepressants: Tricyclic antidepressants are not known to inhibit P-gp and do not directly precipitate digoxin toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tricyclic antidepressants:&lt;/li&gt;&lt;li&gt;â€¢ not known to inhibit P-gp&lt;/li&gt;&lt;li&gt;â€¢ do not&lt;/li&gt;&lt;li&gt;â€¢ digoxin&lt;/li&gt;&lt;li&gt;â€¢ toxicity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational goal is to know the important drug interactions that can precipitate digoxin toxicity.&lt;/li&gt;&lt;li&gt;âž¤ drug interactions&lt;/li&gt;&lt;li&gt;âž¤ digoxin toxicity.&lt;/li&gt;&lt;li&gt;âž¤ Interactions of digoxin:&lt;/li&gt;&lt;li&gt;âž¤ Interactions of digoxin:&lt;/li&gt;&lt;li&gt;âž¤ Diuretics : Cause hypokalemia which increases the risk of digitalis arrhythmias: potassium supplements should be given prophylactically. Calcium : Synergies with digitalis and thus precipitates toxicity. Quinidine : Reduces its renal and biliary clearance by inhibiting efflux transporter P-glycoprotein leading to increase in plasma concentration of digoxin. Verapamil, clarithromycin and amiodarone also increase plasma concentration of digoxin to variable extents.&lt;/li&gt;&lt;li&gt;âž¤ Diuretics : Cause hypokalemia which increases the risk of digitalis arrhythmias: potassium supplements should be given prophylactically.&lt;/li&gt;&lt;li&gt;âž¤ Diuretics&lt;/li&gt;&lt;li&gt;âž¤ hypokalemia&lt;/li&gt;&lt;li&gt;âž¤ increases the risk of digitalis arrhythmias: potassium supplements&lt;/li&gt;&lt;li&gt;âž¤ prophylactically.&lt;/li&gt;&lt;li&gt;âž¤ Calcium : Synergies with digitalis and thus precipitates toxicity.&lt;/li&gt;&lt;li&gt;âž¤ Calcium&lt;/li&gt;&lt;li&gt;âž¤ Synergies with digitalis&lt;/li&gt;&lt;li&gt;âž¤ precipitates toxicity.&lt;/li&gt;&lt;li&gt;âž¤ Quinidine : Reduces its renal and biliary clearance by inhibiting efflux transporter P-glycoprotein leading to increase in plasma concentration of digoxin. Verapamil, clarithromycin and amiodarone also increase plasma concentration of digoxin to variable extents.&lt;/li&gt;&lt;li&gt;âž¤ Quinidine&lt;/li&gt;&lt;li&gt;âž¤ Reduces its renal and biliary clearance&lt;/li&gt;&lt;li&gt;âž¤ inhibiting efflux transporter P-glycoprotein&lt;/li&gt;&lt;li&gt;âž¤ increase in&lt;/li&gt;&lt;li&gt;âž¤ plasma concentration of digoxin.&lt;/li&gt;&lt;li&gt;âž¤ Verapamil, clarithromycin and amiodarone&lt;/li&gt;&lt;li&gt;âž¤ increase plasma concentration of digoxin to variable extents.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following drugs are likely to produce the following ECG abnormality except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Procainamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Flecanide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Quinidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sotalol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Flecanide&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/25/49.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/screenshot-2024-05-08-123410.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Flecainide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Procainamide: Procainamide is a Class Ia antiarrhythmic that can block cardiac potassium channels , which may lead to QT prolongation and the potential development of Torsades de pointes.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Procainamide:&lt;/li&gt;&lt;li&gt;â€¢ Class Ia antiarrhythmic&lt;/li&gt;&lt;li&gt;â€¢ block cardiac potassium channels&lt;/li&gt;&lt;li&gt;â€¢ QT prolongation&lt;/li&gt;&lt;li&gt;â€¢ Torsades de pointes.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Quinidine: Quinidine, also a Class Ia antiarrhythmic, has similar effects on potassium channels and can cause QT prolongation and Torsades de pointes.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Quinidine:&lt;/li&gt;&lt;li&gt;â€¢ Class Ia antiarrhythmic,&lt;/li&gt;&lt;li&gt;â€¢ potassium channels&lt;/li&gt;&lt;li&gt;â€¢ QT&lt;/li&gt;&lt;li&gt;â€¢ prolongation and Torsades de pointes.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sotalol: Sotalol is a Class III antiarrhythmic that can cause QT prolongation and is known to be associated with the risk of Torsades de pointes.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sotalol:&lt;/li&gt;&lt;li&gt;â€¢ Class III antiarrhythmic&lt;/li&gt;&lt;li&gt;â€¢ QT prolongation&lt;/li&gt;&lt;li&gt;â€¢ risk of&lt;/li&gt;&lt;li&gt;â€¢ Torsades de pointes.&lt;/li&gt;&lt;li&gt;â€¢ Flecainide, a Class Ic antiarrhythmic , primarily affects sodium channels and is less likely to cause QT prolongation, making it less likely to be associated with Torsades de pointes compared to the other drugs listed.&lt;/li&gt;&lt;li&gt;â€¢ Flecainide, a Class Ic antiarrhythmic&lt;/li&gt;&lt;li&gt;â€¢ sodium channels&lt;/li&gt;&lt;li&gt;â€¢ less likely&lt;/li&gt;&lt;li&gt;â€¢ QT prolongation,&lt;/li&gt;&lt;li&gt;â€¢ less&lt;/li&gt;&lt;li&gt;â€¢ Torsades de pointes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Flecainide , a Class Ic antiarrhythmic drug, is unlikely to cause QT prolongation and Torsades de pointes compared to Class Ia and III drugs, which can prolong the QT interval and are implicated in this arrhythmia.&lt;/li&gt;&lt;li&gt;âž¤ Flecainide&lt;/li&gt;&lt;li&gt;âž¤ Class Ic antiarrhythmic&lt;/li&gt;&lt;li&gt;âž¤ unlikely to cause QT prolongation&lt;/li&gt;&lt;li&gt;âž¤ Torsades de pointes&lt;/li&gt;&lt;li&gt;âž¤ compared to Class Ia and III&lt;/li&gt;&lt;li&gt;âž¤ prolong the QT interval&lt;/li&gt;&lt;li&gt;âž¤ arrhythmia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following about the use of spironolactone in congestive heart failure are true except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It should be given in low doses to prevent hyperkalemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It affords prognostic benefit in severe heart failure over and above ACEI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It helps to overcome refractoriness to loop diuretics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It affords rapid symptomatic relief in CHF patients&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. It affords rapid symptomatic relief in CHF patients&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) It affords rapid symptomatic relief in CHF patients&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. It should be given in low doses to prevent hyperkalemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ It should be given in low doses to prevent hyperkalemia.&lt;/li&gt;&lt;li&gt;â€¢ This statement is true. Spironolactone is a potassium-sparing diuretic , and one of its potential side effects is hyperkalemia (high blood potassium levels). Therefore, it is typically started at a low dose to minimize this risk.&lt;/li&gt;&lt;li&gt;â€¢ This statement is true. Spironolactone is a potassium-sparing diuretic , and one of its potential side effects is hyperkalemia (high blood potassium levels). Therefore, it is typically started at a low dose to minimize this risk.&lt;/li&gt;&lt;li&gt;â€¢ true.&lt;/li&gt;&lt;li&gt;â€¢ potassium-sparing diuretic&lt;/li&gt;&lt;li&gt;â€¢ hyperkalemia (high blood potassium levels).&lt;/li&gt;&lt;li&gt;â€¢ low dose to minimize this risk.&lt;/li&gt;&lt;li&gt;â€¢ Option B. It affords prognostic benefit in severe HF over and above ACEI.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ It affords prognostic benefit in severe HF over and above ACEI.&lt;/li&gt;&lt;li&gt;â€¢ This statement is true . Spironolactone has been shown to provide a prognostic benefit in patients with severe heart failure, reducing morbidity and mortality when added to standard therapy, including ACE inhibitors (ACEIs).&lt;/li&gt;&lt;li&gt;â€¢ This statement is true . Spironolactone has been shown to provide a prognostic benefit in patients with severe heart failure, reducing morbidity and mortality when added to standard therapy, including ACE inhibitors (ACEIs).&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;li&gt;â€¢ prognostic benefit&lt;/li&gt;&lt;li&gt;â€¢ severe heart&lt;/li&gt;&lt;li&gt;â€¢ failure, reducing morbidity and mortality&lt;/li&gt;&lt;li&gt;â€¢ standard therapy, including ACE inhibitors (ACEIs).&lt;/li&gt;&lt;li&gt;â€¢ Option C. It helps to overcome refractoriness to loop diuretics.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ It helps to overcome refractoriness to loop diuretics.&lt;/li&gt;&lt;li&gt;â€¢ This statement is true . Spironolactone can be used in combination with loop diuretics to overcome diuretic resistance in CHF . L oop diuretics can lead to increased renal potassium and magnesium loss, and adding a potassium-sparing agent like spironolactone can help counteract this effect and enhance diuretic response.&lt;/li&gt;&lt;li&gt;â€¢ This statement is true . Spironolactone can be used in combination with loop diuretics to overcome diuretic resistance in CHF . L oop diuretics can lead to increased renal potassium and magnesium loss, and adding a potassium-sparing agent like spironolactone can help counteract this effect and enhance diuretic response.&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;li&gt;â€¢ combination with loop diuretics&lt;/li&gt;&lt;li&gt;â€¢ diuretic resistance&lt;/li&gt;&lt;li&gt;â€¢ CHF&lt;/li&gt;&lt;li&gt;â€¢ oop diuretics&lt;/li&gt;&lt;li&gt;â€¢ increased renal potassium and magnesium loss,&lt;/li&gt;&lt;li&gt;â€¢ potassium-sparing agent&lt;/li&gt;&lt;li&gt;â€¢ spironolactone&lt;/li&gt;&lt;li&gt;â€¢ counteract this effect and enhance diuretic response.&lt;/li&gt;&lt;li&gt;â€¢ Current evidence suggests the following regarding aldosterone receptor antagonist (spironolactone and eplerenone) therapy in CHF:&lt;/li&gt;&lt;li&gt;â€¢ Current evidence suggests the following regarding aldosterone receptor antagonist (spironolactone and eplerenone) therapy in CHF:&lt;/li&gt;&lt;li&gt;â€¢ It is indicated as add-on therapy to ACE inhibitors + other drugs in moderate-to-severe CHF. It can retard disease progression, reduce episodes of decompensation and death due to heart failure as well as sudden c ardiac deaths , over and above the protection afforded by ACE inhibitors/ARBs Â± Î² blockers. Only low doses (12.5â€“25 mg/day) of spironolactone should be used to avoid hyperkalemia; particularly because of concurrent ACE inhibitor/ARB therapy. It may help restoration of diuretic response to furosemide when refractoriness has developed.&lt;/li&gt;&lt;li&gt;â€¢ It is indicated as add-on therapy to ACE inhibitors + other drugs in moderate-to-severe CHF.&lt;/li&gt;&lt;li&gt;â€¢ add-on therapy to ACE inhibitors + other drugs&lt;/li&gt;&lt;li&gt;â€¢ moderate-to-severe CHF.&lt;/li&gt;&lt;li&gt;â€¢ It can retard disease progression, reduce episodes of decompensation and death due to heart failure as well as sudden c ardiac deaths , over and above the protection afforded by ACE inhibitors/ARBs Â± Î² blockers.&lt;/li&gt;&lt;li&gt;â€¢ retard disease progression, reduce episodes of decompensation and death&lt;/li&gt;&lt;li&gt;â€¢ heart failure&lt;/li&gt;&lt;li&gt;â€¢ sudden&lt;/li&gt;&lt;li&gt;â€¢ ardiac deaths&lt;/li&gt;&lt;li&gt;â€¢ protection afforded by ACE inhibitors/ARBs Â± Î² blockers.&lt;/li&gt;&lt;li&gt;â€¢ Only low doses (12.5â€“25 mg/day) of spironolactone should be used to avoid hyperkalemia; particularly because of concurrent ACE inhibitor/ARB therapy.&lt;/li&gt;&lt;li&gt;â€¢ low doses (12.5â€“25 mg/day)&lt;/li&gt;&lt;li&gt;â€¢ avoid hyperkalemia;&lt;/li&gt;&lt;li&gt;â€¢ concurrent ACE inhibitor/ARB therapy.&lt;/li&gt;&lt;li&gt;â€¢ It may help restoration of diuretic response to furosemide when refractoriness has developed.&lt;/li&gt;&lt;li&gt;â€¢ restoration of diuretic response to furosemide&lt;/li&gt;&lt;li&gt;â€¢ refractoriness has developed.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following statements about the Nitrates in Angina are true except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reduce preload&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sildenafil may pronounce hypotension and should never be combined&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cause redistribution of coronary blood flow&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tolerance is most seen in sublingual administration of nitrates&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Tolerance is most seen in sublingual administration of nitrates&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Tolerance is most seen in sublingual administration of nitrates&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reduce preload: True . Nitrates predominantly dilate veins, leading to a reduction in preload, which decreases the amount of blood returning to the heart , thereby reducing the work the hear t has to do and the oxygen demand.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reduce preload:&lt;/li&gt;&lt;li&gt;â€¢ True&lt;/li&gt;&lt;li&gt;â€¢ Nitrates predominantly dilate veins,&lt;/li&gt;&lt;li&gt;â€¢ reduction in preload,&lt;/li&gt;&lt;li&gt;â€¢ decreases the amount&lt;/li&gt;&lt;li&gt;â€¢ blood returning to the heart&lt;/li&gt;&lt;li&gt;â€¢ reducing the work the hear&lt;/li&gt;&lt;li&gt;â€¢ do and the oxygen demand.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sildenafil may pronounce hypotension and should never be combined: True. Combining nitrates with sildenafil can lead to dangerous potentiation of vasodilatory effects, resulting in severe hypotension, myocardial infarction, and even death.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sildenafil may pronounce hypotension and should never be combined:&lt;/li&gt;&lt;li&gt;â€¢ True.&lt;/li&gt;&lt;li&gt;â€¢ nitrates with sildenafil&lt;/li&gt;&lt;li&gt;â€¢ vasodilatory effects,&lt;/li&gt;&lt;li&gt;â€¢ severe hypotension,&lt;/li&gt;&lt;li&gt;â€¢ myocardial infarction, and even death.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cause redistribution of coronary blood flow: True . Nitrates preferentially dilate larger conducting coronary arteries over arterioles , which may facilitate increased blood flow to ischemic areas of the heart in patients with angina.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cause redistribution of coronary blood flow:&lt;/li&gt;&lt;li&gt;â€¢ True&lt;/li&gt;&lt;li&gt;â€¢ dilate larger&lt;/li&gt;&lt;li&gt;â€¢ conducting coronary arteries&lt;/li&gt;&lt;li&gt;â€¢ arterioles&lt;/li&gt;&lt;li&gt;â€¢ increased blood flow to ischemic areas of the heart&lt;/li&gt;&lt;li&gt;â€¢ angina.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In the context of angina treatment, nitrates are known to reduce preload and can cause redistribution of coronary blood flow , but significant tolerance is not typically associated with intermittent sublingual administration. It is also critical to avoid the combination of nitrates with sildenafil due to the risk of severe hypotension.&lt;/li&gt;&lt;li&gt;âž¤ nitrates&lt;/li&gt;&lt;li&gt;âž¤ reduce preload&lt;/li&gt;&lt;li&gt;âž¤ redistribution of coronary blood flow&lt;/li&gt;&lt;li&gt;âž¤ significant tolerance&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ with intermittent sublingual administration.&lt;/li&gt;&lt;li&gt;âž¤ avoid the&lt;/li&gt;&lt;li&gt;âž¤ combination of nitrates with sildenafil&lt;/li&gt;&lt;li&gt;âž¤ risk of severe hypotension.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Cardiac oxygen demand (MVO2) must be reduced in angina pectoris. The therapeutic rationale for using SL nitroglycerine is based on:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reduction of after load&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Reduction of heart rate and cardiac MVO2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Reduction of preload and cardiac MVO2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increase preload with decrease in cardiac MVO2&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Reduction of preload and cardiac MVO2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Reduction of preload and cardiac MVO2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reduction of afterload: While nitroglycerine may have some effect on reducing afterload due to its arterial vasodilatory properties , its primary mechanism of action is the reduction of preload.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reduction of afterload:&lt;/li&gt;&lt;li&gt;â€¢ nitroglycerine&lt;/li&gt;&lt;li&gt;â€¢ some effect&lt;/li&gt;&lt;li&gt;â€¢ reducing afterload&lt;/li&gt;&lt;li&gt;â€¢ arterial vasodilatory&lt;/li&gt;&lt;li&gt;â€¢ properties&lt;/li&gt;&lt;li&gt;â€¢ primary mechanism of action&lt;/li&gt;&lt;li&gt;â€¢ reduction of preload.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Reduction of heart rate and cardiac MVO2: Nitroglycerine may have a mild effect on heart rate , but its primary mechanism of action is not related to heart rate reduction. It mainly reduces preload, which indirectly decreases cardiac MVO2.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Reduction of heart rate and cardiac MVO2:&lt;/li&gt;&lt;li&gt;â€¢ Nitroglycerine&lt;/li&gt;&lt;li&gt;â€¢ mild effect on heart rate&lt;/li&gt;&lt;li&gt;â€¢ not related to heart rate reduction.&lt;/li&gt;&lt;li&gt;â€¢ reduces preload,&lt;/li&gt;&lt;li&gt;â€¢ indirectly decreases cardiac MVO2.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Increase preload with decrease in cardiac MVO2: Increasing preload would typically increase cardiac workload and oxygen demand rather than decrease it. This option contradicts the therapeutic rationale for using nitroglycerine in angina pectoris.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Increase preload with decrease in cardiac MVO2:&lt;/li&gt;&lt;li&gt;â€¢ Increasing preload&lt;/li&gt;&lt;li&gt;â€¢ increase cardiac workload and&lt;/li&gt;&lt;li&gt;â€¢ oxygen demand&lt;/li&gt;&lt;li&gt;â€¢ decrease it.&lt;/li&gt;&lt;li&gt;â€¢ contradicts&lt;/li&gt;&lt;li&gt;â€¢ nitroglycerine in angina pectoris.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational goal is to understand the therapeutic rationale for using sublingual nitroglycerine in the management of angina pectoris . By reducing preload, nitroglycerine decreases myocardial oxygen demand, providing symptomatic relief in patients with angina . Understanding the mechanisms of action of nitroglycerine is essential for appropriate prescribing and management of angina episode s.&lt;/li&gt;&lt;li&gt;âž¤ therapeutic rationale&lt;/li&gt;&lt;li&gt;âž¤ sublingual nitroglycerine&lt;/li&gt;&lt;li&gt;âž¤ angina&lt;/li&gt;&lt;li&gt;âž¤ pectoris&lt;/li&gt;&lt;li&gt;âž¤ reducing preload,&lt;/li&gt;&lt;li&gt;âž¤ decreases myocardial oxygen demand,&lt;/li&gt;&lt;li&gt;âž¤ providing symptomatic relief&lt;/li&gt;&lt;li&gt;âž¤ angina&lt;/li&gt;&lt;li&gt;âž¤ mechanisms of action of nitroglycerine&lt;/li&gt;&lt;li&gt;âž¤ prescribing and management&lt;/li&gt;&lt;li&gt;âž¤ angina episode&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following antiarrhythmic drug is contraindicated in a patient with interstitial lung disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amiodarone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sotalol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Quinidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lignocaine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Amiodarone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Amiodarone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sotalol: Sotalol is also a class III antiarrhythmic drug but does not carry the same risk for inducing pulmonary toxicity as amiodarone.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sotalol:&lt;/li&gt;&lt;li&gt;â€¢ class III antiarrhythmic drug&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ pulmonary toxicity as&lt;/li&gt;&lt;li&gt;â€¢ amiodarone.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Quinidine: Quinidine is a class Ia antiarrhythmic drug and is not associated with interstitial lung disease as a side effect.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Quinidine:&lt;/li&gt;&lt;li&gt;â€¢ class Ia antiarrhythmic drug&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ interstitial lung disease&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lignocaine: Lignocaine (lidocaine) is a class Ib antiarrhythmic drug used mainly in acute settings for ventricular arrhythmias and does not have pulmonary toxicity akin to amiodarone.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lignocaine:&lt;/li&gt;&lt;li&gt;â€¢ class Ib antiarrhythmic&lt;/li&gt;&lt;li&gt;â€¢ acute settings for ventricular&lt;/li&gt;&lt;li&gt;â€¢ arrhythmias&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ pulmonary toxicity akin to amiodarone.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Amiodarone, while effective as a broad-spectrum antiarrhythmic agent , is contraindicated in patients with interstitial lung disease because of its serious side effect of pulmonary alveolitis and fibrosis.&lt;/li&gt;&lt;li&gt;âž¤ Amiodarone,&lt;/li&gt;&lt;li&gt;âž¤ broad-spectrum antiarrhythmic agent&lt;/li&gt;&lt;li&gt;âž¤ contraindicated in patients&lt;/li&gt;&lt;li&gt;âž¤ interstitial lung disease&lt;/li&gt;&lt;li&gt;âž¤ side effect of pulmonary alveolitis and fibrosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs block late inward sodium ion channels?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ranolazine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Trimetazidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ivabradine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fasudil&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Ranolazine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Ranolazine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Trimetazidine: Trimetazidine acts as a partial fatty acid oxidation inhibitor, optimizing the energy metabolism of the heart during ischemia, but it does not block sodium channels.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Trimetazidine:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ivabradine: Ivabradine selectively inhibits the funny current (If) in the sinoatrial node, resulting in heart rate reduction, which can be beneficial in conditions like angina and heart failure, but it is not a sodium channel blocker.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ivabradine:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Fasudil: Fasudil is a Rho-kinase inhibitor with vasodilatory effects and does not block sodium channels.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Fasudil:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ranolazine is a late inward sodium channel blocker that can be used to treat chronic angina by improving myocardial relaxation and decreasing ischemia without major effects on heart rate or blood pressure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The side-effect of which of the following drug is used as a therapeutic advantage in alopecia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hydralazine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diazoxide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Minoxidil&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nicorandil&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Minoxidil&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Minoxidil&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hydralazine: Hydralazine is an antihypertensive medication that does not have a therapeutic advantage in alopecia. It does not promote hair growth and is not used in the treatment of alopecia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hydralazine:&lt;/li&gt;&lt;li&gt;â€¢ antihypertensive&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ alopecia.&lt;/li&gt;&lt;li&gt;â€¢ does not promote hair growth&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ alopecia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Diazoxide: Diazoxide is a medication used to treat hypoglycemia and hypertensive emergencies . It is not associated with any therapeutic advantage in alopecia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Diazoxide:&lt;/li&gt;&lt;li&gt;â€¢ treat hypoglycemia and hypertensive emergencies&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ alopecia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nicorandil: Nicorandil is a vasodilator medication used to treat angina pectoris. It does not have a therapeutic advantage in alopecia and is not used for this purpose.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nicorandil:&lt;/li&gt;&lt;li&gt;â€¢ vasodilator medication&lt;/li&gt;&lt;li&gt;â€¢ angina pectoris.&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ alopecia&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational goal is to understand the therapeutic use of minoxidil in the treatment of alopecia and how its side effect of promoting hair growth is exploited for this purpose . Recognizing medications with beneficial side effects allows clinicians to repurpose drugs for new indications and optimize patient care.&lt;/li&gt;&lt;li&gt;âž¤ therapeutic use of minoxidil&lt;/li&gt;&lt;li&gt;âž¤ alopecia&lt;/li&gt;&lt;li&gt;âž¤ side effect of&lt;/li&gt;&lt;li&gt;âž¤ promoting hair growth&lt;/li&gt;&lt;li&gt;âž¤ exploited for this purpose&lt;/li&gt;&lt;li&gt;âž¤ beneficial side effects allows clinicians to repurpose drugs for new indications and optimize patient care.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old patient with a history of coronary artery disease and hyperlipidemia presents to the clinic for a routine follow-up. The patient is currently on atorvastatin for LDL cholesterol management but has recently had a lipid panel showing elevated Lipoprotein (a) levels. The patient is interested in exploring medication options that could specifically target the reduction of Lipoprotein (a) levels. Which of the following drugs is most likely to result in a reduction of Lipoprotein (a) levels?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rosuvastatin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fenofibrate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Evolocumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Niacin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Niacin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Niacin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Rosuvastatin: Statins like rosuvastatin are primarily known for their ability to lower LDL cholesterol but have a less pronounced effect on Lipoprotein (a).&lt;/li&gt;&lt;li&gt;â€¢ Option A. Rosuvastatin:&lt;/li&gt;&lt;li&gt;â€¢ Statins&lt;/li&gt;&lt;li&gt;â€¢ their ability to lower LDL cholesterol&lt;/li&gt;&lt;li&gt;â€¢ less&lt;/li&gt;&lt;li&gt;â€¢ Lipoprotein (a).&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fenofibrate: Fenofibrate is used for its potent triglyceride-lowering effects and does not have a significant impact on Lipoprotein (a) levels.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fenofibrate:&lt;/li&gt;&lt;li&gt;â€¢ potent triglyceride-lowering effects&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ Lipoprotein (a) levels.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Evolocumab: Evolocumab, a PCSK9 inhibitor, primarily lowers LDL cholesterol and has a relatively mild effect on reducing Lipoprotein (a) levels compared to niacin.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Evolocumab:&lt;/li&gt;&lt;li&gt;â€¢ PCSK9 inhibitor,&lt;/li&gt;&lt;li&gt;â€¢ lowers LDL cholesterol&lt;/li&gt;&lt;li&gt;â€¢ mild effect on reducing&lt;/li&gt;&lt;li&gt;â€¢ Lipoprotein (a) levels&lt;/li&gt;&lt;li&gt;â€¢ niacin.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Niacin is a lipid-lowering agent that can significantly reduce levels of Lipoprotein (a), distinguishing it from other lipid-modifying therapies that primarily focus on lowering LDL cholesterol or triglycerides.&lt;/li&gt;&lt;li&gt;âž¤ Niacin is a lipid-lowering agent&lt;/li&gt;&lt;li&gt;âž¤ reduce levels of Lipoprotein (a),&lt;/li&gt;&lt;li&gt;âž¤ lipid-modifying&lt;/li&gt;&lt;li&gt;âž¤ primarily focus on lowering LDL cholesterol or triglycerides.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is a direct renin inhibitor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aliskiren&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Losartan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Perindopril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vernakalant&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Aliskiren&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Aliskiren&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Losartan: Losartan is an angiotensin II receptor blocker (ARB), which works further downstream in the RAAS pathway by blocking the angiotensin II type 1 receptors on blood vessels, leading to vasodilation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Losartan:&lt;/li&gt;&lt;li&gt;â€¢ angiotensin II receptor blocker (ARB),&lt;/li&gt;&lt;li&gt;â€¢ downstream in the RAAS pathway&lt;/li&gt;&lt;li&gt;â€¢ blocking the angiotensin II type 1 receptors on blood vessels,&lt;/li&gt;&lt;li&gt;â€¢ vasodilation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Perindopril: Perindopril is an angiotensin-converting enzyme (ACE) inhibitor . It prevents the conversion of angiotensin I to angiotensin II by inhibiting the ACE enzyme.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Perindopril:&lt;/li&gt;&lt;li&gt;â€¢ angiotensin-converting enzyme (ACE) inhibitor&lt;/li&gt;&lt;li&gt;â€¢ prevents&lt;/li&gt;&lt;li&gt;â€¢ angiotensin I to&lt;/li&gt;&lt;li&gt;â€¢ angiotensin II&lt;/li&gt;&lt;li&gt;â€¢ ACE enzyme.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vernakalant: Vernakalant is not related to the RAAS pathway ; it is a class III antiarrhythmic agent that acts as a multiple ion channel blocke r, particularly affecting atrial cells, and is used to treat certain types of arrhythmias.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vernakalant:&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ RAAS pathway&lt;/li&gt;&lt;li&gt;â€¢ class III antiarrhythmic agent&lt;/li&gt;&lt;li&gt;â€¢ multiple&lt;/li&gt;&lt;li&gt;â€¢ ion channel blocke&lt;/li&gt;&lt;li&gt;â€¢ atrial cells,&lt;/li&gt;&lt;li&gt;â€¢ types of arrhythmias.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Aliskiren is the only direct renin inhibitor among the options listed, acting at the rate-limiting step of the RAAS pathway by inhibiting the conversion of angiotensinogen to angiotensin I.&lt;/li&gt;&lt;li&gt;âž¤ Aliskiren&lt;/li&gt;&lt;li&gt;âž¤ renin inhibitor&lt;/li&gt;&lt;li&gt;âž¤ rate-limiting step of the RAAS pathway&lt;/li&gt;&lt;li&gt;âž¤ inhibiting the conversion of angiotensinogen to angiotensin I.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following antihypertensive drug is avoided in patients with high serum uric acid levels?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hydrochlorothiazide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atenolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prazosin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Enalapril&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Hydrochlorothiazide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Hydrochlorothiazide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Atenolol: Atenolol is a cardioselective beta-blocker that does not directly affect serum uric acid levels . It is not contraindicated in patients with high uric acid levels.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Atenolol:&lt;/li&gt;&lt;li&gt;â€¢ cardioselective beta-blocker&lt;/li&gt;&lt;li&gt;â€¢ serum uric acid levels&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ contraindicated in patients&lt;/li&gt;&lt;li&gt;â€¢ high uric acid levels.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Prazosin : Prazosin is an alpha-1 adrenergic antagonist that does not affect serum uric acid levels . It is not contraindicated in patients with hyperuricemia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Prazosin&lt;/li&gt;&lt;li&gt;â€¢ alpha-1 adrenergic antagonist&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ uric acid levels&lt;/li&gt;&lt;li&gt;â€¢ hyperuricemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Enalapril : Enalapril is an angiotensin-converting enzyme (ACE) inhibitor that does not significantly affect serum uric acid levels. It is generally considered safe for use in patients with high uric acid levels.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Enalapril&lt;/li&gt;&lt;li&gt;â€¢ angiotensin-converting enzyme (ACE) inhibitor&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ serum uric acid&lt;/li&gt;&lt;li&gt;â€¢ high uric acid levels.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the association between antihypertensive medications and serum uric acid levels . Thiazide diuretics like hydrochlorothiazide can increase serum uric acid levels and are typically avoided in patients with hyperuricemia or a history of gout.&lt;/li&gt;&lt;li&gt;âž¤ antihypertensive medications and serum uric acid levels&lt;/li&gt;&lt;li&gt;âž¤ Thiazide diuretics&lt;/li&gt;&lt;li&gt;âž¤ hydrochlorothiazide&lt;/li&gt;&lt;li&gt;âž¤ increase serum uric acid levels&lt;/li&gt;&lt;li&gt;âž¤ avoided in patients&lt;/li&gt;&lt;li&gt;âž¤ hyperuricemia or a history of gout.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The anticonvulsant agent useful as an antiarrhythmic belongs to which class of antiarrhythmic drug?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Class Ia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Class Ib&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Class Ic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Class II&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Class Ib&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Class Ib&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Class Ia antiarrhythmics: Drugs in this class, such as quinidine and procainamide , block sodium channels and prolong the action potential duration . While effective in treating arrhythmias, they are not commonly used as anticonvulsants.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Class Ia antiarrhythmics:&lt;/li&gt;&lt;li&gt;â€¢ such as quinidine and procainamide&lt;/li&gt;&lt;li&gt;â€¢ block sodium channels&lt;/li&gt;&lt;li&gt;â€¢ action potential duration&lt;/li&gt;&lt;li&gt;â€¢ treating arrhythmias,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ anticonvulsants.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Class Ic antiarrhythmics: These drugs, including flecainide and propafenone, also block sodium channels but have minimal effects on action potential duration . They are primarily used for supraventricular arrhythmias and are not typically used as anticonvulsants.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Class Ic antiarrhythmics:&lt;/li&gt;&lt;li&gt;â€¢ including flecainide and propafenone,&lt;/li&gt;&lt;li&gt;â€¢ block sodium channels&lt;/li&gt;&lt;li&gt;â€¢ minimal effects on action potential duration&lt;/li&gt;&lt;li&gt;â€¢ supraventricular arrhythmias&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ anticonvulsants.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Class II antiarrhythmics: Class II drugs are beta-adrenergic blockers , such as propranolol and metoprolol, which reduce sympathetic stimulation of the heart . While they may have indirect effects on certain arrhythmias, they are not commonly used as anticonvulsants.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Class II antiarrhythmics:&lt;/li&gt;&lt;li&gt;â€¢ beta-adrenergic blockers&lt;/li&gt;&lt;li&gt;â€¢ propranolol and metoprolol,&lt;/li&gt;&lt;li&gt;â€¢ reduce&lt;/li&gt;&lt;li&gt;â€¢ sympathetic stimulation of the heart&lt;/li&gt;&lt;li&gt;â€¢ indirect effects on certain arrhythmias,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ anticonvulsants.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understanding the classification of antiarrhythmic drugs and their mechanisms of action is crucial for selecting appropriate medications for the treatment of various arrhythmia s. Additionally, recognizing the dual utility of certain medications, like phenytoin, as both anticonvulsants and antiarrhythmics, enhances clinical decision-making in patients with overlapping conditions.&lt;/li&gt;&lt;li&gt;âž¤ classification of antiarrhythmic drugs&lt;/li&gt;&lt;li&gt;âž¤ their mechanisms of action&lt;/li&gt;&lt;li&gt;âž¤ selecting appropriate&lt;/li&gt;&lt;li&gt;âž¤ medications&lt;/li&gt;&lt;li&gt;âž¤ various arrhythmia&lt;/li&gt;&lt;li&gt;âž¤ dual utility of certain medications,&lt;/li&gt;&lt;li&gt;âž¤ phenytoin, as both anticonvulsants and antiarrhythmics,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 33-year-old man is diagnosed with essential hypertension. He is started on an anti-hypertensive medication. After 6 weeks, he notes fatigue, rash over his face, joint aches, and effusions. A serum antinuclear antibody (ANA) test is positive. Which of the following is the most likely agent person was prescribed?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hydralazine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thiazide diuretic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nifedipine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Hydralazine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Hydralazine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hydralazine is associated with the development of a lupus-like syndrome, which is characterized by symptoms such as rash, joint pain, fatigue, and positive ANA, and it is one of the drugs that can induce this condition, summarized by the acronym \&quot;SHIP\&quot; for sulfonamides, hydralazine, isoniazid, and procainamide.&lt;/li&gt;&lt;li&gt;âž¤ Hydralazine&lt;/li&gt;&lt;li&gt;âž¤ development of a lupus-like syndrome,&lt;/li&gt;&lt;li&gt;âž¤ rash, joint&lt;/li&gt;&lt;li&gt;âž¤ pain, fatigue, and positive ANA,&lt;/li&gt;&lt;li&gt;âž¤ one of the drugs&lt;/li&gt;&lt;li&gt;âž¤ induce&lt;/li&gt;&lt;li&gt;âž¤ \&quot;SHIP\&quot;&lt;/li&gt;&lt;li&gt;âž¤ sulfonamides, hydralazine, isoniazid, and procainamide.&lt;/li&gt;&lt;li&gt;âž¤ The drugs causing SLE like syndrome include:&lt;/li&gt;&lt;li&gt;âž¤ SLE like syndrome&lt;/li&gt;&lt;li&gt;âž¤ S: S ulfonamides (including dapsone) H: H ydralazine I: I soniazid P: P rocainamide All SHIP drugs are metabolized by acetylation.&lt;/li&gt;&lt;li&gt;âž¤ S: S ulfonamides (including dapsone)&lt;/li&gt;&lt;li&gt;âž¤ S: S&lt;/li&gt;&lt;li&gt;âž¤ H: H ydralazine&lt;/li&gt;&lt;li&gt;âž¤ H: H&lt;/li&gt;&lt;li&gt;âž¤ I: I soniazid&lt;/li&gt;&lt;li&gt;âž¤ I: I&lt;/li&gt;&lt;li&gt;âž¤ P: P rocainamide All SHIP drugs are metabolized by acetylation.&lt;/li&gt;&lt;li&gt;âž¤ P: P&lt;/li&gt;&lt;li&gt;âž¤ All SHIP drugs are metabolized by acetylation.&lt;/li&gt;&lt;li&gt;âž¤ All SHIP drugs are metabolized by acetylation.&lt;/li&gt;&lt;li&gt;âž¤ SHIP drugs&lt;/li&gt;&lt;li&gt;âž¤ metabolized by acetylation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old patient presented with the symptoms shown in the image below. Patient is a known hypertensive and was taking some antihypertensive drug. Which of the following drug is the likely cause of this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lisinopril&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Clonidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nifedipine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Timolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Lisinopril&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/25/51.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Lisinopril&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Clonidine: Clonidine, a centrally acting alpha-2 adrenergic agonist, is not typically associated with angioedema . Its main adverse effects include dry mouth, sedation, and rebound hypertension if discontinued abruptly.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Clonidine:&lt;/li&gt;&lt;li&gt;â€¢ centrally acting alpha-2 adrenergic agonist,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ angioedema&lt;/li&gt;&lt;li&gt;â€¢ dry mouth, sedation, and rebound hypertension&lt;/li&gt;&lt;li&gt;â€¢ discontinued abruptly.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Nifedipine: Nifedipine is a calcium channel blocker that primarily dilates arterial vessels and is commonly used to treat hypertension and angina . Angioedema is not a typical side effect of nifedipine.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Nifedipine:&lt;/li&gt;&lt;li&gt;â€¢ calcium channel blocker&lt;/li&gt;&lt;li&gt;â€¢ primarily dilates arterial vessels&lt;/li&gt;&lt;li&gt;â€¢ hypertension and angina&lt;/li&gt;&lt;li&gt;â€¢ Angioedema is not&lt;/li&gt;&lt;li&gt;â€¢ side effect&lt;/li&gt;&lt;li&gt;â€¢ Option D. Timolol: Timolol is a non-selective beta-adrenergic blocker used to treat hypertension, angina, and glaucoma. While beta blockers can rarely cause angioedema , it is not a common side effect associated with timolol.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Timolol:&lt;/li&gt;&lt;li&gt;â€¢ non-selective beta-adrenergic blocker&lt;/li&gt;&lt;li&gt;â€¢ hypertension, angina, and glaucoma.&lt;/li&gt;&lt;li&gt;â€¢ beta&lt;/li&gt;&lt;li&gt;â€¢ blockers&lt;/li&gt;&lt;li&gt;â€¢ angioedema&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ side effect&lt;/li&gt;&lt;li&gt;â€¢ timolol.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Angioedema is a rare but potentially serious adverse effect of ACE inhibitors like lisinopril. Recognizing this adverse reaction is essential for prompt discontinuation of the offending medication and initiation of appropriate management to prevent complications.&lt;/li&gt;&lt;li&gt;âž¤ Angioedema&lt;/li&gt;&lt;li&gt;âž¤ rare&lt;/li&gt;&lt;li&gt;âž¤ serious adverse effect&lt;/li&gt;&lt;li&gt;âž¤ ACE inhibitors&lt;/li&gt;&lt;li&gt;âž¤ lisinopril.&lt;/li&gt;&lt;li&gt;âž¤ prompt discontinuation of the offending medication&lt;/li&gt;&lt;li&gt;âž¤ initiation of appropriate management to prevent&lt;/li&gt;&lt;li&gt;âž¤ complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient on digoxin therapy had a level of 1 ng/ml. He was receiving several other drugs and presented 2 months later with flattening of T waves in ECG. Now the plasma level of digoxin is 3.8 ng/ml. Which of the following drug is likely to be responsible?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Triamterene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atenolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Clarithromycin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;KCI&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Clarithromycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Clarithromycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Triamterene: Triamterene is a potassium-sparing diuretic that can increase digoxin levels by reducing its renal clearance. However, the extent of increase observed in this case is less commonly associated with triamterene.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Triamterene:&lt;/li&gt;&lt;li&gt;â€¢ potassium-sparing diuretic&lt;/li&gt;&lt;li&gt;â€¢ increase digoxin levels&lt;/li&gt;&lt;li&gt;â€¢ reducing its renal clearance.&lt;/li&gt;&lt;li&gt;â€¢ extent of increase&lt;/li&gt;&lt;li&gt;â€¢ less&lt;/li&gt;&lt;li&gt;â€¢ triamterene.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Atenolol: Atenolol, a beta-blocker, can increase digoxin levels by delaying its elimination . However, the degree of increase seen here is less characteristic of atenolol&#x27;s interaction with digoxin.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Atenolol:&lt;/li&gt;&lt;li&gt;â€¢ beta-blocker,&lt;/li&gt;&lt;li&gt;â€¢ increase digoxin levels&lt;/li&gt;&lt;li&gt;â€¢ delaying its elimination&lt;/li&gt;&lt;li&gt;â€¢ degree of increase&lt;/li&gt;&lt;li&gt;â€¢ Option D. KCl: Potassium chloride supplementation can potentiate the effects of digoxin , potentially leading to toxicity. However, it typically does not cause such a significant increase in digoxin levels.&lt;/li&gt;&lt;li&gt;â€¢ Option D. KCl:&lt;/li&gt;&lt;li&gt;â€¢ Potassium chloride supplementation&lt;/li&gt;&lt;li&gt;â€¢ digoxin&lt;/li&gt;&lt;li&gt;â€¢ toxicity.&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ increase in digoxin levels.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognizing drug interactions that impact digoxin levels is crucial for preventing digoxin toxicity in patients receiving concurrent therapy . Vigilance and close monitoring of digoxin levels are essential to ensure patient safety.&lt;/li&gt;&lt;li&gt;âž¤ drug interactions&lt;/li&gt;&lt;li&gt;âž¤ digoxin levels&lt;/li&gt;&lt;li&gt;âž¤ preventing digoxin toxicity&lt;/li&gt;&lt;li&gt;âž¤ concurrent&lt;/li&gt;&lt;li&gt;âž¤ therapy&lt;/li&gt;&lt;li&gt;âž¤ Vigilance&lt;/li&gt;&lt;li&gt;âž¤ close monitoring of digoxin levels&lt;/li&gt;&lt;li&gt;âž¤ patient safety.&lt;/li&gt;&lt;li&gt;âž¤ INTERACTIONS OF DIGOXIN&lt;/li&gt;&lt;li&gt;âž¤ INTERACTIONS OF DIGOXIN&lt;/li&gt;&lt;li&gt;âž¤ Hypokalemia, hypomagnesemia, and hypercalcemia may precipitate digoxin toxicity. Drugs causing digoxin toxicity include:&lt;/li&gt;&lt;li&gt;âž¤ Hypokalemia, hypomagnesemia, and hypercalcemia may precipitate digoxin toxicity.&lt;/li&gt;&lt;li&gt;âž¤ Hypokalemia, hypomagnesemia, and hypercalcemia&lt;/li&gt;&lt;li&gt;âž¤ Drugs causing digoxin toxicity include:&lt;/li&gt;&lt;li&gt;âž¤ causing digoxin&lt;/li&gt;&lt;li&gt;âž¤ toxicity&lt;/li&gt;&lt;li&gt;âž¤ Quinidine Verapamil Amiodarone Thiazides Clarithromycin&lt;/li&gt;&lt;li&gt;âž¤ Quinidine&lt;/li&gt;&lt;li&gt;âž¤ Verapamil&lt;/li&gt;&lt;li&gt;âž¤ Amiodarone&lt;/li&gt;&lt;li&gt;âž¤ Thiazides&lt;/li&gt;&lt;li&gt;âž¤ Clarithromycin&lt;/li&gt;&lt;li&gt;âž¤ Renal failure predisposes to digoxin toxicity.&lt;/li&gt;&lt;li&gt;âž¤ Renal failure predisposes to digoxin toxicity.&lt;/li&gt;&lt;li&gt;âž¤ Renal failure&lt;/li&gt;&lt;li&gt;âž¤ digoxin toxicity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 26-year-old female came to hospital for preconception counseling. Patient is a known hypertensive compliant to drug therapy. Which of the following drugs will you advise to stop?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Methyldopa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Labetalol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lisinopril&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nifedipine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lisinopril&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Lisinopril&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Methyldopa: Methyldopa is commonly used in pregnancy for hypertension and is considered safe. It is often continued during pregnancy if the patient is well-controlled.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Methyldopa:&lt;/li&gt;&lt;li&gt;â€¢ commonly used in pregnancy for hypertension&lt;/li&gt;&lt;li&gt;â€¢ safe.&lt;/li&gt;&lt;li&gt;â€¢ well-controlled.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Labetalol: Labetalol is another antihypertensive agent commonly used during pregnancy . It has a good safety profile and is often continued if the patient is well-controlled.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Labetalol:&lt;/li&gt;&lt;li&gt;â€¢ antihypertensive agent&lt;/li&gt;&lt;li&gt;â€¢ during pregnancy&lt;/li&gt;&lt;li&gt;â€¢ good safety profile&lt;/li&gt;&lt;li&gt;â€¢ patient is well-controlled.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nifedipine: Nifedipine is also considered safe for use during pregnancy and is commonly prescribed for hypertension in pregnant women.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nifedipine:&lt;/li&gt;&lt;li&gt;â€¢ safe for use during pregnancy&lt;/li&gt;&lt;li&gt;â€¢ prescribed for hypertension&lt;/li&gt;&lt;li&gt;â€¢ pregnant women.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understanding the safety profiles of antihypertensive medications during pregnancy is essential for preconception counseling. Lisinopril is contraindicated during pregnancy due to its association with fetal malformations, particularly during the second and third trimesters . It is important to discontinue potentially harmful medications before conception to minimize risks to both the mother and the developing fetus.&lt;/li&gt;&lt;li&gt;âž¤ safety profiles of antihypertensive medications&lt;/li&gt;&lt;li&gt;âž¤ pregnancy&lt;/li&gt;&lt;li&gt;âž¤ preconception counseling.&lt;/li&gt;&lt;li&gt;âž¤ Lisinopril is contraindicated during pregnancy&lt;/li&gt;&lt;li&gt;âž¤ fetal malformations,&lt;/li&gt;&lt;li&gt;âž¤ second and&lt;/li&gt;&lt;li&gt;âž¤ third trimesters&lt;/li&gt;&lt;li&gt;âž¤ discontinue&lt;/li&gt;&lt;li&gt;âž¤ harmful medications before conception&lt;/li&gt;&lt;li&gt;âž¤ minimize risks to both&lt;/li&gt;&lt;li&gt;âž¤ mother and the developing fetus.&lt;/li&gt;&lt;li&gt;âž¤ SAFE ANTI-HYPERTENSIVES IN PREGNANCY&lt;/li&gt;&lt;li&gt;âž¤ SAFE ANTI-HYPERTENSIVES IN PREGNANCY&lt;/li&gt;&lt;li&gt;âž¤ B etter              - B eta blockers (Cardio selective and Labetalol) M other            - Methyldopa C are                 - C lonidine D uring             - D ihydropyridine CCB (sustained release nifedipine, amlodipine) H ypertensive   - H ydralazine P regnancy       - P razosin (and other alpha blockers)&lt;/li&gt;&lt;li&gt;âž¤ B etter              - B eta blockers (Cardio selective and Labetalol)&lt;/li&gt;&lt;li&gt;âž¤ B&lt;/li&gt;&lt;li&gt;âž¤ B&lt;/li&gt;&lt;li&gt;âž¤ M other            - Methyldopa&lt;/li&gt;&lt;li&gt;âž¤ M&lt;/li&gt;&lt;li&gt;âž¤ Methyldopa&lt;/li&gt;&lt;li&gt;âž¤ C are                 - C lonidine&lt;/li&gt;&lt;li&gt;âž¤ C&lt;/li&gt;&lt;li&gt;âž¤ C&lt;/li&gt;&lt;li&gt;âž¤ D uring             - D ihydropyridine CCB (sustained release nifedipine, amlodipine)&lt;/li&gt;&lt;li&gt;âž¤ D&lt;/li&gt;&lt;li&gt;âž¤ D&lt;/li&gt;&lt;li&gt;âž¤ H ypertensive   - H ydralazine&lt;/li&gt;&lt;li&gt;âž¤ H&lt;/li&gt;&lt;li&gt;âž¤ H&lt;/li&gt;&lt;li&gt;âž¤ P regnancy       - P razosin (and other alpha blockers)&lt;/li&gt;&lt;li&gt;âž¤ P&lt;/li&gt;&lt;li&gt;âž¤ P&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following antihypertensive drug has a central sympatholytic action?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Levodopa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carbidopa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alpha methyl dopa&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hydralazine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Alpha methyl dopa&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Alpha methyl dopa&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Levodopa : Levodopa is not an antihypertensive drug; it is primarily used in the treatment of Parkinson&#x27;s disease to replenish dopamine levels in the brain.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Levodopa&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ antihypertensive drug;&lt;/li&gt;&lt;li&gt;â€¢ Parkinson&#x27;s disease to&lt;/li&gt;&lt;li&gt;â€¢ replenish dopamine levels&lt;/li&gt;&lt;li&gt;â€¢ Option B. Carbidopa : Carbidopa is often co-administered with levodopa to enhance its therapeutic effects in Parkinson&#x27;s disease . It does not have antihypertensive properties.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Carbidopa&lt;/li&gt;&lt;li&gt;â€¢ co-administered with levodopa&lt;/li&gt;&lt;li&gt;â€¢ enhance its therapeutic effects&lt;/li&gt;&lt;li&gt;â€¢ Parkinson&#x27;s disease&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ antihypertensive properties.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hydralazine : Hydralazine is a direct-acting vasodilator that primarily acts on arterial smooth muscle to decrease peripheral resistance and lower blood pressure. It does not exert its effects through central sympatholytic mechanisms.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hydralazine&lt;/li&gt;&lt;li&gt;â€¢ direct-acting vasodilator&lt;/li&gt;&lt;li&gt;â€¢ acts on arterial smooth muscle to decrease peripheral&lt;/li&gt;&lt;li&gt;â€¢ resistance and lower blood pressure.&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ central sympatholytic mechanisms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understanding the mechanisms of action of different antihypertensive drugs is important for selecting appropriate medications based on the patient&#x27;s condition and comorbidities . Alpha-methyl dopa is a centrally acting antihypertensive agent that reduces sympathetic outflow from the brainstem, leading to vasodilation and decreased blood pressure.&lt;/li&gt;&lt;li&gt;âž¤ mechanisms of action of different antihypertensive drugs&lt;/li&gt;&lt;li&gt;âž¤ selecting appropriate medications&lt;/li&gt;&lt;li&gt;âž¤ patient&#x27;s condition and comorbidities&lt;/li&gt;&lt;li&gt;âž¤ Alpha-methyl dopa&lt;/li&gt;&lt;li&gt;âž¤ centrally acting antihypertensive agent&lt;/li&gt;&lt;li&gt;âž¤ reduces&lt;/li&gt;&lt;li&gt;âž¤ sympathetic outflow&lt;/li&gt;&lt;li&gt;âž¤ brainstem, leading to vasodilation and decreased blood pressure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Inotropic drugs act by stimulating which of the following receptors?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alpha 1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alpha 2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Beta 1&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Beta 2&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Beta 1&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Beta 1&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational goal is to understand the mechanism of action of different inotropic drugs.&lt;/li&gt;&lt;li&gt;âž¤ mechanism of action&lt;/li&gt;&lt;li&gt;âž¤ inotropic drugs.&lt;/li&gt;&lt;li&gt;âž¤ INOTROPICS DRUGS&lt;/li&gt;&lt;li&gt;âž¤ INOTROPICS DRUGS&lt;/li&gt;&lt;li&gt;âž¤ Beta 1 agonists&lt;/li&gt;&lt;li&gt;âž¤ Beta 1 agonists&lt;/li&gt;&lt;li&gt;âž¤ Beta 1 agonists&lt;/li&gt;&lt;li&gt;âž¤ Dopamine Dobutamine Nor-adrenaline Isoprenaline&lt;/li&gt;&lt;li&gt;âž¤ Dopamine&lt;/li&gt;&lt;li&gt;âž¤ Dobutamine&lt;/li&gt;&lt;li&gt;âž¤ Nor-adrenaline&lt;/li&gt;&lt;li&gt;âž¤ Isoprenaline&lt;/li&gt;&lt;li&gt;âž¤ Phosphodiesterase inhibitors&lt;/li&gt;&lt;li&gt;âž¤ Phosphodiesterase inhibitors&lt;/li&gt;&lt;li&gt;âž¤ Phosphodiesterase inhibitors&lt;/li&gt;&lt;li&gt;âž¤ Inamrinone Milrinone Levosimendan&lt;/li&gt;&lt;li&gt;âž¤ Inamrinone&lt;/li&gt;&lt;li&gt;âž¤ Milrinone&lt;/li&gt;&lt;li&gt;âž¤ Levosimendan&lt;/li&gt;&lt;li&gt;âž¤ Cardiac glycosides&lt;/li&gt;&lt;li&gt;âž¤ Cardiac glycosides&lt;/li&gt;&lt;li&gt;âž¤ Cardiac glycosides&lt;/li&gt;&lt;li&gt;âž¤ Digoxin Digitoxin (withdrawn now)&lt;/li&gt;&lt;li&gt;âž¤ Digoxin&lt;/li&gt;&lt;li&gt;âž¤ Digitoxin (withdrawn now)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient of Prinzmetalâ€™s angina is started on isosorbide mono nitrate. What is the mechanism of action of nitrates in this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reduced cardiac contractility&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increased left ventricular end diastolic volume&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreased diastolic perfusion pressure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Endothelium independent coronary vasodilatation&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Endothelium independent coronary vasodilatation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Endothelium independent coronary vasodilatation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reduced cardiac contractility: Incorrect as nitrates do not primarily act by reducing the contractility of the heart.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reduced cardiac contractility:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ nitrates do not&lt;/li&gt;&lt;li&gt;â€¢ reducing the contractility of the heart.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increased left ventricular end diastolic volume: Incorrect because nitrates do not typically increase left ventricular end-diastolic volume; they reduce preload and afterload through vasodilation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increased left ventricular end diastolic volume:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ nitrates do not&lt;/li&gt;&lt;li&gt;â€¢ increase left ventricular end-diastolic volume;&lt;/li&gt;&lt;li&gt;â€¢ reduce preload and afterload&lt;/li&gt;&lt;li&gt;â€¢ vasodilation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Decreased diastolic perfusion pressure: Incorrect as nitrates do not reduce diastolic perfusion pressure; their action is aimed at reducing vasospasm and increasing perfusion.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Decreased diastolic perfusion pressure:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ nitrates do not reduce diastolic perfusion pressure;&lt;/li&gt;&lt;li&gt;â€¢ reducing vasospasm and increasing perfusion.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ In Prinzmetalâ€™s angina, nitrates like isosorbide mononitrate work by causing endothelium independent coronary vasodilation, acting directly on the vascular smooth muscle through NO donation, which leads to pain relief by reversing the coronary vasospasm.&lt;/li&gt;&lt;li&gt;â€¢ Prinzmetalâ€™s angina,&lt;/li&gt;&lt;li&gt;â€¢ isosorbide mononitrate&lt;/li&gt;&lt;li&gt;â€¢ causing endothelium independent coronary vasodilation,&lt;/li&gt;&lt;li&gt;â€¢ vascular smooth muscle through NO donation,&lt;/li&gt;&lt;li&gt;â€¢ leads to pain relief&lt;/li&gt;&lt;li&gt;â€¢ reversing the coronary vasospasm.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the mechanism of action of ezetimibe for the treatment of hypercholesterolemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of HMG-CoA reductase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inhibition of cholesterol absorption in the small intestine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inhibition of bile acid synthesis in the liver&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inhibition of lipoprotein lipase activity&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Inhibition of cholesterol absorption in the small intestine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Inhibition of cholesterol absorption in the small intestine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Inhibition of HMG-CoA reductase: This is the mechanism of action for statins, not ezetimibe. Statins inhibit the rate- l imiting step in cholesterol synthesis in the liver.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Inhibition of HMG-CoA reductase:&lt;/li&gt;&lt;li&gt;â€¢ statins, not ezetimibe. Statins inhibit the rate-&lt;/li&gt;&lt;li&gt;â€¢ imiting step in cholesterol synthesis in the liver.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Inhibition of bile acid synthesis in the liver: Bile acid sequestrants work by this mechanism. They bind bile acids in the intestine, leading to increased excretion of cholesterol in the feces.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Inhibition of bile acid synthesis in the liver:&lt;/li&gt;&lt;li&gt;â€¢ Bile acid sequestrants&lt;/li&gt;&lt;li&gt;â€¢ bile acids&lt;/li&gt;&lt;li&gt;â€¢ intestine,&lt;/li&gt;&lt;li&gt;â€¢ increased excretion of cholesterol in the feces.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Inhibition of lipoprotein lipase activity: Inhibiting lipoprotein lipase would prevent the breakdown of triglycerides, not cholesterol. This is not a mechanism associated with ezetimibe.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Inhibition of lipoprotein lipase activity:&lt;/li&gt;&lt;li&gt;â€¢ Inhibiting lipoprotein lipase&lt;/li&gt;&lt;li&gt;â€¢ breakdown of triglycerides,&lt;/li&gt;&lt;li&gt;â€¢ not a mechanism&lt;/li&gt;&lt;li&gt;â€¢ ezetimibe.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ezetimibe reduces LDL cholesterol by inhibiting the absorption of cholesterol in the small intestine through its action on the NPC1L1 protein.&lt;/li&gt;&lt;li&gt;âž¤ Ezetimibe&lt;/li&gt;&lt;li&gt;âž¤ reduces LDL cholesterol by inhibiting the absorption of cholesterol&lt;/li&gt;&lt;li&gt;âž¤ NPC1L1&lt;/li&gt;&lt;li&gt;âž¤ protein.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following patients should be treated with either an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A 24-year-old woman with type 1 diabetes with two positive spot microalbuminuria tests 1 week apart&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A 32-year-old woman with type 1 diabetes with a blood glucose of 328 mg/dL and a positive spot microalbuminuria test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A 48-year-old man with type 2 diabetes with a positive spot microalbuminuria test 1 week after starting a new exercise program&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A 56-year-old man with type 2 diabetes with two positive spot microalbuminuria tests 3 months apart&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. A 56-year-old man with type 2 diabetes with two positive spot microalbuminuria tests 3 months apart&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) A 56-year-old man with type 2 diabetes with two positive spot microalbuminuria tests 3 months apart&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. The testing interval of 1 week is too soon for confirmation of persistent microalbuminuria.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ interval of 1 week&lt;/li&gt;&lt;li&gt;â€¢ persistent microalbuminuria.&lt;/li&gt;&lt;li&gt;â€¢ Option B. The presence of severe hyperglycemia can transiently increase albumin excretion , potentially confounding the test result.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ severe hyperglycemia&lt;/li&gt;&lt;li&gt;â€¢ transiently increase albumin excretion&lt;/li&gt;&lt;li&gt;â€¢ test result.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Vigorous exercise can also transiently increase albumin excretion, making the test result unreliable.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Vigorous exercise&lt;/li&gt;&lt;li&gt;â€¢ increase albumin excretion,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In the management of diabetic nephropathy, ACE inhibitors or ARBs should be initiated in patients with type 2 diabetes who have confirmed persistent microalbuminuria, indicated by at least two positive microalbuminuria tests spaced 3 to 6 months apart, without the influence of confounding factors.&lt;/li&gt;&lt;li&gt;âž¤ diabetic nephropathy, ACE inhibitors or ARBs&lt;/li&gt;&lt;li&gt;âž¤ type 2 diabetes&lt;/li&gt;&lt;li&gt;âž¤ confirmed persistent microalbuminuria,&lt;/li&gt;&lt;li&gt;âž¤ at least two positive microalbuminuria tests&lt;/li&gt;&lt;li&gt;âž¤ 3 to 6 months&lt;/li&gt;&lt;li&gt;âž¤ without&lt;/li&gt;&lt;li&gt;âž¤ confounding factors.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 75 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test3" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Cell Injury&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Cell Injury&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                53 Questions | 212 Total Marks | 63 min Duration | ~71.32 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;An elderly patient dies due to a cancer and his cells in the cancer affected area were examined. Ultra structurally, the most prominent features found are the loss of mitochondrial cristae and ruptured outer mitochondrial membrane. Which of the following best can be the pattern of cell death here?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Necrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Necroptosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ferroptosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pyroptosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ferroptosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture18.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Ferroptosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Necrosis is a form of cell death characterized by uncontrolled cell lysis , often resulting in inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Necrosis&lt;/li&gt;&lt;li&gt;â€¢ cell death&lt;/li&gt;&lt;li&gt;â€¢ uncontrolled cell lysis&lt;/li&gt;&lt;li&gt;â€¢ inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Necroptosis is a type of programmed necrosis that is dependent on receptor-interacting protein kinases and often associated with inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Necroptosis&lt;/li&gt;&lt;li&gt;â€¢ programmed necrosis&lt;/li&gt;&lt;li&gt;â€¢ receptor-interacting protein kinases&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pyroptosis is an inflammatory form of programmed cell death associated with the activation of caspase-1 and often seen in immune cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pyroptosis&lt;/li&gt;&lt;li&gt;â€¢ inflammatory form of programmed cell death&lt;/li&gt;&lt;li&gt;â€¢ activation of caspase-1&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ferroptosis is a regulated cell death pathway marked by iron-dependent lipid peroxidation , resulting in distinctive ultrastructural changes such as loss of mitochondrial cristae and rupture of the outer mitochondrial membrane , commonly associated with cancer, neurodegeneration, and stroke .&lt;/li&gt;&lt;li&gt;âž¤ Ferroptosis&lt;/li&gt;&lt;li&gt;âž¤ regulated cell death pathway marked by iron-dependent lipid peroxidation&lt;/li&gt;&lt;li&gt;âž¤ loss of mitochondrial cristae and rupture of the outer mitochondrial membrane&lt;/li&gt;&lt;li&gt;âž¤ cancer, neurodegeneration, and stroke&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following statements are true regarding reversible cell injury, except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Formation of amorphous densities in the mitochondrial matrix&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diminished generation of adenosine triphosphate (ATP)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Formation of blebs in the plasma membrane&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Detachment of ribosomes from the granular endoplasmic reticulum&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Formation of amorphous densities in the mitochondrial matrix&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Formation of amorphous densities in the mitochondrial matrix&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Formation of amorphous densities in the mitochondrial matrix is typically associated with irreversible cell injury rather than reversible cell injury. This change indicates severe damage to the mitochondria, often due to sustained injury that compromises mitochondrial function beyond the cell&#x27;s ability to recover.&lt;/li&gt;&lt;li&gt;â€¢ Other Options Explained:&lt;/li&gt;&lt;li&gt;â€¢ Other Options Explained:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Diminished generation of adenosine triphosphate (ATP) : This is characteristic of reversible cell injury. It occurs due to temporary impairment of mitochondrial function, which can recover if the injurious stimulus is removed. Option C. Formation of blebs in the plasma membrane : Blebbing is a response to reversible cell injury. It involves changes in the cytoskeleton and plasma membrane, which can be restored once the injury ceases. Option D. Detachment of ribosomes from the granular endoplasmic reticulum : This change can occur during reversible cell injury and reflects a temporary disruption in protein synthesis. If the injury is mild and transient, normal ribosomal function can resume.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Diminished generation of adenosine triphosphate (ATP) : This is characteristic of reversible cell injury. It occurs due to temporary impairment of mitochondrial function, which can recover if the injurious stimulus is removed.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Diminished generation of adenosine triphosphate (ATP)&lt;/li&gt;&lt;li&gt;â€¢ Option C. Formation of blebs in the plasma membrane : Blebbing is a response to reversible cell injury. It involves changes in the cytoskeleton and plasma membrane, which can be restored once the injury ceases.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Formation of blebs in the plasma membrane&lt;/li&gt;&lt;li&gt;â€¢ Option D. Detachment of ribosomes from the granular endoplasmic reticulum : This change can occur during reversible cell injury and reflects a temporary disruption in protein synthesis. If the injury is mild and transient, normal ribosomal function can resume.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Detachment of ribosomes from the granular endoplasmic reticulum&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Amorphous densities in mitochondria are a hallmark of irreversible injury, while diminished ATP production, membrane blebbing, and ribosome detachment are associated with reversible cell injury&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is a form of programmed cell death that is dependent on the formation of autophagosomes and leads to the degradation of cellular components?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Necroptosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Apoptosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pyroptosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Autophagy&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Autophagy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Autophagy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Necroptosis is a form of programmed cell death that resembles necrosis , characterized by cell swelling and membrane rupture, typically involving death receptors like TNFR1 but is not associated with autophagosomes.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Necroptosis&lt;/li&gt;&lt;li&gt;â€¢ resembles necrosis&lt;/li&gt;&lt;li&gt;â€¢ cell swelling and membrane rupture,&lt;/li&gt;&lt;li&gt;â€¢ TNFR1&lt;/li&gt;&lt;li&gt;â€¢ Option B. Apoptosis is a form of programmed cell death involving cell shrinkage, DNA fragmentation, and the formation of apoptotic bodies, without the formation of autophagosomes .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Apoptosis&lt;/li&gt;&lt;li&gt;â€¢ programmed cell death&lt;/li&gt;&lt;li&gt;â€¢ cell shrinkage, DNA fragmentation, and the formation of apoptotic bodies, without the formation of autophagosomes&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pyroptosis is an inflammatory form of programmed cell death that occurs upon activation of inflammasomes and leads to cell lysis and inflammation, not primarily involving autophagosomes.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pyroptosis&lt;/li&gt;&lt;li&gt;â€¢ inflammatory form of programmed cell death&lt;/li&gt;&lt;li&gt;â€¢ not primarily involving autophagosomes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Autophagy is a form of programmed cell death characterized by the formation of autophagosomes that engulf and degrade cellular components in response to cellular stress.&lt;/li&gt;&lt;li&gt;âž¤ Autophagy&lt;/li&gt;&lt;li&gt;âž¤ programmed cell death&lt;/li&gt;&lt;li&gt;âž¤ formation of autophagosomes&lt;/li&gt;&lt;li&gt;âž¤ engulf and degrade cellular components&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 48&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 48&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old man with a history of heavy smoking complains of chronic cough. On chest radiograph, he has a suspicious lesion on the right upper lobe. Bronchoscopy and biopsy reveals that the mass has bronchial mucosa displays squamous metaplasia. What is the most likely outcome of this lesion if the said individual stops smoking?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atrophy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Malignant transformation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Necrosis and scarring&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Reversion to normal&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Reversion to normal&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Reversion to normal&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atrophy refers to the shrinkage in the size of the cell by loss of cell substance . When it comes to bronchial epithelium, atrophy is less common as a direct result of cessation of smoking.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atrophy&lt;/li&gt;&lt;li&gt;â€¢ shrinkage in the size of the cell&lt;/li&gt;&lt;li&gt;â€¢ loss of cell substance&lt;/li&gt;&lt;li&gt;â€¢ bronchial epithelium, atrophy is less common&lt;/li&gt;&lt;li&gt;â€¢ Option B. Malignant transformation is the process by which cells acquire the abilities to form a malignancy or cancer. Squamous metaplasia can be a precursor to squamous cell carcinoma ; however, it is a potentially reversible process, and the risk of malignant transformation decreases if the irritating stimulus , in this case, smoking, is removed .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Malignant transformation&lt;/li&gt;&lt;li&gt;â€¢ cells acquire the abilities to form a malignancy or cancer.&lt;/li&gt;&lt;li&gt;â€¢ precursor to squamous cell carcinoma&lt;/li&gt;&lt;li&gt;â€¢ reversible process,&lt;/li&gt;&lt;li&gt;â€¢ risk of malignant transformation decreases&lt;/li&gt;&lt;li&gt;â€¢ irritating stimulus&lt;/li&gt;&lt;li&gt;â€¢ smoking, is removed&lt;/li&gt;&lt;li&gt;â€¢ Option C. Necrosis and scarring would occur as a result of cell death and tissue damage. This is more typical of an end-stage process of persistent damage , rather than a result of the cessation of smoking.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Necrosis and scarring&lt;/li&gt;&lt;li&gt;â€¢ result of cell death and tissue damage.&lt;/li&gt;&lt;li&gt;â€¢ end-stage process of persistent damage&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Squamous metaplasia in the bronchial epithelium due to chronic irritation from smoking is a reversible process, and upon cessation of smoking , the epithelium has the potential to revert to its normal state.&lt;/li&gt;&lt;li&gt;âž¤ Squamous metaplasia&lt;/li&gt;&lt;li&gt;âž¤ bronchial epithelium&lt;/li&gt;&lt;li&gt;âž¤ smoking is a reversible process,&lt;/li&gt;&lt;li&gt;âž¤ cessation of smoking&lt;/li&gt;&lt;li&gt;âž¤ revert to its normal state.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 61&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 61&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Physiological hyperplasia and hypertrophy are seen simultaneously in? Uterus in pregnancy Skeletal muscle in athletes Breast at puberty Left ventricle of heart in hypertensive patients&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Only 1 and 2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Both 2 and 4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Both 1 and 3&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All 1, 2, 3 and 4&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Both 1 and 3&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Both 1 and 3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option 1 : During pregnancy, the uterus undergoes both hyperplasia (increased number of cells) and hypertrophy (increase in the size of existing cells) as a physiological response to accommodate and support the developing fetus . This dual increase in size and number of cells allows the uterus to significantly expand during pregnancy .&lt;/li&gt;&lt;li&gt;â€¢ Option 1&lt;/li&gt;&lt;li&gt;â€¢ pregnancy,&lt;/li&gt;&lt;li&gt;â€¢ both hyperplasia (increased number of cells) and hypertrophy (increase in the size of existing cells)&lt;/li&gt;&lt;li&gt;â€¢ accommodate and support the developing fetus&lt;/li&gt;&lt;li&gt;â€¢ allows the uterus&lt;/li&gt;&lt;li&gt;â€¢ expand during pregnancy&lt;/li&gt;&lt;li&gt;â€¢ Option 2: Athletes who undergo rigorous training often experience skeletal muscle hypertrophy , which is the increase in the size of muscle cells , but not typically hyperplasia , which would be an increase in the number of muscle cells. Muscle growth in athletes is usually attributed to hypertrophy from repetitive use and strain .&lt;/li&gt;&lt;li&gt;â€¢ Option 2:&lt;/li&gt;&lt;li&gt;â€¢ experience skeletal muscle hypertrophy&lt;/li&gt;&lt;li&gt;â€¢ increase in the size of muscle cells&lt;/li&gt;&lt;li&gt;â€¢ not typically hyperplasia&lt;/li&gt;&lt;li&gt;â€¢ Muscle growth&lt;/li&gt;&lt;li&gt;â€¢ hypertrophy from repetitive use and strain&lt;/li&gt;&lt;li&gt;â€¢ Option 3: During puberty , the female breast displays both hyperplasia , with the proliferation of glandular epithelium, and hypertrophy , with the enlargement of the glandular epithelial cells . This dual change is stimulated by hormonal influences and is a natural part of sexual maturation .&lt;/li&gt;&lt;li&gt;â€¢ Option 3:&lt;/li&gt;&lt;li&gt;â€¢ During puberty&lt;/li&gt;&lt;li&gt;â€¢ both hyperplasia&lt;/li&gt;&lt;li&gt;â€¢ proliferation of glandular epithelium,&lt;/li&gt;&lt;li&gt;â€¢ hypertrophy&lt;/li&gt;&lt;li&gt;â€¢ enlargement of the glandular epithelial cells&lt;/li&gt;&lt;li&gt;â€¢ by hormonal influences&lt;/li&gt;&lt;li&gt;â€¢ sexual maturation&lt;/li&gt;&lt;li&gt;â€¢ Option 4: In hypertensive patients , the left ventricle may undergo hypertrophy due to increased resistance that the heart has to pump against . This is not a physiological but rather a pathological response and typically does not involve hyperplasia , which would be characterized by an increased number of cardiac muscle cells.&lt;/li&gt;&lt;li&gt;â€¢ Option 4:&lt;/li&gt;&lt;li&gt;â€¢ In hypertensive patients&lt;/li&gt;&lt;li&gt;â€¢ left ventricle&lt;/li&gt;&lt;li&gt;â€¢ hypertrophy due to increased resistance&lt;/li&gt;&lt;li&gt;â€¢ pump against&lt;/li&gt;&lt;li&gt;â€¢ pathological response&lt;/li&gt;&lt;li&gt;â€¢ does not involve hyperplasia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In the uterus during pregnancy and the breast at puberty , physiological changes involve both hyperplasia ( increase in the number of cells) and hypertrophy (increase in the size of cells). These changes are driven by hormonal influences that are part of natural growth and development processes .&lt;/li&gt;&lt;li&gt;âž¤ In the uterus during pregnancy&lt;/li&gt;&lt;li&gt;âž¤ the breast at puberty&lt;/li&gt;&lt;li&gt;âž¤ hyperplasia (&lt;/li&gt;&lt;li&gt;âž¤ hypertrophy&lt;/li&gt;&lt;li&gt;âž¤ driven by hormonal influences&lt;/li&gt;&lt;li&gt;âž¤ natural growth and development processes&lt;/li&gt;&lt;li&gt;âž¤ Ref Robbins and Cotran Pathologic Basis of disease 10th ed - Pg: 57, 58&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ Robbins and Cotran Pathologic Basis of disease 10th ed - Pg: 57, 58&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 36-year-old female Rajvanti underwent a cervical biopsy at AIIMS after a suspicious Pap smear report. On histopathologic examination, it was observed that normal columnar endocervical epithelium was replaced with squamous epithelium in places. Which cellular adaptation does this describe?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hyperplasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypertrophy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metaplasia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dysplasia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Metaplasia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Metaplasia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hyperplasia is an increase in the number of cells in an organ or tissue , usually resulting in an increased volume of the tissue or organ . This process is often stimulated by hormonal or compensatory cellular mechanisms in response to a demand or injury .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Hyperplasia&lt;/li&gt;&lt;li&gt;â€¢ increase in the number of cells&lt;/li&gt;&lt;li&gt;â€¢ organ or tissue&lt;/li&gt;&lt;li&gt;â€¢ an increased volume of the tissue or organ&lt;/li&gt;&lt;li&gt;â€¢ stimulated by hormonal or compensatory&lt;/li&gt;&lt;li&gt;â€¢ demand or injury&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypertrophy refers to an increase in the size of cells, which consequently increases the size of the organ . It does not involve an increase in the number of cells. This is typically seen in muscles due to increased workload, as in the heartâ€™s response to hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Hypertrophy&lt;/li&gt;&lt;li&gt;â€¢ an increase in the size of cells,&lt;/li&gt;&lt;li&gt;â€¢ increases the size of the organ&lt;/li&gt;&lt;li&gt;â€¢ seen&lt;/li&gt;&lt;li&gt;â€¢ muscles due to increased workload,&lt;/li&gt;&lt;li&gt;â€¢ Option D. Dysplasia is an abnormal growth or development of cells and is often considered a precancerous state. It involves changes in size, shape, and organization of mature cells , and it is not a physiological but a pathological process.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Dysplasia&lt;/li&gt;&lt;li&gt;â€¢ abnormal growth or development of cells&lt;/li&gt;&lt;li&gt;â€¢ precancerous state.&lt;/li&gt;&lt;li&gt;â€¢ changes in size, shape, and organization of mature cells&lt;/li&gt;&lt;li&gt;â€¢ pathological process.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Metaplasia often occurs as a result of chronic irritation and represents a reversible change in cell type , as is evident in the case of Rajvantiâ€™s cervical biopsy findings.&lt;/li&gt;&lt;li&gt;âž¤ Metaplasia&lt;/li&gt;&lt;li&gt;âž¤ chronic irritation and represents a reversible change in cell type&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran Pathologic Basis of disease 10th ed PG: 59,60&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran Pathologic Basis of disease 10th ed PG: 59,60&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A smoker was found to have replacement of ciliated columnar epithelium in his respiratory tract to squamous epithelium. Which of the following is the mechanism involved in the observed change?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reprogramming of local tissue stem cells&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased protein synthesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Growth factor driven proliferation of mature cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased cellular protein production.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Reprogramming of local tissue stem cells&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Reprogramming of local tissue stem cells&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Decreased protein synthesis is associated with atrophy, where cells reduce in size due to a loss of cell substance . In tissues, this can occur from disuse, decreased blood supply, malnutrition, or denervation .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Decreased protein synthesis&lt;/li&gt;&lt;li&gt;â€¢ atrophy,&lt;/li&gt;&lt;li&gt;â€¢ cells reduce in size&lt;/li&gt;&lt;li&gt;â€¢ loss of cell substance&lt;/li&gt;&lt;li&gt;â€¢ disuse, decreased blood supply, malnutrition, or denervation&lt;/li&gt;&lt;li&gt;â€¢ Option C. Growth factor-driven proliferation refers to the increase in cell number due to stimulation by growth factors. This is the underlying mechanism of hyperplasia, a condition characterized by an increased number of cells in a tissue or organ, often as a response to a stimulus .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Growth factor-driven proliferation refers to the increase in cell&lt;/li&gt;&lt;li&gt;â€¢ mechanism of hyperplasia,&lt;/li&gt;&lt;li&gt;â€¢ increased number of cells in a tissue or organ,&lt;/li&gt;&lt;li&gt;â€¢ response to a stimulus&lt;/li&gt;&lt;li&gt;â€¢ Option D. Increased cellular protein production is typically observed in hypertrophy , where cells increase in size. This often occurs in response to increased demand or hormonal stimulation , such as in muscle cells after extensive exercise or in the myocardium in response to hypertension .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Increased cellular protein production&lt;/li&gt;&lt;li&gt;â€¢ hypertrophy&lt;/li&gt;&lt;li&gt;â€¢ increased demand or hormonal stimulation&lt;/li&gt;&lt;li&gt;â€¢ muscle cells after extensive exercise&lt;/li&gt;&lt;li&gt;â€¢ myocardium in response to hypertension&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The correct mechanism involved in the change from ciliated columnar epithelium to squamous epithelium in the respiratory tract of a smoker is, reprogramming of local tissue stem cells . Metaplasia occurs due to the reprogramming of stem cells in the tissue to produce a cell type better suited to withstand the stress , in this case, the chronic irritation from smoking .&lt;/li&gt;&lt;li&gt;âž¤ correct mechanism involved&lt;/li&gt;&lt;li&gt;âž¤ ciliated columnar epithelium to squamous epithelium in the respiratory tract of a smoker&lt;/li&gt;&lt;li&gt;âž¤ reprogramming of local tissue stem cells&lt;/li&gt;&lt;li&gt;âž¤ better suited to withstand the stress&lt;/li&gt;&lt;li&gt;âž¤ chronic irritation from smoking&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran Pathologic Basis of disease 10th ed PG: 57, 58, 60,61&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran Pathologic Basis of disease 10th ed PG: 57, 58, 60,61&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of these are premalignant conditions: Anaplasia Metaplasia Hamartoma Dysplasia&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1, 2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1, 2, 3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1, 2, 3, 4&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1, 2, 4&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 1, 2, 3, 4&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 1, 2, 3, 4&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option 1. Anaplasia: This refers to a lack of differentiation within cells and is characteristic of malignant tumors , where cells lose the morphological features of mature cells and their organization . Anaplastic cells often show variations in size and shape , a high nuclear-to-cytoplasmic ratio , and prominent nucleoli .&lt;/li&gt;&lt;li&gt;â€¢ Option 1. Anaplasia:&lt;/li&gt;&lt;li&gt;â€¢ lack of differentiation within cells&lt;/li&gt;&lt;li&gt;â€¢ characteristic of malignant tumors&lt;/li&gt;&lt;li&gt;â€¢ cells lose&lt;/li&gt;&lt;li&gt;â€¢ morphological features of mature cells&lt;/li&gt;&lt;li&gt;â€¢ their organization&lt;/li&gt;&lt;li&gt;â€¢ variations in size and shape&lt;/li&gt;&lt;li&gt;â€¢ nuclear-to-cytoplasmic ratio&lt;/li&gt;&lt;li&gt;â€¢ prominent nucleoli&lt;/li&gt;&lt;li&gt;â€¢ Option 2. Metaplasia: This is a process whereby one differentiated cell type is replaced by another cell type , which can occur due to chronic irritation or inflammation . While metaplasia is not cancer, it can sometimes progress to dysplasia and then to cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option 2. Metaplasia:&lt;/li&gt;&lt;li&gt;â€¢ one differentiated cell type is replaced by another cell type&lt;/li&gt;&lt;li&gt;â€¢ due to chronic irritation or inflammation&lt;/li&gt;&lt;li&gt;â€¢ progress to dysplasia and then to cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option 3. Hamartoma: Although traditionally considered benign, hamartomas are now increasingly recognized as having the potential to become malignant, particularly if they are not monitored or managed appropriately.&lt;/li&gt;&lt;li&gt;â€¢ Option 3. Hamartoma:&lt;/li&gt;&lt;li&gt;â€¢ now increasingly recognized&lt;/li&gt;&lt;li&gt;â€¢ potential to become malignant,&lt;/li&gt;&lt;li&gt;â€¢ Option 4. Dysplasia: Dysplasia is indeed a precancerous condition characterized by the abnormal development and growth of cells within tissues . It can lead to cellular abnormalities and is often seen in epithelial tissue during screening for cancers, such as a Pap smear for cervical cancer .&lt;/li&gt;&lt;li&gt;â€¢ Option 4. Dysplasia:&lt;/li&gt;&lt;li&gt;â€¢ precancerous condition characterized by the abnormal development and growth of cells within tissues&lt;/li&gt;&lt;li&gt;â€¢ cellular abnormalities&lt;/li&gt;&lt;li&gt;â€¢ epithelial tissue&lt;/li&gt;&lt;li&gt;â€¢ Pap smear for cervical cancer&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Anaplasia, metaplasia, and dysplasia are conditions with cells that have an increased risk of malignancy . While a hamartoma is a benign tumor-like malformation , it&#x27;s not typically classified as a premalignant condition, although some literature suggests it may have malignant potential .&lt;/li&gt;&lt;li&gt;âž¤ Anaplasia, metaplasia, and dysplasia&lt;/li&gt;&lt;li&gt;âž¤ increased risk of malignancy&lt;/li&gt;&lt;li&gt;âž¤ hamartoma is a benign tumor-like malformation&lt;/li&gt;&lt;li&gt;âž¤ it may have malignant potential&lt;/li&gt;&lt;li&gt;âž¤ Ref Robbins and Cotran Pathologic Basis of disease 10th ed&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ Robbins and Cotran Pathologic Basis of disease 10th ed&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Post mortem brain of a 90-year-old male with Alzheimer disease is shown in the image. All of the following are correct about the cellular process responsible for his condition except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decreased autophagic vacuoles&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased myofilaments&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreased smooth endoplasmic reticulum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Persistence of residual bodies&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Decreased autophagic vacuoles&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/30/picture4_QJAvoot.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Decreased autophagic vacuoles&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Atrophy is characterized by SHRINKAGE and LOSS of structural ELEMENTS of cells (like myofilaments, ER).&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ SHRINKAGE&lt;/li&gt;&lt;li&gt;â€¢ LOSS of structural ELEMENTS&lt;/li&gt;&lt;li&gt;â€¢ (like myofilaments, ER).&lt;/li&gt;&lt;li&gt;â€¢ Option C. Decreased smooth endoplasmic reticulum is seen in atrophy&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Decreased smooth endoplasmic reticulum&lt;/li&gt;&lt;li&gt;â€¢ atrophy&lt;/li&gt;&lt;li&gt;â€¢ Option D. Some cell debris resists digestion, and they persist as membrane bound residual bodies in cytoplasm (e.g., Lipofuscin granules).&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ cell debris resists digestion,&lt;/li&gt;&lt;li&gt;â€¢ persist&lt;/li&gt;&lt;li&gt;â€¢ membrane bound residual bodies in cytoplasm&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ In the context of cellular atrophy , such as seen in Alzheimer&#x27;s disease, there is an increase , not a decrease, in autophagic vacuoles as cells attempt to degrade damaged proteins and organelles.&lt;/li&gt;&lt;li&gt;â€¢ cellular atrophy&lt;/li&gt;&lt;li&gt;â€¢ there is an increase&lt;/li&gt;&lt;li&gt;â€¢ in autophagic vacuoles&lt;/li&gt;&lt;li&gt;â€¢ degrade damaged proteins and organelles.&lt;/li&gt;&lt;li&gt;â€¢ Ref :- Robbins and Cotran Pathologic Basis of disease 10th ed PG: 59&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ :- Robbins and Cotran Pathologic Basis of disease 10th ed PG: 59&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man suffers a heart attack and expires. Examination of his cardiac tissue reveals the finding as shown in the image. The pigment in the image represents which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Wear and tear pigment&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fat deposits&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Blood pigment&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Form of calcification&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Wear and tear pigment&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/30/3_LpzOHSP.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Wear and tear pigment&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fat deposits: Fat deposits in the heart could suggest a lipid disorder or myocardial steatosis but typically appear as clear vacuoles within the cells , not as the dark, granular pigment seen in the image.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fat deposits:&lt;/li&gt;&lt;li&gt;â€¢ lipid disorder or myocardial steatosis&lt;/li&gt;&lt;li&gt;â€¢ clear vacuoles within the cells&lt;/li&gt;&lt;li&gt;â€¢ Option C. Blood pigment : Hemosiderin , the storage form of iron, can accumulate in tissues following hemorrhage or excessive iron intake , presenting as a golden-yellow to brown pigment, which is different in appearance from the pigment seen here.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Blood pigment&lt;/li&gt;&lt;li&gt;â€¢ Hemosiderin&lt;/li&gt;&lt;li&gt;â€¢ accumulate in tissues&lt;/li&gt;&lt;li&gt;â€¢ hemorrhage or excessive iron intake&lt;/li&gt;&lt;li&gt;â€¢ Option D. Form of calcification: Calcification in tissues appears as basophilic (blue-purple) stippling or clumps within tissues on histology, which does not match the pigment observed in the image.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Form of calcification:&lt;/li&gt;&lt;li&gt;â€¢ basophilic (blue-purple) stippling or clumps&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lipofuscin, the pigment seen in the cardiac tissue of the patient who suffered a heart attack, is indicative of free radical damage and is not harmful to cell function .&lt;/li&gt;&lt;li&gt;âž¤ Lipofuscin, the pigment&lt;/li&gt;&lt;li&gt;âž¤ cardiac tissue&lt;/li&gt;&lt;li&gt;âž¤ suffered a heart attack,&lt;/li&gt;&lt;li&gt;âž¤ free radical damage&lt;/li&gt;&lt;li&gt;âž¤ is not harmful to cell function&lt;/li&gt;&lt;li&gt;âž¤ Ref Robbins and Cotran Pathologic Basis of disease 10th ed PG: 65&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ Robbins and Cotran Pathologic Basis of disease 10th ed PG: 65&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Regarding dystrophic calcification, which of the following statements is CORRECT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It may be caused by multiple myeloma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It never causes organ dysfunction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is associated with hypercalcaemiaâ€™&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Calcium deposition occurs in dead tissues&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Calcium deposition occurs in dead tissues&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/05/screenshot-2024-02-05-114210.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Calcium deposition occurs in dead tissues&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. It may be caused by multiple myeloma : Multiple myeloma itself does not cause dystrophic calcification . However, it can lead to systemic changes that result in pathologic calcifications . Dystrophic calcification is specifically associated with local tissue damage and necrosis , not directly with plasma cell disorders like multiple myeloma.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ It may be caused by multiple myeloma&lt;/li&gt;&lt;li&gt;â€¢ Multiple myeloma&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ dystrophic calcification&lt;/li&gt;&lt;li&gt;â€¢ systemic changes&lt;/li&gt;&lt;li&gt;â€¢ pathologic calcifications&lt;/li&gt;&lt;li&gt;â€¢ Dystrophic calcification&lt;/li&gt;&lt;li&gt;â€¢ local tissue damage and necrosis&lt;/li&gt;&lt;li&gt;â€¢ Option B. It never causes organ dysfunction: This statement is incorrect. While dystrophic calcification occurs in non-viable tissues , it can interfere with organ function depending on the size and location of the calcifications.&lt;/li&gt;&lt;li&gt;â€¢ Option B. It never causes organ dysfunction:&lt;/li&gt;&lt;li&gt;â€¢ dystrophic calcification&lt;/li&gt;&lt;li&gt;â€¢ non-viable tissues&lt;/li&gt;&lt;li&gt;â€¢ interfere&lt;/li&gt;&lt;li&gt;â€¢ organ function depending on the size and location of the calcifications.&lt;/li&gt;&lt;li&gt;â€¢ Option C. It is associated with hypercalcaemia : Dystrophic calcification can occur despite normal serum levels of calcium . It is not typically associated with hypercalcemia, which is more commonly linked with metastatic calcification .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ It is associated with hypercalcaemia&lt;/li&gt;&lt;li&gt;â€¢ Dystrophic calcification&lt;/li&gt;&lt;li&gt;â€¢ despite&lt;/li&gt;&lt;li&gt;â€¢ calcium&lt;/li&gt;&lt;li&gt;â€¢ with metastatic calcification&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Dystrophic calcification is the deposition of calcium salts in non-viable or dying tissues and can occur with normal serum calcium levels , often leading to organ dysfunction if extensive .&lt;/li&gt;&lt;li&gt;âž¤ Dystrophic calcification&lt;/li&gt;&lt;li&gt;âž¤ deposition of calcium salts&lt;/li&gt;&lt;li&gt;âž¤ non-viable or dying tissues&lt;/li&gt;&lt;li&gt;âž¤ normal serum calcium levels&lt;/li&gt;&lt;li&gt;âž¤ organ dysfunction if extensive&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran Pathologic Basis of disease 10th ed PG: 59&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran Pathologic Basis of disease 10th ed PG: 59&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is true about the type of calcification in the image from a patient with papillary thyroid carcinoma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It rarely causes dysfunction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It does not occur on heart valves&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is formed by crystalline calcium phosphate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is specific to coagulative necrosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It is formed by crystalline calcium phosphate&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/30/5_BcTt59r.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/01/pc-4.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) It is formed by crystalline calcium phosphate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. It rarely causes dysfunction: This is incorrect, because Psammoma bodies , while sometimes incidental findings , can be associated with tumor progression and thus potential organ dysfunction , depending on their location and the underlying pathology.&lt;/li&gt;&lt;li&gt;â€¢ Option A. It rarely causes dysfunction:&lt;/li&gt;&lt;li&gt;â€¢ Psammoma bodies&lt;/li&gt;&lt;li&gt;â€¢ incidental findings&lt;/li&gt;&lt;li&gt;â€¢ tumor progression and thus potential organ dysfunction&lt;/li&gt;&lt;li&gt;â€¢ Option B. It does not occur on heart valves: Psammoma bodies are not typically found on heart valves; instead, this option may confuse dystrophic calcification with the calcific degeneration that can occur in heart valves due to different pathophysiological processes .&lt;/li&gt;&lt;li&gt;â€¢ Option B. It does not occur on heart valves:&lt;/li&gt;&lt;li&gt;â€¢ instead,&lt;/li&gt;&lt;li&gt;â€¢ confuse dystrophic calcification with the calcific degeneration&lt;/li&gt;&lt;li&gt;â€¢ occur in heart valves&lt;/li&gt;&lt;li&gt;â€¢ different pathophysiological processes&lt;/li&gt;&lt;li&gt;â€¢ Option D. It is specific to coagulative necrosis: Psammoma bodies are not specific to coagulative necrosis . They can be seen in various types of necrosis and in conditions unrelated to necrosis , such as certain tumors.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ It is specific to coagulative necrosis:&lt;/li&gt;&lt;li&gt;â€¢ Psammoma bodies&lt;/li&gt;&lt;li&gt;â€¢ not specific to coagulative necrosis&lt;/li&gt;&lt;li&gt;â€¢ various types of necrosis&lt;/li&gt;&lt;li&gt;â€¢ unrelated to necrosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Psammoma bodies are calcifications seen in association with certain tumors, including papillary thyroid carcinoma, papillary renal cancer, meningioma and serous cystadenoma of the ovary .&lt;/li&gt;&lt;li&gt;âž¤ Psammoma bodies&lt;/li&gt;&lt;li&gt;âž¤ seen&lt;/li&gt;&lt;li&gt;âž¤ papillary thyroid carcinoma, papillary renal cancer, meningioma and serous cystadenoma of the ovary&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran Pathologic Basis of disease 10th ed PG: 59&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran Pathologic Basis of disease 10th ed PG: 59&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;With regard to metaplasia, which of the following statements is CORRECT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is typically an irreversible process&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It preserves mucus secretion in the respiratory tract&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is the process that occurs in Barrett&#x27;s esophagus&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It can be caused by vitamin B12 deficiency&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It is the process that occurs in Barrett&#x27;s esophagus&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) It is the process that occurs in Barrettâ€™s esophagus&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. It is typically an irreversible process: This is incorrect. Metaplasia is a reversible process , where one adult cell type changes to another to better survive an adverse environment.&lt;/li&gt;&lt;li&gt;â€¢ Option A. It is typically an irreversible process:&lt;/li&gt;&lt;li&gt;â€¢ Metaplasia&lt;/li&gt;&lt;li&gt;â€¢ reversible process&lt;/li&gt;&lt;li&gt;â€¢ Option B. It preserves mucus secretion in the respiratory tract: Incorrect. Metaplasia often leads to the replacement of columnar epithelium with squamous epithelium in the respiratory tract due to smoking , which does not preserve mucus secretion as the new cell type lacks this function .&lt;/li&gt;&lt;li&gt;â€¢ Option B. It preserves mucus secretion in the respiratory tract:&lt;/li&gt;&lt;li&gt;â€¢ Metaplasia&lt;/li&gt;&lt;li&gt;â€¢ replacement of columnar epithelium with squamous epithelium&lt;/li&gt;&lt;li&gt;â€¢ due to smoking&lt;/li&gt;&lt;li&gt;â€¢ does not preserve mucus secretion&lt;/li&gt;&lt;li&gt;â€¢ new cell type lacks this function&lt;/li&gt;&lt;li&gt;â€¢ Option D. It can be caused by vitamin B12 deficiency: This is incorrect. While vitamin deficiencies can lead to changes in epithelia , it is vitamin A deficiency that is typically associated with squamous metaplasia , not vitamin B12 deficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ It can be caused by vitamin B12 deficiency:&lt;/li&gt;&lt;li&gt;â€¢ vitamin deficiencies&lt;/li&gt;&lt;li&gt;â€¢ epithelia&lt;/li&gt;&lt;li&gt;â€¢ vitamin A deficiency&lt;/li&gt;&lt;li&gt;â€¢ with squamous metaplasia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Metaplasia is the process that occurs in Barrettâ€™s esophagus , involving the replacement of squamous epithelium with columnar epithelium as an adaptive response to chronic acid reflux .&lt;/li&gt;&lt;li&gt;âž¤ Metaplasia&lt;/li&gt;&lt;li&gt;âž¤ Barrettâ€™s esophagus&lt;/li&gt;&lt;li&gt;âž¤ squamous epithelium with columnar epithelium&lt;/li&gt;&lt;li&gt;âž¤ adaptive response&lt;/li&gt;&lt;li&gt;âž¤ chronic acid reflux&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran Pathologic Basis of disease 10th ed - Pg:62&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran Pathologic Basis of disease 10th ed - Pg:62&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;With regards to dysplasia, which of the following features is CORRECT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It inevitably progresses to cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is characterized by cellular pleomorphism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is not associated with architectural abnormalities&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is a feature of mesenchymal cells&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It is characterized by cellular pleomorphism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) It is characterized by cellular pleomorphism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. It inevitably progresses to cancer: This is incorrect. Dysplasia refers to disordered cell growth and can be a precursor to cancer but does not inevitably progress to cancer. Some forms of dysplasia may regress or remain stable without progressing to malignancy.&lt;/li&gt;&lt;li&gt;â€¢ Option A. It inevitably progresses to cancer: This is incorrect.&lt;/li&gt;&lt;li&gt;â€¢ Dysplasia&lt;/li&gt;&lt;li&gt;â€¢ disordered cell growth&lt;/li&gt;&lt;li&gt;â€¢ but does not inevitably progress to cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option C. It is not associated with architectural abnormalities: This statement is false . Dysplasia is often associated with a loss of normal tissue architecture , including the uniformity and architectural orientation of cells .&lt;/li&gt;&lt;li&gt;â€¢ Option C. It is not associated with architectural abnormalities: This statement is false&lt;/li&gt;&lt;li&gt;â€¢ associated with a loss of normal tissue architecture&lt;/li&gt;&lt;li&gt;â€¢ uniformity and architectural orientation of cells&lt;/li&gt;&lt;li&gt;â€¢ Option D. It is a feature of mesenchymal cells: Incorrect. Dysplasia is typically a feature of epithelial cells , not mesenchymal cells. Mesenchymal cells can undergo changes that may be equivalent to dysplasia , such as in fibroblastic proliferations, but the term dysplasia is usually used with epithelial pathology .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ It is a feature of mesenchymal cells:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect. Dysplasia&lt;/li&gt;&lt;li&gt;â€¢ epithelial cells&lt;/li&gt;&lt;li&gt;â€¢ Mesenchymal cells&lt;/li&gt;&lt;li&gt;â€¢ equivalent to dysplasia&lt;/li&gt;&lt;li&gt;â€¢ dysplasia is usually used with epithelial pathology&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Dysplasia is characterized by cellular pleomorphism, which refers to variations in size and shape among cells , commonly observed in epithelial tissues where disordered growth is present.&lt;/li&gt;&lt;li&gt;âž¤ Dysplasia&lt;/li&gt;&lt;li&gt;âž¤ cellular pleomorphism,&lt;/li&gt;&lt;li&gt;âž¤ variations in size and shape among cells&lt;/li&gt;&lt;li&gt;âž¤ epithelial tissues&lt;/li&gt;&lt;li&gt;âž¤ disordered growth&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is a preferred site for metastatic calcification?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atherosclerotic vessels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gastric mucosa&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Damaged heart valves&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tuberculous lymph nodes&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Gastric mucosa&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Gastric mucosa&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atherosclerotic vessels: These typically exhibit dystrophic calcification rather than metastatic. Dystrophic calcification occurs in damaged or necrotic tissues and does not necessarily involve a systemic mineral imbalance .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atherosclerotic vessels:&lt;/li&gt;&lt;li&gt;â€¢ dystrophic calcification&lt;/li&gt;&lt;li&gt;â€¢ damaged or necrotic tissues&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ systemic mineral imbalance&lt;/li&gt;&lt;li&gt;â€¢ Option C. Damaged heart valves : Damaged heart valves are more prone to dystrophic calcification because of the local tissue damage, rather than metastatic calcification which occurs in normal tissues.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Damaged heart valves&lt;/li&gt;&lt;li&gt;â€¢ dystrophic calcification&lt;/li&gt;&lt;li&gt;â€¢ rather than metastatic calcification&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tuberculous lymph nodes: Tuberculous lymph nodes would typically have dystrophic calcification due to the localized damage caused by the infection rather than metastatic calcification which is usually related to an abnormal systemic calcium or phosphorus metabolism.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Tuberculous lymph nodes:&lt;/li&gt;&lt;li&gt;â€¢ dystrophic calcification&lt;/li&gt;&lt;li&gt;â€¢ caused by the infection&lt;/li&gt;&lt;li&gt;â€¢ an abnormal systemic calcium or phosphorus metabolism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Metastatic calcification preferably occurs in normal tissues , like the gastric mucosa , when there is an elevated serum calcium level due to conditions such as hyperparathyroidism, bone destruction, vitamin D disorders, or renal failure.&lt;/li&gt;&lt;li&gt;âž¤ Metastatic calcification&lt;/li&gt;&lt;li&gt;âž¤ normal tissues&lt;/li&gt;&lt;li&gt;âž¤ gastric mucosa&lt;/li&gt;&lt;li&gt;âž¤ elevated serum calcium&lt;/li&gt;&lt;li&gt;âž¤ hyperparathyroidism, bone destruction, vitamin D disorders, or renal failure.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran Pathologic Basis of disease 10th ed - Pg:66,67&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran Pathologic Basis of disease 10th ed - Pg:66,67&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old female presented sudden onset hemiplegia. Serial investigations were performed. She was diagnosed with psammomatous meningioma, a subtype of meningioma with several psammoma bodies. Similar type of calcification can be seen in which of the following conditions?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Milk alkali syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atheromatous plaque&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hyperparathyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vitamin A intoxication&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Atheromatous plaque&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Atheromatous plaque&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Milk alkali syndrome: This condition is associated with hypercalcemia and not typically with dystrophic calcification . It results from excessive intake of calcium and absorbable alkali , leading to a constellation of symptoms including renal failure, metabolic alkalosis, and high levels of calcium in the blood .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Milk alkali syndrome:&lt;/li&gt;&lt;li&gt;â€¢ hypercalcemia&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ dystrophic calcification&lt;/li&gt;&lt;li&gt;â€¢ calcium and absorbable alkali&lt;/li&gt;&lt;li&gt;â€¢ renal failure, metabolic alkalosis, and high levels of calcium in the blood&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hyperparathyroidism: Hyperparathyroidism leads to hypercalcemia and can result in metastatic calcification, which occurs in normal tissue s, not specifically in areas of necrosis or degeneration like dystrophic calcification.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Hyperparathyroidism:&lt;/li&gt;&lt;li&gt;â€¢ hypercalcemia&lt;/li&gt;&lt;li&gt;â€¢ metastatic calcification,&lt;/li&gt;&lt;li&gt;â€¢ normal tissue&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vitamin A intoxication: While vitamin A intoxication can lead to a wide range of systemic effects , it is not directly linked with dystrophic calcification, which is localized to areas of tissue damage or necrosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Vitamin A intoxication:&lt;/li&gt;&lt;li&gt;â€¢ can lead&lt;/li&gt;&lt;li&gt;â€¢ systemic effects&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ linked with dystrophic calcification,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Dystrophic calcification is a type of pathological calcification that occurs in dead, dying, or degenerated tissue , where calcium metabolism is typically normal, and serum calcium levels are unchanged. This type of calcification can be observed in atheromatous plaques as well as in psammomatous meningiomas .&lt;/li&gt;&lt;li&gt;âž¤ Dystrophic calcification&lt;/li&gt;&lt;li&gt;âž¤ pathological calcification&lt;/li&gt;&lt;li&gt;âž¤ dead, dying, or degenerated tissue&lt;/li&gt;&lt;li&gt;âž¤ calcium metabolism&lt;/li&gt;&lt;li&gt;âž¤ normal,&lt;/li&gt;&lt;li&gt;âž¤ serum calcium&lt;/li&gt;&lt;li&gt;âž¤ unchanged.&lt;/li&gt;&lt;li&gt;âž¤ atheromatous plaques as well as in psammomatous meningiomas&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran Pathologic Basis of disease 10th ed - Pg:65,66&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran Pathologic Basis of disease 10th ed - Pg:65,66&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man suffered a massive cardiac arrest and encountered sudden death. Post mortem finding of the heart shows complete obstruction of left anterior descending artery by an atherosclerotic plaque. Myocardial injury in this patient has occurred due to which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Trauma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypoxia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Genetic abnormality involving the myocardium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Heavy metals&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hypoxia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Hypoxia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Trauma: Trauma by physical agents is a cause of cell injury , but does not apply in this case&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Trauma:&lt;/li&gt;&lt;li&gt;â€¢ physical agents&lt;/li&gt;&lt;li&gt;â€¢ cell injury&lt;/li&gt;&lt;li&gt;â€¢ Option C . Genetic abnormality involving the myocardium: Genetic abnormalities involving the myocardium such as hypertrophic and dilated cardiomyopathies can lead to hypoxia, but this case describes a classic case of cell injury die to hypoxic ischemic injury.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Genetic abnormality involving the myocardium:&lt;/li&gt;&lt;li&gt;â€¢ Option D . Heavy metals: Heavy metals can cause cell injury buy does not apply to this case.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Heavy metals:&lt;/li&gt;&lt;li&gt;â€¢ can cause cell injury&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Hypoxia is the most common cause of cell injury overall and ischemia is the most common cause of hypoxia.&lt;/li&gt;&lt;li&gt;â€¢ Hypoxia&lt;/li&gt;&lt;li&gt;â€¢ common cause of cell injury&lt;/li&gt;&lt;li&gt;â€¢ ischemia is the most common cause of hypoxia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is a primary consequence of diminished ATP on cellular function?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Intracellular depletion of Ca 2+&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mitochondrial dysfunction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intact membrane&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Release of lysosomal (hydrolytic) enzymes&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Mitochondrial dysfunction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Mitochondrial dysfunction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Diminished ATP can actually lead to an increase in intracellular calcium as ATP-dependent mechanisms that pump calcium out of the cell fail . An increase in intracellular calcium can activate destructive enzymes and pathways.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Diminished ATP&lt;/li&gt;&lt;li&gt;â€¢ increase in intracellular calcium as ATP-dependent mechanisms&lt;/li&gt;&lt;li&gt;â€¢ calcium out of the cell fail&lt;/li&gt;&lt;li&gt;â€¢ Option C. Diminished ATP typically leads to damage of cellular membranes because energy-dependent ion pumps and repair mechanisms fail, rather than preserving membrane integrity.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Diminished ATP&lt;/li&gt;&lt;li&gt;â€¢ cellular membranes&lt;/li&gt;&lt;li&gt;â€¢ energy-dependent ion pumps and repair mechanisms&lt;/li&gt;&lt;li&gt;â€¢ preserving membrane integrity.&lt;/li&gt;&lt;li&gt;â€¢ Option D. A decrease in ATP can contribute to the release of lysosomal enzymes . When ATP is low, cellular components may not be maintained or recycled properly, leading to enzyme leakage and further cellular damage .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ decrease in ATP&lt;/li&gt;&lt;li&gt;â€¢ lysosomal enzymes&lt;/li&gt;&lt;li&gt;â€¢ leading to enzyme leakage and further cellular damage&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Diminished ATP most directly leads to mitochondrial dysfunction, as the mitochondria are the main site of ATP production within the cell. This mitochondrial dysfunction can subsequently lead to additional cellular damage , including the release of lysosomal enzymes and membrane damage.&lt;/li&gt;&lt;li&gt;âž¤ Diminished ATP&lt;/li&gt;&lt;li&gt;âž¤ mitochondrial dysfunction,&lt;/li&gt;&lt;li&gt;âž¤ additional cellular damage&lt;/li&gt;&lt;li&gt;âž¤ release of lysosomal enzymes and membrane damage.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran Pathologic Basis of disease 10th ed (Latest)- Pg: 37&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran Pathologic Basis of disease 10th ed (Latest)- Pg: 37&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the correct combination of most and least sensitive cells to hypoxia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Most sensitive hepatocytes and least sensitive- Lymphocytes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Most sensitive -bone marrow cells and least sensitive -nerve cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Most sensitive -retina and least sensitive- adipose tissue&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Most sensitive -neurons and least sensitive -fibroblasts&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Most sensitive -neurons and least sensitive -fibroblasts&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Most sensitive -neurons and least sensitive fibroblasts&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The cells most sensitive to hypoxia are neurons and least sensitive are fibroblasts.&lt;/li&gt;&lt;li&gt;â€¢ Among CNS cells , there is a hierarchy of sensitivity to hypoxia/ischemia : neurons are the most sensitive (Pyramidal neurons of the hippocampus/ Sommerâ€™s sector &amp;gt; Cerebellar Purkinje cells &amp;gt; Pyramidal neurons of the cerebral cortex) although glial cells (oligodendrocytes and astrocytes) are also vulnerable&lt;/li&gt;&lt;li&gt;â€¢ CNS cells&lt;/li&gt;&lt;li&gt;â€¢ hierarchy of sensitivity to hypoxia/ischemia&lt;/li&gt;&lt;li&gt;â€¢ neurons&lt;/li&gt;&lt;li&gt;â€¢ most sensitive&lt;/li&gt;&lt;li&gt;â€¢ Option B. Most sensitive bone marrow cells and least sensitive neurons : represents most and least sensitive cells with respect to ionizing radiation exposure .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Most sensitive bone marrow cells and least sensitive neurons&lt;/li&gt;&lt;li&gt;â€¢ with respect to ionizing radiation exposure&lt;/li&gt;&lt;li&gt;â€¢ Amongst the body cells , the most sensitive are spermatogonia and erythroblasts, epidermal stem cells, gastrointestinal stem cells. The least sensitive are nerve cells and muscle fibers .&lt;/li&gt;&lt;li&gt;â€¢ body cells&lt;/li&gt;&lt;li&gt;â€¢ most sensitive are spermatogonia and erythroblasts, epidermal stem cells, gastrointestinal stem cells.&lt;/li&gt;&lt;li&gt;â€¢ least sensitive are nerve cells and muscle fibers&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ The cells most sensitive to hypoxia are neurons and least sensitive are fibroblasts.&lt;/li&gt;&lt;li&gt;â€¢ cells most sensitive to hypoxia are neurons&lt;/li&gt;&lt;li&gt;â€¢ least sensitive are fibroblasts.&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins and Cotran Pathologic Basis of disease 10th ed Pg: 37&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Robbins and Cotran Pathologic Basis of disease 10th ed Pg: 37&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the correct mechanism by which hypoxic cell injury occurs?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decreased aerobic oxidative respiration&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased anaerobic glycolysis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreased production of 2,3 DPG from alternative glycolytic pathway&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Decreased pentose phosphate pathway&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Decreased aerobic oxidative respiration&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Decreased aerobic oxidative respiration&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Decreased anaerobic glycolysis: Anaerobic glycolysis actually increases in response to hypoxia as the cell attempts to compensate for the lack of oxygen and maintain ATP production.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Decreased anaerobic glycolysis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Decreased production of 2,3 DPG from alternative glycolytic pathway: This is not the primary mechanism of hypoxic cell injury . While changes in 2,3-DPG levels affect oxygen release from hemoglobin, they do not directly cause cellular injury.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Decreased production of 2,3 DPG from alternative glycolytic pathway:&lt;/li&gt;&lt;li&gt;â€¢ not the primary mechanism of hypoxic cell injury&lt;/li&gt;&lt;li&gt;â€¢ they do not directly cause cellular injury.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Decreased pentose phosphate pathway: This pathway operates independently of oxygen and ATP , so hypoxia does not have a significant direct impact on its activity.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Decreased pentose phosphate pathway:&lt;/li&gt;&lt;li&gt;â€¢ independently of oxygen and ATP&lt;/li&gt;&lt;li&gt;â€¢ hypoxia does not have a significant direct impact on its activity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The primary mechanism of hypoxic cell injury is decreased aerobic oxidative respiration which directly results in diminished ATP production and consequent cellular dysfunction .&lt;/li&gt;&lt;li&gt;âž¤ hypoxic cell injury is decreased aerobic oxidative respiration&lt;/li&gt;&lt;li&gt;âž¤ diminished ATP production and consequent cellular dysfunction&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran Pathologic Basis of disease 10th ed (Latest)- Pg: 37 Dacie and Lewis 11th edition- pg:266&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran Pathologic Basis of disease 10th ed (Latest)- Pg: 37 Dacie and Lewis 11th edition- pg:266&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Given the importance of lifestyle factors in the modulation of lifespan, which of the following interventions is most reliably associated with an extension of longevity?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Regular exercise like walking for 30 minutes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreasing stress&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decrease calorie by 30%&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increase food intake&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Decrease calorie by 30%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Decrease calorie by 30%&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Regular exercise like walking for 30 minutes: Regular physical activity is widely recognized for its benefits in improving health and quality of life , but it has not been definitively shown to extend lifespan.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Regular exercise like walking for 30 minutes:&lt;/li&gt;&lt;li&gt;â€¢ improving health and quality of life&lt;/li&gt;&lt;li&gt;â€¢ not been&lt;/li&gt;&lt;li&gt;â€¢ shown to extend lifespan.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Reducing stress: can have numerous health benefits and can improve quality of life , but its direct impact on extending lifespan is complex and not as well-established as other interventions.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Reducing stress:&lt;/li&gt;&lt;li&gt;â€¢ health benefits and can improve quality of life&lt;/li&gt;&lt;li&gt;â€¢ extending lifespan is complex and not as well-established&lt;/li&gt;&lt;li&gt;â€¢ Option D. Increasing food intake: does not contribute to lifespan extension and, without proper balance , can lead to obesity and associated health problems that may shorten life expectancy.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Increasing food intake:&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ lifespan extension and, without proper balance&lt;/li&gt;&lt;li&gt;â€¢ obesity and associated health problems that may shorten life expectancy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The most reliable intervention for extending lifespan , as i ndicated by extensive research, is reducing caloric intake by approximately 30%. This strategy decreases the nutrient-mediated release of growth factors that have been implicated in accelerating the aging process and increasing mortality.&lt;/li&gt;&lt;li&gt;âž¤ reliable&lt;/li&gt;&lt;li&gt;âž¤ extending lifespan&lt;/li&gt;&lt;li&gt;âž¤ ndicated by extensive research, is reducing caloric intake by approximately 30%.&lt;/li&gt;&lt;li&gt;âž¤ decreases&lt;/li&gt;&lt;li&gt;âž¤ nutrient-mediated release of growth factors&lt;/li&gt;&lt;li&gt;âž¤ accelerating the aging process and increasing mortality.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is a correct statement about senescence?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aging is associated with decreased telomerase activity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aging is associated with increased telomerase activity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stem cells have reduced telomerase activity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Associated with increased cell replication&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Aging is associated with decreased telomerase activity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Aging is associated with decreased telomerase activity&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aging is associated with increased telomerase activity: This is generally incorrect for normal somatic cells , as aging does not typically come with increased telomerase activity, which is often associated with immortalized cancer cells.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aging is associated with increased telomerase activity: This is generally incorrect for normal somatic cells&lt;/li&gt;&lt;li&gt;â€¢ Option C. Stem cells have reduced telomerase activity: This statement is generally not true; stem cells and germ cells often have higher levels of telomerase activity, allowing them to maintain telomere length and proliferative capacity.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Stem cells have reduced telomerase activity:&lt;/li&gt;&lt;li&gt;â€¢ This statement is generally not true;&lt;/li&gt;&lt;li&gt;â€¢ Option D. Associated with increased cell replication: Senescence is actually associated with a decrease or cessation in cell replication due to telomere shortening and the activation of tumor suppressor genes .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Associated with increased cell replication:&lt;/li&gt;&lt;li&gt;â€¢ Senescence&lt;/li&gt;&lt;li&gt;â€¢ decrease or cessation in cell replication due to telomere shortening&lt;/li&gt;&lt;li&gt;â€¢ activation of tumor suppressor genes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Aging in somatic cells is associated with decreased telomerase activity , which contributes to telomere shortening and the subsequent arrest of cell division , a process known as replicative senescence.&lt;/li&gt;&lt;li&gt;âž¤ Aging in somatic cells&lt;/li&gt;&lt;li&gt;âž¤ decreased telomerase activity&lt;/li&gt;&lt;li&gt;âž¤ telomere shortening and the subsequent arrest of cell division&lt;/li&gt;&lt;li&gt;âž¤ replicative senescence.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A chronic alcoholic patient presented with increasing abdominal girth and decreased liver span. Liver biopsy features hepatocytes with reddish inclusions. What is in the content of the inclusions?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Actin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intermediate filaments&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Microtubules&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fibronectin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Intermediate filaments&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/05/screenshot-2024-02-05-120701.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Intermediate filaments&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Actin: Actin is a component of the cytoskeleton involved in various types of cell motility but is not the primary component of the reddish inclusions found in hepatocytes, which are characteristic of Mallory-Denk bodies.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Actin: Actin is&lt;/li&gt;&lt;li&gt;â€¢ Option C. Microtubules: Microtubules are part of the cytoskeleton and are involved in maintaining cell shape and intracellular transport but are not the substance that composes the reddish inclusions seen in this patient&#x27;s liver biopsy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Microtubules: Microtubules&lt;/li&gt;&lt;li&gt;â€¢ Option D. Fibronectin is an extracellular matrix protein that plays a critical role in wound healing and cell adhesion . It is not typically found within hepatocyte inclusions like Mallory-Denk bodies.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Fibronectin&lt;/li&gt;&lt;li&gt;â€¢ extracellular matrix protein&lt;/li&gt;&lt;li&gt;â€¢ wound healing and cell adhesion&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The reddish inclusions found within hepatocytes on a liver biopsy of a chronic alcoholic patient are composed of intermediate filaments, specifically ubiquitinated keratins 8 and 18, characteristic of Mallory-Denk bodies.&lt;/li&gt;&lt;li&gt;âž¤ reddish inclusions&lt;/li&gt;&lt;li&gt;âž¤ hepatocytes on a liver biopsy of a chronic alcoholic patient&lt;/li&gt;&lt;li&gt;âž¤ intermediate filaments,&lt;/li&gt;&lt;li&gt;âž¤ ubiquitinated keratins 8 and 18, characteristic of Mallory-Denk bodies.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with squamous cell carcinoma of lung has undergone pneumonectomy. During the procedure blackish hilar lymph node of 1 cm is seen. What is the etiology of the nodal pigmentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anthracotic pigment&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hemosiderosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lipofusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Melanin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Anthracotic pigment&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Anthracotic pigment&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. This represents iron deposition , typically brownish , and is associated with conditions involving hemorrhage or excessive iron, not the pigmentation seen in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option B. This represents iron deposition&lt;/li&gt;&lt;li&gt;â€¢ brownish&lt;/li&gt;&lt;li&gt;â€¢ hemorrhage or excessive iron,&lt;/li&gt;&lt;li&gt;â€¢ Option C. Known as the \&quot;wear and tear\&quot; pigment , lipofuscin accumulates in aging cells but does not cause the blackish pigmentation typical of anthracosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Known as the \&quot;wear and tear\&quot; pigment&lt;/li&gt;&lt;li&gt;â€¢ accumulates in aging cells&lt;/li&gt;&lt;li&gt;â€¢ Option D. Melanin is a brown to black pigment produced by melanocytes. While melanin is responsible for the pigmentation of the skin and other tissues , it is not related to the pigmentation seen in the lungs related to smoking or pollution .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Melanin&lt;/li&gt;&lt;li&gt;â€¢ brown to black pigment&lt;/li&gt;&lt;li&gt;â€¢ melanocytes.&lt;/li&gt;&lt;li&gt;â€¢ the pigmentation of the skin and other tissues&lt;/li&gt;&lt;li&gt;â€¢ not related&lt;/li&gt;&lt;li&gt;â€¢ lungs related to smoking or pollution&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Anthracotic pigment is responsible for the blackish coloration of the hilar lymph node seen in the patient, associated with the history of lung squamous cell carcinoma, smoking, or exposure to air pollution .&lt;/li&gt;&lt;li&gt;âž¤ Anthracotic pigment is responsible for the blackish coloration of the hilar lymph node&lt;/li&gt;&lt;li&gt;âž¤ history of lung squamous cell carcinoma, smoking, or exposure to air pollution&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman undergoes Pap smear which shows disorganised growth of the cells with hyperchromatic nuclei. Which phenomenon is occurring here?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypertrophy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dysplasia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metaplasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hyperplasia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Dysplasia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Dysplasia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dysplasia refers to the disordered growth and appearance of cells , typically with nuclear abnormalities such as hyperchromasia, and is often a precursor to cancer .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dysplasia&lt;/li&gt;&lt;li&gt;â€¢ disordered growth and appearance of cells&lt;/li&gt;&lt;li&gt;â€¢ hyperchromasia, and is often a precursor to cancer&lt;/li&gt;&lt;li&gt;â€¢ Option C.Metaplasia : This is the replacement of one type of cell with another due to chronic irritation or inflammation, which doesn&#x27;t directly describe disorganized growth or nuclear changes.&lt;/li&gt;&lt;li&gt;â€¢ Option C.Metaplasia :&lt;/li&gt;&lt;li&gt;â€¢ one type of cell with another due to chronic irritation or inflammation,&lt;/li&gt;&lt;li&gt;â€¢ doesn&#x27;t directly describe disorganized growth or nuclear changes.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hyperplasia is an increase in the number of cells in a tissue or organ , not necessarily associated with disorganization or nuclear atypia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hyperplasia&lt;/li&gt;&lt;li&gt;â€¢ increase in the number of cells in a tissue or organ&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Dysplasia is indicated by disorganized cellular growth and hyperchromatic nuclei on a Pap smear , reflecting premalignant changes in the epithelium.&lt;/li&gt;&lt;li&gt;âž¤ disorganized cellular growth and hyperchromatic nuclei on a Pap smear&lt;/li&gt;&lt;li&gt;âž¤ premalignant changes in the epithelium.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the marked structure in given below image:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lipofuscin granules&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Golgi apparatus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Secondary lysosomes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mitochondria&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Lipofuscin granules&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture6.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Lipofuscin granules&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Golgi apparatus: This is an organelle involved in the modification, sorting, and packaging of proteins , but it does not have the granular appearance shown in the image.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Golgi apparatus:&lt;/li&gt;&lt;li&gt;â€¢ modification, sorting, and packaging of proteins&lt;/li&gt;&lt;li&gt;â€¢ does not have the granular appearance&lt;/li&gt;&lt;li&gt;â€¢ Option C. Secondary lysosomes: These are the organelles where digestion of macromolecules occurs. Secondary lysosomes can contain a variety of digested material , but they do not match the specific appearance of the structures shown .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Secondary lysosomes:&lt;/li&gt;&lt;li&gt;â€¢ digestion of macromolecules&lt;/li&gt;&lt;li&gt;â€¢ contain a variety of digested material&lt;/li&gt;&lt;li&gt;â€¢ do not match the specific appearance of the structures shown&lt;/li&gt;&lt;li&gt;â€¢ Option D. Mitochondria: These are organelles responsible for ATP production and have a distinctive double membrane and cristae , which are not depicted in the image provided.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Mitochondria:&lt;/li&gt;&lt;li&gt;â€¢ responsible for ATP production&lt;/li&gt;&lt;li&gt;â€¢ distinctive double membrane and cristae&lt;/li&gt;&lt;li&gt;â€¢ not depicted in the image&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lipofuscin granules are identified in electron microscopy by their characteristic granular appearance, perinuclear position, and intralysosomal location , which align with the structures in the image.&lt;/li&gt;&lt;li&gt;âž¤ Lipofuscin granules are identified in electron microscopy&lt;/li&gt;&lt;li&gt;âž¤ granular appearance, perinuclear position, and intralysosomal location&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the etiology of Werner syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Telomerase lengthening&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lamin mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lipid peroxidation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;DNA helicase defect&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. DNA helicase defect&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) DNA helicase defect&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Telomerase lengthening is typically related to cellular mechanisms that allow for unlimited replication, as seen in cancer cells , not premature aging.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Telomerase lengthening&lt;/li&gt;&lt;li&gt;â€¢ cellular mechanisms&lt;/li&gt;&lt;li&gt;â€¢ unlimited replication,&lt;/li&gt;&lt;li&gt;â€¢ cancer cells&lt;/li&gt;&lt;li&gt;â€¢ Option B . Mutations in the lamin proteins are related to various disorders, including some forms of premature aging, but not specifically Werner syndrome .&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Mutations in the lamin proteins&lt;/li&gt;&lt;li&gt;â€¢ premature aging,&lt;/li&gt;&lt;li&gt;â€¢ not specifically Werner syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option C. While lipid peroxidation can contribute to cellular damage and aging , it is not the genetic etiology of Werner syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ While lipid peroxidation&lt;/li&gt;&lt;li&gt;â€¢ cellular damage and aging&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The genetic etiology of Werner syndrome is a defect in DNA helicase leading to premature aging due to the inability to properly replicate and repair DNA, which results in accelerated chromosomal damage.&lt;/li&gt;&lt;li&gt;âž¤ Werner syndrome is a defect in DNA helicase&lt;/li&gt;&lt;li&gt;âž¤ due to the inability to properly replicate and repair DNA,&lt;/li&gt;&lt;li&gt;âž¤ chromosomal damage.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the false statement regarding reversible cellular injury?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cellular swelling is an early finding of cell injury&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;On removal of offending stimulus, fatty change can be reversed&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Plasma membrane blebs can be seen ultrastructurally&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cellular fragmentation in light microscopy is diagnostic&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Cellular fragmentation in light microscopy is diagnostic&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture7.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Cellular fragmentation in light microscopy is diagnostic&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A.  Cellular swelling , or hydropic change , is one of the earliest manifestations of cellular injury and indicates a reversible stage where function may be restored upon removal of the insult.&lt;/li&gt;&lt;li&gt;â€¢ Option A.  Cellular swelling&lt;/li&gt;&lt;li&gt;â€¢ hydropic change&lt;/li&gt;&lt;li&gt;â€¢ earliest&lt;/li&gt;&lt;li&gt;â€¢ cellular injury&lt;/li&gt;&lt;li&gt;â€¢ function may be restored upon removal of the insult.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fatty change , or steatosis, in cells, such as hepatocytes, is typically reversible when the underlying cause (such as alcohol abuse) is removed.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fatty change&lt;/li&gt;&lt;li&gt;â€¢ typically reversible&lt;/li&gt;&lt;li&gt;â€¢ cause (such as alcohol abuse) is removed.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Blebbing of the plasma membrane is a reversible change often seen in injured cells.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Blebbing&lt;/li&gt;&lt;li&gt;â€¢ plasma membrane&lt;/li&gt;&lt;li&gt;â€¢ reversible change&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cellular fragmentation seen in light microscopy is indicative of irreversible cell injury, such as necrosis , and is not a feature of reversible cell injury .&lt;/li&gt;&lt;li&gt;âž¤ Cellular fragmentation&lt;/li&gt;&lt;li&gt;âž¤ light microscopy&lt;/li&gt;&lt;li&gt;âž¤ irreversible cell&lt;/li&gt;&lt;li&gt;âž¤ necrosis&lt;/li&gt;&lt;li&gt;âž¤ not a feature of reversible cell injury&lt;/li&gt;&lt;li&gt;âž¤ Characteristic features of reversible injury:&lt;/li&gt;&lt;li&gt;âž¤ Characteristic features of reversible injury:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran Pathologic Basis of disease 10th ed (Latest)- Pg: 38&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran Pathologic Basis of disease 10th ed (Latest)- Pg: 38&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Electron microscopy was performed in a renal biopsy obtained from a 45-year-old female on aminoglycoside therapy. Image shows a peculiar finding (marked with an arrow). Which is true regarding this finding?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It occurs due to the accumulation of triglycerides&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Seen exclusively in reversible injury&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Seen exclusively in irreversible cell injury&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thought to be derived from damaged cellular membranes&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Thought to be derived from damaged cellular membranes&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture8.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture9.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Thought to be derived from damaged cellular membranes&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Myelin figures are composed of phospholipids , not triglycerides.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Myelin figures are composed of phospholipids&lt;/li&gt;&lt;li&gt;â€¢ Option B and Option C. Myelin figures can be observed in both reversible and irreversible cell injury scenarios .&lt;/li&gt;&lt;li&gt;â€¢ Option B and Option C.&lt;/li&gt;&lt;li&gt;â€¢ Myelin figures&lt;/li&gt;&lt;li&gt;â€¢ both reversible and irreversible cell injury scenarios&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Myelin figures , which may be seen in renal biopsies from patients with drug-induced nephrotoxicity, are derived from damaged cellular membranes and can be indicative of both reversible and irreversible cell injury.&lt;/li&gt;&lt;li&gt;âž¤ Myelin figures&lt;/li&gt;&lt;li&gt;âž¤ renal biopsies&lt;/li&gt;&lt;li&gt;âž¤ drug-induced nephrotoxicity,&lt;/li&gt;&lt;li&gt;âž¤ damaged cellular membranes&lt;/li&gt;&lt;li&gt;âž¤ both reversible and irreversible cell injury.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran Pathologic Basis of disease 10th ed (Latest)- Pg: 39 Image attribute: https://www.sciencedirect.com/science/article/abs/pii/S0006295202011103&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran Pathologic Basis of disease 10th ed (Latest)- Pg: 39 Image attribute:&lt;/li&gt;&lt;li&gt;âž¤ https://www.sciencedirect.com/science/article/abs/pii/S0006295202011103&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year obese non-alcoholic female presented with mild right sided abdominal pain. Examination was normal. Blood work revealed mild increase in liver enzymes (SGOT and SGPT) with normal Total Bilirubin and direct bilirubin. Ultrasonography performed revealed few hyperechoic regions in the liver. If a biopsy is performed, which finding will most likely be seen?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Accumulation of lipid in the cytoplasm of hepatocytes&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Accumulation of glycogen in the cytoplasm of hepatocytes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Accumulation of iron in the hepatic parenchyma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Accumulation of iron in the Kupffer cells.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Accumulation of lipid in the cytoplasm of hepatocytes&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Accumulation of lipid in the cytoplasm of hepatocytes.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. While glycogen accumulation can occur in diabetes and glycogen storage diseases , it is less likely given the ultrasound findings and clinical presentation.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ glycogen&lt;/li&gt;&lt;li&gt;â€¢ diabetes and glycogen storage diseases&lt;/li&gt;&lt;li&gt;â€¢ Option C. Iron accumulation is seen in conditions such as hemochromatosis but is not typically associated with the clinical picture described, which suggests NAFLD.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Iron accumulation&lt;/li&gt;&lt;li&gt;â€¢ hemochromatosis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Iron accumulation within Kupffer cells may occur secondary to certain conditions but is not indicative of NAFLD , the likely diagnosis in this scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Iron accumulation within Kupffer cells&lt;/li&gt;&lt;li&gt;â€¢ but is not indicative of NAFLD&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The expected histological finding in a biopsy of a patient with non-alcoholic fatty liver disease is the accumulation of lipid within hepatocyte cytoplasm. This condition is characterized by elevated liver enzymes and the presence of fatty infiltrates on imaging.&lt;/li&gt;&lt;li&gt;âž¤ histological finding in a biopsy&lt;/li&gt;&lt;li&gt;âž¤ non-alcoholic fatty liver disease&lt;/li&gt;&lt;li&gt;âž¤ lipid within hepatocyte cytoplasm.&lt;/li&gt;&lt;li&gt;âž¤ elevated liver enzymes and the presence of fatty infiltrates on imaging.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran Pathologic Basis of disease 10th ed (Latest)- Pg: 37&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran Pathologic Basis of disease 10th ed (Latest)- Pg: 37&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following process does not show phases of acute inflammation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Necrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pyroptosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Apoptosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Necroptosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Apoptosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Apoptosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Necrosis involves cell death that triggers an inflammatory response due to the release of intracellular contents into the extracellular space.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Necrosis&lt;/li&gt;&lt;li&gt;â€¢ cell death that triggers an inflammatory&lt;/li&gt;&lt;li&gt;â€¢ intracellular contents into the extracellular space.&lt;/li&gt;&lt;li&gt;â€¢ Option B. This is a highly inflammatory form of programmed cell death where cells swell, lose membrane integrity, and release pro-inflammatory mediators.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ highly inflammatory form of programmed cell death&lt;/li&gt;&lt;li&gt;â€¢ Option D. Necroptosis, sometimes referred to as programmed necrosis , is caspase-independent cell death that morphologically resembles necrosis and is associated with inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Necroptosis,&lt;/li&gt;&lt;li&gt;â€¢ programmed necrosis&lt;/li&gt;&lt;li&gt;â€¢ caspase-independent cell death&lt;/li&gt;&lt;li&gt;â€¢ associated with inflammation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Apoptosis is a caspase-dependent programmed cell death process that typically proceeds without triggering the phases of acute inflammation due to efficient clearance of dying cells.&lt;/li&gt;&lt;li&gt;âž¤ Apoptosis&lt;/li&gt;&lt;li&gt;âž¤ caspase-dependent programmed cell death&lt;/li&gt;&lt;li&gt;âž¤ without triggering the phases of acute inflammation&lt;/li&gt;&lt;li&gt;âž¤ efficient clearance of dying cells.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All are features of reversible cell injury except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Endoplasmic reticulum swelling&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dense deposition of mitochondria&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bleb formation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Decreased ribosomal function&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Dense deposition of mitochondria&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Dense deposition of mitochondria&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. This is a feature of reversible cell injury , where swelling of organelles such as the endoplasmic reticulum occurs as a response to cell injury before permanent damage sets in .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ reversible cell injury&lt;/li&gt;&lt;li&gt;â€¢ swelling of organelles such as the endoplasmic reticulum occurs as a response to cell injury&lt;/li&gt;&lt;li&gt;â€¢ permanent damage sets in&lt;/li&gt;&lt;li&gt;â€¢ Option C. Blebbing of the plasma membrane is a sign of reversible cell injury where the cell morphology is altered but can be restored if the injurious stimulus is removed .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Blebbing&lt;/li&gt;&lt;li&gt;â€¢ of the plasma membrane&lt;/li&gt;&lt;li&gt;â€¢ reversible cell injury&lt;/li&gt;&lt;li&gt;â€¢ restored if the injurious stimulus is removed&lt;/li&gt;&lt;li&gt;â€¢ Option D. A decrease in ribosomal function (detachment of ribosomes from the rough endoplasmic reticulum) is seen with reversible cell injury as a part of the cellular stress response.&lt;/li&gt;&lt;li&gt;â€¢ Option D. A decrease in ribosomal function&lt;/li&gt;&lt;li&gt;â€¢ reversible cell injury as a part of the cellular stress response.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Dense deposition of mitochondria is not a feature of reversible cell injury but rather indicates irreversible damage, typically associated with severe s tructural changes within the mitochondria.&lt;/li&gt;&lt;li&gt;âž¤ Dense deposition of mitochondria&lt;/li&gt;&lt;li&gt;âž¤ reversible cell injury&lt;/li&gt;&lt;li&gt;âž¤ rather indicates irreversible damage,&lt;/li&gt;&lt;li&gt;âž¤ tructural changes within the mitochondria.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th /40&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th /40&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Please read the statements carefully as this is an assertion and reason question Assertion (A): Necrotic cells have a glassy, homogenous appearance when compared to normal cells in irreversible cell injury. Reason (R): There may be loss of nuclear material in irreversible cell injury&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Both Assertion (A) and Reason (R) are the true and Reason (R) is a correct explanation of Assertion (A).&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Both Assertion (A) and Reason (R) are the true but Reason (R) is not the correct explanation of Assertion (A).&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Assertion (A) is true but Reason (R) is false&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Assertion (A) is false but Reason (R) is true&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Both Assertion (A) and Reason (R) are the true but Reason (R) is not the correct explanation of Assertion (A).&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Both Assertion (A) and Reason (R) are the true but Reason (R) is not the correct explanation of Assertion (A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Necrotic cells can exhibit a glassy, homogeneous appearance due to the loss of intracellular components like glycogen , while the loss of nuclear material is also a characteristic of irreversible cell injury , but it is not the explanation for the glassy appearance.&lt;/li&gt;&lt;li&gt;âž¤ Necrotic cells&lt;/li&gt;&lt;li&gt;âž¤ glassy, homogeneous appearance&lt;/li&gt;&lt;li&gt;âž¤ loss of intracellular components like glycogen&lt;/li&gt;&lt;li&gt;âž¤ loss of nuclear material&lt;/li&gt;&lt;li&gt;âž¤ characteristic of irreversible cell injury&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran Pathologic Basis of disease 10th ed (Latest)- Pg: 40&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran Pathologic Basis of disease 10th ed (Latest)- Pg: 40&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Please read the statements carefully as this is an assertion and reason question: Assertion (A): One of the hallmarks of irreversible cell injury is damaged cell membrane Reason (R): When intracellular calcium is increased, activation of phospholipase enzyme is seen&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Both Assertion (A) and Reason (R) are the true and Reason (R) is a correct explanation of Assertion (A).&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Both Assertion (A) and Reason (R) are the true but Reason (R) is not the correct explanation of Assertion (A).&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Assertion (A) is true but Reason (R) is false&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Assertion (A) is false but Reason (R) is true&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Both Assertion (A) and Reason (R) are the true and Reason (R) is a correct explanation of Assertion (A).&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Both Assertion (A) and Reason (R) are the true and Reason (R) is a correctÂ Â Â  explanation of Assertion (A).&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Damaged cell membranes are a hallmark of irreversible cell injury, and this is due in part to the increased intracellular calcium levels that lead to phospholipase activation, which degrades membrane lipids .&lt;/li&gt;&lt;li&gt;âž¤ Damaged cell membranes&lt;/li&gt;&lt;li&gt;âž¤ hallmark of irreversible cell injury,&lt;/li&gt;&lt;li&gt;âž¤ increased intracellular calcium levels&lt;/li&gt;&lt;li&gt;âž¤ phospholipase activation,&lt;/li&gt;&lt;li&gt;âž¤ membrane lipids&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran Pathologic Basis of disease 10th ed (Latest)- Pg: 39&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran Pathologic Basis of disease 10th ed (Latest)- Pg: 39&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Match the type of necrosis and associated disease:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1-d, 2-b, 3-a, 4-c&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1-d, 2-c, 3-a, 4-b&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1-b, 2-c, 3-d, 4-a&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1-b, 2-d, 3-a, 4-c&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 1-d, 2-b, 3-a, 4-c&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture10.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture11.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) 1-d, 2-b, 3-a, 4-c&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ The correct matches for the type of necrosis and associated disease are:&lt;/li&gt;&lt;li&gt;â€¢ Caseous necrosis â€” d. Mycobacterial infection Fibrinoid necrosis â€”b. Polyarteritis nodosa Liquefactive necrosis â€”a. Staphylococcus aureus infection Fat necrosis â€” c. Acute pancreatitis&lt;/li&gt;&lt;li&gt;â€¢ Caseous necrosis â€” d. Mycobacterial infection&lt;/li&gt;&lt;li&gt;â€¢ Fibrinoid necrosis â€”b. Polyarteritis nodosa&lt;/li&gt;&lt;li&gt;â€¢ Liquefactive necrosis â€”a. Staphylococcus aureus infection&lt;/li&gt;&lt;li&gt;â€¢ Fat necrosis â€” c. Acute pancreatitis&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins and Cotran Pathologic Basis of disease 10th ed (Latest)- Pg: 41&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Robbins and Cotran Pathologic Basis of disease 10th ed (Latest)- Pg: 41&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man suffered a massive cardiac arrest and encountered sudden death. Post mortem finding of the heart shows complete obstruction of left anterior descending artery by an atherosclerotic plaque. Which type of necrosis will be identified in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Coagulative necrosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fibrinoid necrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Caseous necrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Gangrenous necrosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Coagulative necrosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture12.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Coagulative necrosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fibrinoid necrosis is usually associated with immune reactions in blood vessels , as seen in conditions like vasculitis, not with ischemic heart disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fibrinoid necrosis&lt;/li&gt;&lt;li&gt;â€¢ immune reactions in blood vessels&lt;/li&gt;&lt;li&gt;â€¢ vasculitis, not with ischemic heart disease.&lt;/li&gt;&lt;li&gt;â€¢ Option C. This type of necrosis is characteristic of tuberculosis infections, where affected tissues display a cheese-like appearance, not typically associated with myocardial infarction.&lt;/li&gt;&lt;li&gt;â€¢ Option C. This type of necrosis&lt;/li&gt;&lt;li&gt;â€¢ tuberculosis infections,&lt;/li&gt;&lt;li&gt;â€¢ cheese-like appearance,&lt;/li&gt;&lt;li&gt;â€¢ Option D. Gangrenous necrosis is a term used more commonly in the clinical setting to describe limb death due to severe ischemia, and although it can involve coagulative necrosis, it&#x27;s not the specific type seen with a blocked coronary artery in the heart .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Gangrenous necrosis&lt;/li&gt;&lt;li&gt;â€¢ limb death due to severe ischemia,&lt;/li&gt;&lt;li&gt;â€¢ it can involve coagulative necrosis, it&#x27;s not the specific&lt;/li&gt;&lt;li&gt;â€¢ blocked coronary artery in the heart&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In the event of a massive cardiac arrest with an obstructed left anterior descending artery, the type of necrosis expected in the heart is coagulative necrosis , which is characterized by the preservation of the basic outline of the cells after cell death due to ischemia .&lt;/li&gt;&lt;li&gt;âž¤ massive cardiac arrest&lt;/li&gt;&lt;li&gt;âž¤ obstructed left anterior descending artery,&lt;/li&gt;&lt;li&gt;âž¤ heart is coagulative necrosis&lt;/li&gt;&lt;li&gt;âž¤ preservation of the basic outline of the cells after cell death due to ischemia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;As a baby develops in utero, fingers and toes are attached together in the form of webs. Around 10 weeks of gestation, fingers and toes separate, elongate and lose their webbing. Which of the following physiological processes aids this?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Free radical injury in utero&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Necroptosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ferroptosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Apoptosis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Apoptosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Apoptosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Free radical injury is typically harmful and not a normal part of physiological development.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Free radical injury&lt;/li&gt;&lt;li&gt;â€¢ harmful and not a normal part of physiological development.&lt;/li&gt;&lt;li&gt;â€¢ Option B. This is a form of programmed cell death , but it is not responsible for the normal differentiation and development processes that occur in utero .&lt;/li&gt;&lt;li&gt;â€¢ Option B. This is a form of programmed cell death&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ normal differentiation and development&lt;/li&gt;&lt;li&gt;â€¢ in utero&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ferroptosis is an iron-dependent form of non-apoptotic cell death , not involved in the typical development of fingers and toes.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ferroptosis&lt;/li&gt;&lt;li&gt;â€¢ iron-dependent&lt;/li&gt;&lt;li&gt;â€¢ non-apoptotic cell death&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Apoptosis plays a key role in embryonic development , including the separation and elongation of fingers and toes , by removing excess cells to shape the developing tissues correctly .&lt;/li&gt;&lt;li&gt;âž¤ Apoptosis plays&lt;/li&gt;&lt;li&gt;âž¤ embryonic development&lt;/li&gt;&lt;li&gt;âž¤ including the separation and elongation of fingers and toes&lt;/li&gt;&lt;li&gt;âž¤ removing excess cells to shape the developing tissues correctly&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran Pathologic Basis of disease 10th ed (Latest)- Pg: 42&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Robbins and Cotran Pathologic Basis of disease 10th ed (Latest)- Pg: 42&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the correctly matched option about the pattern of cell death and the DNA electrophoresis pattern shown:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Necrosis (A), Apoptosis(B), normal pattern (C)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Necrosis (B), Apoptosis(C), normal pattern (A)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Necrosis (C), Apoptosis(B), normal pattern (A)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Necrosis (B), Apoptosis(A), normal pattern (C)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Necrosis (C), Apoptosis(B), normal pattern (A)&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture13.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Necrosis (C), Apoptosis(B), normal pattern (A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The image shown is an agarose gel used for DNA electrophoresis, displaying three distinct patterns which correlate with different cellular states :&lt;/li&gt;&lt;li&gt;â€¢ an agarose gel used for DNA electrophoresis,&lt;/li&gt;&lt;li&gt;â€¢ different cellular states&lt;/li&gt;&lt;li&gt;â€¢ Lane A shows a normal DNA pattern used as a reference. Lane B displays a ladder pattern , characteristic of DNA fragmentation occurring during apoptosis , where the DNA is cleaved at internucleosomal regions . Lane C shows a smear pattern , which is typical for necrosis, where DNA is randomly degraded.&lt;/li&gt;&lt;li&gt;â€¢ Lane A shows a normal DNA pattern used as a reference.&lt;/li&gt;&lt;li&gt;â€¢ Lane A&lt;/li&gt;&lt;li&gt;â€¢ normal DNA pattern&lt;/li&gt;&lt;li&gt;â€¢ Lane B displays a ladder pattern , characteristic of DNA fragmentation occurring during apoptosis , where the DNA is cleaved at internucleosomal regions .&lt;/li&gt;&lt;li&gt;â€¢ Lane B&lt;/li&gt;&lt;li&gt;â€¢ ladder pattern&lt;/li&gt;&lt;li&gt;â€¢ DNA fragmentation occurring during apoptosis&lt;/li&gt;&lt;li&gt;â€¢ DNA is cleaved at internucleosomal regions&lt;/li&gt;&lt;li&gt;â€¢ Lane C shows a smear pattern , which is typical for necrosis, where DNA is randomly degraded.&lt;/li&gt;&lt;li&gt;â€¢ Lane C&lt;/li&gt;&lt;li&gt;â€¢ smear pattern&lt;/li&gt;&lt;li&gt;â€¢ necrosis,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In DNA electrophoresis, a step ladder pattern is indicative of apoptosis due to regular internucleosomal DNA cleavage , whereas a smear pattern is associated with the random DNA degradation seen in necrosis.&lt;/li&gt;&lt;li&gt;âž¤ DNA electrophoresis,&lt;/li&gt;&lt;li&gt;âž¤ step ladder pattern&lt;/li&gt;&lt;li&gt;âž¤ apoptosis due to regular internucleosomal DNA cleavage&lt;/li&gt;&lt;li&gt;âž¤ random DNA degradation seen in necrosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the true statement about the genes regulating apoptosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Genes which inhibit apoptosis: bcl-XS&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pro apoptosis genes: MCL-1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;BH3 genes: BCL-XL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Gene acting as apoptosis initiators: BAD&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Gene acting as apoptosis initiators: BAD&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture14.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Gene acting as apoptosis initiators: BAD&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bcl-XS is a pro-apoptotic member of the Bcl-2 family, not an inhibitor of apoptosis&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bcl-XS&lt;/li&gt;&lt;li&gt;â€¢ pro-apoptotic member of the Bcl-2 family,&lt;/li&gt;&lt;li&gt;â€¢ Option B. MCL-1 has a complex role in apoptosis. It has both pro- and anti-apoptotic isoforms . However, MCL-1 is generally considered to be anti-apoptotic.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ MCL-1 has a complex role in apoptosis.&lt;/li&gt;&lt;li&gt;â€¢ pro- and anti-apoptotic isoforms&lt;/li&gt;&lt;li&gt;â€¢ anti-apoptotic.&lt;/li&gt;&lt;li&gt;â€¢ Option C. BCL-XL is an anti-apoptotic member of the Bcl-2 family , not a BH3-only protein. BH3-only proteins are pro-apoptotic.&lt;/li&gt;&lt;li&gt;â€¢ Option C. BCL-XL&lt;/li&gt;&lt;li&gt;â€¢ anti-apoptotic member&lt;/li&gt;&lt;li&gt;â€¢ Bcl-2 family&lt;/li&gt;&lt;li&gt;â€¢ BH3-only proteins are pro-apoptotic.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ BAD is a pro-apoptotic gene that acts as an initiator of apoptosis . It is part of the BH3-only subgroup of the Bcl-2 family , which promotes apoptosis by neutralizing the function of anti-apoptotic proteins within the cell .Top of FormBottom of Form&lt;/li&gt;&lt;li&gt;âž¤ BAD&lt;/li&gt;&lt;li&gt;âž¤ pro-apoptotic gene&lt;/li&gt;&lt;li&gt;âž¤ initiator of apoptosis&lt;/li&gt;&lt;li&gt;âž¤ BH3-only subgroup of the Bcl-2 family&lt;/li&gt;&lt;li&gt;âž¤ promotes apoptosis&lt;/li&gt;&lt;li&gt;âž¤ neutralizing the function of anti-apoptotic proteins within the cell&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Apoptosome is formed by the binding of cytochrome C with which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Apaf 1&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bcl-2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;FADD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;TNF&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Apaf 1&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Apaf 1&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. BCL-2 has anti-apoptotic activity.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ BCL-2&lt;/li&gt;&lt;li&gt;â€¢ anti-apoptotic activity.&lt;/li&gt;&lt;li&gt;â€¢ Option C. FADD is a key component of the death receptor or extrinsic pathway . This extrinsic apoptosis pathway can be inhibited by a protein called FLIP, which binds to pro- caspase - 8 , thereby blocking FADD binding , but cannot activate the caspase .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ death receptor or extrinsic pathway&lt;/li&gt;&lt;li&gt;â€¢ protein called FLIP,&lt;/li&gt;&lt;li&gt;â€¢ pro- caspase - 8&lt;/li&gt;&lt;li&gt;â€¢ blocking FADD binding&lt;/li&gt;&lt;li&gt;â€¢ cannot activate the caspase&lt;/li&gt;&lt;li&gt;â€¢ Option D. Death receptors in the death receptor pathway or extrinsic pathway are type 1 TNF receptor (TNFR1) pathway and a related protein called Fas (CD95).&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ death receptor pathway or extrinsic pathway are type 1 TNF receptor (TNFR1) pathway&lt;/li&gt;&lt;li&gt;â€¢ Fas (CD95).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The apoptosome is formed by the binding of cytochrome C with Apaf-1 , initiating the activation of caspase-9 , which is a key event in the intrinsic pathway of apoptosis.&lt;/li&gt;&lt;li&gt;âž¤ apoptosome&lt;/li&gt;&lt;li&gt;âž¤ cytochrome C with Apaf-1&lt;/li&gt;&lt;li&gt;âž¤ caspase-9&lt;/li&gt;&lt;li&gt;âž¤ intrinsic pathway of apoptosis.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th /45&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th /45&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the role of annexin V in cellular processes, and how is it associated with pathological conditions?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Marker of hairy cell leukemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Not associated with caspase dependent programmed cell death&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Marker of necrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Antibodies directed against annexin V are seen in antiphospholipid syndrome&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Antibodies directed against annexin V are seen in antiphospholipid syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Antibodies directed against annexin V are seen in antiphospholipid syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Annexin A1, not annexin V , is associated with hairy cell leukemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Annexin A1, not annexin V&lt;/li&gt;&lt;li&gt;â€¢ hairy cell leukemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Annexin V is a marker of apoptosis , which is a caspase-dependent programmed cell death process .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Annexin V&lt;/li&gt;&lt;li&gt;â€¢ apoptosis&lt;/li&gt;&lt;li&gt;â€¢ caspase-dependent programmed cell death process&lt;/li&gt;&lt;li&gt;â€¢ Option C. Annexin V is not a marker of necrosis ; instead, it binds to phosphatidylserine on the outer leaflet of the plasma membrane , which is a hallmark of apoptosis .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Annexin V is not a marker of necrosis&lt;/li&gt;&lt;li&gt;â€¢ phosphatidylserine&lt;/li&gt;&lt;li&gt;â€¢ outer leaflet of the plasma membrane&lt;/li&gt;&lt;li&gt;â€¢ hallmark of apoptosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Annexin V is associated with apoptosis, where it binds to phosphatidylserine on the surface of apoptotic cells . Antibodies against annexin V are characteristic of antiphospholipid syndrome, where they can interfere with annexin V&#x27;s normal anticoagulant function, contributing to a pro-thrombotic state .&lt;/li&gt;&lt;li&gt;âž¤ Annexin V&lt;/li&gt;&lt;li&gt;âž¤ binds to phosphatidylserine on the surface of apoptotic cells&lt;/li&gt;&lt;li&gt;âž¤ Antibodies against&lt;/li&gt;&lt;li&gt;âž¤ antiphospholipid syndrome,&lt;/li&gt;&lt;li&gt;âž¤ interfere with annexin V&#x27;s normal anticoagulant function,&lt;/li&gt;&lt;li&gt;âž¤ pro-thrombotic state&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A developing embryo undergoes physiological apoptosis. Which of the following processes contribute to the absence of inflammation during apoptosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pinocytosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Entosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Efferocytosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Exocytosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Efferocytosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture15.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Efferocytosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pinocytosis is a form of endocytosis that cells use to ingest extracellular fluid and small particles , not specifically for clearing apoptotic cells .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pinocytosis&lt;/li&gt;&lt;li&gt;â€¢ endocytosis&lt;/li&gt;&lt;li&gt;â€¢ ingest extracellular fluid and small particles&lt;/li&gt;&lt;li&gt;â€¢ clearing apoptotic cells&lt;/li&gt;&lt;li&gt;â€¢ Option B. Entosis is a process where one cell is engulfed by another cell, but it&#x27;s not related to the clearance of apoptotic cells to prevent inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Entosis&lt;/li&gt;&lt;li&gt;â€¢ one cell is engulfed by another cell,&lt;/li&gt;&lt;li&gt;â€¢ Option D. Exocytosis is the process of vesicles fusing with the plasma membrane to release their contents outside the cell , not related to the engulfment and clearance of apoptotic cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Exocytosis&lt;/li&gt;&lt;li&gt;â€¢ process of vesicles fusing with the plasma membrane to release their contents outside the cell&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Efferocytosis is the engulfment of apoptotic cells by phagocytes . This process is highly efficient and quick , leading to the rapid removal of dying cells without triggering inflammation , a crucial mechanism during embryonic development to maintain tissue homeostasis.&lt;/li&gt;&lt;li&gt;âž¤ Efferocytosis&lt;/li&gt;&lt;li&gt;âž¤ engulfment of apoptotic cells by phagocytes&lt;/li&gt;&lt;li&gt;âž¤ highly efficient and quick&lt;/li&gt;&lt;li&gt;âž¤ rapid removal of dying cells without triggering inflammation&lt;/li&gt;&lt;li&gt;âž¤ to maintain tissue homeostasis.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 46&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 46&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is a form of programmed cell death that is dependent on caspase-1 and leads to the release of pro-inflammatory cytokines such as IL-1Î² and IL-18?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Necrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Apoptosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pyroptosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Autophagy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pyroptosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Pyroptosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Necrosis is a form of cell death that occurs due to injury or disease and is characterized by the uncontrolled release of cellular contents , not typically associated with a caspase-dependent mechanism.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Necrosis&lt;/li&gt;&lt;li&gt;â€¢ cell death&lt;/li&gt;&lt;li&gt;â€¢ due to injury or disease&lt;/li&gt;&lt;li&gt;â€¢ uncontrolled release of cellular contents&lt;/li&gt;&lt;li&gt;â€¢ Option B. Although apoptosis is a form of programmed cell death , it is primarily associated with caspase-3 and caspase-9 and does not typically result in an inflammatory response.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Although apoptosis&lt;/li&gt;&lt;li&gt;â€¢ programmed cell death&lt;/li&gt;&lt;li&gt;â€¢ with caspase-3 and caspase-9&lt;/li&gt;&lt;li&gt;â€¢ Option D. Autophagy is a process of cellular \&quot;self-eating\&quot; that recycles cellular components and does not directly lead to cell death or the release of pro-inflammatory cytokines.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Autophagy&lt;/li&gt;&lt;li&gt;â€¢ cellular \&quot;self-eating\&quot;&lt;/li&gt;&lt;li&gt;â€¢ cellular components and does not directly lead to cell death&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pyroptosis is a type of programmed cell death that is dependent on caspase-1 activation and results in the release of pro-inflammatory cytokines such as IL-1Î² and IL-18. It is initiated in response to infection by intracellular pathogens and can be triggered by the activation of pattern recognition receptors such as NOD-like receptors.&lt;/li&gt;&lt;li&gt;âž¤ Pyroptosis&lt;/li&gt;&lt;li&gt;âž¤ programmed cell death&lt;/li&gt;&lt;li&gt;âž¤ caspase-1 activation&lt;/li&gt;&lt;li&gt;âž¤ pro-inflammatory cytokines such as IL-1Î² and IL-18.&lt;/li&gt;&lt;li&gt;âž¤ infection by intracellular pathogens&lt;/li&gt;&lt;li&gt;âž¤ triggered by&lt;/li&gt;&lt;li&gt;âž¤ NOD-like receptors.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 47&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 47&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which caspase is not typically involved in the process of pyroptosis, a form of cell death associated with microbial infection and inflammatory response?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Caspase 1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Caspase 3&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Caspase 4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Caspase 5&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Caspase 3&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Caspase 3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Caspase 1 is a central enzyme in the pyroptotic pathway , responsible for the cleavage of pro-inflammatory cytokines like IL-1Î² and initiating the pyroptotic cell death .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Caspase 1&lt;/li&gt;&lt;li&gt;â€¢ pyroptotic pathway&lt;/li&gt;&lt;li&gt;â€¢ cleavage of pro-inflammatory cytokines like IL-1Î²&lt;/li&gt;&lt;li&gt;â€¢ pyroptotic cell death&lt;/li&gt;&lt;li&gt;â€¢ Option C. Caspase 4 is implicated in the detection of bacterial endotoxins and can initiate noncanonical pyroptosis upon sensing these intracellular signals.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Caspase 4&lt;/li&gt;&lt;li&gt;â€¢ detection of bacterial endotoxins&lt;/li&gt;&lt;li&gt;â€¢ noncanonical pyroptosis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Similar to caspase 4, caspase 5 is involved in the noncanonical pyroptosis pathway and participates in immune defense against intracellular pathogens .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Similar to caspase 4, caspase 5&lt;/li&gt;&lt;li&gt;â€¢ noncanonical pyroptosis&lt;/li&gt;&lt;li&gt;â€¢ immune defense against intracellular pathogens&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Caspase 3 , does not play a role in pyroptosis but is a crucial mediator of apoptosis .&lt;/li&gt;&lt;li&gt;âž¤ Caspase 3&lt;/li&gt;&lt;li&gt;âž¤ does not play a role in pyroptosis&lt;/li&gt;&lt;li&gt;âž¤ crucial mediator of apoptosis&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 9th e/p 47)&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 9th e/p 47)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A middle aged man 45-year-old man presents with increasing abdominal girth and yellow discoloration of his skin and sclera. He had hepatomegaly and jaundice on physical examination. A Prussian blue stain of a liver biopsy is shown in the image. What is the major intracellular iron storage protein in this patientâ€™s hepatocytes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bilirubin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Haptoglobin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hemoglobin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hemosiderin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hemosiderin&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture16.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Hemosiderin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bilirubin is a breakdown product of hemoglobin and is not a storage form of iron.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bilirubin&lt;/li&gt;&lt;li&gt;â€¢ product of hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ Option B. Haptoglobin binds free hemoglobin released from erythrocytes , not iron directly, and is not a storage protein for iron within cells.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Haptoglobin&lt;/li&gt;&lt;li&gt;â€¢ free hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ erythrocytes&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hemoglobin is the oxygen-carrying protein found in red blood cells , not an iron storage protein in hepatocytes.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ oxygen-carrying protein&lt;/li&gt;&lt;li&gt;â€¢ red blood cells&lt;/li&gt;&lt;li&gt;â€¢ not an iron storage protein in hepatocytes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hemosiderin, is the major iron storage complex within cells . Its accumulation, indicated by Prussian blue staining in a liver biopsy , is indicative of iron overload and is commonly seen in conditions like hemochromatosis.&lt;/li&gt;&lt;li&gt;âž¤ Hemosiderin,&lt;/li&gt;&lt;li&gt;âž¤ iron storage complex within cells&lt;/li&gt;&lt;li&gt;âž¤ Prussian blue staining in a liver biopsy&lt;/li&gt;&lt;li&gt;âž¤ iron overload&lt;/li&gt;&lt;li&gt;âž¤ hemochromatosis.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 65&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 65&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT true about free radical injury?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is an auto catalytic reaction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hydroxyl radical is the most powerful free radical&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vitamins A, B and C are powerful antioxidants&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Intracellular ratio of oxidized glutathione (GSSG) to reduced glutathione (GSH) reflects the oxidative state of the cell.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Vitamins A, B and C are powerful antioxidants&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Vitamins A, B and C are powerful antioxidants&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Free radical reactions can propagate themselves in an autocatalytic manner.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Free radical&lt;/li&gt;&lt;li&gt;â€¢ propagate themselves&lt;/li&gt;&lt;li&gt;â€¢ autocatalytic manner.&lt;/li&gt;&lt;li&gt;â€¢ Option B. The hydroxyl radical is indeed one of the most reactive free radicals.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ hydroxyl radical&lt;/li&gt;&lt;li&gt;â€¢ reactive free radicals.&lt;/li&gt;&lt;li&gt;â€¢ Option D. The intracellular ratio of oxidized glutathione (GSSG) to reduced glutathione (GSH) reflects the oxidative state of the cell.This ratio is a key indicator of cellular oxidative stress.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ oxidized glutathione (GSSG) to reduced glutathione (GSH)&lt;/li&gt;&lt;li&gt;â€¢ oxidative state of the&lt;/li&gt;&lt;li&gt;â€¢ indicator of cellular oxidative stress.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While Vitamins A and C are antioxidants,  Vitamin B does not serve as an antioxidant.&lt;/li&gt;&lt;li&gt;âž¤ Vitamins A and C are antioxidants,  Vitamin B does not serve as an antioxidant.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 52-3&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 52-3&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man presents with Hodgkin lymphoma undergoes 3 sessions of radiotherapy. Microscopic examination in the field of radiation reveals numerous acidophilic bodies and small cells with pyknotic nuclei. Which of the following proteins most likely played a key role in triggering radiation-induced cell death in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cytochrome P450&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;p53&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Î²-Catenin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;E-Cadherin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. p53&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cytochrome P450 enzymes are involved in drug metabolism and are not directly associated with the cellular response to DNA damage .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cytochrome P450&lt;/li&gt;&lt;li&gt;â€¢ enzymes&lt;/li&gt;&lt;li&gt;â€¢ drug metabolism&lt;/li&gt;&lt;li&gt;â€¢ not directly associated with the cellular response to DNA damage&lt;/li&gt;&lt;li&gt;â€¢ Option C. Î²-Catenin is involved in cell signaling and adhesion, with roles in the Wnt signaling pathway and not directly in DNA damage response.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Î²-Catenin&lt;/li&gt;&lt;li&gt;â€¢ signaling and adhesion,&lt;/li&gt;&lt;li&gt;â€¢ Option D. E-Cadherin is a cell adhesion molecule important for maintaining cell-to-cell junctions and is not involved in the DNA damage response.&lt;/li&gt;&lt;li&gt;â€¢ Option D. E-Cadherin&lt;/li&gt;&lt;li&gt;â€¢ maintaining cell-to-cell junctions&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Following DNA damage from radiotherapy , p53 assesses the severity of genomic abnormalities and determines whether to activate repair mechanisms or proceed to apoptosis if the damage is beyond repair .&lt;/li&gt;&lt;li&gt;âž¤ DNA damage&lt;/li&gt;&lt;li&gt;âž¤ radiotherapy&lt;/li&gt;&lt;li&gt;âž¤ p53&lt;/li&gt;&lt;li&gt;âž¤ genomic abnormalities and determines whether to activate repair mechanisms or proceed to apoptosis&lt;/li&gt;&lt;li&gt;âž¤ beyond repair&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th /45&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th /45&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 20-year-old man goes on a fun trip to Goa and spends 6 hours on the beach in day time. The next day he has a darker complexion. His skin does not show warmth, erythema, or tenderness. His skin tone fades to its original appearance within a month. Which of the following substances contributes the most to the biochemical process leading to these skin changes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Iron oxide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tyrosine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Homogentisic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glycogen&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Tyrosine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Tyrosine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Heme containing iron as part of hemosiderin from breakdown of red blood cells can impart a brownish colour, but this is typically local from trauma or more global as part of an iron storage disease such as hemochromatosis . Iron oxide is also used in tattoo pigments .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Heme&lt;/li&gt;&lt;li&gt;â€¢ hemosiderin from breakdown of red blood cells&lt;/li&gt;&lt;li&gt;â€¢ iron storage disease such as hemochromatosis&lt;/li&gt;&lt;li&gt;â€¢ Iron oxide&lt;/li&gt;&lt;li&gt;â€¢ tattoo pigments&lt;/li&gt;&lt;li&gt;â€¢ Option C. Homogentisic acid can be part of the process of the rare disease alkaptonuria, in which a black pigment is deposited in connective tissues&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Homogentisic acid&lt;/li&gt;&lt;li&gt;â€¢ alkaptonuria,&lt;/li&gt;&lt;li&gt;â€¢ black pigment is deposited in connective tissues&lt;/li&gt;&lt;li&gt;â€¢ Option D. Glycogen in quantity is starch-like and imparts a paler colour to organs in which it is stored in excess . It does not involve the skin.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Glycogen&lt;/li&gt;&lt;li&gt;â€¢ paler colour to organs&lt;/li&gt;&lt;li&gt;â€¢ excess&lt;/li&gt;&lt;li&gt;â€¢ does not involve the skin.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Tyrosine is the key substrate in melanin synthesis , which is enhanced by UV exposure , leading to tanning of the skin . Tyrosinase is the enzyme responsible for the conversion of tyrosine to dihydroxyphenylalanine (DOPA) in the melanin synthesis pathway.&lt;/li&gt;&lt;li&gt;â€¢ Tyrosine&lt;/li&gt;&lt;li&gt;â€¢ melanin synthesis&lt;/li&gt;&lt;li&gt;â€¢ UV exposure&lt;/li&gt;&lt;li&gt;â€¢ leading to tanning of the skin&lt;/li&gt;&lt;li&gt;â€¢ tyrosine to dihydroxyphenylalanine (DOPA)&lt;/li&gt;&lt;li&gt;â€¢ melanin synthesis pathway.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old ingests a large amount of paracetamol and 12 hours later develops malaise and abdominal pain. Laboratory studies show an elevated ALT. N-acetylcysteine is administered to aid in generation of which of the following enzymes within cells as a protective mechanism to reduce the number of free radicals?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glutathione peroxidase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Catalase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hydrogen peroxide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;NADPH oxidase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Glutathione peroxidase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Glutathione peroxidase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Catalase is an enzyme found in the peroxisomes of cells that decomposes hydrogen peroxide into water and oxygen . It does not directly use substrates provided by N-acetylcysteine for its action.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Catalase&lt;/li&gt;&lt;li&gt;â€¢ peroxisomes of cells&lt;/li&gt;&lt;li&gt;â€¢ hydrogen peroxide into water and oxygen&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hydrogen peroxide is not an enzyme ; rather, it is a reactive oxygen species that is decomposed by enzymes such as catalase and glutathione peroxidase.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hydrogen peroxide&lt;/li&gt;&lt;li&gt;â€¢ not an enzyme&lt;/li&gt;&lt;li&gt;â€¢ reactive oxygen&lt;/li&gt;&lt;li&gt;â€¢ catalase and glutathione peroxidase.&lt;/li&gt;&lt;li&gt;â€¢ Option D. NADPH oxidase is an enzyme complex found in phagocytes that generates reactive oxygen species , such as hydrogen peroxide, used for the killing of pathogens . It is not involved in the detoxification of free radicals related to paracetamol toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option D. NADPH oxidase&lt;/li&gt;&lt;li&gt;â€¢ phagocytes that generates reactive oxygen species&lt;/li&gt;&lt;li&gt;â€¢ hydrogen peroxide,&lt;/li&gt;&lt;li&gt;â€¢ killing of pathogens&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ detoxification of free radicals related to paracetamol toxicity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ N-acetylcysteine aids in the synthesis of glutathione , thereby enhancing the activity of glutathione peroxidase to reduce the oxidative stress caused by a paracetamol overdose .&lt;/li&gt;&lt;li&gt;âž¤ N-acetylcysteine aids&lt;/li&gt;&lt;li&gt;âž¤ glutathione&lt;/li&gt;&lt;li&gt;âž¤ activity of glutathione peroxidase&lt;/li&gt;&lt;li&gt;âž¤ oxidative stress caused by a paracetamol overdose&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man has a 30-year history of poorly controlled diabetes mellitus. He has had extensive black discoloration of skin and soft tissue of his right foot, with areas of yellowish exudate, for the past 2 months. Staphylococcus aureus is cultured from this exudate. A below-the-knee amputation is performed. The amputation specimen received in the surgical pathology laboratory is most likely to demonstrate which of the following pathologic abnormalities?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Neoplasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gangrene&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vasculitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Caseation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Gangrene&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Gangrene&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. A neoplasm is a mass lesion.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Vasculitis (with either thrombosis or hemorrhage), would be more likely manifested throughout the body. Coagulopathy is not a feature of diabetes mellitus .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Vasculitis (with either thrombosis or hemorrhage),&lt;/li&gt;&lt;li&gt;â€¢ Coagulopathy is not a feature of diabetes mellitus&lt;/li&gt;&lt;li&gt;â€¢ Option D. Caseation is a part of granulomatous inflammation. Caseating granulomas are soft, cheesy, and white.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ granulomatous inflammation.&lt;/li&gt;&lt;li&gt;â€¢ soft, cheesy, and white.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Gangrene, particularly wet gangrene is characterized by black discoloration and exudate in a diabetic patient, and is a consequence of coagulative necrosis coupled with bacterial infection , typically necessitating amputation of the affected area.&lt;/li&gt;&lt;li&gt;âž¤ Gangrene,&lt;/li&gt;&lt;li&gt;âž¤ wet gangrene&lt;/li&gt;&lt;li&gt;âž¤ black discoloration and exudate in a diabetic patient,&lt;/li&gt;&lt;li&gt;âž¤ coagulative necrosis coupled with bacterial infection&lt;/li&gt;&lt;li&gt;âž¤ amputation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man with a history of chronic obstructive pulmonary disease (COPD) presents to the hospital with shortness of breath and fever. A chest x-ray shows evidence of pneumonia, and he is started on antibiotics. Despite treatment, his condition deteriorates, and a bronchoalveolar lavage is performed, which reveals the presence of cells undergoing a type of cell death characterized by swelling, membrane rupture, and the release of damage-associated molecular patterns (DAMPs). What type of cell death is this most likely to be?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Apoptosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pyroptosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Autophagy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Necroptosis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Necroptosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Necroptosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Apoptosis is a form of programmed cell death involving cell shrinkage, chromatin condensation, membrane blebbing, and DNA fragmentation , without inflammation or DAMP release.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Apoptosis&lt;/li&gt;&lt;li&gt;â€¢ programmed cell death&lt;/li&gt;&lt;li&gt;â€¢ cell shrinkage, chromatin condensation, membrane blebbing, and DNA fragmentation&lt;/li&gt;&lt;li&gt;â€¢ Option B: Pyroptosis is a form of inflammatory programmed cell death associated with infection and is characterized by the activation of inflammatory caspases , cell swelling, membrane pore formation, and release of inflammatory cytokines.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Pyroptosis&lt;/li&gt;&lt;li&gt;â€¢ inflammatory programmed cell death&lt;/li&gt;&lt;li&gt;â€¢ infection&lt;/li&gt;&lt;li&gt;â€¢ inflammatory caspases&lt;/li&gt;&lt;li&gt;â€¢ cell swelling, membrane pore formation, and release of inflammatory cytokines.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Autophagy is a process where cells degrade their own components through the lysosomal machinery , typically as a survival mechanism in response to stress, without immediate cell death or DAMP release.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Autophagy&lt;/li&gt;&lt;li&gt;â€¢ cells degrade their own components through the lysosomal machinery&lt;/li&gt;&lt;li&gt;â€¢ without immediate cell death or DAMP release.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Necroptosis is a form of programmed cell death marked by cellular swelling, membrane disruption, and DAMP release, which can be associated with conditions such as COPD and infection-related inflammation.&lt;/li&gt;&lt;li&gt;âž¤ programmed cell death&lt;/li&gt;&lt;li&gt;âž¤ cellular swelling, membrane disruption, and DAMP release,&lt;/li&gt;&lt;li&gt;âž¤ COPD and infection-related inflammation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The lifestyle patterns of healthy persons from 20 to 30 years of age are studied. A subset of these persons has a lifestyle characterized by consumption of a lot of pizza and very little physical exercise. Which of the following tissue changes is most likely to develop in this subset of persons as a consequence of this lifestyle?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fatty metamorphosis of liver&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fatty degeneration of myocardium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypertrophy of steatocytes&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metaplasia of muscle to adipose tissue&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hypertrophy of steatocytes&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture17.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Hypertrophy of steatocytes&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fatty change in the liver is due to toxic and metabolic derangements, such as those that occur with malnutrition or alcoholism .  Similarly, fatty change in the heart (Option B) is a consequence of toxic or hypoxic events.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ toxic and metabolic derangements,&lt;/li&gt;&lt;li&gt;â€¢ malnutrition or alcoholism&lt;/li&gt;&lt;li&gt;â€¢ (Option B)&lt;/li&gt;&lt;li&gt;â€¢ Option D . Muscle does not typically undergo metaplasia in response to weight gain . Adipocytes in fascial planes and around the muscle can increase in size. The muscle may atrophy in response to the sedentary lifestyle .&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Muscle does not&lt;/li&gt;&lt;li&gt;â€¢ metaplasia&lt;/li&gt;&lt;li&gt;â€¢ weight gain&lt;/li&gt;&lt;li&gt;â€¢ atrophy in response to the sedentary lifestyle&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ In adults, hypertrophy of adipocytes, or steatocytes, is the primary tissue change associated with weight gain due to excessive caloric intake and insufficient exercise , as this leads to an increase in fat cell size .&lt;/li&gt;&lt;li&gt;âž¤ hypertrophy of adipocytes, or steatocytes,&lt;/li&gt;&lt;li&gt;âž¤ weight gain due to excessive caloric intake and insufficient exercise&lt;/li&gt;&lt;li&gt;âž¤ increase in fat cell size&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 23-year-old woman Yashi gives birth to her first child. She begins breast feeding the infant. She continues breast feeding for almost 6 months with no difficulties and no complications. Which of the following cellular processes that began in the breast during pregnancy allowed her to nurse the infant for this period of time?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ductal epithelial metaplasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stromal hypertrophy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Epithelial dysplasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lobular hyperplasia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lobular hyperplasia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Lobular hyperplasia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Metaplasia is the exchange of the normal epithelium for another in response to chronic irritation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Metaplasia&lt;/li&gt;&lt;li&gt;â€¢ exchange of the normal epithelium&lt;/li&gt;&lt;li&gt;â€¢ chronic irritation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. The stroma of the breast consists of connective tissue that provides structural support , but does not have cells that produce milk.&lt;/li&gt;&lt;li&gt;â€¢ Option B. The stroma of the breast&lt;/li&gt;&lt;li&gt;â€¢ connective tissue that provides structural support&lt;/li&gt;&lt;li&gt;â€¢ Option C. Dysplasia in epithelia is a pre-malignant change not part of normal physiologic events . This would be a precursor to breast cancer . Pregnancy is a protective factor against breast cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Dysplasia in epithelia&lt;/li&gt;&lt;li&gt;â€¢ pre-malignant change not part of normal physiologic events&lt;/li&gt;&lt;li&gt;â€¢ precursor to breast cancer&lt;/li&gt;&lt;li&gt;â€¢ Pregnancy is&lt;/li&gt;&lt;li&gt;â€¢ protective factor against breast cancer.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lobular hyperplasia that is particularly influenced by progesterone , facilitates lactation postpartum.&lt;/li&gt;&lt;li&gt;âž¤ Lobular hyperplasia&lt;/li&gt;&lt;li&gt;âž¤ influenced by progesterone&lt;/li&gt;&lt;li&gt;âž¤ lactation postpartum.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 63 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test4" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Endocrinology&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Endocrinology&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                36 Questions | 144 Total Marks | 46 min Duration | ~76.67 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;True about insulinoma is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alpha cell tumor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Most of them are malignant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;C-peptide level is elevated&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is not associated with MEN 1 syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. C-peptide level is elevated&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) C-peptide level is elevated&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: Alpha cell tumor: This is incorrect; insulinomas arise from beta cells of the pancreas , which are responsible for the production of insulin.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Alpha cell tumor:&lt;/li&gt;&lt;li&gt;â€¢ insulinomas arise from beta cells&lt;/li&gt;&lt;li&gt;â€¢ pancreas&lt;/li&gt;&lt;li&gt;â€¢ Option B: Most of them are malignant: The majority of insulinomas are benign ; only a small percentage are malignant.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Most of them are malignant:&lt;/li&gt;&lt;li&gt;â€¢ majority of insulinomas are benign&lt;/li&gt;&lt;li&gt;â€¢ Option D: It is not associated with MEN 1 syndrome : This is incorrect; insulinomas can be associated with Multiple Endocrine Neoplasia Type 1 .&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ It is not associated with MEN 1 syndrome&lt;/li&gt;&lt;li&gt;â€¢ insulinomas&lt;/li&gt;&lt;li&gt;â€¢ Multiple Endocrine Neoplasia Type 1&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Insulinomas are beta-cell tumors , most of which are benign and can present with hypoglycemia and elevated levels of insulin and C-peptide in the blood . They may also be associated with MEN 1 syndrome .&lt;/li&gt;&lt;li&gt;âž¤ Insulinomas&lt;/li&gt;&lt;li&gt;âž¤ beta-cell tumors&lt;/li&gt;&lt;li&gt;âž¤ benign&lt;/li&gt;&lt;li&gt;âž¤ present with hypoglycemia&lt;/li&gt;&lt;li&gt;âž¤ elevated levels of insulin&lt;/li&gt;&lt;li&gt;âž¤ C-peptide in the blood&lt;/li&gt;&lt;li&gt;âž¤ MEN 1 syndrome&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1124&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1124&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Fine needle aspiration cytology is not able to detect which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Papillary carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hashimoto thyroiditis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Follicular cancer&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Medullary cancer&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Follicular cancer&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Follicular cancer&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: Papillary carcinoma: FNAC is usually diagnostic for papillary carcinoma due to its distinctive cytological features , including nuclear grooves and psammoma bodies .&lt;/li&gt;&lt;li&gt;â€¢ Option A: Papillary carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ FNAC&lt;/li&gt;&lt;li&gt;â€¢ diagnostic for papillary carcinoma&lt;/li&gt;&lt;li&gt;â€¢ distinctive cytological features&lt;/li&gt;&lt;li&gt;â€¢ nuclear grooves&lt;/li&gt;&lt;li&gt;â€¢ psammoma bodies&lt;/li&gt;&lt;li&gt;â€¢ Option B: Hashimoto thyroiditis: FNAC can suggest this diagnosis when lymphocytes and Hurthle cells are present , indicating an autoimmune process .&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Hashimoto thyroiditis:&lt;/li&gt;&lt;li&gt;â€¢ diagnosis when lymphocytes&lt;/li&gt;&lt;li&gt;â€¢ Hurthle cells are present&lt;/li&gt;&lt;li&gt;â€¢ autoimmune process&lt;/li&gt;&lt;li&gt;â€¢ Option D: Medullary cancer: FNAC can suggest medullary carcinoma by demonstrating amyloid and calcitonin in cells , but a definitive diagnosis often requires additional tests such as serum calcitonin levels.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Medullary cancer:&lt;/li&gt;&lt;li&gt;â€¢ FNAC&lt;/li&gt;&lt;li&gt;â€¢ medullary carcinoma&lt;/li&gt;&lt;li&gt;â€¢ demonstrating amyloid&lt;/li&gt;&lt;li&gt;â€¢ calcitonin in cells&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While FNAC is a useful tool in the initial assessment of thyroid nodules, it cannot distinguish between follicular adenoma and follicular carcinoma due to the necessity of examining capsular and vascular invasion histologically.&lt;/li&gt;&lt;li&gt;âž¤ FNAC is a useful tool&lt;/li&gt;&lt;li&gt;âž¤ initial assessment of thyroid nodules,&lt;/li&gt;&lt;li&gt;âž¤ cannot distinguish between follicular adenoma&lt;/li&gt;&lt;li&gt;âž¤ follicular carcinoma&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th 1089&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th 1089&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Psammoma bodies are seen in all except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Papillary carcinoma of thyroid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Adenocarcinoma of colon&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Meningioma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Papillary cancer of the ovary&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Adenocarcinoma of colon&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Adenocarcinoma of colon&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Papillary carcinoma of thyroid: It is known to frequently have psammoma bodies , which are calcified concentric structures found within the tumor tissue.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Papillary carcinoma of thyroid:&lt;/li&gt;&lt;li&gt;â€¢ frequently have psammoma bodies&lt;/li&gt;&lt;li&gt;â€¢ calcified concentric structures&lt;/li&gt;&lt;li&gt;â€¢ Option C: Meningioma: This benign brain tumor often contains psammoma bodies , contributing to its classic histological appearance .&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Meningioma:&lt;/li&gt;&lt;li&gt;â€¢ benign brain tumor&lt;/li&gt;&lt;li&gt;â€¢ psammoma bodies&lt;/li&gt;&lt;li&gt;â€¢ classic histological appearance&lt;/li&gt;&lt;li&gt;â€¢ Option D: Papillary cancer of the ovary (serous cystadenoma of the ovary): Similar to papillary thyroid carcinoma , ovarian papillary tumors can also exhibit psammoma bodies .&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Papillary cancer of the ovary (serous cystadenoma of the ovary):&lt;/li&gt;&lt;li&gt;â€¢ papillary thyroid carcinoma&lt;/li&gt;&lt;li&gt;â€¢ ovarian papillary tumors&lt;/li&gt;&lt;li&gt;â€¢ exhibit psammoma bodies&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Psammoma bodies are calcified structures often found in certain neoplasms such as papillary carcinoma of the thyroid, meningioma , and papillary cancer of the ovary (serous cystadenoma of the ovary) but are not typically seen in adenocarcinoma of the colon .&lt;/li&gt;&lt;li&gt;âž¤ Psammoma bodies&lt;/li&gt;&lt;li&gt;âž¤ calcified structures&lt;/li&gt;&lt;li&gt;âž¤ found in certain neoplasms&lt;/li&gt;&lt;li&gt;âž¤ papillary carcinoma&lt;/li&gt;&lt;li&gt;âž¤ thyroid, meningioma&lt;/li&gt;&lt;li&gt;âž¤ papillary cancer of the ovary&lt;/li&gt;&lt;li&gt;âž¤ adenocarcinoma of the colon&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1098&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1098&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Necrobiosis lipoidica is seen in:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Diabetes insipidus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lyme disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diabetes mellitus&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Simmonds disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Diabetes mellitus&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/21/picture1.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Diabetes mellitus&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: Diabetes insipidus: This is a condition characterized by polyuria and polydipsia due to issues with vasopressin (ADH); it is not associated with skin changes like necrobiosis lipoidica.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Diabetes insipidus:&lt;/li&gt;&lt;li&gt;â€¢ polyuria and polydipsia&lt;/li&gt;&lt;li&gt;â€¢ issues with vasopressin&lt;/li&gt;&lt;li&gt;â€¢ Option B: Lyme disease : Caused by Borrelia burgdorferi and transmitted by ticks , Lyme disease can present with a variety of symptoms including erythema migrans, but not necrobiosis lipoidica.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Lyme disease&lt;/li&gt;&lt;li&gt;â€¢ Borrelia burgdorferi&lt;/li&gt;&lt;li&gt;â€¢ transmitted by ticks&lt;/li&gt;&lt;li&gt;â€¢ Lyme disease&lt;/li&gt;&lt;li&gt;â€¢ Option D: Simmonds disease: Also known as Sheehan&#x27;s syndrome , is postpartum hypopituitarism , not associated with necrobiosis lipoidica.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Simmonds disease:&lt;/li&gt;&lt;li&gt;â€¢ Sheehan&#x27;s syndrome&lt;/li&gt;&lt;li&gt;â€¢ postpartum hypopituitarism&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Necrobiosis lipoidica is a skin condition primarily associated with diabetes mellitus , presenting as well-circumscribed, waxy plaques typically on the shins with a yellowish center and telangiectatic borders .&lt;/li&gt;&lt;li&gt;âž¤ Necrobiosis lipoidica&lt;/li&gt;&lt;li&gt;âž¤ skin condition&lt;/li&gt;&lt;li&gt;âž¤ diabetes mellitus&lt;/li&gt;&lt;li&gt;âž¤ well-circumscribed, waxy plaques&lt;/li&gt;&lt;li&gt;âž¤ shins&lt;/li&gt;&lt;li&gt;âž¤ yellowish center&lt;/li&gt;&lt;li&gt;âž¤ telangiectatic borders&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mauriacâ€™s syndrome is characterized by all except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Diabetes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Obesity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dwarfism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cardiomegaly&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Cardiomegaly&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Cardiomegaly&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Diabetes: Mauriac&#x27;s syndrome is specifically associated with poorly controlled type 1 diabetes mellitus in children .&lt;/li&gt;&lt;li&gt;â€¢ Option A: Diabetes:&lt;/li&gt;&lt;li&gt;â€¢ Mauriac&#x27;s syndrome&lt;/li&gt;&lt;li&gt;â€¢ poorly controlled type 1 diabetes mellitus&lt;/li&gt;&lt;li&gt;â€¢ children&lt;/li&gt;&lt;li&gt;â€¢ Option B: Obesity: Despite being a sign of poor glycemic control , obesity is not a characteristic of Mauriac&#x27;s syndrome . Instead, patients may present with Cushingoid features.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Obesity:&lt;/li&gt;&lt;li&gt;â€¢ sign of poor glycemic control&lt;/li&gt;&lt;li&gt;â€¢ obesity&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ Mauriac&#x27;s syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option C: Dwarfism: Growth impairment or stunted growth is a classical component of Mauriac&#x27;s syndrome due to chronic hyperglycemia and its metabolic effects.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Dwarfism:&lt;/li&gt;&lt;li&gt;â€¢ Growth impairment&lt;/li&gt;&lt;li&gt;â€¢ stunted growth&lt;/li&gt;&lt;li&gt;â€¢ classical component of Mauriac&#x27;s syndrome&lt;/li&gt;&lt;li&gt;â€¢ chronic hyperglycemia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Mauriac&#x27;s syndrome is associated with type 1 diabetes mellitus in children and presents with hepatomegaly , growth retardation , and Cushingoid features , but not with cardiomegaly.&lt;/li&gt;&lt;li&gt;âž¤ Mauriac&#x27;s syndrome&lt;/li&gt;&lt;li&gt;âž¤ type 1 diabetes mellitus&lt;/li&gt;&lt;li&gt;âž¤ children&lt;/li&gt;&lt;li&gt;âž¤ hepatomegaly&lt;/li&gt;&lt;li&gt;âž¤ growth retardation&lt;/li&gt;&lt;li&gt;âž¤ Cushingoid features&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the primary contributor to insulin resistance in liver disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decreased insulin release&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Steatosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hepatocyte dysfunction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Decreased â€˜Câ€™ peptide level&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Steatosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Steatosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: Decreased insulin release: This refers to a problem with insulin secretion from the pancreas , not resistance at the level of hepatic or peripheral tissues and does not directly relate to liver disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Decreased insulin release:&lt;/li&gt;&lt;li&gt;â€¢ problem with insulin secretion&lt;/li&gt;&lt;li&gt;â€¢ pancreas&lt;/li&gt;&lt;li&gt;â€¢ Option C: Hepatocyte dysfunction: While hepatocyte dysfunction can contribute to metabolic disturbances , it is a broader term that includes various liver impairments, not specific to insulin resistance.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Hepatocyte dysfunction:&lt;/li&gt;&lt;li&gt;â€¢ hepatocyte dysfunction&lt;/li&gt;&lt;li&gt;â€¢ metabolic disturbances&lt;/li&gt;&lt;li&gt;â€¢ Option D: Decreased â€˜Câ€™ peptide level: C-peptide is a byproduct of insulin production . Lower levels may indicate reduced insulin secretion but are not a direct cause of insulin resistance in the liver.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Decreased â€˜Câ€™ peptide level:&lt;/li&gt;&lt;li&gt;â€¢ C-peptide&lt;/li&gt;&lt;li&gt;â€¢ byproduct of insulin production&lt;/li&gt;&lt;li&gt;â€¢ Lower levels&lt;/li&gt;&lt;li&gt;â€¢ reduced insulin secretion&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hepatic steatosis , or fatty liver disease , is a significant contributor to insulin resistance , which impairs both the liver&#x27;s response to insulin and the peripheral action of insulin .&lt;/li&gt;&lt;li&gt;âž¤ Hepatic steatosis&lt;/li&gt;&lt;li&gt;âž¤ fatty liver disease&lt;/li&gt;&lt;li&gt;âž¤ contributor to insulin resistance&lt;/li&gt;&lt;li&gt;âž¤ impairs both the liver&#x27;s response&lt;/li&gt;&lt;li&gt;âž¤ insulin&lt;/li&gt;&lt;li&gt;âž¤ peripheral action of insulin&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbin 10th/ 1140, Joslinâ€™s Diabetes Mellitus 14/e p436&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbin 10th/ 1140, Joslinâ€™s Diabetes Mellitus 14/e p436&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;According to ADA guidelines, the diagnosis of diabetes is made when the fasting blood glucose is more than?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;126 mg/dL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;100 mg/dL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;140 mg/dL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;200 mg/dL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 126 mg/dL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) 126 mg/dL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B: 100 mg/dL: This is considered the upper limit of normal for fasting glucose , with levels between 100 mg/dL and 125 mg/dL indicating impaired fasting glucose or prediabetes.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ 100 mg/dL:&lt;/li&gt;&lt;li&gt;â€¢ upper limit of normal for fasting glucose&lt;/li&gt;&lt;li&gt;â€¢ levels between 100 mg/dL&lt;/li&gt;&lt;li&gt;â€¢ 125 mg/dL&lt;/li&gt;&lt;li&gt;â€¢ impaired fasting glucose&lt;/li&gt;&lt;li&gt;â€¢ Option C: 140 mg/dL: This level is above the diagnostic criteria for diabetes when measured fasting and may also indicate diabetes if it is a 2-hour postprandial or oral glucose tolerance test (OGTT) value.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ 140 mg/dL:&lt;/li&gt;&lt;li&gt;â€¢ above the diagnostic criteria&lt;/li&gt;&lt;li&gt;â€¢ diabetes&lt;/li&gt;&lt;li&gt;â€¢ measured fasting&lt;/li&gt;&lt;li&gt;â€¢ indicate diabetes&lt;/li&gt;&lt;li&gt;â€¢ Option D: 200 mg/dL: A level of 200 mg/dL or higher may indicate diabetes if it is from a random plasma glucose test accompanied by classic symptoms of hyperglycemia or hyperglycemic crisis, or during an OGTT.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ 200 mg/dL:&lt;/li&gt;&lt;li&gt;â€¢ level of 200 mg/dL&lt;/li&gt;&lt;li&gt;â€¢ higher&lt;/li&gt;&lt;li&gt;â€¢ diabetes&lt;/li&gt;&lt;li&gt;â€¢ random plasma glucose test&lt;/li&gt;&lt;li&gt;â€¢ classic symptoms&lt;/li&gt;&lt;li&gt;â€¢ hyperglycemia&lt;/li&gt;&lt;li&gt;â€¢ hyperglycemic&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A fasting blood glucose level of 126 mg/dL or higher is diagnostic for diabetes mellitus according to ADA guidelines .&lt;/li&gt;&lt;li&gt;âž¤ fasting blood glucose level of 126 mg/dL&lt;/li&gt;&lt;li&gt;âž¤ higher&lt;/li&gt;&lt;li&gt;âž¤ diabetes mellitus&lt;/li&gt;&lt;li&gt;âž¤ ADA guidelines&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th /1110&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th /1110&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Most common association in MEN I is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gastrinoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Insulinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lipoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glucagonoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Gastrinoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Gastrinoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Insulinoma: Insulinomas are also associated with MEN I and result in hypoglycemia due to unregulated insulin secretion , but they are less common compared to gastrinomas.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Insulinoma:&lt;/li&gt;&lt;li&gt;â€¢ associated with MEN I&lt;/li&gt;&lt;li&gt;â€¢ hypoglycemia&lt;/li&gt;&lt;li&gt;â€¢ unregulated insulin secretion&lt;/li&gt;&lt;li&gt;â€¢ less common&lt;/li&gt;&lt;li&gt;â€¢ Option C: Lipoma : While patients with MEN I may develop non-endocrine tumors like lipomas , these are not as commonly associated with the syndrome as endocrine tumors.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Lipoma&lt;/li&gt;&lt;li&gt;â€¢ MEN I may develop non-endocrine tumors&lt;/li&gt;&lt;li&gt;â€¢ lipomas&lt;/li&gt;&lt;li&gt;â€¢ Option D: Glucagonoma : Glucagonomas, which secrete glucagon , are rare pancreatic endocrine tumors and are less commonly associated with MEN I than gastrinomas.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Glucagonoma&lt;/li&gt;&lt;li&gt;â€¢ secrete glucagon&lt;/li&gt;&lt;li&gt;â€¢ rare pancreatic endocrine tumors&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In the context of MEN I , gastrinomas are the most commonly associated functional pancreatic endocrine tumors , often leading to Zollinger-Ellison syndrome , characterized by peptic ulcer disease , gastroesophageal reflux , and diarrhea due to hypergastrinemia .&lt;/li&gt;&lt;li&gt;âž¤ MEN I&lt;/li&gt;&lt;li&gt;âž¤ gastrinomas&lt;/li&gt;&lt;li&gt;âž¤ most commonly associated functional pancreatic endocrine tumors&lt;/li&gt;&lt;li&gt;âž¤ Zollinger-Ellison syndrome&lt;/li&gt;&lt;li&gt;âž¤ peptic ulcer disease&lt;/li&gt;&lt;li&gt;âž¤ gastroesophageal reflux&lt;/li&gt;&lt;li&gt;âž¤ diarrhea&lt;/li&gt;&lt;li&gt;âž¤ hypergastrinemia&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1140&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1140&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What marker is indicative of a non-functional pancreatic neuroendocrine tumor (PNET)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chromogranin-A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CD100&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CEA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;PSA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Chromogranin-A&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Chromogranin-A&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B: CD100: CD100 is not a recognized marker for PNETs . CD markers are generally used in the characterization of lymphocytes and other cells of the immune system.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ CD100:&lt;/li&gt;&lt;li&gt;â€¢ not a recognized marker for PNETs&lt;/li&gt;&lt;li&gt;â€¢ Option C: CEA: Carcinoembryonic antigen (CEA) is a tumor marker associated with colorectal cancer and some other adenocarcinomas, not specifically with PNETs.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ CEA:&lt;/li&gt;&lt;li&gt;â€¢ tumor marker associated with colorectal cancer&lt;/li&gt;&lt;li&gt;â€¢ Option D: PSA: Prostate-specific antigen (PSA) is used as a marker for prostate cancer . It has no relevance in the diagnosis of PNETs.&lt;/li&gt;&lt;li&gt;â€¢ Option D: PSA:&lt;/li&gt;&lt;li&gt;â€¢ marker for prostate cancer&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Chromogranin A is a marker for pancreatic non-functional neuroendocrine tumours .&lt;/li&gt;&lt;li&gt;âž¤ Chromogranin A&lt;/li&gt;&lt;li&gt;âž¤ marker for pancreatic non-functional neuroendocrine tumours&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th 720&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th 720&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old male presents to the clinic with complaints of bilateral lower extremity swelling and fatigue for the past several months. He has a past medical history significant for poorly controlled diabetes mellitus, hypertension, and obesity. Laboratory investigations reveal elevated serum creatinine and proteinuria. A renal biopsy is performed, which demonstrates deposition of amyloid proteins in the glomeruli. Which of the following types of diabetes mellitus is most commonly associated with this renal complication?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Maturity onset DM&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Type I DM&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Type II DM&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Type II DM&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Type II DM&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: Maturity onset diabetes of the young (MODY) is characterized by monogenic defects of Î²-cell function but is not typically associated with amyloid deposition in the islets.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Maturity onset diabetes of the young&lt;/li&gt;&lt;li&gt;â€¢ monogenic defects of Î²-cell function&lt;/li&gt;&lt;li&gt;â€¢ Option B: Type I DM is an autoimmune disorder leading to Î²-cell destruction and does not typically involve amyloid deposition.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Type I DM&lt;/li&gt;&lt;li&gt;â€¢ autoimmune disorder&lt;/li&gt;&lt;li&gt;â€¢ Î²-cell destruction&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Amyloid deposition in the islets of Langerhans is a feature specifically associated with Type II diabetes mellitus , which can contribute to the dysfunction of insulin-secreting pancreatic Î²-cells .&lt;/li&gt;&lt;li&gt;âž¤ Amyloid deposition&lt;/li&gt;&lt;li&gt;âž¤ islets of Langerhans&lt;/li&gt;&lt;li&gt;âž¤ Type II diabetes mellitus&lt;/li&gt;&lt;li&gt;âž¤ dysfunction of insulin-secreting pancreatic Î²-cells&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 261&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 261&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following thyroid carcinoma variants is not associated with aggressiveness?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Follicular variant&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Unencapsulated&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tall cell variant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oxyphilic (Hurthle) cell type&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Follicular variant&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Follicular variant&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B: Unencapsulated: Lack of encapsulation is a feature associated with increased aggressiveness in papillary carcinoma . Encapsulation can help contain the tumor and prevent its spread . So, this option matches the criteria for aggressiveness.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Unencapsulated:&lt;/li&gt;&lt;li&gt;â€¢ Lack of encapsulation&lt;/li&gt;&lt;li&gt;â€¢ increased aggressiveness in papillary carcinoma&lt;/li&gt;&lt;li&gt;â€¢ Encapsulation&lt;/li&gt;&lt;li&gt;â€¢ contain the tumor&lt;/li&gt;&lt;li&gt;â€¢ prevent its spread&lt;/li&gt;&lt;li&gt;â€¢ Option C: Tall cell variant: The tall cell variant of papillary carcinoma is associated with a more aggressive behavior compared to classical papillary carcinoma . Therefore, this option matches the criteria for aggressiveness.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Tall cell variant:&lt;/li&gt;&lt;li&gt;â€¢ papillary carcinoma&lt;/li&gt;&lt;li&gt;â€¢ more aggressive behavior&lt;/li&gt;&lt;li&gt;â€¢ classical papillary carcinoma&lt;/li&gt;&lt;li&gt;â€¢ Option D: Oxyphilic (Hurthle) cell type: Hurthle cell carcinoma, a variant of follicular thyroid carcinoma , is generally considered more aggressive than papillary carcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Oxyphilic (Hurthle) cell type:&lt;/li&gt;&lt;li&gt;â€¢ variant of follicular thyroid carcinoma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The f ollicular variant of papillary carcinoma tends to have a better prognosis compared to classical papillary carcinoma as it is less aggressive in its behavior .&lt;/li&gt;&lt;li&gt;âž¤ f&lt;/li&gt;&lt;li&gt;âž¤ ollicular variant of papillary carcinoma&lt;/li&gt;&lt;li&gt;âž¤ better prognosis&lt;/li&gt;&lt;li&gt;âž¤ classical papillary carcinoma&lt;/li&gt;&lt;li&gt;âž¤ less aggressive in its behavior&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1091&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1091&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following thyroid carcinomas originates from C-cells?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Medullary carcinoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Follicular carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Papillary carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anaplastic carcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Medullary carcinoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Medullary carcinoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B: Follicular carcinoma: This carcinoma arises from follicular cells , which are responsible for synthesizing and secreting thyroid hormones , not calcitonin.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Follicular carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ carcinoma arises from follicular cells&lt;/li&gt;&lt;li&gt;â€¢ synthesizing&lt;/li&gt;&lt;li&gt;â€¢ secreting thyroid hormones&lt;/li&gt;&lt;li&gt;â€¢ Option C: Papillary carcinoma: The most common type of thyroid cancer , also derived from follicular cells , and not from C-cells.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Papillary carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ common type of thyroid cancer&lt;/li&gt;&lt;li&gt;â€¢ follicular cells&lt;/li&gt;&lt;li&gt;â€¢ Option D: Anaplastic carcinoma: A rare and highly aggressive thyroid cancer that arises from follicular cells and has a poor prognosis ; it does not originate from C-cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Anaplastic carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ rare and highly aggressive thyroid cancer&lt;/li&gt;&lt;li&gt;â€¢ arises from follicular cells&lt;/li&gt;&lt;li&gt;â€¢ has a poor prognosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Medullary carcinoma of the thyroid is derived from C-cells , which are distinct from follicular cells that give rise to the more common papillary and follicular thyroid carcinomas . Medullary thyroid carcinoma is characterized by the production of calcitonin and may be associated with multiple endocrine neoplasia type 2 (MEN2).&lt;/li&gt;&lt;li&gt;âž¤ Medullary carcinoma&lt;/li&gt;&lt;li&gt;âž¤ thyroid is derived from C-cells&lt;/li&gt;&lt;li&gt;âž¤ distinct from follicular cells&lt;/li&gt;&lt;li&gt;âž¤ rise to the more common papillary&lt;/li&gt;&lt;li&gt;âž¤ follicular thyroid carcinomas&lt;/li&gt;&lt;li&gt;âž¤ Medullary thyroid carcinoma&lt;/li&gt;&lt;li&gt;âž¤ production of calcitonin&lt;/li&gt;&lt;li&gt;âž¤ multiple endocrine neoplasia type 2&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1095&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1095&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Hurthle cell tumor is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Papillary carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Follicular carcinoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Medullary carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ionizing radiation in early decades is a major risk factor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Follicular carcinoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Follicular carcinoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: Papillary carcinoma â€“ This is the most common type of thyroid carcinoma , but Hurthle cell tumors are not classified as papillary carcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Papillary carcinoma&lt;/li&gt;&lt;li&gt;â€¢ thyroid carcinoma&lt;/li&gt;&lt;li&gt;â€¢ Hurthle cell tumors&lt;/li&gt;&lt;li&gt;â€¢ papillary carcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Medullary carcinoma â€“ This type arises from parafollicular C cells , which is not related to the follicular cells that give rise to Hurthle cell tumors .&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Medullary carcinoma&lt;/li&gt;&lt;li&gt;â€¢ arises from parafollicular C cells&lt;/li&gt;&lt;li&gt;â€¢ not related to the follicular cells&lt;/li&gt;&lt;li&gt;â€¢ Hurthle cell tumors&lt;/li&gt;&lt;li&gt;â€¢ Option D: Ionizing radiation in early decades is a major risk factor â€“ While exposure to ionizing radiation is a known risk factor for thyroid carcinoma , it is not specifically tied to the pathogenesis of Hurthle cell tumors, which are a variant of follicular carcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Ionizing radiation in early decades is a major risk factor&lt;/li&gt;&lt;li&gt;â€¢ exposure to ionizing radiation&lt;/li&gt;&lt;li&gt;â€¢ risk factor&lt;/li&gt;&lt;li&gt;â€¢ thyroid carcinoma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hurthle cell tumors are a variant of follicular thyroid carcinoma , which are characterized by distinctive large cells with abundant granular cytoplasm and are encapsulated . They differ from papillary and medullary thyroid carcinomas both in terms of their origin and histological appearance.&lt;/li&gt;&lt;li&gt;âž¤ Hurthle cell tumors&lt;/li&gt;&lt;li&gt;âž¤ variant of follicular thyroid carcinoma&lt;/li&gt;&lt;li&gt;âž¤ distinctive large cells&lt;/li&gt;&lt;li&gt;âž¤ abundant granular cytoplasm&lt;/li&gt;&lt;li&gt;âž¤ encapsulated&lt;/li&gt;&lt;li&gt;âž¤ differ from papillary&lt;/li&gt;&lt;li&gt;âž¤ medullary thyroid carcinomas&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1089&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1089&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;About papillary carcinoma of thyroid, all are true except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prognosis better&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Psammoma body present in 50% cases&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Early metastasis with poor prognosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Spreads by the lymphatic route&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Early metastasis with poor prognosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Early metastasis with poor prognosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Prognosis better: This is true . Papillary carcinoma of the thyroid generally has an excellent prognosis, especially when diagnosed early and in younger patients.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Prognosis better:&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;li&gt;â€¢ Option B: Psammoma body present in 50% cases: Psammoma bodies are calcifications that are often found in papillary thyroid carcinoma but may not be present in as many as 50% of cases.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Psammoma body present in 50% cases:&lt;/li&gt;&lt;li&gt;â€¢ Option D: Spreads by the lymphatic route: This is true . Papillary thyroid carcinoma commonly spreads to regional lymph nodes via lymphatics.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Spreads by the lymphatic route:&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Papillary carcinoma of the thyroid typically has a favorable prognosis , even with early lymphatic spread , contrasting with other cancers where early metastasis often correlates with a poor prognosis .&lt;/li&gt;&lt;li&gt;âž¤ Papillary carcinoma&lt;/li&gt;&lt;li&gt;âž¤ thyroid&lt;/li&gt;&lt;li&gt;âž¤ favorable prognosis&lt;/li&gt;&lt;li&gt;âž¤ early lymphatic spread&lt;/li&gt;&lt;li&gt;âž¤ contrasting&lt;/li&gt;&lt;li&gt;âž¤ cancers&lt;/li&gt;&lt;li&gt;âž¤ early metastasis&lt;/li&gt;&lt;li&gt;âž¤ poor prognosis&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1086&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1086&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 51-year-old man Sonu with a history of recurrent calcium-containing renal stones presents to the emergency room with excruciating flank pain and blood in the urine. This patient is likely to have which of the following underlying disorders?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anemia of chronic disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic Proteus infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hyperparathyroidism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hyperaldosteronism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hyperparathyroidism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Hyperparathyroidism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: Anemia of chronic disease â€“ This condition is associated with long-standing , chronic illnesses that lead to alterations in iron metabolism and erythropoiesis but is not directly related to calcium stone formation.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Anemia of chronic disease&lt;/li&gt;&lt;li&gt;â€¢ long-standing&lt;/li&gt;&lt;li&gt;â€¢ chronic illnesses&lt;/li&gt;&lt;li&gt;â€¢ alterations in iron metabolism&lt;/li&gt;&lt;li&gt;â€¢ erythropoiesis&lt;/li&gt;&lt;li&gt;â€¢ Option B: Chronic Proteus infection â€“ While Proteus bacteria can increase the risk for struvite stone formation due to urease production , it is not typically associated with calcium stone formation.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Chronic Proteus infection&lt;/li&gt;&lt;li&gt;â€¢ Proteus bacteria&lt;/li&gt;&lt;li&gt;â€¢ increase the risk for struvite stone formation&lt;/li&gt;&lt;li&gt;â€¢ urease production&lt;/li&gt;&lt;li&gt;â€¢ Option D: Hyperaldosteronism â€“ This condition leads to hypertension and hypokalemia due to excess aldosterone and is not typically associated with calcium-containing renal stone disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Hyperaldosteronism&lt;/li&gt;&lt;li&gt;â€¢ hypertension&lt;/li&gt;&lt;li&gt;â€¢ hypokalemia&lt;/li&gt;&lt;li&gt;â€¢ excess aldosterone&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recurrent calcium-containing renal stones may suggest an underlying disorder of calcium metabolism, such as hyperparathyroidism , due to its association with increased PTH levels , hypercalcemia , and hypercalciuria .&lt;/li&gt;&lt;li&gt;âž¤ Recurrent calcium-containing renal stones&lt;/li&gt;&lt;li&gt;âž¤ underlying disorder of calcium metabolism,&lt;/li&gt;&lt;li&gt;âž¤ hyperparathyroidism&lt;/li&gt;&lt;li&gt;âž¤ increased PTH levels&lt;/li&gt;&lt;li&gt;âž¤ hypercalcemia&lt;/li&gt;&lt;li&gt;âž¤ hypercalciuria&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 9/e p1103&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 9/e p1103&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Most common thyroid cancer after radiation exposure is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Papillary cancer&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Medullary cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Follicular cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anaplastic cancer&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Papillary cancer&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Papillary cancer&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B: Medullary cancer: Medullary thyroid cancer arises from parafollicular C-cells and is typically associated with genetic mutations in the RET proto-oncogene , not with radiation exposure.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Medullary cancer:&lt;/li&gt;&lt;li&gt;â€¢ arises from parafollicular C-cells&lt;/li&gt;&lt;li&gt;â€¢ genetic mutations in the RET proto-oncogene&lt;/li&gt;&lt;li&gt;â€¢ Option C: Follicular cancer: While not associated with radiation exposure , the incidence of follicular carcinoma is higher in areas with iodine deficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Follicular cancer:&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ radiation exposure&lt;/li&gt;&lt;li&gt;â€¢ Option D: Anaplastic cancer: Anaplastic thyroid cancer is a rare and aggressive form of thyroid cancer that generally occurs in the elderly population and is not associated with radiation exposure.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Anaplastic cancer:&lt;/li&gt;&lt;li&gt;â€¢ rare and aggressive form of thyroid cancer&lt;/li&gt;&lt;li&gt;â€¢ occurs in the elderly population&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Papillary thyroid carcinoma is the most common thyroid cancer associated with childhood exposure to ionizing radiation , which can significantly increase the risk of this cancer .&lt;/li&gt;&lt;li&gt;âž¤ Papillary thyroid carcinoma&lt;/li&gt;&lt;li&gt;âž¤ most common thyroid cancer&lt;/li&gt;&lt;li&gt;âž¤ childhood exposure&lt;/li&gt;&lt;li&gt;âž¤ ionizing radiation&lt;/li&gt;&lt;li&gt;âž¤ increase the risk of this cancer&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1086&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1086&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Orphan Annie eye nuclei appearance is characteristic of:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Papillary carcinoma thyroid&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carcinoma pituitary&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Paraganglioma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Meningioma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Papillary carcinoma thyroid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/23/screenshot-2024-04-23-094905.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Papillary carcinoma thyroid&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ &#x27;Orphan Annie eye&#x27; nuclei is a distinctive cytological feature of papillary carcinoma of the thyroid , which is important for diagnosis and distinguishing it from other neoplasms.&lt;/li&gt;&lt;li&gt;âž¤ &#x27;Orphan Annie eye&#x27; nuclei&lt;/li&gt;&lt;li&gt;âž¤ distinctive cytological feature&lt;/li&gt;&lt;li&gt;âž¤ papillary carcinoma&lt;/li&gt;&lt;li&gt;âž¤ thyroid&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th 1087&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th 1087&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The laboratory screening test which suggests normal thyroid function is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;TSH&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Free T4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;T3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Free T3&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. TSH&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) TSH&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B: Free T4: Free T4 measurement reflects the biologically active portion of thyroxine and can be normal in early or mild forms of thyroid dysfunction .&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Free T4:&lt;/li&gt;&lt;li&gt;â€¢ Free T4 measurement reflects&lt;/li&gt;&lt;li&gt;â€¢ biologically active portion of thyroxine&lt;/li&gt;&lt;li&gt;â€¢ normal in early or mild forms&lt;/li&gt;&lt;li&gt;â€¢ thyroid dysfunction&lt;/li&gt;&lt;li&gt;â€¢ Option C: T3: Total T3 levels can be affected by factors that influence binding proteins and are not the first line of screening; they are more helpful in diagnosing hyperthyroidism or in certain clinical situations like T3 toxicosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ T3:&lt;/li&gt;&lt;li&gt;â€¢ affected by factors&lt;/li&gt;&lt;li&gt;â€¢ influence binding proteins&lt;/li&gt;&lt;li&gt;â€¢ not the first line of screening;&lt;/li&gt;&lt;li&gt;â€¢ Option D: Free T3: Similar to T3, Free T3 is not the first line of screening but rather used for specific clinical indications and is less commonly measured than TSH or Free T4.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Free T3:&lt;/li&gt;&lt;li&gt;â€¢ Free T3 is not the first line of screening&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ TSH is the most sensitive initial screening test for evaluating thyroid function because it reflects the pituitary&#x27;s response to the serum concentration of free thyroid hormones , particularly free T4.&lt;/li&gt;&lt;li&gt;âž¤ TSH&lt;/li&gt;&lt;li&gt;âž¤ most sensitive initial screening test&lt;/li&gt;&lt;li&gt;âž¤ evaluating thyroid function&lt;/li&gt;&lt;li&gt;âž¤ reflects the pituitary&#x27;s response&lt;/li&gt;&lt;li&gt;âž¤ serum concentration&lt;/li&gt;&lt;li&gt;âž¤ free thyroid hormones&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1083&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1083&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Medullary carcinoma of the thyroid is associated with which of the following syndrome:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;MEN I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;MEN II&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fraumeni syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hashimotoâ€™s thyroiditis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. MEN II&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) MEN II&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: MEN I â€“ Incorrect. MEN I typically involves tumors of the parathyroid glands , pituitary gland , and pancreas , not medullary thyroid carcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ MEN I â€“ Incorrect.&lt;/li&gt;&lt;li&gt;â€¢ tumors of the parathyroid glands&lt;/li&gt;&lt;li&gt;â€¢ pituitary gland&lt;/li&gt;&lt;li&gt;â€¢ pancreas&lt;/li&gt;&lt;li&gt;â€¢ Option C: Li-Fraumeni syndrome â€“ Incorrect. This is a hereditary cancer syndrome associated with a variety of cancers , including sarcomas, breast cancer, and brain tumors, but not specifically medullary thyroid carcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Li-Fraumeni syndrome â€“ Incorrect.&lt;/li&gt;&lt;li&gt;â€¢ hereditary cancer syndrome&lt;/li&gt;&lt;li&gt;â€¢ variety of cancers&lt;/li&gt;&lt;li&gt;â€¢ Option D: Hashimotoâ€™s thyroiditis â€“ Incorrect. This is an autoimmune disease of the thyroid gland and is not directly associated with medullary thyroid carcinoma , although thyroid cancer can occur more frequently in the setting of Hashimoto&#x27;s thyroiditis.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Hashimotoâ€™s thyroiditis â€“ Incorrect.&lt;/li&gt;&lt;li&gt;â€¢ autoimmune disease&lt;/li&gt;&lt;li&gt;â€¢ thyroid gland&lt;/li&gt;&lt;li&gt;â€¢ medullary thyroid carcinoma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Medullary thyroid carcinoma is commonly associated with Multiple Endocrine Neoplasia type II (MEN II), which includes two subtypes , MEN IIA and MEN IIB , both characterized by the occurrence of medullary thyroid carcinoma and p heochromocytomas . MEN IIA also includes parathyroid adenomas or hyperplasia.&lt;/li&gt;&lt;li&gt;âž¤ Medullary thyroid carcinoma&lt;/li&gt;&lt;li&gt;âž¤ Multiple Endocrine Neoplasia type II&lt;/li&gt;&lt;li&gt;âž¤ two subtypes&lt;/li&gt;&lt;li&gt;âž¤ MEN IIA&lt;/li&gt;&lt;li&gt;âž¤ MEN IIB&lt;/li&gt;&lt;li&gt;âž¤ occurrence of medullary thyroid carcinoma&lt;/li&gt;&lt;li&gt;âž¤ heochromocytomas&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1129&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1129&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman with a family history of endocrine neoplasia presents with a thyroid nodule. Histological examination of the nodule after fine-needle aspiration biopsy reveals amyloid deposition. Which of the following types of thyroid carcinoma is the woman most likely to have?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Papillary&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Follicular&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Medullary&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anaplastic&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Medullary&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Medullary&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: Papillary carcinoma: This is the most common type of thyroid cancer and is characterized by branching papillae and often presents with psammoma bodies . It is not typically associated with amyloid deposition.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Papillary carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ most common type of thyroid cancer&lt;/li&gt;&lt;li&gt;â€¢ branching papillae&lt;/li&gt;&lt;li&gt;â€¢ psammoma bodies&lt;/li&gt;&lt;li&gt;â€¢ Option B: Follicular carcinoma : It does not characteristically involve amyloid deposition .&lt;/li&gt;&lt;li&gt;â€¢ Option B: Follicular carcinoma&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ involve amyloid deposition&lt;/li&gt;&lt;li&gt;â€¢ Option D: Anaplastic carcinoma: This is a highly aggressive and undifferentiated form of thyroid cancer . Amyloid is not a feature of anaplastic thyroid carcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Anaplastic carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ highly aggressive&lt;/li&gt;&lt;li&gt;â€¢ undifferentiated form of thyroid cancer&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Medullary thyroid carcinoma is unique among thyroid cancers as it originates from parafollicular C-cells and is associated with amyloid deposition within the tumor , which can be identified histologically. This type of carcinoma can occur sporadically or as part of the multiple endocrine neoplasia type 2 syndromes.&lt;/li&gt;&lt;li&gt;âž¤ Medullary thyroid carcinoma&lt;/li&gt;&lt;li&gt;âž¤ unique&lt;/li&gt;&lt;li&gt;âž¤ thyroid cancers&lt;/li&gt;&lt;li&gt;âž¤ originates from parafollicular C-cells&lt;/li&gt;&lt;li&gt;âž¤ amyloid deposition&lt;/li&gt;&lt;li&gt;âž¤ tumor&lt;/li&gt;&lt;li&gt;âž¤ type of carcinoma&lt;/li&gt;&lt;li&gt;âž¤ sporadically&lt;/li&gt;&lt;li&gt;âž¤ part of the multiple endocrine neoplasia type 2 syndromes.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1091&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1091&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which is not seen in MEN I:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Parathyroid adenoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pancreatic cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prolactinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Medullary carcinoma thyroid&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Medullary carcinoma thyroid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Medullary carcinoma thyroid&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Multiple Endocrine Neoplasia type I (MEN I) is characterized by the presence of tumors in parathyroid glands , anterior pituitary, and pancreatic islets , and does not commonly include medullary carcinoma of the thyroid, which is associated with MEN II.&lt;/li&gt;&lt;li&gt;âž¤ Multiple Endocrine Neoplasia type I&lt;/li&gt;&lt;li&gt;âž¤ presence of tumors in parathyroid glands&lt;/li&gt;&lt;li&gt;âž¤ anterior pituitary,&lt;/li&gt;&lt;li&gt;âž¤ pancreatic islets&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th 1091&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th 1091&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 47-year-old woman presents with a solitary thyroid nodule. Fine needle aspiration cytology (FNAC) is performed, and the pathologist reports that the distinction between a benign and a malignant lesion cannot be made with certainty. Which type of thyroid nodule is most notorious for requiring histologic examination beyond FNAC to establish a definitive diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Papillary carcinoma of thyroid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carcinoma breast&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Adenocarcinoma lung&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Follicular carcinoma of thyroid&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Follicular carcinoma of thyroid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Follicular carcinoma of thyroid&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: Papillary carcinoma of thyroid : Papillary carcinoma typically shows distinctive nuclear features on FNAC which are usually diagnostic, making it sufficient for diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Papillary carcinoma of thyroid&lt;/li&gt;&lt;li&gt;â€¢ distinctive nuclear features on FNAC&lt;/li&gt;&lt;li&gt;â€¢ Option B: Carcinoma breast : FNAC can be diagnostic for breast carcinoma, showing malignant cells , but a core biopsy is often preferred for additional architectural and immunohistochemical information.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Carcinoma breast&lt;/li&gt;&lt;li&gt;â€¢ diagnostic for breast carcinoma,&lt;/li&gt;&lt;li&gt;â€¢ malignant cells&lt;/li&gt;&lt;li&gt;â€¢ Option C: Adenocarcinoma lung : While FNAC can suggest adenocarcinoma of the lung by demonstrating malignant glandular cells, a core biopsy is usually required for complete characterization.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Adenocarcinoma lung&lt;/li&gt;&lt;li&gt;â€¢ FNAC&lt;/li&gt;&lt;li&gt;â€¢ adenocarcinoma of the lung&lt;/li&gt;&lt;li&gt;â€¢ malignant glandular cells,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While FNAC can suggest follicular neoplasm , it cannot differentiate follicular carcinoma from follicular adenoma as the latter requires the identification of capsular or vascular invasion, which necessitates histological examination of the entire surgical specimen.&lt;/li&gt;&lt;li&gt;âž¤ FNAC&lt;/li&gt;&lt;li&gt;âž¤ follicular neoplasm&lt;/li&gt;&lt;li&gt;âž¤ cannot differentiate follicular carcinoma&lt;/li&gt;&lt;li&gt;âž¤ follicular adenoma&lt;/li&gt;&lt;li&gt;âž¤ latter requires the identification of capsular&lt;/li&gt;&lt;li&gt;âž¤ vascular invasion,&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1089&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1089&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 56-year-old female presents to her primary care physician with a history of a progressively enlarging neck mass over the past several years. She reports no symptoms of dysphagia, dyspnea, or hoarseness. Physical examination reveals a palpable, non-tender, firm mass in the anterior neck consistent with a long-standing goitre. Which malignancy develops in long standing goitre?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Papillary carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Follicular carcinoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Medullary carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anaplastic carcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Follicular carcinoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Follicular carcinoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: Papillary carcinoma: This is the most common thyroid malignancy and can occur with or without a preceding goiter . It has a distinctive histological appearance but is not particularly associated with iodine deficiency or long-standing goiters.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Papillary carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ most common thyroid malignancy&lt;/li&gt;&lt;li&gt;â€¢ with or without a preceding goiter&lt;/li&gt;&lt;li&gt;â€¢ Option C: Medullary carcinoma: This type of cancer arises from parafollicular C cells producing calcitonin and is commonly associated with genetic syndromes like MEN 2, rather than long-standing goiters.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Medullary carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ cancer arises from parafollicular C cells&lt;/li&gt;&lt;li&gt;â€¢ calcitonin&lt;/li&gt;&lt;li&gt;â€¢ genetic syndromes like MEN 2,&lt;/li&gt;&lt;li&gt;â€¢ Option D: Anaplastic carcinoma: This is a very aggressive form of thyroid cancer that can arise de novo or from existing well-differentiated tumors but isn&#x27;t specifically linked to long-standing goiters.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Anaplastic carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ very aggressive form of thyroid cancer&lt;/li&gt;&lt;li&gt;â€¢ arise de novo&lt;/li&gt;&lt;li&gt;â€¢ existing well-differentiated tumors&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Follicular carcinoma of the thyroid is associated with iodine deficiency and is more likely to develop in the setting of a long-standing goiter . This malignancy is notorious for hematogenous spread and requires thorough histological examination to differentiate it from benign conditions.&lt;/li&gt;&lt;li&gt;âž¤ thyroid is associated with iodine deficiency&lt;/li&gt;&lt;li&gt;âž¤ develop in the setting of a long-standing goiter&lt;/li&gt;&lt;li&gt;âž¤ malignancy&lt;/li&gt;&lt;li&gt;âž¤ notorious for hematogenous spread&lt;/li&gt;&lt;li&gt;âž¤ histological examination&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1089&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1089&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old patient presents with symptoms of hypercalcemia, peptic ulcer disease, and a pituitary mass on imaging. Given these clinical features, which of the following conditions is least likely to be part of the patient&#x27;s underlying syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Foregut carcinoid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Posterior pituitary tumors&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pancreatic neuroendocrine tumors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Parathyroid hyperplasia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Posterior pituitary tumors&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Posterior pituitary tumors&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: Foregut carcinoid - Foregut carcinoids (including those found in the thymus, lung, and stomach) are part of the spectrum of MEN-1 syndrome , although less common compared to other manifestations.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Foregut carcinoid&lt;/li&gt;&lt;li&gt;â€¢ part of the spectrum of MEN-1 syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option C: Pancreatic neuroendocrine tumors - These tumors are a hallmark of MEN-1 and can produce a variety of symptoms depending on the hormone they secrete (e.g., gastrin, insulin).&lt;/li&gt;&lt;li&gt;â€¢ Option C: Pancreatic neuroendocrine tumors&lt;/li&gt;&lt;li&gt;â€¢ hallmark of MEN-1&lt;/li&gt;&lt;li&gt;â€¢ produce a variety of symptoms&lt;/li&gt;&lt;li&gt;â€¢ hormone they secrete&lt;/li&gt;&lt;li&gt;â€¢ Option D: Parathyroid hyperplasia - Primary hyperparathyroidism due to parathyroid hyperplasia is the most common feature of MEN-1 syndrome, causing hypercalcemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Parathyroid hyperplasia&lt;/li&gt;&lt;li&gt;â€¢ Primary hyperparathyroidism&lt;/li&gt;&lt;li&gt;â€¢ parathyroid hyperplasia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ MEN-1 syndrome, also known as Wermer syndrome, is characterized by anterior pituitary tumors, pancreatic neuroendocrine tumors , and parathyroid hyperplasia, but not by tumors of the posterior pituitary.&lt;/li&gt;&lt;li&gt;âž¤ MEN-1 syndrome,&lt;/li&gt;&lt;li&gt;âž¤ Wermer syndrome,&lt;/li&gt;&lt;li&gt;âž¤ anterior pituitary tumors,&lt;/li&gt;&lt;li&gt;âž¤ pancreatic neuroendocrine tumors&lt;/li&gt;&lt;li&gt;âž¤ parathyroid hyperplasia,&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1129&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1129&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are feature of granulomatous thyroiditis except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hyperthyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypothyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Painless&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Giant cell on histological examination&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Painless&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Painless&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: In the initial phase of granulomatous (subacute) thyroiditis , there may be a transient hyperthyroid phase due to the inflammatory destruction of thyroid follicles leading to the release of preformed thyroid hormones into circulation .&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ initial phase of granulomatous&lt;/li&gt;&lt;li&gt;â€¢ thyroiditis&lt;/li&gt;&lt;li&gt;â€¢ transient hyperthyroid phase&lt;/li&gt;&lt;li&gt;â€¢ inflammatory destruction of thyroid follicles&lt;/li&gt;&lt;li&gt;â€¢ release of preformed thyroid hormones into circulation&lt;/li&gt;&lt;li&gt;â€¢ Option B: Following the hyperthyroid phase of granulomatous thyroiditis, there is a hypothyroid phase as the damaged thyroid may be temporarily unable to produce sufficient hormones . This is usually self-limited, and normal thyroid function often returns, but some patients may develop permanent hypothyroidism.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ hyperthyroid phase&lt;/li&gt;&lt;li&gt;â€¢ granulomatous thyroiditis,&lt;/li&gt;&lt;li&gt;â€¢ hypothyroid phase&lt;/li&gt;&lt;li&gt;â€¢ damaged thyroid&lt;/li&gt;&lt;li&gt;â€¢ temporarily unable to produce sufficient hormones&lt;/li&gt;&lt;li&gt;â€¢ Option D: Granulomatous thyroiditis is characterized histologically by granuloma formation with giant cells . These multinucleated giant cells are part of the body&#x27;s response to inflammation and are involved in the degradation of thyroglobulin, which is released during the follicular destruction.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Granulomatous thyroiditis&lt;/li&gt;&lt;li&gt;â€¢ histologically&lt;/li&gt;&lt;li&gt;â€¢ granuloma formation with giant cells&lt;/li&gt;&lt;li&gt;â€¢ multinucleated giant cells&lt;/li&gt;&lt;li&gt;â€¢ body&#x27;s response to inflammation&lt;/li&gt;&lt;li&gt;â€¢ degradation of thyroglobulin,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Granulomatous thyroiditis is the most common cause of thyroid pain, not a painless condition.&lt;/li&gt;&lt;li&gt;âž¤ Granulomatous thyroiditis&lt;/li&gt;&lt;li&gt;âž¤ thyroid pain,&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th 1093&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th 1093&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Brown tumour is seen in:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hyperthyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypothyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hyperparathyroidism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypoparathyroidism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hyperparathyroidism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/23/screenshot-2024-04-23-101457.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Brown tumors are associated with hyperparathyroidism and represent a severe manifestation of osteitis fibrosa cystica , where excessive bone resorption leads to fibrous and cystic bone changes .&lt;/li&gt;&lt;li&gt;âž¤ Brown tumors&lt;/li&gt;&lt;li&gt;âž¤ hyperparathyroidism&lt;/li&gt;&lt;li&gt;âž¤ represent a severe manifestation&lt;/li&gt;&lt;li&gt;âž¤ osteitis fibrosa cystica&lt;/li&gt;&lt;li&gt;âž¤ excessive bone resorption&lt;/li&gt;&lt;li&gt;âž¤ fibrous&lt;/li&gt;&lt;li&gt;âž¤ cystic bone changes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Most common cause of Cushingâ€™s syndrome is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Exogenous corticosteroids&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pituitary tumor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Adrenal adenoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Adrenal carcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Exogenous corticosteroids&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Exogenous corticosteroids&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: A pituitary adenoma that secretes adrenocorticotropic hormone (ACTH) can cause Cushing&#x27;s disease , which is a subset of Cushing&#x27;s syndrome. This is the most common cause of endogenous Cushing&#x27;s syndrome , but overall less common than the exogenous form caused by taking corticosteroid medications.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ pituitary adenoma&lt;/li&gt;&lt;li&gt;â€¢ secretes adrenocorticotropic hormone&lt;/li&gt;&lt;li&gt;â€¢ Cushing&#x27;s disease&lt;/li&gt;&lt;li&gt;â€¢ common cause of endogenous Cushing&#x27;s syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option C: An adrenal adenoma is a benign tumor of the adrenal gland that can autonomously secrete cortisol . It&#x27;s a less common cause of Cushing&#x27;s syndrome compared to exogenous steroid use and pituitary tumors but should be considered, especially when ACTH levels are low.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ adrenal adenoma&lt;/li&gt;&lt;li&gt;â€¢ benign tumor&lt;/li&gt;&lt;li&gt;â€¢ adrenal gland&lt;/li&gt;&lt;li&gt;â€¢ autonomously secrete cortisol&lt;/li&gt;&lt;li&gt;â€¢ less common cause of Cushing&#x27;s syndrome&lt;/li&gt;&lt;li&gt;â€¢ exogenous steroid use&lt;/li&gt;&lt;li&gt;â€¢ pituitary tumors&lt;/li&gt;&lt;li&gt;â€¢ Option D: Adrenal carcinomas are rare but can also cause Cushing&#x27;s syndrome by secreting excessive amounts of cortisol . They are more aggressive than adenomas and can be associated with a worse prognosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Adrenal carcinomas&lt;/li&gt;&lt;li&gt;â€¢ rare&lt;/li&gt;&lt;li&gt;â€¢ cause Cushing&#x27;s syndrome&lt;/li&gt;&lt;li&gt;â€¢ secreting excessive amounts of cortisol&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Exogenous corticosteroids are the most common cause of Cushing&#x27;s syndrome , primarily due to the widespread use of corticosteroid medications for a variety of medical conditions.&lt;/li&gt;&lt;li&gt;âž¤ Exogenous corticosteroids&lt;/li&gt;&lt;li&gt;âž¤ most common cause of Cushing&#x27;s syndrome&lt;/li&gt;&lt;li&gt;âž¤ widespread use of corticosteroid medications&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1115&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1115&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Submucosal neuroma is associated with:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;MEN I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;MEN II A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;MEN II B&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. MEN II B&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) MEN II B&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Multiple Endocrine Neoplasia type I (MEN I) is a syndrome characterized by the presence of tumors in the parathyroid glands , pancreatic islet cells , and the anterior pituitary gland . Submucosal neuromas are not typically associated with MEN I.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Multiple Endocrine Neoplasia type I (MEN I)&lt;/li&gt;&lt;li&gt;â€¢ syndrome&lt;/li&gt;&lt;li&gt;â€¢ presence of tumors&lt;/li&gt;&lt;li&gt;â€¢ parathyroid glands&lt;/li&gt;&lt;li&gt;â€¢ pancreatic islet cells&lt;/li&gt;&lt;li&gt;â€¢ anterior pituitary gland&lt;/li&gt;&lt;li&gt;â€¢ Option B: Multiple Endocrine Neoplasia type II A (MEN II A) is a syndrome that includes medullary thyroid carcinoma , pheochromocytoma , and primary hyperparathyroidism . It does not typically present with submucosal neuromas.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Multiple Endocrine Neoplasia type II A (MEN II A)&lt;/li&gt;&lt;li&gt;â€¢ syndrome&lt;/li&gt;&lt;li&gt;â€¢ includes medullary thyroid carcinoma&lt;/li&gt;&lt;li&gt;â€¢ pheochromocytoma&lt;/li&gt;&lt;li&gt;â€¢ primary hyperparathyroidism&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Submucosal neuromas are associated with MEN II B and can contribute to the diagnosis of this syndrome.&lt;/li&gt;&lt;li&gt;âž¤ Submucosal neuromas&lt;/li&gt;&lt;li&gt;âž¤ MEN II B&lt;/li&gt;&lt;li&gt;âž¤ Ref: Robbins 10 th 1130&lt;/li&gt;&lt;li&gt;âž¤ Ref: Robbins 10 th 1130&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Most common site of pheochromocytoma after adrenal gland is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hilum of kidney&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Organs of Zuckerkandl&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Neck&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Urinary bladder&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Organs of Zuckerkandl&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Organs of Zuckerkandl&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: The hilum of the kidney is an area where the renal artery enters and the renal vein and ureter exit . While it is close to the adrenal glands , it is not a common site for extra-adrenal pheochromocytomas , which are tumors that arise from chromaffin cells typically found in the adrenal medulla.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ hilum of the kidney&lt;/li&gt;&lt;li&gt;â€¢ area where the renal artery enters&lt;/li&gt;&lt;li&gt;â€¢ renal vein and ureter exit&lt;/li&gt;&lt;li&gt;â€¢ close to the adrenal glands&lt;/li&gt;&lt;li&gt;â€¢ not a common site for extra-adrenal pheochromocytomas&lt;/li&gt;&lt;li&gt;â€¢ Option C: While chromaffin tissue can be found along the sympathetic chain in the neck , pheochromocytomas are not commonly found in this location.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ chromaffin tissue&lt;/li&gt;&lt;li&gt;â€¢ found along&lt;/li&gt;&lt;li&gt;â€¢ sympathetic chain in the neck&lt;/li&gt;&lt;li&gt;â€¢ Option D: Pheochromocytomas can occur in the urinary bladder , but it is an uncommon site . When they do occur in this location, they can cause symptoms such as hypertension, palpitations, and headache during micturition.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Pheochromocytomas&lt;/li&gt;&lt;li&gt;â€¢ urinary bladder&lt;/li&gt;&lt;li&gt;â€¢ uncommon site&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Organs of Zuckerkandl are the most common extra-adrenal pheochromocytoma .&lt;/li&gt;&lt;li&gt;âž¤ Organs of Zuckerkandl&lt;/li&gt;&lt;li&gt;âž¤ most common extra-adrenal pheochromocytoma&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1130&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1130&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;True about adrenal pheochromocytoma is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chromaffin negative&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mostly malignant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bilateral in 10% of cases&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Unilateral in 10% of cases&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Bilateral in 10% of cases&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Bilateral in 10% of cases&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Adrenal pheochromocytomas are typically chromaffin positive , meaning they stain positively for chromaffin , which is indicative of catecholamine-secreting cells . These tumors arise from chromaffin cells in the adrenal medulla.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Adrenal pheochromocytomas&lt;/li&gt;&lt;li&gt;â€¢ chromaffin positive&lt;/li&gt;&lt;li&gt;â€¢ stain positively for chromaffin&lt;/li&gt;&lt;li&gt;â€¢ catecholamine-secreting cells&lt;/li&gt;&lt;li&gt;â€¢ Option B: While pheochromocytomas can be malignant , most are benign . The malignancy rate is estimated to be about 10% in adrenal pheochromocytomas. Malignancy is usually determined by the presence of metastasis rather than histological features.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ pheochromocytomas can be malignant&lt;/li&gt;&lt;li&gt;â€¢ benign&lt;/li&gt;&lt;li&gt;â€¢ malignancy rate&lt;/li&gt;&lt;li&gt;â€¢ about 10% in adrenal pheochromocytomas.&lt;/li&gt;&lt;li&gt;â€¢ Option D: This statement is incorrect because unilateral pheochromocytomas are much more common than 10%. The majority of pheochromocytomas are unilateral.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ unilateral pheochromocytomas&lt;/li&gt;&lt;li&gt;â€¢ much more common than 10%.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While most adrenal pheochromocytomas are benign and unilateral, they can be bilateral in 10% of cases , especially in hereditary syndromes .&lt;/li&gt;&lt;li&gt;âž¤ adrenal pheochromocytomas are benign and unilateral,&lt;/li&gt;&lt;li&gt;âž¤ bilateral in 10% of cases&lt;/li&gt;&lt;li&gt;âž¤ hereditary syndromes&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1127&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1127&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male presents to the emergency department with complaints of episodic headaches, palpitations, and sweating. Physical examination reveals elevated blood pressure and a palpable abdominal mass. Which of the following tumors is most likely to exhibit the \&quot;rule of 10\&quot; characteristic?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pheochromocytoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oncocytoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Renal cell carcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Pheochromocytoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Pheochromocytoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B: Oncocytomas are benign renal epithelial tumors that typically do not follow the \&quot;rule of 10s\&quot;. They are usually asymptomatic and are often found incidentally during imaging for other conditions.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Oncocytomas&lt;/li&gt;&lt;li&gt;â€¢ benign renal epithelial tumors&lt;/li&gt;&lt;li&gt;â€¢ do not follow the \&quot;rule of 10s\&quot;.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Lymphomas are cancers of the lymphatic system and do not follow the \&quot;rule of 10s\&quot;. They have various subtypes with differing presentations and prognoses.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Lymphomas&lt;/li&gt;&lt;li&gt;â€¢ cancers of the lymphatic system&lt;/li&gt;&lt;li&gt;â€¢ do not follow the \&quot;rule of 10s\&quot;.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults and does not adhere to the \&quot;rule of 10s\&quot;. RCC has different subtypes with varying clinical behaviors and genetic associations.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Renal cell carcinoma (RCC)&lt;/li&gt;&lt;li&gt;â€¢ most common type of kidney cancer&lt;/li&gt;&lt;li&gt;â€¢ adults&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pheochromocytoma is classically described by the \&quot;rule of 10s\&quot;, which can be helpful in remembering the characteristics of this tumor for diagnosis and management decisions .&lt;/li&gt;&lt;li&gt;âž¤ Pheochromocytoma&lt;/li&gt;&lt;li&gt;âž¤ \&quot;rule of 10s\&quot;,&lt;/li&gt;&lt;li&gt;âž¤ helpful in remembering&lt;/li&gt;&lt;li&gt;âž¤ tumor for diagnosis&lt;/li&gt;&lt;li&gt;âž¤ management decisions&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th 1127&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th 1127&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which one of the following is not seen in pheochromocytoma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypertension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Episodic palpitations&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Weight loss&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diarrhea&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Diarrhea&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Diarrhea&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Hypertension is a hallmark sign of pheochromocytoma and can be sustained or paroxysmal due to episodic catecholamine secretion by the tumor.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Hypertension&lt;/li&gt;&lt;li&gt;â€¢ hallmark sign of pheochromocytoma&lt;/li&gt;&lt;li&gt;â€¢ Option B: Episodic palpitations are a common symptom of pheochromocytoma due to episodic release of catecholamines , particularly norepinephrine , which stimulates the heart and causes increased contractility and heart rate.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Episodic palpitations&lt;/li&gt;&lt;li&gt;â€¢ common symptom of pheochromocytoma&lt;/li&gt;&lt;li&gt;â€¢ episodic release of catecholamines&lt;/li&gt;&lt;li&gt;â€¢ norepinephrine&lt;/li&gt;&lt;li&gt;â€¢ Option C: Weight loss is frequently seen in pheochromocytoma patients . The excess catecholamines can increase metabolism and cause a hyperadrenergic state , leading to weight loss even in the presence of a good appetite.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Weight loss&lt;/li&gt;&lt;li&gt;â€¢ seen in pheochromocytoma patients&lt;/li&gt;&lt;li&gt;â€¢ excess catecholamines&lt;/li&gt;&lt;li&gt;â€¢ increase metabolism&lt;/li&gt;&lt;li&gt;â€¢ hyperadrenergic state&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While hypertension , episodic palpitations , and weight loss are common in pheochromocytoma , diarrhea is not typically associated with this condition.&lt;/li&gt;&lt;li&gt;âž¤ hypertension&lt;/li&gt;&lt;li&gt;âž¤ episodic palpitations&lt;/li&gt;&lt;li&gt;âž¤ weight loss&lt;/li&gt;&lt;li&gt;âž¤ pheochromocytoma&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1127&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1127&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mitotic figures and giant cells are seen in which of the following tumor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Benign and malignant thyroid cancers&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Benign and malignant pheochromocytoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Benign and malignant liver tumors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Benign and malignant renal tumors&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Benign and malignant pheochromocytoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Benign and malignant pheochromocytoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: Thyroid cancers can indeed present with mitotic figures , especially in more aggressive forms such as anaplastic thyroid carcinoma . However, giant cells are particularly characteristic of certain inflammatory conditions such as subacute thyroiditis, rather than thyroid neoplasms.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Thyroid cancers&lt;/li&gt;&lt;li&gt;â€¢ present with mitotic figures&lt;/li&gt;&lt;li&gt;â€¢ more aggressive forms&lt;/li&gt;&lt;li&gt;â€¢ anaplastic thyroid carcinoma&lt;/li&gt;&lt;li&gt;â€¢ Option C: Benign and malignant liver tumors \\ such as hepatocellular carcinoma can show mitotic figures , indicating a high proliferative rate . However, giant cells are more typical of specific liver pathologies such as giant cell hepatitis, not necessarily of benign or malignant liver tumors.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Benign and malignant liver tumors&lt;/li&gt;&lt;li&gt;â€¢ hepatocellular carcinoma&lt;/li&gt;&lt;li&gt;â€¢ show mitotic figures&lt;/li&gt;&lt;li&gt;â€¢ high proliferative rate&lt;/li&gt;&lt;li&gt;â€¢ Option D: In renal tumors , mitotic figures are also indicative of a higher grade of malignancy , especially in clear cell renal carcinoma . Giant cells are not a characteristic feature of common benign or malignant renal tumors.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ renal tumors&lt;/li&gt;&lt;li&gt;â€¢ mitotic figures&lt;/li&gt;&lt;li&gt;â€¢ higher grade of malignancy&lt;/li&gt;&lt;li&gt;â€¢ clear cell renal carcinoma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The histological presence of mitotic figures and giant cells in pheochromocytomas is not indicative of malignancy ; instead, malignancy is confirmed by the presence of metastatic disease .&lt;/li&gt;&lt;li&gt;âž¤ histological presence&lt;/li&gt;&lt;li&gt;âž¤ mitotic figures&lt;/li&gt;&lt;li&gt;âž¤ giant cells in pheochromocytomas&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ malignancy&lt;/li&gt;&lt;li&gt;âž¤ malignancy&lt;/li&gt;&lt;li&gt;âž¤ presence of metastatic disease&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1127&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1127&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Homer wright rosettes are seen in:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Neuroblastoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nephroblastoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hepatoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ependymoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Neuroblastoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Neuroblastoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B: Also known as Wilms&#x27; tumor , nephroblastoma is a kidney tumor usually found in children . It can show other types of rosette formations, but not typically Homer Wright rosettes.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Wilms&#x27; tumor&lt;/li&gt;&lt;li&gt;â€¢ nephroblastoma&lt;/li&gt;&lt;li&gt;â€¢ kidney tumor&lt;/li&gt;&lt;li&gt;â€¢ found in children&lt;/li&gt;&lt;li&gt;â€¢ Option C: Hepatoma , or hepatocellular carcinoma , is a liver tumor and does not feature the presence of Homer Wright rosettes. Its pathology is markedly different from that of neuroblastic tumors.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Hepatoma&lt;/li&gt;&lt;li&gt;â€¢ hepatocellular carcinoma&lt;/li&gt;&lt;li&gt;â€¢ liver tumor&lt;/li&gt;&lt;li&gt;â€¢ Option D: Ependymomas are glial cell tumors that can form rosettes known as perivascular rosettes or ependymal rosettes , which are distinct from Homer Wright rosettes.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Ependymomas&lt;/li&gt;&lt;li&gt;â€¢ glial cell tumors&lt;/li&gt;&lt;li&gt;â€¢ form rosettes&lt;/li&gt;&lt;li&gt;â€¢ perivascular rosettes&lt;/li&gt;&lt;li&gt;â€¢ ependymal rosettes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Homer wright rosettes are seen in Neuroblastoma.&lt;/li&gt;&lt;li&gt;âž¤ Homer wright rosettes&lt;/li&gt;&lt;li&gt;âž¤ Neuroblastoma.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 480&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 480&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not part of the â€œrule of 10â€ in pheochromocytoma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;10% are bilateral&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;10% are malignant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;10% are extra adrenal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;10% are symptomatic&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 10% are symptomatic&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) 10% are symptomatic&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: In the context of pheochromocytoma , approximately 10% of tumors can be found bilaterally , often associated with hereditary conditions such as Multiple Endocrine Neoplasia types 2A and 2B , von Hippel-Lindau disease , and neurofibromatosis type 1 .&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ pheochromocytoma&lt;/li&gt;&lt;li&gt;â€¢ approximately 10% of tumors&lt;/li&gt;&lt;li&gt;â€¢ bilaterally&lt;/li&gt;&lt;li&gt;â€¢ hereditary conditions&lt;/li&gt;&lt;li&gt;â€¢ Multiple Endocrine Neoplasia types 2A&lt;/li&gt;&lt;li&gt;â€¢ 2B&lt;/li&gt;&lt;li&gt;â€¢ von Hippel-Lindau disease&lt;/li&gt;&lt;li&gt;â€¢ neurofibromatosis type 1&lt;/li&gt;&lt;li&gt;â€¢ Option B: Pheochromocytomas are usually benign , but about 10% can be malignant . Malignancy is determined by the presence of metastases rather than the histological appearance of the primary tumor.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Pheochromocytomas&lt;/li&gt;&lt;li&gt;â€¢ benign&lt;/li&gt;&lt;li&gt;â€¢ 10% can be malignant&lt;/li&gt;&lt;li&gt;â€¢ Option C: Around 10% of pheochromocytomas are located outside of the adrenal glands , commonly in the abdomen in locations like the organ of Zuckerkandl . These are termed paragangliomas.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ 10% of pheochromocytomas&lt;/li&gt;&lt;li&gt;â€¢ located outside of the adrenal glands&lt;/li&gt;&lt;li&gt;â€¢ abdomen&lt;/li&gt;&lt;li&gt;â€¢ organ of Zuckerkandl&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The \&quot;rule of 10\&quot; in pheochromocytoma refers to the observation that approximately:&lt;/li&gt;&lt;li&gt;âž¤ \&quot;rule of 10\&quot;&lt;/li&gt;&lt;li&gt;âž¤ pheochromocytoma&lt;/li&gt;&lt;li&gt;âž¤ observation&lt;/li&gt;&lt;li&gt;âž¤ 10% of pheochromocytomas are extra-adrenal. 10% of pheochromocytomas are bilateral, affecting both adrenal glands. 10% of pheochromocytomas are malignant.&lt;/li&gt;&lt;li&gt;âž¤ 10% of pheochromocytomas are extra-adrenal.&lt;/li&gt;&lt;li&gt;âž¤ 10% of pheochromocytomas are bilateral, affecting both adrenal glands.&lt;/li&gt;&lt;li&gt;âž¤ 10% of pheochromocytomas are malignant.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1127&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1127&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not a feature of Sipple Syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pheochromocytoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Medullary carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hyperthyroidism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hyperparathyroidism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hyperthyroidism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Hyperthyroidism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: Pheochromocytoma is a characteristic feature of MEN 2A and presents as a catecholamine-secreting tumor typically originating in the adrenal medulla.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Pheochromocytoma&lt;/li&gt;&lt;li&gt;â€¢ feature of MEN 2A&lt;/li&gt;&lt;li&gt;â€¢ catecholamine-secreting tumor&lt;/li&gt;&lt;li&gt;â€¢ Option B: Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor of the thyroid and a principal feature of MEN 2A . It arises from the parafollicular C-cells of the thyroid gland and secretes calcitonin.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Medullary thyroid carcinoma&lt;/li&gt;&lt;li&gt;â€¢ neuroendocrine tumor&lt;/li&gt;&lt;li&gt;â€¢ thyroid&lt;/li&gt;&lt;li&gt;â€¢ principal feature of MEN 2A&lt;/li&gt;&lt;li&gt;â€¢ Option D: Primary hyperparathyroidism is part of the MEN 2A syndrome and is due to hyperplasia or adenoma of the parathyroid glands leading to excessive secretion of parathyroid hormone (PTH).&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Primary hyperparathyroidism&lt;/li&gt;&lt;li&gt;â€¢ part of the MEN 2A syndrome&lt;/li&gt;&lt;li&gt;â€¢ due to hyperplasia&lt;/li&gt;&lt;li&gt;â€¢ adenoma of the parathyroid glands&lt;/li&gt;&lt;li&gt;â€¢ excessive secretion of parathyroid hormone&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While pheochromocytoma , medullary thyroid carcinoma , and hyperparathyroidism are part of the Sipple syndrome , hyperthyroidism is not.&lt;/li&gt;&lt;li&gt;âž¤ pheochromocytoma&lt;/li&gt;&lt;li&gt;âž¤ medullary thyroid carcinoma&lt;/li&gt;&lt;li&gt;âž¤ hyperparathyroidism&lt;/li&gt;&lt;li&gt;âž¤ Sipple syndrome&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1130&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1130&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 46 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test5" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Gastrointestinal System&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Gastrointestinal System&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                34 Questions | 136 Total Marks | 44 min Duration | ~77.65 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;Mechanism of action of an aprepitant is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;RANK ligand inhibitor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;NMDA antagonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;NK 1 receptor antagonist&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;5 HT3 antagonist&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. NK 1 receptor antagonist&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) NK 1 receptor antagonist&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. RANK ligand inhibitor: Incorrect because RANK ligand inhibitors like denosumab are used to treat osteoporosis and bone metastases , not nausea and vomiting. These drugs inhibit RANK ligand, a protein essential for the formation and survival of osteoclasts, which are involved in bone resorption.&lt;/li&gt;&lt;li&gt;â€¢ Option A. RANK ligand inhibitor:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ RANK ligand inhibitors&lt;/li&gt;&lt;li&gt;â€¢ denosumab&lt;/li&gt;&lt;li&gt;â€¢ treat osteoporosis&lt;/li&gt;&lt;li&gt;â€¢ bone&lt;/li&gt;&lt;li&gt;â€¢ metastases&lt;/li&gt;&lt;li&gt;â€¢ inhibit RANK ligand,&lt;/li&gt;&lt;li&gt;â€¢ formation and survival of&lt;/li&gt;&lt;li&gt;â€¢ osteoclasts,&lt;/li&gt;&lt;li&gt;â€¢ bone resorption.&lt;/li&gt;&lt;li&gt;â€¢ Option B. NMDA antagonist: Incorrect as NMDA antagonists, such as memantine , target cognitive decline in Alzheimerâ€™s disease rather than nausea and vomiting.&lt;/li&gt;&lt;li&gt;â€¢ Option B. NMDA antagonist:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ NMDA antagonists,&lt;/li&gt;&lt;li&gt;â€¢ memantine&lt;/li&gt;&lt;li&gt;â€¢ target cognitive&lt;/li&gt;&lt;li&gt;â€¢ Alzheimerâ€™s disease&lt;/li&gt;&lt;li&gt;â€¢ nausea and vomiting.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 5 HT3 antagonist: Incorrect because 5-HT3 antagonists, like ondansetron and granisetron , also prevent nausea and vomiting in settings like chemotherapy and post-operation but function by blocking 5-HT3 receptors on the vagus nerve and in the central nervous system , not NK1 receptors.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 5 HT3 antagonist:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ 5-HT3 antagonists,&lt;/li&gt;&lt;li&gt;â€¢ ondansetron and granisetron&lt;/li&gt;&lt;li&gt;â€¢ prevent nausea and&lt;/li&gt;&lt;li&gt;â€¢ vomiting&lt;/li&gt;&lt;li&gt;â€¢ chemotherapy and post-operation&lt;/li&gt;&lt;li&gt;â€¢ blocking 5-HT3 receptors&lt;/li&gt;&lt;li&gt;â€¢ vagus nerve&lt;/li&gt;&lt;li&gt;â€¢ central nervous system&lt;/li&gt;&lt;li&gt;â€¢ not NK1 receptors.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ NK1 receptor antagonist used primarily to prevent delayed chemotherapy-induced nausea and vomiting by inhibiting the action of substance P on NK1 receptors.&lt;/li&gt;&lt;li&gt;âž¤ NK1 receptor antagonist&lt;/li&gt;&lt;li&gt;âž¤ prevent delayed chemotherapy-induced nausea and vomiting&lt;/li&gt;&lt;li&gt;âž¤ inhibiting&lt;/li&gt;&lt;li&gt;âž¤ substance P on NK1 receptors.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Despite their short half-lives (2 hrs), proton pump inhibitors (PPIs) cause a prolonged suppression of acid secretion (up to 48 hrs) because?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;They are pro-drugs and undergo activation gradually&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;From stomach, these quickly reach the parietal cells and enter acid secretory canaliculi and stay there, blocking the secretion of acid for a long time&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;They irreversible inhibit the proton pump molecule&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;They are available as enteric coated capsules, from which drug is gradually released&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. They irreversible inhibit the proton pump molecule&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) They irreversible inhibit the proton pump molecule&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. They are pro-drugs and undergo activation gradually: Incorrect because while PPIs are indeed prodrugs that are activated within the acidic environment of the parietal cells , the gradual activation does not directly contribute to the prolonged acid suppression . The prolongation comes from the irreversible inhibition of the pumps.&lt;/li&gt;&lt;li&gt;â€¢ Option A. They are pro-drugs and undergo activation gradually:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ PPIs&lt;/li&gt;&lt;li&gt;â€¢ prodrugs&lt;/li&gt;&lt;li&gt;â€¢ within&lt;/li&gt;&lt;li&gt;â€¢ parietal cells&lt;/li&gt;&lt;li&gt;â€¢ gradual activation does not&lt;/li&gt;&lt;li&gt;â€¢ prolonged acid&lt;/li&gt;&lt;li&gt;â€¢ suppression&lt;/li&gt;&lt;li&gt;â€¢ irreversible inhibition of the pumps.&lt;/li&gt;&lt;li&gt;â€¢ Option B. From stomach, these quickly reach the parietal cells and enter acid secretory canaliculi and stay there, blocking the secretion of acid for a long time: Incorrect because PPIs do not travel directly from the stomach to the parietal cells. They must first be absorbed from the intestine and then distributed to the parietal cells via the bloodstream.&lt;/li&gt;&lt;li&gt;â€¢ Option B. From stomach, these quickly reach the parietal cells and enter acid secretory canaliculi and stay there, blocking the secretion of acid for a long time:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ PPIs do not&lt;/li&gt;&lt;li&gt;â€¢ stomach to the parietal cells.&lt;/li&gt;&lt;li&gt;â€¢ absorbed from the intestine&lt;/li&gt;&lt;li&gt;â€¢ distributed to the parietal cells&lt;/li&gt;&lt;li&gt;â€¢ bloodstream.&lt;/li&gt;&lt;li&gt;â€¢ Option D. They are available as enteric coated capsules, from which drug is gradually released: Incorrect as the enteric coating only serves to protect the drug from gastric acid degradation rather than prolonging its action at the site of the proton pumps.&lt;/li&gt;&lt;li&gt;â€¢ Option D. They are available as enteric coated capsules, from which drug is gradually released:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ enteric coating&lt;/li&gt;&lt;li&gt;â€¢ protect the drug&lt;/li&gt;&lt;li&gt;â€¢ gastric acid degradation&lt;/li&gt;&lt;li&gt;â€¢ prolonging its action&lt;/li&gt;&lt;li&gt;â€¢ site of the proton pumps.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Proton pump inhibitor s cause prolonged acid suppression by irreversibly binding to and inactivating the proton pumps in the stomach, and acid secretion only resumes once new pumps are synthesized and active.&lt;/li&gt;&lt;li&gt;âž¤ Proton pump inhibitor&lt;/li&gt;&lt;li&gt;âž¤ prolonged acid suppression&lt;/li&gt;&lt;li&gt;âž¤ irreversibly binding to&lt;/li&gt;&lt;li&gt;âž¤ inactivating the proton pumps&lt;/li&gt;&lt;li&gt;âž¤ acid secretion&lt;/li&gt;&lt;li&gt;âž¤ resumes&lt;/li&gt;&lt;li&gt;âž¤ new pumps are synthesized and active.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient of peptic ulcer was prescribed ranitidine and sucralfate in the morning hours. Why is this combination incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ranitidine combines with sucralfate and prevents its action&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Combination of these two drugs produces serious side effects like agranulocytosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ranitidine increases the gastric pH so sucralfate is not able to act&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sucralfate inhibits the absorption of ranitidine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ranitidine increases the gastric pH so sucralfate is not able to act&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Ranitidine increases the gastric pH so sucralfate is not able to act&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ranitidine combines with sucralfate and prevents its action: Incorrect because ranitidine does not chemically combine with sucralfate ; the issue is the pH environment alteration.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ranitidine combines with sucralfate and prevents its action:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ ranitidine does not&lt;/li&gt;&lt;li&gt;â€¢ sucralfate&lt;/li&gt;&lt;li&gt;â€¢ pH environment alteration.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Combination of these two drugs produces serious side effects like agranulocytosis: Incorrect as there is no evidence to suggest that agranulocytosis is a common side effect of combining these two drugs.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Combination of these two drugs produces serious side effects like agranulocytosis:&lt;/li&gt;&lt;li&gt;â€¢ no&lt;/li&gt;&lt;li&gt;â€¢ agranulocytosis&lt;/li&gt;&lt;li&gt;â€¢ common side effect&lt;/li&gt;&lt;li&gt;â€¢ two drugs.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sucralfate inhibits the absorption of ranitidine: Incorrect because sucralfate does not affect the absorption of ranitidine; its primary interaction is with the gastric pH affecting its own mechanism of action.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sucralfate inhibits the absorption of ranitidine:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ sucralfate does not&lt;/li&gt;&lt;li&gt;â€¢ absorption of ranitidine;&lt;/li&gt;&lt;li&gt;â€¢ gastric pH&lt;/li&gt;&lt;li&gt;â€¢ own mechanism of action.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sucralfate needs an acidic environment to be effective. Co-administration with ranitidine, which raises gastric pH, can impair the effectiveness of sucralfate in treating ulcers.&lt;/li&gt;&lt;li&gt;âž¤ Sucralfate&lt;/li&gt;&lt;li&gt;âž¤ acidic environment&lt;/li&gt;&lt;li&gt;âž¤ effective.&lt;/li&gt;&lt;li&gt;âž¤ Co-administration&lt;/li&gt;&lt;li&gt;âž¤ ranitidine,&lt;/li&gt;&lt;li&gt;âž¤ raises gastric pH,&lt;/li&gt;&lt;li&gt;âž¤ impair&lt;/li&gt;&lt;li&gt;âž¤ effectiveness of sucralfate&lt;/li&gt;&lt;li&gt;âž¤ ulcers.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following adverse effects are associated with the use of proton pump inhibitors except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Community acquired pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Clostridium difficile infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Osteoporosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypothyroidism&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hypothyroidism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Hypothyroidism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Community acquired pneumonia: Correctly associated with PPIs. Some studies have indicated an increased risk of pneumonia, particularly in vulnerable groups such as the elderly or those with existing respiratory conditions , possibly due to alterations in stomach pH affecting gut and respiratory flora.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Community acquired pneumonia:&lt;/li&gt;&lt;li&gt;â€¢ PPIs.&lt;/li&gt;&lt;li&gt;â€¢ increased risk of&lt;/li&gt;&lt;li&gt;â€¢ pneumonia,&lt;/li&gt;&lt;li&gt;â€¢ elderly&lt;/li&gt;&lt;li&gt;â€¢ existing respiratory conditions&lt;/li&gt;&lt;li&gt;â€¢ alterations in stomach pH&lt;/li&gt;&lt;li&gt;â€¢ gut and respiratory flora.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Clostridium difficile infection: Correctly associated with PPIs. The reduction in gastric acidity can lead to an environment more conducive to the growth of Clostridium difficile , potentially resulting in severe and life-threatening infections.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Clostridium difficile infection:&lt;/li&gt;&lt;li&gt;â€¢ Correctly&lt;/li&gt;&lt;li&gt;â€¢ PPIs.&lt;/li&gt;&lt;li&gt;â€¢ reduction in gastric acidity&lt;/li&gt;&lt;li&gt;â€¢ more conducive&lt;/li&gt;&lt;li&gt;â€¢ growth of Clostridium difficile&lt;/li&gt;&lt;li&gt;â€¢ severe and life-threatening infections.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Osteoporosis: Correctly associated with PPIs . Chronic use of PPIs may impact calcium absorption and bone metabolism, leading to an increased risk of osteoporosis and related fractures, especially in populations at risk like postmenopausal women and the elderly.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Osteoporosis:&lt;/li&gt;&lt;li&gt;â€¢ Correctly&lt;/li&gt;&lt;li&gt;â€¢ PPIs&lt;/li&gt;&lt;li&gt;â€¢ Chronic&lt;/li&gt;&lt;li&gt;â€¢ PPIs&lt;/li&gt;&lt;li&gt;â€¢ impact calcium absorption&lt;/li&gt;&lt;li&gt;â€¢ bone metabolism,&lt;/li&gt;&lt;li&gt;â€¢ increased risk of osteoporosis&lt;/li&gt;&lt;li&gt;â€¢ fractures,&lt;/li&gt;&lt;li&gt;â€¢ risk like postmenopausal women&lt;/li&gt;&lt;li&gt;â€¢ elderly.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While PPIs are linked to several significant adverse effects such as increased risks of community-acquired pneumonia, Clostridium difficile infections , and osteoporosis , they are not associated with causing or worsening hypothyroidism.&lt;/li&gt;&lt;li&gt;âž¤ PPIs are linked&lt;/li&gt;&lt;li&gt;âž¤ adverse effects&lt;/li&gt;&lt;li&gt;âž¤ increased risks of community-acquired pneumonia,&lt;/li&gt;&lt;li&gt;âž¤ Clostridium&lt;/li&gt;&lt;li&gt;âž¤ difficile infections&lt;/li&gt;&lt;li&gt;âž¤ osteoporosis&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ causing or worsening hypothyroidism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs have least affinity for CYP3A4?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Omeprazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lansoprazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Esomeprazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rabeprazole&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Rabeprazole&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Rabeprazole&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Omeprazole: Incorrect because Omeprazole is extensively metabolized by CYP3A4, making it more likely to interact with other drugs metabolized by this enzyme.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Omeprazole:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Omeprazole&lt;/li&gt;&lt;li&gt;â€¢ extensively metabolized by CYP3A4,&lt;/li&gt;&lt;li&gt;â€¢ more likely&lt;/li&gt;&lt;li&gt;â€¢ interact&lt;/li&gt;&lt;li&gt;â€¢ other drugs&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lansoprazole: Incorrect as Lansoprazole also has significant metabolism via CYP3A4, similar to omeprazole, which increases its potential for drug interactions.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lansoprazole:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Lansoprazole&lt;/li&gt;&lt;li&gt;â€¢ CYP3A4,&lt;/li&gt;&lt;li&gt;â€¢ omeprazole,&lt;/li&gt;&lt;li&gt;â€¢ increases its potential&lt;/li&gt;&lt;li&gt;â€¢ drug interactions.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Esomeprazole: Incorrect because Esomeprazole, the S-isomer of omeprazole, is extensively metabolized by CYP3A4 , thus having a higher affinity for this enzyme compared to rabeprazole.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Esomeprazole:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Esomeprazole,&lt;/li&gt;&lt;li&gt;â€¢ S-isomer of omeprazole,&lt;/li&gt;&lt;li&gt;â€¢ metabolized by CYP3A4&lt;/li&gt;&lt;li&gt;â€¢ higher affinity for this enzyme&lt;/li&gt;&lt;li&gt;â€¢ rabeprazole.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Rabeprazole has the least affinity for the enzyme CYP3A4 among the listed PPIs , potentially leading to fewer drug interactions related to metabolism by this pathway.&lt;/li&gt;&lt;li&gt;âž¤ Rabeprazole&lt;/li&gt;&lt;li&gt;âž¤ least affinity&lt;/li&gt;&lt;li&gt;âž¤ CYP3A4&lt;/li&gt;&lt;li&gt;âž¤ listed PPIs&lt;/li&gt;&lt;li&gt;âž¤ fewer drug interactions&lt;/li&gt;&lt;li&gt;âž¤ metabolism&lt;/li&gt;&lt;li&gt;âž¤ this pathway.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old pregnant woman has a history of rheumatoid arthritis which has been managed successfully with NSAIDs. However, she has recently visited her general practitioner complaining of burning epigastric pain worsened by food intake. Which of the following ulcer medication is most likely contraindicated in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Famotidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Omeprazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Misoprostol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ranitidine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Misoprostol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Misoprostol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Famotidine: Incorrect as Famotidine, an H2 receptor antagonist, is generally considered safe for use during pregnancy . It works by reducing stomach acid and is not known to harm the fetus.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Famotidine:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ H2 receptor antagonist,&lt;/li&gt;&lt;li&gt;â€¢ considered safe&lt;/li&gt;&lt;li&gt;â€¢ during pregnancy&lt;/li&gt;&lt;li&gt;â€¢ reducing stomach acid&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ harm the fetus.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Omeprazole: Incorrect because Omeprazole , a proton pump inhibitor , is also used to manage ulcer symptoms by reducing acid production. While its use in pregnancy should be cautious, it is not specifically contraindicated like Misoprostol.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Omeprazole:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Omeprazole&lt;/li&gt;&lt;li&gt;â€¢ proton pump inhibitor&lt;/li&gt;&lt;li&gt;â€¢ used&lt;/li&gt;&lt;li&gt;â€¢ reducing&lt;/li&gt;&lt;li&gt;â€¢ acid production.&lt;/li&gt;&lt;li&gt;â€¢ use in pregnancy&lt;/li&gt;&lt;li&gt;â€¢ cautious,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ contraindicated&lt;/li&gt;&lt;li&gt;â€¢ Misoprostol.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ranitidine: Incorrect as Ranitidine, another H2 receptor antagonist, is typically safe for use during pregnancy. It works similarly to Famotidine by reducing gastric acid and is not associated with significant risks to the developing fetus.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ranitidine:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ H2 receptor antagonist,&lt;/li&gt;&lt;li&gt;â€¢ safe&lt;/li&gt;&lt;li&gt;â€¢ during pregnancy.&lt;/li&gt;&lt;li&gt;â€¢ similarly to Famotidine&lt;/li&gt;&lt;li&gt;â€¢ reducing gastric acid&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ risks&lt;/li&gt;&lt;li&gt;â€¢ developing fetus.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Misoprostol is contraindicated in pregnant patients due to its potential to induce uterine contractions and risk causing abortion.&lt;/li&gt;&lt;li&gt;âž¤ Misoprostol&lt;/li&gt;&lt;li&gt;âž¤ contraindicated in pregnant&lt;/li&gt;&lt;li&gt;âž¤ its potential&lt;/li&gt;&lt;li&gt;âž¤ induce uterine contractions&lt;/li&gt;&lt;li&gt;âž¤ risk&lt;/li&gt;&lt;li&gt;âž¤ abortion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Drug implicated in prolonging QT interval is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Domperidone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Metoclopramide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cisapride&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Omeprazole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cisapride&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/03/screenshot-2024-05-03-095836.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Cisapride&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Domperidone: Incorrect because while Domperidone does have some cardiac risk , it is more specifically associated with an increased risk of serious ventricular arrhythmias and sudden cardiac death rather than QT prolongation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Domperidone:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Domperidone&lt;/li&gt;&lt;li&gt;â€¢ cardiac risk&lt;/li&gt;&lt;li&gt;â€¢ increased risk of serious ventricular arrhythmias&lt;/li&gt;&lt;li&gt;â€¢ sudden cardiac death&lt;/li&gt;&lt;li&gt;â€¢ Option B. Metoclopramide: Incorrect as Metoclopramide, another prokinetic agent, primarily affects dopamine receptors and has not been commonly associated with QT prolongation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Metoclopramide:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ prokinetic agent,&lt;/li&gt;&lt;li&gt;â€¢ dopamine receptors&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ QT prolongation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Omeprazole: Incorrect because Omeprazole, a proton pump inhibitor, does not typically cause QT prolongation as part of its side effect profile.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Omeprazole:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ proton pump inhibitor,&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ QT prolongation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cisapride is associated with QT interval prolongation and can lead to torsades de pointes , particularly at high concentrations or when combined with other drugs that inhibit its metabolism.&lt;/li&gt;&lt;li&gt;âž¤ Cisapride&lt;/li&gt;&lt;li&gt;âž¤ QT interval prolongation&lt;/li&gt;&lt;li&gt;âž¤ torsades de pointes&lt;/li&gt;&lt;li&gt;âž¤ high concentrations&lt;/li&gt;&lt;li&gt;âž¤ combined with other drugs&lt;/li&gt;&lt;li&gt;âž¤ inhibit its metabolism.&lt;/li&gt;&lt;li&gt;âž¤ Important drugs causing QT prolongation&lt;/li&gt;&lt;li&gt;âž¤ Important drugs causing QT prolongation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following statements about treatment of diarrhea are correct except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Opioids delay passage of gut contents by reducing peristalsis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Loperamide is an opioid with anti-motility action&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti-motility drugs are best drugs for infective diarrhea&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diphenoxylate overdose can cause respiratory depression&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Anti-motility drugs are best drugs for infective diarrhea&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Anti-motility drugs are best drugs for infective diarrhea&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Opioids delay passage of gut contents by reducing peristalsis: Correct , opioids inhibit gastrointestinal motility, leading to slower transit times and more water absorption , which can help alleviate diarrhea symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Opioids delay passage of gut contents by reducing peristalsis:&lt;/li&gt;&lt;li&gt;â€¢ Correct&lt;/li&gt;&lt;li&gt;â€¢ inhibit gastrointestinal motility,&lt;/li&gt;&lt;li&gt;â€¢ slower transit&lt;/li&gt;&lt;li&gt;â€¢ more water absorption&lt;/li&gt;&lt;li&gt;â€¢ alleviate diarrhea symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Loperamide is an opioid with anti-motility action: Correct , loperamide acts on opioid receptors in the gastrointestinal tract to reduce motility and increase the absorption of fluids, making it effective in managing diarrhea.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Loperamide is an opioid with anti-motility action:&lt;/li&gt;&lt;li&gt;â€¢ Correct&lt;/li&gt;&lt;li&gt;â€¢ loperamide&lt;/li&gt;&lt;li&gt;â€¢ opioid receptors&lt;/li&gt;&lt;li&gt;â€¢ gastrointestinal&lt;/li&gt;&lt;li&gt;â€¢ tract&lt;/li&gt;&lt;li&gt;â€¢ reduce motility&lt;/li&gt;&lt;li&gt;â€¢ increase the absorption of fluids,&lt;/li&gt;&lt;li&gt;â€¢ Option D. Diphenoxylate overdose can cause respiratory depression: Correct, diphenoxylate is an opioid and, like other opioids, can cause significant respiratory depression if overdosed.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Diphenoxylate overdose can cause respiratory depression:&lt;/li&gt;&lt;li&gt;â€¢ Correct,&lt;/li&gt;&lt;li&gt;â€¢ diphenoxylate&lt;/li&gt;&lt;li&gt;â€¢ opioid&lt;/li&gt;&lt;li&gt;â€¢ respiratory depression&lt;/li&gt;&lt;li&gt;â€¢ overdosed.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While anti-motility drugs are effective in managing non-infective diarrhea, they are not recommended for treating infective diarrhea due to the risk of prolonging the presence of pathogens in the gastrointestinal tract.&lt;/li&gt;&lt;li&gt;âž¤ anti-motility drugs&lt;/li&gt;&lt;li&gt;âž¤ effective&lt;/li&gt;&lt;li&gt;âž¤ non-infective diarrhea,&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ treating infective diarrhea&lt;/li&gt;&lt;li&gt;âž¤ risk&lt;/li&gt;&lt;li&gt;âž¤ presence of pathogens&lt;/li&gt;&lt;li&gt;âž¤ gastrointestinal tract.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;False statement about racecadotril is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is a pro-drug that is converted to peripherally acting enkephalinase inhibitor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is a drug used in treatment of constipation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is metabolized by liver&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It has anti- secretory action in GIT&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It is a drug used in treatment of constipation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) It is drug used in constipation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. It is a pro-drug that is converted to peripherally acting enkephalinase inhibitor: Correct , racecadotril is a pro-drug that is metabolized into thiorphan , which acts peripherally to inhibit enkephalinase , thus prolonging the action of naturally occurring opioids that decrease gut motility.&lt;/li&gt;&lt;li&gt;â€¢ Option A. It is a pro-drug that is converted to peripherally acting enkephalinase inhibitor:&lt;/li&gt;&lt;li&gt;â€¢ Correct&lt;/li&gt;&lt;li&gt;â€¢ racecadotril&lt;/li&gt;&lt;li&gt;â€¢ pro-drug&lt;/li&gt;&lt;li&gt;â€¢ metabolized into thiorphan&lt;/li&gt;&lt;li&gt;â€¢ peripherally&lt;/li&gt;&lt;li&gt;â€¢ inhibit enkephalinase&lt;/li&gt;&lt;li&gt;â€¢ prolonging the action&lt;/li&gt;&lt;li&gt;â€¢ naturally occurring&lt;/li&gt;&lt;li&gt;â€¢ opioids&lt;/li&gt;&lt;li&gt;â€¢ decrease gut motility.&lt;/li&gt;&lt;li&gt;â€¢ Option C. It is metabolized by liver: Correct, racecadotril undergoes metabolic processes in the liver, converting it into its active form.&lt;/li&gt;&lt;li&gt;â€¢ Option C. It is metabolized by liver:&lt;/li&gt;&lt;li&gt;â€¢ Correct, racecadotril&lt;/li&gt;&lt;li&gt;â€¢ metabolic&lt;/li&gt;&lt;li&gt;â€¢ liver,&lt;/li&gt;&lt;li&gt;â€¢ its active&lt;/li&gt;&lt;li&gt;â€¢ form.&lt;/li&gt;&lt;li&gt;â€¢ Option D. It has anti-secretory action in GIT: Correct, by inhibiting the breakdown of enkephalins, racecadotril enhances their natural anti-secretory effects in the gastrointestinal tract, which is beneficial in treating diarrhea.&lt;/li&gt;&lt;li&gt;â€¢ Option D. It has anti-secretory action in GIT:&lt;/li&gt;&lt;li&gt;â€¢ Correct,&lt;/li&gt;&lt;li&gt;â€¢ inhibiting the breakdown of enkephalins,&lt;/li&gt;&lt;li&gt;â€¢ racecadotril&lt;/li&gt;&lt;li&gt;â€¢ natural&lt;/li&gt;&lt;li&gt;â€¢ anti-secretory effects in the gastrointestinal tract,&lt;/li&gt;&lt;li&gt;â€¢ beneficial&lt;/li&gt;&lt;li&gt;â€¢ treating diarrhea.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Racecadotril is indicated for the treatment of acute diarrhea and works by reducing gastrointestinal secretion; it is not used for constipation and indeed would be contraindicated in such cases.&lt;/li&gt;&lt;li&gt;âž¤ Racecadotril&lt;/li&gt;&lt;li&gt;âž¤ indicated&lt;/li&gt;&lt;li&gt;âž¤ acute diarrhea&lt;/li&gt;&lt;li&gt;âž¤ reducing gastrointestinal secretion;&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ constipation&lt;/li&gt;&lt;li&gt;âž¤ indeed&lt;/li&gt;&lt;li&gt;âž¤ contraindicated&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Racecadotril is used for?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic diarrhea&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute secretory diarrhea&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chronic constipation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diabetic gastroparesis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Acute secretory diarrhea&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Acute secretory diarrhea&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic diarrhea: Incorrect because Racecadotril is not used for chronic diarrhea conditions as its effects are more suited to acute cases.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic diarrhea:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Racecadotril&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ chronic diarrhea&lt;/li&gt;&lt;li&gt;â€¢ acute cases.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chronic constipation: Incorrect as Racecadotril&#x27;s mechanism of reducing fluid secretion would be detrimental in constipation , potentially worsening the condition.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chronic constipation:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Racecadotril&#x27;s&lt;/li&gt;&lt;li&gt;â€¢ reducing fluid secretion&lt;/li&gt;&lt;li&gt;â€¢ detrimental in&lt;/li&gt;&lt;li&gt;â€¢ constipation&lt;/li&gt;&lt;li&gt;â€¢ worsening the condition.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Diabetic gastroparesis: Incorrect because Racecadotril does not affect gastric emptying or motility , which are the primary concerns in diabetic gastroparesis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Diabetic gastroparesis:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Racecadotril&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ gastric emptying or motility&lt;/li&gt;&lt;li&gt;â€¢ diabetic gastroparesis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Racecadotril is specifically used for acute secretory diarrhea due to its ability to reduce fluid secretion in the gut , thereby decreasing stool output without significantly affecting intestinal motility.&lt;/li&gt;&lt;li&gt;âž¤ Racecadotril&lt;/li&gt;&lt;li&gt;âž¤ used for acute secretory diarrhea&lt;/li&gt;&lt;li&gt;âž¤ ability to reduce fluid secretion&lt;/li&gt;&lt;li&gt;âž¤ gut&lt;/li&gt;&lt;li&gt;âž¤ decreasing stool output&lt;/li&gt;&lt;li&gt;âž¤ without&lt;/li&gt;&lt;li&gt;âž¤ intestinal motility.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Most important mechanism of action for antiemetic property of metoclopramide is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;5-HT3 antagonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;D2-antagonist&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;5-HT4 agonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;M3-antagonist&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. D2-antagonist&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/03/screenshot-2024-05-03-104212.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) D2-antagonist&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. 5-HT3 antagonist: Incorrect because while 5-HT3 antagonists are indeed used as antiemetics, metoclopramide does not act through this mechanism. Drugs like ondansetron are typical examples of 5-HT3 antagonists.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 5-HT3 antagonist: Incorrect because while 5-HT3 antagonists are indeed used as antiemetics, metoclopramide does not act through this mechanism. Drugs like ondansetron are typical examples of 5-HT3 antagonists.&lt;/li&gt;&lt;li&gt;â€¢ Option C. 5-HT4 agonist: Incorrect as metoclopramide does have some agonistic action at 5-HT4 receptors which promotes gastric emptying, but this is not the primary mechanism responsible for its antiemetic effects.&lt;/li&gt;&lt;li&gt;â€¢ Option C. 5-HT4 agonist: Incorrect&lt;/li&gt;&lt;li&gt;â€¢ metoclopramide&lt;/li&gt;&lt;li&gt;â€¢ agonistic action at 5-HT4 receptors&lt;/li&gt;&lt;li&gt;â€¢ promotes&lt;/li&gt;&lt;li&gt;â€¢ gastric&lt;/li&gt;&lt;li&gt;â€¢ emptying,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ antiemetic effects.&lt;/li&gt;&lt;li&gt;â€¢ Option D. M3-antagonist: Incorrect because metoclopramide does not function as an M3 muscarinic antagonist . Antimuscarinics like scopolamine work by this mechanism for their antiemetic effects, which is different from how metoclopramide operates.&lt;/li&gt;&lt;li&gt;â€¢ Option D. M3-antagonist: Incorrect&lt;/li&gt;&lt;li&gt;â€¢ metoclopramide does not&lt;/li&gt;&lt;li&gt;â€¢ M3 muscarinic antagonist&lt;/li&gt;&lt;li&gt;â€¢ Antimuscarinics&lt;/li&gt;&lt;li&gt;â€¢ scopolamine&lt;/li&gt;&lt;li&gt;â€¢ mechanism&lt;/li&gt;&lt;li&gt;â€¢ antiemetic effects,&lt;/li&gt;&lt;li&gt;â€¢ metoclopramide operates.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Anti-emetics&lt;/li&gt;&lt;li&gt;âž¤ Anti-emetics&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are going on a trip to a hill station with a friend who developed nausea and vomiting while travelling in the hills previously. Which of the following measure can be taken to prevent such an episode this time?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Diphenhydramine one hour before the trip&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Scopolamine patch one night before the trip&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ranitidine one night and one hour before the trip&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pantoprazole-one hour before the trip&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Scopolamine patch one night before the trip&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Scopolamine patch one night before the trip&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Diphenhydramine one hour before the trip: Incorrect as diphenhydramine, while also used to treat motion sickness due to its antihistaminic properties, is generally considered less effective than scopolamine. It also has sedative effects , which can be undesirable for some travelers.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Diphenhydramine one hour before the trip:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ diphenhydramine,&lt;/li&gt;&lt;li&gt;â€¢ used to treat motion sickness&lt;/li&gt;&lt;li&gt;â€¢ antihistaminic properties,&lt;/li&gt;&lt;li&gt;â€¢ less effective&lt;/li&gt;&lt;li&gt;â€¢ sedative effects&lt;/li&gt;&lt;li&gt;â€¢ undesirable&lt;/li&gt;&lt;li&gt;â€¢ some travelers.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ranitidine one night and one hour before the trip: Incorrect because Ranitidine is an H2 receptor antagonist primarily used for reducing gastric acid and does not have antiemetic properties effective against motion sickness.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ranitidine one night and one hour before the trip:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ H2 receptor antagonist&lt;/li&gt;&lt;li&gt;â€¢ reducing gastric acid&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ antiemetic&lt;/li&gt;&lt;li&gt;â€¢ motion sickness.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pantoprazole one hour before the trip: Incorrect as Pantoprazole , a proton pump inhibitor, reduces stomach acid production but does not prevent nausea and vomiting due to motion sickness.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pantoprazole one hour before the trip:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Pantoprazole&lt;/li&gt;&lt;li&gt;â€¢ proton pump inhibitor,&lt;/li&gt;&lt;li&gt;â€¢ reduces&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ nausea and vomiting&lt;/li&gt;&lt;li&gt;â€¢ motion sickness.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Scopolamine patch is a very effective preventive measure against motion sickness due to its muscarinic antagonist properties and should be applied 12 hours before travel to ensure efficacy.&lt;/li&gt;&lt;li&gt;âž¤ Scopolamine patch&lt;/li&gt;&lt;li&gt;âž¤ very effective&lt;/li&gt;&lt;li&gt;âž¤ against motion sickness&lt;/li&gt;&lt;li&gt;âž¤ muscarinic antagonist properties&lt;/li&gt;&lt;li&gt;âž¤ 12 hours before travel&lt;/li&gt;&lt;li&gt;âž¤ efficacy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;On a trip, 4 hours after having lunch at a restaurant, your friend develops diarrhea, and had 5 loose stools. There are signs of minimal dehydration. What should be your management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Buy ORS and give after preparing according to instructions.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ORS and antibiotics, both tinidazole and ofloxacin.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Give only ofloxacin because tinidazole is not required as Giardia will not cause diarrhea within 4 hours.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Go to a hospital as he needs to be shown immediately, as night is approaching.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Buy ORS and give after preparing according to instructions.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Buy ORS and give after preparing according to instructions&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. ORS and antibiotics, both tinidazole and ofloxacin: Incorrect because antibiotics are not recommended without a specific diagnosis that indicates a bacterial infection, and their unnecessary use can lead to resistance and other complications. Furthermore, antibiotics are not effective against viruses or non-bacterial agents that might cause diarrhea.&lt;/li&gt;&lt;li&gt;â€¢ Option B. ORS and antibiotics, both tinidazole and ofloxacin:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ antibiotics&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ without&lt;/li&gt;&lt;li&gt;â€¢ specific&lt;/li&gt;&lt;li&gt;â€¢ diagnosis&lt;/li&gt;&lt;li&gt;â€¢ indicates a bacterial infection,&lt;/li&gt;&lt;li&gt;â€¢ unnecessary use&lt;/li&gt;&lt;li&gt;â€¢ resistance and other complications.&lt;/li&gt;&lt;li&gt;â€¢ antibiotics&lt;/li&gt;&lt;li&gt;â€¢ not effective against viruses&lt;/li&gt;&lt;li&gt;â€¢ non-bacterial agents&lt;/li&gt;&lt;li&gt;â€¢ diarrhea.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Give only ofloxacin because tinidazole is not required as Giardia will not cause diarrhea within 4 hours: Incorrect as this assumes a specific diagnosis without evidence , and the use of antibiotics like ofloxacin should be guided by a medical professional following appropriate tests.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Give only ofloxacin because tinidazole is not required as Giardia will not cause diarrhea within 4 hours:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ specific diagnosis without evidence&lt;/li&gt;&lt;li&gt;â€¢ use of antibiotics&lt;/li&gt;&lt;li&gt;â€¢ ofloxacin&lt;/li&gt;&lt;li&gt;â€¢ guided by a medical professional following appropriate tests.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Go to a hospital as he needs to be shown immediately, as night is approaching: Not necessary at this stage as the symptoms are mild and manageable with ORS. Hospital visits are advised if symptoms escalate or if there are signs of severe dehydration or other complications .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Go to a hospital as he needs to be shown immediately, as night is approaching:&lt;/li&gt;&lt;li&gt;â€¢ Not&lt;/li&gt;&lt;li&gt;â€¢ symptoms are mild and manageable with ORS.&lt;/li&gt;&lt;li&gt;â€¢ Hospital visits&lt;/li&gt;&lt;li&gt;â€¢ symptoms escalate&lt;/li&gt;&lt;li&gt;â€¢ dehydration or other complications&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ ORS is the first line of management for mild cases of diarrhea with minimal dehydration . It&#x27;s effective, safe, and does not contribute to antibiotic resistance.&lt;/li&gt;&lt;li&gt;âž¤ ORS&lt;/li&gt;&lt;li&gt;âž¤ first line of management for mild cases of diarrhea&lt;/li&gt;&lt;li&gt;âž¤ minimal dehydration&lt;/li&gt;&lt;li&gt;âž¤ effective, safe,&lt;/li&gt;&lt;li&gt;âž¤ does not&lt;/li&gt;&lt;li&gt;âž¤ antibiotic resistance.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is a Guanylate Cyclase C agonist used in irritable bowel syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lubiprostine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Linaclotide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tegaserod&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Methyl naltrexone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Linaclotide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/03/screenshot-2024-05-03-105608.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Linaclotide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lubiprostone: Incorrect because Lubiprostone works by activating chloride channels rather than acting as a guanylate Cyclase-C agonist. It is used primarily for treating chronic idiopathic constipation and IBS-C but via a different mechanism.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lubiprostone:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Lubiprostone&lt;/li&gt;&lt;li&gt;â€¢ activating chloride channels&lt;/li&gt;&lt;li&gt;â€¢ acting as a guanylate&lt;/li&gt;&lt;li&gt;â€¢ Cyclase-C agonist.&lt;/li&gt;&lt;li&gt;â€¢ used&lt;/li&gt;&lt;li&gt;â€¢ treating chronic idiopathic constipation&lt;/li&gt;&lt;li&gt;â€¢ IBS-C&lt;/li&gt;&lt;li&gt;â€¢ Option C. Tegaserod: Incorrect as Tegaserod is a 5-HT4 receptor agonist, not a guanylate Cyclase-C agonist. Itâ€™s used to treat IBS-C in women by enhancing peristaltic reflex and bowel motility.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Tegaserod:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ 5-HT4 receptor agonist, not&lt;/li&gt;&lt;li&gt;â€¢ guanylate Cyclase-C agonist.&lt;/li&gt;&lt;li&gt;â€¢ used&lt;/li&gt;&lt;li&gt;â€¢ IBS-C&lt;/li&gt;&lt;li&gt;â€¢ enhancing peristaltic reflex and bowel motility.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Methyl naltrexone: Incorrect because Methyl naltrexone is a peripheral opioid receptor antagonist used specifically for opioid-induced constipation , acting by blocking the effects of opioids in the gut without affecting the central nervous system.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Methyl naltrexone:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Methyl naltrexone&lt;/li&gt;&lt;li&gt;â€¢ peripheral opioid receptor antagonist&lt;/li&gt;&lt;li&gt;â€¢ opioid-induced constipation&lt;/li&gt;&lt;li&gt;â€¢ blocking the effects of opioids&lt;/li&gt;&lt;li&gt;â€¢ without&lt;/li&gt;&lt;li&gt;â€¢ central nervous system.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Lubiprostone is a?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chloride channel activator&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chloride channel inhibitor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sodium channel activator&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sodium channel inhibitor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Chloride channel activator&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/03/screenshot-2024-05-03-110054.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Chloride channel activator&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chloride channel inhibitor: Incorrect as Lubiprostone does the opposite by activating, not inhibiting, chloride channels.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chloride channel inhibitor:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Lubiprostone&lt;/li&gt;&lt;li&gt;â€¢ opposite by activating,&lt;/li&gt;&lt;li&gt;â€¢ not inhibiting,&lt;/li&gt;&lt;li&gt;â€¢ chloride channels.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sodium channel activator: Incorrect because Lubiprostone does not affect sodium channels ; its action is specific to chloride channels.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sodium channel activator:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Lubiprostone does not&lt;/li&gt;&lt;li&gt;â€¢ sodium channels&lt;/li&gt;&lt;li&gt;â€¢ specific to&lt;/li&gt;&lt;li&gt;â€¢ chloride channels.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sodium channel inhibitor: Incorrect as Lubiprostone has no activity on sodium channels , either as an activator or inhibitor.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sodium channel inhibitor:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Lubiprostone&lt;/li&gt;&lt;li&gt;â€¢ no activity&lt;/li&gt;&lt;li&gt;â€¢ sodium channels&lt;/li&gt;&lt;li&gt;â€¢ either as an activator or&lt;/li&gt;&lt;li&gt;â€¢ inhibitor.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is an antagonist of a peptide and is used to reduce chemotherapy induced nausea and vomiting?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atrial natriuretic peptide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aprepitant&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bradykinin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Enalapril&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Aprepitant&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Aprepitant&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atrial natriuretic peptide: Incorrect as this peptide is involved in the regulation of blood pressure and fluid balance, not in the treatment of nausea or vomiting.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atrial natriuretic peptide:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ peptide&lt;/li&gt;&lt;li&gt;â€¢ regulation of blood pressure and fluid balance,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ nausea or vomiting.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bradykinin: Incorrect because Bradykinin is a peptide that plays a role in inflammation and blood pressure regulation , not directly in the control of nausea or vomiting.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bradykinin:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Bradykinin is a peptide&lt;/li&gt;&lt;li&gt;â€¢ inflammation and blood pressure&lt;/li&gt;&lt;li&gt;â€¢ regulation&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ control of nausea or vomiting.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Enalapril: Incorrect as Enalapril is an ACE inhibitor used primarily to treat high blood pressure and heart failure, and has no role in managing chemotherapy-induced nausea and vomiting.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Enalapril:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Enalapril&lt;/li&gt;&lt;li&gt;â€¢ is&lt;/li&gt;&lt;li&gt;â€¢ ACE inhibitor&lt;/li&gt;&lt;li&gt;â€¢ high blood pressure&lt;/li&gt;&lt;li&gt;â€¢ heart failure,&lt;/li&gt;&lt;li&gt;â€¢ no&lt;/li&gt;&lt;li&gt;â€¢ chemotherapy-induced nausea and vomiting.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Aprepitant is an NK1 receptor antagonist used specifically to prevent chemotherapy-induced nausea and vomiting by blocking the action of substance P.&lt;/li&gt;&lt;li&gt;âž¤ Aprepitant&lt;/li&gt;&lt;li&gt;âž¤ NK1 receptor antagonist&lt;/li&gt;&lt;li&gt;âž¤ prevent chemotherapy-induced nausea and vomiting&lt;/li&gt;&lt;li&gt;âž¤ blocking the&lt;/li&gt;&lt;li&gt;âž¤ action of substance P.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Drug used in irritable bowel syndrome with constipation is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lubiprostone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Loperamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alosetron&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Clonidine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Lubiprostone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/03/screenshot-2024-05-03-111701.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Lubiprostone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Loperamide: Incorrect because Loperamide is primarily an anti-diarrheal medication, used to treat irritable bowel syndrome with diarrhea (IBS-D) due to its action as a Âµ-opioid receptor agonist, which decreases intestinal motility.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Loperamide:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Loperamide&lt;/li&gt;&lt;li&gt;â€¢ anti-diarrheal medication,&lt;/li&gt;&lt;li&gt;â€¢ treat irritable bowel&lt;/li&gt;&lt;li&gt;â€¢ syndrome with diarrhea (IBS-D)&lt;/li&gt;&lt;li&gt;â€¢ Âµ-opioid receptor agonist,&lt;/li&gt;&lt;li&gt;â€¢ decreases intestinal motility.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Alosetron: Incorrect as Alosetron is a 5-HT3 receptor antagonist used specifically for IBS with predominant diarrhea (IBS-D), where it helps by reducing visceral pain and slowing colonic transit.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Alosetron:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Alosetron is a 5-HT3 receptor antagonist&lt;/li&gt;&lt;li&gt;â€¢ IBS&lt;/li&gt;&lt;li&gt;â€¢ predominant diarrhea&lt;/li&gt;&lt;li&gt;â€¢ (IBS-D),&lt;/li&gt;&lt;li&gt;â€¢ reducing visceral pain&lt;/li&gt;&lt;li&gt;â€¢ slowing colonic transit.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Clonidine: Incorrect because Clonidine is an alpha-2 agonist used mainly in the management of hypertension and not typically for BSI . It has some applications in diabetic diarrhea , but not in IBS with constipation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Clonidine:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Clonidine&lt;/li&gt;&lt;li&gt;â€¢ alpha-2 agonist&lt;/li&gt;&lt;li&gt;â€¢ management of hypertension&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ BSI&lt;/li&gt;&lt;li&gt;â€¢ diabetic diarrhea&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ IBS with constipation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which is not an osmotic laxative?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sorbitol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Magnesium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Polyethylene glycol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bisacodyl&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Bisacodyl&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/03/screenshot-2024-05-03-112100.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Bisacodyl&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sorbitol: Incorrect as Sorbitol is an osmotic laxative that works by drawing water into the large intestine, increasing the water content in stools , which makes them easier to pass.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sorbitol:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Sorbitol&lt;/li&gt;&lt;li&gt;â€¢ osmotic laxative&lt;/li&gt;&lt;li&gt;â€¢ drawing water into the large intestine,&lt;/li&gt;&lt;li&gt;â€¢ increasing&lt;/li&gt;&lt;li&gt;â€¢ water content in stools&lt;/li&gt;&lt;li&gt;â€¢ easier to pass.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Magnesium (e.g., magnesium citrate): Incorrect because magnesium compounds are osmotic laxatives . They increase the amount of water in the intestines , primarily through osmosis, which softens the stool and naturally stimulates bowel movement.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Magnesium (e.g., magnesium citrate):&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ magnesium compounds&lt;/li&gt;&lt;li&gt;â€¢ osmotic laxatives&lt;/li&gt;&lt;li&gt;â€¢ increase&lt;/li&gt;&lt;li&gt;â€¢ amount of water in the intestines&lt;/li&gt;&lt;li&gt;â€¢ osmosis,&lt;/li&gt;&lt;li&gt;â€¢ softens the stool&lt;/li&gt;&lt;li&gt;â€¢ naturally stimulates bowel movement.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Polyethylene glycol: Incorrect as it is an osmotic laxative known for its ability to retain water in the stool, which results in softer stools and promotes regular bowel movements.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Polyethylene glycol:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ osmotic laxative&lt;/li&gt;&lt;li&gt;â€¢ ability to retain water in the stool,&lt;/li&gt;&lt;li&gt;â€¢ softer stools&lt;/li&gt;&lt;li&gt;â€¢ promotes regular bowel movements.&lt;/li&gt;&lt;li&gt;â€¢ Educational Objectiv:&lt;/li&gt;&lt;li&gt;â€¢ Educational Objectiv:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Pirenzepine is used for:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gastric ulcer&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glaucoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypertension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Congestive cardiac failure&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Gastric ulcer&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Gastric ulcer&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Glaucoma : Incorrect as Pirenzepine is not used to treat glaucoma. While muscarinic antagonists can affect eye conditions, pirenzepineâ€™s specific action on gastric secretions does not extend to intraocular pressure control.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Glaucoma&lt;/li&gt;&lt;li&gt;â€¢ : Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Pirenzepine&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ treat glaucoma.&lt;/li&gt;&lt;li&gt;â€¢ muscarinic antagonists&lt;/li&gt;&lt;li&gt;â€¢ eye conditions, pirenzepineâ€™s&lt;/li&gt;&lt;li&gt;â€¢ gastric secretions does not&lt;/li&gt;&lt;li&gt;â€¢ intraocular pressure control.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hypertension: Incorrect because Pirenzepine does not play a role in the management of blood pressure. Its pharmacological effects are confined to the digestive system.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hypertension:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Pirenzepine does not&lt;/li&gt;&lt;li&gt;â€¢ blood pressure.&lt;/li&gt;&lt;li&gt;â€¢ pharmacological effects&lt;/li&gt;&lt;li&gt;â€¢ digestive system.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Congestive cardiac failure: Incorrect as Pirenzepine is not indicated for heart conditions like congestive cardiac failure . Its primary mechanism of action does not influence cardiac function or fluid management.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Congestive cardiac failure:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Pirenzepine&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ heart conditions&lt;/li&gt;&lt;li&gt;â€¢ congestive cardiac failure&lt;/li&gt;&lt;li&gt;â€¢ primary mechanism of action does not&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pirenzepine is utilized in the management of gastric and duodenal ulcers due to its ability to selectively block M1 muscarinic receptors in the stomach, reducing gastric acid secretion which is beneficial for treating peptic ulcers.&lt;/li&gt;&lt;li&gt;âž¤ Pirenzepine&lt;/li&gt;&lt;li&gt;âž¤ gastric and duodenal ulcers&lt;/li&gt;&lt;li&gt;âž¤ its ability to selectively block M1 muscarinic receptors&lt;/li&gt;&lt;li&gt;âž¤ reducing gastric acid secretion&lt;/li&gt;&lt;li&gt;âž¤ beneficial&lt;/li&gt;&lt;li&gt;âž¤ peptic ulcers.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the drug of choice for treatment of chemotherapy-induced vomiting?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Granisetron&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prazosin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Clonidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dimenhydrinate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Granisetron&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Granisetron&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prazosin: Incorrect because Prazosin is an alpha-1 blocker used primarily for managing hypertension and benign prostatic hyperplasia, not for vomiting.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prazosin:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Clonidine: Incorrect as Clonidine is an alpha-2 agonist, used mainly for hypertension, ADHD, and anxiety disorders, and does not have a primary role in controlling chemotherapy-induced vomiting.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Clonidine:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Dimenhydrinate: Incorrect because Dimenhydrinate, an antihistamine, is primarily used for motion sickness and vertigo. While it can treat nausea and vomiting, it is not the drug of choice for chemotherapy-induced vomiting.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Dimenhydrinate:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Granisetron is the drug of choice for managing chemotherapy-induced vomiting due to its effective inhibition of 5-HT3 receptors, critical in blocking the emetic pathway triggered by chemotherapy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the mechanism of action of teduglutide in short bowel syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;GLP-2 analog&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;5HT-1B/1D Agonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;GLP-1 analogs&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;C-peptide analogs&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. GLP-2 analog&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) GLP-2 analog&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. 5HT-1B/1D Agonist: Incorrect because 5HT-1B/1D agonists, such as triptans, are primarily used for migraine relief through vasoconstriction and inhibition of CGRP release, not for treating intestinal issues.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 5HT-1B/1D Agonist:&lt;/li&gt;&lt;li&gt;â€¢ Option C. GLP-1 analogs: Incorrect as GLP-1 analogs like exenatide and liraglutide are used in diabetes management due to their effects on insulin secretion and appetite suppression, rather than intestinal growth or nutrient absorption.&lt;/li&gt;&lt;li&gt;â€¢ Option C. GLP-1 analogs:&lt;/li&gt;&lt;li&gt;â€¢ Option D. C-peptide analogs: Incorrect because C-peptide analogs relate to insulin processing and are not used for treating conditions like short bowel syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option D. C-peptide analogs:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Teduglutide acts as a GLP-2 analog, which is critical for promoting intestinal growth and enhancing the absorptive functions of the gut, making it effective in managing short bowel syndrome.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient present with chronic diarrhea and is prescribed an anti-diarrheal medication. Which of the following drugs acts by inhibiting 5-HT and is used specifically for irritable bowel syndrome with diarrhea (IBS-D)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alosetron&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Clozapine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tegaserod&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mosapride&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Alosetron&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Alosetron&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Clozapine: Incorrect because Clozapine is an atypical antipsychotic primarily used for the treatment of schizophrenia and is not used for treating diarrhea or IBS.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Clozapine:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ atypical antipsychotic&lt;/li&gt;&lt;li&gt;â€¢ schizophrenia and&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ treating diarrhea or IBS.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Tegaserod: Incorrect as Tegaserod is a 5-HT4 receptor partial agonist, primarily used for the treatment of constipation-predominant irritable bowel syndrome (IBS-C) , not diarrhea.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Tegaserod:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Tegaserod&lt;/li&gt;&lt;li&gt;â€¢ 5-HT4 receptor partial agonist,&lt;/li&gt;&lt;li&gt;â€¢ used for the treatment&lt;/li&gt;&lt;li&gt;â€¢ constipation-predominant irritable bowel syndrome (IBS-C)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Mosapride: Incorrect because Mosapride is a 5-HT4 agonist used to enhance gastrointestinal motility , commonly prescribed for conditions like GERD and functional dyspepsia, but not specifically for IBS-D.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Mosapride:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Mosapride is a 5-HT4 agonist&lt;/li&gt;&lt;li&gt;â€¢ gastrointestinal motility&lt;/li&gt;&lt;li&gt;â€¢ GERD&lt;/li&gt;&lt;li&gt;â€¢ functional dyspepsia,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Alosetron&lt;/li&gt;&lt;li&gt;âž¤ Alosetron&lt;/li&gt;&lt;li&gt;âž¤ It is approved for the treatment of diarrhea predominant lBS in women. It is more potent antagonist of the 5-HT3 receptor than ondansetron. It shows significant improvements in abdominal pain as well as stool frequency, consistency and urgency in lBS patients. It also diminishes visceral sensitivity and slow colonic transit. Its major adverse effect is high incidence of development of ischemic colitis.&lt;/li&gt;&lt;li&gt;âž¤ It is approved for the treatment of diarrhea predominant lBS in women.&lt;/li&gt;&lt;li&gt;âž¤ treatment of diarrhea predominant lBS in women.&lt;/li&gt;&lt;li&gt;âž¤ It is more potent antagonist of the 5-HT3 receptor than ondansetron.&lt;/li&gt;&lt;li&gt;âž¤ antagonist of the 5-HT3 receptor&lt;/li&gt;&lt;li&gt;âž¤ It shows significant improvements in abdominal pain as well as stool frequency, consistency and urgency in lBS patients.&lt;/li&gt;&lt;li&gt;âž¤ improvements&lt;/li&gt;&lt;li&gt;âž¤ abdominal pain&lt;/li&gt;&lt;li&gt;âž¤ stool frequency,&lt;/li&gt;&lt;li&gt;âž¤ consistency&lt;/li&gt;&lt;li&gt;âž¤ urgency&lt;/li&gt;&lt;li&gt;âž¤ It also diminishes visceral sensitivity and slow colonic transit.&lt;/li&gt;&lt;li&gt;âž¤ diminishes&lt;/li&gt;&lt;li&gt;âž¤ visceral sensitivity&lt;/li&gt;&lt;li&gt;âž¤ slow colonic transit.&lt;/li&gt;&lt;li&gt;âž¤ Its major adverse effect is high incidence of development of ischemic colitis.&lt;/li&gt;&lt;li&gt;âž¤ major adverse effect&lt;/li&gt;&lt;li&gt;âž¤ high&lt;/li&gt;&lt;li&gt;âž¤ ischemic colitis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the incorrect statement regarding proton pump inhibitors:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Available as enteric coated tablets&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acts from the luminal side of gastric parietal cells&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inactive at neutral pH&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Should be taken on empty stomach&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Acts from the luminal side of gastric parietal cells&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Acts from the luminal side of gastric parietal cells&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Available as enteric coated tablets: This statement is correct . All PPIs are administered orally in enteric coated form to protect them from molecular transformation in the acidic gastric juice.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Available as enteric coated tablets:&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ PPIs&lt;/li&gt;&lt;li&gt;â€¢ orally&lt;/li&gt;&lt;li&gt;â€¢ enteric coated form&lt;/li&gt;&lt;li&gt;â€¢ protect&lt;/li&gt;&lt;li&gt;â€¢ from molecular transformation in the acidic gastric juice.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Inactive at neutral pH: This statement is correct. Omeprazole is inactive at neutral pH , but at pH less than 5, it rearranges to two charged cationic forms (a sulphenic acid and a sulphenamide configurations ) that react covalently with SH groups of the H+K+ATPase enzyme and inactivate it irreversibly.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Inactive at neutral pH:&lt;/li&gt;&lt;li&gt;â€¢ correct.&lt;/li&gt;&lt;li&gt;â€¢ inactive&lt;/li&gt;&lt;li&gt;â€¢ neutral pH&lt;/li&gt;&lt;li&gt;â€¢ pH less than 5,&lt;/li&gt;&lt;li&gt;â€¢ two charged cationic forms&lt;/li&gt;&lt;li&gt;â€¢ sulphenic acid&lt;/li&gt;&lt;li&gt;â€¢ sulphenamide configurations&lt;/li&gt;&lt;li&gt;â€¢ covalently with SH groups&lt;/li&gt;&lt;li&gt;â€¢ H+K+ATPase enzyme&lt;/li&gt;&lt;li&gt;â€¢ inactivate it irreversibly.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Should be taken on an empty stomach: This statement is correct. Bioavailability of a ll PPIs is reduced by food; they should be taken on an empty stomach, followed 1 hour later by a meal to activate the H+K+ ATPase and make it more susceptible to the PPI.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Should be taken on an empty stomach:&lt;/li&gt;&lt;li&gt;â€¢ correct.&lt;/li&gt;&lt;li&gt;â€¢ Bioavailability&lt;/li&gt;&lt;li&gt;â€¢ ll PPIs is reduced&lt;/li&gt;&lt;li&gt;â€¢ food;&lt;/li&gt;&lt;li&gt;â€¢ empty stomach,&lt;/li&gt;&lt;li&gt;â€¢ 1 hour later&lt;/li&gt;&lt;li&gt;â€¢ activate the H+K+ ATPase&lt;/li&gt;&lt;li&gt;â€¢ more susceptible to&lt;/li&gt;&lt;li&gt;â€¢ the PPI.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Proton pump inhibitors should be administered on an empty stomach to ensure maximum absorption and effectiveness . This should be followed by a meal an hour later to enhance the activation of gastric acid pumps, making them more susceptible to inhibition by the drug.&lt;/li&gt;&lt;li&gt;âž¤ Proton pump inhibitors&lt;/li&gt;&lt;li&gt;âž¤ administered on an empty stomach&lt;/li&gt;&lt;li&gt;âž¤ maximum absorption and effectiveness&lt;/li&gt;&lt;li&gt;âž¤ a meal an hour later to enhance the activation of gastric acid pumps,&lt;/li&gt;&lt;li&gt;âž¤ more susceptible&lt;/li&gt;&lt;li&gt;âž¤ inhibition by the drug.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs are not included in triple drug regimen for H. pylori associated peptic ulcer disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;PPI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amoxicillin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tetracycline&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Clarithromycin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Tetracycline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/03/screenshot-2024-05-03-114045.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Tetracycline&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. PPI: Incorrect because proton pump inhibitors (such as Lansoprazole) are a crucial component of the triple therapy regimen, aiding in reducing gastric acid secretion to create a less acidic environment which enhances the effectiveness of antibiotics .&lt;/li&gt;&lt;li&gt;â€¢ Option A. PPI:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ proton pump inhibitors (such as Lansoprazole)&lt;/li&gt;&lt;li&gt;â€¢ triple therapy&lt;/li&gt;&lt;li&gt;â€¢ reducing gastric acid secretion&lt;/li&gt;&lt;li&gt;â€¢ less acidic environment&lt;/li&gt;&lt;li&gt;â€¢ effectiveness of antibiotics&lt;/li&gt;&lt;li&gt;â€¢ Option B. Amoxicillin: Incorrect as Amoxicillin is one of the antibiotics recommended in the triple therapy , working by inhibiting the cell wall synthesis of H. pylori bacteria.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Amoxicillin:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ one of the antibiotics&lt;/li&gt;&lt;li&gt;â€¢ triple therapy&lt;/li&gt;&lt;li&gt;â€¢ inhibiting the&lt;/li&gt;&lt;li&gt;â€¢ cell wall synthesis&lt;/li&gt;&lt;li&gt;â€¢ H. pylori bacteria.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Clarithromycin: Incorrect because Clarithromycin is included in the regimen and works by inhibiting protein synthesis of H. pylori , effectively helping in its eradication.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Clarithromycin:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Clarithromycin&lt;/li&gt;&lt;li&gt;â€¢ inhibiting protein synthesis of H. pylori&lt;/li&gt;&lt;li&gt;â€¢ helping&lt;/li&gt;&lt;li&gt;â€¢ eradication.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following best describes the rationale of prucalopride in management of constipation dominant IBS?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;5 HT3 antagonism resulting in decreased stimulation of extrinsic primary afferent neurons&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;5 HT1P antagonism resulting in decreased stimulation of intrinsic primary afferent neurons&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;5 HT4 agonism resulting in increased CGRP release and enhanced motility&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stimulation of type 2 chloride channel in small intestine increasing the volume of luminal contents.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 5 HT4 agonism resulting in increased CGRP release and enhanced motility&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 5 HT4 agonism resulting in increased CGRP release and enhanced motility&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. 5 HT3 antagonism resulting in decreased stimulation of extrinsic primary afferent neurons: Incorrect as 5-HT3 antagonists are primarily used in the management of diarrhea-predominant IBS (IBS-D), where they help by reducing gut motility and fluid secretion.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 5 HT3 antagonism resulting in decreased stimulation of extrinsic primary afferent neurons:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect as 5-HT3&lt;/li&gt;&lt;li&gt;â€¢ antagonists&lt;/li&gt;&lt;li&gt;â€¢ diarrhea-predominant IBS (IBS-D),&lt;/li&gt;&lt;li&gt;â€¢ reducing gut motility&lt;/li&gt;&lt;li&gt;â€¢ and fluid secretion.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 5 HT1P antagonism resulting in decreased stimulation of intrinsic primary afferent neurons: Incorrect because there is no recognized 5-HT1P receptor in current serotonin receptor classification relevant to IBS management.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 5 HT1P antagonism resulting in decreased stimulation of intrinsic primary afferent neurons:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ no&lt;/li&gt;&lt;li&gt;â€¢ 5-HT1P receptor&lt;/li&gt;&lt;li&gt;â€¢ serotonin receptor&lt;/li&gt;&lt;li&gt;â€¢ IBS management.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Stimulation of type 2 chloride channel in small intestine increasing the volume of luminal contents: Incorrect as this describes the action of lubiprostone , not prucalopride. Lubiprostone works by activating type 2 chloride channels , leading to increased intestinal fluid secretion and stool passage.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Stimulation of type 2 chloride channel in small intestine increasing the volume of luminal contents:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ action of lubiprostone&lt;/li&gt;&lt;li&gt;â€¢ Lubiprostone&lt;/li&gt;&lt;li&gt;â€¢ activating type 2 chloride channels&lt;/li&gt;&lt;li&gt;â€¢ increased intestinal fluid secretion and stool passage.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Prucalopride enhances gastrointestinal motility through 5-HT4 agonism, which increases neurotransmitter release, notably CGRP, promoting enhanced peristalsis and improving symptoms of constipation-dominant IBS.&lt;/li&gt;&lt;li&gt;âž¤ Prucalopride&lt;/li&gt;&lt;li&gt;âž¤ gastrointestinal motility through 5-HT4 agonism,&lt;/li&gt;&lt;li&gt;âž¤ increases neurotransmitter&lt;/li&gt;&lt;li&gt;âž¤ CGRP,&lt;/li&gt;&lt;li&gt;âž¤ peristalsis&lt;/li&gt;&lt;li&gt;âž¤ improving&lt;/li&gt;&lt;li&gt;âž¤ constipation-dominant IBS.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 27-year-old woman who is 34 weeks pregnant is on bed rest and visits her obstetrician. During the visit, she informs her physician that she has been experiencing mild constipation. Which of the following medications will most likely be recommended to her?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Castor oil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Docusate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mineral oil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Loperamide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Docusate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Docusate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Castor oil: Incorrect because castor oil is generally not recommended during pregnancy . It can trigger uterine contractions , which may pose risks to the fetus.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Castor oil:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ castor oil&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ pregnancy&lt;/li&gt;&lt;li&gt;â€¢ trigger uterine&lt;/li&gt;&lt;li&gt;â€¢ contractions&lt;/li&gt;&lt;li&gt;â€¢ pose risks to the fetus.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mineral oil: Incorrect as mineral oil is also not recommended during pregnancy . It can decrease the absorption of fat- s oluble vitamins , which are crucial for fetal development.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mineral oil:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ pregnancy&lt;/li&gt;&lt;li&gt;â€¢ decrease the absorption of fat-&lt;/li&gt;&lt;li&gt;â€¢ oluble vitamins&lt;/li&gt;&lt;li&gt;â€¢ crucial for fetal development.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Loperamide: Incorrect because loperamide is an anti-diarrheal medication, not a treatment for constipation. It works by slowing down gut movement, which would be counterproductive in the treatment of constipation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Loperamide:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ loperamide&lt;/li&gt;&lt;li&gt;â€¢ anti-diarrheal medication, not&lt;/li&gt;&lt;li&gt;â€¢ constipation.&lt;/li&gt;&lt;li&gt;â€¢ slowing down gut movement,&lt;/li&gt;&lt;li&gt;â€¢ counterproductive&lt;/li&gt;&lt;li&gt;â€¢ constipation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Docusate is commonly recommended for treating constipation in pregnant women due to its efficacy and safety profile . It helps soften stools without the risks associated with other laxatives like castor oil and mineral oil , which can adversely affect pregnancy.&lt;/li&gt;&lt;li&gt;âž¤ Docusate&lt;/li&gt;&lt;li&gt;âž¤ treating constipation&lt;/li&gt;&lt;li&gt;âž¤ pregnant women&lt;/li&gt;&lt;li&gt;âž¤ its efficacy and safety profile&lt;/li&gt;&lt;li&gt;âž¤ helps&lt;/li&gt;&lt;li&gt;âž¤ soften stools without&lt;/li&gt;&lt;li&gt;âž¤ other laxatives like castor oil and mineral oil&lt;/li&gt;&lt;li&gt;âž¤ pregnancy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An elderly woman with a recent history of myocardial infarction is seeking a medication to help treat her occasional heartburn. She is currently taking several medications, including aspirin, clopidogrel, simvastatin, metoprolol, and lisinopril. Which of the following choices should be avoided in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Calcium citrate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Famotidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Omeprazole&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ranitidine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Omeprazole&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Omeprazole&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Calcium citrate: This option is considered safe for treating heartburn and does not interact adversely with clopidogrel or the other medications the patient is taking.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Calcium citrate:&lt;/li&gt;&lt;li&gt;â€¢ safe for treating heartburn&lt;/li&gt;&lt;li&gt;â€¢ does not interact&lt;/li&gt;&lt;li&gt;â€¢ clopidogrel or&lt;/li&gt;&lt;li&gt;â€¢ other medications&lt;/li&gt;&lt;li&gt;â€¢ Option B. Famotidine: Famotidine is an H2-receptor antagonist and does not interfere with the CYP2C19 enzyme, making it a safe option for this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Famotidine:&lt;/li&gt;&lt;li&gt;â€¢ H2-receptor antagonist&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ CYP2C19 enzyme,&lt;/li&gt;&lt;li&gt;â€¢ safe&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ranitidine: Although ranitidine is also an H2-receptor antagonist, it has been found to be safe in terms of not significantly affecting the metabolism of clopidogrel like omeprazole does. However, due to other concerns such as potential NDMA contamination, ranitidine has been recalled in many markets.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ranitidine:&lt;/li&gt;&lt;li&gt;â€¢ H2-receptor antagonist,&lt;/li&gt;&lt;li&gt;â€¢ safe in terms&lt;/li&gt;&lt;li&gt;â€¢ metabolism of clopidogrel like omeprazole does.&lt;/li&gt;&lt;li&gt;â€¢ potential NDMA&lt;/li&gt;&lt;li&gt;â€¢ contamination,&lt;/li&gt;&lt;li&gt;â€¢ ranitidine&lt;/li&gt;&lt;li&gt;â€¢ recalled in many markets.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While treating heartburn in patients on multiple medications, especially those on clopidogrel post-myocardial infarction, it is important to avoid proton pump inhibitors like omeprazole due to their potential to inhibit CYP2C19 and reduce the effectiveness of clopidogrel , thereby increasing the risk of cardiovascular events.&lt;/li&gt;&lt;li&gt;âž¤ heartburn in patients&lt;/li&gt;&lt;li&gt;âž¤ multiple medications,&lt;/li&gt;&lt;li&gt;âž¤ clopidogrel post-myocardial infarction,&lt;/li&gt;&lt;li&gt;âž¤ avoid proton pump inhibitors&lt;/li&gt;&lt;li&gt;âž¤ omeprazole&lt;/li&gt;&lt;li&gt;âž¤ inhibit CYP2C19&lt;/li&gt;&lt;li&gt;âž¤ reduce&lt;/li&gt;&lt;li&gt;âž¤ clopidogrel&lt;/li&gt;&lt;li&gt;âž¤ increasing the risk of cardiovascular events.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In emergency department, an intern gave an anti-emetic drug to a patient and the patient then developed abnormal posture and torticollis. Most likely drug is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ondansetron&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dexamethasone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metoclopramide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dronabinol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Metoclopramide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Metoclopramide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ondansetron: Incorrect because Ondansetron is a 5-HT3 receptor antagonist that is generally used to prevent nausea and vomiting associated with cancer chemotherapy and surgery and does not typically cause extrapyramidal side effects.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ondansetron:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Ondansetron is a 5-HT3 receptor antagonist&lt;/li&gt;&lt;li&gt;â€¢ used to prevent nausea and&lt;/li&gt;&lt;li&gt;â€¢ vomiting&lt;/li&gt;&lt;li&gt;â€¢ cancer chemotherapy and surgery&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ extrapyramidal side effects.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dexamethasone : Incorrect as Dexamethasone is a corticosteroid used as an antiemetic in chemotherapy s ettings. It works by reducing inflammation and does not cause extrapyramidal symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dexamethasone&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ corticosteroid&lt;/li&gt;&lt;li&gt;â€¢ antiemetic in chemotherapy s&lt;/li&gt;&lt;li&gt;â€¢ reducing inflammation&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ extrapyramidal symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Dronabinol: Incorrect because Dronabinol is a cannabinoid receptor agonist used to treat nausea and vomiting caused by chemotherapy and to stimulate appetite. Its side effects may include dysphoria, dizziness, and ataxia but not dystonia or torticollis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Dronabinol:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Dronabinol&lt;/li&gt;&lt;li&gt;â€¢ cannabinoid receptor agonist&lt;/li&gt;&lt;li&gt;â€¢ nausea and vomiting&lt;/li&gt;&lt;li&gt;â€¢ chemotherapy&lt;/li&gt;&lt;li&gt;â€¢ stimulate appetite.&lt;/li&gt;&lt;li&gt;â€¢ dysphoria, dizziness, and ataxia&lt;/li&gt;&lt;li&gt;â€¢ not dystonia or torticollis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Metoclopramide , while effective as an antiemetic and for promoting gastric motility , can cause extrapyramidal symptoms such as dystonia due to its antagonistic effects on dopamine D2 receptors . These effects are important to monitor, especially in emergency settings.&lt;/li&gt;&lt;li&gt;âž¤ Metoclopramide&lt;/li&gt;&lt;li&gt;âž¤ antiemetic and for promoting gastric motility&lt;/li&gt;&lt;li&gt;âž¤ extrapyramidal&lt;/li&gt;&lt;li&gt;âž¤ dystonia&lt;/li&gt;&lt;li&gt;âž¤ antagonistic effects&lt;/li&gt;&lt;li&gt;âž¤ dopamine&lt;/li&gt;&lt;li&gt;âž¤ D2 receptors&lt;/li&gt;&lt;li&gt;âž¤ important to monitor,&lt;/li&gt;&lt;li&gt;âž¤ emergency&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which one of the following is the CFTR channel inhibitor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Linaclotide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Crofelemer&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alvimopan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prucalopride&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Crofelemer&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Crofelemer&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A.  Linaclotide: Linaclotide is a guanylate cyclase-C agonist used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation . It works by increasing the secretion of chloride and bicarbonate ions in the intestine, leading to increased fluid secretion and accelerated gastrointestinal transit time.&lt;/li&gt;&lt;li&gt;â€¢ Option A.  Linaclotide:&lt;/li&gt;&lt;li&gt;â€¢ guanylate cyclase-C agonist&lt;/li&gt;&lt;li&gt;â€¢ irritable bowel syndrome&lt;/li&gt;&lt;li&gt;â€¢ constipation&lt;/li&gt;&lt;li&gt;â€¢ chronic idiopathic constipation&lt;/li&gt;&lt;li&gt;â€¢ increasing the secretion of chloride and bicarbonate ions&lt;/li&gt;&lt;li&gt;â€¢ increased fluid secretion&lt;/li&gt;&lt;li&gt;â€¢ accelerated gastrointestinal transit time.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Alvimopan: Alvimopan is a peripherally acting mu-opioid receptor antagonist used to treat postoperative ileus. It works by blocking the action of opioids on the mu-opioid receptor in the gastrointestinal tract, which can reduce gastrointestinal motility and cause constipation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Alvimopan:&lt;/li&gt;&lt;li&gt;â€¢ mu-opioid receptor antagonist&lt;/li&gt;&lt;li&gt;â€¢ postoperative ileus.&lt;/li&gt;&lt;li&gt;â€¢ blocking the action of opioids&lt;/li&gt;&lt;li&gt;â€¢ mu-opioid receptor&lt;/li&gt;&lt;li&gt;â€¢ gastrointestinal tract,&lt;/li&gt;&lt;li&gt;â€¢ reduce gastrointestinal motility&lt;/li&gt;&lt;li&gt;â€¢ constipation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Prucalopride : Prucalopride is a selective serotonin type 4 (5-HT4) receptor agonist used in the treatment of chronic idiopathic constipation . It works by stimulating colonic motility and accelerating gastrointestinal transit time, which can lead to increased bowel movements.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Prucalopride&lt;/li&gt;&lt;li&gt;â€¢ selective serotonin type 4 (5-HT4) receptor agonist&lt;/li&gt;&lt;li&gt;â€¢ chronic&lt;/li&gt;&lt;li&gt;â€¢ idiopathic constipation&lt;/li&gt;&lt;li&gt;â€¢ stimulating colonic motility&lt;/li&gt;&lt;li&gt;â€¢ accelerating gastrointestinal transit time,&lt;/li&gt;&lt;li&gt;â€¢ increased bowel movements.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Crofelemer is unique as a CFTR channel inhibitor, making it effective in treating diarrhea by reducing chloride and water secretion into the intestines , which contrasts with other options that primarily affect motility or opioid receptor antagonism.&lt;/li&gt;&lt;li&gt;âž¤ Crofelemer&lt;/li&gt;&lt;li&gt;âž¤ CFTR channel inhibitor,&lt;/li&gt;&lt;li&gt;âž¤ treating diarrhea by reducing chloride and water secretion&lt;/li&gt;&lt;li&gt;âž¤ intestines&lt;/li&gt;&lt;li&gt;âž¤ contrasts&lt;/li&gt;&lt;li&gt;âž¤ other options&lt;/li&gt;&lt;li&gt;âž¤ motility or opioid receptor antagonism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Selective M1 antagonist used in Gastric ulcer is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Omeprazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ranitidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pirenzepine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Misoprostol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pirenzepine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/03/screenshot-2024-05-03-120507.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Pirenzepine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Omeprazole: Incorrect because Omeprazole is a proton pump inhibitor (PPI) that works by irreversibly blocking the hydrogen/potassium ATPase enzyme in the stomach , leading to a significant reduction in gastric acid secretion. It does not act as a muscarinic antagonist.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Omeprazole:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Omeprazole is a proton pump inhibitor (PPI)&lt;/li&gt;&lt;li&gt;â€¢ irreversibly blocking&lt;/li&gt;&lt;li&gt;â€¢ hydrogen/potassium ATPase enzyme in the stomach&lt;/li&gt;&lt;li&gt;â€¢ reduction in gastric acid secretion.&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ muscarinic antagonist.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ranitidine: Incorrect as Ranitidine is an H2 blocker that competitively inhibits histamine at H2 receptors on parietal cells, thereby decreasing gastric acid secretion . It is not a muscarinic antagonist.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ranitidine:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ H2 blocker&lt;/li&gt;&lt;li&gt;â€¢ competitively inhibits&lt;/li&gt;&lt;li&gt;â€¢ histamine&lt;/li&gt;&lt;li&gt;â€¢ H2 receptors on parietal cells,&lt;/li&gt;&lt;li&gt;â€¢ decreasing gastric acid secretion&lt;/li&gt;&lt;li&gt;â€¢ Option D. Misoprostol: Incorrect because Misoprostol is a mucosal protectant used primarily to prevent gastric ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) by mimicking the action of prostaglandins . It does not involve muscarinic receptor antagonism.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Misoprostol:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ mucosal protectant&lt;/li&gt;&lt;li&gt;â€¢ prevent gastric ulcers&lt;/li&gt;&lt;li&gt;â€¢ nonsteroidal anti-inflammatory drugs (NSAIDs)&lt;/li&gt;&lt;li&gt;â€¢ mimicking&lt;/li&gt;&lt;li&gt;â€¢ prostaglandins&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ muscarinic receptor&lt;/li&gt;&lt;li&gt;â€¢ antagonism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman has been complaining of chronic constipation for several months. She has been taking a laxative regularly for relief. She underwent colonoscopy which reveals the presence of dark black discoloration of colon (melanosis coli). Which of the following medications is most likely causing this discoloration of the colon?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Liquid paraffin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Senna&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bisacodyl&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Psyllium&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Senna&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Senna&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Liquid paraffin: Incorrect because liquid paraffin, a lubricant laxative , does not cause melanosis coli. It works by coating the stool and the gut, easing the passage of stool without affecting the mucosa&#x27;s pigmentation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Liquid paraffin:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ liquid paraffin,&lt;/li&gt;&lt;li&gt;â€¢ lubricant laxative&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ melanosis coli.&lt;/li&gt;&lt;li&gt;â€¢ stool and the gut,&lt;/li&gt;&lt;li&gt;â€¢ easing&lt;/li&gt;&lt;li&gt;â€¢ passage of stool&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bisacodyl: Incorrect as bisacodyl, a stimulant laxative, primarily induces bowel movements by stimulating nerve endings in the colon wall but is not linked to the development of melanosis coli.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bisacodyl:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ bisacodyl,&lt;/li&gt;&lt;li&gt;â€¢ stimulant laxative,&lt;/li&gt;&lt;li&gt;â€¢ bowel movements by stimulating nerve endings&lt;/li&gt;&lt;li&gt;â€¢ colon wall&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ development of melanosis coli.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Psyllium: Incorrect because psyllium , a bulk-forming laxative , absorbs water in the intestine to form a viscous liquid that promotes bowel movements. It does not cause discoloration of the colon&#x27;s mucosa.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Psyllium:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ psyllium&lt;/li&gt;&lt;li&gt;â€¢ bulk-forming laxative&lt;/li&gt;&lt;li&gt;â€¢ absorbs water&lt;/li&gt;&lt;li&gt;â€¢ intestine to form a viscous liquid&lt;/li&gt;&lt;li&gt;â€¢ promotes bowel movements.&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ discoloration of the colon&#x27;s mucosa.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Senna , an anthraquinone-containing laxative, is associated with melanosis coli, a benign condition marked by dark pigmentation of the colon. This condition highlights the need to reassess and possibly adjust chronic constipation management.&lt;/li&gt;&lt;li&gt;âž¤ Senna&lt;/li&gt;&lt;li&gt;âž¤ anthraquinone-containing laxative,&lt;/li&gt;&lt;li&gt;âž¤ melanosis coli,&lt;/li&gt;&lt;li&gt;âž¤ benign&lt;/li&gt;&lt;li&gt;âž¤ dark pigmentation of&lt;/li&gt;&lt;li&gt;âž¤ colon.&lt;/li&gt;&lt;li&gt;âž¤ reassess and possibly&lt;/li&gt;&lt;li&gt;âž¤ chronic constipation management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following drugs are used for constipation dominant IBS except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lubiprostone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Linaclotide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alosetron&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prucalopride&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Alosetron&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/03/screenshot-2024-05-03-121117.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Alosetron&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lubiprostone: Incorrect because Lubiprostone is indeed used for constipation-dominant IBS. It is a chloride channel activator that increases fluid secretion in the intestine , which facilitates stool passage and alleviates constipation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lubiprostone:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ constipation-dominant IBS.&lt;/li&gt;&lt;li&gt;â€¢ chloride channel&lt;/li&gt;&lt;li&gt;â€¢ activator&lt;/li&gt;&lt;li&gt;â€¢ increases fluid secretion in the intestine&lt;/li&gt;&lt;li&gt;â€¢ facilitates stool passage and alleviates constipation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Linaclotide: Incorrect as Linaclotide is used for IBS-C . It is a guanylate cyclase-C agonist that increases both chloride and bicarbonate secretion into the intestine , enhancing fluid secretion and improving bowel movement.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Linaclotide:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ used for IBS-C&lt;/li&gt;&lt;li&gt;â€¢ guanylate cyclase-C agonist&lt;/li&gt;&lt;li&gt;â€¢ increases both chloride and&lt;/li&gt;&lt;li&gt;â€¢ bicarbonate secretion&lt;/li&gt;&lt;li&gt;â€¢ intestine&lt;/li&gt;&lt;li&gt;â€¢ fluid secretion and improving bowel movement.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Prucalopride: Incorrect because Prucalopride is a 5-HT4 agonist that enhances gastrointestinal motility, making it suitable for treating IBS-C by accelerating transit time through the colon.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Prucalopride:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Prucalopride is a 5-HT4 agonist&lt;/li&gt;&lt;li&gt;â€¢ gastrointestinal motility,&lt;/li&gt;&lt;li&gt;â€¢ IBS-C by accelerating transit&lt;/li&gt;&lt;li&gt;â€¢ colon.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Drugs Used in IBS&lt;/li&gt;&lt;li&gt;âž¤ Drugs Used in IBS&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Anti-Platelet therapy is usually given for patients with stroke, MI and peripheral vascular disease. PPIs are frequently administered along with these drugs to prevent the risk of increased gastrointestinal erosions and bleeding. The interaction between clopidogrel and PPI has recently been given much attention due to its clinical significance. The metabolizing enzyme common to these two drugs is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CYP2C10&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CYPA2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CYP2C19&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CYP2C20&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. CYP2C19&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) CYP2C19&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. CYP2C10: Incorrect as CYP2C10 is not a recognized enzyme in the cytochrome P450 family that is relevant to clopidogrel or PPI metabolism.&lt;/li&gt;&lt;li&gt;â€¢ Option A. CYP2C10:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ CYP2C10&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ cytochrome P450&lt;/li&gt;&lt;li&gt;â€¢ relevant to clopidogrel or PPI metabolism.&lt;/li&gt;&lt;li&gt;â€¢ Option B. CYPA2: Incorrect because CYPA2 does not exist. The cytochrome P450 enzymes are typically designated with a format starting with CYP followed by numbers and letters (e.g., CYP2C19).&lt;/li&gt;&lt;li&gt;â€¢ Option B. CYPA2:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ CYPA2 does not&lt;/li&gt;&lt;li&gt;â€¢ cytochrome P450 enzymes&lt;/li&gt;&lt;li&gt;â€¢ format&lt;/li&gt;&lt;li&gt;â€¢ CYP&lt;/li&gt;&lt;li&gt;â€¢ numbers and letters (e.g., CYP2C19).&lt;/li&gt;&lt;li&gt;â€¢ Option D. CYP2C20: Incorrect as CYP2C20 is not an established member of the cytochrome P450 enzyme family involved in the metabolism of clopidogrel or PPIs.&lt;/li&gt;&lt;li&gt;â€¢ Option D. CYP2C20:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ CYP2C20&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ cytochrome P450 enzyme family&lt;/li&gt;&lt;li&gt;â€¢ clopidogrel or PPIs.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ CYP2C19 is the key enzyme involved in the activation of clopidogrel and that certain PPIs, such as omeprazole and esomeprazole , can inhibit this enzyme , potentially reducing the antiplatelet activity of clopidogrel .&lt;/li&gt;&lt;li&gt;âž¤ CYP2C19&lt;/li&gt;&lt;li&gt;âž¤ activation of clopidogrel&lt;/li&gt;&lt;li&gt;âž¤ PPIs, such as omeprazole and esomeprazole&lt;/li&gt;&lt;li&gt;âž¤ inhibit this enzyme&lt;/li&gt;&lt;li&gt;âž¤ reducing the antiplatelet activity of clopidogrel&lt;/li&gt;&lt;li&gt;âž¤ Awareness of this interaction is crucial when managing patients who require both antiplatelet and gastric protective therapies.&lt;/li&gt;&lt;li&gt;âž¤ Awareness of this interaction&lt;/li&gt;&lt;li&gt;âž¤ crucial&lt;/li&gt;&lt;li&gt;âž¤ require both antiplatelet and gastric protective therapies.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not a prokinetic drug?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;5HT4-agonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;D2 blocker&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Macrolides&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diphenoxymethane&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Diphenoxymethane&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/03/screenshot-2024-05-03-121706.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Diphenoxymethane&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. 5HT4-agonist: Incorrect as 5HT4-agonists , such as mosapride, tegaserod, and prucalopride, are indeed prokinetic drugs. They stimulate peristalsis and increase gastric emptying by acting on the 5HT4 receptors in the gastrointestinal tract.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 5HT4-agonist:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ 5HT4-agonists&lt;/li&gt;&lt;li&gt;â€¢ mosapride, tegaserod, and prucalopride,&lt;/li&gt;&lt;li&gt;â€¢ prokinetic drugs.&lt;/li&gt;&lt;li&gt;â€¢ stimulate peristalsis&lt;/li&gt;&lt;li&gt;â€¢ increase gastric emptying&lt;/li&gt;&lt;li&gt;â€¢ 5HT4 receptors in the gastrointestinal tract.&lt;/li&gt;&lt;li&gt;â€¢ Option B. D2 blocker: Incorrect because D2 blockers like metoclopramide and domperidone are used as prokinetic drugs due to their ability to enhance gastrointestinal motility by blocking dopamine receptors, which promotes gastric emptying and decreases nausea and vomiting.&lt;/li&gt;&lt;li&gt;â€¢ Option B. D2 blocker:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ D2 blockers&lt;/li&gt;&lt;li&gt;â€¢ metoclopramide and domperidone&lt;/li&gt;&lt;li&gt;â€¢ prokinetic drugs&lt;/li&gt;&lt;li&gt;â€¢ ability to enhance gastrointestinal motility&lt;/li&gt;&lt;li&gt;â€¢ blocking dopamine receptors,&lt;/li&gt;&lt;li&gt;â€¢ gastric emptying&lt;/li&gt;&lt;li&gt;â€¢ decreases&lt;/li&gt;&lt;li&gt;â€¢ nausea and vomiting.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Macrolides: Incorrect as certain macrolides, such as erythromycin , act as motilin receptor agonists in the gut and are used for their prokinetic effects to stimulate gastric motility.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Macrolides:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ erythromycin&lt;/li&gt;&lt;li&gt;â€¢ motilin receptor agonists&lt;/li&gt;&lt;li&gt;â€¢ prokinetic effects to stimulate gastric motility.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 44 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test6" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Heamatology&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Heamatology&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                132 Questions | 528 Total Marks | 142 min Duration | ~64.55 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A 16-year-old male presents with jaundice and anemia. His blood smear shows spherical red blood cells, and laboratory tests reveal an increase in mean corpuscular hemoglobin concentration (MCHC). Which of the following is the most likely cause of his anemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Iron deficiency anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Megaloblastic anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anemia of chronic disease â€‹â€‹â€‹&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hereditary spherocytosis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hereditary spherocytosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Â Hereditary spherocytosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Iron deficiency anemia: It is characterized by a decrease in the amount of hemoglobin in red blood cells, leading to a decreased MCHC .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Iron deficiency anemia:&lt;/li&gt;&lt;li&gt;â€¢ decrease in the amount of hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ decreased MCHC&lt;/li&gt;&lt;li&gt;â€¢ Option B. Megaloblastic anemia: It can be associated with vitamin B12 or folate deficiency and ha s macrocytosis . This condition is associated with a normal or decreased MCHC.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Megaloblastic anemia:&lt;/li&gt;&lt;li&gt;â€¢ vitamin B12 or folate deficiency&lt;/li&gt;&lt;li&gt;â€¢ s macrocytosis&lt;/li&gt;&lt;li&gt;â€¢ normal or decreased MCHC.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anemia of chronic disease: The anomie is often normocytic and normochromic , with a normal MCH&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anemia of chronic disease:&lt;/li&gt;&lt;li&gt;â€¢ normocytic and normochromic&lt;/li&gt;&lt;li&gt;â€¢ normal MCH&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hereditary spherocytosis often presents with an elevated MCHC due to the spherical shape of red blood cells , which concentrates the haemoglobin content&lt;/li&gt;&lt;li&gt;âž¤ Hereditary spherocytosis&lt;/li&gt;&lt;li&gt;âž¤ elevated MCHC&lt;/li&gt;&lt;li&gt;âž¤ spherical shape of red blood cells&lt;/li&gt;&lt;li&gt;âž¤ haemoglobin content&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 639&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 639&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The best method for estimation of hemoglobin concentration in blood is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acid hematin method&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alkali hematin method&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cyanmethemoglobin method&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Any of the above â€‹â€‹â€‹â€‹â€‹â€‹&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cyanmethemoglobin method&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/25/picture37.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Â Cyanmethemoglobin method&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. The acid hematin method involves converting hemoglobin to acid hematin using an acidic solution . This method is less frequently used due to its lower specificity and sensitivity compared to other methods.&lt;/li&gt;&lt;li&gt;â€¢ Option A. The acid hematin&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin to acid hematin&lt;/li&gt;&lt;li&gt;â€¢ acidic solution&lt;/li&gt;&lt;li&gt;â€¢ less frequently&lt;/li&gt;&lt;li&gt;â€¢ lower specificity and sensitivity&lt;/li&gt;&lt;li&gt;â€¢ Option B. Similar to the acid hematin method, the alkali hematin method involves the conversion of hemoglobin to alkali hematin using an alkaline solution . It is also not commonly used in clinical practice because it can be less accurate and is affected by turbidity caused by the presence of other substances in the blood.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Similar to the acid hematin&lt;/li&gt;&lt;li&gt;â€¢ alkali hematin&lt;/li&gt;&lt;li&gt;â€¢ conversion of hemoglobin to alkali hematin&lt;/li&gt;&lt;li&gt;â€¢ alkaline solution&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Reticulocytes are BEST stained with:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Methyl violet&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Brilliant Cresyl blue&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;New methylene blue&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Indigo carmine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. New methylene blue&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. New methylene blue&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Methyl violet is a basic dye that can be used to stain acidic components of cells like nucleic acids, but it is not the best choice for staining reticulocytes. It is commonly used in Gram staining.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Methyl violet&lt;/li&gt;&lt;li&gt;â€¢ basic dye&lt;/li&gt;&lt;li&gt;â€¢ acidic components&lt;/li&gt;&lt;li&gt;â€¢ nucleic acids,&lt;/li&gt;&lt;li&gt;â€¢ Option B. Brilliant Cresyl blue is used to stain reticulocytes by binding to the residual ribosomal RNA . It is a vital stain, but it is not the optimal dye for reticulocyte staining as it may not be as sensitive as new methylene blue .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Brilliant Cresyl&lt;/li&gt;&lt;li&gt;â€¢ stain reticulocytes&lt;/li&gt;&lt;li&gt;â€¢ residual ribosomal RNA&lt;/li&gt;&lt;li&gt;â€¢ not the optimal dye for reticulocyte staining&lt;/li&gt;&lt;li&gt;â€¢ not be as sensitive as new methylene blue&lt;/li&gt;&lt;li&gt;â€¢ Option D. Indigo carmine is not used for staining blood cells ; it is a dye more commonly used in medical procedures to highlight structures and assess the function of certain organs, such as during kidney surgery.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Indigo carmine&lt;/li&gt;&lt;li&gt;â€¢ staining blood cells&lt;/li&gt;&lt;li&gt;â€¢ dye&lt;/li&gt;&lt;li&gt;â€¢ highlight structures&lt;/li&gt;&lt;li&gt;â€¢ assess the function&lt;/li&gt;&lt;li&gt;â€¢ kidney surgery.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Reticulocytes are stained in living state in vitro so staining with dyes like brilliant cresyl blue and new methylene blue (Best stain) is referred to as supravital staining.&lt;/li&gt;&lt;li&gt;âž¤ Reticulocytes&lt;/li&gt;&lt;li&gt;âž¤ in living state&lt;/li&gt;&lt;li&gt;âž¤ new methylene blue (Best stain)&lt;/li&gt;&lt;li&gt;âž¤ supravital staining.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 637&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 637&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 20-year-old female presents with the following laboratory values: hemoglobin 9gm%, MCV is 55%, RBC is 4.5 million/mm3. There is no history of blood transfusion. What is the most likely diagnosis out of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thalassemia major&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Thalassemia minor&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Iron deficiency anemia â€‹&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anemia of chronic disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Thalassemia minor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Thalassemia minor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Patients with thalassemia major typically present with severe anemia requiring regular blood transfusions. The degree of anemia in the vignette is not consistent with thalassemia major.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Patients with thalassemia&lt;/li&gt;&lt;li&gt;â€¢ major&lt;/li&gt;&lt;li&gt;â€¢ severe anemia&lt;/li&gt;&lt;li&gt;â€¢ blood transfusions.&lt;/li&gt;&lt;li&gt;â€¢ vignette&lt;/li&gt;&lt;li&gt;â€¢ Option C. Iron deficiency anemia typically presents with microcytic and hypochromic anemia . The Mentzer index is generally greater than 13 , which is not the case here.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Iron deficiency anemia&lt;/li&gt;&lt;li&gt;â€¢ microcytic and hypochromic anemia&lt;/li&gt;&lt;li&gt;â€¢ Mentzer index&lt;/li&gt;&lt;li&gt;â€¢ greater than 13&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anemia of chronic disease usually presents with normocytic or sometimes microcytic anemia , but it is often characterized by a normal or increased storage iron level , which can be evaluated by serum ferritin.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anemia of chronic disease&lt;/li&gt;&lt;li&gt;â€¢ normocytic or sometimes microcytic anemia&lt;/li&gt;&lt;li&gt;â€¢ normal or increased storage iron level&lt;/li&gt;&lt;li&gt;â€¢ serum ferritin.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ When presented with mild to moderate microcytic anemia and an MCV/RBC count that yields a Mentzer index of less than 13, thalassemia minor is a likely diagnosis.&lt;/li&gt;&lt;li&gt;âž¤ mild to moderate microcytic anemia&lt;/li&gt;&lt;li&gt;âž¤ MCV/RBC count&lt;/li&gt;&lt;li&gt;âž¤ Mentzer index of less than 13, thalassemia minor&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 13-yr-girl with fatigue and weakness was found to be having reduced hemoglobin. Her MCV 70fl, MCH 22pg and RDW was 28. What is her most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Iron deficiency anemia â€‹â€‹â€‹â€‹â€‹&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Thalassemia minor â€‹â€‹â€‹&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sideroblastic anemia â€‹â€‹â€‹â€‹â€‹&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thalassemia major â€‹â€‹â€‹â€‹â€‹â€‹&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Iron deficiency anemia â€‹â€‹â€‹â€‹â€‹&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Iron deficiency anemia:&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Thalassemia minor often presents with microcytosis and a low MCH , but RDW is typically normal because the red blood cells are uniformly small .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Thalassemia minor&lt;/li&gt;&lt;li&gt;â€¢ microcytosis and a low MCH&lt;/li&gt;&lt;li&gt;â€¢ RDW&lt;/li&gt;&lt;li&gt;â€¢ normal&lt;/li&gt;&lt;li&gt;â€¢ red blood cells are uniformly small&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sideroblastic anemia can also present with microcytosis, but it is usually associated with ringed sideroblasts in the bone marrow and may show elevated iron indices.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sideroblastic anemia&lt;/li&gt;&lt;li&gt;â€¢ microcytosis,&lt;/li&gt;&lt;li&gt;â€¢ ringed sideroblasts&lt;/li&gt;&lt;li&gt;â€¢ bone marrow&lt;/li&gt;&lt;li&gt;â€¢ elevated iron indices.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thalassemia major presents with severe microcytic anemia , usually early in life , and patients are typically symptomatic with a history of blood transfusions.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thalassemia major presents&lt;/li&gt;&lt;li&gt;â€¢ severe microcytic anemia&lt;/li&gt;&lt;li&gt;â€¢ early in life&lt;/li&gt;&lt;li&gt;â€¢ history of blood transfusions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ An elevated RDW in the context of microcytic, hypochromic anemia is suggestive of iron deficiency anemia , which can be distinguished from thalassemia minor by the increased RDW.&lt;/li&gt;&lt;li&gt;âž¤ elevated RDW&lt;/li&gt;&lt;li&gt;âž¤ microcytic, hypochromic anemia&lt;/li&gt;&lt;li&gt;âž¤ iron deficiency anemia&lt;/li&gt;&lt;li&gt;âž¤ thalassemia minor by the increased RDW.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old male with a history of progressive fatigue and a recent diagnosis of alcoholism presents for evaluation. His complete blood count shows a macrocytic anemia and the bone marrow biopsy reveals the presence of ringed sideroblasts. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Iron deficiency anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Myelodysplastic syndrome â€‹â€‹â€‹â€‹â€‹&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thalassemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anemia of chronic disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Myelodysplastic syndrome â€‹â€‹â€‹â€‹â€‹&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Myelodysplastic syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Iron deficiency anemia is characterized by microcytic, hypochromic red cells without the presence of ringed sideroblasts in the bone marrow.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Iron deficiency anemia&lt;/li&gt;&lt;li&gt;â€¢ microcytic, hypochromic red cells&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thalassemia syndromes are hereditary hemoglobinopathies leading to ineffective erythropoiesis and anemia , but they do not typically present with ringed sideroblasts.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thalassemia syndromes&lt;/li&gt;&lt;li&gt;â€¢ hereditary hemoglobinopathies&lt;/li&gt;&lt;li&gt;â€¢ ineffective erythropoiesis and anemia&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anemia of chronic disease can cause a microcytic anemia , but it is usually normocytic and does not present with ringed sideroblasts.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anemia of chronic disease&lt;/li&gt;&lt;li&gt;â€¢ microcytic anemia&lt;/li&gt;&lt;li&gt;â€¢ normocytic&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Myelodysplastic syndrome (MDS) is associated with ineffective hematopoiesis and the presence of ringed sideroblasts&lt;/li&gt;&lt;li&gt;âž¤ Myelodysplastic syndrome (MDS)&lt;/li&gt;&lt;li&gt;âž¤ ineffective hematopoiesis&lt;/li&gt;&lt;li&gt;âž¤ ringed sideroblasts&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th /620&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th /620&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30 years old female undergoes blood investigations which reveal RBC count 4.5 million, MCV 55fl and TLC 8000/mm3. There is no history of blood transfusion. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Iron deficiency anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Thalassemia major&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thalassemia minor&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Megaloblastic anemia â€‹â€‹â€‹â€‹â€‹â€‹&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Thalassemia minor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Thalassemia minor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Iron deficiency anemia (IDA) is characterized by microcytic, hypochromic red cells , often with a high RDW and low serum ferritin levels .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Iron deficiency anemia&lt;/li&gt;&lt;li&gt;â€¢ microcytic, hypochromic red cells&lt;/li&gt;&lt;li&gt;â€¢ high RDW and low serum ferritin levels&lt;/li&gt;&lt;li&gt;â€¢ Option B. Thalassemia major presents with severe microcytic anemia usually requiring blood transfusions for survival , often diagnosed in childhood.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Thalassemia major presents&lt;/li&gt;&lt;li&gt;â€¢ severe microcytic anemia&lt;/li&gt;&lt;li&gt;â€¢ blood transfusions for survival&lt;/li&gt;&lt;li&gt;â€¢ Option D. Megaloblastic anemia Megaloblastic anemia is characterized by macrocytosis with an MCV typically greater than 100 fL due to impaired DNA synthesis .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Megaloblastic anemia Megaloblastic&lt;/li&gt;&lt;li&gt;â€¢ macrocytosis&lt;/li&gt;&lt;li&gt;â€¢ MCV&lt;/li&gt;&lt;li&gt;â€¢ 100 fL due to impaired DNA synthesis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with microcytic anemia and an MCV of 55 fL, a normal TLC, and no history of transfusion, thalassemia minor is likely, particularly when using indices such as the Mentzer index (MCV/RBC count), which is less than 13 in thalassemia minor.&lt;/li&gt;&lt;li&gt;âž¤ microcytic anemia&lt;/li&gt;&lt;li&gt;âž¤ an MCV of 55 fL, a normal TLC,&lt;/li&gt;&lt;li&gt;âž¤ no history of transfusion, thalassemia minor&lt;/li&gt;&lt;li&gt;âž¤ Mentzer index (MCV/RBC count),&lt;/li&gt;&lt;li&gt;âž¤ less than 13&lt;/li&gt;&lt;li&gt;âž¤ Ref: Robbins 10 th 644&lt;/li&gt;&lt;li&gt;âž¤ Ref: Robbins 10 th 644&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The pathogenesis of hypochromic anemia in lead poisoning is due to:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of enzymes involved in heme biosynthesis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Binding of lead to transferrin, inhibiting the transÂ­port of iron&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Binding of lead to cell membrane of erythroid preÂ­cursors.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Binding of lead to ferritin inhibiting their breakÂ­down into hemosiderin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Inhibition of enzymes involved in heme biosynthesis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Inhibition of enzymes involved in heme bioÂ­synthesis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lead does not bind to transferrin directly&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lead&lt;/li&gt;&lt;li&gt;â€¢ Option C. While lead can affect cell membrane s, the primary mechanism of hypochromic anemia in lead poisoning is related to its impact on enzymes involved in heme biosynthesis, not direct binding to cell membranes.&lt;/li&gt;&lt;li&gt;â€¢ Option C. While lead can affect&lt;/li&gt;&lt;li&gt;â€¢ cell membrane&lt;/li&gt;&lt;li&gt;â€¢ hypochromic anemia&lt;/li&gt;&lt;li&gt;â€¢ enzymes involved in heme biosynthesis,&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lead does not directly bind to ferritin to inhibit their breakdown. The primary effect is on heme synthesis enzymes.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lead does not directly&lt;/li&gt;&lt;li&gt;â€¢ ferritin to inhibit their breakdown.&lt;/li&gt;&lt;li&gt;â€¢ heme synthesis enzymes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The primary pathogenesis of hypochromic anemia in lead poisoning involves the inhibition of enzymes necessary for heme biosynthesis , such as aminolevulinic acid dehydratase (ALAD) and ferrochelatase, leading to reduced heme and hemoglobin production.&lt;/li&gt;&lt;li&gt;âž¤ hypochromic anemia in lead poisoning&lt;/li&gt;&lt;li&gt;âž¤ inhibition of enzymes necessary&lt;/li&gt;&lt;li&gt;âž¤ heme biosynthesis&lt;/li&gt;&lt;li&gt;âž¤ aminolevulinic acid dehydratase (ALAD) and ferrochelatase,&lt;/li&gt;&lt;li&gt;âž¤ heme and hemoglobin production.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 411, Tejinder Singh 1st/147&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 411, Tejinder Singh 1st/147&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presented with fatigue and dyspnea. His peripheral blood smear demonstrated microcytic hypochromic red blood cells and pencil cells. The likely diagnosis in him is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;B12 deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Iron deficiency anemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thalassemia minor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sickle cell anemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Iron deficiency anemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Iron deficiency anemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Vitamin B12 deficiency typically causes macrocytic anemia , not microcytic, and would not present with pencil cells on the blood smear.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Vitamin B12 deficiency&lt;/li&gt;&lt;li&gt;â€¢ macrocytic anemia&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thalassemia minor often presents with microcytosis, but red cells are usually target cells rather than pencil cells, and other hematologic indices such as hemoglobin A2 levels can help in the diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thalassemia minor&lt;/li&gt;&lt;li&gt;â€¢ microcytosis, but red cells are usually target cells&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin A2 levels&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sickle cell anemia usually presents with normocytic anemia and sickled red cells on the blood smear, not pencil cells, and are associated with hemoglobin Son electrophoresis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sickle cell anemia&lt;/li&gt;&lt;li&gt;â€¢ normocytic anemia and sickled red cells&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin Son electrophoresis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Iron deficiency anemia is characterized by microcytic, hypochromic red blood cells with the presence of pencil cells on the peripheral blood smear . Iron deficiency anemia is a common cause of anemia worldwide and should be considered in patients presenting with symptoms of anemia and microcytosis.&lt;/li&gt;&lt;li&gt;âž¤ microcytic, hypochromic red blood cells&lt;/li&gt;&lt;li&gt;âž¤ peripheral blood smear&lt;/li&gt;&lt;li&gt;âž¤ Iron deficiency anemia&lt;/li&gt;&lt;li&gt;âž¤ common&lt;/li&gt;&lt;li&gt;âž¤ anemia worldwide&lt;/li&gt;&lt;li&gt;âž¤ anemia and microcytosis.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/e p658&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/e p658&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old male is evaluated for anemia. Laboratory findings reveal increased serum ferritin, decreased total iron-binding capacity (TIBC), increased serum iron, and elevated transferrin saturation. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anemia of chronic disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sideroblastic anemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Iron deficiency anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thalassemia minor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Sideroblastic anemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anemia of chronic disease - Typically presents with normal to increased serum ferritin , normal to decreased serum iron, and low transferrin saturation due to the sequestration of iron in macrophages .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anemia of chronic disease&lt;/li&gt;&lt;li&gt;â€¢ normal to increased serum ferritin&lt;/li&gt;&lt;li&gt;â€¢ normal to decreased serum iron, and low transferrin saturation&lt;/li&gt;&lt;li&gt;â€¢ sequestration of iron in macrophages&lt;/li&gt;&lt;li&gt;â€¢ Option C. Iron deficiency anemia - Manifests with decreased serum ferritin, increased TIBC, decreased serum iron, and low transferrin saturation due to a lack of iron stores.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Iron deficiency anemia&lt;/li&gt;&lt;li&gt;â€¢ decreased serum ferritin, increased TIBC, decreased serum iron, and low&lt;/li&gt;&lt;li&gt;â€¢ transferrin saturation&lt;/li&gt;&lt;li&gt;â€¢ lack of iron stores.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thalassemia minor - This condition usually presents with normal iron studies and is characterized by microcytic red blood cells without an increase in iron parameters.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thalassemia minor&lt;/li&gt;&lt;li&gt;â€¢ normal iron studies&lt;/li&gt;&lt;li&gt;â€¢ microcytic red blood cells&lt;/li&gt;&lt;li&gt;â€¢ increase in iron parameters.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sideroblastic anemia is indicated by increased serum ferritin , decreased TIBC, increased serum iron, and elevated transferrin saturation , reflecting a defect in the incorporation of iron into hemoglobin within the erythroid precursors in the bone marrow .&lt;/li&gt;&lt;li&gt;âž¤ Sideroblastic anemia&lt;/li&gt;&lt;li&gt;âž¤ increased serum ferritin&lt;/li&gt;&lt;li&gt;âž¤ decreased TIBC, increased serum iron, and elevated transferrin saturation&lt;/li&gt;&lt;li&gt;âž¤ iron into hemoglobin&lt;/li&gt;&lt;li&gt;âž¤ erythroid precursors in the bone marrow&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a patient with raised LDH, elevated bilirubin and hemoglobinuria. Peripheral smear shows schistocytes. What would the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Red cell enzyme defect â€‹â€‹â€‹â€‹â€‹&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypersplenism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mechanical heart valves â€‹â€‹â€‹â€‹â€‹&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thyroid dysfunction&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Mechanical heart valves â€‹â€‹â€‹â€‹â€‹&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/25/picture38.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Mechanical heart valves&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Red cell enzyme defects typically do not cause microangiopathic hemolytic anemia with schistocytes.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Red cell enzyme&lt;/li&gt;&lt;li&gt;â€¢ do not&lt;/li&gt;&lt;li&gt;â€¢ microangiopathic hemolytic anemia with schistocytes.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypersplenism is associated with the sequestration and destruction of blood cells in the spleen but is not typically associated with the specific findings mentioned in the question.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypersplenism is associated&lt;/li&gt;&lt;li&gt;â€¢ sequestration and destruction of blood cells&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thyroid dysfunction is not known to cause microangiopathic hemolytic anemia with schistocytes.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thyroid dysfunction&lt;/li&gt;&lt;li&gt;â€¢ not known&lt;/li&gt;&lt;li&gt;â€¢ microangiopathic hemolytic anemia with schistocytes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The correct diagnosis in a patient with elevated LDH, hyperbilirubinemia, hemoglobinuria, and schistocytes on the peripheral blood smear is mechanical heart valve -related hemolysis.&lt;/li&gt;&lt;li&gt;âž¤ elevated LDH, hyperbilirubinemia, hemoglobinuria, and schistocytes on the peripheral blood smear&lt;/li&gt;&lt;li&gt;âž¤ mechanical heart valve&lt;/li&gt;&lt;li&gt;âž¤ hemolysis.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/e p650&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th/e p650&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a patient diagnosed with iron deficiency anemia, the values of all of the following increase except&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Total iron binding capacity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;RBC protoporphyrin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Transferrin saturation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Transferrin receptor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Transferrin saturation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Â Transferrin saturation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Total iron binding capacity (TIBC): TIBC increases in iron deficiency anemia . It represents the maximum amount of iron that can be bound to transferrin.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Total iron binding capacity (TIBC):&lt;/li&gt;&lt;li&gt;â€¢ increases&lt;/li&gt;&lt;li&gt;â€¢ iron deficiency anemia&lt;/li&gt;&lt;li&gt;â€¢ iron&lt;/li&gt;&lt;li&gt;â€¢ bound to transferrin.&lt;/li&gt;&lt;li&gt;â€¢ Option B. RBC protoporphyrin: RBC protoporphyrin increases in iron deficiency anemia . It reflects decreased availability of iron for heme synthesis .&lt;/li&gt;&lt;li&gt;â€¢ Option B. RBC protoporphyrin:&lt;/li&gt;&lt;li&gt;â€¢ increases in iron deficiency anemia&lt;/li&gt;&lt;li&gt;â€¢ decreased&lt;/li&gt;&lt;li&gt;â€¢ iron for heme synthesis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Transferrin receptor: Transferrin receptor levels increase in iron deficiency anemia . It is a marker of increased demand for iron by erythroid precursors .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Transferrin receptor:&lt;/li&gt;&lt;li&gt;â€¢ increase in iron deficiency anemia&lt;/li&gt;&lt;li&gt;â€¢ increased&lt;/li&gt;&lt;li&gt;â€¢ iron by erythroid precursors&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Transferrin saturation decreases in iron deficiency anemia , reflecting a reduced percentage of transferrin loaded with iron due to diminished iron stores , whereas total iron binding capacity, RBC protoporphyrin, and transferrin receptor levels increase in response to this condition.&lt;/li&gt;&lt;li&gt;âž¤ Transferrin saturation decreases&lt;/li&gt;&lt;li&gt;âž¤ iron deficiency anemia&lt;/li&gt;&lt;li&gt;âž¤ reduced&lt;/li&gt;&lt;li&gt;âž¤ transferrin&lt;/li&gt;&lt;li&gt;âž¤ iron due to diminished iron stores&lt;/li&gt;&lt;li&gt;âž¤ total iron binding capacity, RBC protoporphyrin, and transferrin receptor levels increase&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 12-year-old with history of recurrent infection and bleeding gums. On investigations the patient had pancytopenia and the peripheral smear showed macrocytes. The bone marrow biopsy showed no megakaryocytes and filled with fat globules. What is your diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Myelodysplasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aplastic anemia â€‹â€‹â€‹â€‹â€‹â€‹&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ITP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;PNH&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Aplastic anemia â€‹â€‹â€‹â€‹â€‹â€‹&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Â Aplastic anemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The given clinical presentation of a 12-year-old with recurrent infections, bleeding gums, pancytopenia, macrocytes on peripheral smear, absence of megakaryocytes in bone marrow, and the presence of fat globules in the bone marrow biopsy is suggestive of aplastic anemia. Aplastic anemia is characterized by a deficiency of all blood cell types (pancytopenia) due to bone marrow failure . The absence of megakaryocytes in the bone marrow biopsy indicates a lack of platelet precursors, which can lead to bleeding manifestations . The presence of fat globules suggests replacement of hematopoietic cells by adipose tissue in the bone marrow.&lt;/li&gt;&lt;li&gt;â€¢ 12-year-old&lt;/li&gt;&lt;li&gt;â€¢ recurrent infections, bleeding gums, pancytopenia, macrocytes on peripheral&lt;/li&gt;&lt;li&gt;â€¢ smear, absence of megakaryocytes in bone marrow,&lt;/li&gt;&lt;li&gt;â€¢ presence of fat globules&lt;/li&gt;&lt;li&gt;â€¢ aplastic anemia.&lt;/li&gt;&lt;li&gt;â€¢ Aplastic anemia&lt;/li&gt;&lt;li&gt;â€¢ deficiency of all blood cell types (pancytopenia)&lt;/li&gt;&lt;li&gt;â€¢ bone marrow failure&lt;/li&gt;&lt;li&gt;â€¢ absence of megakaryocytes&lt;/li&gt;&lt;li&gt;â€¢ lack of platelet precursors,&lt;/li&gt;&lt;li&gt;â€¢ bleeding manifestations&lt;/li&gt;&lt;li&gt;â€¢ fat globules&lt;/li&gt;&lt;li&gt;â€¢ hematopoietic cells by adipose tissue&lt;/li&gt;&lt;li&gt;â€¢ EXPLANATION:&lt;/li&gt;&lt;li&gt;â€¢ EXPLANATION:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Myelodysplastic syndromes : may also present with cytopenias and dysplastic changes in the bone marrow, but the absence of megakaryocytes and the presence of fat globules are not typical features.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Myelodysplastic syndromes :&lt;/li&gt;&lt;li&gt;â€¢ cytopenias and dysplastic&lt;/li&gt;&lt;li&gt;â€¢ absence of megakaryocytes&lt;/li&gt;&lt;li&gt;â€¢ presence of fat globules are not typical features.&lt;/li&gt;&lt;li&gt;â€¢ Option C. ITP: is characterized by isolated thrombocytopenia without affecting other cell lines. It does not typically present with pancytopenia or the absence of megakaryocytes in the bone marrow.&lt;/li&gt;&lt;li&gt;â€¢ Option C. ITP:&lt;/li&gt;&lt;li&gt;â€¢ isolated thrombocytopenia&lt;/li&gt;&lt;li&gt;â€¢ Option D. PNH: is characterized by hemolysis, often presenting with hemoglobinuria. However, it is not typically associated with pancytopenia and fat globules in the bone marrow.&lt;/li&gt;&lt;li&gt;â€¢ Option D. PNH:&lt;/li&gt;&lt;li&gt;â€¢ hemolysis,&lt;/li&gt;&lt;li&gt;â€¢ hemoglobinuria.&lt;/li&gt;&lt;li&gt;â€¢ not typically&lt;/li&gt;&lt;li&gt;â€¢ pancytopenia and fat globules in the bone&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The clinical presentation of recurrent infections, bleeding gums, pancytopenia, macrocytes on peripheral smear, absence of megakaryocytes in bone marrow , and presence of fat globules in bone marrow biopsy is indicative of aplastic anemia . This diagnosis is supported by the bone marrow biopsy findings showing a lack of megakaryocytes, indicative of platelet precursor deficiency, and fat globules suggesting the replacement of hematopoietic cells by adipose tissue .&lt;/li&gt;&lt;li&gt;âž¤ recurrent infections, bleeding gums, pancytopenia, macrocytes on peripheral smear, absence of megakaryocytes in bone marrow&lt;/li&gt;&lt;li&gt;âž¤ presence of fat globules&lt;/li&gt;&lt;li&gt;âž¤ aplastic anemia&lt;/li&gt;&lt;li&gt;âž¤ bone marrow biopsy&lt;/li&gt;&lt;li&gt;âž¤ lack of megakaryocytes, indicative of platelet precursor deficiency,&lt;/li&gt;&lt;li&gt;âž¤ fat globules&lt;/li&gt;&lt;li&gt;âž¤ hematopoietic cells by adipose tissue&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/458&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/458&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An elderly female with mediastinal mass undergoes a microscopic examination showing red cell aplasia. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bronchogenic cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Thymoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Non-Hodgkin lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Squamous cell carcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Thymoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Â Thymoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bronchogenic cancer often presents as a mediastinal mass , especially in smokers . However, it is not commonly associated with red cell aplasia, but rather with other paraneoplastic syndromes such as hypercalcemia (due to production of PTH-related protein) or the secretion of ADH or ACTH.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bronchogenic cancer&lt;/li&gt;&lt;li&gt;â€¢ mediastinal mass&lt;/li&gt;&lt;li&gt;â€¢ smokers&lt;/li&gt;&lt;li&gt;â€¢ paraneoplastic syndromes such as hypercalcemia (due to production of PTH-related protein) or the secretion of ADH or ACTH.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Non-Hodgkin lymphoma can present as a mediastinal mass . It may cause bone marrow involvement leading to various cytopenias but is not specifically associated with pure red cell aplasia .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Non-Hodgkin lymphoma&lt;/li&gt;&lt;li&gt;â€¢ mediastinal mass&lt;/li&gt;&lt;li&gt;â€¢ bone marrow&lt;/li&gt;&lt;li&gt;â€¢ cytopenias&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ pure red cell aplasia&lt;/li&gt;&lt;li&gt;â€¢ Option D. Squamous cell carcinoma typically arises from the epithelial cells of the skin or mucous membranes and is not commonly found within the mediastinum. It is associated with paraneoplastic syndromes , but not typically with red cell aplasia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Squamous cell carcinoma&lt;/li&gt;&lt;li&gt;â€¢ epithelial cells of the skin or mucous membranes&lt;/li&gt;&lt;li&gt;â€¢ paraneoplastic syndromes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Thymoma is the likely diagnosis in an elderly patient with a mediastinal mass and red cell aplasia, as thymomas are associated with this condition and other paraneoplastic syndromes such as myasthenia gravis, hypogammaglobulinemia, and multi-organ autoimmunity.&lt;/li&gt;&lt;li&gt;âž¤ Thymoma&lt;/li&gt;&lt;li&gt;âž¤ mediastinal mass and red cell aplasia, as thymomas&lt;/li&gt;&lt;li&gt;âž¤ paraneoplastic syndromes&lt;/li&gt;&lt;li&gt;âž¤ myasthenia gravis, hypogammaglobulinemia, and multi-organ autoimmunity.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/e p493&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/e p493&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient has been eating junk food regularly for few months and avoids fruits and vegetables. His hemoglobin is 9 g/dl and MCV is &amp;gt;125 fl. What is the deficiency she would likely be having?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cyanocobalamin deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Folate deficiency&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sideroblastic anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acute blood loss&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Folate deficiency&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Â Folate deficiency&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cyanocobalamin (Vitamin B12) deficiency typically develops over years due to the substantial stores in the liver . While it can cause megaloblastic anemia with a high MCV, the patient&#x27;s short history of symptoms makes this less likely.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cyanocobalamin (Vitamin B12)&lt;/li&gt;&lt;li&gt;â€¢ deficiency&lt;/li&gt;&lt;li&gt;â€¢ over years due to the substantial stores in the liver&lt;/li&gt;&lt;li&gt;â€¢ megaloblastic anemia&lt;/li&gt;&lt;li&gt;â€¢ high MCV,&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sideroblastic anemia is characterized by the presence of ringed sideroblasts in the bone marrow and can be associated with certain drugs and toxins, genetic disorders , or may be idiopathic . It doesn&#x27;t typically relate directly to dietary habits and usually shows a normal or increased MCV but not typically in the megaloblastic range (&amp;gt;100 fL).&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sideroblastic anemia&lt;/li&gt;&lt;li&gt;â€¢ ringed sideroblasts&lt;/li&gt;&lt;li&gt;â€¢ drugs and toxins, genetic disorders&lt;/li&gt;&lt;li&gt;â€¢ idiopathic&lt;/li&gt;&lt;li&gt;â€¢ Option D. Acute blood loss would cause anemia with a low or normal MCV (microcytic or normocytic), not the high MCV (&amp;gt;100 fL) that is typical of megaloblastic anemias. Plus, there is no history suggestive of blood loss.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Acute blood loss would cause anemia&lt;/li&gt;&lt;li&gt;â€¢ low or normal MCV (microcytic or normocytic),&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Folate deficiency is the likely cause of megaloblastic anemia with a high MCV in a patient with a diet lacking in fruits and vegetables and a relatively quick onset of symptoms , as folate stores are depleted much more rapidly than vitamin B12 stores .&lt;/li&gt;&lt;li&gt;âž¤ Folate deficiency&lt;/li&gt;&lt;li&gt;âž¤ megaloblastic anemia&lt;/li&gt;&lt;li&gt;âž¤ high MCV&lt;/li&gt;&lt;li&gt;âž¤ fruits and vegetables and a relatively quick onset of symptoms&lt;/li&gt;&lt;li&gt;âž¤ folate stores are depleted much more rapidly than vitamin B12 stores&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old female presents with fatigue, pallor, and a smooth tongue. She reports a vegetarian diet with minimal animal product intake. Laboratory tests show a high mean corpuscular volume (MCV) and hypersegmented neutrophils. A peripheral blood smear likely would reveal which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hereditary spherocytosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Iron deficiency anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sickle cell anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Megaloblastic anemia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Megaloblastic anemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Megaloblastic anemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hereditary spherocytosis is characterized by the presence of spherocytes , which are small, dense red blood cells without the central pallor, not macropolycytes .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hereditary spherocytosis&lt;/li&gt;&lt;li&gt;â€¢ presence of spherocytes&lt;/li&gt;&lt;li&gt;â€¢ small, dense red blood cells without the central pallor, not macropolycytes&lt;/li&gt;&lt;li&gt;â€¢ Option B. Iron deficiency anemia typically shows microcytic, hypochromic red blood cells due to decreased hemoglobin content, not macropolycytes.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Iron deficiency anemia&lt;/li&gt;&lt;li&gt;â€¢ microcytic, hypochromic red blood cells&lt;/li&gt;&lt;li&gt;â€¢ decreased hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sickle cell anemia is identified by the presence of sickle-shaped cells due to abnormal hemoglobin , which does not include macropolycytes.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sickle cell anemia&lt;/li&gt;&lt;li&gt;â€¢ sickle-shaped cells due to abnormal hemoglobin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Macropolycytes in a peripheral blood smear are a feature of megaloblastic anemia , which is often due to vitamin B12 or folate deficiency and is characterized by macrocytosis and hypersegmented neutrophils.&lt;/li&gt;&lt;li&gt;âž¤ Macropolycytes&lt;/li&gt;&lt;li&gt;âž¤ megaloblastic anemia&lt;/li&gt;&lt;li&gt;âž¤ due to vitamin B12 or folate deficiency&lt;/li&gt;&lt;li&gt;âž¤ macrocytosis and hypersegmented neutrophils.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 652&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 652&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All are laboratory finding in iron deficiency anemia except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decreased serum iron&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increased total iron binding capacity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreased serum ferritin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased mean corpuscular volume&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Increased mean corpuscular volume&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Increased mean corpuscular volume&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Decreased serum iron: In iron deficiency anemia, there is a decrease in serum iron levels because there is insufficient iron available for hemoglobin synthesis .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Decreased serum iron:&lt;/li&gt;&lt;li&gt;â€¢ decrease in serum iron levels&lt;/li&gt;&lt;li&gt;â€¢ insufficient iron&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin synthesis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increased total iron binding capacity (TIBC): TIBC increases in iron deficiency anemia. It represents the maximum amount of iron that can be bound to transferrin .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increased total iron binding capacity (TIBC):&lt;/li&gt;&lt;li&gt;â€¢ maximum amount of iron&lt;/li&gt;&lt;li&gt;â€¢ transferrin&lt;/li&gt;&lt;li&gt;â€¢ Option C. Decreased serum ferritin: Serum ferritin levels decrease in iron deficiency anemia . Ferritin is an indicator of iron stores, and low levels suggest depleted iron stores.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Decreased serum ferritin:&lt;/li&gt;&lt;li&gt;â€¢ iron deficiency anemia&lt;/li&gt;&lt;li&gt;â€¢ iron stores, and low levels&lt;/li&gt;&lt;li&gt;â€¢ depleted iron stores.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Increased mean corpuscular volume (MCV) is not a finding in iron deficiency anemia ; rather, this condition is characterized by a decreased MCV due to microcytic, hypochromic red blood cells resulting from insufficient iron for hemoglobin synthesis.&lt;/li&gt;&lt;li&gt;âž¤ Increased mean corpuscular volume (MCV)&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ iron deficiency anemia&lt;/li&gt;&lt;li&gt;âž¤ decreased MCV due to microcytic, hypochromic red blood cells&lt;/li&gt;&lt;li&gt;âž¤ insufficient iron for hemoglobin synthesis.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 652&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 652&lt;/li&gt;&lt;li&gt;âž¤ Robbins 10 th / 658&lt;/li&gt;&lt;li&gt;âž¤ Robbins 10 th / 658&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old male is undergoing workup for fatigue and joint pain. His serum ferritin levels are markedly elevated, and a liver biopsy shows iron deposition. Which of the following most directly regulates iron uptake in the gut?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mucosal cell iron stores&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Route of administration&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Preparation administered&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Age of the patient&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Mucosal cell iron stores&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Mucosal cell iron stores&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. The route of administration, such as oral or parenteral , can influence the rate of iron absorption but does not directly regulate iron uptake at the molecular level .&lt;/li&gt;&lt;li&gt;â€¢ Option B. The route of administration,&lt;/li&gt;&lt;li&gt;â€¢ oral or parenteral&lt;/li&gt;&lt;li&gt;â€¢ iron absorption&lt;/li&gt;&lt;li&gt;â€¢ iron uptake at the molecular level&lt;/li&gt;&lt;li&gt;â€¢ Option C. The preparation administered , for example, ferrous sulfate versus ferric gluconate , can affect the efficiency of absorption but , like the route, does not regulate the iron uptake process per se.&lt;/li&gt;&lt;li&gt;â€¢ Option C. The preparation administered&lt;/li&gt;&lt;li&gt;â€¢ ferrous sulfate versus ferric gluconate&lt;/li&gt;&lt;li&gt;â€¢ efficiency of absorption but&lt;/li&gt;&lt;li&gt;â€¢ does not regulate the iron uptake process&lt;/li&gt;&lt;li&gt;â€¢ Option D. The age of the patient can affect the demand for iron , especially during growth spurts or aging , but it is not a direct regulator of iron uptake in the gut.&lt;/li&gt;&lt;li&gt;â€¢ Option D. The age of the patient&lt;/li&gt;&lt;li&gt;â€¢ demand for iron&lt;/li&gt;&lt;li&gt;â€¢ growth spurts or aging&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Mucosal cell iron stores , through their regulation of hepcidin synthesis, play a direct role in regulating iron uptake across the gut mucosa , which is crucial for maintaining systemic iron homeostasis .&lt;/li&gt;&lt;li&gt;âž¤ Mucosal cell iron stores&lt;/li&gt;&lt;li&gt;âž¤ hepcidin synthesis,&lt;/li&gt;&lt;li&gt;âž¤ regulating iron uptake&lt;/li&gt;&lt;li&gt;âž¤ gut mucosa&lt;/li&gt;&lt;li&gt;âž¤ systemic iron homeostasis&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 658&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ Robbins 10 th / 658&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male with a history of hereditary hemochromatosis is being evaluated for his condition. Which of the following is considered the most important but nonspecific regulator of iron metabolism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hepcidin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;DMT1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ferroportin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ferritin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Hepcidin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Hepcidin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. DMT1 (Divalent metal transporter 1) is a specific transporter that moves ferrous iron across the apical membrane of enterocytes. While important for iron uptake, it has a more focused role.&lt;/li&gt;&lt;li&gt;â€¢ Option B. DMT1&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ferroportin is the protein responsible for exporting iron from cells into the plasma. It has a specific function and is regulated by hepcidin.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ferroportin&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ferritin is the primary intracellular iron storage protein and is a marker of iron stores but does not regulate iron metabolism directly.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ferritin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hepcidin is the most important but nonspecific regulator of iron metabolism since it not only controls iron homeostasis but also has broader effects including antimicrobial activity and is influenced by various physiological and pathological conditions.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Robbins 10th/ 652&lt;/li&gt;&lt;li&gt;âž¤ Ref: Robbins 10th/ 652&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old male presents with dark urine in the morning and has been found to have hemolytic anemia on laboratory evaluation. A diagnostic test reveals increased sensitivity of his red blood cells to lysis in acidified serum. Which of the following underlying defects is most consistent with these findings?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Spectrin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Defect in complement activating proteins&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Defective GPI anchor&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mannose-binding residue effect&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Defective GPI anchor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Â Defective GPI anchor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Spectrin is a cytoskeletal protein that helps maintain the red blood cell&#x27;s shape . Defects in spectrin can cause hereditary spherocytosis but are not associated with increased red cell lysis in acidified serum.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Spectrin is a cytoskeletal protein&lt;/li&gt;&lt;li&gt;â€¢ red blood cell&#x27;s shape&lt;/li&gt;&lt;li&gt;â€¢ hereditary spherocytosis&lt;/li&gt;&lt;li&gt;â€¢ Option B. A defect in complement activating proteins may lead to conditions such as hereditary angioedema , but they do not result in the increased red cell lysis characteristic of the Ham test.&lt;/li&gt;&lt;li&gt;â€¢ Option B. A defect in complement&lt;/li&gt;&lt;li&gt;â€¢ hereditary angioedema&lt;/li&gt;&lt;li&gt;â€¢ Option D. The Mannose-binding lectin pathway is involved in innate immunity and can lead to opsonization and phagocytosis of pathogens, but defects here do not lead to the clinical picture described.&lt;/li&gt;&lt;li&gt;â€¢ Option D. The Mannose-binding lectin&lt;/li&gt;&lt;li&gt;â€¢ innate immunity&lt;/li&gt;&lt;li&gt;â€¢ opsonization and phagocytosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A defective GPI anchor is implicated in paroxysmal nocturnal hemoglobinuria (PNH), a condition that can be diagnosed with the Ham test , indicating increased red blood cell lysis in acidified serum due to increased complement sensitivity.&lt;/li&gt;&lt;li&gt;âž¤ defective GPI anchor&lt;/li&gt;&lt;li&gt;âž¤ paroxysmal nocturnal hemoglobinuria (PNH),&lt;/li&gt;&lt;li&gt;âž¤ Ham test&lt;/li&gt;&lt;li&gt;âž¤ increased red blood cell lysis&lt;/li&gt;&lt;li&gt;âž¤ increased complement sensitivity.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 645&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 645&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old man presents with acrocyanosis and hemolysis after exposure to cold temperatures. His direct Coombs&#x27; test is positive with cold sub type of antibodies. Which of the following antibodies is most likely responsible for his condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti IgM&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti IgG&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti IgA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Donath-Landsteiner antibody&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Donath-Landsteiner antibody&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Donath-Landsteiner antibody&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A.  Anti-IgM would imply an antibody against IgM itself, which is not the cause of cold hemagglutinin disease . Cold agglutinins are typically IgM antibodies that can agglutinate and lyse red blood cells at cold temperatures.&lt;/li&gt;&lt;li&gt;â€¢ Option A.  Anti-IgM would imply&lt;/li&gt;&lt;li&gt;â€¢ antibody against IgM&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ cold hemagglutinin disease&lt;/li&gt;&lt;li&gt;â€¢ Option B.  Anti-IgG suggests an antibody against IgG , which is not typically involved in cold hemagglutinin disease . IgG antibodies can, however, cause warm autoimmune hemolytic anemia .&lt;/li&gt;&lt;li&gt;â€¢ Option B.  Anti-IgG suggests&lt;/li&gt;&lt;li&gt;â€¢ antibody against IgG&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ cold hemagglutinin disease&lt;/li&gt;&lt;li&gt;â€¢ warm autoimmune hemolytic anemia&lt;/li&gt;&lt;li&gt;â€¢ Option C.  Anti-IgA indicates an antibody against IgA and is not associated with cold hemagglutinin disease.&lt;/li&gt;&lt;li&gt;â€¢ Option C.  Anti-IgA indicates&lt;/li&gt;&lt;li&gt;â€¢ antibody against IgA&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Donath-Landsteiner antibody is the cause of paroxysmal cold hemoglobinuria , a rare type of cold hemagglutinin disease , which can present with symptoms like acrocyanosis and hemolysis after cold exposure .&lt;/li&gt;&lt;li&gt;âž¤ Donath-Landsteiner antibody&lt;/li&gt;&lt;li&gt;âž¤ paroxysmal cold hemoglobinuria&lt;/li&gt;&lt;li&gt;âž¤ cold hemagglutinin disease&lt;/li&gt;&lt;li&gt;âž¤ acrocyanosis and hemolysis after cold exposure&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 648&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 648&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Microspherocytes in peripheral blood smear are seen in:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Congenital spherocytosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Autoimmune acquired hemolytic anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thalassemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Congenital spherocytosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Congenital spherocytosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. In autoimmune hemolytic anemia , spherocytes can also be present due to the partial phagocytosis of the red blood cell membrane by macrophages in response to antibody binding .&lt;/li&gt;&lt;li&gt;â€¢ Option B. In autoimmune&lt;/li&gt;&lt;li&gt;â€¢ hemolytic anemia&lt;/li&gt;&lt;li&gt;â€¢ spherocytes&lt;/li&gt;&lt;li&gt;â€¢ partial phagocytosis of the red blood cell membrane&lt;/li&gt;&lt;li&gt;â€¢ macrophages&lt;/li&gt;&lt;li&gt;â€¢ antibody binding&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thalassemia typically presents with target cells and microcytes on blood smear, not specifically spherocytes. It involves a defect in hemoglobin production .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thalassemia typically&lt;/li&gt;&lt;li&gt;â€¢ target cells and microcytes&lt;/li&gt;&lt;li&gt;â€¢ defect in hemoglobin production&lt;/li&gt;&lt;li&gt;â€¢ Option D. While spherocytes can be seen in autoimmune hemolytic anemia , they are not a feature of thalassemia. Hence, the presence of spherocytes is not common to all the conditions listed.&lt;/li&gt;&lt;li&gt;â€¢ Option D. While spherocytes&lt;/li&gt;&lt;li&gt;â€¢ autoimmune hemolytic anemia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Congenital spherocytosis is the condition most consistently associated with the presence of small, round red blood cells without central pallor (spherocytes) on a peripheral blood smear .&lt;/li&gt;&lt;li&gt;âž¤ Congenital spherocytosis&lt;/li&gt;&lt;li&gt;âž¤ small, round red blood cells without central pallor (spherocytes) on a peripheral blood smear&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with signs of anemia and a history of taking a medication known to cause hemolysis. Blood tests reveal anemia, and a direct antiglobulin test (DAT) is performed. Which of the following conditions is least likely to be associated with a positive direct Coombs test?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Drug induced AIHA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aplastic anemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hemolytic anemia due to transfusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hemolytic disease of newborn&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Aplastic anemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Aplastic anemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Drug-induced AIHA can lead to the production of antibodies against red blood cells (RBCs) or induce the RBCs to adsorb plasma proteins, in either case leading to a positive Coombs test.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Drug-induced AIHA&lt;/li&gt;&lt;li&gt;â€¢ antibodies against red blood cells (RBCs)&lt;/li&gt;&lt;li&gt;â€¢ RBCs to adsorb plasma proteins,&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hemolytic anemia due to a transfusion reaction can occur if the transfused blood is not compatible with the patient&#x27;s blood type , leading to antibody-mediated destruction of RBCs and a positive Coombs test .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hemolytic anemia&lt;/li&gt;&lt;li&gt;â€¢ transfusion reaction&lt;/li&gt;&lt;li&gt;â€¢ not compatible&lt;/li&gt;&lt;li&gt;â€¢ patient&#x27;s blood type&lt;/li&gt;&lt;li&gt;â€¢ antibody-mediated destruction of RBCs&lt;/li&gt;&lt;li&gt;â€¢ positive Coombs test&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hemolytic disease of the newborn, such as Rh or ABO incompatibility, involves maternal antibodies targeting fetal RBCs , which would yield a positive Coombs test.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hemolytic disease&lt;/li&gt;&lt;li&gt;â€¢ Rh or ABO incompatibility,&lt;/li&gt;&lt;li&gt;â€¢ maternal antibodies&lt;/li&gt;&lt;li&gt;â€¢ fetal RBCs&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A positive direct Coombs test indicates the presence of antibodies bound to RBCs , which is seen in conditions like drug-induced AIHA, hemolytic transfusion reactions, and hemolytic disease of the newborn, but not in aplastic anemia.&lt;/li&gt;&lt;li&gt;âž¤ positive direct Coombs test&lt;/li&gt;&lt;li&gt;âž¤ presence of antibodies&lt;/li&gt;&lt;li&gt;âž¤ RBCs&lt;/li&gt;&lt;li&gt;âž¤ drug-induced AIHA, hemolytic transfusion reactions, and hemolytic disease of the newborn,&lt;/li&gt;&lt;li&gt;âž¤ not in aplastic anemia.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 655&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 655&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 26-yearâ€‘old female presents with pallor with a hemoglobin of 9.5 g/dL, PCV 30 mm Hg and RBC count of 2 million per cubic millimeters. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sideroblastic anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Iron deficiency anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thalassemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Folic acid deficiency&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Folic acid deficiency&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/10/whatsapp-image-2024-09-10-at-114902-am.jpeg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Folic acid deficiency&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sideroblastic anemia usually results in a microcytic anemia due to ineffective iron utilization , making it an unlikely cause of macrocytic anemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sideroblastic anemia&lt;/li&gt;&lt;li&gt;â€¢ microcytic anemia&lt;/li&gt;&lt;li&gt;â€¢ ineffective iron utilization&lt;/li&gt;&lt;li&gt;â€¢ Option B. Iron deficiency anemia typically presents with microcytic, hypochromic anemia due to the reduced hemoglobin content within RBC s, not macrocytic anemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Iron deficiency anemia&lt;/li&gt;&lt;li&gt;â€¢ microcytic, hypochromic anemia&lt;/li&gt;&lt;li&gt;â€¢ reduced&lt;/li&gt;&lt;li&gt;â€¢ RBC&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thalassemia is another cause of microcytic anemia , associated with genetic mutations leading to abnormal hemoglobin production . It does not cause macrocytic anemia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thalassemia is another&lt;/li&gt;&lt;li&gt;â€¢ microcytic anemia&lt;/li&gt;&lt;li&gt;â€¢ genetic mutations&lt;/li&gt;&lt;li&gt;â€¢ abnormal hemoglobin production&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Upon finding an MCV of 150 fL , which indicates macrocytic anemia, folic acid deficiency becomes the most likely diagnosis among the options provided because it, along with vitamin B12 deficiency, can cause macrocytosis .&lt;/li&gt;&lt;li&gt;âž¤ MCV of 150 fL&lt;/li&gt;&lt;li&gt;âž¤ macrocytic anemia, folic acid deficiency&lt;/li&gt;&lt;li&gt;âž¤ vitamin B12 deficiency, can cause macrocytosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with anemia and jaundice. The osmotic fragility test is normal, but the patient has an enlarged spleen. which of the following is not an intrinsic cause of of hemolytic anemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;G6PD deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hereditary spherocytosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypersplenism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pyruvate kinase deficiency&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hypersplenism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Hypersplenism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. G6PD deficiency is an intrinsic cause of hemolytic anemia due to a defect in the red blood cell enzyme G6PD, which is necessary to protect the cell from oxidative damage.&lt;/li&gt;&lt;li&gt;â€¢ Option A. G6PD deficiency&lt;/li&gt;&lt;li&gt;â€¢ intrinsic&lt;/li&gt;&lt;li&gt;â€¢ hemolytic anemia&lt;/li&gt;&lt;li&gt;â€¢ red blood cell enzyme G6PD,&lt;/li&gt;&lt;li&gt;â€¢ protect the cell&lt;/li&gt;&lt;li&gt;â€¢ oxidative damage.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hereditary spherocytosis is an intrinsic cause of hemolytic anemia characterized by a defect in the red blood cell membrane proteins that provide structural support , resulting in spherical red blood cells that are prone to destruction .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hereditary&lt;/li&gt;&lt;li&gt;â€¢ spherocytosis&lt;/li&gt;&lt;li&gt;â€¢ intrinsic cause of hemolytic anemia&lt;/li&gt;&lt;li&gt;â€¢ red blood cell membrane proteins&lt;/li&gt;&lt;li&gt;â€¢ structural support&lt;/li&gt;&lt;li&gt;â€¢ spherical red blood cells&lt;/li&gt;&lt;li&gt;â€¢ prone to destruction&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pyruvate kinase deficiency is an intrinsic cause of hemolytic anemia due to a defect in the enzyme pyruvate kinase , which is involved in the glycolytic pathway of red blood cells , leading to a lack of ATP and subsequent cell death .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pyruvate kinase&lt;/li&gt;&lt;li&gt;â€¢ deficiency&lt;/li&gt;&lt;li&gt;â€¢ hemolytic anemia&lt;/li&gt;&lt;li&gt;â€¢ enzyme pyruvate kinase&lt;/li&gt;&lt;li&gt;â€¢ glycolytic pathway of red blood cells&lt;/li&gt;&lt;li&gt;â€¢ lack of ATP&lt;/li&gt;&lt;li&gt;â€¢ subsequent cell death&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hypersplenism is an extracorpuscular cause of hemolytic anemia and not an intrinsic defect of the red blood cell itself , which distinguishes it from conditions such as G6PD deficiency, hereditary spherocytosis, and pyruvate kinase deficiency that are intrinsic to the red cells.&lt;/li&gt;&lt;li&gt;âž¤ Hypersplenism&lt;/li&gt;&lt;li&gt;âž¤ extracorpuscular&lt;/li&gt;&lt;li&gt;âž¤ hemolytic anemia&lt;/li&gt;&lt;li&gt;âž¤ not an intrinsic defect of the red blood cell itself&lt;/li&gt;&lt;li&gt;âž¤ G6PD deficiency, hereditary spherocytosis, and pyruvate kinase deficiency&lt;/li&gt;&lt;li&gt;âž¤ intrinsic to the red cells.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Robbins 9/e 631&lt;/li&gt;&lt;li&gt;âž¤ Ref: Robbins 9/e 631&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old male presents with fatigue, light-headedness, and a beefy-red tongue. Laboratory tests show macrocytosis and hypersegmented neutrophils. Which of the following laboratory findings is inconsistent with untreated megaloblastic anemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased reticulocyte count&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Raised Bilirubin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mild splenomegaly&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nucleated RBC&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Increased reticulocyte count&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Increased reticulocyte count&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Raised bilirubin levels can be seen in megaloblastic anemia due to increased destruction of defective erythroid precursor cells in the bone marrow, which release bilirubin into the blood.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Raised bilirubin&lt;/li&gt;&lt;li&gt;â€¢ megaloblastic anemia&lt;/li&gt;&lt;li&gt;â€¢ increased destruction of defective erythroid precursor&lt;/li&gt;&lt;li&gt;â€¢ cells in the bone marrow,&lt;/li&gt;&lt;li&gt;â€¢ bilirubin&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mild splenomegaly may be observed in megaloblastic anemia as the spleen works to filter the abnormal cells from the bloodstream.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mild splenomegaly&lt;/li&gt;&lt;li&gt;â€¢ megaloblastic anemia&lt;/li&gt;&lt;li&gt;â€¢ filter the abnormal cells&lt;/li&gt;&lt;li&gt;â€¢ bloodstream.&lt;/li&gt;&lt;li&gt;â€¢ Option D. The presence of nucleated RBCs in the peripheral blood smear is a sign of severe anemia , including megaloblastic anemia , where immature and abnormal erythroid precursor cells are released into the bloodstream.&lt;/li&gt;&lt;li&gt;â€¢ Option D. The presence&lt;/li&gt;&lt;li&gt;â€¢ nucleated RBCs&lt;/li&gt;&lt;li&gt;â€¢ severe anemia&lt;/li&gt;&lt;li&gt;â€¢ megaloblastic anemia&lt;/li&gt;&lt;li&gt;â€¢ immature and abnormal erythroid precursor cells&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ in untreated megaloblastic anemia , the reticulocyte count is low due to impaired DNA synthesis and ineffective erythropoiesis. An increased reticulocyte count after initiating treatment with vitamin B12 and folate supplementation indicates a positive response to therapy.&lt;/li&gt;&lt;li&gt;âž¤ untreated megaloblastic anemia&lt;/li&gt;&lt;li&gt;âž¤ reticulocyte count is low due to impaired DNA synthesis&lt;/li&gt;&lt;li&gt;âž¤ ineffective erythropoiesis.&lt;/li&gt;&lt;li&gt;âž¤ increased reticulocyte count&lt;/li&gt;&lt;li&gt;âž¤ vitamin B12 and folate supplementation&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 645, Wintrobeâ€™s 12th/1151-3&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 645, Wintrobeâ€™s 12th/1151-3&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old male presents with fatigue, pallor, and glossitis. Laboratory findings show macrocytic anemia. He reports frequently consuming raw fish. Which organism is most likely responsible for his anemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ancylostoma duodenale&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diphyllobothrium latum&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Giardia lamblia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Taenia solium&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Diphyllobothrium latum&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.Â Diphyllobothrium latum&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ancylostoma duodenale: Ancylostoma duodenale, or hookworm, causes iron deficiency anemia by chronic blood loss in the intestines where the worms attach to the mucosa and feed on blood , leading to microcytic hypochromic anemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ancylostoma duodenale:&lt;/li&gt;&lt;li&gt;â€¢ hookworm, causes iron deficiency anemia&lt;/li&gt;&lt;li&gt;â€¢ chronic blood loss in the intestines&lt;/li&gt;&lt;li&gt;â€¢ mucosa and feed on blood&lt;/li&gt;&lt;li&gt;â€¢ microcytic hypochromic anemia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Giardia lamblia: Giardiasis, caused by Giardia lamblia, typically leads to malabsorption and diarrhea but does not directly cause anemia . It is not known to cause megaloblastic anemia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Giardia lamblia:&lt;/li&gt;&lt;li&gt;â€¢ malabsorption and diarrhea&lt;/li&gt;&lt;li&gt;â€¢ does not directly&lt;/li&gt;&lt;li&gt;â€¢ cause anemia&lt;/li&gt;&lt;li&gt;â€¢ Option D: Taenia solium: Taenia solium, or pork tapeworm , usually causes intestinal disturbances or systemic issues when in its larval form but does not cause megaloblastic anemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Taenia solium:&lt;/li&gt;&lt;li&gt;â€¢ pork tapeworm&lt;/li&gt;&lt;li&gt;â€¢ intestinal disturbances or systemic issues&lt;/li&gt;&lt;li&gt;â€¢ larval form&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The correct answer is Option B: Diphyllobothrium latum or fish tapeworm causes megaloblastic anemia due to vitamin B12 deficiency ,&lt;/li&gt;&lt;li&gt;âž¤ Option B: Diphyllobothrium latum or fish tapeworm causes megaloblastic anemia due to vitamin B12 deficiency&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 651&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 651&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old male with a history of strict vegetarianism presents with weakness and paresthesias. A CBC shows macrocytosis, and his serum vitamin B12 level is low. Which of the following is most consistent with the pathophysiology of his condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Microcytic hypochromic anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sickled red cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anemia occurs after 3-4 years of poor absorption&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Development of polycythemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Anemia occurs after 3-4 years of poor absorption&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Anemia occurs after 3-4 years of poor absorption&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Microcytic hypochromic anemia is typically associated with iron deficiency, thalassemia, or other disorders of hemoglobin synthesis, not with vitamin B12 deficiency .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Microcytic hypochromic anemia&lt;/li&gt;&lt;li&gt;â€¢ iron deficiency, thalassemia,&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin synthesis,&lt;/li&gt;&lt;li&gt;â€¢ vitamin B12 deficiency&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sickled red cells are characteristic of sickle cell anemia , a genetic disorder caused by a mutation in the hemoglobin gene , not related to vitamin B12 absorption.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Sickled red cells&lt;/li&gt;&lt;li&gt;â€¢ sickle cell anemia&lt;/li&gt;&lt;li&gt;â€¢ genetic disorder&lt;/li&gt;&lt;li&gt;â€¢ mutation in the hemoglobin gene&lt;/li&gt;&lt;li&gt;â€¢ Option D. Polycythemia refers to an increased concentration of hemoglobin in the blood , typically not related to vitamin B12 deficiency. Instead, vitamin B12 deficiency would lead to a decrease in red cell production due to maturation failure .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Polycythemia&lt;/li&gt;&lt;li&gt;â€¢ increased concentration of hemoglobin in the blood&lt;/li&gt;&lt;li&gt;â€¢ vitamin B12 deficiency&lt;/li&gt;&lt;li&gt;â€¢ decrease in red cell production&lt;/li&gt;&lt;li&gt;â€¢ maturation failure&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ When considering a diagnosis of megaloblastic anemia due to vitamin B12 deficiency, significant hepatic stores of vitamin B12 can delay the onset of anemia for several years in patients with poor dietary intake .&lt;/li&gt;&lt;li&gt;âž¤ megaloblastic anemia due to vitamin B12 deficiency,&lt;/li&gt;&lt;li&gt;âž¤ hepatic stores of vitamin B12&lt;/li&gt;&lt;li&gt;âž¤ delay the onset of anemia for several years&lt;/li&gt;&lt;li&gt;âž¤ poor dietary intake&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 651-2&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 651-2&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old female presents with fatigue, weakness, and shortness of breath. Laboratory investigations reveal macrocytic anemia, and the FIGLU test is conducted to assess the etiology. FIGLU test is done for:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cyanocobalamin deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Folic acid deficiency&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thiamine deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Riboflavin deficiency&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Folic acid deficiency&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Folic acid deficiency&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Vitamin B12 deficiency can lead to macrocytic anemia and is usually confirmed by low serum levels of B12 or elevated serum methylmalonic acid and homocysteine levels , not typically with a FIGLU test.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Vitamin B12&lt;/li&gt;&lt;li&gt;â€¢ macrocytic anemia&lt;/li&gt;&lt;li&gt;â€¢ low serum levels of B12 or elevated serum methylmalonic acid and homocysteine levels&lt;/li&gt;&lt;li&gt;â€¢ Option C. Deficiency of thiamine leads to conditions like beriberi or Wernicke-Korsakoff syndrome , not typically associated with macrocytic anemia or a positive FIGLU test.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Deficiency&lt;/li&gt;&lt;li&gt;â€¢ thiamine&lt;/li&gt;&lt;li&gt;â€¢ beriberi or Wernicke-Korsakoff syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option D. Riboflavin deficiency is associated with symptoms such as angular stomatitis and glossitis, but not usually with macrocytic anemia, and it does not cause elevated FIGLU levels.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Riboflavin&lt;/li&gt;&lt;li&gt;â€¢ angular stomatitis and glossitis,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with unexplained macrocytic anemia, a positive FIGLU test in the urine indicates a deficiency in folate . FIGLU is a biomarker for intracellular levels of folate .&lt;/li&gt;&lt;li&gt;âž¤ unexplained macrocytic anemia,&lt;/li&gt;&lt;li&gt;âž¤ positive FIGLU test&lt;/li&gt;&lt;li&gt;âž¤ deficiency in folate&lt;/li&gt;&lt;li&gt;âž¤ biomarker&lt;/li&gt;&lt;li&gt;âž¤ for&lt;/li&gt;&lt;li&gt;âž¤ intracellular levels of folate&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Hypersegmented neutrophils are present in which of the following anemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hemolytic â€‹â€‹â€‹â€‹â€‹&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Iron deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Megaloblastic â€‹â€‹â€‹â€‹â€‹â€‹&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aplastic&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Megaloblastic â€‹â€‹â€‹â€‹â€‹â€‹&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Megaloblastic&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hemolytic anemias are characterized by the premature destruction of red blood cells, but they do not typically cause hypersegmentation of neutrophils .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hemolytic&lt;/li&gt;&lt;li&gt;â€¢ anemias&lt;/li&gt;&lt;li&gt;â€¢ hypersegmentation of neutrophils&lt;/li&gt;&lt;li&gt;â€¢ Option B. Iron deficiency anemia is characterized by microcytic and hypochromic red blood cells , and it does not usually result in hypersegmentation of neutrophils.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Iron deficiency anemia&lt;/li&gt;&lt;li&gt;â€¢ microcytic and hypochromic red blood cells&lt;/li&gt;&lt;li&gt;â€¢ Option D. Aplastic anemia is characterized by a reduction in the number of all blood cell types (red blood cells, white blood cells, and platelets) due to bone marrow failure . It does not cause hypersegmentation of neutrophils.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Aplastic anemia&lt;/li&gt;&lt;li&gt;â€¢ reduction in the number of all blood cell types (red blood cells, white blood cells, and platelets)&lt;/li&gt;&lt;li&gt;â€¢ bone marrow failure&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hypersegmented neutrophils are indicative of megaloblastic anemia , a condition arising from impaired DNA synthesis which leads to abnormally large red blood cells and distinctive changes in neutrophils . This finding is not typical of hemolytic, iron deficiency, or aplastic anemias.&lt;/li&gt;&lt;li&gt;âž¤ Hypersegmented neutrophils&lt;/li&gt;&lt;li&gt;âž¤ megaloblastic anemia&lt;/li&gt;&lt;li&gt;âž¤ impaired DNA synthesis&lt;/li&gt;&lt;li&gt;âž¤ large red blood cells&lt;/li&gt;&lt;li&gt;âž¤ distinctive changes in neutrophils&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 652&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 652&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 24-year-old woman presents with mild anemia noted on routine screening. She reports a family history of anemia but has no significant personal medical history. She denies any symptoms of anemia. A hemoglobin electrophoresis is performed, showing an increased HbA2 level. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Beta thalassemia trait&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sickle cell anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hereditory spherocytosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;G6 PD deficiency&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Beta thalassemia trait&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Beta thalassemia trait&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sickle cell anemia is characterized by a mutation in the beta-globin gene that leads to the production of hemoglobin S. Hemoglobin electrophoresis in sickle cell anemia typically shows a predominance of HbS and possibly elevated HbF but not HbA2.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sickle cell anemia&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hereditary spherocytosis is a disorder of the red blood cell membrane leading to spherical erythrocytes and hemolytic anemia. It does not involve abnormalities in hemoglobin synthesis or elevated HbA2 levels.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hereditary spherocytosis&lt;/li&gt;&lt;li&gt;â€¢ Option D. G6PD deficiency is an X-linked enzymatic defect leading to hemolytic anemia under conditions of oxidative stress. It is not associated with an increase in HbA2 on electrophoresis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. G6PD deficiency&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ When a hemoglobin electrophoresis reveals increased HbA2 levels, it is indicative of beta thalassemia trait, reflecting an imbalance in globin chain production.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 641&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 641&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT a clinical presentation feature of paroxysmal nocturnal hemoglobinuria?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thrombosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Leukemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Aplastic anemia â€‹â€‹â€‹â€‹â€‹&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hemolysis â€‹â€‹â€‹â€‹â€‹&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Leukemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Leukemi&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Thrombosis, particularly in unusual sites such as the hepatic or cerebral veins , is a well-recognized complication of paroxysmal nocturnal hemoglobinuria (PNH) due to the increased propensity for red blood cells to activate the complement system and the coagulation cascade .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Thrombosis,&lt;/li&gt;&lt;li&gt;â€¢ hepatic or cerebral veins&lt;/li&gt;&lt;li&gt;â€¢ of paroxysmal nocturnal hemoglobinuria (PNH)&lt;/li&gt;&lt;li&gt;â€¢ increased propensity for red blood cells&lt;/li&gt;&lt;li&gt;â€¢ complement system and the coagulation cascade&lt;/li&gt;&lt;li&gt;â€¢ Option C. Aplastic anemia can be a presenting feature of PNH due to the associated bone marrow failure that can occur with the disease process.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Aplastic anemia&lt;/li&gt;&lt;li&gt;â€¢ PNH due to the associated bone marrow failure&lt;/li&gt;&lt;li&gt;â€¢ Option D. Intravascular hemolysis is a hallmark of PNH , caused by the increased sensitivity of red blood cells to complement due to a deficiency in GPI-anchored proteins that normally protect the cell membrane from complement activation .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Intravascular hemolysis&lt;/li&gt;&lt;li&gt;â€¢ hallmark of PNH&lt;/li&gt;&lt;li&gt;â€¢ increased sensitivity of red blood cells to complement due to a deficiency in GPI-anchored proteins&lt;/li&gt;&lt;li&gt;â€¢ cell membrane from complement activation&lt;/li&gt;&lt;li&gt;â€¢ ducational Objective:&lt;/li&gt;&lt;li&gt;â€¢ ducational Objective:&lt;/li&gt;&lt;li&gt;â€¢ PNH is characterized by hemolytic anemia, pancytopenia, and thrombosis , but leukemia is not a feature of PNH but may be a secondary complication of the disease.&lt;/li&gt;&lt;li&gt;â€¢ PNH&lt;/li&gt;&lt;li&gt;â€¢ hemolytic anemia, pancytopenia, and thrombosis&lt;/li&gt;&lt;li&gt;â€¢ leukemia is not a feature of PNH&lt;/li&gt;&lt;li&gt;â€¢ secondary complication&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins 10th/e p648&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins 10th/e p648&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male presents with fatigue, weakness, and pallor. Laboratory investigations reveal a microcytic, hypochromic anemia. Peripheral blood smear shows microcytic red blood cells, and bone marrow biopsy confirms the presence of ringed sideroblasts. The patient does not have a history of significant alcohol consumption. Which of the following treatments is most likely to improve the anemia in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Iron â€‹â€‹â€‹â€‹â€‹â€‹&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;B1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pyridoxine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;B12&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pyridoxine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Pyridoxine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. iron supplementation is used for iron deficiency anemia, which typically does not feature ringed sideroblasts. In sideroblastic anemia , there is usually adequate or increased iron in the body , but it&#x27;s not properly incorporated into hemoglobin.&lt;/li&gt;&lt;li&gt;â€¢ Option A. iron supplementation is used&lt;/li&gt;&lt;li&gt;â€¢ iron deficiency anemia,&lt;/li&gt;&lt;li&gt;â€¢ sideroblastic anemia&lt;/li&gt;&lt;li&gt;â€¢ adequate or increased iron in the body&lt;/li&gt;&lt;li&gt;â€¢ Option B.Thiamine deficiency does not typically cause sideroblastic anemia , so supplementation would not address the underlying pathophysiology in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option B.Thiamine deficiency&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ sideroblastic anemia&lt;/li&gt;&lt;li&gt;â€¢ would not address&lt;/li&gt;&lt;li&gt;â€¢ pathophysiology&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vitamin B12 deficiency causes megaloblastic anemia , not typically sideroblastic anemia, so this would not be the treatment of choice for a patient with ringed sideroblasts .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vitamin B12 deficiency&lt;/li&gt;&lt;li&gt;â€¢ megaloblastic anemia&lt;/li&gt;&lt;li&gt;â€¢ sideroblastic anemia,&lt;/li&gt;&lt;li&gt;â€¢ not be the&lt;/li&gt;&lt;li&gt;â€¢ treatment of choice&lt;/li&gt;&lt;li&gt;â€¢ ringed sideroblasts&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sideroblastic anemia can be responsive to pyridoxine supplementation, especially when ringed sideroblasts are observed on bone marrow biopsy and the patient does not have a history of conditions that could cause secondary sideroblastic anemia , such as alcoholism or lead poisoning.&lt;/li&gt;&lt;li&gt;âž¤ Sideroblastic anemia&lt;/li&gt;&lt;li&gt;âž¤ pyridoxine supplementation,&lt;/li&gt;&lt;li&gt;âž¤ ringed sideroblasts&lt;/li&gt;&lt;li&gt;âž¤ bone marrow biopsy&lt;/li&gt;&lt;li&gt;âž¤ does not&lt;/li&gt;&lt;li&gt;âž¤ cause secondary sideroblastic anemia&lt;/li&gt;&lt;li&gt;âž¤ alcoholism or lead poisoning.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old man with a history of rheumatoid arthritis presents with fatigue and exertional dyspnea. Laboratory tests show a mild anemia with a hemoglobin of 10 g/dL. Further workup reveals the following: serum ferritin is elevated, total iron-binding capacity (TIBC) is decreased, serum iron is reduced, and transferrin saturation percentage is decreased. Which laboratory finding is most characteristic of the anemia of chronic disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;TIBC â†‘&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;S. Iron â†‘&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;BM iron â†“&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;S. ferritin â†‘&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. S. ferritin â†‘&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. S. ferritin â†‘&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. TIBC is typically increased due to the body&#x27;s attempt to increase iron binding capacity in response to low iron stores , which is not the case in anemia of chronic disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. TIBC is typically&lt;/li&gt;&lt;li&gt;â€¢ increased&lt;/li&gt;&lt;li&gt;â€¢ increase iron binding capacity&lt;/li&gt;&lt;li&gt;â€¢ low iron stores&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anemia of chronic disease typically presents with decreased serum iron due to sequestration of iron within macrophages and hepatocytes .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anemia of chronic disease&lt;/li&gt;&lt;li&gt;â€¢ decreased serum iron due to sequestration of iron&lt;/li&gt;&lt;li&gt;â€¢ macrophages and hepatocytes&lt;/li&gt;&lt;li&gt;â€¢ Option C. In anemia of chronic disease , bone marrow iron stores are usually normal or increased , not decreased.&lt;/li&gt;&lt;li&gt;â€¢ Option C. In anemia of chronic disease&lt;/li&gt;&lt;li&gt;â€¢ iron stores&lt;/li&gt;&lt;li&gt;â€¢ normal or increased&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The most characteristic laboratory finding in anemia of chronic disease is increased serum ferritin, reflecting sequestered iron stores that are not available for effective erythropoiesis despite the body having adequate or increased total iron.&lt;/li&gt;&lt;li&gt;âž¤ anemia of chronic disease&lt;/li&gt;&lt;li&gt;âž¤ increased serum ferritin,&lt;/li&gt;&lt;li&gt;âž¤ sequestered iron stores&lt;/li&gt;&lt;li&gt;âž¤ effective erythropoiesis despite the body&lt;/li&gt;&lt;li&gt;âž¤ adequate or increased total iron.&lt;/li&gt;&lt;li&gt;âž¤ Robbins 10 th / 659&lt;/li&gt;&lt;li&gt;âž¤ Robbins 10 th / 659&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Hypochromic microcytic blood picture is seen in all of the following conditions except&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Iron deficiency anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lead poisoning&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rheumatoid arthritis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sideroblastic anemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Rheumatoid arthritis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Iron deficiency anemia classically presents with a hypochromic microcytic blood picture due to a deficiency in iron , leading to reduced hemoglobin synthesis and, consequently, smaller red blood cells with less hemoglobin .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Iron deficiency anemia&lt;/li&gt;&lt;li&gt;â€¢ hypochromic microcytic&lt;/li&gt;&lt;li&gt;â€¢ deficiency in iron&lt;/li&gt;&lt;li&gt;â€¢ reduced hemoglobin synthesis&lt;/li&gt;&lt;li&gt;â€¢ smaller red blood cells with less hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lead poisoning causes hypochromic microcytic anemia by interfering with several enzymatic steps in the heme synthesis pathway, leading to inadequate production of hemoglobin and microcytosis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lead poisoning causes&lt;/li&gt;&lt;li&gt;â€¢ hypochromic microcytic anemia&lt;/li&gt;&lt;li&gt;â€¢ enzymatic steps&lt;/li&gt;&lt;li&gt;â€¢ heme synthesis pathway,&lt;/li&gt;&lt;li&gt;â€¢ inadequate&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin and microcytosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sideroblastic anemia is characterized by the presence of ring sideroblasts in the bone marrow and can present with a hypochromic microcytic blood picture due to ineffective iron utilization and heme synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sideroblastic anemia&lt;/li&gt;&lt;li&gt;â€¢ presence of ring sideroblasts&lt;/li&gt;&lt;li&gt;â€¢ hypochromic microcytic&lt;/li&gt;&lt;li&gt;â€¢ ineffective iron utilization and heme synthesis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Rheumatoid arthritis is least likely to be associated with a hypochromic microcytic blood picture among the options provided, as it is more typically linked to normocytic or mildly microcytic anemia of chronic disease .&lt;/li&gt;&lt;li&gt;âž¤ Rheumatoid arthritis&lt;/li&gt;&lt;li&gt;âž¤ hypochromic microcytic&lt;/li&gt;&lt;li&gt;âž¤ normocytic or mildly microcytic anemia of chronic disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman with a history of rheumatoid arthritis presents with fatigue and pallor. Her blood tests show mild anemia. Additional laboratory tests are ordered to determine the cause of her anemia. Which of the following laboratory findings is most consistent with a diagnosis of anemia of chronic disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Serum ferritin is decreased&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Reduced hepcidin levels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Transferrin saturation is decreased&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Total iron binding capacity is increased â€‹â€‹â€‹â€‹â€‹&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Transferrin saturation is decreased&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Transferrin saturation is decreased&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A.  In iron deficiency anemia , serum ferritin, which reflects body iron stores, is decreased.&lt;/li&gt;&lt;li&gt;â€¢ Option A.  In iron deficiency anemia&lt;/li&gt;&lt;li&gt;â€¢ serum ferritin,&lt;/li&gt;&lt;li&gt;â€¢ iron stores, is decreased.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hepcidin levels are typically increased in anemia of chronic disease because it is an inflammatory marker that blocks the release of iron from body stores, contributing to the anemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hepcidin&lt;/li&gt;&lt;li&gt;â€¢ increased in anemia of chronic disease&lt;/li&gt;&lt;li&gt;â€¢ blocks the release of iron&lt;/li&gt;&lt;li&gt;â€¢ Option D. In anemia of chronic disease, TIBC is usually normal or decreased , not increased , because the body&#x27;s iron is sequestered due to inflammation and is not readily available for erythropoiesis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. In anemia&lt;/li&gt;&lt;li&gt;â€¢ TIBC&lt;/li&gt;&lt;li&gt;â€¢ normal or decreased&lt;/li&gt;&lt;li&gt;â€¢ not increased&lt;/li&gt;&lt;li&gt;â€¢ body&#x27;s iron is sequestered&lt;/li&gt;&lt;li&gt;â€¢ inflammation&lt;/li&gt;&lt;li&gt;â€¢ not readily available for erythropoiesis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In anemia of chronic disease , transferrin saturation is decreased due to limited iron utilization, despite adequate or increased iron stores reflected by normal or increased serum ferritin levels.&lt;/li&gt;&lt;li&gt;âž¤ anemia of chronic disease&lt;/li&gt;&lt;li&gt;âž¤ transferrin saturation&lt;/li&gt;&lt;li&gt;âž¤ decreased due to limited iron utilization,&lt;/li&gt;&lt;li&gt;âž¤ adequate or increased iron&lt;/li&gt;&lt;li&gt;âž¤ stores&lt;/li&gt;&lt;li&gt;âž¤ normal or increased serum ferritin levels.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/e p658&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/e p658&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following test best differentiates cobalamin and folate deficiency?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Plasma homocysteine levels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Peripheral smear showing megaloblasts&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;High value of mean cell volume&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Serum methylmalonic acid levels&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Serum methylmalonic acid levels&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Serum methylmalonic acid levels&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Plasma homocysteine levels are elevated in both cobalamin (vitamin B12) and folate deficiencies, as both vitamins are involved in the metabolism of homocysteine . Therefore, it does not differentiate between the two.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Plasma homocysteine levels&lt;/li&gt;&lt;li&gt;â€¢ elevated&lt;/li&gt;&lt;li&gt;â€¢ cobalamin (vitamin B12) and folate deficiencies,&lt;/li&gt;&lt;li&gt;â€¢ metabolism of homocysteine&lt;/li&gt;&lt;li&gt;â€¢ Option B. Peripheral smear showing megaloblasts is a feature common to both cobalamin and folate deficiencies , as both lead to impaired DNA synthesis and resultant megaloblastic anemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Peripheral smear&lt;/li&gt;&lt;li&gt;â€¢ megaloblasts&lt;/li&gt;&lt;li&gt;â€¢ cobalamin and folate deficiencies&lt;/li&gt;&lt;li&gt;â€¢ impaired DNA synthesis and resultant megaloblastic anemia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. A high mean cell volume (MCV) is indicative of macrocytic anemia , which can result from either cobalamin or folate deficiency . This finding is not specific to either condition.&lt;/li&gt;&lt;li&gt;â€¢ Option C. A high mean cell volume&lt;/li&gt;&lt;li&gt;â€¢ macrocytic anemia&lt;/li&gt;&lt;li&gt;â€¢ either cobalamin or folate deficiency&lt;/li&gt;&lt;li&gt;â€¢ not specific&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Serum methylmalonic acid levels is one of diagnostic test that differentiates between cobalamin and folate deficiencies, since it is increased in cobalamin deficiency but remains normal in folate deficiency.&lt;/li&gt;&lt;li&gt;âž¤ Serum methylmalonic acid&lt;/li&gt;&lt;li&gt;âž¤ diagnostic test&lt;/li&gt;&lt;li&gt;âž¤ cobalamin and folate deficiencies,&lt;/li&gt;&lt;li&gt;âž¤ increased in cobalamin deficiency&lt;/li&gt;&lt;li&gt;âž¤ normal in folate deficiency.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 16-year-old male presents with jaundice and anemia. A blood smear shows numerous spherocytes, and a family history reveals a similar condition in his mother. Which of the following proteins, if defective, is most likely to be the cause of his hereditary spherocytosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ankyrin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Palladin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glycophorin C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anion transport protein&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Ankyrin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Ankyrin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Ankyrin is a key protein in the RBC membrane that links the integral membrane proteins to the underlying spectrin-actin cytoskeleton. Mutations in ankyrin are the most common cause of hereditary spherocytosis.&lt;/li&gt;&lt;li&gt;â€¢ Other Option:&lt;/li&gt;&lt;li&gt;â€¢ Other Option:&lt;/li&gt;&lt;li&gt;â€¢ Option B : Palladin is not commonly associated with the RBC membrane or hereditary spherocytosis. This protein is involved in cytoskeletal organization and cell morphology, mainly in non-erythroid cells.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Option C : Glycophorin C is another membrane protein of the RBC; however, deficiencies in glycophorin C are more commonly associated with hereditary elliptocytosis, not hereditary spherocytosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Option D : The anion transport protein, also known as band 3, is an integral membrane protein of the RBC. Defects in band 3 are a well-established cause of hereditary spherocytosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ankyrin is the most commonly mutated protein in hereditary spherocytosis. It plays a crucial role in linking the RBC membrane proteins to the spectrin-actin cytoskeleton, maintaining the biconcave shape of RBCs. Defects in ankyrin result in loss of membrane stability, leading to the formation of spherocytes and increased RBC destruction.&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10th/ 635)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An Rh -ve woman became pregnant with Rh +ve fetus. Within few days after birth, the infant developed jaundice, ascites, hepatomegaly and edema. The likely substance(s) deposited in skin and sclera in jaundice is/are given below. Which is the best possible answer?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Biliverdin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Conjugated and unconjugated bilirubin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Unconjugated bilirubin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Conjugated bilirubin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Conjugated and unconjugated bilirubin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Conjugated and unconjugated bilirubin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Biliverdin is a green tetrapyrrolic bile pigment , and it is an intermediate product in the breakdown of heme . It is subsequently reduced to bilirubin in the liver. Biliverdin itself does not contribute to the yellow discoloration seen in jaundice.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Biliverdin is a green tetrapyrrolic&lt;/li&gt;&lt;li&gt;â€¢ bile pigment&lt;/li&gt;&lt;li&gt;â€¢ intermediate product&lt;/li&gt;&lt;li&gt;â€¢ heme&lt;/li&gt;&lt;li&gt;â€¢ reduced to bilirubin&lt;/li&gt;&lt;li&gt;â€¢ Biliverdin&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ yellow discoloration&lt;/li&gt;&lt;li&gt;â€¢ Option C. Unconjugated bilirubin is the form that is i nitially produced during the breakdown of hemoglobin . While it does accumulate in conditions of increased hemolysis , it is not water-soluble and requires conjugation by the liver to become water-soluble .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Unconjugated bilirubin&lt;/li&gt;&lt;li&gt;â€¢ nitially produced&lt;/li&gt;&lt;li&gt;â€¢ breakdown of hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ accumulate&lt;/li&gt;&lt;li&gt;â€¢ increased hemolysis&lt;/li&gt;&lt;li&gt;â€¢ not water-soluble&lt;/li&gt;&lt;li&gt;â€¢ conjugation by the liver to become water-soluble&lt;/li&gt;&lt;li&gt;â€¢ Option D. Conjugated bilirubin is water-soluble and can be excreted into the bile and urine. High levels of conjugated bilirubin can indicate liver dysfunction or biliary obstruction , but on its own does not typically cause the systemic findings seen in erythroblastosis fetalis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Conjugated bilirubin&lt;/li&gt;&lt;li&gt;â€¢ water-soluble&lt;/li&gt;&lt;li&gt;â€¢ excreted into the bile and urine. High levels of conjugated bilirubin&lt;/li&gt;&lt;li&gt;â€¢ liver dysfunction or biliary obstruction&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Both conjugated and unconjugated bilirubin can deposit in the skin and sclera in newborns with erythroblastosis fetalis, contributing to the yellow discoloration observed in jaundice.&lt;/li&gt;&lt;li&gt;âž¤ conjugated and unconjugated bilirubin&lt;/li&gt;&lt;li&gt;âž¤ skin and sclera&lt;/li&gt;&lt;li&gt;âž¤ erythroblastosis fetalis,&lt;/li&gt;&lt;li&gt;âž¤ yellow discoloration&lt;/li&gt;&lt;li&gt;âž¤ jaundice.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 857&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 857&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old patient presents with fatigue, episodes of dark urine, especially in the morning, and a recent history of thrombosis. Lab tests show hemolytic anemia and cytopenias. Which of the following findings is least likely to be associated with the likely diagnosis of paroxysmal nocturnal hemoglobinuria (PNH)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;LDH levels are raised&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increased hemosiderin in urine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreased leukocyte alkaline phosphatase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased platelets&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Increased platelets&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.Â  Increased platelets&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. LDH levels are raised: True as LDH (lactate dehydrogenase) levels are often elevated in PNH due to intravascular hemolysis .&lt;/li&gt;&lt;li&gt;â€¢ Option A. LDH levels are raised:&lt;/li&gt;&lt;li&gt;â€¢ True&lt;/li&gt;&lt;li&gt;â€¢ LDH (lactate dehydrogenase)&lt;/li&gt;&lt;li&gt;â€¢ elevated in PNH&lt;/li&gt;&lt;li&gt;â€¢ intravascular hemolysis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increased hemosiderin in urine: True ; Hemolysis in PNH can result in the release of free hemoglobin , which is filtered by the kidneys , leading to hemosiderinuria.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increased hemosiderin in urine:&lt;/li&gt;&lt;li&gt;â€¢ True&lt;/li&gt;&lt;li&gt;â€¢ PNH&lt;/li&gt;&lt;li&gt;â€¢ free hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ kidneys&lt;/li&gt;&lt;li&gt;â€¢ hemosiderinuria.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Decreased leukocyte alkaline phosphatase: True; PNH cells are deficient in GPI-linked proteins, including alkaline phosphatase . Therefore, leukocyte alkaline phosphatase is decreased in PNH .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Decreased leukocyte alkaline phosphatase:&lt;/li&gt;&lt;li&gt;â€¢ True; PNH cells&lt;/li&gt;&lt;li&gt;â€¢ GPI-linked proteins,&lt;/li&gt;&lt;li&gt;â€¢ alkaline phosphatase&lt;/li&gt;&lt;li&gt;â€¢ leukocyte alkaline phosphatase&lt;/li&gt;&lt;li&gt;â€¢ decreased in PNH&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Thrombocytopenia , not thrombocytosis, is a common feature of PNH due to increased platelet consumption and intravascular thrombosis , leading to a decreased platelet count .&lt;/li&gt;&lt;li&gt;âž¤ Thrombocytopenia&lt;/li&gt;&lt;li&gt;âž¤ common feature of PNH&lt;/li&gt;&lt;li&gt;âž¤ increased platelet consumption and intravascular thrombosis&lt;/li&gt;&lt;li&gt;âž¤ decreased platelet count&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 645&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 645&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with fatigue, pallor, and dark urine. Laboratory tests reveal anemia with increased bilirubin levels. Which of the following laboratory findings is inconsistent with a diagnosis of hemolytic anemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Yellowing of eyes and sclera&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increased LDH&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decrease in haptoglobin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Low reticulocyte count&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Low reticulocyte count&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Low reticulocyte count&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Yellowing of eyes and sclera is due to hyperbilirubinemia , which is commonly seen in hemolytic anemia as a result of increased breakdown of red blood cells .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Yellowing of eyes&lt;/li&gt;&lt;li&gt;â€¢ and sclera&lt;/li&gt;&lt;li&gt;â€¢ hyperbilirubinemia&lt;/li&gt;&lt;li&gt;â€¢ hemolytic anemia&lt;/li&gt;&lt;li&gt;â€¢ increased breakdown of red blood cells&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increased lactate dehydrogenase (LDH) is often observed in hemolytic anemia because this intracellular enzyme is released into the blood when red cells are destroyed .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increased lactate&lt;/li&gt;&lt;li&gt;â€¢ dehydrogenase&lt;/li&gt;&lt;li&gt;â€¢ hemolytic anemia&lt;/li&gt;&lt;li&gt;â€¢ intracellular enzyme&lt;/li&gt;&lt;li&gt;â€¢ red cells are destroyed&lt;/li&gt;&lt;li&gt;â€¢ Option C. A decrease in haptoglobin is expected in hemolytic anemia. Haptoglobin binds free hemoglobin released from lysed red blood cells , and its levels drop as it is consumed in this process.&lt;/li&gt;&lt;li&gt;â€¢ Option C. A decrease in haptoglobin&lt;/li&gt;&lt;li&gt;â€¢ Haptoglobin binds free hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ lysed red blood cells&lt;/li&gt;&lt;li&gt;â€¢ levels drop&lt;/li&gt;&lt;li&gt;â€¢ consumed&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hemolytic anemia is typically characterized by an increased reticulocyte count as the bone marrow compensates for the loss of red blood cells . A low reticulocyte count suggests an inadequate bone marrow response .&lt;/li&gt;&lt;li&gt;âž¤ Hemolytic anemia&lt;/li&gt;&lt;li&gt;âž¤ increased reticulocyte count&lt;/li&gt;&lt;li&gt;âž¤ bone marrow compensates&lt;/li&gt;&lt;li&gt;âž¤ red blood cells&lt;/li&gt;&lt;li&gt;âž¤ low reticulocyte count&lt;/li&gt;&lt;li&gt;âž¤ inadequate bone marrow response&lt;/li&gt;&lt;li&gt;âž¤ Ref: Robbins 10 th / 634&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Robbins 10 th / 634&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old female presented with fatiguability and dyspnea on exertion. She was found to be having a hemoglobin of 6 g/dL. What will be most likely finding in her peripheral blood smear?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Macrocytic hypochromic red cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Target cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Reduced poikilocytosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Microcytic and hypochromic red cell&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Microcytic and hypochromic red cell&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Microcytic and hypochromic red cells&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Macrocytosis (larger than normal red cells) typically indicates a deficiency in vitamin B12 or folate , not iron. While hypochromia refers to red cells with reduced hemoglobin content, it is not typically associated with macrocytosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Macrocytosis&lt;/li&gt;&lt;li&gt;â€¢ (larger than normal red cells)&lt;/li&gt;&lt;li&gt;â€¢ vitamin B12 or folate&lt;/li&gt;&lt;li&gt;â€¢ Option B. Target cells can be seen in various hemoglobinopathies, liver disease, and post-splenectomy, but they are not characteristic of iron deficiency anemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Target cells&lt;/li&gt;&lt;li&gt;â€¢ hemoglobinopathies, liver disease, and post-splenectomy,&lt;/li&gt;&lt;li&gt;â€¢ Option C. Poikilocytosis refers to abnormally shaped red blood cells and is a nonspecific finding. The term \&quot;reduced poikilocytosis\&quot; is not typically used to describe findings in anemia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Poikilocytosis&lt;/li&gt;&lt;li&gt;â€¢ abnormally shaped red blood cells&lt;/li&gt;&lt;li&gt;â€¢ nonspecific finding.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ When evaluating a patient with anemia, particularly in the setting of fatigue and dyspnea on exertion with a significantly low hemoglobin level , finding microcytic and hypochromic red cells on the peripheral blood smear strongly suggests iron deficiency anemia .&lt;/li&gt;&lt;li&gt;âž¤ fatigue and dyspnea on exertion&lt;/li&gt;&lt;li&gt;âž¤ low hemoglobin level&lt;/li&gt;&lt;li&gt;âž¤ microcytic and hypochromic red cells&lt;/li&gt;&lt;li&gt;âž¤ iron deficiency anemia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young child presents with the sudden onset of hemoglobinuria following a viral infection. He was noted to have red urine after playing outside in the cold weather. A specific antibody test is positive when his blood is cooled and then warmed. Which of the following antibodies is most likely responsible for this patientâ€™s condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Warm agglutination&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cold agglutination&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Paroxysmal nocturnal hemoglobinuria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Immune thrombocytopeniax`&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Cold agglutination&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Cold agglutination&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Warm agglutinins are antibodies , typically IgG , that react with red blood cell antigens at body temperature and are often involved in autoimmune hemolytic anemia , not typically causing hemoglobinuria upon cold exposure.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Warm agglutinins are antibodies&lt;/li&gt;&lt;li&gt;â€¢ IgG&lt;/li&gt;&lt;li&gt;â€¢ red blood cell antigens at body temperature&lt;/li&gt;&lt;li&gt;â€¢ autoimmune hemolytic anemia&lt;/li&gt;&lt;li&gt;â€¢ Option C. PNH is a condition caused by a mutation leading to a deficiency of GPI-anchored proteins on the cell surface , which makes red blood cells sensitive to complement-mediated lysis ; it does not involve the Donath-Landsteiner antibody.&lt;/li&gt;&lt;li&gt;â€¢ Option C. PNH is a condition caused&lt;/li&gt;&lt;li&gt;â€¢ deficiency of GPI-anchored proteins on the cell surface&lt;/li&gt;&lt;li&gt;â€¢ red blood cells sensitive to complement-mediated lysis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Immune thrombocytopenia is characterized by antibodies, usually IgG , that target platelets for destruction by the spleen, which is unrelated to hemoglobinuria upon cold exposure .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Immune thrombocytopenia&lt;/li&gt;&lt;li&gt;â€¢ antibodies, usually IgG&lt;/li&gt;&lt;li&gt;â€¢ platelets&lt;/li&gt;&lt;li&gt;â€¢ spleen,&lt;/li&gt;&lt;li&gt;â€¢ unrelated to hemoglobinuria upon cold exposure&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Donath-Landsteiner antibody , a cold agglutinin with anti-P specificity , is responsible for hemoglobinuria in patients with paroxysmal cold hemoglobinuria, a condition that is triggered by cold temperatures .&lt;/li&gt;&lt;li&gt;âž¤ Donath-Landsteiner antibody&lt;/li&gt;&lt;li&gt;âž¤ cold agglutinin&lt;/li&gt;&lt;li&gt;âž¤ anti-P specificity&lt;/li&gt;&lt;li&gt;âž¤ hemoglobinuria&lt;/li&gt;&lt;li&gt;âž¤ paroxysmal cold hemoglobinuria,&lt;/li&gt;&lt;li&gt;âž¤ cold temperatures&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 660&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 660&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old African American male presents to the emergency room with jaundice and dark urine after taking a sulfa drug for a urinary tract infection. He has a past medical history of a similar episode after eating fava beans. His labs reveal hemolytic anemia. Which of the following is NOT a consequence of the enzyme deficiency this patient most likely has?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decrease in reduced glutathione&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decrease in NADPH&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased in lipid peroxidation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Decreased RBC membrane damage â€‹â€‹â€‹&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Decreased RBC membrane damage â€‹â€‹â€‹&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Decreased RBC membrane damage&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. In G6PD deficiency , there is a decrease in reduced glutathione due to insufficient NADPH , leading to decreased ability to neutralize oxidative stress in red blood cells.&lt;/li&gt;&lt;li&gt;â€¢ Option A. In G6PD deficiency&lt;/li&gt;&lt;li&gt;â€¢ decrease in reduced glutathione&lt;/li&gt;&lt;li&gt;â€¢ insufficient NADPH&lt;/li&gt;&lt;li&gt;â€¢ decreased ability to neutralize oxidative stress&lt;/li&gt;&lt;li&gt;â€¢ Option B. G6PD deficiency results in a decrease in NADPH production , a critical factor in maintaining the reduced state of glutathione.&lt;/li&gt;&lt;li&gt;â€¢ Option B. G6PD deficiency&lt;/li&gt;&lt;li&gt;â€¢ decrease in NADPH production&lt;/li&gt;&lt;li&gt;â€¢ reduced state of glutathione.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Without enough reduced glutathione , red blood cells are more susceptible to oxidative stress , leading to increased lipid peroxidation and membrane damage .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Without enough&lt;/li&gt;&lt;li&gt;â€¢ reduced glutathione&lt;/li&gt;&lt;li&gt;â€¢ more susceptible to oxidative stress&lt;/li&gt;&lt;li&gt;â€¢ lipid peroxidation and membrane damage&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Decreased red blood cell membrane damage is not associated with G6PD deficiency.&lt;/li&gt;&lt;li&gt;âž¤ Decreased red blood cell membrane&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ G6PD deficiency.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/e p640&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/e p640&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old woman with a prosthetic heart valve presents with anemia and schistocytes on peripheral smear. Which of the following conditions is least likely to be associated with microangiopathic hemolytic anemia (MAHA)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antiphospholipid antibody syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Thrombotic thrombocytopenic purpura&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Microscopic polyangiitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metallic cardiac valves&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Metallic cardiac valves&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Metallic cardiac valves&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Antiphospholipid antibody syndrome is characterized by the presence of autoantibodies that increase the risk of thrombosis , which can lead to MAHA due to mechanical damage to red cells as they pass through the narrowed, thrombosed vessels .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Antiphospholipid antibody&lt;/li&gt;&lt;li&gt;â€¢ autoantibodies&lt;/li&gt;&lt;li&gt;â€¢ thrombosis&lt;/li&gt;&lt;li&gt;â€¢ MAHA&lt;/li&gt;&lt;li&gt;â€¢ mechanical damage&lt;/li&gt;&lt;li&gt;â€¢ red cells&lt;/li&gt;&lt;li&gt;â€¢ thrombosed vessels&lt;/li&gt;&lt;li&gt;â€¢ Option B. Thrombotic thrombocytopenic purpura (TTP) is a well-known cause of MAHA and is due to the formation of microthrombi that shear red blood cells as they traverse the microcirculation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Thrombotic thrombocytopenic&lt;/li&gt;&lt;li&gt;â€¢ MAHA&lt;/li&gt;&lt;li&gt;â€¢ microthrombi&lt;/li&gt;&lt;li&gt;â€¢ shear red blood cells&lt;/li&gt;&lt;li&gt;â€¢ traverse the microcirculation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Microscopic polyangiitis is a type of small vessel vasculitis and can be associated with MAHA due to the damage to red cells caused by the inflammation of blood vessels.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Microscopic polyangiitis&lt;/li&gt;&lt;li&gt;â€¢ small vessel vasculitis&lt;/li&gt;&lt;li&gt;â€¢ MAHA&lt;/li&gt;&lt;li&gt;â€¢ red cells&lt;/li&gt;&lt;li&gt;â€¢ inflammation of blood vessels.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Metallic cardiac valves are associated with macroangiopathic hemolytic anemia due to physical destruction of red blood cells rather than microangiopathic hemolytic anemia, which is characterized by red cell fragmentation in the microcirculation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with an acute hemolytic episode after taking an antimalarial drug. His urine is dark brown, almost black. Laboratory findings are suggestive of intravascular hemolysis. A deficiency in which of the following enzymes is most likely responsible for this patientâ€™s condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Controlling reduction stress on RBC&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Controlling oxidative stress on RBC&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Maintaining flexibility of cell membrane&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Component of electron transport chain&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Controlling oxidative stress on RBC&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Controlling oxidative stress on RBC&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Controlling reduction stress on RBC refers to the balance of redox states within the cell. While redox balance is crucial, there is no specific enzyme known as the â€˜reduction stress controllerâ€™ in RBCs.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Controlling reduction stress&lt;/li&gt;&lt;li&gt;â€¢ RBC&lt;/li&gt;&lt;li&gt;â€¢ redox states&lt;/li&gt;&lt;li&gt;â€¢ Option C. Maintaining flexibility of cell membrane is related to the cytoskeletal proteins of the RBC , such as spectrin , and does not involve G6PD.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Maintaining flexibility&lt;/li&gt;&lt;li&gt;â€¢ cell membrane&lt;/li&gt;&lt;li&gt;â€¢ cytoskeletal proteins of the RBC&lt;/li&gt;&lt;li&gt;â€¢ spectrin&lt;/li&gt;&lt;li&gt;â€¢ Option D. Components of the electron transport chain are involved in energy production in the mitochondria , which RBCs lack ; hence, it does not relate to the integrity of RBCs .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Components of the electron&lt;/li&gt;&lt;li&gt;â€¢ energy production in the mitochondria&lt;/li&gt;&lt;li&gt;â€¢ RBCs lack&lt;/li&gt;&lt;li&gt;â€¢ integrity of RBCs&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The role of G6PD is in maintaining the redox balance to protect RBCs from oxidative stress , where its deficiency can lead to hemolytic anemia upon exposure to certain oxidative drugs or foods .&lt;/li&gt;&lt;li&gt;âž¤ G6PD&lt;/li&gt;&lt;li&gt;âž¤ redox balance&lt;/li&gt;&lt;li&gt;âž¤ RBCs from oxidative stress&lt;/li&gt;&lt;li&gt;âž¤ hemolytic anemia upon exposure to certain oxidative drugs or foods&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th /640&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th /640&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with acrocyanosis and hemolytic anemia after exposure to cold weather. Laboratory tests reveal agglutination of red blood cells at temperatures between 4 to 6Â°C. Which type of immunoglobulin is most likely responsible for this agglutination?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IgG&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IgM&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IgA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IgD&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. IgM&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. IgM&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. IgG antibodies are generally involved in warm autoimmune hemolytic anemias and do not typically cause agglutination at low temperatures.&lt;/li&gt;&lt;li&gt;â€¢ Option A. IgG antibodies&lt;/li&gt;&lt;li&gt;â€¢ warm autoimmune hemolytic anemias&lt;/li&gt;&lt;li&gt;â€¢ Option C. IgA antibodies are mainly secretory antibodies and do not usually cause agglutination of red blood cells in cold environments.&lt;/li&gt;&lt;li&gt;â€¢ Option C. IgA antibodies&lt;/li&gt;&lt;li&gt;â€¢ secretory antibodies&lt;/li&gt;&lt;li&gt;â€¢ Option D. IgD antibodies are found in very low concentrations in serum and are not associated with cold agglutination of red blood cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D. IgD antibodies&lt;/li&gt;&lt;li&gt;â€¢ very low concentrations in serum&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ IgM antibodies , known as cold agglutinins , can cause agglutination of red blood cells at low temperatures , as seen in cold agglutinin disease .&lt;/li&gt;&lt;li&gt;âž¤ IgM antibodies&lt;/li&gt;&lt;li&gt;âž¤ cold agglutinins&lt;/li&gt;&lt;li&gt;âž¤ agglutination of red blood cells&lt;/li&gt;&lt;li&gt;âž¤ low temperatures&lt;/li&gt;&lt;li&gt;âž¤ cold agglutinin disease&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 648&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 648&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A child presents with acute renal failure, thrombocytopenia, and a microangiopathic hemolytic anemia after a diarrheal illness. A peripheral blood smear shows fragmented red cells, including helmet cells. Which condition is most consistent with these findings?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hemolytic uremic syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Polysplenia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Spherocytosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acanthocytosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Hemolytic uremic syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Hemolytic uremic syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Polysplenia is a condition where multiple small spleens are present and is typically associated with congenital abnormalities ; it does not characteristically present with schistocytes or helmet cells.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Polysplenia&lt;/li&gt;&lt;li&gt;â€¢ multiple small spleens&lt;/li&gt;&lt;li&gt;â€¢ congenital abnormalities&lt;/li&gt;&lt;li&gt;â€¢ Option C. Spherocytosis is a disorder causing spherically shaped red blood cells due to a defect in the RBC membrane, not typically associated with schistocytes or helmet cells.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Spherocytosis&lt;/li&gt;&lt;li&gt;â€¢ spherically shaped red blood cells&lt;/li&gt;&lt;li&gt;â€¢ RBC membrane,&lt;/li&gt;&lt;li&gt;â€¢ Option D. Acanthocytosis refers to spur cells with spiculated membranes , which are seen in liver disease and abetalipoproteinemia, among others, and does not present with helmet cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Acanthocytosis&lt;/li&gt;&lt;li&gt;â€¢ spur cells with spiculated membranes&lt;/li&gt;&lt;li&gt;â€¢ liver disease and abetalipoproteinemia,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Helmet cells on a blood smear are characteristic of microangiopathic hemolytic anemias , such as those seen in hemolytic uremic syndrome (HUS), which can present with renal failure and thrombocytopenia following gastroenteritis .&lt;/li&gt;&lt;li&gt;âž¤ Helmet cells&lt;/li&gt;&lt;li&gt;âž¤ microangiopathic hemolytic anemias&lt;/li&gt;&lt;li&gt;âž¤ hemolytic uremic syndrome (HUS),&lt;/li&gt;&lt;li&gt;âž¤ renal failure and thrombocytopenia&lt;/li&gt;&lt;li&gt;âž¤ gastroenteritis&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 662&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 662&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman presents with fatigue, pallor, and shortness of breath on exertion. Her blood tests show a low hemoglobin concentration and a mean corpuscular volume (MCV) within the low-normal range. To further evaluate her anemia, which of the following mean corpuscular hemoglobin concentration (MCHC) values would suggest a diagnosis of iron deficiency anemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;lt;32&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;&amp;lt;34&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;&amp;lt;28&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;&amp;lt;30&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. &lt;34&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&amp;lt;34&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ At all ages the normal MCHC should be 34; values below that indicate that red cells are hypochromic , which occurs in iron deficiency anaemia.&lt;/li&gt;&lt;li&gt;â€¢ At all ages the normal MCHC should be 34;&lt;/li&gt;&lt;li&gt;â€¢ below&lt;/li&gt;&lt;li&gt;â€¢ hypochromic&lt;/li&gt;&lt;li&gt;â€¢ iron deficiency anaemia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ When evaluating for iron deficiency anemia , an MCHC value below 34 g/dL is indicative of hypochromic red blood cells , which is a typical laboratory finding in this condition.&lt;/li&gt;&lt;li&gt;âž¤ iron deficiency anemia&lt;/li&gt;&lt;li&gt;âž¤ MCHC value below 34 g/dL&lt;/li&gt;&lt;li&gt;âž¤ hypochromic red blood cells&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old male presents with jaundice and anemia. His peripheral blood smear shows numerous small, dense, and spherically shaped red blood cells. He reports a family history of similar symptoms. A defect in which of the following is the most likely cause of his anemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Autoimmune hemolytic anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hereditary spherocytosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Microangiopathic haemolytic anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thermal injury causing anemia â€‹â€‹â€‹â€‹&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hereditary spherocytosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Â Hereditary spherocytosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Autoimmune hemolytic anemia is caused by antibodies targeting and destroying red blood cells , not by an intrinsic defect in the red blood cell membrane.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Autoimmune hemolytic anemia&lt;/li&gt;&lt;li&gt;â€¢ antibodies&lt;/li&gt;&lt;li&gt;â€¢ destroying red blood cells&lt;/li&gt;&lt;li&gt;â€¢ Option C. Leading to red blood cell fragmentation Microangiopathic hemolytic anemia is caused by red blood cells being damaged as they pass through narrowed or damaged small blood vessels , not by an intrinsic membrane defect.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Leading to red blood cell fragmentation Microangiopathic hemolytic anemia&lt;/li&gt;&lt;li&gt;â€¢ narrowed or damaged small blood vessels&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thermal injury causes anemia due to direct heat damage to the red blood cells or indirect effects following burn injury , not due to intrinsic membrane defects .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thermal injury causes anemia&lt;/li&gt;&lt;li&gt;â€¢ direct heat damage to the red blood cells&lt;/li&gt;&lt;li&gt;â€¢ burn injury&lt;/li&gt;&lt;li&gt;â€¢ intrinsic membrane defects&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hereditary spherocytosis and other disorders such as hereditary elliptocytosis and abetalipoproteinemia involve intrinsic red cell membrane defects , leading to characteristic morphological changes in red blood cells and associated clinical symptoms.&lt;/li&gt;&lt;li&gt;âž¤ Hereditary spherocytosis&lt;/li&gt;&lt;li&gt;âž¤ hereditary elliptocytosis and abetalipoproteinemia&lt;/li&gt;&lt;li&gt;âž¤ intrinsic red cell membrane defects&lt;/li&gt;&lt;li&gt;âž¤ morphological changes in red blood cells&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 632&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 632&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 6-years-old child belonging to Punjabi family with past history of blood transfusions presented with hemoglobin 3.5 g/dl, MCV â€“ 30 fl, MCHC â€“ 20. Peripheral smear findings of microcytic hypochromic anemia with target cell and reduced osmotic fragility. What is the he probable diagnosis of patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alpha thalassemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Beta thalassemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sickle cell anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;G6PD deficiency&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Beta thalassemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Beta thalassemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alpha thalassemia typically presents with microcytic anemia and can be severe depending on the number of gene deletions but is less common in the Punjabi population.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alpha thalassemia&lt;/li&gt;&lt;li&gt;â€¢ microcytic anemia&lt;/li&gt;&lt;li&gt;â€¢ severe&lt;/li&gt;&lt;li&gt;â€¢ number of gene deletions&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sickle cell anemia usually presents with normocytic anemia and not typically microcytic anemia. It can have target cells but is most commonly associated with the African population.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sickle cell anemia&lt;/li&gt;&lt;li&gt;â€¢ normocytic anemia&lt;/li&gt;&lt;li&gt;â€¢ African population.&lt;/li&gt;&lt;li&gt;â€¢ Option D. G6PD deficiency can lead to hemolytic anemia, often episodic and related to oxidative stress, but it typically does not cause a microcytic hypochromic anemia or a reduced MCV and MCHC.&lt;/li&gt;&lt;li&gt;â€¢ Option D. G6PD deficiency&lt;/li&gt;&lt;li&gt;â€¢ hemolytic anemia,&lt;/li&gt;&lt;li&gt;â€¢ oxidative stress,&lt;/li&gt;&lt;li&gt;â€¢ does not cause a microcytic hypochromic anemia or a reduced&lt;/li&gt;&lt;li&gt;â€¢ MCV and MCHC.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The  presentation of s evere microcytic hypochromic anemia with target cells , a history of multiple blood transfusions, and reduced osmotic fragility in a child from an ethnicity with a high prevalence of thalassemia strongly suggests beta thalassemia major as the most likely diagnosis.&lt;/li&gt;&lt;li&gt;âž¤ evere microcytic hypochromic anemia with target cells&lt;/li&gt;&lt;li&gt;âž¤ multiple blood transfusions,&lt;/li&gt;&lt;li&gt;âž¤ reduced&lt;/li&gt;&lt;li&gt;âž¤ osmotic fragility&lt;/li&gt;&lt;li&gt;âž¤ ethnicity with a high prevalence of thalassemia&lt;/li&gt;&lt;li&gt;âž¤ beta thalassemia major&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;NESTROF test is a screening test for which of the following conditions?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Î²- thalassemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hereditary spherocytosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Autoimmune haemolytic anaemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Megaloblastic anaemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Î²- thalassemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.Â  Î²&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Î²-thalassemia - NESTROFT is used to screen for beta-thalassemia because red blood cells in this condition exhibit increased fragility in hypotonic solutions due to their membrane characteristics.&lt;/li&gt;&lt;li&gt;â€¢ Î²-thalassemia&lt;/li&gt;&lt;li&gt;â€¢ NESTROFT is&lt;/li&gt;&lt;li&gt;â€¢ screen for beta-thalassemia&lt;/li&gt;&lt;li&gt;â€¢ increased fragility&lt;/li&gt;&lt;li&gt;â€¢ in hypotonic solutions&lt;/li&gt;&lt;li&gt;â€¢ membrane characteristics.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ NESTROFT is a screening test for beta-thalassemia, which is based on the increased osmotic fragility of red blood cells in this condition.&lt;/li&gt;&lt;li&gt;âž¤ NESTROFT&lt;/li&gt;&lt;li&gt;âž¤ beta-thalassemia,&lt;/li&gt;&lt;li&gt;âž¤ increased osmotic fragility&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the cause of alpha thalassemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Deletion of alpha genes&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Deletion of beta genes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Excess of alpha genes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Single amino acid substitution in alpha chain&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Deletion of alpha genes&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Deletion of alpha genes&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Deletion of alpha genes is the primary cause of alpha thalassemia. The number of deleted genes can affect the severity of the disease ; the loss of two genes causes mild disease, while the loss of all four genes leads to hydrops fetalis .&lt;/li&gt;&lt;li&gt;â€¢ Deletion of alpha genes&lt;/li&gt;&lt;li&gt;â€¢ alpha thalassemia.&lt;/li&gt;&lt;li&gt;â€¢ severity of the disease&lt;/li&gt;&lt;li&gt;â€¢ loss of two genes&lt;/li&gt;&lt;li&gt;â€¢ loss of all four genes leads to hydrops fetalis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Deletion of beta genes leads to beta thalassemia. This condition results from mutations in the beta-globin gene on chromosome 11 , not the alpha-globin gene on chromosome 16.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Deletion of beta&lt;/li&gt;&lt;li&gt;â€¢ beta thalassemia.&lt;/li&gt;&lt;li&gt;â€¢ mutations in the beta-globin gene&lt;/li&gt;&lt;li&gt;â€¢ chromosome 11&lt;/li&gt;&lt;li&gt;â€¢ Option C. Excess of alpha genes does not cause alpha thalassemia. Typically, an imbalance between alpha and beta chains due to a relative lack of alpha genes is what causes thalassemias.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Excess of alpha&lt;/li&gt;&lt;li&gt;â€¢ does not cause alpha thalassemia.&lt;/li&gt;&lt;li&gt;â€¢ imbalance between alpha and beta chains&lt;/li&gt;&lt;li&gt;â€¢ alpha genes&lt;/li&gt;&lt;li&gt;â€¢ thalassemias.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Single amino acid substitution in the alpha chain is commonly associated with hemoglobin variants like Hemoglobin C or S, but not with thalassemia , which is a quantitative problem with globin chain production.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Single amino&lt;/li&gt;&lt;li&gt;â€¢ alpha chain&lt;/li&gt;&lt;li&gt;â€¢ Hemoglobin C or S,&lt;/li&gt;&lt;li&gt;â€¢ not with thalassemia&lt;/li&gt;&lt;li&gt;â€¢ quantitative problem with globin chain production.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Alpha thalassemia is most commonly caused by the deletion of alpha genes on chromosome 16 , which leads to a quantitative reduction in the production of alpha-globin chains.&lt;/li&gt;&lt;li&gt;âž¤ Alpha thalassemia&lt;/li&gt;&lt;li&gt;âž¤ deletion of alpha genes on chromosome 16&lt;/li&gt;&lt;li&gt;âž¤ quantitative reduction&lt;/li&gt;&lt;li&gt;âž¤ alpha-globin chains.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;HbH is formed due to which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Deletion of 4 alpha chains&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Deletion of 3 alpha chains&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Deletion of 2 alpha chains&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Deletion of 1 alpha chain&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Deletion of 3 alpha chains&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Deletion of 3 alpha chains&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Deletion of all 4 alpha chains typically results in hydrops fetalis and is usually incompatible with life ; hence it does not lead to the formation of HbH.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Deletion&lt;/li&gt;&lt;li&gt;â€¢ of all 4 alpha chains&lt;/li&gt;&lt;li&gt;â€¢ hydrops fetalis&lt;/li&gt;&lt;li&gt;â€¢ incompatible with life&lt;/li&gt;&lt;li&gt;â€¢ Option D. Deletion of 1 alpha chain usually causes no significant clinical symptoms and is known as silent carrier state ; it does not lead to HbH formation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Deletion&lt;/li&gt;&lt;li&gt;â€¢ of 1&lt;/li&gt;&lt;li&gt;â€¢ alpha chain&lt;/li&gt;&lt;li&gt;â€¢ silent carrier state&lt;/li&gt;&lt;li&gt;â€¢ Option C: Deletion of 2 alpha chains often causes a milder form of alpha thalassemia, known as alpha thalassemia trait or alpha thalassemia minor , not typically associated with the formation of HbH.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Deletion of 2&lt;/li&gt;&lt;li&gt;â€¢ alpha chains&lt;/li&gt;&lt;li&gt;â€¢ alpha thalassemia,&lt;/li&gt;&lt;li&gt;â€¢ alpha thalassemia trait or alpha thalassemia minor&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ HbH disease is caused by the deletion of three alpha-globin genes , which leads to an excess of beta-globin chains that form the abnormal hemoglobin H (beta4).&lt;/li&gt;&lt;li&gt;âž¤ HbH disease&lt;/li&gt;&lt;li&gt;âž¤ deletion of three alpha-globin genes&lt;/li&gt;&lt;li&gt;âž¤ excess of beta-globin chains&lt;/li&gt;&lt;li&gt;âž¤ abnormal hemoglobin H (beta4).&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 645&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 645&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is affected in sickled hemoglobin; HbS?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Stability&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Function&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Affinity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Solubility&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Solubility&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Solubility&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Stability refers to the hemoglobin molecule&#x27;s resistance to denaturation and degradation . While HbS can be less stable under deoxygenating conditions, this is not the primary issue.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Stability&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin molecule&#x27;s resistance to denaturation and degradation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Function pertains to the ability of hemoglobin to carry oxygen . HbS can still carry oxygen , but the sickling process can hinder its release to tissues.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Function pertains&lt;/li&gt;&lt;li&gt;â€¢ ability&lt;/li&gt;&lt;li&gt;â€¢ carry oxygen&lt;/li&gt;&lt;li&gt;â€¢ carry oxygen&lt;/li&gt;&lt;li&gt;â€¢ Option C. Affinity refers to the hemoglobin&#x27;s ability to bind oxygen . HbS has a slightly different oxygen affinity compared to normal hemoglobin, but again, this is not the main problem.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Affinity refers&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&#x27;s ability&lt;/li&gt;&lt;li&gt;â€¢ bind oxygen&lt;/li&gt;&lt;li&gt;â€¢ HbS&lt;/li&gt;&lt;li&gt;â€¢ slightly different oxygen&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sickle cell hemoglobin (HbS) is primarily characterized by reduced solubility under deoxygenated conditions, leading to polymerization and sickling of red blood cells. This results in vaso-occlusive crises and chronic hemolytic anemia.&lt;/li&gt;&lt;li&gt;âž¤ Sickle cell hemoglobin (HbS)&lt;/li&gt;&lt;li&gt;âž¤ reduced solubility&lt;/li&gt;&lt;li&gt;âž¤ deoxygenated&lt;/li&gt;&lt;li&gt;âž¤ polymerization and sickling&lt;/li&gt;&lt;li&gt;âž¤ vaso-occlusive crises and chronic hemolytic anemia.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 638&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 638&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following manifestations is common to sickle cell anemia and thalassemia major?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Autosplenectomy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bone marrow expansion in the calvarium&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Effective erythropoeisis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Predisposition to *Hemophilus influenzae *infections&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Bone marrow expansion in the calvarium&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Bone marrow expansion in the calvarium&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A . Autosplenectomy is the process of spleen shrinkage and fibrosis due to chronic damage, commonly seen in sickle cell anemia as a result of repeated vaso-occlusive episodes but is not a typical feature of thalassemia major.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ Option C . Effective erythropoiesis refers to the production of functional red blood cells that successfully mature and enter circulation. This is not characteristic of either condition, as both sickle cell anemia and thalassemia major are marked by ineffective erythropoiesis resulting in inadequate functional red cell production.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Option D . Predisposition to Hemophilus influenzae infections is more commonly associated with asplenic or hyposplenic individuals, but it is not directly related to the bone marrow changes seen on skull x-rays.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Both sickle cell anemia and thalassemia major can lead to bone marrow expansion in the calvarium as a compensatory response to increased erythropoietic demand due to chronic hemolytic anemia.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/ 640&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;One of the common variants of sickle cell anemia frequently marked by lesser degree of haemolytic anemia and greater propensity for the development of retinopathy and aseptic necrosis of bones is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sickle cell trait&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Haemoglobin SC disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sickle thalassaemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sickle â€“Hb E disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Sickle thalassaemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Sickle thalassaemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sickle cell trait , the heterozygous form of sickle cell disease, usually causes no symptoms or a very mild clinical course and does not typically lead to complications like retinopathy or aseptic necrosis of bones.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sickle cell trait&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hemoglobin SC disease is a compound heterozygous condition with one sickle cell gene and one gene for hemoglobin C. It can present with a clinical picture similar to sickle cell disease but usually with a milder course.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sickle-Hb E disease involves coinheritance of the sickle cell gene and hemoglobin E gene. It usually presents with milder symptoms compared to sickle cell anemia but can have clinical variability.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sickle-Hb E disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sickle thalassemia often presents with less severe hemolytic anemia compared to sickle cell anemia but has a greater propensity for complications such as retinopathy and aseptic necrosis of bones.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All are seen in Thalasemia major except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Transfusion dependency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Splenoheptatomegaly&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ineffective erythropoiesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Macrocytic anaemia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Macrocytic anaemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Macrocytic anaemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Transfusion dependency is a characteristic of thalassemia major, as patients often require regular blood transfusions to manage severe anemia due to ineffective erythropoiesis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Transfusion dependency&lt;/li&gt;&lt;li&gt;â€¢ thalassemia major,&lt;/li&gt;&lt;li&gt;â€¢ blood transfusions&lt;/li&gt;&lt;li&gt;â€¢ ineffective erythropoiesis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Splenohepatomegaly in thalassemia major results from extramedullary hematopoiesis, where the spleen and liver try to compensate for the anemia by producing blood cells, and from iron overload due to repeated transfusions.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Splenohepatomegaly&lt;/li&gt;&lt;li&gt;â€¢ extramedullary hematopoiesis,&lt;/li&gt;&lt;li&gt;â€¢ blood cells, and from iron overload due to repeated transfusions.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ineffective erythropoiesis refers to the bone marrow&#x27;s inability to produce mature and functional red blood cells , a hallmark of thalassemia major due to mutations affecting hemoglobin production.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ineffective erythropoiesis&lt;/li&gt;&lt;li&gt;â€¢ inability to produce mature and functional red blood cells&lt;/li&gt;&lt;li&gt;â€¢ hallmark of thalassemia major&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Thalassemia major typically presents with transfusion dependency, splenohepatomegaly, and ineffective erythropoiesis but not with macrocytic anemia , which is more consistent with deficiencies in vitamin B12 or folate.&lt;/li&gt;&lt;li&gt;âž¤ Thalassemia major&lt;/li&gt;&lt;li&gt;âž¤ transfusion dependency, splenohepatomegaly, and ineffective erythropoiesis&lt;/li&gt;&lt;li&gt;âž¤ macrocytic anemia&lt;/li&gt;&lt;li&gt;âž¤ more consistent with deficiencies in vitamin B12 or folate.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 638&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 638&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Bone infarcts are seen in:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Iron deficiency anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Thalassemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sickle cell anemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hereditary spherocytosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Sickle cell anemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Sickle cell anemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Iron deficiency anemia usually presents with symptoms related to a lack of hemoglobin and oxygen delivery, such as fatigue and pallor , not bone infarcts.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Iron deficiency anemia&lt;/li&gt;&lt;li&gt;â€¢ lack of hemoglobin and oxygen delivery,&lt;/li&gt;&lt;li&gt;â€¢ fatigue and pallor&lt;/li&gt;&lt;li&gt;â€¢ Option B. Thalassemia can cause bone deformities due to marrow expansion but does not typically cause bone infarcts.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Thalassemia can cause bone&lt;/li&gt;&lt;li&gt;â€¢ due to marrow expansion&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hereditary spherocytosis typically involves hemolysis and anemia due to defects in the red blood cell membrane , but it does not usually result in bone infarcts.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hereditary spherocytosis&lt;/li&gt;&lt;li&gt;â€¢ hemolysis&lt;/li&gt;&lt;li&gt;â€¢ anemia&lt;/li&gt;&lt;li&gt;â€¢ red blood cell membrane&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Bone infarcts are a common complication in sickle cell anemia due to vaso-occlusive events caused by the abnormal, sickled red blood cells .&lt;/li&gt;&lt;li&gt;âž¤ Bone infarcts&lt;/li&gt;&lt;li&gt;âž¤ sickle cell anemia&lt;/li&gt;&lt;li&gt;âž¤ vaso-occlusive events&lt;/li&gt;&lt;li&gt;âž¤ abnormal, sickled red blood cells&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 640)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 640)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 18-year-old Afro American boy presenting with a non healing ulcer of the foot, with recurrent pneumonia and chronic hemolytic anemia. The peripheral blood erythrocytes showed some peculiar appearance. Most likely cause is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Trinucleotide repeat&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Genomic imprinting â€‹â€‹â€‹â€‹â€‹â€‹&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Single amino acid base substitution&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Antibody to red cell membrane&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Single amino acid base substitution&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Single amino acid base substitution&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Trinucleotide repeat expansions cause disorders such as Huntington&#x27;s disease and some forms of muscular dystrophy , not sickle cell anemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Trinucleotide repeat expansions&lt;/li&gt;&lt;li&gt;â€¢ Huntington&#x27;s disease&lt;/li&gt;&lt;li&gt;â€¢ muscular dystrophy&lt;/li&gt;&lt;li&gt;â€¢ not sickle cell anemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Genomic imprinting is a form of gene expression regulation that does not relate to the structural changes in hemoglobin seen in sickle cell anemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Genomic imprinting is a form of gene expression regulation&lt;/li&gt;&lt;li&gt;â€¢ Option D. Antibody to red cell membrane would suggest an autoimmune hemolytic anemia rather than a genetically determined structural hemoglobinopathy.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Antibody to red cell membrane would suggest&lt;/li&gt;&lt;li&gt;â€¢ autoimmune&lt;/li&gt;&lt;li&gt;â€¢ genetically&lt;/li&gt;&lt;li&gt;â€¢ structural hemoglobinopathy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sickle cell anemia is caused by a single amino acid substitution ( valine for glutamic acid) at the sixth position of the Î²-globin chain of hemoglobin, which results in the sickling of red cells and related complications.&lt;/li&gt;&lt;li&gt;âž¤ Sickle cell anemia&lt;/li&gt;&lt;li&gt;âž¤ single amino acid substitution&lt;/li&gt;&lt;li&gt;âž¤ valine for glutamic acid)&lt;/li&gt;&lt;li&gt;âž¤ sixth&lt;/li&gt;&lt;li&gt;âž¤ Î²-globin chain&lt;/li&gt;&lt;li&gt;âž¤ sickling of red cells&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 648&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 648&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 56-yearâ€‘old female presents in the month of December with chronic fatigue and cyanosis of nose with blue lips. A peripheral blood smear showed the following image. What is the most likely cause of the findings seen?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Clumps of RBCs due to IgM mediated cold autoimÂ­mune haemolytic anemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Clumps of RBCs due to IgG mediated warm autoÂ­immune haemolytic anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;RBC lysis due to hemoglobinopathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Clumps of RBCs due to IgG mediated cold autoimÂ­mune haemolytic anemia â€‹â€‹â€‹â€‹â€‹â€‹&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Clumps of RBCs due to IgM mediated cold autoimÂ­mune haemolytic anemia&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/26/picture1_67TV6O2.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Clumps of RBCs due to IgM mediated cold autoimmune haemolytic anemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Warm autoimmune hemolytic anemia (WAIHA) involves IgG antibodies that react with red blood cells at body temperature, leading to their destruction by the spleen . This would not typically be associated with cold exposure and is not consistent with the symptom of cyanosis, which is related to cold.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Warm autoimmune&lt;/li&gt;&lt;li&gt;â€¢ IgG antibodies&lt;/li&gt;&lt;li&gt;â€¢ at body temperature,&lt;/li&gt;&lt;li&gt;â€¢ spleen&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hemoglobinopathies, such as sickle cell disease , can cause hemolytic anemia , but the red blood cells do not clump in response to cold. Instead, hemoglobinopathies typically involve structural abnormalities of the hemoglobin molecule itself.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hemoglobinopathies,&lt;/li&gt;&lt;li&gt;â€¢ sickle cell disease&lt;/li&gt;&lt;li&gt;â€¢ hemolytic anemia&lt;/li&gt;&lt;li&gt;â€¢ red blood cells do not clump in&lt;/li&gt;&lt;li&gt;â€¢ response to cold.&lt;/li&gt;&lt;li&gt;â€¢ structural abnormalities of the hemoglobin molecule itself.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cold agglutinin disease can sometime s involve IgG antibodies , but it is more commonly associated with IgM antibodies. IgG-mediated hemolysis at cold temperatures is much less common and would not explain the typical clumping seen in CAHA.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cold agglutinin&lt;/li&gt;&lt;li&gt;â€¢ sometime&lt;/li&gt;&lt;li&gt;â€¢ IgG antibodies&lt;/li&gt;&lt;li&gt;â€¢ more commonly associated with IgM antibodies.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ It is important to recognize the clinical and laboratory findings consistent with cold autoimmune hemolytic anemia (CAHA), where IgM antibodies bind to red blood cells at low temperatures , causing them to agglutinate . This can lead to hemolytic anemia , resulting in symptoms such as chronic fatigue and cyanosis upon cold exposure.&lt;/li&gt;&lt;li&gt;âž¤ cold autoimmune hemolytic anemia (CAHA),&lt;/li&gt;&lt;li&gt;âž¤ IgM antibodies bind to red blood cells at low temperatures&lt;/li&gt;&lt;li&gt;âž¤ to agglutinate&lt;/li&gt;&lt;li&gt;âž¤ hemolytic anemia&lt;/li&gt;&lt;li&gt;âž¤ chronic fatigue and cyanosis&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 643-4&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 643-4&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following if present provide protection against malaria except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Duffy blood group&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sickle cell anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thalassemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;G6PD deficiency&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Duffy blood group&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Duffy blood group&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sickle cell disease: P falciparum cannot multiply properly in the presence of HbS Î± and Î² thalassemia:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sickle cell disease:&lt;/li&gt;&lt;li&gt;â€¢ HbS Î± and Î² thalassemia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. G6 PD deficiency: G6PD is required for respiration of plasÂ¬modium&lt;/li&gt;&lt;li&gt;â€¢ Option D. G6 PD deficiency:&lt;/li&gt;&lt;li&gt;â€¢ respiration of plasÂ¬modium&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The absence of the Duffy blood group, the trait for sickle cell disease, thalassemia traits, and G6PD deficiency are all known to confer some protection against malaria due to various mechanisms that interfere with the parasite&#x27;s ability to infect or survive within red blood cells . However, the Duffy blood group&#x27;s absence , while protective against Plasmodium vivax , does not provide protection against P. falciparum, the most common and virulent cause of malaria.&lt;/li&gt;&lt;li&gt;âž¤ absence of the Duffy blood group, the trait for sickle cell disease, thalassemia traits, and G6PD deficiency&lt;/li&gt;&lt;li&gt;âž¤ against malaria&lt;/li&gt;&lt;li&gt;âž¤ parasite&#x27;s ability to infect or survive within red blood cells&lt;/li&gt;&lt;li&gt;âž¤ Duffy blood group&#x27;s absence&lt;/li&gt;&lt;li&gt;âž¤ against Plasmodium vivax&lt;/li&gt;&lt;li&gt;âž¤ does not provide protection against P. falciparum, the most common and virulent cause of malaria.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 403&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 403&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old male presents with fatigue and widespread purpura. Blood work reveals a marked decrease in platelets, with counts persistently below 20,000/ÂµL. The patient&#x27;s history includes recurrent epistaxis and one instance of hematuria. Bone marrow biopsy reveals a hypocellular marrow with a markedly reduced number of megakaryocytes. All of the following can cause megakaryocytic thrombocytopenia, except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Idiopathic thrombocytopenia purpura&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Systemic lupus erythematosus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Aplastic anemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Disseminated intravascular coagulation (DIC)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Aplastic anemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Aplastic anemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Idiopathic thrombocytopenic purpura [ITP]: ITP is characterized by autoimmune destruction of platelets . It typically presents with isolated thrombocytopenia and may show an increased number of megakaryocytes in the bone marrow due to compensatory production.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Idiopathic thrombocytopenic purpura [ITP]:&lt;/li&gt;&lt;li&gt;â€¢ autoimmune destruction of platelets&lt;/li&gt;&lt;li&gt;â€¢ Option B. Systemic lupus erythematosus [SLE]: SLE can cause thrombocytopenia due to autoantibody-mediated platelet destruction . Megakaryocytes may be increased in the bone marrow as the body tries to compensate for the peripheral platelet destruction.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Systemic lupus erythematosus [SLE]:&lt;/li&gt;&lt;li&gt;â€¢ cause thrombocytopenia&lt;/li&gt;&lt;li&gt;â€¢ autoantibody-mediated platelet destruction&lt;/li&gt;&lt;li&gt;â€¢ Option D. Disseminated intravascular coagulation [DIC]: DIC is a condition that leads to the systemic activation of the coagulation cascade , resulting in widespread microthrombi and secondary consumption of platelets and coagulation factors . This can also lead to a compensatory increase in megakaryocytes in the bone marrow.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Disseminated intravascular coagulation [DIC]:&lt;/li&gt;&lt;li&gt;â€¢ leads to the systemic activation of the coagulation cascade&lt;/li&gt;&lt;li&gt;â€¢ widespread microthrombi&lt;/li&gt;&lt;li&gt;â€¢ secondary consumption of platelets&lt;/li&gt;&lt;li&gt;â€¢ coagulation factors&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In megakaryocytic thrombocytopenia , there is an increase in bone marrow megakaryocytes as a compensatory mechanism for peripheral platelet destruction , but in aplastic anemia, there is bone marrow failure and reduced megakaryocytes.&lt;/li&gt;&lt;li&gt;âž¤ megakaryocytic thrombocytopenia&lt;/li&gt;&lt;li&gt;âž¤ increase in bone marrow megakaryocytes&lt;/li&gt;&lt;li&gt;âž¤ compensatory mechanism&lt;/li&gt;&lt;li&gt;âž¤ peripheral platelet destruction&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All are true about thrombotic thrombocytopenic purpura except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Microangiopathic hemolytic anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Thrombocytopenia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Normal complement level&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Grossly abnormal coagulation tests&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Grossly abnormal coagulation tests&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Grossly abnormal coagulation tests&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Microangiopathic hemolytic anemia: True . TTP is associated with the formation of microclots that damage red blood cells , leading to hemolysis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Microangiopathic hemolytic anemia:&lt;/li&gt;&lt;li&gt;â€¢ True&lt;/li&gt;&lt;li&gt;â€¢ TTP&lt;/li&gt;&lt;li&gt;â€¢ microclots that damage red blood cells&lt;/li&gt;&lt;li&gt;â€¢ hemolysis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Thrombocytopenia: True . TTP is characterized by low platelet counts due to the formation of platelet-rich microclots.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Thrombocytopenia:&lt;/li&gt;&lt;li&gt;â€¢ True&lt;/li&gt;&lt;li&gt;â€¢ TTP&lt;/li&gt;&lt;li&gt;â€¢ low platelet counts&lt;/li&gt;&lt;li&gt;â€¢ platelet-rich microclots.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Normal complement level: True . Unlike other conditions such as hemolytic uremic syndrome (HUS), TTP is not typically associated with complement activation, so complement levels are generally normal .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Normal complement level:&lt;/li&gt;&lt;li&gt;â€¢ True&lt;/li&gt;&lt;li&gt;â€¢ hemolytic uremic syndrome (HUS), TTP is not&lt;/li&gt;&lt;li&gt;â€¢ complement activation,&lt;/li&gt;&lt;li&gt;â€¢ normal&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ TTP doesn&#x27;t grossly affect the standard coagulation tests . So, the coagulation tests such as PT (prothrombin time) and APTT (activated partial thromboplastin time) are typically normal . Direct lines from Robbinsâ€¦ â€œIf coagulation tests indicate a major consumption of procoagulants, the diagnosis of TTP is doubtful â€.&lt;/li&gt;&lt;li&gt;â€¢ TTP doesn&#x27;t&lt;/li&gt;&lt;li&gt;â€¢ affect the standard coagulation tests&lt;/li&gt;&lt;li&gt;â€¢ coagulation tests&lt;/li&gt;&lt;li&gt;â€¢ PT&lt;/li&gt;&lt;li&gt;â€¢ APTT&lt;/li&gt;&lt;li&gt;â€¢ normal&lt;/li&gt;&lt;li&gt;â€¢ coagulation tests&lt;/li&gt;&lt;li&gt;â€¢ major consumption of procoagulants,&lt;/li&gt;&lt;li&gt;â€¢ TTP is doubtful&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins 10 th / 665&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Robbins 10 th / 665&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A newborn baby presented with profuse bleeding from the umbilical stump after birth. Rest of the examination and PT, APTT are within normal limits. Most likely diagnosis is which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Factor X deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glanzmannâ€™s thrombasthenia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Von Willebrand disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bernard Soulier disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Glanzmannâ€™s thrombasthenia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Glanzmannâ€™s thrombasthenia &amp;gt; (d) Bernard Soulier disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Factor X deficiency: Factor X deficiency is a rare bleeding disorder where the clotting factor X is either deficient or not functioning properly . It typically presents with a prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT), which are not normal in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Factor X deficiency:&lt;/li&gt;&lt;li&gt;â€¢ rare bleeding disorder&lt;/li&gt;&lt;li&gt;â€¢ clotting factor X&lt;/li&gt;&lt;li&gt;â€¢ deficient or not functioning properly&lt;/li&gt;&lt;li&gt;â€¢ prolonged prothrombin time&lt;/li&gt;&lt;li&gt;â€¢ activated partial thromboplastin time&lt;/li&gt;&lt;li&gt;â€¢ Option C. von Willebrand disease: Von Willebrand disease is the most common hereditary bleeding disorder and is caused by a qualitative or quantitative deficiency of von Willebrand factor (vWF). vWF is crucial for platelet adhesion; however, PT and aPTT can be normal in mild cases, but there&#x27;s often an abnormal bleeding time or abnormal vWF assays.&lt;/li&gt;&lt;li&gt;â€¢ Option C. von Willebrand disease:&lt;/li&gt;&lt;li&gt;â€¢ most common hereditary bleeding disorder&lt;/li&gt;&lt;li&gt;â€¢ qualitative or quantitative deficiency of von Willebrand factor&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bernard-Soulier disease: Bernard-Soulier syndrome is another rare platelet disorder , caused by a deficiency or dysfunction of the platelet glycoprotein Ib-IX-V complex , important for platelet adhesion to the vascular subendothelium. Similar to Glanzmannâ€™s thrombasthenia, PT and aPTT are normal, but the platelet function is impaired, leading to bleeding.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bernard-Soulier disease:&lt;/li&gt;&lt;li&gt;â€¢ rare platelet disorder&lt;/li&gt;&lt;li&gt;â€¢ deficiency or dysfunction of the platelet glycoprotein Ib-IX-V complex&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ The presence of normal PT and aPTT despite bleeding symptoms points towards a platelet function disorder rather than a clotting factor deficiency . Glanzmannâ€™s thrombasthenia and Bernard-Soulier syndrome are both characterized by normal coagulation tests and abnormal platelet function ; however, Glanzmannâ€™s thrombasthenia is generally considered more likely when these two conditions are indistinguishable based on clinical and laboratory findings.&lt;/li&gt;&lt;li&gt;âž¤ presence of normal PT&lt;/li&gt;&lt;li&gt;âž¤ aPTT despite bleeding symptoms&lt;/li&gt;&lt;li&gt;âž¤ platelet function disorder&lt;/li&gt;&lt;li&gt;âž¤ clotting factor deficiency&lt;/li&gt;&lt;li&gt;âž¤ Glanzmannâ€™s thrombasthenia&lt;/li&gt;&lt;li&gt;âž¤ Bernard-Soulier syndrome&lt;/li&gt;&lt;li&gt;âž¤ normal coagulation tests&lt;/li&gt;&lt;li&gt;âž¤ abnormal platelet function&lt;/li&gt;&lt;li&gt;âž¤ Ref : Wintrobeâ€™s 12th/1365-1370&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Wintrobeâ€™s 12th/1365-1370&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25 years old asymptomatic pregnant female underwent a pre-op coagulation test. Her bleeding time is 3 minutes, PT is 15/14sec, a PTT is 45/35 sec, platelet count is 2.5 lac/ mm 3 and factor VIII levels were 60IU/dL. What is her most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Factor IX deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lupus anticoagulant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Factor VIII inhibitors&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;VWD â€“ Type III&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Factor VIII inhibitors&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Factor VIII inhibitors&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Factor IX deficiency: Factor IX deficiency, also known as Hemophilia B or Christmas disease , is a bleeding disorder caused by a deficiency of clotting factor IX . It is an X-linked recessive disorder , making it much less likely in females . It presents with a prolonged aPTT but normal PT and bleeding time , which does not fully match the patient&#x27;s profile since her PT and bleeding time are within normal limits.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Factor IX deficiency:&lt;/li&gt;&lt;li&gt;â€¢ Hemophilia B&lt;/li&gt;&lt;li&gt;â€¢ Christmas disease&lt;/li&gt;&lt;li&gt;â€¢ bleeding disorder&lt;/li&gt;&lt;li&gt;â€¢ deficiency of clotting factor IX&lt;/li&gt;&lt;li&gt;â€¢ X-linked recessive disorder&lt;/li&gt;&lt;li&gt;â€¢ less likely in females&lt;/li&gt;&lt;li&gt;â€¢ prolonged aPTT&lt;/li&gt;&lt;li&gt;â€¢ normal PT&lt;/li&gt;&lt;li&gt;â€¢ bleeding time&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lupus anticoagulant: The presence of lupus anticoagulant, an autoimmune inhibitor , is associated with prolonged aPTT and may also lead to a prolonged PT . It is part of the antiphospholipid syndrome and can cause both bleeding and thrombotic episodes. Patients often have thrombocytopenia, which is not the case here as the patient has a normal platelet count.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lupus anticoagulant:&lt;/li&gt;&lt;li&gt;â€¢ autoimmune inhibitor&lt;/li&gt;&lt;li&gt;â€¢ prolonged aPTT&lt;/li&gt;&lt;li&gt;â€¢ lead to a prolonged PT&lt;/li&gt;&lt;li&gt;â€¢ Option D. VWD â€“ Type III: Von Willebrand Disease (VWD) Type III is the most severe form of VWD and is characterized by a markedly reduced or absent von Willebrand factor , leading to a significant bleeding tendency . Patients usually have a prolonged bleeding time and a decreased factor VIII activity, which is not consistent with this patient&#x27;s normal bleeding time and near-normal factor VIII levels.&lt;/li&gt;&lt;li&gt;â€¢ Option D. VWD â€“ Type III:&lt;/li&gt;&lt;li&gt;â€¢ most severe form of VWD&lt;/li&gt;&lt;li&gt;â€¢ markedly reduced&lt;/li&gt;&lt;li&gt;â€¢ absent von Willebrand factor&lt;/li&gt;&lt;li&gt;â€¢ bleeding tendency&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ This patientâ€™s normal bleeding time and PT but prolonged aPTT, along with the presence of normal factor VIII activity , suggest the presence of an inhibitor against factor VIII rather than a deficiency, which is consistent with acquired hemophilia .&lt;/li&gt;&lt;li&gt;âž¤ normal bleeding time&lt;/li&gt;&lt;li&gt;âž¤ PT but prolonged aPTT,&lt;/li&gt;&lt;li&gt;âž¤ presence of normal factor VIII activity&lt;/li&gt;&lt;li&gt;âž¤ presence of an inhibitor against factor VIII&lt;/li&gt;&lt;li&gt;âž¤ acquired hemophilia&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 672-3, Wintrobe 12th/1447-1453, HarÂ­rison 21 st /980&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 672-3, Wintrobe 12th/1447-1453, HarÂ­rison 21 st /980&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;True about prothrombin time to:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Immediate refrigeration to preserve factor viability&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Platelet-rich plasma is essential&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Done within 2 hours&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Activated with kaolin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Done within 2 hours&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture1_R5zNr7B.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Done within 2 hours&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Immediate refrigeration to preserve factor viability: While it&#x27;s true that certain coagulation factors are temperature sensitive , prothrombin time (PT) testing typically requires the sample to be kept at room temperature to prevent the cold activation of factors and potential precipitation of fibrinogen. Immediate refrigeration is not required for PT.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Immediate refrigeration to preserve factor viability:&lt;/li&gt;&lt;li&gt;â€¢ coagulation factors&lt;/li&gt;&lt;li&gt;â€¢ temperature sensitive&lt;/li&gt;&lt;li&gt;â€¢ prothrombin time&lt;/li&gt;&lt;li&gt;â€¢ testing&lt;/li&gt;&lt;li&gt;â€¢ kept at room temperature&lt;/li&gt;&lt;li&gt;â€¢ prevent the cold activation of factors&lt;/li&gt;&lt;li&gt;â€¢ Option B. Platelet-rich plasma is essential: PT is actually performed on platelet-poor plasma , not platelet-rich plasma. The presence of platelets can affect the test results by providing phospholipid surfaces that could artificially shorten the clotting time.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Platelet-rich plasma is essential:&lt;/li&gt;&lt;li&gt;â€¢ PT&lt;/li&gt;&lt;li&gt;â€¢ performed&lt;/li&gt;&lt;li&gt;â€¢ platelet-poor plasma&lt;/li&gt;&lt;li&gt;â€¢ Option D. Activated with kaolin: PT is not activated with kaolin . Instead, thromboplastin (a combination of tissue factor and phospholipids) is used to activate the extrinsic pathway of coagulation . Kaolin is used as an activator in the activated partial thromboplastin time (aPTT) test, which evaluates the intrinsic pathway.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Activated with kaolin:&lt;/li&gt;&lt;li&gt;â€¢ PT&lt;/li&gt;&lt;li&gt;â€¢ not activated with kaolin&lt;/li&gt;&lt;li&gt;â€¢ thromboplastin&lt;/li&gt;&lt;li&gt;â€¢ activate the extrinsic pathway of coagulation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The PT test must be done on platelet-poor plasma and usually within 2 hours of sample collection to ensure accurate results , using thromboplastin for activation.&lt;/li&gt;&lt;li&gt;âž¤ PT test&lt;/li&gt;&lt;li&gt;âž¤ done on platelet-poor plasma&lt;/li&gt;&lt;li&gt;âž¤ within 2 hours of sample collection&lt;/li&gt;&lt;li&gt;âž¤ accurate results&lt;/li&gt;&lt;li&gt;âž¤ thromboplastin for activation.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Dacie and Lewis practical hematology 10th/392, 398&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Dacie and Lewis practical hematology 10th/392, 398&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Patient with bleeding due to platelet function defects has which of the following features?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Normal platelet count and normal bleeding time&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Normal platelet count and increased bleeding time&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreased platelet count and increased bleeding time&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Normal platelet count and decreased bleeding time&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Normal platelet count and increased bleeding time&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Normal platelet count and increased&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Normal platelet count and normal bleeding time: This option would suggest no defect in platelet function or number , which would not typically be associated with a bleeding disorder.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Normal platelet count and normal bleeding time:&lt;/li&gt;&lt;li&gt;â€¢ no defect in platelet function&lt;/li&gt;&lt;li&gt;â€¢ number&lt;/li&gt;&lt;li&gt;â€¢ Option C. Decreased platelet count and increased bleeding time: This suggests a quantitative defect of platelets , such as thrombocytopenia , rather than a functional defect. Although patients with thrombocytopenia will also have an increased bleeding time, the platelet count in functional defects remains normal.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Decreased platelet count and increased bleeding time:&lt;/li&gt;&lt;li&gt;â€¢ quantitative defect of platelets&lt;/li&gt;&lt;li&gt;â€¢ thrombocytopenia&lt;/li&gt;&lt;li&gt;â€¢ Option D. Normal platelet count and decreased bleeding time: A decreased bleeding time indicates an efficient clotting process , which would not align with platelet function defects.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Normal platelet count and decreased bleeding time:&lt;/li&gt;&lt;li&gt;â€¢ decreased bleeding time&lt;/li&gt;&lt;li&gt;â€¢ efficient clotting process&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Platelet function defects present with a normal platelet count but impaired function , leading to an increased bleeding time , whereas quantitative disorders would show an altered platelet count .&lt;/li&gt;&lt;li&gt;âž¤ Platelet function defects&lt;/li&gt;&lt;li&gt;âž¤ normal platelet count&lt;/li&gt;&lt;li&gt;âž¤ impaired function&lt;/li&gt;&lt;li&gt;âž¤ increased bleeding time&lt;/li&gt;&lt;li&gt;âž¤ quantitative disorders&lt;/li&gt;&lt;li&gt;âž¤ altered platelet count&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 655&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 655&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 9-year-old boy with no significant past medical history is brought to the pediatrician by his parents who are concerned about his recent onset of spontaneous bruising and a single episode of nose bleeding that took longer than expected to cease. The child has no known allergies, and there is no family history of bleeding disorders. On physical examination, the paediatrician notes several bruises of varying sizes on his legs and arms, as well as petechiae on his ankles. Initial laboratory tests reveal an elevated prothrombin time (PT) and an elevated activated partial thromboplastin time (aPTT), but a normal platelet count and bleeding time (BT). What is the most likely defect in this child&#x27;s coagulation pathway?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Extrinsic pathway&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intrinsic pathway&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Platelet function&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Common pathway&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Common pathway&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Common pathway&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Extrinsic pathway: A defect in the extrinsic pathway would typically lead to an isolated elevation of PT , as this pathway is evaluated by the PT test. This does not explain the elevated aPTT observed in the patient.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Extrinsic pathway:&lt;/li&gt;&lt;li&gt;â€¢ lead to an isolated elevation of PT&lt;/li&gt;&lt;li&gt;â€¢ Option B. Intrinsic pathway: A defect in the intrinsic pathway would typically result in an isolated elevation of aPTT , as this pathway is evaluated by the aPTT test. This also does not explain the elevated PT observed in the patient.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Intrinsic pathway:&lt;/li&gt;&lt;li&gt;â€¢ result in an isolated elevation of aPTT&lt;/li&gt;&lt;li&gt;â€¢ Option C. Platelet function: Platelet function defects usually result in a prolonged bleeding time (BT) and normal coagulation tests (PT and aPTT). Since the patient has a normal BT, this is unlikely to be the correct diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Platelet function:&lt;/li&gt;&lt;li&gt;â€¢ prolonged bleeding time&lt;/li&gt;&lt;li&gt;â€¢ normal coagulation tests&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Defect in the extrinsic pathway causes elevation of PT Defect in the intrinsic pathway causes elevation of aPTT . Defect in common pathway cause elevation of both PT and aPTT . Platelet function defect causes elevation of BT .&lt;/li&gt;&lt;li&gt;âž¤ Defect in the extrinsic pathway causes elevation of PT&lt;/li&gt;&lt;li&gt;âž¤ extrinsic pathway&lt;/li&gt;&lt;li&gt;âž¤ PT&lt;/li&gt;&lt;li&gt;âž¤ Defect in the intrinsic pathway causes elevation of aPTT .&lt;/li&gt;&lt;li&gt;âž¤ intrinsic pathway&lt;/li&gt;&lt;li&gt;âž¤ aPTT&lt;/li&gt;&lt;li&gt;âž¤ Defect in common pathway cause elevation of both PT and aPTT .&lt;/li&gt;&lt;li&gt;âž¤ common pathway&lt;/li&gt;&lt;li&gt;âž¤ both PT and aPTT&lt;/li&gt;&lt;li&gt;âž¤ Platelet function defect causes elevation of BT .&lt;/li&gt;&lt;li&gt;âž¤ Platelet function defect&lt;/li&gt;&lt;li&gt;âž¤ BT&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 120&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 120&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 4-year-old boy is brought to the clinic with a history of recurrent ear infections, easy bruising, and severe eczema. On examination, the child has widespread petechiae and a weeping rash over his arms and legs. Laboratory tests reveal thrombocytopenia with an average platelet volume less than the reference range. The boy&#x27;s immunoglobulin levels are also noted to be abnormally low. The presence of small sized platelets on the peripheral smear is characteristic of:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Idiopathic thrombocytopenia purpura (ITP)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bernard Soulier syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Disseminated intravascular coagulation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Wiskott Aldrich syndrome&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Wiskott Aldrich syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Wiskott Aldrich syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Idiopathic thrombocytopenic purpura [ITP]: ITP is characterized by autoimmune destruction of platelets , typically leading to thrombocytopenia with normal-sized platelets and no associated eczema or immunodeficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Idiopathic thrombocytopenic purpura [ITP]:&lt;/li&gt;&lt;li&gt;â€¢ autoimmune destruction of platelets&lt;/li&gt;&lt;li&gt;â€¢ thrombocytopenia with normal-sized platelets&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bernard-Soulier syndrome: Bernard-Soulier syndrome is a platelet function disorder due to a deficiency in glycoprotein Ib, the platelet receptor for von Willebrand factor . Patients may have thrombocytopenia with large platelets and no associated eczema or immunodeficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bernard-Soulier syndrome:&lt;/li&gt;&lt;li&gt;â€¢ platelet function disorder&lt;/li&gt;&lt;li&gt;â€¢ glycoprotein Ib,&lt;/li&gt;&lt;li&gt;â€¢ von Willebrand factor&lt;/li&gt;&lt;li&gt;â€¢ thrombocytopenia&lt;/li&gt;&lt;li&gt;â€¢ Option C. Disseminated intravascular coagulation [DIC]: DIC is a secondary condition resulting from another underlying disease . It is characterized by widespread activation of coagulation , which can lead to the consumption of platelets and coagulation factors . Platelet size is typically not affected, and it is not associated with eczema or immunodeficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Disseminated intravascular coagulation [DIC]:&lt;/li&gt;&lt;li&gt;â€¢ underlying disease&lt;/li&gt;&lt;li&gt;â€¢ activation of coagulation&lt;/li&gt;&lt;li&gt;â€¢ consumption of platelets and coagulation factors&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The characteristic features of Wiskott-Aldrich syndrome , include thrombocytopenia with small platelets, eczema, and recurrent infections due to immunodeficiency.&lt;/li&gt;&lt;li&gt;âž¤ Wiskott-Aldrich syndrome&lt;/li&gt;&lt;li&gt;âž¤ thrombocytopenia with small platelets, eczema, and recurrent infections&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 243&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 243&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old female presents with easy bruising and prolonged bleeding after minor injuries. She has a family history of bleeding disorders. Which of the following is caused by VWF factor deficiency?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reduced platelet function&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Reduced factor VIII in plasma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Defective platelet adhesion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reduced Platelet aggregation: True . VWF plays a crucial role in platelet adhesion by binding to platelets and stabilizing the interaction between platelets and the damaged blood vessel wall . Its reduced levels lead to reduced platelet functioning .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reduced Platelet aggregation:&lt;/li&gt;&lt;li&gt;â€¢ True&lt;/li&gt;&lt;li&gt;â€¢ platelet adhesion by binding to platelets&lt;/li&gt;&lt;li&gt;â€¢ platelets and the damaged blood vessel wall&lt;/li&gt;&lt;li&gt;â€¢ reduced levels lead to reduced platelet functioning&lt;/li&gt;&lt;li&gt;â€¢ Option B. Reduced factor VIII in plasma: True . VWF serves as a carrier protein for factor VIII , protecting it from rapid clearance and degradation . Therefore, a deficiency in VWF can result in decreased levels of factor VIII in the plasma.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Reduced factor VIII in plasma:&lt;/li&gt;&lt;li&gt;â€¢ True&lt;/li&gt;&lt;li&gt;â€¢ carrier protein for factor VIII&lt;/li&gt;&lt;li&gt;â€¢ clearance and degradation&lt;/li&gt;&lt;li&gt;â€¢ decreased levels of factor VIII&lt;/li&gt;&lt;li&gt;â€¢ Option C. Defective platelet adhesion : True . VWF is essential for the initial adhesion of platelets to the damaged blood vessel wall , facilitating the formation of a stable plug at the site of injury.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Defective platelet adhesion&lt;/li&gt;&lt;li&gt;â€¢ True&lt;/li&gt;&lt;li&gt;â€¢ adhesion of platelets to the damaged blood vessel wall&lt;/li&gt;&lt;li&gt;â€¢ stable plug at the site of injury.&lt;/li&gt;&lt;li&gt;â€¢ So, the correct answer is (d) All of the above. Von Willebrand factor deficiency affects both platelet function and factor VIII levels in the plasma .&lt;/li&gt;&lt;li&gt;â€¢ Von Willebrand factor deficiency&lt;/li&gt;&lt;li&gt;â€¢ platelet function and factor VIII levels in the plasma&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ VWF deficiency impairs platelet adhesion and aggregation at the site of vascular injury, and reduces the plasma level of factor VIII by decreasing its stability in circulation.&lt;/li&gt;&lt;li&gt;â€¢ platelet adhesion and aggregation&lt;/li&gt;&lt;li&gt;â€¢ vascular injury,&lt;/li&gt;&lt;li&gt;â€¢ reduces the plasma level of factor VIII&lt;/li&gt;&lt;li&gt;â€¢ decreasing its stability&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins 10 th / 660&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Robbins 10 th / 660&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 22-year-old male presents with a history of recurrent nosebleeds, easy bruising, and prolonged bleeding after minor injuries. He has a deficiency of glycoprotein IIb-IIIa complex. Glycoprotein IIb-IIIa complex is deficient in which of the following conditions?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bernard Soulier syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glanzmann disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Von willebrand disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Gray platelet syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Glanzmann disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Glanzmann disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bernard Soulier syndrome is associated with a deficiency of glycoprotein Ib-IX-V complex .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Bernard Soulier syndrome&lt;/li&gt;&lt;li&gt;â€¢ glycoprotein Ib-IX-V complex&lt;/li&gt;&lt;li&gt;â€¢ Option C. von Willebrand disease is associated with deficiencies or dysfunction of von Willebrand factor , not the glycoprotein IIb-IIIa complex.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ von Willebrand disease&lt;/li&gt;&lt;li&gt;â€¢ von Willebrand factor&lt;/li&gt;&lt;li&gt;â€¢ Option D. Gray platelet syndrome is a rare platelet disorder characterized by grayish platelets and a deficiency of alpha-granules.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Gray platelet syndrome&lt;/li&gt;&lt;li&gt;â€¢ rare platelet disorder&lt;/li&gt;&lt;li&gt;â€¢ grayish platelets and a deficiency of alpha-granules.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Glycoprotein IIb-IIIa complex is deficient in Glanzmannâ€™s disease .&lt;/li&gt;&lt;li&gt;â€¢ Glycoprotein IIb-IIIa complex&lt;/li&gt;&lt;li&gt;â€¢ Glanzmannâ€™s disease&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins 10 th /120&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Robbins 10 th /120&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old woman with a diagnosis of chronic immune thrombocytopenic purpura (ITP) returns for a follow-up visit. She previously responded well to a course of glucocorticoids but presented again with petechiae and a platelet count of 25,000/Î¼L. She has no splenomegaly on examination. All the following statements are correct about treatment in chronic immune thrombocytopenic purpura except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Most of the patients respond to immunosuppressive doses of glucocorticoids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Relapse is rare&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Splenectomy is the treatment of choice for relapse&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Minority have refractory forms of ITP and difficult to treat&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Relapse is rare&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Relapse is rare&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A . While initial treatment with glucocorticoids can be effective, many patients with chronic ITP may not achieve sustained remission and can experience relapses.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ glucocorticoids&lt;/li&gt;&lt;li&gt;â€¢ chronic ITP&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ remission and can experience relapses.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Splenectomy is typically considered after glucocorticoids and other medical therapies have failed , making it not a first-line treatment, but rather a treatment for relapsed or refractory cases .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Splenectomy&lt;/li&gt;&lt;li&gt;â€¢ after glucocorticoids and other medical therapies have failed&lt;/li&gt;&lt;li&gt;â€¢ relapsed or refractory cases&lt;/li&gt;&lt;li&gt;â€¢ Option D. Some patients with chronic ITP do not respond to conventional therapies or relapse following initial therapy , which may suggest a refractory form of the disease .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ chronic ITP&lt;/li&gt;&lt;li&gt;â€¢ conventional therapies or relapse following initial therapy&lt;/li&gt;&lt;li&gt;â€¢ refractory form of the disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Direct quoteâ€¦. â€œAlmost all patients respond to glucoÂ­corticoids (which inhibit phagocyte function), but many eventually relapse .â€&lt;/li&gt;&lt;li&gt;âž¤ respond to glucoÂ­corticoids&lt;/li&gt;&lt;li&gt;âž¤ many eventually relapse&lt;/li&gt;&lt;li&gt;âž¤ In individuals with severe thrombocytopenia, spleÂ­nectomy normalizes the platelet counts. Immunomodulatory agents such as intravenous immunoglobulin or anti-CD20 antibody (rituximab) are often effective in patients who relapse after splenectomy or for whom splenectomy is contraindicated.&lt;/li&gt;&lt;li&gt;âž¤ In individuals with severe thrombocytopenia, spleÂ­nectomy normalizes the platelet counts.&lt;/li&gt;&lt;li&gt;âž¤ severe thrombocytopenia, spleÂ­nectomy normalizes&lt;/li&gt;&lt;li&gt;âž¤ platelet counts.&lt;/li&gt;&lt;li&gt;âž¤ Immunomodulatory agents such as intravenous immunoglobulin or anti-CD20 antibody (rituximab) are often effective in patients who relapse after splenectomy or for whom splenectomy is contraindicated.&lt;/li&gt;&lt;li&gt;âž¤ Immunomodulatory agents&lt;/li&gt;&lt;li&gt;âž¤ intravenous immunoglobulin or anti-CD20 antibody (rituximab)&lt;/li&gt;&lt;li&gt;âž¤ relapse after splenectomy&lt;/li&gt;&lt;li&gt;âž¤ splenectomy is contraindicated.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 659&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 659&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old male requires a blood transfusion after a severe car accident. He is known to have the Bombay phenotype. Prior to the transfusion, his blood sample is sent to the laboratory for compatibility testing. Based on his blood group, which of the following statements is incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lack of H, A and B antigen on RBCs&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lack of H, A and B substance in saliva&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lack of antigens of several blood group systems&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;H, A and B antibody will always be present in seÂ­rum&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lack of antigens of several blood group systems&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Lack of antigens of several blood group systems&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. His red blood cells lack H, A, and B antigens: This statement is correct. Individuals with the Bombay blood group do not express A, B, or H antigens on their red blood cells due to a homozygous mutation in the H gene (hh genotype).&lt;/li&gt;&lt;li&gt;â€¢ Option A. His red blood cells lack H, A, and B antigens:&lt;/li&gt;&lt;li&gt;â€¢ correct.&lt;/li&gt;&lt;li&gt;â€¢ do not express A, B, or H antigens on their red blood cells&lt;/li&gt;&lt;li&gt;â€¢ (hh genotype).&lt;/li&gt;&lt;li&gt;â€¢ Option B. His saliva does not contain H, A, and B substances: This statement is correct. The lack of H antigen also affects the presence of these antigens in body fluids , including saliva , because the H antigen is a precursor for A and B antigen synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. His saliva does not contain H, A, and B substances:&lt;/li&gt;&lt;li&gt;â€¢ correct.&lt;/li&gt;&lt;li&gt;â€¢ antigens in body fluids&lt;/li&gt;&lt;li&gt;â€¢ saliva&lt;/li&gt;&lt;li&gt;â€¢ H antigen is a precursor for A and B antigen synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. His serum contains antibodies against H, A, and B antigens: This statement is correct . Because individuals with the Bombay phenotype do not express A, B, or H antigens on their red blood cells , they will form antibodies against these antigens if exposed.&lt;/li&gt;&lt;li&gt;â€¢ Option D. His serum contains antibodies against H, A, and B antigens:&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ do not express A, B, or H antigens on their red blood cells&lt;/li&gt;&lt;li&gt;â€¢ antibodies against&lt;/li&gt;&lt;li&gt;â€¢ exposed.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Individuals with the Bombay phenotype lack A, B, and H antigens on their red blood cells and in their saliva, and their serum contains antibodies against these antigens.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Wintrobeâ€™s hematology 12th/635-6&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Wintrobeâ€™s hematology 12th/635-6&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The anticoagulant of choice for anticoagulation testing:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Heparin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;EDTA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sodium oxalate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;3.2% trisodium citrate&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 3.2% trisodium citrate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) 3.2% trisodium citrate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Heparin is an anticoagulant that acts by potentiating the activity of antithrombin III, thereby inhibiting thrombin and other coagulation factors. While heparin is commonly used in clinical settings for anticoagulation, it is not the anticoagulant of choice for anticoagulation testing, as it can interfere with clotting assays.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Heparin&lt;/li&gt;&lt;li&gt;â€¢ anticoagulant&lt;/li&gt;&lt;li&gt;â€¢ activity of antithrombin III,&lt;/li&gt;&lt;li&gt;â€¢ inhibiting thrombin and&lt;/li&gt;&lt;li&gt;â€¢ other coagulation factors.&lt;/li&gt;&lt;li&gt;â€¢ used in clinical settings&lt;/li&gt;&lt;li&gt;â€¢ anticoagulation,&lt;/li&gt;&lt;li&gt;â€¢ not the anticoagulant of choice for anticoagulation testing,&lt;/li&gt;&lt;li&gt;â€¢ Option B. EDTA is an anticoagulant that chelates calcium ions , preventing the coagulation process by inhibiting clotting factors that depend on calcium . EDTA is commonly used for collecting blood samples for hematology studies, such as complete blood counts .&lt;/li&gt;&lt;li&gt;â€¢ Option B. EDTA&lt;/li&gt;&lt;li&gt;â€¢ anticoagulant&lt;/li&gt;&lt;li&gt;â€¢ chelates calcium ions&lt;/li&gt;&lt;li&gt;â€¢ preventing the coagulation&lt;/li&gt;&lt;li&gt;â€¢ inhibiting clotting factors&lt;/li&gt;&lt;li&gt;â€¢ calcium&lt;/li&gt;&lt;li&gt;â€¢ collecting blood samples for hematology studies,&lt;/li&gt;&lt;li&gt;â€¢ complete blood counts&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sodium oxalate also chelates calcium ions , similar to EDTA , and is used for collecting blood samples for glucose testing (enolase acting as a glycolysis inhibitor).&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sodium oxalate&lt;/li&gt;&lt;li&gt;â€¢ chelates calcium ions&lt;/li&gt;&lt;li&gt;â€¢ EDTA&lt;/li&gt;&lt;li&gt;â€¢ glucose testing (enolase acting as a glycolysis inhibitor).&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ The anticoagulant of choice for anticoagulation testing is 3.2% trisodium citrate.&lt;/li&gt;&lt;li&gt;â€¢ anticoagulant of choice for anticoagulation&lt;/li&gt;&lt;li&gt;â€¢ 3.2% trisodium citrate.&lt;/li&gt;&lt;li&gt;â€¢ Question Id-15404 Unique Key-Q7889064&lt;/li&gt;&lt;li&gt;â€¢ Question Id-15404 Unique Key-Q7889064&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;As a primary healthcare worker, you collect blood samples to measure fasting blood glucose levels in a population screening for diabetes. To ensure accurate results, which anticoagulant should be used to prevent glycolysis in the sample during transport to the laboratory ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;EDTA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Heparin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Potassium oxalate + sodium fluoride&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tri Sodium citrate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Potassium oxalate + sodium fluoride&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Potassium oxalate + sodium fluoride&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. EDTA: Ethylenediaminetetraacetic acid (EDTA) is commonly used as an anticoagulant in hematology for complete blood count testing but not for glucose estimation because it does not prevent glycolysis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. EDTA:&lt;/li&gt;&lt;li&gt;â€¢ Ethylenediaminetetraacetic acid&lt;/li&gt;&lt;li&gt;â€¢ anticoagulant in hematology&lt;/li&gt;&lt;li&gt;â€¢ complete blood&lt;/li&gt;&lt;li&gt;â€¢ count testing&lt;/li&gt;&lt;li&gt;â€¢ Option B. Heparin: Heparin is an anticoagulant that prevents blood clotting by inhibiting thrombin but does not prevent glycolysis, so it is not the best choice for glucose testing.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Heparin:&lt;/li&gt;&lt;li&gt;â€¢ anticoagulant&lt;/li&gt;&lt;li&gt;â€¢ inhibiting thrombin&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tri Sodium citrate: Trisodium citrate is used mainly for coagulation tests and does not inhibit glycolysis , making it unsuitable for glucose estimation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tri Sodium citrate:&lt;/li&gt;&lt;li&gt;â€¢ coagulation tests&lt;/li&gt;&lt;li&gt;â€¢ does not inhibit glycolysis&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Direct quote â€˜ enolase enzyme in the glycolysis is inhibited by fluoride , and when blood samples are taken for measurement of glucose , it is collected in tubes containing fluoride to inhibit glycolysis.â€™&lt;/li&gt;&lt;li&gt;â€¢ enolase enzyme in the glycolysis is inhibited by fluoride&lt;/li&gt;&lt;li&gt;â€¢ blood samples&lt;/li&gt;&lt;li&gt;â€¢ glucose&lt;/li&gt;&lt;li&gt;â€¢ collected in tubes&lt;/li&gt;&lt;li&gt;â€¢ fluoride to inhibit glycolysis.â€™&lt;/li&gt;&lt;li&gt;â€¢ Ref : Henryâ€™s 21 st /188, Harper 27th/152&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Henryâ€™s 21 st /188, Harper 27th/152&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Most common blood transfusion reaction is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Febrile non-hemolytic transfusion reaction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hemolysis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Transmission of infections&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Electrolyte imbalance&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Febrile non-hemolytic transfusion reaction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Febrile non-hemolytic transfusion reaction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hemolysis: it is a serious but less common transfusion reaction. It occurs when red blood cells are destroyed, leading to the release of hemoglobin into the bloodstream . Hemolysis can be caused by various factors, including ABO incompatibility, improper storage , or bacterial contamination .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hemolysis:&lt;/li&gt;&lt;li&gt;â€¢ serious but less common&lt;/li&gt;&lt;li&gt;â€¢ red blood cells are destroyed,&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin into the bloodstream&lt;/li&gt;&lt;li&gt;â€¢ various factors,&lt;/li&gt;&lt;li&gt;â€¢ ABO incompatibility, improper storage&lt;/li&gt;&lt;li&gt;â€¢ bacterial contamination&lt;/li&gt;&lt;li&gt;â€¢ Option C. Transmission of Infections: While the transmission of infections is a serious concern in blood transfusions, it is not the most common transfusion reaction. Stringent screening and testing procedures for donated blood have significantly reduced the risk of transmitting infections, making FNHTR more common.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Transmission of Infections:&lt;/li&gt;&lt;li&gt;â€¢ serious concern in blood transfusions,&lt;/li&gt;&lt;li&gt;â€¢ not the most common&lt;/li&gt;&lt;li&gt;â€¢ Stringent screening and testing procedures for donated blood&lt;/li&gt;&lt;li&gt;â€¢ reduced&lt;/li&gt;&lt;li&gt;â€¢ transmitting infections,&lt;/li&gt;&lt;li&gt;â€¢ Option D. Electrolyte Imbalance: Electrolyte imbalances are not a common transfusion reaction. However, in some cases, transfusions with large volumes of blood or specific blood components can lead to electrolyte disturbances . This is not the primary or most common transfusion reaction.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Electrolyte Imbalance:&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ transfusions with large volumes of blood or specific blood components&lt;/li&gt;&lt;li&gt;â€¢ electrolyte disturbances&lt;/li&gt;&lt;li&gt;â€¢ not the primary&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Most common blood transfusion reaction is Febrile non-hemolytic transfusion reaction.&lt;/li&gt;&lt;li&gt;â€¢ blood transfusion&lt;/li&gt;&lt;li&gt;â€¢ Febrile non-hemolytic transfusion reaction.&lt;/li&gt;&lt;li&gt;â€¢ Ref: Robbins 10 th 667&lt;/li&gt;&lt;li&gt;â€¢ Ref:&lt;/li&gt;&lt;li&gt;â€¢ Robbins 10 th 667&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old male involved in a motor vehicle collision requires a massive transfusion due to severe hemorrhagic shock. He receives 15 units of packed red blood cells within a 24-hour period. Which of the following complications is likely to result after several units of blood have been transferred?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metabolic alkalosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Metabolic acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Respiratory alkalosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Respiratory acidosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Metabolic alkalosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Metabolic alkalosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Metabolic acidosis: While metabolic acidosis can be present initially due to hypoperfusion and lactic acidosis , the administration of several units of blood typically results in the correction of the acidosis, potentially overshooting into alkalosis due to the reasons mentioned above.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Metabolic acidosis:&lt;/li&gt;&lt;li&gt;â€¢ due to hypoperfusion and lactic acidosis&lt;/li&gt;&lt;li&gt;â€¢ potentially overshooting into alkalosis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Respiratory alkalosis: Respiratory alkalosis typically results from hyperventilation, which may occur in patients in pain or with anxiety , but it is not directly related to the transfusion of blood products.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Respiratory alkalosis:&lt;/li&gt;&lt;li&gt;â€¢ hyperventilation,&lt;/li&gt;&lt;li&gt;â€¢ pain or with anxiety&lt;/li&gt;&lt;li&gt;â€¢ Option D. Respiratory acidosis: Respiratory acidosis is caused by hypoventilation and the accumulation of carbon dioxide in the blood. It is not a common complication associated with blood transfusion itself, unless there are underlying respiratory issues or transfusion-related complications affecting lung function.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Respiratory acidosis:&lt;/li&gt;&lt;li&gt;â€¢ hypoventilation and the accumulation of carbon dioxide&lt;/li&gt;&lt;li&gt;â€¢ underlying respiratory issues or transfusion-related complications affecting lung function.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Massive Transfusion is defined as the need to transfuse from one to two times the patientâ€™s normal blood volÂ­ume . In a normal adult, this is equivalent to 10-20 units . Most common abnormality is metabolic alkalosis . It reÂ­sults from conversion of citrate (present in stored blood) and lactate (accumulated due to hypoperfusion) to bicarÂ­bonate.&lt;/li&gt;&lt;li&gt;âž¤ Massive Transfusion&lt;/li&gt;&lt;li&gt;âž¤ one to two times the patientâ€™s normal blood volÂ­ume&lt;/li&gt;&lt;li&gt;âž¤ 10-20 units&lt;/li&gt;&lt;li&gt;âž¤ metabolic alkalosis&lt;/li&gt;&lt;li&gt;âž¤ citrate (present in stored blood) and lactate (accumulated due to hypoperfusion) to bicarÂ­bonate.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Robbins 10 th / 668&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Robbins 10 th / 668&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old man with a history of hemophilia A requires a blood product transfusion during a surgical procedure. ABO incompatibility is not seen with:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fresh frozen plasma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Platelet rich plasma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Single donor platelets&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cryoprecipitate&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Cryoprecipitate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Cryoprecipitate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fresh frozen plasma: FFP contains all coagulation factors , including soluble ABO antigens . ABO incompatibility can lead to hemolytic reactions ; thus, it should be matched with the recipient&#x27;s blood group .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fresh frozen plasma:&lt;/li&gt;&lt;li&gt;â€¢ coagulation factors&lt;/li&gt;&lt;li&gt;â€¢ ABO antigens&lt;/li&gt;&lt;li&gt;â€¢ ABO incompatibility&lt;/li&gt;&lt;li&gt;â€¢ hemolytic reactions&lt;/li&gt;&lt;li&gt;â€¢ matched&lt;/li&gt;&lt;li&gt;â€¢ recipient&#x27;s blood group&lt;/li&gt;&lt;li&gt;â€¢ Option B. Platelet-rich plasma: PRP is derived from whole blood and retains the ABO antigens . Transfusion with incompatible PRP can also lead to hemolytic reactions.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Platelet-rich plasma:&lt;/li&gt;&lt;li&gt;â€¢ whole blood and retains the ABO antigens&lt;/li&gt;&lt;li&gt;â€¢ incompatible PRP&lt;/li&gt;&lt;li&gt;â€¢ hemolytic reactions.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Single donor platelets: Single donor platelets carry the donor&#x27;s ABO antigens , and while the risk is lower compared to red cell transfusion, ABO compatibility is still preferred to minimize the risk of reaction.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Single donor platelets:&lt;/li&gt;&lt;li&gt;â€¢ donor&#x27;s ABO antigens&lt;/li&gt;&lt;li&gt;â€¢ lower compared to red cell transfusion, ABO compatibility&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While ABO matching is ideal for all blood components , cryoprecipitate is the least likely to cause an ABO incompatibility reaction due to its low content of plasma and ABO antigens .&lt;/li&gt;&lt;li&gt;âž¤ ABO matching&lt;/li&gt;&lt;li&gt;âž¤ blood components&lt;/li&gt;&lt;li&gt;âž¤ cryoprecipitate&lt;/li&gt;&lt;li&gt;âž¤ ABO incompatibility reaction&lt;/li&gt;&lt;li&gt;âž¤ low content of plasma&lt;/li&gt;&lt;li&gt;âž¤ ABO antigens&lt;/li&gt;&lt;li&gt;âž¤ Ref : Wintrobes 12 th /850&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Wintrobes 12 th /850&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55 years old male accident victim in casualty urgently needs blood. The blood bank is unable to determine his ABO group, as his red cell group and plasma group do not match. Emergency transfusion of the patient should be with:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;RBC corresponding to his red cell group and colloids/ crystalloid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Whole blood corresponding to his plasma group&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;O positive RBC and colloids/crystalloid&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;AB negative whole blood&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. O positive RBC and colloids/crystalloid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) O positive RBC and colloids/crystalloid&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. RBCs corresponding to his red cell group and colloids/crystalloid: While it might seem intuitive to use RBCs corresponding to his red cell group, in cases where there is a discrepancy and the patient&#x27;s blood group cannot be confirmed, it is safer to use group O RBCs, which are considered universal donors .&lt;/li&gt;&lt;li&gt;â€¢ Option A. RBCs corresponding to his red cell group and colloids/crystalloid:&lt;/li&gt;&lt;li&gt;â€¢ discrepancy and the patient&#x27;s blood group cannot be confirmed,&lt;/li&gt;&lt;li&gt;â€¢ safer to use group O RBCs,&lt;/li&gt;&lt;li&gt;â€¢ universal donors&lt;/li&gt;&lt;li&gt;â€¢ Option B. Whole blood corresponding to his plasma group: When the ABO group cannot be determined, using whole blood of a specific group is not recommended due to the risk of an ABO incompatibility reaction .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Whole blood corresponding to his plasma group:&lt;/li&gt;&lt;li&gt;â€¢ not recommended&lt;/li&gt;&lt;li&gt;â€¢ ABO incompatibility reaction&lt;/li&gt;&lt;li&gt;â€¢ Option D. AB negative whole blood: AB negative blood is considered the universal plasma donor , not the universal RBC donor . This option could result in an ABO incompatibility reaction if the patient is not AB negative.&lt;/li&gt;&lt;li&gt;â€¢ Option D. AB negative whole blood:&lt;/li&gt;&lt;li&gt;â€¢ universal plasma donor&lt;/li&gt;&lt;li&gt;â€¢ not the universal RBC donor&lt;/li&gt;&lt;li&gt;â€¢ ABO incompatibility reaction if the patient is not AB negative.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ O positive RBCs can be used in males and non-childbearing potential females, with colloids or crystalloid solutions to manage volume, as this approach minimizes the risk of hemolytic transfusion reactions .&lt;/li&gt;&lt;li&gt;âž¤ O positive RBCs&lt;/li&gt;&lt;li&gt;âž¤ males and non-childbearing potential females, with colloids or crystalloid solutions&lt;/li&gt;&lt;li&gt;âž¤ minimizes&lt;/li&gt;&lt;li&gt;âž¤ hemolytic transfusion reactions&lt;/li&gt;&lt;li&gt;âž¤ Ref: Wintrobes 12 th 836&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Wintrobes 12 th 836&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Although more than 400 blood groups have been identified, the ABO blood system re-mains the most important in clinical medicine because:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It was the first blood group system to be discovered&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It has four different blood group A, B, AB, O (H)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ABO (H) antigens are present in most body tissues and fluids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ABO (H) antibodies are invariably present in plasma when persons RBC lack the corresponding antigen&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. ABO (H) antibodies are invariably present in plasma when persons RBC lack the corresponding antigen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) ABO (H) antibodies are invariably present in plasma when persons RBC lacks the corresponding antigen&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The presence of naturally occurring antibodies in individuals against ABO antigens they do not possess on their red blood cells is the critical factor that can lead to hemolytic reactions if incompatible blood is transfused.&lt;/li&gt;&lt;li&gt;âž¤ antibodies&lt;/li&gt;&lt;li&gt;âž¤ against ABO antigens&lt;/li&gt;&lt;li&gt;âž¤ do not possess on their red blood cells&lt;/li&gt;&lt;li&gt;âž¤ lead to hemolytic reactions&lt;/li&gt;&lt;li&gt;âž¤ incompatible blood&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Carbohydrate present in blood group substance is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fucose&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Deoxyribose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ribulose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ribose&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Fucose&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Fucose&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Deoxyribose: Deoxyribose is a sugar found in DNA , not associated with the ABO blood group antigens.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Deoxyribose:&lt;/li&gt;&lt;li&gt;â€¢ sugar found in DNA&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ribulose: Ribulose is a pentose sugar involved in metabolic pathways, like the pentose phosphate pathway, but it is not related to blood group antigen formation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ribulose:&lt;/li&gt;&lt;li&gt;â€¢ pentose sugar&lt;/li&gt;&lt;li&gt;â€¢ pentose phosphate pathway,&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ribose: Ribose is a sugar component of RNA and is not involved in the structure of ABO blood group antigens.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ribose:&lt;/li&gt;&lt;li&gt;â€¢ sugar component of RNA&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Fucose is added to the glycolipid or glycoprotein backbone of red blood cells to form the H antigen.&lt;/li&gt;&lt;li&gt;âž¤ Fucose&lt;/li&gt;&lt;li&gt;âž¤ glycolipid or glycoprotein backbone&lt;/li&gt;&lt;li&gt;âž¤ H antigen.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 23-year-old male presents to the clinic with recurrent, spontaneous joint hemarthroses. Family history is significant for similar symptoms in his maternal uncles. Laboratory evaluation reveals a specific factor deficiency. Which laboratory finding is most consistent with a diagnosis of Hemophilia A?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prolonged PTT&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prolonged PT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Low platelet count&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Abnormal BT&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Prolonged PTT&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Prolonged PTT&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prolonged PT: The prothrombin time (PT) test evaluates the extrinsic and common pathways .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prolonged PT:&lt;/li&gt;&lt;li&gt;â€¢ extrinsic and common pathways&lt;/li&gt;&lt;li&gt;â€¢ Option C. Low platelet count: Hemophilia A does not affect the platelet count ; it is a coagulation factor deficiency and does not involve quantitative platelet defects.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Low platelet count:&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ platelet count&lt;/li&gt;&lt;li&gt;â€¢ coagulation factor deficiency&lt;/li&gt;&lt;li&gt;â€¢ quantitative platelet defects.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Abnormal BT : Bleeding time tests primary hemostasis , which includes platelet function .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Abnormal BT&lt;/li&gt;&lt;li&gt;â€¢ primary hemostasis&lt;/li&gt;&lt;li&gt;â€¢ platelet function&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hemophilia A , a genetic disorder characterized by factor VIII deficiency leads to impaired function of the intrinsic coagulation pathway . This manifests clinically with a prolonged activated partial thromboplastin time (PTT) and a normal prothrombin time (PT) and bleeding time (BT).&lt;/li&gt;&lt;li&gt;âž¤ Hemophilia A&lt;/li&gt;&lt;li&gt;âž¤ factor VIII deficiency&lt;/li&gt;&lt;li&gt;âž¤ impaired&lt;/li&gt;&lt;li&gt;âž¤ intrinsic coagulation pathway&lt;/li&gt;&lt;li&gt;âž¤ prolonged activated partial thromboplastin time (PTT) and a normal prothrombin time (PT) and bleeding time (BT).&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 668&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 668&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A medical student working in a blood bank is tasked with handling stored red blood cells (RBCs) for transfusion purposes. What is the recommended storage temperature for preserving the viability and function of RBCs?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;2â€“6 Â°C&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;â€“2 toâ€“4 Â°C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;37 Â°C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;20â€“25Â°C&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 2â€“6 Â°C&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture2.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) 2â€“6 Â°C&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ The recommended storage temperature for preserving the viability and function of RBCs is 2-6 degree Celsius .&lt;/li&gt;&lt;li&gt;â€¢ storage temperature&lt;/li&gt;&lt;li&gt;â€¢ viability and function of RBCs&lt;/li&gt;&lt;li&gt;â€¢ 2-6 degree Celsius&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins 10 th /; Essentials of Hematology 2nd/500&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Robbins 10 th /; Essentials of Hematology 2nd/500&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male is scheduled for a red blood cell transfusion due to severe anemia. To optimize the transfusion process, which of the following needle sizes is recommended for the administration of red blood cells?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;With a 16â€“18 G needle&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;With a 18â€“20 G needle&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;With a 20â€“22 G needle&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;With a 22â€“24 G needle&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. With a 18â€“20 G needle&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture3.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) With a 18â€“20 G needle&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A needle gauge of 18-20 G is recommended for transfusion to minimize hemolysis and allow for an adequate flow rate .&lt;/li&gt;&lt;li&gt;âž¤ 18-20 G&lt;/li&gt;&lt;li&gt;âž¤ transfusion to minimize hemolysis&lt;/li&gt;&lt;li&gt;âž¤ adequate flow rate&lt;/li&gt;&lt;li&gt;âž¤ Ref : Essentials of Hematology 2nd/500&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Essentials of Hematology 2nd/500&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old individual is scheduled to donate blood for a local blood drive. To ensure the safety of the blood supply, the donor&#x27;s blood will be screened for various infectious diseases. Among the following options, which one is typically NOT included in the routine screening for donated blood?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Malaria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hep B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HIV&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dengue&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Dengue&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Dengue&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Malaria is routinely screened for in donated blood because it is caused by parasites transmitted through the bite of infected mosquitoes . Screening helps prevent the transmission of malaria through blood transfusions .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Malaria&lt;/li&gt;&lt;li&gt;â€¢ donated blood&lt;/li&gt;&lt;li&gt;â€¢ parasites transmitted through the bite of infected mosquitoes&lt;/li&gt;&lt;li&gt;â€¢ Screening helps&lt;/li&gt;&lt;li&gt;â€¢ malaria&lt;/li&gt;&lt;li&gt;â€¢ blood transfusions&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hepatitis B is a viral infection that can be transmitted through blood transfusions. Screening for Hepatitis B surface antigen (HBsAg) is essential to prevent the transmission of the virus to recipients of donated blood .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Hepatitis B&lt;/li&gt;&lt;li&gt;â€¢ viral infection&lt;/li&gt;&lt;li&gt;â€¢ blood transfusions.&lt;/li&gt;&lt;li&gt;â€¢ Hepatitis B surface antigen (HBsAg)&lt;/li&gt;&lt;li&gt;â€¢ virus to recipients of donated blood&lt;/li&gt;&lt;li&gt;â€¢ Option C. Screening for HIV is crucial in donated blood to prevent the transmission of the virus to recipients . HIV screening typically involves testing for antibodies to HIV-1 and HIV-2 , ensuring the safety of the blood supply .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Screening for HIV&lt;/li&gt;&lt;li&gt;â€¢ donated blood to prevent the transmission of the virus to recipients&lt;/li&gt;&lt;li&gt;â€¢ antibodies to HIV-1 and HIV-2&lt;/li&gt;&lt;li&gt;â€¢ safety of the blood supply&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ While diseases such as HIV, Hepatitis B, and Malaria are routinely screened for in donated blood to ensure the safety of the blood supply , Dengue is not typically included in routine screening protocols as it is primarily transmitted by mosquitoes rather than through blood transfusions .&lt;/li&gt;&lt;li&gt;â€¢ HIV, Hepatitis B, and Malaria&lt;/li&gt;&lt;li&gt;â€¢ donated blood to ensure the safety of the blood supply&lt;/li&gt;&lt;li&gt;â€¢ Dengue is not&lt;/li&gt;&lt;li&gt;â€¢ screening protocols&lt;/li&gt;&lt;li&gt;â€¢ mosquitoes rather than through blood transfusions&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young boy presented with recurrent episodes of melena. The physician also found presence of dermatitis like rashes and multiple petechiae. His platelet count was low but red cell and white blood cell counts were normal. Which of the following is the diagnostic investigation in this case?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-platelet antibodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bone marrow examination&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;WASP gene study&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Platelet function analyzer&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. WASP gene study&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture4.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) WASP gene study&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti-platelet antibodies are antibodies produced by the immune system against platelets, which can result in conditions like immune thrombocytopenic purpura (ITP ). While it could be considered in cases of thrombocytopenia, the clinical presentation described in the question is more indicative of a specific underlying genetic disorder rather than an autoimmune cause.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Anti-platelet antibodies&lt;/li&gt;&lt;li&gt;â€¢ antibodies&lt;/li&gt;&lt;li&gt;â€¢ against platelets,&lt;/li&gt;&lt;li&gt;â€¢ immune thrombocytopenic purpura (ITP&lt;/li&gt;&lt;li&gt;â€¢ more indicative of a specific underlying genetic disorder&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bone marrow examination is a valuable diagnostic tool in cases of unexplained thrombocytopenia to assess for abnormalities in platelet production or destruction . However, in this case, the clinical presentation and history strongly suggest a specific genetic disorder rather than a primary bone marrow disorder.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Bone marrow examination&lt;/li&gt;&lt;li&gt;â€¢ unexplained thrombocytopenia&lt;/li&gt;&lt;li&gt;â€¢ abnormalities in platelet production or destruction&lt;/li&gt;&lt;li&gt;â€¢ specific genetic disorder&lt;/li&gt;&lt;li&gt;â€¢ Option D . Platelet function analyzers are used to assess platelet function in various bleeding disorders . While they may be useful in certain contexts, the clinical presentation described in the question suggests a genetic disorder rather than a primary platelet dysfunction .&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Platelet function analyzers&lt;/li&gt;&lt;li&gt;â€¢ platelet function&lt;/li&gt;&lt;li&gt;â€¢ bleeding disorders&lt;/li&gt;&lt;li&gt;â€¢ genetic disorder&lt;/li&gt;&lt;li&gt;â€¢ primary platelet dysfunction&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ The clinical presentation described, including thrombocytopenia, recurrent infections, and eczema , is suggestive of Wiskott-Aldrich syndrome , a rare X-linked recessive disorder . Genetic analysis of the WASP gene is the diagnostic investigation of choice to confirm the diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ clinical presentation&lt;/li&gt;&lt;li&gt;â€¢ thrombocytopenia, recurrent infections, and eczema&lt;/li&gt;&lt;li&gt;â€¢ Wiskott-Aldrich syndrome&lt;/li&gt;&lt;li&gt;â€¢ rare X-linked recessive disorder&lt;/li&gt;&lt;li&gt;â€¢ WASP gene&lt;/li&gt;&lt;li&gt;â€¢ diagnostic investigation of choice&lt;/li&gt;&lt;li&gt;â€¢ diagnosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Normal platelet count is found in:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Wiskott Aldrich syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Henoch Schonlein purpura&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Immune thrombocytopenia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dengue fever&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Henoch Schonlein purpura&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Henoch Schonlein purpura&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ All other options have decreased platelet count except Henoch Schonlein purpura . Though it has the word purÂ­pura in its name, but the platelet count in this condition is normal . Th e skin manifestations in HSP are due to small vessel vasculitis .&lt;/li&gt;&lt;li&gt;â€¢ All other options&lt;/li&gt;&lt;li&gt;â€¢ decreased platelet count&lt;/li&gt;&lt;li&gt;â€¢ Henoch Schonlein purpura&lt;/li&gt;&lt;li&gt;â€¢ platelet count in this condition is normal&lt;/li&gt;&lt;li&gt;â€¢ e&lt;/li&gt;&lt;li&gt;â€¢ skin manifestations in HSP&lt;/li&gt;&lt;li&gt;â€¢ small vessel vasculitis&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins 10 th / 526-527&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Robbins 10 th / 526-527&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is true about h/h blood group?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lacks H-antigen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lacks A-antigen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lacks B antigen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old patient is scheduled for coagulation studies to assess their clotting function. To prevent blood clotting during the tests, which of the following anticoagulants is commonly used in coagulation studies?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Calcium citrate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;EDTA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sodium bromide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Trisodium citrate&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Trisodium citrate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture5.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Trisodium citrate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Calcium citrate is not commonly used as an a nticoagulant in coagulation studies . In fact, it contains calcium ions , which promote clotting rather than preventing it . Therefore, it is not suitable for use in coagulation tests.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Calcium citrate&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ nticoagulant in coagulation studies&lt;/li&gt;&lt;li&gt;â€¢ calcium ions&lt;/li&gt;&lt;li&gt;â€¢ promote clotting rather than preventing it&lt;/li&gt;&lt;li&gt;â€¢ not suitable&lt;/li&gt;&lt;li&gt;â€¢ coagulation tests.&lt;/li&gt;&lt;li&gt;â€¢ Option B. EDTA is commonly used as an anticoagulant for blood samples for tests such as complete blood count (CBC). However, it is not typically used in coagulation studies because it can interfere with calcium-dependent coagulation pathways.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ EDTA&lt;/li&gt;&lt;li&gt;â€¢ anticoagulant&lt;/li&gt;&lt;li&gt;â€¢ complete blood count (CBC).&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ coagulation studies&lt;/li&gt;&lt;li&gt;â€¢ interfere with calcium-dependent coagulation pathways.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sodium bromide is not commonly used as an anticoagulant in coagulation studies . It is primarily used in analytical chemistry and not for blood sample collection or coagulation tests .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Sodium bromide&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ anticoagulant in coagulation studies&lt;/li&gt;&lt;li&gt;â€¢ analytical chemistry&lt;/li&gt;&lt;li&gt;â€¢ not for blood sample collection&lt;/li&gt;&lt;li&gt;â€¢ coagulation tests&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Trisodium citrate is the correct anticoagulant for coagulation studies.&lt;/li&gt;&lt;li&gt;â€¢ It chelates calcium ions and is used to prevent blood clotting during tests like prothrombin time (PT) and activated partial thromboplastin time (APTT).&lt;/li&gt;&lt;li&gt;â€¢ chelates calcium ions&lt;/li&gt;&lt;li&gt;â€¢ blood clotting&lt;/li&gt;&lt;li&gt;â€¢ prothrombin time (PT) and activated partial thromboplastin time (APTT).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A medical student is reviewing the chromosomal locations of blood group antigens. When considering the Rh blood group system, including the Rh antigen, which of the following chromosomes houses the relevant genes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;9&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;19&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;13&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 1&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) 1&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A laboratory technician is preparing blood samples for various tests requiring the chelation of calcium ions to prevent blood clotting. Which of the following anticoagulants is commonly used?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;EDTA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oxalate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sodium citrate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. EDTA is an anticoagulant commonly used in laboratory settings for tests such as complete blood count (CBC) . It chelates calcium ions , preventing blood clotting by binding to calcium , which is essential for the coagulation cascade.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ EDTA&lt;/li&gt;&lt;li&gt;â€¢ anticoagulant&lt;/li&gt;&lt;li&gt;â€¢ complete blood count (CBC)&lt;/li&gt;&lt;li&gt;â€¢ chelates calcium ions&lt;/li&gt;&lt;li&gt;â€¢ preventing blood clotting by binding to calcium&lt;/li&gt;&lt;li&gt;â€¢ Option B. Oxalate is another anticoagulant that chelates calcium ions , thus preventing blood clotting . It is commonly used in laboratory settings for tests such as blood glucose measurement .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Oxalate&lt;/li&gt;&lt;li&gt;â€¢ another anticoagulant&lt;/li&gt;&lt;li&gt;â€¢ calcium ions&lt;/li&gt;&lt;li&gt;â€¢ blood clotting&lt;/li&gt;&lt;li&gt;â€¢ blood glucose measurement&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sodium citrate is a third anticoagulant that chelates calcium ions , effectively preventing blood clotting during various laboratory tests. It is commonly used for coagulation studies such as prothrombin time (PT) and activated partial thromboplastin time (APTT).&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Sodium citrate&lt;/li&gt;&lt;li&gt;â€¢ third anticoagulant&lt;/li&gt;&lt;li&gt;â€¢ calcium ions&lt;/li&gt;&lt;li&gt;â€¢ preventing blood clotting&lt;/li&gt;&lt;li&gt;â€¢ prothrombin time (PT) and activated partial thromboplastin time (APTT).&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ EDTA, oxalate, and sodium citrate are all anticoagulants commonly used in laboratory settings. They prevent blood clotting by chelating calcium ions , which are essential for the coagulation cascade . Each anticoagulant has its specific applications in different types of laboratory tests .&lt;/li&gt;&lt;li&gt;â€¢ EDTA, oxalate, and sodium citrate&lt;/li&gt;&lt;li&gt;â€¢ anticoagulants&lt;/li&gt;&lt;li&gt;â€¢ blood clotting by chelating calcium ions&lt;/li&gt;&lt;li&gt;â€¢ coagulation cascade&lt;/li&gt;&lt;li&gt;â€¢ specific applications in different types of laboratory tests&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young boy came with dyspnea and was found to have a mediastinal mass. Which of the following is known to produce mediastinal lymphadenopathy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Diffuse large B cell Lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;B cell lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mediastinal rich B cell lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;T cell Lymphoblastic ALL&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. T cell Lymphoblastic ALL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) T cell Lymphoblastic ALL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Diffuse large B-cell lymphoma (DLBCL) is a type of B-cell lymphoma that typically presents with nodal or extranodal masses , but it is not specifically associated with mediastinal lymphadenopathy.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Diffuse large B-cell lymphoma (DLBCL)&lt;/li&gt;&lt;li&gt;â€¢ B-cell lymphoma&lt;/li&gt;&lt;li&gt;â€¢ nodal or extranodal masses&lt;/li&gt;&lt;li&gt;â€¢ not specifically&lt;/li&gt;&lt;li&gt;â€¢ mediastinal lymphadenopathy.&lt;/li&gt;&lt;li&gt;â€¢ Option B . B-cell rich T-cell lymphoma is not a well-recognized entity . The common types of lymphomas are generally classified as either B-cell or T-cell lymphomas .&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ B-cell rich T-cell lymphoma&lt;/li&gt;&lt;li&gt;â€¢ not a well-recognized entity&lt;/li&gt;&lt;li&gt;â€¢ B-cell or T-cell lymphomas&lt;/li&gt;&lt;li&gt;â€¢ Option C. \&quot; Mediastinal rich B-cell lymphoma\&quot; is not a recognized term , and it doesn&#x27;t correspond to a specific subtype of lymphoma. However, primary mediastinal large B-cell lymphoma (PMBCL) is a distinct entity that can cause mediastinal masses.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Mediastinal rich B-cell lymphoma\&quot;&lt;/li&gt;&lt;li&gt;â€¢ not a recognized term&lt;/li&gt;&lt;li&gt;â€¢ subtype of lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ primary mediastinal large B-cell lymphoma (PMBCL)&lt;/li&gt;&lt;li&gt;â€¢ mediastinal masses.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ T-cell Lymphoblastic ALL is associated with mediastinal lymphadenopathy , typically presenting with symptoms such as dyspnea due to compression of thoracic structures.&lt;/li&gt;&lt;li&gt;âž¤ T-cell Lymphoblastic ALL&lt;/li&gt;&lt;li&gt;âž¤ mediastinal lymphadenopathy&lt;/li&gt;&lt;li&gt;âž¤ dyspnea due to compression of thoracic structures.&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 595)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 595)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old male presents with painless enlargement of a cervical lymph node. Excisional biopsy reveals a subtype of Hodgkinâ€™s disease, which is histogenetically distinct from all the other subtypes. Which of the following is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lymphocyte predominant&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nodular sclerosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mixed cellularity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lymphocyte depleted&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Lymphocyte predominant&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Lymphocyte predominant&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Nodular Sclerosis : Nodular sclerosis is the most common subtype of Hodgkin&#x27;s lymphoma in the world. It is characterized by the presence of collagen bands dividing the lymph node architecture into nodules . Reed-Sternberg cells , the hallmark cells of Hodgkin&#x27;s lymphoma, are found in lacunar spaces. This subtype often affects young adults and typically presents with mediastinal involvement . It has a favorable prognosis.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Nodular Sclerosis&lt;/li&gt;&lt;li&gt;â€¢ most common&lt;/li&gt;&lt;li&gt;â€¢ Hodgkin&#x27;s lymphoma in the world.&lt;/li&gt;&lt;li&gt;â€¢ collagen bands&lt;/li&gt;&lt;li&gt;â€¢ lymph node architecture into nodules&lt;/li&gt;&lt;li&gt;â€¢ Reed-Sternberg cells&lt;/li&gt;&lt;li&gt;â€¢ Hodgkin&#x27;s lymphoma,&lt;/li&gt;&lt;li&gt;â€¢ young adults&lt;/li&gt;&lt;li&gt;â€¢ mediastinal involvement&lt;/li&gt;&lt;li&gt;â€¢ Option C: Mixed Cellularity: This subtype is characterized by a mixed inflammatory infiltrate , including eosinophils, plasma cells, and histiocytes , along with Reed-Sternberg cells . It is often associated with an advanced stage of the disease and has a less favorable prognosis compared to nodular sclerosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Mixed Cellularity:&lt;/li&gt;&lt;li&gt;â€¢ mixed inflammatory infiltrate&lt;/li&gt;&lt;li&gt;â€¢ eosinophils, plasma cells, and histiocytes&lt;/li&gt;&lt;li&gt;â€¢ Reed-Sternberg cells&lt;/li&gt;&lt;li&gt;â€¢ advanced stage of the disease&lt;/li&gt;&lt;li&gt;â€¢ Option D: Lymphocyte Depleted : This subtype is characterized by a scarcity of lymphocytes and an abundance of Reed-Sternberg cells . It is associated with an advanced stage of the disease and is often seen in immunocompromised individuals . Lymphocyte-depleted Hodgkin&#x27;s lymphoma has a less favorable prognosis .&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Lymphocyte Depleted&lt;/li&gt;&lt;li&gt;â€¢ subtype&lt;/li&gt;&lt;li&gt;â€¢ scarcity of lymphocytes&lt;/li&gt;&lt;li&gt;â€¢ an abundance of Reed-Sternberg cells&lt;/li&gt;&lt;li&gt;â€¢ with&lt;/li&gt;&lt;li&gt;â€¢ advanced stage of the disease&lt;/li&gt;&lt;li&gt;â€¢ immunocompromised individuals&lt;/li&gt;&lt;li&gt;â€¢ less favorable prognosis&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Lymphocyte predominant Hodgkinâ€™s disease is histogenetically distinct from other subtypes, characterized by a nodular pattern with a predominance of lymphocytes and the presence of popcorn cells .&lt;/li&gt;&lt;li&gt;â€¢ Lymphocyte predominant Hodgkinâ€™s disease&lt;/li&gt;&lt;li&gt;â€¢ histogenetically distinct&lt;/li&gt;&lt;li&gt;â€¢ subtypes,&lt;/li&gt;&lt;li&gt;â€¢ nodular pattern&lt;/li&gt;&lt;li&gt;â€¢ predominance of lymphocytes&lt;/li&gt;&lt;li&gt;â€¢ popcorn cells&lt;/li&gt;&lt;li&gt;â€¢ (Ref: Robbins 10 th 613)&lt;/li&gt;&lt;li&gt;â€¢ (Ref: Robbins 10 th 613)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Over-expression of BCL-2 proteins occurs in:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Burkittâ€™s lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Follicular lymphoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diffuse large B-cell lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Small lymphocytic lymphoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Follicular lymphoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Follicular lymphoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Burkitt&#x27;s lymphoma is associated with a translocation involving the MYC gene.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Burkitt&#x27;s lymphoma&lt;/li&gt;&lt;li&gt;â€¢ translocation&lt;/li&gt;&lt;li&gt;â€¢ MYC gene.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous group of lymphomas and may have various genetic alterations, but it is not primarily associated with BCL-2 over-expression .&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Diffuse large B-cell lymphoma (DLBCL)&lt;/li&gt;&lt;li&gt;â€¢ heterogeneous group of lymphomas&lt;/li&gt;&lt;li&gt;â€¢ genetic alterations,&lt;/li&gt;&lt;li&gt;â€¢ with BCL-2 over-expression&lt;/li&gt;&lt;li&gt;â€¢ Option D: Small lymphocytic lymphoma (SLL) is closely related to chronic lymphocytic leukemia (CLL) and is not typically associated with BCL-2 over-expression as a defining characteristic.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Small lymphocytic lymphoma (SLL)&lt;/li&gt;&lt;li&gt;â€¢ closely&lt;/li&gt;&lt;li&gt;â€¢ chronic lymphocytic leukemia (CLL)&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ BCL-2 over-expression&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Over-expression of BCL-2 proteins is commonly associated with follicular lymphoma due to the t (14;18) chromosomal translocation.&lt;/li&gt;&lt;li&gt;âž¤ Over-expression of BCL-2 proteins&lt;/li&gt;&lt;li&gt;âž¤ follicular lymphoma&lt;/li&gt;&lt;li&gt;âž¤ t (14;18) chromosomal translocation.&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th 600)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th 600)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;â€˜Starry skyâ€™ appearance is seen in:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Burkittâ€™s lymphoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mantle cell lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Extra nodal marginal zone B-cell lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chronic myeloid leukemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Burkittâ€™s lymphoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Burkittâ€™s lymphoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Mantle cell lymphoma does not typically exhibit the \&quot; starry sky\&quot; appearance.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Mantle cell lymphoma&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ starry sky\&quot;&lt;/li&gt;&lt;li&gt;â€¢ Option C: Extra nodal marginal zone B-cell lymphoma is not typically associated with the \&quot;starry sky \&quot; appearance.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Extra nodal marginal zone B-cell lymphoma is not&lt;/li&gt;&lt;li&gt;â€¢ \&quot;starry sky&lt;/li&gt;&lt;li&gt;â€¢ Option D: Chronic myeloid leukemia is a myeloproliferative disorder involving the myeloid lineage , and it does not show the \&quot;starry sky\&quot; appearance.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Chronic myeloid leukemia&lt;/li&gt;&lt;li&gt;â€¢ myeloproliferative disorder&lt;/li&gt;&lt;li&gt;â€¢ myeloid lineage&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ \&quot;starry sky\&quot;&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The \&quot;starry sky \&quot; appearance is characteristically seen in Burkitt&#x27;s lymphoma .&lt;/li&gt;&lt;li&gt;âž¤ \&quot;starry sky&lt;/li&gt;&lt;li&gt;âž¤ Burkitt&#x27;s lymphoma&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th 598)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th 598)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All are B cell lymphomas except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Burkittâ€™s lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mycosis fungoides&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mantle cell lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Follicular cell lymphoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Mycosis fungoides&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Mycosis fungoides&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Burkitt&#x27;s lymphoma is indeed a B-cell lymphoma. It is an aggressive form of non-Hodgkin lymphoma that is associated with the Epstein-Barr virus (EBV) and characterized by the translocation involving the MYC gene .&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Burkitt&#x27;s lymphoma&lt;/li&gt;&lt;li&gt;â€¢ B-cell lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ non-Hodgkin lymphoma&lt;/li&gt;&lt;li&gt;â€¢ Epstein-Barr virus (EBV)&lt;/li&gt;&lt;li&gt;â€¢ translocation&lt;/li&gt;&lt;li&gt;â€¢ MYC gene&lt;/li&gt;&lt;li&gt;â€¢ Option C: Mantle cell lymphoma is a B-cell lymphoma characterized by the proliferation of malignant B-cells with characteristic involvement of the mantle zone in lymphoid follicles .&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Mantle cell lymphoma&lt;/li&gt;&lt;li&gt;â€¢ B-cell lymphoma&lt;/li&gt;&lt;li&gt;â€¢ proliferation of malignant B-cells&lt;/li&gt;&lt;li&gt;â€¢ mantle zone in lymphoid follicles&lt;/li&gt;&lt;li&gt;â€¢ Option D: Follicular lymphoma is a B-cell lymphoma . It is a slow-growing, indolent lymphoma characterized by the proliferation of abnormal B-cells within the lymph nodes.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Follicular lymphoma&lt;/li&gt;&lt;li&gt;â€¢ B-cell lymphoma&lt;/li&gt;&lt;li&gt;â€¢ slow-growing, indolent lymphoma&lt;/li&gt;&lt;li&gt;â€¢ abnormal B-cells&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Mycosis fungoides is a type of cutaneous T-cell lymphoma and not a B-cell lymphoma.&lt;/li&gt;&lt;li&gt;âž¤ Mycosis fungoides&lt;/li&gt;&lt;li&gt;âž¤ cutaneous T-cell lymphoma&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th 606)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th 606)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th 606)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which one of the following Non-Hodgkin Lymphomas is aggressive?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Follicular Lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Burkitt Lymphoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Small lymphocytic lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lymphoplasmacytic lymphoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Burkitt Lymphoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Burkitt Lymphoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Follicular Lymphoma is an indolent (slow-growing) Non-Hodgkin Lymphoma . It has a more chronic course and tends to be less aggressive compared to Burkitt Lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Follicular Lymphoma&lt;/li&gt;&lt;li&gt;â€¢ indolent (slow-growing) Non-Hodgkin Lymphoma&lt;/li&gt;&lt;li&gt;â€¢ more chronic course&lt;/li&gt;&lt;li&gt;â€¢ less aggressive&lt;/li&gt;&lt;li&gt;â€¢ Option C: Small lymphocytic lymphoma is a low-grade, indolent lymphoma that is related to chronic lymphocytic leukemia (CLL). It is characterized by the proliferation of small mature B-cells.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Small lymphocytic lymphoma&lt;/li&gt;&lt;li&gt;â€¢ low-grade, indolent lymphoma&lt;/li&gt;&lt;li&gt;â€¢ chronic lymphocytic leukemia (CLL).&lt;/li&gt;&lt;li&gt;â€¢ proliferation of small mature B-cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Lymphoplasmacytic lymphoma is typically an indolent lymphoma characterized by the infiltration of the bone marrow and other tissues by small lymphocytes, plasma cells, and lymphoplasmacytic cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Lymphoplasmacytic lymphoma&lt;/li&gt;&lt;li&gt;â€¢ indolent lymphoma&lt;/li&gt;&lt;li&gt;â€¢ infiltration of the bone marrow&lt;/li&gt;&lt;li&gt;â€¢ small lymphocytes, plasma cells, and lymphoplasmacytic cells.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Burkitt Lymphoma is an aggressive Non-Hodgkin Lymphoma characterized by a high proliferation rate and MYC gene translocation . â€œ Burkitt lymphoma is believed to be the fastest growing huÂ­man tumor â€ â€¦direct line&lt;/li&gt;&lt;li&gt;âž¤ Burkitt Lymphoma&lt;/li&gt;&lt;li&gt;âž¤ aggressive Non-Hodgkin Lymphoma&lt;/li&gt;&lt;li&gt;âž¤ high proliferation rate&lt;/li&gt;&lt;li&gt;âž¤ MYC gene translocation&lt;/li&gt;&lt;li&gt;âž¤ Burkitt lymphoma&lt;/li&gt;&lt;li&gt;âž¤ fastest growing huÂ­man tumor&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbin 10 th 598)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbin 10 th 598)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old male presents with persistent skin lesions, including pruritic, erythematous patches and plaques and is diagnosed with mycosis fungoides. Which of the following is true about this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fungal infections of skin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Leukemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Exfoliative erythroderma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cutaneous lymphoma&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Cutaneous lymphoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Cutaneous lymphoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: (Fungal infections of skin): The term \&quot; mycosis fungoides \&quot; might misleadingly suggest a fungal infection, but the condition is not caused by fungi . It is actually a type of non-Hodgkin lymphoma and has no infectious etiology .&lt;/li&gt;&lt;li&gt;â€¢ Option A: (Fungal infections of skin):&lt;/li&gt;&lt;li&gt;â€¢ mycosis fungoides&lt;/li&gt;&lt;li&gt;â€¢ misleadingly suggest a fungal infection,&lt;/li&gt;&lt;li&gt;â€¢ not caused by fungi&lt;/li&gt;&lt;li&gt;â€¢ non-Hodgkin lymphoma&lt;/li&gt;&lt;li&gt;â€¢ no infectious etiology&lt;/li&gt;&lt;li&gt;â€¢ Option B: (Leukemia): Leukemia generally refers to c ancers of the blood or bone marrow characterized by an abnormal proliferation of blood cells . Mycosis fungoides can sometimes progress to a leukemic phase known as SÃ©zary syndrome , but it primarily manifests with skin involvement and is not initially leukemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B: (Leukemia):&lt;/li&gt;&lt;li&gt;â€¢ ancers of the blood or bone marrow&lt;/li&gt;&lt;li&gt;â€¢ abnormal proliferation of blood cells&lt;/li&gt;&lt;li&gt;â€¢ Mycosis fungoides&lt;/li&gt;&lt;li&gt;â€¢ progress&lt;/li&gt;&lt;li&gt;â€¢ leukemic phase&lt;/li&gt;&lt;li&gt;â€¢ SÃ©zary syndrome&lt;/li&gt;&lt;li&gt;â€¢ skin involvement&lt;/li&gt;&lt;li&gt;â€¢ Option C: (Exfoliative erythroderma): While patients with advanced mycosis fungoides may develop exfoliative erythroderma , which is widespread inflammation and scaling of the skin, this is not the primary or sole manifestation of the disease .&lt;/li&gt;&lt;li&gt;â€¢ Option C: (Exfoliative erythroderma):&lt;/li&gt;&lt;li&gt;â€¢ advanced mycosis fungoides&lt;/li&gt;&lt;li&gt;â€¢ exfoliative erythroderma&lt;/li&gt;&lt;li&gt;â€¢ widespread inflammation&lt;/li&gt;&lt;li&gt;â€¢ scaling of the skin,&lt;/li&gt;&lt;li&gt;â€¢ not the primary&lt;/li&gt;&lt;li&gt;â€¢ manifestation of the disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Mycosis fungoides is a cutaneous T-cell lymphoma that may present with pruritic, erythematous patches and plaques , and is characterized histologically by Sezary Lutzner cells with a cerebriform contour&lt;/li&gt;&lt;li&gt;âž¤ Mycosis fungoides&lt;/li&gt;&lt;li&gt;âž¤ cutaneous T-cell lymphoma&lt;/li&gt;&lt;li&gt;âž¤ pruritic, erythematous patches and plaques&lt;/li&gt;&lt;li&gt;âž¤ Sezary Lutzner cells&lt;/li&gt;&lt;li&gt;âž¤ cerebriform contour&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th 605)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th 605)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Myelofibrosis leading to a dry tap on bone marrow aspiration is seen with which of the following conditions?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Burkittâ€™s lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute erythroblastic leukemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute megakaryocytic leukemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acute undifferentiated leukemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Acute megakaryocytic leukemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Acute megakaryocytic leukemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Burkittâ€™s lymphoma is a type of non-Hodgkin lymphoma that primarily involves B cells. It typically presents with rapidly growing tumors , often in the jaw or abdomen . Bone marrow involvement in Burkitt&#x27;s lymphoma is uncommon. While bone marrow examination may reveal lymphoma cells , it is not typically associated with myelofibrosis, and a dry tap is not a characteristic finding.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Burkittâ€™s lymphoma&lt;/li&gt;&lt;li&gt;â€¢ non-Hodgkin lymphoma&lt;/li&gt;&lt;li&gt;â€¢ B cells.&lt;/li&gt;&lt;li&gt;â€¢ rapidly&lt;/li&gt;&lt;li&gt;â€¢ growing tumors&lt;/li&gt;&lt;li&gt;â€¢ jaw or abdomen&lt;/li&gt;&lt;li&gt;â€¢ bone marrow&lt;/li&gt;&lt;li&gt;â€¢ lymphoma cells&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ myelofibrosis, and a dry tap&lt;/li&gt;&lt;li&gt;â€¢ Option B: Acute erythroblastic leukemia (erythroleukemia) is a rare subtype of acute myeloid leukemia (AML) characterized by the proliferation of immature erythroid precursors . This condition can infiltrate the bone marrow , leading to a hypercellular marrow with an excess o f erythroid precursors . Myelofibrosis and dry tap are not typical features of acute erythroblastic leukemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Acute erythroblastic leukemia (erythroleukemia)&lt;/li&gt;&lt;li&gt;â€¢ subtype of acute myeloid leukemia (AML)&lt;/li&gt;&lt;li&gt;â€¢ proliferation of immature erythroid precursors&lt;/li&gt;&lt;li&gt;â€¢ infiltrate the bone marrow&lt;/li&gt;&lt;li&gt;â€¢ hypercellular marrow&lt;/li&gt;&lt;li&gt;â€¢ f erythroid precursors&lt;/li&gt;&lt;li&gt;â€¢ Option D: Acute undifferentiated leukemia refers to a subtype of acute leukemia in which the blasts (immature cells) in the bone marrow lack specific features that would allow classification into myeloid or lymphoid lineages. While acute leukemias can sometimes be associated with bone marrow fibrosis , the dry tap is not typically a defining feature of this subtype.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Acute undifferentiated leukemia&lt;/li&gt;&lt;li&gt;â€¢ subtype of acute leukemia&lt;/li&gt;&lt;li&gt;â€¢ blasts (immature cells)&lt;/li&gt;&lt;li&gt;â€¢ lack specific features&lt;/li&gt;&lt;li&gt;â€¢ myeloid or lymphoid lineages.&lt;/li&gt;&lt;li&gt;â€¢ acute leukemias&lt;/li&gt;&lt;li&gt;â€¢ bone marrow fibrosis&lt;/li&gt;&lt;li&gt;â€¢ dry tap is not&lt;/li&gt;&lt;li&gt;â€¢ subtype.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Acute megakaryocytic leukemia , a subtype of acute myeloid leukemia characterized by the proliferation of megakaryocytic precursors , is associated with the development of myelofibrosis within the bone marrow, which can lead to a &#x27; dry tap&#x27; during bone marrow aspiration due to increased fibrous tissue.&lt;/li&gt;&lt;li&gt;âž¤ Acute megakaryocytic leukemia&lt;/li&gt;&lt;li&gt;âž¤ subtype of acute myeloid leukemia&lt;/li&gt;&lt;li&gt;âž¤ proliferation of megakaryocytic&lt;/li&gt;&lt;li&gt;âž¤ precursors&lt;/li&gt;&lt;li&gt;âž¤ development of myelofibrosis&lt;/li&gt;&lt;li&gt;âž¤ dry tap&#x27;&lt;/li&gt;&lt;li&gt;âž¤ bone&lt;/li&gt;&lt;li&gt;âž¤ marrow aspiration due to increased fibrous tissue.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Adult patient presents with generalized lymphadenopÂ­athy and blood film shows 70% immature looking lymÂ­phocytes. What should be the next best investigation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Genotyping/karyotyping&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Immunophenotyping&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bone marrow&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Peripheral smear study&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Immunophenotyping&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Immunophenotyping&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Genotyping/Karyotyping is used to detect chromosomal abnormalities and gene mutations, which can provide information on prognosis and guide treatment , but it is not typically the first step following a blood film analysis showing immature lymphocytes .&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Genotyping/Karyotyping&lt;/li&gt;&lt;li&gt;â€¢ chromosomal abnormalities and gene mutations,&lt;/li&gt;&lt;li&gt;â€¢ prognosis and guide treatment&lt;/li&gt;&lt;li&gt;â€¢ not typically the first step following a blood film analysis&lt;/li&gt;&lt;li&gt;â€¢ immature lymphocytes&lt;/li&gt;&lt;li&gt;â€¢ Option C: Bone Marrow Aspiration/Biopsy is used to examine the morphology of marrow cells and architecture , which can confirm a diagnosis suggested by immunophenotyping , but it&#x27;s usually not the first follow-up test when a specific leukemia subtype is suspected from a blood smear .&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Bone Marrow Aspiration/Biopsy&lt;/li&gt;&lt;li&gt;â€¢ morphology of marrow cells and architecture&lt;/li&gt;&lt;li&gt;â€¢ suggested by immunophenotyping&lt;/li&gt;&lt;li&gt;â€¢ not the first follow-up test&lt;/li&gt;&lt;li&gt;â€¢ specific leukemia subtype&lt;/li&gt;&lt;li&gt;â€¢ blood smear&lt;/li&gt;&lt;li&gt;â€¢ Option D: Peripheral Smear Study is an initial investigation that has already been performed, showing immature lymphocytes . This prompts further investigation with more specific tests like immunophenotyping, rather than repeating the same analysis .&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Peripheral Smear Study&lt;/li&gt;&lt;li&gt;â€¢ initial investigation&lt;/li&gt;&lt;li&gt;â€¢ performed, showing immature lymphocytes&lt;/li&gt;&lt;li&gt;â€¢ investigation&lt;/li&gt;&lt;li&gt;â€¢ immunophenotyping, rather than repeating the same analysis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The presence of immature lymphocytes in a patient with generalized lymphadenopathy strongly suggests a need for immunophenotyping to identify the specific type of leukemia . It may be chronic lymphocytic leukemia which can be picked up by certain surface markers like CD19, CD20, CD23, and CD5.&lt;/li&gt;&lt;li&gt;âž¤ immature lymphocytes&lt;/li&gt;&lt;li&gt;âž¤ generalized lymphadenopathy&lt;/li&gt;&lt;li&gt;âž¤ immunophenotyping&lt;/li&gt;&lt;li&gt;âž¤ leukemia&lt;/li&gt;&lt;li&gt;âž¤ chronic lymphocytic leukemia&lt;/li&gt;&lt;li&gt;âž¤ surface markers&lt;/li&gt;&lt;li&gt;âž¤ CD19, CD20, CD23, and CD5.&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 597)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 597)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Origin of CLL/SLL is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Progenitor B cell&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mature B cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;NaÃ¯ve B cells&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Germinal centre&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. NaÃ¯ve B cells&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. NaÃ¯ve B cells&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Ig genes of some CLL/SLL are somatically hypermutated, whereas others are not, suggesting that the cell of origin may be either a post-germinal center memory B cell or a naive B cell . It is not originating from progenitor B cell or mature B cell.&lt;/li&gt;&lt;li&gt;â€¢ Ig genes&lt;/li&gt;&lt;li&gt;â€¢ hypermutated,&lt;/li&gt;&lt;li&gt;â€¢ cell of origin&lt;/li&gt;&lt;li&gt;â€¢ post-germinal center memory B cell&lt;/li&gt;&lt;li&gt;â€¢ naive B cell&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ progenitor B cell or mature B cell.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The cell of origin for CLL/SLL is the naive B cell , which may or may not undergo somatic hypermutation, suggesting that CLL/SLL can arise from a pre-germinal center B cell.&lt;/li&gt;&lt;li&gt;âž¤ cell&lt;/li&gt;&lt;li&gt;âž¤ CLL/SLL is the naive B cell&lt;/li&gt;&lt;li&gt;âž¤ somatic hypermutation,&lt;/li&gt;&lt;li&gt;âž¤ CLL/SLL&lt;/li&gt;&lt;li&gt;âž¤ pre-germinal center B cell.&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10th/e p597)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10th/e p597)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the least likely to be a pre-leukaemic condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Paroxysmal nocturnal haemoglobinuria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aplastic anaemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Paroxysmal cold haemoglobinuria&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Myelodysplastic syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Paroxysmal cold haemoglobinuria&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Paroxysmal cold haemoglobinuria&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: â€œPNH: about 5% to 10% of patients eventually develop acute myeloid leukemia or a myÂ­elodysplastic syndrome , possibly because hematopoietic stem cells have suffered some type of genetic damage â€™.&lt;/li&gt;&lt;li&gt;â€¢ Option A: â€œPNH:&lt;/li&gt;&lt;li&gt;â€¢ 5% to 10%&lt;/li&gt;&lt;li&gt;â€¢ acute myeloid leukemia or a myÂ­elodysplastic syndrome&lt;/li&gt;&lt;li&gt;â€¢ hematopoietic stem cells&lt;/li&gt;&lt;li&gt;â€¢ genetic damage&lt;/li&gt;&lt;li&gt;â€¢ Option B: Aplastic anemia results from a fundamental stem cell defect supported by the presence of karyotypic aberrations in many cases; the occasional transÂ­formation of aplasia into myeloid neoplasms , typically myelodysplasia or acute myeloid leukemia; and the assoÂ­ciation with abnormally short telomeres .&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Aplastic anemia&lt;/li&gt;&lt;li&gt;â€¢ stem cell defect&lt;/li&gt;&lt;li&gt;â€¢ karyotypic aberrations&lt;/li&gt;&lt;li&gt;â€¢ aplasia into myeloid neoplasms&lt;/li&gt;&lt;li&gt;â€¢ myelodysplasia or acute myeloid leukemia;&lt;/li&gt;&lt;li&gt;â€¢ short telomeres&lt;/li&gt;&lt;li&gt;â€¢ Option D: The term â€œmyelodysplastic syndromeâ€ (MDS) refers to a group of clonal stem cell disorders characterized by maturation defects that are associated with ineffective hematopoiesis and a high risk of transformation to AML .&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ â€œmyelodysplastic syndromeâ€&lt;/li&gt;&lt;li&gt;â€¢ clonal stem cell disorders&lt;/li&gt;&lt;li&gt;â€¢ maturation defects&lt;/li&gt;&lt;li&gt;â€¢ ineffective hematopoiesis&lt;/li&gt;&lt;li&gt;â€¢ high risk of transformation to AML&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Paroxysmal Cold Hemoglobinuria (PCH) is primarily an autoimmune hemolytic anemia and not commonly associated with transformation to leukemia , which makes it the least likely condition to be pre-leukemic .&lt;/li&gt;&lt;li&gt;â€¢ Paroxysmal Cold Hemoglobinuria (PCH)&lt;/li&gt;&lt;li&gt;â€¢ autoimmune hemolytic anemia&lt;/li&gt;&lt;li&gt;â€¢ not commonly&lt;/li&gt;&lt;li&gt;â€¢ transformation to leukemia&lt;/li&gt;&lt;li&gt;â€¢ least likely condition to be pre-leukemic&lt;/li&gt;&lt;li&gt;â€¢ (Ref: Robbins 10 th / 545)&lt;/li&gt;&lt;li&gt;â€¢ (Ref: Robbins 10 th / 545)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 6-year-old child presents with pallor that required two blood transfusions previously. He has now developed fever and petechial haemorrhages. His hemoglobin is 9 g/dL, platelet count is 20,000/mm 3 and TLC is 60,000/mm 3 . Flow cytometry reveals the cells to be CD10+ve, MPO+ ve, CD 19 + ve, CD 33 â€“ ve, CD 117 + ve, and CD3 â€“ ve. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ALL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;AML&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mixed phenotypic leukaemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Undifferentiated leukaemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Mixed phenotypic leukaemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/picture6.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Mixed phenotypic leukaemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Acute Lymphoblastic Leukemia (ALL): ALL is a malignancy characterized by the overproduction of immature lymphoid cells , known as lymphoblasts, in the bone marrow. It is the most common type of cancer in children and is characterized by the presence of B or T lymphoid markers , but not typically myeloid markers. The flow cytometry results in the vignette showing CD10 and CD19 positivity suggest a lymphoid origin , which would be consistent with ALL. However, the presence of MPO , which is a myeloid marker, makes pure ALL less likely .&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Acute Lymphoblastic Leukemia (ALL):&lt;/li&gt;&lt;li&gt;â€¢ overproduction of immature lymphoid cells&lt;/li&gt;&lt;li&gt;â€¢ lymphoblasts,&lt;/li&gt;&lt;li&gt;â€¢ children&lt;/li&gt;&lt;li&gt;â€¢ B or T lymphoid markers&lt;/li&gt;&lt;li&gt;â€¢ vignette showing CD10 and CD19 positivity&lt;/li&gt;&lt;li&gt;â€¢ lymphoid origin&lt;/li&gt;&lt;li&gt;â€¢ ALL.&lt;/li&gt;&lt;li&gt;â€¢ MPO&lt;/li&gt;&lt;li&gt;â€¢ myeloid marker, makes pure ALL less likely&lt;/li&gt;&lt;li&gt;â€¢ Option B: Acute Myeloid Leukemia (AML): AML is a malignancy of myeloid lineage cells and is associated with the presence of myeloid markers such as CD13, CD33, and myeloperoxidase (MPO). It usually presents with signs of bone marrow failure like anemia, infection, and bleeding due to dysfunctional hematopoiesis . CD117 can also be present in AML . In the given case, the presence of MPO and CD117 supports myeloid involvement, but the additional presence of B-cell markers (CD10, CD19) would be atypical for AML .&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Acute Myeloid Leukemia (AML):&lt;/li&gt;&lt;li&gt;â€¢ myeloid lineage cells&lt;/li&gt;&lt;li&gt;â€¢ CD13, CD33,&lt;/li&gt;&lt;li&gt;â€¢ myeloperoxidase (MPO).&lt;/li&gt;&lt;li&gt;â€¢ bone marrow failure like anemia, infection, and bleeding due to dysfunctional hematopoiesis&lt;/li&gt;&lt;li&gt;â€¢ CD117&lt;/li&gt;&lt;li&gt;â€¢ AML&lt;/li&gt;&lt;li&gt;â€¢ MPO and CD117 supports myeloid involvement,&lt;/li&gt;&lt;li&gt;â€¢ B-cell markers (CD10, CD19) would be atypical for AML&lt;/li&gt;&lt;li&gt;â€¢ Option D: Undifferentiated Leukemia: Undifferentiated leukemia is a term used when l eukemic cells do not express lineage-specific markers that allow classification as either myeloid or lymphoid . These cells may express non-lineage specific markers like CD34, HLA-DR, and TdT, but lack definitive markers for B-cell, T-cell, or myeloid cell lines. In the vignette, the presence of lineage-specific markers does not support the diagnosis of undifferentiated leukemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Undifferentiated Leukemia:&lt;/li&gt;&lt;li&gt;â€¢ Undifferentiated leukemia&lt;/li&gt;&lt;li&gt;â€¢ eukemic cells&lt;/li&gt;&lt;li&gt;â€¢ lineage-specific markers&lt;/li&gt;&lt;li&gt;â€¢ myeloid or lymphoid&lt;/li&gt;&lt;li&gt;â€¢ non-lineage specific markers like CD34, HLA-DR, and TdT,&lt;/li&gt;&lt;li&gt;â€¢ lack&lt;/li&gt;&lt;li&gt;â€¢ B-cell, T-cell, or myeloid cell lines.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ B lymphoid markers: CD10, CD19 and CD79 T lineage markers: CD2, CD3 and CD7 Myeloid markers ; CD13, CD33, CD117 and myeloperoxidase (MPO). Non lineage specific markers of hematopoietic progenitor cells: CD34, HLA-DR and TdT&lt;/li&gt;&lt;li&gt;â€¢ B lymphoid markers: CD10, CD19 and CD79&lt;/li&gt;&lt;li&gt;â€¢ B&lt;/li&gt;&lt;li&gt;â€¢ CD10, CD19 and CD79&lt;/li&gt;&lt;li&gt;â€¢ T lineage markers: CD2, CD3 and CD7&lt;/li&gt;&lt;li&gt;â€¢ T&lt;/li&gt;&lt;li&gt;â€¢ CD2, CD3 and CD7&lt;/li&gt;&lt;li&gt;â€¢ Myeloid markers ; CD13, CD33, CD117 and myeloperoxidase (MPO).&lt;/li&gt;&lt;li&gt;â€¢ Myeloid markers&lt;/li&gt;&lt;li&gt;â€¢ CD13, CD33, CD117 and myeloperoxidase (MPO).&lt;/li&gt;&lt;li&gt;â€¢ Non lineage specific markers of hematopoietic progenitor cells: CD34, HLA-DR and TdT&lt;/li&gt;&lt;li&gt;â€¢ Non lineage&lt;/li&gt;&lt;li&gt;â€¢ CD34, HLA-DR and TdT&lt;/li&gt;&lt;li&gt;â€¢ (Ref: Wintrobes 12 th /1814-8, Dacie and Lewis hematolÂ­ogy 10 th /344-6)&lt;/li&gt;&lt;li&gt;â€¢ (Ref: Wintrobes 12 th /1814-8, Dacie and Lewis hematolÂ­ogy 10 th /344-6)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Non-specific esterase is positive in all the categories of AML except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;M3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;M4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;M5&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;M6&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. M6&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) M6&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: (M3 - Acute Promyelocytic Leukemia, APL): M3 or APL is characterized by a specific chromosomal translocation t(15;17), which leads to the production of the PML-RARA fusion protein. The morphological hallmark of APL is the presence of promyelocytes with heavy granulation and Auer rods . Nonspecific esterase staining may be positive in a minority of APL cases, but this is not the main diagnostic marker. APL is particularly associated with a risk of disseminated intravascular coagulation (DIC) and is treated uniquely with all-trans retinoic acid (ATRA) and arsenic trioxide , which target the PML-RARA fusion protein.&lt;/li&gt;&lt;li&gt;â€¢ Option A: (M3 - Acute Promyelocytic Leukemia, APL):&lt;/li&gt;&lt;li&gt;â€¢ specific chromosomal translocation t(15;17),&lt;/li&gt;&lt;li&gt;â€¢ PML-RARA fusion protein.&lt;/li&gt;&lt;li&gt;â€¢ APL&lt;/li&gt;&lt;li&gt;â€¢ promyelocytes with heavy granulation and Auer rods&lt;/li&gt;&lt;li&gt;â€¢ APL&lt;/li&gt;&lt;li&gt;â€¢ disseminated intravascular coagulation&lt;/li&gt;&lt;li&gt;â€¢ all-trans retinoic acid (ATRA) and arsenic trioxide&lt;/li&gt;&lt;li&gt;â€¢ PML-RARA fusion protein.&lt;/li&gt;&lt;li&gt;â€¢ Option B: (M4 - Acute Myelomonocytic Leukemia): M4 or acute myelomonocytic leukemia is characterized by the proliferation of both myeloid and monocyte cells . Nonspecific esterase staining is positive because of the monocytic component, distinguishing it from other forms of AML . These cells often show dual esterase staining when stained with both specific and nonspecific esterase, reflecting their mixed lineage.&lt;/li&gt;&lt;li&gt;â€¢ Option B: (M4 - Acute Myelomonocytic Leukemia):&lt;/li&gt;&lt;li&gt;â€¢ both myeloid and monocyte cells&lt;/li&gt;&lt;li&gt;â€¢ Nonspecific esterase&lt;/li&gt;&lt;li&gt;â€¢ positive&lt;/li&gt;&lt;li&gt;â€¢ monocytic component,&lt;/li&gt;&lt;li&gt;â€¢ AML&lt;/li&gt;&lt;li&gt;â€¢ dual esterase&lt;/li&gt;&lt;li&gt;â€¢ both specific and nonspecific esterase,&lt;/li&gt;&lt;li&gt;â€¢ mixed lineage.&lt;/li&gt;&lt;li&gt;â€¢ Option C: (M5 - Acute Monocytic Leukemia): M5 or acute monocytic leukemia is characterized by an excess of monocytes in the bone marrow and blood . Nonspecific esterase staining is strongly positive in these cells, which reflects the presence of the monocytic component . M5 can be further subdivided into M5a and M5b , based on the maturity of the monocytes.&lt;/li&gt;&lt;li&gt;â€¢ Option C: (M5 - Acute Monocytic Leukemia):&lt;/li&gt;&lt;li&gt;â€¢ excess of monocytes&lt;/li&gt;&lt;li&gt;â€¢ bone marrow and blood&lt;/li&gt;&lt;li&gt;â€¢ Nonspecific esterase&lt;/li&gt;&lt;li&gt;â€¢ strongly positive&lt;/li&gt;&lt;li&gt;â€¢ monocytic component&lt;/li&gt;&lt;li&gt;â€¢ subdivided into M5a and M5b&lt;/li&gt;&lt;li&gt;â€¢ maturity of the monocytes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Non-specific esterase (NSE) staining is characteristic of M4 and M5 subtypes of AML due to their monocytic components and is not a feature of the M6 class , which is marked by a proliferation of erythroid precursors.&lt;/li&gt;&lt;li&gt;âž¤ Non-specific esterase (NSE)&lt;/li&gt;&lt;li&gt;âž¤ M4 and M5 subtypes of AML&lt;/li&gt;&lt;li&gt;âž¤ monocytic components&lt;/li&gt;&lt;li&gt;âž¤ M6 class&lt;/li&gt;&lt;li&gt;âž¤ proliferation of erythroid precursors.&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th /618)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th /618)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements pertaining to leukemia is correct?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Blasts of acute myeloid leukemia are typically SuÂ­dan black negative&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Blasts of acute lymphoblastic leukemia are typically myeloperoxidase positive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Low leucocyte alkaline phosphatase score is characÂ­teristically seen in blastic phase of chronic myeloid leukemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tartarate resistant acid phosphatase positivity is typically seen in hairy cell leukemia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Tartarate resistant acid phosphatase positivity is typically seen in hairy cell leukemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Tartarate resistant acid phosphatase positivity is typically seen in hairy cell leukemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Blasts in acute myeloid leukemia (AML) are often Sudan black positive . This histochemical stain is used to detect the presence of myeloid granules in blasts , which are typically abundant in AML cells .&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Blasts&lt;/li&gt;&lt;li&gt;â€¢ acute myeloid leukemia (AML)&lt;/li&gt;&lt;li&gt;â€¢ Sudan black positive&lt;/li&gt;&lt;li&gt;â€¢ myeloid granules in blasts&lt;/li&gt;&lt;li&gt;â€¢ abundant in AML cells&lt;/li&gt;&lt;li&gt;â€¢ Option B: Blasts of acute lymphoblastic leukemia (ALL) are generally myeloperoxidase (MPO) negative . MPO is an enzyme found predominantly in myeloid cells and is used as a marker to distinguish AML (where blasts are typically MPO positive) from ALL .&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Blasts of acute lymphoblastic leukemia (ALL)&lt;/li&gt;&lt;li&gt;â€¢ myeloperoxidase (MPO) negative&lt;/li&gt;&lt;li&gt;â€¢ myeloid cells&lt;/li&gt;&lt;li&gt;â€¢ distinguish AML (where blasts are typically MPO positive) from ALL&lt;/li&gt;&lt;li&gt;â€¢ Option C: A low leukocyte alkaline phosphatase (LAP) score is seen in the chronic phase of chronic myeloid leukemia (CML), reflecting the abundance of immature leukocytes. However, the LAP score often increases when CML progresses to the blast crisis phase , due to the presence of a higher proportion of mature leukocytes.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ low leukocyte alkaline phosphatase (LAP)&lt;/li&gt;&lt;li&gt;â€¢ chronic myeloid leukemia (CML),&lt;/li&gt;&lt;li&gt;â€¢ immature leukocytes.&lt;/li&gt;&lt;li&gt;â€¢ LAP score&lt;/li&gt;&lt;li&gt;â€¢ increases&lt;/li&gt;&lt;li&gt;â€¢ CML progresses to the blast crisis phase&lt;/li&gt;&lt;li&gt;â€¢ higher&lt;/li&gt;&lt;li&gt;â€¢ mature leukocytes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Tartarate resistant acid phosphatase (TRAP) positivity is typically seen in hairy cell leukemia (HCL), which is useful for its diagnosis and differentiation from other hematologic disorders.&lt;/li&gt;&lt;li&gt;âž¤ Tartarate resistant acid phosphatase (TRAP) positivity&lt;/li&gt;&lt;li&gt;âž¤ hairy cell leukemia (HCL),&lt;/li&gt;&lt;li&gt;âž¤ diagnosis and differentiation&lt;/li&gt;&lt;li&gt;âž¤ hematologic disorders.&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 604)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 604)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is having poor prognosis in ALL?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;TLC 4000-10000&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Age &amp;lt; 10 year&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Presence of testicular involvement at presentation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Presence of blasts in peripheral smear&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Presence of testicular involvement at presentation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Presence of testicular involvement at presentaÂ­tion&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: (TLC 4000-10000): Total leukocyte count (TLC) at presentation is an important prognostic factor in ALL . Normal or moderately elevated TLCs are generally associated with a better prognosis . A very high TLC , particularly above 100,000, is typically considered a poor prognostic indicator in ALL , particularly in T-cell ALL .&lt;/li&gt;&lt;li&gt;â€¢ Option A: (TLC 4000-10000):&lt;/li&gt;&lt;li&gt;â€¢ prognostic factor in ALL&lt;/li&gt;&lt;li&gt;â€¢ Normal or moderately elevated TLCs&lt;/li&gt;&lt;li&gt;â€¢ better prognosis&lt;/li&gt;&lt;li&gt;â€¢ very high TLC&lt;/li&gt;&lt;li&gt;â€¢ 100,000,&lt;/li&gt;&lt;li&gt;â€¢ poor prognostic indicator in ALL&lt;/li&gt;&lt;li&gt;â€¢ T-cell ALL&lt;/li&gt;&lt;li&gt;â€¢ Option B: (Age &amp;lt; 10 year): Age is a significant prognostic factor in ALL. Children under 1 year of age and adults over 35 years of age have a poorer prognosis compared to children aged 1 to 10 years, who tend to respond better to therapy .&lt;/li&gt;&lt;li&gt;â€¢ Option B: (Age &amp;lt; 10 year):&lt;/li&gt;&lt;li&gt;â€¢ under 1 year of age&lt;/li&gt;&lt;li&gt;â€¢ 35 years of age&lt;/li&gt;&lt;li&gt;â€¢ poorer prognosis&lt;/li&gt;&lt;li&gt;â€¢ 1 to 10 years,&lt;/li&gt;&lt;li&gt;â€¢ better to therapy&lt;/li&gt;&lt;li&gt;â€¢ Option D: (Presence of blasts in peripheral smear): The presence of blasts in the peripheral blood smear is characteristic of ALL but on its own is not necessarily a poor prognostic indicator . The percentage and the total number of blasts can provide more specific prognostic information , with a higher burden sometimes indicating more aggressive disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D: (Presence of blasts in peripheral smear):&lt;/li&gt;&lt;li&gt;â€¢ blasts&lt;/li&gt;&lt;li&gt;â€¢ not necessarily a poor prognostic indicator&lt;/li&gt;&lt;li&gt;â€¢ total number of blasts&lt;/li&gt;&lt;li&gt;â€¢ more specific prognostic information&lt;/li&gt;&lt;li&gt;â€¢ higher burden&lt;/li&gt;&lt;li&gt;â€¢ more aggressive disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The presence of testicular involvement at presentation in Acute Lymphoblastic Leukemia (ALL) is associated with a poorer prognosis due to the risk of extramedullary relapse and the need for more aggressive treatment .&lt;/li&gt;&lt;li&gt;âž¤ presence of testicular&lt;/li&gt;&lt;li&gt;âž¤ Acute Lymphoblastic Leukemia (ALL)&lt;/li&gt;&lt;li&gt;âž¤ poorer prognosis&lt;/li&gt;&lt;li&gt;âž¤ extramedullary relapse&lt;/li&gt;&lt;li&gt;âž¤ more aggressive treatment&lt;/li&gt;&lt;li&gt;âž¤ Prognostic factors in ALL&lt;/li&gt;&lt;li&gt;âž¤ Prognostic factors in ALL&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A peripheral smear with increased neutrophils, basophils, eosinophils, and platelets is highly suggestive of:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute myeloid leukemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute lymphoblastic leukemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chronic myelogenous leukemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Myelodysplastic syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Chronic myelogenous leukemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Chronic myelogenous leukemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Acute Myeloid Leukemia (AML): is characterized by the rapid growth of abnormal myeloid cells in the bone marrow. While AML may show increased myeloid cells in the peripheral smear, it typically presents with blasts and a decrease in mature cells , unlike the broad spectrum of increased cells seen in the question.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Acute Myeloid Leukemia (AML):&lt;/li&gt;&lt;li&gt;â€¢ rapid growth&lt;/li&gt;&lt;li&gt;â€¢ abnormal myeloid cells&lt;/li&gt;&lt;li&gt;â€¢ increased myeloid cells&lt;/li&gt;&lt;li&gt;â€¢ blasts and a decrease in mature cells&lt;/li&gt;&lt;li&gt;â€¢ Option B: Acute Lymphoblastic Leukemia (ALL): primarily affects lymphoid cells . It is characterized by the presence of lymphoblasts in the peripheral blood. The question describes an increase in myeloid cell lineages (neutrophils, basophils, eosinophils, and platelets), making ALL less likely.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Acute Lymphoblastic Leukemia (ALL):&lt;/li&gt;&lt;li&gt;â€¢ primarily affects lymphoid cells&lt;/li&gt;&lt;li&gt;â€¢ lymphoblasts&lt;/li&gt;&lt;li&gt;â€¢ Option D: Myelodysplastic Syndrome (MDS): is a group of disorders characterized by ineffective hematopoiesis . While MDS can present with cytopenias and dysplastic changes in blood cells, the specific pattern described in the question (increased neutrophils, basophils, eosinophils, and platelets) is more indicative of CML.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Myelodysplastic Syndrome (MDS):&lt;/li&gt;&lt;li&gt;â€¢ group of disorders&lt;/li&gt;&lt;li&gt;â€¢ ineffective hematopoiesis&lt;/li&gt;&lt;li&gt;â€¢ cytopenias and dysplastic&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Chronic myeloid leukemia is a stem cell disease that is characterized by leukocytosis with granulocytic immaturities, basophilia, splenomegaly and distinct chromosomal abnormality Philadelphia chromosome .&lt;/li&gt;&lt;li&gt;â€¢ Chronic myeloid leukemia&lt;/li&gt;&lt;li&gt;â€¢ stem cell disease&lt;/li&gt;&lt;li&gt;â€¢ leukocytosis with granulocytic immaturities, basophilia, splenomegaly&lt;/li&gt;&lt;li&gt;â€¢ Philadelphia chromosome&lt;/li&gt;&lt;li&gt;â€¢ (Ref: Robbins 10 th / 622)&lt;/li&gt;&lt;li&gt;â€¢ (Ref: Robbins 10 th / 622)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;AML with gum infiltration and hepatosplenomegaly is most likely associated with which of the following subtypes of AML?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;M1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;M3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;M2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;M4&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. M4&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) M4&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: (M1 - Acute Myeloblastic Leukemia without maturation): M1 subtype is characterized by a proliferation of myeloblasts without significant differentiation . While organomegaly can occur , M1 is not typically associated with gum infiltration.&lt;/li&gt;&lt;li&gt;â€¢ Option A: (M1 - Acute Myeloblastic Leukemia without maturation):&lt;/li&gt;&lt;li&gt;â€¢ proliferation of myeloblasts without&lt;/li&gt;&lt;li&gt;â€¢ differentiation&lt;/li&gt;&lt;li&gt;â€¢ organomegaly can occur&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ gum infiltration.&lt;/li&gt;&lt;li&gt;â€¢ Option B: (M3 - Acute Promyelocytic Leukemia): M3 subtype is unique due to its association with the t(15;17) translocation and the PML-RARA fusion gene . It can present with disseminated intravascular coagulation (DIC), but gum infiltration is less characteristic of M3 .&lt;/li&gt;&lt;li&gt;â€¢ Option B: (M3 - Acute Promyelocytic Leukemia):&lt;/li&gt;&lt;li&gt;â€¢ M3 subtype&lt;/li&gt;&lt;li&gt;â€¢ t(15;17) translocation&lt;/li&gt;&lt;li&gt;â€¢ PML-RARA fusion gene&lt;/li&gt;&lt;li&gt;â€¢ disseminated intravascular coagulation (DIC),&lt;/li&gt;&lt;li&gt;â€¢ gum infiltration&lt;/li&gt;&lt;li&gt;â€¢ less&lt;/li&gt;&lt;li&gt;â€¢ M3&lt;/li&gt;&lt;li&gt;â€¢ Option C: (M2 - Acute Myeloblastic Leukemia with maturation): M2 subtype shows some degree of myeloid maturation . It can occasionally involve extramedullary sites , but gum infiltration and hepatosplenomegaly are more typical of AML with monocytic differentiation , such as M4 and M5 .&lt;/li&gt;&lt;li&gt;â€¢ Option C: (M2 - Acute Myeloblastic Leukemia with maturation):&lt;/li&gt;&lt;li&gt;â€¢ M2&lt;/li&gt;&lt;li&gt;â€¢ degree of myeloid maturation&lt;/li&gt;&lt;li&gt;â€¢ extramedullary sites&lt;/li&gt;&lt;li&gt;â€¢ gum infiltration and hepatosplenomegaly&lt;/li&gt;&lt;li&gt;â€¢ more typical of AML with monocytic differentiation&lt;/li&gt;&lt;li&gt;â€¢ M4 and M5&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Acute Myelomonocytic Leukemia (M4) is commonly associated with extramedullary manifestations such as gum infiltration and hepatosplenomegaly due to the infiltrative nature of the monocytic component of the leukemia.&lt;/li&gt;&lt;li&gt;âž¤ Acute Myelomonocytic Leukemia (M4)&lt;/li&gt;&lt;li&gt;âž¤ gum infiltration and hepatosplenomegaly&lt;/li&gt;&lt;li&gt;âž¤ infiltrative nature of the monocytic component&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 618)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 618)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old man was referred with a 2 week history of fever weakness and bleeding gum. Peripheral smear showed pancytopenia. The bone marrow examination revealed 26% blasts frequency exhibiting Auer rods and mature myeloid cells. An occasional neutrophil with pseudo Pelger-Huet anomaly was also detected. Which of the following cytochemical stains is most likely to be positive?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acid phosphatase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Non-specific esterase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Myeloperoxidase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Toluidine blue&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Myeloperoxidase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Myeloperoxidase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: (Acid Phosphatase): Acid phosphatase staining is primarily used to identify cells of the T-lymphoid lineage and is a key diagnostic marker in T-cell acute lymphoblastic leukemia (ALL). It would not typically be positive in myeloid cells or AML .&lt;/li&gt;&lt;li&gt;â€¢ Option A: (Acid Phosphatase):&lt;/li&gt;&lt;li&gt;â€¢ T-lymphoid lineage&lt;/li&gt;&lt;li&gt;â€¢ T-cell acute lymphoblastic leukemia (ALL).&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ positive in myeloid cells or AML&lt;/li&gt;&lt;li&gt;â€¢ Option B: (Non-Specific Esterase): Non-specific esterase staining is characteristic of monocytes and their malignant counterparts in acute monocytic leukemia (AML M5 subtype). It&#x27;s not a specific marker for myeloblasts, which are the predominant cells in most AML subtypes.&lt;/li&gt;&lt;li&gt;â€¢ Option B: (Non-Specific Esterase):&lt;/li&gt;&lt;li&gt;â€¢ monocytes and their malignant counterparts in acute monocytic leukemia (AML M5 subtype).&lt;/li&gt;&lt;li&gt;â€¢ Option D: (Toluidine Blue): Toluidine blue staining is used to highlight mast cells and is not typically used in the diagnosis of AML or other types of leukemia .&lt;/li&gt;&lt;li&gt;â€¢ Option D: (Toluidine Blue):&lt;/li&gt;&lt;li&gt;â€¢ mast cells&lt;/li&gt;&lt;li&gt;â€¢ AML or other types of leukemia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with acute onset of pancytopenia and 26% blasts exhibiting Auer rods in the bone marrow , myeloperoxidase (MPO) staining is most likely to be positive , supporting a diagnosis of Acute Myeloid Leukemia (AML).&lt;/li&gt;&lt;li&gt;âž¤ acute onset of pancytopenia and 26% blasts&lt;/li&gt;&lt;li&gt;âž¤ Auer rods in the bone marrow&lt;/li&gt;&lt;li&gt;âž¤ myeloperoxidase (MPO)&lt;/li&gt;&lt;li&gt;âž¤ positive&lt;/li&gt;&lt;li&gt;âž¤ Acute Myeloid Leukemia (AML).&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 621)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 621)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;â€œSmudge cellsâ€ in the peripheral smear are characteristic of:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic myelogenous leukemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic lymphocytic leukemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute myelogenous leukemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acute lymphoblastic leukemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Chronic lymphocytic leukemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Chronic lymphocytic leukemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Chronic Myelogenous Leukemia (CML) is characterized by the presence of the Philadelphia chromosome and an increase in myeloid cells , particularly granulocytes . Smudge cells are not a typical feature of CML.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Chronic Myelogenous Leukemia (CML)&lt;/li&gt;&lt;li&gt;â€¢ Philadelphia chromosome&lt;/li&gt;&lt;li&gt;â€¢ increase in myeloid cells&lt;/li&gt;&lt;li&gt;â€¢ granulocytes&lt;/li&gt;&lt;li&gt;â€¢ Option C: Acute Myelogenous Leukemia (AML) is characterized by the rapid proliferation of immature myeloid cells . Smudge cells are not a characteristic feature of AML.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Acute Myelogenous Leukemia (AML)&lt;/li&gt;&lt;li&gt;â€¢ immature myeloid cells&lt;/li&gt;&lt;li&gt;â€¢ Smudge cells&lt;/li&gt;&lt;li&gt;â€¢ AML.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Acute Lymphoblastic Leukemia (ALL) primarily affects lymphoid cells , and it is characterized by the presence of lymphoblasts in the peripheral blood. Smudge cells are not a typical finding in ALL.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Acute Lymphoblastic Leukemia (ALL)&lt;/li&gt;&lt;li&gt;â€¢ lymphoid cells&lt;/li&gt;&lt;li&gt;â€¢ presence of lymphoblasts&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Smudge cells in the peripheral smear are characteristic of Chronic Lymphocytic Leukemia (CLL), due to the increased fragility of the abnormal lymphocytes encountered in this disease.&lt;/li&gt;&lt;li&gt;â€¢ Smudge cells&lt;/li&gt;&lt;li&gt;â€¢ Chronic Lymphocytic Leukemia (CLL), due to the increased fragility of the abnormal lymphocytes encountered in this disease.&lt;/li&gt;&lt;li&gt;â€¢ (Ref: Robbins 7th/673, 9/e 593)&lt;/li&gt;&lt;li&gt;â€¢ (Ref: Robbins 7th/673, 9/e 593)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Chromosomal translocation characteristic in acute promyelocytic leukemia is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;t (15;17)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;t (9;22)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;t (17;21)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;t (8: 21)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. t (15;17)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. t (15: 17)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: t (9;22): This translocation is characteristic of Chronic Myelogenous Leukemia (CML) and is known as the Philadelphia chromosome. It involves the fusion of the BCR (breakpoint cluster region) gene on chromosome 22 with the ABL1 (Abelson murine leukemia viral oncogene homolog 1) gene on chromosome 9, resulting in the BCR-ABL1 fusion gene . This fusion gene produces a constitutively active tyrosine kinase , contributing to the pathogenesis of CML.&lt;/li&gt;&lt;li&gt;â€¢ Option B: t (9;22):&lt;/li&gt;&lt;li&gt;â€¢ Chronic Myelogenous Leukemia (CML)&lt;/li&gt;&lt;li&gt;â€¢ Philadelphia chromosome.&lt;/li&gt;&lt;li&gt;â€¢ BCR (breakpoint cluster region)&lt;/li&gt;&lt;li&gt;â€¢ chromosome 22 with the ABL1 (Abelson murine&lt;/li&gt;&lt;li&gt;â€¢ leukemia viral oncogene homolog 1)&lt;/li&gt;&lt;li&gt;â€¢ chromosome 9,&lt;/li&gt;&lt;li&gt;â€¢ BCR-ABL1 fusion gene&lt;/li&gt;&lt;li&gt;â€¢ tyrosine kinase&lt;/li&gt;&lt;li&gt;â€¢ CML.&lt;/li&gt;&lt;li&gt;â€¢ Option C: t (17;21): This translocation is not a well-known chromosomal abnormality in leukemia. It doesn&#x27;t correspond to a recognized leukemia subtype.&lt;/li&gt;&lt;li&gt;â€¢ Option C: t (17;21):&lt;/li&gt;&lt;li&gt;â€¢ not a well-known&lt;/li&gt;&lt;li&gt;â€¢ leukemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D: t (8;21): This translocation is characteristic of Acute Myeloid Leukemia (AML) with maturation (AML-M2 subtype). It involves the fusion of the AML1 (also known as RUNX1) gene on chromosome 21 with the ETO (Eight-Twenty-One) gene on chromosome 8 , resulting in the AML1-ETO fusion gene . This translocation is associated with a subtype of AML and is used in its classification.&lt;/li&gt;&lt;li&gt;â€¢ Option D: t (8;21):&lt;/li&gt;&lt;li&gt;â€¢ Acute Myeloid Leukemia (AML)&lt;/li&gt;&lt;li&gt;â€¢ (AML-M2 subtype).&lt;/li&gt;&lt;li&gt;â€¢ AML1 (also known as RUNX1) gene on chromosome 21 with the ETO (Eight-Twenty-One) gene on chromosome 8&lt;/li&gt;&lt;li&gt;â€¢ AML1-ETO fusion gene&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ The chromosomal translocation characteristic of Acute Promyelocytic Leukemia is t(15;17), resulting in the PML-RARA fusion gene .&lt;/li&gt;&lt;li&gt;â€¢ chromosomal translocation&lt;/li&gt;&lt;li&gt;â€¢ Acute Promyelocytic Leukemia is t(15;17),&lt;/li&gt;&lt;li&gt;â€¢ PML-RARA fusion gene&lt;/li&gt;&lt;li&gt;â€¢ (Ref: Robbins 10 th / 613)&lt;/li&gt;&lt;li&gt;â€¢ (Ref: Robbins 10 th / 613)&lt;/li&gt;&lt;li&gt;â€¢ (Ref: Robbins 10 th / 613)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The difference between leukemia and leukemoid reaction is done by:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Elevated total leukocyte count&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Leucocyte alkaline phosphatase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Erythrocyte sedimentation rate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Presence of immature cells&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Leucocyte alkaline phosphatase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Leucocyte alkaline phosphatase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Elevated total leukocyte count: Both leukemia and leukemoid reaction can result in an elevated total leukocyte count. However, the specific characteristics of the white blood cells, along with other parameters, help differentiate between the two.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Elevated total leukocyte count:&lt;/li&gt;&lt;li&gt;â€¢ Both leukemia and leukemoid reaction&lt;/li&gt;&lt;li&gt;â€¢ elevated total leukocyte count.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Erythrocyte sedimentation rate (ESR): is a non-specific marker of inflammation and is not commonly used to differentiate between leukemia and leukemoid reaction.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Erythrocyte sedimentation rate (ESR):&lt;/li&gt;&lt;li&gt;â€¢ non-specific marker of inflammation&lt;/li&gt;&lt;li&gt;â€¢ Option D. Presence of immature cells: The presence of immature or blast cells is not helpful for differentiating between leukemia from a leukemoid reaction. The percentage of immature cells is a crucial factor in distinguishing leukemia from a leukemoid reaction.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Presence of immature cells:&lt;/li&gt;&lt;li&gt;â€¢ immature or blast cells&lt;/li&gt;&lt;li&gt;â€¢ not helpful&lt;/li&gt;&lt;li&gt;â€¢ leukemia from a leukemoid reaction.&lt;/li&gt;&lt;li&gt;â€¢ percentage of immature cells&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Leukocyte alkaline phosphatase (LAP) score helps differentiate between chronic myeloid leukemia (CML), where it is typically low , and a leukemoid reaction, where it is normal or elevated.&lt;/li&gt;&lt;li&gt;â€¢ Leukocyte alkaline phosphatase (LAP)&lt;/li&gt;&lt;li&gt;â€¢ chronic myeloid leukemia (CML), where it is typically low&lt;/li&gt;&lt;li&gt;â€¢ leukemoid reaction, where it is normal or elevated.&lt;/li&gt;&lt;li&gt;â€¢ (Ref: Robbins 10 th / 584)&lt;/li&gt;&lt;li&gt;â€¢ (Ref: Robbins 10 th / 584)&lt;/li&gt;&lt;li&gt;â€¢ (Ref: Robbins 10 th / 584)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In myelodysplastic syndrome, the following statement is incorrect:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Platelet counts in the bone marrow are normal or elevated&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Leucocyte counts in the marrow are normal or elevated&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Always has hypocellular bone marrow&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Refractory anemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Always has hypocellular bone marrow&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Platelet counts in the bone marrow are often normal or elevated in myelodysplastic syndrome (MDS). This condition is characterized by ineffective hematopoiesis , and it commonly leads to cytopenias in the peripheral blood . Thrombocytopenia is a common feature in MDS , and it contributes to the increased risk of bleeding in affected individuals.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Platelet counts&lt;/li&gt;&lt;li&gt;â€¢ normal or elevated in myelodysplastic syndrome (MDS).&lt;/li&gt;&lt;li&gt;â€¢ ineffective hematopoiesis&lt;/li&gt;&lt;li&gt;â€¢ cytopenias in the peripheral blood&lt;/li&gt;&lt;li&gt;â€¢ Thrombocytopenia&lt;/li&gt;&lt;li&gt;â€¢ MDS&lt;/li&gt;&lt;li&gt;â€¢ increased risk of bleeding&lt;/li&gt;&lt;li&gt;â€¢ Option B: Leucocyte counts in the bone marrow are normal or elevated: This statement is correct&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Leucocyte counts in the bone marrow are normal or elevated:&lt;/li&gt;&lt;li&gt;â€¢ Option D: Refractory anemia: This statement is correct. Refractory anemia is a common subtype of MDS , characterized by ineffective erythropoiesis leading to anemia that does not respond well to conventional treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Refractory anemia:&lt;/li&gt;&lt;li&gt;â€¢ Refractory anemia&lt;/li&gt;&lt;li&gt;â€¢ subtype of MDS&lt;/li&gt;&lt;li&gt;â€¢ ineffective erythropoiesis&lt;/li&gt;&lt;li&gt;â€¢ anemia&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ conventional treatment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Myelodysplastic syndrome (MDS) does not always have hypocellular bone marrow ; it is often hypercellular or normocellular.&lt;/li&gt;&lt;li&gt;âž¤ Myelodysplastic syndrome (MDS) does not&lt;/li&gt;&lt;li&gt;âž¤ hypocellular bone marrow&lt;/li&gt;&lt;li&gt;âž¤ hypercellular or normocellular.&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 620-1)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 620-1)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 620-1)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The presence of the Philadelphia chromosome is associated with a worse prognosis in patients with which of the following diseases?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute lymphoblastic leukemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute myelogenous leukemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chronic lymphocytic leukemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chronic myelogenous leukemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Acute lymphoblastic leukemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Acute lymphoblastic leukemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: (Acute Myelogenous Leukemia, AML): The Philadelphia chromosome is not commonly associated with AML . AML has other chromosomal abnormalities that are more predictive of prognosis , such as the presence of mutations in genes like FLT3, NPM1, or alterations like t(15;17) in acute promyelocytic leukemia (APL).&lt;/li&gt;&lt;li&gt;â€¢ Option B: (Acute Myelogenous Leukemia, AML):&lt;/li&gt;&lt;li&gt;â€¢ Philadelphia chromosome&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ AML&lt;/li&gt;&lt;li&gt;â€¢ more predictive of prognosis&lt;/li&gt;&lt;li&gt;â€¢ FLT3, NPM1, or alterations like t(15;17) in acute promyelocytic leukemia (APL).&lt;/li&gt;&lt;li&gt;â€¢ Option C: (Chronic Lymphocytic Leukemia, CLL): CLL is typically not associated with the Philadelphia chromosome. CLL has its own prognostic markers, such as deletions in chromosome 13q, 11q, and trisomy 12 , or the mutation status of IGHV (immunoglobulin heavy chain variable region genes).&lt;/li&gt;&lt;li&gt;â€¢ Option C: (Chronic Lymphocytic Leukemia, CLL):&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ Philadelphia chromosome.&lt;/li&gt;&lt;li&gt;â€¢ deletions in chromosome 13q, 11q, and trisomy 12&lt;/li&gt;&lt;li&gt;â€¢ IGHV (immunoglobulin heavy chain variable region genes).&lt;/li&gt;&lt;li&gt;â€¢ Option D: (Chronic Myelogenous Leukemia, CML): The Philadelphia chromosome is the hallmark of CML and is present in the vast majority of cases. The presence of this chromosome is part of the diagnostic criteria for CML and is not considered a worse prognostic factor within this disease context. The treatment for CML includes TKIs , which target the BCR-ABL1 protein resulting from the Philadelphia chromosome translocation.&lt;/li&gt;&lt;li&gt;â€¢ Option D: (Chronic Myelogenous Leukemia, CML):&lt;/li&gt;&lt;li&gt;â€¢ Philadelphia chromosome&lt;/li&gt;&lt;li&gt;â€¢ hallmark of CML&lt;/li&gt;&lt;li&gt;â€¢ presence of this chromosome&lt;/li&gt;&lt;li&gt;â€¢ CML&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ worse prognostic factor&lt;/li&gt;&lt;li&gt;â€¢ TKIs&lt;/li&gt;&lt;li&gt;â€¢ BCR-ABL1 protein&lt;/li&gt;&lt;li&gt;â€¢ Philadelphia chromosome translocation.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ The presence of the Philadelphia chromosome , a translocation from the long arm of chromosome 22 to chromosome 9 [t(9;22)], is associated with a favorable prognosis in chronic myelogenous leukemia but it associated with an unfavorable outcome in Acute lymphoblastic leukemia .&lt;/li&gt;&lt;li&gt;â€¢ Philadelphia chromosome&lt;/li&gt;&lt;li&gt;â€¢ translocation from the long arm of chromosome 22 to chromosome 9 [t(9;22)],&lt;/li&gt;&lt;li&gt;â€¢ favorable prognosis&lt;/li&gt;&lt;li&gt;â€¢ chronic myelogenous leukemia but&lt;/li&gt;&lt;li&gt;â€¢ unfavorable outcome in Acute lymphoblastic leukemia&lt;/li&gt;&lt;li&gt;â€¢ (Ref: Robbins 10 th / 601)&lt;/li&gt;&lt;li&gt;â€¢ (Ref: Robbins 10 th / 601)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Burkittâ€™s lymphoma is associated most commonly with of the following translocations?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;t (8:14)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;t (9:22)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;t (11:14)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;t (8:21)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. t (8:14)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. t (8:14)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: t (9:22) : is associated with Chronic Myelogenous Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL) but not Burkitt&#x27;s lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ Option B: t (9:22)&lt;/li&gt;&lt;li&gt;â€¢ Chronic Myelogenous Leukemia (CML)&lt;/li&gt;&lt;li&gt;â€¢ Acute Lymphoblastic Leukemia (ALL)&lt;/li&gt;&lt;li&gt;â€¢ Option C: t (11;14) : is associated with Mantle Cell Lymphoma but not Burkitt&#x27;s lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ Option C: t (11;14)&lt;/li&gt;&lt;li&gt;â€¢ Mantle Cell Lymphoma&lt;/li&gt;&lt;li&gt;â€¢ Option D: t (8:21) : is associated with Acute Myeloid Leukemia (AML) with maturation but not Burkitt&#x27;s lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ t (8:21)&lt;/li&gt;&lt;li&gt;â€¢ Acute Myeloid Leukemia (AML)&lt;/li&gt;&lt;li&gt;â€¢ maturation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Burkitt&#x27;s lymphoma is most commonly associated with the translocation t(8;14) , involving the c-MYC gene on chromosome 8 and the immunoglobulin heavy chain gene on chromosome 14.&lt;/li&gt;&lt;li&gt;âž¤ Burkitt&#x27;s lymphoma&lt;/li&gt;&lt;li&gt;âž¤ translocation t(8;14)&lt;/li&gt;&lt;li&gt;âž¤ c-MYC gene on chromosome 8 and&lt;/li&gt;&lt;li&gt;âž¤ immunoglobulin heavy chain gene on chromosome 14.&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 602)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 602)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mantle cell lymphomas are positive for all of the following, except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CD 23&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CD 20&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CD 5&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CD 43&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. CD 23&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) CD 23&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Mantle cell lymphomas are positive for CD20 , a B-cell marker .&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ positive for CD20&lt;/li&gt;&lt;li&gt;â€¢ B-cell marker&lt;/li&gt;&lt;li&gt;â€¢ Option C: Mantle cell lymphomas are positive for CD5, a T-cell marker. This is a characteristic feature of mantle cell lymphomas and helps distinguish them from other B-cell lymphomas.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ positive for CD5,&lt;/li&gt;&lt;li&gt;â€¢ T-cell marker.&lt;/li&gt;&lt;li&gt;â€¢ mantle cell lymphomas&lt;/li&gt;&lt;li&gt;â€¢ distinguish them from other B-cell lymphomas.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Mantle cell lymphomas are positive for CD43, a cell adhesion molecule and marker of T-lymphocytes . It is commonly expressed in mantle cell lymphomas.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ positive for CD43,&lt;/li&gt;&lt;li&gt;â€¢ cell adhesion molecule&lt;/li&gt;&lt;li&gt;â€¢ marker of T-lymphocytes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Mantle cell lymphomas are typically negative for CD23 , helping to distinguish them from other small B-cell lymphomas like CLL and follicular lymphoma.&lt;/li&gt;&lt;li&gt;âž¤ Mantle cell lymphomas&lt;/li&gt;&lt;li&gt;âž¤ negative for CD23&lt;/li&gt;&lt;li&gt;âž¤ small B-cell lymphomas like CLL and&lt;/li&gt;&lt;li&gt;âž¤ follicular lymphoma.&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th /602)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th /602)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following statements about hairy cell leukemia are true except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Splenomegaly is conspicuous&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Results from an expansion of neoplastic T-lymphoÂ­cytes&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cells are positive for Tartarate Resistant Acid phosÂ­phatase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The cells express CD25 consistently&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Results from an expansion of neoplastic T-lymphoÂ­cytes&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Results from an expansion of neoplastic T-lymphocytes&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Splenomegaly is a characteristic feature of hairy cell leukemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Splenomegaly&lt;/li&gt;&lt;li&gt;â€¢ Option C: Cells are positive for Tartrate-Resistant Acid Phosphatase (TRAP ) which is a helpful diagnostic marker for HCL.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Cells are positive&lt;/li&gt;&lt;li&gt;â€¢ Tartrate-Resistant Acid Phosphatase (TRAP&lt;/li&gt;&lt;li&gt;â€¢ Option D: Hairy cells consistently express CD25 (also known as the interleukin-2 receptor alpha chain).&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Hairy cells&lt;/li&gt;&lt;li&gt;â€¢ CD25&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Hairy cell leukemia results from an expansion of neoplastic B-lymphocytes, not T-lymphocytes.&lt;/li&gt;&lt;li&gt;â€¢ Hairy cell leukemia&lt;/li&gt;&lt;li&gt;â€¢ neoplastic B-lymphocytes,&lt;/li&gt;&lt;li&gt;â€¢ (Ref: Robbins 10 th 604)&lt;/li&gt;&lt;li&gt;â€¢ (Ref: Robbins 10 th 604)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Post transplant lymphoma occurs due to proliferation of which of the following cells:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;T-cell&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;B-cell&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;NK cell&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Monocyte&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. B-cell&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. B-cell&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: (T-cell): T-cell proliferative disorders post-transplant are less common . The immunosuppression used to prevent graft rejection often targets T-cells to a greater extent, which paradoxically may result in a lesser incidence of T-cell lymphomas .&lt;/li&gt;&lt;li&gt;â€¢ Option A: (T-cell):&lt;/li&gt;&lt;li&gt;â€¢ post-transplant&lt;/li&gt;&lt;li&gt;â€¢ less common&lt;/li&gt;&lt;li&gt;â€¢ prevent graft rejection&lt;/li&gt;&lt;li&gt;â€¢ T-cells to a greater extent,&lt;/li&gt;&lt;li&gt;â€¢ lesser incidence of T-cell lymphomas&lt;/li&gt;&lt;li&gt;â€¢ Option C: (NK cell): Natural Killer (NK) cell neoplasms are rare in the post-transplant setting . NK cells are a part of the innate immune system and are not typically involved in the pathogenesis of PTLDs.&lt;/li&gt;&lt;li&gt;â€¢ Option C: (NK cell):&lt;/li&gt;&lt;li&gt;â€¢ neoplasms&lt;/li&gt;&lt;li&gt;â€¢ post-transplant setting&lt;/li&gt;&lt;li&gt;â€¢ innate immune system&lt;/li&gt;&lt;li&gt;â€¢ Option D: (Monocyte): Monocytes are not commonly the source of post-transplant neoplasms . While monocytes and other cells of the myeloid lineage can give rise to cancers, such as acute or chronic myeloid leukemias, they are not the typical cells implicated in PTLDs.&lt;/li&gt;&lt;li&gt;â€¢ Option D: (Monocyte):&lt;/li&gt;&lt;li&gt;â€¢ not commonly&lt;/li&gt;&lt;li&gt;â€¢ post-transplant neoplasms&lt;/li&gt;&lt;li&gt;â€¢ monocytes&lt;/li&gt;&lt;li&gt;â€¢ other cells&lt;/li&gt;&lt;li&gt;â€¢ myeloid lineage&lt;/li&gt;&lt;li&gt;â€¢ rise to cancers,&lt;/li&gt;&lt;li&gt;â€¢ acute or chronic myeloid leukemias,&lt;/li&gt;&lt;li&gt;â€¢ not the typical cells&lt;/li&gt;&lt;li&gt;â€¢ PTLDs.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Post-transplant lymphoma, or PTLD, occurs most frequently due to the proliferation of B-cells , often as a result of reduced T-cell- mediated immune regulation due to immunosuppressive therapy .&lt;/li&gt;&lt;li&gt;âž¤ Post-transplant lymphoma,&lt;/li&gt;&lt;li&gt;âž¤ PTLD,&lt;/li&gt;&lt;li&gt;âž¤ proliferation of B-cells&lt;/li&gt;&lt;li&gt;âž¤ reduced T-cell-&lt;/li&gt;&lt;li&gt;âž¤ immunosuppressive therapy&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th 1310)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th 1310)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Histological presence of â€œHallmark Cellsâ€ with horse shoe-like or embryoid like nuclei and voluminous cytoplasm are seen in:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anaplastic large cell lymphoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Familial Medullary Carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Familial Neuroblastoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lymphocyte predominance type Hodgkinâ€™s lymphoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Anaplastic large cell lymphoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/picture3_gFdbepj.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Anaplastic large cell lymphoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: (Familial Medullary Carcinoma): Familial medullary carcinoma of the thyroid is a calcitonin-producing tumor that arises from parafollicular C cells of the thyroid. It is associated with mutations in the RET proto-oncogene but does not have hallmark cells as described in ALCL.&lt;/li&gt;&lt;li&gt;â€¢ Option B: (Familial Medullary Carcinoma):&lt;/li&gt;&lt;li&gt;â€¢ thyroid&lt;/li&gt;&lt;li&gt;â€¢ parafollicular C cells&lt;/li&gt;&lt;li&gt;â€¢ RET proto-oncogene&lt;/li&gt;&lt;li&gt;â€¢ Option C: (Familial Neuroblastoma): Familial neuroblastoma is a rare pediatric malignancy of the sympathetic nervous system . Histologically, it shows small, round, blue cells and is not characterized by hallmark cells with horseshoe-like nuclei.&lt;/li&gt;&lt;li&gt;â€¢ Option C: (Familial Neuroblastoma):&lt;/li&gt;&lt;li&gt;â€¢ rare pediatric malignancy&lt;/li&gt;&lt;li&gt;â€¢ sympathetic nervous system&lt;/li&gt;&lt;li&gt;â€¢ small, round, blue cells&lt;/li&gt;&lt;li&gt;â€¢ Option D: (Lymphocyte predominance type Hodgkinâ€™s lymphoma): This type of Hodgkinâ€™s lymphoma is characterized by the presence of popcorn cells (lymphocytic and histiocytic cells) and not by hallmark cells. It&#x27;s different from the classic Reed-Sternberg cells seen in other subtypes of Hodgkin&#x27;s lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ Option D: (Lymphocyte predominance type Hodgkinâ€™s lymphoma):&lt;/li&gt;&lt;li&gt;â€¢ Hodgkinâ€™s lymphoma&lt;/li&gt;&lt;li&gt;â€¢ popcorn cells (lymphocytic and histiocytic cells)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The presence of â€œHallmark Cells â€ with horseshoe-like nuclei and abundant cytoplasm is characteristic of anaplastic large cell lymphoma.&lt;/li&gt;&lt;li&gt;âž¤ â€œHallmark Cells&lt;/li&gt;&lt;li&gt;âž¤ horseshoe-like nuclei&lt;/li&gt;&lt;li&gt;âž¤ abundant cytoplasm&lt;/li&gt;&lt;li&gt;âž¤ anaplastic large cell lymphoma.&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbin 10 th 606)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbin 10 th 606)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The lymphocytic and histiocytic variant of Reed- Sternberg cell is seen in:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Follicular center lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lymphocyte depleted Hodgkinâ€™s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nodular sclerosis Hodgkinâ€™s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lymphocyte predominant Hodgkinâ€™s disease&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lymphocyte predominant Hodgkinâ€™s disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Lymphocyte predominant Hodgkinâ€™s disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Follicular center lymphoma: Reed-Sternberg cells are not typically associated with follicular center lymphoma , which is a subtype of non-Hodgkin&#x27;s lymphoma .&lt;/li&gt;&lt;li&gt;â€¢ Option A: Follicular center lymphoma:&lt;/li&gt;&lt;li&gt;â€¢ Reed-Sternberg cells&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ follicular center lymphoma&lt;/li&gt;&lt;li&gt;â€¢ non-Hodgkin&#x27;s lymphoma&lt;/li&gt;&lt;li&gt;â€¢ Option B: In the lymphocyte-depleted subtype of Hodgkin&#x27;s disease , the Reed-Sternberg cells are surrounded by a small number of lymphocytes and a significant number o f histiocytes (macrophages). This variant is associated with a poorer prognosis compared to other subtypes of Hodgkin&#x27;s lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ lymphocyte-depleted subtype of Hodgkin&#x27;s disease&lt;/li&gt;&lt;li&gt;â€¢ Reed-Sternberg cells&lt;/li&gt;&lt;li&gt;â€¢ small number of lymphocytes&lt;/li&gt;&lt;li&gt;â€¢ f histiocytes (macrophages).&lt;/li&gt;&lt;li&gt;â€¢ poorer prognosis&lt;/li&gt;&lt;li&gt;â€¢ Option C: Nodular sclerosis Hodgkinâ€™s disease: The nodular sclerosis subtype of Hodgkin&#x27;s disease typically features Reed-Sternberg cells with a lacunar (empty) appearance, surrounded by fibrous bands.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Nodular sclerosis Hodgkinâ€™s disease:&lt;/li&gt;&lt;li&gt;â€¢ subtype of Hodgkin&#x27;s disease&lt;/li&gt;&lt;li&gt;â€¢ Reed-Sternberg cells with a lacunar (empty)&lt;/li&gt;&lt;li&gt;â€¢ fibrous bands.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The lymphocytic and histiocytic (L&amp;amp;H) variant of Reed-Sternberg cells , often called \&quot;popcorn cells,\&quot; is characteristic of lymphocyte predominant Hodgkinâ€™s disease .&lt;/li&gt;&lt;li&gt;âž¤ lymphocytic and histiocytic (L&amp;amp;H)&lt;/li&gt;&lt;li&gt;âž¤ Reed-Sternberg cells&lt;/li&gt;&lt;li&gt;âž¤ \&quot;popcorn cells,\&quot;&lt;/li&gt;&lt;li&gt;âž¤ predominant Hodgkinâ€™s disease&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th /613&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th /613&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old female presents with painless swelling of a supraclavicular lymph node. Excisional biopsy reveals a nodular pattern with a predominance of lymphocytes, and characteristic large, atypical mononuclear or multinucleated cells with a \&quot;popcorn\&quot; appearance. Immunohistochemistry shows positive staining for CD20 and CD45. What subtype of Hodgkin&#x27;s lymphoma is most likely to be diagnosed in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lymphocyte dominant Hodgkin&#x27;s lymphoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lymphocyte depleted Hodgkin&#x27;s lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nodular sclerosis Hodgkin&#x27;s lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mixed type Hodgkin&#x27;s lymphoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Lymphocyte dominant Hodgkin&#x27;s lymphoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/picture4_6TMNz9L.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Lymphocyte dominant&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: (Lymphocyte depleted Hodgkin&#x27;s lymphoma): This rare subtype is marked by a lack of lymphocytes and an abundance of classic Reed-Sternberg cells . It often presents in more advanced stages and has a worse prognosis. It does not typically contain popcorn cells.&lt;/li&gt;&lt;li&gt;â€¢ Option B: (Lymphocyte depleted Hodgkin&#x27;s lymphoma):&lt;/li&gt;&lt;li&gt;â€¢ rare subtype&lt;/li&gt;&lt;li&gt;â€¢ lack of lymphocytes&lt;/li&gt;&lt;li&gt;â€¢ classic Reed-Sternberg cells&lt;/li&gt;&lt;li&gt;â€¢ more advanced stages&lt;/li&gt;&lt;li&gt;â€¢ worse prognosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C: (Nodular sclerosis Hodgkin&#x27;s lymphoma): The most common subtype, characterized by the presence of collagen bands dividing the lymph node into nodules and Reed-Sternberg cells within lacunar spaces. This subtype usually affects young adults , and it is not primarily associated with popcorn cells.&lt;/li&gt;&lt;li&gt;â€¢ Option C: (Nodular sclerosis Hodgkin&#x27;s lymphoma):&lt;/li&gt;&lt;li&gt;â€¢ most common subtype,&lt;/li&gt;&lt;li&gt;â€¢ presence of collagen bands&lt;/li&gt;&lt;li&gt;â€¢ lymph node into nodules&lt;/li&gt;&lt;li&gt;â€¢ Reed-Sternberg cells&lt;/li&gt;&lt;li&gt;â€¢ young adults&lt;/li&gt;&lt;li&gt;â€¢ Option D: (Mixed type Hodgkin&#x27;s lymphoma): Also known as mixed cellularity Hodgkin&#x27;s lymphoma , it is characterized by a mixed infiltrate that includes eosinophils, plasma cells, neutrophils, and Reed-Sternberg cells . It does not have a predominance of lymphocytes nor does it typically show popcorn cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D: (Mixed type Hodgkin&#x27;s lymphoma):&lt;/li&gt;&lt;li&gt;â€¢ mixed cellularity Hodgkin&#x27;s lymphoma&lt;/li&gt;&lt;li&gt;â€¢ mixed infiltrate&lt;/li&gt;&lt;li&gt;â€¢ eosinophils, plasma cells, neutrophils, and Reed-Sternberg cells&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A biopsy showing a nodular pattern with a predominance of lymphocytes and characteristic \&quot; popcorn\&quot; cells that are positive for CD20 and CD45 is diagnostic of Lymphocyte Predominant Hodgkin&#x27;s Lymphoma.&lt;/li&gt;&lt;li&gt;âž¤ nodular pattern with a predominance of lymphocytes&lt;/li&gt;&lt;li&gt;âž¤ popcorn\&quot; cells&lt;/li&gt;&lt;li&gt;âž¤ CD20 and CD45&lt;/li&gt;&lt;li&gt;âž¤ Lymphocyte Predominant Hodgkin&#x27;s Lymphoma.&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th /613)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th /613)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The CD marker of histiocytosis is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CD 1a&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CD 1b&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CD 1c&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CD 1d&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. CD 1a&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/picture6_YFhykpf.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)Â  CD 1a&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In Langerhans cell histiocytosis, tumor cells typically express the surface marker CD1a and contain intracytoplasmic Birbeck granules .&lt;/li&gt;&lt;li&gt;âž¤ In Langerhans cell histiocytosis,&lt;/li&gt;&lt;li&gt;âž¤ surface marker CD1a&lt;/li&gt;&lt;li&gt;âž¤ intracytoplasmic Birbeck granules&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th 620)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th 620)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Q34. A 60-year-old male with a known history of multiple myeloma presents with worsening renal function. A renal biopsy is performed to assess the renal involvement. Which of the following findings would be considered atypical or not commonly associated with renal complications of multiple myeloma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tubular casts&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amyloidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Wire loop lesions&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Renal tubular necrosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Wire loop lesions&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Wire loop lesions&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Tubular casts: These can result from the precipitation of light chains in the renal tubules , leading to cast formation. This is a common finding in multiple myeloma-associated renal disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Tubular casts:&lt;/li&gt;&lt;li&gt;â€¢ precipitation of light chains in the renal tubules&lt;/li&gt;&lt;li&gt;â€¢ cast&lt;/li&gt;&lt;li&gt;â€¢ multiple myeloma-associated renal disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Amyloidosis: Amyloid deposition in the kidneys is a known complication of multiple myeloma, leading to renal impairment.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Amyloidosis:&lt;/li&gt;&lt;li&gt;â€¢ kidneys is a known complication of multiple myeloma,&lt;/li&gt;&lt;li&gt;â€¢ renal&lt;/li&gt;&lt;li&gt;â€¢ impairment.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Renal tubular necrosis: Direct infiltration of myeloma cells into the renal tubules can cause tubular necrosis, contributing to renal dysfunction.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Renal tubular necrosis:&lt;/li&gt;&lt;li&gt;â€¢ Direct infiltration of myeloma cells&lt;/li&gt;&lt;li&gt;â€¢ renal tubules&lt;/li&gt;&lt;li&gt;â€¢ tubular necrosis,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Wire loop lesions are not typically associated with multiple myeloma and are characteristic of lupus nephritis.&lt;/li&gt;&lt;li&gt;âž¤ Wire loop lesions&lt;/li&gt;&lt;li&gt;âž¤ not typically associated with multiple myeloma&lt;/li&gt;&lt;li&gt;âž¤ lupus nephritis.&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 225)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 225)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the least common presentation of multiple myeloma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hyperviscosity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bone pains&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Infection&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hyperviscosity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Hyperviscosity&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: (Anemia): Anemia is a common finding in multiple myeloma, typically normocytic and normochromic, caused by the replacement of bone marrow with myeloma cells , which impairs normal blood cell production.&lt;/li&gt;&lt;li&gt;â€¢ Option A: (Anemia):&lt;/li&gt;&lt;li&gt;â€¢ Anemia is a common&lt;/li&gt;&lt;li&gt;â€¢ typically normocytic and normochromic,&lt;/li&gt;&lt;li&gt;â€¢ bone marrow with myeloma cells&lt;/li&gt;&lt;li&gt;â€¢ Option C: (Bone Pains): Bone pain, particularly in the back or chest , is a very common symptom of multiple myeloma. It results from bone destruction due to the infiltration and activation of osteoclasts by myeloma cells, leading to lytic lesions or fractures.&lt;/li&gt;&lt;li&gt;â€¢ Option C: (Bone Pains):&lt;/li&gt;&lt;li&gt;â€¢ Bone pain,&lt;/li&gt;&lt;li&gt;â€¢ back or chest&lt;/li&gt;&lt;li&gt;â€¢ very common&lt;/li&gt;&lt;li&gt;â€¢ bone destruction&lt;/li&gt;&lt;li&gt;â€¢ infiltration and activation of osteoclasts by myeloma cells,&lt;/li&gt;&lt;li&gt;â€¢ Option D: (Infection): Patients with multiple myeloma have an increased risk of infections due to an impaired immune response , both from the disease itself and as a consequence of treatment, making infection a common presentation.&lt;/li&gt;&lt;li&gt;â€¢ Option D: (Infection):&lt;/li&gt;&lt;li&gt;â€¢ increased risk of infections due to an impaired immune response&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hyperviscosity is the least common presentation of multiple myeloma compared to anemia, bone pains, and infection.&lt;/li&gt;&lt;li&gt;âž¤ Hyperviscosity&lt;/li&gt;&lt;li&gt;âž¤ least common&lt;/li&gt;&lt;li&gt;âž¤ multiple myeloma compared to anemia, bone pains, and infection.&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 609)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 609)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male presents with fatigue, weakness, and recurrent infections. Flow cytometry analysis of bone marrow aspirate shows infiltration of small lymphocytes, plasma cells, and lymphoplasmacytoid cells. The patient is diagnosed with lymphoplasmacytoid lymphoma. Which immunoglobulin is most likely to be associated with this lymphoma subtype?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IgG&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IgA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IgD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IgM&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. IgM&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) IgM&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: (IgG): While IgG is the most common immunoglobulin produced in multiple myeloma , it is not typically associated with lymphoplasmacytoid lymphoma, also known as WaldenstrÃ¶mâ€™s macroglobulinemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A: (IgG):&lt;/li&gt;&lt;li&gt;â€¢ IgG&lt;/li&gt;&lt;li&gt;â€¢ most&lt;/li&gt;&lt;li&gt;â€¢ immunoglobulin&lt;/li&gt;&lt;li&gt;â€¢ multiple myeloma&lt;/li&gt;&lt;li&gt;â€¢ Option B: (IgA): IgA is another immunoglobulin that can be produced in multiple myeloma but is less commonly associated with lymphoplasmacytoid lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ Option B: (IgA):&lt;/li&gt;&lt;li&gt;â€¢ IgA&lt;/li&gt;&lt;li&gt;â€¢ immunoglobulin&lt;/li&gt;&lt;li&gt;â€¢ multiple myeloma&lt;/li&gt;&lt;li&gt;â€¢ Option C: (IgD): IgD paraproteinemia is very rare in plasma cell dyscrasias and is not commonly seen in lymphoplasmacytoid lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ Option C: (IgD):&lt;/li&gt;&lt;li&gt;â€¢ IgD paraproteinemia&lt;/li&gt;&lt;li&gt;â€¢ plasma cell dyscrasias&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lymphoplasmacytoid lymphoma, known as WaldenstrÃ¶mâ€™s macroglobulinemia, is most commonly associated with the overproduction of monoclonal IgM .&lt;/li&gt;&lt;li&gt;âž¤ Lymphoplasmacytoid lymphoma,&lt;/li&gt;&lt;li&gt;âž¤ WaldenstrÃ¶mâ€™s macroglobulinemia,&lt;/li&gt;&lt;li&gt;âž¤ monoclonal IgM&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 604)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 604)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male who is a diagnosed case of multiple myeloma has come up for follow-up. Elevated levels of which of the following is a poor prognostic factor in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Beta 2 microglobulin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Creatine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Albumin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Beta 2 microglobulin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Beta 2 microglobulin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Elevated creatinine levels can indicate impaired renal function , which is a common complication in multiple myeloma. However, it is not a specific prognostic factor on its own.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Elevated creatinine levels&lt;/li&gt;&lt;li&gt;â€¢ impaired renal function&lt;/li&gt;&lt;li&gt;â€¢ Option C: Low levels of albumin are associated with poor prognosis in various diseases, including multiple myeloma. However, an increase in albumin is not typically considered a poor prognostic factor in this context.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Low levels of albumin&lt;/li&gt;&lt;li&gt;â€¢ poor prognosis in various diseases,&lt;/li&gt;&lt;li&gt;â€¢ Option D: Anemia is a common feature of multiple myeloma and is associated with a poorer prognosis. However, the presence of anemia itself may not necessarily indicate a worsening prognosis without considering other factors.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Anemia is a common&lt;/li&gt;&lt;li&gt;â€¢ multiple myeloma&lt;/li&gt;&lt;li&gt;â€¢ poorer prognosis.&lt;/li&gt;&lt;li&gt;â€¢ presence of&lt;/li&gt;&lt;li&gt;â€¢ anemia itself&lt;/li&gt;&lt;li&gt;â€¢ worsening prognosis&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Elevated serum levels of Beta 2 microglobulin are a powerful prognostic factor in multiple myeloma, reflecting tumor burden and the extent of tumor cell infiltration.&lt;/li&gt;&lt;li&gt;â€¢ Elevated serum levels of Beta 2 microglobulin&lt;/li&gt;&lt;li&gt;â€¢ powerful prognostic factor&lt;/li&gt;&lt;li&gt;â€¢ tumor cell infiltration.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with lymphoma with CD10 and bcl2 marker is likely to be diagnosed with which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mycosis fungoides&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Follicular lymphoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Burkittâ€™s lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hodgkin lymphoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Follicular lymphoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Follicular lymphoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Mycosis fungoides is a type of cutaneous T-cell lymphoma , primarily involving the skin . CD10 and bcl-2 markers are not typically associated with mycosis fungoides.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Mycosis fungoides&lt;/li&gt;&lt;li&gt;â€¢ cutaneous T-cell lymphoma&lt;/li&gt;&lt;li&gt;â€¢ skin&lt;/li&gt;&lt;li&gt;â€¢ Option C: Burkitt&#x27;s lymphoma is an aggressive B-cell lymphoma, often associated with the Epstein-Barr virus. It is characterized by a high proliferation rate and a characteristic translocation involving the c-Myc gene . CD10 can be expressed in Burkitt&#x27;s lymphoma, but bcl-2 is typically negative.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Burkitt&#x27;s lymphoma&lt;/li&gt;&lt;li&gt;â€¢ aggressive B-cell lymphoma,&lt;/li&gt;&lt;li&gt;â€¢ Epstein-Barr virus.&lt;/li&gt;&lt;li&gt;â€¢ high proliferation&lt;/li&gt;&lt;li&gt;â€¢ translocation involving the c-Myc gene&lt;/li&gt;&lt;li&gt;â€¢ CD10&lt;/li&gt;&lt;li&gt;â€¢ Burkitt&#x27;s lymphoma,&lt;/li&gt;&lt;li&gt;â€¢ bcl-2 is typically negative.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Hodgkin lymphoma is characterized by the presence of Reed-Sternberg cells . CD10 and bcl-2 are not t ypical markers for Hodgkin lymphoma . Classical Hodgkin lymphoma is more commonly associated with CD15 and CD30 expression.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Hodgkin lymphoma&lt;/li&gt;&lt;li&gt;â€¢ presence of Reed-Sternberg cells&lt;/li&gt;&lt;li&gt;â€¢ CD10 and bcl-2 are not t&lt;/li&gt;&lt;li&gt;â€¢ Hodgkin lymphoma&lt;/li&gt;&lt;li&gt;â€¢ CD15 and CD30 expression.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ A lymphoma with positive CD10 and bcl2 markers is likely to be diagnosed as follicular lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ positive CD10 and bcl2 markers&lt;/li&gt;&lt;li&gt;â€¢ follicular lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ (Ref: Robbins 10th/e p468)&lt;/li&gt;&lt;li&gt;â€¢ (Ref: Robbins 10th/e p468)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An elderly male with dragging sensation in abdomen presents in the OPD. His cell count had elevated total leucocyte count and increased platelet count. His peripheral smear shows metamyelocytes, myelocytes, eosinophilia and basophilia (image given for reference). Which of the following is the likely genetic anomaly present in this individual?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;t (9; 22)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;t (15; 17)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;t (8; 14)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;t (8; 21)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. t (9; 22)&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/picture7_WdmXOwZ.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. t (9; 22)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: t (15;17) : is associated with acute promyelocytic leukemia (APL). It involves the fusion of the PML (promyelocytic leukemia) gene on chromosome 15 with the RARA (retinoic acid receptor alpha) gene on chromosome 17 , resulting in the PML-RARA fusion gene. This fusion gene plays a crucial role in the pathogenesis of APL.&lt;/li&gt;&lt;li&gt;â€¢ Option B: t (15;17)&lt;/li&gt;&lt;li&gt;â€¢ acute promyelocytic leukemia (APL).&lt;/li&gt;&lt;li&gt;â€¢ PML (promyelocytic&lt;/li&gt;&lt;li&gt;â€¢ leukemia) gene on chromosome 15 with the RARA (retinoic acid receptor alpha) gene on chromosome 17&lt;/li&gt;&lt;li&gt;â€¢ PML-RARA fusion gene.&lt;/li&gt;&lt;li&gt;â€¢ Option C: t (8;14) : is associated with Burkitt&#x27;s lymphoma. It involves the c-MYC gene on chromosome 8 and the immunoglobulin heavy chain gene on chromosome 14 . The dysregulation of c-MYC , a proto-oncogene, contributes to the rapid and uncontrolled proliferation of B cells in Burkitt&#x27;s lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ Option C: t (8;14)&lt;/li&gt;&lt;li&gt;â€¢ Burkitt&#x27;s lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ c-MYC gene on chromosome 8&lt;/li&gt;&lt;li&gt;â€¢ immunoglobulin&lt;/li&gt;&lt;li&gt;â€¢ heavy chain gene on chromosome 14&lt;/li&gt;&lt;li&gt;â€¢ c-MYC&lt;/li&gt;&lt;li&gt;â€¢ rapid and uncontrolled&lt;/li&gt;&lt;li&gt;â€¢ proliferation of B cells&lt;/li&gt;&lt;li&gt;â€¢ Option D: t (8;21) : is associated with acute myeloid leukemia (AML) , particularly the subtype known as AML with t(8;21), also called AML-M2. It involves the fusion of the AML1 (acute myeloid leukemia 1) gene on chromosome 21 with the ETO (eight-twenty-one) gene on chromosome 8, resulting in the AML1-ETO fusion gene.&lt;/li&gt;&lt;li&gt;â€¢ Option D: t (8;21)&lt;/li&gt;&lt;li&gt;â€¢ acute myeloid leukemia (AML)&lt;/li&gt;&lt;li&gt;â€¢ AML with t(8;21),&lt;/li&gt;&lt;li&gt;â€¢ AML-M2.&lt;/li&gt;&lt;li&gt;â€¢ AML1 (acute myeloid leukemia 1) gene on chromosome 21 with the ETO (eight-twenty-one) gene on chromosome 8,&lt;/li&gt;&lt;li&gt;â€¢ AML1-ETO fusion gene.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The genetic anomaly likely present in an elderly male with an elevated leukocyte and platelet count , peripheral smear showing metamyelocytes, myelocytes, eosinophilia, and basophilia is t (9;22), which is associated with chronic myeloid leukemia (CML).&lt;/li&gt;&lt;li&gt;âž¤ genetic anomaly&lt;/li&gt;&lt;li&gt;âž¤ elderly male&lt;/li&gt;&lt;li&gt;âž¤ elevated leukocyte and platelet count&lt;/li&gt;&lt;li&gt;âž¤ metamyelocytes, myelocytes, eosinophilia, and basophilia is t (9;22),&lt;/li&gt;&lt;li&gt;âž¤ chronic myeloid leukemia (CML).&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10th/e p622)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10th/e p622)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A male patient with splenomegaly with myeloid hyperplasia. Whatâ€™s is the next best investigation to be done?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Whole body PET CT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Leucocyte alkaline phosphatase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Immunophenotyping&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;FISH in the peripheral blood smear&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. FISH in the peripheral blood smear&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. FISH in the peripheral blood smear&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Whole-body PET CT (Positron Emission Tomography with Computed Tomography) is a valuable imaging tool, particularly in the evaluation of lymphomas and solid tumors. However, it may not be the first-line investigation for myeloid hyperplasia or diseases primarily involving the bone marrow.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ PET CT (Positron Emission Tomography with Computed Tomography)&lt;/li&gt;&lt;li&gt;â€¢ lymphomas and solid tumors.&lt;/li&gt;&lt;li&gt;â€¢ not be the first-line investigation for myeloid hyperplasia&lt;/li&gt;&lt;li&gt;â€¢ primarily&lt;/li&gt;&lt;li&gt;â€¢ bone marrow.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Leucocyte alkaline phosphatase (LAP) is an enzyme that can be measured to assess the activity of neutrophils . Low LAP scores may be associated with conditions like chronic myeloid leukemia (CML). However, this test alone might not provide a definitive diagnosis and is often used in conjunction with other tests.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Leucocyte alkaline phosphatase (LAP)&lt;/li&gt;&lt;li&gt;â€¢ enzyme&lt;/li&gt;&lt;li&gt;â€¢ to assess the activity of neutrophils&lt;/li&gt;&lt;li&gt;â€¢ Low LAP&lt;/li&gt;&lt;li&gt;â€¢ chronic myeloid leukemia (CML).&lt;/li&gt;&lt;li&gt;â€¢ definitive diagnosis&lt;/li&gt;&lt;li&gt;â€¢ Option C: Immunophenotyping is a crucial investigation in the context of hematological disorders . It involves the analysis of cell surface markers on blood or bone marrow cells but is more useful for other leukemias like ALL, AML or CLL.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Immunophenotyping&lt;/li&gt;&lt;li&gt;â€¢ hematological disorders&lt;/li&gt;&lt;li&gt;â€¢ cell surface markers&lt;/li&gt;&lt;li&gt;â€¢ blood or bone marrow cells&lt;/li&gt;&lt;li&gt;â€¢ ALL, AML or CLL.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For a male patient with splenomegaly and myeloid hyperplasia , the next best investigation is Fluorescence in situ hybridization (FISH) in the peripheral blood smear, particularly to detect chromosomal abnormalities such as the Philadelphia chromosome in chronic myeloid leukemia (CML).&lt;/li&gt;&lt;li&gt;âž¤ male&lt;/li&gt;&lt;li&gt;âž¤ splenomegaly and myeloid hyperplasia&lt;/li&gt;&lt;li&gt;âž¤ Fluorescence in situ hybridization (FISH)&lt;/li&gt;&lt;li&gt;âž¤ Philadelphia chromosome&lt;/li&gt;&lt;li&gt;âž¤ chronic myeloid leukemia (CML).&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10th/e p482)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10th/e p482)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Lacunar cells are seen in which type of Hodgkinâ€™s lymphoma:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lymphocyte predominance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lyphocyte depletion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nodular sclerosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mixed cellularity&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Nodular sclerosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/picture5_RDkaQxW.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Nodular sclerosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: (Lymphocyte Predominance): This subtype is characterized by the presence of Reed-Sternberg cell variants called popcorn cells , which are usually CD20 positive , and not by lacunar cells . It has a nodular pattern and an abundance of reactive lymphocytes .&lt;/li&gt;&lt;li&gt;â€¢ Option A: (Lymphocyte Predominance):&lt;/li&gt;&lt;li&gt;â€¢ subtype&lt;/li&gt;&lt;li&gt;â€¢ presence of Reed-Sternberg cell&lt;/li&gt;&lt;li&gt;â€¢ popcorn cells&lt;/li&gt;&lt;li&gt;â€¢ CD20 positive&lt;/li&gt;&lt;li&gt;â€¢ not by lacunar cells&lt;/li&gt;&lt;li&gt;â€¢ nodular pattern&lt;/li&gt;&lt;li&gt;â€¢ an abundance of reactive lymphocytes&lt;/li&gt;&lt;li&gt;â€¢ Option B: (Lymphocyte Depletion): This rare and aggressive subtype contains few lymphocytes and numerous Reed-Sternberg cells , often in a background that may include fibrosis , but not typically lacunar cells .&lt;/li&gt;&lt;li&gt;â€¢ Option B: (Lymphocyte Depletion):&lt;/li&gt;&lt;li&gt;â€¢ rare and aggressive&lt;/li&gt;&lt;li&gt;â€¢ few lymphocytes and numerous Reed-Sternberg cells&lt;/li&gt;&lt;li&gt;â€¢ fibrosis&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ lacunar cells&lt;/li&gt;&lt;li&gt;â€¢ Option D: (Mixed Cellularity): Mixed cellularity Hodgkin&#x27;s lymphoma is noted for a diverse cellular composition that includes numerous classic Reed-Sternberg cells among inflammatory cells , but not specifically lacunar cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D: (Mixed Cellularity):&lt;/li&gt;&lt;li&gt;â€¢ diverse cellular composition&lt;/li&gt;&lt;li&gt;â€¢ Reed-Sternberg cells among inflammatory cells&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lacunar cells are a characteristic feature of the nodular sclerosis subtype of Hodgkinâ€™s lymphoma .&lt;/li&gt;&lt;li&gt;âž¤ Lacunar cells&lt;/li&gt;&lt;li&gt;âž¤ nodular sclerosis subtype of Hodgkinâ€™s lymphoma&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th 618)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th 618)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Irradiation of white blood cells prior to transfusion prevents which of the following complications?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;TRALI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;HLA alloimmunisation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Graft versus host disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Immunomodulation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Graft versus host disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Graft versus host disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: (TRALI - Transfusion-Related Acute Lung Injury): TRALI is a serious complication characterized by acute respiratory distress following transfusion. It is thought to be caused by donor antibodies against recipient leukocytes . Irradiation does not prevent TRALI.&lt;/li&gt;&lt;li&gt;â€¢ Option A: (TRALI - Transfusion-Related Acute Lung Injury):&lt;/li&gt;&lt;li&gt;â€¢ acute respiratory distress&lt;/li&gt;&lt;li&gt;â€¢ transfusion.&lt;/li&gt;&lt;li&gt;â€¢ donor antibodies against recipient leukocytes&lt;/li&gt;&lt;li&gt;â€¢ Option B: (HLA alloimmunization): HLA alloimmunization can occur when a patient develops antibodies against HLA antigens from transfused blood . While leukoreduction can reduce the risk, irradiation of blood products does not prevent HLA alloimmunization.&lt;/li&gt;&lt;li&gt;â€¢ Option B: (HLA alloimmunization):&lt;/li&gt;&lt;li&gt;â€¢ patient develops antibodies against HLA antigens from transfused blood&lt;/li&gt;&lt;li&gt;â€¢ Option D: (Immunomodulation): Immunomodulation refers to the potential immune system changes in transfusion recipients, potentially leading to an increased risk of postoperative infections and malignancy recurrence . Irradiationâ€™s role in preventing immunomodulation is not clearly established.&lt;/li&gt;&lt;li&gt;â€¢ Option D: (Immunomodulation):&lt;/li&gt;&lt;li&gt;â€¢ potential immune system&lt;/li&gt;&lt;li&gt;â€¢ transfusion recipients,&lt;/li&gt;&lt;li&gt;â€¢ postoperative infections&lt;/li&gt;&lt;li&gt;â€¢ malignancy recurrence&lt;/li&gt;&lt;li&gt;â€¢ Irradiationâ€™s&lt;/li&gt;&lt;li&gt;â€¢ immunomodulation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Irradiation of white and red blood cells prior to transfusion is primarily used to prevent graft versus host disease.&lt;/li&gt;&lt;li&gt;âž¤ Irradiation of white&lt;/li&gt;&lt;li&gt;âž¤ red blood cells prior&lt;/li&gt;&lt;li&gt;âž¤ prevent graft versus host disease.&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10th/e p671-2)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10th/e p671-2)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 142 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test7" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Immunity&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Immunity&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                50 Questions | 200 Total Marks | 60 min Duration | ~72.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A 9-month-old girl with a history of recurrent pulmonary infections is found to have a congenital deficiency of adenosine deaminase, which is associated with a virtual absence of lymphocytes in her peripheral lymphoid organs. What is the appropriate diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bruton X-linked agammaglobulinemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;DiGeorge syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Isolated IgA deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Severe combined immunodeficiency&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Severe combined immunodeficiency&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Severe combined immunodeficiency&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Bruton X-linked agammaglobulinemia: This is a disorder characterized by the absence of B cells and low levels of all immunoglobulins, but it does not typically involve T cells or adenosine deaminase deficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Bruton X-linked agammaglobulinemia:&lt;/li&gt;&lt;li&gt;â€¢ B cells and low levels of all immunoglobulins,&lt;/li&gt;&lt;li&gt;â€¢ Option B: DiGeorge syndrome: This condition is due to thymic hypoplasia or aplasia, leading to T cell deficiency . While it may present with recurrent infections , it is not associated with adenosine deaminase deficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option B: DiGeorge syndrome:&lt;/li&gt;&lt;li&gt;â€¢ thymic hypoplasia or aplasia,&lt;/li&gt;&lt;li&gt;â€¢ T cell deficiency&lt;/li&gt;&lt;li&gt;â€¢ recurrent infections&lt;/li&gt;&lt;li&gt;â€¢ Option C: Isolated IgA deficiency: This is the most common primary immunodeficiency and usually presents with recurrent mucosal infections . It is characterized by low or absent IgA levels but does not involve a global lack of lymphocytes or adenosine deaminase deficiency .&lt;/li&gt;&lt;li&gt;â€¢ Option C: Isolated IgA deficiency:&lt;/li&gt;&lt;li&gt;â€¢ primary immunodeficiency&lt;/li&gt;&lt;li&gt;â€¢ recurrent mucosal infections&lt;/li&gt;&lt;li&gt;â€¢ low or absent IgA&lt;/li&gt;&lt;li&gt;â€¢ global lack of lymphocytes or adenosine deaminase deficiency&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ SCID is a group of disorders involving both B and T cell deficiencies . Adenosine deaminase deficiency is a specific form of SCID that leads to the accumulation of metabolites toxic to lymphocytes, resulting in their absence.&lt;/li&gt;&lt;li&gt;âž¤ SCID&lt;/li&gt;&lt;li&gt;âž¤ B and T cell deficiencies&lt;/li&gt;&lt;li&gt;âž¤ Adenosine deaminase deficiency&lt;/li&gt;&lt;li&gt;âž¤ SCID&lt;/li&gt;&lt;li&gt;âž¤ metabolites toxic to lymphocytes, resulting in their absence.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male presents with numbness and tingling in his hands and feet. He also reports weakness and difficulty walking. Examination reveals enlarged tongue, carpal tunnel syndrome, and a waddling gait. Biopsy of the sural nerve shows deposits of amyloid protein. Which of the following is not correct about this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Congo red is the commonest stain used for diagnosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Electron microscopy shows non branching fibrils&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Spectroscopy shows beta pleated structure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Apple green birefringence with PAS staining&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Apple green birefringence with PAS staining&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Apple green birefringence with PAS staining&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Congo red staining is indeed the most common method used for the diagnosis of amyloidosis . When viewed under polarized light, amyloid deposits stained with Congo red show a characteristic apple green birefringence.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Congo red staining&lt;/li&gt;&lt;li&gt;â€¢ diagnosis of amyloidosis&lt;/li&gt;&lt;li&gt;â€¢ polarized light, amyloid deposits&lt;/li&gt;&lt;li&gt;â€¢ apple green birefringence.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Electron microscopy of amyloid fibrils typically shows non-branching, linear fibrils . This is due to the beta-pleated sheet configuration of the proteins that make up the fibrils , which is a hallmark of amyloid deposits .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Electron microscopy of amyloid fibrils&lt;/li&gt;&lt;li&gt;â€¢ non-branching, linear fibrils&lt;/li&gt;&lt;li&gt;â€¢ due to the beta-pleated sheet configuration&lt;/li&gt;&lt;li&gt;â€¢ make up the fibrils&lt;/li&gt;&lt;li&gt;â€¢ hallmark of amyloid deposits&lt;/li&gt;&lt;li&gt;â€¢ Option C. On spectroscopy , the beta-pleated sheet conformation of the amyloid fibrils results in a distinct pattern . This structure is stable and resistant to proteolysis , which is why amyloid deposits are typically insoluble and accumulate in various tissues.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ On spectroscopy&lt;/li&gt;&lt;li&gt;â€¢ beta-pleated sheet&lt;/li&gt;&lt;li&gt;â€¢ amyloid fibrils&lt;/li&gt;&lt;li&gt;â€¢ distinct pattern&lt;/li&gt;&lt;li&gt;â€¢ stable and resistant to proteolysis&lt;/li&gt;&lt;li&gt;â€¢ insoluble&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Amyloid deposits do not exhibit apple green birefringence when stained with PAS; this characteristic is observed with Congo red staining under polarized light.&lt;/li&gt;&lt;li&gt;âž¤ Apple green birefringence is seen with Congo red under polarised light&lt;/li&gt;&lt;li&gt;âž¤ Apple green birefringence is seen with Congo red under polarised light&lt;/li&gt;&lt;li&gt;âž¤ Robbins 10 th /259&lt;/li&gt;&lt;li&gt;âž¤ Robbins 10 th /259&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old patient presents with a history of recurrent anaphylaxis. As part of the diagnostic workup, a biopsy from a suspected lesion was taken and stained with Toluidine blue. Which type of cell is most likely to be highlighted by this stain in the patient&#x27;s tissue sample?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Macrophages&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Plasma cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mast cell&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Eosinophil&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Mast cell&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/23/picture5.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Mast cell&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Macrophages are phagocytic immune cells involved in the inflammatory response and tissue repair . They do not have a high affinity for Toluidine blue staining.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Macrophages&lt;/li&gt;&lt;li&gt;â€¢ phagocytic immune cells&lt;/li&gt;&lt;li&gt;â€¢ inflammatory response&lt;/li&gt;&lt;li&gt;â€¢ tissue repair&lt;/li&gt;&lt;li&gt;â€¢ high affinity for Toluidine blue staining.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Plasma cells are antibody-producing cells derived from B lymphocytes . They have abundant rough endoplasmic reticulum for antibody production but are not specifically stained by Toluidine blue.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Plasma cells&lt;/li&gt;&lt;li&gt;â€¢ antibody-producing cells derived from B lymphocytes&lt;/li&gt;&lt;li&gt;â€¢ abundant rough endoplasmic reticulum for antibody production&lt;/li&gt;&lt;li&gt;â€¢ Option D. Eosinophils are involved in combating parasitic infections and allergic reactions . They contain eosinophilic granules but are not specifically highlighted by Toluidine blue.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Eosinophils&lt;/li&gt;&lt;li&gt;â€¢ parasitic infections and allergic reactions&lt;/li&gt;&lt;li&gt;â€¢ eosinophilic granules&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Toluidine blue is a metachromatic dye with an affinity for acidic tissue components , particularly the granules in mast cells , which makes it a valuable stain for identifying these cells in tissue sections.&lt;/li&gt;&lt;li&gt;âž¤ Toluidine blue&lt;/li&gt;&lt;li&gt;âž¤ metachromatic dye&lt;/li&gt;&lt;li&gt;âž¤ acidic tissue components&lt;/li&gt;&lt;li&gt;âž¤ granules in mast cells&lt;/li&gt;&lt;li&gt;âž¤ for identifying these cells in tissue sections.&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10th/e p206)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10th/e p206)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male with a history of hypertension presents with a sudden onset of severe pain, redness, and swelling in the big toe. His serum uric acid levels are elevated. Which pattern recognition receptor is most likely involved in the inflammatory response seen in this patient&#x27;s condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;NOD like receptor&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;GPCR&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;C type of lectin receptor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Toll like receptor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. NOD like receptor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) NOD like receptor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: G Protein-Coupled Receptor (GPCR): GPCRs are a large protein family of receptors that sense molecules outside the cell and activate internal signal transduction pathways and, ultimately, cellular responses. They are not primarily known for recognizing uric acid crystals.&lt;/li&gt;&lt;li&gt;â€¢ Option B: G Protein-Coupled Receptor (GPCR):&lt;/li&gt;&lt;li&gt;â€¢ large protein family&lt;/li&gt;&lt;li&gt;â€¢ outside the cell and activate internal signal transduction pathways&lt;/li&gt;&lt;li&gt;â€¢ Option C: C-type Lectin Receptor (CLR): C-type lectin receptors are a class of pattern recognition receptors that are key players in the immune system, recognizing fungal pathogens and playing a role in antifungal immunity. They are not directly involved in the recognition of uric acid crystals.&lt;/li&gt;&lt;li&gt;â€¢ Option C: C-type Lectin Receptor (CLR):&lt;/li&gt;&lt;li&gt;â€¢ class of pattern recognition receptors&lt;/li&gt;&lt;li&gt;â€¢ recognizing fungal pathogens&lt;/li&gt;&lt;li&gt;â€¢ antifungal immunity.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Toll-like Receptor (TLR): Toll-like receptors are a class of proteins that play a key role in the innate immune system . They recognize structurally conserved molecules derived from microbes and are important in the initial immune response, not specifically in the recognition of uric acid crystals associated with gout.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Toll-like Receptor (TLR):&lt;/li&gt;&lt;li&gt;â€¢ class of proteins&lt;/li&gt;&lt;li&gt;â€¢ innate immune system&lt;/li&gt;&lt;li&gt;â€¢ microbes and are important in the initial immune response,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ NOD-like receptors (NLRs) are involved in the detection of danger-associated molecular patterns such as uric acid, which is relevant in the pathogenesis of gout.&lt;/li&gt;&lt;li&gt;âž¤ NOD-like receptors (NLRs)&lt;/li&gt;&lt;li&gt;âž¤ danger-associated molecular patterns&lt;/li&gt;&lt;li&gt;âž¤ uric acid,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old man participates in a clinical study examining immune function. He is in excellent health with no history of immune-related disorders. A complete blood count with differential and a lymphocyte subset panel are performed. Which of the following is the expected normal ratio of T cells to B cells in this individual&#x27;s peripheral blood?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1:1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1:3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;3:1&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1:4&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 3:1&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 3:1&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ In the peripheral blood of a healthy individual, T cells are 60â€“70% and B cells are 10â€“20% of the lymphocytes. So, the best answer with the given options is 3:1.&lt;/li&gt;&lt;li&gt;â€¢ T cells are 60â€“70% and B cells are 10â€“20% of the lymphocytes.&lt;/li&gt;&lt;li&gt;â€¢ 3:1.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The typical ratio of T cells to B cells in the peripheral blood of a healthy individual is approximately 3:1 , reflecting the predominance of T cells, which comprise 60â€“70% of lymphocytes, while B cells make up about 10â€“20%.&lt;/li&gt;&lt;li&gt;âž¤ T cells to B cells in the peripheral blood&lt;/li&gt;&lt;li&gt;âž¤ 3:1&lt;/li&gt;&lt;li&gt;âž¤ predominance of T cells, which comprise 60â€“70% of lymphocytes, while B cells make up about 10â€“20%.&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10th/e p195 )&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10th/e p195 )&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old female with a history of recurrent viral infections is referred to an immunologist for evaluation. Laboratory studies are ordered to assess her immune cell populations, including a flow cytometry panel to identify various lymphocyte subsets based on surface markers. Which of the following cell surface markers is most commonly associated with natural killer (NK) cells?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CD25&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CD3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CD94&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CD68&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. CD94&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) CD94&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: CD25: CD25 is the alpha chain of the IL-2 receptor , which is expressed on activated T and B cells, and some NK cells. It&#x27;s not specific for NK cells , as it is also present on regulatory T cells (Tregs).&lt;/li&gt;&lt;li&gt;â€¢ Option A: CD25:&lt;/li&gt;&lt;li&gt;â€¢ alpha chain&lt;/li&gt;&lt;li&gt;â€¢ IL-2 receptor&lt;/li&gt;&lt;li&gt;â€¢ T and B cells, and some NK cells.&lt;/li&gt;&lt;li&gt;â€¢ not specific for NK cells&lt;/li&gt;&lt;li&gt;â€¢ T cells (Tregs).&lt;/li&gt;&lt;li&gt;â€¢ Option B: CD3: CD3 is a complex of proteins associated with the T-cell receptor (TCR) on T-lymphocytes. It is not found on NK cells, which do not express TCRs.&lt;/li&gt;&lt;li&gt;â€¢ Option B: CD3:&lt;/li&gt;&lt;li&gt;â€¢ T-cell receptor (TCR) on T-lymphocytes.&lt;/li&gt;&lt;li&gt;â€¢ not found on NK cells,&lt;/li&gt;&lt;li&gt;â€¢ Option D: CD68: CD68 is a marker associated with macrophages and is not expressed on NK cells . It is typically used to identify cells of the myeloid lineage , particularly in the context of tissue-resident macrophages.&lt;/li&gt;&lt;li&gt;â€¢ Option D: CD68:&lt;/li&gt;&lt;li&gt;â€¢ macrophages&lt;/li&gt;&lt;li&gt;â€¢ not expressed on NK cells&lt;/li&gt;&lt;li&gt;â€¢ myeloid lineage&lt;/li&gt;&lt;li&gt;â€¢ tissue-resident macrophages.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The surface marker CD94 is predominantly expressed on natural killer (NK) cells and a subset of CD8+ T cells and is involved in the recognition of non-classical MHC class I molecules&lt;/li&gt;&lt;li&gt;âž¤ surface marker CD94&lt;/li&gt;&lt;li&gt;âž¤ natural killer (NK) cells and a subset of CD8+ T cells&lt;/li&gt;&lt;li&gt;âž¤ non-classical MHC class I molecules&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a patient with a suspected immune deficiency, various components of the immune system are being assessed to identify the potential defect. Which of the following immune components is primarily associated with adaptive immunity rather than innate immunity?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alpha defensins&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;B lymphocytes&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Delta gamma T lymphocytes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lectin pathway&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. B lymphocytes&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) B lymphocytes&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Alpha Defensins: Alpha defensins are antimicrobial peptides produced by Paneth cells in the intestines . They play a crucial role in the innate immune response by directly killing microbes and contribute to the innate defense of mucosal surfaces.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Alpha Defensins:&lt;/li&gt;&lt;li&gt;â€¢ antimicrobial peptides&lt;/li&gt;&lt;li&gt;â€¢ Paneth cells in the intestines&lt;/li&gt;&lt;li&gt;â€¢ innate immune&lt;/li&gt;&lt;li&gt;â€¢ microbes and contribute to the innate defense of mucosal surfaces.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Delta Gamma T Lymphocytes: Delta gamma T cells (Î³Î´ T cells) are a subset of T cells that have T cell receptors different from the classic Î±Î² T cell receptors. These cells can respond to certain antigens without the need for antigen processing and presentation by MHC molecules , bridging innate and adaptive immunity . They are often considered a part of the innate immune system due to their rapid response and lack of requirement for specific antigen presentation.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Delta Gamma T Lymphocytes:&lt;/li&gt;&lt;li&gt;â€¢ subset of T cells&lt;/li&gt;&lt;li&gt;â€¢ Î±Î² T cell receptors.&lt;/li&gt;&lt;li&gt;â€¢ without&lt;/li&gt;&lt;li&gt;â€¢ antigen processing and presentation by MHC molecules&lt;/li&gt;&lt;li&gt;â€¢ innate and adaptive immunity&lt;/li&gt;&lt;li&gt;â€¢ rapid response and lack of requirement for specific antigen presentation.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Lectin Pathway: The lectin pathway is part of the complement system , which is a key component of the innate immune system. It involves the binding of mannose-binding lectin to pathogens , leading to their opsonization and subsequent phagocytosis or lysis .&lt;/li&gt;&lt;li&gt;â€¢ Option D: Lectin Pathway:&lt;/li&gt;&lt;li&gt;â€¢ complement system&lt;/li&gt;&lt;li&gt;â€¢ mannose-binding lectin to pathogens&lt;/li&gt;&lt;li&gt;â€¢ opsonization and subsequent phagocytosis or lysis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ B lymphocytes are part of the adaptive immune system and are responsible for humoral immunity through the production of antibodies.&lt;/li&gt;&lt;li&gt;âž¤ B lymphocytes&lt;/li&gt;&lt;li&gt;âž¤ adaptive immune system&lt;/li&gt;&lt;li&gt;âž¤ humoral immunity&lt;/li&gt;&lt;li&gt;âž¤ production of antibodies.&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10th/e p195)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10th/e p195)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;MHC-I will present antigen to:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Helper T cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Natural killer cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Suppressor T cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cytotoxic T cells&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Cytotoxic T cells&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Cytotoxic T cells&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Helper T cells: Helper T cells (CD4+ T cells) are primarily activated by antigens presented on MHC class II molecules . They are crucial for the orchestration of the immune response, including the activation of B cells and other T cells.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Helper T cells:&lt;/li&gt;&lt;li&gt;â€¢ (CD4+ T cells)&lt;/li&gt;&lt;li&gt;â€¢ antigens presented on MHC class II molecules&lt;/li&gt;&lt;li&gt;â€¢ orchestration of the immune response,&lt;/li&gt;&lt;li&gt;â€¢ B cells and other T cells.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Natural killer cells: Natural killer (NK) cells are part of the innate immune system and do not require antigen presentation by MHC molecules for activation . Instead, they monitor the level of MHC class I expression and can be activated when they detect reduced MHC I levels , which is often indicative of viral infection or malignancy.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Natural killer cells:&lt;/li&gt;&lt;li&gt;â€¢ innate immune system&lt;/li&gt;&lt;li&gt;â€¢ do not require antigen presentation&lt;/li&gt;&lt;li&gt;â€¢ MHC molecules for activation&lt;/li&gt;&lt;li&gt;â€¢ monitor&lt;/li&gt;&lt;li&gt;â€¢ MHC class I expression&lt;/li&gt;&lt;li&gt;â€¢ activated&lt;/li&gt;&lt;li&gt;â€¢ reduced MHC I levels&lt;/li&gt;&lt;li&gt;â€¢ viral infection or malignancy.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Suppressor T cells: Suppression or regulatory T cells (Tregs), often referred to in the context of CD4+ T cells with suppressive function, do not directly interact with MHC class I. They regulate the immune response to maintain tolerance to self-antigens and prevent autoimmune disease.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Suppressor T cells:&lt;/li&gt;&lt;li&gt;â€¢ CD4+ T cells&lt;/li&gt;&lt;li&gt;â€¢ do not directly interact with MHC class I.&lt;/li&gt;&lt;li&gt;â€¢ self-antigens and prevent autoimmune disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ MHC class I molecules present antigens to cytotoxic T cells (CD8+ T cells) whereas MHC class II molecules present antigens to CD4+ T cells.&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10th/e p198)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10th/e p198)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a clinical case where a patient presents with contact dermatitis after using a new cosmetic product, which cell type is most likely responsible for the patient&#x27;s delayed-type hypersensitivity (DTH) reaction?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Macrophages&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dendritic cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cytotoxic T cells&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mast cells&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cytotoxic T cells&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Cytotoxic T cells&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Macrophages: Macrophages are involved in DTH reactions primarily as effector cells that respond to cytokines produced by T-helper cells. They are not the initial responders but are critical for the amplification and persistence of the reaction.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Macrophages:&lt;/li&gt;&lt;li&gt;â€¢ DTH reactions&lt;/li&gt;&lt;li&gt;â€¢ cytokines produced&lt;/li&gt;&lt;li&gt;â€¢ by T-helper cells.&lt;/li&gt;&lt;li&gt;â€¢ amplification and persistence of the reaction.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Dendritic Cells: Dendritic cells are antigen-presenting cells that are crucial for initiating a DTH reaction. They capture, process, and present antigens on their surface to T cells but are not the cells that directly mediate the DTH response.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Dendritic Cells:&lt;/li&gt;&lt;li&gt;â€¢ antigen-presenting cells&lt;/li&gt;&lt;li&gt;â€¢ DTH reaction.&lt;/li&gt;&lt;li&gt;â€¢ capture,&lt;/li&gt;&lt;li&gt;â€¢ process, and present antigens&lt;/li&gt;&lt;li&gt;â€¢ not the cells&lt;/li&gt;&lt;li&gt;â€¢ DTH response.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Mast Cells: Mast cells are associated with immediate hypersensitivity reactions , such as allergies and anaphylaxis, due to their release of histamine and other mediators . They are not typically involved in DTH reactions, which are T cell-mediated and occur over a longer period.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Mast Cells:&lt;/li&gt;&lt;li&gt;â€¢ immediate hypersensitivity reactions&lt;/li&gt;&lt;li&gt;â€¢ allergies and anaphylaxis,&lt;/li&gt;&lt;li&gt;â€¢ histamine and other mediators&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While cytotoxic T cells can contribute to certain types of cell-mediated immunity , the classic DTH reaction is mainly driven by CD4+ T-helper cells, particularly the Th1 subtype.&lt;/li&gt;&lt;li&gt;âž¤ cytotoxic T cells&lt;/li&gt;&lt;li&gt;âž¤ cell-mediated immunity&lt;/li&gt;&lt;li&gt;âž¤ CD4+ T-helper cells, particularly the Th1 subtype.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Robbins 10th/e p214&lt;/li&gt;&lt;li&gt;âž¤ Ref: Robbins 10th/e p214&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the process of lymphocyte development, which of the following processes occurs in T cells but not in B cells?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antigen Specific Receptors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Class I MHC Expression&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Positive selection during development&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Positive selection during development&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Positive selection during development&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Antigen-Specific Receptors: Both B cells and T cells develop antigen-specific receptors. B cells produce a membrane-bound form of antibody as their antigen-specific receptor , while T cells develop T-cell receptors (TCRs).&lt;/li&gt;&lt;li&gt;â€¢ Option A: Antigen-Specific Receptors:&lt;/li&gt;&lt;li&gt;â€¢ B cells and T cells&lt;/li&gt;&lt;li&gt;â€¢ antigen-specific receptors.&lt;/li&gt;&lt;li&gt;â€¢ membrane-bound form of antibody&lt;/li&gt;&lt;li&gt;â€¢ antigen-specific receptor&lt;/li&gt;&lt;li&gt;â€¢ T cells develop T-cell receptors (TCRs).&lt;/li&gt;&lt;li&gt;â€¢ Option B: Class I MHC Expression: Both B cells and T cells express Class I MHC molecules. These are present on nearly all nucleated cells in the body and are important for presenting endogenous antigens to CD8+ cytotoxic T cells.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Class I MHC Expression:&lt;/li&gt;&lt;li&gt;â€¢ B cells and T cells express Class I MHC molecules.&lt;/li&gt;&lt;li&gt;â€¢ nucleated cells in the body&lt;/li&gt;&lt;li&gt;â€¢ endogenous antigens to CD8+ cytotoxic T cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D: All of the Above: Since only positive selection is unique to T cells, this option is not correct.&lt;/li&gt;&lt;li&gt;â€¢ Option D: All of the Above:&lt;/li&gt;&lt;li&gt;â€¢ not correct.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Positive selection during development, which ensures that T cells have T-cell receptors capable of recognizing self-MHC molecules, occurs in T cells but not in B cells. Understanding the unique and shared aspects of T and B cell development is important for recognizing how different immune deficiencies can affect the immune system&#x27;s function.&lt;/li&gt;&lt;li&gt;âž¤ T cells have T-cell receptors capable of recognizing self-MHC molecules,&lt;/li&gt;&lt;li&gt;âž¤ T cells&lt;/li&gt;&lt;li&gt;âž¤ not in B cells.&lt;/li&gt;&lt;li&gt;âž¤ unique and shared aspects of T and B cell development&lt;/li&gt;&lt;li&gt;âž¤ different immune deficiencies&lt;/li&gt;&lt;li&gt;âž¤ immune system&#x27;s function.&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Immunology by SK Gupta 1st/142-150, Robbins 10 th 194-6, 216)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Immunology by SK Gupta 1st/142-150, Robbins 10 th 194-6, 216)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A researcher is studying the structure of MHC molecules and their role in antigen presentation. When considering MHC class I molecules and their interaction with T cells, which structural component of the MHC class I molecule is responsible for forming the peptide-binding cleft?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alfa and Beta chain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Distal domain alfa 1 and 2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alfa and beta microglobulin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Proximal domain alfa 1 and 2&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Distal domain alfa 1 and 2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Distal domain alfa 1 and 2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Alpha and Beta chain: The MHC class II molecule consists of two separate protein chains, alpha and beta , each contributing to the formation of the antigen-binding cleft . This option is not accurate for MHC class I molecules .&lt;/li&gt;&lt;li&gt;â€¢ Option A: Alpha and Beta chain:&lt;/li&gt;&lt;li&gt;â€¢ MHC class II molecule&lt;/li&gt;&lt;li&gt;â€¢ alpha and beta&lt;/li&gt;&lt;li&gt;â€¢ antigen-binding cleft&lt;/li&gt;&lt;li&gt;â€¢ not accurate for MHC class I molecules&lt;/li&gt;&lt;li&gt;â€¢ Option C: Alpha and Beta2-microglobulin: Beta 2-microglobulin is a component of the MHC class I molecule but does not form part of the antigen-binding cleft . Instead, it supports the structure of the MHC class I molecule.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Alpha and Beta2-microglobulin:&lt;/li&gt;&lt;li&gt;â€¢ MHC class I molecule&lt;/li&gt;&lt;li&gt;â€¢ does not form part of the antigen-binding cleft&lt;/li&gt;&lt;li&gt;â€¢ MHC class I molecule.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Proximal domain alpha 1 and 2: The proximal domains of MHC molecules are not involved in peptide binding ; they are closer to the membrane and play a role in maintaining the structure of the molecule on the cell surface.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Proximal domain alpha 1 and 2:&lt;/li&gt;&lt;li&gt;â€¢ not involved in peptide binding&lt;/li&gt;&lt;li&gt;â€¢ structure of the molecule on the cell surface.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The peptide-binding cleft of MHC class I molecules is formed by the distal domains of the alpha 1 and alpha 2 chains whereas peptide-binding cleft of MHC class II molecules is formed by the distal domains of the alpha 1 and beta 1 chains .&lt;/li&gt;&lt;li&gt;âž¤ peptide-binding cleft of MHC class I molecules&lt;/li&gt;&lt;li&gt;âž¤ distal domains of the alpha 1 and alpha 2 chains&lt;/li&gt;&lt;li&gt;âž¤ peptide-binding cleft of MHC class II molecules&lt;/li&gt;&lt;li&gt;âž¤ distal domains of the alpha 1 and beta 1 chains&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 195)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 195)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Function of CD4 is all except :&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Memory&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Immunoglobulin production&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Activation of macrophages&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cytotoxicity&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Immunoglobulin production&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Immunoglobulin production&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Memory: CD4+ T cells differentiate into memory T cells following antigen exposure , which provides long-term immunity by remembering the antigen for faster response upon re-exposure .&lt;/li&gt;&lt;li&gt;â€¢ Option A: Memory:&lt;/li&gt;&lt;li&gt;â€¢ CD4+ T cells&lt;/li&gt;&lt;li&gt;â€¢ memory T cells&lt;/li&gt;&lt;li&gt;â€¢ antigen exposure&lt;/li&gt;&lt;li&gt;â€¢ long-term immunity by remembering the antigen for faster response upon re-exposure&lt;/li&gt;&lt;li&gt;â€¢ Option C: Activation of Macrophages: Th1 subset of CD4+ T cells can activate macrophages by secreting cytokines such as IFN-Î³ and TNF-Î± , enhancing their microbicidal activity .&lt;/li&gt;&lt;li&gt;â€¢ Option C: Activation of Macrophages:&lt;/li&gt;&lt;li&gt;â€¢ Th1 subset of CD4+ T cells&lt;/li&gt;&lt;li&gt;â€¢ macrophages&lt;/li&gt;&lt;li&gt;â€¢ IFN-Î³ and TNF-Î±&lt;/li&gt;&lt;li&gt;â€¢ microbicidal activity&lt;/li&gt;&lt;li&gt;â€¢ Option D: Cytotoxicity: CD4+ T cells are generally not cytotoxic ; this function is characteristic of CD8+ cytotoxic T cells which kill virus-infected cells and tumor cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Cytotoxicity:&lt;/li&gt;&lt;li&gt;â€¢ CD4+ T cells&lt;/li&gt;&lt;li&gt;â€¢ not cytotoxic&lt;/li&gt;&lt;li&gt;â€¢ CD8+ cytotoxic T cells&lt;/li&gt;&lt;li&gt;â€¢ virus-infected cells and tumor cells.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ CD4+ T cells are pivotal for immune responses , including memory formation and macrophage activation, but they do not directly produce immunoglobulins ; this is the function of plasma cells derived from B cells.&lt;/li&gt;&lt;li&gt;âž¤ CD4+ T cells&lt;/li&gt;&lt;li&gt;âž¤ immune responses&lt;/li&gt;&lt;li&gt;âž¤ memory formation and macrophage activation,&lt;/li&gt;&lt;li&gt;âž¤ do not directly produce immunoglobulins&lt;/li&gt;&lt;li&gt;âž¤ plasma cells derived from B cells.&lt;/li&gt;&lt;li&gt;âž¤ ( Ref: Robbins 10 th / 190-191)&lt;/li&gt;&lt;li&gt;âž¤ ( Ref: Robbins 10 th / 190-191)&lt;/li&gt;&lt;li&gt;âž¤ (&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a hospital outbreak of a severe systemic inflammatory response syndrome, an infectious disease consultant suggests the possibility of superantigen involvement. Which of the following mechanisms best l the action of bacterial superantigens in the context of this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Binds to B7 and CD28 co-stimulatory molecules&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Binds to the beta chain of TCR and MHC class II molecules of APC stimulating T cell activation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Binds to the CD4 + molecule causing T cell activation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Is presented by macrophages to a larger-than-normal number of T helper CD4 + lymphocytes&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Binds to the beta chain of TCR and MHC class II molecules of APC stimulating T cell activation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/23/picture2.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Binds to the beta chain of TCR and MHC class II molecules of APC stimulating T cell activation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Binds to B7 and CD28 co-stimulatory molecules: These molecules are involved in the second signal required for T cell activation. However, superantigens do not typically bind to these molecules directly.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Binds to B7 and CD28 co-stimulatory molecules:&lt;/li&gt;&lt;li&gt;â€¢ second signal required for T cell activation.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Binds to the CD4+ molecule causing T cell activation: While CD4+ is a co-receptor for TCRs on helper T cells, superantigens do not primarily function by binding to CD4+ molecules. They act more broadly to cross-link TCRs and MHC class II molecules.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Binds to the CD4+ molecule causing T cell activation:&lt;/li&gt;&lt;li&gt;â€¢ co-receptor for TCRs on helper T cells, superantigens&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ binding to CD4+ molecules.&lt;/li&gt;&lt;li&gt;â€¢ cross-link TCRs and MHC class II molecules.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Is presented by macrophages to a larger-than-normal number of T helper CD4+ lymphocytes: Superantigens do not get presented in the conventional sense as peptides by APCs . Instead, they interact with TCRs and MHC class II molecules to non-specifically activate a large number of T cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Is presented by macrophages to a larger-than-normal number of T helper CD4+ lymphocytes:&lt;/li&gt;&lt;li&gt;â€¢ peptides by APCs&lt;/li&gt;&lt;li&gt;â€¢ TCRs and MHC class II molecules to non-specifically&lt;/li&gt;&lt;li&gt;â€¢ T cells.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Superantigens are bacterial products that can cause a massive T cell response by binding to the beta chain of TCRs and MHC class II molecules on APCs , leading to the non-specific activation of T cells. Some examples include toxic shock syndrome toxin-1 (TSST-1), Streptococcal pyrogenic exotoxins (SPE), Staphylococcal enterotoxins (SE), and enterotoxogenic E. coli (ETEC) enterotoxin.&lt;/li&gt;&lt;li&gt;âž¤ Superantigens&lt;/li&gt;&lt;li&gt;âž¤ massive T cell response&lt;/li&gt;&lt;li&gt;âž¤ TCRs and MHC class II molecules on APCs&lt;/li&gt;&lt;li&gt;âž¤ non-specific activation of T cells.&lt;/li&gt;&lt;li&gt;âž¤ toxic shock syndrome toxin-1 (TSST-1), Streptococcal pyrogenic exotoxins (SPE), Staphylococcal enterotoxins (SE), and enterotoxogenic E. coli (ETEC) enterotoxin.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In evaluating a patient&#x27;s immune status, particularly the cellular immunity involving T lymphocytes, which surface marker is characteristic of memory T cells as opposed to naive T cells?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CD45RA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CD45RB&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CD45RC&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CD45RO&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. CD45RO&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) CD45RO&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: CD45RA: CD45RA is a marker typically found on naive T cells . These cells have not yet encountered their specific antigen and are not yet differentiated into effector or memory cells.&lt;/li&gt;&lt;li&gt;â€¢ Option A: CD45RA:&lt;/li&gt;&lt;li&gt;â€¢ naive T cells&lt;/li&gt;&lt;li&gt;â€¢ not yet&lt;/li&gt;&lt;li&gt;â€¢ specific antigen&lt;/li&gt;&lt;li&gt;â€¢ not yet differentiated into effector or memory cells.&lt;/li&gt;&lt;li&gt;â€¢ Option B: CD45RB: CD45RB is expressed on all leukocytes and is not specific to either naive or memory T cells .&lt;/li&gt;&lt;li&gt;â€¢ Option B: CD45RB:&lt;/li&gt;&lt;li&gt;â€¢ all leukocytes&lt;/li&gt;&lt;li&gt;â€¢ not specific to either naive or memory T cells&lt;/li&gt;&lt;li&gt;â€¢ Option C: CD45RC: CD45RC&#x27;s expression can vary but is not specifically associated with memory T cells . It is another isoform of the CD45 molecule .&lt;/li&gt;&lt;li&gt;â€¢ Option C: CD45RC:&lt;/li&gt;&lt;li&gt;â€¢ memory T cells&lt;/li&gt;&lt;li&gt;â€¢ isoform of the CD45 molecule&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ CD45RO is a cell surface marker characteristic of memory T cells , which play a crucial role in the immune system&#x27;s ability to respond more rapidly and effectively upon re-exposure to pathogens.&lt;/li&gt;&lt;li&gt;âž¤ CD45RO&lt;/li&gt;&lt;li&gt;âž¤ memory T cells&lt;/li&gt;&lt;li&gt;âž¤ immune system&#x27;s ability&lt;/li&gt;&lt;li&gt;âž¤ rapidly and effectively&lt;/li&gt;&lt;li&gt;âž¤ re-exposure to pathogens.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a clinical scenario where a male child presents with recurrent infections, eczema, and thrombocytopenia, which of the following genetic evaluations is most appropriate to confirm the suspected diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;B cell tyrosine kinase activity detection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;WASP gene mutation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Adenosine deaminase activity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ANA titre&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. WASP gene mutation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) WASP gene mutation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: B cell tyrosine kinase activity detection: The detection of B cell tyrosine kinase activity is relevant for X-linked agammaglobulinemia (XLA) , which is characterized by the absence of mature B cells and low levels of immunoglobulins. This condition does not typically present with eczema or thrombocytopenia.&lt;/li&gt;&lt;li&gt;â€¢ Option A: B cell tyrosine kinase activity detection:&lt;/li&gt;&lt;li&gt;â€¢ B cell tyrosine kinase activity&lt;/li&gt;&lt;li&gt;â€¢ X-linked agammaglobulinemia (XLA)&lt;/li&gt;&lt;li&gt;â€¢ absence of mature B cells and low levels of immunoglobulins.&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ eczema or thrombocytopenia.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Adenosine deaminase activity: Reduced or absent adenosine deaminase activity is characteristic of severe combined immunodeficiency (SCID), which presents with severe recurrent infections . However, SCID does not typically involve eczema or thrombocytopenia as presenting features.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Adenosine deaminase activity:&lt;/li&gt;&lt;li&gt;â€¢ Reduced or absent adenosine deaminase activity&lt;/li&gt;&lt;li&gt;â€¢ severe combined immunodeficiency (SCID),&lt;/li&gt;&lt;li&gt;â€¢ recurrent infections&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ eczema or thrombocytopenia&lt;/li&gt;&lt;li&gt;â€¢ Option D: ANA titre: ANA titres are typically measured when autoimmune conditions, such as systemic lupus erythematosus (SLE), are suspected. These conditions can present with rash and are associated with immune dysregulation , but they do not typically cause thrombocytopenia as a primary manifestation.&lt;/li&gt;&lt;li&gt;â€¢ Option D: ANA titre:&lt;/li&gt;&lt;li&gt;â€¢ autoimmune conditions, such as systemic lupus erythematosus (SLE),&lt;/li&gt;&lt;li&gt;â€¢ rash and are associated with immune dysregulation&lt;/li&gt;&lt;li&gt;â€¢ do not typically cause thrombocytopenia as a primary manifestation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For a male child with recurrent infections, eczema, and thrombocytopenia, the most appropriate genetic evaluation is testing for WASP gene mutations to confirm a diagnosis of Wiskott-Aldrich syndrome.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old male presents with fever, fatigue, and abdominal pain. Laboratory tests reveal elevated liver enzymes and positive serology for hepatitis B virus. Which of the following molecules is involved in presenting viral peptides to cytotoxic T cells?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;MHC III&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;MHC class I&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;MHC class II&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Any of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. MHC class I&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) MHC class I&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: MHC Class III: There is no MHC class III involved in antigen presentation to T cells . MHC class III genes encode components of the complement system and some inflammatory cytokines .&lt;/li&gt;&lt;li&gt;â€¢ Option A: MHC Class III:&lt;/li&gt;&lt;li&gt;â€¢ no MHC class III involved in antigen presentation to T cells&lt;/li&gt;&lt;li&gt;â€¢ complement system and some inflammatory cytokines&lt;/li&gt;&lt;li&gt;â€¢ Option C: MHC Class II: MHC class II molecules present exogenous antigens to helper T cells (CD4+ T cells). These are typically expressed by professional antigen-presenting cells such as dendritic cells, macrophages, and B cells.&lt;/li&gt;&lt;li&gt;â€¢ Option C: MHC Class II:&lt;/li&gt;&lt;li&gt;â€¢ exogenous antigens to helper T cells (CD4+ T cells).&lt;/li&gt;&lt;li&gt;â€¢ professional antigen-presenting cells&lt;/li&gt;&lt;li&gt;â€¢ dendritic cells, macrophages, and B cells.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ MHC class I , which presents endogenous viral peptides to cytotoxic T cells , initiates a cellular immune response essential for the control of viral infections such as hepatitis B .&lt;/li&gt;&lt;li&gt;âž¤ MHC class I&lt;/li&gt;&lt;li&gt;âž¤ endogenous viral peptides to cytotoxic T cells&lt;/li&gt;&lt;li&gt;âž¤ cellular immune response&lt;/li&gt;&lt;li&gt;âž¤ viral infections such as hepatitis B&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Runt disease is associated with:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute rejection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hyperacute rejection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chronic rejection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Graft versus host disease&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Graft versus host disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Graft versus host disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Acute Rejection: This is a cell-mediated immune response that occurs days to months after transplantation. It involves direct cytotoxicity and inflammation, primarily affecting solid organ transplants, not typically associated with bone marrow transplants.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Acute Rejection:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Hyperacute Rejection: This type of rejection occurs within minutes to hours after transplantation due to pre-existing antibodies in the recipient against graft antigens, leading to rapid thrombosis and necrosis of the graft. It is usually associated with organ transplants.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Hyperacute Rejection:&lt;/li&gt;&lt;li&gt;â€¢ Option C: Chronic Rejection: Chronic rejection is a long-term process where the graft is slowly lost over months to years due to a complex interplay of cellular and humoral immune responses. It often manifests as a gradual loss of function of the transplanted organ.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Chronic Rejection:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ GVHD, exemplified by \&quot;runt disease\&quot; in the question, is a condition wherein immunocompetent cells from a donor mount an immune response against the host&#x27;s tissues.&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / p236)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / p236)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a patient who has undergone kidney transplantation and is now presenting with signs of renal dysfunction, which complement activation product is a known histological marker for the diagnosis of antibody-mediated rejection in transplant biopsies?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;C3d&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;C5a&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;C3b&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;C4d&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. C4d&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) C4d&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: C3d: C3d is a breakdown product of the complement component C3 and can indicate complement activation , but it is not the most specific marker for antibody-mediated rejection.&lt;/li&gt;&lt;li&gt;â€¢ Option A: C3d:&lt;/li&gt;&lt;li&gt;â€¢ component C3&lt;/li&gt;&lt;li&gt;â€¢ complement activation&lt;/li&gt;&lt;li&gt;â€¢ not the most specific marker for antibody-mediated rejection.&lt;/li&gt;&lt;li&gt;â€¢ Option B: C5a: C5a is an anaphylatoxin produced during complement activation that has potent inflammatory effects and can recruit neutrophils and macrophages . While it plays a role in inflammation , it is not typically used as a histological marker for antibody-mediated rejection.&lt;/li&gt;&lt;li&gt;â€¢ Option B: C5a:&lt;/li&gt;&lt;li&gt;â€¢ anaphylatoxin&lt;/li&gt;&lt;li&gt;â€¢ recruit neutrophils and macrophages&lt;/li&gt;&lt;li&gt;â€¢ inflammation&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ antibody-mediated rejection.&lt;/li&gt;&lt;li&gt;â€¢ Option C: C3b: C3b is another breakdown product of C3 and acts as an opsonin that promotes phagocytosis and further complement activation. It is not specifically used as a marker for antibody-mediated rejection in transplant patients.&lt;/li&gt;&lt;li&gt;â€¢ Option C: C3b:&lt;/li&gt;&lt;li&gt;â€¢ acts as an opsonin&lt;/li&gt;&lt;li&gt;â€¢ phagocytosis and further complement activation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ C4d is the specific histological marker used to identify antibody-mediated rejection in organ transplants . Its detection is significant for the diagnosis and management of this type of rejection .&lt;/li&gt;&lt;li&gt;âž¤ C4d&lt;/li&gt;&lt;li&gt;âž¤ antibody-mediated rejection in organ transplants&lt;/li&gt;&lt;li&gt;âž¤ significant for the diagnosis and management of this type of rejection&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th 238)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th 238)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a patient with progressive fatigue, kidney dysfunction, and an echocardiogram suggesting restrictive cardiomyopathy, a biopsy is performed, and the pathologist observes eosinophilic, fibrillary material in the tissue that stains with Congo red. This finding is most consistent with which pattern of protein accumulation in amyloidosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Accumulation of amyloid proteins in the extracellular space&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Accumulation of amyloid proteins in the intracellular space&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Accumulation of amyloid proteins in the cytoplasmic space&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Accumulation of amyloid proteins in the mitochondrial space&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Accumulation of amyloid proteins in the extracellular space&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Accumulation of amyloid proteins in the extracellular space&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option B: intracellular accumulation of amyloid proteins , is not a key feature of amyloidosis .&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ intracellular accumulation of amyloid proteins&lt;/li&gt;&lt;li&gt;â€¢ not a key feature of amyloidosis&lt;/li&gt;&lt;li&gt;â€¢ Option C and D: accumulation of amyloid proteins in the cytoplasmic and mitochondrial space , respectively, are also not key features of amyloidosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C and D:&lt;/li&gt;&lt;li&gt;â€¢ amyloid proteins in the cytoplasmic and mitochondrial space&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The key feature of amyloidosis is the extracellular accumulation of amyloid proteins , which can lead to a range of clinical manifestations depending on the organs affected.&lt;/li&gt;&lt;li&gt;âž¤ amyloidosis is the extracellular accumulation of amyloid proteins&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old man with no prior allergies receives penicillin for a bacterial infection. Two days later, he presents with wheezing and laboratory tests showing hemolysis with a positive direct Coombs test. Which hypersensitivity reaction is most likely responsible for this patient&#x27;s presentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Type I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Type II&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Type III&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Type IV&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Type II&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Type II&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Type I Hypersensitivity: Type I hypersensitivity reactions are immediate reactions mediated by IgE antibodies. Typical manifestations include urticaria, angioedema, asthma, and anaphylaxis, usually occurring within minutes to hours after exposure to the allergen.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Type I Hypersensitivity:&lt;/li&gt;&lt;li&gt;â€¢ immediate reactions mediated by IgE antibodies.&lt;/li&gt;&lt;li&gt;â€¢ urticaria, angioedema, asthma, and anaphylaxis,&lt;/li&gt;&lt;li&gt;â€¢ minutes to hours&lt;/li&gt;&lt;li&gt;â€¢ allergen.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Type III Hypersensitivity: Type III hypersensitivity reactions are immune complex-mediated . They occur when antigens and IgG antibodies form immune complexes that deposit in various tissues, causing inflammation and tissue damage, such as in s erum sickness or certain glomerulonephritides.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Type III Hypersensitivity:&lt;/li&gt;&lt;li&gt;â€¢ immune complex-mediated&lt;/li&gt;&lt;li&gt;â€¢ antigens and IgG antibodies form immune complexes&lt;/li&gt;&lt;li&gt;â€¢ erum sickness or certain glomerulonephritides.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Type IV Hypersensitivity: Type IV hypersensitivity reactions are delayed-type reactions mediated by T cells . Symptoms typically appear 48-72 hours after exposure to the antigen , as seen in contact dermatitis or a positive tuberculosis skin test .&lt;/li&gt;&lt;li&gt;â€¢ Option D: Type IV Hypersensitivity:&lt;/li&gt;&lt;li&gt;â€¢ delayed-type reactions mediated by T cells&lt;/li&gt;&lt;li&gt;â€¢ 48-72 hours after exposure to the antigen&lt;/li&gt;&lt;li&gt;â€¢ contact dermatitis or a positive tuberculosis skin test&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The patient&#x27;s hemolysis following penicillin administration suggests a type II hypersensitivity reaction, where the drug acts as a hapten, binding to red blood cell membranes and inducing an antibody response against the drug-protein complex .&lt;/li&gt;&lt;li&gt;âž¤ hemolysis following penicillin&lt;/li&gt;&lt;li&gt;âž¤ type II hypersensitivity reaction,&lt;/li&gt;&lt;li&gt;âž¤ hapten, binding to red blood cell membranes&lt;/li&gt;&lt;li&gt;âž¤ inducing an antibody response against the drug-protein complex&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Hyperacute rejection is due to?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Preformed antibodies&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cytotoxic T-lymphocyte mediated injury&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Circulating macrophage mediated injury&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Endothelitis caused by donor antibodies&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Preformed antibodies&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Preformed antibodies&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Cytotoxic T-lymphocyte mediated injury: While cytotoxic T-lymphocytes play a crucial role in cellular rejection, they are not typically involved in the immediate rejection seen in hyperacute reactions, which occur due to the presence of pre-existing antibodies.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Cytotoxic T-lymphocyte mediated injury:&lt;/li&gt;&lt;li&gt;â€¢ Option C: Circulating macrophage mediated injury: Macrophages are involved in antibody-mediated responses and can contribute to cellular rejection; however, they are not the primary mediators of hyperacute rejection.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Circulating macrophage mediated injury:&lt;/li&gt;&lt;li&gt;â€¢ Option D: Endothelitis caused by donor antibodies: Endothelitis is associated with acute and chronic rejection due to the recipient&#x27;s immune response against the donor endothelium, not the other way around. Donor antibodies do not cause hyperacute rejection.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Endothelitis caused by donor antibodies:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The presence of preformed antibodies against donor antigens in the recipient&#x27;s blood is the primary cause of hyperacute rejection. This type of rejection can occur due to prior sensitization to HLA antigens through pregnancy, blood transfusions, or previous transplants&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 233-234)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 233-234)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old female patient, six weeks post-hematopoietic stem cell transplantation, presents with a widespread rash, severe diarrhea, and jaundice. She underwent transplantation for acute myelogenous leukemia and received cells from a matched unrelated donor. Which organ is least likely to be affected by graft-versus-host disease (GVHD) in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Skin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;GIT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Liver&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lung&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lung&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Lung&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Skin: The skin is often the earliest and most commonly affected organ in GVHD , presenting with rash and potential progression to desquamation.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Skin:&lt;/li&gt;&lt;li&gt;â€¢ earliest and most commonly affected organ in GVHD&lt;/li&gt;&lt;li&gt;â€¢ rash&lt;/li&gt;&lt;li&gt;â€¢ desquamation.&lt;/li&gt;&lt;li&gt;â€¢ Option B: GIT (Gastrointestinal Tract): The GIT is a major target in GVHD , often manifesting as diarrhea, which can range from mild to severe, and may be associated with abdominal pain and bleeding.&lt;/li&gt;&lt;li&gt;â€¢ Option B: GIT (Gastrointestinal Tract):&lt;/li&gt;&lt;li&gt;â€¢ GVHD&lt;/li&gt;&lt;li&gt;â€¢ diarrhea,&lt;/li&gt;&lt;li&gt;â€¢ mild to severe,&lt;/li&gt;&lt;li&gt;â€¢ abdominal pain and bleeding.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Liver: Hepatic involvement in GVHD typically presents with jaundice and elevated liver enzymes, which can progress to severe liver dysfunction.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Liver:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In GVHD, the skin, GIT, and liver are commonly involved , while the lungs are less frequently affected, particularly in the acute phase of the disease .&lt;/li&gt;&lt;li&gt;âž¤ GVHD, the skin, GIT, and liver are commonly involved&lt;/li&gt;&lt;li&gt;âž¤ lungs are less frequently&lt;/li&gt;&lt;li&gt;âž¤ acute phase of the disease&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 236)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 236)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young boy presents to the emergency department with sudden shortness of breath. He also complains of abdominal pain and few episodes of vomiting. In the hospital, he slowly developed a rash on his chest, arms, and legs. His breathing became faster with audible wheezing. On physical examination, he had hypotension and tachycardia. A rash is on his right arm, as shown in the image. After being administered appropriate treatment, the boy improves significantly, and he is able to breathe comfortably. Which of the following is the best marker that could be measured in the serum of this boy to help establish a definitive diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prostaglandin D2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Serotonin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Histamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tryptase&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Tryptase&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/23/picture3.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Tryptase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Prostaglandin D2: Prostaglandin D2 is one of many mediators released during an allergic reaction , but it is not typically measured in the acute setting due to its short half-life and the availability of more stable markers.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Prostaglandin D2:&lt;/li&gt;&lt;li&gt;â€¢ allergic reaction&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ short half-life and the availability of more stable markers.&lt;/li&gt;&lt;li&gt;â€¢ \\Option B: Serotonin: Serotonin can be involved in allergic reactions and contributes to the pathophysiology of certain types of hypersensitivity . However, it is not the primary marker used for the diagnosis of anaphylaxis.&lt;/li&gt;&lt;li&gt;â€¢ \\Option B: Serotonin:&lt;/li&gt;&lt;li&gt;â€¢ allergic reactions and contributes to the pathophysiology&lt;/li&gt;&lt;li&gt;â€¢ hypersensitivity&lt;/li&gt;&lt;li&gt;â€¢ not the primary marker used for the diagnosis of anaphylaxis.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Histamine: Histamine is a primary mediator in allergic reactions and is released during anaphylaxis . While histamine levels can rise rapidly during anaphylaxis, its short half-life in the circulation makes it a less reliable marker than tryptase for post-event testing.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Histamine:&lt;/li&gt;&lt;li&gt;â€¢ allergic reactions and is released during anaphylaxis&lt;/li&gt;&lt;li&gt;â€¢ rise rapidly&lt;/li&gt;&lt;li&gt;â€¢ short half-life&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The measurement of serum tryptase is the gold standard for confirming a diagnosis of anaphylaxis. It should be measured during the acute phase of the reaction and compared to a baseline level taken 24 hours or more after the event.&lt;/li&gt;&lt;li&gt;âž¤ serum tryptase is the gold standard for confirming a diagnosis of anaphylaxis.&lt;/li&gt;&lt;li&gt;âž¤ acute phase of the reaction&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a patient presenting with signs and symptoms suggestive of an autoimmune disorder, which of the following mechanisms is most likely to contribute to the prevention, rather than the development, of autoimmunity?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Infections&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Expression of cryptic antigens&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Negative selective of T cells in thymus&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Receptor editing&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Negative selective of T cells in thymus&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Negative selective of T cells in thymus&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Infections: Infections can sometimes trigger autoimmunity through mechanisms such as molecular mimicry , where an immune response to an infectious agent cross-reacts with self-antigens.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Infections:&lt;/li&gt;&lt;li&gt;â€¢ trigger autoimmunity&lt;/li&gt;&lt;li&gt;â€¢ molecular mimicry&lt;/li&gt;&lt;li&gt;â€¢ immune response to an infectious agent cross-reacts with self-antigens.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Expression of Cryptic Antigens: Cryptic antigens are self-antigens that are normally not visible to the immune system but can cause an autoimmune response when exposed due to tissue damage or other processes.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Expression of Cryptic Antigens:&lt;/li&gt;&lt;li&gt;â€¢ self-antigens&lt;/li&gt;&lt;li&gt;â€¢ not visible to the immune system&lt;/li&gt;&lt;li&gt;â€¢ autoimmune response&lt;/li&gt;&lt;li&gt;â€¢ tissue damage or other processes.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Receptor Editing: Receptor editing refers to the alteration of B cell receptors on immature B cells in the bone marrow. If an immature B cell has a receptor that binds to self-antigens , the cell can edit its receptor to avoid self-reactivity . However, failures in this process can contribute to autoimmunity.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Receptor Editing:&lt;/li&gt;&lt;li&gt;â€¢ alteration of B cell receptors on immature B cells&lt;/li&gt;&lt;li&gt;â€¢ receptor that binds to self-antigens&lt;/li&gt;&lt;li&gt;â€¢ self-reactivity&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Negative selection of T cells in the thymus, which involves the apoptosis of T cells that react strongly to self-antigens , is a defence mechanism against autoimmunity, not a contributing factor to it. This central tolerance mechanism is crucial for preventing the development of autoimmune diseases.&lt;/li&gt;&lt;li&gt;âž¤ Negative selection of T cells in the thymus,&lt;/li&gt;&lt;li&gt;âž¤ apoptosis of T cells&lt;/li&gt;&lt;li&gt;âž¤ self-antigens&lt;/li&gt;&lt;li&gt;âž¤ autoimmunity,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;References:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â†³ Reference Robbins 10 th /218-220&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old female presents with a history of itching, hives, and difficulty breathing after eating a peanut butter sandwich. On examination, she has wheezing and diffuse urticaria. Which of the following hypersensitivity reactions is most likely responsible for her symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Type I hypersensitivity reaction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Type II hypersensitivity reaction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Type III hypersensitivity reaction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Type IV hypersensitivity reaction&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Type I hypersensitivity reaction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Type I hypersensitivity reaction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Type II Hypersensitivity Reaction: Type II hypersensitivity is antibody-mediated and usually targets cellular antigens, leading to conditions like hemolytic anemia, thrombocytopenia, and certain drug reactions. It is not associated with allergies to foods.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Type II Hypersensitivity Reaction:&lt;/li&gt;&lt;li&gt;â€¢ antibody-mediated&lt;/li&gt;&lt;li&gt;â€¢ targets cellular antigens,&lt;/li&gt;&lt;li&gt;â€¢ hemolytic anemia, thrombocytopenia, and certain drug reactions.&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ allergies to foods.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Type III Hypersensitivity Reaction: Type III hypersensitivity involves immune complex deposition and is implicated in conditions like serum sickness and certain glomerulonephritides. It is not typically involved in reactions to foods.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Type III Hypersensitivity Reaction:&lt;/li&gt;&lt;li&gt;â€¢ immune complex deposition&lt;/li&gt;&lt;li&gt;â€¢ serum sickness and certain glomerulonephritides.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Type IV Hypersensitivity Reaction: Type IV hypersensitivity, or delayed-type hypersensitivity , is T cell-mediated and occurs 48â€“72 hours after exposure to an antigen , as seen in contact dermatitis or a positive tuberculosis skin test . It does not cause immediate symptoms like those seen in anaphylaxis.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Type IV Hypersensitivity Reaction:&lt;/li&gt;&lt;li&gt;â€¢ delayed-type hypersensitivity&lt;/li&gt;&lt;li&gt;â€¢ T cell-mediated and occurs 48â€“72 hours after exposure to an antigen&lt;/li&gt;&lt;li&gt;â€¢ dermatitis or a positive tuberculosis skin test&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The patient&#x27;s symptoms of itching, hives, and difficulty breathing immediately following ingestion of a known allergen are indicative of a Type I hypersensitivity reaction . This reaction is mediated by IgE antibodies specific to the allergen , leading to mast cell degranulation and the release of histamine and other mediators .&lt;/li&gt;&lt;li&gt;âž¤ itching, hives, and difficulty breathing immediately following ingestion of a known allergen are indicative of a Type I hypersensitivity reaction&lt;/li&gt;&lt;li&gt;âž¤ IgE antibodies specific to the allergen&lt;/li&gt;&lt;li&gt;âž¤ cell degranulation and the release of histamine and other mediators&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In evaluating a patient with a suspected diagnosis of drug-induced lupus erythematosus (DILE), which of the following statements is INCORRECT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Affects males and females equally&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Renal and CNS involvement is uncommon&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti histone antibody levels are low&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The disease remits after withdrawal of the offending drug&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Anti histone antibody levels are low&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Anti histone antibody levels are low&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Affects males and females equally: DILE does not demonstrate the same female predominance as systemic lupus erythematosus (SLE). Both males and females are affected equally.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Affects males and females equally:&lt;/li&gt;&lt;li&gt;â€¢ female predominance&lt;/li&gt;&lt;li&gt;â€¢ Option B: Renal and CNS involvement is uncommon: Unlike SLE, DILE typically spares the kidneys and central nervous system , with these organ systems being less commonly involved.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Renal and CNS involvement is uncommon:&lt;/li&gt;&lt;li&gt;â€¢ spares the kidneys and central nervous system&lt;/li&gt;&lt;li&gt;â€¢ Option D: The disease remits after withdrawal of the offending drug: One of the key features of DILE is that symptoms usually resolve upon withdrawal of the offending drug , differentiating it from idiopathic SLE , which is a chronic condition.&lt;/li&gt;&lt;li&gt;â€¢ Option D: The disease remits after withdrawal of the offending drug:&lt;/li&gt;&lt;li&gt;â€¢ DILE&lt;/li&gt;&lt;li&gt;â€¢ withdrawal of the offending drug&lt;/li&gt;&lt;li&gt;â€¢ idiopathic SLE&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Drug-induced lupus erythematosus is characterized by high levels of anti-histone antibodies , and unlike idiopathic SLE , it affects males and females equally, renal and CNS involvement are uncommon , and the condition usually remits after withdrawal of the offending drug .&lt;/li&gt;&lt;li&gt;âž¤ Drug-induced lupus erythematosus&lt;/li&gt;&lt;li&gt;âž¤ high levels of anti-histone antibodies&lt;/li&gt;&lt;li&gt;âž¤ idiopathic SLE&lt;/li&gt;&lt;li&gt;âž¤ males and females equally, renal and CNS involvement are uncommon&lt;/li&gt;&lt;li&gt;âž¤ withdrawal of the offending drug&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;References:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â†³ Reference Robbins 10 th /229&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In each of the following clinical scenarios, a specific type of hypersensitivity reaction is implicated. Identify the INCORRECT pairing:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IgA vasculitis -Type III hypersensitivity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Post streptococcal glomerulonephritis-Immune complex disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Schick test - Delayed Hypersensitivity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mismatched blood transfusion - Type II hypersensitivity&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Schick test - Delayed Hypersensitivity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Schick test - Delayed Hypersensitivity&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: IgA Vasculitis - Type III Hypersensitivity: IgA vasculitis, formerly known as Henoch-SchÃ¶nlein purpura, is characterized by IgA-dominant immune complex deposition, thus aligning with a Type III hypersensitivity reaction.&lt;/li&gt;&lt;li&gt;â€¢ Option A: IgA Vasculitis - Type III Hypersensitivity:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Post Streptococcal Glomerulonephritis - Immune Complex Disease: Post-streptococcal glomerulonephritis is a classic example of an immune complex disease, where antibodies against streptococcal antigens form complexes that deposit in the glomeruli, representing a Type III hypersensitivity reaction.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Post Streptococcal Glomerulonephritis - Immune Complex Disease:&lt;/li&gt;&lt;li&gt;â€¢ Option D: Mismatched Blood Transfusion - Type II Hypersensitivity: Mismatched blood transfusion reactions occur when the recipient&#x27;s antibodies bind to antigens on the donor red blood cells, leading to hemolysis. This is a classic Type II hypersensitivity reaction.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Mismatched Blood Transfusion - Type II Hypersensitivity:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Schick test is not a delayed Type IV hypersensitivity reaction; it is a demonstration of the presence or absence of immunity to diphtheria toxin and is a form of Type III hypersensitivity&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the context of human leukocyte antigen (HLA) genetics, the HLA class III region has been implicated in which of the following processes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Transplant rejection phenomenon&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Governing susceptibility to autoimmune diseases&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Immune surveillance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Antigen presentation and elimination&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Governing susceptibility to autoimmune diseases&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Governing susceptibility to autoimmune diseases&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Transplant Rejection Phenomenon: Transplant rejection typically involves HLA class I and class II regions, as these regions encode for molecules directly involved in antigen presentation that can be recognized by the recipient&#x27;s immune system , leading to rejection.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Transplant Rejection Phenomenon:&lt;/li&gt;&lt;li&gt;â€¢ HLA class I and class II regions,&lt;/li&gt;&lt;li&gt;â€¢ antigen presentation&lt;/li&gt;&lt;li&gt;â€¢ recipient&#x27;s immune system&lt;/li&gt;&lt;li&gt;â€¢ rejection.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Immune Surveillance: While immune surveillance is an essential function of the immune system in identifying and d estroying pathogens and abnormal cells , it is more closely associated with HLA class I and II molecules&#x27; ability to present antigens.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Immune Surveillance:&lt;/li&gt;&lt;li&gt;â€¢ immune system&lt;/li&gt;&lt;li&gt;â€¢ estroying pathogens and abnormal cells&lt;/li&gt;&lt;li&gt;â€¢ HLA class I and II molecules&#x27;&lt;/li&gt;&lt;li&gt;â€¢ Option D: Antigen Presentation and Elimination: Antigen presentation and elimination are directly related to HLA class I and class II molecules , which present peptides to T cells . The HLA class III region is not primarily involved in antigen presentation .&lt;/li&gt;&lt;li&gt;â€¢ Option D: Antigen Presentation and Elimination:&lt;/li&gt;&lt;li&gt;â€¢ HLA class I and class II molecules&lt;/li&gt;&lt;li&gt;â€¢ peptides to T cells&lt;/li&gt;&lt;li&gt;â€¢ HLA class III region is not primarily involved in antigen presentation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The HLA class III region is involved in the regulation of susceptibility to autoimmune diseases due to its role in encoding early components of the complement system.&lt;/li&gt;&lt;li&gt;âž¤ HLA class III region&lt;/li&gt;&lt;li&gt;âž¤ susceptibility to autoimmune diseases&lt;/li&gt;&lt;li&gt;âž¤ encoding early components of the complement system.&lt;/li&gt;&lt;li&gt;âž¤ (Ref: 10 th / 215)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: 10 th / 215)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which combination of strategies is employed to minimize the risk of graft-versus-host disease (GVHD) following bone marrow transplantation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;T-cell removal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prior immune suppression&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Post procedure immune suppression&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: T-cell Removal: T-cell depletion from the donor graft is a method used to reduce the incidence and severity of GVHD by removing the cells most responsible for the alloreactive response .&lt;/li&gt;&lt;li&gt;â€¢ Option A: T-cell Removal:&lt;/li&gt;&lt;li&gt;â€¢ donor graft&lt;/li&gt;&lt;li&gt;â€¢ incidence and severity of GVHD&lt;/li&gt;&lt;li&gt;â€¢ alloreactive response&lt;/li&gt;&lt;li&gt;â€¢ Option B: Prior Immune Suppression: Immunosuppressive therapy prior to transplantation can reduce the recipient&#x27;s immune response to the donor graft and is used to condition the recipient.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Prior Immune Suppression:&lt;/li&gt;&lt;li&gt;â€¢ transplantation&lt;/li&gt;&lt;li&gt;â€¢ recipient&#x27;s immune response&lt;/li&gt;&lt;li&gt;â€¢ Option C: Post Procedure Immune Suppression: Following the transplantation, immunosuppressive drugs such as methotrexate and cyclophosphamide are used to further prevent GVHD.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Post Procedure Immune Suppression:&lt;/li&gt;&lt;li&gt;â€¢ transplantation, immunosuppressive&lt;/li&gt;&lt;li&gt;â€¢ methotrexate and cyclophosphamide&lt;/li&gt;&lt;li&gt;â€¢ prevent GVHD.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The prevention of GVHD in bone marrow transplantation involves a multimodal approach , including optimal donor matching, pre-transplant conditioning with immunosuppressive drugs, T-cell depletion of the donor marrow, and post-transplant immunosuppression .&lt;/li&gt;&lt;li&gt;âž¤ prevention of GVHD in bone marrow transplantation&lt;/li&gt;&lt;li&gt;âž¤ multimodal approach&lt;/li&gt;&lt;li&gt;âž¤ optimal donor matching, pre-transplant&lt;/li&gt;&lt;li&gt;âž¤ immunosuppressive drugs, T-cell depletion of the donor marrow, and post-transplant immunosuppression&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a patient with Epstein-Barr virus (EBV) infection presenting with symptoms of autoimmunity, which mechanism is most likely contributing to the production of autoantibodies?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Molecular mimicry&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Polyclonal B cell activation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Expressing sequestrated antigens&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Antigenic cross reactivity&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Polyclonal B cell activation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Molecular Mimicry: Molecular mimicry involves an infectious agent sharing epitopes with the host, leading to an immune response that cross-reacts with self-tissues. It is a known mechanism in certain autoimmune diseases but is not the primary mechanism by which EBV induces autoimmunity .&lt;/li&gt;&lt;li&gt;â€¢ Option A: Molecular Mimicry:&lt;/li&gt;&lt;li&gt;â€¢ infectious agent&lt;/li&gt;&lt;li&gt;â€¢ epitopes&lt;/li&gt;&lt;li&gt;â€¢ immune response&lt;/li&gt;&lt;li&gt;â€¢ cross-reacts with self-tissues.&lt;/li&gt;&lt;li&gt;â€¢ autoimmune diseases&lt;/li&gt;&lt;li&gt;â€¢ the primary mechanism&lt;/li&gt;&lt;li&gt;â€¢ EBV induces autoimmunity&lt;/li&gt;&lt;li&gt;â€¢ Option C: Expressing sequestrated antigens: Sequestered antigens, normally hidden from the immune system, may become exposed due to t issue damage or other pathological processes , which could induce an autoimmune response. However, this is not typically associated with EBV infection.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Expressing sequestrated antigens:&lt;/li&gt;&lt;li&gt;â€¢ immune system,&lt;/li&gt;&lt;li&gt;â€¢ issue damage or other pathological processes&lt;/li&gt;&lt;li&gt;â€¢ autoimmune response.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Antigenic Cross-reactivity: Antigenic cross-reactivity refers to an immune response against one antigen that reacts with a different but structurally similar antigen . While it can contribute to autoimmunity, it is not the primary process implicated in EBV-related autoimmunity.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Antigenic Cross-reactivity:&lt;/li&gt;&lt;li&gt;â€¢ immune response against one antigen&lt;/li&gt;&lt;li&gt;â€¢ structurally similar antigen&lt;/li&gt;&lt;li&gt;â€¢ autoimmunity,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The development of autoimmunity in the context of EBV infection is primarily associated with polyclonal B cell activation , leading to the production of autoantibodies.&lt;/li&gt;&lt;li&gt;âž¤ autoimmunity&lt;/li&gt;&lt;li&gt;âž¤ EBV infection&lt;/li&gt;&lt;li&gt;âž¤ polyclonal B cell activation&lt;/li&gt;&lt;li&gt;âž¤ autoantibodies.&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th 220)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th 220)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;14-year-old girl experiences episodes of pallor, pain, and cyanosis in her extremities upon exposure to cold. This condition often precedes the development of which systemic disease, known for its cutaneous manifestations and association with such vascular phenomena?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Systemic lupus erythematosus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Scleroderma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rheumatoid arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Histiocytosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Scleroderma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Scleroderma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Systemic Lupus Erythematosus (SLE): SLE is a chronic autoimmune disease with various clinical presentations, including Raynaud&#x27;s phenomenon . However, SLE is characterized more by systemic symptoms and less by the cutaneous changes described.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Systemic Lupus Erythematosus (SLE):&lt;/li&gt;&lt;li&gt;â€¢ chronic autoimmune disease&lt;/li&gt;&lt;li&gt;â€¢ including Raynaud&#x27;s phenomenon&lt;/li&gt;&lt;li&gt;â€¢ systemic symptoms&lt;/li&gt;&lt;li&gt;â€¢ less by the cutaneous changes described.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Rheumatoid Arthritis (RA): RA is a chronic inflammatory disease primarily affecting the joints. While vascular symptoms can occur, they are not as prominent as the articular manifestations and not typically preceded by Raynaud&#x27;s phenomenon.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Rheumatoid Arthritis (RA):&lt;/li&gt;&lt;li&gt;â€¢ chronic inflammatory disease&lt;/li&gt;&lt;li&gt;â€¢ joints.&lt;/li&gt;&lt;li&gt;â€¢ not as prominent&lt;/li&gt;&lt;li&gt;â€¢ articular manifestations&lt;/li&gt;&lt;li&gt;â€¢ Option D: Histiocytosis: Histiocytosis refers to a group of disorders characterized by the proliferation of histiocytes . It does not commonly present with Raynaud&#x27;s phenomenon as an initial symptom.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Histiocytosis:&lt;/li&gt;&lt;li&gt;â€¢ group of disorders&lt;/li&gt;&lt;li&gt;â€¢ proliferation of histiocytes&lt;/li&gt;&lt;li&gt;â€¢ does not commonly&lt;/li&gt;&lt;li&gt;â€¢ Raynaud&#x27;s phenomenon&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Raynaud&#x27;s phenomenon , characterized by episodic vasoconstriction of the arteries and arterioles of the extremities , is commonly associated with scleroderma and can precede other symptoms of the disease .&lt;/li&gt;&lt;li&gt;âž¤ Raynaud&#x27;s phenomenon&lt;/li&gt;&lt;li&gt;âž¤ vasoconstriction of the arteries and arterioles of the extremities&lt;/li&gt;&lt;li&gt;âž¤ scleroderma&lt;/li&gt;&lt;li&gt;âž¤ other symptoms of the disease&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 228-229)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 228-229)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A child presents with cerebellar ataxia, telangiectasias, and recurrent respiratory infections. Laboratory investigations show immunodeficiency. Which immunoglobulin is most commonly deficient in this patient, who is likely to have Ataxia-Telangiectasia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IgG&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IgM&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IgA&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IgD&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. IgA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) IgA&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Patients with ataxia telangiectasia (AT) present in the first decade of life with progressive telangiectatic lesions associated with deficits in cerebellar function and nystagmus . There is a high incidence of recurrent pulmonary infections ( bronchiectasis ) and neoplasms of the lymphatic and reticuloendothelial system. It is caused due to defect in DNA repair genes . Thymic hypoplasia with cellular and humoral (IgA and IgG2) immunodeficiencies , premature aging and endocrine disorders such as insulin resistance or type-I DM . The most striking neuropathologic changes include loss of Purkinje, granule and basket cells in the cerebellar cortex as well as of neurons in the deep cerebellar nuclei. A poorly developed or absent thymus gland is the most consistent defect of the lymphoid system.&lt;/li&gt;&lt;li&gt;â€¢ Patients with ataxia telangiectasia (AT) present in the first decade of life with progressive telangiectatic lesions associated with deficits in cerebellar function and nystagmus . There is a high incidence of recurrent pulmonary infections ( bronchiectasis ) and neoplasms of the lymphatic and reticuloendothelial system.&lt;/li&gt;&lt;li&gt;â€¢ ataxia telangiectasia (AT)&lt;/li&gt;&lt;li&gt;â€¢ first decade of life&lt;/li&gt;&lt;li&gt;â€¢ progressive telangiectatic lesions&lt;/li&gt;&lt;li&gt;â€¢ cerebellar function and nystagmus&lt;/li&gt;&lt;li&gt;â€¢ recurrent pulmonary infections&lt;/li&gt;&lt;li&gt;â€¢ bronchiectasis&lt;/li&gt;&lt;li&gt;â€¢ neoplasms of the lymphatic and reticuloendothelial system.&lt;/li&gt;&lt;li&gt;â€¢ It is caused due to defect in DNA repair genes .&lt;/li&gt;&lt;li&gt;â€¢ defect in DNA repair genes&lt;/li&gt;&lt;li&gt;â€¢ Thymic hypoplasia with cellular and humoral (IgA and IgG2) immunodeficiencies , premature aging and endocrine disorders such as insulin resistance or type-I DM .&lt;/li&gt;&lt;li&gt;â€¢ cellular and humoral (IgA and IgG2) immunodeficiencies&lt;/li&gt;&lt;li&gt;â€¢ premature aging&lt;/li&gt;&lt;li&gt;â€¢ insulin resistance or type-I DM&lt;/li&gt;&lt;li&gt;â€¢ The most striking neuropathologic changes include loss of Purkinje, granule and basket cells in the cerebellar cortex as well as of neurons in the deep cerebellar nuclei.&lt;/li&gt;&lt;li&gt;â€¢ loss of Purkinje, granule and basket cells&lt;/li&gt;&lt;li&gt;â€¢ A poorly developed or absent thymus gland is the most consistent defect of the lymphoid system.&lt;/li&gt;&lt;li&gt;â€¢ poorly developed or absent thymus gland&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The most consistent immunoglobulin deficiency observed in Ataxia-Telangiectasia is IgA.&lt;/li&gt;&lt;li&gt;âž¤ consistent immunoglobulin&lt;/li&gt;&lt;li&gt;âž¤ Ataxia-Telangiectasia is IgA.&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 242-243)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 242-243)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following lesions/conditions shows most specific anatomic changes in HIV infection?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lymph nodes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Opportunistic infections&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CNS lesions&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Kaposiâ€™s sarcoma (blood vessels)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. CNS lesions&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) CNS lesions&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Lymph Nodes: Lymph nodes in HIV infection often show non-specific changes such as lymphadenopathy, which are not unique to HIV.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Lymph Nodes:&lt;/li&gt;&lt;li&gt;â€¢ non-specific changes such as lymphadenopathy,&lt;/li&gt;&lt;li&gt;â€¢ not unique to HIV.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Opportunistic Infections: Opportunistic infections associated with HIV can present with a variety of histological patterns , depending on the organism involved , but these changes are not specific to HIV itself.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Opportunistic Infections:&lt;/li&gt;&lt;li&gt;â€¢ HIV&lt;/li&gt;&lt;li&gt;â€¢ histological patterns&lt;/li&gt;&lt;li&gt;â€¢ organism involved&lt;/li&gt;&lt;li&gt;â€¢ not specific to HIV itself.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Kaposiâ€™s Sarcoma (Blood Vessels): Kaposiâ€™s sarcoma is associated with HIV infection but is caused by human herpesvirus 8 (HHV-8) infection . Its presence in the skin or organs isn&#x27;t specific for HIV, as it can occur in other immunosuppressed states .&lt;/li&gt;&lt;li&gt;â€¢ Option D: Kaposiâ€™s Sarcoma (Blood Vessels):&lt;/li&gt;&lt;li&gt;â€¢ HIV infection&lt;/li&gt;&lt;li&gt;â€¢ human herpesvirus 8 (HHV-8) infection&lt;/li&gt;&lt;li&gt;â€¢ skin or organs isn&#x27;t specific for HIV,&lt;/li&gt;&lt;li&gt;â€¢ immunosuppressed states&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The CNS lesions in patients with HIV are among the few pathological findings that can be specific and diagnostic , reflecting the unique neuropathology associated with HIV infection and its complications.&lt;/li&gt;&lt;li&gt;âž¤ CNS lesions&lt;/li&gt;&lt;li&gt;âž¤ HIV&lt;/li&gt;&lt;li&gt;âž¤ few pathological findings&lt;/li&gt;&lt;li&gt;âž¤ specific and diagnostic&lt;/li&gt;&lt;li&gt;âž¤ neuropathology associated with HIV infection&lt;/li&gt;&lt;li&gt;âž¤ Direct quote from Robbinsâ€¦. â€œThe anatomic changes in the tissues (except of lesions in the brain ) are neither specific nor diagnosticâ€.&lt;/li&gt;&lt;li&gt;âž¤ (except of lesions in the brain&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th 254-255)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th 254-255)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In an HIV-positive patient presenting with neurological symptoms, imaging studies reveal a mass lesion in the brain. Which type of CNS neoplasm is most commonly associated with this clinical scenario?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Medulloblastoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Astrocytoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Primary CNS Iymphoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ependymoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Primary CNS Iymphoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Primary CNS Iymphoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Medulloblastoma: Medulloblastoma is a type of malignant primary brain tumor most commonly found in children and is not particularly associated with HIV or immunosuppression .&lt;/li&gt;&lt;li&gt;â€¢ Option A: Medulloblastoma:&lt;/li&gt;&lt;li&gt;â€¢ malignant primary brain tumor&lt;/li&gt;&lt;li&gt;â€¢ found in children&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ HIV or immunosuppression&lt;/li&gt;&lt;li&gt;â€¢ Option B: Astrocytoma: Astrocytomas are a broad group of glial tumors and can occur in individuals with or without HIV . They are not the most common CNS neoplasm in the setting of HIV.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Astrocytoma:&lt;/li&gt;&lt;li&gt;â€¢ group of glial tumors&lt;/li&gt;&lt;li&gt;â€¢ with or without HIV&lt;/li&gt;&lt;li&gt;â€¢ Option D: Ependymoma: Ependymomas are tumors derived from ependymal cells of the ventricular system and are not specifically associated with HIV or immunosuppression.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Ependymoma:&lt;/li&gt;&lt;li&gt;â€¢ ependymal cells&lt;/li&gt;&lt;li&gt;â€¢ ventricular system&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Primary CNS lymphoma is the most common CNS neoplasm in patients with HIV, particularly in those with severe immunosuppression. It is typically of B-cell origin and often associated with EBV infection.&lt;/li&gt;&lt;li&gt;âž¤ Primary CNS lymphoma&lt;/li&gt;&lt;li&gt;âž¤ most common CNS neoplasm&lt;/li&gt;&lt;li&gt;âž¤ with HIV,&lt;/li&gt;&lt;li&gt;âž¤ severe immunosuppression.&lt;/li&gt;&lt;li&gt;âž¤ B-cell origin&lt;/li&gt;&lt;li&gt;âž¤ EBV infection.&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 9/e p254-255)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 9/e p254-255)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient concerned about the risk of HIV transmission through medical products is reassured that certain blood products and derivatives are safe and do not pose a risk of transmitting HIV due to the methods of processing involved. Which of the following is NOT associated with the transmission of HIV?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Whole blood&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Platelets&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Plasma derived Hepatitis B vaccine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Leucocytes&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Plasma derived Hepatitis B vaccine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Plasma derived Hepatitis B vaccine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Whole Blood: Transfusions of whole blood have a risk of HIV transmission if the blood is contaminated , as HIV can be present in sufficient quantities to establish an infection in the recipient.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Whole Blood:&lt;/li&gt;&lt;li&gt;â€¢ risk of HIV transmission if the blood is contaminated&lt;/li&gt;&lt;li&gt;â€¢ sufficient quantities to establish an infection in the recipient.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Platelets: Platelet transfusions carry a risk of HIV transmission if the donor blood is infected, as platelets are derived from whole blood which may contain the virus .&lt;/li&gt;&lt;li&gt;â€¢ Option B: Platelets:&lt;/li&gt;&lt;li&gt;â€¢ risk of HIV transmission if the donor blood is infected,&lt;/li&gt;&lt;li&gt;â€¢ platelets&lt;/li&gt;&lt;li&gt;â€¢ whole blood which may contain the virus&lt;/li&gt;&lt;li&gt;â€¢ Option D: Leukocytes : Transfusions involving leukocytes (white blood cells) can transmit HIV, as these cells can harbor the virus.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Leukocytes&lt;/li&gt;&lt;li&gt;â€¢ leukocytes (white blood cells) can transmit HIV,&lt;/li&gt;&lt;li&gt;â€¢ harbor the virus.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Plasma-derived Hepatitis B vaccines are not associated with the transmission of HIV because of the rigorous methods used to inactivate or remove viral contaminants during the manufacturing process&lt;/li&gt;&lt;li&gt;âž¤ Plasma-derived Hepatitis B vaccines&lt;/li&gt;&lt;li&gt;âž¤ transmission of HIV&lt;/li&gt;&lt;li&gt;âž¤ inactivate or remove viral contaminants&lt;/li&gt;&lt;li&gt;âž¤ manufacturing process&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In evaluating a 2-month-old infant for HIV infection, which diagnostic method is NOT appropriate due to the potential for false-positive results from passive transfer of maternal antibodies?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;DNA â€“PCR&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Viral culture&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HIV ELISA&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;P 24 antigen assay&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. HIV ELISA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) HIV ELISA&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: DNA-PCR: DNA-PCR is a sensitive method for detecting the presence of HIV DNA within a child&#x27;s cells and can be used from birth to accurately diagnose congenital HIV infection .&lt;/li&gt;&lt;li&gt;â€¢ Option A: DNA-PCR:&lt;/li&gt;&lt;li&gt;â€¢ HIV DNA within a child&#x27;s cells&lt;/li&gt;&lt;li&gt;â€¢ birth to accurately diagnose congenital HIV infection&lt;/li&gt;&lt;li&gt;â€¢ Option B: Viral Culture: Viral culture using peripheral blood mononuclear cells (PBMC) can be used to grow the virus from the infant&#x27;s blood cells , providing direct evidence of HIV infection.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Viral Culture:&lt;/li&gt;&lt;li&gt;â€¢ peripheral blood mononuclear cells (PBMC)&lt;/li&gt;&lt;li&gt;â€¢ virus from the infant&#x27;s blood cells&lt;/li&gt;&lt;li&gt;â€¢ HIV infection.&lt;/li&gt;&lt;li&gt;â€¢ Option D: P24 Antigen Assay: The p24 antigen assay detects viral core protein p24 , which can be used to diagnose HIV infection in infants , as it is not affected by the presence of maternal antibodies .&lt;/li&gt;&lt;li&gt;â€¢ Option D: P24 Antigen Assay:&lt;/li&gt;&lt;li&gt;â€¢ viral core protein p24&lt;/li&gt;&lt;li&gt;â€¢ HIV infection in infants&lt;/li&gt;&lt;li&gt;â€¢ not affected by the presence of maternal antibodies&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In infants, direct detection methods for HIV such as DNA-PCR and p24 antigen assay are preferred over antibody detection methods like HIV ELISA , which can yield false-positive results due to the presence of maternal antibodies.&lt;/li&gt;&lt;li&gt;âž¤ HIV such as DNA-PCR and p24 antigen assay&lt;/li&gt;&lt;li&gt;âž¤ HIV ELISA&lt;/li&gt;&lt;li&gt;âž¤ false-positive&lt;/li&gt;&lt;li&gt;âž¤ presence of maternal antibodies.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following anatomical locations is considered an immune-privileged site, where immune responses are typically reduced to prevent potential damage from inflammation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Area postrema&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Loop of Henle&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Optic nerve&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Seminiferous tubules&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Seminiferous tubules&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Seminiferous tubules&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Area postrema: The area postrema is a structure in the brain that controls vomiting in response to toxins , but it is not traditionally considered an immune-privileged site.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Area postrema:&lt;/li&gt;&lt;li&gt;â€¢ controls vomiting in response to toxins&lt;/li&gt;&lt;li&gt;â€¢ Option B: Loop of Henle: The Loop of Henle is part of the nephron in the kidney involved in the concentration of urine and is not an immune-privileged site .&lt;/li&gt;&lt;li&gt;â€¢ Option B: Loop of Henle:&lt;/li&gt;&lt;li&gt;â€¢ nephron in the kidney&lt;/li&gt;&lt;li&gt;â€¢ concentration of urine&lt;/li&gt;&lt;li&gt;â€¢ not an immune-privileged site&lt;/li&gt;&lt;li&gt;â€¢ Option C: Optic nerve: While the optic nerve is part of the central nervous system (CNS), which is considered immune-privileged , the term typically refers to the eye as a whole rather than individual structures within it .&lt;/li&gt;&lt;li&gt;â€¢ Option C: Optic nerve:&lt;/li&gt;&lt;li&gt;â€¢ central nervous system (CNS),&lt;/li&gt;&lt;li&gt;â€¢ immune-privileged&lt;/li&gt;&lt;li&gt;â€¢ eye as a whole&lt;/li&gt;&lt;li&gt;â€¢ within it&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Immune-privileged sites such as the seminiferous tubules, eyes, and brain are areas where immune responses are specifically downregulated to prevent damage that can occur from inflammation .&lt;/li&gt;&lt;li&gt;âž¤ Immune-privileged&lt;/li&gt;&lt;li&gt;âž¤ seminiferous tubules, eyes, and brain&lt;/li&gt;&lt;li&gt;âž¤ immune responses are specifically downregulated&lt;/li&gt;&lt;li&gt;âž¤ inflammation&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th 214)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th 214)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A healthcare worker with no known risk factors for tuberculosis (TB) receives a Mantoux test as part of a routine screening and returns to have the test read. The induration is noted to be less than 5 mm. What does this Mantoux test reading likely indicate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tuberculous infections&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Disseminated TB&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreased Susceptibility to tuberculosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Immunity to TB&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Disseminated TB&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Disseminated TB&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tuberculous Infections : The Mantoux test measures cell-mediated immunity to tubercular antigens, and an induration of less than 5 mm typically does not suggest active tuberculosis infection in individuals without risk factors.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tuberculous Infections&lt;/li&gt;&lt;li&gt;â€¢ Option C. Decreased Susceptibility to Tuberculosis : A negative Mantoux test, defined as an induration of less than 5 mm in low-risk individuals, suggests that the person has not been sensitized to TB antigens and has not developed a measurable cell-mediated immune response. If it is due to immunosuppression, it is associated with increased (not decreased) susceptibity to tuberculosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Decreased Susceptibility to Tuberculosis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Immunity to TB : The Mantoux test does not measure immunity to TB. A negative test does not imply immunity but rather that the individual has not had a prior infection that elicited a cellular immune response.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Immunity to TB&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A Mantoux test induration of less than 5 mm in an individual without risk factors is considered negative and suggests that the person has not been sensitized to TB antigens. It does not confirm active tuberculosis or immunity to TB.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with chronic nonmalignant lymphoproliferation, autoimmune cytopenias, and a family history suggestive of a genetic syndrome. Genetic testing for which of the following genes is most likely to confirm the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;PTPN22&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;FAS&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;FADD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;NOD like receptor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. FAS&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) FAS&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: PTPN22: The PTPN22 gene encodes a tyrosine phosphatase involved in T cell receptor signaling. Mutations in this gene are associated with various autoimmune conditions, such as rheumatoid arthritis and type 1 diabetes , but not typically with autoimmune lymphoproliferative syndrome (ALPS).&lt;/li&gt;&lt;li&gt;â€¢ Option A: PTPN22:&lt;/li&gt;&lt;li&gt;â€¢ tyrosine phosphatase involved in T cell receptor signaling.&lt;/li&gt;&lt;li&gt;â€¢ rheumatoid arthritis and type 1 diabetes&lt;/li&gt;&lt;li&gt;â€¢ autoimmune lymphoproliferative syndrome (ALPS).&lt;/li&gt;&lt;li&gt;â€¢ Option C: FADD: FADD is an adaptor protein involved in the apoptotic pathway . While important for apoptosis , known mutations in FADD are not classically associated with ALPS.&lt;/li&gt;&lt;li&gt;â€¢ Option C: FADD:&lt;/li&gt;&lt;li&gt;â€¢ adaptor protein&lt;/li&gt;&lt;li&gt;â€¢ apoptotic pathway&lt;/li&gt;&lt;li&gt;â€¢ apoptosis&lt;/li&gt;&lt;li&gt;â€¢ Option D: NOD-like Receptor: NOD-like receptors are intracellular sensors of microbial motifs and cell stress that lead to inflammation, not apoptosis. Mutations in NOD-like receptors are associated with autoinflammatory syndromes, not ALPS.&lt;/li&gt;&lt;li&gt;â€¢ Option D: NOD-like Receptor:&lt;/li&gt;&lt;li&gt;â€¢ intracellular sensors of microbial motifs&lt;/li&gt;&lt;li&gt;â€¢ cell stress&lt;/li&gt;&lt;li&gt;â€¢ inflammation, not apoptosis.&lt;/li&gt;&lt;li&gt;â€¢ NOD-like receptors&lt;/li&gt;&lt;li&gt;â€¢ autoinflammatory syndromes, not ALPS.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Autoimmune lymphoproliferative syndrome (ALPS) is often caused by mutations in the FAS gene , which leads to defects in the apoptotic pathway, specifically in the programmed cell death of lymphocytes . This condition is characterized by autoimmune manifestations similar to systemic lupus erythematosus (SLE).&lt;/li&gt;&lt;li&gt;âž¤ Autoimmune lymphoproliferative syndrome (ALPS)&lt;/li&gt;&lt;li&gt;âž¤ mutations in the FAS gene&lt;/li&gt;&lt;li&gt;âž¤ apoptotic pathway,&lt;/li&gt;&lt;li&gt;âž¤ programmed cell death of lymphocytes&lt;/li&gt;&lt;li&gt;âž¤ autoimmune manifestations similar to systemic lupus erythematosus (SLE).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 26-year-old female presents with complaints of fatigue since 2 months. She has persistent arthralgia of the distal and proximal interphalangeal joints of both hands and reports that when the weather turns cold her hands frequently change colors. Her physical examination is normal and there is no tenderness or deformity of the joints of the hands. A complete blood count is normal and her antinuclear antibody titer is elevated at 1:90. Which of the following additional tests would confirm the diagnosis of lupus erythematosus?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Positive SS-A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Positive anti-Smith antibody&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Positive anti-cyclic citrullinated peptide (CCP-IgG)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Positive rheumatoid factor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Positive anti-Smith antibody&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Positive anti-Smith antibody&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Positive SS-A: SS-A (or Ro) antibodies are associated with SLE and SjÃ¶grenâ€™s syndrome. Although they can be present in SLE, they are not specific to it, especially when considering the patient&#x27;s clinical presentation.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Positive SS-A:&lt;/li&gt;&lt;li&gt;â€¢ SLE and SjÃ¶grenâ€™s syndrome.&lt;/li&gt;&lt;li&gt;â€¢ not specific to&lt;/li&gt;&lt;li&gt;â€¢ Option C: Positive anti-cyclic citrullinated peptide (CCP-IgG): Anti-CCP IgG is highly specific for rheumatoid arthritis and is not typically used in the diagnosis of SLE.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Positive anti-cyclic citrullinated peptide (CCP-IgG):&lt;/li&gt;&lt;li&gt;â€¢ highly specific for rheumatoid arthritis&lt;/li&gt;&lt;li&gt;â€¢ Option D: Positive rheumatoid factor: Rheumatoid factor can be positive in a variety of rheumatologic diseases, including SLE , but it is not specific for SLE and is more commonly associated with rheumatoid arthritis.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Positive rheumatoid factor:&lt;/li&gt;&lt;li&gt;â€¢ rheumatologic diseases, including SLE&lt;/li&gt;&lt;li&gt;â€¢ not specific for SLE&lt;/li&gt;&lt;li&gt;â€¢ more commonly associated with rheumatoid arthritis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ When evaluating a patient for SLE, the anti-Smith antibody test is the most specific serological test and can confirm the diagnosis when the clinical picture is suggestive of the disease.&lt;/li&gt;&lt;li&gt;âž¤ anti-Smith antibody test is the most specific serological test&lt;/li&gt;&lt;li&gt;âž¤ confirm the diagnosis&lt;/li&gt;&lt;li&gt;âž¤ Ref Robbins 10 th / 222&lt;/li&gt;&lt;li&gt;âž¤ Ref Robbins 10 th / 222&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the context of systemic lupus erythematosus (SLE), which cell type is historically known for its role in the formation of lupus erythematosus (LE) cells, a phenomenon once used in the diagnosis of SLE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lymphocyte&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Endothelial cell&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Eosinophil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Neutrophil&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Neutrophil&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Neutrophil&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Lymphocyte: Lymphocytes are primarily involved in adaptive immune responses and are not typically phagocytic cells associated with the formation of LE cells.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Lymphocyte:&lt;/li&gt;&lt;li&gt;â€¢ adaptive immune responses&lt;/li&gt;&lt;li&gt;â€¢ not typically phagocytic cells&lt;/li&gt;&lt;li&gt;â€¢ formation of LE cells.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Endothelial Cell: Endothelial cells line blood vessels and are not involved in phagocytosis or the formation of LE cells .&lt;/li&gt;&lt;li&gt;â€¢ Option B: Endothelial Cell:&lt;/li&gt;&lt;li&gt;â€¢ blood vessels&lt;/li&gt;&lt;li&gt;â€¢ not involved in phagocytosis or the formation of LE cells&lt;/li&gt;&lt;li&gt;â€¢ Option C: Eosinophil: Eosinophils are involved in allergic reactions and parasitic infections and do not form LE cells.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Eosinophil:&lt;/li&gt;&lt;li&gt;â€¢ allergic reactions and parasitic infections&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ LE cells are neutrophils or macrophages that have phagocytosed nuclear material . The demonstration of LE cells used to be a diagnostic test for SLE , reflecting the autoantibody-mediated destruction of cells leading to the presentation of nuclear antigens to these phagocytes.&lt;/li&gt;&lt;li&gt;âž¤ LE cells are neutrophils or macrophages&lt;/li&gt;&lt;li&gt;âž¤ phagocytosed nuclear material&lt;/li&gt;&lt;li&gt;âž¤ LE cells&lt;/li&gt;&lt;li&gt;âž¤ diagnostic test for SLE&lt;/li&gt;&lt;li&gt;âž¤ autoantibody-mediated destruction of cells&lt;/li&gt;&lt;li&gt;âž¤ nuclear antigens to these phagocytes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with enlargement of salivary glands, fibrosis of the pancreas, and increased serum levels of IgG4. Which condition from the following list is not typically associated with the spectrum of IgG4-related disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mikulicz syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Riedel thyroiditis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Idiopathic retroperitoneal fibrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Celiac disease&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Celiac disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Celiac disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Mikulicz syndrome: Mikulicz syndrome involves enlargement and fibrosis of the salivary and lacrimal glands and is a recognized part of the IgG4-related disease spectrum .&lt;/li&gt;&lt;li&gt;â€¢ Option A: Mikulicz syndrome:&lt;/li&gt;&lt;li&gt;â€¢ enlargement and fibrosis of the salivary and lacrimal glands&lt;/li&gt;&lt;li&gt;â€¢ IgG4-related disease spectrum&lt;/li&gt;&lt;li&gt;â€¢ Option B: Riedel thyroiditis: Riedel thyroiditis is a fibrosing inflammatory process involving the thyroid gland , often associated with IgG4-related disease .&lt;/li&gt;&lt;li&gt;â€¢ Option B: Riedel thyroiditis:&lt;/li&gt;&lt;li&gt;â€¢ fibrosing inflammatory process&lt;/li&gt;&lt;li&gt;â€¢ thyroid gland&lt;/li&gt;&lt;li&gt;â€¢ IgG4-related disease&lt;/li&gt;&lt;li&gt;â€¢ Option C: Idiopathic retroperitoneal fibrosis: Idiopathic retroperitoneal fibrosis is characterized by fibrous tissue in the retroperitoneum and can be associated with IgG4-related disease.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Idiopathic retroperitoneal fibrosis:&lt;/li&gt;&lt;li&gt;â€¢ fibrous tissue&lt;/li&gt;&lt;li&gt;â€¢ retroperitoneum and can be associated with IgG4-related disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ IgG4-related disease is a fibro-inflammatory condition characterized by several features, including tissue infiltration with IgG4-positive plasma cells . It does not encompass celiac disease , which has a d ifferent pathophysiology related to gluten sensitivity.&lt;/li&gt;&lt;li&gt;âž¤ IgG4-related disease&lt;/li&gt;&lt;li&gt;âž¤ fibro-inflammatory&lt;/li&gt;&lt;li&gt;âž¤ tissue infiltration with IgG4-positive plasma cells&lt;/li&gt;&lt;li&gt;âž¤ does not encompass celiac disease&lt;/li&gt;&lt;li&gt;âž¤ ifferent pathophysiology related to gluten sensitivity.&lt;/li&gt;&lt;li&gt;âž¤ Ref Robbins 10 th /232&lt;/li&gt;&lt;li&gt;âž¤ Ref Robbins 10 th /232&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Match the following complement deficiencies with the disorders given:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1-d, 2-c, 3-a, 4-b&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1-b, 2-d, 3-a, 4-c&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1-c, 2-d, 3-b, 4-a&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1-d, 2-a, 3-b, 4-c&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 1-b, 2-d, 3-a, 4-c&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/01/screenshot-2024-06-01-104551.JPG&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/01/screenshot-2024-06-01-122206.JPG&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 1-b, 2-d, 3-a, 4-c&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A middle-aged lady 30-year-old woman complains of diplopia and drooping eyelids. She undergoes investigation which reveals a mediastinal mass. The symptoms of muscle weakness in this patient are caused by antibodies directed against which of the following cellular components?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thyroid-stimulating hormone (TSH) receptor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Calcium channel&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acetylcholine receptor&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rheumatoid factor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Acetylcholine receptor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Acetylcholine receptor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Thyroid-stimulating hormone (TSH) receptor: Antibodies against the TSH receptor are characteristic of Graves&#x27; disease , an autoimmune disorder that leads to hyperthyroidism , not typically associated with muscle weakness.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Thyroid-stimulating hormone (TSH) receptor:&lt;/li&gt;&lt;li&gt;â€¢ Antibodies&lt;/li&gt;&lt;li&gt;â€¢ TSH receptor&lt;/li&gt;&lt;li&gt;â€¢ Graves&#x27; disease&lt;/li&gt;&lt;li&gt;â€¢ hyperthyroidism&lt;/li&gt;&lt;li&gt;â€¢ Option B: Calcium channel: Antibodies to calcium channels is associated with Lambert-Eaton myasthenic syndrome, which can cause muscle weakness; however, the presence of a mediastinal mass is more suggestive of thymoma associated with myasthenia gravis.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Calcium channel:&lt;/li&gt;&lt;li&gt;â€¢ Antibodies to calcium channels&lt;/li&gt;&lt;li&gt;â€¢ Lambert-Eaton myasthenic syndrome,&lt;/li&gt;&lt;li&gt;â€¢ muscle weakness;&lt;/li&gt;&lt;li&gt;â€¢ mediastinal mass is more suggestive of thymoma&lt;/li&gt;&lt;li&gt;â€¢ myasthenia gravis.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Rheumatoid factor: Rheumatoid factor is an autoantibody observed in rheumatoid arthritis, which primarily affects joints and is not typically involved in th e neuromuscular transmission pathology seen in myasthenia gravis .&lt;/li&gt;&lt;li&gt;â€¢ Option D: Rheumatoid factor:&lt;/li&gt;&lt;li&gt;â€¢ autoantibody&lt;/li&gt;&lt;li&gt;â€¢ rheumatoid arthritis,&lt;/li&gt;&lt;li&gt;â€¢ e neuromuscular transmission&lt;/li&gt;&lt;li&gt;â€¢ myasthenia gravis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The presence of a mediastinal mass and symptoms such as diplopia and ptosis in a young adult are highly suggestive of myasthenia gravis , which is caused by autoantibodies against the acetylcholine receptor, leading to muscle weakness.&lt;/li&gt;&lt;li&gt;âž¤ mediastinal mass&lt;/li&gt;&lt;li&gt;âž¤ diplopia and ptosis in a young adult&lt;/li&gt;&lt;li&gt;âž¤ myasthenia gravis&lt;/li&gt;&lt;li&gt;âž¤ autoantibodies against the acetylcholine receptor,&lt;/li&gt;&lt;li&gt;âž¤ muscle weakness.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young truck driver with AIDS complains of difficulty swallowing. Examination of his oral cavity demonstrates whitish membranes covering much of his tongue and palate. He has similar lesions in his esophagus also. These pathologic findings are fundamentally caused by loss of which of the following immune cells in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;B lymphocytes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Helper T lymphocytes&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Killer T lymphocytes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Monocytes/macrophages&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Helper T lymphocytes&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Helper T lymphocytes.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: B lymphocytes: B lymphocytes are responsible for humoral immunity and produce antibodies . While B cell function can be affected secondary to T cell impairment in HIV, the primary defect in AIDS is not the direct loss of B cells.&lt;/li&gt;&lt;li&gt;â€¢ Option A: B lymphocytes:&lt;/li&gt;&lt;li&gt;â€¢ humoral immunity and produce antibodies&lt;/li&gt;&lt;li&gt;â€¢ secondary to T cell impairment in HIV,&lt;/li&gt;&lt;li&gt;â€¢ Option C: Killer T lymphocytes: CD8+ killer T lymphocytes, or cytotoxic T cells, are essential for killing virus-infected cells. While these cells can be affected in HIV/AIDS, the primary immunologic defect causing the susceptibility to opportunistic infections in AIDS is the loss of helper T cells, not cytotoxic T cells.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Killer T lymphocytes:&lt;/li&gt;&lt;li&gt;â€¢ cytotoxic T cells, are essential for killing virus-infected cells.&lt;/li&gt;&lt;li&gt;â€¢ HIV/AIDS, the primary immunologic defect&lt;/li&gt;&lt;li&gt;â€¢ loss of helper T cells, not cytotoxic T cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Monocytes/macrophages: Monocytes/macrophages are involved in phagocytosis and antigen presentation . They can be infected by HIV and play a role in the disease pathogenesis, but the fundamental defect causing the increased susceptibility to opportunistic infections in AIDS is the loss of CD4+ helper T cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Monocytes/macrophages:&lt;/li&gt;&lt;li&gt;â€¢ phagocytosis and antigen presentation&lt;/li&gt;&lt;li&gt;â€¢ HIV&lt;/li&gt;&lt;li&gt;â€¢ increased susceptibility to opportunistic infections in AIDS is the loss of CD4+ helper T cells.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The depletion of CD4+ helper T lymphocytes is the hallmark of HIV infection leading to AIDS . The consequent immunosuppression manifests as susceptibility to opportunistic infections , including oral and esophageal candidiasis.&lt;/li&gt;&lt;li&gt;âž¤ depletion of CD4+ helper T lymphocytes&lt;/li&gt;&lt;li&gt;âž¤ hallmark of HIV infection leading to AIDS&lt;/li&gt;&lt;li&gt;âž¤ immunosuppression&lt;/li&gt;&lt;li&gt;âž¤ susceptibility to opportunistic infections&lt;/li&gt;&lt;li&gt;âž¤ oral and esophageal candidiasis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 16-year-old girl presents to his family physician for treatment of oozing blisters and crusts on her wrists after wearing some artificial jewellery. Which of the following best describes the pathogenesis of these skin lesions?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cytotoxic antibody production&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Delayed-type hypersensitivity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Deposition of anti gliadin antibodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Deposition of circulating immune complexes&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Delayed-type hypersensitivity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Delayed type hypersensitivity&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Cytotoxic antibody production: Cytotoxic antibodies, typically IgG or IgM, mediate destruction of target cells by complement activation or antibody-dependent cellular cytotoxicity, not typically involved in contact dermatitis.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Cytotoxic antibody production:&lt;/li&gt;&lt;li&gt;â€¢ IgG or IgM,&lt;/li&gt;&lt;li&gt;â€¢ target cells by complement activation&lt;/li&gt;&lt;li&gt;â€¢ antibody-dependent cellular cytotoxicity,&lt;/li&gt;&lt;li&gt;â€¢ Option C: Deposition of anti-gliadin antibodies: Anti-gliadin antibodies are associated with celiac disease and can be involved in dermatitis herpetiformis but are not related to contact dermatitis from jewelry.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Deposition of anti-gliadin antibodies:&lt;/li&gt;&lt;li&gt;â€¢ celiac disease&lt;/li&gt;&lt;li&gt;â€¢ dermatitis herpetiformis&lt;/li&gt;&lt;li&gt;â€¢ Option D: Deposition of circulating immune complexes: Immune complex deposition is a feature of type III hypersensitivity reactions , which involve antigen-antibody complexes that deposit in various tissues , not the skin reaction seen in contact dermatitis.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Deposition of circulating immune complexes:&lt;/li&gt;&lt;li&gt;â€¢ Immune complex&lt;/li&gt;&lt;li&gt;â€¢ type III hypersensitivity reactions&lt;/li&gt;&lt;li&gt;â€¢ antigen-antibody complexes&lt;/li&gt;&lt;li&gt;â€¢ various tissues&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Contact dermatitis is a classic example of a delayed-type hypersensitivity reaction , a type IV hypersensitivity, where upon exposure to an allergen , T lymphocytes mediate an allergic response leading to skin lesions such as urticaria and blisters that rupture and heal with crusts.&lt;/li&gt;&lt;li&gt;âž¤ Contact dermatitis&lt;/li&gt;&lt;li&gt;âž¤ delayed-type hypersensitivity reaction&lt;/li&gt;&lt;li&gt;âž¤ type IV hypersensitivity,&lt;/li&gt;&lt;li&gt;âž¤ an allergen&lt;/li&gt;&lt;li&gt;âž¤ T lymphocytes&lt;/li&gt;&lt;li&gt;âž¤ allergic response&lt;/li&gt;&lt;li&gt;âž¤ urticaria and blisters that rupture and heal with crusts.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following cells would you identify as the most potent stimulator of naÃ¯ve T cells?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mature dendritic cell&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Follicular dendritic cell&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Macrophages&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;B cell&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Mature dendritic cell&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Mature dendritic cell&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Follicular dendritic cell: Follicular dendritic cells, primarily found in the lymph nodes , do not express MHC class II molecules; they present antigens to B cells in humoral immune responses, not naÃ¯ve T cells.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Follicular dendritic cell:&lt;/li&gt;&lt;li&gt;â€¢ lymph nodes&lt;/li&gt;&lt;li&gt;â€¢ present antigens to B cells in humoral immune responses,&lt;/li&gt;&lt;li&gt;â€¢ Option C: Macrophages: While macrophages can serve as APCs and activate T cells , they are less potent than dendritic cells and typically engage in phagocytosis and antigen presentation during inflammation .&lt;/li&gt;&lt;li&gt;â€¢ Option C: Macrophages:&lt;/li&gt;&lt;li&gt;â€¢ APCs and activate T cells&lt;/li&gt;&lt;li&gt;â€¢ less potent&lt;/li&gt;&lt;li&gt;â€¢ dendritic cells&lt;/li&gt;&lt;li&gt;â€¢ phagocytosis and antigen presentation during inflammation&lt;/li&gt;&lt;li&gt;â€¢ Option D: B cell: B cells can present antigens to helper T cells , particularly in the context of humoral immune responses, but they are not the most potent APCs for initiating responses in naÃ¯ve T cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D: B cell:&lt;/li&gt;&lt;li&gt;â€¢ helper T cells&lt;/li&gt;&lt;li&gt;â€¢ humoral immune responses,&lt;/li&gt;&lt;li&gt;â€¢ most potent APCs&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The most potent stimulator of a naÃ¯ve T cell is the mature dendritic cell due to its high expression of MHC molecules and the ability to provide the necessary costimulatory signals required for T cell activation.&lt;/li&gt;&lt;li&gt;âž¤ potent stimulator&lt;/li&gt;&lt;li&gt;âž¤ naÃ¯ve T cell&lt;/li&gt;&lt;li&gt;âž¤ mature dendritic cell&lt;/li&gt;&lt;li&gt;âž¤ high expression of MHC molecules&lt;/li&gt;&lt;li&gt;âž¤ costimulatory signals&lt;/li&gt;&lt;li&gt;âž¤ T cell activation.&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th 191)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th 191)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Toll like receptors, recognize bacterial products and stimulates immune response by:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Perforin and granzyme mediated apoptosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;FADD ligand apoptosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Transcription of nuclear factor mediated by NF-Îº b which recruits cytokines&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cyclin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Transcription of nuclear factor mediated by NF-Îº b which recruits cytokines&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Transcription of nuclear factor mediated by NF-ÎºÎ² which recruits cytokines&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Perforin and granzyme-mediated apoptosis is a mechanism utilized by cytotoxic T cells and natural killer cells to induce cell death in infected or abnormal cells.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Perforin and granzyme-mediated apoptosis&lt;/li&gt;&lt;li&gt;â€¢ cytotoxic T cells and natural killer cells&lt;/li&gt;&lt;li&gt;â€¢ cell death in infected or abnormal cells.&lt;/li&gt;&lt;li&gt;â€¢ Option B: FADD ligand apoptosis involves the Fas-associated death domain protein , part of the extrinsic pathway for apoptosis, typically triggered by the Fas ligand binding to its receptor.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ FADD ligand apoptosis&lt;/li&gt;&lt;li&gt;â€¢ Fas-associated death domain protein&lt;/li&gt;&lt;li&gt;â€¢ extrinsic pathway for apoptosis,&lt;/li&gt;&lt;li&gt;â€¢ Fas ligand&lt;/li&gt;&lt;li&gt;â€¢ Option D: Cyclin proteins are involved in the regulation of the cell cycle and do not have a direct role in immune responses or signaling .&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Cyclin proteins&lt;/li&gt;&lt;li&gt;â€¢ cell cycle&lt;/li&gt;&lt;li&gt;â€¢ do not&lt;/li&gt;&lt;li&gt;â€¢ immune responses or signaling&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Toll-like receptors are membrane proteins that recognize a variety of microbe-derived molecules and stimulate innate immune responses against the microbes . These derive there name due to homology to a Drosophila protein called â€˜Tollâ€™. The Toll-like receptors are expressed on many immune cells of the body. Signaling by Toll-like receptors result in the activation of transcription factors notably NF-Îº b .&lt;/li&gt;&lt;li&gt;âž¤ The Toll-like receptors&lt;/li&gt;&lt;li&gt;âž¤ membrane proteins&lt;/li&gt;&lt;li&gt;âž¤ microbe-derived molecules&lt;/li&gt;&lt;li&gt;âž¤ innate immune&lt;/li&gt;&lt;li&gt;âž¤ microbes&lt;/li&gt;&lt;li&gt;âž¤ homology to a Drosophila protein&lt;/li&gt;&lt;li&gt;âž¤ Toll-like receptors&lt;/li&gt;&lt;li&gt;âž¤ immune cells of the body.&lt;/li&gt;&lt;li&gt;âž¤ Signaling by Toll-like receptors&lt;/li&gt;&lt;li&gt;âž¤ activation of transcription factors notably NF-Îº&lt;/li&gt;&lt;li&gt;âž¤ b .&lt;/li&gt;&lt;li&gt;âž¤ Ref: Robbins 10 th / 187&lt;/li&gt;&lt;li&gt;âž¤ Ref: Robbins 10 th / 187&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the context of a cell-mediated immune response, a 30-year-old patient with chronic granulomatous disease is being evaluated for cytokine profiles to assess T-helper cell function. Which cytokine is predominantly expected to be produced by T-helper type 1 (TH1) cells in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IL-2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IL-4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IL-5&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IL-10&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. IL-2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) IL-2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Options B: IL-4 is characteristic of TH2 cells and is vital in humoral immunity. It promotes the differentiation of B cells into plasma cells and class switching to IgE , which is important for type I hypersensitivity reactions.&lt;/li&gt;&lt;li&gt;â€¢ Options B:&lt;/li&gt;&lt;li&gt;â€¢ IL-4&lt;/li&gt;&lt;li&gt;â€¢ TH2 cells&lt;/li&gt;&lt;li&gt;â€¢ humoral immunity.&lt;/li&gt;&lt;li&gt;â€¢ B cells into plasma cells&lt;/li&gt;&lt;li&gt;â€¢ IgE&lt;/li&gt;&lt;li&gt;â€¢ type I hypersensitivity reactions.&lt;/li&gt;&lt;li&gt;â€¢ Options C: IL-5 is another cytokine produced by TH2 cells , promoting growth and differentiation of B cells . It also stimulates the production and activation of eosinophils .&lt;/li&gt;&lt;li&gt;â€¢ Options C:&lt;/li&gt;&lt;li&gt;â€¢ IL-5&lt;/li&gt;&lt;li&gt;â€¢ TH2 cells&lt;/li&gt;&lt;li&gt;â€¢ growth and differentiation of B cells&lt;/li&gt;&lt;li&gt;â€¢ production and activation of eosinophils&lt;/li&gt;&lt;li&gt;â€¢ Options D: IL-10 is an anti-inflammatory cytokine that can be produced by various cells, including some TH2 cells, and regulatory T cells . It is known to inhibit the synthesis of pro-inflammatory cytokines and can downregulate TH1 responses.&lt;/li&gt;&lt;li&gt;â€¢ Options D:&lt;/li&gt;&lt;li&gt;â€¢ IL-10&lt;/li&gt;&lt;li&gt;â€¢ anti-inflammatory cytokine&lt;/li&gt;&lt;li&gt;â€¢ various cells, including some TH2 cells, and regulatory T cells&lt;/li&gt;&lt;li&gt;â€¢ pro-inflammatory cytokines and can downregulate TH1 responses.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ IL-2 , is this cytokine that is primarily produced by TH1 cells and is integral to cell-mediated immune responses , particularly in the defense against intracellular pathogens and in mediating type IV hypersensitivity reactions.&lt;/li&gt;&lt;li&gt;âž¤ IL-2&lt;/li&gt;&lt;li&gt;âž¤ cytokine&lt;/li&gt;&lt;li&gt;âž¤ TH1 cells&lt;/li&gt;&lt;li&gt;âž¤ cell-mediated immune responses&lt;/li&gt;&lt;li&gt;âž¤ intracellular pathogens&lt;/li&gt;&lt;li&gt;âž¤ type IV hypersensitivity reactions.&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 198)&lt;/li&gt;&lt;li&gt;âž¤ (Ref: Robbins 10 th / 198)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male with a history of chronic inflammatory disease presents with fatigue, weight loss, and edema. Physical examination reveals macroglossia and periorbital purpura. Laboratory studies show renal insufficiency and proteinuria. To confirm the suspected diagnosis of amyloidosis, which of the following diagnostic tests should be performed?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Blood culture&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Urine culture&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bone marrow biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Biopsy of affected tissue&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Biopsy of affected tissue&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Biopsy of affected tissue&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ A definitive diagnosis of amyloidosis requires a biopsy of affected tissue, such as the skin, kidney, liver, or gastrointestinal tract. The biopsy specimen is examined under a microscope to identify the presence of amyloid fibrils . Additional tests, such as immunohistochemistry, mass spectrometry, or electron microscopy, may be used to determine the specific type of amyloid protein involved.&lt;/li&gt;&lt;li&gt;â€¢ A definitive diagnosis of amyloidosis requires a biopsy of affected tissue, such as the skin, kidney, liver, or gastrointestinal tract.&lt;/li&gt;&lt;li&gt;â€¢ amyloidosis&lt;/li&gt;&lt;li&gt;â€¢ biopsy of affected tissue, such as the skin, kidney, liver, or gastrointestinal tract.&lt;/li&gt;&lt;li&gt;â€¢ The biopsy specimen is examined under a microscope to identify the presence of amyloid fibrils . Additional tests, such as immunohistochemistry, mass spectrometry, or electron microscopy, may be used to determine the specific type of amyloid protein involved.&lt;/li&gt;&lt;li&gt;â€¢ biopsy specimen&lt;/li&gt;&lt;li&gt;â€¢ amyloid fibrils&lt;/li&gt;&lt;li&gt;â€¢ immunohistochemistry, mass spectrometry, or electron microscopy,&lt;/li&gt;&lt;li&gt;â€¢ specific type of amyloid protein&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Biopsy of affected tissue is the gold standard for confirming the diagnosis of amyloidosis . It involves taking a sample from affected organs like the kidney, liver, or gastrointestinal tract and identifying amyloid fibrils under a microscope with additional confirmatory tests such as immunohistochemistry or electron microscopy.&lt;/li&gt;&lt;li&gt;âž¤ Biopsy&lt;/li&gt;&lt;li&gt;âž¤ gold standard for confirming the diagnosis of amyloidosis&lt;/li&gt;&lt;li&gt;âž¤ kidney, liver, or gastrointestinal tract&lt;/li&gt;&lt;li&gt;âž¤ amyloid fibrils under a microscope&lt;/li&gt;&lt;li&gt;âž¤ immunohistochemistry or electron microscopy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 60 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test8" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Inflammation&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Inflammation&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                50 Questions | 200 Total Marks | 60 min Duration | ~72.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A 55-year-old man presents with a painful left shoulder and a history of rheumatoid arthritis. Examination reveals a swollen and tender shoulder joint with limited range of motion. Which of the following mechanisms is responsible for the leukocyte migration to the affected joint?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased vascular permeability&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vasodilation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chemotaxis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Opsonization&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Chemotaxis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Chemotaxis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increased vascular permeability allows for the extravasation of fluid and cells from the circulation into the tissues . This is a vital part of the inflammatory response that leads to edema . However, while it facilitates the movement of leukocytes out of the capillaries, it is not the mechanism that specifically directs their migration to the site of inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increased vascular permeability&lt;/li&gt;&lt;li&gt;â€¢ extravasation of fluid and cells from the circulation into the tissues&lt;/li&gt;&lt;li&gt;â€¢ inflammatory response&lt;/li&gt;&lt;li&gt;â€¢ edema&lt;/li&gt;&lt;li&gt;â€¢ movement of leukocytes out of the&lt;/li&gt;&lt;li&gt;â€¢ capillaries,&lt;/li&gt;&lt;li&gt;â€¢ Option B. Vasodilation , the widening of blood vessels , is mediated by various inflammatory mediators and leads to increased blood flow. This process causes the classic signs of redness and warmth but does not specifically direct leukocytes to the site of inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Vasodilation&lt;/li&gt;&lt;li&gt;â€¢ widening of blood vessels&lt;/li&gt;&lt;li&gt;â€¢ inflammatory mediators&lt;/li&gt;&lt;li&gt;â€¢ leads to increased blood flow.&lt;/li&gt;&lt;li&gt;â€¢ classic signs of redness and warmth&lt;/li&gt;&lt;li&gt;â€¢ direct leukocytes to the site of inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Opsonization involves the tagging of pathogens with molecules such as antibodies or complement proteins that enhance their uptake by phagocytes. It is an essential process in the immune response to pathogens but does not involve the migration of leukocytes to the site of inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Opsonization&lt;/li&gt;&lt;li&gt;â€¢ tagging of pathogens&lt;/li&gt;&lt;li&gt;â€¢ antibodies or complement proteins&lt;/li&gt;&lt;li&gt;â€¢ phagocytes.&lt;/li&gt;&lt;li&gt;â€¢ essential process in the immune response&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Chemotaxis is the mechanism that drives leukocytes to migrate to the affected joint in rheumatoid arthritis , guided by chemokines and cytokines produced in response to the inflammatory process.&lt;/li&gt;&lt;li&gt;âž¤ Chemotaxis&lt;/li&gt;&lt;li&gt;âž¤ drives leukocytes to migrate to the affected joint in rheumatoid arthritis&lt;/li&gt;&lt;li&gt;âž¤ chemokines and cytokines&lt;/li&gt;&lt;li&gt;âž¤ inflammatory process.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 8-year-old girl presented to the emergency department with a two-day history of nausea, vomiting and periumbilical and lower abdominal pain. She experienced fever also earlier in the day. Physical exam showed local tenderness and rigidity with rebound pain in the lower abdomen. Laboratory tests revealed leucoytosis and elevated ESR and C-reactive protein. She underwent an exploratory laparotomy. The pain experienced by this patient is MOST LIKELY the result of the formation of which of the following two chemical mediators?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Complement C3b and IgG&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Interleukin-1 and tumor necrosis factor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Histamine and serotonin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prostaglandin and bradykinin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Prostaglandin and bradykinin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/05/screenshot-2024-02-05-152521.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Prostaglandin and bradykinin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Complement C3b is a part of the complement system , which enhances the ability of antibodies and phagocytic cells to clear microbes and damaged cells, promote inflammation, and attack the pathogen&#x27;s cell membrane. IgG is an antibody isotype that plays a crucial role in the immune response by binding to pathogens and marking them for destruction . While both are integral to the immune response and opsonization, they are not directly associated with the sensation of pain.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Complement C3b&lt;/li&gt;&lt;li&gt;â€¢ complement system&lt;/li&gt;&lt;li&gt;â€¢ antibodies and phagocytic cells to clear microbes and damaged cells, promote inflammation,&lt;/li&gt;&lt;li&gt;â€¢ cell membrane. IgG&lt;/li&gt;&lt;li&gt;â€¢ immune response by binding to pathogens and marking them for destruction&lt;/li&gt;&lt;li&gt;â€¢ immune response and opsonization,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ sensation of pain.&lt;/li&gt;&lt;li&gt;â€¢ Option B. IL-1 and TNF are cytokines that play a central role in the regulation of immune and inflammatory responses . IL-1 induces fever and the production of other cytokines , while TNF has a wide range of pro-inflammatory effects, including the activation of endothelial cells and leukocytes . They can indirectly contribute to pain by promoting the inflammatory process , but they are not the primary chemical mediators directly responsible for pain sensation.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ IL-1 and TNF&lt;/li&gt;&lt;li&gt;â€¢ cytokines&lt;/li&gt;&lt;li&gt;â€¢ immune and inflammatory responses&lt;/li&gt;&lt;li&gt;â€¢ IL-1&lt;/li&gt;&lt;li&gt;â€¢ fever&lt;/li&gt;&lt;li&gt;â€¢ other cytokines&lt;/li&gt;&lt;li&gt;â€¢ TNF&lt;/li&gt;&lt;li&gt;â€¢ pro-inflammatory effects,&lt;/li&gt;&lt;li&gt;â€¢ activation of&lt;/li&gt;&lt;li&gt;â€¢ endothelial cells and leukocytes&lt;/li&gt;&lt;li&gt;â€¢ pain by promoting the inflammatory process&lt;/li&gt;&lt;li&gt;â€¢ Option C. Histamine is released by mast cells and plays a role in the local immune response to foreign pathogens . It causes dilation of the capillaries, contraction of smooth muscle, and increased gastric acid secretion , leading to symptoms like swelling, redness, and itching . Serotonin is a neurotransmitter that can modulate mood and pain perception centrally, but peripherally, it can contribute to vasoconstriction and blood clotting . While both histamine and serotonin contribute to inflammation and can cause discomfort, they are not the main mediators for pain in acute inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Histamine&lt;/li&gt;&lt;li&gt;â€¢ mast cells&lt;/li&gt;&lt;li&gt;â€¢ local immune response to foreign pathogens&lt;/li&gt;&lt;li&gt;â€¢ dilation of the capillaries, contraction of smooth muscle, and increased gastric acid secretion&lt;/li&gt;&lt;li&gt;â€¢ swelling, redness, and itching&lt;/li&gt;&lt;li&gt;â€¢ Serotonin&lt;/li&gt;&lt;li&gt;â€¢ neurotransmitter&lt;/li&gt;&lt;li&gt;â€¢ mood and pain perception&lt;/li&gt;&lt;li&gt;â€¢ vasoconstriction and blood clotting&lt;/li&gt;&lt;li&gt;â€¢ both histamine and serotonin contribute to inflammation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male presents with a non-healing ulcer on his left foot. Biopsy reveals the presence of granulomas on histological examination. Which of the following diseases is most likely to be associated with this finding?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tuberculosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rheumatoid arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Systemic lupus erythematosus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sarcoidosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Tuberculosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Tuberculosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. While RA can lead to chronic inflammation and the formation of rheumatoid nodules (which are granuloma-like structures), it is not typically associated with granulomatous inflammation or non-healing ulcers on the skin.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ RA&lt;/li&gt;&lt;li&gt;â€¢ chronic inflammation and the formation of rheumatoid nodules (which are granuloma-like structures),&lt;/li&gt;&lt;li&gt;â€¢ Option C . Lesions in SLE are more typically characterized by interface dermatitis rather than granulomas.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ SLE&lt;/li&gt;&lt;li&gt;â€¢ interface dermatitis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sarcoidosis: Sarcoidosis is a multisystem inflammatory disease characterized by non-caseating granulomas. It can affect any organ, most commonly the lungs and lymph nodes . Skin involvement in sarcoidosis can occur, and while sarcoidosis can cause skin lesions , they do not typically present as non-healing ulcers.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Sarcoidosis:&lt;/li&gt;&lt;li&gt;â€¢ multisystem inflammatory disease&lt;/li&gt;&lt;li&gt;â€¢ non-caseating granulomas.&lt;/li&gt;&lt;li&gt;â€¢ lungs and lymph nodes&lt;/li&gt;&lt;li&gt;â€¢ sarcoidosis can cause skin lesions&lt;/li&gt;&lt;li&gt;â€¢ do not&lt;/li&gt;&lt;li&gt;â€¢ non-healing ulcers.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with a non-healing ulcer on the lower extremity and granulomas on histological examination , tuberculosis is one the most likely cause in India.&lt;/li&gt;&lt;li&gt;âž¤ non-healing ulcer on the lower extremity&lt;/li&gt;&lt;li&gt;âž¤ granulomas on histological examination&lt;/li&gt;&lt;li&gt;âž¤ tuberculosis&lt;/li&gt;&lt;li&gt;âž¤ India.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All are involved in generating free oxygen radical for killing of bacteria except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Superoxide dismutase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fentonâ€™s reaction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;NADPH oxidase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glutathion peroxidase&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Glutathion peroxidase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Glutathion peroxidase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Superoxide Dismutase (SOD) is an antioxidant enzyme that protects cells from the damaging effects of superoxide radicals (O2â€¢âˆ’) by catalyzing their conversion to oxygen (O2) and hydrogen peroxide (H2O2). It is crucial in modulating ROS levels and preventing cellular damage, but it does not directly generate free radicals for bacterial killing.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Superoxide Dismutase (SOD)&lt;/li&gt;&lt;li&gt;â€¢ antioxidant enzyme&lt;/li&gt;&lt;li&gt;â€¢ protects cells&lt;/li&gt;&lt;li&gt;â€¢ superoxide radicals (O2â€¢âˆ’)&lt;/li&gt;&lt;li&gt;â€¢ oxygen (O2) and hydrogen peroxide (H2O2).&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ free radicals for bacterial killing.&lt;/li&gt;&lt;li&gt;â€¢ Option B. The Fenton reaction describes the iron-catalyzed conversion of hydrogen peroxide into hydroxyl radicals (â€¢OH), which are highly reactive and can cause significant damage to cellular components. This reaction can contribute to the bactericidal activity of phagocytes following engulfment of pathogens .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Fenton reaction&lt;/li&gt;&lt;li&gt;â€¢ iron-catalyzed&lt;/li&gt;&lt;li&gt;â€¢ hydrogen peroxide into hydroxyl radicals (â€¢OH),&lt;/li&gt;&lt;li&gt;â€¢ highly reactive&lt;/li&gt;&lt;li&gt;â€¢ damage to cellular components.&lt;/li&gt;&lt;li&gt;â€¢ bactericidal activity of phagocytes following engulfment of pathogens&lt;/li&gt;&lt;li&gt;â€¢ Option C. NADPH oxidase is a critical enzyme in phagocytes that generates superoxide radicals (O2â€¢âˆ’) by transferring electrons from NADPH to molecular oxygen (O2) . This process is a key step in the respiratory burst t hat occurs during phagocytosis, leading to the production of other ROS that aid in killing engulfed bacteria.&lt;/li&gt;&lt;li&gt;â€¢ Option C. NADPH oxidase&lt;/li&gt;&lt;li&gt;â€¢ phagocytes&lt;/li&gt;&lt;li&gt;â€¢ superoxide radicals (O2â€¢âˆ’)&lt;/li&gt;&lt;li&gt;â€¢ NADPH to molecular oxygen (O2)&lt;/li&gt;&lt;li&gt;â€¢ respiratory burst t&lt;/li&gt;&lt;li&gt;â€¢ during phagocytosis,&lt;/li&gt;&lt;li&gt;â€¢ ROS that aid in killing engulfed bacteria.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Glutathione peroxidase is the enzyme that functions primarily to neutralize hydrogen peroxide, not to produce ROS for microbial killing. It acts to safeguard the cell from the potentially harmful effects of oxidative stress.&lt;/li&gt;&lt;li&gt;âž¤ Glutathione peroxidase&lt;/li&gt;&lt;li&gt;âž¤ functions&lt;/li&gt;&lt;li&gt;âž¤ hydrogen peroxide,&lt;/li&gt;&lt;li&gt;âž¤ safeguard the cell from the potentially harmful effects of oxidative stress.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman presents with a red, swollen and painful right ankle after twisting it while playing soccer. Examination reveals a warm, tender, and erythematous ankle. Which of the following mechanisms is responsible for the redness and warmth of the affected area?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased vascular permeability&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vasodilation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chemotaxis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Opsonization&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Vasodilation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Vasodilation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increased vascular permeability occurs as part of the inflammatory response , allowing plasma proteins and leukocytes to leave the circulation and enter the site of injury or infection. This is essential for delivering immune cells and mediators to the affected tissue but is more associated with swelling and pain than with redness and warmth.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Increased vascular permeability&lt;/li&gt;&lt;li&gt;â€¢ inflammatory response&lt;/li&gt;&lt;li&gt;â€¢ plasma proteins and leukocytes&lt;/li&gt;&lt;li&gt;â€¢ injury or infection.&lt;/li&gt;&lt;li&gt;â€¢ immune cells and mediators to the affected tissue&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chemotaxis refers to the movement of cells, particularly leukocytes, towards the site of injury in response to chemical signals. While chemotaxis is a crucial component of the inflammatory response, leading to the accumulation of immune cells at the site of damage , it does not directly cause redness or warmth.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ movement of cells, particularly leukocytes, towards the site of injury&lt;/li&gt;&lt;li&gt;â€¢ chemical signals.&lt;/li&gt;&lt;li&gt;â€¢ immune cells at the site of damage&lt;/li&gt;&lt;li&gt;â€¢ Option D. Opsonization involves the marking of pathogens for destruction by immune cells . Opsonins, such as antibodies or components of the complement system, coat the surface of pathogens , making them more recognizable and easier to engulf by phagocytes . This process is integral to the immune response but does not result in the redness or warmth of inflamed tissue.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Opsonization&lt;/li&gt;&lt;li&gt;â€¢ marking of pathogens for destruction by immune cells&lt;/li&gt;&lt;li&gt;â€¢ antibodies or components&lt;/li&gt;&lt;li&gt;â€¢ coat the surface of pathogens&lt;/li&gt;&lt;li&gt;â€¢ recognizable and easier to engulf by phagocytes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Vasodilation is the process responsible for the redness and warmth in the affected area of an acute injury, as it increases blood flow to the site , bringing with it immune cells and nutrients necessary for tissue repair.&lt;/li&gt;&lt;li&gt;âž¤ Vasodilation&lt;/li&gt;&lt;li&gt;âž¤ responsible for the redness and warmth&lt;/li&gt;&lt;li&gt;âž¤ increases blood flow to the site&lt;/li&gt;&lt;li&gt;âž¤ immune cells and nutrients necessary for tissue repair.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;This specimen shows mixed acute and chronic inflammation. Which of the following best reflects the order of events which led to neutrophil infiltration of the tissue?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Adhesion, margination, migration through tissues, migration across vessel wall, rolling.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Adhesion, margination, rolling, migration through tissues, migration across vessel wall.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Margination, rolling, adhesion, migration across vessel wall, migration through tissues.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Migration across vessel wall, margination, rolling, adhesion, migration through tissues.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Margination, rolling, adhesion, migration across vessel wall, migration through tissues.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Margination, rolling, adhesion, migration across vessel wall, migration through tissues.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Margination, Rolling, Adhesion, Migration across Vessel Wall, Migration through Tissues&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Margination is the process by which neutrophils move to the periphery of the blood vessels at the site of inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Margination&lt;/li&gt;&lt;li&gt;â€¢ neutrophils move to the periphery of the blood vessels&lt;/li&gt;&lt;li&gt;â€¢ Rolling is the next step where neutrophils roll along the vessel wall, slowed down by selectins .&lt;/li&gt;&lt;li&gt;â€¢ Rolling&lt;/li&gt;&lt;li&gt;â€¢ neutrophils roll along the vessel wall, slowed down by selectins&lt;/li&gt;&lt;li&gt;â€¢ Adhesion is where neutrophils firmly adhere to the endothelium via integrins .&lt;/li&gt;&lt;li&gt;â€¢ Adhesion&lt;/li&gt;&lt;li&gt;â€¢ neutrophils firmly adhere to the endothelium via integrins&lt;/li&gt;&lt;li&gt;â€¢ Migration across the vessel wall, or transmigration, occurs next as neutrophils pass through the endothelium. Finally, migration through tissues allows neutrophils to move towards the inflammatory stimulus .&lt;/li&gt;&lt;li&gt;â€¢ Migration across the vessel wall,&lt;/li&gt;&lt;li&gt;â€¢ transmigration,&lt;/li&gt;&lt;li&gt;â€¢ neutrophils&lt;/li&gt;&lt;li&gt;â€¢ endothelium.&lt;/li&gt;&lt;li&gt;â€¢ neutrophils to move towards the inflammatory stimulus&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The correct order of events leading to neutrophil infiltration during acute inflammation is C. Margination, rolling, adhesion, migration across vessel wall, and migration through tissues.&lt;/li&gt;&lt;li&gt;âž¤ neutrophil infiltration during acute inflammation&lt;/li&gt;&lt;li&gt;âž¤ Margination, rolling, adhesion, migration across vessel wall, and migration through tissues.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In acute inflammation endothelial cell contraction leads to:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Delayed transient increase in permeability&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Immediate transient increase in permeability&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Delayed prolonged increase in permeability&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Immediate transient decrease in permeability&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Immediate transient increase in permeability&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/screenshot-2024-04-24-103848.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Endothelial cell contraction is a rapid response to inflammatory mediators like histamine and bradykinin. This contraction leads to the formation of gaps between endothelial cells, allowing for the immediate passage of fluid and small molecules into the surrounding tissue. This increase in permeability is transient, typically lasting for 15-30 minutes.&lt;/li&gt;&lt;li&gt;â€¢ Other options:&lt;/li&gt;&lt;li&gt;â€¢ Other options:&lt;/li&gt;&lt;li&gt;â€¢ A. Delayed transient increase in permeability: While some mechanisms of increased permeability can be delayed, endothelial contraction results in an immediate increase. c. Delayed prolonged increase in permeability: Endothelial cell contraction is an immediate response, not a delayed one. Additionally, the increase in permeability caused by contraction is transient, not prolonged. d. Immediate transient decrease in permeability: Endothelial contraction leads to an increase, not a decrease, in permeability.&lt;/li&gt;&lt;li&gt;â€¢ A. Delayed transient increase in permeability: While some mechanisms of increased permeability can be delayed, endothelial contraction results in an immediate increase.&lt;/li&gt;&lt;li&gt;â€¢ A. Delayed transient increase in permeability:&lt;/li&gt;&lt;li&gt;â€¢ c. Delayed prolonged increase in permeability: Endothelial cell contraction is an immediate response, not a delayed one. Additionally, the increase in permeability caused by contraction is transient, not prolonged.&lt;/li&gt;&lt;li&gt;â€¢ c. Delayed prolonged increase in permeability:&lt;/li&gt;&lt;li&gt;â€¢ d. Immediate transient decrease in permeability: Endothelial contraction leads to an increase, not a decrease, in permeability.&lt;/li&gt;&lt;li&gt;â€¢ d. Immediate transient decrease in permeability:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Endothelial cell contraction is an important mechanism in acute inflammation, leading to an immediate and transient increase in vascular permeability.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;After binding of complement and antibody on the surface of encapsulated bacteria, the process of phagocytosis by polymorphonuclear leukocytes involves which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fc and C3b&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Receptor-mediated endocytosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Respiratory burst&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pseudopod extension&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pseudopod extension&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Pseudopod extension&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Both Fc fragment of IgG and C3b are required in opsonization . It takes place before phagocytosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ IgG and C3b&lt;/li&gt;&lt;li&gt;â€¢ opsonization&lt;/li&gt;&lt;li&gt;â€¢ phagocytosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Respiratory burst occurs after the formation of the phagolysosome.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Respiratory burst&lt;/li&gt;&lt;li&gt;â€¢ phagolysosome.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Receptor-mediated endocytosis is a process by which cells internalize molecules (such as proteins) by the inward budding of plasma membrane vesicles containing proteins with receptor sites specific to the molecules being internalized. While this is a form of cellular uptake, it is not the primary mechanism by which PMNs phagocytose pathogens.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Receptor-mediated endocytosis&lt;/li&gt;&lt;li&gt;â€¢ cells internalize&lt;/li&gt;&lt;li&gt;â€¢ molecules (such as proteins)&lt;/li&gt;&lt;li&gt;â€¢ budding of plasma membrane vesicles&lt;/li&gt;&lt;li&gt;â€¢ receptor sites&lt;/li&gt;&lt;li&gt;â€¢ internalized.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ After the binding of complement and antibody on the surface of encapsulated bacteria , pseudopod extension is the physical act of phagocytosis where the PMN&#x27;s cytoplasm extends to surround and engulf the pathogen .&lt;/li&gt;&lt;li&gt;âž¤ complement and antibody&lt;/li&gt;&lt;li&gt;âž¤ encapsulated bacteria&lt;/li&gt;&lt;li&gt;âž¤ pseudopod extension&lt;/li&gt;&lt;li&gt;âž¤ phagocytosis&lt;/li&gt;&lt;li&gt;âž¤ PMN&#x27;s cytoplasm&lt;/li&gt;&lt;li&gt;âž¤ surround and engulf the pathogen&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / p78&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / p78&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Most infections follow the stereotypic pattern â€“ first appearance of neutrophils followed by macrophages, which of the following infections is an exception to this case?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Staphylococcus aureus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Streptococcus pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pseudomonas&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Listeria monocytogenes&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pseudomonas&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Pseudomonas&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Staphylococcus aureus infections typically follow the classic acute inflammatory response with an initial predominance of neutrophils . These are common bacteria that can cause a wide range of illnesses, from minor skin infections to life-threatening diseases , and the initial immune response is usually marked by neutrophilic infiltration .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Staphylococcus aureus&lt;/li&gt;&lt;li&gt;â€¢ classic acute inflammatory response&lt;/li&gt;&lt;li&gt;â€¢ neutrophils&lt;/li&gt;&lt;li&gt;â€¢ wide range of illnesses, from minor skin infections to life-threatening diseases&lt;/li&gt;&lt;li&gt;â€¢ neutrophilic infiltration&lt;/li&gt;&lt;li&gt;â€¢ Option B. Streptococcus pneumoniae , a common cause of pneumonia and other infections, also elicits a typical acute inflammatory response. The bodyâ€™s initial defense mechanism against such encapsulated bacteria often involves a strong neutrophil response to contain the infection .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Streptococcus pneumoniae&lt;/li&gt;&lt;li&gt;â€¢ typical acute inflammatory response.&lt;/li&gt;&lt;li&gt;â€¢ encapsulated bacteria&lt;/li&gt;&lt;li&gt;â€¢ strong neutrophil&lt;/li&gt;&lt;li&gt;â€¢ infection&lt;/li&gt;&lt;li&gt;â€¢ Option D. Listeria monocytogenes infections typically induce a mixed inflammatory response , which includes a significant number of neutrophils , but the immune response also prominently features macrophages and T cells . This bacterium is intracellular and requires cell-mediated immunity for its clearance; hence, T cells and macrophages are crucial.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Listeria monocytogenes&lt;/li&gt;&lt;li&gt;â€¢ mixed inflammatory response&lt;/li&gt;&lt;li&gt;â€¢ neutrophils&lt;/li&gt;&lt;li&gt;â€¢ prominently features macrophages and T cells&lt;/li&gt;&lt;li&gt;â€¢ bacterium is intracellular and requires cell-mediated immunity&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Unlike most infections, which have a stereotypic pattern of neutrophilic infiltration followed by a lymphocytic and monocytic response , Pseudomonas infections are characterized by a prolonged recruitment of neutrophils .&lt;/li&gt;&lt;li&gt;âž¤ stereotypic pattern of neutrophilic infiltration&lt;/li&gt;&lt;li&gt;âž¤ lymphocytic and monocytic response&lt;/li&gt;&lt;li&gt;âž¤ Pseudomonas&lt;/li&gt;&lt;li&gt;âž¤ prolonged recruitment of neutrophils&lt;/li&gt;&lt;li&gt;âž¤ Other exceptions to the stereotypic pattern are:&lt;/li&gt;&lt;li&gt;âž¤ Other exceptions&lt;/li&gt;&lt;li&gt;âž¤ Viral infections, lymphocytes may be the first cells to arrive. Some hypersensitivity reactions are dominated by activated lymphocytes, macrophages, and plasma cells (reflecting the immune response); and in Helminthic infections and allergic reactions, eosinophils may be the main cell type.&lt;/li&gt;&lt;li&gt;âž¤ Viral infections, lymphocytes may be the first cells to arrive.&lt;/li&gt;&lt;li&gt;âž¤ Viral infections, lymphocytes&lt;/li&gt;&lt;li&gt;âž¤ Some hypersensitivity reactions are dominated by activated lymphocytes, macrophages, and plasma cells (reflecting the immune response); and in&lt;/li&gt;&lt;li&gt;âž¤ hypersensitivity reactions&lt;/li&gt;&lt;li&gt;âž¤ lymphocytes, macrophages, and plasma cells (reflecting the immune response);&lt;/li&gt;&lt;li&gt;âž¤ Helminthic infections and allergic reactions, eosinophils may be the main cell type.&lt;/li&gt;&lt;li&gt;âž¤ Helminthic infections and allergic reactions, eosinophils&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran Pathologic Basis of disease 10th ed- Pg: 79&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran Pathologic Basis of disease 10th ed- Pg: 79&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-day female infant presented with recurrent bacterial infections and suspected developmental delay. Extensive screening was performed and a defect in CD 18 gene resulted in deficient beta-2 integrins. Which of the following steps of inflammation could be severely affected in this infant?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Diapedesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Adhesion&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Margination&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rolling&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Adhesion&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/05/screenshot-2024-02-05-160906_YCS9bdv.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Adhesion&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Beta-2 integrins , which are deficient in this infant due to a CD18 gene defect , are critical for leukocyte adhesion to the endothelium , an essential step for proper immune function and a process that is severely affected in conditions like Leukocyte Adhesion Deficiency .&lt;/li&gt;&lt;li&gt;âž¤ Beta-2 integrins&lt;/li&gt;&lt;li&gt;âž¤ deficient in this infant due to a CD18 gene defect&lt;/li&gt;&lt;li&gt;âž¤ leukocyte adhesion to the endothelium&lt;/li&gt;&lt;li&gt;âž¤ immune function and a process&lt;/li&gt;&lt;li&gt;âž¤ Leukocyte Adhesion Deficiency&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran Pathologic Basis of disease 10th ed- Pg: 78&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran Pathologic Basis of disease 10th ed- Pg: 78&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT involved in chemotaxis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;C5a&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IL-8&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IL-12&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Leukotriene- B4&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. IL-12&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/05/screenshot-2024-02-05-161445.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) IL-12&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. C5a is a component of the complement system that acts as a potent chemoattractant. It plays a crucial role in immune responses by attracting neutrophils and monocytes to sites of infection or inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. C5a&lt;/li&gt;&lt;li&gt;â€¢ Option B. IL-8 , or interleukin-8, is a chemokine produced by various cell types, including macrophages and epithelial cells. It has a strong chemotactic activity for neutrophils, guiding them to the site of infection or tissue injury.&lt;/li&gt;&lt;li&gt;â€¢ Option B. IL-8&lt;/li&gt;&lt;li&gt;â€¢ Option D. Leukotriene B4 (LTB4) is a lipid mediator produced from arachidonic acid. It serves as a strong chemoattractant and activator of neutrophils, leading them towards areas of inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Leukotriene B4&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ IL-12 does not act as a chemoattractant; instead, it is involved in the activation of T cells and NK cells and the production of IFN-gamma.&lt;/li&gt;&lt;li&gt;âž¤ IL-12&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran Pathologic Basis of disease 10th ed- Pg:  79, 89&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran Pathologic Basis of disease 10th ed- Pg:  79, 89&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Match the following:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1c-2b-3a&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1b-2a-3c&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1a-2b-3c&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1c-2a-3b&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 1b-2a-3c&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/06/screenshot-2024-02-06-174328.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 1b-2a-3c&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Actions of Nitric Oxide&lt;/li&gt;&lt;li&gt;â€¢ Actions of Nitric Oxide&lt;/li&gt;&lt;li&gt;â€¢ iNOS- Microbial killing eNOS- Vasodilation nNOS- Neurotransmitter&lt;/li&gt;&lt;li&gt;â€¢ iNOS- Microbial killing&lt;/li&gt;&lt;li&gt;â€¢ iNOS- Microbial killing&lt;/li&gt;&lt;li&gt;â€¢ eNOS- Vasodilation&lt;/li&gt;&lt;li&gt;â€¢ eNOS- Vasodilation&lt;/li&gt;&lt;li&gt;â€¢ nNOS- Neurotransmitter&lt;/li&gt;&lt;li&gt;â€¢ nNOS- Neurotransmitter&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins and Cotran Pathologic Basis of disease 10th ed- Pg: 83&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Robbins and Cotran Pathologic Basis of disease 10th ed- Pg: 83&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following diseases is associated with an over-activation in the complement pathway?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Systemic lupus erythematosus (SLE)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Multiple sclerosis (MS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hereditary angioedema (HAE)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Psoriasis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hereditary angioedema (HAE)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Hereditary angioedema&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Systemic Lupus Erythematosus (SLE): SLE is an autoimmune disease characterized by the production of autoantibodies that form immune complexes. These complexes can trigger the complement system , often leading to complement depletion . It is not typically associated with an over-activation of the complement pathway.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Systemic Lupus Erythematosus (SLE):&lt;/li&gt;&lt;li&gt;â€¢ autoimmune disease&lt;/li&gt;&lt;li&gt;â€¢ immune complexes.&lt;/li&gt;&lt;li&gt;â€¢ trigger the complement system&lt;/li&gt;&lt;li&gt;â€¢ complement depletion&lt;/li&gt;&lt;li&gt;â€¢ Option B. Multiple Sclerosis (MS): MS is a chronic autoimmune, inflammatory neurological disease that primarily affects the central nervous system . The complement system may play a role in the pathology of MS ; however, it is not characterized by over-activation of the complement pathway.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Multiple Sclerosis (MS):&lt;/li&gt;&lt;li&gt;â€¢ chronic autoimmune, inflammatory neurological disease&lt;/li&gt;&lt;li&gt;â€¢ central nervous system&lt;/li&gt;&lt;li&gt;â€¢ may play a role in the pathology of MS&lt;/li&gt;&lt;li&gt;â€¢ Option D. Psoriasis is a chronic inflammatory skin disease with a complex pathogenesis involving the immune system . While the complement system may be activated as part of the inflammatory process in psoriasis , the disease is not primarily associated with an over-activation of the complement pathway.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ chronic inflammatory skin disease&lt;/li&gt;&lt;li&gt;â€¢ immune system&lt;/li&gt;&lt;li&gt;â€¢ complement system&lt;/li&gt;&lt;li&gt;â€¢ activated&lt;/li&gt;&lt;li&gt;â€¢ inflammatory process in psoriasis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ HAE is associated with over-activation of the complement pathway due to C1 inhibitor deficiency , leading to excessive bradykinin release and recurrent angioedema.&lt;/li&gt;&lt;li&gt;âž¤ HAE&lt;/li&gt;&lt;li&gt;âž¤ over-activation&lt;/li&gt;&lt;li&gt;âž¤ complement pathway&lt;/li&gt;&lt;li&gt;âž¤ C1 inhibitor deficiency&lt;/li&gt;&lt;li&gt;âž¤ bradykinin release&lt;/li&gt;&lt;li&gt;âž¤ recurrent angioedema.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman presents to the clinic with complaints of joint pain and swelling in her knees and fingers for the past 6 months. She reports a history of asthma and hypertension, for which she takes regular medications. On examination, there is tenderness and swelling in the affected joints, and laboratory investigations show an elevated level of C-reactive protein (CRP). Which of the following arachidonic acid metabolites is most likely responsible for the patient&#x27;s symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prostaglandins&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Leukotrienes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thromboxanes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lipoxins&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Prostaglandins&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Prostaglandins&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Leukotrienes are produced from arachidonic acid via the lipoxygenase pathway and are primarily involved in the pathogenesis of asthma and allergic reactions. While they contribute to inflammation, they are not the main mediators of pain and joint destruction in rheumatoid arthritis.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Leukotrienes&lt;/li&gt;&lt;li&gt;â€¢ arachidonic acid via the lipoxygenase pathway&lt;/li&gt;&lt;li&gt;â€¢ asthma and allergic reactions.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thromboxanes are also derived from arachidonic acid and are involved in platelet aggregation and vasoconstriction . They play a role in thrombosis and hemostasis but are not directly responsible for the symptoms of rheumatoid arthritis, such as joint pain and swelling.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Thromboxanes&lt;/li&gt;&lt;li&gt;â€¢ arachidonic acid&lt;/li&gt;&lt;li&gt;â€¢ platelet aggregation and vasoconstriction&lt;/li&gt;&lt;li&gt;â€¢ thrombosis and hemostasis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lipoxins are anti-inflammatory and pro-resolving lipid mediators that can inhibit neutrophil chemotaxis and adhesion. They are involved in the resolution phase of inflammation and do not contribute to the symptoms of rheumatoid arthritis.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ anti-inflammatory and pro-resolving lipid mediators&lt;/li&gt;&lt;li&gt;â€¢ neutrophil chemotaxis and adhesion.&lt;/li&gt;&lt;li&gt;â€¢ resolution phase of inflammation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In rheumatoid arthritis , prostaglandins are significant contributors to the clinical manifestations of pain, inflammation, and joint destruction .&lt;/li&gt;&lt;li&gt;âž¤ rheumatoid arthritis&lt;/li&gt;&lt;li&gt;âž¤ prostaglandins&lt;/li&gt;&lt;li&gt;âž¤ pain, inflammation, and joint destruction&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Activated Partial thromboplastin time correlates with which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Platelet functions and common pathway&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Extrinsic and common pathway&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intrinsic and common pathway&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vessel wall integrity and intrinsic pathway&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Intrinsic and common pathway&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Intrinsic and common pathway&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Platelet function tests assess platelet aggregation and adhesion , which are not measured by the aPTT. The aPTT test measures factors in the intrinsic and common coagulation pathways but not platelet function.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Platelet function&lt;/li&gt;&lt;li&gt;â€¢ platelet aggregation and adhesion&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ aPTT.&lt;/li&gt;&lt;li&gt;â€¢ aPTT test&lt;/li&gt;&lt;li&gt;â€¢ intrinsic and common coagulation pathways&lt;/li&gt;&lt;li&gt;â€¢ not platelet function.&lt;/li&gt;&lt;li&gt;â€¢ Option B. The extrinsic pathway is assessed by the Prothrombin time (PT) test and involves factor VII. The aPTT does not evaluate the extrinsic pathway.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ extrinsic pathway&lt;/li&gt;&lt;li&gt;â€¢ Prothrombin time (PT) test&lt;/li&gt;&lt;li&gt;â€¢ VII.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vessel wall integrity is not specifically assessed by the aPTT . The intrinsic pathway does involve endothelial interaction , but the aPTT test does not measure vessel wall function.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Vessel wall integrity&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ aPTT&lt;/li&gt;&lt;li&gt;â€¢ intrinsic pathway&lt;/li&gt;&lt;li&gt;â€¢ endothelial interaction&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The activated Partial thromboplastin time (aPTT) test evaluates the factors of the intrinsic and common coagulation pathways and is used to monitor heparin therapy, diagnose coagulation factor deficiencies , and assess the potential presence of inhibitors .&lt;/li&gt;&lt;li&gt;âž¤ activated Partial thromboplastin time (aPTT)&lt;/li&gt;&lt;li&gt;âž¤ intrinsic and common coagulation pathways&lt;/li&gt;&lt;li&gt;âž¤ monitor heparin therapy,&lt;/li&gt;&lt;li&gt;âž¤ coagulation factor deficiencies&lt;/li&gt;&lt;li&gt;âž¤ potential presence of inhibitors&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following are properties of neutrophils? Short living inflammatory response Involved in Neutrophil Extracellular trap (NET) formation Produces large quantities of nitric oxide Major site for production of cytokines&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Only 1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1 and 2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1, 2 and 3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1,2, 3 and 4&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 1 and 2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/screenshot-2024-04-24-110356.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 1 and 2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Neutrophils contribute to early defense mechanisms in infection through rapid, potent inflammatory responses and the formation of NETs .&lt;/li&gt;&lt;li&gt;âž¤ early defense mechanisms in infection through rapid, potent inflammatory responses and the formation of NETs&lt;/li&gt;&lt;li&gt;âž¤ Differences between the functions of neutrophils and macrophages&lt;/li&gt;&lt;li&gt;âž¤ Differences between the functions of neutrophils and macrophages&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran Pathologic Basis of disease 10th ed- Pg: 81&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran Pathologic Basis of disease 10th ed- Pg: 81&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which one of the following is a false statement about Neutrophil Extracellular Trap (NETs)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;They are extracellular fibrillar networks preventing spread of microbes by trapping them&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;They provide high concentration of antimicrobial substances at site of infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Neutrophils remain intact after producing the network&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The network contains nuclear chromatin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Neutrophils remain intact after producing the network&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Neutrophils remain intact after producing the network&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. This statement is true . NETs are composed of decondensed chromatin and granular proteins , and they serve to trap bacteria, fungi, and other pathogens , thereby limiting their spread and facilitating their destruction .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;li&gt;â€¢ decondensed chromatin and granular proteins&lt;/li&gt;&lt;li&gt;â€¢ bacteria, fungi, and other pathogens&lt;/li&gt;&lt;li&gt;â€¢ limiting&lt;/li&gt;&lt;li&gt;â€¢ spread and facilitating their destruction&lt;/li&gt;&lt;li&gt;â€¢ Option B. This statement is also true. NETs concentrate antimicrobial proteins from neutrophil granules, including enzymes like neutrophil elastase and myeloperoxidase , which help to neutralize pathogens.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ true. NETs concentrate antimicrobial proteins&lt;/li&gt;&lt;li&gt;â€¢ neutrophil elastase and myeloperoxidase&lt;/li&gt;&lt;li&gt;â€¢ neutralize pathogens.&lt;/li&gt;&lt;li&gt;â€¢ Option D. NETs are composed of DNA fibers that are expelled from the neutrophil and are associated with histones and other proteins , which give NETs their characteristic appearance and functionality.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ NETs&lt;/li&gt;&lt;li&gt;â€¢ DNA fibers&lt;/li&gt;&lt;li&gt;â€¢ neutrophil&lt;/li&gt;&lt;li&gt;â€¢ histones&lt;/li&gt;&lt;li&gt;â€¢ proteins&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ NETosis , the process of forming Neutrophil Extracellular Traps , leads to the release of nuclear contents and cell death .&lt;/li&gt;&lt;li&gt;âž¤ NETosis&lt;/li&gt;&lt;li&gt;âž¤ Neutrophil Extracellular Traps&lt;/li&gt;&lt;li&gt;âž¤ nuclear contents and cell death&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following are opsonins? Mannose binding lectin C3b C5a IL-6 IgG&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1,2,3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1,4,5&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1,2,5&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;3,5&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 1,2,5&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 1,2,5&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Opsonization is the process of coating a foreign particle and preparing it for phagocytosis . Important examples include:&lt;/li&gt;&lt;li&gt;â€¢ Opsonization&lt;/li&gt;&lt;li&gt;â€¢ foreign particle&lt;/li&gt;&lt;li&gt;â€¢ phagocytosis&lt;/li&gt;&lt;li&gt;â€¢ Mannose binding lectin C3b, C4b, C5b IgM and Fc receptor of IgG C-reactive protein (CRP) Fibrinogen&lt;/li&gt;&lt;li&gt;â€¢ Mannose binding lectin&lt;/li&gt;&lt;li&gt;â€¢ C3b, C4b, C5b&lt;/li&gt;&lt;li&gt;â€¢ IgM and Fc receptor of IgG&lt;/li&gt;&lt;li&gt;â€¢ C-reactive protein (CRP)&lt;/li&gt;&lt;li&gt;â€¢ Fibrinogen&lt;/li&gt;&lt;li&gt;â€¢ Since C5a is a chemotactic meolecule and IL-6 is an acute phase reactant, so options A, B and D are incorrect.&lt;/li&gt;&lt;li&gt;â€¢ C5a is a chemotactic meolecule&lt;/li&gt;&lt;li&gt;â€¢ IL-6 is an acute phase reactant,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Mannose-binding lectin, C3b, and IgG are opsonins that aid in the phagocytosis of pathogens.&lt;/li&gt;&lt;li&gt;âž¤ Mannose-binding lectin, C3b, and IgG&lt;/li&gt;&lt;li&gt;âž¤ opsonins&lt;/li&gt;&lt;li&gt;âž¤ phagocytosis of pathogens.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran Pathologic Basis of disease 10th ed- Pg: 80&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran Pathologic Basis of disease 10th ed- Pg: 80&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not an antioxidant?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Catalase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Superoxide dismutase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phagocyte oxidase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Iron free transferrin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Phagocyte oxidase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Phagocyte oxidase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Catalase is an enzyme found in nearly all living organisms exposed to oxygen . It catalyzes the decomposition of hydrogen peroxide to water and oxygen, thereby protecting the cell from oxidative damage caused by reactive oxygen species (ROS). Thus, it acts as an antioxidant.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Catalase&lt;/li&gt;&lt;li&gt;â€¢ living organisms exposed to oxygen&lt;/li&gt;&lt;li&gt;â€¢ decomposition of hydrogen peroxide to water and oxygen,&lt;/li&gt;&lt;li&gt;â€¢ protecting the cell&lt;/li&gt;&lt;li&gt;â€¢ oxidative damage&lt;/li&gt;&lt;li&gt;â€¢ reactive oxygen species (ROS).&lt;/li&gt;&lt;li&gt;â€¢ antioxidant.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Superoxide Dismutase (SOD) is an enzyme that protects the cell against harmful effects of superoxide radicals by catalyzing their conversion into less harmful molecules, oxygen and hydrogen peroxide . It is indeed an antioxidant enzyme .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Superoxide Dismutase (SOD)&lt;/li&gt;&lt;li&gt;â€¢ cell against harmful effects&lt;/li&gt;&lt;li&gt;â€¢ superoxide radicals&lt;/li&gt;&lt;li&gt;â€¢ catalyzing&lt;/li&gt;&lt;li&gt;â€¢ less harmful molecules, oxygen and hydrogen peroxide&lt;/li&gt;&lt;li&gt;â€¢ antioxidant enzyme&lt;/li&gt;&lt;li&gt;â€¢ Option D. Transferrin is a glycoprotein that binds iron ions and transports them to different parts of the body. Iron-free transferrin, also known as apotransferrin , can bind free iron and, by doing so, limits iron-induced oxidative stress since free iron can catalyze the formation of harmful free radicals. Therefore, it has antioxidant properties .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Transferrin is a glycoprotein&lt;/li&gt;&lt;li&gt;â€¢ iron ions&lt;/li&gt;&lt;li&gt;â€¢ Iron-free transferrin, also known as apotransferrin&lt;/li&gt;&lt;li&gt;â€¢ free iron&lt;/li&gt;&lt;li&gt;â€¢ iron-induced oxidative stress&lt;/li&gt;&lt;li&gt;â€¢ free iron can catalyze&lt;/li&gt;&lt;li&gt;â€¢ harmful free radicals.&lt;/li&gt;&lt;li&gt;â€¢ antioxidant properties&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Unlike the other options listed, phagocyte oxidase is not an antioxidant . Instead, it generates reactive oxygen species as part of the immune response to destroy pathogens.&lt;/li&gt;&lt;li&gt;âž¤ phagocyte oxidase is not an antioxidant&lt;/li&gt;&lt;li&gt;âž¤ reactive oxygen species&lt;/li&gt;&lt;li&gt;âž¤ immune response to destroy pathogens.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran Pathologic Basis of disease 10th ed- Pg: 82&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran Pathologic Basis of disease 10th ed- Pg: 82&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Major basic protein is seen in?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Neutrophils&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Eosinophils&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Basophils&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Macrophages&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Eosinophils&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Eosinophils&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Neutrophils , known for their role in the rapid response to bacterial infection, contain various granules filled with different enzymes and antimicrobial proteins . However, major basic protein is not one of them.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Neutrophils&lt;/li&gt;&lt;li&gt;â€¢ rapid response to bacterial infection,&lt;/li&gt;&lt;li&gt;â€¢ granules&lt;/li&gt;&lt;li&gt;â€¢ enzymes and antimicrobial proteins&lt;/li&gt;&lt;li&gt;â€¢ major basic protein is not&lt;/li&gt;&lt;li&gt;â€¢ Option C. Basophils , similar to mast cells , are involved in allergic reactions and contain histamine and heparin in their granules . They do not contain major basic protein.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Basophils&lt;/li&gt;&lt;li&gt;â€¢ mast cells&lt;/li&gt;&lt;li&gt;â€¢ allergic reactions and contain histamine and heparin in their granules&lt;/li&gt;&lt;li&gt;â€¢ Option D. Macrophages are versatile cells involved in both phagocytosis and antigen presentation . They secrete a wide array of substances but do not contain major basic protein as a predominant component.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Macrophages&lt;/li&gt;&lt;li&gt;â€¢ versatile cells&lt;/li&gt;&lt;li&gt;â€¢ phagocytosis and antigen presentation&lt;/li&gt;&lt;li&gt;â€¢ wide array of substances&lt;/li&gt;&lt;li&gt;â€¢ do not contain major basic protein&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Major basic protein is a key component of eosinophils and has a role in the immune response , particularly in the destruction of helminthic parasites and in allergic reactions .&lt;/li&gt;&lt;li&gt;âž¤ Major basic protein&lt;/li&gt;&lt;li&gt;âž¤ eosinophils&lt;/li&gt;&lt;li&gt;âž¤ immune response&lt;/li&gt;&lt;li&gt;âž¤ helminthic parasites and in allergic reactions&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th Pg 83&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th Pg 83&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not present in the primary granules of neutrophils:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Myeloperoxidase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Defensin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acid hydrolases&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lactoferrin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lactoferrin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Lactoferrin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Options A, B and C are components of primary neutrophilic granules.&lt;/li&gt;&lt;li&gt;â€¢ Options A, B&lt;/li&gt;&lt;li&gt;â€¢ C&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lactoferrin is a component of secondary granules present in neutrophils .&lt;/li&gt;&lt;li&gt;âž¤ Lactoferrin&lt;/li&gt;&lt;li&gt;âž¤ secondary granules&lt;/li&gt;&lt;li&gt;âž¤ neutrophils&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran Pathologic Basis of disease 10th ed- Pg: 82&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran Pathologic Basis of disease 10th ed- Pg: 82&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 1 year old boy had complaints of recurrent fever. He had been treated for severe pneumonia 3 weeks back. Clinical examination revealed mild pallor, oral thrush, micrognathia, low-set right ear. Skin examination was remarkable with patchy hypopigmentation around face, trunk, back, abdomen, perianal region, hands and feet along with hypopigmented silver gray hair. Peripheral smear showed abnormal inclusions as shown in the given image. Identify the defect associated with this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Defective respiratory burst&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Defective phagolysosome fusion&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Defective primary neutrophil granules&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Defect in RAG gene&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Defective phagolysosome fusion&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/05/picture2_9FQIxoB.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Defective phagolysosome fusion&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Seen in Chronic granulomatous disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Chronic granulomatous disease.&lt;/li&gt;&lt;li&gt;â€¢ Option C. MPO deficiency - This condition has minimal susceptibility to infection .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ susceptibility to infection&lt;/li&gt;&lt;li&gt;â€¢ Option D. Associated with X-linked SCID (Severe combined immunodeficiency disease)&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ X-linked SCID (Severe combined immunodeficiency disease)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Chediak-Higashi syndrome is diagnosed by the presence of giant granules in leukocytes and is caused by a defect in the fusion of phagosomes with lysosomes , leading to impaired microbial killing .&lt;/li&gt;&lt;li&gt;âž¤ Chediak-Higashi syndrome&lt;/li&gt;&lt;li&gt;âž¤ giant granules in leukocytes&lt;/li&gt;&lt;li&gt;âž¤ defect in the fusion of phagosomes with lysosomes&lt;/li&gt;&lt;li&gt;âž¤ impaired microbial killing&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran Pathologic Basis of disease 10th ed- Pg: 82,83&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran Pathologic Basis of disease 10th ed- Pg: 82,83&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about reactive oxygen species is true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;MPO catalyzes the conversion of hydrogen peroxide to hypochlorite&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Catalases in peroxisomes help in clearing hydroxyl radicals&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Superoxide anions are generated during Fenton reaction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Manganese superoxide dismutase is located in the cytoplasm&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. MPO catalyzes the conversion of hydrogen peroxide to hypochlorite&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) MPO catalyzes the conversion of hydrogen peroxide to hypochlorite&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Options B. Catalase enzyme decomposes hydroge peroxide to ater and oxygen&lt;/li&gt;&lt;li&gt;â€¢ Options B.&lt;/li&gt;&lt;li&gt;â€¢ Catalase&lt;/li&gt;&lt;li&gt;â€¢ enzyme&lt;/li&gt;&lt;li&gt;â€¢ hydroge peroxide&lt;/li&gt;&lt;li&gt;â€¢ ater and oxygen&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hydroxyl radicals are produced during fenton reaction from superoxide anions .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hydroxyl&lt;/li&gt;&lt;li&gt;â€¢ radicals&lt;/li&gt;&lt;li&gt;â€¢ fenton reaction&lt;/li&gt;&lt;li&gt;â€¢ superoxide anions&lt;/li&gt;&lt;li&gt;â€¢ Option D. Manganese superoxide dismutase is located in the mitochondria&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Manganese&lt;/li&gt;&lt;li&gt;â€¢ superoxide&lt;/li&gt;&lt;li&gt;â€¢ mitochondria&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ MPO catalyzes the conversion of hydrogen peroxide to hypochlorite .&lt;/li&gt;&lt;li&gt;âž¤ MPO&lt;/li&gt;&lt;li&gt;âž¤ hydrogen peroxide to hypochlorite&lt;/li&gt;&lt;li&gt;âž¤ Ref : Pg no.52-53, 82-83, Robbins and Cotran Pathologic basis of diseases 10th edition&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Pg no.52-53, 82-83, Robbins and Cotran Pathologic basis of diseases 10th edition&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All are functions of integrins except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Platelet aggregation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diapedesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cell to cell interactions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Wound healing&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Wound healing&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Wound healing&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Integrins on platelets, specifically Î±IIbÎ²3 , are central to platelet aggregation . When activated, they bind to fibrinogen, which allows platelets to cross-link with each other, a fundamental step in clot formation .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Integrins on platelets,&lt;/li&gt;&lt;li&gt;â€¢ Î±IIbÎ²3&lt;/li&gt;&lt;li&gt;â€¢ platelet aggregation&lt;/li&gt;&lt;li&gt;â€¢ fibrinogen,&lt;/li&gt;&lt;li&gt;â€¢ platelets to cross-link with each other,&lt;/li&gt;&lt;li&gt;â€¢ clot formation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Diapedesis is the process of leukocytes moving through the endothelial junctions of blood vessels to enter the tissue at an inflammation site . Integrins on leukocytes mediate their firm adhesion to the endothelial cells before transmigration.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Diapedesis&lt;/li&gt;&lt;li&gt;â€¢ endothelial junctions of blood vessels to enter the tissue at an inflammation site&lt;/li&gt;&lt;li&gt;â€¢ Integrins on leukocytes&lt;/li&gt;&lt;li&gt;â€¢ firm adhesion to the endothelial cells&lt;/li&gt;&lt;li&gt;â€¢ transmigration.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Integrins facilitate cell-cell adhesive interactions by binding to cell-adhesion molecules on other cells, which is critical for cellular communication and migration .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ cell-cell adhesive interactions&lt;/li&gt;&lt;li&gt;â€¢ cell-adhesion molecules on other cells,&lt;/li&gt;&lt;li&gt;â€¢ cellular communication and migration&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Integrins play a role in specific aspects of wound healing related to cell adhesion and migration but do not encompass the entire process of wound healing, which involves complex interactions and the contribution of various molecules and cell types.&lt;/li&gt;&lt;li&gt;âž¤ Integrins&lt;/li&gt;&lt;li&gt;âž¤ wound healing&lt;/li&gt;&lt;li&gt;âž¤ cell adhesion and migration but do not encompass the entire process of wound healing,&lt;/li&gt;&lt;li&gt;âž¤ Functions of integrins:&lt;/li&gt;&lt;li&gt;âž¤ Functions of integrins:&lt;/li&gt;&lt;li&gt;âž¤ Allow cells to attach t o laminin and fibronectin thus linking the intracellular cytoskeleton with the outside world . Facilitate cell-cell adhesive interactions . Mediate firm adhesion and migration of leukocytes across endothelium and epithelium at sites of inflammation . Play a critical role in platelet aggregation&lt;/li&gt;&lt;li&gt;âž¤ Allow cells to attach t o laminin and fibronectin thus linking the intracellular cytoskeleton with the outside world .&lt;/li&gt;&lt;li&gt;âž¤ o laminin and fibronectin&lt;/li&gt;&lt;li&gt;âž¤ intracellular cytoskeleton&lt;/li&gt;&lt;li&gt;âž¤ outside world&lt;/li&gt;&lt;li&gt;âž¤ Facilitate cell-cell adhesive interactions .&lt;/li&gt;&lt;li&gt;âž¤ cell-cell adhesive interactions&lt;/li&gt;&lt;li&gt;âž¤ Mediate firm adhesion and migration of leukocytes across endothelium and epithelium at sites of inflammation .&lt;/li&gt;&lt;li&gt;âž¤ firm adhesion and migration of leukocytes across endothelium and epithelium at sites of inflammation&lt;/li&gt;&lt;li&gt;âž¤ Play a critical role in platelet aggregation&lt;/li&gt;&lt;li&gt;âž¤ platelet aggregation&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 24-25&lt;/li&gt;&lt;li&gt;âž¤ Ref :&lt;/li&gt;&lt;li&gt;âž¤ Robbins 10 th / 24-25&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man presents to the emergency department with a painful and swollen left leg that has been gradually worsening over the past week. He reports a history of recent surgery on his left leg. Which of the following mechanisms is responsible for the edema formation in the affected leg?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased vascular permeability&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vasodilation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chemotaxis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Opsonization&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Increased vascular permeability&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Increased vascular permeability&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Vasodilation is the widening of blood vessels . While it is a component of inflammation and can contribute to the initial stages of swelling by increasing blood flow to the affected area , it does not directly cause the protein-rich fluid leakage that results in sustained edema.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Vasodilation&lt;/li&gt;&lt;li&gt;â€¢ widening of blood vessels&lt;/li&gt;&lt;li&gt;â€¢ swelling by increasing blood flow to the affected area&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chemotaxis is the movement of immune cells towards a chemical signal , often seen in the context of inflammation where cells migrate towards higher concentrations of certain chemokines released at the site of injury or infection . It is a cellular migratory mechanism and does not directly lead to edema.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chemotaxis&lt;/li&gt;&lt;li&gt;â€¢ immune cells towards a chemical signal&lt;/li&gt;&lt;li&gt;â€¢ cells migrate towards higher concentrations of certain chemokines&lt;/li&gt;&lt;li&gt;â€¢ site of injury or infection&lt;/li&gt;&lt;li&gt;â€¢ Option D. Opsonization is a process by which pathogens are marked for destruction by the immune system . This process enhances the ability of phagocytes to recognize, engulf, and destroy pathogens and does not relate to the development of edema.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Opsonization&lt;/li&gt;&lt;li&gt;â€¢ pathogens are marked for destruction by the immune system&lt;/li&gt;&lt;li&gt;â€¢ phagocytes to recognize, engulf, and destroy pathogens&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The correct answer is A) Increased Vascular Permeability. Post-surgical edema is typically due to increased vascular permeability , which is part of the inflammatory response allowing fluid and proteins to leak into the interstitial tissue, leading to swelling.&lt;/li&gt;&lt;li&gt;âž¤ Increased Vascular Permeability. Post-surgical edema&lt;/li&gt;&lt;li&gt;âž¤ due to increased vascular permeability&lt;/li&gt;&lt;li&gt;âž¤ inflammatory response allowing fluid and proteins to leak into the interstitial tissue, leading to swelling.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An elderly coal miner with a history of smoking and emphysema develops severe air-flow obstruction and expires. His autopsy reveals a â€œblack lung,â€ with coal-dust nodules scattered throughout the parenchyma and a central area of dense fibrosis. The coal dust entrapped within this minerâ€™s lung was sequestered primarily by which of the following cells?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Endothelial cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fibroblasts&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lymphocytes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Macrophages&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Macrophages&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Macrophages&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Endothelial cells line the blood vessels and are involved in the exchange of substances between the bloodstream and surrounding tissues.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Endothelial&lt;/li&gt;&lt;li&gt;â€¢ cells&lt;/li&gt;&lt;li&gt;â€¢ blood vessels&lt;/li&gt;&lt;li&gt;â€¢ exchange of substances between the bloodstream and surrounding tissues.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fibroblasts are the main cell type involved in tissue repair and fibrosis . In response to lung injury, they produce the extracellular matrix and collagen leading to fibrosis, but they do not phagocytose foreign materials such as coal dust .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fibroblasts&lt;/li&gt;&lt;li&gt;â€¢ main cell&lt;/li&gt;&lt;li&gt;â€¢ tissue repair and fibrosis&lt;/li&gt;&lt;li&gt;â€¢ extracellular matrix and collagen leading to fibrosis,&lt;/li&gt;&lt;li&gt;â€¢ do not phagocytose foreign materials&lt;/li&gt;&lt;li&gt;â€¢ coal dust&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lymphocytes , including T and B cells , are primarily involved in the immune response against pathogens and are not known for phagocytosing materials like coal dust .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lymphocytes&lt;/li&gt;&lt;li&gt;â€¢ T and B cells&lt;/li&gt;&lt;li&gt;â€¢ immune response against pathogens&lt;/li&gt;&lt;li&gt;â€¢ are not known for phagocytosing materials like coal dust&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ In conditions such as coal workers&#x27; pneumoconiosis , also known as \&quot;black lung ,\&quot; macrophages are the primary cells responsible for sequestering coal dust . They phagocytose the dust particles and become the centre of coal-dust nodules , which may lead to lung fibrosis.&lt;/li&gt;&lt;li&gt;âž¤ coal workers&#x27; pneumoconiosis&lt;/li&gt;&lt;li&gt;âž¤ \&quot;black lung&lt;/li&gt;&lt;li&gt;âž¤ macrophages&lt;/li&gt;&lt;li&gt;âž¤ sequestering coal dust&lt;/li&gt;&lt;li&gt;âž¤ phagocytose the dust particles&lt;/li&gt;&lt;li&gt;âž¤ centre of coal-dust nodules&lt;/li&gt;&lt;li&gt;âž¤ lung fibrosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old female presents with wheezing, shortness of breath, and cough. She has a history of asthma and is afebrile. On examination, her lungs show diffuse wheezing and decreased air entry. Which of the following chemical mediators is most likely involved in the pathogenesis of her inflammation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prostaglandins&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Leukotrienes&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Histamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Interleukin-6 (IL-6)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Leukotrienes&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Leukotrienes&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Prostaglandins are eicosanoids derived from arachidonic acid that can cause vasodilation and increase the permeability of blood vessels . They can play a role in inflammation and are associated with pain and fever , but they are not the most significant mediators in bronchoconstriction associated with asthma.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Prostaglandins&lt;/li&gt;&lt;li&gt;â€¢ eicosanoids&lt;/li&gt;&lt;li&gt;â€¢ arachidonic acid&lt;/li&gt;&lt;li&gt;â€¢ vasodilation and increase the permeability of blood vessels&lt;/li&gt;&lt;li&gt;â€¢ inflammation and are associated with pain and fever&lt;/li&gt;&lt;li&gt;â€¢ Option C. Histamine is released by mast cells and plays a significant role in immediate hypersensitivity reactions . It can cause bronchoconstriction, increase vascular permeability, and cause smooth muscle contraction, but it is not the primary mediator in ongoing asthmatic responses.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Histamine&lt;/li&gt;&lt;li&gt;â€¢ mast cells&lt;/li&gt;&lt;li&gt;â€¢ immediate hypersensitivity reactions&lt;/li&gt;&lt;li&gt;â€¢ bronchoconstriction, increase vascular permeability, and cause smooth muscle contraction,&lt;/li&gt;&lt;li&gt;â€¢ Option D. IL-6 is a cytokine involved in the acute-phase reaction and plays a role in chronic inflammation and autoimmunity . While it is involved in systemic inflammation, it is not a major direct mediator of bronchoconstriction in asthma.&lt;/li&gt;&lt;li&gt;â€¢ Option D. IL-6&lt;/li&gt;&lt;li&gt;â€¢ cytokine&lt;/li&gt;&lt;li&gt;â€¢ acute-phase reaction&lt;/li&gt;&lt;li&gt;â€¢ chronic inflammation and autoimmunity&lt;/li&gt;&lt;li&gt;â€¢ systemic inflammation,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In the context of asthma, leukotrienes are critical mediators that contribute to bronchial constriction, mucus secretion, and airway inflammation, leading to symptoms like wheezing and shortness of breath.&lt;/li&gt;&lt;li&gt;âž¤ asthma, leukotrienes are critical mediators&lt;/li&gt;&lt;li&gt;âž¤ bronchial constriction, mucus secretion, and airway inflammation,&lt;/li&gt;&lt;li&gt;âž¤ wheezing and shortness of breath.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old male presents with a history of chronic gastritis and recurrent episodes of epigastric pain. Which of the following chemical mediators is most likely involved in the pathogenesis of his symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Histamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Leukotrienes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prostaglandins&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bradykinin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Prostaglandins&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Prostaglandins&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Prostaglandins are eicosanoids derived from arachidonic acid that can cause vasodilation and increase the permeability of blood vessels . They can play a role in maintaining the integrity of the gastric mucosa by promoting mucus and bicarbonate secretion, as well as by increasing mucosal blood flow. They also inhibit gastric acid secretion . Chronic gastritis , particularly if caused by prolonged use of nonsteroidal anti-inflammatory drugs (NSAIDs) or Helicobacter pylori infection, can lead to a decreas e in prostaglandin levels . This decrease in prostaglandins can disrupt the mucosal barrier, leading to increased susceptibility to gastri c damage and ulcer formation . Therefore, in this patient with chronic gastritis and recurrent epigastric pain , the involvement of prostaglandins in the pathogenesis of his symptoms is most likely.&lt;/li&gt;&lt;li&gt;â€¢ Prostaglandins&lt;/li&gt;&lt;li&gt;â€¢ eicosanoids&lt;/li&gt;&lt;li&gt;â€¢ arachidonic acid&lt;/li&gt;&lt;li&gt;â€¢ vasodilation and increase the permeability of blood&lt;/li&gt;&lt;li&gt;â€¢ vessels&lt;/li&gt;&lt;li&gt;â€¢ integrity of the gastric&lt;/li&gt;&lt;li&gt;â€¢ mucus and bicarbonate secretion,&lt;/li&gt;&lt;li&gt;â€¢ increasing mucosal blood flow.&lt;/li&gt;&lt;li&gt;â€¢ inhibit gastric acid secretion&lt;/li&gt;&lt;li&gt;â€¢ Chronic gastritis&lt;/li&gt;&lt;li&gt;â€¢ nonsteroidal anti-inflammatory drugs (NSAIDs)&lt;/li&gt;&lt;li&gt;â€¢ Helicobacter pylori infection,&lt;/li&gt;&lt;li&gt;â€¢ decreas&lt;/li&gt;&lt;li&gt;â€¢ prostaglandin levels&lt;/li&gt;&lt;li&gt;â€¢ disrupt the mucosal barrier,&lt;/li&gt;&lt;li&gt;â€¢ increased susceptibility to gastri&lt;/li&gt;&lt;li&gt;â€¢ damage and ulcer formation&lt;/li&gt;&lt;li&gt;â€¢ chronic gastritis and recurrent epigastric pain&lt;/li&gt;&lt;li&gt;â€¢ prostaglandins in the pathogenesis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understanding the role of prostaglandins in maintaining gastric mucosal integrity and how their depletion can contribute to the development of gastritis and associated symptoms, such as epigastric pain .&lt;/li&gt;&lt;li&gt;âž¤ prostaglandins in maintaining gastric mucosal integrity&lt;/li&gt;&lt;li&gt;âž¤ depletion can contribute to the development of gastritis&lt;/li&gt;&lt;li&gt;âž¤ epigastric pain&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following complement component can be activated is both common as well as alternative pathways?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;C1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;C2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;C3&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;C4&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. C3&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) C3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. C1 is the first component of the classical pathway of complement activation . It is not involved in the alternative pathway , which is initiated by spontaneous hydrolysis or microbial surface constituents .&lt;/li&gt;&lt;li&gt;â€¢ Option A. C1&lt;/li&gt;&lt;li&gt;â€¢ first component&lt;/li&gt;&lt;li&gt;â€¢ complement activation&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ alternative pathway&lt;/li&gt;&lt;li&gt;â€¢ hydrolysis or microbial surface constituents&lt;/li&gt;&lt;li&gt;â€¢ Option B. C2 is part of the classical and lectin pathways . It forms a complex with C4 to produce the C3 convertase C4b2a . C2 is not involved in the alternative pathway.&lt;/li&gt;&lt;li&gt;â€¢ Option B. C2&lt;/li&gt;&lt;li&gt;â€¢ classical and lectin pathways&lt;/li&gt;&lt;li&gt;â€¢ complex with C4&lt;/li&gt;&lt;li&gt;â€¢ C3 convertase C4b2a&lt;/li&gt;&lt;li&gt;â€¢ Option D. C4 is involved in the classical and lectin pathways where, along with C2 , it forms the C3 convertase . It is not part of the alternative pathway, which bypasses C4 .&lt;/li&gt;&lt;li&gt;â€¢ Option D. C4&lt;/li&gt;&lt;li&gt;â€¢ classical and lectin pathways&lt;/li&gt;&lt;li&gt;â€¢ with C2&lt;/li&gt;&lt;li&gt;â€¢ C3 convertase&lt;/li&gt;&lt;li&gt;â€¢ bypasses C4&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ C3 is a key component in the complement system that is activated by all three pathways: classical, lectin, and alternative. Its activation is pivotal in the complement-mediated immune response , including opsonization and formation of the membrane attack complex.&lt;/li&gt;&lt;li&gt;âž¤ C3&lt;/li&gt;&lt;li&gt;âž¤ complement system&lt;/li&gt;&lt;li&gt;âž¤ classical, lectin, and alternative.&lt;/li&gt;&lt;li&gt;âž¤ complement-mediated immune response&lt;/li&gt;&lt;li&gt;âž¤ opsonization&lt;/li&gt;&lt;li&gt;âž¤ formation of the membrane attack complex.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not an inflammatory mediator?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tumor Necrosis Factor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Myeloperoxidase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Interferons&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Interleukin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Myeloperoxidase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Myeloperoxidase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. TNF is a cytokine that plays a crucial role in inflammation. It is involved in systemic inflammation and is one of the cytokines that make up the acute phase reaction. TNF can cause fever, apoptotic cell death, sepsis , and it can stimulate the acute phase reaction .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ TNF is a cytokine&lt;/li&gt;&lt;li&gt;â€¢ inflammation.&lt;/li&gt;&lt;li&gt;â€¢ systemic inflammation&lt;/li&gt;&lt;li&gt;â€¢ acute phase reaction.&lt;/li&gt;&lt;li&gt;â€¢ fever, apoptotic cell death, sepsis&lt;/li&gt;&lt;li&gt;â€¢ acute phase reaction&lt;/li&gt;&lt;li&gt;â€¢ Option C. Interferons are a group of signaling proteins made and released by host cells in response to the presence of pathogens such as viruses, bacteria, parasites, or tumor cells. IFNs allow communication between cells to trigger the protective defenses of the immune system that help clear pathogens. They are considered inflammatory mediators due to their role in immune activation.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Interferons&lt;/li&gt;&lt;li&gt;â€¢ signaling proteins&lt;/li&gt;&lt;li&gt;â€¢ host cells&lt;/li&gt;&lt;li&gt;â€¢ viruses, bacteria, parasites, or tumor cells.&lt;/li&gt;&lt;li&gt;â€¢ protective defenses of the immune system&lt;/li&gt;&lt;li&gt;â€¢ clear pathogens.&lt;/li&gt;&lt;li&gt;â€¢ inflammatory mediators due to their role in immune activation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Interleukins are a group of cytokines that were first seen to be expressed by leukocytes. They are a key component of the immune system and play important roles in initiating and regulating inflammation, cell proliferation, differentiation, and apoptosis .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Interleukins&lt;/li&gt;&lt;li&gt;â€¢ leukocytes.&lt;/li&gt;&lt;li&gt;â€¢ immune system&lt;/li&gt;&lt;li&gt;â€¢ initiating and regulating inflammation, cell proliferation, differentiation, and apoptosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While MPO has a role in pathogen destruction by neutrophils , it is not traditionally considered a mediator of inflammation in the same way that cytokines and interferons are, which actively regulate the inflammatory response.&lt;/li&gt;&lt;li&gt;âž¤ MPO&lt;/li&gt;&lt;li&gt;âž¤ neutrophils&lt;/li&gt;&lt;li&gt;âž¤ not traditionally considered a mediator of inflammation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Nephrocalcinosis in a systemic granulomatous disease is due to:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Overproduction of 1,25 dihydroxy vitamin D&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dystrophic calcification&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mutation in calcium sensing receptors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased reabsorption of calcium&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Overproduction of 1,25 dihydroxy vitamin D&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Overproduction of 1,25 dihydroxy vitamin D&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dystrophic calcification occurs in areas of necrosis or damage, irrespective of serum calcium levels . This type of calcification is not directly related to systemic granulomatous disease or vitamin D metabolism.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Dystrophic calcification&lt;/li&gt;&lt;li&gt;â€¢ necrosis or damage,&lt;/li&gt;&lt;li&gt;â€¢ serum calcium levels&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ systemic granulomatous disease or vitamin D metabolism.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mutations in calcium-sensing receptors (CaSR) can lead to alterations in calcium homeostasis . However, CaSR mutations typically cause disorders such as familial hypocalciuric hypercalcemia, not nephrocalcinosis in the context of granulomatous disease.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Mutations&lt;/li&gt;&lt;li&gt;â€¢ calcium-sensing receptors (CaSR)&lt;/li&gt;&lt;li&gt;â€¢ calcium homeostasis&lt;/li&gt;&lt;li&gt;â€¢ CaSR mutations&lt;/li&gt;&lt;li&gt;â€¢ familial hypocalciuric hypercalcemia,&lt;/li&gt;&lt;li&gt;â€¢ Option D. While increased reabsorption of calcium in the kidneys can contribute to hypercalcemia, it is not typically due to systemic granulomatous disease . It may occur as a secondary effect of hypercalcemia from other causes, such as primary hyperparathyroidism.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ increased reabsorption of calcium&lt;/li&gt;&lt;li&gt;â€¢ hypercalcemia,&lt;/li&gt;&lt;li&gt;â€¢ granulomatous disease&lt;/li&gt;&lt;li&gt;â€¢ secondary effect of hypercalcemia&lt;/li&gt;&lt;li&gt;â€¢ primary hyperparathyroidism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In systemic granulomatous diseases, the overproduction of the active form o f vitamin D by macrophages leads to increased calcium absorption and can result in nephrocalcinosis due to calcium deposition in the kidneys .&lt;/li&gt;&lt;li&gt;âž¤ systemic granulomatous diseases,&lt;/li&gt;&lt;li&gt;âž¤ f vitamin D by macrophages&lt;/li&gt;&lt;li&gt;âž¤ increased calcium absorption&lt;/li&gt;&lt;li&gt;âž¤ nephrocalcinosis&lt;/li&gt;&lt;li&gt;âž¤ calcium deposition in the kidneys&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Bradykinin is associated with all of the following actions in acute inflammation excep:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vasodilatation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vasoconstriction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increase vascular permeability&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Vasoconstriction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Vasoconstriction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bradykinin is well known for causing pain . It binds to receptors on pain fibers , leading to their activation . This is a common and well-recognized effect of bradykinin.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Bradykinin&lt;/li&gt;&lt;li&gt;â€¢ causing pain&lt;/li&gt;&lt;li&gt;â€¢ receptors on pain fibers&lt;/li&gt;&lt;li&gt;â€¢ activation&lt;/li&gt;&lt;li&gt;â€¢ Option B. One of the primary actions of bradykinin is causing vasodilation . It acts on vascular smooth muscles and leads to the relaxation of blood vessels , contributing to the increased blood flow observed in inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ bradykinin&lt;/li&gt;&lt;li&gt;â€¢ vasodilation&lt;/li&gt;&lt;li&gt;â€¢ vascular smooth muscles&lt;/li&gt;&lt;li&gt;â€¢ relaxation of blood vessels&lt;/li&gt;&lt;li&gt;â€¢ increased blood flow&lt;/li&gt;&lt;li&gt;â€¢ inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bradykinin increases vascular permeability , allowing fluid, proteins, and cells to leave the blood vessels and move into the tissues , contributing to the swelling and edema associated with inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Bradykinin increases vascular permeability&lt;/li&gt;&lt;li&gt;â€¢ fluid, proteins, and cells to leave the blood vessels&lt;/li&gt;&lt;li&gt;â€¢ move into the tissues&lt;/li&gt;&lt;li&gt;â€¢ swelling and edema&lt;/li&gt;&lt;li&gt;â€¢ inflammation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Bradykinin is involved in increasing vascular permeability , causing arteriolar dilation, bronchial smooth muscle contraction, and pain , but not vasoconstriction.&lt;/li&gt;&lt;li&gt;âž¤ Bradykinin&lt;/li&gt;&lt;li&gt;âž¤ increasing vascular permeability&lt;/li&gt;&lt;li&gt;âž¤ arteriolar dilation, bronchial smooth muscle contraction, and pain&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A small boy injured his thumb with a rusty nail. Few hours later, the thumb appears red and swollen. Initial swelling of the boyâ€™s thumb is primarily due to which of the following mechanisms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decreased intravascular hydrostatic pressure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased venular permeability&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased capillary permeability&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased intravascular oncotic pressure&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Increased capillary permeability&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Increased capillary permeability&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Decreased hydrostatic pressure inside blood vessels would not lead to edema ; instead, it would potentially decrease the tendency for fluid to leave the capillaries.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Decreased hydrostatic pressure&lt;/li&gt;&lt;li&gt;â€¢ not lead to edema&lt;/li&gt;&lt;li&gt;â€¢ decrease the tendency for fluid to leave the capillaries.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Decreased permeability of venules would also not be expected to cause swelling , as it would reduce the leakage of fluid from the vessels into the surrounding tissue.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Decreased permeability of venules&lt;/li&gt;&lt;li&gt;â€¢ not be expected to cause swelling&lt;/li&gt;&lt;li&gt;â€¢ reduce the leakage of fluid&lt;/li&gt;&lt;li&gt;â€¢ vessels into the surrounding tissue.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Oncotic pressure is the osmotic pressure exerted by proteins (e.g., albumin) in the blood plasma . An increase in oncotic pressure would tend to pull fluid into the vessels, not out into the tissues, and therefore would not cause swelling .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Oncotic pressure&lt;/li&gt;&lt;li&gt;â€¢ osmotic pressure&lt;/li&gt;&lt;li&gt;â€¢ proteins (e.g., albumin) in the blood plasma&lt;/li&gt;&lt;li&gt;â€¢ increase in oncotic pressure&lt;/li&gt;&lt;li&gt;â€¢ pull fluid into the vessels, not out into the tissues,&lt;/li&gt;&lt;li&gt;â€¢ would not cause swelling&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Following tissue injury and subsequent inflammation , increased capillary permeability allows fluid and proteins to leak out into the tissue , resulting in the clinical presentation of swelling and redness.&lt;/li&gt;&lt;li&gt;âž¤ tissue injury and subsequent inflammation&lt;/li&gt;&lt;li&gt;âž¤ increased capillary permeability allows fluid and proteins to leak out into the tissue&lt;/li&gt;&lt;li&gt;âž¤ swelling and redness.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 20-year-old male presented with weight loss, low grade fever and cough with expectoration. Sputum testing for acid fast bacilli was positive, which of the following cytokines are involved in the pathogenesis of this disease:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IL4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IL10&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IFN-É£&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IL13&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. IFN-É£&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) IFN-É£&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. IL4 &amp;amp; IL 13 activated macrophages are alternatively activated macrophages and they are involved in tissue repair and termination of inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. IL4 &amp;amp; IL 13&lt;/li&gt;&lt;li&gt;â€¢ alternatively activated macrophages&lt;/li&gt;&lt;li&gt;â€¢ tissue repair and termination of inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. and B. They are anti-inflammatory cytokines&lt;/li&gt;&lt;li&gt;â€¢ Option A. and B.&lt;/li&gt;&lt;li&gt;â€¢ anti-inflammatory cytokines&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In tuberculosis, IFN-Î³ plays a crucial role in the activation of macrophages and the formation of granulomas, which are central to the body&#x27;s defense against the bacilli .&lt;/li&gt;&lt;li&gt;âž¤ tuberculosis,&lt;/li&gt;&lt;li&gt;âž¤ macrophages and the formation of granulomas,&lt;/li&gt;&lt;li&gt;âž¤ central&lt;/li&gt;&lt;li&gt;âž¤ body&#x27;s defense against the bacilli&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 98&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 98&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male presents with redness, swelling, and pain in his right knee. He reports a history of gout and takes allopurinol. Which of the following chemical mediators is most likely involved in the pathogenesis of his acute inflammation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Leukotriene B4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tumor necrosis factor alpha (TNF-Î±)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Interleukin-1 (IL-1)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Histamine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Interleukin-1 (IL-1)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Interleukin-1 (IL-1)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Leukotriene B4 (LTB4) is an eicosanoid that acts as a potent chemoattractant and activator of neutrophils . It is involved in various inflammatory responses, including gout , but is not the primary cytokine implicated in the acute phase of gouty arthritis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Leukotriene B4&lt;/li&gt;&lt;li&gt;â€¢ eicosanoid&lt;/li&gt;&lt;li&gt;â€¢ chemoattractant and activator of neutrophils&lt;/li&gt;&lt;li&gt;â€¢ inflammatory responses, including gout&lt;/li&gt;&lt;li&gt;â€¢ Option B. TNF-Î± is a pro-inflammatory cytokine produced primarily by macrophages. It has a wide range of actions, including the induction o f fever, apoptotic cell death, and inflammation. While TNF-Î± is involved in gouty inflammation, it is not the most directly implicated in the crystalline-induced inflammation seen in gout.&lt;/li&gt;&lt;li&gt;â€¢ Option B. TNF-Î±&lt;/li&gt;&lt;li&gt;â€¢ a pro-inflammatory cytokine&lt;/li&gt;&lt;li&gt;â€¢ macrophages.&lt;/li&gt;&lt;li&gt;â€¢ f fever, apoptotic cell death, and inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Histamine is involved in immediate allergic responses and contributes to th e vasodilation and increased vascular permeability seen in the early stages of inflammation. In the context of gout, histamine may contribute to the initial response but is not a key mediator in the ongoing inflammatory process.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Histamine&lt;/li&gt;&lt;li&gt;â€¢ immediate allergic responses&lt;/li&gt;&lt;li&gt;â€¢ e vasodilation and increased vascular permeability&lt;/li&gt;&lt;li&gt;â€¢ inflammation.&lt;/li&gt;&lt;li&gt;â€¢ gout, histamine&lt;/li&gt;&lt;li&gt;â€¢ initial response but&lt;/li&gt;&lt;li&gt;â€¢ not a key mediator in the ongoing inflammatory process.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ In the context of gout, IL-1 is critical for the inflammatory response to monosodium urate crystals in joints. IL-1 inhibitors are also used in the treatment of gouty arthritis, highlighting the central role of IL-1 in the disease process.&lt;/li&gt;&lt;li&gt;âž¤ gout, IL-1&lt;/li&gt;&lt;li&gt;âž¤ inflammatory response&lt;/li&gt;&lt;li&gt;âž¤ monosodium urate crystals&lt;/li&gt;&lt;li&gt;âž¤ gouty arthritis, highlighting&lt;/li&gt;&lt;li&gt;âž¤ IL-1 in the disease process.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old female presents with fever, cough, and shortness of breath. Her chest X-ray shows bilateral pulmonary infiltrates. Which of the following chemical mediators is most likely involved in the pathogenesis of her acute inflammation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Leukotriene B4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tumor necrosis factor alpha (TNF-Î±)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Interleukin-1 (IL-1)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Histamine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Tumor necrosis factor alpha (TNF-Î±)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Tumor necrosis factor alpha (TNF-Î±)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Leukotriene B4 (LTB4) is involved in the inflammatory process , mainly by attracting neutrophils to sites of inflammation . While it is a potent chemoattractant and can contribute to inflammation in the lungs , it is not the primary mediator in ARDS.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Leukotriene B4&lt;/li&gt;&lt;li&gt;â€¢ (LTB4)&lt;/li&gt;&lt;li&gt;â€¢ inflammatory process&lt;/li&gt;&lt;li&gt;â€¢ neutrophils to sites of inflammation&lt;/li&gt;&lt;li&gt;â€¢ chemoattractant&lt;/li&gt;&lt;li&gt;â€¢ inflammation in the lungs&lt;/li&gt;&lt;li&gt;â€¢ Option C. IL-1 is another important pro-inflammatory cytokine and plays a role similar to TNF-Î± in promoting inflammation . However, it is not as specifically implicated in ARDS as TNF-Î±.&lt;/li&gt;&lt;li&gt;â€¢ Option C. IL-1&lt;/li&gt;&lt;li&gt;â€¢ pro-inflammatory cytokine&lt;/li&gt;&lt;li&gt;â€¢ similar to TNF-Î± in promoting inflammation&lt;/li&gt;&lt;li&gt;â€¢ Option D. Histamine is a mediator of allergic reactions and contributes to bronchoconstriction and increased vascular permeability . While histamine may be involved in the early stages of some types of lung injury , particularly those with an allergic or anaphylactic component, it is not the primary mediator in ARDS.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Histamine&lt;/li&gt;&lt;li&gt;â€¢ allergic reactions&lt;/li&gt;&lt;li&gt;â€¢ bronchoconstriction and increased vascular permeability&lt;/li&gt;&lt;li&gt;â€¢ histamine may&lt;/li&gt;&lt;li&gt;â€¢ lung injury&lt;/li&gt;&lt;li&gt;â€¢ allergic or anaphylactic component,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ TNF-Î± is a critical mediator in the pathogenesis of acute lung injury and ARDS , promoting the recruitment of inflammatory cells to the lungs and contributing to the tissue damage and impaired gas exchange characteristic of these conditions.&lt;/li&gt;&lt;li&gt;âž¤ TNF-Î±&lt;/li&gt;&lt;li&gt;âž¤ acute lung injury and ARDS&lt;/li&gt;&lt;li&gt;âž¤ recruitment of inflammatory cells to the lungs&lt;/li&gt;&lt;li&gt;âž¤ tissue damage and impaired gas exchange&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old female presents with fever, cough, and shortness of breath. Her chest X-ray shows bilateral pulmonary infiltrates. Which of the following factors in the coagulation cascade is most likely involved in the pathogenesis of her acute inflammation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Factor II (prothrombin)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Factor V (proaccelerin)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Factor VII (proconvertin)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Factor XII (Hageman factor)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Factor XII (Hageman factor)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Factor XII (Hageman factor)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Factor II , or prothrombin , is a plasma protein that is converted into thrombin in the coagulation cascade. Thrombin is a key enzyme that converts fibrinogen to fibrin, leading to clot formation. While it is central to the coagulation process, it is not known for initiating the inflammatory response in acute lung injury.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Factor II&lt;/li&gt;&lt;li&gt;â€¢ prothrombin&lt;/li&gt;&lt;li&gt;â€¢ plasma protein&lt;/li&gt;&lt;li&gt;â€¢ thrombin&lt;/li&gt;&lt;li&gt;â€¢ converts fibrinogen to fibrin,&lt;/li&gt;&lt;li&gt;â€¢ clot formation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Factor V is a coagulation factor that works with factor X to convert prothrombin to thrombin . It is important in the progression of the coagulation cascade, but again, it is not specifically involved in the initiation of the inflammatory process in lung injury.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Factor V&lt;/li&gt;&lt;li&gt;â€¢ coagulation factor&lt;/li&gt;&lt;li&gt;â€¢ factor X to convert prothrombin to thrombin&lt;/li&gt;&lt;li&gt;â€¢ Option C. Factor VII is involved in initiating the extrinsic pathway of the coagulation cascade upon tissue injury . While it is crucial for the body&#x27;s response to vascular injury , it is not directly involved in the inflammation associated with acute lung injury.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Factor VII&lt;/li&gt;&lt;li&gt;â€¢ extrinsic pathway of the coagulation cascade&lt;/li&gt;&lt;li&gt;â€¢ tissue injury&lt;/li&gt;&lt;li&gt;â€¢ body&#x27;s response to vascular injury&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In the context of acute lung injury , the activation of Factor XII can lead to the formation of fibrin clots in the pulmonary vasculature and contribute to the inflammatory response through the production of bradykinin.&lt;/li&gt;&lt;li&gt;âž¤ acute lung injury&lt;/li&gt;&lt;li&gt;âž¤ Factor XII&lt;/li&gt;&lt;li&gt;âž¤ formation of fibrin clots in the pulmonary vasculature&lt;/li&gt;&lt;li&gt;âž¤ inflammatory response&lt;/li&gt;&lt;li&gt;âž¤ production of bradykinin.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old male presents with fever, fatigue, and joint pain. He reports a history of intravenous drug use and is found to have a positive blood culture for Staphylococcus aureus. Which of the following systems is most likely involved in the pathogenesis of his acute inflammation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Complement system&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Kinin system&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Clotting system&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. The complement system is a part of the innate immune system that enhances the ability of antibodies and phagocytic cells to clear microbes and damaged cells, promotes inflammation, and attacks the pathogen&#x27;s cell membrane . It is often activated in bacterial infections and plays a role in the opsonization of pathogens , recruitment of inflammatory cells, and direct killing of bacteria via the membrane attack complex.&lt;/li&gt;&lt;li&gt;â€¢ Option A. The complement system&lt;/li&gt;&lt;li&gt;â€¢ innate immune system&lt;/li&gt;&lt;li&gt;â€¢ antibodies and phagocytic cells&lt;/li&gt;&lt;li&gt;â€¢ microbes and damaged cells, promotes inflammation,&lt;/li&gt;&lt;li&gt;â€¢ cell membrane&lt;/li&gt;&lt;li&gt;â€¢ bacterial infections&lt;/li&gt;&lt;li&gt;â€¢ opsonization of pathogens&lt;/li&gt;&lt;li&gt;â€¢ recruitment of inflammatory cells, and direct killing of&lt;/li&gt;&lt;li&gt;â€¢ bacteria via the membrane attack complex.&lt;/li&gt;&lt;li&gt;â€¢ Option B. The kinin system leads to the production of bradykinin , a potent vasodilator that increases vascular permeability and contributes to the pain associated with inflammation . The kinin system works in conjunction with other inflammatory pathways to contribute to the inflammatory response .&lt;/li&gt;&lt;li&gt;â€¢ Option B. The kinin system leads to the production of bradykinin&lt;/li&gt;&lt;li&gt;â€¢ vasodilator&lt;/li&gt;&lt;li&gt;â€¢ increases vascular permeability&lt;/li&gt;&lt;li&gt;â€¢ pain associated with inflammation&lt;/li&gt;&lt;li&gt;â€¢ conjunction with other inflammatory pathways&lt;/li&gt;&lt;li&gt;â€¢ inflammatory response&lt;/li&gt;&lt;li&gt;â€¢ Option C. The clotting system or coagulation cascade can be triggered by inflammatory responses and tissue damage . It contributes to the containment of infection by trapping pathogens within fibrin clots and can lead to the activation of certain aspects of the immune response.&lt;/li&gt;&lt;li&gt;â€¢ Option C. The clotting system&lt;/li&gt;&lt;li&gt;â€¢ coagulation cascade&lt;/li&gt;&lt;li&gt;â€¢ inflammatory responses and tissue damage&lt;/li&gt;&lt;li&gt;â€¢ infection by trapping pathogens within fibrin clots&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In the setting of a systemic bacterial infection , the complement system, kinin system, and clotting system are all implicated in the pathogenesis of acute inflammation. These systems work in concert to control the spread of infection, recruit immune cells, and create an environment conducive to the destruction of the pathogen&lt;/li&gt;&lt;li&gt;âž¤ systemic bacterial infection&lt;/li&gt;&lt;li&gt;âž¤ complement system, kinin system, and clotting system are all implicated in the pathogenesis of acute inflammation.&lt;/li&gt;&lt;li&gt;âž¤ infection, recruit immune cells, and create an environment conducive to the destruction of the pathogen&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old female presents with a painful and tender nodule on her shin. She reports a history of tuberculosis and was treated successfully. A biopsy of the lesion shows a granulomatous inflammation with giant cells. What type of giant cells is most likely present in her lesion?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Langhans giant cells&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Foreign body giant cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Touton giant cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Warthin-Finkeldey giant cells&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Langhans giant cells&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Langhans giant cells&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Foreign body giant cells arise when foreign materials, too large to be phagocytosed by a single macrophage, are present in the tissue. Their nuclei are haphazardly arranged within the cell , and these cells are often associated with chronic inflammation due to persistent foreign bodies.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Foreign body giant cells&lt;/li&gt;&lt;li&gt;â€¢ phagocytosed&lt;/li&gt;&lt;li&gt;â€¢ single macrophage,&lt;/li&gt;&lt;li&gt;â€¢ nuclei are haphazardly arranged within the cell&lt;/li&gt;&lt;li&gt;â€¢ Option C. Touton giant cells are typically found in fat necrosis and some tumors . They have a ring of nuclei surrounded by foamy cytoplasm and are not typically associated with granulomatous inflammation from tuberculosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Touton giant cells&lt;/li&gt;&lt;li&gt;â€¢ fat necrosis and some tumors&lt;/li&gt;&lt;li&gt;â€¢ ring of nuclei surrounded by foamy cytoplasm&lt;/li&gt;&lt;li&gt;â€¢ Option D . Warthin-Finkeldey giant cells are multinucleated giant cells found in the hyperplastic lymphoid tissue , commonly associated with measles and other viral infections , not tuberculosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ . Warthin-Finkeldey giant cells&lt;/li&gt;&lt;li&gt;â€¢ multinucleated giant cells&lt;/li&gt;&lt;li&gt;â€¢ hyperplastic lymphoid tissue&lt;/li&gt;&lt;li&gt;â€¢ measles and other viral infections&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with a history of tuberculosis , Langhans giant cells are indicative of a granulomatous response to mycobacterial antigens. These cells are formed from the fusion of macrophages and are characteristic of the granulomas seen in tuberculosis.&lt;/li&gt;&lt;li&gt;âž¤ history of tuberculosis&lt;/li&gt;&lt;li&gt;âž¤ Langhans giant cells&lt;/li&gt;&lt;li&gt;âž¤ granulomatous&lt;/li&gt;&lt;li&gt;âž¤ mycobacterial antigens.&lt;/li&gt;&lt;li&gt;âž¤ fusion of macrophages&lt;/li&gt;&lt;li&gt;âž¤ granulomas seen in tuberculosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male presents with erythema nodosum and polyarthralgia. Chest x-ray reveals bilateral hilar lymphadenopathy. Biopsy of the lymph nodes shows non-caseating granulomas. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tuberculosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sarcoidosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Histoplasmosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hodgkin&#x27;s Lymphoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Sarcoidosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Sarcoidosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tuberculosis, caused by Mycobacterium tuberculosis , typically presents with caseating granulomas , not non-caseating. It can cause similar symptoms and chest radiograph findings, but the granulomas in tuberculosis usually exhibit central necrosis .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tuberculosis,&lt;/li&gt;&lt;li&gt;â€¢ Mycobacterium tuberculosis&lt;/li&gt;&lt;li&gt;â€¢ caseating granulomas&lt;/li&gt;&lt;li&gt;â€¢ granulomas in tuberculosis usually exhibit central necrosis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Histoplasmosis is a fungal infection that can cause granulomatous inflammation . It often presents with symptoms similar to tuberculosis and can affect the lungs and lymph nodes . However, it is more commonly associated with caseating granulomas and typically occurs in endemic areas .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Histoplasmosis&lt;/li&gt;&lt;li&gt;â€¢ fungal infection&lt;/li&gt;&lt;li&gt;â€¢ granulomatous inflammation&lt;/li&gt;&lt;li&gt;â€¢ tuberculosis&lt;/li&gt;&lt;li&gt;â€¢ lungs and lymph nodes&lt;/li&gt;&lt;li&gt;â€¢ caseating granulomas and typically occurs in endemic areas&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hodgkin&#x27;s lymphoma is a type of lymphoma that can present with lymphadenopathy ; however, it is diagnosed by the presence of Reed-Sternberg cells in the lymph nodes , not non-caseating granulomas.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hodgkin&#x27;s lymphoma&lt;/li&gt;&lt;li&gt;â€¢ lymphadenopathy&lt;/li&gt;&lt;li&gt;â€¢ Reed-Sternberg cells in the lymph nodes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ This diagnosis of sarcoidosis is supported by the clinical presentation of erythema nodosum, polyarthralgia, bilateral hilar lymphadenopathy, and biopsy findings of non-caseating granulomas.&lt;/li&gt;&lt;li&gt;âž¤ sarcoidosis is supported&lt;/li&gt;&lt;li&gt;âž¤ erythema nodosum, polyarthralgia, bilateral hilar lymphadenopathy, and biopsy findings of non-caseating granulomas.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old female presents with a painless mass on her thigh. She reports a history of trauma to the area several years ago. Imaging studies show a well-defined mass with calcifications. A biopsy of the lesion shows a granulomatous inflammation with giant cells. Which of the following mechanisms is most likely responsible for the development of granulomatous inflammation in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic exposure to smoking&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Immune dysregulation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Foreign body reaction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Foreign body reaction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Foreign body reaction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic smoking can cause a variety of pulmonary problems and has been associated with an increased risk of developing granulomas in the lungs . However, it is less likely to cause a localized granulomatous reaction in the soft tissue of the thigh as a response to an old injury.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Chronic smoking&lt;/li&gt;&lt;li&gt;â€¢ increased risk of developing granulomas in the lungs&lt;/li&gt;&lt;li&gt;â€¢ localized granulomatous&lt;/li&gt;&lt;li&gt;â€¢ Option B. Immune dysregulation can lead to granulomatous diseases like sarcoidosis, where the immune system creates granulomas in various organs without a known foreign body or pathogen. This systemic process usually doesn&#x27;t result in an isolated thigh mass related to a previous trauma.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Immune dysregulation&lt;/li&gt;&lt;li&gt;â€¢ granulomatous diseases like sarcoidosis,&lt;/li&gt;&lt;li&gt;â€¢ granulomas in various organs without a known foreign body or pathogen.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In the setting of a prior trauma with subsequent development of a mass , the biopsy showing granulomatous inflammation with giant cells is most consistent with a foreign body reaction.&lt;/li&gt;&lt;li&gt;âž¤ prior trauma with subsequent development of a mass&lt;/li&gt;&lt;li&gt;âž¤ biopsy showing granulomatous inflammation with giant cells&lt;/li&gt;&lt;li&gt;âž¤ foreign body reaction.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old female presents with a painful and tender nodule on her lower leg. She reports a history of travel to an endemic area for leprosy and was treated successfully. A biopsy of the lesion shows a granulomatous inflammation with giant cells. What is the pathophysiology underlying this patient&#x27;s condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Immune system dysfunction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Genetic defect in the NADPH oxidase enzyme&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chronic exposure to environmental toxins&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chronic viral infection&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Immune system dysfunction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Immune system dysfunction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Enzyme A genetic defect in NADPH oxidase results in chronic granulomatous disease , a condition where phagocytes can ingest but cannot kill certain bacteria and fungi due to a lack of reactive oxygen species production. This is different from the immune response to leprosy.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Enzyme A genetic defect in NADPH oxidase&lt;/li&gt;&lt;li&gt;â€¢ chronic granulomatous disease&lt;/li&gt;&lt;li&gt;â€¢ phagocytes can ingest&lt;/li&gt;&lt;li&gt;â€¢ cannot kill certain bacteria and fungi due to a lack of reactive oxygen&lt;/li&gt;&lt;li&gt;â€¢ Option C. Environmental toxins can lead to various forms of inflammation and tissue damage , but they are not typically associated with granulomatous inflammation due to an infectious disease like leprosy.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Environmental toxins&lt;/li&gt;&lt;li&gt;â€¢ inflammation and tissue damage&lt;/li&gt;&lt;li&gt;â€¢ Option D. Chronic viral infections can lead to persistent immune responses and sometimes granulomatous inflammation ; however, leprosy is a bacterial infection , not viral.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Chronic viral infections&lt;/li&gt;&lt;li&gt;â€¢ immune responses&lt;/li&gt;&lt;li&gt;â€¢ granulomatous inflammation&lt;/li&gt;&lt;li&gt;â€¢ leprosy is a bacterial infection&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In the context of leprosy, granulomatous inflammation is a result of the body&#x27;s immune response to the intracellular pathogen, Mycobacterium leprae . The formation of granulomas , often containing giant cells , is a way the immune system attempts to contain the pathogen.&lt;/li&gt;&lt;li&gt;âž¤ leprosy, granulomatous inflammation&lt;/li&gt;&lt;li&gt;âž¤ intracellular pathogen, Mycobacterium leprae&lt;/li&gt;&lt;li&gt;âž¤ granulomas&lt;/li&gt;&lt;li&gt;âž¤ giant cells&lt;/li&gt;&lt;li&gt;âž¤ immune system&lt;/li&gt;&lt;li&gt;âž¤ pathogen.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old male presents with recurrent skin abscesses and infections. His medical history is significant for chronic granulomatous disease (CGD). What is the underlying pathophysiology of CGD?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Defects in phagocytic cell migration&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Defects in phagocytic cell activation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Defects in phagocytic cell killing&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Defects in phagocytic cell proliferation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Defects in phagocytic cell killing&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Defects in phagocytic cell killing&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ CGD is an inherited disorder of the immune system that affects the function of phagocytic cells, such as neutrophils and macrophages . The underlying defect in CGD is a deficiency in one of the components of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex , which is responsible for generating reactive oxygen species (ROS) that are necessary for the killing of ingested microorganisms. As a result, individuals with CGD are more susceptible to bacterial and fungal infections, as well as chronic granulomatous inflammation.&lt;/li&gt;&lt;li&gt;â€¢ CGD&lt;/li&gt;&lt;li&gt;â€¢ inherited disorder of the immune system&lt;/li&gt;&lt;li&gt;â€¢ function of phagocytic cells, such as neutrophils and macrophages&lt;/li&gt;&lt;li&gt;â€¢ deficiency&lt;/li&gt;&lt;li&gt;â€¢ nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex&lt;/li&gt;&lt;li&gt;â€¢ generating reactive oxygen species (ROS)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old female presents with cough and shortness of breath. She reports a history of exposure to birds and bird droppings. A chest x-ray shows bilateral nodular infiltrates, and a biopsy of the lung shows granulomatous inflammation. What is the underlying pathophysiology of the granulomatous inflammation in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Defects in phagocytic cell migration&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Defects in phagocytic cell activation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Defects in phagocytic cell killing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Defects in phagocytic cell proliferation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Defects in phagocytic cell activation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Defects in phagocytic cell activation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. While migration to the site of infection is essential for the immune response , CGD specifically involves a defect in the killing of pathogens after phagocytosis, rather than the migration of phagocytic cells.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ migration&lt;/li&gt;&lt;li&gt;â€¢ immune response&lt;/li&gt;&lt;li&gt;â€¢ killing of pathogens after phagocytosis,&lt;/li&gt;&lt;li&gt;â€¢ Option C. CGD is caused by a genetic defect in the NADPH oxidase complex , which is critical for the respiratory burst in phagocytes that produces reactive oxygen species necessary for the killing of pathogens . Patients with CGD cannot effectively destroy certain bacteria and fungi, leading to recurrent infections and granuloma formation.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ genetic defect in the NADPH oxidase complex&lt;/li&gt;&lt;li&gt;â€¢ respiratory burst in phagocytes that produces reactive oxygen&lt;/li&gt;&lt;li&gt;â€¢ killing of pathogens&lt;/li&gt;&lt;li&gt;â€¢ CGD cannot effectively destroy certain bacteria and fungi, leading to recurrent infections and granuloma formation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. CGD is not related to the proliferation of phagocytic cells ; it involves the cells&#x27; functionality post-phagocytosis, particularly their ability to kill ingested pathogens.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ CGD is not related&lt;/li&gt;&lt;li&gt;â€¢ proliferation of phagocytic cells&lt;/li&gt;&lt;li&gt;â€¢ functionality post-phagocytosis,&lt;/li&gt;&lt;li&gt;â€¢ kill ingested pathogens.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The pathophysiology of CGD is due to a defect in the NADPH oxidase complex within phagocytes, leading to impaired killing of ingested bacteria and fungi . This results in an increased susceptibility to infections and the formation of granulomas.&lt;/li&gt;&lt;li&gt;âž¤ CGD is due to a defect in the NADPH oxidase complex&lt;/li&gt;&lt;li&gt;âž¤ impaired killing of ingested bacteria and fungi&lt;/li&gt;&lt;li&gt;âž¤ increased susceptibility to infections and the formation of granulomas.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following serum proteins activates the complement, coagulation, and fibrinolytic systems at the site of injury in the patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bradykinin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hageman factor&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Kallikrein&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Plasmin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hageman factor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Hageman factor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bradykinin is a peptide produced as a result of kallikrein&#x27;s action on kininogen . While bradykinin contributes to vasodilation and increased vascular permeability , it is not involved in the activation of the complement or coagulation systems.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bradykinin&lt;/li&gt;&lt;li&gt;â€¢ peptide&lt;/li&gt;&lt;li&gt;â€¢ kallikrein&#x27;s action on kininogen&lt;/li&gt;&lt;li&gt;â€¢ vasodilation and increased vascular permeability&lt;/li&gt;&lt;li&gt;â€¢ complement or coagulation systems.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Kallikrein is an enzyme that comes from prekallikrein, which is indeed activated by Hageman factor. It plays a role in the generation of bradykinin but does not directly activate the complement or coagulation systems.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Kallikrein&lt;/li&gt;&lt;li&gt;â€¢ prekallikrein,&lt;/li&gt;&lt;li&gt;â€¢ Hageman factor.&lt;/li&gt;&lt;li&gt;â€¢ activate the complement or coagulation systems.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Plasmin is involved in fibrinolysis , breaking down clots after they have formed. Its precursor, plasminogen, is converted to plasmin by the action of activators, one of which is the Hageman factor-mediated pathway .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Plasmin is involved in fibrinolysis&lt;/li&gt;&lt;li&gt;â€¢ precursor, plasminogen, is converted to plasmin&lt;/li&gt;&lt;li&gt;â€¢ Hageman factor-mediated pathway&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Activation of Hageman factor at the site of injury initiates processes that balance coagulation and fibrinolysis , control local blood flow, and contribute to the innate immune response .&lt;/li&gt;&lt;li&gt;âž¤ Activation of Hageman factor&lt;/li&gt;&lt;li&gt;âž¤ balance coagulation and fibrinolysis&lt;/li&gt;&lt;li&gt;âž¤ local blood flow,&lt;/li&gt;&lt;li&gt;âž¤ innate immune response&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 20-year-old man sustains a deep, open laceration over his left thigh in a motorcycle accident. The wound is cleaned and sutured. Which of the following cell types mediates contraction of the wound to facilitate healing?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Endothelial cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fibroblasts&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Macrophages&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Myofibroblasts&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Myofibroblasts&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Myofibroblasts&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A . Endothelial cells respond to growth factors and form capillaries, which are necessary for the delivery of nutrients and inflammatory cells .&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ Endothelial&lt;/li&gt;&lt;li&gt;â€¢ growth factors and form capillaries,&lt;/li&gt;&lt;li&gt;â€¢ nutrients and inflammatory cells&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fibroblasts tend to be solitary cells, surrounded by collagen fibers .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Fibroblasts&lt;/li&gt;&lt;li&gt;â€¢ solitary cells, surrounded by collagen fibers&lt;/li&gt;&lt;li&gt;â€¢ Option C . Macrophages or smooth muscle cells mediate wound contraction&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Macrophages&lt;/li&gt;&lt;li&gt;â€¢ smooth muscle cells&lt;/li&gt;&lt;li&gt;â€¢ wound contraction&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Myofibroblasts are responsible for wound contraction, which helps reduce the size of the wound and is essential for wound healing.&lt;/li&gt;&lt;li&gt;âž¤ Myofibroblasts&lt;/li&gt;&lt;li&gt;âž¤ wound contraction,&lt;/li&gt;&lt;li&gt;âž¤ wound and is essential for wound healing.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old woman presents with a painless lesion on her ear lobe (shown in the image) after getting her ears pierced 3 months ago. Which of the following best explains the pathogenesis of this lesion?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased turnover of extracellular matrix proteoglycans&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Exuberant formation of granulation tissue&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased growth of capillary endothelial cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Maturation arrest of collagen assembly&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Maturation arrest of collagen assembly&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/06/picture1.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. While extracellular matrix components , including proteoglycans, play a role in wound healing , their turnover is not the primary defect in keloid formation.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ extracellular matrix components&lt;/li&gt;&lt;li&gt;â€¢ proteoglycans,&lt;/li&gt;&lt;li&gt;â€¢ wound healing&lt;/li&gt;&lt;li&gt;â€¢ Option B. Granulation tissue is the new connective tissue and microscopic blood vessels that form on the surfaces of a wound during the healing process . Exuberant granulation tissue can lead to hypertrophic scars , which are similar to keloids but do not grow beyond the boundaries of the original wound.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Granulation tissue&lt;/li&gt;&lt;li&gt;â€¢ new connective tissue and microscopic blood vessels&lt;/li&gt;&lt;li&gt;â€¢ surfaces of a wound during the healing process&lt;/li&gt;&lt;li&gt;â€¢ Exuberant granulation tissue&lt;/li&gt;&lt;li&gt;â€¢ hypertrophic scars&lt;/li&gt;&lt;li&gt;â€¢ similar to keloids&lt;/li&gt;&lt;li&gt;â€¢ Option C. This process is more related to the formation of granulation tissue during wound healing . Although it is an essential part of the healing process, it does not specifically lead to keloids.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ formation of granulation tissue&lt;/li&gt;&lt;li&gt;â€¢ healing&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In keloids , there is an imbalance in the synthesis and degradation of collagen , with an increase in the ratio of type III to type I collagen . This suggests a failure in the normal maturation process of collagen during wound healing , leading to the excessive scar formation typical of keloids .&lt;/li&gt;&lt;li&gt;âž¤ In keloids&lt;/li&gt;&lt;li&gt;âž¤ synthesis and degradation of collagen&lt;/li&gt;&lt;li&gt;âž¤ increase in the ratio of type III to type I collagen&lt;/li&gt;&lt;li&gt;âž¤ failure&lt;/li&gt;&lt;li&gt;âž¤ maturation process&lt;/li&gt;&lt;li&gt;âž¤ collagen during wound healing&lt;/li&gt;&lt;li&gt;âž¤ excessive scar formation typical of keloids&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A school boy scrapes the palms of his hands. The wounds are cleaned and covered with sterile gauze. Which of the following terms best characterizes the healing of these superficial abrasions?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Secondary intention&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Granulation tissue&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Primary intention&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Regeneration&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Regeneration&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Regeneration&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Healing by secondary intention occurs when a wound is left open and closes naturally by the process of granulation tissue formation, contraction, and epithelialization. It is typical for deeper wounds, extensive damage, or when the edges cannot be brought together .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ secondary intention&lt;/li&gt;&lt;li&gt;â€¢ wound is left open&lt;/li&gt;&lt;li&gt;â€¢ closes naturally&lt;/li&gt;&lt;li&gt;â€¢ granulation tissue formation, contraction, and epithelialization.&lt;/li&gt;&lt;li&gt;â€¢ deeper wounds, extensive damage, or when the edges cannot be brought together&lt;/li&gt;&lt;li&gt;â€¢ Option B. Granulation tissue is the new connective tissue and tiny blood vessels that form on the surface of a wound during the healing process . It typically occurs in deeper wounds that need to fill in with new tissue.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Granulation tissue&lt;/li&gt;&lt;li&gt;â€¢ new connective tissue and tiny blood vessels&lt;/li&gt;&lt;li&gt;â€¢ wound&lt;/li&gt;&lt;li&gt;â€¢ healing process&lt;/li&gt;&lt;li&gt;â€¢ deeper wounds&lt;/li&gt;&lt;li&gt;â€¢ new tissue.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Healing by primary intention happens when the wound edges are brought together , as in a surgical incision or a clean cut . The edges are approximated and heal with minimal scar formation.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ primary intention&lt;/li&gt;&lt;li&gt;â€¢ wound edges are brought together&lt;/li&gt;&lt;li&gt;â€¢ surgical incision or a clean cut&lt;/li&gt;&lt;li&gt;â€¢ approximated&lt;/li&gt;&lt;li&gt;â€¢ minimal scar formation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Superficial abrasions heal by regeneration because they involve only the epidermis or the upper dermis, which can fully restore the normal tissue organization and function . The process is mediated by the migration of epithelial cells to cover the wound surface.&lt;/li&gt;&lt;li&gt;âž¤ Superficial abrasions&lt;/li&gt;&lt;li&gt;âž¤ regeneration&lt;/li&gt;&lt;li&gt;âž¤ epidermis or the upper dermis,&lt;/li&gt;&lt;li&gt;âž¤ fully restore&lt;/li&gt;&lt;li&gt;âž¤ normal tissue organization and function&lt;/li&gt;&lt;li&gt;âž¤ migration of epithelial cells to cover the wound surface.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following nutritional factors is required for proper collagen assembly in the scar tissue of the patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Folic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Thiamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vitamin A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vitamin C&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Vitamin C&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Vitamin C&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Folic acid is crucial for DNA synthesis and repair, and cell division . It is particularly important in rapidly dividing tissues, like those in a healing wound , but it is not directly involved in collagen synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Folic&lt;/li&gt;&lt;li&gt;â€¢ acid&lt;/li&gt;&lt;li&gt;â€¢ DNA synthesis and repair, and cell division&lt;/li&gt;&lt;li&gt;â€¢ dividing tissues,&lt;/li&gt;&lt;li&gt;â€¢ healing wound&lt;/li&gt;&lt;li&gt;â€¢ Option B. Thiamine (Vitamin B1) is important in carbohydrate metabolism and energy production , but it does not play a direct role in collagen synthesis or wound healing.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Thiamine&lt;/li&gt;&lt;li&gt;â€¢ carbohydrate metabolism and energy production&lt;/li&gt;&lt;li&gt;â€¢ Option C. Vitamin A is involved in cell proliferation, immune function, and inflammatory response. It can help with wound healing and has been shown to reverse the inhibition of collagen synthesis that is caused by steroids . However, its role is not in the hydroxylation of proline residues in collagen.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Vitamin A&lt;/li&gt;&lt;li&gt;â€¢ cell proliferation, immune function, and inflammatory response.&lt;/li&gt;&lt;li&gt;â€¢ wound healing&lt;/li&gt;&lt;li&gt;â€¢ reverse the inhibition of collagen synthesis&lt;/li&gt;&lt;li&gt;â€¢ steroids&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Vitamin C is required for the hydroxylation of proline and lysine in collagen synthesis , making it essential for proper collagen assembly and wound healing . Deficiency in vitamin C leads to scurvy , characterized by poor wound healing and abnormal collagen with decreased tensile strength .&lt;/li&gt;&lt;li&gt;âž¤ Vitamin C&lt;/li&gt;&lt;li&gt;âž¤ hydroxylation of proline and lysine in collagen synthesis&lt;/li&gt;&lt;li&gt;âž¤ essential for proper collagen assembly and wound healing&lt;/li&gt;&lt;li&gt;âž¤ Deficiency in vitamin C leads to scurvy&lt;/li&gt;&lt;li&gt;âž¤ poor wound healing and abnormal collagen with decreased tensile strength&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old female presents with joint pain, stiffness, and swelling in her hands and wrists. She reports a history of psoriasis and has been diagnosed with psoriatic arthritis. Which cytokine is most likely involved in the pathogenesis of her disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tumor necrosis factor-alpha (TNF-Î±)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Interleukin-6 (IL-6)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Interleukin-1 beta (IL-1 Î² )&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Interleukin-10 (IL-10)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Tumor necrosis factor-alpha (TNF-Î±)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Tumor necrosis factor-alpha (TNF-Î±)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. IL-6 is another pro-inflammatory cytokine involved in the immune response and inflammation . While it plays a role in the pathophysiology of various arthritic conditions, including rheumatoid arthritis, TNF-Î± is more specifically targeted in the treatment of psoriatic arthritis.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ pro-inflammatory cytokine&lt;/li&gt;&lt;li&gt;â€¢ immune response and inflammation&lt;/li&gt;&lt;li&gt;â€¢ pathophysiology&lt;/li&gt;&lt;li&gt;â€¢ rheumatoid arthritis,&lt;/li&gt;&lt;li&gt;â€¢ TNF-Î± is more specifically targeted in the treatment of psoriatic arthritis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. IL-1Î² is a pro-inflammatory cytokine that contributes to inflammation and cellular damage in many autoimmune diseases. Like TNF-Î± and IL-6 , it is involved in the inflammatory cascade but is not as prominent a target in psoriatic arthritis as TNF-Î±.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ pro-inflammatory cytokine&lt;/li&gt;&lt;li&gt;â€¢ inflammation and cellular damage&lt;/li&gt;&lt;li&gt;â€¢ autoimmune&lt;/li&gt;&lt;li&gt;â€¢ diseases.&lt;/li&gt;&lt;li&gt;â€¢ TNF-Î± and IL-6&lt;/li&gt;&lt;li&gt;â€¢ inflammatory cascade&lt;/li&gt;&lt;li&gt;â€¢ Option D. IL-10 is an anti-inflammatory cytokine that helps to regulate the immune response and dampen inflammation . It&#x27;s typically not the target in psoriatic arthritis treatment strategies but rather part of the body&#x27;s natural mechanism to control excessive inflammation .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ IL-10&lt;/li&gt;&lt;li&gt;â€¢ anti-inflammatory cytokine&lt;/li&gt;&lt;li&gt;â€¢ immune response and dampen inflammation&lt;/li&gt;&lt;li&gt;â€¢ body&#x27;s natural mechanism to control excessive inflammation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ TNF-Î± i s critically involved in the inflammatory processes of psoriatic arthritis and is a primary target for therapeutic intervention . Biologic agents that inhibit TNF-Î±, such as infliximab , have been effective in reducing the inflammation and joint damage associated with psoriatic arthritis .&lt;/li&gt;&lt;li&gt;âž¤ TNF-Î± i&lt;/li&gt;&lt;li&gt;âž¤ inflammatory processes of psoriatic arthritis&lt;/li&gt;&lt;li&gt;âž¤ therapeutic intervention&lt;/li&gt;&lt;li&gt;âž¤ Biologic agents&lt;/li&gt;&lt;li&gt;âž¤ infliximab&lt;/li&gt;&lt;li&gt;âž¤ reducing the inflammation and joint damage associated with psoriatic arthritis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 60 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test9" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Liver&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Liver&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                30 Questions | 120 Total Marks | 40 min Duration | ~80.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;Function of hepatic stellate cells is/are:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Formation of sinusoids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vitamin A storage&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increases blood perfusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phagocytosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Vitamin A storage&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Vitamin A storage&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Hepatic sinusoids are specialized blood vessels within the liver that facilitate exchange between the blood and hepatocytes . Sinusoid formation involves complex interactions between various cell types during liver development.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Hepatic sinusoids&lt;/li&gt;&lt;li&gt;â€¢ specialized blood vessels&lt;/li&gt;&lt;li&gt;â€¢ liver&lt;/li&gt;&lt;li&gt;â€¢ facilitate exchange between the blood&lt;/li&gt;&lt;li&gt;â€¢ hepatocytes&lt;/li&gt;&lt;li&gt;â€¢ Option C: Hepatic stellate cells do not directly regulate blood perfusion in the liver . Blood perfusion within the liver is primarily regulated by hepatic blood flow dynamics , which involve interactions between hepatic arteries, portal veins, and hepatic sinusoids.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Hepatic stellate cells&lt;/li&gt;&lt;li&gt;â€¢ not directly regulate blood perfusion&lt;/li&gt;&lt;li&gt;â€¢ liver&lt;/li&gt;&lt;li&gt;â€¢ Blood perfusion&lt;/li&gt;&lt;li&gt;â€¢ liver&lt;/li&gt;&lt;li&gt;â€¢ regulated by hepatic blood flow dynamics&lt;/li&gt;&lt;li&gt;â€¢ Option D: Phagocytic activity in the liver is primarily carried out by Kupffer cells , which are specialized macrophages located within the hepatic sinusoids . Kupffer cells play a crucial role in clearing pathogens, cellular debris, and foreign particles from the bloodstream, contributing to liver defense and immune function.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Phagocytic activity&lt;/li&gt;&lt;li&gt;â€¢ liver&lt;/li&gt;&lt;li&gt;â€¢ carried out by Kupffer cells&lt;/li&gt;&lt;li&gt;â€¢ specialized macrophages&lt;/li&gt;&lt;li&gt;â€¢ hepatic sinusoids&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Hepatic stellate cells have diverse functions , including their involvement in liver fibrosis , the primary function attributed to them is the storage and metabolism of vitamin A .&lt;/li&gt;&lt;li&gt;â€¢ Hepatic stellate cells&lt;/li&gt;&lt;li&gt;â€¢ diverse functions&lt;/li&gt;&lt;li&gt;â€¢ involvement in liver fibrosis&lt;/li&gt;&lt;li&gt;â€¢ primary function&lt;/li&gt;&lt;li&gt;â€¢ storage and metabolism of vitamin A&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbinsâ€™ 10th/ 824&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Robbinsâ€™ 10th/ 824&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;After passing his physical exam, a young army recruit gives urine and blood samples for further testing. Serum analysis yields elevated ALT, HBsAg, Anti-HBc, HBeAg, and bilirubin. All other values are normal. Which of the following is the hepatitis B status of this recruit?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Asymptomatic carrier&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic active carrier&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fulminant hepatitis B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Recovered from acute self-limited HBV&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Chronic active carrier&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Chronic active carrier&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: An asymptomatic carrier does not have eleÂ­vated ALT and bilirubin .&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ asymptomatic carrier&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ eleÂ­vated ALT and bilirubin&lt;/li&gt;&lt;li&gt;â€¢ Option C: The absence of findings on physical examination rules out fulminant hepatitis B&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ absence of findings&lt;/li&gt;&lt;li&gt;â€¢ physical examination rules out&lt;/li&gt;&lt;li&gt;â€¢ Option D: Recovery from acute self-limited HBV is assoÂ­ciated with the presence of anti-HBs and the decrease in HBsAg and HBeAg .&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Recovery from acute self-limited HBV&lt;/li&gt;&lt;li&gt;â€¢ presence of anti-HBs&lt;/li&gt;&lt;li&gt;â€¢ decrease in HBsAg and HBeAg&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ The presence of elevated ALT , HBsAg, anti-HBc , HBeAg, and bilirubin are indicative of active hepatitis B infection .&lt;/li&gt;&lt;li&gt;â€¢ presence of elevated ALT&lt;/li&gt;&lt;li&gt;â€¢ HBsAg, anti-HBc&lt;/li&gt;&lt;li&gt;â€¢ HBeAg,&lt;/li&gt;&lt;li&gt;â€¢ bilirubin&lt;/li&gt;&lt;li&gt;â€¢ active hepatitis B infection&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins 10th/ 839&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Robbins 10th/ 839&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following condition is associated with unconjugated hyperbilirubinemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dubin-Johnson syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rotor syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gilbert syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Gall stones&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Gilbert syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Gilbert syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: Dubin-Johnson syndrome: it is characterized by conjugated hyperbilirubinemia . It is a rare genetic disorder where there is impaired excretion of conjugated bilirubin from the liver.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Dubin-Johnson syndrome:&lt;/li&gt;&lt;li&gt;â€¢ conjugated hyperbilirubinemia&lt;/li&gt;&lt;li&gt;â€¢ rare genetic disorder&lt;/li&gt;&lt;li&gt;â€¢ impaired excretion&lt;/li&gt;&lt;li&gt;â€¢ conjugated bilirubin&lt;/li&gt;&lt;li&gt;â€¢ Option B: Rotor syndrome: it is also associated with conjugated hyperbilirubinemia . It is a benign condition characterized by elevated levels of both conjugated and unconjugated bilirubin.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Rotor syndrome:&lt;/li&gt;&lt;li&gt;â€¢ conjugated hyperbilirubinemia&lt;/li&gt;&lt;li&gt;â€¢ Option D: Gall stones: they can lead to obstructive jaundice , causing elevated levels of both conjugated and unconjugated bilirubin . However, the primary association is with conjugated hyperbilirubinemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Gall stones:&lt;/li&gt;&lt;li&gt;â€¢ lead to obstructive jaundice&lt;/li&gt;&lt;li&gt;â€¢ elevated levels of both conjugated&lt;/li&gt;&lt;li&gt;â€¢ unconjugated bilirubin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Gilbert syndrome is a common inherited condition associated with unconjugated hyperbilirubinemia.&lt;/li&gt;&lt;li&gt;âž¤ Gilbert syndrome&lt;/li&gt;&lt;li&gt;âž¤ inherited condition&lt;/li&gt;&lt;li&gt;âž¤ unconjugated hyperbilirubinemia.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 853&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 853&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with unconjugated bilirubinemia has increased excretion of urobilinogen in his urine. This can be seen in all of the following conditions, except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;G6PD deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hemolytic anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hereditary spherocytosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Biliary cirrhosis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Biliary cirrhosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Biliary cirrhosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: G6PD deficiency can lead to hemolysis , resulting in increased unconjugated bilirubin production . Therefore, it is associated with increased urobilinogen excretion.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ G6PD deficiency&lt;/li&gt;&lt;li&gt;â€¢ lead to hemolysis&lt;/li&gt;&lt;li&gt;â€¢ increased unconjugated bilirubin production&lt;/li&gt;&lt;li&gt;â€¢ Option B: Hemolytic anemia, where red blood cells are destroyed prematurely , increase the production of unconjugated bilirubin . This can lead to increased urobilinogen in the urine.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Hemolytic anemia,&lt;/li&gt;&lt;li&gt;â€¢ red blood cells&lt;/li&gt;&lt;li&gt;â€¢ destroyed prematurely&lt;/li&gt;&lt;li&gt;â€¢ increase the production&lt;/li&gt;&lt;li&gt;â€¢ unconjugated bilirubin&lt;/li&gt;&lt;li&gt;â€¢ Option C: Hereditary spherocytosis is a hemolytic disorder characterized by spherical-shaped red blood cells , leading to increased bilirubin production . It is associated with increased urobilinogen excretion.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Hereditary spherocytosis&lt;/li&gt;&lt;li&gt;â€¢ hemolytic disorder&lt;/li&gt;&lt;li&gt;â€¢ spherical-shaped red blood cells&lt;/li&gt;&lt;li&gt;â€¢ increased bilirubin production&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Biliary cirrhosis is associated with conjugated hyperbilirubinemia .&lt;/li&gt;&lt;li&gt;â€¢ Biliary cirrhosis&lt;/li&gt;&lt;li&gt;â€¢ conjugated hyperbilirubinemia&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins 10 th 855&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Robbins 10 th 855&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In post-hepatic jaundice, the concentration of conjugated bilirubin in the blood is higher than that of unconjugated bilirubin because:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;There is an increased rate of destruction of red blood cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The unconjugated bilirubin is trapped by the bile stone produced in the bile duct&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The conjugation process of bilirubin in liver remains operative without any interference&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The UDP glucuronyl transferase activity is increased manifold in obstructive jaundice&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. The conjugation process of bilirubin in liver remains operative without any interference&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) The conjugation process of bilirubin in liver reÂ­mains operative without any interference&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Increased destruction of red blood cells (hemolysis) primarily leads to unconjugated hyperbilirubinemia , not conjugated hyperbilirubinemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Increased destruction&lt;/li&gt;&lt;li&gt;â€¢ red blood cells&lt;/li&gt;&lt;li&gt;â€¢ unconjugated hyperbilirubinemia&lt;/li&gt;&lt;li&gt;â€¢ Option B: Bile stones (gallstones) can cause obstruction and may lead to obstructive jaundice , but the bilirubin trapped is primarily conjugated, not unconjugated.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Bile stones&lt;/li&gt;&lt;li&gt;â€¢ obstruction&lt;/li&gt;&lt;li&gt;â€¢ lead to obstructive jaundice&lt;/li&gt;&lt;li&gt;â€¢ Option D: In obstructive jaundice , there is no direct increase in UDP glucuronyl transferase activity . The elevated levels of conjugated bilirubin result from impaired excretion rather than increased conjugation.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ obstructive jaundice&lt;/li&gt;&lt;li&gt;â€¢ no direct increase in UDP glucuronyl transferase activity&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ In post-hepatic jaundice , the concentration of conjugated bilirubin in the blood is higher than that of unconjugated bilirubin because the flow of bile is obstructed , leading to the accumulation of conjugated bilirubin in the blood.&lt;/li&gt;&lt;li&gt;â€¢ post-hepatic jaundice&lt;/li&gt;&lt;li&gt;â€¢ concentration of conjugated bilirubin&lt;/li&gt;&lt;li&gt;â€¢ blood is higher&lt;/li&gt;&lt;li&gt;â€¢ unconjugated bilirubin&lt;/li&gt;&lt;li&gt;â€¢ flow of bile is obstructed&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins 10 th /&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Robbins 10 th /&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following diseases is not a cause of indirect hyperbilirubinemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rotorâ€™s syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Criggler Najjar syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gilbert syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hereditary spherocytosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Rotorâ€™s syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Rotorâ€™s syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Criggler Najjar syndrome is a hereditary disorder characterized by deficiency or absence of UDP-glucuronosyltransferase enzyme activity , leading to impaired conjugation of bilirubin . It is a cause of indirect hyperbilirubinemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Criggler Najjar syndrome&lt;/li&gt;&lt;li&gt;â€¢ hereditary disorder&lt;/li&gt;&lt;li&gt;â€¢ deficiency or absence of UDP-glucuronosyltransferase enzyme activity&lt;/li&gt;&lt;li&gt;â€¢ impaired conjugation of bilirubin&lt;/li&gt;&lt;li&gt;â€¢ Option C: Gilbert syndrome is a common inherited disorder characterized by mild deficiency of UDP-glucuronosyltransferase enzyme activity , resulting in reduced conjugation of bilirubin . It is a cause of indirect hyperbilirubinemia.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Gilbert syndrome&lt;/li&gt;&lt;li&gt;â€¢ common inherited disorder&lt;/li&gt;&lt;li&gt;â€¢ mild deficiency of UDP-glucuronosyltransferase enzyme activity&lt;/li&gt;&lt;li&gt;â€¢ reduced conjugation of bilirubin&lt;/li&gt;&lt;li&gt;â€¢ Option D: Hereditary spherocytosis is a hemolytic disorder characterized by spherical-shaped red blood cells . It can lead to increased production of unconjugated bilirubin due to premature destruction of red blood cells (hemolysis). Therefore, it is not a cause of indirect hyperbilirubinemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Hereditary spherocytosis&lt;/li&gt;&lt;li&gt;â€¢ hemolytic disorder&lt;/li&gt;&lt;li&gt;â€¢ spherical-shaped red blood cells&lt;/li&gt;&lt;li&gt;â€¢ lead to increased production of unconjugated bilirubin&lt;/li&gt;&lt;li&gt;â€¢ premature destruction of red blood cells&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Rotorâ€™s syndrome is a cause of direct hyperbilirubinemia .&lt;/li&gt;&lt;li&gt;â€¢ Rotorâ€™s syndrome&lt;/li&gt;&lt;li&gt;â€¢ direct hyperbilirubinemia&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins 10th/ 853&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Robbins 10th/ 853&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman Aishwarya goes to her gynecologist Dr. Raina Chawla for a pre-pregnancy examination. Routine prenatal laboratory testing demonstrates normal hematological profile with controlled sugar as well negative TORCH infections. She normal liver function tests with the following profile: HBsAg negative, anti- HBcAg (-), anti- HBeAg (-), HBV DNA polymerase (-) but anti- HBsAg is positive. Which of the following likely represents the status of the patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hepatitis B carrier&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Recently infected with hepatitis B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Immunized against hepatitis B&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Infected with hepatitis B and highly transmissible&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Immunized against hepatitis B&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Immunized against hepatitis B&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Hepatitis B carrier: This status would be indicated by the presence of hepatitis B surface antigen (HBsAg) in the serum for more than six months . A carrier is also often positive for hepatitis B e antigen (HBeAg) or has detectable levels of HBV DNA, reflecting ongoing replication of the virus. However, this patient is negative for HBsAg, HBeAg, and HBV DNA polymerase, so she is not a carrier.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Hepatitis B carrier:&lt;/li&gt;&lt;li&gt;â€¢ presence of hepatitis B surface antigen&lt;/li&gt;&lt;li&gt;â€¢ serum for more than six months&lt;/li&gt;&lt;li&gt;â€¢ Option C: Immunized against hepatitis B: The presence of antibodies to HBsAg (anti-HBs) without the presence of HBsAg or anti-HBc suggests immunity from vaccination . This is because the hepatitis B vaccine contains HBsAg, which stimulates the production of anti-HBs without causing an infection.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Immunized against hepatitis B:&lt;/li&gt;&lt;li&gt;â€¢ presence of antibodies to HBsAg&lt;/li&gt;&lt;li&gt;â€¢ presence of HBsAg or anti-HBc&lt;/li&gt;&lt;li&gt;â€¢ immunity from vaccination&lt;/li&gt;&lt;li&gt;â€¢ Option D: Infected with hepatitis B and highly transmissible: If the patient were infected and highly infectious , we would expect to see positive HBeAg and HBV DNA polymerase since these are markers of high levels of viral replication and infectivity . However, this patient is negative for both.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Infected with hepatitis B and highly transmissible:&lt;/li&gt;&lt;li&gt;â€¢ infected and highly infectious&lt;/li&gt;&lt;li&gt;â€¢ positive HBeAg and HBV DNA polymerase&lt;/li&gt;&lt;li&gt;â€¢ markers of high levels of viral replication&lt;/li&gt;&lt;li&gt;â€¢ infectivity&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The presence of anti-HBsAg in the absence of HBsAg and other markers of infection indicates that the patient has been successfully immunized against hepatitis B. The hepatitis B vaccine induces the production of anti-HBs antibodies, which provide immunity to the virus.&lt;/li&gt;&lt;li&gt;âž¤ presence of anti-HBsAg&lt;/li&gt;&lt;li&gt;âž¤ absence of HBsAg&lt;/li&gt;&lt;li&gt;âž¤ markers of infection&lt;/li&gt;&lt;li&gt;âž¤ patient has been successfully immunized against hepatitis B.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/ 835&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th/ 835&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An eminent hepatobiliary expert Dr. Sarin conducts a study in hepatitis B patients for which the patients are followed for almost a decade. Their detailed history regarding the mode of transmission of HBV is taken. A battery of tests including periodic serologic testing for HBs Ag, anti HBs and anti-HBc, and serum levels of bilirubin, SOT, SGPT, alkaline phosphatase, and prothrombin time is conducted. Dr. Sarin finds that a particular group of patients happen to be chronic carriers of HBV. This finding is most likely to be associated with which of the following modes of transmission of HBV?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Blood transfusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Heterosexual transmission&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vertical transmission during childbirth&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Needle stick injury&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Vertical transmission during childbirth&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Vertical transmission during childbirth&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: Blood transfusion: Though hepatitis B can be transmitted through blood transfusions , the risk is significantly reduced due to rigorous screening protocols for blood and blood products . Chronic carriage from this mode is less likely in the current era due to these safeguards.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Blood transfusion:&lt;/li&gt;&lt;li&gt;â€¢ hepatitis B&lt;/li&gt;&lt;li&gt;â€¢ transmitted through blood transfusions&lt;/li&gt;&lt;li&gt;â€¢ reduced due to rigorous screening protocols&lt;/li&gt;&lt;li&gt;â€¢ blood and blood products&lt;/li&gt;&lt;li&gt;â€¢ Option B: Heterosexual transmission: Hepatitis B can be spread through sexual contact ; however, chronic carrier status is less commonly associated with this mode of transmission compared to others, particularly vertical transmission during childbirth.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Heterosexual transmission:&lt;/li&gt;&lt;li&gt;â€¢ Hepatitis B&lt;/li&gt;&lt;li&gt;â€¢ spread through sexual contact&lt;/li&gt;&lt;li&gt;â€¢ chronic carrier status&lt;/li&gt;&lt;li&gt;â€¢ less commonly associated&lt;/li&gt;&lt;li&gt;â€¢ mode of transmission&lt;/li&gt;&lt;li&gt;â€¢ Option D: Needle stick injury: While hepatitis B can be transmitted via needle stick injuries , and the risk is higher compared to HIV and HCV, the development of chronic carrier status from this mode is less frequent than with vertical transmission.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Needle stick injury:&lt;/li&gt;&lt;li&gt;â€¢ hepatitis B&lt;/li&gt;&lt;li&gt;â€¢ transmitted via needle stick injuries&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Chronic carrier status of HBV is most closely associated with vertical transmission due to the lack of a mature immune response in newborns , which is necessary to clear the virus and prevent chronic infection .&lt;/li&gt;&lt;li&gt;âž¤ Chronic carrier status of HBV&lt;/li&gt;&lt;li&gt;âž¤ vertical transmission&lt;/li&gt;&lt;li&gt;âž¤ lack of a mature immune response&lt;/li&gt;&lt;li&gt;âž¤ newborns&lt;/li&gt;&lt;li&gt;âž¤ clear the virus&lt;/li&gt;&lt;li&gt;âž¤ prevent chronic infection&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/ 837&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th/ 837&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 34-year-old man Bholu presents to his physician with loss of appetite, nausea and vomiting, and fatigue. Laboratory examination confirms the diagnosis of hepatitis B, and the man becomes icteric 2 weeks later. This patient may also be particularly vulnerable to the development of which of the following disorders?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Berry aneurysm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Coronary artery aneurysm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Polyarteritis nodosa&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Giant cell arteritis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Polyarteritis nodosa&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Polyarteritis nodosa&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: Berry aneurysm: A berry aneurysm is typically associated with conditions like polycystic kidney disease and hypertension , and it predominantly affects the cerebral vasculature . It is not commonly linked to hepatitis B infection.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Berry aneurysm:&lt;/li&gt;&lt;li&gt;â€¢ polycystic kidney disease&lt;/li&gt;&lt;li&gt;â€¢ hypertension&lt;/li&gt;&lt;li&gt;â€¢ affects the cerebral vasculature&lt;/li&gt;&lt;li&gt;â€¢ Option B: Coronary artery aneurysm : This type of aneurysm is often associated with Kawasaki disease or atherosclerosis , and there is no direct link to hepatitis B infection for the development of coronary artery aneurysms.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Coronary artery aneurysm&lt;/li&gt;&lt;li&gt;â€¢ aneurysm&lt;/li&gt;&lt;li&gt;â€¢ Kawasaki disease&lt;/li&gt;&lt;li&gt;â€¢ atherosclerosis&lt;/li&gt;&lt;li&gt;â€¢ no direct link to hepatitis B infection&lt;/li&gt;&lt;li&gt;â€¢ Option D: Giant cell arteritis : Giant cell arteritis typically affects the large and medium arteries of older adults , particularly the temporal arteries, and is not associated with hepatitis B infection.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Giant cell arteritis&lt;/li&gt;&lt;li&gt;â€¢ affects the large and medium arteries of older adults&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ There is a well-established association between hepatitis B infection and the development of polyarteritis nodosa , a systemic necrotizing vasculitis that can affect various organ systems and can be fatal if untreated .&lt;/li&gt;&lt;li&gt;âž¤ well-established association between hepatitis B infection&lt;/li&gt;&lt;li&gt;âž¤ development of polyarteritis nodosa&lt;/li&gt;&lt;li&gt;âž¤ systemic necrotizing vasculitis&lt;/li&gt;&lt;li&gt;âž¤ affect various organ systems&lt;/li&gt;&lt;li&gt;âž¤ fatal if untreated&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/ 510&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th/ 510&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not a part of HELLP syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hemolysis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Elevated liver enzymes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thrombocytopenia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Retroplacental hemorrhage&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Retroplacental hemorrhage&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Retroplacental hemorrhage&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Hemolysis: This is a component of HELLP syndrome . It can be confirmed by laboratory findings such as anemia, elevated lactate dehydrogenase (LDH), and the presence of schistocytes on peripheral smear.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Hemolysis:&lt;/li&gt;&lt;li&gt;â€¢ component of HELLP syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option B: Elevated liver enzymes: Elevated liver enzymes, including aspartate aminotransferase (AST) and alanine aminotransferase (ALT), are represented by the EL in HELLP . They reflect hepatic injury, which is part of this syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Elevated liver enzymes:&lt;/li&gt;&lt;li&gt;â€¢ aspartate aminotransferase&lt;/li&gt;&lt;li&gt;â€¢ alanine aminotransferase&lt;/li&gt;&lt;li&gt;â€¢ EL in HELLP&lt;/li&gt;&lt;li&gt;â€¢ Option C: Thrombocytopenia: The LP in HELLP stands for low platelets , this can result in an increased risk of bleeding.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Thrombocytopenia:&lt;/li&gt;&lt;li&gt;â€¢ LP in HELLP&lt;/li&gt;&lt;li&gt;â€¢ low platelets&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ HELLP syndrome is characterized by Hemolysis, Elevated Liver enzymes , and Low Platelet count , and does not include retroplacental hemorrhage as a component.&lt;/li&gt;&lt;li&gt;âž¤ HELLP syndrome&lt;/li&gt;&lt;li&gt;âž¤ Hemolysis, Elevated Liver enzymes&lt;/li&gt;&lt;li&gt;âž¤ Low Platelet count&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ retroplacental hemorrhage&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/ 870&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th/ 870&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A nurse sustains a needle prick injury while caring for a patient with suspected hepatitis B infection. Which of the following suggests active phase of hepatitis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IgM anti HBc&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IgG anti HBc&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IgG anti HBs&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IgM anti Hbe&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. IgM anti HBc&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) IgM anti HBc&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B: IgG anti-HBc: IgG antibody to HBcAg indicates a past or chronic infection . It remains positive after an acute infection has been resolved and can also be present in chronic carriers of hepatitis B.&lt;/li&gt;&lt;li&gt;â€¢ Option B: IgG anti-HBc:&lt;/li&gt;&lt;li&gt;â€¢ IgG antibody&lt;/li&gt;&lt;li&gt;â€¢ HBcAg&lt;/li&gt;&lt;li&gt;â€¢ past or chronic infection&lt;/li&gt;&lt;li&gt;â€¢ remains positive after&lt;/li&gt;&lt;li&gt;â€¢ acute infection&lt;/li&gt;&lt;li&gt;â€¢ Option C: IgG anti-HBs: The presence of IgG antibodies to hepatitis B surface antigen (anti-HBs) suggests immunity to hepatitis B , which can occur through vaccination or recovery from past infection. It does not indicate an active phase of infection.&lt;/li&gt;&lt;li&gt;â€¢ Option C: IgG anti-HBs:&lt;/li&gt;&lt;li&gt;â€¢ presence of IgG antibodies&lt;/li&gt;&lt;li&gt;â€¢ hepatitis B surface antigen&lt;/li&gt;&lt;li&gt;â€¢ immunity to hepatitis B&lt;/li&gt;&lt;li&gt;â€¢ occur through vaccination&lt;/li&gt;&lt;li&gt;â€¢ Option D: IgM anti-HBe: IgM antibody to hepatitis B e antigen (anti-HBe) is not a standard marker for the active phase of hepatitis . Anti-HBe generally indicates a lower level of viral replication and infectivity.&lt;/li&gt;&lt;li&gt;â€¢ Option D: IgM anti-HBe:&lt;/li&gt;&lt;li&gt;â€¢ IgM antibody&lt;/li&gt;&lt;li&gt;â€¢ hepatitis B e antigen&lt;/li&gt;&lt;li&gt;â€¢ not a standard marker&lt;/li&gt;&lt;li&gt;â€¢ active phase of hepatitis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ IgM anti HBc antibody becomes detectable shortly before the onset of symptoms and is a marker of the active phase of hepatitis B infection , reflecting recent exposure and active viral replication.&lt;/li&gt;&lt;li&gt;âž¤ IgM anti HBc&lt;/li&gt;&lt;li&gt;âž¤ antibody&lt;/li&gt;&lt;li&gt;âž¤ detectable&lt;/li&gt;&lt;li&gt;âž¤ before the onset of symptoms&lt;/li&gt;&lt;li&gt;âž¤ marker of the active phase of hepatitis B infection&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 833&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 833&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old male presents to the clinic with complaints of fatigue, dark urine, and yellow discoloration of the skin and eyes for the past week. He reports recent travel to a developing country and consuming local food and water. Physical examination reveals jaundice. Laboratory tests show elevated serum bilirubin levels, particularly the unconjugated fraction. Which hepatitis virus is most likely responsible for the maximum ground appearance change in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hepatitis A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hepatitis B&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hepatitis C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hepatitis E&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hepatitis B&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Hep B&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: Hepatitis A virus can cause acute liver disease , but it is not typically associated with ground glass hepatocyte appearance . It is characterized by a self-limiting course and does not lead to chronic liver disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Hepatitis A&lt;/li&gt;&lt;li&gt;â€¢ virus&lt;/li&gt;&lt;li&gt;â€¢ acute liver disease&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ ground glass hepatocyte appearance&lt;/li&gt;&lt;li&gt;â€¢ Option C: While hepatitis C can lead to chronic liver disease and eventually to cirrhosis and hepatocellular carcinoma , it is not particularly associated with ground glass hepatocyte appearance. It typically shows more of a lymphocytic response and steatosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ hepatitis C&lt;/li&gt;&lt;li&gt;â€¢ lead to chronic liver disease&lt;/li&gt;&lt;li&gt;â€¢ cirrhosis and hepatocellular carcinoma&lt;/li&gt;&lt;li&gt;â€¢ Option D: Hepatitis E virus is another cause of acute viral hepatitis and is known for its prevalence in developing countries through contaminated water . However, it does not cause the ground glass hepatocyte appearance that is seen with hepatitis B.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Hepatitis E&lt;/li&gt;&lt;li&gt;â€¢ virus&lt;/li&gt;&lt;li&gt;â€¢ acute viral hepatitis&lt;/li&gt;&lt;li&gt;â€¢ prevalence in developing countries&lt;/li&gt;&lt;li&gt;â€¢ contaminated water&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ground glass hepatocyte appearance is characteristic of hepatitis B infection due to the cytoplasmic accumulation of hepatitis B surface antigen (HBsAg).&lt;/li&gt;&lt;li&gt;âž¤ Ground glass hepatocyte appearance&lt;/li&gt;&lt;li&gt;âž¤ hepatitis B infection&lt;/li&gt;&lt;li&gt;âž¤ cytoplasmic accumulation of hepatitis B surface antigen&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/ 834&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/ 834&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The following are true attributes of hepatitis B infection except :&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Infants develop chronic infections&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;HBc Ag in serum is indicative of active infection&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Can cause hepatocellular cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Interferons are used for treatment&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. HBc Ag in serum is indicative of active infection&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) HBc Ag in serum is indicative of active infection&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: Infants infected with the hepatitis B virus (HBV) at birth , especially from mothers with high viral loads , have a high risk of developing chronic infections because their immune systems are not fully developed to clear the virus.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Infants infected&lt;/li&gt;&lt;li&gt;â€¢ hepatitis B virus&lt;/li&gt;&lt;li&gt;â€¢ birth&lt;/li&gt;&lt;li&gt;â€¢ mothers with high viral loads&lt;/li&gt;&lt;li&gt;â€¢ high risk of developing chronic infections&lt;/li&gt;&lt;li&gt;â€¢ Option C: Chronic HBV infection is a known risk factor for hepatocellular carcinoma (HCC). The virus can integrate into the host genome and lead to mutations that contribute to oncogenesis.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Chronic HBV infection&lt;/li&gt;&lt;li&gt;â€¢ risk factor for hepatocellular carcinoma&lt;/li&gt;&lt;li&gt;â€¢ Option D: Interferons , specifically pegylated interferon , have been used in the treatment of chronic hepatitis B . They work by modulating the immune response to help control or eliminate the virus.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Interferons&lt;/li&gt;&lt;li&gt;â€¢ pegylated interferon&lt;/li&gt;&lt;li&gt;â€¢ used in the treatment of chronic hepatitis B&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ HBcAg is typically not found in the serum ; its antibodies indicate past or ongoing infection. HBeAg is a better indicator of active replication and infectivity of hepatitis B.&lt;/li&gt;&lt;li&gt;âž¤ HBcAg&lt;/li&gt;&lt;li&gt;âž¤ typically not found in the serum&lt;/li&gt;&lt;li&gt;âž¤ antibodies&lt;/li&gt;&lt;li&gt;âž¤ past or ongoing infection.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th 833&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th 833&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man with a history of chronic alcohol abuse presents with abdominal pain and hepatomegaly. Liver biopsy reveals abnormal intracellular inclusions in hepatocytes. Immunohistochemical analysis demonstrates the presence of intermediate filaments. Which protein is the major component of these inclusions?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vimentin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cytokeratin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Keratin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Collagen&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Cytokeratin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/23/screenshot-2024-04-23-124753.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Cytokeratin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: Vimentin is an intermediate filament protein found in mesenchymal cells and is not typically associated with hepatocyte inclusions. It&#x27;s more commonly related to cells of mesenchymal origin.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Vimentin&lt;/li&gt;&lt;li&gt;â€¢ intermediate filament protein&lt;/li&gt;&lt;li&gt;â€¢ mesenchymal cells&lt;/li&gt;&lt;li&gt;â€¢ Option C: Keratins are a broader family of fibrous structural proteins ; cytokeratins are a subtype found in epithelial cells . In the context of liver pathology, it is more accurate to specify cytokeratins as the component of the inclusions.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Keratins&lt;/li&gt;&lt;li&gt;â€¢ broader family&lt;/li&gt;&lt;li&gt;â€¢ fibrous structural proteins&lt;/li&gt;&lt;li&gt;â€¢ cytokeratins&lt;/li&gt;&lt;li&gt;â€¢ subtype found in epithelial cells&lt;/li&gt;&lt;li&gt;â€¢ Option D: Collagen is a structural protein found in connective tissues , such as tendons and ligaments , and is not involved in the formation of Mallory bodies within hepatocytes.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Collagen&lt;/li&gt;&lt;li&gt;â€¢ structural protein&lt;/li&gt;&lt;li&gt;â€¢ connective tissues&lt;/li&gt;&lt;li&gt;â€¢ tendons and ligaments&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Mallory bodies , which are abnormal intracellular inclusions found in hepatocytes , especially in conditions like alcoholic liver disease , are composed predominantly of cytokeratin intermediate filaments (CK 8 and 18).&lt;/li&gt;&lt;li&gt;âž¤ Mallory bodies&lt;/li&gt;&lt;li&gt;âž¤ abnormal intracellular inclusions&lt;/li&gt;&lt;li&gt;âž¤ hepatocytes&lt;/li&gt;&lt;li&gt;âž¤ alcoholic liver disease&lt;/li&gt;&lt;li&gt;âž¤ cytokeratin intermediate filaments&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th 843&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th 843&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not associated with Mallory hyaline bodies?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alcoholic liver disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Primary biliary cirrhosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Secondary biliary cirrhosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Indian childhood cirrhosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Secondary biliary cirrhosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Secondary biliary cirrhosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Mallory bodies are associated with various liver diseases , particularly those involving chronic hepatocellular injury , but are not typically found in secondary biliary cirrhosis .&lt;/li&gt;&lt;li&gt;âž¤ Mallory bodies&lt;/li&gt;&lt;li&gt;âž¤ various liver diseases&lt;/li&gt;&lt;li&gt;âž¤ chronic hepatocellular injury&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ secondary biliary cirrhosis&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 843&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 843&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old male with a history of diabetes mellitus and joint pains presents with skin hyperpigmentation and elevated serum ferritin. A liver biopsy is performed, and the resulting slide is shown. The patient&#x27;s liver biopsy is notable for a blue staining pattern within the hepatocytes. Given below is the histopathology of liver biopsy of a patient with hemochromatosis. Which of the following stain has been used?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prussian blue&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alcian blue&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Von kossa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Crystal violet&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Prussian blue&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/08/io58.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Prussian blue&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B: Alcian blue: Alcian blue stains acidic polysaccharides and glycosaminoglycans in tissues blue , which is used to identify mucopolysaccharides . It is not used for iron staining.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Alcian blue: Alcian blue stains acidic polysaccharides&lt;/li&gt;&lt;li&gt;â€¢ glycosaminoglycans in tissues blue&lt;/li&gt;&lt;li&gt;â€¢ identify mucopolysaccharides&lt;/li&gt;&lt;li&gt;â€¢ Option C: Von Kossa: The Von Kossa stain is used to detect calcium salts , which appear black under microscopy. This would not be the appropriate stain for identifying iron deposits in the liver.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Von Kossa:&lt;/li&gt;&lt;li&gt;â€¢ Von Kossa stain&lt;/li&gt;&lt;li&gt;â€¢ detect calcium salts&lt;/li&gt;&lt;li&gt;â€¢ appear black under microscopy.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Crystal violet: Crystal violet is a basic dye that stains the components of cells purple or blue-violet and is often used in Gram staining of bacteria . It is not used for the detection of iron in tissue samples.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Crystal violet: Crystal violet&lt;/li&gt;&lt;li&gt;â€¢ basic dye&lt;/li&gt;&lt;li&gt;â€¢ stains the components of cells purple&lt;/li&gt;&lt;li&gt;â€¢ blue-violet&lt;/li&gt;&lt;li&gt;â€¢ used in Gram staining of bacteria&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ This stain is used to detect iron deposits in tissues and is characteristic of the pathology seen in hemochromatosis , where iron accumulation occurs within the hepatocytes.&lt;/li&gt;&lt;li&gt;âž¤ stain is used to detect iron deposits&lt;/li&gt;&lt;li&gt;âž¤ tissues&lt;/li&gt;&lt;li&gt;âž¤ pathology seen in hemochromatosis&lt;/li&gt;&lt;li&gt;âž¤ iron accumulation occurs&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 849&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 849&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;True about Fibrolamellar carcinoma of Liver is all, except :&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Females do not increased incidence than males&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Has good prognosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Not associated with liver cirrhosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Serum AFP levels are usually &amp;gt; 1000 mg/litre&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Serum AFP levels are usually &gt; 1000 mg/litre&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Serum AFP levels are usually &amp;gt; 1000 mg/liter&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Unlike conventional hepatocellular carcinoma , fibrolamellar carcinoma does not show a significant gender predilection . Both males and females are affected, and there is no clear male predominance.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ conventional hepatocellular carcinoma&lt;/li&gt;&lt;li&gt;â€¢ fibrolamellar carcinoma&lt;/li&gt;&lt;li&gt;â€¢ gender predilection&lt;/li&gt;&lt;li&gt;â€¢ Option B: Generally, fibrolamellar carcinoma is associated with a better prognosis compared to conventional hepatocellular carcinoma . It often occurs in younger individuals and is less likely to be associated with cirrhosis . Surgical resection is the primary treatment, and if the tumor is resected early, the prognosis can be relatively favorable.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ fibrolamellar carcinoma&lt;/li&gt;&lt;li&gt;â€¢ better prognosis&lt;/li&gt;&lt;li&gt;â€¢ conventional hepatocellular carcinoma&lt;/li&gt;&lt;li&gt;â€¢ occurs in younger individuals&lt;/li&gt;&lt;li&gt;â€¢ less likely to be associated with cirrhosis&lt;/li&gt;&lt;li&gt;â€¢ Option C: Fibrolamellar carcinoma is characteristically not associated with liver cirrhosis . This is in contrast to conventional hepatocellular carcinoma, which is often linked to cirrhosis, especially in the setting of chronic liver diseases.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Fibrolamellar carcinoma&lt;/li&gt;&lt;li&gt;â€¢ not associated with liver cirrhosis&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ AFP levels in fibrolamellar variant are generally not as markedly elevated as in other types of hepatocellular carcinoma&lt;/li&gt;&lt;li&gt;â€¢ AFP levels&lt;/li&gt;&lt;li&gt;â€¢ fibrolamellar variant&lt;/li&gt;&lt;li&gt;â€¢ not as markedly elevated&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins 10th/ 873&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins 10th/ 873&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not correct about fibrolamellar variant of hepatocellular carcinoma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Occurs in young males and females&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hepatitis B virus is an important risk factor&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Often has a better prognosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Is a hard scirrhous tumor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hepatitis B virus is an important risk factor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Hepatitis B is an important risk factor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Fibrolamellar carcinoma can occur in both young males and females , typically in individuals without underlying liver disease or cirrhosis .&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Fibrolamellar carcinoma&lt;/li&gt;&lt;li&gt;â€¢ occur in both young males&lt;/li&gt;&lt;li&gt;â€¢ females&lt;/li&gt;&lt;li&gt;â€¢ individuals without underlying liver disease&lt;/li&gt;&lt;li&gt;â€¢ cirrhosis&lt;/li&gt;&lt;li&gt;â€¢ Option C: Fibrolamellar carcinoma is generally associated with a better prognosis compared to conventional hepatocellular carcinoma .&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Fibrolamellar carcinoma&lt;/li&gt;&lt;li&gt;â€¢ better prognosis&lt;/li&gt;&lt;li&gt;â€¢ conventional hepatocellular carcinoma&lt;/li&gt;&lt;li&gt;â€¢ Option D: Fibrolamellar carcinoma can present as a firm or hard tumor , but the classic description involves a large tumor with a central scar, giving a \&quot;stellate\&quot; or \&quot;wheel spoke\&quot; appearance on imaging.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Fibrolamellar carcinoma&lt;/li&gt;&lt;li&gt;â€¢ present as a firm or hard tumor&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Fibrolamellar carcinoma is not strongly associated with viral hepatitis , including hepatitis B .&lt;/li&gt;&lt;li&gt;â€¢ Fibrolamellar carcinoma&lt;/li&gt;&lt;li&gt;â€¢ not strongly associated&lt;/li&gt;&lt;li&gt;â€¢ viral hepatitis&lt;/li&gt;&lt;li&gt;â€¢ hepatitis B&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins 10th/ 869&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Robbins 10th/ 869&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man with a history of chronic hepatitis B and cirrhosis presents with abdominal pain, unintentional weight loss, and fatigue. Imaging studies reveal a liver mass, and a biopsy confirms the diagnosis of the most common primary malignant tumor of the liver in adults. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Squamous cell carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hepatoblastoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hepatocellular carcinoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hepatoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hepatocellular carcinoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Hepatocellular carcinoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A: Squamous cell carcinoma: Squamous cell carcinoma is a type of cancer that usually arises in the skin or tissues that line the internal organs, but it is not typically found in the liver.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Squamous cell carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ type of cancer&lt;/li&gt;&lt;li&gt;â€¢ arises in the skin&lt;/li&gt;&lt;li&gt;â€¢ tissues&lt;/li&gt;&lt;li&gt;â€¢ Option B: Hepatoblastoma: Hepatoblastoma is a rare malignant liver tumor that is most common in children, not adults.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Hepatoblastoma:&lt;/li&gt;&lt;li&gt;â€¢ rare malignant liver tumor&lt;/li&gt;&lt;li&gt;â€¢ Option D: Hepatoma: Hepatoma is an older term that has been used synonymously with hepatocellular carcinoma. While it technically refers to the same cancer, the term hepatocellular carcinoma is more precise and widely used in modern medical literature.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Hepatoma:&lt;/li&gt;&lt;li&gt;â€¢ older term that has been used synonymously with hepatocellular carcinoma.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ It is the most common primary malignant tumor of the liver in adults and is often associated with chronic liver disease such as hepatitis B-induced cirrhosis .&lt;/li&gt;&lt;li&gt;âž¤ most common primary malignant tumor&lt;/li&gt;&lt;li&gt;âž¤ liver in adults&lt;/li&gt;&lt;li&gt;âž¤ associated with chronic liver disease&lt;/li&gt;&lt;li&gt;âž¤ hepatitis B-induced cirrhosis&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/ 870&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/ 870&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which is not correct about hepatocellular carcinoma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;More in females&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rise of AFP noted&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Has stronger propensity to invade vascular channels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chronic HBV has high rate of hepatocellular carcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. More in females&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) More in females&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B: Elevated levels of alpha-fetoprotein (AFP) are commonly associated with HCC . AFP can be used as a tumor marker for HCC, and its elevation is often noted in individuals with this malignancy.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Elevated levels of alpha-fetoprotein&lt;/li&gt;&lt;li&gt;â€¢ associated with HCC&lt;/li&gt;&lt;li&gt;â€¢ Option C: HCC has a strong propensity to invade vascular channels , leading to features such as portal vein invasion . This invasion is associated with a poorer prognosis .&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ HCC has a strong propensity&lt;/li&gt;&lt;li&gt;â€¢ invade vascular channels&lt;/li&gt;&lt;li&gt;â€¢ portal vein invasion&lt;/li&gt;&lt;li&gt;â€¢ invasion&lt;/li&gt;&lt;li&gt;â€¢ poorer prognosis&lt;/li&gt;&lt;li&gt;â€¢ Option D: Chronic infection with hepatitis B virus (HBV) is a significant risk factor for the development of hepatocellular carcinoma . Chronic inflammation and cirrhosis associated with HBV infection contribute to the increased risk.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Chronic infection with hepatitis B virus&lt;/li&gt;&lt;li&gt;â€¢ risk factor for the development&lt;/li&gt;&lt;li&gt;â€¢ hepatocellular carcinoma&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Hepatocellular carcinoma (HCC) is more common in males than females .&lt;/li&gt;&lt;li&gt;â€¢ Hepatocellular carcinoma&lt;/li&gt;&lt;li&gt;â€¢ common in males than females&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins 10th/ 869&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Robbins 10th/ 869&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young woman Ms Shaano who is otherwise normal goes for an annual examination in a nursing home. Her blood investigations reveal hemoglobin is 15 gm/ dl, TLC is 7,000/mm 3 , ESR is 12 mm/hr. Her kidney and liver function tests are also normal. She undergoes a radiological scanning too. Dr. Sethi, the radiologist describes her findings to be normal except a mass in the right lobe of the liver. A biopsy is taken which confirms the diagnosis of a liver adenoma. Which of the following is likely to be associated with this lesion?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Polycythemia vera&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hepatitis B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oral contraceptives&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Polyvinyl chloride&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Oral contraceptives&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Oral contraceptives&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B: Hepatitis B may lead to hepatocellular carcinoma .&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Hepatitis B&lt;/li&gt;&lt;li&gt;â€¢ hepatocellular carcinoma&lt;/li&gt;&lt;li&gt;â€¢ Option A: Polycythemia vera is associated with thrombosis of the hepatic veins .&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Polycythemia vera&lt;/li&gt;&lt;li&gt;â€¢ thrombosis of the hepatic veins&lt;/li&gt;&lt;li&gt;â€¢ Option D: Polyvinyl chloride , thorotrast (a contrast material) and arsenic are the risk factors for development of angioÂ¬sarcoma of the liver . Immunohistochemical staining of these tumor cells is positive for the CD 31 cell marker.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Polyvinyl chloride&lt;/li&gt;&lt;li&gt;â€¢ thorotrast&lt;/li&gt;&lt;li&gt;â€¢ arsenic&lt;/li&gt;&lt;li&gt;â€¢ risk factors for development of angioÂ¬sarcoma of the liver&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Liver adenomas are benign tumors of the liver that are commonly associated with the use of oral contraceptives in young women .&lt;/li&gt;&lt;li&gt;âž¤ Liver adenomas&lt;/li&gt;&lt;li&gt;âž¤ benign tumors of the liver&lt;/li&gt;&lt;li&gt;âž¤ use of oral contraceptives in young women&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/ 867&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th/ 867&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old patient presents with jaundice, abdominal pain, and weight loss. Imaging studies reveal a mass lesion whose biopsy confirms the diagnosis of cholangiocarcinoma. Which of the following locations is the most common site for cholangiocarcinoma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Distal biliary tree&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hilum&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intrahepatic biliary duct&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Multifocal&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hilum&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Hilum&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: Cholangiocarcinoma can occur in the distal biliary tree , but perihilar tumors at the hilum are more common.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Cholangiocarcinoma&lt;/li&gt;&lt;li&gt;â€¢ distal biliary tree&lt;/li&gt;&lt;li&gt;â€¢ Option C: Cholangiocarcinoma can also arise within the intrahepatic biliary ducts but this is not the commonest site.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Cholangiocarcinoma&lt;/li&gt;&lt;li&gt;â€¢ arise within the intrahepatic biliary ducts&lt;/li&gt;&lt;li&gt;â€¢ Option D: Cholangiocarcinoma can be multifocal , involving multiple sites along the biliary tree . However, the most common single site is the hilum.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Cholangiocarcinoma&lt;/li&gt;&lt;li&gt;â€¢ multifocal&lt;/li&gt;&lt;li&gt;â€¢ multiple sites along the biliary tree&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cholangiocarcinoma is a cancer arising from bile duct cells , with the most common site being the hilum of the liver , also known as perihilar or Klatskin tumors .&lt;/li&gt;&lt;li&gt;âž¤ Cholangiocarcinoma&lt;/li&gt;&lt;li&gt;âž¤ cancer arising from bile duct cells&lt;/li&gt;&lt;li&gt;âž¤ most common site being the hilum of the liver&lt;/li&gt;&lt;li&gt;âž¤ perihilar or Klatskin tumors&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th 871&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th 871&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Cholangiocarcinoma of liver is caused by:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hepatitis B infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cirrhosis of liver&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Antitrypsin deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Clonorchis sinensis infection&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Clonorchis sinensis infection&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Clonorchis sinensis infection&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: Hepatitis B infection is a risk factor for hepatocellular carcinoma , but it is not a well-established risk factor for cholangiocarcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Hepatitis B infection&lt;/li&gt;&lt;li&gt;â€¢ risk factor for hepatocellular carcinoma&lt;/li&gt;&lt;li&gt;â€¢ Option B: Cirrhosis is more commonly associated with hepatocellular carcinoma rather than cholangiocarcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Cirrhosis&lt;/li&gt;&lt;li&gt;â€¢ commonly associated with hepatocellular carcinoma&lt;/li&gt;&lt;li&gt;â€¢ Option C: Alpha-1 antitrypsin deficiency is primarily associated with lung and liver diseases , but it is not a well-established risk factor for cholangiocarcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Alpha-1 antitrypsin deficiency&lt;/li&gt;&lt;li&gt;â€¢ lung and liver diseases&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Chronic infection with the liver fluke Clonorchis sinensis is a known risk factor for cholangiocarcinoma due to the chronic inflammation and damage it causes to the bile ducts.&lt;/li&gt;&lt;li&gt;âž¤ Chronic infection&lt;/li&gt;&lt;li&gt;âž¤ liver fluke Clonorchis sinensis&lt;/li&gt;&lt;li&gt;âž¤ cholangiocarcinoma&lt;/li&gt;&lt;li&gt;âž¤ chronic inflammation&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th 871&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th 871&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old patient presents with jaundice, abdominal pain, and weight loss. Imaging studies reveal a mass in the bile duct. Biopsy confirms the diagnosis of the most common bile duct tumor. Which histological type is most frequently associated with tumors of the bile duct?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Adenocarcinoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Squamous cell cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Transitional cell carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Adenocarcinoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Adenocarcinoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Tumors of the bile duct most commonly are adenocarcinomas , which originate from the glandular epithelial cells lining the bile ducts .&lt;/li&gt;&lt;li&gt;âž¤ Tumors of the bile duct&lt;/li&gt;&lt;li&gt;âž¤ adenocarcinomas&lt;/li&gt;&lt;li&gt;âž¤ originate from the glandular epithelial cells lining the bile ducts&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th 871&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th 871&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old male film actor Sallu Kahn looses weight rapÂ­idly for one of his forthcoming films. He experiences occaÂ­sional abdominal discomfort few days after that and guided by his physician, he undergoes a radiological scan (HIDA scan) is shown to have slow and incomplete gallbladder emptying in response to cholecystokinin stimulation. This patient is likely to develop which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Black pigment stones&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Brown pigment stones&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Biliary sludge&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phospholipid stones&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Biliary sludge&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Biliary sludge&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option: Brown pigment stones are most likely to arise in cases of biliary tract infection .&lt;/li&gt;&lt;li&gt;â€¢ Option:&lt;/li&gt;&lt;li&gt;â€¢ Brown pigment&lt;/li&gt;&lt;li&gt;â€¢ biliary tract infection&lt;/li&gt;&lt;li&gt;â€¢ Option A: Black pigment stones are most likely to arise in cases of intravascular hemolysis.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Black pigment stones&lt;/li&gt;&lt;li&gt;â€¢ intravascular hemolysis.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Gallstones do not typically contain phosphoÂ­lipid as a primary ingredient.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ do not&lt;/li&gt;&lt;li&gt;â€¢ contain phosphoÂ­lipid&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Rapid weight loss can lead to gallbladder hypomotility , resulting in the formation of biliary sludge , which is a mixture of cholesterol crystals , calcium bilirubinate , and mucus that can precede stone formation .&lt;/li&gt;&lt;li&gt;âž¤ Rapid weight loss&lt;/li&gt;&lt;li&gt;âž¤ gallbladder hypomotility&lt;/li&gt;&lt;li&gt;âž¤ formation of biliary sludge&lt;/li&gt;&lt;li&gt;âž¤ mixture of cholesterol crystals&lt;/li&gt;&lt;li&gt;âž¤ calcium bilirubinate&lt;/li&gt;&lt;li&gt;âž¤ mucus&lt;/li&gt;&lt;li&gt;âž¤ precede stone formation&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th 871&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th 871&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 38-year-old patient presents with recurrent episodes of jaundice and pruritus. Liver biopsy reveals characteristic \&quot;onion skin fibrosis\&quot; around the bile ducts. Laboratory tests show elevated alkaline phosphatase levels. Which of the following conditions is most likely associated with the histological finding described?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Primary biliary cirrhosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Primary sclerosing cholangitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Extrahepatic biliary fibrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Congenital hepatic fibrosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Primary sclerosing cholangitis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Primary sclerosing cholangitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: Primary biliary cirrhosis is a distinct autoimmune liver disease characterized by the destruction of small bile ducts within the liver . \&quot;Onion skin fibrosis \&quot; is not a typical histological finding in primary biliary cirrhosis .&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Primary biliary cirrhosis&lt;/li&gt;&lt;li&gt;â€¢ distinct autoimmune liver disease&lt;/li&gt;&lt;li&gt;â€¢ destruction of small bile ducts&lt;/li&gt;&lt;li&gt;â€¢ liver&lt;/li&gt;&lt;li&gt;â€¢ \&quot;Onion skin fibrosis&lt;/li&gt;&lt;li&gt;â€¢ not a typical histological finding&lt;/li&gt;&lt;li&gt;â€¢ primary biliary cirrhosis&lt;/li&gt;&lt;li&gt;â€¢ Option C: Extrahepatic biliary fibrosis : This term is nonspecific and not commonly used as a diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Extrahepatic biliary fibrosis&lt;/li&gt;&lt;li&gt;â€¢ Option D: Congenital hepatic fibrosis is a developmental disorder of the liver and is not associated with onion skin fibrosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Congenital hepatic fibrosis&lt;/li&gt;&lt;li&gt;â€¢ developmental disorder of the liver&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Primary sclerosing cholangitis is associated with characteristic \&quot;onion skin fibrosis \&quot; around bile ducts and elevated alkaline phosphatase levels , reflecting bile duct inflammation and fibrosis.&lt;/li&gt;&lt;li&gt;âž¤ Primary sclerosing cholangitis&lt;/li&gt;&lt;li&gt;âž¤ associated with characteristic \&quot;onion skin fibrosis&lt;/li&gt;&lt;li&gt;âž¤ around bile ducts&lt;/li&gt;&lt;li&gt;âž¤ elevated alkaline phosphatase levels&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th 861&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th 861&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old patient with a history of chronic liver disease presents with new-onset jaundice and pruritus. The patient is concerned about the risk of developing liver cancer. Which of the following is the most significant risk factor for cholangiocarcinoma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Obesity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Primary sclerosing cholangitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Salmonella carrier state&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HBV infection&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Primary sclerosing cholangitis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Primary sclerosing cholangitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The most significant risk factor for cholangiocarcinoma is primary sclerosing cholangitis , which is associated with chronic inflammation and increased risk of malignancy in the bile ducts .&lt;/li&gt;&lt;li&gt;âž¤ most significant risk factor&lt;/li&gt;&lt;li&gt;âž¤ cholangiocarcinoma&lt;/li&gt;&lt;li&gt;âž¤ primary sclerosing cholangitis&lt;/li&gt;&lt;li&gt;âž¤ associated with chronic inflammation&lt;/li&gt;&lt;li&gt;âž¤ increased risk of malignancy&lt;/li&gt;&lt;li&gt;âž¤ bile ducts&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th 871&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th 871&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old patient presents with painless jaundice, pruritus, and weight loss. Imaging studies reveal a nodular mass obstructing the bile ducts at the hepatic hilum. Biopsy confirms the diagnosis of a Klatskin tumor. Which of the following best describes this tumor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Nodular type of cholangiocarcinoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fibrolamellar hepatocellular carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gall bladder carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hepatocellular carcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Nodular type of cholangiocarcinoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Nodular type of cholangiocarcinoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B: Fibrolamellar hepatocellular carcinoma: This is a distinct variant of hepatocellular carcinoma that typically affects younger individuals and has a characteristic appearance on imaging and histology, different from Klatskin tumors.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Fibrolamellar hepatocellular carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ distinct variant of hepatocellular carcinoma&lt;/li&gt;&lt;li&gt;â€¢ Option C: Gall bladder carcinoma: Gall bladder carcinoma typically arises in the gall bladder itself and not in the bile ducts, hence it is not a Klatskin tumor.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Gall bladder carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ arises in the gall bladder itself&lt;/li&gt;&lt;li&gt;â€¢ Option D: Hepatocellular carcinoma: This is a primary liver cancer that originates from hepatocytes . A Klatskin tumor, however, arises from the biliary epithelium at the confluence of the left and right hepatic bile ducts.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Hepatocellular carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ primary liver cancer&lt;/li&gt;&lt;li&gt;â€¢ originates from hepatocytes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Klatskin tumors are nodular cholangiocarcinomas located at the hepatic hilum and are known for causing biliary obstruction .&lt;/li&gt;&lt;li&gt;âž¤ Klatskin tumors&lt;/li&gt;&lt;li&gt;âž¤ nodular cholangiocarcinomas&lt;/li&gt;&lt;li&gt;âž¤ hepatic hilum&lt;/li&gt;&lt;li&gt;âž¤ causing biliary obstruction&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/871&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/871&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old patient presents with fatigue, hepatomegaly, and neurological symptoms such as tremors and dysarthria. Ophthalmic examination reveals a brownish ring around the cornea. Laboratory tests show elevated urinary copper levels and decreased ceruloplasmin levels. Which of the following conditions is most likely responsible for the observed ophthalmic finding in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Wilsonâ€™s disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alpha 1 antitrypsin deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hemochromatosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Primary biliary cirrhosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Wilsonâ€™s disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Wilsonâ€™s disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B: Alpha-1 antitrypsin deficiency: Alpha-1 antitrypsin deficiency is a genetic condition that can lead to liver and lung disease due to the accumulation of abnormal alpha-1 antitrypsin protein in the hepatocytes . It does not cause the Kayser-Fleischer ring.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Alpha-1 antitrypsin deficiency:&lt;/li&gt;&lt;li&gt;â€¢ genetic condition&lt;/li&gt;&lt;li&gt;â€¢ lead to liver and lung disease&lt;/li&gt;&lt;li&gt;â€¢ accumulation of abnormal alpha-1 antitrypsin protein&lt;/li&gt;&lt;li&gt;â€¢ hepatocytes&lt;/li&gt;&lt;li&gt;â€¢ Option C: Hemochromatosis: Hemochromatosis is a hereditary condition characterized by excessive iron accumulation in various organs but does not lead to the formation of a Kayser-Fleischer ring.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Hemochromatosis:&lt;/li&gt;&lt;li&gt;â€¢ hereditary condition&lt;/li&gt;&lt;li&gt;â€¢ excessive iron accumulation&lt;/li&gt;&lt;li&gt;â€¢ organs&lt;/li&gt;&lt;li&gt;â€¢ Option D: Primary biliary cirrhosis: Primary biliary cirrhosis is an autoimmune liver disease characterized by the destruction of intrahepatic bile ducts . While it may lead to cirrhosis and associated symptoms, it does not cause the ophthalmic findings seen in Wilsonâ€™s disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Primary biliary cirrhosis:&lt;/li&gt;&lt;li&gt;â€¢ autoimmune liver disease&lt;/li&gt;&lt;li&gt;â€¢ destruction of intrahepatic bile ducts&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The presence of a Kayser-Fleischer ring , neurological symptoms , elevated urinary copper levels , and decreased ceruloplasmin are all diagnostic of Wilson&#x27;s disease , a disorder of copper metabolism.&lt;/li&gt;&lt;li&gt;âž¤ presence of a Kayser-Fleischer ring&lt;/li&gt;&lt;li&gt;âž¤ neurological symptoms&lt;/li&gt;&lt;li&gt;âž¤ elevated urinary copper levels&lt;/li&gt;&lt;li&gt;âž¤ decreased ceruloplasmin&lt;/li&gt;&lt;li&gt;âž¤ Wilson&#x27;s disease&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th /850&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th /850&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 22-year-old patient presents with persistent jaundice and darkly pigmented liver tissue observed on imaging studies. Laboratory tests reveal elevated levels of conjugated bilirubin, and liver biopsy shows pigmented granules within hepatocytes. Genetic testing reveals a mutation in the MRP2 gene. Which of the following liver disorders is most likely associated with the observed findings in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Criggler Najjar syndrome type I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Criggler Najjar syndrome type II&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dubin Johnson syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rotor syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Dubin Johnson syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Dubin Johnson syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: Crigler Najjar syndrome type I is characterized by severe unconjugated hyperbilirubinemia due to a deficiency of UDP-glucuronosyltransferase enzyme activity.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Crigler Najjar syndrome type I&lt;/li&gt;&lt;li&gt;â€¢ severe unconjugated hyperbilirubinemia&lt;/li&gt;&lt;li&gt;â€¢ Option B: Crigler Najjar syndrome type II is also characterized by unconjugated hyperbilirubinemia , but it is less severe than type I.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Crigler Najjar syndrome type II&lt;/li&gt;&lt;li&gt;â€¢ unconjugated hyperbilirubinemia&lt;/li&gt;&lt;li&gt;â€¢ Option D: Rotor syndrome is another rare disorder characterized by mild conjugated hyperbilirubinemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Rotor syndrome&lt;/li&gt;&lt;li&gt;â€¢ rare disorder&lt;/li&gt;&lt;li&gt;â€¢ mild conjugated hyperbilirubinemia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Dubin-Johnson syndrome is characterized by conjugated hyperbilirubinemia and darkly pigmented liver due to a mutation in the MRP2 gene , leading to impaired excretion of bilirubin glucuronides.&lt;/li&gt;&lt;li&gt;âž¤ Dubin-Johnson syndrome&lt;/li&gt;&lt;li&gt;âž¤ conjugated hyperbilirubinemia&lt;/li&gt;&lt;li&gt;âž¤ darkly pigmented liver&lt;/li&gt;&lt;li&gt;âž¤ mutation in the MRP2 gene&lt;/li&gt;&lt;li&gt;âž¤ impaired excretion of bilirubin glucuronides.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th 856&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th 856&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 40 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test10" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Male And Female Genital Tract&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Male And Female Genital Tract&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                36 Questions | 144 Total Marks | 46 min Duration | ~76.67 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A 25-year-old female presents with abdominal pain and a pelvic mass. Histological examination of the ovarian tumor reveals the presence of Schiller-Duval bodies. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dysgerminoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Teratoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Yolk sac tumor&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Granulosa cell tumor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Yolk sac tumor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/23/screenshot-2024-04-23-160557.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Yolk sac tumor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A . Dysgerminoma are type of ovarian germ cell tumor , but they are characterized by monotonous sheets of large , undifferentiated cells resembling primordial germ cells .&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A&lt;/li&gt;&lt;li&gt;â€¢ Dysgerminoma&lt;/li&gt;&lt;li&gt;â€¢ ovarian germ cell tumor&lt;/li&gt;&lt;li&gt;â€¢ monotonous sheets of large&lt;/li&gt;&lt;li&gt;â€¢ undifferentiated cells&lt;/li&gt;&lt;li&gt;â€¢ primordial germ cells&lt;/li&gt;&lt;li&gt;â€¢ Option B . Teratoma are composed of multiple germ cell layers and can contain a variety of tissues such as epithelium, hair , and cartilage .&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B&lt;/li&gt;&lt;li&gt;â€¢ Teratoma&lt;/li&gt;&lt;li&gt;â€¢ composed of multiple germ cell layers&lt;/li&gt;&lt;li&gt;â€¢ contain a variety of tissues&lt;/li&gt;&lt;li&gt;â€¢ epithelium, hair&lt;/li&gt;&lt;li&gt;â€¢ cartilage&lt;/li&gt;&lt;li&gt;â€¢ Option D . Granulosa cell tumors are sex cord-stromal tumors , and they are characterized by the presence of Call-Exner bodies . These bodies are small, eosinophilic fluid-filled spaces surrounded by granulosa cells.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D&lt;/li&gt;&lt;li&gt;â€¢ Granulosa cell tumors&lt;/li&gt;&lt;li&gt;â€¢ sex cord-stromal tumors&lt;/li&gt;&lt;li&gt;â€¢ presence of Call-Exner bodies&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The presence of Schiller-Duval bodies in an ovarian mass biopsy is pathognomonic for yolk sac tumors , also known as endodermal sinus tumors , and is the most likely diagnosis in a young woman presenting with these histological findings.&lt;/li&gt;&lt;li&gt;âž¤ presence of Schiller-Duval bodies&lt;/li&gt;&lt;li&gt;âž¤ ovarian mass biopsy&lt;/li&gt;&lt;li&gt;âž¤ pathognomonic for yolk sac tumors&lt;/li&gt;&lt;li&gt;âž¤ endodermal sinus tumors&lt;/li&gt;&lt;li&gt;âž¤ young woman&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1025&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1025&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old male was investigated for infertility. Semen analysis revealed azoospermia and biopsy was taken which is shown in the image. What is the likely diagnosis in the patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Orchitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sertoli cell only tumor&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Testicular atrophy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Non-seminomatous germ cell tumor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Sertoli cell only tumor&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/28/untitled-546.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Sertoli cell only tumor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation;&lt;/li&gt;&lt;li&gt;â€¢ Option A. Orchitis usually presents with signs of inflammation, not solely with the absence of germ cells as in the biopsy image.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Orchitis&lt;/li&gt;&lt;li&gt;â€¢ Option C . Testicular atrophy involves shrinkage and decreased cellular density in the seminiferous tubules, ofte accompanied by fibrosis, which is not demonstrated in the biopsy provided.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Testicular atrophy&lt;/li&gt;&lt;li&gt;â€¢ Option D . Non-seminomatous germ cell tumors typically display malignant cells with various histologic patterns, which are not evident in the biopsy image.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Non-seminomatous germ cell tumors&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sertoli cell only syndrome, also known as germ cell aplasia, is diagnosed when testicular biopsy reveals seminiferous tubules with only Sertoli cells and an absence of germ cells, correlating with clinical findings of azoospermia and infertility in a male patient.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman undergoes a breast biopsy after a suspicious mammogram. Histological examination reveals a tumor with lack of tubule formation, discohesive cells and a low mitotic rate. Immunohistochemistry shows positive estrogen receptor (ER) and progesterone receptor (PR) staining. What is the most likely histological type of breast cancer?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Invasive ductal carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Invasive lobular carcinoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Medullary carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ductal carcinoma in situ (DCIS)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Invasive lobular carcinoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Invasive lobular carcinoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Invasive ductal carcinoma tends to form glandular structures and does not usually present with the \&quot;Indian file\&quot; pattern of cell arrangement seen in invasive lobular carcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Invasive ductal carcinoma&lt;/li&gt;&lt;li&gt;â€¢ glandular structures&lt;/li&gt;&lt;li&gt;â€¢ Option C. Medullary carcinoma has a higher mitotic rate and a lymphocytic infiltrate , which differs from the low mitotic rate and discohesive cells described in the biopsy report.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Medullary carcinoma&lt;/li&gt;&lt;li&gt;â€¢ higher mitotic rate&lt;/li&gt;&lt;li&gt;â€¢ lymphocytic infiltrate&lt;/li&gt;&lt;li&gt;â€¢ Option D . Ductal carcinoma in situ represents an early form of breast cancer that is confined to the ducts and usually forms duct-like structures, unlike the pattern described.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Ductal carcinoma&lt;/li&gt;&lt;li&gt;â€¢ in situ&lt;/li&gt;&lt;li&gt;â€¢ early form of breast cancer&lt;/li&gt;&lt;li&gt;â€¢ confined to the ducts&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Invasive lobular carcinoma is characterized by the absence of tubule formation , discohesive cells , a low mitotic rate , and positive hormone receptor status .&lt;/li&gt;&lt;li&gt;âž¤ Invasive lobular carcinoma&lt;/li&gt;&lt;li&gt;âž¤ absence of tubule formation&lt;/li&gt;&lt;li&gt;âž¤ discohesive cells&lt;/li&gt;&lt;li&gt;âž¤ low mitotic rate&lt;/li&gt;&lt;li&gt;âž¤ positive hormone receptor status&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 47-year-old woman presents for evaluation of a hard, poorly defined mass in her left breast. She reports no pain or discharge, but she has noted a recent change in the shape of the breast. There is no family history of breast cancer. A mammogram reveals microcalcifications in the upper outer quadrant of the left breast. A biopsy of the lesion is performed. The type of mammary ductal carcinoma in situ (DCIS) most likely to result in a palpable abnormality in the breast is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Apocrine DCIS&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Neuroendocrine DCIS&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Will-differentiated DCIS&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Comedo DCIS&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Comedo DCIS&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Comedo DCIS&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Apocrine DCIS presents with characteristic apocrine cytologic features under microscopy but is not the most likely to form a palpable mass.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Apocrine DCIS&lt;/li&gt;&lt;li&gt;â€¢ characteristic apocrine cytologic features under microscopy&lt;/li&gt;&lt;li&gt;â€¢ Option B. Neuroendocrine DCIS is a rare form and typically does not present as a palpable lesion in the breast.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Neuroendocrine DCIS&lt;/li&gt;&lt;li&gt;â€¢ rare form&lt;/li&gt;&lt;li&gt;â€¢ Option C. Well-differentiated DCIS may show microcalcifications on mammography , but palpable masses are less common than in the comedo subtype.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Well-differentiated DCIS&lt;/li&gt;&lt;li&gt;â€¢ show microcalcifications&lt;/li&gt;&lt;li&gt;â€¢ mammography&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Comedo DCIS is most likely to present as a palpable mass due to the associated necrosis and calcifications . It is often found on mammography and can form a more solid , palpable lesion compared to other subtypes of DCIS.&lt;/li&gt;&lt;li&gt;âž¤ Comedo DCIS&lt;/li&gt;&lt;li&gt;âž¤ present as a palpable mass&lt;/li&gt;&lt;li&gt;âž¤ associated necrosis&lt;/li&gt;&lt;li&gt;âž¤ calcifications&lt;/li&gt;&lt;li&gt;âž¤ found on mammography&lt;/li&gt;&lt;li&gt;âž¤ form a more solid&lt;/li&gt;&lt;li&gt;âž¤ palpable lesion&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1060&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1060&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;BRCA 1 gene is located on:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chromosome 13&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chromosome 11&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chromosome 17&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chromosome 22&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Chromosome 17&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Chromosome 17&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Tumor-suppressor gene , BRCA-1 (17q21) encodes a zinc finger protein , and the product therefore may function as a transcription factor. The gene appears to be involved in gene repair . BRCA-2 (13q12) is also associated with an increased incidence of breast cancer in men and women .&lt;/li&gt;&lt;li&gt;â€¢ Tumor-suppressor gene , BRCA-1 (17q21) encodes a zinc finger protein , and the product therefore may function as a transcription factor. The gene appears to be involved in gene repair .&lt;/li&gt;&lt;li&gt;â€¢ Tumor-suppressor gene&lt;/li&gt;&lt;li&gt;â€¢ BRCA-1&lt;/li&gt;&lt;li&gt;â€¢ encodes&lt;/li&gt;&lt;li&gt;â€¢ zinc finger protein&lt;/li&gt;&lt;li&gt;â€¢ product&lt;/li&gt;&lt;li&gt;â€¢ involved in gene repair&lt;/li&gt;&lt;li&gt;â€¢ BRCA-2 (13q12) is also associated with an increased incidence of breast cancer in men and women .&lt;/li&gt;&lt;li&gt;â€¢ BRCA-2&lt;/li&gt;&lt;li&gt;â€¢ associated with an increased incidence of breast cancer&lt;/li&gt;&lt;li&gt;â€¢ men and women&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ BRCA 1 gene is located on Chromosome 17q and BRCA2 gene is located on chromosome 13q.&lt;/li&gt;&lt;li&gt;â€¢ BRCA 1 gene&lt;/li&gt;&lt;li&gt;â€¢ Chromosome 17q&lt;/li&gt;&lt;li&gt;â€¢ BRCA2 gene&lt;/li&gt;&lt;li&gt;â€¢ chromosome 13q.&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbin 10 th / 1045&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Robbin 10 th / 1045&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Increased susceptibility to sporadic breast cancer is likely to be associated with a mutation in the following gene?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;p53&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;BRCA-1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Retinoblastoma (Rb)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;H-Ras&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. p53&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) p53&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. The BRCA1 gene mutation carries a high risk for developing breast and ovarian cancers . Individuals with this mutation have a lifetime risk of breast cancer that is significantly higher than the general population.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ BRCA1 gene mutation&lt;/li&gt;&lt;li&gt;â€¢ high risk for developing breast&lt;/li&gt;&lt;li&gt;â€¢ ovarian cancers&lt;/li&gt;&lt;li&gt;â€¢ Option C . While the Rb gene is crucial in controlling cell proliferation and its mutation is primarily associated with retinoblastoma , it is not a leading cause of breast cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Rb gene&lt;/li&gt;&lt;li&gt;â€¢ controlling cell proliferation&lt;/li&gt;&lt;li&gt;â€¢ mutation&lt;/li&gt;&lt;li&gt;â€¢ associated with retinoblastoma&lt;/li&gt;&lt;li&gt;â€¢ Option D . H-Ras is part of the Ras gene family ; while mutations in these genes can lead to cancer , they are not typically associated with hereditary breast cancer syndromes.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ H-Ras&lt;/li&gt;&lt;li&gt;â€¢ part of the Ras gene family&lt;/li&gt;&lt;li&gt;â€¢ mutations&lt;/li&gt;&lt;li&gt;â€¢ genes can lead to cancer&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The p53 gene mutation is the most important gene mutation increasing susceptibility to breast cancer .&lt;/li&gt;&lt;li&gt;âž¤ p53 gene mutation&lt;/li&gt;&lt;li&gt;âž¤ most important gene mutation increasing susceptibility&lt;/li&gt;&lt;li&gt;âž¤ breast cancer&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1051&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1051&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A female patient presented with a firm mass of 2 Ã— 2 cm in the upper outer quadrant of the breast. She gives a family history of ovarian carcinoma. The investigation that needs to be done to assess for mutations is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;p53&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;BRCA-2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Her 2/Neu gene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;C-myc gene&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. BRCA-2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) BRCA2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. The p53 gene , when mutated , can lead to a variety of cancers ; however, in the context of a family history suggesting a hereditary breast and ovarian cancer syndrome, BRCA1 and BRCA2 gene testing is more directly relevant.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ The p53 gene&lt;/li&gt;&lt;li&gt;â€¢ mutated&lt;/li&gt;&lt;li&gt;â€¢ variety of cancers&lt;/li&gt;&lt;li&gt;â€¢ Option C . Her 2/Neu gene amplification is associated with breast cancer aggressiveness and treatment decisions but is not a part of routine genetic screening for hereditary breast and ovarian cancer syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Her 2/Neu gene&lt;/li&gt;&lt;li&gt;â€¢ associated with breast cancer aggressiveness&lt;/li&gt;&lt;li&gt;â€¢ treatment decisions&lt;/li&gt;&lt;li&gt;â€¢ Option D. C-myc is an oncogene implicated in the pathogenesis of various cancers , including breast cancer , but it does not have a direct role in hereditary breast and ovarian cancer syndromes.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ C-myc&lt;/li&gt;&lt;li&gt;â€¢ oncogene implicated&lt;/li&gt;&lt;li&gt;â€¢ pathogenesis of various cancers&lt;/li&gt;&lt;li&gt;â€¢ breast cancer&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ BRCA2 genetic testing is indicated in a patient with a breast mass and a family history of ovarian carcinoma , as mutations in the BRCA1 and BRCA2 genes are strongly associated with hereditary breast and ovarian cancer syndromes .&lt;/li&gt;&lt;li&gt;âž¤ BRCA2 genetic testing&lt;/li&gt;&lt;li&gt;âž¤ breast mass&lt;/li&gt;&lt;li&gt;âž¤ family history of ovarian carcinoma&lt;/li&gt;&lt;li&gt;âž¤ mutations&lt;/li&gt;&lt;li&gt;âž¤ BRCA1 and BRCA2 genes&lt;/li&gt;&lt;li&gt;âž¤ hereditary breast&lt;/li&gt;&lt;li&gt;âž¤ ovarian cancer syndromes&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1058&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1058&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All invasive breast carcinomas are graded histologically with the following scoring system:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Nottingham&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Birmingham&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cunningham&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Welham&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Nottingham&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Nottingham&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman presents with a suspicious breast mass. A core biopsy is performed, and immunohistochemistry (IHC) reveals a HER2/neu score of 2. Given the equivocal HER2 status, which technique is most appropriate for further evaluation to determine the HER2/neu gene amplification status?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Polymerase Chain Reaction (PCR)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fluorescence In Situ Hybridization (FISH)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Southern Blotting&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Western Blotting&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Fluorescence In Situ Hybridization (FISH)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Polymerase Chain Reaction (PCR ) is a technique used to amplify DNA but is not typically employed to assess gene amplification status. It is more suitable for studying the presence or absence of specific DNA sequences.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Polymerase Chain Reaction (PCR&lt;/li&gt;&lt;li&gt;â€¢ technique&lt;/li&gt;&lt;li&gt;â€¢ amplify DNA&lt;/li&gt;&lt;li&gt;â€¢ Option C. Southern blotting is a technique used to detect specific DNA sequences in a DNA sample .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Southern blotting&lt;/li&gt;&lt;li&gt;â€¢ detect specific DNA sequences&lt;/li&gt;&lt;li&gt;â€¢ DNA sample&lt;/li&gt;&lt;li&gt;â€¢ Option D. Western blotting is a technique used to detect specific proteins in a sample . It is not applicable to assess gene amplification and is more suited for protein analysis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Western blotting&lt;/li&gt;&lt;li&gt;â€¢ detect specific proteins in a sample&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cases of equivocal HER2/neu IHC results which is IHC score of 2 , further recommended technique is Fluorescence In Situ Hybridization (FISH) for evaluation of HER2/neu gene amplification status in breast cancer .&lt;/li&gt;&lt;li&gt;âž¤ equivocal HER2/neu IHC&lt;/li&gt;&lt;li&gt;âž¤ IHC score of 2&lt;/li&gt;&lt;li&gt;âž¤ Fluorescence In Situ Hybridization&lt;/li&gt;&lt;li&gt;âž¤ HER2/neu gene amplification status&lt;/li&gt;&lt;li&gt;âž¤ breast cancer&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman presents with a palpable lump in her left breast. A biopsy is performed, and the histopathological examination reveals invasive ductal carcinoma. Immunohistochemistry (IHC) shows a HER2/neu score of 3+. What is the most appropriate next step in managing this patient&#x27;s breast cancer?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Initiate hormonal therapy with tamoxifen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Administer chemotherapy with doxorubicin and cyclophosphamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prescribe trastuzumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Recommend radiotherapy for local control&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Prescribe trastuzumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Prescribe trastuzumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. While hormonal therapy is an essential part of the treatment for hormone receptor-positive breast cancer , the HER2/neu status of the tumor guides the use of targeted therapies such as trastuzumab.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ hormonal therapy&lt;/li&gt;&lt;li&gt;â€¢ treatment for hormone receptor-positive breast cancer&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chemotherapy may be a component of treatment for breast cancer, but for HER2/neu-positive tumors, trastuzumab is a key targeted therapy that has been shown to significantly improve outcomes.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Chemotherapy&lt;/li&gt;&lt;li&gt;â€¢ component of treatment for breast cancer,&lt;/li&gt;&lt;li&gt;â€¢ Option D. Radiotherapy could be part of the comprehensive treatment for breast cancer , particularly for local control, but is not directly related to the HER2/neu overexpression finding.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Radiotherapy&lt;/li&gt;&lt;li&gt;â€¢ comprehensive treatment for breast cancer&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For a patient with a HER2/neu score of 3+ indicating HER2 protein overexpression , trastuzumab is the most appropriate next step for targeted therapy in the management of HER2-positive breast cancer.&lt;/li&gt;&lt;li&gt;âž¤ HER2/neu score of 3+ indicating HER2 protein overexpression&lt;/li&gt;&lt;li&gt;âž¤ trastuzumab&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old postmenopausal woman is diagnosed with estrogen receptor-positive (ER+) and progesterone receptor-positive (PR+) invasive lobular carcinoma of the breast. What is the most appropriate adjuvant endocrine therapy for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;An aromatase inhibitor&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Selective estrogen receptor modulator (SERM) like tamoxifen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gonadotropin-releasing hormone agonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Progestin therapy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. An aromatase inhibitor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) An aromatase inhibitor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Tamoxifen, a SERM , can be used in postmenopausal women but is often reserved for those who cannot tolerate aromatase inhibitors or for premenopausal women.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Tamoxifen, a SERM&lt;/li&gt;&lt;li&gt;â€¢ used in postmenopausal women&lt;/li&gt;&lt;li&gt;â€¢ cannot tolerate aromatase inhibitors&lt;/li&gt;&lt;li&gt;â€¢ Option C. Gonadotropin-releasing hormone agonists are used in premenopausal women to suppress ovarian estrogen production , which is not applicable in postmenopausal women.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Gonadotropin-releasing&lt;/li&gt;&lt;li&gt;â€¢ hormone agonists&lt;/li&gt;&lt;li&gt;â€¢ premenopausal women&lt;/li&gt;&lt;li&gt;â€¢ suppress ovarian estrogen production&lt;/li&gt;&lt;li&gt;â€¢ Option D. Progestin therapy is not typically used in the treatment of hormone receptor-positive breast cancer .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Progestin therapy&lt;/li&gt;&lt;li&gt;â€¢ hormone receptor-positive breast cancer&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a postmenopausal woman with ER+ and PR+ breast cancer , the most appropriate adjuvant endocrine therapy is an aromatase inhibitor , which has been shown to be more effective than tamoxifen in this patient population.&lt;/li&gt;&lt;li&gt;âž¤ postmenopausal woman&lt;/li&gt;&lt;li&gt;âž¤ ER+ and PR+ breast cancer&lt;/li&gt;&lt;li&gt;âž¤ endocrine therapy&lt;/li&gt;&lt;li&gt;âž¤ aromatase inhibitor&lt;/li&gt;&lt;li&gt;âž¤ effective than tamoxifen&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman presents with a painless breast lump that has been gradually increasing in size over the past few months. On examination, a well-defined, mobile, rubbery mass is palpable in the upper outer quadrant of her left breast. Mammography reveals a well-circumscribed, round mass without microcalcifications. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Invasive ductal carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fibroadenoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ductal carcinoma in situ (DCIS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phylloides tumor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Fibroadenoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Fibroadenoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Invasive Ductal Carcinoma (IDC): it is the most common type of breast cancer. It often presents as an irregularly shaped mass with spiculated margins on imaging. Microcalcifications are a common finding in IDC. Unlike fibroadenomas, IDC tends to infiltrate surrounding tissues invasively.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Invasive Ductal Carcinoma (IDC):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ductal Carcinoma in Situ (DCIS): it is a non-invasive condition where abnormal cells are found in the lining of a breast duct but have not invaded surrounding tissues. It is usually detected through mammography and does not typically present as a palpable mass.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ductal Carcinoma in Situ (DCIS):&lt;/li&gt;&lt;li&gt;â€¢ non-invasive condition&lt;/li&gt;&lt;li&gt;â€¢ abnormal cells are found in the lining&lt;/li&gt;&lt;li&gt;â€¢ breast duct&lt;/li&gt;&lt;li&gt;â€¢ Option D. Phylloides Tumor are rare fibroepithelial tumors that may mimic fibroadenomas clinically . They are typically larger than fibroadenomas and may have a leaf-like appearance on imaging . Phylloides tumors have a potential for rapid growth and a higher risk of recurrence compared to fibroadenomas.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Phylloides Tumor&lt;/li&gt;&lt;li&gt;â€¢ rare fibroepithelial tumors&lt;/li&gt;&lt;li&gt;â€¢ mimic fibroadenomas clinically&lt;/li&gt;&lt;li&gt;â€¢ larger&lt;/li&gt;&lt;li&gt;â€¢ fibroadenomas&lt;/li&gt;&lt;li&gt;â€¢ leaf-like appearance on imaging&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Fibroadenoma is the most likely diagnosis for a young woman presenting with a well-defined, mobile, rubbery breast mass and a mammogram showing a well-circumscribed, non-calcified round lesion.&lt;/li&gt;&lt;li&gt;âž¤ Fibroadenoma&lt;/li&gt;&lt;li&gt;âž¤ young woman&lt;/li&gt;&lt;li&gt;âž¤ well-defined, mobile, rubbery breast mass&lt;/li&gt;&lt;li&gt;âž¤ mammogram&lt;/li&gt;&lt;li&gt;âž¤ well-circumscribed, non-calcified round lesion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which is not a correct match for the following ovarian tumors and their histological findings?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Teratoma: Epithelium, hair and cartilage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dysgerminoma: Nonlymphocytic infiltration&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Yolk sac tumor: Schiller Duval body&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Granulosa cell tumor: Call Exner body&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Dysgerminoma: Nonlymphocytic infiltration&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Dysgerminoma: Nonlymphocytic infiltration&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Correct. Teratomas are mixed germ cell tumors that can contain various types of tissue , such as hair, skin, and teeth, reflecting their origin from multiple germ layers.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Correct.&lt;/li&gt;&lt;li&gt;â€¢ Teratomas&lt;/li&gt;&lt;li&gt;â€¢ mixed germ cell tumors&lt;/li&gt;&lt;li&gt;â€¢ various types of tissue&lt;/li&gt;&lt;li&gt;â€¢ hair, skin,&lt;/li&gt;&lt;li&gt;â€¢ teeth,&lt;/li&gt;&lt;li&gt;â€¢ Option C. Correct. Yolk sac tumors are characterized by the presence of Schiller-Duval bodies , a distinctive histological feature.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Correct.&lt;/li&gt;&lt;li&gt;â€¢ Yolk sac tumors&lt;/li&gt;&lt;li&gt;â€¢ presence of Schiller-Duval bodies&lt;/li&gt;&lt;li&gt;â€¢ Option D. Correct . Granulosa cell tumors are often characterized by the presence of Call-Exner bodies.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Correct&lt;/li&gt;&lt;li&gt;â€¢ Granulosa cell tumors&lt;/li&gt;&lt;li&gt;â€¢ presence of Call-Exner bodies.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Dysgerminomas typically exhibit lymphocytic infiltration , not nonlymphocytic infiltration , distinguishing them from the other tumor types listed. This is crucial for pathology recognition and accurate diagnosis in the clinical setting.&lt;/li&gt;&lt;li&gt;âž¤ Dysgerminomas&lt;/li&gt;&lt;li&gt;âž¤ exhibit lymphocytic infiltration&lt;/li&gt;&lt;li&gt;âž¤ not nonlymphocytic infiltration&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1025-6&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1025-6&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are caused by lethal strains of HPV, except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cervical carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oral carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Laryngeal papillomatosis.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anorectal carcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Laryngeal papillomatosis.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Laryngeal papillomatosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A . Cervical carcinoma: Persistent infection with these high-risk HPV types especially HPV 16, 18, 31 and 33 , can lead to the progression of cervical dysplasia to invasive carcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A&lt;/li&gt;&lt;li&gt;â€¢ Cervical carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ Persistent infection&lt;/li&gt;&lt;li&gt;â€¢ high-risk HPV types&lt;/li&gt;&lt;li&gt;â€¢ HPV 16, 18, 31 and 33&lt;/li&gt;&lt;li&gt;â€¢ progression of cervical dysplasia&lt;/li&gt;&lt;li&gt;â€¢ Option B . Oral carcinoma: HPV infection , especially with types 16 and 18 , has been linked to the development of oral and oropharyngeal cancers , particularly in the tonsillar and base of the tongue areas.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B&lt;/li&gt;&lt;li&gt;â€¢ Oral carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ HPV infection&lt;/li&gt;&lt;li&gt;â€¢ types 16 and 18&lt;/li&gt;&lt;li&gt;â€¢ linked to the development of oral&lt;/li&gt;&lt;li&gt;â€¢ oropharyngeal cancers&lt;/li&gt;&lt;li&gt;â€¢ Option D . Anorectal carcinoma: High-risk HPV types , including 16 and 18 , are implicated in the development of anal and anorectal carcinomas . These cancers are more prevalent in individuals with persistent HPV infection.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D&lt;/li&gt;&lt;li&gt;â€¢ Anorectal carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ High-risk HPV types&lt;/li&gt;&lt;li&gt;â€¢ 16 and 18&lt;/li&gt;&lt;li&gt;â€¢ development of anal&lt;/li&gt;&lt;li&gt;â€¢ anorectal carcinomas&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Laryngeal papillomatosis is typically caused by the low-risk human papillomavirus (HPV) types 6 and 11 , which are not commonly associated with malignancy . In contrast, high-risk HPV types, particularly 16 and 18, are associated with an increased risk of developing cancers such as cervical carcinoma, oral carcinoma, and anorectal carcinoma.&lt;/li&gt;&lt;li&gt;âž¤ Laryngeal papillomatosis&lt;/li&gt;&lt;li&gt;âž¤ low-risk human papillomavirus&lt;/li&gt;&lt;li&gt;âž¤ types 6 and 11&lt;/li&gt;&lt;li&gt;âž¤ not commonly associated with malignancy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old female presents with a history of persistent genital warts. Upon further investigation, it is found that the Human Papillomavirus (HPV) responsible for her condition produces a protein that interacts with the Retinoblastoma (Rb) tumor suppressor protein, leading to its degradation. Which of the following HPV proteins is involved in this process?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;E6&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;E7&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;LMP1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tax&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. E7&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) E7&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. E6 protein of HPV interacts with cellular proteins , including p53 , leading to its degradation , which can disrupt cell cycle control and apoptosis regulation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. E6&lt;/li&gt;&lt;li&gt;â€¢ protein&lt;/li&gt;&lt;li&gt;â€¢ HPV&lt;/li&gt;&lt;li&gt;â€¢ cellular proteins&lt;/li&gt;&lt;li&gt;â€¢ p53&lt;/li&gt;&lt;li&gt;â€¢ degradation&lt;/li&gt;&lt;li&gt;â€¢ Option C. LMP1: Latent Membrane Protein 1 is a protein produced by the Epstein-Barr virus . It plays a role in oncogenesis by activating signaling pathways involved in cell proliferation and survival.&lt;/li&gt;&lt;li&gt;â€¢ Option C. LMP1:&lt;/li&gt;&lt;li&gt;â€¢ Latent Membrane Protein 1&lt;/li&gt;&lt;li&gt;â€¢ protein&lt;/li&gt;&lt;li&gt;â€¢ Epstein-Barr virus&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tax is a protein produced by the Human T-cell Leukemia Virus type 1 (HTLV-1), not HPV. Tax protein is known to interact with various cellular proteins and pathways, promoting cell proliferation and inhibiting apoptosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tax&lt;/li&gt;&lt;li&gt;â€¢ protein&lt;/li&gt;&lt;li&gt;â€¢ Human T-cell Leukemia Virus type 1&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The HPV E7 protein has a role in promoting cellular proliferation and potential oncogenesis through interaction with the retinoblastoma (Rb) tumor suppressor protein , leading to its degradation.&lt;/li&gt;&lt;li&gt;âž¤ HPV E7 protein&lt;/li&gt;&lt;li&gt;âž¤ role in promoting cellular proliferation&lt;/li&gt;&lt;li&gt;âž¤ potential oncogenesis&lt;/li&gt;&lt;li&gt;âž¤ interaction&lt;/li&gt;&lt;li&gt;âž¤ retinoblastoma&lt;/li&gt;&lt;li&gt;âž¤ tumor suppressor protein&lt;/li&gt;&lt;li&gt;âž¤ degradation.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/e p324&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th/e p324&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old woman presents for a routine Pap smear. The cytology report reveals koilocytes, nuclear enlargement, and perinuclear clearing in some of the cells. The fixative used in Pap smear is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Methanol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ethanol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Formalin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Air drying&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Ethanol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Ethanol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Methanol is a fixative but not the primary choice for Pap smears because it can cause shrinkage and hardening of cells, which may interfere with cytological interpretation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Methanol&lt;/li&gt;&lt;li&gt;â€¢ fixative&lt;/li&gt;&lt;li&gt;â€¢ not the primary choice for Pap smears&lt;/li&gt;&lt;li&gt;â€¢ Option C. Formalin is used for histopathological specimens and is not suitable for Pap smears, as it can over-fix cells, leading to difficulties in cytological interpretation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Formalin&lt;/li&gt;&lt;li&gt;â€¢ histopathological specimens&lt;/li&gt;&lt;li&gt;â€¢ Option D. Air drying is not a fixative and can result in poor preservation of cellular morphology on Pap smear slides.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Air drying&lt;/li&gt;&lt;li&gt;â€¢ not a fixative&lt;/li&gt;&lt;li&gt;â€¢ result in poor preservation of cellular morphology&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ethanol is the primary fixative used in Pap smear preparations , effectively preserving the morphology of cervical cells for cytological evaluation and the identification of abnormalities such as koilocytes , which are indicative of HPV infection.&lt;/li&gt;&lt;li&gt;âž¤ Ethanol&lt;/li&gt;&lt;li&gt;âž¤ primary fixative&lt;/li&gt;&lt;li&gt;âž¤ Pap smear preparations&lt;/li&gt;&lt;li&gt;âž¤ preserving the morphology of cervical cells&lt;/li&gt;&lt;li&gt;âž¤ cytological evaluation&lt;/li&gt;&lt;li&gt;âž¤ identification of abnormalities&lt;/li&gt;&lt;li&gt;âž¤ koilocytes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The following are the instruments used in Pap smear:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cytobrush&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ayer spatula&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fixative and retractor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cytobrush: It is a brush-like instrument used to collect cells from the endocervical canal .&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A.&lt;/li&gt;&lt;li&gt;â€¢ Cytobrush:&lt;/li&gt;&lt;li&gt;â€¢ brush-like instrument&lt;/li&gt;&lt;li&gt;â€¢ collect cells from the endocervical canal&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ayer spatula : It is a wooden or plastic spatula used to sample cells from the outer cervix .&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B.&lt;/li&gt;&lt;li&gt;â€¢ Ayer spatula&lt;/li&gt;&lt;li&gt;â€¢ wooden or plastic spatula&lt;/li&gt;&lt;li&gt;â€¢ sample cells&lt;/li&gt;&lt;li&gt;â€¢ outer cervix&lt;/li&gt;&lt;li&gt;â€¢ Option C . Fixative and Retractor: After collecting the cells , they are transferred onto a glass slide , fixed , and then examined under a microscope . A retractor may be used to help visualize and access the cervix during the procedure.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C&lt;/li&gt;&lt;li&gt;â€¢ Fixative and Retractor:&lt;/li&gt;&lt;li&gt;â€¢ collecting the cells&lt;/li&gt;&lt;li&gt;â€¢ transferred onto a glass slide&lt;/li&gt;&lt;li&gt;â€¢ fixed&lt;/li&gt;&lt;li&gt;â€¢ examined under a microscope&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ All of the mentioned instruments (cytobrush, Ayer spatula, fixative, and retractor) are used in the Pap smear procedure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Arrange the steps of Pap smear in the correct sequence: Retract vagina Take smear Make smear on the slide Fixate the slide&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;4, 3, 2, 1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;4, 3, 1, 2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1, 2, 3, 4&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1, 2, 4, 3&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 1, 2, 3, 4&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/23/screenshot-2024-04-23-163037.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 1, 2, 3, 4&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ The steps of Pap smear include retracting the vagina to visualize the cervix , taking a smear of cervical cells , making a smear on a slide , and fixating the slide with a suitable fixative like ethanol to preserve the sample for transportation and analysis .&lt;/li&gt;&lt;li&gt;â€¢ Pap smear&lt;/li&gt;&lt;li&gt;â€¢ retracting the vagina&lt;/li&gt;&lt;li&gt;â€¢ visualize the cervix&lt;/li&gt;&lt;li&gt;â€¢ smear of cervical cells&lt;/li&gt;&lt;li&gt;â€¢ smear on a slide&lt;/li&gt;&lt;li&gt;â€¢ fixating the slide&lt;/li&gt;&lt;li&gt;â€¢ suitable fixative&lt;/li&gt;&lt;li&gt;â€¢ ethanol&lt;/li&gt;&lt;li&gt;â€¢ preserve the sample&lt;/li&gt;&lt;li&gt;â€¢ transportation and analysis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A female presented in the gynecology OPD with the presentation as given in the image. The examination revealed presence of high-risk HPV. Which of the following is the causative agent?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;6&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;11&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;18&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;32&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 18&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/28/untitled-547.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 18&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. HPV 6 is incorrect because it is associated with low-risk lesions such as genital warts rather than high-risk cervical pathologies.&lt;/li&gt;&lt;li&gt;â€¢ Option A. HPV 6&lt;/li&gt;&lt;li&gt;â€¢ associated with low-risk lesions&lt;/li&gt;&lt;li&gt;â€¢ genital warts&lt;/li&gt;&lt;li&gt;â€¢ Option B. HPV 11 is also incorrect for the same reason as HPV 6 ; it is linked to benign lesions and not high-risk cervical dysplasias or cancers.&lt;/li&gt;&lt;li&gt;â€¢ Option B. HPV 11&lt;/li&gt;&lt;li&gt;â€¢ same reason as HPV 6&lt;/li&gt;&lt;li&gt;â€¢ Option D. HPV 32 is not typically implicated in high-risk cervical disease .&lt;/li&gt;&lt;li&gt;â€¢ Option D. HPV 32&lt;/li&gt;&lt;li&gt;â€¢ implicated in high-risk cervical disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ HPV 16 and 18 are involved in the pathogenesis of high-grade cervical dysplasias and cervical cancer .&lt;/li&gt;&lt;li&gt;âž¤ HPV 16&lt;/li&gt;&lt;li&gt;âž¤ 18 are involved in the pathogenesis&lt;/li&gt;&lt;li&gt;âž¤ high-grade cervical dysplasias&lt;/li&gt;&lt;li&gt;âž¤ cervical cancer&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1001&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1001&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman undergoes Pap smear which shows disorganised growth of the cells with hyperchromatic nuclei. Which phenomenon is occurring here?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypertrophy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dysplasia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metaplasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hyperplasia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Dysplasia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Dysplasia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypertrophy refers to an increase in the size of cells without an increase in the number of cells.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypertrophy&lt;/li&gt;&lt;li&gt;â€¢ increase in the size of cells&lt;/li&gt;&lt;li&gt;â€¢ Option C. Metaplasia is a reversible change in which one adult cell type is replaced by another cell type.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Metaplasia&lt;/li&gt;&lt;li&gt;â€¢ reversible change&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hyperplasia is an increase in the number of cells in a tissue or organ.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hyperplasia&lt;/li&gt;&lt;li&gt;â€¢ increase in the number of cells&lt;/li&gt;&lt;li&gt;â€¢ tissue&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Dysplasia represents an early sign of potential malignant transformation in cervical epithelial cells and is characterized by disorganized cellular architecture and nuclear atypia .&lt;/li&gt;&lt;li&gt;âž¤ Dysplasia&lt;/li&gt;&lt;li&gt;âž¤ early sign&lt;/li&gt;&lt;li&gt;âž¤ malignant transformation&lt;/li&gt;&lt;li&gt;âž¤ cervical epithelial cells&lt;/li&gt;&lt;li&gt;âž¤ disorganized cellular architecture&lt;/li&gt;&lt;li&gt;âž¤ nuclear atypia&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/e p719-720&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th/e p719-720&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Benign hyperplasia of prostate first develops in:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Central zone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Peripheral zone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Periurethral transition zone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Any of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Periurethral transition zone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Periurethral transition zone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Incorrect, as the central zone is not the typical starting point for BPH .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ central zone&lt;/li&gt;&lt;li&gt;â€¢ not the typical starting point for BPH&lt;/li&gt;&lt;li&gt;â€¢ Option B. Incorrect, because the peripheral zone is primarily associated with prostate cancer rather than BPH.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ peripheral zone&lt;/li&gt;&lt;li&gt;â€¢ associated with prostate cancer&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Benign prostatic hyperplasia commonly begins in the periurethral transition zone of the prostate .&lt;/li&gt;&lt;li&gt;âž¤ Benign prostatic hyperplasia&lt;/li&gt;&lt;li&gt;âž¤ begins in the periurethral transition zone&lt;/li&gt;&lt;li&gt;âž¤ prostate&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 982&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 982&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The commonest site for extragonadal germ cell tumour is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pineal gland&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mediastinum&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Retroperitoneum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sacrococcygeal region&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Mediastinum&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Mediastinum&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pineal gland. While EGCTs can occur in the pineal gland, it is not the most common site for these tumors.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Pineal gland.&lt;/li&gt;&lt;li&gt;â€¢ not the most common site&lt;/li&gt;&lt;li&gt;â€¢ Option C . Retroperitoneum . EGCTs can also arise in the retroperitoneum but less frequently than in the mediastinum.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Retroperitoneum&lt;/li&gt;&lt;li&gt;â€¢ arise in the retroperitoneum&lt;/li&gt;&lt;li&gt;â€¢ less frequently&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sacrococcygeal region . Although EGCTs can be found in the sacrococcygeal region , it is a less common site compared to the mediastinum.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Sacrococcygeal region&lt;/li&gt;&lt;li&gt;â€¢ EGCTs&lt;/li&gt;&lt;li&gt;â€¢ found in the sacrococcygeal region&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The mediastinum , especially the anterior mediastinum , is the most common site for extragonadal germ cell tumors .&lt;/li&gt;&lt;li&gt;âž¤ mediastinum&lt;/li&gt;&lt;li&gt;âž¤ anterior mediastinum&lt;/li&gt;&lt;li&gt;âž¤ extragonadal germ cell tumors&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 480&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 480&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which one of the following is not used as a tumor marker in testicular tumors?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;AFP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;LDH&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HCG&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CEA&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. CEA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) CEA&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. AFP (Alpha-fetoprotein) is a tumor marker used in the diagnosis and management of non-seminomatous germ cell tumors of the testis .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ AFP&lt;/li&gt;&lt;li&gt;â€¢ tumor marker&lt;/li&gt;&lt;li&gt;â€¢ diagnosis and management&lt;/li&gt;&lt;li&gt;â€¢ non-seminomatous germ cell tumors&lt;/li&gt;&lt;li&gt;â€¢ testis&lt;/li&gt;&lt;li&gt;â€¢ Option B. LDH (Lactate Dehydrogenase) is a less specific marker but can be elevated in testicular cancers and is used to gauge prognosis and response to treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ LDH&lt;/li&gt;&lt;li&gt;â€¢ less specific marker&lt;/li&gt;&lt;li&gt;â€¢ elevated in testicular cancers&lt;/li&gt;&lt;li&gt;â€¢ Option C. HCG (Human Chorionic Gonadotropin) is another marker important for certain types of testicular cancers , such as choriocarcinomas , and can also be elevated in other non-seminomatous germ cell tumors .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ HCG&lt;/li&gt;&lt;li&gt;â€¢ marker&lt;/li&gt;&lt;li&gt;â€¢ types of testicular cancers&lt;/li&gt;&lt;li&gt;â€¢ choriocarcinomas&lt;/li&gt;&lt;li&gt;â€¢ elevated&lt;/li&gt;&lt;li&gt;â€¢ non-seminomatous germ cell tumors&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The tumor markers commonly used for testicular cancers include AFP, LDH , and HCG . CEA is not used as a marker for testicular tumors and is more relevant in other cancers like those of the gastrointestinal tract.&lt;/li&gt;&lt;li&gt;âž¤ tumor markers&lt;/li&gt;&lt;li&gt;âž¤ testicular cancers&lt;/li&gt;&lt;li&gt;âž¤ AFP, LDH&lt;/li&gt;&lt;li&gt;âž¤ HCG&lt;/li&gt;&lt;li&gt;âž¤ CEA&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ marker for testicular tumors&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 981&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 981&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following genes are associated with seminoma except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;PLAP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;C-KIT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;OCT-4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CDK-4&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. CDK-4&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) CDK-4&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. PLAP (Placental Alkaline Phosphatase) is a tumor marker expressed in seminomas and can be used in the diagnosis and follow-up of patients with this type of tumor.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ PLAP&lt;/li&gt;&lt;li&gt;â€¢ tumor marker expressed in seminomas&lt;/li&gt;&lt;li&gt;â€¢ used in the diagnosis&lt;/li&gt;&lt;li&gt;â€¢ follow-up of patients&lt;/li&gt;&lt;li&gt;â€¢ Option B. C-KIT is a proto-oncogene that encodes for a tyrosine kinase receptor ; mutations in C-KIT are found in a subset of seminomas, making it relevant to their pathogenesis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. C-KIT&lt;/li&gt;&lt;li&gt;â€¢ proto-oncogene&lt;/li&gt;&lt;li&gt;â€¢ encodes for a tyrosine kinase receptor&lt;/li&gt;&lt;li&gt;â€¢ Option C. OCT-4 (Octamer-binding transcription factor 4) is a transcription factor involved in maintaining the pluripotency of embryonic stem cells . It is highly expressed in seminomas and is considered a reliable diagnostic marker.&lt;/li&gt;&lt;li&gt;â€¢ Option C. OCT-4&lt;/li&gt;&lt;li&gt;â€¢ transcription factor&lt;/li&gt;&lt;li&gt;â€¢ maintaining the pluripotency&lt;/li&gt;&lt;li&gt;â€¢ embryonic stem cells&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ When assessing seminomas , key genes to consider include PLAP, C-KIT, and OCT-4 , which are commonly expressed in these tumors . CDK-4 is not specifically linked to seminomas and is more generally involved in the cell cycle regulation of many cell types .&lt;/li&gt;&lt;li&gt;âž¤ assessing seminomas&lt;/li&gt;&lt;li&gt;âž¤ PLAP, C-KIT,&lt;/li&gt;&lt;li&gt;âž¤ OCT-4&lt;/li&gt;&lt;li&gt;âž¤ expressed in these tumors&lt;/li&gt;&lt;li&gt;âž¤ CDK-4&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ linked to seminomas&lt;/li&gt;&lt;li&gt;âž¤ involved in the cell cycle regulation&lt;/li&gt;&lt;li&gt;âž¤ many cell types&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/ 978&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th/ 978&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The cytogenicity of solid tumors is not easily assessed especially in carcinoma cervix because:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metaphase is distinct&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Due to contamination with infectious agents&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;High mitotic rate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Deficient tissue sample&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Due to contamination with infectious agents&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Due to contamination with infectious agents&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option C. While a high mitotic rate is a characteristic of rapidly dividing cancer cells , it doesn&#x27;t necessarily hinder cytogenetic analysis . In fact, a high mitotic rate is often beneficial for cytogenetic studies as it provides more cells in the dividing phase for analysis.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ high mitotic rate&lt;/li&gt;&lt;li&gt;â€¢ characteristic of rapidly dividing cancer cells&lt;/li&gt;&lt;li&gt;â€¢ doesn&#x27;t&lt;/li&gt;&lt;li&gt;â€¢ hinder cytogenetic analysis&lt;/li&gt;&lt;li&gt;â€¢ high mitotic rate&lt;/li&gt;&lt;li&gt;â€¢ beneficial for cytogenetic studies&lt;/li&gt;&lt;li&gt;â€¢ Option D. Deficient tissue sample : A deficient tissue sample may indeed hinder cytogenetic analysis . If the sample is insufficient or of low quality , it may not yield enough viable cells for proper analysis.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Deficient tissue sample&lt;/li&gt;&lt;li&gt;â€¢ deficient tissue sample&lt;/li&gt;&lt;li&gt;â€¢ hinder cytogenetic analysis&lt;/li&gt;&lt;li&gt;â€¢ sample is insufficient&lt;/li&gt;&lt;li&gt;â€¢ low quality&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Deficient tissue sampling like sampling from non-representative areas or the necrotic areas will impair the results in most of the solid tumors but the commonest problem with cancer of the cervix is the high contamination rate . So, option â€˜Bâ€™ is better than option â€˜Dâ€™.&lt;/li&gt;&lt;li&gt;â€¢ Deficient tissue sampling&lt;/li&gt;&lt;li&gt;â€¢ sampling from non-representative areas&lt;/li&gt;&lt;li&gt;â€¢ necrotic areas&lt;/li&gt;&lt;li&gt;â€¢ impair the results&lt;/li&gt;&lt;li&gt;â€¢ solid tumors&lt;/li&gt;&lt;li&gt;â€¢ commonest problem with cancer of the cervix&lt;/li&gt;&lt;li&gt;â€¢ high contamination rate&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;With regard to the malignant behavior of leiomyosarcoma, the most important criterion is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Blood vessel penetration by tumor cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tumor cells in lymphatic channels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lymphocyte infiltration&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The number of mitoses per high power field&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. The number of mitoses per high power field&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) The number of mitoses per high power field&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Blood vessel penetration by tumor cells is a feature observed in malignant tumors . However, while significant, it is not the most critical factor in diagnosing leiomyosarcoma.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Blood vessel penetration by tumor cells&lt;/li&gt;&lt;li&gt;â€¢ feature observed in malignant tumors&lt;/li&gt;&lt;li&gt;â€¢ Option B. The presence of tumor cells in lymphatic channels is another indication of potential malignancy and can signify the spread of cancer, but it&#x27;s not the primary criterion for diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. The presence of tumor cells in lymphatic channels&lt;/li&gt;&lt;li&gt;â€¢ indication of potential malignancy&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lymphocyte infiltration is often a sign of an immune response to the tumor rather than a direct indication of malignancy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lymphocyte infiltration&lt;/li&gt;&lt;li&gt;â€¢ sign of an immune response to the tumor&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A high mitotic index is indicative of aggressive tumor behavior and malignancy , aiding in the differentiation between benign and malignant smooth muscle tumors such as leiomyomas and leiomyosarcomas , respectively.&lt;/li&gt;&lt;li&gt;âž¤ high mitotic index&lt;/li&gt;&lt;li&gt;âž¤ aggressive tumor behavior&lt;/li&gt;&lt;li&gt;âž¤ malignancy&lt;/li&gt;&lt;li&gt;âž¤ differentiation between benign&lt;/li&gt;&lt;li&gt;âž¤ malignant smooth muscle tumors&lt;/li&gt;&lt;li&gt;âž¤ leiomyomas&lt;/li&gt;&lt;li&gt;âž¤ leiomyosarcomas&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1021&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1021&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Sections from a solid-cystic unilateral ovarian tumor in a 30-year-old female show a tumor composed of diffuse sheets of small cells with doubtful nuclear grooving and scanty cytoplasm. No Call-Exner bodies are seen. The ideal immunohistochemistry panel would include:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vimentin, epithelial membrane antigen, inhibin, CD99&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Desmin, S-100 protein, smooth muscle antigen, cytokeratin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chromogranin, CD45, CD99, CD20&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CD3, Chromogranin, CD 45, Synaptophysin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Vimentin, epithelial membrane antigen, inhibin, CD99&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Vimentin, epithelial membrane antigen, inhibin, CD99&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Encompasses markers like Desmin and Smooth Muscle Antigen (SMA) for smooth muscle tumors , S-100 for neural tumors , and Cytokeratin for epithelial tumors . This panel isnâ€™t as specific for granulosa cell tumors as Option A.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Encompasses markers&lt;/li&gt;&lt;li&gt;â€¢ Desmin and Smooth Muscle Antigen&lt;/li&gt;&lt;li&gt;â€¢ smooth muscle tumors&lt;/li&gt;&lt;li&gt;â€¢ S-100&lt;/li&gt;&lt;li&gt;â€¢ neural tumors&lt;/li&gt;&lt;li&gt;â€¢ Cytokeratin for epithelial tumors&lt;/li&gt;&lt;li&gt;â€¢ Option C: Has markers like Chromogranin and CD45 , which are used for neuroendocrine and hematolymphoid tumors , respectively.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ markers like Chromogranin&lt;/li&gt;&lt;li&gt;â€¢ CD45&lt;/li&gt;&lt;li&gt;â€¢ used for neuroendocrine&lt;/li&gt;&lt;li&gt;â€¢ hematolymphoid tumors&lt;/li&gt;&lt;li&gt;â€¢ Option D: Includes CD3 and CD45 , markers for T-lymphocytes and leukocytes respectively, along with Chromogranin and Synaptophysin , which are neuroendocrine markers. This panel is not suitable for a granulosa cell tumor.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ CD3 and CD45&lt;/li&gt;&lt;li&gt;â€¢ markers for T-lymphocytes&lt;/li&gt;&lt;li&gt;â€¢ leukocytes&lt;/li&gt;&lt;li&gt;â€¢ Chromogranin&lt;/li&gt;&lt;li&gt;â€¢ Synaptophysin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In diagnosing granulosa cell tumors , an IHC panel including Vimentin, EMA , Inhibin , and CD99 can be valuable . Vimentin and Inhibin are particularly important in this setting, with Inhibin being a specific marker for sex cord-stromal tumors like granulosa cell tumors . The absence of Call-Exner bodies does not exclude the diagnosis of granulosa cell tumors , as these are not present in all cases. This panel can help confirm the diagnosis and differentiate it from other neoplasms.&lt;/li&gt;&lt;li&gt;âž¤ diagnosing granulosa cell tumors&lt;/li&gt;&lt;li&gt;âž¤ IHC panel including Vimentin, EMA&lt;/li&gt;&lt;li&gt;âž¤ Inhibin&lt;/li&gt;&lt;li&gt;âž¤ CD99&lt;/li&gt;&lt;li&gt;âž¤ valuable&lt;/li&gt;&lt;li&gt;âž¤ Vimentin&lt;/li&gt;&lt;li&gt;âž¤ Inhibin&lt;/li&gt;&lt;li&gt;âž¤ Inhibin being a specific marker for sex cord-stromal tumors&lt;/li&gt;&lt;li&gt;âž¤ granulosa cell tumors&lt;/li&gt;&lt;li&gt;âž¤ absence of Call-Exner bodies&lt;/li&gt;&lt;li&gt;âž¤ not exclude the diagnosis of granulosa cell tumors&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with chronic pelvic pain undergoes a hysterectomy. The resected uterus is filled with nodules composed of benign smooth muscle cells. Which of the following terms best describes these nodules?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Angiosarcoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Leiomyoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Leiomyosarcoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rhabdomyoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Leiomyoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Leiomyoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Angiosarcoma: This term refers to a malignant tumor derived from blood vessels , not smooth muscle.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Angiosarcoma:&lt;/li&gt;&lt;li&gt;â€¢ refers to a malignant tumor&lt;/li&gt;&lt;li&gt;â€¢ blood vessels&lt;/li&gt;&lt;li&gt;â€¢ Option C. Leiomyosarcoma: This term refers to a malignant smooth muscle tumor , and the description in the question indicates benign nodules.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Leiomyosarcoma:&lt;/li&gt;&lt;li&gt;â€¢ malignant smooth muscle tumor&lt;/li&gt;&lt;li&gt;â€¢ Option D. Rhabdomyoma: This term refers to a benign tumor derived from striated muscle , not smooth muscle.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Rhabdomyoma:&lt;/li&gt;&lt;li&gt;â€¢ benign tumor derived from striated muscle&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Leiomyomas are benign neoplasms originating from the myometrium and are commonly referred to as uterine fibroids . They are the most prevalent benign gynecological tumors in women of reproductive age and are often associated with symptoms like chronic pelvic pain , abnormal uterine bleeding , and reproductive dysfunction .&lt;/li&gt;&lt;li&gt;âž¤ Leiomyomas&lt;/li&gt;&lt;li&gt;âž¤ benign neoplasms&lt;/li&gt;&lt;li&gt;âž¤ myometrium&lt;/li&gt;&lt;li&gt;âž¤ commonly referred to as uterine fibroids&lt;/li&gt;&lt;li&gt;âž¤ most prevalent benign gynecological tumors&lt;/li&gt;&lt;li&gt;âž¤ women of reproductive age&lt;/li&gt;&lt;li&gt;âž¤ chronic pelvic pain&lt;/li&gt;&lt;li&gt;âž¤ abnormal uterine bleeding&lt;/li&gt;&lt;li&gt;âž¤ reproductive dysfunction&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1021&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1021&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Endodermal sinus tumor is characterized by:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Call Exner body&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Psammoma body&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Schiller-Duval body&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Homer wright body&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Schiller-Duval body&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Schiller-Duval body&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Call Exner body: Seen in granulosa cell tumors of the ovary .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Call Exner body:&lt;/li&gt;&lt;li&gt;â€¢ granulosa cell tumors&lt;/li&gt;&lt;li&gt;â€¢ ovary&lt;/li&gt;&lt;li&gt;â€¢ Option B. Psammoma body: Seen in various tumors , including papillary thyroid carcinoma and serous ovarian tumors .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Psammoma body:&lt;/li&gt;&lt;li&gt;â€¢ various tumors&lt;/li&gt;&lt;li&gt;â€¢ papillary thyroid carcinoma&lt;/li&gt;&lt;li&gt;â€¢ serous ovarian tumors&lt;/li&gt;&lt;li&gt;â€¢ Option D. Homer Wright body: Seen in neuroblastoma and medulloblastoma.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Homer Wright body:&lt;/li&gt;&lt;li&gt;â€¢ neuroblastoma&lt;/li&gt;&lt;li&gt;â€¢ medulloblastoma.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The presence of Schiller-Duval bodies is a distinctive histological feature of endodermal sinus tumors (yolk sac tumors), which are aggressive germ cell neoplasms often found in the gonads . Recognition of these bodies, which resemble a glomerulus with a central blood vessel surrounded by germ cells , aids in differentiating endodermal sinus tumors from other germ cell tumors . They are a pathognomonic finding, supporting the diagnosis when identified microscopically.&lt;/li&gt;&lt;li&gt;âž¤ presence of Schiller-Duval bodies&lt;/li&gt;&lt;li&gt;âž¤ histological feature&lt;/li&gt;&lt;li&gt;âž¤ endodermal sinus tumors&lt;/li&gt;&lt;li&gt;âž¤ aggressive germ cell neoplasms&lt;/li&gt;&lt;li&gt;âž¤ gonads&lt;/li&gt;&lt;li&gt;âž¤ resemble a glomerulus&lt;/li&gt;&lt;li&gt;âž¤ central blood vessel&lt;/li&gt;&lt;li&gt;âž¤ germ cells&lt;/li&gt;&lt;li&gt;âž¤ differentiating endodermal sinus tumors&lt;/li&gt;&lt;li&gt;âž¤ other germ cell tumors&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 974&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 974&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An adenofibroma of the ovary in which the epithelial component consists of the nests of transitional cells is called:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thecoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Brenner tumour&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Serous cystadenoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Granulose cell tumor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Brenner tumour&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Brenner tumour&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Thecoma: An ovarian sex cord-stromal tumor .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Thecoma:&lt;/li&gt;&lt;li&gt;â€¢ ovarian sex cord-stromal tumor&lt;/li&gt;&lt;li&gt;â€¢ Option C. Serous cystadenoma: An ovarian epithelial tumor characterized by the presence of serous cysts .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Serous cystadenoma:&lt;/li&gt;&lt;li&gt;â€¢ ovarian epithelial tumor&lt;/li&gt;&lt;li&gt;â€¢ presence of serous cysts&lt;/li&gt;&lt;li&gt;â€¢ Option D. Granulosa cell tumor: Another type of ovarian sex cord-stromal tumor .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Granulosa cell tumor:&lt;/li&gt;&lt;li&gt;â€¢ ovarian sex cord-stromal tumor&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The Brenner tumor is an uncommon ovarian neoplasm characterized by solid and cystic components with transitional epithelium resembling bladder urothelium . The histopathological features of Brenner tumours often present as nests of transitional cells.&lt;/li&gt;&lt;li&gt;âž¤ Brenner tumor&lt;/li&gt;&lt;li&gt;âž¤ uncommon ovarian neoplasm&lt;/li&gt;&lt;li&gt;âž¤ solid and cystic components&lt;/li&gt;&lt;li&gt;âž¤ transitional epithelium&lt;/li&gt;&lt;li&gt;âž¤ bladder urothelium&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1025&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1025&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A lady with abdominal mass was investigated. On surgery, she was found to have bilateral ovarian masses with smooth surface. On microscopy they revealed mucin secreting cells with signet ring shape. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dysgerminoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Krukenberg tumor&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mucinous adenocarcinoma of the ovaries&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dermoid cyst&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Krukenberg tumor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Krukenberg tumor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Dysgerminoma: Dysgerminomas are germ cell tumors typically found in the ovaries . Histologically, they are characterized by uniform, undifferentiated cells with clear cytoplasm and central nuclei. They do not have the mucin-secreting signet ring cells that are characteristic of Krukenberg tumors.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Dysgerminoma:&lt;/li&gt;&lt;li&gt;â€¢ germ cell tumors&lt;/li&gt;&lt;li&gt;â€¢ found in the ovaries&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mucinous Adenocarcinoma of the Ovaries: Primary mucinous adenocarcinomas of the ovaries originate within the ovary itself . They also contain mucin-secreting cells, but unlike Krukenberg tumors, they are not metastatic and typically present as multilocular cystic masses with a sticky gelatinous fluid.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mucinous Adenocarcinoma of the Ovaries:&lt;/li&gt;&lt;li&gt;â€¢ Primary mucinous adenocarcinomas&lt;/li&gt;&lt;li&gt;â€¢ ovaries originate within the ovary itself&lt;/li&gt;&lt;li&gt;â€¢ Option D. Dermoid Cyst: Also known as mature cystic teratomas , dermoid cysts are benign tumors that contain well-differentiated derivations from at least two of the three germ layers : ectoderm , mesoderm , and endoderm . They may contain various tissues such as hair, teeth, and sebaceous material, and are not associated with signet ring cells or mucin production.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Dermoid Cyst:&lt;/li&gt;&lt;li&gt;â€¢ mature cystic teratomas&lt;/li&gt;&lt;li&gt;â€¢ dermoid cysts&lt;/li&gt;&lt;li&gt;â€¢ benign tumors&lt;/li&gt;&lt;li&gt;â€¢ well-differentiated derivations&lt;/li&gt;&lt;li&gt;â€¢ two of the three germ layers&lt;/li&gt;&lt;li&gt;â€¢ ectoderm&lt;/li&gt;&lt;li&gt;â€¢ mesoderm&lt;/li&gt;&lt;li&gt;â€¢ endoderm&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ The presence of bilateral ovarian masses with mucin-secreting signet ring cells is pathognomonic for a Krukenberg tumor , which indicates that the primary tumor is most likely in the gastrointestinal tract , especially the stomach .&lt;/li&gt;&lt;li&gt;â€¢ presence of bilateral ovarian masses&lt;/li&gt;&lt;li&gt;â€¢ mucin-secreting signet ring cells&lt;/li&gt;&lt;li&gt;â€¢ pathognomonic for a Krukenberg tumor&lt;/li&gt;&lt;li&gt;â€¢ primary tumor&lt;/li&gt;&lt;li&gt;â€¢ gastrointestinal tract&lt;/li&gt;&lt;li&gt;â€¢ stomach&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins 10 th 1030&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Robbins 10 th 1030&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Most common subtype of endometrial carcinoma on histopathology is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Clear cell&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Adenocarcinoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Squamous cell carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Transitional cell carcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Adenocarcinoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Adenocarcinoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Clear Cell: Clear cell carcinoma of the endometrium is a rare subtype and is typically associated with a more aggressive behavior and worse prognosis than endometrioid adenocarcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Clear Cell:&lt;/li&gt;&lt;li&gt;â€¢ endometrium&lt;/li&gt;&lt;li&gt;â€¢ rare subtype&lt;/li&gt;&lt;li&gt;â€¢ more aggressive behavior&lt;/li&gt;&lt;li&gt;â€¢ worse prognosis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Squamous Cell Carcinoma : Squamous cell carcinoma of the endometrium is exceedingly rare because the endometrium normally does not contain squamous cells ; they may appear secondary to metaplastic processes.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Squamous Cell Carcinoma&lt;/li&gt;&lt;li&gt;â€¢ endometrium&lt;/li&gt;&lt;li&gt;â€¢ exceedingly rare&lt;/li&gt;&lt;li&gt;â€¢ endometrium normally&lt;/li&gt;&lt;li&gt;â€¢ not contain squamous cells&lt;/li&gt;&lt;li&gt;â€¢ Option D. Transitional Cell Carcinoma: Transitional cell carcinoma is another rare subtype of endometrial cancer that resembles urothelial carcinoma of the bladder . This type of carcinoma is not commonly found in the endometrium.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Transitional Cell Carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ another rare subtype&lt;/li&gt;&lt;li&gt;â€¢ endometrial cancer&lt;/li&gt;&lt;li&gt;â€¢ resembles urothelial carcinoma of the bladder&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Adenocarcinoma , especially the endometrioid subtype , is the most common form of endometrial cancer .&lt;/li&gt;&lt;li&gt;â€¢ Adenocarcinoma&lt;/li&gt;&lt;li&gt;â€¢ endometrioid subtype&lt;/li&gt;&lt;li&gt;â€¢ common&lt;/li&gt;&lt;li&gt;â€¢ endometrial cancer&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins 10 th / 1010&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Robbins 10 th / 1010&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All are true about condylomata acuminata except which of the following:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Caused by HPV&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sexually transmitted&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Progresses to malignancy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Occurs in genitalia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Progresses to malignancy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Progresses to malignancy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Caused by HPV This statement is true . Condylomata acuminata, also known as genital warts, are caused by certain types of the human papillomavirus (HPV), particularly HPV types 6 and 11.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Caused by HPV&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sexually transmitted This is true as well. HPV, which causes condylomata acuminata, is transmitted through sexual contact.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sexually transmitted&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;li&gt;â€¢ Option D. Occurs in genitalia This statement is true . Condylomata acuminata typically appear in the moist mucocutaneous regions of the genitalia and are characterized by their cauliflower-like appearance.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Occurs in genitalia&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Condylomata acuminata are benign lesions caused by HPV and are sexually transmitted . They typically appear in the genitalia and, while they may persist or recur, they rarely progress to malignancy .&lt;/li&gt;&lt;li&gt;âž¤ Condylomata acuminata&lt;/li&gt;&lt;li&gt;âž¤ benign lesions&lt;/li&gt;&lt;li&gt;âž¤ HPV&lt;/li&gt;&lt;li&gt;âž¤ sexually transmitted&lt;/li&gt;&lt;li&gt;âž¤ appear in the genitalia&lt;/li&gt;&lt;li&gt;âž¤ rarely progress to malignancy&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 970&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 970&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Risk factor for endometrial carcinoma is all except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Obesity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Smoking&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Infertility&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tamoxifen&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Smoking&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Smoking&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Obesity: Obese women have an increased risk of endometrial carcinoma , likely due to the excess production of estrogen in adipose tissue .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Obesity:&lt;/li&gt;&lt;li&gt;â€¢ increased risk of endometrial carcinoma&lt;/li&gt;&lt;li&gt;â€¢ excess production&lt;/li&gt;&lt;li&gt;â€¢ estrogen&lt;/li&gt;&lt;li&gt;â€¢ adipose tissue&lt;/li&gt;&lt;li&gt;â€¢ Option C. Infertility: Infertile women, especially those with polycystic ovary syndrome (PCOS), are at an increased risk . This may be related to anovulation and unopposed estrogen stimulation .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Infertility:&lt;/li&gt;&lt;li&gt;â€¢ polycystic ovary syndrome&lt;/li&gt;&lt;li&gt;â€¢ increased risk&lt;/li&gt;&lt;li&gt;â€¢ anovulation&lt;/li&gt;&lt;li&gt;â€¢ unopposed estrogen stimulation&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tamoxifen: Tamoxifen, a selective estrogen receptor modulator (SERM) used in the treatment of breast cancer , has estrogenic effects on the endometrium and is associated with an increased risk of endometrial carcinoma .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tamoxifen:&lt;/li&gt;&lt;li&gt;â€¢ selective estrogen receptor modulator&lt;/li&gt;&lt;li&gt;â€¢ treatment of breast cancer&lt;/li&gt;&lt;li&gt;â€¢ estrogenic effects&lt;/li&gt;&lt;li&gt;â€¢ endometrium&lt;/li&gt;&lt;li&gt;â€¢ increased risk of endometrial carcinoma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Obesity , infertility , and the use of tamoxifen are known risk factors for developing endometrial carcinoma . In contrast, smoking has been associated with a decreased risk of endometrial carcinoma , likely due to its anti-estrogenic effects , which counteract the estrogen-driven proliferation of the endometrial lining .&lt;/li&gt;&lt;li&gt;âž¤ Obesity&lt;/li&gt;&lt;li&gt;âž¤ infertility&lt;/li&gt;&lt;li&gt;âž¤ use of tamoxifen&lt;/li&gt;&lt;li&gt;âž¤ risk factors&lt;/li&gt;&lt;li&gt;âž¤ endometrial carcinoma&lt;/li&gt;&lt;li&gt;âž¤ smoking&lt;/li&gt;&lt;li&gt;âž¤ associated with a decreased risk of endometrial carcinoma&lt;/li&gt;&lt;li&gt;âž¤ anti-estrogenic effects&lt;/li&gt;&lt;li&gt;âž¤ counteract&lt;/li&gt;&lt;li&gt;âž¤ estrogen-driven proliferation&lt;/li&gt;&lt;li&gt;âž¤ endometrial lining&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1012&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1012&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Most common primary ovarian tumor amongst the following is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fibroma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Teratoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mucinous cystadenoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Serous cystadenoma&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Serous cystadenoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Serous cystadenoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fibroma: Fibromas are ovarian tumors composed of fibrous tissue .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fibroma:&lt;/li&gt;&lt;li&gt;â€¢ ovarian tumors&lt;/li&gt;&lt;li&gt;â€¢ fibrous tissue&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ovarian teratomas , also known as dermoid cysts , are the neoplasms that can contain elements derived from all three germ layers (ectoderm, mesoderm, and endoderm)&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ovarian teratomas&lt;/li&gt;&lt;li&gt;â€¢ dermoid cysts&lt;/li&gt;&lt;li&gt;â€¢ neoplasms&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mucinous cystadenoma: Mucinous cystadenomas are ovarian tumors that contain mucin-secreting epithelial cells ..&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mucinous cystadenoma:&lt;/li&gt;&lt;li&gt;â€¢ ovarian tumors&lt;/li&gt;&lt;li&gt;â€¢ mucin-secreting epithelial cells&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Serous cystadenomas are the most common ovarian neoplasms .&lt;/li&gt;&lt;li&gt;â€¢ Serous cystadenomas&lt;/li&gt;&lt;li&gt;â€¢ most common ovarian neoplasms&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins 10 th 1024&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Robbins 10 th 1024&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old woman experienced dull pain in lower abdomen for past 6 months and minimal vaginal bleeding on 3 occasions. Her last menstrual period was 12 years ago. Pelvic examination shows a right adnexal mass and the uterus appears normal in size. An abdominal ultrasound shows 8 cm solid mass. A total abdominal hysterectomy was done and mass was diagnosed as granulosa tumour. Which of the following additional lesion is most likely to be found in excised specimen?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Partial hydatiform mole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Endometrial hyperplasia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metastases to uterine serosa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Condyloma acuminate of cervix&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Endometrial hyperplasia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. A partial hydatidiform mole is a gestational trophoblastic disease characterized by abnormal fetal development and hydropic changes in the placenta . It&#x27;s more associated with abnormalities in fertilization and placental development during pregnancy .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ A partial hydatidiform mole&lt;/li&gt;&lt;li&gt;â€¢ gestational trophoblastic disease&lt;/li&gt;&lt;li&gt;â€¢ abnormal fetal development&lt;/li&gt;&lt;li&gt;â€¢ hydropic changes&lt;/li&gt;&lt;li&gt;â€¢ placenta&lt;/li&gt;&lt;li&gt;â€¢ abnormalities in fertilization&lt;/li&gt;&lt;li&gt;â€¢ placental development&lt;/li&gt;&lt;li&gt;â€¢ pregnancy&lt;/li&gt;&lt;li&gt;â€¢ Option C. While metastases can occur in various cancers , granulosa cell tumors of the ovary typically spread within the pelvic and abdominal cavities . Distant metastases, especially to the uterine serosa, are less common.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ While metastases can occur in various cancers&lt;/li&gt;&lt;li&gt;â€¢ granulosa cell tumors&lt;/li&gt;&lt;li&gt;â€¢ ovary&lt;/li&gt;&lt;li&gt;â€¢ spread within the pelvic&lt;/li&gt;&lt;li&gt;â€¢ abdominal cavities&lt;/li&gt;&lt;li&gt;â€¢ Option D. Condyloma acuminata , caused by human papillomavirus (HPV), is a sexually transmitted infection that manifests as genital warts . It is unrelated to granulosa cell tumors of the ovary.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Condyloma acuminata&lt;/li&gt;&lt;li&gt;â€¢ human papillomavirus&lt;/li&gt;&lt;li&gt;â€¢ sexually transmitted infection&lt;/li&gt;&lt;li&gt;â€¢ genital warts&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ It is important to recognize the endocrine effects of granulosa cell tumors , which are a type of sex cord-stromal tumor of the ovary . These tumors are known to secrete estrogen , which can lead to proliferative changes in the endometrium , such as endometrial hyperplasia . In postmenopausal women , unopposed estrogen can significantly increase the risk of developing endometrial hyperplasia , which can progress to endometrial carcinoma .&lt;/li&gt;&lt;li&gt;âž¤ recognize the endocrine effects of granulosa cell tumors&lt;/li&gt;&lt;li&gt;âž¤ type of sex cord-stromal tumor&lt;/li&gt;&lt;li&gt;âž¤ ovary&lt;/li&gt;&lt;li&gt;âž¤ tumors&lt;/li&gt;&lt;li&gt;âž¤ secrete estrogen&lt;/li&gt;&lt;li&gt;âž¤ proliferative changes&lt;/li&gt;&lt;li&gt;âž¤ endometrium&lt;/li&gt;&lt;li&gt;âž¤ endometrial hyperplasia&lt;/li&gt;&lt;li&gt;âž¤ postmenopausal women&lt;/li&gt;&lt;li&gt;âž¤ unopposed estrogen&lt;/li&gt;&lt;li&gt;âž¤ increase the risk of developing endometrial hyperplasia&lt;/li&gt;&lt;li&gt;âž¤ endometrial carcinoma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 46 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test11" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Neoplasia&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Neoplasia&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                50 Questions | 200 Total Marks | 60 min Duration | ~72.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;An elderly female with mediastinal mass undergoes a microscopic examination showing red cell aplasia. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bronchogenic carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Thymoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Non-Hodgkin lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Squamous cell carcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Thymoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Thymoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bronchogenic carcinoma: Bronchogenic carcinoma refers to a type of lung cancer originating from the bronchi . Although it can present with a mediastinal mass , it is not typically associated with pure red cell aplasia , which is a reduction in the production of red blood cells .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bronchogenic carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ type of lung cancer&lt;/li&gt;&lt;li&gt;â€¢ bronchi&lt;/li&gt;&lt;li&gt;â€¢ mediastinal mass&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ pure red cell aplasia&lt;/li&gt;&lt;li&gt;â€¢ reduction in the production of red blood cells&lt;/li&gt;&lt;li&gt;â€¢ Option C. Non-Hodgkin lymphoma: Non-Hodgkin lymphoma is a diverse group of blood malignancies that includes any kind of lymphoma except Hodgkin&#x27;s lymphomas . Types of Non-Hodgkin lymphoma can involve the mediastinum but are not typically associated with pure red cell aplasia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Non-Hodgkin lymphoma:&lt;/li&gt;&lt;li&gt;â€¢ diverse group of blood malignancies&lt;/li&gt;&lt;li&gt;â€¢ lymphoma&lt;/li&gt;&lt;li&gt;â€¢ Hodgkin&#x27;s lymphomas&lt;/li&gt;&lt;li&gt;â€¢ Types of Non-Hodgkin lymphoma&lt;/li&gt;&lt;li&gt;â€¢ mediastinum&lt;/li&gt;&lt;li&gt;â€¢ not typically&lt;/li&gt;&lt;li&gt;â€¢ pure red cell aplasia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Squamous cell carcinoma: Squamous cell carcinoma can arise in various organs, including the lungs, but is not commonly associated with pure red cell aplasia or mediastinal masses unless it is metastatic from another primary location .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Squamous cell carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ Squamous cell carcinoma&lt;/li&gt;&lt;li&gt;â€¢ organs,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ pure red cell aplasia or mediastinal masses&lt;/li&gt;&lt;li&gt;â€¢ metastatic from&lt;/li&gt;&lt;li&gt;â€¢ primary location&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Thymomas are mediastinal tumors that may be associated with paraneoplastic syndromes, including pure red cell aplasia, which is characterized by a selective decrease in red blood cell precursors.&lt;/li&gt;&lt;li&gt;âž¤ Thymomas&lt;/li&gt;&lt;li&gt;âž¤ mediastinal tumors&lt;/li&gt;&lt;li&gt;âž¤ paraneoplastic syndromes,&lt;/li&gt;&lt;li&gt;âž¤ pure red cell aplasia,&lt;/li&gt;&lt;li&gt;âž¤ decrease&lt;/li&gt;&lt;li&gt;âž¤ red blood cell precursors.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/e p493&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th/e p493&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Match the following genes correctly with their tumors:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A-2, B-3, C-4, D-1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A-3, B-2, C-1, D-4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A-4, B-3, C-2, D-1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A-2, B-1, C-4, D-3&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. A-2, B-1, C-4, D-3&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/08/screenshot-2024-02-08-150523.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-100314.JPG&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) A-2, B-1, C-4, D-3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ C- myc is associated with Burkittâ€™s lymphoma (Ref: Robbinsâ€¦316) PLAG 1 is associated with pleomorphic adenoma (Ref: Robbinsâ€¦748) N myc is associated with neuroblastoma (Ref: Robbinsâ€¦289) Rb is associated with retinoblastoma (Ref: Robbinsâ€¦147)&lt;/li&gt;&lt;li&gt;âž¤ C- myc is associated with Burkittâ€™s lymphoma (Ref: Robbinsâ€¦316)&lt;/li&gt;&lt;li&gt;âž¤ C- myc&lt;/li&gt;&lt;li&gt;âž¤ Burkittâ€™s lymphoma&lt;/li&gt;&lt;li&gt;âž¤ PLAG 1 is associated with pleomorphic adenoma (Ref: Robbinsâ€¦748)&lt;/li&gt;&lt;li&gt;âž¤ PLAG 1&lt;/li&gt;&lt;li&gt;âž¤ pleomorphic adenoma&lt;/li&gt;&lt;li&gt;âž¤ N myc is associated with neuroblastoma (Ref: Robbinsâ€¦289)&lt;/li&gt;&lt;li&gt;âž¤ N myc&lt;/li&gt;&lt;li&gt;âž¤ neuroblastoma&lt;/li&gt;&lt;li&gt;âž¤ Rb is associated with retinoblastoma (Ref: Robbinsâ€¦147)&lt;/li&gt;&lt;li&gt;âž¤ Rb&lt;/li&gt;&lt;li&gt;âž¤ retinoblastoma&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 147, 289, 316, 748&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 147, 289, 316, 748&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 31-year-old female has fecal blood identified during a physical examination. A colonoscopy reveals an ulcerated mass in her proximal rectum. In the past, she was operated and treated for a ductal carcinoma of her left breast and a malignant thyroid tumor. Of the following, what is the most likely mutation if she is diagnosed with Cowdenâ€™s syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mutation of the PTEN gene&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mutation of the CDKN2 gene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mutation of RB gene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mutation of the WT gene&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Mutation of the PTEN gene&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Mutation of the PTEN gene&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mutations of CDKN2 are associated with malignant melanoma&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ CDKN2&lt;/li&gt;&lt;li&gt;â€¢ malignant melanoma&lt;/li&gt;&lt;li&gt;â€¢ Option C. RB with retinoblastoma.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ RB&lt;/li&gt;&lt;li&gt;â€¢ retinoblastoma.&lt;/li&gt;&lt;li&gt;â€¢ Option D. WT with Wilms tumor&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ WT&lt;/li&gt;&lt;li&gt;â€¢ Wilms tumor&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Patients with Cowdens syndrome have mutation of the PTEN gene .&lt;/li&gt;&lt;li&gt;â€¢ Patients&lt;/li&gt;&lt;li&gt;â€¢ Cowdens syndrome&lt;/li&gt;&lt;li&gt;â€¢ mutation of the PTEN gene&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins and Cotran pathologic basis of disease 10th edition page:292 table: 7.7&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Robbins and Cotran pathologic basis of disease 10th edition page:292 table: 7.7&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with Burkitt lymphoma presents with lethargy, weakness, and oliguria after receiving the first cycle of chemotherapy. Laboratory tests reveal abnormalities consistent with tumor lysis syndrome (TLS). Which of the following laboratory findings is LEAST likely to be associated with this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hyperuricemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hyperkalemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hyperphosphatemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypercalcemia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hypercalcemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Hypercalcemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hyperuricemia is typically seen in TLS due to the increased turnover of nucleic acids from rapid cell lysis , leading to excess production of uric acid .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Hyperuricemia&lt;/li&gt;&lt;li&gt;â€¢ TLS&lt;/li&gt;&lt;li&gt;â€¢ increased&lt;/li&gt;&lt;li&gt;â€¢ nucleic acids from rapid cell lysis&lt;/li&gt;&lt;li&gt;â€¢ uric acid&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hyperkalemia results from the release of potassium , the most abundant intracellular cation , into the bloodstream when cells lyse .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Hyperkalemia&lt;/li&gt;&lt;li&gt;â€¢ release of potassium&lt;/li&gt;&lt;li&gt;â€¢ intracellular cation&lt;/li&gt;&lt;li&gt;â€¢ bloodstream&lt;/li&gt;&lt;li&gt;â€¢ cells lyse&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hyperphosphatemia occurs due to the release of intracellular phosphate into the extracellular fluid during cell lysis.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Hyperphosphatemia&lt;/li&gt;&lt;li&gt;â€¢ intracellular phosphate into the extracellular fluid&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Tumor lysis syndrome is characterized by hyperuricemia, hyperkalemia, and hyperphosphatemia, but not hypercalcemia ; instead, hypocalcemia occurs due to the complexing of calcium with elevated phosphate levels .&lt;/li&gt;&lt;li&gt;âž¤ Tumor lysis&lt;/li&gt;&lt;li&gt;âž¤ hyperuricemia, hyperkalemia, and hyperphosphatemia,&lt;/li&gt;&lt;li&gt;âž¤ not hypercalcemia&lt;/li&gt;&lt;li&gt;âž¤ hypocalcemia&lt;/li&gt;&lt;li&gt;âž¤ complexing of calcium with elevated phosphate levels&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In reviewing the pathology report for a patient diagnosed with colonic adenocarcinoma, which of the following findings is most indicative of the tumor&#x27;s grade?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Number of positive lymph nodes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Size of the tumor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metastatic spread to another organ&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Number of mitotic figures per high power-field&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Number of mitotic figures per high power-field&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Number of mitotic figures per high power field.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. While the number of positive lymph nodes is crucial for staging a tumor under the &#x27;N&#x27; category in the TNM classification system , it does not determine the histologic grade of the tumor .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ the number of positive lymph nodes&lt;/li&gt;&lt;li&gt;â€¢ staging a tumor&lt;/li&gt;&lt;li&gt;â€¢ &#x27;N&#x27; category in the TNM classification system&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ histologic grade of the tumor&lt;/li&gt;&lt;li&gt;â€¢ Option B. The size of the tumor is used to determine the &#x27;T&#x27; category in the TNM system and contributes to the staging, but not grading, of cancer .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ size of the tumor&lt;/li&gt;&lt;li&gt;â€¢ &#x27;T&#x27; category in the TNM system&lt;/li&gt;&lt;li&gt;â€¢ staging,&lt;/li&gt;&lt;li&gt;â€¢ not grading, of cancer&lt;/li&gt;&lt;li&gt;â€¢ Option C. The presence of metastasis is classified under the &#x27;M&#x27; category of the TNM system and, like A and B, is used in staging rather than grading.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ presence of metastasis&lt;/li&gt;&lt;li&gt;â€¢ &#x27;M&#x27; category of the TNM system&lt;/li&gt;&lt;li&gt;â€¢ A and B, is used in staging&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The grade of a tumor is determined by its histologic differentiation, which includes the assessment of mitotic activity , specifically the number of mitotic figures per high power field , and not by the TNM staging factors such as tumor size, nodal involvement, or metastasis .&lt;/li&gt;&lt;li&gt;âž¤ grade of a tumor&lt;/li&gt;&lt;li&gt;âž¤ histologic differentiation,&lt;/li&gt;&lt;li&gt;âž¤ assessment of mitotic activity&lt;/li&gt;&lt;li&gt;âž¤ number of mitotic figures&lt;/li&gt;&lt;li&gt;âž¤ high power field&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ TNM staging factors&lt;/li&gt;&lt;li&gt;âž¤ tumor size, nodal involvement, or metastasis&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 246&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran pathologic basis of disease 10th edition page: 246&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male presents to his family physician because of complaints of blood in his stool and intermittent constipation. Fecal occult blood testing is positive. A colonoscopy is performed, revealing a large adenocarcinoma of the sigmoid colon. As the tumor was removed, a researcher tested the tumor and identified a mutation of RAS gene. Of the following, what was one mechanism by which the tumor developed?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of apoptosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Abnormal GTPase activity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Abnormal tyrosine kinase activity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Up-regulation of cytokine receptor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Abnormal GTPase activity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Abnormal GTPase activity&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: While inhibition of apoptosis is a common mechanism in tumorigenesis , mutations in the RAS gene typically do not result in the direct inhibition of apoptotic pathways .&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ inhibition of apoptosis&lt;/li&gt;&lt;li&gt;â€¢ tumorigenesis&lt;/li&gt;&lt;li&gt;â€¢ mutations&lt;/li&gt;&lt;li&gt;â€¢ RAS gene&lt;/li&gt;&lt;li&gt;â€¢ do not&lt;/li&gt;&lt;li&gt;â€¢ direct inhibition of apoptotic pathways&lt;/li&gt;&lt;li&gt;â€¢ Option C: Abnormal tyrosine kinase activity is often associated with mutations in other proto-oncogenes and is not the primary mechanism of action for RAS mutations.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Abnormal tyrosine kinase activity&lt;/li&gt;&lt;li&gt;â€¢ mutations&lt;/li&gt;&lt;li&gt;â€¢ proto-oncogenes&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ RAS mutations.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Up-regulation of cytokine receptor expression is a mechanism that could l ead to increased cell signaling for proliferation but is not directly related to RAS mutations.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Up-regulation&lt;/li&gt;&lt;li&gt;â€¢ cytokine receptor&lt;/li&gt;&lt;li&gt;â€¢ ead to increased cell signaling for proliferation&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ RAS mutations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Mutations in the RAS gene lead to abnormal GTPase activity, resulting in uncontrolled cell division and mitogenesis , which can contribute to tumorigenesis, such as in colon adenocarcinoma.&lt;/li&gt;&lt;li&gt;âž¤ Mutations&lt;/li&gt;&lt;li&gt;âž¤ RAS gene&lt;/li&gt;&lt;li&gt;âž¤ abnormal GTPase activity,&lt;/li&gt;&lt;li&gt;âž¤ uncontrolled cell division and mitogenesis&lt;/li&gt;&lt;li&gt;âž¤ tumorigenesis,&lt;/li&gt;&lt;li&gt;âž¤ colon adenocarcinoma.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 286&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran pathologic basis of disease 10th edition page: 286&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old male with a past medical history significant for HIV infection has a CD4 count 120 cells/mmÂ³ . The patient is started on antiretroviral therapy, and further evaluation is planned. All of the following are AIDS defining malignancies except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Non-Hodgkinâ€™s lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Invasive cervical carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Kaposi sarcoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Melanoma&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Melanoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Melanoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Non-Hodgkinâ€™s lymphoma , including primary lymphoma of the brain , is an AIDS-defining malignancy . This can be due to the weakened immune system&#x27;s inability to control oncogenic viruses like EBV, which is associated with lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Non-Hodgkinâ€™s lymphoma&lt;/li&gt;&lt;li&gt;â€¢ primary lymphoma of the brain&lt;/li&gt;&lt;li&gt;â€¢ AIDS-defining malignancy&lt;/li&gt;&lt;li&gt;â€¢ due to the weakened immune system&#x27;s&lt;/li&gt;&lt;li&gt;â€¢ oncogenic viruses&lt;/li&gt;&lt;li&gt;â€¢ EBV,&lt;/li&gt;&lt;li&gt;â€¢ lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Invasive cervical carcinoma is considered an AIDS-defining condition due to the association with human papillomavirus (HPV) and the increased risk of this malignancy in individuals with compromised immune systems .&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Invasive cervical carcinoma&lt;/li&gt;&lt;li&gt;â€¢ AIDS-defining&lt;/li&gt;&lt;li&gt;â€¢ human papillomavirus (HPV)&lt;/li&gt;&lt;li&gt;â€¢ increased risk of this malignancy&lt;/li&gt;&lt;li&gt;â€¢ compromised immune systems&lt;/li&gt;&lt;li&gt;â€¢ Option C: Kaposi sarcoma , caused by human herpesvirus 8 (HHV-8), is commonly seen in patients with AIDS and is one of the most recognizable AIDS-defining malignancies .&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Kaposi sarcoma&lt;/li&gt;&lt;li&gt;â€¢ human herpesvirus 8 (HHV-8),&lt;/li&gt;&lt;li&gt;â€¢ AIDS&lt;/li&gt;&lt;li&gt;â€¢ AIDS-defining malignancies&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Non-Hodgkinâ€™s lymphoma , invasive cervical carcinoma, and Kaposi sarcoma are considered AIDS-defining malignancies , which occur with increased frequency in patients with advanced HIV/AIDS due to their immunocompromised state . Melanoma is not part of this category.&lt;/li&gt;&lt;li&gt;âž¤ Non-Hodgkinâ€™s lymphoma&lt;/li&gt;&lt;li&gt;âž¤ invasive cervical carcinoma, and Kaposi sarcoma&lt;/li&gt;&lt;li&gt;âž¤ AIDS-defining malignancies&lt;/li&gt;&lt;li&gt;âž¤ increased frequency in patients&lt;/li&gt;&lt;li&gt;âž¤ HIV/AIDS due to their immunocompromised state&lt;/li&gt;&lt;li&gt;âž¤ Melanoma is not part of this category.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 256&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 256&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A researcher is studying the metabolic activity of cancer cells and notes that despite adequate oxygen availability, the cells exhibit an increased rate of glycolysis followed by lactic acid fermentation. What is the primary reason for cancer cells to exhibit this metabolic pathway, known as the Warburg effect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;To reduce the uptake of glucose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;To increase its lifespan and become immortal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;To enhance ATP production&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;To make intermediated required for proliferation&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. To make intermediated required for proliferation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) To make intermediated required for proliferation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. The Warburg effect is characterized by an increased uptake of glucose , not a reduction , as cancer cells have high energy demands .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Warburg effect&lt;/li&gt;&lt;li&gt;â€¢ increased uptake of glucose&lt;/li&gt;&lt;li&gt;â€¢ not a reduction&lt;/li&gt;&lt;li&gt;â€¢ cancer cells have high energy demands&lt;/li&gt;&lt;li&gt;â€¢ Option B. While the Warburg effect contributes to the cancer cells&#x27; survival , it does not directly increase their lifespan or cause immortality . Instead, it supports the high metabolic demands of proliferation.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Warburg effect&lt;/li&gt;&lt;li&gt;â€¢ cancer cells&#x27; survival&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ increase their lifespan&lt;/li&gt;&lt;li&gt;â€¢ immortality&lt;/li&gt;&lt;li&gt;â€¢ high metabolic demands of proliferation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. The Warburg effect does not enhance ATP production since aerobic glycolysis is less efficient than oxidative phosphorylation , generating only 2 ATP molecules per glucose molecule compared to 36 ATP from oxidative phosphorylation.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Warburg effect does not&lt;/li&gt;&lt;li&gt;â€¢ ATP production&lt;/li&gt;&lt;li&gt;â€¢ aerobic glycolysis is less efficient than oxidative phosphorylation&lt;/li&gt;&lt;li&gt;â€¢ 2 ATP&lt;/li&gt;&lt;li&gt;â€¢ glucose molecule compared to 36 ATP&lt;/li&gt;&lt;li&gt;â€¢ oxidative phosphorylation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Warburg effect , or aerobic glycolysis , in cancer cells is an adaptation that allows for the rapid synthesis of the macromolecules and organelles needed for cell growth and division , not for increased ATP production .&lt;/li&gt;&lt;li&gt;âž¤ Warburg effect&lt;/li&gt;&lt;li&gt;âž¤ aerobic glycolysis&lt;/li&gt;&lt;li&gt;âž¤ rapid synthesis of the macromolecules&lt;/li&gt;&lt;li&gt;âž¤ organelles&lt;/li&gt;&lt;li&gt;âž¤ cell growth and division&lt;/li&gt;&lt;li&gt;âž¤ not for increased ATP production&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th / 299&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th / 299&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A woman presents to the gynecology clinic with genital lesions, as shown in the image. Upon examination, these lesions tests positive for a high-risk HPV subtype. Which of the following HPV subtypes is most likely the causative agent of her condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;6&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;11&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;18&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;32&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 18&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/untitled-550.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 18&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. HPV-6 is associated with low-risk HPV infections, which typically cause genital warts , but are not highly associated with cervical cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ HPV-6&lt;/li&gt;&lt;li&gt;â€¢ low-risk HPV infections,&lt;/li&gt;&lt;li&gt;â€¢ genital warts&lt;/li&gt;&lt;li&gt;â€¢ not highly associated with cervical cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Similar to HPV-6 , HPV-11 is also considered low-risk for cervical cancer and is more commonly associated with the development of genital warts .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Similar to HPV-6&lt;/li&gt;&lt;li&gt;â€¢ HPV-11&lt;/li&gt;&lt;li&gt;â€¢ low-risk for cervical cancer&lt;/li&gt;&lt;li&gt;â€¢ genital warts&lt;/li&gt;&lt;li&gt;â€¢ Option D. HPV-32 is less commonly associated with cervical pathology and is not typically classified among the high-risk HPV subtypes responsible for cervical cancer .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ HPV-32&lt;/li&gt;&lt;li&gt;â€¢ less commonly&lt;/li&gt;&lt;li&gt;â€¢ cervical pathology&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ cervical cancer&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ High-risk HPV subtypes , particularly HPV-16 and HPV-18 , are most commonly associated with cervical cancer and its precursor lesions . While the scenario indicates a high-risk HPV subtype, the lesions depicted are characteristic of condylomata acuminata, typically caused by low-risk HPV subtypes.&lt;/li&gt;&lt;li&gt;âž¤ High-risk HPV subtypes&lt;/li&gt;&lt;li&gt;âž¤ HPV-16 and HPV-18&lt;/li&gt;&lt;li&gt;âž¤ cervical cancer&lt;/li&gt;&lt;li&gt;âž¤ its precursor lesions&lt;/li&gt;&lt;li&gt;âž¤ indicates a high-risk HPV subtype,&lt;/li&gt;&lt;li&gt;âž¤ condylomata acuminata,&lt;/li&gt;&lt;li&gt;âž¤ low-risk HPV subtypes.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th /1001&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th /1001&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A middle-aged male presents with a painless, slow-growing swelling in the neck. Fine needle aspiration cytology (FNAC) is performed. For which of the following thyroid cancers is FNAC least likely to provide a definitive diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Papillary thyroid cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Follicular thyroid cancer&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Medullary thyroid cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anapalstic thyroid cancer&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Follicular thyroid cancer&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Follicular thyroid cancer&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. FNAC is highly effective for diagnosing papillary thyroid cancer due to characteristic cytological features such as nuclear grooves and pseudoinclusions.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ FNAC is highly effective&lt;/li&gt;&lt;li&gt;â€¢ papillary thyroid cancer&lt;/li&gt;&lt;li&gt;â€¢ nuclear grooves and pseudoinclusions.&lt;/li&gt;&lt;li&gt;â€¢ Option C. FNAC can suggest a diagnosis of medullary thyroid cancer by demonstrating amyloid and calcitonin-rich cells ; however, serum calcitonin levels and genetic testing are also important for diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ FNAC can suggest&lt;/li&gt;&lt;li&gt;â€¢ medullary thyroid&lt;/li&gt;&lt;li&gt;â€¢ amyloid and calcitonin-rich cells&lt;/li&gt;&lt;li&gt;â€¢ serum calcitonin levels and genetic testing&lt;/li&gt;&lt;li&gt;â€¢ important for diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. FNAC can often suggest anaplastic thyroid cancer due to the presence of highly atypical cells and necrotic material ; however, the aggressive nature of the disease often requires rapid additional diagnostic and therapeutic interventions.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ FNAC&lt;/li&gt;&lt;li&gt;â€¢ anaplastic thyroid cancer&lt;/li&gt;&lt;li&gt;â€¢ highly atypical cells and necrotic material&lt;/li&gt;&lt;li&gt;â€¢ aggressive nature of the disease&lt;/li&gt;&lt;li&gt;â€¢ diagnostic and therapeutic interventions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ FNAC has limitations in diagnosing follicular thyroid cancer because it requires histological evidence of capsular or vascular invasion to differentiate between benign and malignant lesions , which cannot be determined by cytology alone .&lt;/li&gt;&lt;li&gt;âž¤ FNAC&lt;/li&gt;&lt;li&gt;âž¤ diagnosing follicular thyroid cancer&lt;/li&gt;&lt;li&gt;âž¤ histological evidence of capsular&lt;/li&gt;&lt;li&gt;âž¤ vascular invasion&lt;/li&gt;&lt;li&gt;âž¤ benign and malignant lesions&lt;/li&gt;&lt;li&gt;âž¤ cannot be determined by cytology alone&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An elderly female is being evaluated by her family physician for significant weight loss. Over the past 10 weeks, she has developed a velvety hyperpigmentation of the skin on the posterior neck and bilateral axilla. Her routine blood work is normal except for a hemoglobin level of 8.6 g/dL. Her HbA1c is 5.4%, and a plain chest radiograph is normal. What is the next step in the evaluation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bone scan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CT chest with contrast&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Skin Biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Upper and lower endoscopy&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Upper and lower endoscopy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Upper and lower endoscopy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. A bone scan might be useful in evaluating bone metastasis if there&#x27;s suspicion for a metastatic process , but it&#x27;s not the first step in the evaluation of a patient with suspected gastrointestinal malignancy and acanthosis nigricans.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ A bone scan&lt;/li&gt;&lt;li&gt;â€¢ bone metastasis&lt;/li&gt;&lt;li&gt;â€¢ metastatic process&lt;/li&gt;&lt;li&gt;â€¢ not the first step&lt;/li&gt;&lt;li&gt;â€¢ suspected gastrointestinal malignancy and acanthosis nigricans.&lt;/li&gt;&lt;li&gt;â€¢ Option B. While a CT chest with contrast could identify thoracic pathology , it wouldn&#x27;t be the initial investigation for suspected gastric malignancy , especially with normal chest X-ray findings and the presence of acanthosis nigricans .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ CT chest with contrast&lt;/li&gt;&lt;li&gt;â€¢ thoracic pathology&lt;/li&gt;&lt;li&gt;â€¢ wouldn&#x27;t be&lt;/li&gt;&lt;li&gt;â€¢ gastric malignancy&lt;/li&gt;&lt;li&gt;â€¢ normal chest X-ray findings and the presence of acanthosis nigricans&lt;/li&gt;&lt;li&gt;â€¢ Option C. A skin biopsy could confirm acanthosis nigricans but wouldn&#x27;t address the underlying cause of the patient&#x27;s systemic symptoms and weight loss.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ skin biopsy&lt;/li&gt;&lt;li&gt;â€¢ acanthosis nigricans&lt;/li&gt;&lt;li&gt;â€¢ wouldn&#x27;t&lt;/li&gt;&lt;li&gt;â€¢ patient&#x27;s systemic symptoms and weight loss.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In an elderly patient without obesity or diabetes, the presence of acanthosis nigricans and significant weight loss is concerning for an underlying malignancy, particularly gastrointestinal in origin , thus warranting endoscopic evaluation.&lt;/li&gt;&lt;li&gt;âž¤ elderly patient&lt;/li&gt;&lt;li&gt;âž¤ obesity or diabetes,&lt;/li&gt;&lt;li&gt;âž¤ acanthosis nigricans&lt;/li&gt;&lt;li&gt;âž¤ weight loss&lt;/li&gt;&lt;li&gt;âž¤ underlying malignancy, particularly gastrointestinal in origin&lt;/li&gt;&lt;li&gt;âž¤ endoscopic evaluation.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran pathologic basis of disease 10th edition page:329&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran pathologic basis of disease 10th edition page:329&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A child presents to the OPD with proptosis. The mass responsible for same was biopsied and found to be a desmin positive tumor. Which of the following is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Leukemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ewing sarcoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Embryonal rhabdomyosarcoma&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Embryonal rhabdomyosarcoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/08/screenshot-2024-02-08-151003_DGH9row.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Embryonal rhabdomyosarcoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins 10 th /332&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins 10 th /332&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 46-year-old female presents to her family physician because she palpated a nodule in her left breast during a breast self-examination. She subsequently undergoes a partial mastectomy. The mass is examined by a pathologist who makes a diagnosis of invasive ductal carcinoma. Subsequent genetic testing reveals a mutation of the BRCA2 gene. Of the following, what is the location for this mutation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;17p&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;17q&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;13q&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;13p&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 13q&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 13q&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. 17p refers to the short arm of chromosome 17 , which is where the gene for the p53 protein is located, not BRCA2 . p53 is commonly mutated in many forms of cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ 17p&lt;/li&gt;&lt;li&gt;â€¢ short arm of chromosome 17&lt;/li&gt;&lt;li&gt;â€¢ p53 protein&lt;/li&gt;&lt;li&gt;â€¢ not BRCA2&lt;/li&gt;&lt;li&gt;â€¢ Option B. 17q refers to the long arm of chromosome 17. This is the location of the BRCA1 gene , not BRCA2.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ 17q&lt;/li&gt;&lt;li&gt;â€¢ long arm of chromosome 17.&lt;/li&gt;&lt;li&gt;â€¢ location of the BRCA1 gene&lt;/li&gt;&lt;li&gt;â€¢ Option D. 13p would refer to the short arm of chromosome 13 , which is not the correct location for the BRCA2 gene.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ 13p&lt;/li&gt;&lt;li&gt;â€¢ short arm of chromosome 13&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ BRCA2 gene.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The BRCA2 gene is located on the long arm of chromosome 13 , at the cytogenetic band 13q .&lt;/li&gt;&lt;li&gt;âž¤ BRCA2 gene&lt;/li&gt;&lt;li&gt;âž¤ long arm of chromosome 13&lt;/li&gt;&lt;li&gt;âž¤ cytogenetic band 13q&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th ed/ 293-4&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th ed/ 293-4&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old female presents with persistent cervical dysplasia on Pap smear. Further investigation reveals infection with high-risk HPV. Molecular analysis indicates the presence of a viral protein that interferes with the tumor suppressor Rb gene, promoting cell cycle progression. Which of the following protein produced by HPV suppresses Rb gene?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;E6&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;E7&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;LMP1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tax&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. E7&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) E7&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. The E6 protein of HPV is involved in the degradation of the p53 tumor suppressor protein , not the Rb protein . p53 is another critical regulator of the cell cycle and apoptosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ E6 protein of HPV&lt;/li&gt;&lt;li&gt;â€¢ p53 tumor suppressor protein&lt;/li&gt;&lt;li&gt;â€¢ not the Rb protein&lt;/li&gt;&lt;li&gt;â€¢ p53&lt;/li&gt;&lt;li&gt;â€¢ critical regulator of the cell cycle and apoptosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. LMP1 is an oncogenic protein associated with Epstein-Barr virus (EBV), not HPV. It is involved in the development of various lymphomas and nasopharyngeal carcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ LMP1&lt;/li&gt;&lt;li&gt;â€¢ oncogenic protein&lt;/li&gt;&lt;li&gt;â€¢ Epstein-Barr virus (EBV), not HPV.&lt;/li&gt;&lt;li&gt;â€¢ lymphomas and nasopharyngeal carcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tax is a protein associated with Human T-cell lymphotropic virus type 1 (HTLV-1), not HPV. It plays a role in the development of adult T-cell leukemia/lymphoma (ATLL).&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Tax&lt;/li&gt;&lt;li&gt;â€¢ Human T-cell lymphotropic virus type 1 (HTLV-1), not HPV.&lt;/li&gt;&lt;li&gt;â€¢ adult T-cell leukemia/lymphoma (ATLL).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ E6 promotes the degradation of p53, and E7 inactivates the Rb protein , disrupting normal cell cycle control and contributing to the risk of cervical cancer development.&lt;/li&gt;&lt;li&gt;âž¤ E6&lt;/li&gt;&lt;li&gt;âž¤ degradation of p53, and E7 inactivates the Rb protein&lt;/li&gt;&lt;li&gt;âž¤ normal cell cycle control&lt;/li&gt;&lt;li&gt;âž¤ cervical cancer development.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th /324&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th /324&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 4-year-old boy is evaluated by his pediatrician for 1 week of intermittent hematuria. On examination he appears well developed and well nourished, except a right flank mass is palpable. A biopsy of the mass is performed, which reveals primitive looking small blue cells with glomerular and tubular structures (image). Which of the following indicates poor prognosis for the patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reduced rate of proliferation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Absence of metastasis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anaplasia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sparing of basement membrane&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Anaplasia&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/08/screenshot-2024-02-08-194503.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Anaplasia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Reduced rate of proliferation actually suggests a better prognosis as it indicates slower tumor growth.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Reduced rate of proliferation&lt;/li&gt;&lt;li&gt;â€¢ Option B: Absence of metastasis is a favorable prognostic factor, not a poor prognostic indicator.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Absence of metastasis&lt;/li&gt;&lt;li&gt;â€¢ Option D: Sparing of basement membrane suggests the tumor is less invasive, which is associated with better outcomes.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Sparing of basement membrane&lt;/li&gt;&lt;li&gt;â€¢ Ref: Robbins and Cotran pathologic basis of disease 10th edition page: 292&lt;/li&gt;&lt;li&gt;â€¢ Ref: Robbins and Cotran pathologic basis of disease 10th edition page: 292&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the context of tumor biology, which of the following statements is correct?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;BRCA1 is an oncogene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;EGFR positive in non small cell cancer&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Her 2 amplification is seen in most breast cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;N myc is a tumor suppressor gene&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. EGFR positive in non small cell cancer&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) EGFR positive in non small cell cancer&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. BRCA1 is not an oncogene but a tumor suppressor gene. Mutations in BRCA1 are associated with an increased risk of breast and ovarian cancers.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ BRCA1&lt;/li&gt;&lt;li&gt;â€¢ not an oncogene&lt;/li&gt;&lt;li&gt;â€¢ tumor suppressor gene. Mutations in BRCA1&lt;/li&gt;&lt;li&gt;â€¢ increased risk of&lt;/li&gt;&lt;li&gt;â€¢ breast and ovarian cancers.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Her2 amplification occurs in some breast cancer cases but is not seen in the majority. It is significant because Her2 status can affect treatment options and prognosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Her2&lt;/li&gt;&lt;li&gt;â€¢ some breast cancer&lt;/li&gt;&lt;li&gt;â€¢ not seen&lt;/li&gt;&lt;li&gt;â€¢ majority.&lt;/li&gt;&lt;li&gt;â€¢ Her2 status can affect treatment options and prognosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. N myc is a proto-oncogene , not a tumor suppressor gene . It can become an oncogene when mutated or overexpressed, as seen in some cases of neuroblastoma.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ N myc&lt;/li&gt;&lt;li&gt;â€¢ proto-oncogene&lt;/li&gt;&lt;li&gt;â€¢ not a tumor suppressor gene&lt;/li&gt;&lt;li&gt;â€¢ oncogene&lt;/li&gt;&lt;li&gt;â€¢ mutated or overexpressed,&lt;/li&gt;&lt;li&gt;â€¢ neuroblastoma.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ BRCA1 is a tumor suppressor gene , EGFR can be overexpressed in non-small cell lung cancer, Her2 is amplified in a subset of breast cancers , and N myc is a proto-oncogene associated with certain types of cancer (neuroblastoma).&lt;/li&gt;&lt;li&gt;âž¤ BRCA1&lt;/li&gt;&lt;li&gt;âž¤ suppressor gene&lt;/li&gt;&lt;li&gt;âž¤ EGFR&lt;/li&gt;&lt;li&gt;âž¤ non-small cell lung cancer,&lt;/li&gt;&lt;li&gt;âž¤ Her2&lt;/li&gt;&lt;li&gt;âž¤ subset of breast cancers&lt;/li&gt;&lt;li&gt;âž¤ N myc&lt;/li&gt;&lt;li&gt;âž¤ proto-oncogene&lt;/li&gt;&lt;li&gt;âž¤ (neuroblastoma).&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th /285, 292&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th /285, 292&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with a growth suspected to be related to a low risk HPV subtypes. Which of the following is most likely responsible with HPV strains 6 and 11?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cervical carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oral carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Laryngeal papillomatosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anorectal carcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Laryngeal papillomatosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Laryngeal papillomatosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cervical carcinoma is typically caused by high-risk HPV strains such as HPV-16 and HPV-18 , not the low-risk strains that cause laryngeal papillomatosis .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Cervical carcinoma&lt;/li&gt;&lt;li&gt;â€¢ high-risk HPV strains&lt;/li&gt;&lt;li&gt;â€¢ HPV-16 and HPV-18&lt;/li&gt;&lt;li&gt;â€¢ not the low-risk strains&lt;/li&gt;&lt;li&gt;â€¢ laryngeal papillomatosis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Oral carcinoma can also be caused by high-risk HPV strains , particularly HPV-16 , which is associated with oropharyngeal cancers .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Oral carcinoma&lt;/li&gt;&lt;li&gt;â€¢ high-risk HPV strains&lt;/li&gt;&lt;li&gt;â€¢ HPV-16&lt;/li&gt;&lt;li&gt;â€¢ oropharyngeal cancers&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anorectal carcinoma is associated with high-risk HPV strains , similar to cervical and oral carcinomas .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Anorectal carcinoma&lt;/li&gt;&lt;li&gt;â€¢ high-risk HPV strains&lt;/li&gt;&lt;li&gt;â€¢ cervical and oral carcinomas&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Low-risk HPV strains , such as HPV-6 and HPV-11, are associated with benign conditions such as laryngeal papillomatosis, while high-risk HPV strains are associated with malignancies like cervical, oral, and anorectal carcinoma.&lt;/li&gt;&lt;li&gt;âž¤ Low-risk HPV strains&lt;/li&gt;&lt;li&gt;âž¤ HPV-6 and HPV-11,&lt;/li&gt;&lt;li&gt;âž¤ benign conditions such as laryngeal papillomatosis,&lt;/li&gt;&lt;li&gt;âž¤ high-risk HPV strains&lt;/li&gt;&lt;li&gt;âž¤ cervical, oral, and anorectal carcinoma.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;45-year-old woman is diagnosed with breast cancer, and her tumor cells demonstrate overexpression of the HER2/neu proto-oncogene. What is the primary mechanism by which HER2/neu contributes to the pathophysiology of her cancer?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of cell proliferation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Promotion of apoptosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stimulation of angiogenesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Activation of cell signaling pathways&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Activation of cell signaling pathways&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Activation of cell signaling pathways&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Inhibition of cell proliferation is not associated with HER2/neu overexpression; instead, HER2/neu leads to increased cell proliferation .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Inhibition of cell proliferation&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ HER2/neu overexpression;&lt;/li&gt;&lt;li&gt;â€¢ HER2/neu&lt;/li&gt;&lt;li&gt;â€¢ increased cell proliferation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Promotion of apoptosis is not a mechanism of HER2/neu action . In contrast, HER2/neu overexpression tends to confer resistance to apoptotic signals .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Promotion of apoptosis&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ HER2/neu action&lt;/li&gt;&lt;li&gt;â€¢ HER2/neu overexpression&lt;/li&gt;&lt;li&gt;â€¢ resistance to apoptotic signals&lt;/li&gt;&lt;li&gt;â€¢ Option C. While HER2/neu overexpression can have d ownstream effects that might indirectly promote angiogenesis , this is not the primary action of the proto-oncogene.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ HER2/neu&lt;/li&gt;&lt;li&gt;â€¢ ownstream effects&lt;/li&gt;&lt;li&gt;â€¢ indirectly promote angiogenesis&lt;/li&gt;&lt;li&gt;â€¢ not the primary action of the proto-oncogene.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Overexpression of the HER2/neu proto-oncogene in breast cancer leads to the activation of cell signaling pathways that promote cell proliferation and survival. This overexpression is associated with a more aggressive disease phenotype and a poorer prognosis . Targeted therapies against HER2/neu can be effective in treating tumors with this over-expression .&lt;/li&gt;&lt;li&gt;âž¤ Overexpression of the HER2/neu proto-oncogene in breast cancer&lt;/li&gt;&lt;li&gt;âž¤ cell signaling pathways&lt;/li&gt;&lt;li&gt;âž¤ cell proliferation and survival.&lt;/li&gt;&lt;li&gt;âž¤ more aggressive disease phenotype and a poorer prognosis&lt;/li&gt;&lt;li&gt;âž¤ Targeted&lt;/li&gt;&lt;li&gt;âž¤ against HER2/neu&lt;/li&gt;&lt;li&gt;âž¤ treating tumors with this over-expression&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old male presents to his family care physician because of balance problems. A CT scan of his head reveals a mass near the pontomedullary junction. The mass is excised and diagnosed as a schwannoma. Four years later, he presents with headaches and is found to have two meningiomas. Of the following, what is the most likely mutation that he possesses?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mutation of the PTEN&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mutation of the CDKN2 gene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mutation of the NF2 gene&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mutation of the WT&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Mutation of the NF2 gene&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Mutation of the NF2 gene&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mutations of PTEN are associated with colonic adenocarcinoma , breast and thyroid tumors .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Mutations of PTEN&lt;/li&gt;&lt;li&gt;â€¢ colonic adenocarcinoma&lt;/li&gt;&lt;li&gt;â€¢ breast and thyroid tumors&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mutations of CDKN2 are associated with familial melanoma&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Mutations of CDKN2&lt;/li&gt;&lt;li&gt;â€¢ familial melanoma&lt;/li&gt;&lt;li&gt;â€¢ Option D. Mutations of WT are associated with Wilms tumor&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Mutations of WT&lt;/li&gt;&lt;li&gt;â€¢ Wilms tumor&lt;/li&gt;&lt;li&gt;â€¢ NF1, neurofibromin 1 , is a tumor suppressor gene found on chromosome 17q11.2 NF2, merlin or schannomin, is a tumor suppressor gene on chromosome  22q11-13.1&lt;/li&gt;&lt;li&gt;â€¢ NF1, neurofibromin 1 , is a tumor suppressor gene found on chromosome 17q11.2&lt;/li&gt;&lt;li&gt;â€¢ NF1, neurofibromin 1&lt;/li&gt;&lt;li&gt;â€¢ tumor suppressor gene&lt;/li&gt;&lt;li&gt;â€¢ chromosome 17q11.2&lt;/li&gt;&lt;li&gt;â€¢ NF2, merlin or schannomin, is a tumor suppressor gene on chromosome  22q11-13.1&lt;/li&gt;&lt;li&gt;â€¢ NF2, merlin or schannomin,&lt;/li&gt;&lt;li&gt;â€¢ tumor suppressor gene&lt;/li&gt;&lt;li&gt;â€¢ chromosome  22q11-13.1&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ The NF2 gene encodes a protein called merlin or schwannomin and is associated with Neurofibromatosis type II , which is characterized by multiple central nervous system tumors including schwannomas, meningiomas, and ependymomas.&lt;/li&gt;&lt;li&gt;â€¢ The NF2 gene&lt;/li&gt;&lt;li&gt;â€¢ protein&lt;/li&gt;&lt;li&gt;â€¢ merlin or schwannomin&lt;/li&gt;&lt;li&gt;â€¢ Neurofibromatosis type II&lt;/li&gt;&lt;li&gt;â€¢ multiple central nervous system tumors&lt;/li&gt;&lt;li&gt;â€¢ schwannomas, meningiomas, and ependymomas.&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins and Cotran pathologic basis of disease 10th edition page:292 table: 7.7&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Robbins and Cotran pathologic basis of disease 10th edition page:292 table: 7.7&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old man presents to the emergency department with persistent abdominal pain and diarrhea. CT scan reveals the presence of a tumor in the pancreas. Biopsy confirms the diagnosis of pancreatic adenocarcinoma. Genetic testing reveals a mutation in the KRAS proto-oncogene. Which of the following best describes the role of KRAS in this case?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Stimulation of apoptosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inhibition of angiogenesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Activation of cell cycle arrest&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Promotion of cell proliferation&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Promotion of cell proliferation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Promotion of cell proliferation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ KRAS is a proto-oncogene that encodes for a protein involved in cell signaling pathways that regulate cell growth and division . Mutations in KRAS can lead to the activation of these pathways, promoting cell proliferation and survival . KRAS mutations are common in pancreatic adenocarcinoma and are associated with a poorer prognosis&lt;/li&gt;&lt;li&gt;â€¢ KRAS&lt;/li&gt;&lt;li&gt;â€¢ proto-oncogene&lt;/li&gt;&lt;li&gt;â€¢ cell signaling pathways&lt;/li&gt;&lt;li&gt;â€¢ cell growth and division&lt;/li&gt;&lt;li&gt;â€¢ Mutations in KRAS&lt;/li&gt;&lt;li&gt;â€¢ activation of these pathways, promoting cell proliferation and survival&lt;/li&gt;&lt;li&gt;â€¢ KRAS mutations&lt;/li&gt;&lt;li&gt;â€¢ pancreatic adenocarcinoma&lt;/li&gt;&lt;li&gt;â€¢ poorer prognosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman presents to her primary care physician for a routine health check-up. She has no complaints and her medical history is unremarkable. She undergoes a Pap smear as part of her cervical cancer screening. The cytology report describes disorganized growth of cells with hyperchromatic nuclei. Which of the following best characterizes the cellular changes seen in this patient&#x27;s Pap smear?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypertrophy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dysplasia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metaplasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hyperplasia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Dysplasia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Dysplasia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypertrophy: Hypertrophy refers to an increase in the size of cells , leading to an increase in the size of the organ . It is usually seen in response to increased demand or stimulation by hormones or growth factors . Unlike hyperplasia , hypertrophy does not involve an increase in the number of cells . An example would be the increase in muscle mass due to exercise.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypertrophy:&lt;/li&gt;&lt;li&gt;â€¢ increase in the size of cells&lt;/li&gt;&lt;li&gt;â€¢ increase in the size of the organ&lt;/li&gt;&lt;li&gt;â€¢ increased demand or stimulation by hormones or growth factors&lt;/li&gt;&lt;li&gt;â€¢ Unlike hyperplasia&lt;/li&gt;&lt;li&gt;â€¢ does not involve&lt;/li&gt;&lt;li&gt;â€¢ increase in the number of cells&lt;/li&gt;&lt;li&gt;â€¢ increase in muscle mass due to exercise.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Metaplasia: Metaplasia is the reversible change from one type of cell to another due to abnormal stimulus , which can potentially predispose to malignancy if the stimulus persists . A classic example is Barrettâ€™s esophagus , where the normal squamous epithelium of the esophagus changes to a columnar epithelium in response to chronic gastric acid exposure .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Metaplasia:&lt;/li&gt;&lt;li&gt;â€¢ reversible change from one type of cell to another due to abnormal stimulus&lt;/li&gt;&lt;li&gt;â€¢ predispose to malignancy&lt;/li&gt;&lt;li&gt;â€¢ persists&lt;/li&gt;&lt;li&gt;â€¢ Barrettâ€™s esophagus&lt;/li&gt;&lt;li&gt;â€¢ normal squamous epithelium of the esophagus changes to a columnar epithelium&lt;/li&gt;&lt;li&gt;â€¢ chronic gastric acid exposure&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hyperplasia: Hyperplasia is an increase in the number of cells in an organ or tissue, which may subsequently increase the size of the organ or tissue. It is a response to a stimulus and is usually a controlled process . Hyperplasia can be a physiological response , such as the proliferation of glandular epithelium of the female breast at puberty or pathologic as seen in endometrial hyperplasia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hyperplasia:&lt;/li&gt;&lt;li&gt;â€¢ an increase in the number of cells in an organ or tissue,&lt;/li&gt;&lt;li&gt;â€¢ increase the size of the organ or tissue.&lt;/li&gt;&lt;li&gt;â€¢ stimulus&lt;/li&gt;&lt;li&gt;â€¢ controlled process&lt;/li&gt;&lt;li&gt;â€¢ Hyperplasia&lt;/li&gt;&lt;li&gt;â€¢ physiological response&lt;/li&gt;&lt;li&gt;â€¢ proliferation of glandular epithelium&lt;/li&gt;&lt;li&gt;â€¢ female breast at puberty or pathologic&lt;/li&gt;&lt;li&gt;â€¢ endometrial hyperplasia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Dysplasia, is a term used to describe disorganized growth of cells with varying size, shape, and orientation, often with hyperchromatic nuclei, suggestive of a precancerous state .&lt;/li&gt;&lt;li&gt;âž¤ Dysplasia,&lt;/li&gt;&lt;li&gt;âž¤ disorganized growth of cells with varying size, shape, and orientation,&lt;/li&gt;&lt;li&gt;âž¤ hyperchromatic nuclei,&lt;/li&gt;&lt;li&gt;âž¤ precancerous state&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/e p719-720&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th/e p719-720&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 56-year-old man was working in a benzene factory for a long time. He retired 5 years ago. What would be the possible complication in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bladder cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Blood cancer&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lung cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Skin cancer&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Blood cancer&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Blood cancer&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bladder cancer: Bladder cancer is typically associated with exposure to aromatic amines and chemicals used in the dye industry . Although occupational exposure is a risk factor , benzene exposure is not traditionally linked with bladder cancer .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bladder cancer:&lt;/li&gt;&lt;li&gt;â€¢ exposure to aromatic amines&lt;/li&gt;&lt;li&gt;â€¢ chemicals&lt;/li&gt;&lt;li&gt;â€¢ dye industry&lt;/li&gt;&lt;li&gt;â€¢ occupational exposure&lt;/li&gt;&lt;li&gt;â€¢ risk factor&lt;/li&gt;&lt;li&gt;â€¢ benzene&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ bladder cancer&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lung cancer: While lung cancer is often associated with occupational exposures, particularly to substances like asbestos or radon, benzene is not strongly linked to lung cancer . Smoking remains the primary risk factor for lung cancer .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lung cancer:&lt;/li&gt;&lt;li&gt;â€¢ with occupational exposures,&lt;/li&gt;&lt;li&gt;â€¢ asbestos or radon, benzene&lt;/li&gt;&lt;li&gt;â€¢ not strongly&lt;/li&gt;&lt;li&gt;â€¢ lung cancer&lt;/li&gt;&lt;li&gt;â€¢ Smoking&lt;/li&gt;&lt;li&gt;â€¢ primary risk factor for lung cancer&lt;/li&gt;&lt;li&gt;â€¢ Option D. Skin cancer: Exposure to ultraviolet (UV) radiation is the most significant risk factor for skin cancer. Some chemicals can increase the risk of skin cancer , but benzene is not typically implicated in this type of malignancy.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Skin cancer:&lt;/li&gt;&lt;li&gt;â€¢ ultraviolet (UV) radiation&lt;/li&gt;&lt;li&gt;â€¢ risk factor for skin cancer.&lt;/li&gt;&lt;li&gt;â€¢ increase the risk of skin cancer&lt;/li&gt;&lt;li&gt;â€¢ benzene is not&lt;/li&gt;&lt;li&gt;â€¢ malignancy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Benzene exposure , especially in occupational settings , is associated with an increased risk of hematological malignancies, particularly acute myeloid leukemia , due to its metabolism to toxic compounds that disrupt cell differentiation in the bone marrow.&lt;/li&gt;&lt;li&gt;âž¤ Benzene exposure&lt;/li&gt;&lt;li&gt;âž¤ occupational settings&lt;/li&gt;&lt;li&gt;âž¤ increased risk of hematological malignancies,&lt;/li&gt;&lt;li&gt;âž¤ acute myeloid leukemia&lt;/li&gt;&lt;li&gt;âž¤ its metabolism to toxic compounds&lt;/li&gt;&lt;li&gt;âž¤ cell differentiation in the bone marrow.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th/e p198&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th/e p198&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 8-year-old child is referred to a dermatologist for several \&quot;suspicious\&quot; pigmented lesions on his face and neck. Further history reveals the patient has had problems seeing out of his right eye; he is referred to an ophthalmologist, who diagnoses ocular melanoma. Based on the patientâ€™s symptoms, the diagnosis of xeroderma pigmentosum is considered. This condition results from?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aberrant expression of a receptor tyrosine kinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;An inborn defect in DNA repair&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chemical carcinogenesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;DNA viral infection&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. An inborn defect in DNA repair&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) An inborn defect in DNA repair&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aberrant expression of the gene for a receptor tyrosine kinase , such as the Her-2/neu gene product , can cause breast cancer .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Aberrant expression&lt;/li&gt;&lt;li&gt;â€¢ gene&lt;/li&gt;&lt;li&gt;â€¢ receptor tyrosine kinase&lt;/li&gt;&lt;li&gt;â€¢ Her-2/neu gene product&lt;/li&gt;&lt;li&gt;â€¢ breast cancer&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chemical carcinogens have highly reactive electrophile groups that directly damage DNA , leading to mutations and eventually cancer .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Chemical carcinogens&lt;/li&gt;&lt;li&gt;â€¢ highly reactive electrophile groups&lt;/li&gt;&lt;li&gt;â€¢ damage DNA&lt;/li&gt;&lt;li&gt;â€¢ mutations and eventually cancer&lt;/li&gt;&lt;li&gt;â€¢ Option D. A retrovirus is responsible for the development of T-cell leukemia/lymphoma .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ retrovirus&lt;/li&gt;&lt;li&gt;â€¢ development of T-cell leukemia/lymphoma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Xeroderma pigmentosum is a condition resulting from a hereditary deficiency in the nucleotide excision repair pathway , leading to an inability to repair UV-induced thymine dimers , with resultant increased skin and ocular malignancies .&lt;/li&gt;&lt;li&gt;âž¤ Xeroderma pigmentosum&lt;/li&gt;&lt;li&gt;âž¤ hereditary deficiency&lt;/li&gt;&lt;li&gt;âž¤ nucleotide excision repair pathway&lt;/li&gt;&lt;li&gt;âž¤ inability to repair UV-induced thymine dimers&lt;/li&gt;&lt;li&gt;âž¤ increased skin and ocular malignancies&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with a family history of colon cancer. They undergo genetic testing, which reveals a mutation in the APC gene. Which of the following is true about APC?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is a proto-oncogene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is involved in DNA repair&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is a tumor suppressor gene&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is not involved in colon cancer&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It is a tumor suppressor gene&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) It is a tumor suppressor gene&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A.  It is a proto-oncogene. Proto-oncogenes are normal genes that can become oncogenes due to mutations or increased expression . Oncogenes can cause the cells to grow and proliferate excessively . The APC gene , however, functions as a tumor suppressor gene, not a proto-oncogene.&lt;/li&gt;&lt;li&gt;â€¢ Option A.  It is a proto-oncogene.&lt;/li&gt;&lt;li&gt;â€¢ normal genes&lt;/li&gt;&lt;li&gt;â€¢ oncogenes due to mutations or increased expression&lt;/li&gt;&lt;li&gt;â€¢ Oncogenes&lt;/li&gt;&lt;li&gt;â€¢ cells to grow and proliferate excessively&lt;/li&gt;&lt;li&gt;â€¢ APC gene&lt;/li&gt;&lt;li&gt;â€¢ tumor suppressor gene, not a proto-oncogene.&lt;/li&gt;&lt;li&gt;â€¢ Option B. It is involved in DNA repair. While DNA repair mechanisms are essential in the prevention of cancer , the APC gene itself is not primarily involved in DNA repair processes . Its primary function relates to the regulation of cell growth and division.&lt;/li&gt;&lt;li&gt;â€¢ Option B. It is involved in DNA repair.&lt;/li&gt;&lt;li&gt;â€¢ DNA repair&lt;/li&gt;&lt;li&gt;â€¢ prevention of cancer&lt;/li&gt;&lt;li&gt;â€¢ APC gene itself is not&lt;/li&gt;&lt;li&gt;â€¢ DNA repair processes&lt;/li&gt;&lt;li&gt;â€¢ primary function&lt;/li&gt;&lt;li&gt;â€¢ regulation of cell growth and division.&lt;/li&gt;&lt;li&gt;â€¢ Option D. It is not involved in colon cancer. This statement is incorrect . The APC gene is implicated in colon cancer , as mutations in this gene are commonly found in both sporadic and hereditary forms of colorectal cancer .&lt;/li&gt;&lt;li&gt;â€¢ Option D. It is not involved in colon cancer.&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ APC gene&lt;/li&gt;&lt;li&gt;â€¢ colon cancer&lt;/li&gt;&lt;li&gt;â€¢ mutations&lt;/li&gt;&lt;li&gt;â€¢ gene&lt;/li&gt;&lt;li&gt;â€¢ both sporadic and hereditary forms of colorectal cancer&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ APC gene is a tumor suppressor gene. Mutations in the APC gene lead to a loss of function , resulting in increased cell proliferation and a higher risk for developing colorectal cancer .&lt;/li&gt;&lt;li&gt;âž¤ APC gene&lt;/li&gt;&lt;li&gt;âž¤ tumor suppressor gene.&lt;/li&gt;&lt;li&gt;âž¤ APC gene&lt;/li&gt;&lt;li&gt;âž¤ loss of function&lt;/li&gt;&lt;li&gt;âž¤ increased cell proliferation and a higher risk for developing colorectal cancer&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with a history of breast cancer. They undergo genetic testing, which reveals a mutation in the BRCA1 gene. Which of the following is true about BRCA1?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is a proto-oncogene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is involved in cell cycle regulation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is a tumor suppressor gene&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is not involved in breast cancer&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It is a tumor suppressor gene&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) It is a tumor suppressor gene&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. It is a proto-oncogene. Proto-oncogenes are genes that normally help cells grow . When a proto-oncogene mutates or becomes overactive , it becomes an oncogene and can lead to cancer . BRCA1 , however, is known as a tumor suppressor gene .&lt;/li&gt;&lt;li&gt;â€¢ Option A. It is a proto-oncogene.&lt;/li&gt;&lt;li&gt;â€¢ genes&lt;/li&gt;&lt;li&gt;â€¢ cells grow&lt;/li&gt;&lt;li&gt;â€¢ proto-oncogene mutates or becomes overactive&lt;/li&gt;&lt;li&gt;â€¢ oncogene&lt;/li&gt;&lt;li&gt;â€¢ lead to cancer&lt;/li&gt;&lt;li&gt;â€¢ BRCA1&lt;/li&gt;&lt;li&gt;â€¢ tumor suppressor gene&lt;/li&gt;&lt;li&gt;â€¢ Option B. It is involved in cell cycle regulation. While the BRCA1 gene does play a role in cell cycle regulation as part of its function in response to DNA damage , it is more specifically characterized as a gene involved in DNA repair pathways, particularly double-strand break repair .&lt;/li&gt;&lt;li&gt;â€¢ Option B. It is involved in cell cycle regulation.&lt;/li&gt;&lt;li&gt;â€¢ BRCA1 gene&lt;/li&gt;&lt;li&gt;â€¢ cell cycle regulation&lt;/li&gt;&lt;li&gt;â€¢ function&lt;/li&gt;&lt;li&gt;â€¢ DNA damage&lt;/li&gt;&lt;li&gt;â€¢ more&lt;/li&gt;&lt;li&gt;â€¢ gene&lt;/li&gt;&lt;li&gt;â€¢ DNA repair pathways,&lt;/li&gt;&lt;li&gt;â€¢ double-strand break repair&lt;/li&gt;&lt;li&gt;â€¢ Option D. It is not involved in breast cancer. This statement is incorrect as mutations in the BRCA1 gene are well-established risk factors for breast cancer , as well as ovarian cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option D. It is not involved in breast cancer.&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ BRCA1 gene are well-established risk factors&lt;/li&gt;&lt;li&gt;â€¢ breast cancer&lt;/li&gt;&lt;li&gt;â€¢ ovarian cancer.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ BRCA1 gene is a tumor suppressor gene involved in DNA repair . Mutations in BRCA1 increase the risk of breast and ovarian cancers by impairing the repair of DNA damage, which prevents the proper regulation of cell growth and division, thereby contributing to tumorigenesis.&lt;/li&gt;&lt;li&gt;âž¤ BRCA1 gene&lt;/li&gt;&lt;li&gt;âž¤ tumor suppressor gene&lt;/li&gt;&lt;li&gt;âž¤ DNA repair&lt;/li&gt;&lt;li&gt;âž¤ Mutations in BRCA1&lt;/li&gt;&lt;li&gt;âž¤ risk of breast and ovarian cancers&lt;/li&gt;&lt;li&gt;âž¤ prevents&lt;/li&gt;&lt;li&gt;âž¤ proper regulation of cell growth and division,&lt;/li&gt;&lt;li&gt;âž¤ tumorigenesis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old male undergoes a colectomy. The pathologist identifies more than 100 polyps in the resected specimen as well as a focus of invasive adenocarcinoma. Of the following, what is the functional mechanism of the gene mutation causing his disease process?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decreased breakdown of Î²-catenin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increased breakdown of Î²-catenin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lack of production of Î²-catenin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Decreased activity of Î²-catenin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Decreased breakdown of Î²-catenin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Decreased breakdown of Î²-catenin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increased breakdown of Î²-catenin: An increased breakdown of Î²-catenin would actually be a protective mechanism against the development of neoplasia , as it would prevent the excessive cell proliferation associated with colorectal cancer . This is not the mechanism involved in FAP .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increased breakdown of Î²-catenin:&lt;/li&gt;&lt;li&gt;â€¢ protective mechanism against the development of neoplasia&lt;/li&gt;&lt;li&gt;â€¢ prevent&lt;/li&gt;&lt;li&gt;â€¢ excessive cell proliferation&lt;/li&gt;&lt;li&gt;â€¢ colorectal cancer&lt;/li&gt;&lt;li&gt;â€¢ not the mechanism involved in FAP&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lack of production of Î²-catenin: FAP is not characterized by a lack of production of Î²-catenin . Instead, Î²-catenin production is normal , but its breakdown is impaired due to the non-functional APC protein.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lack of production of Î²-catenin:&lt;/li&gt;&lt;li&gt;â€¢ FAP&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ lack of production of Î²-catenin&lt;/li&gt;&lt;li&gt;â€¢ Î²-catenin production is normal&lt;/li&gt;&lt;li&gt;â€¢ its breakdown&lt;/li&gt;&lt;li&gt;â€¢ impaired&lt;/li&gt;&lt;li&gt;â€¢ non-functional APC protein.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Decreased activity of Î²-catenin In FAP , Î²-catenin activity is not decreased . In fact, due to the loss of APC function and decreased breakdown of Î²-catenin , its activity within the Wnt signaling pathway is increased , leading to enhanced transcription of proliferation genes .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Decreased activity of Î²-catenin&lt;/li&gt;&lt;li&gt;â€¢ FAP&lt;/li&gt;&lt;li&gt;â€¢ Î²-catenin&lt;/li&gt;&lt;li&gt;â€¢ not decreased&lt;/li&gt;&lt;li&gt;â€¢ due to the loss of APC function and decreased breakdown of Î²-catenin&lt;/li&gt;&lt;li&gt;â€¢ Wnt signaling pathway is increased&lt;/li&gt;&lt;li&gt;â€¢ transcription of proliferation genes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In Familial Adenomatous Polyposis , mutations in the APC tumor suppressor gene lead to decreased breakdown of Î²-catenin , which accumulates in the nucleus and activates transcription factors that promote cell proliferation and reduce apoptosis , contributing to the development of colorectal neoplasia . APC is also called as Gatekeeper of Colonic Neoplasia and its locus is on chromosome 5q21.&lt;/li&gt;&lt;li&gt;âž¤ Familial Adenomatous Polyposis&lt;/li&gt;&lt;li&gt;âž¤ mutations&lt;/li&gt;&lt;li&gt;âž¤ APC tumor suppressor gene&lt;/li&gt;&lt;li&gt;âž¤ decreased breakdown of Î²-catenin&lt;/li&gt;&lt;li&gt;âž¤ accumulates in the nucleus and activates transcription factors&lt;/li&gt;&lt;li&gt;âž¤ cell proliferation and reduce apoptosis&lt;/li&gt;&lt;li&gt;âž¤ development of colorectal neoplasia&lt;/li&gt;&lt;li&gt;âž¤ APC&lt;/li&gt;&lt;li&gt;âž¤ Gatekeeper of Colonic Neoplasia&lt;/li&gt;&lt;li&gt;âž¤ locus is on chromosome 5q21.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the false statement?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Telomerase is not active in somatic cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is a reverse transcriptase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It&#x27;s activity is more in Germ cells than stem cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Double stranded breaks is repaired by telomerase&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Double stranded breaks is repaired by telomerase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Double stranded breaks is repaired by telomerase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Telomerase activity is absent in most normal human somatic cells because of the lack of expression of TERT&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Telomerase activity&lt;/li&gt;&lt;li&gt;â€¢ absent&lt;/li&gt;&lt;li&gt;â€¢ normal human somatic cells&lt;/li&gt;&lt;li&gt;â€¢ lack of expression of TERT&lt;/li&gt;&lt;li&gt;â€¢ Option B. Telomerase core enzyme is composed of a reverse transcriptase subunit and a non-coding RNA used as a template for elongation .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Telomerase core enzyme&lt;/li&gt;&lt;li&gt;â€¢ reverse transcriptase&lt;/li&gt;&lt;li&gt;â€¢ non-coding RNA&lt;/li&gt;&lt;li&gt;â€¢ template for elongation&lt;/li&gt;&lt;li&gt;â€¢ Option C. Germ cells and stem cells have high telomerase activity&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Germ cells and stem cells&lt;/li&gt;&lt;li&gt;â€¢ high telomerase activity&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Telomerase is not responsible for repairing double-stranded DNA breaks . Its main function is to elongate telomeres , which are the protective ends of chromosomes , using an RNA template that is part of the enzyme .&lt;/li&gt;&lt;li&gt;âž¤ Telomerase&lt;/li&gt;&lt;li&gt;âž¤ not responsible&lt;/li&gt;&lt;li&gt;âž¤ repairing double-stranded DNA breaks&lt;/li&gt;&lt;li&gt;âž¤ elongate telomeres&lt;/li&gt;&lt;li&gt;âž¤ protective ends of chromosomes&lt;/li&gt;&lt;li&gt;âž¤ RNA template&lt;/li&gt;&lt;li&gt;âž¤ enzyme&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is associated with loss of function mutation in RET proto-oncogene?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Medullary carcinoma of the thyroid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pheochromocytoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hirschsprung disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pituitary adenoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hirschsprung disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Hirschsprung disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Options A and B: Gain of function mutations in RET proto-oncogene occurs in medullary thyroid carcinoma (Option A) and pheochromocytoma (Option B) as part of multiple endocrine neoplasia type 2A and 2B syndromes.&lt;/li&gt;&lt;li&gt;â€¢ Options A and B:&lt;/li&gt;&lt;li&gt;â€¢ Option D: Pituitary adenomas are typically associated with mutations in other genes such as MEN1 and are not directly linked to RET proto-oncogene mutations.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Loss of function mutation in the RET proto-oncogene is associated with Hirschsprung disease, which is characterized by the absence of ganglion cells in the distal colon, leading to functional intestinal obstruction.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Match the following:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1-a, 2-b, 3-c&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1-c, 2-b, 3-a&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1-a, 2-c, 3-b&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1-b, 2-a, 3-c&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 1-a, 2-c, 3-b&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/screenshot-2024-02-08-153127.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-131530.JPG&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 1-a, 2-c, 3-b&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 323&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Robbins and Cotran pathologic basis of disease 10th edition page: 323&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the false statement:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Benzopyrene causes lung carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Allen test is used to asses chemical Mutagenicity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Indirect agents require Cytochrome P450 for conversion into carcinogen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chemical carcinogen converts salmonella into histidine positive type&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Allen test is used to asses chemical Mutagenicity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Allen test is used to asses chemical mutagenicity&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Benzo[a]pyrene , are formed during the high-temperature combustion of tobacco in cigarettes and are implicated in the causation of lung cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Benzo[a]pyrene&lt;/li&gt;&lt;li&gt;â€¢ high-temperature&lt;/li&gt;&lt;li&gt;â€¢ tobacco in cigarettes&lt;/li&gt;&lt;li&gt;â€¢ causation of lung cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Indirect-acting carcinogens require metabolic conversion to become active carcinogens by using cytochrome P-450â€“dependent monooxygenases&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ metabolic&lt;/li&gt;&lt;li&gt;â€¢ active carcinogens&lt;/li&gt;&lt;li&gt;â€¢ cytochrome P-450â€“dependent monooxygenases&lt;/li&gt;&lt;li&gt;â€¢ Option D. The Ames test uses several strains of the bacterium Salmonella typhimurium that carry mutations in genes involved in histidine synthesis .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Ames test&lt;/li&gt;&lt;li&gt;â€¢ several strains of the bacterium Salmonella typhimurium&lt;/li&gt;&lt;li&gt;â€¢ mutations in genes&lt;/li&gt;&lt;li&gt;â€¢ histidine synthesis&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Ames test checkss the capability of the tested substance in creating mutations that result in a return to a \&quot;prototrophic \&quot; state, so that the cells can grow on a histidine-free medium.&lt;/li&gt;&lt;li&gt;â€¢ Ames test&lt;/li&gt;&lt;li&gt;â€¢ capability of the tested substance&lt;/li&gt;&lt;li&gt;â€¢ mutations&lt;/li&gt;&lt;li&gt;â€¢ \&quot;prototrophic&lt;/li&gt;&lt;li&gt;â€¢ cells can grow on a histidine-free medium.&lt;/li&gt;&lt;li&gt;â€¢ Ref : 1. Robbins and Cotran pathologic basis of disease 10th edition page: 322&lt;/li&gt;&lt;li&gt;â€¢ Ref : 1. Robbins and Cotran pathologic basis of disease 10th edition page: 322&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old patient with a history of chronic immunosuppression presents with cutaneous lesions and EBV infection. EBV is involved in the pathogenesis of all except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hodgkin&#x27;s Lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Burkitt&#x27;s lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nasopharyngeal Carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Kaposi sarcoma&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Kaposi sarcoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Kaposi sarcoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hodgkin&#x27;s Lymphoma : EBV is associated with a subset of Hodgkin&#x27;s Lymphoma . In these cases, the virus is present in the malignant Reed-Sternberg cells and is thought to contribute to their formation .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hodgkin&#x27;s Lymphoma :&lt;/li&gt;&lt;li&gt;â€¢ EBV&lt;/li&gt;&lt;li&gt;â€¢ subset of Hodgkin&#x27;s Lymphoma&lt;/li&gt;&lt;li&gt;â€¢ virus&lt;/li&gt;&lt;li&gt;â€¢ malignant Reed-Sternberg cells&lt;/li&gt;&lt;li&gt;â€¢ contribute to their formation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Burkitt&#x27;s lymphoma: EBV is closely associated with Burkitt&#x27;s lymphoma, especially the endemic variant found in malaria-prone regions of Africa. The virus is believed to drive the proliferation of B cells which, through additional genetic mutations, can develop into this aggressive form of lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Burkitt&#x27;s lymphoma:&lt;/li&gt;&lt;li&gt;â€¢ EBV&lt;/li&gt;&lt;li&gt;â€¢ Burkitt&#x27;s lymphoma,&lt;/li&gt;&lt;li&gt;â€¢ endemic variant&lt;/li&gt;&lt;li&gt;â€¢ malaria-prone regions of Africa.&lt;/li&gt;&lt;li&gt;â€¢ proliferation of B cells&lt;/li&gt;&lt;li&gt;â€¢ additional genetic mutations,&lt;/li&gt;&lt;li&gt;â€¢ aggressive form of lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Nasopharyngeal Carcinoma : EBV infection has been implicated in the development of nasopharyngeal carcinoma , particularly in populations where the cancer is endemic . The virus&#x27;s DNA is often found in the malignant cells.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Nasopharyngeal Carcinoma :&lt;/li&gt;&lt;li&gt;â€¢ EBV infection&lt;/li&gt;&lt;li&gt;â€¢ development of nasopharyngeal carcinoma&lt;/li&gt;&lt;li&gt;â€¢ cancer is endemic&lt;/li&gt;&lt;li&gt;â€¢ virus&#x27;s DNA&lt;/li&gt;&lt;li&gt;â€¢ malignant cells.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Kaposi sarcoma is not associated with EBV but is caused by HHV-8 . While EBV is linked to various lymphomas and nasopharyngeal carcinoma , Kaposi sarcoma&#x27;s pathogenesis involves a different herpesvirus.&lt;/li&gt;&lt;li&gt;âž¤ Kaposi sarcoma&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ EBV&lt;/li&gt;&lt;li&gt;âž¤ HHV-8&lt;/li&gt;&lt;li&gt;âž¤ EBV is linked&lt;/li&gt;&lt;li&gt;âž¤ lymphomas and nasopharyngeal carcinoma&lt;/li&gt;&lt;li&gt;âž¤ Kaposi sarcoma&#x27;s pathogenesis involves a different herpesvirus.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 325-6&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran pathologic basis of disease 10th edition page: 325-6&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Match the tumor with their biological carcinogens:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1-d, 2-b, 3-a, 4-c&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1-d, 2-c, 3-a, 4-b&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1-b, 2-c, 3-d, 4-a&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1-b, 2-d, 3-a, 4-c&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 1-b, 2-d, 3-a, 4-c&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/screenshot-2024-02-08-153832.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/screenshot-2024-02-08-153934.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) 1-b, 2-d, 3-a, 4-c&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Match the paraneoplastic syndromes with associated neoplasm?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1-a, 2-d, 3-c, 4-b&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1-b, 2-c, 3-d, 4-a&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1-c, 2-b, 3-a, 4-d&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1-d, 2-a, 3-b, 4-c&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 1-a, 2-d, 3-c, 4-b&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/screenshot-2024-02-08-154023.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/screenshot-2024-02-08-154108.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) 1-a, 2-d, 3-c, 4-b&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 329&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Robbins and Cotran pathologic basis of disease 10th edition page: 329&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is false about Knudson&#x27;s two-hit hypothesis theory on retinoblastoma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It involves both alleles of RB at chromosome locus 13q14&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;In sporadic cases, both normal RB alleles must undergo somatic mutation in the same retinoblast&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Familial type is inherited as an autosomal recessive trait&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;In familial cases, children inherit one defective copy of the RB gene and the other copy is normal&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Familial type is inherited as an autosomal recessive trait&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Familial type is inherited as an autosomal recessive trait&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Knudson&#x27;s hypothesis&lt;/li&gt;&lt;li&gt;â€¢ two-hit hypothesis or multiple-hit hypothesis states&lt;/li&gt;&lt;li&gt;â€¢ mutations in a cell&#x27;s DNA&lt;/li&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Two mutations (hits), involving both alleles of RB at chromosome locus 13q14, are required to produce retinoblastoma.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Two mutations&lt;/li&gt;&lt;li&gt;â€¢ both alleles of RB at chromosome locus 13q14,&lt;/li&gt;&lt;li&gt;â€¢ retinoblastoma.&lt;/li&gt;&lt;li&gt;â€¢ Option B. In sporadic cases , both normal RB alleles must undergo somatic mutation in the same retinoblast (two hits).&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ In sporadic cases&lt;/li&gt;&lt;li&gt;â€¢ RB alleles&lt;/li&gt;&lt;li&gt;â€¢ somatic mutation&lt;/li&gt;&lt;li&gt;â€¢ Option D. In familial cases, children inherit one defective copy of the RB gene in the germline (the first hit), and the other copy is normal. Retinoblastoma develops when the normal RB allele is mutated in retinoblasts as a result of a spontaneous somatic mutation (the second hit).&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ defective copy of the RB gene in the germline (the first hit),&lt;/li&gt;&lt;li&gt;â€¢ Retinoblastoma&lt;/li&gt;&lt;li&gt;â€¢ normal RB allele&lt;/li&gt;&lt;li&gt;â€¢ mutated in retinoblasts&lt;/li&gt;&lt;li&gt;â€¢ spontaneous somatic mutation (the second hit).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Familial retinoblastoma is inherited in an autosomal dominant pattern, not autosomal recessive. According to Knudson&#x27;s two-hit hypothesis , a single inherited mutation in one allele of the RB gene is sufficient to predispose to retinoblastoma , but a second somatic mutation in the other allele must occur for the cancer to develop .&lt;/li&gt;&lt;li&gt;âž¤ Familial retinoblastoma&lt;/li&gt;&lt;li&gt;âž¤ an autosomal dominant pattern,&lt;/li&gt;&lt;li&gt;âž¤ Knudson&#x27;s two-hit hypothesis&lt;/li&gt;&lt;li&gt;âž¤ single inherited mutation&lt;/li&gt;&lt;li&gt;âž¤ one allele of the RB gene&lt;/li&gt;&lt;li&gt;âž¤ retinoblastoma&lt;/li&gt;&lt;li&gt;âž¤ a second somatic mutation&lt;/li&gt;&lt;li&gt;âž¤ other allele&lt;/li&gt;&lt;li&gt;âž¤ cancer to develop&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Match the Immuno- markers with its associated neoplasm:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1-c, 2-a, 3-d, 4-b&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1-c, 2-d, 3-b, 4-a&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1-c, 2-b, 3-a, 4-d&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1-b, 2-c, 3-d, 4-a&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 1-b, 2-c, 3-d, 4-a&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/screenshot-2024-02-08-154335.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/25/screenshot-2024-04-25-123409.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) 1-b, 2-c, 3-d, 4-a&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 270&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Robbins and Cotran pathologic basis of disease 10th edition page: 270&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A physician is considering the differential diagnoses for a patient&#x27;s elevated serum tumor marker levels. Carcinoembryonic antigen (CEA) is known to be elevated in various malignancies and benign conditions. Which of the following conditions is NOT typically associated with an elevated CEA level?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alcoholic cirrhosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carcinoma colon&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Carcinoma prostate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Emphysema&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Carcinoma prostate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/screenshot-2024-02-08-154619.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Carcinoma prostate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alcoholic cirrhosis Alcoholic cirrhosis can lead to elevated CEA levels. CEA is not specific for malignancy and can be raised in a variety of benign liver conditions, including cirrhosis, especially when related to alcohol use .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alcoholic cirrhosis&lt;/li&gt;&lt;li&gt;â€¢ elevated CEA levels.&lt;/li&gt;&lt;li&gt;â€¢ not specific&lt;/li&gt;&lt;li&gt;â€¢ malignancy&lt;/li&gt;&lt;li&gt;â€¢ benign liver conditions, including cirrhosis,&lt;/li&gt;&lt;li&gt;â€¢ alcohol use&lt;/li&gt;&lt;li&gt;â€¢ Option B. Carcinoma of the colon CEA levels are frequently elevated in colorectal cancer and can be used as a marker for monitoring treatment response or disease recurrence after the removal of the primary tumor .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Carcinoma of the colon&lt;/li&gt;&lt;li&gt;â€¢ CEA&lt;/li&gt;&lt;li&gt;â€¢ elevated&lt;/li&gt;&lt;li&gt;â€¢ colorectal cancer&lt;/li&gt;&lt;li&gt;â€¢ treatment response or disease&lt;/li&gt;&lt;li&gt;â€¢ primary tumor&lt;/li&gt;&lt;li&gt;â€¢ Option D. Emphysema Chronic lung conditions, including emphysema, can also result in elevated CEA levels , even though these are not malignant conditions. Smoking, which is a risk factor for emphysema , can itself cause elevated CEA levels.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Emphysema&lt;/li&gt;&lt;li&gt;â€¢ elevated CEA levels&lt;/li&gt;&lt;li&gt;â€¢ not malignant conditions. Smoking,&lt;/li&gt;&lt;li&gt;â€¢ risk factor&lt;/li&gt;&lt;li&gt;â€¢ emphysema&lt;/li&gt;&lt;li&gt;â€¢ elevated CEA levels.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Carcinoma of the prostate , is not associated with elevated CEA levels . Instead, prostate-specific antigen (PSA) is the tumor marker commonly elevated in prostate cancer . CEA is used primarily for monitoring colorectal cancer and can be elevated in various benign conditions , including liver and lung diseases .&lt;/li&gt;&lt;li&gt;âž¤ Carcinoma of the prostate&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ elevated CEA levels&lt;/li&gt;&lt;li&gt;âž¤ prostate-specific antigen (PSA)&lt;/li&gt;&lt;li&gt;âž¤ tumor marker&lt;/li&gt;&lt;li&gt;âž¤ prostate cancer&lt;/li&gt;&lt;li&gt;âž¤ CEA&lt;/li&gt;&lt;li&gt;âž¤ monitoring colorectal cancer&lt;/li&gt;&lt;li&gt;âž¤ elevated&lt;/li&gt;&lt;li&gt;âž¤ benign conditions&lt;/li&gt;&lt;li&gt;âž¤ liver and lung diseases&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 336&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran pathologic basis of disease 10th edition page: 336&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Most common carcinoma associated with inferior vena cava metastasis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Small cell carcinoma lung&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gastric adenocarcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Renal cell carcinoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Papillary carcinoma thyroid&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Renal cell carcinoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Renal cell carcinoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Small cell carcinoma of the lung While lung cancers can invade vascular structures, small cell carcinoma of the lung more commonly involves the superior vena cava (SVC), leading to SVC syndrome, rather than the IVC.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Small cell carcinoma of the lung&lt;/li&gt;&lt;li&gt;â€¢ lung cancers&lt;/li&gt;&lt;li&gt;â€¢ vascular structures, small cell carcinoma of the lung&lt;/li&gt;&lt;li&gt;â€¢ superior vena cava (SVC),&lt;/li&gt;&lt;li&gt;â€¢ SVC syndrome,&lt;/li&gt;&lt;li&gt;â€¢ Option B: Gastric adenocarcinoma Gastric adenocarcinoma typically metastasizes to the liver, peritoneum, and lymph nodes . Direct invasion into the IVC is rare with gastric cancers.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Gastric adenocarcinoma&lt;/li&gt;&lt;li&gt;â€¢ metastasizes to the liver, peritoneum, and lymph nodes&lt;/li&gt;&lt;li&gt;â€¢ invasion into the IVC&lt;/li&gt;&lt;li&gt;â€¢ Option D: Papillary carcinoma of the thyroid : Thyroid cancers, including papillary carcinoma, primarily spread to regional neck lymph nodes and, less commonly , to distant sites . Direct IVC invasion is not characteristic of thyroid carcinomas .&lt;/li&gt;&lt;li&gt;â€¢ Option D: Papillary carcinoma of the thyroid :&lt;/li&gt;&lt;li&gt;â€¢ papillary carcinoma,&lt;/li&gt;&lt;li&gt;â€¢ regional neck lymph nodes&lt;/li&gt;&lt;li&gt;â€¢ less commonly&lt;/li&gt;&lt;li&gt;â€¢ distant sites&lt;/li&gt;&lt;li&gt;â€¢ Direct IVC invasion&lt;/li&gt;&lt;li&gt;â€¢ thyroid carcinomas&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Renal cell carcinoma is the carcinoma most commonly associated with metastasis to the inferior vena cava . This type of tumor can grow within the kidney&#x27;s collecting system and extend into the renal vein and then into the IVC .&lt;/li&gt;&lt;li&gt;âž¤ Renal cell carcinoma&lt;/li&gt;&lt;li&gt;âž¤ metastasis to the inferior vena cava&lt;/li&gt;&lt;li&gt;âž¤ grow within the kidney&#x27;s collecting system&lt;/li&gt;&lt;li&gt;âž¤ extend into the renal vein&lt;/li&gt;&lt;li&gt;âž¤ IVC&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 78-year-old Navy veteran with a smoking habit of 600 packs per year is diagnosed with cancer. During his military career, he was involved in the use of asbestos insulation to fireproof naval combat ships. Which cancer do both smoke and asbestos contribute to, given his environmental exposure to both?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bladder cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lung cancer&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cancer of the throat&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Esophageal cancer&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Lung cancer&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Lung cancer&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bladder cancer Tobacco smoking is a well-known risk factor for bladder cancer due to the systemic absorption of carcinogens present in smoke . However, asbestos exposure is not typically associated with bladder cancer .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bladder cancer&lt;/li&gt;&lt;li&gt;â€¢ Tobacco smoking&lt;/li&gt;&lt;li&gt;â€¢ well-known risk factor&lt;/li&gt;&lt;li&gt;â€¢ due&lt;/li&gt;&lt;li&gt;â€¢ systemic absorption of carcinogens&lt;/li&gt;&lt;li&gt;â€¢ smoke&lt;/li&gt;&lt;li&gt;â€¢ asbestos exposure&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ bladder cancer&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cancer of the throat While smoking is a risk factor for throat cancer, including cancers of the larynx and pharynx , asbestos has not been as strongly linked to throat cancer compared to lung cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cancer of the throat&lt;/li&gt;&lt;li&gt;â€¢ smoking is a risk factor&lt;/li&gt;&lt;li&gt;â€¢ throat cancer,&lt;/li&gt;&lt;li&gt;â€¢ larynx and pharynx&lt;/li&gt;&lt;li&gt;â€¢ asbestos has not&lt;/li&gt;&lt;li&gt;â€¢ throat cancer compared to lung cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Esophageal cancer: Smoking is also a risk factor for esophageal cancer , but asbestos exposure is more specifically associated with lung cancer and mesothelioma rather than esophageal cancer .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Esophageal cancer:&lt;/li&gt;&lt;li&gt;â€¢ Smoking&lt;/li&gt;&lt;li&gt;â€¢ risk factor for esophageal cancer&lt;/li&gt;&lt;li&gt;â€¢ asbestos exposure&lt;/li&gt;&lt;li&gt;â€¢ more&lt;/li&gt;&lt;li&gt;â€¢ lung cancer and mesothelioma&lt;/li&gt;&lt;li&gt;â€¢ esophageal cancer&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Both cigarette smoke and asbestos are significant risk factors for lung cancer , and their combined exposure greatly increases the risk , even more so than exposure to either risk factor alone .&lt;/li&gt;&lt;li&gt;âž¤ Both cigarette smoke and asbestos&lt;/li&gt;&lt;li&gt;âž¤ risk factors for lung cancer&lt;/li&gt;&lt;li&gt;âž¤ increases the risk&lt;/li&gt;&lt;li&gt;âž¤ more&lt;/li&gt;&lt;li&gt;âž¤ either risk factor alone&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 321&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran pathologic basis of disease 10th edition page: 321&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old woman presents with endometrial carcinoma. Her mother died of endometrial cancer when she was 50, and her 42-year-old brother was recently diagnosed with colon cancer. You begin to suspect a familial cancer syndrome. Which gene in this family is most likely to be mutated?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;WT-1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;APC&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;MSH2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;p53&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. MSH2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) MSH2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. WT-1 mutations predispose patients to Wilms tumors.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ WT-1 mutations&lt;/li&gt;&lt;li&gt;â€¢ Wilms tumors.&lt;/li&gt;&lt;li&gt;â€¢ Option B. APC is mutated in familial adenomatous polyposis (FAP).&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ APC&lt;/li&gt;&lt;li&gt;â€¢ familial adenomatous polyposis (FAP).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Germline mutations in p53 are seen in Li Fraumeni syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Germline mutations&lt;/li&gt;&lt;li&gt;â€¢ p53&lt;/li&gt;&lt;li&gt;â€¢ Li Fraumeni syndrome.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ This family likely has Lynch syndrome (Hereditary Non-Polyposis Colorectal Cancer, HNPCC), associated with mutations in DNA mismatch repair genes such as MSH2 , often presenting with gynecological malignancies before colorectal tumors.&lt;/li&gt;&lt;li&gt;âž¤ family&lt;/li&gt;&lt;li&gt;âž¤ Lynch syndrome (Hereditary Non-Polyposis Colorectal Cancer, HNPCC),&lt;/li&gt;&lt;li&gt;âž¤ mutations in DNA mismatch repair genes&lt;/li&gt;&lt;li&gt;âž¤ MSH2&lt;/li&gt;&lt;li&gt;âž¤ gynecological malignancies before colorectal tumors.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran pathologic basis of disease 10th edition page:314&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran pathologic basis of disease 10th edition page:314&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old female with a strong family history of various cancers is being evaluated for genetic predisposition. Understanding the role of tumor suppressor genes, particularly p53, is crucial for her assessment. Which of the following statements about the function of p53 is incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It regulates cellular senescence&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;P53 inactivation causes cell cycle arrest at G2-M&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cancers demonstrate biallelic loss of function mutations in TP53&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;p53 can be inactivated by E6 protein of HPV&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. P53 inactivation causes cell cycle arrest at G2-M&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) P53 inactivation causes cell cycle arrest at G2-M&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. It regulates cellular senescence. This is true . p53 plays a role in halting cell proliferation when cells become old (senescent), potentially preventing the replication of damaged DNA .&lt;/li&gt;&lt;li&gt;â€¢ Option A. It regulates cellular senescence.&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;li&gt;â€¢ p53&lt;/li&gt;&lt;li&gt;â€¢ halting cell proliferation&lt;/li&gt;&lt;li&gt;â€¢ cells&lt;/li&gt;&lt;li&gt;â€¢ (senescent),&lt;/li&gt;&lt;li&gt;â€¢ replication of damaged DNA&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cancers often exhibit biallelic loss of function mutations in TP53. True. Many cancers demonstrate loss of function in both alleles of the TP53 gene, which encodes th e p53 protein , leading to unregulated cell growth.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cancers often exhibit biallelic loss of function mutations in TP53.&lt;/li&gt;&lt;li&gt;â€¢ True.&lt;/li&gt;&lt;li&gt;â€¢ loss of function&lt;/li&gt;&lt;li&gt;â€¢ both alleles of the TP53 gene,&lt;/li&gt;&lt;li&gt;â€¢ e p53 protein&lt;/li&gt;&lt;li&gt;â€¢ unregulated cell growth.&lt;/li&gt;&lt;li&gt;â€¢ Option D. p53 can be inactivated by the E6 protein of HPV. This is true. Human papillomavirus (HPV) can lead to cancer development through its E6 protein , which inactivates p53, thereby preventing it from performing its tumor suppressor functions.&lt;/li&gt;&lt;li&gt;â€¢ Option D. p53 can be inactivated by the E6 protein of HPV.&lt;/li&gt;&lt;li&gt;â€¢ true. Human papillomavirus (HPV)&lt;/li&gt;&lt;li&gt;â€¢ E6 protein&lt;/li&gt;&lt;li&gt;â€¢ inactivates p53,&lt;/li&gt;&lt;li&gt;â€¢ preventing&lt;/li&gt;&lt;li&gt;â€¢ tumor suppressor functions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ p53 inactivation does not cause cell cycle arrest at the G2-M checkpoint . Activation of p53 leads to cell cycle arrest , allowing time for DNA repair or triggering apoptosis if the damage is irreparable . This function is critical in preventing the proliferation of cells with genetic damage.&lt;/li&gt;&lt;li&gt;âž¤ p53 inactivation does not&lt;/li&gt;&lt;li&gt;âž¤ cell cycle arrest at the G2-M checkpoint&lt;/li&gt;&lt;li&gt;âž¤ Activation of p53&lt;/li&gt;&lt;li&gt;âž¤ cell cycle arrest&lt;/li&gt;&lt;li&gt;âž¤ DNA repair or triggering apoptosis&lt;/li&gt;&lt;li&gt;âž¤ irreparable&lt;/li&gt;&lt;li&gt;âž¤ proliferation of cells with genetic damage.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran pathologic basis of disease 10th edition page:296&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran pathologic basis of disease 10th edition page:296&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old man presents with anemia and abdominal pain. On examination, he has pigmented macules over the palms, soles, and oral mucosa. Further investigations reveal loss-of-function mutations of the STK11 gene. What is the most probable diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;HNPCC&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gorlin syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Von Hipplel - Lindau syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Peutz Jeghers syndrome&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Peutz Jeghers syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Peutz Jeghers syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. HNPCC: HNPCC, also known as Lynch syndrome , is an autosomal dominant condition predisposing individuals to early-onset colorectal cancer and other malignancies . It is associated with mutations in mismatch repair genes, not STK11.&lt;/li&gt;&lt;li&gt;â€¢ Option A. HNPCC:&lt;/li&gt;&lt;li&gt;â€¢ Lynch syndrome&lt;/li&gt;&lt;li&gt;â€¢ autosomal dominant condition&lt;/li&gt;&lt;li&gt;â€¢ early-onset colorectal cancer and other malignancies&lt;/li&gt;&lt;li&gt;â€¢ mutations in mismatch repair genes,&lt;/li&gt;&lt;li&gt;â€¢ Option B. Gorlin syndrome: Gorlin syndrome, or nevoid basal cell carcinoma syndrome , is characterized by multiple basal cell carcinomas, odontogenic keratocysts, and skeletal anomalies . It is associated with mutations in the PTCH1 gene , not STK11.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Gorlin syndrome:&lt;/li&gt;&lt;li&gt;â€¢ nevoid basal cell carcinoma syndrome&lt;/li&gt;&lt;li&gt;â€¢ multiple basal cell carcinomas, odontogenic keratocysts, and skeletal anomalies&lt;/li&gt;&lt;li&gt;â€¢ mutations in the PTCH1 gene&lt;/li&gt;&lt;li&gt;â€¢ Option C. Von Hippel-Lindau syndrome: Von Hippel-Lindau syndrome is a hereditary cancer syndrome associated with a variety of tumors, including hemangioblastomas, clear cell renal cell carcinoma, and pheochromocytomas. It is related to mutations in the VHL gene .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Von Hippel-Lindau syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Von Hippel-Lindau syndrome&lt;/li&gt;&lt;li&gt;â€¢ hereditary cancer&lt;/li&gt;&lt;li&gt;â€¢ hemangioblastomas, clear cell renal cell carcinoma, and pheochromocytomas.&lt;/li&gt;&lt;li&gt;â€¢ VHL gene&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Peutz-Jeghers syndrome is an autosomal dominant disorder associated with gastrointestinal polyps and mucocutaneous pigmentation, due to mutations in the STK11 gene , and it elevates the risk of multiple cancers .&lt;/li&gt;&lt;li&gt;âž¤ Peutz-Jeghers syndrome&lt;/li&gt;&lt;li&gt;âž¤ autosomal dominant disorder&lt;/li&gt;&lt;li&gt;âž¤ gastrointestinal polyps and mucocutaneous pigmentation,&lt;/li&gt;&lt;li&gt;âž¤ STK11 gene&lt;/li&gt;&lt;li&gt;âž¤ risk of multiple cancers&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following mechanisms does not lead to immune evasion by the tumor cells?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of PD1 receptor on T-cells&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Upregulation of expression of PDL1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Induction of galectin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Induction of regulatory T-cells&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Inhibition of PD1 receptor on T-cells&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Inhibition of PD1 receptor on T-cells&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Upregulation of expression of PDL1: Tumor cells often upregulate PD-L1, which binds to the PD1 receptor on T cells, leading to the inhibition of the immune response against the tumor, effectively allowing the tumor to evade the immune system.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Upregulation of expression of PDL1:&lt;/li&gt;&lt;li&gt;â€¢ Tumor cells often upregulate PD-L1,&lt;/li&gt;&lt;li&gt;â€¢ PD1 receptor on T cells,&lt;/li&gt;&lt;li&gt;â€¢ inhibition of the immune response&lt;/li&gt;&lt;li&gt;â€¢ tumor,&lt;/li&gt;&lt;li&gt;â€¢ tumor to evade the immune system.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Induction of galectin Tumor cells can induce galectins, which are beta-galactoside-binding proteins that can negatively regulate T-cell apoptosis , affect T-cell receptor signaling, or contribute to the creation of an immunosuppressive tumor microenvironment, facilitating immune evasion .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Induction of galectin&lt;/li&gt;&lt;li&gt;â€¢ galectins,&lt;/li&gt;&lt;li&gt;â€¢ beta-galactoside-binding proteins&lt;/li&gt;&lt;li&gt;â€¢ negatively regulate T-cell apoptosis&lt;/li&gt;&lt;li&gt;â€¢ T-cell receptor signaling,&lt;/li&gt;&lt;li&gt;â€¢ immunosuppressive tumor microenvironment, facilitating immune evasion&lt;/li&gt;&lt;li&gt;â€¢ ; Option D. Induction of regulatory T-cells: Tumors may induce regulatory T cells (Tregs), which suppress the activation of the immune system and maintain tolerance to self-antigens, thus aiding in tumor immune evasion.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Induction of regulatory T-cells:&lt;/li&gt;&lt;li&gt;â€¢ Tumors&lt;/li&gt;&lt;li&gt;â€¢ regulatory T cells (Tregs),&lt;/li&gt;&lt;li&gt;â€¢ tolerance to self-antigens,&lt;/li&gt;&lt;li&gt;â€¢ tumor immune evasion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Inhibition of the PD1 receptor on T cells does not lead to immune evasion by tumor cells; rather, it activates the immune response against the tumor. PD1 receptor inhibition is a strategy used in cancer immunotherapy to overcome tumor-induced immune suppression.&lt;/li&gt;&lt;li&gt;âž¤ Inhibition of the PD1 receptor on T cells does not&lt;/li&gt;&lt;li&gt;âž¤ immune evasion&lt;/li&gt;&lt;li&gt;âž¤ activates the immune response&lt;/li&gt;&lt;li&gt;âž¤ tumor. PD1 receptor&lt;/li&gt;&lt;li&gt;âž¤ cancer immunotherapy&lt;/li&gt;&lt;li&gt;âž¤ tumor-induced immune&lt;/li&gt;&lt;li&gt;âž¤ suppression.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 312&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran pathologic basis of disease 10th edition page: 312&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A dermatology resident is reviewing cases of skin cancer to understand the etiological role of different types of ultraviolet (UV) radiation. Which type of UV radiation is primarily responsible for the development of cutaneous cancers through the formation of DNA damage?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Only UVA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Only UVB&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Both UVB and UVC&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Both UVA and UVC&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Only UVB&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/25/screenshot-2024-04-25-125100.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Only UVB&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Only UVA: UVA radiation contributes to skin aging and can penetrate more deeply into the skin , but it is less effective than UVB at causing the direct DNA damage that leads to cutaneous cancers .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Only UVA:&lt;/li&gt;&lt;li&gt;â€¢ skin aging&lt;/li&gt;&lt;li&gt;â€¢ deeply into the skin&lt;/li&gt;&lt;li&gt;â€¢ less effective&lt;/li&gt;&lt;li&gt;â€¢ UVB at causing the direct DNA damage&lt;/li&gt;&lt;li&gt;â€¢ cutaneous cancers&lt;/li&gt;&lt;li&gt;â€¢ Option C. Both UVB and UVC: While UVB does cause cutaneous cancers , UVC is mostly absorbed by the ozone layer and does not reach the Earth&#x27;s surface to affect skin . Therefore, in the natural environment, UVC does not contribute to skin cancers .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Both UVB and UVC:&lt;/li&gt;&lt;li&gt;â€¢ UVB does cause cutaneous cancers&lt;/li&gt;&lt;li&gt;â€¢ UVC&lt;/li&gt;&lt;li&gt;â€¢ absorbed by the ozone layer&lt;/li&gt;&lt;li&gt;â€¢ does not reach the Earth&#x27;s surface to affect skin&lt;/li&gt;&lt;li&gt;â€¢ natural environment, UVC does not contribute to skin cancers&lt;/li&gt;&lt;li&gt;â€¢ Option D. Both UVA and UVC: Although UVA can contribute to DNA damage indirectly through the generation of reactive oxygen species, it is primarily UVB, not UVC, that is associated with the direct DNA damage causing cutaneous cancers.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Both UVA and UVC:&lt;/li&gt;&lt;li&gt;â€¢ UVA can contribute to DNA damage&lt;/li&gt;&lt;li&gt;â€¢ reactive oxygen&lt;/li&gt;&lt;li&gt;â€¢ it is primarily UVB,&lt;/li&gt;&lt;li&gt;â€¢ direct DNA damage causing cutaneous cancers.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ UVB is the form of ultraviolet radiation primarily responsible for causing cutaneous cancers due to its ability to induce the formation of pyrimidine dimers in DNA.&lt;/li&gt;&lt;li&gt;âž¤ UVB&lt;/li&gt;&lt;li&gt;âž¤ ultraviolet radiation&lt;/li&gt;&lt;li&gt;âž¤ cutaneous cancers&lt;/li&gt;&lt;li&gt;âž¤ induce&lt;/li&gt;&lt;li&gt;âž¤ pyrimidine dimers in DNA.&lt;/li&gt;&lt;li&gt;âž¤ UV portion of the solar spectrum is divided into three wavelength ranges :&lt;/li&gt;&lt;li&gt;âž¤ UV portion&lt;/li&gt;&lt;li&gt;âž¤ solar spectrum&lt;/li&gt;&lt;li&gt;âž¤ three wavelength ranges&lt;/li&gt;&lt;li&gt;âž¤ Ref : â€‹â€‹ https://www.cancer.org/healthy/cancer-causes/radiation-exposure/uv-radiation.html&lt;/li&gt;&lt;li&gt;âž¤ Ref : â€‹â€‹&lt;/li&gt;&lt;li&gt;âž¤ https://www.cancer.org/healthy/cancer-causes/radiation-exposure/uv-radiation.html&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following malignancies is caused by HTLV-1?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Enteropathy associated T-cell lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Adult T-cell leukemia/ lymphoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diffuse large B cell lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;B cell lymphomas&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Adult T-cell leukemia/ lymphoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Adult T-cell leukemia/ lymphoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Human T-cell leukemia-lymphoma virus (HTLV-1) causes adult T-cell leukemia/lymphoma (ATLL). HTLV-1 encodes the viral protein Tax , which leads to polyclonal expansion of T cells. It exhibits tropism for CD4+ T cells. Human infection requires transmission of infected T cells through sexual intercourse, blood products or breast feeding. Leukemia develops only in 3-5% of infected individuals , typically after a long latent period of 40-60 years .&lt;/li&gt;&lt;li&gt;â€¢ Human T-cell leukemia-lymphoma virus (HTLV-1) causes adult T-cell leukemia/lymphoma (ATLL).&lt;/li&gt;&lt;li&gt;â€¢ Human T-cell leukemia-lymphoma virus (HTLV-1)&lt;/li&gt;&lt;li&gt;â€¢ adult T-cell leukemia/lymphoma (ATLL).&lt;/li&gt;&lt;li&gt;â€¢ HTLV-1 encodes the viral protein Tax , which leads to polyclonal expansion of T cells. It exhibits tropism for CD4+ T cells.&lt;/li&gt;&lt;li&gt;â€¢ viral protein Tax&lt;/li&gt;&lt;li&gt;â€¢ polyclonal expansion of T cells.&lt;/li&gt;&lt;li&gt;â€¢ tropism for CD4+ T cells.&lt;/li&gt;&lt;li&gt;â€¢ Human infection requires transmission of infected T cells through sexual intercourse, blood products or breast feeding.&lt;/li&gt;&lt;li&gt;â€¢ transmission of infected T cells through sexual intercourse, blood products or breast feeding.&lt;/li&gt;&lt;li&gt;â€¢ Leukemia develops only in 3-5% of infected individuals , typically after a long latent period of 40-60 years .&lt;/li&gt;&lt;li&gt;â€¢ 3-5% of infected individuals&lt;/li&gt;&lt;li&gt;â€¢ long latent period of 40-60 years&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ The malignancy caused by HTLV-1 is Adult T-cell leukemia/lymphoma (ATLL), which is marked by a proliferation of CD4+ T cells. Transmission of HTLV-1 occurs through sexual contact, blood products, or breast feeding, and the development of leukemia is rare , affecting only a small percentage of those infected after a long latency period .&lt;/li&gt;&lt;li&gt;â€¢ HTLV-1 is Adult T-cell leukemia/lymphoma (ATLL),&lt;/li&gt;&lt;li&gt;â€¢ proliferation of CD4+ T cells.&lt;/li&gt;&lt;li&gt;â€¢ sexual contact, blood products, or breast feeding,&lt;/li&gt;&lt;li&gt;â€¢ leukemia is rare&lt;/li&gt;&lt;li&gt;â€¢ infected after a long latency period&lt;/li&gt;&lt;li&gt;â€¢ Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 324,5,6&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Robbins and Cotran pathologic basis of disease 10th edition page: 324,5,6&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old male presents with fever, sore throat, and lymphadenopathy. Serological tests are positive for Epstein-Barr virus (EBV) infection. Which of the following statements about the pathophysiology of EBV is incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It uses the complement receptor CD21 to attach and infect B cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is implicated in B-cell lymphomas in immunosuppressed people&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is a potent inducer of B-cell growth and transformation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;EBV infection always results in Burkitt lymphoma&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. EBV infection always results in Burkitt lymphoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) EBV infection always results in Burkitt lymphoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. It uses the complement receptor CD21 to attach and infect B cells. This is correct. EBV uses the CD21 receptor , which is the complement receptor on B cells, to infect them .&lt;/li&gt;&lt;li&gt;â€¢ Option A. It uses the complement receptor CD21 to attach and infect B cells.&lt;/li&gt;&lt;li&gt;â€¢ correct. EBV&lt;/li&gt;&lt;li&gt;â€¢ CD21 receptor&lt;/li&gt;&lt;li&gt;â€¢ complement receptor on B cells, to infect them&lt;/li&gt;&lt;li&gt;â€¢ Option B. It is implicated in B-cell lymphomas in individuals with immunosuppression. True. EBV is associated with various B-cell lymphomas, especially in individuals who are immunosuppressed, such as those with HIV or post-transplant patients.&lt;/li&gt;&lt;li&gt;â€¢ Option B. It is implicated in B-cell lymphomas in individuals with immunosuppression.&lt;/li&gt;&lt;li&gt;â€¢ True. EBV&lt;/li&gt;&lt;li&gt;â€¢ B-cell lymphomas,&lt;/li&gt;&lt;li&gt;â€¢ immunosuppressed,&lt;/li&gt;&lt;li&gt;â€¢ HIV or post-transplant patients.&lt;/li&gt;&lt;li&gt;â€¢ Option C. It is a potent inducer of B-cell growth and transformation. This is correct. EBV can drive B-cell growth and transformation , contributing to the development of diseases like infectious mononucleosis and , in some cases, B-cell lymphomas.&lt;/li&gt;&lt;li&gt;â€¢ Option C. It is a potent inducer of B-cell growth and transformation.&lt;/li&gt;&lt;li&gt;â€¢ correct. EBV&lt;/li&gt;&lt;li&gt;â€¢ B-cell growth and transformation&lt;/li&gt;&lt;li&gt;â€¢ infectious mononucleosis and&lt;/li&gt;&lt;li&gt;â€¢ B-cell lymphomas.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ EBV infection does not always lead to Burkitt lymphoma . While EBV can infect B cells and is associated with various lymphomas, the outcome of infection ranges from asymptomatic to infectious mononucleosis, with only a minority progressing to Burkitt lymphoma or other types of B-cell lymphoma.&lt;/li&gt;&lt;li&gt;âž¤ EBV infection does not&lt;/li&gt;&lt;li&gt;âž¤ Burkitt lymphoma&lt;/li&gt;&lt;li&gt;âž¤ EBV&lt;/li&gt;&lt;li&gt;âž¤ B cells&lt;/li&gt;&lt;li&gt;âž¤ various lymphomas,&lt;/li&gt;&lt;li&gt;âž¤ asymptomatic to infectious mononucleosis,&lt;/li&gt;&lt;li&gt;âž¤ minority progressing to Burkitt lymphoma&lt;/li&gt;&lt;li&gt;âž¤ B-cell lymphoma.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 326&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 326&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old patient presents with loss of weight and appetite. On clinical examination, grade IV clubbing is evident. Imaging shows periosteal new bone formation and left knee joint effusion. Which of the following tumors is associated with this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bronchogenic carcinoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carcinoma of the pancreas&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Esophageal carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acute myeloid leukemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Bronchogenic carcinoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Bronchogenic carcinoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Carcinoma of the pancreas: While patients with pancreatic cancer may develop paraneoplastic syndromes, hypertrophic osteoarthropathy is not typically associated with this type of malignancy.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Carcinoma of the pancreas:&lt;/li&gt;&lt;li&gt;â€¢ paraneoplastic syndromes, hypertrophic osteoarthropathy&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ type of malignancy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Esophageal carcinoma: Esophageal carcinoma can be associated with paraneoplastic phenomena including clubbing , but it is less commonly associated with hypertrophic osteoarthropathy compared to bronchogenic carcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Esophageal carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ Esophageal carcinoma&lt;/li&gt;&lt;li&gt;â€¢ paraneoplastic phenomena&lt;/li&gt;&lt;li&gt;â€¢ clubbing&lt;/li&gt;&lt;li&gt;â€¢ less&lt;/li&gt;&lt;li&gt;â€¢ hypertrophic osteoarthropathy&lt;/li&gt;&lt;li&gt;â€¢ Option D. Acute myeloid leukemia: Hematologic malignancies like AML are not commonly associated with hypertrophic osteoarthropathy . Paraneoplastic syndromes are more commonly associated with solid tumors.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Acute myeloid leukemia:&lt;/li&gt;&lt;li&gt;â€¢ Hematologic&lt;/li&gt;&lt;li&gt;â€¢ AML&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ hypertrophic osteoarthropathy&lt;/li&gt;&lt;li&gt;â€¢ Paraneoplastic syndromes&lt;/li&gt;&lt;li&gt;â€¢ solid tumors.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hypertrophic osteoarthropathy is characterized by the following:&lt;/li&gt;&lt;li&gt;âž¤ Hypertrophic osteoarthropathy&lt;/li&gt;&lt;li&gt;âž¤ Periosteal new bone formation , primarily at the distal ends of long bones, metatarsals, metacarpals, and proximal phalanges Arthritis of the adjacent joints Clubbing of the digits&lt;/li&gt;&lt;li&gt;âž¤ Periosteal new bone formation , primarily at the distal ends of long bones, metatarsals, metacarpals, and proximal phalanges&lt;/li&gt;&lt;li&gt;âž¤ Periosteal new bone formation&lt;/li&gt;&lt;li&gt;âž¤ distal ends of long bones, metatarsals, metacarpals, and proximal phalanges&lt;/li&gt;&lt;li&gt;âž¤ Arthritis of the adjacent joints&lt;/li&gt;&lt;li&gt;âž¤ Arthritis of the adjacent joints&lt;/li&gt;&lt;li&gt;âž¤ Clubbing of the digits&lt;/li&gt;&lt;li&gt;âž¤ Clubbing of the digits&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old patient presents with generalized tiredness, malaise, muscle weakness, and bone pain. Laboratory investigations reveal serum calcium to be 13 mg/dL. Which of the following lung cancers is implicated in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Small cell carcinoma of lung&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Adenosquamous carcinoma of lung&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Squamous cell carcinoma of lung&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Large cell carcinoma of lung&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Squamous cell carcinoma of lung&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Squamous cell carcinoma of lung&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Small cell carcinoma of the lung: Small cell carcinoma of the lung is more commonly associated with paraneoplastic syndromes like SIADH or Cushing&#x27;s syndrome due to ectopic ACTH production, rather than hypercalcemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Small cell carcinoma of the lung:&lt;/li&gt;&lt;li&gt;â€¢ more&lt;/li&gt;&lt;li&gt;â€¢ paraneoplastic syndromes like SIADH or Cushing&#x27;s syndrome&lt;/li&gt;&lt;li&gt;â€¢ ectopic ACTH production,&lt;/li&gt;&lt;li&gt;â€¢ hypercalcemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Adenosquamous carcinoma of the lung: Adenosquamous carcinoma of the lung can produce paraneoplastic syndromes , but it is not the most common type associated with hypercalcemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Adenosquamous carcinoma of the lung:&lt;/li&gt;&lt;li&gt;â€¢ paraneoplastic syndromes&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ hypercalcemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Large cell carcinoma of the lung: Large cell carcinoma can present with several paraneoplastic syndromes , but it is not the most frequent cause of paraneoplastic hypercalcemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Large cell carcinoma of the lung:&lt;/li&gt;&lt;li&gt;â€¢ several paraneoplastic syndromes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Squamous cell carcinoma of the lung is frequently associated with paraneoplastic hypercalcemia, often due to the secretion of PTHrP, leading to elevated calcium levels that manifest with symptoms such as fatigue, muscle weakness, and bone pain .&lt;/li&gt;&lt;li&gt;âž¤ Squamous cell carcinoma of the lung&lt;/li&gt;&lt;li&gt;âž¤ paraneoplastic hypercalcemia,&lt;/li&gt;&lt;li&gt;âž¤ secretion of PTHrP,&lt;/li&gt;&lt;li&gt;âž¤ elevated calcium levels&lt;/li&gt;&lt;li&gt;âž¤ fatigue, muscle weakness, and bone pain&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 329&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran pathologic basis of disease 10th edition page: 329&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old patient notices spontaneously appearing and disappearing painful, linearly arranged nodules in different parts of the body. Which of the following malignancies is not associated with this clinical presentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Uterine carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pancreatic carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bronchogenic carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bladder carcinoma&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Bladder carcinoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Bladder carcinoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Uterine carcinoma: Uterine carcinoma, particularly when adenocarcinoma , can be associated with Trousseau syndrome due to its propensity to induce a hypercoagulable state , leading to venous thromboembolism.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Uterine carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ adenocarcinoma&lt;/li&gt;&lt;li&gt;â€¢ Trousseau syndrome&lt;/li&gt;&lt;li&gt;â€¢ propensity to induce a hypercoagulable state&lt;/li&gt;&lt;li&gt;â€¢ venous thromboembolism.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pancreatic carcinoma: Pancreatic carcinoma is strongly associated with Trousseau syndrome . The tumor&#x27;s release of mucins and procoagulant substances can trigger a hypercoagulable state .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pancreatic carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ Pancreatic carcinoma&lt;/li&gt;&lt;li&gt;â€¢ Trousseau syndrome&lt;/li&gt;&lt;li&gt;â€¢ mucins and procoagulant substances&lt;/li&gt;&lt;li&gt;â€¢ hypercoagulable state&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bronchogenic carcinoma: Bronchogenic carcinoma, especially adenocarcinoma subtype, is known to produce substances that activate the coagulation system, thus it can be associated with Trousseau syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bronchogenic carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ adenocarcinoma subtype,&lt;/li&gt;&lt;li&gt;â€¢ activate the coagulation system,&lt;/li&gt;&lt;li&gt;â€¢ Trousseau syndrome.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Bladder carcinoma is not commonly associated with Trousseau syndrome , which is characterized by migratory thrombophlebitis and is often seen with deep-seated adenocarcinomas like those of the pancreas, lung, and other visceral organs.&lt;/li&gt;&lt;li&gt;âž¤ Bladder carcinoma&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ Trousseau syndrome&lt;/li&gt;&lt;li&gt;âž¤ migratory thrombophlebitis&lt;/li&gt;&lt;li&gt;âž¤ deep-seated adenocarcinomas&lt;/li&gt;&lt;li&gt;âž¤ pancreas, lung, and other visceral organs.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 329&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran pathologic basis of disease 10th edition page: 329&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following are oncofetal antigens? Alpha-fetoprotein Carcinoembryonic antigen Human chorionic gonadotropin Placental alkaline phosphatase Immunoglobulins&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1 and 3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1, 3 and 4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;3, 4 and 5&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1 and 2&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 1 and 2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) 1 and 2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Alpha-fetoprotein (AFP) and carcinoembryonic antigen (CEA) are oncofetal antigens.&lt;/li&gt;&lt;li&gt;â€¢ Alpha-fetoprotein (AFP) and carcinoembryonic antigen (CEA) are oncofetal antigens.&lt;/li&gt;&lt;li&gt;â€¢ Alpha-fetoprotein is a valuable clinical aid in diagnosis, prognosis, and monitoring of the following tumors:&lt;/li&gt;&lt;li&gt;â€¢ Alpha-fetoprotein&lt;/li&gt;&lt;li&gt;â€¢ diagnosis, prognosis, and monitoring of the following tumors:&lt;/li&gt;&lt;li&gt;â€¢ Primary hepatocellular carcinoma Hepatoblastoma Non-seminomatous testicular germ cell tumors Embryonal carcinoma Teratomas Choriocarcinoma&lt;/li&gt;&lt;li&gt;â€¢ Primary hepatocellular carcinoma&lt;/li&gt;&lt;li&gt;â€¢ Hepatoblastoma&lt;/li&gt;&lt;li&gt;â€¢ Non-seminomatous testicular germ cell tumors&lt;/li&gt;&lt;li&gt;â€¢ Embryonal carcinoma&lt;/li&gt;&lt;li&gt;â€¢ Teratomas&lt;/li&gt;&lt;li&gt;â€¢ Choriocarcinoma&lt;/li&gt;&lt;li&gt;â€¢ Carcinoembryonic antigen is normally detected in the glycocalyx of fetal epithelial cells . It is useful in detection, assessing recurrence, and prognosis of the following tumors:&lt;/li&gt;&lt;li&gt;â€¢ Carcinoembryonic antigen&lt;/li&gt;&lt;li&gt;â€¢ glycocalyx of fetal epithelial cells&lt;/li&gt;&lt;li&gt;â€¢ detection, assessing recurrence, and prognosis&lt;/li&gt;&lt;li&gt;â€¢ Adenocarcinoma of lung Colorectal carcinoma&lt;/li&gt;&lt;li&gt;â€¢ Adenocarcinoma of lung&lt;/li&gt;&lt;li&gt;â€¢ Colorectal carcinoma&lt;/li&gt;&lt;li&gt;â€¢ CEA levels &amp;gt;5 g/dL are noted in ascitic fluid associated with malignancy.&lt;/li&gt;&lt;li&gt;â€¢ CEA levels &amp;gt;5 g/dL&lt;/li&gt;&lt;li&gt;â€¢ ascitic fluid&lt;/li&gt;&lt;li&gt;â€¢ malignancy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Alpha-fetoprotein and carcinoembryonic antigen are oncofetal antigens , which are expressed during fetal development and re-expressed in certain malignancies, aiding in the diagnosis, prognosis, and monitoring of these cancers.&lt;/li&gt;&lt;li&gt;âž¤ Alpha-fetoprotein and carcinoembryonic antigen&lt;/li&gt;&lt;li&gt;âž¤ oncofetal antigens&lt;/li&gt;&lt;li&gt;âž¤ fetal development and re-expressed&lt;/li&gt;&lt;li&gt;âž¤ malignancies,&lt;/li&gt;&lt;li&gt;âž¤ diagnosis, prognosis, and monitoring of these cancers.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 336&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins and Cotran pathologic basis of disease 10th edition page: 336&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient is diagnosed with a malignancy that is associated with an overexpression of the c-Myc gene. Which of the following is the most likely mechanism of this overexpression?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gene amplification&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chromosomal translocation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Point mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Gene deletion&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Gene amplification&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Gene amplification&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chromosomal translocation: While chromosomal translocations can result in c-Myc overexpression , such as the translocation seen in Burkitt lymphoma (t(8;14), it is less common than gene amplification for the overexpression of c-Myc in a broader range of malignancies.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chromosomal translocation:&lt;/li&gt;&lt;li&gt;â€¢ c-Myc overexpression&lt;/li&gt;&lt;li&gt;â€¢ translocation seen in Burkitt lymphoma (t(8;14),&lt;/li&gt;&lt;li&gt;â€¢ overexpression of c-Myc&lt;/li&gt;&lt;li&gt;â€¢ Option C. Point mutation: Point mutations can activate oncogenes or inactivate tumor suppressor genes, but they are not typically associated with the overexpression of c-Myc. Instead , they might alter the function of the resulting protein.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Point mutation:&lt;/li&gt;&lt;li&gt;â€¢ activate oncogenes&lt;/li&gt;&lt;li&gt;â€¢ inactivate tumor suppressor genes,&lt;/li&gt;&lt;li&gt;â€¢ overexpression of c-Myc. Instead&lt;/li&gt;&lt;li&gt;â€¢ Option D. Gene deletion: Gene deletion generally leads to a loss of gene function and is more commonly associated with tumor suppressor genes rather than proto-oncogenes like c-Myc. Deletion would not result in overexpression but rather in reduced expression or loss of function.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Gene deletion:&lt;/li&gt;&lt;li&gt;â€¢ loss of gene function&lt;/li&gt;&lt;li&gt;â€¢ tumor suppressor genes&lt;/li&gt;&lt;li&gt;â€¢ proto-oncogenes like c-Myc. Deletion would not&lt;/li&gt;&lt;li&gt;â€¢ overexpression&lt;/li&gt;&lt;li&gt;â€¢ loss of function.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Gene amplification is a common mechanism for overexpression of the c-Myc gene in various malignancies, leading to increased cell growth and proliferation due to the extra copies of the gene being transcribed.&lt;/li&gt;&lt;li&gt;âž¤ Gene amplification&lt;/li&gt;&lt;li&gt;âž¤ overexpression of the c-Myc gene&lt;/li&gt;&lt;li&gt;âž¤ increased cell&lt;/li&gt;&lt;li&gt;âž¤ growth and proliferation&lt;/li&gt;&lt;li&gt;âž¤ extra copies of the gene&lt;/li&gt;&lt;li&gt;âž¤ transcribed.&lt;/li&gt;&lt;li&gt;âž¤ The C-myc gene is a proto-oncogene that codes for a transcription factor involved in cell proliferation and differentiation . Overexpression of c-Myc is seen in many malignancies, and it is often due to gene amplification, which results in an increased number of copies of the gene . Chromosomal translocations can also lead to c-Myc overexpression, but they are less common.&lt;/li&gt;&lt;li&gt;âž¤ The C-myc gene is a proto-oncogene that codes for a transcription factor involved in cell proliferation and differentiation . Overexpression of c-Myc is seen in many malignancies, and it is often due to gene amplification, which results in an increased number of copies of the gene .&lt;/li&gt;&lt;li&gt;âž¤ C-myc gene is a proto-oncogene&lt;/li&gt;&lt;li&gt;âž¤ transcription factor&lt;/li&gt;&lt;li&gt;âž¤ cell proliferation and differentiation&lt;/li&gt;&lt;li&gt;âž¤ Overexpression of c-Myc&lt;/li&gt;&lt;li&gt;âž¤ gene amplification,&lt;/li&gt;&lt;li&gt;âž¤ increased number of copies of the gene&lt;/li&gt;&lt;li&gt;âž¤ Chromosomal translocations can also lead to c-Myc overexpression, but they are less common.&lt;/li&gt;&lt;li&gt;âž¤ Chromosomal translocations&lt;/li&gt;&lt;li&gt;âž¤ lead to c-Myc overexpression,&lt;/li&gt;&lt;li&gt;âž¤ less common.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 60 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test12" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Renal System&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Renal System&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                14 Questions | 56 Total Marks | 24 min Duration | ~102.86 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A mother brings her child with a history of narrow stream of urine for long days. She complaints that he often gets infected because of this. On examination, a suspicion of urethral stricture is made. All of the following are complications of urethral stricture except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Urinary Incontinence&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Urethral Calculi&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bilateral Hydronephrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Periurethral abscess&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Urinary Incontinence&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Urethral Calculi : Urethral strictures can lead to urinary retention and stasis , predisposing to the formation of urethral calculi (stones).&lt;/li&gt;&lt;li&gt;â€¢ Option B. Urethral Calculi&lt;/li&gt;&lt;li&gt;â€¢ lead to urinary retention and stasis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bilateral Hydronephrosis : Urethral obstruction caused by strictures can result in back pressure on the kidneys , leading to bilateral hydronephrosis due to dilation of the renal pelvis and calyces.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bilateral Hydronephrosis&lt;/li&gt;&lt;li&gt;â€¢ caused by strictures can result in back pressure on the kidneys&lt;/li&gt;&lt;li&gt;â€¢ bilateral hydronephrosis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Periurethral Abscess : Urinary stasis caused by urethral strictures can predispose to the development of periurethral abscesses due to bacterial infection in the surrounding tissues.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Periurethral Abscess&lt;/li&gt;&lt;li&gt;â€¢ Urinary stasis&lt;/li&gt;&lt;li&gt;â€¢ urethral strictures&lt;/li&gt;&lt;li&gt;â€¢ predispose to the development of periurethral abscesses&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Urinary Incontinence is not a complication of urethral stricture, whereas urinary retention can be a complication of it.&lt;/li&gt;&lt;li&gt;â€¢ Urinary Incontinence&lt;/li&gt;&lt;li&gt;â€¢ urethral stricture,&lt;/li&gt;&lt;li&gt;â€¢ Ref : Nelson 21 st Edition, Chapter 559 Page No- From 11076.&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Nelson 21 st Edition, Chapter 559 Page No- From 11076.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A mother brings her 6-month-old male child with complaints of dribbling of urine and recurrent urinary tract infections. During her prenatal visits, the doctor mentioned abnormal radiographic findings, but she forgot about it due to the long gap since her last pregnancy. Upon reviewing her old medical file, you find the following ultrasound (USG) image. Based on the clinical features and the image provided, what is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ureterocele&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Posterior urethral valve&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stricture of urethra&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Neurogenic bladder&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Posterior urethral valve&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/23/picture4_ROz1eXV.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Posterior urethral valve.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ureterocele : While ureterocele is a congenital anomaly involving the distal ureter, it typically presents with a cystic dilatation at the ureteric orifice within the bladder, rather than causing obstruction in the urethra. There will be an adder head or Cobra head appearance on IVP .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ureterocele&lt;/li&gt;&lt;li&gt;â€¢ adder head or Cobra head&lt;/li&gt;&lt;li&gt;â€¢ appearance&lt;/li&gt;&lt;li&gt;â€¢ IVP&lt;/li&gt;&lt;li&gt;â€¢ Option C. Urethral stricture : Urethral stricture refers to narrowing of the urethra due to scar tissue or inflammation. While it can cause urinary flow obstruction, it typically presents differently and is less common in infants.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Urethral stricture&lt;/li&gt;&lt;li&gt;â€¢ narrowing of the urethra&lt;/li&gt;&lt;li&gt;â€¢ scar tissue or inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Neurogenic bladder : Neurogenic bladder dysfunction is often associated with conditions affecting the central or peripheral nervous system , leading to abnormal bladder function. While it can cause urinary symptoms, the clinical presentation and imaging findings in this case are more suggestive of posterior urethral valves. This will show the Christmas tree appearance not the keyhole appearance.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Neurogenic bladder&lt;/li&gt;&lt;li&gt;â€¢ conditions affecting the central or peripheral nervous system&lt;/li&gt;&lt;li&gt;â€¢ abnormal bladder function.&lt;/li&gt;&lt;li&gt;â€¢ Christmas tree appearance&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The clinical presentation of dribbling of urine and recurrent urinary tract infections in a male child , along with the history of prenatal radiographic findings suggestive of an abnormality , raises suspicion for posterior urethral valves (PUV).&lt;/li&gt;&lt;li&gt;â€¢ dribbling of urine&lt;/li&gt;&lt;li&gt;â€¢ recurrent urinary tract infections&lt;/li&gt;&lt;li&gt;â€¢ male child&lt;/li&gt;&lt;li&gt;â€¢ history of prenatal radiographic findings&lt;/li&gt;&lt;li&gt;â€¢ abnormality&lt;/li&gt;&lt;li&gt;â€¢ raises suspicion for posterior urethral valves&lt;/li&gt;&lt;li&gt;â€¢ Ref : Nelson 21 st Edition, Chapter 555 Page No- From 10988.&lt;/li&gt;&lt;li&gt;â€¢ Ref :&lt;/li&gt;&lt;li&gt;â€¢ Nelson 21 st Edition, Chapter 555 Page No- From 10988.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 5-month-old boy is brought to the pediatric clinic by his mother due to recurrent fever without a clear source. This is his fourth episode since birth. On examination, abdominal masses are palpable bilaterally, which resolve after the child urinates. A urinalysis reveals the presence of white blood cells (WBCs), suggestive of a urinary tract infection (UTI). What is the most appropriate next step in the management of this child?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Urine culture for UTI, USG and MCU for Ureterocele.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Urine culture for UTI, USG and MCU for PUV&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Urine culture for UTI, USG and MCU for Hydroureteronephrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Urine culture for UTI, USG and MCU for Urethral stricture.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Urine culture for UTI, USG and MCU for PUV&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)Â  Urine culture for UTI, USG and MCU for PUV&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A . Urine culture for UTI, USG, and MCU for ureterocele: Ureterocele is a cystic dilatation of the distal ureter , which may cause urinary obstruction . However, the presentation described is more suggestive of PUV rather than ureterocele.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A&lt;/li&gt;&lt;li&gt;â€¢ Urine culture for UTI, USG, and MCU for ureterocele: Ureterocele&lt;/li&gt;&lt;li&gt;â€¢ cystic dilatation of the distal ureter&lt;/li&gt;&lt;li&gt;â€¢ urinary obstruction&lt;/li&gt;&lt;li&gt;â€¢ Option C . Urine culture for UTI, USG, and MCU for hydroureteronephrosis : Hydroureteronephrosis refers to dilation of the ureter and renal pelvis due to urinary obstruction . While it can be associated with PUV, the specific evaluation for PUV with VCUG is warranted in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C&lt;/li&gt;&lt;li&gt;â€¢ Urine culture for UTI, USG, and MCU for hydroureteronephrosis&lt;/li&gt;&lt;li&gt;â€¢ dilation of the ureter and renal pelvis due to urinary obstruction&lt;/li&gt;&lt;li&gt;â€¢ Option D . Urine culture for UTI, USG, and MCU for urethral stricture : Urethral stricture is an uncommon cause of urinary obstruction in infants and is less likely given the clinical presentation described.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D&lt;/li&gt;&lt;li&gt;â€¢ Urine culture for UTI, USG, and MCU for urethral stricture&lt;/li&gt;&lt;li&gt;â€¢ Urethral stricture&lt;/li&gt;&lt;li&gt;â€¢ uncommon cause of urinary obstruction in infants&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The clinical presentation suggestive of posterior urethral valves (PUV) in an infant with recurrent fever and urinary symptoms , and to determine the appropriate diagnostic evaluation, including urine culture for UTI , ultrasonography (USG) of the kidneys and bladder , and voiding cystourethrogram (VCUG) to evaluate for PUV.&lt;/li&gt;&lt;li&gt;âž¤ posterior urethral valves&lt;/li&gt;&lt;li&gt;âž¤ infant with recurrent fever&lt;/li&gt;&lt;li&gt;âž¤ urinary symptoms&lt;/li&gt;&lt;li&gt;âž¤ including urine culture for UTI&lt;/li&gt;&lt;li&gt;âž¤ ultrasonography&lt;/li&gt;&lt;li&gt;âž¤ of the kidneys&lt;/li&gt;&lt;li&gt;âž¤ bladder&lt;/li&gt;&lt;li&gt;âž¤ voiding cystourethrogram&lt;/li&gt;&lt;li&gt;âž¤ Ref : Nelson 21 st Edition, Chapter 555 Page No- From 10988.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Nelson 21 st Edition, Chapter 555 Page No- From 10988.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;On your first day in the pediatric department, while exploring, you encounter a child with urogenital abnormalities. A third-year postgradate (PG) resident passes by and asks you which congenital anomaly is associated with an increased risk of bladder carcinoma. What will be your reply?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bladder exstrophy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ureterocele&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rt side renal agenesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Duplication ureter&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Bladder exstrophy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)Â  Bladder exstrophy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ureterocele : Ureterocele is a congenital anomaly involving the dilatation of the distal ureter within the bladder . While it can lead to complications such as urinary obstruction and vesicoureteral reflux , it is not typically associated with an increased risk of bladder carcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ureterocele&lt;/li&gt;&lt;li&gt;â€¢ congenital anomaly involving the dilatation of the distal ureter&lt;/li&gt;&lt;li&gt;â€¢ bladder&lt;/li&gt;&lt;li&gt;â€¢ urinary obstruction and vesicoureteral reflux&lt;/li&gt;&lt;li&gt;â€¢ Option C. Right-sided renal agenesis : Right-sided renal agenesis refers to the absence of the right kidney. This condition is not directly associated with an increased risk of bladder carcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Right-sided renal agenesis&lt;/li&gt;&lt;li&gt;â€¢ absence of the right kidney.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Duplication ureter : Duplication ureter is a congenital anomaly where the ureteric bud bifurcates during embryonic development , resulting in two ureters draining a single kidney . While it can lead to complications such as urinary tract obstruction and vesicoureteral reflux, it is not typically associated with an increased risk of bladder carcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Duplication ureter&lt;/li&gt;&lt;li&gt;â€¢ congenital anomaly where the ureteric bud bifurcates during embryonic development&lt;/li&gt;&lt;li&gt;â€¢ two ureters draining a single kidney&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Bladder exstrophy is associated with an increased risk of bladder carcinoma and is important for the management and follow-up of patients with this condition.&lt;/li&gt;&lt;li&gt;âž¤ Bladder exstrophy&lt;/li&gt;&lt;li&gt;âž¤ increased risk of bladder carcinoma&lt;/li&gt;&lt;li&gt;âž¤ management and follow-up of patients with this condition.&lt;/li&gt;&lt;li&gt;âž¤ Ref - Nelson 21 st Edition page 11019&lt;/li&gt;&lt;li&gt;âž¤ Ref - Nelson 21 st Edition page 11019&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A mother in India brings her 2-day-old son to the pediatric clinic with concerns of his condition at birth. She reports that her son has had constant leakage of urine from the lower abdominal region since delivery. On examination, the infant has a wide separation of the pubic bones and a visibly externalized bladder through the abdominal wall, as shown in the accompanying image. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Posterior urethral valves&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vesicoureteral reflux&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bladder exstrophy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prune belly syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Bladder exstrophy&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/23/picture6_Y9LYUkO.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Bladder exstrophy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Posterior Urethral Valves : This condition is an obstructive developmental anomaly in male infants , presenting with a distended bladder , difficulty with urination , and potentially renal damage . It would not present with an externalized bladder or pubic diastasis and typically leads to a range of symptoms from urinary tract infections to renal failure.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Posterior Urethral Valves&lt;/li&gt;&lt;li&gt;â€¢ obstructive developmental anomaly in male infants&lt;/li&gt;&lt;li&gt;â€¢ distended bladder&lt;/li&gt;&lt;li&gt;â€¢ difficulty with urination&lt;/li&gt;&lt;li&gt;â€¢ potentially renal damage&lt;/li&gt;&lt;li&gt;â€¢ Option B. Vesicoureteral Reflux : It involves the backflow of urine from the bladder into the ureters and potentially the kidneys . While it can present with recurrent UTIs and may be associated with other congenital abnormalities of the urinary tract, it does not cause the anatomical changes seen in the image, such as an everted bladder and diastasis of the pubic symphysis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Vesicoureteral Reflux&lt;/li&gt;&lt;li&gt;â€¢ backflow of urine from the bladder into the ureters and potentially the kidneys&lt;/li&gt;&lt;li&gt;â€¢ Option D. Prune Belly Syndrome : Also known as Eagle-Barrett syndrome , it is characterized by a triad of abdominal muscle deficiency , cryptorchidism (undescended testes), and urinary tract anomalies . The abdominal wall is thin and wrinkled, resembling a prune, which is not consistent with the exposed bladder in the image. It does not present with bladder exstrophy but may include a range of urinary tract malformations and symptoms related to the urinary system.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Prune Belly Syndrome&lt;/li&gt;&lt;li&gt;â€¢ Eagle-Barrett syndrome&lt;/li&gt;&lt;li&gt;â€¢ triad of abdominal muscle deficiency&lt;/li&gt;&lt;li&gt;â€¢ cryptorchidism&lt;/li&gt;&lt;li&gt;â€¢ urinary tract anomalies&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Bladder exstrophy is a rare congenital anomaly where the bladder is open and exposed on the lower abdominal wall . It is due to failure of fusion of the lower abdominal wall and bladder during embryonic development.&lt;/li&gt;&lt;li&gt;âž¤ Bladder exstrophy&lt;/li&gt;&lt;li&gt;âž¤ rare congenital anomaly&lt;/li&gt;&lt;li&gt;âž¤ bladder is open and exposed on the lower abdominal wall&lt;/li&gt;&lt;li&gt;âž¤ failure of fusion of the lower abdominal wall&lt;/li&gt;&lt;li&gt;âž¤ bladder during embryonic development.&lt;/li&gt;&lt;li&gt;âž¤ Clinical features include a wide pubic diastasis, everted bladder neck, and urine leakage from the lower abdominal wall. Surgical reconstruction is the mainstay of treatment.&lt;/li&gt;&lt;li&gt;âž¤ pubic diastasis, everted bladder neck, and urine leakage from the lower abdominal wall.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Nelson 21 st Edition, Chapter 556 Page No- 11019 to 11022.&lt;/li&gt;&lt;li&gt;âž¤ Ref :&lt;/li&gt;&lt;li&gt;âž¤ Nelson 21 st Edition, Chapter 556 Page No- 11019 to 11022.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 16-year-old female presents to a rural health clinic, with a 1-day history of stabbing pain in her left groin, accompanied by white vaginal discharge and mild dysuria that has persisted for the past week. She denies experiencing any abnormal vaginal bleeding, noting her last menstrual period was about 3 weeks ago. The patient has no history of sexually transmitted diseases (STDs) and has been sexually active for the past year, relying on oral contraceptives for birth control. She mentions that her sexual partners sporadically use condoms. Upon examination, she is found to be afebrile, but exhibits tenderness in the left lower quadrant and suprapubic area during deep palpation. In the context of the Indian health system, what is the most appropriate next step in her management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reassure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Perform urinalysis and urine pregnancy testing&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Perform Ultrasonography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Perform pelvic examination and Pap smear&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Perform urinalysis and urine pregnancy testing&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reassure : It would be premature to reassure the patient without further investigation, given her symptoms and sexual history.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reassure&lt;/li&gt;&lt;li&gt;â€¢ Option C. Perform Ultrasonography : Ultrasonography could be useful later for diagnostic clarification but is not the immediate next step before confirming UTI or pregnancy status.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Perform Ultrasonography&lt;/li&gt;&lt;li&gt;â€¢ Option Perform Pelvic Examination and Pap Smear : While a pelvic exam might be necessary for a comprehensive evaluation, it should follow initial urine tests. A Pap smear is not indicated in this acute setting and is generally not recommended for individuals under the age of 21.&lt;/li&gt;&lt;li&gt;â€¢ Option Perform Pelvic Examination and Pap Smear&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Performing urinalysis and urine pregnancy testing is the initial step to be taken in all sexually active female with complaints of UTI.&lt;/li&gt;&lt;li&gt;âž¤ STD is a concern in this patient with pyuria and abdominal pain. In addition to pelvic inflammatory disease (PID), possible etiologies include UTI, ovarian torsion, ovarian cyst, and ectopic pregnancy. So, the first step in evaluation should always be urinalysis and pregnancy testing.&lt;/li&gt;&lt;li&gt;âž¤ STD is a concern in this patient with pyuria and abdominal pain.&lt;/li&gt;&lt;li&gt;âž¤ In addition to pelvic inflammatory disease (PID), possible etiologies include UTI, ovarian torsion, ovarian cyst, and ectopic pregnancy.&lt;/li&gt;&lt;li&gt;âž¤ So, the first step in evaluation should always be urinalysis and pregnancy testing.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Nelson 21 st Edition, Chapter 553 Page No- From 10943.&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Nelson 21 st Edition, Chapter 553 Page No- From 10943.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 11-year-old boy is brought to your CHC in a suburban area of India by his mother. She reports her son has been experiencing irritation and itching of the penis, along with a burning sensation during urination. The child has not reported an increase in the frequency of urination or changes in the appearance of his urine. Upon doing laundry, his mother observed a whitish-yellow stain on his underwear. The boy is uncircumcised, and his medical history is otherwise unremarkable. On physical examination, there is significant erythema of the glans penis and a whitish exudate is noted upon retraction of the foreskin. A urinalysis does not show any abnormalities. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gonococcal urethritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Candidal balanitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nongonococcal urethritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Herpes infection&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Candidal balanitis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Candidal balanitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Gonococcal urethritis : Caused by the bacterium Neisseria gonorrhoeae , it typically presents with purulent discharge and can be confirmed with gram stain or culture . Urinalysis can sometimes show signs of infection.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Gonococcal urethritis&lt;/li&gt;&lt;li&gt;â€¢ bacterium Neisseria gonorrhoeae&lt;/li&gt;&lt;li&gt;â€¢ purulent discharge&lt;/li&gt;&lt;li&gt;â€¢ confirmed with gram stain or culture&lt;/li&gt;&lt;li&gt;â€¢ Option C. Nongonococcal urethritis : Usually caused by Chlamydia trachomatis or Mycoplasma genitalium , it presents with mucopurulent or clear discharge , but urinalysis would often show signs of infection such as white blood cells.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Nongonococcal urethritis&lt;/li&gt;&lt;li&gt;â€¢ Chlamydia trachomatis or Mycoplasma genitalium&lt;/li&gt;&lt;li&gt;â€¢ mucopurulent or clear discharge&lt;/li&gt;&lt;li&gt;â€¢ Option D. Herpes infection : Genital herpes can cause painful vesicular lesions on the glans or shaft of the penis. It is less likely to present with whitish exudate and would not typically result in an unremarkable urinalysis if lesions were present.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Herpes infection&lt;/li&gt;&lt;li&gt;â€¢ painful vesicular lesions&lt;/li&gt;&lt;li&gt;â€¢ glans or shaft of the penis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Candidal balanitis is an infection of the glans penis that is commonly caused by the fungus Candida albicans , particularly in uncircumcised males . The symptoms described, such as itching and burning of the penis , along with the whitish exudate upon retraction of the foreskin , are characteristic of this diagnosis. The unremarkable urinalysis helps rule out bacterial infections that would typically present with pyuria or bacteriuria.&lt;/li&gt;&lt;li&gt;âž¤ Candidal balanitis&lt;/li&gt;&lt;li&gt;âž¤ infection of the glans penis&lt;/li&gt;&lt;li&gt;âž¤ fungus Candida albicans&lt;/li&gt;&lt;li&gt;âž¤ uncircumcised males&lt;/li&gt;&lt;li&gt;âž¤ itching and burning of the penis&lt;/li&gt;&lt;li&gt;âž¤ whitish exudate upon retraction of the foreskin&lt;/li&gt;&lt;li&gt;âž¤ Ref : Nelson 21 st Edition&lt;/li&gt;&lt;li&gt;âž¤ Ref :&lt;/li&gt;&lt;li&gt;âž¤ Nelson 21 st Edition&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A mother brings her male child with clinical features of recurrent Urinary tract infection. On examination, the child was febrile. An Ultrasound examination reveals the presence of bilateral hydroureteronephrosis. A diagnosis of posterior urethral valve is suspected. What is the investigation of choice for posterior urethral valve?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anterograde urethroscopy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Voiding Cystourethroscopy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cystourethroscopy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Retrograde urethroscopy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Voiding Cystourethroscopy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Voiding Cystourethroscopy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anterograde urethroscopy is used for posterior urethral pathologies .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Anterograde urethroscopy&lt;/li&gt;&lt;li&gt;â€¢ posterior urethral pathologies&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cystourethroscopy has less or no significance in diagnosis of PUV.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Cystourethroscopy&lt;/li&gt;&lt;li&gt;â€¢ less or no significance in diagnosis of PUV.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Retrograde urethroscopy is used for anterior urethral pathologies&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Retrograde urethroscopy&lt;/li&gt;&lt;li&gt;â€¢ anterior urethral pathologies&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Voiding cystourethroscopy (VCUG) is the investigation of choice for confirming the diagnosis of posterior urethral valves (PUV). PUV is a congenital anomaly characterized by abnormal membranous folds within the posterior urethra , leading to obstruction of urinary flow .&lt;/li&gt;&lt;li&gt;âž¤ Voiding cystourethroscopy&lt;/li&gt;&lt;li&gt;âž¤ investigation of choice for confirming the diagnosis of posterior urethral valves&lt;/li&gt;&lt;li&gt;âž¤ PUV&lt;/li&gt;&lt;li&gt;âž¤ congenital anomaly&lt;/li&gt;&lt;li&gt;âž¤ abnormal membranous folds&lt;/li&gt;&lt;li&gt;âž¤ posterior urethra&lt;/li&gt;&lt;li&gt;âž¤ obstruction of urinary flow&lt;/li&gt;&lt;li&gt;âž¤ VCUG allows direct visualization of the urethra and bladder during voiding , enabling identification of the obstructive valves . It also provides information on the severity of obstruction and associated bladder abnormalities.&lt;/li&gt;&lt;li&gt;âž¤ VCUG allows direct visualization&lt;/li&gt;&lt;li&gt;âž¤ urethra and bladder during voiding&lt;/li&gt;&lt;li&gt;âž¤ enabling identification&lt;/li&gt;&lt;li&gt;âž¤ obstructive valves&lt;/li&gt;&lt;li&gt;âž¤ provides information on the severity of obstruction&lt;/li&gt;&lt;li&gt;âž¤ Ref : Nelson 21 st Edition, Chapter 555 Page No- From 10988.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Nelson 21 st Edition, Chapter 555 Page No- From 10988.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A pregnant woman presents for routine ultrasound at 28 weeks gestation. On examination, oligohydramnios was noted. A 4D USG reveals the findings of flattened nose, low-set ears, and limb deformities. The baby was delivered after a few weeks and the image of the baby is given below. Which of the following is the most likely diagnosis based on the history and clinical features?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Trisomy 21&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Potterâ€™s syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Patau syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Turner syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Potterâ€™s syndrome&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/23/picture7_W1JCVeh.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Potterâ€™s syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Trisomy 21 : The clinical features mentioned in this case is not consistent with Down Syndrome . In case of it there will be clinical features of intellectual disability, Mongoloid slant of eyes, large tongue and single simian crease will be mentioned.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Trisomy 21&lt;/li&gt;&lt;li&gt;â€¢ not consistent with Down Syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option C. Patau syndrome - trisomy 13 it also shows features of cleft lip and palate and VSD whereas the other symptoms are only characteristic of Potters syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Patau syndrome&lt;/li&gt;&lt;li&gt;â€¢ trisomy 13&lt;/li&gt;&lt;li&gt;â€¢ cleft lip and palate and VSD&lt;/li&gt;&lt;li&gt;â€¢ Option D. The clinical features mentioned in this case is not consistent with Turner Syndrome. In case of it there will be clinical features of short stature, widely placed nipples, shield type chest will be seen.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ not consistent with Turner Syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Ref : Nelson 20 th Edition, Page No- 2554.&lt;/li&gt;&lt;li&gt;â€¢ Ref : Nelson 20 th Edition, Page No- 2554.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A mother brings her 3-year-old girl child with complaints of fever and crying during micturition. On examination, the left side loin of the child has a mass which resolves after urination. On routine urine analysis, UTI was suspected. On asking history, the mother admits to multiple episodes of UTI. USG shows hydronephrosis and the following appearance. What is the diagnosis based on the clinical features and radiological findings?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vesicoureteric reflux&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hydronephrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ureterocele&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Posterior urethral Valve&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ureterocele&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/23/picture5_iy5W8S8.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Ureterocele&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Vesicoureteric reflux : Vesicoureteric reflux involves the retrograde flow of urine from the bladder into the ureters , often leading to recurrent UTIs and, in severe cases, hydronephrosis. However, it typically does not present with a mass in the loin that resolves after urination.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Vesicoureteric reflux&lt;/li&gt;&lt;li&gt;â€¢ retrograde flow of urine from the bladder into the ureters&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hydronephrosis : Hydronephrosis refers to the dilation of the renal pelvis and calyces due to obstruction of urinary flow . While it can be associated with ureterocele, it is not the primary diagnosis in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hydronephrosis&lt;/li&gt;&lt;li&gt;â€¢ dilation of the renal pelvis&lt;/li&gt;&lt;li&gt;â€¢ calyces&lt;/li&gt;&lt;li&gt;â€¢ obstruction of urinary flow&lt;/li&gt;&lt;li&gt;â€¢ Option D. Posterior urethral valve : Posterior urethral valve is a condition affecting male infants , leading to obstructive uropathy and features such as dribbling of urine, recurrent UTIs , and characteristic imaging findings. It is less common in female children.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Posterior urethral valve&lt;/li&gt;&lt;li&gt;â€¢ affecting male infants&lt;/li&gt;&lt;li&gt;â€¢ obstructive uropathy&lt;/li&gt;&lt;li&gt;â€¢ dribbling of urine, recurrent UTIs&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ureterocele is a congenital abnormality where the distal end of the ureter balloons within the bladder , leading to obstructive uropathy . This can result in hydronephrosis and recurrent UTIs. The characteristic ultrasound (USG) appearance often shows a cystic dilatation at the ureteric orifice within the bladder.&lt;/li&gt;&lt;li&gt;âž¤ Ureterocele is a congenital abnormality&lt;/li&gt;&lt;li&gt;âž¤ distal end of the ureter balloons within the bladder&lt;/li&gt;&lt;li&gt;âž¤ obstructive uropathy&lt;/li&gt;&lt;li&gt;âž¤ hydronephrosis and recurrent UTIs.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Nelson 21 st Edition page 10987&lt;/li&gt;&lt;li&gt;âž¤ Ref : Nelson 21 st Edition&lt;/li&gt;&lt;li&gt;âž¤ page 10987&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 11-year-old boy presents to the emergency department with complaints of severe pain and swelling in his scrotum. On examination, his right testicle is found to be tender, high-riding, and horizontal. A preliminary diagnosis of testicular torsion was made. Which of the following clinical features is most commonly associated with testicular torsion in children?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pain that improves with elevation of the affected testicle&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nausea and vomiting&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Absent cremasteric reflex&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Scrotal erythema and warmth&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Absent cremasteric reflex&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Absent cremasteric reflex&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pain that improves with elevation of the affected testicle : This is not typically observed in testicular torsion . Elevation of the testicle may worsen the pain due to further compromise of blood flow.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pain that improves with elevation of the affected testicle&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ testicular torsion&lt;/li&gt;&lt;li&gt;â€¢ Prehnâ€™s sign positivity which is seen in case of Epididymoorchitis.&lt;/li&gt;&lt;li&gt;â€¢ Prehnâ€™s sign positivity&lt;/li&gt;&lt;li&gt;â€¢ Epididymoorchitis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Nausea : While nausea can occur with testicular torsion due to severe pain , they are not specific to this condition and can be seen in various other causes of acute scrotal pain.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Nausea&lt;/li&gt;&lt;li&gt;â€¢ testicular torsion due to severe pain&lt;/li&gt;&lt;li&gt;â€¢ Option D. Scrotal erythema and warmth : Scrotal erythema and warmth may be present in cases of epididymitis or orchitis , which are inflammatory conditions of the scrotum, but they are not typically seen in testicular torsion.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Scrotal erythema and warmth&lt;/li&gt;&lt;li&gt;â€¢ present in cases of epididymitis or orchitis&lt;/li&gt;&lt;li&gt;â€¢ inflammatory conditions of the scrotum,&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Testicular torsion is a surgical emergency characterized by the twisting of the spermatic cord , leading to compromised blood flow to the testicle .&lt;/li&gt;&lt;li&gt;â€¢ Testicular torsion&lt;/li&gt;&lt;li&gt;â€¢ surgical emergency&lt;/li&gt;&lt;li&gt;â€¢ twisting of the spermatic cord&lt;/li&gt;&lt;li&gt;â€¢ compromised blood flow to the testicle&lt;/li&gt;&lt;li&gt;â€¢ Clinical features commonly associated with testicular torsion include sudden onset severe testicular pain, swelling, tenderness, and a high-riding, horizontal orientation of the affected testicle.&lt;/li&gt;&lt;li&gt;â€¢ Clinical features&lt;/li&gt;&lt;li&gt;â€¢ testicular torsion&lt;/li&gt;&lt;li&gt;â€¢ The cremasteric reflex , which normally causes elevation of the testicle upon stroking the inner thigh , is typically absent in cases of testicular torsion due to the compromised blood supply.&lt;/li&gt;&lt;li&gt;â€¢ cremasteric reflex&lt;/li&gt;&lt;li&gt;â€¢ elevation of the testicle upon stroking the inner thigh&lt;/li&gt;&lt;li&gt;â€¢ Ref : Nelson 21st Edition, Chapter 560 Page No- From 11092- 11096.&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Nelson 21st Edition, Chapter 560 Page No- From 11092- 11096.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A mother seeks medical attention for her 2-month-old son, who has been experiencing abdominal distension, constipation, and difficulty urinating since birth. During the physical examination, the physician notes the infant&#x27;s abdomen is significantly distended and there is an apparent absence of abdominal muscles. Additionally, the child presents with an empty scrotum due to bilateral undescended testes. Based on the clinical presentation and the physical features observed, what is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prune belly syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bladder exstrophy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypospadiasis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Posterior urethral valves&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Prune belly syndrome&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/23/picture8_6E0qKof.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Prune belly syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bladder exstrophy : It involves the abnormal development and exposure of the bladder to the outside of the body , not typically associated with the absence of abdominal muscles or undescended testes.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bladder exstrophy&lt;/li&gt;&lt;li&gt;â€¢ abnormal development and exposure of the bladder to the outside of the body&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hypospadias : A congenital condition where the opening of the urethra is on the underside of the penis , not at the tip. It does not involve abdominal distension, absence of abdominal muscles, or undescended testes.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hypospadias&lt;/li&gt;&lt;li&gt;â€¢ congenital condition&lt;/li&gt;&lt;li&gt;â€¢ opening of the urethra is on the underside of the penis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Posterior urethral valves : A condition that causes obstruction of urine flow in male infants , but it is not associated with the absence of abdominal muscles or the abdominal findings described.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Posterior urethral valves&lt;/li&gt;&lt;li&gt;â€¢ causes obstruction of urine flow in male infants&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Prune belly syndrome/ Eagle-Barrett syndrome , is characterized by a triad that includes the absence of abdominal muscles, undescended testes , and urinary tract anomalies .&lt;/li&gt;&lt;li&gt;âž¤ Prune belly syndrome/ Eagle-Barrett syndrome&lt;/li&gt;&lt;li&gt;âž¤ triad&lt;/li&gt;&lt;li&gt;âž¤ absence of abdominal muscles, undescended testes&lt;/li&gt;&lt;li&gt;âž¤ urinary tract anomalies&lt;/li&gt;&lt;li&gt;âž¤ Ref : Nelson 21 st Edition page 2749&lt;/li&gt;&lt;li&gt;âž¤ Ref : Nelson 21 st Edition page 2749&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 4-year-old boy is brought to a pediatric outpatient department in a tertiary care hospital in India by his mother, who is concerned that her son has never passed urine from the tip of his penis. The child has otherwise been healthy with no significant medical history. On physical examination, the urethral orifice is not located at the usual position at the tip of the penis. The rest of the genital examination shows normal testicular descent and no other abnormalities. Which among the following is the most common congenital urethral anomaly?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Epispadias&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Urethral stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bladder exstrophy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypospadias&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hypospadias&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Hypospadias&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Epispadias : This is a less common condition where the urethral opening is on the upper surface of the penis . It often presents with more severe anatomical anomalies and can be associated with bladder exstrophy.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Epispadias&lt;/li&gt;&lt;li&gt;â€¢ less common condition&lt;/li&gt;&lt;li&gt;â€¢ urethral opening is on the upper surface of the penis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Urethral stenosis : This involves a narrowing of the urethra , which can lead to difficulty urinating but does not involve abnormal placement of the urethral opening.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Urethral stenosis&lt;/li&gt;&lt;li&gt;â€¢ narrowing of the urethra&lt;/li&gt;&lt;li&gt;â€¢ lead to difficulty urinating&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bladder exstrophy : A rare congenital condition where the bladder and associated structures are exposed outside the abdomen . It is usually noticeable immediately after birth due to the visible bladder tissue and associated abnormalities.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Bladder exstrophy&lt;/li&gt;&lt;li&gt;â€¢ rare congenital condition&lt;/li&gt;&lt;li&gt;â€¢ bladder&lt;/li&gt;&lt;li&gt;â€¢ structures are exposed outside the abdomen&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hypospadias is the most common congenital urethral anomaly and management involves surgical repair.&lt;/li&gt;&lt;li&gt;âž¤ most common congenital urethral anomaly and&lt;/li&gt;&lt;li&gt;âž¤ Ref : Nelson 21 st Edition, Page No- 1063.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Nelson 21 st Edition, Page No- 1063.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A mother brings her 8-year-old boy with complaints of bedwetting. On asking history, she informs that he does about 3 to 4 times per week. On further evaluation, he has a normal urine stream, daytime urine continence, and no history of UTIs. His physical examination is normal. Which of the following is the most appropriate next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ultrasound of abdomen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Reassurance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Use of enuresis alarm&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Desmopressin acetate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Use of enuresis alarm&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Use of enuresis alarm&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ultrasound of abdomen : Routine ultrasound of the abdomen is not indicated in the initial evaluation of primary nocturnal enuresis without other concerning symptoms or signs.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ultrasound of abdomen&lt;/li&gt;&lt;li&gt;â€¢ Routine ultrasound&lt;/li&gt;&lt;li&gt;â€¢ abdomen is not indicated in the initial evaluation of primary nocturnal enuresis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Reassurance : While reassurance is an important aspect of management, it alone may not be sufficient for addressing primary nocturnal enuresis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Reassurance&lt;/li&gt;&lt;li&gt;â€¢ alone may not be sufficient for addressing primary nocturnal enuresis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Desmopressin acetate : Desmopressin acetate, a synthetic form of antidiuretic hormone (ADH), is another treatment option for primary nocturnal enuresis , particularly for children who do not respond to behavioral interventions such as enuresis alarms or who need additional help in achieving dry nights . However, it is typically reserved for cases where behavioral therapy has failed.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Desmopressin acetate&lt;/li&gt;&lt;li&gt;â€¢ synthetic form of antidiuretic hormone&lt;/li&gt;&lt;li&gt;â€¢ primary nocturnal enuresis&lt;/li&gt;&lt;li&gt;â€¢ children&lt;/li&gt;&lt;li&gt;â€¢ behavioral interventions such as enuresis alarms&lt;/li&gt;&lt;li&gt;â€¢ achieving dry nights&lt;/li&gt;&lt;li&gt;â€¢ behavioral therapy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Nocturnal enuresis occurs in 15% of 5-year-olds with a resolution rate of 15% per year . Males are more frequently affected, and family history is common . Initial evaluation includes a history of wetting pattern, prior UTI, and developmental, social, and emotional history.&lt;/li&gt;&lt;li&gt;âž¤ Nocturnal enuresis&lt;/li&gt;&lt;li&gt;âž¤ 15% of 5-year-olds&lt;/li&gt;&lt;li&gt;âž¤ resolution rate of 15% per year&lt;/li&gt;&lt;li&gt;âž¤ Males&lt;/li&gt;&lt;li&gt;âž¤ affected, and family history is common&lt;/li&gt;&lt;li&gt;âž¤ The enuresis alarm has a success rate of 70% to 90% and requires parental support. Pharmacologic interventions include nighttime doses of imipramine or oral desmopressin acetate. Following use of desmopressin acetate, fluid intake is restricted to avoid hyponatremia. Pharmacologic treatment usually is reserved for special occasions.&lt;/li&gt;&lt;li&gt;âž¤ The enuresis alarm has a success rate of 70% to 90% and requires parental support.&lt;/li&gt;&lt;li&gt;âž¤ Pharmacologic interventions include nighttime doses of imipramine or oral desmopressin acetate.&lt;/li&gt;&lt;li&gt;âž¤ Following use of desmopressin acetate, fluid intake is restricted to avoid hyponatremia.&lt;/li&gt;&lt;li&gt;âž¤ Pharmacologic treatment usually is reserved for special occasions.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Nelson 21 st Edition, Chapter 558 Page No- From 11044.&lt;/li&gt;&lt;li&gt;âž¤ Ref :&lt;/li&gt;&lt;li&gt;âž¤ Nelson 21 st Edition, Chapter 558 Page No- From 11044.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 24 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test13" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Respiratory System&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Respiratory System&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                102 Questions | 408 Total Marks | 112 min Duration | ~65.88 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;â€‹â€‹â€‹â€‹â€‹ A 36-year-old male presents to clinic for a routine health check-up. He has no significant past medical history and leads an active lifestyle. During his respiratory examination, you note the following parameters: His respiratory rate is 16 breaths per minute, tidal volume is measured at 400 mL, and dead space volume is estimated to be 150 mL. What is the patient&#x27;s alveolar ventilation per minute?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;25 mL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;400 mL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;4000 mL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;6400 mL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 4000 mL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/screenshot-2024-02-26-145036.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 4000 mL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ The alveolar ventilation per minute can be defined as the total volume of new air entering the alveoli in one minute . The alveolar ventilation per minute can be expressed as Alveolar ventilation per min = (Tidal volume - dead space) x rate of respiration Here, tidal volume = 400 mL, respiratory rate = 16/min Dead space volume = 150 mL Alveolar ventilation /min = (400 - 150) x 16 = 250 x 16 = 4000 mL&lt;/li&gt;&lt;li&gt;â€¢ The alveolar ventilation per minute can be defined as the total volume of new air entering the alveoli in one minute .&lt;/li&gt;&lt;li&gt;â€¢ alveolar ventilation&lt;/li&gt;&lt;li&gt;â€¢ per minute&lt;/li&gt;&lt;li&gt;â€¢ total volume&lt;/li&gt;&lt;li&gt;â€¢ air&lt;/li&gt;&lt;li&gt;â€¢ alveoli&lt;/li&gt;&lt;li&gt;â€¢ one minute&lt;/li&gt;&lt;li&gt;â€¢ The alveolar ventilation per minute can be expressed as Alveolar ventilation per min = (Tidal volume - dead space) x rate of respiration Here, tidal volume = 400 mL, respiratory rate = 16/min Dead space volume = 150 mL Alveolar ventilation /min = (400 - 150) x 16 = 250 x 16 = 4000 mL&lt;/li&gt;&lt;li&gt;â€¢ Alveolar ventilation per min = (Tidal volume - dead space) x rate of respiration Here, tidal volume = 400 mL, respiratory rate = 16/min Dead space volume = 150 mL Alveolar ventilation /min = (400 - 150) x 16 = 250 x 16 = 4000 mL&lt;/li&gt;&lt;li&gt;â€¢ Alveolar ventilation per min = (Tidal volume - dead space) x rate of respiration&lt;/li&gt;&lt;li&gt;â€¢ Here, tidal volume = 400 mL, respiratory rate = 16/min&lt;/li&gt;&lt;li&gt;â€¢ tidal volume&lt;/li&gt;&lt;li&gt;â€¢ Dead space volume = 150 mL&lt;/li&gt;&lt;li&gt;â€¢ Dead space&lt;/li&gt;&lt;li&gt;â€¢ Alveolar ventilation /min = (400 - 150) x 16 = 250 x 16 = 4000 mL&lt;/li&gt;&lt;li&gt;â€¢ Alveolar ventilation&lt;/li&gt;&lt;li&gt;â€¢ #Extra edge: Types of Dead Spaces â€“&lt;/li&gt;&lt;li&gt;â€¢ #Extra edge: Types of Dead Spaces&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand and accurately calculate alveolar ventilation rates using patient respiratory parameters .&lt;/li&gt;&lt;li&gt;âž¤ Understand and accurately calculate alveolar ventilation rates using patient respiratory parameters .&lt;/li&gt;&lt;li&gt;âž¤ respiratory parameters&lt;/li&gt;&lt;li&gt;âž¤ Ref: Guyton and Hall Textbook of Medical Physiology, 2 nd South Asia Edition, Pg No: 34&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Guyton and Hall Textbook of Medical Physiology, 2 nd South Asia Edition, Pg No: 34&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old male presents to the emergency department with a four-week history of progressive breathlessness. He reports episodes of wheezing, especially at night and early in the morning. His past medical history includes occasional allergic rhinitis but no prior episodes of similar symptoms. On physical examination, you note expiratory wheezing bilaterally. He denies any history of smoking. A spirometry test is conducted diagnosis of bronchial asthma was made. Based on the clinical presentation and diagnosis, which of the following spirometry findings is most likely in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decreased FEV1, Increased FEV 1 /FVC&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased FEV1, Decreased FEV 1 /FVC&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased FEV1, Decreased FEV 1 /FVC&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Normal FEV1, Increased FEV 1 /FVC&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Decreased FEV1, Decreased FEV 1 /FVC&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-06-06%20125136.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Decreased FEV1, Decreased FEV1/FVC&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize decreased FVC and decreased FEV1/FVC ratio in spirometry as indicative of bronchial asthma in symptomatic patients.&lt;/li&gt;&lt;li&gt;âž¤ Recognize decreased FVC and decreased FEV1/FVC ratio in spirometry as indicative of bronchial asthma in symptomatic patients.&lt;/li&gt;&lt;li&gt;âž¤ Recognize decreased FVC and decreased FEV1/FVC ratio in spirometry as indicative of bronchial asthma in symptomatic patients.&lt;/li&gt;&lt;li&gt;âž¤ decreased FVC&lt;/li&gt;&lt;li&gt;âž¤ decreased FEV1/FVC&lt;/li&gt;&lt;li&gt;âž¤ spirometry&lt;/li&gt;&lt;li&gt;âž¤ bronchial asthma&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg No: 630&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg No: 630&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman presents to your clinic for a routine physical examination. She is a non-smoker and has no significant past medical history. During her respiratory assessment, you decide to evaluate her lung volumes and capacities as part of a complete pulmonary function test. What is the expected normal Inspiratory Reserve Volume (IRV) in this Healthy Adult Female?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;500 mL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1000 mL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1500 mL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;3000 mL&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 3000 mL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/screenshot-2024-02-26-145612.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) 3000 mL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Inspiratory Reserve Volume (IRV) is a term used in pulmonary physiology to describe the additional amount of air that can be inhaled after a normal tidal inhalation. Essentially, it&#x27;s the extra volume of air that a person can draw into their lungs above the regular , relaxed inhalation. IRV is one component of lung volumes , which are typically measured during pulmonary function tests . In healthy adults, the IRV can vary based on factors such as age , gender , body size , and physical condition . On average: For adult males , the IRV is typically around 3000 to 3300 milliliters (mL) . For adult females , the IRV is usually slightly less , ranging from about 1900 to 2100 mL.&lt;/li&gt;&lt;li&gt;â€¢ Inspiratory Reserve Volume (IRV) is a term used in pulmonary physiology to describe the additional amount of air that can be inhaled after a normal tidal inhalation. Essentially, it&#x27;s the extra volume of air that a person can draw into their lungs above the regular , relaxed inhalation. IRV is one component of lung volumes , which are typically measured during pulmonary function tests .&lt;/li&gt;&lt;li&gt;â€¢ Inspiratory Reserve Volume (IRV)&lt;/li&gt;&lt;li&gt;â€¢ pulmonary physiology&lt;/li&gt;&lt;li&gt;â€¢ inhaled&lt;/li&gt;&lt;li&gt;â€¢ normal tidal inhalation.&lt;/li&gt;&lt;li&gt;â€¢ extra volume&lt;/li&gt;&lt;li&gt;â€¢ draw&lt;/li&gt;&lt;li&gt;â€¢ lungs above&lt;/li&gt;&lt;li&gt;â€¢ regular&lt;/li&gt;&lt;li&gt;â€¢ relaxed inhalation.&lt;/li&gt;&lt;li&gt;â€¢ lung volumes&lt;/li&gt;&lt;li&gt;â€¢ pulmonary function tests&lt;/li&gt;&lt;li&gt;â€¢ In healthy adults, the IRV can vary based on factors such as age , gender , body size , and physical condition .&lt;/li&gt;&lt;li&gt;â€¢ age&lt;/li&gt;&lt;li&gt;â€¢ gender&lt;/li&gt;&lt;li&gt;â€¢ body size&lt;/li&gt;&lt;li&gt;â€¢ physical condition&lt;/li&gt;&lt;li&gt;â€¢ On average: For adult males , the IRV is typically around 3000 to 3300 milliliters (mL) . For adult females , the IRV is usually slightly less , ranging from about 1900 to 2100 mL.&lt;/li&gt;&lt;li&gt;â€¢ For adult males , the IRV is typically around 3000 to 3300 milliliters (mL) . For adult females , the IRV is usually slightly less , ranging from about 1900 to 2100 mL.&lt;/li&gt;&lt;li&gt;â€¢ For adult males , the IRV is typically around 3000 to 3300 milliliters (mL) .&lt;/li&gt;&lt;li&gt;â€¢ males&lt;/li&gt;&lt;li&gt;â€¢ around 3000&lt;/li&gt;&lt;li&gt;â€¢ 3300 milliliters (mL)&lt;/li&gt;&lt;li&gt;â€¢ For adult females , the IRV is usually slightly less , ranging from about 1900 to 2100 mL.&lt;/li&gt;&lt;li&gt;â€¢ females&lt;/li&gt;&lt;li&gt;â€¢ less&lt;/li&gt;&lt;li&gt;â€¢ about 1900&lt;/li&gt;&lt;li&gt;â€¢ 2100 mL.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Determine the normal range of Inspiratory Reserve Volume (IRV) in healthy adult females, recognizing 3000 mL as a typical upper value.&lt;/li&gt;&lt;li&gt;âž¤ Determine the normal range of Inspiratory Reserve Volume (IRV) in healthy adult females, recognizing 3000 mL as a typical upper value.&lt;/li&gt;&lt;li&gt;âž¤ normal range&lt;/li&gt;&lt;li&gt;âž¤ Inspiratory Reserve Volume (IRV)&lt;/li&gt;&lt;li&gt;âž¤ recognizing 3000 mL&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg No: 629&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg No: 629&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A pulmonologist is assessing the respiratory function of a 30-year-old male athlete and measures the maximal voluntary ventilation (MVV). The doctor asks his medical students to estimate the normal value of MVV in a healthy adult male. During the assessment, subject moves 40 liters of air in and out of her lungs with maximum effort over 15 seconds. What is her MVV (in liters per minute)? Which of the following is the correct value?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;40 L/min&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;80 L/min&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;120 L/min&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;160 L/min&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 160 L/min&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) 160 L/min&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The maximal voluntary ventilation can be defined as the largest volume of air that can be moved inside and outside the lungs in one minute by means of voluntary effort of respiration&lt;/li&gt;&lt;li&gt;â€¢ The maximal voluntary ventilation can be defined as the largest volume of air that can be moved inside and outside the lungs in one minute by means of voluntary effort of respiration&lt;/li&gt;&lt;li&gt;â€¢ The maximal voluntary ventilation can be defined as the largest volume of air that can be moved inside and outside the lungs in one minute by means of voluntary effort of respiration&lt;/li&gt;&lt;li&gt;â€¢ maximal voluntary ventilation&lt;/li&gt;&lt;li&gt;â€¢ largest volume&lt;/li&gt;&lt;li&gt;â€¢ air&lt;/li&gt;&lt;li&gt;â€¢ inside&lt;/li&gt;&lt;li&gt;â€¢ outside&lt;/li&gt;&lt;li&gt;â€¢ one minute&lt;/li&gt;&lt;li&gt;â€¢ voluntary effort&lt;/li&gt;&lt;li&gt;â€¢ respiration&lt;/li&gt;&lt;li&gt;â€¢ In the given example&lt;/li&gt;&lt;li&gt;â€¢ In the given example&lt;/li&gt;&lt;li&gt;â€¢ Air moved in 15 seconds = 40 L&lt;/li&gt;&lt;li&gt;â€¢ Air moved in 15 seconds = 40 L&lt;/li&gt;&lt;li&gt;â€¢ Air moved in 15 seconds = 40 L&lt;/li&gt;&lt;li&gt;â€¢ Hence, in one minute the MVV = 40 L/15 sec Ã— 60 =160 L/min&lt;/li&gt;&lt;li&gt;â€¢ Hence, in one minute the MVV = 40 L/15 sec Ã— 60&lt;/li&gt;&lt;li&gt;â€¢ =160 L/min&lt;/li&gt;&lt;li&gt;â€¢ Among the options given, Option D. 160 L/min will be the appropriate one , rest all Option A, Option B and Option C are incorrect.&lt;/li&gt;&lt;li&gt;â€¢ Among the options given, Option D.&lt;/li&gt;&lt;li&gt;â€¢ , rest all Option A, Option B and Option C are incorrect.&lt;/li&gt;&lt;li&gt;â€¢ The normal range for Maximal Voluntary Ventilation (MVV) varies depending on factors like age, sex, and body size, exercise or physical training but generally falls within the range of 50â€“250 L/min. A healthy, fit young male adult might have an MVV of around 140 - 170 L/min.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The objective of this question is to understand the concept of maximal voluntary ventilation (MVV) and its normal value in a healthy adult male, which is important in assessing lung function and respiratory muscle strength .&lt;/li&gt;&lt;li&gt;âž¤ The objective of this question is to understand the concept of maximal voluntary ventilation (MVV) and its normal value in a healthy adult male, which is important in assessing lung function and respiratory muscle strength .&lt;/li&gt;&lt;li&gt;âž¤ The objective of this question is to understand the concept of maximal voluntary ventilation (MVV) and its normal value in a healthy adult male, which is important in assessing lung function and respiratory muscle strength .&lt;/li&gt;&lt;li&gt;âž¤ concept&lt;/li&gt;&lt;li&gt;âž¤ maximal voluntary ventilation (MVV)&lt;/li&gt;&lt;li&gt;âž¤ assessing lung function&lt;/li&gt;&lt;li&gt;âž¤ respiratory muscle strength&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganongâ€™s Review of Medical Physiology, 25th Edition, Pg No: 629&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganongâ€™s Review of Medical Physiology, 25th Edition, Pg No: 629&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a respiratory physiology class, a medical professor presents a clinical scenario to test the students&#x27; understanding of lung volumes. He asks, \&quot;Which of the following equations correctly represents tidal volume?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inspiratory Capacity â€“ Expiratory Reserve Volume&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inspiratory Reserve Volume â€“ Expiratory Reserve Volume&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inspiratory Capacity â€“ Inspiratory Reserve Volume&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Expiratory Reserve Volume â€“ Residual Volume&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Inspiratory Capacity â€“ Inspiratory Reserve Volume&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/screenshot-2024-02-26-145652.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Inspiratory Capacity â€“ Inspiratory Reserve Volume&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Inspiratory Capacity (IC) includes Tidal Volume ( TV ) and Inspiratory Reserve Volume ( IRV ). Subtracting Expiratory Reserve Volume ( ERV ) from IC does not yield TV.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Tidal Volume&lt;/li&gt;&lt;li&gt;â€¢ TV&lt;/li&gt;&lt;li&gt;â€¢ IRV&lt;/li&gt;&lt;li&gt;â€¢ ERV&lt;/li&gt;&lt;li&gt;â€¢ IC&lt;/li&gt;&lt;li&gt;â€¢ Option B. Subtracting ERV from IRV does not give TV. TV is the volume of air inhaled or exhaled in a normal breath .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ TV&lt;/li&gt;&lt;li&gt;â€¢ volume&lt;/li&gt;&lt;li&gt;â€¢ air&lt;/li&gt;&lt;li&gt;â€¢ inhaled&lt;/li&gt;&lt;li&gt;â€¢ exhaled&lt;/li&gt;&lt;li&gt;â€¢ normal breath&lt;/li&gt;&lt;li&gt;â€¢ Option D. Subtracting Residual Volume (RV) from ERV does not provide TV. RV is the volume of air remaining in the lungs after a maximal exhalation .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ RV&lt;/li&gt;&lt;li&gt;â€¢ volume&lt;/li&gt;&lt;li&gt;â€¢ air&lt;/li&gt;&lt;li&gt;â€¢ lungs&lt;/li&gt;&lt;li&gt;â€¢ after&lt;/li&gt;&lt;li&gt;â€¢ maximal exhalation&lt;/li&gt;&lt;li&gt;â€¢ Tidal Volume = Inspiratory Capacity â€“ Inspiratory Reserve Volume (TV = IC â€“ IRV)&lt;/li&gt;&lt;li&gt;â€¢ Tidal Volume = Inspiratory Capacity â€“ Inspiratory Reserve Volume (TV = IC â€“ IRV)&lt;/li&gt;&lt;li&gt;â€¢ Tidal Volume = Inspiratory Capacity â€“ Inspiratory Reserve Volume (TV = IC â€“ IRV)&lt;/li&gt;&lt;li&gt;â€¢ #Extra Edge: Definitions and normal values of various lung volumes and capacities:&lt;/li&gt;&lt;li&gt;â€¢ #Extra Edge:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The objective of this question is to assess understanding of lung volumes and capacities , particularly the calculation of tidal volume within the context of respiratory physiology.&lt;/li&gt;&lt;li&gt;âž¤ understanding&lt;/li&gt;&lt;li&gt;âž¤ lung volumes&lt;/li&gt;&lt;li&gt;âž¤ capacities&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 629&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 629&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male with a history of smoking for 10 years presented to OPD for regular checkup. He is asymptomatic but concerned about his lung health due to his smoking history. A physiciandecides to conduct a pulmonary function test to assess his lung volumes and capacities. Which lung volume measurement represents the total amount of air that can be exhaled after a maximal inhalation.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Total Lung Capacity (TLC)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vital Capacity (VC)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Residual Volume (RV)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Functional Residual Capacity (FRC)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Vital Capacity (VC)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/01.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Vital capacity&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The vital capacity (VC) can be defined as the maximal volume of air expired from maximal inspiratory level and will be equal to the sum of tidal volume (TV), inspiratory reserve volume (IRV) and expiratory reserve volume (ERV). Lung volumes and capacity measurements. Lung volumes recorded by a spirometer . Lung capacities are determined from volume recordings .&lt;/li&gt;&lt;li&gt;â€¢ The vital capacity (VC) can be defined as the maximal volume of air expired from maximal inspiratory level and will be equal to the sum of tidal volume (TV), inspiratory reserve volume (IRV) and expiratory reserve volume (ERV).&lt;/li&gt;&lt;li&gt;â€¢ maximal volume&lt;/li&gt;&lt;li&gt;â€¢ expired&lt;/li&gt;&lt;li&gt;â€¢ maximal inspiratory level&lt;/li&gt;&lt;li&gt;â€¢ equal&lt;/li&gt;&lt;li&gt;â€¢ sum&lt;/li&gt;&lt;li&gt;â€¢ tidal volume&lt;/li&gt;&lt;li&gt;â€¢ inspiratory reserve volume&lt;/li&gt;&lt;li&gt;â€¢ expiratory reserve volume&lt;/li&gt;&lt;li&gt;â€¢ Lung volumes and capacity measurements. Lung volumes recorded by a spirometer . Lung capacities are determined from volume recordings .&lt;/li&gt;&lt;li&gt;â€¢ Lung volumes and capacity measurements.&lt;/li&gt;&lt;li&gt;â€¢ spirometer&lt;/li&gt;&lt;li&gt;â€¢ volume recordings&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Identify Vital Capacity as the lung volume measurement indicating the total amount of air exhaled after a maximal inhalation .&lt;/li&gt;&lt;li&gt;âž¤ Identify Vital Capacity as the lung volume measurement indicating the total amount of air exhaled after a maximal inhalation .&lt;/li&gt;&lt;li&gt;âž¤ Vital Capacity&lt;/li&gt;&lt;li&gt;âž¤ lung volume measurement&lt;/li&gt;&lt;li&gt;âž¤ total amount&lt;/li&gt;&lt;li&gt;âž¤ air exhaled&lt;/li&gt;&lt;li&gt;âž¤ maximal inhalation&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 629&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 629&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old male presents to your clinic for a routine physical examination. He is a non-smoker with no significant past medical history. As part of the examination, you perform a spirometry test. The results show a tidal volume of 460 mL and an inspiratory capacity of 3380 mL. He also has a known expiratory reserve volume of 1060 mL. Calculate his IRV.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;600 mL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1520 mL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;2920 mL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;3840 mL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 2920 mL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 2920 mL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The additional volume of air that can be inspired above the tidal respiration is termed as Inspiratory Reserve Volume (IRV) The Inspiratory Capacity (IC) can be defined as the sum of the tidal volume ( TV ) and the inspiratory reserve volume (IRV)&lt;/li&gt;&lt;li&gt;â€¢ The additional volume of air that can be inspired above the tidal respiration is termed as Inspiratory Reserve Volume (IRV)&lt;/li&gt;&lt;li&gt;â€¢ additional volume&lt;/li&gt;&lt;li&gt;â€¢ air&lt;/li&gt;&lt;li&gt;â€¢ above&lt;/li&gt;&lt;li&gt;â€¢ tidal respiration&lt;/li&gt;&lt;li&gt;â€¢ Inspiratory Reserve Volume&lt;/li&gt;&lt;li&gt;â€¢ The Inspiratory Capacity (IC) can be defined as the sum of the tidal volume ( TV ) and the inspiratory reserve volume (IRV)&lt;/li&gt;&lt;li&gt;â€¢ Inspiratory Capacity&lt;/li&gt;&lt;li&gt;â€¢ sum&lt;/li&gt;&lt;li&gt;â€¢ tidal volume&lt;/li&gt;&lt;li&gt;â€¢ TV&lt;/li&gt;&lt;li&gt;â€¢ inspiratory reserve volume&lt;/li&gt;&lt;li&gt;â€¢ Here, tidal volume = 460 mL,&lt;/li&gt;&lt;li&gt;â€¢ tidal volume&lt;/li&gt;&lt;li&gt;â€¢ inspiratory capacity = 3380 mL&lt;/li&gt;&lt;li&gt;â€¢ inspiratory capacity&lt;/li&gt;&lt;li&gt;â€¢ IC = TV + IRV&lt;/li&gt;&lt;li&gt;â€¢ IRV = IC â€“ TV = 3380 - 460 = 2920 mL&lt;/li&gt;&lt;li&gt;â€¢ # Lung volumes and capacity measurements . Lung volumes recorded by a spirometer . Lung capacities are determined from volume recordings .&lt;/li&gt;&lt;li&gt;â€¢ Lung volumes&lt;/li&gt;&lt;li&gt;â€¢ capacity measurements&lt;/li&gt;&lt;li&gt;â€¢ spirometer&lt;/li&gt;&lt;li&gt;â€¢ volume recordings&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Inspiratory Capacity (IC) can be defined as the sum of the Tidal Volume (TV) and the Inspiratory Reserve Volume (IRV)&lt;/li&gt;&lt;li&gt;âž¤ Inspiratory Capacity (IC) can be defined as the sum of the Tidal Volume (TV) and the Inspiratory Reserve Volume (IRV)&lt;/li&gt;&lt;li&gt;âž¤ Inspiratory Capacity&lt;/li&gt;&lt;li&gt;âž¤ sum&lt;/li&gt;&lt;li&gt;âž¤ Tidal Volume&lt;/li&gt;&lt;li&gt;âž¤ Inspiratory Reserve Volume&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 629&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 629&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male with a history of chronic obstructive pulmonary disease (COPD) undergoes spirometry to assess his lung function. Based on the spirometry results, the physician asks the medical students to calculate a specific lung capacity or volume. Which of the following represents the correct calculation or interpretation of lung volumes and capacities in this clinical context?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vital Capacity = Tidal Volume + Inspiratory Reserve Volume + Expiratory Capacity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Total Lung Capacity = Vital Capacity + Expiratory Reserve Volume&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Functional Residual Capacity = Expiratory Reserve Volume + Residual Volume&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inspiratory Capacity = Total Lung Capacity - Residual Volume&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Functional Residual Capacity = Expiratory Reserve Volume + Residual Volume&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Functional Residual Capacity = Expiratory Reserve Volume + Residual Volume&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A . incorrect as the Vital Capacity = Tidal Volume + Inspiratory Reserve Volume + Expiratory Reserve Volume ( Not Expiratory Capacity): Vital Capacity (VC) is the maximum volume of air a person can exhale after a maximum inhalation, which is indeed the sum of TV, IRV, and ERV.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ Option B . incorrect as the Total Lung Capacity = Vital Capacity + Residual Volume (Not Expiratory Reserve Volume): Total Lung Capacity (TLC) is the total volume of air in the lungs after a maximal inspiration, which includes VC and RV. This statement is also correct.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Option D . incorrect as the Inspiratory Capacity = Total Lung Capacity - Functional Residual Capacity ( Not Residual Volume): Inspiratory Capacity (IC) is the maximum volume of air that can be inhaled from the end-expiratory position, not TLC minus FRC.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The objective of this question is to test understanding of lung volumes and capacities, particularly in a clinical setting involving a patient with a respiratory condition like COPD.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 54-year-old male presents to the medicine outpatient department with persistent cough, breathlessness, and recent unexplained weight loss. His medical history is significant for long-term exposure to environmental pollutants. After thorough evaluation, he is diagnosed with pulmonary fibrosis. Which of the following pulmonary function test findings is most likely to be observed in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decreased FVC, Normal FEV 1 /FVC&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increased FVC, Increased FEV 1 /FVC&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreased FVC, Decreased FEV 1 /FVC&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased FVC, Normal FEV 1 /FVC&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Decreased FVC, Normal FEV 1 /FVC&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/screenshot-2024-02-26-145453_QA89ZD1.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Decreased FVC, Normal FEV1/FVC&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ This is a case of pulmonary fibrosis , which is a restrictive lung disease FVC refers to forced vital capacity, i.e. i.e. the total amount of air coming out of the lung in during quick and forceful expiration after maximum inspiration FEV refers to forced expiratory volume and FEV1 refers to forced expiratory volume in the first second i.e. amount of air coming out of the lung in 1st second during quick and forceful expiration after maximum inspiration. In restrictive lung diseases, the FVC will be decreased, but the ratio of FEV1/FVC will be normal or even increased, especially in severe condition due to drastic reduction in the FVC This can be used to differentiate between the obstructive and restrictive lung diseases . Lung disease measurements:&lt;/li&gt;&lt;li&gt;â€¢ This is a case of pulmonary fibrosis , which is a restrictive lung disease&lt;/li&gt;&lt;li&gt;â€¢ This is a case of pulmonary fibrosis , which is a restrictive lung disease&lt;/li&gt;&lt;li&gt;â€¢ pulmonary fibrosis&lt;/li&gt;&lt;li&gt;â€¢ restrictive lung disease&lt;/li&gt;&lt;li&gt;â€¢ FVC refers to forced vital capacity, i.e. i.e. the total amount of air coming out of the lung in during quick and forceful expiration after maximum inspiration FEV refers to forced expiratory volume and FEV1 refers to forced expiratory volume in the first second i.e. amount of air coming out of the lung in 1st second during quick and forceful expiration after maximum inspiration.&lt;/li&gt;&lt;li&gt;â€¢ FVC refers to forced vital capacity, i.e. i.e. the total amount of air coming out of the lung in during quick and forceful expiration after maximum inspiration FEV refers to forced expiratory volume and FEV1 refers to forced expiratory volume in the first second i.e. amount of air coming out of the lung in 1st second during quick and forceful expiration after maximum inspiration.&lt;/li&gt;&lt;li&gt;â€¢ In restrictive lung diseases, the FVC will be decreased, but the ratio of FEV1/FVC will be normal or even increased, especially in severe condition due to drastic reduction in the FVC&lt;/li&gt;&lt;li&gt;â€¢ In restrictive lung diseases, the FVC will be decreased, but the ratio of FEV1/FVC will be normal or even increased, especially in severe condition due to drastic reduction in the FVC&lt;/li&gt;&lt;li&gt;â€¢ This can be used to differentiate between the obstructive and restrictive lung diseases .&lt;/li&gt;&lt;li&gt;â€¢ This can be used to differentiate between the obstructive and restrictive lung diseases .&lt;/li&gt;&lt;li&gt;â€¢ obstructive&lt;/li&gt;&lt;li&gt;â€¢ restrictive lung diseases&lt;/li&gt;&lt;li&gt;â€¢ Lung disease measurements:&lt;/li&gt;&lt;li&gt;â€¢ Lung disease measurements:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Recognize that pulmonary fibrosis typically presents with decreased Forced Vital Capacity (FVC) and normal Forced Expiratory Volume in 1 second ( FEV1 )/ FVC ratio in pulmonary function tests .&lt;/li&gt;&lt;li&gt;âž¤ Recognize that pulmonary fibrosis typically presents with decreased Forced Vital Capacity (FVC) and normal Forced Expiratory Volume in 1 second ( FEV1 )/ FVC ratio in pulmonary function tests .&lt;/li&gt;&lt;li&gt;âž¤ Recognize that pulmonary fibrosis typically presents with decreased Forced Vital Capacity (FVC) and normal Forced Expiratory Volume in 1 second ( FEV1 )/ FVC ratio in pulmonary function tests .&lt;/li&gt;&lt;li&gt;âž¤ pulmonary fibrosis&lt;/li&gt;&lt;li&gt;âž¤ decreased Forced Vital Capacity (FVC)&lt;/li&gt;&lt;li&gt;âž¤ FEV1&lt;/li&gt;&lt;li&gt;âž¤ FVC&lt;/li&gt;&lt;li&gt;âž¤ ratio&lt;/li&gt;&lt;li&gt;âž¤ pulmonary function tests&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 630&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 630&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 27-year-old man is breathing quietly. He then inhales as much air as possible and exhales as much air as he can, producing the spirogram shown in the previous figure. What is his Expiratory Reserve Volume (in Liters)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;2.0&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;2.5&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;3.0&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;3.5&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 2.0&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/02.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/03.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) 2.0&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The Expiratory Reserve Volume (ERV) is the maximum extra volume of air that can be expired by forceful expiration after the end of a normal tidal expiration. ERV is equal to the difference between the Functional Residual Capacity (FRC, 3 L) and the Residual Volume (RV, 1 L).&lt;/li&gt;&lt;li&gt;â€¢ The Expiratory Reserve Volume (ERV) is the maximum extra volume of air that can be expired by forceful expiration after the end of a normal tidal expiration.&lt;/li&gt;&lt;li&gt;â€¢ Expiratory Reserve Volume&lt;/li&gt;&lt;li&gt;â€¢ maximum&lt;/li&gt;&lt;li&gt;â€¢ forceful expiration&lt;/li&gt;&lt;li&gt;â€¢ after&lt;/li&gt;&lt;li&gt;â€¢ end&lt;/li&gt;&lt;li&gt;â€¢ ERV is equal to the difference between the Functional Residual Capacity (FRC, 3 L) and the Residual Volume (RV, 1 L).&lt;/li&gt;&lt;li&gt;â€¢ equal&lt;/li&gt;&lt;li&gt;â€¢ difference between&lt;/li&gt;&lt;li&gt;â€¢ Functional Residual Capacity&lt;/li&gt;&lt;li&gt;â€¢ Residual Volume&lt;/li&gt;&lt;li&gt;â€¢ ERV = FRC â€“ RV&lt;/li&gt;&lt;li&gt;â€¢ = 3L â€“ 1L    = 2L&lt;/li&gt;&lt;li&gt;â€¢ # Lung volumes and capacity measurements. Lung volumes recorded by a spirometer . Lung capacities are determined from volume recordings .&lt;/li&gt;&lt;li&gt;â€¢ spirometer&lt;/li&gt;&lt;li&gt;â€¢ volume recordings&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The objective of this question is to test understanding of lung volumes and capacities , particularly the corelation of FRC, ERV and RV in a graph format.&lt;/li&gt;&lt;li&gt;âž¤ The objective of this question is to test understanding of lung volumes and capacities , particularly the corelation of FRC, ERV and RV in a graph format.&lt;/li&gt;&lt;li&gt;âž¤ test&lt;/li&gt;&lt;li&gt;âž¤ lung volumes&lt;/li&gt;&lt;li&gt;âž¤ capacities&lt;/li&gt;&lt;li&gt;âž¤ corelation&lt;/li&gt;&lt;li&gt;âž¤ FRC, ERV&lt;/li&gt;&lt;li&gt;âž¤ RV&lt;/li&gt;&lt;li&gt;âž¤ Ref : Guyton and Hall Textbook of Medical Physiology, 2 nd South Asia Edition, Pg no: 342&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Guyton and Hall Textbook of Medical Physiology, 2 nd South Asia Edition, Pg no: 342&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 63-year-old male on ventilator support with a long history of smoking and chronic bronchitis is undergoing evaluation for respiratory difficulties. His spirometry shows a significant reduction in forced expiratory volume, and a CT scan reveals emphysematous changes in the lungs. In this scenario, what would be the expected changes in both anatomical and alveolar dead space?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased Anatomical Dead Space, Decreased Alveolar Dead Space&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased Anatomical Dead Space, Increased Alveolar Dead Space&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased both Anatomical and Alveolar Dead Space&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Decreased both Anatomical and Alveolar Dead Space&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Increased both Anatomical and Alveolar Dead Space&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Increased both Anatomical and Alveolar Dead Space.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Inaccurate in this context. Chronic bronchitis and emphysema, particularly when the patient is on ventilator support , typically lead to an increase in both anatomical and alveolar dead space . Ventilation doesn&#x27;t decrease alveolar dead space.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Inaccurate&lt;/li&gt;&lt;li&gt;â€¢ ventilator support&lt;/li&gt;&lt;li&gt;â€¢ increase&lt;/li&gt;&lt;li&gt;â€¢ both anatomical&lt;/li&gt;&lt;li&gt;â€¢ alveolar dead space&lt;/li&gt;&lt;li&gt;â€¢ Option B: Not relevant here. The conditions described, along with ventilator use , are more likely to increase both types of dead space rather than decrease anatomical dead space .&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Not&lt;/li&gt;&lt;li&gt;â€¢ ventilator use&lt;/li&gt;&lt;li&gt;â€¢ increase both types&lt;/li&gt;&lt;li&gt;â€¢ dead space&lt;/li&gt;&lt;li&gt;â€¢ decrease anatomical dead space&lt;/li&gt;&lt;li&gt;â€¢ Option D: Unlikely in this clinical scenario. Both anatomical and alveolar dead spaces tend to increase in COPD and with ventilator support.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Both anatomical&lt;/li&gt;&lt;li&gt;â€¢ alveolar dead spaces&lt;/li&gt;&lt;li&gt;â€¢ increase&lt;/li&gt;&lt;li&gt;â€¢ COPD&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand how chronic respiratory conditions like COPD and the use of mechanical ventilation can lead to increased anatomical and alveolar dead space , affecting gas exchange efficiency .&lt;/li&gt;&lt;li&gt;âž¤ Understand how chronic respiratory conditions like COPD and the use of mechanical ventilation can lead to increased anatomical and alveolar dead space , affecting gas exchange efficiency .&lt;/li&gt;&lt;li&gt;âž¤ COPD&lt;/li&gt;&lt;li&gt;âž¤ mechanical ventilation&lt;/li&gt;&lt;li&gt;âž¤ increased anatomical&lt;/li&gt;&lt;li&gt;âž¤ alveolar dead space&lt;/li&gt;&lt;li&gt;âž¤ affecting gas exchange efficiency&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg. no: 641&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg. no: 641&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with chronic respiratory symptoms is undergoing a diagnostic workup. The attending pulmonologist is reviewing Weibel&#x27;s classification of the bronchial tree with the medical team to assist in the localization of the pathology. Match the correct generation of bronchioles to their defining characteristics as per Weibel&#x27;s model: Match the following:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A-2, B-1, C-3, D-4&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A-3, B-2, C-1, D-4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A-3, B-1, C-4, D-2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A-4, B-3, C-2, D-1&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. A-2, B-1, C-3, D-4&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/screenshot-2024-02-26-145827.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/screenshot-2024-02-26-145839.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) A-2, B-1, C-3, D-4&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Statement A: Generation 7 - Main Bronchi (2) : This generation, consisting of the main bronchi, has cartilaginous rings and is part of the purely conducting airway , indicating the option for the main bronchi .&lt;/li&gt;&lt;li&gt;â€¢ Statement A: Generation 7 - Main Bronchi (2) : This generation, consisting of the main bronchi, has cartilaginous rings and is part of the purely conducting airway , indicating the option for the main bronchi .&lt;/li&gt;&lt;li&gt;â€¢ Statement A: Generation 7 - Main Bronchi (2)&lt;/li&gt;&lt;li&gt;â€¢ cartilaginous rings&lt;/li&gt;&lt;li&gt;â€¢ airway&lt;/li&gt;&lt;li&gt;â€¢ main bronchi&lt;/li&gt;&lt;li&gt;â€¢ Statement B: Generation 12 - Terminal bronchioles (1) : As the final segment of the conducting airways, the terminal bronchioles are correctly matched with generation 12, which is immediately prior to the respiratory portion of the airways .&lt;/li&gt;&lt;li&gt;â€¢ Statement B: Generation 12 - Terminal bronchioles (1) : As the final segment of the conducting airways, the terminal bronchioles are correctly matched with generation 12, which is immediately prior to the respiratory portion of the airways .&lt;/li&gt;&lt;li&gt;â€¢ Statement B: Generation 12 - Terminal bronchioles (1)&lt;/li&gt;&lt;li&gt;â€¢ respiratory portion&lt;/li&gt;&lt;li&gt;â€¢ airways&lt;/li&gt;&lt;li&gt;â€¢ Statement C: Generation 17 - Respiratory bronchioles (3) : The transitional bronchioles at generation 17, where the first alveoli appear , match the respiratory bronchioles , marking the beginning of the respiratory zone .&lt;/li&gt;&lt;li&gt;â€¢ Statement C: Generation 17 - Respiratory bronchioles (3) : The transitional bronchioles at generation 17, where the first alveoli appear , match the respiratory bronchioles , marking the beginning of the respiratory zone .&lt;/li&gt;&lt;li&gt;â€¢ Statement C: Generation 17 - Respiratory bronchioles (3)&lt;/li&gt;&lt;li&gt;â€¢ first alveoli appear&lt;/li&gt;&lt;li&gt;â€¢ respiratory bronchioles&lt;/li&gt;&lt;li&gt;â€¢ beginning&lt;/li&gt;&lt;li&gt;â€¢ respiratory zone&lt;/li&gt;&lt;li&gt;â€¢ Statement D: Generation 23 - Alveolar sacs (4) : This generation is well within the respiratory zone and includes the alveolar sacs , where extensive gas exchange takes place, making it the correct match for the alveolar sacs .&lt;/li&gt;&lt;li&gt;â€¢ Statement D: Generation 23 - Alveolar sacs (4) : This generation is well within the respiratory zone and includes the alveolar sacs , where extensive gas exchange takes place, making it the correct match for the alveolar sacs .&lt;/li&gt;&lt;li&gt;â€¢ Statement D: Generation 23 - Alveolar sacs (4)&lt;/li&gt;&lt;li&gt;â€¢ respiratory zone&lt;/li&gt;&lt;li&gt;â€¢ alveolar sacs&lt;/li&gt;&lt;li&gt;â€¢ extensive gas exchange&lt;/li&gt;&lt;li&gt;â€¢ correct match&lt;/li&gt;&lt;li&gt;â€¢ alveolar sacs&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The aim is to challenge the learnerâ€™s ability to integrate complex anatomical knowledge of the bronchial tree with clinical concepts, using Weibel&#x27;s classification for precise localization of pulmonary lesions .&lt;/li&gt;&lt;li&gt;âž¤ The aim is to challenge the learnerâ€™s ability to integrate complex anatomical knowledge of the bronchial tree with clinical concepts, using Weibel&#x27;s classification for precise localization of pulmonary lesions .&lt;/li&gt;&lt;li&gt;âž¤ learnerâ€™s ability&lt;/li&gt;&lt;li&gt;âž¤ integrate&lt;/li&gt;&lt;li&gt;âž¤ anatomical knowledge&lt;/li&gt;&lt;li&gt;âž¤ bronchial tree&lt;/li&gt;&lt;li&gt;âž¤ Weibel&#x27;s classification&lt;/li&gt;&lt;li&gt;âž¤ precise localization&lt;/li&gt;&lt;li&gt;âž¤ pulmonary lesions&lt;/li&gt;&lt;li&gt;âž¤ (Refer : Ganongâ€™s Review of Medical physiology, 25th edition, pg. no : 610, 611)&lt;/li&gt;&lt;li&gt;âž¤ (Refer : Ganongâ€™s Review of Medical physiology, 25th edition, pg. no : 610, 611)&lt;/li&gt;&lt;li&gt;âž¤ Question level: Intermediate.&lt;/li&gt;&lt;li&gt;âž¤ Question level: Intermediate.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old female with a history of Chronic Obstructive Pulmonary Disease (COPD) presents to your clinic for a Follow-Up visit. She is currently on a maintenance Inhaler and reports moderate improvement in her symptoms. At which Lung Volume do the Elastic Recoil Forces of the lungs balance exactly with the Elastic Recoil Forces of the Chest Wall, a state particularly relevant in the management of patients with COPD?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Residual Volume&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Functional Residual Capacity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Expiratory Reserve Volume&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tidal Volume&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Functional Residual Capacity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Functional Residual Capacity&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the significance of Functional Residual Capacity (FRC) as the lung volume where elastic recoil forces of the lungs balance with those of the chest wall , particularly in COPD management .&lt;/li&gt;&lt;li&gt;âž¤ Understand the significance of Functional Residual Capacity (FRC) as the lung volume where elastic recoil forces of the lungs balance with those of the chest wall , particularly in COPD management .&lt;/li&gt;&lt;li&gt;âž¤ elastic recoil forces&lt;/li&gt;&lt;li&gt;âž¤ chest wall&lt;/li&gt;&lt;li&gt;âž¤ COPD management&lt;/li&gt;&lt;li&gt;âž¤ Ref : Guyton and Hall Textbook of Medical Physiology, 2 nd South Asia Edition, Pg. no: 342&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Guyton and Hall Textbook of Medical Physiology, 2 nd South Asia Edition, Pg. no: 342&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Calculate the Expiratory Reserve Volume, if the Vital Capacity is 4380 mL, Tidal Volume is 480 mL and Inspiratory Reserve Volume is 2840 mL?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1060 mL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1540 mL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;2020 mL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;2360 mL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 1060 mL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) 1060 mL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The Vital Capacity (VC) can be defined as the maximal volume of air expired from maximal inspiratory level The vital capacity will be equal to the sum of tidal volume (TV), inspiratory reserve volume (IRV) and expiratory reserve volume (ERV)&lt;/li&gt;&lt;li&gt;â€¢ The Vital Capacity (VC) can be defined as the maximal volume of air expired from maximal inspiratory level&lt;/li&gt;&lt;li&gt;â€¢ Vital Capacity&lt;/li&gt;&lt;li&gt;â€¢ maximal volume&lt;/li&gt;&lt;li&gt;â€¢ air&lt;/li&gt;&lt;li&gt;â€¢ expired&lt;/li&gt;&lt;li&gt;â€¢ maximal inspiratory level&lt;/li&gt;&lt;li&gt;â€¢ The vital capacity will be equal to the sum of tidal volume (TV), inspiratory reserve volume (IRV) and expiratory reserve volume (ERV)&lt;/li&gt;&lt;li&gt;â€¢ equal&lt;/li&gt;&lt;li&gt;â€¢ sum&lt;/li&gt;&lt;li&gt;â€¢ tidal volume&lt;/li&gt;&lt;li&gt;â€¢ inspiratory reserve volume&lt;/li&gt;&lt;li&gt;â€¢ expiratory reserve volume&lt;/li&gt;&lt;li&gt;â€¢ VC = TV + IRV+ ERV&lt;/li&gt;&lt;li&gt;â€¢ ERV = VC â€“ (TV + IRV)&lt;/li&gt;&lt;li&gt;â€¢ = 4380 â€“ (480 + 2840)&lt;/li&gt;&lt;li&gt;â€¢ = 4380 â€“ 3320 = 1060 mL&lt;/li&gt;&lt;li&gt;â€¢ # Lung volumes and capacity measurements. Lung volumes recorded by a spirometer . Lung capacities are determined from volume recordings .&lt;/li&gt;&lt;li&gt;â€¢ spirometer&lt;/li&gt;&lt;li&gt;â€¢ volume recordings&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ To understand and calculate various lung volumes and capacities , which is essential for assessing pulmonary function and diagnosing respiratory conditions .&lt;/li&gt;&lt;li&gt;âž¤ To understand and calculate various lung volumes and capacities , which is essential for assessing pulmonary function and diagnosing respiratory conditions .&lt;/li&gt;&lt;li&gt;âž¤ understand&lt;/li&gt;&lt;li&gt;âž¤ calculate&lt;/li&gt;&lt;li&gt;âž¤ lung volumes&lt;/li&gt;&lt;li&gt;âž¤ capacities&lt;/li&gt;&lt;li&gt;âž¤ pulmonary function&lt;/li&gt;&lt;li&gt;âž¤ diagnosing respiratory conditions&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg. No: 629&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg. No: 629&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Difference in the Course of Inspiratory Loop and the Expiratory Loop in the Curve which leads to Hysteresis in the Lung compliance curve is due to:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Difference in Alveolar Pressure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Difference in Surfactant Concentration&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Difference in Airway Resistance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Active Inspiration, Passive Expiration&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Difference in Surfactant Concentration&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/04.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/500.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Difference in Concentration of Surfactant during Inspiration and Expiration&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alveolar pressure does change between inspiration and expiration , contributing to the mechanics of breathing . However, this change doesn&#x27;t directly explain hysteresis in the lung compliance curve, which is more related to surfactant dynamics.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ between inspiration&lt;/li&gt;&lt;li&gt;â€¢ expiration&lt;/li&gt;&lt;li&gt;â€¢ mechanics&lt;/li&gt;&lt;li&gt;â€¢ breathing&lt;/li&gt;&lt;li&gt;â€¢ Option C. Airway resistance varies during breathing , affecting airflow dynamics , but it&#x27;s not the primary cause of hysteresis in the lung compliance curve, which is more influenced by surfactant behavior and lung tissue characteristics .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ breathing&lt;/li&gt;&lt;li&gt;â€¢ affecting airflow dynamics&lt;/li&gt;&lt;li&gt;â€¢ more influenced&lt;/li&gt;&lt;li&gt;â€¢ surfactant behavior&lt;/li&gt;&lt;li&gt;â€¢ lung tissue characteristics&lt;/li&gt;&lt;li&gt;â€¢ Option D. While breathing phases involve active and passive mechanisms , this doesn&#x27;t explain the compliance curve hysteresis, which is more closely tied to changes in lung tissue properties and surfactant action throughout the respiratory cycle .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ breathing phases&lt;/li&gt;&lt;li&gt;â€¢ active&lt;/li&gt;&lt;li&gt;â€¢ passive mechanisms&lt;/li&gt;&lt;li&gt;â€¢ tied&lt;/li&gt;&lt;li&gt;â€¢ changes&lt;/li&gt;&lt;li&gt;â€¢ lung tissue properties&lt;/li&gt;&lt;li&gt;â€¢ surfactant action&lt;/li&gt;&lt;li&gt;â€¢ respiratory cycle&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that the primary cause of hysteresis in the lung compliance curve is the variable behavior of pulmonary surfactant during inspiration and expiration , influencing the lung&#x27;s mechanical properties and ventilation efficiency .&lt;/li&gt;&lt;li&gt;âž¤ Understand that the primary cause of hysteresis in the lung compliance curve is the variable behavior of pulmonary surfactant during inspiration and expiration , influencing the lung&#x27;s mechanical properties and ventilation efficiency .&lt;/li&gt;&lt;li&gt;âž¤ Understand that the primary cause of hysteresis in the lung compliance curve is the variable behavior of pulmonary surfactant during inspiration and expiration , influencing the lung&#x27;s mechanical properties and ventilation efficiency .&lt;/li&gt;&lt;li&gt;âž¤ primary cause&lt;/li&gt;&lt;li&gt;âž¤ hysteresis&lt;/li&gt;&lt;li&gt;âž¤ lung compliance&lt;/li&gt;&lt;li&gt;âž¤ curve&lt;/li&gt;&lt;li&gt;âž¤ behavior&lt;/li&gt;&lt;li&gt;âž¤ pulmonary surfactant&lt;/li&gt;&lt;li&gt;âž¤ inspiration&lt;/li&gt;&lt;li&gt;âž¤ expiration&lt;/li&gt;&lt;li&gt;âž¤ lung&#x27;s mechanical properties&lt;/li&gt;&lt;li&gt;âž¤ ventilation efficiency&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganongâ€™s Review of Medical Physiology, 26 th Edition, Pg no: 620&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganongâ€™s Review of Medical Physiology, 26 th Edition, Pg no: 620&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman with a history of Chronic Obstructive Pulmonary Disease (COPD) is referred to a Pulmonary Function Laboratory for a complete Lung Function Assessment. The Pulmonologist wants to measure her Functional Residual Capacity (FRC) to evaluate the severity of her Lung Condition. Which of the following gases is commonly used to measure the Functional Residual Capacity (FRC) of the Lungs in Pulmonary Function Tests?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Radon&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Helium&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Neon&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Argon&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Helium&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Helium&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Incorrect . Radon is not used in pulmonary function testing due to its radio activity and health hazards .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ radio activity&lt;/li&gt;&lt;li&gt;â€¢ health hazards&lt;/li&gt;&lt;li&gt;â€¢ Option C. Incorrect . Neon is not typically used for measuring FRC in pulmonary function tests. Helium is preferred due to its better diffusion properties and safety .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ better diffusion properties&lt;/li&gt;&lt;li&gt;â€¢ safety&lt;/li&gt;&lt;li&gt;â€¢ Option D. Incorrect . Argon, while an inert gas , is not commonly used in pulmonary function testing for measuring FRC.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ inert gas&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Identify Helium as the gas commonly used in pulmonary function tests to measure Functional Residual Capacity (FRC) in patients with conditions like COPD .&lt;/li&gt;&lt;li&gt;âž¤ Helium&lt;/li&gt;&lt;li&gt;âž¤ pulmonary function tests&lt;/li&gt;&lt;li&gt;âž¤ Functional Residual Capacity&lt;/li&gt;&lt;li&gt;âž¤ COPD&lt;/li&gt;&lt;li&gt;âž¤ Ref: Guyton and Hall Textbook of Medical Physiology, 2 nd South Asia Edition, Pg no: 342&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Guyton and Hall Textbook of Medical Physiology, 2 nd South Asia Edition, Pg no: 342&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 24-year-old Healthy Male Volunteers for a Respiratory Physiology Study at a University Laboratory. He is an avid runner with no History of Smoking or Respiratory Illness. The researchers are measuring the Total Compliance of Both Lungs, to establish Normal Reference Values for Healthy Young Adults. In this 24-year-Old Healthy Male, what is the expected Normal Value of the Total Compliance of Both Lungs?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;0.1 L/cm H 2 O&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;0.2 L/cm H 2 O&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;0.4 L/cm H 2 O&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;0.6 L/cm H 2 O&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 0.2 L/cm H 2 O&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 0.2 L/cm H2O&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The compliance of the lungs can be defined as the extent to which the lungs will expand , when there is a unit increase of the trans-pulmonary pressure The compliance can be represented as the change in lung volume divided by the change in trans-pulmonary pressure :&lt;/li&gt;&lt;li&gt;â€¢ The compliance of the lungs can be defined as the extent to which the lungs will expand , when there is a unit increase of the trans-pulmonary pressure&lt;/li&gt;&lt;li&gt;â€¢ extent&lt;/li&gt;&lt;li&gt;â€¢ lungs&lt;/li&gt;&lt;li&gt;â€¢ expand&lt;/li&gt;&lt;li&gt;â€¢ unit increase&lt;/li&gt;&lt;li&gt;â€¢ trans-pulmonary pressure&lt;/li&gt;&lt;li&gt;â€¢ The compliance can be represented as the change in lung volume divided by the change in trans-pulmonary pressure :&lt;/li&gt;&lt;li&gt;â€¢ change&lt;/li&gt;&lt;li&gt;â€¢ lung volume&lt;/li&gt;&lt;li&gt;â€¢ change&lt;/li&gt;&lt;li&gt;â€¢ trans-pulmonary pressure&lt;/li&gt;&lt;li&gt;â€¢ Compliance=( D V)/( D P)&lt;/li&gt;&lt;li&gt;â€¢ In a healthy adult male , the normal value of the total compliance of both the lungs will be around 0.2 L / cm H 2 O or 200 mL / cm H 2 O .&lt;/li&gt;&lt;li&gt;â€¢ In a healthy adult male , the normal value of the total compliance of both the lungs will be around 0.2 L / cm H 2 O or 200 mL / cm H 2 O .&lt;/li&gt;&lt;li&gt;â€¢ healthy adult male&lt;/li&gt;&lt;li&gt;â€¢ total compliance&lt;/li&gt;&lt;li&gt;â€¢ both&lt;/li&gt;&lt;li&gt;â€¢ lungs&lt;/li&gt;&lt;li&gt;â€¢ around 0.2 L&lt;/li&gt;&lt;li&gt;â€¢ cm H 2 O&lt;/li&gt;&lt;li&gt;â€¢ 200 mL / cm H 2 O&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Determine the normal value of total lung compliance in a healthy young adult , which is typically around 0.2 L/cm H2O.&lt;/li&gt;&lt;li&gt;âž¤ normal value&lt;/li&gt;&lt;li&gt;âž¤ total lung compliance&lt;/li&gt;&lt;li&gt;âž¤ healthy young adult&lt;/li&gt;&lt;li&gt;âž¤ 0.2 L/cm H2O.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Guyton and Hall Textbook of Medical Physiology, 2 nd South Asia Edition, Pg no: 336&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Guyton and Hall Textbook of Medical Physiology, 2 nd South Asia Edition, Pg no: 336&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old male with a history of chronic bronchitis presents to his primary care physician for a routine check-up. He has been stable on his current medication regimen and reports no new respiratory symptoms. At the end of normal respiration (exhalation), which of the following statements best describes the relationship between the Elastic Recoil of the Lungs and the Chest Wall?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The Elastic Recoil of the Lungs will be Greater than that of the Chest Wall&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The Elastic Recoil of the Lungs will be Lower than that of the Chest Wall&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The Elastic Recoil of the Lungs and the Chest Wall exactly Balance Each Other&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The Elastic Recoil of the Lungs will be Maximal&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. The Elastic Recoil of the Lungs and the Chest Wall exactly Balance Each Other&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) The Elastic Recoil of the Lungs and the Chest Wall exactly Balance Each Other&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Incorrect . At the end of a normal exhalation, the elastic recoil of the lungs is not greater than that of the chest wall. Instead, they are in balance .&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ balance&lt;/li&gt;&lt;li&gt;â€¢ Option B: Incorrect . The elastic recoil of the lungs is not lower than that of the chest wall at the end of a normal exhalation; they are balanced .&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ balanced&lt;/li&gt;&lt;li&gt;â€¢ Option D: Incorrect . The elastic recoil of the lungs is not maximal at the end of a normal exhalation. It is balanced with the chest wall&#x27;s recoil .&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ balanced&lt;/li&gt;&lt;li&gt;â€¢ chest wall&#x27;s recoil&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ To understand the mechanics of breathing , particularly the balance between the elastic recoil of the lungs and the chest wall at the end of a normal exhalation , which is crucial in maintaining lung volumes and respiratory function , especially in patients with chronic respiratory conditions like bronchitis .Top of Form&lt;/li&gt;&lt;li&gt;âž¤ To understand the mechanics of breathing , particularly the balance between the elastic recoil of the lungs and the chest wall at the end of a normal exhalation , which is crucial in maintaining lung volumes and respiratory function , especially in patients with chronic respiratory conditions like bronchitis .Top of Form&lt;/li&gt;&lt;li&gt;âž¤ mechanics&lt;/li&gt;&lt;li&gt;âž¤ breathing&lt;/li&gt;&lt;li&gt;âž¤ balance between&lt;/li&gt;&lt;li&gt;âž¤ elastic recoil&lt;/li&gt;&lt;li&gt;âž¤ lungs&lt;/li&gt;&lt;li&gt;âž¤ chest wall&lt;/li&gt;&lt;li&gt;âž¤ end&lt;/li&gt;&lt;li&gt;âž¤ normal exhalation&lt;/li&gt;&lt;li&gt;âž¤ maintaining lung volumes&lt;/li&gt;&lt;li&gt;âž¤ respiratory function&lt;/li&gt;&lt;li&gt;âž¤ chronic respiratory conditions&lt;/li&gt;&lt;li&gt;âž¤ bronchitis&lt;/li&gt;&lt;li&gt;âž¤ Ref : Guyton and Hall Textbook of Medical Physiology, 2 nd South Asia Edition, Pg no: 342&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Guyton and Hall Textbook of Medical Physiology, 2 nd South Asia Edition, Pg no: 342&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 63-year-old female with a history of progressive shortness of breath is Refer to a pulmonologist. She has a 10-year history of rheumatoid arthritis and recently developed a persistent dry cough. A high-resolution CT scan of her chest suggests interstitial lung disease, causing decreased lung compliance. In which of the following conditions is lung compliance decreased? Pulmonary fibrosis Premature infants Alveolar atelectasis Emphysema&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;2 only&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1,2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1,2,3&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1,2,3,4&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 1,2,3&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 1,2,3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The compliance of the lungs can be defined as the extent to which the lungs will expand , when there is a unit increase of the trans-pulmonary pressure The lung compliance will be decreased in pulmonary fibrosis and alveolar atelectasis In premature infants and in conditions with reduced production of the surfactants , the compliance will be decreased The lung compliance will be increased in emphysema&lt;/li&gt;&lt;li&gt;â€¢ The compliance of the lungs can be defined as the extent to which the lungs will expand , when there is a unit increase of the trans-pulmonary pressure&lt;/li&gt;&lt;li&gt;â€¢ extent&lt;/li&gt;&lt;li&gt;â€¢ expand&lt;/li&gt;&lt;li&gt;â€¢ increase&lt;/li&gt;&lt;li&gt;â€¢ trans-pulmonary pressure&lt;/li&gt;&lt;li&gt;â€¢ The lung compliance will be decreased in pulmonary fibrosis and alveolar atelectasis&lt;/li&gt;&lt;li&gt;â€¢ decreased&lt;/li&gt;&lt;li&gt;â€¢ pulmonary fibrosis&lt;/li&gt;&lt;li&gt;â€¢ alveolar atelectasis&lt;/li&gt;&lt;li&gt;â€¢ In premature infants and in conditions with reduced production of the surfactants , the compliance will be decreased&lt;/li&gt;&lt;li&gt;â€¢ infants&lt;/li&gt;&lt;li&gt;â€¢ reduced production&lt;/li&gt;&lt;li&gt;â€¢ surfactants&lt;/li&gt;&lt;li&gt;â€¢ decreased&lt;/li&gt;&lt;li&gt;â€¢ The lung compliance will be increased in emphysema&lt;/li&gt;&lt;li&gt;â€¢ increased&lt;/li&gt;&lt;li&gt;â€¢ emphysema&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize conditions associated with decreased lung compliance , specifically pulmonary fibrosis , premature infants , and alveolar atelectasis .&lt;/li&gt;&lt;li&gt;âž¤ Recognize conditions associated with decreased lung compliance , specifically pulmonary fibrosis , premature infants , and alveolar atelectasis .&lt;/li&gt;&lt;li&gt;âž¤ decreased lung compliance&lt;/li&gt;&lt;li&gt;âž¤ pulmonary fibrosis&lt;/li&gt;&lt;li&gt;âž¤ premature infants&lt;/li&gt;&lt;li&gt;âž¤ alveolar atelectasis&lt;/li&gt;&lt;li&gt;âž¤ Ref : Guyton and Hall Textbook of Medical Physiology, 2 nd South Asia Edition, Pg no: 338&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Guyton and Hall Textbook of Medical Physiology, 2 nd South Asia Edition, Pg no: 338&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old patient with a history of Chronic Obstructive Pulmonary Disease (COPD) is admitted to the hospital due to worsening Respiratory Distress. While discussing the patient&#x27;s condition, the attending physician asks the Intern, Which of the following Alveolar Epithelial Cells are known as Granular Pneumocytes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Type I Pneumocytes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Type II Pneumocytes&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Type III Pneumocytes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Both a and b&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Type II Pneumocytes&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/05.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Type II Pneumocytes&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Type I pneumocytes are responsible for gas exchange in the alveoli . They are thin and flat cells that make up the majority of the alveolar surface . They are not referred to as granular pneumocytes.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ gas exchange&lt;/li&gt;&lt;li&gt;â€¢ alveoli&lt;/li&gt;&lt;li&gt;â€¢ thin&lt;/li&gt;&lt;li&gt;â€¢ flat cells&lt;/li&gt;&lt;li&gt;â€¢ make up&lt;/li&gt;&lt;li&gt;â€¢ majority&lt;/li&gt;&lt;li&gt;â€¢ alveolar surface&lt;/li&gt;&lt;li&gt;â€¢ Option C. There is no such category as Type III pneumocytes in the classification of alveolar epithelial cells .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ alveolar epithelial cells&lt;/li&gt;&lt;li&gt;â€¢ Option D. While both Type I and Type II pneumocytes are important in lung function , Type II pneumocytes are specifically known as granular pneumocytes due to the presence of granules in their cytoplasm , which are involved in surfactant production . The surfactants are secreted from the type II pneumocytes&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ lung function&lt;/li&gt;&lt;li&gt;â€¢ granular pneumocytes&lt;/li&gt;&lt;li&gt;â€¢ presence&lt;/li&gt;&lt;li&gt;â€¢ granules&lt;/li&gt;&lt;li&gt;â€¢ cytoplasm&lt;/li&gt;&lt;li&gt;â€¢ surfactant production&lt;/li&gt;&lt;li&gt;â€¢ secreted&lt;/li&gt;&lt;li&gt;â€¢ type II pneumocytes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the different types of alveolar epithelial cells in the lungs , specifically the role of Type II pneumocytes as granular pneumocytes involved in surfactant production , which is crucial for preventing alveolar collapse and maintaining lung function , especially in conditions like COPD .&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the different types of alveolar epithelial cells in the lungs , specifically the role of Type II pneumocytes as granular pneumocytes involved in surfactant production , which is crucial for preventing alveolar collapse and maintaining lung function , especially in conditions like COPD .&lt;/li&gt;&lt;li&gt;âž¤ different types&lt;/li&gt;&lt;li&gt;âž¤ alveolar epithelial cells&lt;/li&gt;&lt;li&gt;âž¤ lungs&lt;/li&gt;&lt;li&gt;âž¤ role&lt;/li&gt;&lt;li&gt;âž¤ Type II pneumocytes&lt;/li&gt;&lt;li&gt;âž¤ granular pneumocytes&lt;/li&gt;&lt;li&gt;âž¤ surfactant production&lt;/li&gt;&lt;li&gt;âž¤ preventing alveolar collapse&lt;/li&gt;&lt;li&gt;âž¤ maintaining lung function&lt;/li&gt;&lt;li&gt;âž¤ COPD&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 623&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 623&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The intrapleural pressure will be A 40-year-old healthy male participates in a study at a respiratory physiology lab. The researchers are measuring various respiratory parameters, including intrapleural pressure, to better understand the mechanics of breathing. One of the researchers asks the students to identify the normal intrapleural pressure at the base of the lungs during the start of inspiration in a healthy adult. What would be the Ans?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;â€“ 0.5 mm Hg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;â€“ 1.5 mm Hg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;â€“ 2.5 mm Hg&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;â€“ 4.5 mm Hg&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. â€“ 2.5 mm Hg&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) â€“ 2.5 mm Hg&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ When the inspiratory muscles are contracted at the onset of inspiration , the intra-thoracic volume will be increased .&lt;/li&gt;&lt;li&gt;â€¢ When the inspiratory muscles are contracted at the onset of inspiration , the intra-thoracic volume will be increased .&lt;/li&gt;&lt;li&gt;â€¢ inspiratory muscles&lt;/li&gt;&lt;li&gt;â€¢ contracted&lt;/li&gt;&lt;li&gt;â€¢ onset&lt;/li&gt;&lt;li&gt;â€¢ inspiration&lt;/li&gt;&lt;li&gt;â€¢ intra-thoracic&lt;/li&gt;&lt;li&gt;â€¢ volume&lt;/li&gt;&lt;li&gt;â€¢ increased&lt;/li&gt;&lt;li&gt;â€¢ At the beginning of inspiration, the intra pleural pressure at the base of the lungs will be around â€“ 2.5 mm Hg (in relation to the atmospheric pressure ) decreased to around â€“ 6 mm Hg and the lungs will be pulled into an expanded position .&lt;/li&gt;&lt;li&gt;â€¢ At the beginning of inspiration, the intra pleural pressure at the base of the lungs will be around â€“ 2.5 mm Hg (in relation to the atmospheric pressure ) decreased to around â€“ 6 mm Hg and the lungs will be pulled into an expanded position .&lt;/li&gt;&lt;li&gt;â€¢ intra pleural pressure&lt;/li&gt;&lt;li&gt;â€¢ base&lt;/li&gt;&lt;li&gt;â€¢ lungs&lt;/li&gt;&lt;li&gt;â€¢ 2.5 mm Hg&lt;/li&gt;&lt;li&gt;â€¢ atmospheric pressure&lt;/li&gt;&lt;li&gt;â€¢ decreased&lt;/li&gt;&lt;li&gt;â€¢ 6 mm Hg&lt;/li&gt;&lt;li&gt;â€¢ pulled&lt;/li&gt;&lt;li&gt;â€¢ expanded position&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the variations in intrapleural pressure during different phases of the respiratory cycle , particularly its negative value at the onset of inspiration .&lt;/li&gt;&lt;li&gt;âž¤ Understand the variations in intrapleural pressure during different phases of the respiratory cycle , particularly its negative value at the onset of inspiration .&lt;/li&gt;&lt;li&gt;âž¤ intrapleural pressure&lt;/li&gt;&lt;li&gt;âž¤ different phases&lt;/li&gt;&lt;li&gt;âž¤ respiratory cycle&lt;/li&gt;&lt;li&gt;âž¤ negative value&lt;/li&gt;&lt;li&gt;âž¤ onset&lt;/li&gt;&lt;li&gt;âž¤ inspiration&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 628&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 628&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a Medical Simulation Exercise, a patient presents with Respiratory Distress. The Medical Team is discussing the various pressures involved in the Respiratory System. Which of the following statements accurately describes the relationship between the Different Pressures in the Pulmonary Circulation for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Intra-Pleural Pressure is always Greater than Intra-Pulmonary Pressure (IPP) during Inspiration.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Trans-Pulmonary Pressure (TPP) is the difference between Intra-Pleural Pressure (ITP) and Intra-Pulmonary Pressure.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intra-Pulmonary Pressure (IPP) is always higher than Atmospheric Pressure.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Trans-Respiratory pressure is the difference between Intra-Pleural Pressure (ITP) and Trans-Pulmonary Pressure (TPP).&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Trans-Pulmonary Pressure (TPP) is the difference between Intra-Pleural Pressure (ITP) and Intra-Pulmonary Pressure.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ Option A. This statement is not true . During inspiration, Intrapleural pressure is usually more negative ( less ) than IPP, creating a pressure gradient that keeps the airways open .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ not true&lt;/li&gt;&lt;li&gt;â€¢ more negative&lt;/li&gt;&lt;li&gt;â€¢ less&lt;/li&gt;&lt;li&gt;â€¢ pressure gradient&lt;/li&gt;&lt;li&gt;â€¢ airways open&lt;/li&gt;&lt;li&gt;â€¢ Option C. This statement is false , during inspiration Intrapulmonary pressure is lesser than atmospheric pressure. IPP is typically slightly above atmospheric pressure during expiration and below during inspiration.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ false&lt;/li&gt;&lt;li&gt;â€¢ lesser&lt;/li&gt;&lt;li&gt;â€¢ IPP&lt;/li&gt;&lt;li&gt;â€¢ above&lt;/li&gt;&lt;li&gt;â€¢ expiration&lt;/li&gt;&lt;li&gt;â€¢ below&lt;/li&gt;&lt;li&gt;â€¢ Option D. This statement is incorrect . Trans-respiratory pressure is the pressure difference across the lung wall and is calculated as the difference between intrapulmonary pressure (IPP) and atmospheric pressure (ITP).&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ lung wall&lt;/li&gt;&lt;li&gt;â€¢ intrapulmonary pressure&lt;/li&gt;&lt;li&gt;â€¢ atmospheric pressure&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the relationships between intrapleural pressure (ITP), intrapulmonary pressure (IPP), transpulmonary pressure (TPP), and atmospheric pressure in the context of pulmonary mechanics. It&#x27;s important to grasp these concepts for diagnosing and managing respiratory conditions.&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the relationships between intrapleural pressure (ITP), intrapulmonary pressure (IPP), transpulmonary pressure (TPP), and atmospheric pressure in the context of pulmonary mechanics. It&#x27;s important to grasp these concepts for diagnosing and managing respiratory conditions.&lt;/li&gt;&lt;li&gt;âž¤ between intrapleural pressure&lt;/li&gt;&lt;li&gt;âž¤ intrapulmonary pressure&lt;/li&gt;&lt;li&gt;âž¤ transpulmonary pressure&lt;/li&gt;&lt;li&gt;âž¤ atmospheric pressure&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 623&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 623&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Assertion : The intrapleural pressure will be negative or positive depending on the extent of respiration Reason : The pressure in the space between the lungs and the chest wall will be sub atmospheric in nature during quiet breathing. Which of the following is True?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The assertion statement is correct, but the reason statement is incorrect&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Both the Assertion and the Reason statements are correct&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The assertion statement is incorrect, but the reason statement is correct&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Both the assertion and the reason statements are incorrect&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Both the Assertion and the Reason statements are correct&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Both the Assertion and the Reason statements are correct&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Both the lungs and the chest wall are structures, which are elastic in nature There will be a thin layer of fluid (called as pleural fluid ) present in-between the lungs and the chest wall (the space is known as the intrapleural space ) The pressure in the intrapleural space between the lungs and the chest wall (known as the intrapleural pressure) will be subatmospheric in nature during quiet breathing. This intrapleural pressure will be negative or positive depending on the extent of respiration. Normally it is negative but during forceful expiration it can become positive, e.g. during a Valsalva maneuver&lt;/li&gt;&lt;li&gt;â€¢ Both the lungs and the chest wall are structures, which are elastic in nature&lt;/li&gt;&lt;li&gt;â€¢ Both the lungs and the chest wall are structures, which are elastic in nature&lt;/li&gt;&lt;li&gt;â€¢ Both&lt;/li&gt;&lt;li&gt;â€¢ lungs&lt;/li&gt;&lt;li&gt;â€¢ chest wall&lt;/li&gt;&lt;li&gt;â€¢ elastic&lt;/li&gt;&lt;li&gt;â€¢ There will be a thin layer of fluid (called as pleural fluid ) present in-between the lungs and the chest wall (the space is known as the intrapleural space )&lt;/li&gt;&lt;li&gt;â€¢ There will be a thin layer of fluid (called as pleural fluid ) present in-between the lungs and the chest wall (the space is known as the intrapleural space )&lt;/li&gt;&lt;li&gt;â€¢ thin layer&lt;/li&gt;&lt;li&gt;â€¢ fluid&lt;/li&gt;&lt;li&gt;â€¢ pleural fluid&lt;/li&gt;&lt;li&gt;â€¢ lungs&lt;/li&gt;&lt;li&gt;â€¢ chest wall&lt;/li&gt;&lt;li&gt;â€¢ intrapleural space&lt;/li&gt;&lt;li&gt;â€¢ The pressure in the intrapleural space between the lungs and the chest wall (known as the intrapleural pressure) will be subatmospheric in nature during quiet breathing.&lt;/li&gt;&lt;li&gt;â€¢ The pressure in the intrapleural space between the lungs and the chest wall (known as the intrapleural pressure) will be subatmospheric in nature during quiet breathing.&lt;/li&gt;&lt;li&gt;â€¢ This intrapleural pressure will be negative or positive depending on the extent of respiration. Normally it is negative but during forceful expiration it can become positive, e.g. during a Valsalva maneuver&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize that intrapleural pressure is consistently subatmospheric regardless of the phase of respiration .&lt;/li&gt;&lt;li&gt;âž¤ Recognize that intrapleural pressure is consistently subatmospheric regardless of the phase of respiration .&lt;/li&gt;&lt;li&gt;âž¤ Recognize that intrapleural pressure is consistently subatmospheric regardless of the phase of respiration .&lt;/li&gt;&lt;li&gt;âž¤ intrapleural pressure&lt;/li&gt;&lt;li&gt;âž¤ subatmospheric regardless&lt;/li&gt;&lt;li&gt;âž¤ phase&lt;/li&gt;&lt;li&gt;âž¤ respiration&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 628&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 628&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A resident is reviewing lung tissue samples under the microscope during a tutorial session on pulmonary histology. The attending pathologist points out the different cell types present in the alveolar epithelium and emphasizes the distinct characteristics of type I and type II pneumocytes. Differentiation between these cell types is crucial for understanding the pathology. Which of the following statements about type I pneumocytes is incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Flat Epithelial Cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Large Cytoplasmic Extensions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Majority of the Alveolar Epithelium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lamellar Inclusion Bodies Present&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lamellar Inclusion Bodies Present&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/05_4p5a7fY.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Lamellar Inclusion Bodies Present&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Correct . Type I pneumocytes are indeed flat epithelial cells , which allows for efficient gas exchange across the alveolar-capillary barrier.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Correct&lt;/li&gt;&lt;li&gt;â€¢ flat epithelial cells&lt;/li&gt;&lt;li&gt;â€¢ efficient gas exchange&lt;/li&gt;&lt;li&gt;â€¢ Option B: Correct . Type I pneumocytes have large cytoplasmic extensions , facilitating a thin barrier for gas exchange.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Correct&lt;/li&gt;&lt;li&gt;â€¢ large cytoplasmic extensions&lt;/li&gt;&lt;li&gt;â€¢ thin barrier&lt;/li&gt;&lt;li&gt;â€¢ Option C: Correct . Type I pneumocytes constitute the majority of the alveolar epithelium , covering most of the alveolar surface area.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Correct&lt;/li&gt;&lt;li&gt;â€¢ majority&lt;/li&gt;&lt;li&gt;â€¢ alveolar epithelium&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Differentiate between type I and type II pneumocytes , noting that lamellar inclusion bodies are not present in type I pneumocytes.&lt;/li&gt;&lt;li&gt;âž¤ Differentiate between type I and type II pneumocytes , noting that lamellar inclusion bodies are not present in type I pneumocytes.&lt;/li&gt;&lt;li&gt;âž¤ type&lt;/li&gt;&lt;li&gt;âž¤ I&lt;/li&gt;&lt;li&gt;âž¤ type II pneumocytes&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 623&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 623&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old female with a history of asthma presents to the clinic for a routine follow-up. She has been experiencing increased frequency of asthma attacks and has been using her rescue inhaler more often. The attending physician notes that the patient&#x27;s condition might be influenced by various substances produced in the lungs that can affect bronchial reactivity and inflammation. In the context of this patient&#x27;s asthma, which of the following substances are synthesized in the lungs? Surfactant Histamine Kallikrein Angiotensin&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1 only&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1,2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1,2,3&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1,2,3,4&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 1,2,3&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 1,2,3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The surfactants are synthesized and secreted from the type II pneumocytes of the alveolar epithelium , which reduce the surface tension in the alveoli The substances like histamine , kallikrein and prostaglandins are synthesized , stored and released into the bloodstream from the lungs The Angiotensin Converting Enzyme or ACE (not angiotensin) will be secreted from the lungs (angiotensin will be synthesized as a precursor angiotensinogen from the liver).&lt;/li&gt;&lt;li&gt;â€¢ The surfactants are synthesized and secreted from the type II pneumocytes of the alveolar epithelium , which reduce the surface tension in the alveoli&lt;/li&gt;&lt;li&gt;â€¢ synthesized&lt;/li&gt;&lt;li&gt;â€¢ secreted&lt;/li&gt;&lt;li&gt;â€¢ type II pneumocytes&lt;/li&gt;&lt;li&gt;â€¢ alveolar epithelium&lt;/li&gt;&lt;li&gt;â€¢ reduce&lt;/li&gt;&lt;li&gt;â€¢ alveoli&lt;/li&gt;&lt;li&gt;â€¢ The substances like histamine , kallikrein and prostaglandins are synthesized , stored and released into the bloodstream from the lungs&lt;/li&gt;&lt;li&gt;â€¢ histamine&lt;/li&gt;&lt;li&gt;â€¢ kallikrein&lt;/li&gt;&lt;li&gt;â€¢ prostaglandins&lt;/li&gt;&lt;li&gt;â€¢ synthesized&lt;/li&gt;&lt;li&gt;â€¢ stored&lt;/li&gt;&lt;li&gt;â€¢ bloodstream&lt;/li&gt;&lt;li&gt;â€¢ lungs&lt;/li&gt;&lt;li&gt;â€¢ The Angiotensin Converting Enzyme or ACE (not angiotensin) will be secreted from the lungs (angiotensin will be synthesized as a precursor angiotensinogen from the liver).&lt;/li&gt;&lt;li&gt;â€¢ Angiotensin Converting Enzyme&lt;/li&gt;&lt;li&gt;â€¢ ACE&lt;/li&gt;&lt;li&gt;â€¢ secreted&lt;/li&gt;&lt;li&gt;â€¢ lungs&lt;/li&gt;&lt;li&gt;â€¢ precursor angiotensinogen&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Identify surfactant , histamine , and kallikrein as substances synthesized in the lungs that can influence bronchial reactivity and inflammation in conditions like asthma .&lt;/li&gt;&lt;li&gt;âž¤ Identify surfactant , histamine , and kallikrein as substances synthesized in the lungs that can influence bronchial reactivity and inflammation in conditions like asthma .&lt;/li&gt;&lt;li&gt;âž¤ surfactant&lt;/li&gt;&lt;li&gt;âž¤ histamine&lt;/li&gt;&lt;li&gt;âž¤ kallikrein&lt;/li&gt;&lt;li&gt;âž¤ synthesized&lt;/li&gt;&lt;li&gt;âž¤ lungs&lt;/li&gt;&lt;li&gt;âž¤ influence bronchial reactivity&lt;/li&gt;&lt;li&gt;âž¤ inflammation&lt;/li&gt;&lt;li&gt;âž¤ asthma&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 637&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 637&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Statement A: In a patient with emphysema characterized by extensive alveolar destruction and airspace enlargement, lung compliance tends to be lower due to reduced elastic recoil. Statement B: In individuals with severe pulmonary hypertension, which elevates pulmonary vascular resistance, lung compliance often increases due to decreased resistance in the pulmonary vasculature. Which of the following is correct?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The Statement A is True, the Statement B is False&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The Statement A is False, the Statement B is True&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Both the Statements A and B are True&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Both the Statements A and B are False&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Both the Statements A and B are False&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/06.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Both the Statements A and B are false&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The compliance of the lungs can be defined as the extent to which the lungs will expand, when there is a unit increase of the transpulmonary pressure. The elasticity of lungs refers to return back to its normal position i.e. recoil, allowing them to expand during inhalation and contract during exhalation. This property is influenced by the elastic fibers within the lung tissue and the surface tension in the alveoli.&lt;/li&gt;&lt;li&gt;â€¢ Statement A : In emphysema, lung compliance is typically increased, not decreased. Emphysema involves the destruction of alveolar walls, leading to increased lung compliance and decreased elasticity. Statement B : In pulmonary hypertension , lung compliance is often decreased , not increased. Pulmonary hypertension results in increased pressure within the pulmonary vasculature , which can lead to reduced lung compliance . The lung compliance will also be decreased in conditions like pulmonary fibrosis and alveolar atelectasis .&lt;/li&gt;&lt;li&gt;â€¢ Statement A : In emphysema, lung compliance is typically increased, not decreased. Emphysema involves the destruction of alveolar walls, leading to increased lung compliance and decreased elasticity.&lt;/li&gt;&lt;li&gt;â€¢ Statement A : In emphysema, lung compliance is typically increased, not decreased. Emphysema involves the destruction of alveolar walls, leading to increased lung compliance and decreased elasticity.&lt;/li&gt;&lt;li&gt;â€¢ Statement A&lt;/li&gt;&lt;li&gt;â€¢ Statement B : In pulmonary hypertension , lung compliance is often decreased , not increased. Pulmonary hypertension results in increased pressure within the pulmonary vasculature , which can lead to reduced lung compliance .&lt;/li&gt;&lt;li&gt;â€¢ Statement B : In pulmonary hypertension , lung compliance is often decreased , not increased. Pulmonary hypertension results in increased pressure within the pulmonary vasculature , which can lead to reduced lung compliance .&lt;/li&gt;&lt;li&gt;â€¢ Statement B&lt;/li&gt;&lt;li&gt;â€¢ pulmonary hypertension&lt;/li&gt;&lt;li&gt;â€¢ decreased&lt;/li&gt;&lt;li&gt;â€¢ increased pressure&lt;/li&gt;&lt;li&gt;â€¢ pulmonary vasculature&lt;/li&gt;&lt;li&gt;â€¢ lead&lt;/li&gt;&lt;li&gt;â€¢ reduced lung compliance&lt;/li&gt;&lt;li&gt;â€¢ The lung compliance will also be decreased in conditions like pulmonary fibrosis and alveolar atelectasis .&lt;/li&gt;&lt;li&gt;â€¢ The lung compliance will also be decreased in conditions like pulmonary fibrosis and alveolar atelectasis .&lt;/li&gt;&lt;li&gt;â€¢ decreased&lt;/li&gt;&lt;li&gt;â€¢ pulmonary fibrosis&lt;/li&gt;&lt;li&gt;â€¢ alveolar atelectasis&lt;/li&gt;&lt;li&gt;â€¢ In emphysema and fibrosis , the lung compliance curves can be seen:&lt;/li&gt;&lt;li&gt;â€¢ emphysema&lt;/li&gt;&lt;li&gt;â€¢ fibrosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that in emphysema , lung compliance is increased , and in pulmonary hypertension , lung compliance is decreased .&lt;/li&gt;&lt;li&gt;âž¤ Understand that in emphysema , lung compliance is increased , and in pulmonary hypertension , lung compliance is decreased .&lt;/li&gt;&lt;li&gt;âž¤ Understand that in emphysema , lung compliance is increased , and in pulmonary hypertension , lung compliance is decreased .&lt;/li&gt;&lt;li&gt;âž¤ emphysema&lt;/li&gt;&lt;li&gt;âž¤ increased&lt;/li&gt;&lt;li&gt;âž¤ pulmonary hypertension&lt;/li&gt;&lt;li&gt;âž¤ decreased&lt;/li&gt;&lt;li&gt;âž¤ Ref : Guyton and Hall Textbook of Medical Physiology, 2 nd South Asia edition, Pg no: 338&lt;/li&gt;&lt;li&gt;âž¤ Ref : Guyton and Hall Textbook of Medical Physiology, 2 nd South Asia edition, Pg no: 338&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a session on pulmonary physiology, the role of surfactant proteins in lung function is discussed. Which of the following statements is correct regarding surfactant proteins SP-A, SP-D, and SP-C?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Surfactant Proteins SP-A and SP-D are part of the Collectin Family, and SP-C is a Larger Glycoprotein compared to SP-A.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Surfactant Proteins SP-A and SP-D are not part of the Collectin Family, but SP-C is a Larger Glycoprotein compared to SP-A.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Surfactant Proteins SP-A and SP-D are not part of the Collectin Family, and SP-C is not a Larger Glycoprotein compared to SP-A.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Surfactant Proteins SP-A and SP-D are part of the Collectin Family, and SP-C is not a Larger Glycoprotein compared to SP-A.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Surfactant Proteins SP-A and SP-D are part of the Collectin Family, and SP-C is not a Larger Glycoprotein compared to SP-A.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Surfactant Proteins SP-A and SP-D are part of the Collectin Family, and SP-C is not a Larger Glycoprotein compared to SP-A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Incorrect . While statement A is true , statement B is false because SP-C is a small hydrophobic protein , not a larger glycoprotein compared to SP-A.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ statement A&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;li&gt;â€¢ statement B&lt;/li&gt;&lt;li&gt;â€¢ false&lt;/li&gt;&lt;li&gt;â€¢ SP-C&lt;/li&gt;&lt;li&gt;â€¢ small hydrophobic protein&lt;/li&gt;&lt;li&gt;â€¢ Option B: Incorrect . Statement A is true as SP-A and SP-D are collectins . Statement B is false because SP-C is not larger than SP-A.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ SP-A&lt;/li&gt;&lt;li&gt;â€¢ SP-D&lt;/li&gt;&lt;li&gt;â€¢ collectins&lt;/li&gt;&lt;li&gt;â€¢ false&lt;/li&gt;&lt;li&gt;â€¢ Option C: Incorrect . SP-A and SP-D are indeed part of the collectin family . SP-C is a small hydrophobic protein , not a larger glycoprotein compared to SP-A.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ collectin family&lt;/li&gt;&lt;li&gt;â€¢ SP-C&lt;/li&gt;&lt;li&gt;â€¢ small hydrophobic protein&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ To understand the classification and characteristics of surfactant proteins , specifically the roles of SP-A and SP-D as collectins and the nature of SP-C as a small hydrophobic protein , essential for lung function and innate immunity .&lt;/li&gt;&lt;li&gt;âž¤ classification&lt;/li&gt;&lt;li&gt;âž¤ characteristics&lt;/li&gt;&lt;li&gt;âž¤ surfactant proteins&lt;/li&gt;&lt;li&gt;âž¤ SP-A&lt;/li&gt;&lt;li&gt;âž¤ SP-D&lt;/li&gt;&lt;li&gt;âž¤ collectins&lt;/li&gt;&lt;li&gt;âž¤ nature&lt;/li&gt;&lt;li&gt;âž¤ SP-C&lt;/li&gt;&lt;li&gt;âž¤ small hydrophobic protein&lt;/li&gt;&lt;li&gt;âž¤ essential&lt;/li&gt;&lt;li&gt;âž¤ lung function&lt;/li&gt;&lt;li&gt;âž¤ innate immunity&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 631, 632&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 631, 632&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old male with a history of pulmonary fibrosis is seen in the pulmonology clinic. He complains of progressive shortness of breath over the past few months. His pulmonary function tests show reduced lung volumes, and the physician decides to explain the concept of lung compliance to the residents present. To illustrate this, the physician discusses how lung compliance can be quantitatively assessed and poses a related question to the residents. In the context of this patient with pulmonary fibrosis, which formula correctly represents the mathematical expression for lung compliance?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Î”V Ã— Î”P&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Î”V / Î”P&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Î”P / Î”V&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Î” V- Î” P / Î” V&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Î”V / Î”P&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/27/screenshot-2024-02-27-123823.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The compliance of the lungs can be defined as the extent to which the lungs will expand , when there is a unit increase of the transpulmonary pressure The compliance can be represented as the change in lung volume ( Î”V ) divided by the change in transpulmonary pressure ( Î”P ) The lung compliance can be represented mathematically as&lt;/li&gt;&lt;li&gt;â€¢ The compliance of the lungs can be defined as the extent to which the lungs will expand , when there is a unit increase of the transpulmonary pressure&lt;/li&gt;&lt;li&gt;â€¢ extent&lt;/li&gt;&lt;li&gt;â€¢ lungs&lt;/li&gt;&lt;li&gt;â€¢ expand&lt;/li&gt;&lt;li&gt;â€¢ increase&lt;/li&gt;&lt;li&gt;â€¢ transpulmonary pressure&lt;/li&gt;&lt;li&gt;â€¢ The compliance can be represented as the change in lung volume ( Î”V ) divided by the change in transpulmonary pressure ( Î”P )&lt;/li&gt;&lt;li&gt;â€¢ change&lt;/li&gt;&lt;li&gt;â€¢ lung volume&lt;/li&gt;&lt;li&gt;â€¢ Î”V&lt;/li&gt;&lt;li&gt;â€¢ transpulmonary pressure&lt;/li&gt;&lt;li&gt;â€¢ Î”P&lt;/li&gt;&lt;li&gt;â€¢ The lung compliance can be represented mathematically as&lt;/li&gt;&lt;li&gt;â€¢ mathematically&lt;/li&gt;&lt;li&gt;â€¢ Compliance = Î”V / Î”P&lt;/li&gt;&lt;li&gt;â€¢ Compliance = Î”V / Î”P&lt;/li&gt;&lt;li&gt;â€¢ Graphically, different diseases with increase and decrease in compliance is&lt;/li&gt;&lt;li&gt;â€¢ increase&lt;/li&gt;&lt;li&gt;â€¢ decrease&lt;/li&gt;&lt;li&gt;â€¢ compliance&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that lung compliance is calculated as the change in lung volume (Î”V) divided by the change in pleural pressure (Î”P).&lt;/li&gt;&lt;li&gt;âž¤ Understand that lung compliance is calculated as the change in lung volume (Î”V) divided by the change in pleural pressure (Î”P).&lt;/li&gt;&lt;li&gt;âž¤ lung compliance&lt;/li&gt;&lt;li&gt;âž¤ change&lt;/li&gt;&lt;li&gt;âž¤ lung volume&lt;/li&gt;&lt;li&gt;âž¤ change&lt;/li&gt;&lt;li&gt;âž¤ pleural pressure&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg No: 629&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg No: 629&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 34-week gestational age newborn is admitted to the neonatal intensive care unit (NICU) with signs of respiratory distress shortly after birth. Considering the condition of this premature newborn, how is the surface tension in the alveoli related to the surfactant concentration per unit area?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Directly proportional to the Surfactant Concentration per unit area&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inversely proportional to the Surfactant Concentration per unit area&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Does not depend directly on the Surfactant Concentration&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Equal to the Surfactant Concentration multiplied with Surface Area&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Inversely proportional to the Surfactant Concentration per unit area&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Inversely proportional to the Surfactant Concentration per unit area&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ In the alveoli , surface tension is inversely proportional to the concentration of surfactant per unit area. Surfactants, composed primarily of phospholipids , reduce the surface tension at the air-liquid interface within the alveoli. Higher concentrations of surfactant result in greater reductions in surface tension, which is crucial in preventing the collapse of the alveoli (atelectasis) during exhalation . In premature infants like the one in this case, insufficient surfactant production can lead to increased surface tension , making them more susceptible to respiratory distress syndrome . Understanding this relationship is vital in the management and treatment of respiratory distress in newborns , especially those born prematurely .&lt;/li&gt;&lt;li&gt;â€¢ In the alveoli , surface tension is inversely proportional to the concentration of surfactant per unit area.&lt;/li&gt;&lt;li&gt;â€¢ alveoli&lt;/li&gt;&lt;li&gt;â€¢ inversely proportional&lt;/li&gt;&lt;li&gt;â€¢ Surfactants, composed primarily of phospholipids , reduce the surface tension at the air-liquid interface within the alveoli.&lt;/li&gt;&lt;li&gt;â€¢ phospholipids&lt;/li&gt;&lt;li&gt;â€¢ reduce&lt;/li&gt;&lt;li&gt;â€¢ surface tension&lt;/li&gt;&lt;li&gt;â€¢ air-liquid&lt;/li&gt;&lt;li&gt;â€¢ Higher concentrations of surfactant result in greater reductions in surface tension, which is crucial in preventing the collapse of the alveoli (atelectasis) during exhalation . In premature infants like the one in this case, insufficient surfactant production can lead to increased surface tension , making them more susceptible to respiratory distress syndrome .&lt;/li&gt;&lt;li&gt;â€¢ Higher concentrations&lt;/li&gt;&lt;li&gt;â€¢ surfactant&lt;/li&gt;&lt;li&gt;â€¢ greater reductions&lt;/li&gt;&lt;li&gt;â€¢ collapse&lt;/li&gt;&lt;li&gt;â€¢ alveoli&lt;/li&gt;&lt;li&gt;â€¢ during exhalation&lt;/li&gt;&lt;li&gt;â€¢ insufficient surfactant production&lt;/li&gt;&lt;li&gt;â€¢ increased surface tension&lt;/li&gt;&lt;li&gt;â€¢ more susceptible&lt;/li&gt;&lt;li&gt;â€¢ respiratory distress syndrome&lt;/li&gt;&lt;li&gt;â€¢ Understanding this relationship is vital in the management and treatment of respiratory distress in newborns , especially those born prematurely .&lt;/li&gt;&lt;li&gt;â€¢ management&lt;/li&gt;&lt;li&gt;â€¢ treatment&lt;/li&gt;&lt;li&gt;â€¢ respiratory distress&lt;/li&gt;&lt;li&gt;â€¢ newborns&lt;/li&gt;&lt;li&gt;â€¢ born prematurely&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize that alveolar surface tension is inversely proportional to the surfactant concentration per unit area in the lungs .&lt;/li&gt;&lt;li&gt;âž¤ Recognize that alveolar surface tension is inversely proportional to the surfactant concentration per unit area in the lungs .&lt;/li&gt;&lt;li&gt;âž¤ alveolar surface tension&lt;/li&gt;&lt;li&gt;âž¤ inversely proportional&lt;/li&gt;&lt;li&gt;âž¤ surfactant concentration&lt;/li&gt;&lt;li&gt;âž¤ lungs&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg No: 623&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg No: 623&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;S tatement A : During inspiration, the intra-pleural pressure is typically reduced to approximately -6 mm Hg, creating a more negative pressure within the pleural space. S tatement B: Inspiration is a passive process characterized by the expansion of the chest cavity without the active contraction of respiratory muscles. Which of the following options accurately describes the correctness of these statements?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The Statement A is True, the Statement B is False&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The Statement A is False, the Statement B is True&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Both the Statements A and B are True&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Both the Statements A and B are False&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. The Statement A is True, the Statement B is False&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) The Statement A is True, the Statement B is False&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ Statement A: During inspiration , the diaphragm and external intercostal muscles contract , causing the chest cavity to expand and the intra-pleural pressure to become more negative , typically around -6 mm Hg .&lt;/li&gt;&lt;li&gt;â€¢ Statement A:&lt;/li&gt;&lt;li&gt;â€¢ inspiration&lt;/li&gt;&lt;li&gt;â€¢ diaphragm&lt;/li&gt;&lt;li&gt;â€¢ external intercostal muscles contract&lt;/li&gt;&lt;li&gt;â€¢ chest cavity&lt;/li&gt;&lt;li&gt;â€¢ expand&lt;/li&gt;&lt;li&gt;â€¢ intra-pleural&lt;/li&gt;&lt;li&gt;â€¢ pressure&lt;/li&gt;&lt;li&gt;â€¢ negative&lt;/li&gt;&lt;li&gt;â€¢ around -6 mm Hg&lt;/li&gt;&lt;li&gt;â€¢ Statement B: Contrary to common misconception, inspiration is an active process that requires the contraction of respiratory muscles to increase the thoracic volume and facilitate air intake . The statement clarifies this misconception by asserting its falseness. The inspiration is an active process (not passive process),&lt;/li&gt;&lt;li&gt;â€¢ Statement B:&lt;/li&gt;&lt;li&gt;â€¢ inspiration&lt;/li&gt;&lt;li&gt;â€¢ active process&lt;/li&gt;&lt;li&gt;â€¢ contraction&lt;/li&gt;&lt;li&gt;â€¢ respiratory muscles&lt;/li&gt;&lt;li&gt;â€¢ increase&lt;/li&gt;&lt;li&gt;â€¢ thoracic volume&lt;/li&gt;&lt;li&gt;â€¢ facilitate air intake&lt;/li&gt;&lt;li&gt;â€¢ active process&lt;/li&gt;&lt;li&gt;â€¢ When the inspiratory muscles are contracted , the intra thoracic volume will be increased , At the beginning of inspiration , the intra pleural pressure at the base of the lungs will be around â€“ 2.5 mm Hg (in relation to the atmospheric pressure )&lt;/li&gt;&lt;li&gt;â€¢ When the inspiratory muscles are contracted , the intra thoracic volume will be increased , At the beginning of inspiration , the intra pleural pressure at the base of the lungs will be around â€“ 2.5 mm Hg (in relation to the atmospheric pressure )&lt;/li&gt;&lt;li&gt;â€¢ inspiratory muscles&lt;/li&gt;&lt;li&gt;â€¢ contracted&lt;/li&gt;&lt;li&gt;â€¢ intra thoracic volume&lt;/li&gt;&lt;li&gt;â€¢ increased&lt;/li&gt;&lt;li&gt;â€¢ beginning&lt;/li&gt;&lt;li&gt;â€¢ inspiration&lt;/li&gt;&lt;li&gt;â€¢ intra pleural pressure&lt;/li&gt;&lt;li&gt;â€¢ base&lt;/li&gt;&lt;li&gt;â€¢ lungs&lt;/li&gt;&lt;li&gt;â€¢ 2.5 mm Hg&lt;/li&gt;&lt;li&gt;â€¢ atmospheric pressure&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that during inspiration , the intra-pleural pressure decreases (e.g., to - 6 mm Hg ), and that inspiration is an active , not passive, process.&lt;/li&gt;&lt;li&gt;âž¤ Understand that during inspiration , the intra-pleural pressure decreases (e.g., to - 6 mm Hg ), and that inspiration is an active , not passive, process.&lt;/li&gt;&lt;li&gt;âž¤ during inspiration&lt;/li&gt;&lt;li&gt;âž¤ intra-pleural pressure decreases&lt;/li&gt;&lt;li&gt;âž¤ 6 mm Hg&lt;/li&gt;&lt;li&gt;âž¤ active&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 628&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 628&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A team of pediatricians in a neonatal intensive care unit (NICU) is discussing a case of a premature infant born at 28 weeks gestation. The infant is experiencing respiratory distress, a common complication in premature newborns. In the context of surfactants, which of the following statements about pulmonary surfactants is incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prevention of Pulmonary Edema&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Phospholipid Film formation will be Inhibited&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lamellar Bodies involved&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Decrease the Effect of Surface Tension&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Phospholipid Film formation will be Inhibited&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Phospholipid Film Formation will be Inhibited&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pulmonary surfactants reduce the surface tension within the alveoli , which helps to keep the alveoli open during both inspiration and expiration . Without surfactants, the surface tension would be much higher , causing the alveoli to collapse and leading to pulmonary edema . Therefore, this statement is correct .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ reduce&lt;/li&gt;&lt;li&gt;â€¢ surface tension&lt;/li&gt;&lt;li&gt;â€¢ alveoli&lt;/li&gt;&lt;li&gt;â€¢ open&lt;/li&gt;&lt;li&gt;â€¢ both inspiration&lt;/li&gt;&lt;li&gt;â€¢ expiration&lt;/li&gt;&lt;li&gt;â€¢ higher&lt;/li&gt;&lt;li&gt;â€¢ alveoli&lt;/li&gt;&lt;li&gt;â€¢ collapse&lt;/li&gt;&lt;li&gt;â€¢ leading&lt;/li&gt;&lt;li&gt;â€¢ pulmonary edema&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lamellar bodies are found in type II alveolar cells , store and secrete pulmonary surfactants into the alveoli . When surfactants are released from lamellar bodies , they spread across the alveolar surface , reducing surface tension and promoting lung expansion . Therefore, this statement is correct .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ type II alveolar cells&lt;/li&gt;&lt;li&gt;â€¢ store&lt;/li&gt;&lt;li&gt;â€¢ secrete pulmonary surfactants&lt;/li&gt;&lt;li&gt;â€¢ alveoli&lt;/li&gt;&lt;li&gt;â€¢ released&lt;/li&gt;&lt;li&gt;â€¢ lamellar bodies&lt;/li&gt;&lt;li&gt;â€¢ spread&lt;/li&gt;&lt;li&gt;â€¢ alveolar surface&lt;/li&gt;&lt;li&gt;â€¢ reducing surface tension&lt;/li&gt;&lt;li&gt;â€¢ promoting&lt;/li&gt;&lt;li&gt;â€¢ lung expansion&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonary surfactants decrease the effect of surface tension within the alveoli . This reduction in surface tension allows the alveoli to remain open during expiration , preventing their collapse and making it easier for the newborn to breathe . Therefore, this statement is correct .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ decrease&lt;/li&gt;&lt;li&gt;â€¢ effect&lt;/li&gt;&lt;li&gt;â€¢ surface tension&lt;/li&gt;&lt;li&gt;â€¢ alveoli&lt;/li&gt;&lt;li&gt;â€¢ reduction&lt;/li&gt;&lt;li&gt;â€¢ allows&lt;/li&gt;&lt;li&gt;â€¢ alveoli&lt;/li&gt;&lt;li&gt;â€¢ remain open&lt;/li&gt;&lt;li&gt;â€¢ expiration&lt;/li&gt;&lt;li&gt;â€¢ collapse&lt;/li&gt;&lt;li&gt;â€¢ easier&lt;/li&gt;&lt;li&gt;â€¢ newborn&lt;/li&gt;&lt;li&gt;â€¢ breathe&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize that pulmonary surfactants facilitate phospholipid film formation in the alveoli , which is critical for reducing surface tension and preventing alveolar collapse in newborns , especially preterm infants .&lt;/li&gt;&lt;li&gt;âž¤ Recognize that pulmonary surfactants facilitate phospholipid film formation in the alveoli , which is critical for reducing surface tension and preventing alveolar collapse in newborns , especially preterm infants .&lt;/li&gt;&lt;li&gt;âž¤ Recognize that pulmonary surfactants facilitate phospholipid film formation in the alveoli , which is critical for reducing surface tension and preventing alveolar collapse in newborns , especially preterm infants .&lt;/li&gt;&lt;li&gt;âž¤ pulmonary surfactants&lt;/li&gt;&lt;li&gt;âž¤ phospholipid film&lt;/li&gt;&lt;li&gt;âž¤ alveoli&lt;/li&gt;&lt;li&gt;âž¤ reducing surface tension&lt;/li&gt;&lt;li&gt;âž¤ preventing alveolar collapse&lt;/li&gt;&lt;li&gt;âž¤ newborns&lt;/li&gt;&lt;li&gt;âž¤ preterm infants&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 631,632&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 631,632&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old male with a longstanding diagnosis of pulmonary fibrosis presents to the pulmonology clinic. The attending physician wishes to further investigate his lung compliance using a standard technique. The physician notes that with a certain applied pressure, the patientâ€™s lungs inflate with an additional volume of 250 mL. In a subsequent test, a modified pressure results in a 400 mL of lung volume. If the pressure differential between the two tests is 10 cm H2O, calculate the patient&#x27;s lung compliance based on these findings.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;15 mL/cm H2O&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;25 mL/cm H2O&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;40 mL/cm H2O&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;60 mL/cm H2O&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 15 mL/cm H2O&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_37xTfIC.png&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_6ibXrJm.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) 15 mL/cm H2O&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Lung compliance is a measure of how much the lung volume changes in response to pressure. In conditions like pulmonary fibrosis , lung compliance is decreased because the lungs are stiff and less able to expand with applied pressure.&lt;/li&gt;&lt;li&gt;âž¤ pulmonary fibrosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old male with a history of chronic obstructive pulmonary disease (COPD) is admitted to the emergency department with acute shortness of breath. His oxygen saturation is 88% on room air, and he is promptly started on supplemental oxygen. In the context of oxygen transport in the blood, what is the shape of the curve formed between the percentage saturation of the oxygen-carrying capacity of hemoglobin and the partial pressure of oxygen (PO 2 )?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Linear&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sigmoid&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Parabola&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hyperbola&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Sigmoid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/07.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Sigmoid&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The Oxygenâ€“Hemoglobin Dissociation Curve (called as ODC) will depict the relationship between the percentage saturation of the oxygen carrying capacity of hemoglobin ( SaO 2 ) to the partial pressure of oxygen ( PO 2 ) The curve formed will have a characteristic sigmoid shape , because of the interconversion of tense-relaxed ( Tâ€“R ) configurations of hemoglobin The small changes at low oxygen partial pressure will lead to large changes in percentage saturation of hemoglobin The sigmoid shape curve seen in the oxygen-hemoglobin curve is:&lt;/li&gt;&lt;li&gt;â€¢ The Oxygenâ€“Hemoglobin Dissociation Curve (called as ODC) will depict the relationship between the percentage saturation of the oxygen carrying capacity of hemoglobin ( SaO 2 ) to the partial pressure of oxygen ( PO 2 )&lt;/li&gt;&lt;li&gt;â€¢ depict&lt;/li&gt;&lt;li&gt;â€¢ relationship&lt;/li&gt;&lt;li&gt;â€¢ percentage saturation&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ carrying capacity&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ SaO 2&lt;/li&gt;&lt;li&gt;â€¢ partial pressure&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ PO 2&lt;/li&gt;&lt;li&gt;â€¢ The curve formed will have a characteristic sigmoid shape , because of the interconversion of tense-relaxed ( Tâ€“R ) configurations of hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ sigmoid shape&lt;/li&gt;&lt;li&gt;â€¢ interconversion&lt;/li&gt;&lt;li&gt;â€¢ tense-relaxed&lt;/li&gt;&lt;li&gt;â€¢ Tâ€“R&lt;/li&gt;&lt;li&gt;â€¢ configurations&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ The small changes at low oxygen partial pressure will lead to large changes in percentage saturation of hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ small changes&lt;/li&gt;&lt;li&gt;â€¢ low oxygen partial pressure&lt;/li&gt;&lt;li&gt;â€¢ large changes&lt;/li&gt;&lt;li&gt;â€¢ percentage saturation&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ The sigmoid shape curve seen in the oxygen-hemoglobin curve is:&lt;/li&gt;&lt;li&gt;â€¢ sigmoid shape curve&lt;/li&gt;&lt;li&gt;â€¢ oxygen-hemoglobin curve&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the sigmoid shape of the oxygen-hemoglobin dissociation curve , which illustrates the relationship between hemoglobin saturation and the partial pressure of oxygen ( PO 2 ).&lt;/li&gt;&lt;li&gt;âž¤ Recognize the sigmoid shape of the oxygen-hemoglobin dissociation curve , which illustrates the relationship between hemoglobin saturation and the partial pressure of oxygen ( PO 2 ).&lt;/li&gt;&lt;li&gt;âž¤ sigmoid shape&lt;/li&gt;&lt;li&gt;âž¤ oxygen-hemoglobin dissociation curve&lt;/li&gt;&lt;li&gt;âž¤ between&lt;/li&gt;&lt;li&gt;âž¤ hemoglobin saturation&lt;/li&gt;&lt;li&gt;âž¤ partial pressure&lt;/li&gt;&lt;li&gt;âž¤ oxygen&lt;/li&gt;&lt;li&gt;âž¤ PO 2&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 640&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 640&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In evaluating a patient&#x27;s respiratory function, understanding the relationship between hemoglobin&#x27;s oxygenation status and its capacity to carry carbon dioxide is important. Which of the following statements is correct regarding deoxygenated hemoglobin and the release of carbon dioxide in the lungs?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Deoxygenated Hemoglobin has a Decreased Capacity to Carry Carbon Dioxide, and the release of Carbon Dioxide is facilitated in the Lungs.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Deoxygenated Hemoglobin has a Decreased Capacity to Carry Carbon Dioxide, but the release of Carbon Dioxide is not facilitated in the Lungs.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Deoxygenated Hemoglobin has an Increased Capacity to Carry Carbon Dioxide, but the release of Carbon Dioxide is facilitated in the Lungs.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Both the Capacity of Deoxygenated Hemoglobin to Carry Carbon Dioxide and the release of Carbon Dioxide in the Lungs are Decreased.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Deoxygenated Hemoglobin has an Increased Capacity to Carry Carbon Dioxide, but the release of Carbon Dioxide is facilitated in the Lungs.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/08.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Deoxygenated&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Incorrect . Deoxygenated haemoglobin actually has an increased capacity to carry carbon dioxide (the Haldane effect ), not decreased.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ increased capacity&lt;/li&gt;&lt;li&gt;â€¢ carry carbon dioxide&lt;/li&gt;&lt;li&gt;â€¢ Haldane effect&lt;/li&gt;&lt;li&gt;â€¢ Option B. Incorrect . The assertion is incorrect as deoxygenated hemoglobin has an increased capacity to carry carbon dioxide , and the reason is correct about the facilitation of carbon dioxide release in the lungs .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ deoxygenated hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ increased capacity&lt;/li&gt;&lt;li&gt;â€¢ carry carbon dioxide&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ facilitation&lt;/li&gt;&lt;li&gt;â€¢ carbon dioxide&lt;/li&gt;&lt;li&gt;â€¢ lungs&lt;/li&gt;&lt;li&gt;â€¢ Option D. Incorrect . Deoxygenated hemoglobin has an increased capacity to carry carbon dioxide , and the release of carbon dioxide in the lungs is facilitated.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ increased capacity&lt;/li&gt;&lt;li&gt;â€¢ carry carbon dioxide&lt;/li&gt;&lt;li&gt;â€¢ release&lt;/li&gt;&lt;li&gt;â€¢ carbon dioxide&lt;/li&gt;&lt;li&gt;â€¢ lungs&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ To understand the Haldane effect , where deoxygenated hemoglobin has an increased capacity to bind carbon dioxide , and the physiological mechanisms facilitating carbon dioxide release in the lungs , important in respiratory physiology and pathophysiology .Top of Form&lt;/li&gt;&lt;li&gt;âž¤ To understand the Haldane effect , where deoxygenated hemoglobin has an increased capacity to bind carbon dioxide , and the physiological mechanisms facilitating carbon dioxide release in the lungs , important in respiratory physiology and pathophysiology .Top of Form&lt;/li&gt;&lt;li&gt;âž¤ Haldane effect&lt;/li&gt;&lt;li&gt;âž¤ deoxygenated hemoglobin&lt;/li&gt;&lt;li&gt;âž¤ increased capacity&lt;/li&gt;&lt;li&gt;âž¤ bind carbon dioxide&lt;/li&gt;&lt;li&gt;âž¤ physiological mechanisms&lt;/li&gt;&lt;li&gt;âž¤ carbon dioxide release&lt;/li&gt;&lt;li&gt;âž¤ lungs&lt;/li&gt;&lt;li&gt;âž¤ respiratory physiology&lt;/li&gt;&lt;li&gt;âž¤ pathophysiology&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg. No: 642&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg. No: 642&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a discussion about the factors affecting oxygen delivery to tissues, the variations in the oxygen dissociation curve are being reviewed. Which of the following conditions regarding these variations is incorrectly matched?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased pH â€“ Left Shift&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increased pCO 2 â€“ Left Shift&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased Temperature â€“ Right Shift&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased H + - Right Shift&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Increased pCO 2 â€“ Left Shift&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/09.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Increased pCO2â€“ Left Shift&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Correct . Increased pH (alkalosis) causes a leftward shift in the oxygen dissociation curve , indicating a higher affinity of hemoglobin for oxygen .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Correct&lt;/li&gt;&lt;li&gt;â€¢ Increased pH&lt;/li&gt;&lt;li&gt;â€¢ leftward shift&lt;/li&gt;&lt;li&gt;â€¢ oxygen dissociation curve&lt;/li&gt;&lt;li&gt;â€¢ higher affinity&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ Option C. Correct . Increased temperature causes a rightward shift in the oxygen dissociation curve , decreasing hemoglobin&#x27;s affinity for oxygen and facilitating oxygen release .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Correct&lt;/li&gt;&lt;li&gt;â€¢ Increased temperature&lt;/li&gt;&lt;li&gt;â€¢ rightward shift&lt;/li&gt;&lt;li&gt;â€¢ oxygen dissociation curve&lt;/li&gt;&lt;li&gt;â€¢ decreasing hemoglobin&#x27;s affinity&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ facilitating oxygen release&lt;/li&gt;&lt;li&gt;â€¢ Option D. Correct . Increased H+ (acidosis) leads to a rightward shift in the oxygen dissociation curve , reducing hemoglobin&#x27;s affinity for oxygen , which aids in oxygen unloading in tissues .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Correct&lt;/li&gt;&lt;li&gt;â€¢ Increased H+&lt;/li&gt;&lt;li&gt;â€¢ rightward shift&lt;/li&gt;&lt;li&gt;â€¢ oxygen dissociation curve&lt;/li&gt;&lt;li&gt;â€¢ reducing hemoglobin&#x27;s affinity&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ aids&lt;/li&gt;&lt;li&gt;â€¢ oxygen unloading&lt;/li&gt;&lt;li&gt;â€¢ tissues&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ To understand the factors influencing the oxygen dissociation curve , particularly the effects of pH , pCO 2 , temperature , and H+ concentration , which is essential in understanding oxygen transport and delivery under various physiological and pathological conditions .&lt;/li&gt;&lt;li&gt;âž¤ To understand the factors influencing the oxygen dissociation curve , particularly the effects of pH , pCO 2 , temperature , and H+ concentration , which is essential in understanding oxygen transport and delivery under various physiological and pathological conditions .&lt;/li&gt;&lt;li&gt;âž¤ oxygen dissociation curve&lt;/li&gt;&lt;li&gt;âž¤ effects of pH&lt;/li&gt;&lt;li&gt;âž¤ pCO 2&lt;/li&gt;&lt;li&gt;âž¤ temperature&lt;/li&gt;&lt;li&gt;âž¤ H+ concentration&lt;/li&gt;&lt;li&gt;âž¤ understanding oxygen transport&lt;/li&gt;&lt;li&gt;âž¤ delivery&lt;/li&gt;&lt;li&gt;âž¤ physiological&lt;/li&gt;&lt;li&gt;âž¤ pathological conditions&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg. No: 641&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg. No: 641&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old patient with a history of chronic obstructive pulmonary disease (COPD) is admitted to the emergency department with severe shortness of breath. The ABG results indicate an elevated partial pressure of carbon dioxide (PCO2). The physician explains the concept to the medical students. In the context of this, consider the following statements Physiologically which of the following is true in the normal healthy adult: Statement A : The partial pressure of carbon dioxide in the blood leaving the lungs will be 40 mm Hg Statement B : The carbon dioxide can pass through all the biological membranes easily Which of the following is true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The Statement A is True, the Statement B is False&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The Statement A is False, the Statement B is True&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Both the Statements A and B are True&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Both the Statements A and B are False&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Both the Statements A and B are True&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Both the Statements A and B are True&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Statement A : The Carbon Dioxide will diffuse from the Venous Blood ( pCO 2 of 46 mm Hg ) into the Alveoli ( pCO 2 of 40 mm Hg ) along the gradient&lt;/li&gt;&lt;li&gt;â€¢ Statement A&lt;/li&gt;&lt;li&gt;â€¢ Carbon Dioxide&lt;/li&gt;&lt;li&gt;â€¢ Venous Blood&lt;/li&gt;&lt;li&gt;â€¢ pCO 2&lt;/li&gt;&lt;li&gt;â€¢ 46 mm Hg&lt;/li&gt;&lt;li&gt;â€¢ Alveoli&lt;/li&gt;&lt;li&gt;â€¢ pCO 2&lt;/li&gt;&lt;li&gt;â€¢ 40 mm Hg&lt;/li&gt;&lt;li&gt;â€¢ gradient&lt;/li&gt;&lt;li&gt;â€¢ Statement B : The Diffusing Capacity of Carbon Dioxide will be much Greater than that of Oxygen&lt;/li&gt;&lt;li&gt;â€¢ Statement B&lt;/li&gt;&lt;li&gt;â€¢ Diffusing Capacity&lt;/li&gt;&lt;li&gt;â€¢ Carbon Dioxide&lt;/li&gt;&lt;li&gt;â€¢ Greater than&lt;/li&gt;&lt;li&gt;â€¢ Oxygen&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that the partial pressure of carbon dioxide in blood leaving the lungs is typically around 40 mm Hg and that carbon dioxide can easily diffuse through biological membranes .&lt;/li&gt;&lt;li&gt;âž¤ Understand that the partial pressure of carbon dioxide in blood leaving the lungs is typically around 40 mm Hg and that carbon dioxide can easily diffuse through biological membranes .&lt;/li&gt;&lt;li&gt;âž¤ Understand that the partial pressure of carbon dioxide in blood leaving the lungs is typically around 40 mm Hg and that carbon dioxide can easily diffuse through biological membranes .&lt;/li&gt;&lt;li&gt;âž¤ partial pressure&lt;/li&gt;&lt;li&gt;âž¤ carbon dioxide&lt;/li&gt;&lt;li&gt;âž¤ blood&lt;/li&gt;&lt;li&gt;âž¤ lungs&lt;/li&gt;&lt;li&gt;âž¤ around 40 mm Hg&lt;/li&gt;&lt;li&gt;âž¤ carbon dioxide&lt;/li&gt;&lt;li&gt;âž¤ diffuse&lt;/li&gt;&lt;li&gt;âž¤ biological membranes&lt;/li&gt;&lt;li&gt;âž¤ Ref :  Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 635&lt;/li&gt;&lt;li&gt;âž¤ Ref :  Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 635&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old patient with a history of chronic respiratory alkalosis due to hyperventilation presents to the emergency department. The patient&#x27;s arterial blood gases (ABG) reveal an elevated pH and decreased pCO2. The physician discusses the factors affecting oxygen release from hemoglobin. Which of the following options accurately identifies the factor that will NOT prevent the release of oxygen from hemoglobin in this case?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decreased pCO 2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increased Temperature&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased pH&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased Oxygen Affinity&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Increased Temperature&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/10.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Increased Temperature&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ Option A. A decreased partial pressure of carbon dioxide (pCO2) will prevent the release of oxygen from hemoglobin and enhance the binding of oxygen to H b. This is known as the Halden effect, where a lower pCO2 levels increase the oxygen-binding capacity of hemoglobin, facilitating oxygen loading on hemoglobin.&lt;/li&gt;&lt;li&gt;â€¢ Option A. A decreased partial pressure of carbon dioxide (pCO2)&lt;/li&gt;&lt;li&gt;â€¢ b. This is known as the Halden effect, where a lower pCO2 levels increase the oxygen-binding capacity of hemoglobin, facilitating oxygen loading on hemoglobin.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Elevated pH ( alkalosis ) can increase the oxygen affinity of hemoglobin and prevent oxygen release. Hemoglobin releases oxygen under acidic pH.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Elevated pH&lt;/li&gt;&lt;li&gt;â€¢ alkalosis&lt;/li&gt;&lt;li&gt;â€¢ Option D. An increased oxygen affinity means that hemoglobin binds oxygen more tightly. This will prevent the release of oxygen from hemoglobin and enhance the binding of oxygen to Hb&lt;/li&gt;&lt;li&gt;â€¢ Option D. An increased oxygen affinity means&lt;/li&gt;&lt;li&gt;â€¢ more tightly.&lt;/li&gt;&lt;li&gt;â€¢ from hemoglobin and enhance the binding of oxygen to Hb&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the factors that influence oxygen release from hemoglobin . In this case, the correct Ans highlights that increased temperature promotes oxygen release from hemoglobin , contrary to the other factors mentioned which can affect oxygen binding but do not prevent its release.Top of Form&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the factors that influence oxygen release from hemoglobin . In this case, the correct Ans highlights that increased temperature promotes oxygen release from hemoglobin , contrary to the other factors mentioned which can affect oxygen binding but do not prevent its release.Top of Form&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the factors that influence oxygen release from hemoglobin . In this case, the correct Ans highlights that increased temperature promotes oxygen release from hemoglobin , contrary to the other factors mentioned which can affect oxygen binding but do not prevent its release.Top of Form&lt;/li&gt;&lt;li&gt;âž¤ understand&lt;/li&gt;&lt;li&gt;âž¤ influence oxygen release&lt;/li&gt;&lt;li&gt;âž¤ hemoglobin&lt;/li&gt;&lt;li&gt;âž¤ increased temperature&lt;/li&gt;&lt;li&gt;âž¤ oxygen release&lt;/li&gt;&lt;li&gt;âž¤ hemoglobin&lt;/li&gt;&lt;li&gt;âž¤ affect oxygen&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 641&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 641&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a respiratory physiology, on the discussion the transport of carbon dioxide in the blood and its interactions with hemoglobin. Consider the following statements: Statement A: The carbon dioxide in the erythrocytes can react with amino groups of hemoglobin. Statement B: The carbon dioxide uptake will be facilitated in the lungs. Which of the following options give accurate representation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The Statement A is True, the Statement B is False&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The Statement A is False, the Statement B is True&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Both the Statements A and B are True&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Both the Statements A and B are False&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. The Statement A is True, the Statement B is False&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/picture1_7kqC46n.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) The Statement A is True, the Statement B is False&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Statement A (True): Carbon dioxide (CO 2 ) in the blood can react with amino groups of hemoglobin to form carbamino compounds . This reaction, known as carbamino formation , is one of the mechanisms by which CO 2 is transported in the blood .&lt;/li&gt;&lt;li&gt;â€¢ Statement A (True):&lt;/li&gt;&lt;li&gt;â€¢ Carbon dioxide&lt;/li&gt;&lt;li&gt;â€¢ amino groups&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ carbamino compounds&lt;/li&gt;&lt;li&gt;â€¢ carbamino formation&lt;/li&gt;&lt;li&gt;â€¢ CO 2&lt;/li&gt;&lt;li&gt;â€¢ transported&lt;/li&gt;&lt;li&gt;â€¢ blood&lt;/li&gt;&lt;li&gt;â€¢ Statement B (False): Carbon dioxide uptake in the lungs involves the release of CO 2 from carbamino compounds and bicarbonate ions , allowing it to be exhaled . This process is facilitated in the lungs , not its uptake&lt;/li&gt;&lt;li&gt;â€¢ Statement B (False):&lt;/li&gt;&lt;li&gt;â€¢ release&lt;/li&gt;&lt;li&gt;â€¢ CO 2&lt;/li&gt;&lt;li&gt;â€¢ carbamino compounds&lt;/li&gt;&lt;li&gt;â€¢ bicarbonate ions&lt;/li&gt;&lt;li&gt;â€¢ exhaled&lt;/li&gt;&lt;li&gt;â€¢ lungs&lt;/li&gt;&lt;li&gt;â€¢ A part of the carbon dioxide (CO 2 ) in the red blood cells will react with the amino groups of the hemoglobin and also with other proteins This results in the formation of carbamino compounds which can be seen as:&lt;/li&gt;&lt;li&gt;â€¢ A part of the carbon dioxide (CO 2 ) in the red blood cells will react with the amino groups of the hemoglobin and also with other proteins&lt;/li&gt;&lt;li&gt;â€¢ carbon dioxide&lt;/li&gt;&lt;li&gt;â€¢ (CO 2 )&lt;/li&gt;&lt;li&gt;â€¢ red blood cells&lt;/li&gt;&lt;li&gt;â€¢ amino groups&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ proteins&lt;/li&gt;&lt;li&gt;â€¢ This results in the formation of carbamino compounds which can be seen as:&lt;/li&gt;&lt;li&gt;â€¢ formation&lt;/li&gt;&lt;li&gt;â€¢ carbamino compounds&lt;/li&gt;&lt;li&gt;â€¢ The uptake of carbon dioxide will be facilitated in the tissues (not lungs as mentioned), where CO 2 will be accumulated as a result of metabolism.&lt;/li&gt;&lt;li&gt;â€¢ The uptake of carbon dioxide will be facilitated in the tissues (not lungs as mentioned), where CO 2 will be accumulated as a result of metabolism.&lt;/li&gt;&lt;li&gt;â€¢ uptake&lt;/li&gt;&lt;li&gt;â€¢ tissues&lt;/li&gt;&lt;li&gt;â€¢ CO 2&lt;/li&gt;&lt;li&gt;â€¢ accumulated&lt;/li&gt;&lt;li&gt;â€¢ result of metabolism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize that carbon dioxide in erythrocytes can react with amino groups of hemoglobin , and that carbon dioxide uptake is actually facilitated in the tissues , not in the lungs.&lt;/li&gt;&lt;li&gt;âž¤ Recognize that carbon dioxide in erythrocytes can react with amino groups of hemoglobin , and that carbon dioxide uptake is actually facilitated in the tissues , not in the lungs.&lt;/li&gt;&lt;li&gt;âž¤ carbon dioxide&lt;/li&gt;&lt;li&gt;âž¤ erythrocytes&lt;/li&gt;&lt;li&gt;âž¤ amino groups&lt;/li&gt;&lt;li&gt;âž¤ hemoglobin&lt;/li&gt;&lt;li&gt;âž¤ carbon dioxide&lt;/li&gt;&lt;li&gt;âž¤ facilitated&lt;/li&gt;&lt;li&gt;âž¤ tissues&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg No: 642&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg No: 642&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old male developed acute mountain sickness during a trekking expedition. He was rushed to the nearby hospital and admitted to the emergency ward. An immediate ABG analysis was done. Which of the following could be expected in the oxygen dissociation curve of this individual, if his pCO 2 is High?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oxygen Dissociation Curve will become Linear&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oxygen Dissociation Curve will be Shifted to the Right&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oxygen Dissociation Curve will be Shifted to the Left&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No Effect on the Oxygen Dissociation Curve&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Oxygen Dissociation Curve will be Shifted to the Right&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/11.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Oxygen Dissociation Curve will be Shifted to the Right&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Incorrect . Changes in pCO 2 levels do not linearize the oxygen dissociation curve; they shift its position either to the right or left .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ pCO 2&lt;/li&gt;&lt;li&gt;â€¢ position&lt;/li&gt;&lt;li&gt;â€¢ right&lt;/li&gt;&lt;li&gt;â€¢ left&lt;/li&gt;&lt;li&gt;â€¢ Option C. Incorrect . A leftward shift occurs in conditions like alkalosis ( decreased pCO 2 or increased pH ), not with high pCO 2 .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ leftward shift&lt;/li&gt;&lt;li&gt;â€¢ alkalosis&lt;/li&gt;&lt;li&gt;â€¢ decreased pCO 2&lt;/li&gt;&lt;li&gt;â€¢ increased pH&lt;/li&gt;&lt;li&gt;â€¢ Option D. Incorrect . Changes in pCO 2 significantly affect the oxygen dissociation curve , shifting its position to either the right or left depending on the direction of change .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Changes&lt;/li&gt;&lt;li&gt;â€¢ pCO 2&lt;/li&gt;&lt;li&gt;â€¢ affect&lt;/li&gt;&lt;li&gt;â€¢ oxygen dissociation curve&lt;/li&gt;&lt;li&gt;â€¢ position&lt;/li&gt;&lt;li&gt;â€¢ either&lt;/li&gt;&lt;li&gt;â€¢ right&lt;/li&gt;&lt;li&gt;â€¢ left&lt;/li&gt;&lt;li&gt;â€¢ direction&lt;/li&gt;&lt;li&gt;â€¢ change&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ To understand the impact of pCO 2 levels on the oxygen dissociation curve , especially how high pCO2 levels lead to a rightward shift , which is crucial in managing conditions like acute mountain sickness and understanding oxygen delivery mechanisms under different physiological states .Top of Form&lt;/li&gt;&lt;li&gt;âž¤ To understand the impact of pCO 2 levels on the oxygen dissociation curve , especially how high pCO2 levels lead to a rightward shift , which is crucial in managing conditions like acute mountain sickness and understanding oxygen delivery mechanisms under different physiological states .Top of Form&lt;/li&gt;&lt;li&gt;âž¤ impact&lt;/li&gt;&lt;li&gt;âž¤ pCO 2 levels&lt;/li&gt;&lt;li&gt;âž¤ oxygen dissociation curve&lt;/li&gt;&lt;li&gt;âž¤ high pCO2 levels&lt;/li&gt;&lt;li&gt;âž¤ rightward shift&lt;/li&gt;&lt;li&gt;âž¤ managing conditions&lt;/li&gt;&lt;li&gt;âž¤ acute mountain sickness&lt;/li&gt;&lt;li&gt;âž¤ oxygen delivery mechanisms&lt;/li&gt;&lt;li&gt;âž¤ physiological states&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 641&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 641&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In understanding the changes that occur in stored blood, particularly in relation to oxygen delivery, which of the following statements is correct regarding the oxygen dissociation curve and levels of 2,3-diphosphoglycerate (2,3-DPG) in stored blood?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The Oxygen Dissociation Curve Shifts to the Right due to Increased Levels of 2, 3-DPG in Stored Blood.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The Oxygen Dissociation Curve Shifts to the Right, but Levels of 2, 3-DPG Decrease in Stored Blood.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The Oxygen Dissociation Curve Shifts to the Left due to Increased Levels of 2, 3-DPG in Stored Blood.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The Oxygen Dissociation Curve Shifts to the Left and Levels of 2, 3-DPG Decrease in Stored Blood.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. The Oxygen Dissociation Curve Shifts to the Left and Levels of 2, 3-DPG Decrease in Stored Blood.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/12.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) The Oxygen Dissociation Curve Shifts to the Left and Levels of 2, 3-DPG Decrease in Stored Blood.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Incorrect . In stored blood , levels of 2, 3-DPG decrease , not increase, which would not cause a rightward shift in the oxygen dissociation curve.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ stored blood&lt;/li&gt;&lt;li&gt;â€¢ decrease&lt;/li&gt;&lt;li&gt;â€¢ Option B. Incorrect . While the oxygen dissociation curve does shift in stored blood , it shifts to the left , not to the right, due to a decrease in 2, 3-DPG levels .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ oxygen dissociation curve&lt;/li&gt;&lt;li&gt;â€¢ stored blood&lt;/li&gt;&lt;li&gt;â€¢ shifts&lt;/li&gt;&lt;li&gt;â€¢ left&lt;/li&gt;&lt;li&gt;â€¢ decrease&lt;/li&gt;&lt;li&gt;â€¢ 2, 3-DPG levels&lt;/li&gt;&lt;li&gt;â€¢ Option C. Incorrect . Although 2,3-DPG levels decrease in stored blood , this leads to a leftward shift in the oxygen dissociation curve , not a rightward shift.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ decrease&lt;/li&gt;&lt;li&gt;â€¢ stored blood&lt;/li&gt;&lt;li&gt;â€¢ leftward shift&lt;/li&gt;&lt;li&gt;â€¢ oxygen dissociation curve&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ To understand the changes in oxygen delivery characteristics of stored blood , particularly the decrease in 2, 3-DPG levels over time and its impact on the oxygen dissociation curve , which is crucial for clinical decisions regarding blood transfusions and managing patients with stored blood .&lt;/li&gt;&lt;li&gt;âž¤ To understand the changes in oxygen delivery characteristics of stored blood , particularly the decrease in 2, 3-DPG levels over time and its impact on the oxygen dissociation curve , which is crucial for clinical decisions regarding blood transfusions and managing patients with stored blood .&lt;/li&gt;&lt;li&gt;âž¤ To understand the changes in oxygen delivery characteristics of stored blood , particularly the decrease in 2, 3-DPG levels over time and its impact on the oxygen dissociation curve , which is crucial for clinical decisions regarding blood transfusions and managing patients with stored blood .&lt;/li&gt;&lt;li&gt;âž¤ oxygen delivery&lt;/li&gt;&lt;li&gt;âž¤ stored blood&lt;/li&gt;&lt;li&gt;âž¤ decrease&lt;/li&gt;&lt;li&gt;âž¤ 2, 3-DPG levels&lt;/li&gt;&lt;li&gt;âž¤ impact&lt;/li&gt;&lt;li&gt;âž¤ oxygen dissociation curve&lt;/li&gt;&lt;li&gt;âž¤ regarding blood transfusions&lt;/li&gt;&lt;li&gt;âž¤ managing patients&lt;/li&gt;&lt;li&gt;âž¤ stored blood&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 641, 642&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 641, 642&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67-year-old male with a history of chronic bronchitis is admitted to the hospital with shortness of breath and a productive cough. His arterial blood gas (ABG) analysis shows elevated levels of carbon dioxide. The attending physician uses this opportunity to discuss with a group of medical students about the transport of carbon dioxide in the blood. What is the major form through which carbon dioxide is carried in the blood?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dissolved Form&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carboxy-Hb&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bicarbonate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Carbamino-Hb&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Bicarbonate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/13.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Bicarbonate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. A small portion of carbon dioxide is carried in Dissolved Form. CO 2 is somewhat soluble in blood , but the capacity for direct dissolution is limited .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Dissolved&lt;/li&gt;&lt;li&gt;â€¢ soluble&lt;/li&gt;&lt;li&gt;â€¢ blood&lt;/li&gt;&lt;li&gt;â€¢ direct dissolution&lt;/li&gt;&lt;li&gt;â€¢ limited&lt;/li&gt;&lt;li&gt;â€¢ Option B. Carboxyhaemoglobin (Carboxy-Hb) form involves carbon dioxide binding directly to haemoglobin . However, it is not a major pathway for CO 2 transport. It&#x27;s more relevant for other gases like carbon monoxide.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Carboxyhaemoglobin&lt;/li&gt;&lt;li&gt;â€¢ carbon dioxide&lt;/li&gt;&lt;li&gt;â€¢ haemoglobin&lt;/li&gt;&lt;li&gt;â€¢ Option D. Carbamino-Hemoglobins (Carbamino-Hb) : Here, CO 2 binds to the amino groups on haemoglobin to form carbamino compounds. While this contributes to CO 2 transport , it is not the primary method.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Carbamino-Hemoglobins&lt;/li&gt;&lt;li&gt;â€¢ amino groups&lt;/li&gt;&lt;li&gt;â€¢ haemoglobin&lt;/li&gt;&lt;li&gt;â€¢ form carbamino compounds.&lt;/li&gt;&lt;li&gt;â€¢ CO 2 transport&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize that the major form of carbon dioxide transport in the blood is as bicarbonate .&lt;/li&gt;&lt;li&gt;âž¤ Recognize that the major form of carbon dioxide transport in the blood is as bicarbonate .&lt;/li&gt;&lt;li&gt;âž¤ major form&lt;/li&gt;&lt;li&gt;âž¤ carbon dioxide transport&lt;/li&gt;&lt;li&gt;âž¤ blood&lt;/li&gt;&lt;li&gt;âž¤ bicarbonate&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg No: 643&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg No: 643&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following factors will not have an influence on the oxygen dissociation curve? Temperature Hydrogen Ion Concentration 2,3-Bisphosphoglycerate Partial Pressure of CO 2&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;None&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;2 only&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1,2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;2,3&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. None&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/14.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) None&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The Oxygenâ€“Hemoglobin Dissociation Curve will depict the relationship between the percentage saturation of the oxygen carrying capacity of hemoglobin ( SaO 2 ) to the partial pressure of oxygen ( PO 2 ). The ODC will be influenced by factors like temperature , hydrogen ion concentration ( pH ), the levels of 2,3-diphosphoglycerate or bisphosphoglycerate ( 2,3-DPG or 2,3-BPG ) and the partial pressure of carbon dioxide ( pCO 2 ) Note the words â€˜will not have an influenceâ€™, so the Ans will be â€˜Noneâ€™.&lt;/li&gt;&lt;li&gt;â€¢ The Oxygenâ€“Hemoglobin Dissociation Curve will depict the relationship between the percentage saturation of the oxygen carrying capacity of hemoglobin ( SaO 2 ) to the partial pressure of oxygen ( PO 2 ).&lt;/li&gt;&lt;li&gt;â€¢ Oxygenâ€“Hemoglobin Dissociation Curve&lt;/li&gt;&lt;li&gt;â€¢ between&lt;/li&gt;&lt;li&gt;â€¢ percentage saturation&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ carrying capacity&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ SaO 2&lt;/li&gt;&lt;li&gt;â€¢ partial pressure&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ PO 2&lt;/li&gt;&lt;li&gt;â€¢ The ODC will be influenced by factors like temperature , hydrogen ion concentration ( pH ), the levels of 2,3-diphosphoglycerate or bisphosphoglycerate ( 2,3-DPG or 2,3-BPG ) and the partial pressure of carbon dioxide ( pCO 2 )&lt;/li&gt;&lt;li&gt;â€¢ temperature&lt;/li&gt;&lt;li&gt;â€¢ hydrogen ion concentration&lt;/li&gt;&lt;li&gt;â€¢ pH&lt;/li&gt;&lt;li&gt;â€¢ levels&lt;/li&gt;&lt;li&gt;â€¢ 2,3-diphosphoglycerate&lt;/li&gt;&lt;li&gt;â€¢ bisphosphoglycerate&lt;/li&gt;&lt;li&gt;â€¢ 2,3-DPG&lt;/li&gt;&lt;li&gt;â€¢ 2,3-BPG&lt;/li&gt;&lt;li&gt;â€¢ partial pressure&lt;/li&gt;&lt;li&gt;â€¢ carbon dioxide&lt;/li&gt;&lt;li&gt;â€¢ pCO 2&lt;/li&gt;&lt;li&gt;â€¢ Note the words â€˜will not have an influenceâ€™, so the Ans will be â€˜Noneâ€™.&lt;/li&gt;&lt;li&gt;â€¢ Increase and decrease of different factors causing shift of oxy-Haemoglobin curve is shown as&lt;/li&gt;&lt;li&gt;â€¢ Increase&lt;/li&gt;&lt;li&gt;â€¢ decrease&lt;/li&gt;&lt;li&gt;â€¢ different factors&lt;/li&gt;&lt;li&gt;â€¢ shift&lt;/li&gt;&lt;li&gt;â€¢ oxy-Haemoglobin curve&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that temperature , hydrogen ion concentration , 2, 3-bisphosphoglycerate levels , and partial pressure of CO 2 all influence the oxygen dissociation curve .&lt;/li&gt;&lt;li&gt;âž¤ Understand that temperature , hydrogen ion concentration , 2, 3-bisphosphoglycerate levels , and partial pressure of CO 2 all influence the oxygen dissociation curve .&lt;/li&gt;&lt;li&gt;âž¤ temperature&lt;/li&gt;&lt;li&gt;âž¤ hydrogen ion concentration&lt;/li&gt;&lt;li&gt;âž¤ 2, 3-bisphosphoglycerate levels&lt;/li&gt;&lt;li&gt;âž¤ partial pressure&lt;/li&gt;&lt;li&gt;âž¤ CO 2&lt;/li&gt;&lt;li&gt;âž¤ oxygen dissociation curve&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg No: 640, 641&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg No: 640, 641&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old patient with Chronic Respiratory Disease is undergoing Evaluation for Oxygen Therapy. Understanding the Oxygen-Carrying Capacity of Hemoglobin is crucial in this context. Which of the following best describes the relationship between Hemoglobin Saturation and Levels?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hemoglobin Saturation Decreases with Increasing Oxygen Partial Pressure.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hemoglobin Saturation is Inversely Proportional to the Partial Pressure of Oxygen.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hemoglobin Saturation Increases with Increasing Oxygen Partial Pressure, due to Cooperative Binding of Oxygen Molecules.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hemoglobin Saturation is unrelated to the Partial Pressure of Oxygen.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hemoglobin Saturation Increases with Increasing Oxygen Partial Pressure, due to Cooperative Binding of Oxygen Molecules.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Hemoglobin Saturation Increases with Increasing Oxygen Partial Pressure, due to Cooperative Binding of Oxygen Molecules.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Incorrect . This contradicts the physiological response ; hemoglobin saturation increases with Saturation Increases with Increasing Oxygen Partial Pressure , due to Cooperative Binding of Oxygen Molecules&lt;/li&gt;&lt;li&gt;â€¢ Option A. Incorrect&lt;/li&gt;&lt;li&gt;â€¢ physiological response&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ saturation increases&lt;/li&gt;&lt;li&gt;â€¢ Increases&lt;/li&gt;&lt;li&gt;â€¢ Increasing Oxygen Partial Pressure&lt;/li&gt;&lt;li&gt;â€¢ Cooperative Binding&lt;/li&gt;&lt;li&gt;â€¢ Oxygen Molecules&lt;/li&gt;&lt;li&gt;â€¢ Option B. Incorrect. It suggests a decrease in hemoglobin saturation with increasing PaO 2 , opposite to the actual physiological relationship .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Incorrect.&lt;/li&gt;&lt;li&gt;â€¢ decrease&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin saturation&lt;/li&gt;&lt;li&gt;â€¢ increasing PaO 2&lt;/li&gt;&lt;li&gt;â€¢ opposite&lt;/li&gt;&lt;li&gt;â€¢ actual physiological relationship&lt;/li&gt;&lt;li&gt;â€¢ Option D. Incorrect. Hemoglobin&#x27;s oxygen saturation is directly influenced by PaO 2 levels .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Incorrect. Hemoglobin&#x27;s oxygen&lt;/li&gt;&lt;li&gt;â€¢ directly&lt;/li&gt;&lt;li&gt;â€¢ PaO 2 levels&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Understand the relationship between partial pressure of oxygen and hemoglobin saturation , crucial for effective management of oxygen therapy in respiratory diseases .&lt;/li&gt;&lt;li&gt;âž¤ Understand the relationship between partial pressure of oxygen and hemoglobin saturation , crucial for effective management of oxygen therapy in respiratory diseases .&lt;/li&gt;&lt;li&gt;âž¤ between partial pressure&lt;/li&gt;&lt;li&gt;âž¤ oxygen&lt;/li&gt;&lt;li&gt;âž¤ hemoglobin&lt;/li&gt;&lt;li&gt;âž¤ saturation&lt;/li&gt;&lt;li&gt;âž¤ effective management&lt;/li&gt;&lt;li&gt;âž¤ oxygen therapy&lt;/li&gt;&lt;li&gt;âž¤ respiratory diseases&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg No: 640&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg No: 640&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient undergoing treatment for Chronic Anemia has been noted to have a Decrease in 2, 3-DPG Levels. The Healthcare Team is considering the implications for Oxygen Delivery to Tissues. What effect would a Decreased Level of 2, 3-DPG have on the Oxygen Dissociation Curve of Hemoglobin?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It would cause a Rightward Shift, indicating Increased Oxygen Release to Tissues.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It would cause a Leftward Shift, indicating Increased Oxygen Affinity.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;There would be no Significant Change in the Curve, as 2, 3-DPG Levels do not Affect Hemoglobin&#x27;s Oxygen Affinity.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The Curve could Shift in any direction, depending on Concurrent Changes in pH and CO 2 levels.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It would cause a Leftward Shift, indicating Increased Oxygen Affinity.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/15.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) It would cause a Leftward Shift, indicating Increased Oxygen Affinity.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Incorrect. A decrease in 2,3-DPG levels would not lead to a rightward shift; this shift usually indicates a decreased affinity for oxygen, facilitating release to tissues.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Incorrect. 2,3-DPG levels are significant modulators of hemoglobin&#x27;s affinity for oxygen, and changes in 2,3-DPG concentration are known to affect the curve.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Incorrect. While pH and CO2 levels do affect the curve, the specific question about 2,3-DPG is directly related to its effect on oxygen affinity, which typically results in a leftward shift when 2,3-DPG levels decrease.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The objective is to understand the role of 2,3-DPG in regulating hemoglobin&#x27;s oxygen-binding affinity and the implications of its levels on the oxygen dissociation curve.&lt;/li&gt;&lt;li&gt;âž¤ Increase and decrease of different factors causing shift of oxy-Haemoglobin curve is shown as â€“&lt;/li&gt;&lt;li&gt;âž¤ ( Ref: Ganong&#x27;s Review of Medical physiology, 25 th edition, pg no: 641)&lt;/li&gt;&lt;li&gt;âž¤ ( Ref: Ganong&#x27;s Review of Medical physiology, 25 th edition, pg no: 641)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a hospital&#x27;s hyperbaric unit, a medical team is treating a diver with symptoms of decompression sickness. The team discusses the different symptoms associated with Caisson&#x27;s Disease and asks the students to identify the incorrect association. Which of the following associations with Caisson&#x27;s Disease is incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chokes - Respiratory distress due to pulmonary barotrauma.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Strokes - Cerebral arterial gas embolism.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bends - Nitrogen bubbles in the joints causing pain.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Neurological deficits - CO2 toxicity.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Neurological deficits - CO2 toxicity.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/screenshot-2024-02-26-165432.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Neurological deficits - CO2 toxicity.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Correct association. &#x27;Strokes&#x27; can result from cerebral arterial gas embolism, which is a serious complication of decompression sickness where gas bubbles form in the brain&#x27;s arterial circulation.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Option C: Correct association. &#x27;Bends&#x27; is the common term for joint pain in decompression sickness, caused by nitrogen bubbles forming in the joints due to rapid decompression.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Discern between the correct and incorrect associations of various symptoms with decompression sickness in a clinical setting.&lt;/li&gt;&lt;li&gt;âž¤ Top of Form&lt;/li&gt;&lt;li&gt;âž¤ A part of the carbon dioxide in the red blood cells will react with the amino groups of the hemoglobin, forming carbamino-Hb (2.6 mL)&lt;/li&gt;&lt;li&gt;âž¤ A part of the carbon dioxide in the red blood cells will react with the amino groups of the hemoglobin, forming carbamino-Hb (2.6 mL)&lt;/li&gt;&lt;li&gt;âž¤ So, the total will be 49 mL (43.8 + 2.6 + 2.6), 50 mL will be the appropriate option.&lt;/li&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Identify that the typical volume of carbon dioxide in each decilitre of arterial blood is approximately 50 mL.&lt;/li&gt;&lt;li&gt;âž¤ ( Ref: Ganongâ€™s Review of Medical physiology, 25 th edition, pg no: 643)&lt;/li&gt;&lt;li&gt;âž¤ ( Ref: Ganongâ€™s Review of Medical physiology, 25 th edition, pg no: 643)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old male with a history of loss of consciousness is admitted to the emergency ward, where he is diagnosed with hypothermia, presenting a body temperature of 94.8Â°F. In this context, how does hypothermia affect the oxygen dissociation curve (ODC)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Causes a rightward shift, suggesting a decreased affinity of hemoglobin for oxygen.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Causes a leftward shift, suggesting an increased affinity of hemoglobin for oxygen.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Has no significant effect on the ODC.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Results in a parabolic shift, indicating complex alterations in oxygen affinity.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Causes a leftward shift, suggesting an increased affinity of hemoglobin for oxygen.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/17.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Causes a leftward shift, suggesting an increased affinity of hemoglobin for oxygen.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A : Incorrect. Hypothermia typically causes a leftward shift in the ODC, not a rightward shift.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ Option C : Incorrect. Hypothermia does have an effect on the ODC.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Option D : Incorrect. The effect of hypothermia on the ODC is generally a leftward shift, not a parabolic one.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The objective is to understand the effect of body temperature changes, specifically hypothermia, on the oxygen dissociation curve and its implications for oxygen delivery in the body.&lt;/li&gt;&lt;li&gt;âž¤ ( Ref: Ganong&#x27;s Review of Medical physiology, 25 th edition, pg no: 641)&lt;/li&gt;&lt;li&gt;âž¤ ( Ref: Ganong&#x27;s Review of Medical physiology, 25 th edition, pg no: 641)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A medical instructor is discussing the oxygen-carrying capacity of hemoglobin with a group of medical students. The instructor explains that understanding the oxygen-binding capacity of hemoglobin is essential for comprehending how oxygen is transported in the blood. After full saturation, what would be the volume of oxygen present in each gram of hemoglobin?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1.34 mL of O 2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1.79 mL of O 2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;2.39 mL of O 2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;2.79 mL of O 2&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 1.34 mL of O 2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) 1.34 mL of O2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Incorrect . This value is higher than the standard oxygen-carrying capacity of hemoglobin . The correct value is closer to 1.34 mL per gram .&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ higher&lt;/li&gt;&lt;li&gt;â€¢ standard oxygen-carrying capacity&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ 1.34 mL per&lt;/li&gt;&lt;li&gt;â€¢ gram&lt;/li&gt;&lt;li&gt;â€¢ Option C: Incorrect . This value significantly exceeds the typical oxygen-carrying capacity of hemoglobin .&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ exceeds&lt;/li&gt;&lt;li&gt;â€¢ oxygen-carrying capacity&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ Option D: Incorrect . This value is much higher than what is physiologically possible for hemoglobin , which can carry approximately 1.34 mL of oxygen per gram when fully saturated .&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ higher&lt;/li&gt;&lt;li&gt;â€¢ physiologically possible&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ carry&lt;/li&gt;&lt;li&gt;â€¢ 1.34 mL&lt;/li&gt;&lt;li&gt;â€¢ oxygen per gram&lt;/li&gt;&lt;li&gt;â€¢ fully saturated&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize that each gram of fully saturated hemoglobin can carry approximately 1.39 mL of oxygen .&lt;/li&gt;&lt;li&gt;âž¤ Recognize that each gram of fully saturated hemoglobin can carry approximately 1.39 mL of oxygen .&lt;/li&gt;&lt;li&gt;âž¤ each gram&lt;/li&gt;&lt;li&gt;âž¤ fully saturated&lt;/li&gt;&lt;li&gt;âž¤ carry&lt;/li&gt;&lt;li&gt;âž¤ approximately 1.39 mL&lt;/li&gt;&lt;li&gt;âž¤ oxygen&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg No: 640&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg No: 640&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Dr. Jones, a Pulmonologist, is managing a 65-year-old male patient with Chronic Obstructive Pulmonary Disease (COPD). The patient is experiencing an exacerbation characterized by Increased Breathlessness, Cough, and Altered Blood Gases. She ponders what Percentage of CO 2 is expected to be carried to the Lungs in the form of Carbamino Compounds (Carbamino-CO 2 ) in this scenario. What is the most likely percentage?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;10%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;20%&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;50%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;70%&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 20%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 20%&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Gas Transport â€“ CO 2&lt;/li&gt;&lt;li&gt;â€¢ Gas Transport â€“ CO 2&lt;/li&gt;&lt;li&gt;â€¢ Normal â†’ 4ml % or 200 ml / min&lt;/li&gt;&lt;li&gt;â€¢ Normal â†’ 4ml % or 200 ml / min&lt;/li&gt;&lt;li&gt;â€¢ Forms â†’&lt;/li&gt;&lt;li&gt;â€¢ Forms â†’&lt;/li&gt;&lt;li&gt;â€¢ Bicarbonate â€“ 70%&lt;/li&gt;&lt;li&gt;â€¢ Carbamino (Hb / Albumin) â€“ 20%&lt;/li&gt;&lt;li&gt;â€¢ Dissolve â€“ always less â€“ 10%&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the mechanisms of CO 2 transport in the blood, particularly the role of carbamino compounds in carrying a portion of CO 2 to the lungs .&lt;/li&gt;&lt;li&gt;âž¤ Understand the mechanisms of CO 2 transport in the blood, particularly the role of carbamino compounds in carrying a portion of CO 2 to the lungs .&lt;/li&gt;&lt;li&gt;âž¤ Understand the mechanisms of CO 2 transport in the blood, particularly the role of carbamino compounds in carrying a portion of CO 2 to the lungs .&lt;/li&gt;&lt;li&gt;âž¤ mechanisms&lt;/li&gt;&lt;li&gt;âž¤ CO 2&lt;/li&gt;&lt;li&gt;âž¤ CO 2&lt;/li&gt;&lt;li&gt;âž¤ lungs&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 643&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 643&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a Physiology Lecture, a Professor discusses the Oxygen-Binding properties of different proteins found in the human body. The focus shifts to Myoglobin, a Protein found in Muscle Tissue, which plays a crucial role in storing Oxygen for Muscle Use. How many Moles of Oxygen are expected to be carried by a Single Molecule of Myoglobin?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;4&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 1&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) 1.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The myoglobin is an Iron containing pigment distributed in the skeletal muscle , which can bind with oxygen . The myoglobin will resemble hemoglobin , but the major difference is that it binds with only one mol of oxygen (only one oxygen binding site) per protein . Myoglobin is a monomeric protein , whereas haemoglobin is a tetramer . The hemoglobin of the red blood cells can bind with 4 oxygen molecules .&lt;/li&gt;&lt;li&gt;â€¢ The myoglobin is an Iron containing pigment distributed in the skeletal muscle , which can bind with oxygen .&lt;/li&gt;&lt;li&gt;â€¢ Iron containing pigment&lt;/li&gt;&lt;li&gt;â€¢ skeletal muscle&lt;/li&gt;&lt;li&gt;â€¢ bind&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ The myoglobin will resemble hemoglobin , but the major difference is that it binds with only one mol of oxygen (only one oxygen binding site) per protein .&lt;/li&gt;&lt;li&gt;â€¢ resemble hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ major difference&lt;/li&gt;&lt;li&gt;â€¢ binds&lt;/li&gt;&lt;li&gt;â€¢ only one mol&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ per protein&lt;/li&gt;&lt;li&gt;â€¢ Myoglobin is a monomeric protein , whereas haemoglobin is a tetramer .&lt;/li&gt;&lt;li&gt;â€¢ monomeric protein&lt;/li&gt;&lt;li&gt;â€¢ haemoglobin&lt;/li&gt;&lt;li&gt;â€¢ tetramer&lt;/li&gt;&lt;li&gt;â€¢ The hemoglobin of the red blood cells can bind with 4 oxygen molecules .&lt;/li&gt;&lt;li&gt;â€¢ red blood cells&lt;/li&gt;&lt;li&gt;â€¢ bind&lt;/li&gt;&lt;li&gt;â€¢ 4 oxygen molecules&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that a single molecule of myoglobin is capable of carrying one mole of oxygen .&lt;/li&gt;&lt;li&gt;âž¤ Understand that a single molecule of myoglobin is capable of carrying one mole of oxygen .&lt;/li&gt;&lt;li&gt;âž¤ single molecule&lt;/li&gt;&lt;li&gt;âž¤ myoglobin&lt;/li&gt;&lt;li&gt;âž¤ one mole&lt;/li&gt;&lt;li&gt;âž¤ oxygen&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg No: 641&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg No: 641&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A mother comes to the hospital with her newborn baby. On examination, surfactants are not adequately found, and collapse of alveoli was seen. What will be the most probable diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bronchial Asthma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Respiratory Distress Syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pleural Effusion&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Respiratory Distress Syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Respiratory Distress Syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bronchial Asthma , t ypically presents in older children or adults with episodic wheezing and reversible airway obstruction , not usually associated with surfactant deficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ ,&lt;/li&gt;&lt;li&gt;â€¢ older children&lt;/li&gt;&lt;li&gt;â€¢ adults&lt;/li&gt;&lt;li&gt;â€¢ episodic wheezing&lt;/li&gt;&lt;li&gt;â€¢ reversible airway obstruction&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pneumonia , an infection of the alveoli and respiratory tract ; while it can cause respiratory distress , it is not primarily due to a lack of surfactant.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ ,&lt;/li&gt;&lt;li&gt;â€¢ infection&lt;/li&gt;&lt;li&gt;â€¢ alveoli&lt;/li&gt;&lt;li&gt;â€¢ respiratory tract&lt;/li&gt;&lt;li&gt;â€¢ respiratory distress&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pleural Effusion, a ccumulation of fluid in the pleural space , which can compress the lung but does not directly relate to surfactant deficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ fluid&lt;/li&gt;&lt;li&gt;â€¢ pleural space&lt;/li&gt;&lt;li&gt;â€¢ compress&lt;/li&gt;&lt;li&gt;â€¢ lung&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Identify the presentation of Neonatal Respiratory Distress Syndrome (RDS) , which is characterized by a deficiency of pulmonary surfactant and subsequent alveolar collapse , primarily seen in premature infants .Top of Form&lt;/li&gt;&lt;li&gt;âž¤ Identify the presentation of Neonatal Respiratory Distress Syndrome (RDS) , which is characterized by a deficiency of pulmonary surfactant and subsequent alveolar collapse , primarily seen in premature infants .Top of Form&lt;/li&gt;&lt;li&gt;âž¤ Neonatal Respiratory Distress Syndrome (RDS)&lt;/li&gt;&lt;li&gt;âž¤ deficiency&lt;/li&gt;&lt;li&gt;âž¤ pulmonary surfactant&lt;/li&gt;&lt;li&gt;âž¤ subsequent alveolar collapse&lt;/li&gt;&lt;li&gt;âž¤ premature infants&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 641&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 641&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a respiratory medicine clinic, a patient with chronic lung disease is undergoing evaluation for oxygen therapy. Understanding the principles of gas solubility and partial pressures is crucial in such a managment. Which of the following statements is True in this context?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;In a Simple Solution at Equal Partial Pressures, more Oxygen is expected to be present than Carbon Dioxide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The Solubility of Oxygen is Greater than that of Carbon Dioxide.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Both the Statements A and B are True&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. None&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) None&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Incorrect. This statement is false because, at equal partial pressures , carbon dioxide is more soluble in blood than oxygen , resulting in more dissolved carbon dioxide than oxygen .&lt;/li&gt;&lt;li&gt;â€¢ Option A: Incorrect.&lt;/li&gt;&lt;li&gt;â€¢ false&lt;/li&gt;&lt;li&gt;â€¢ equal partial pressures&lt;/li&gt;&lt;li&gt;â€¢ carbon dioxide&lt;/li&gt;&lt;li&gt;â€¢ soluble&lt;/li&gt;&lt;li&gt;â€¢ blood&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ carbon dioxide&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ Option B: Incorrect . This is false because carbon dioxide is more soluble than oxygen .&lt;/li&gt;&lt;li&gt;â€¢ Option B: Incorrect&lt;/li&gt;&lt;li&gt;â€¢ false&lt;/li&gt;&lt;li&gt;â€¢ carbon dioxide&lt;/li&gt;&lt;li&gt;â€¢ soluble&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ Option C: Incorrect . Both statements A and B are false due to the higher solubility of carbon dioxide compared to oxygen .&lt;/li&gt;&lt;li&gt;â€¢ Option C: Incorrect&lt;/li&gt;&lt;li&gt;â€¢ false&lt;/li&gt;&lt;li&gt;â€¢ higher solubility&lt;/li&gt;&lt;li&gt;â€¢ carbon dioxide&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that at equal partial pressures , carbon dioxide is more soluble in a simple solution than oxygen , contrary to what might be initially assumed.&lt;/li&gt;&lt;li&gt;âž¤ Understand that at equal partial pressures , carbon dioxide is more soluble in a simple solution than oxygen , contrary to what might be initially assumed.&lt;/li&gt;&lt;li&gt;âž¤ equal partial pressures&lt;/li&gt;&lt;li&gt;âž¤ carbon dioxide&lt;/li&gt;&lt;li&gt;âž¤ soluble&lt;/li&gt;&lt;li&gt;âž¤ simple solution&lt;/li&gt;&lt;li&gt;âž¤ oxygen&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 641&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 641&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Dr. Lee, a Critical Care Specialist, is treating a 45-year-old Female patient who was admitted with Severe Pneumonia. The patient&#x27;s condition is complicated by Sepsis. Dr. Lee is considering the factors that could facilitate the Delivery of Oxygen to the patient&#x27;s tissues under these conditions. Which of the following factors would most likely Enhance Oxygen Delivery in this Clinical Scenario? Increased PCO 2 Increased Temperature Increased pH Increased 2, 3-DPG&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1,2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1,2,4&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1,3,4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1,2,3,4&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 1,2,4&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/19.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 1,2,4&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option 1 : An increase in PCO 2 ( partial pressure of carbon dioxide ) typically reflects hypoventilation or impaired gas exchange , often seen in conditions like pneumonia . Increased PCO 2 causes a rightward shift in the oxygen-hemoglobin dissociation curve , facilitating oxygen unloading to the tissues . However, this is a compensatory mechanism and not ideal as it reflects underlying respiratory dysfunction.&lt;/li&gt;&lt;li&gt;â€¢ Option 1&lt;/li&gt;&lt;li&gt;â€¢ partial pressure&lt;/li&gt;&lt;li&gt;â€¢ carbon dioxide&lt;/li&gt;&lt;li&gt;â€¢ reflects&lt;/li&gt;&lt;li&gt;â€¢ hypoventilation&lt;/li&gt;&lt;li&gt;â€¢ impaired gas exchange&lt;/li&gt;&lt;li&gt;â€¢ pneumonia&lt;/li&gt;&lt;li&gt;â€¢ Increased PCO 2&lt;/li&gt;&lt;li&gt;â€¢ rightward shift&lt;/li&gt;&lt;li&gt;â€¢ oxygen-hemoglobin dissociation curve&lt;/li&gt;&lt;li&gt;â€¢ oxygen unloading&lt;/li&gt;&lt;li&gt;â€¢ tissues&lt;/li&gt;&lt;li&gt;â€¢ Option 2 : Elevated body temperature (fever), common in sepsis , also causes a rightward shift in the oxygen-hemoglobin dissociation curve . This shift enhances oxygen delivery to tissues , which is beneficial in the context of infection where tissues have increased metabolic demands . Yet, prolonged high temperature can be detrimental to cellular function .&lt;/li&gt;&lt;li&gt;â€¢ Option 2&lt;/li&gt;&lt;li&gt;â€¢ Elevated body temperature&lt;/li&gt;&lt;li&gt;â€¢ sepsis&lt;/li&gt;&lt;li&gt;â€¢ rightward shift&lt;/li&gt;&lt;li&gt;â€¢ oxygen-hemoglobin dissociation curve&lt;/li&gt;&lt;li&gt;â€¢ oxygen delivery&lt;/li&gt;&lt;li&gt;â€¢ tissues&lt;/li&gt;&lt;li&gt;â€¢ infection&lt;/li&gt;&lt;li&gt;â€¢ increased&lt;/li&gt;&lt;li&gt;â€¢ metabolic demands&lt;/li&gt;&lt;li&gt;â€¢ high temperature&lt;/li&gt;&lt;li&gt;â€¢ cellular function&lt;/li&gt;&lt;li&gt;â€¢ Option 3 : An increase in pH ( alkalosis ) leads to a leftward shift in the oxygen-hemoglobin dissociation curve , which means hemoglobin holds onto oxygen more tightly and is less willing to release it to tissues. In a septic patient, this would not facilitate oxygen delivery; instead, it might impair it.&lt;/li&gt;&lt;li&gt;â€¢ Option 3&lt;/li&gt;&lt;li&gt;â€¢ increase&lt;/li&gt;&lt;li&gt;â€¢ pH&lt;/li&gt;&lt;li&gt;â€¢ alkalosis&lt;/li&gt;&lt;li&gt;â€¢ leftward shift&lt;/li&gt;&lt;li&gt;â€¢ oxygen-hemoglobin dissociation curve&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ tightly&lt;/li&gt;&lt;li&gt;â€¢ might&lt;/li&gt;&lt;li&gt;â€¢ impair&lt;/li&gt;&lt;li&gt;â€¢ Option 4 : 2, 3-Diphosphoglycerate ( 2, 3-DPG) levels increase in conditions like anemia , hypoxemia , or chronic lung disease . Increased 2, 3-DPG in red blood cells enhances the release of oxygen from hemoglobin , thus improving oxygen delivery to tissues . This is particularly useful in states of chronic hypoxia .&lt;/li&gt;&lt;li&gt;â€¢ Option 4&lt;/li&gt;&lt;li&gt;â€¢ 2, 3-DPG) levels increase&lt;/li&gt;&lt;li&gt;â€¢ anemia&lt;/li&gt;&lt;li&gt;â€¢ hypoxemia&lt;/li&gt;&lt;li&gt;â€¢ chronic lung disease&lt;/li&gt;&lt;li&gt;â€¢ Increased&lt;/li&gt;&lt;li&gt;â€¢ red blood cells&lt;/li&gt;&lt;li&gt;â€¢ release&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ improving oxygen&lt;/li&gt;&lt;li&gt;â€¢ delivery&lt;/li&gt;&lt;li&gt;â€¢ tissues&lt;/li&gt;&lt;li&gt;â€¢ states&lt;/li&gt;&lt;li&gt;â€¢ chronic hypoxia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize that increased PCO 2 , increased temperature , and increased 2,3-DPG levels facilitate the delivery of oxygen to tissues .&lt;/li&gt;&lt;li&gt;âž¤ Recognize that increased PCO 2 , increased temperature , and increased 2,3-DPG levels facilitate the delivery of oxygen to tissues .&lt;/li&gt;&lt;li&gt;âž¤ increased PCO 2&lt;/li&gt;&lt;li&gt;âž¤ increased temperature&lt;/li&gt;&lt;li&gt;âž¤ increased 2,3-DPG levels&lt;/li&gt;&lt;li&gt;âž¤ delivery&lt;/li&gt;&lt;li&gt;âž¤ oxygen&lt;/li&gt;&lt;li&gt;âž¤ tissues&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg. no: 641&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg. no: 641&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a Critical Care Unit, a patient with Severe Anemia and Hypoxia is being treated. The Medical Team discusses the primary Mode of Oxygen Transport in the Blood, Crucial for managing the patient&#x27;s condition. Which of the following will be the Predominant Mode of Transport of Oxygen in the Blood?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Free Form&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dissolved Form&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oxyhemoglobin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Carbonic Acid&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Oxyhemoglobin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/21.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Oxyhemoglobin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A . Incorrect . Oxygen is poorly soluble in blood ; only a very small amount is carried in free form .&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Oxygen&lt;/li&gt;&lt;li&gt;â€¢ poorly soluble&lt;/li&gt;&lt;li&gt;â€¢ blood&lt;/li&gt;&lt;li&gt;â€¢ very small amount&lt;/li&gt;&lt;li&gt;â€¢ free form&lt;/li&gt;&lt;li&gt;â€¢ Option B . Incorrect . While oxygen is dissolved in the plasma , this accounts for only a small fraction of the total oxygen transport .&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ plasma&lt;/li&gt;&lt;li&gt;â€¢ small fraction&lt;/li&gt;&lt;li&gt;â€¢ total oxygen transport&lt;/li&gt;&lt;li&gt;â€¢ Option D . Incorrect . Carbonic acid is involved in the transport of carbon dioxide , not oxygen.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ transport&lt;/li&gt;&lt;li&gt;â€¢ carbon dioxide&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Identify oxyhemoglobin as the predominant mode of oxygen transport in the blood .&lt;/li&gt;&lt;li&gt;âž¤ Identify oxyhemoglobin as the predominant mode of oxygen transport in the blood .&lt;/li&gt;&lt;li&gt;âž¤ oxyhemoglobin&lt;/li&gt;&lt;li&gt;âž¤ predominant mode&lt;/li&gt;&lt;li&gt;âž¤ oxygen&lt;/li&gt;&lt;li&gt;âž¤ transport&lt;/li&gt;&lt;li&gt;âž¤ blood&lt;/li&gt;&lt;li&gt;âž¤ Ref: Guyton and Hall Textbook of Medical Physiology, 2 nd South Asia Edition, Pg no: 371&lt;/li&gt;&lt;li&gt;âž¤ Ref: Guyton and Hall Textbook of Medical Physiology, 2 nd South Asia Edition, Pg no: 371&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old female presents to the emergency department with symptoms of disorientation and acute confusion. Her medical history is significant for type 2 diabetes mellitus and hypertension, both managed with medication. She has no known history of respiratory or renal disorders. On examination, her vital signs are stable, but she appears visibly disoriented to time and place. The ABG results of the patient reveal a blood pH of 7.25. Based on this finding, which of the following conditions can be expected in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;OHDC will be Shifted to the Right&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;OHDC will be Shifted to the Left&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;OHDC will become Linear&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No Effect on the OHDC Curve&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. OHDC will be Shifted to the Right&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/22.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) ODC will be Shifted to the Right.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. A leftward shift in the OHDC occurs in alkalosis ( higher pH ), decreased CO 2 , or lower temperatures . It indicates an increased affinity of hemoglobin for oxygen , making it harder for oxygen to dissociate from hemoglobin and be delivered to tissues. This is not applicable in the presented case of acidosis.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ leftward shift&lt;/li&gt;&lt;li&gt;â€¢ OHDC&lt;/li&gt;&lt;li&gt;â€¢ alkalosis&lt;/li&gt;&lt;li&gt;â€¢ higher pH&lt;/li&gt;&lt;li&gt;â€¢ decreased CO 2&lt;/li&gt;&lt;li&gt;â€¢ lower temperatures&lt;/li&gt;&lt;li&gt;â€¢ increased affinity&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ harder&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ delivered&lt;/li&gt;&lt;li&gt;â€¢ Option C. The OHDC does not become linear under physiological conditions. It is sigmoidal , reflecting the cooperative binding of oxygen to hemoglobin . This option is not relevant to the patient&#x27;s condition.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ linear&lt;/li&gt;&lt;li&gt;â€¢ sigmoidal&lt;/li&gt;&lt;li&gt;â€¢ reflecting&lt;/li&gt;&lt;li&gt;â€¢ cooperative binding&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ Option D. Changes in blood pH do affect the OHDC . Acidosis or alkalosis will shift the curve right or left , respectively. Therefore, no effect on the OHDC curve is incorrect in the context of this patientâ€™s acidosis .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Changes&lt;/li&gt;&lt;li&gt;â€¢ blood pH&lt;/li&gt;&lt;li&gt;â€¢ affect&lt;/li&gt;&lt;li&gt;â€¢ OHDC&lt;/li&gt;&lt;li&gt;â€¢ Acidosis&lt;/li&gt;&lt;li&gt;â€¢ alkalosis&lt;/li&gt;&lt;li&gt;â€¢ shift&lt;/li&gt;&lt;li&gt;â€¢ curve right&lt;/li&gt;&lt;li&gt;â€¢ left&lt;/li&gt;&lt;li&gt;â€¢ no effect&lt;/li&gt;&lt;li&gt;â€¢ OHDC curve&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ context&lt;/li&gt;&lt;li&gt;â€¢ patientâ€™s acidosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that a blood pH of 7.25 , indicating acidosis , will result in a rightward shift of the Oxygen Dissociation Curve ( ODC ).&lt;/li&gt;&lt;li&gt;âž¤ Understand that a blood pH of 7.25 , indicating acidosis , will result in a rightward shift of the Oxygen Dissociation Curve ( ODC ).&lt;/li&gt;&lt;li&gt;âž¤ blood pH&lt;/li&gt;&lt;li&gt;âž¤ 7.25&lt;/li&gt;&lt;li&gt;âž¤ acidosis&lt;/li&gt;&lt;li&gt;âž¤ rightward shift&lt;/li&gt;&lt;li&gt;âž¤ Oxygen Dissociation Curve&lt;/li&gt;&lt;li&gt;âž¤ ODC&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 641&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 641&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male with a history of Chronic Obstructive Pulmonary Disease (COPD) presents to the Clinic for a Follow-Up Appointment. He reports Increased Shortness of Breath with Minimal Exertion. During the visit, the Physician decides to review his recent Blood Gas Analysis to Assess his Respiratory Status. What is the Typical Range of the Partial Pressure of Carbon Dioxide (PCO 2 ) in Venous Blood for a Healthy Individual?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;24 mm Hg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;32 mm Hg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;46 mm Hg&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;54 mm Hg&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 46 mm Hg&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 46 mm Hg&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The Partial Pressure of Carbon Dioxide (PCO 2 ) in Venous Blood is typically higher than in Arterial Blood , as it reflects the Carbon Dioxide being transported from the Body&#x27;s tissues back to the lungs for exhalation . In a healthy individual, Venous PCO 2 usually ranges from about 40 to 50 mmHg . This range indicates the normal accumulation of carbon dioxide in the blood as a result of tissue metabolism . In patients with respiratory conditions such as COPD , as in the case of this patient, the venous PCO 2 might be higher due to impaired gas exchange and the reduced ability of the lungs to expel carbon dioxide effectively .&lt;/li&gt;&lt;li&gt;â€¢ The Partial Pressure of Carbon Dioxide (PCO 2 ) in Venous Blood is typically higher than in Arterial Blood , as it reflects the Carbon Dioxide being transported from the Body&#x27;s tissues back to the lungs for exhalation .&lt;/li&gt;&lt;li&gt;â€¢ Partial Pressure&lt;/li&gt;&lt;li&gt;â€¢ Carbon Dioxide&lt;/li&gt;&lt;li&gt;â€¢ Venous Blood&lt;/li&gt;&lt;li&gt;â€¢ higher than&lt;/li&gt;&lt;li&gt;â€¢ Arterial Blood&lt;/li&gt;&lt;li&gt;â€¢ Carbon Dioxide&lt;/li&gt;&lt;li&gt;â€¢ Body&#x27;s tissues&lt;/li&gt;&lt;li&gt;â€¢ back&lt;/li&gt;&lt;li&gt;â€¢ lungs&lt;/li&gt;&lt;li&gt;â€¢ exhalation&lt;/li&gt;&lt;li&gt;â€¢ In a healthy individual, Venous PCO 2 usually ranges from about 40 to 50 mmHg . This range indicates the normal accumulation of carbon dioxide in the blood as a result of tissue metabolism .&lt;/li&gt;&lt;li&gt;â€¢ Venous PCO 2&lt;/li&gt;&lt;li&gt;â€¢ about 40&lt;/li&gt;&lt;li&gt;â€¢ 50 mmHg&lt;/li&gt;&lt;li&gt;â€¢ normal accumulation&lt;/li&gt;&lt;li&gt;â€¢ carbon dioxide&lt;/li&gt;&lt;li&gt;â€¢ blood&lt;/li&gt;&lt;li&gt;â€¢ tissue metabolism&lt;/li&gt;&lt;li&gt;â€¢ In patients with respiratory conditions such as COPD , as in the case of this patient, the venous PCO 2 might be higher due to impaired gas exchange and the reduced ability of the lungs to expel carbon dioxide effectively .&lt;/li&gt;&lt;li&gt;â€¢ respiratory conditions&lt;/li&gt;&lt;li&gt;â€¢ COPD&lt;/li&gt;&lt;li&gt;â€¢ venous PCO 2&lt;/li&gt;&lt;li&gt;â€¢ higher&lt;/li&gt;&lt;li&gt;â€¢ impaired gas exchange&lt;/li&gt;&lt;li&gt;â€¢ reduced ability&lt;/li&gt;&lt;li&gt;â€¢ lungs&lt;/li&gt;&lt;li&gt;â€¢ expel carbon dioxide&lt;/li&gt;&lt;li&gt;â€¢ effectively&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize that the typical range of the partial pressure of carbon dioxide (PCO 2 ) in venous blood for a healthy individual is around 46 mm Hg .&lt;/li&gt;&lt;li&gt;âž¤ Recognize that the typical range of the partial pressure of carbon dioxide (PCO 2 ) in venous blood for a healthy individual is around 46 mm Hg .&lt;/li&gt;&lt;li&gt;âž¤ typical range&lt;/li&gt;&lt;li&gt;âž¤ partial pressure&lt;/li&gt;&lt;li&gt;âž¤ carbon dioxide (PCO 2 )&lt;/li&gt;&lt;li&gt;âž¤ venous blood&lt;/li&gt;&lt;li&gt;âž¤ healthy individual&lt;/li&gt;&lt;li&gt;âž¤ around 46 mm Hg&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 635&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 635&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old female presents to the emergency department with symptoms of breathlessness and fatigue. On physical examination, she appears pale and her vital signs include a heart rate of 95 bpm, respiratory rate of 22 breaths per minute, and BP of 120/80 mmHg. Laboratory investigations reveal anemia with a hemoglobin level of 9 g/dL. In the context of this patient&#x27;s anemia, which of the following can be expected regarding her oxygen hemoglobin dissociation curve (OHDC)? Increased Oxygen Affinity of Hemoglobin ODC Curve Shifted to Left Increased 2,3-DPG ODC Curve Shifted to Right&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1,2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;4 only&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;2 only&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;3,4&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 3,4&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/22_rdFtSUt.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) 3,4&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The right shift of the oxygenâ€“hemoglobin dissociation curve (ODC) will favor the release of oxygen from hemoglobin , whereas the left shift will prevent the release of oxygen Increased 2,3-diphosphoglycerate ( DPG) levels will shift the curve to the right and decreased 2,3-DPG levels will shift the curve to the left In this patient, due to anemia , the 2,3-DPG levels will be increased , and the oxygen dissociation curve will be shifted to the right ( decreased oxygen affinity )&lt;/li&gt;&lt;li&gt;â€¢ The right shift of the oxygenâ€“hemoglobin dissociation curve (ODC) will favor the release of oxygen from hemoglobin , whereas the left shift will prevent the release of oxygen&lt;/li&gt;&lt;li&gt;â€¢ right shift&lt;/li&gt;&lt;li&gt;â€¢ oxygenâ€“hemoglobin dissociation curve (ODC)&lt;/li&gt;&lt;li&gt;â€¢ release&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ left shift&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ Increased 2,3-diphosphoglycerate ( DPG) levels will shift the curve to the right and decreased 2,3-DPG levels will shift the curve to the left&lt;/li&gt;&lt;li&gt;â€¢ Increased&lt;/li&gt;&lt;li&gt;â€¢ DPG) levels&lt;/li&gt;&lt;li&gt;â€¢ right&lt;/li&gt;&lt;li&gt;â€¢ decreased&lt;/li&gt;&lt;li&gt;â€¢ shift&lt;/li&gt;&lt;li&gt;â€¢ curve&lt;/li&gt;&lt;li&gt;â€¢ left&lt;/li&gt;&lt;li&gt;â€¢ In this patient, due to anemia , the 2,3-DPG levels will be increased , and the oxygen dissociation curve will be shifted to the right ( decreased oxygen affinity )&lt;/li&gt;&lt;li&gt;â€¢ due&lt;/li&gt;&lt;li&gt;â€¢ anemia&lt;/li&gt;&lt;li&gt;â€¢ increased&lt;/li&gt;&lt;li&gt;â€¢ oxygen dissociation&lt;/li&gt;&lt;li&gt;â€¢ curve&lt;/li&gt;&lt;li&gt;â€¢ shifted&lt;/li&gt;&lt;li&gt;â€¢ right&lt;/li&gt;&lt;li&gt;â€¢ decreased oxygen affinity&lt;/li&gt;&lt;li&gt;â€¢ Increase and decrease of different factors causing shift of oxy-Haemoglobin curve is shown as â€“&lt;/li&gt;&lt;li&gt;â€¢ Increase&lt;/li&gt;&lt;li&gt;â€¢ decrease&lt;/li&gt;&lt;li&gt;â€¢ shift&lt;/li&gt;&lt;li&gt;â€¢ oxy-Haemoglobin curve&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Understand that in anemia , there is typically an increase in 2,3-DPG levels leading to a rightward shift of the oxygen dissociation curve (ODC), facilitating oxygen delivery to tissues .&lt;/li&gt;&lt;li&gt;âž¤ Understand that in anemia , there is typically an increase in 2,3-DPG levels leading to a rightward shift of the oxygen dissociation curve (ODC), facilitating oxygen delivery to tissues .&lt;/li&gt;&lt;li&gt;âž¤ anemia&lt;/li&gt;&lt;li&gt;âž¤ increase&lt;/li&gt;&lt;li&gt;âž¤ 2,3-DPG levels&lt;/li&gt;&lt;li&gt;âž¤ rightward shift&lt;/li&gt;&lt;li&gt;âž¤ oxygen dissociation curve&lt;/li&gt;&lt;li&gt;âž¤ oxygen&lt;/li&gt;&lt;li&gt;âž¤ tissues&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 641)&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 641)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male with a history of Chronic Obstructive Pulmonary Disease (COPD) presents to the clinic for a routine check-up. He is currently on a regimen of inhaled corticosteroids and long-acting bronchodilators. The physician explains the mechanisms of oxygen transport in the blood to the patient. What percentage of oxygen is transported from the lungs to the tissues bound to hemoglobin in red blood cells?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;lt; 10%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;60%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;80%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;95%&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 95%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/21_6EF33TI.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) 95%&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The predominant mode of transport of oxygen in the blood is in chemical combination with hemoglobin ( oxyhemoglobin ) under normal conditions Around 97-99% of the oxygen will be transported from the lungs to the tissues in the hemoglobin (as oxy-Hb) of the red blood cells ( 95% will be the appropriate choice ) The remaining 1-3% of oxygen will be transported in the dissolved form in the plasma and blood cells .&lt;/li&gt;&lt;li&gt;â€¢ The predominant mode of transport of oxygen in the blood is in chemical combination with hemoglobin ( oxyhemoglobin ) under normal conditions&lt;/li&gt;&lt;li&gt;â€¢ predominant&lt;/li&gt;&lt;li&gt;â€¢ chemical combination&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ oxyhemoglobin&lt;/li&gt;&lt;li&gt;â€¢ normal conditions&lt;/li&gt;&lt;li&gt;â€¢ Around 97-99% of the oxygen will be transported from the lungs to the tissues in the hemoglobin (as oxy-Hb) of the red blood cells ( 95% will be the appropriate choice )&lt;/li&gt;&lt;li&gt;â€¢ 97-99%&lt;/li&gt;&lt;li&gt;â€¢ transported&lt;/li&gt;&lt;li&gt;â€¢ lungs&lt;/li&gt;&lt;li&gt;â€¢ tissues&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ red blood cells&lt;/li&gt;&lt;li&gt;â€¢ 95%&lt;/li&gt;&lt;li&gt;â€¢ choice&lt;/li&gt;&lt;li&gt;â€¢ The remaining 1-3% of oxygen will be transported in the dissolved form in the plasma and blood cells .&lt;/li&gt;&lt;li&gt;â€¢ 1-3%&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ plasma&lt;/li&gt;&lt;li&gt;â€¢ blood cells&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize that approximately 97-99% of oxygen transported from the lungs to the tissues is bound to hemoglobin in red blood cells .&lt;/li&gt;&lt;li&gt;âž¤ Recognize that approximately 97-99% of oxygen transported from the lungs to the tissues is bound to hemoglobin in red blood cells .&lt;/li&gt;&lt;li&gt;âž¤ approximately 97-99%&lt;/li&gt;&lt;li&gt;âž¤ lungs&lt;/li&gt;&lt;li&gt;âž¤ tissues&lt;/li&gt;&lt;li&gt;âž¤ hemoglobin&lt;/li&gt;&lt;li&gt;âž¤ red blood cells&lt;/li&gt;&lt;li&gt;âž¤ Ref : Guyton and Hall Textbook of Medical Physiology, 2 nd South Asia Edition, Pg no: 371&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Guyton and Hall Textbook of Medical Physiology, 2 nd South Asia Edition, Pg no: 371&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following correctly matched? Oxygen Release â€“ Right Shift Hyperthermia â€“ Left Shift Decreased Partial Pressure of CO 2 â€“ Right Shift Increased pH â€“ Left Shift&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1,3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1,4&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;2,3,4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1,2,3,4&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 1,4&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/22_x718gKc.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 1,4&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The right shift of the oxygenâ€“hemoglobin dissociation curve (ODC) will favor the release of oxygen from hemoglobin , whereas the left shift will prevent the release of oxygen When the pH is increased , the curve will be shifted to the left When the temperature is increased ( hyperthermia ), the curve will be shifted to the right (not left as mentioned), favoring oxygen release When the partial pressure of carbon dioxide is decreased (pCO 2 ), the curve will be shifted to the left (not right), preventing oxygen release .&lt;/li&gt;&lt;li&gt;â€¢ The right shift of the oxygenâ€“hemoglobin dissociation curve (ODC) will favor the release of oxygen from hemoglobin , whereas the left shift will prevent the release of oxygen&lt;/li&gt;&lt;li&gt;â€¢ right shift&lt;/li&gt;&lt;li&gt;â€¢ oxygenâ€“hemoglobin dissociation curve (ODC)&lt;/li&gt;&lt;li&gt;â€¢ release&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ left shift&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ When the pH is increased , the curve will be shifted to the left&lt;/li&gt;&lt;li&gt;â€¢ pH&lt;/li&gt;&lt;li&gt;â€¢ increased&lt;/li&gt;&lt;li&gt;â€¢ left&lt;/li&gt;&lt;li&gt;â€¢ When the temperature is increased ( hyperthermia ), the curve will be shifted to the right (not left as mentioned), favoring oxygen release&lt;/li&gt;&lt;li&gt;â€¢ temperature&lt;/li&gt;&lt;li&gt;â€¢ increased&lt;/li&gt;&lt;li&gt;â€¢ hyperthermia&lt;/li&gt;&lt;li&gt;â€¢ right&lt;/li&gt;&lt;li&gt;â€¢ favoring oxygen release&lt;/li&gt;&lt;li&gt;â€¢ When the partial pressure of carbon dioxide is decreased (pCO 2 ), the curve will be shifted to the left (not right), preventing oxygen release .&lt;/li&gt;&lt;li&gt;â€¢ partial pressure&lt;/li&gt;&lt;li&gt;â€¢ carbon dioxide&lt;/li&gt;&lt;li&gt;â€¢ decreased&lt;/li&gt;&lt;li&gt;â€¢ (pCO 2&lt;/li&gt;&lt;li&gt;â€¢ curve&lt;/li&gt;&lt;li&gt;â€¢ left&lt;/li&gt;&lt;li&gt;â€¢ preventing oxygen release&lt;/li&gt;&lt;li&gt;â€¢ Increase and decrease of different factors causing shift of oxy-Haemoglobin curve is shown as&lt;/li&gt;&lt;li&gt;â€¢ Increase&lt;/li&gt;&lt;li&gt;â€¢ decrease&lt;/li&gt;&lt;li&gt;â€¢ shift&lt;/li&gt;&lt;li&gt;â€¢ oxy-Haemoglobin curve&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that oxygen release is favored by a right shift in the oxygen dissociation curve , and an increased pH results in a left shift of the curve .&lt;/li&gt;&lt;li&gt;âž¤ Understand that oxygen release is favored by a right shift in the oxygen dissociation curve , and an increased pH results in a left shift of the curve .&lt;/li&gt;&lt;li&gt;âž¤ oxygen&lt;/li&gt;&lt;li&gt;âž¤ right shift&lt;/li&gt;&lt;li&gt;âž¤ oxygen dissociation curve&lt;/li&gt;&lt;li&gt;âž¤ increased pH&lt;/li&gt;&lt;li&gt;âž¤ left shift&lt;/li&gt;&lt;li&gt;âž¤ curve&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 641&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 641&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;One patient, a long-distance runner, exhibits High Levels of Myoglobin. The Cardiologist uses this case to illustrate the Oxygen-Binding Characteristics of Myoglobin and Hemoglobin and regarding their Cooperative Binding and the shape of the Myoglobin Dissociation Curve. Which of the following is True?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The Cooperative Binding of Oxygen can be seen with Myoglobin and Hemoglobin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The Myoglobin Dissociation Curve will be in the Shape of Rectangular Hyperbola&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Both A and B are True&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. The Myoglobin Dissociation Curve will be in the Shape of Rectangular Hyperbola&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/23.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Incorrect . Cooperative binding of oxygen is a characteristic of hemoglobin , not myoglobin. Hemoglobin&#x27;s structure allows it to exhibit cooperative binding , while myoglobin , with its single polypeptide chain , does not show this behavior.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Cooperative binding&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ Hemoglobin&#x27;s structure&lt;/li&gt;&lt;li&gt;â€¢ exhibit cooperative binding&lt;/li&gt;&lt;li&gt;â€¢ myoglobin&lt;/li&gt;&lt;li&gt;â€¢ single polypeptide chain&lt;/li&gt;&lt;li&gt;â€¢ Option C. Incorrect . While the statement about myoglobin&#x27;s dissociation curve is true, the assertion that myoglobin exhibits cooperative binding is false .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ myoglobin&#x27;s dissociation curve&lt;/li&gt;&lt;li&gt;â€¢ myoglobin exhibits&lt;/li&gt;&lt;li&gt;â€¢ cooperative binding&lt;/li&gt;&lt;li&gt;â€¢ false&lt;/li&gt;&lt;li&gt;â€¢ Option D. Incorrect as Option B is a true statement.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Recognize that cooperative binding of oxygen is a characteristic of hemoglobin , not myoglobin, and that myoglobin&#x27;s dissociation curve is indeed a rectangular hyperbola .&lt;/li&gt;&lt;li&gt;âž¤ Recognize that cooperative binding of oxygen is a characteristic of hemoglobin , not myoglobin, and that myoglobin&#x27;s dissociation curve is indeed a rectangular hyperbola .&lt;/li&gt;&lt;li&gt;âž¤ cooperative binding&lt;/li&gt;&lt;li&gt;âž¤ hemoglobin&lt;/li&gt;&lt;li&gt;âž¤ myoglobin&#x27;s dissociation curve&lt;/li&gt;&lt;li&gt;âž¤ rectangular hyperbola&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 641&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg no: 641&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A Third-Year Medical Student is rotating in the Obstetrics Department and attends a Lecture on Fetal Physiology. The Lecturer discusses the unique aspects of Fetal Hemoglobin and its role in Oxygen Transport from the Mother to the Fetus. Which of the following characteristics can be Expected in Fetal Hemoglobin (HbF) compared to Adult Hemoglobin (HbA)? Increased Oxygen Affinity OHDC Curve Shifted to Left Increased Oxygen Delivery ODC Curve Shifted to Right&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1,2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;4 only&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;2 only&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;3,4&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 1,2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/24.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) 1,2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The right shift of the oxygenâ€“hemoglobin dissociation curve (OHDC) will favor the release of oxygen from hemoglobin, thereby facilitating the oxygen delivery to the tissues The left shift of the curve will prevent the release of oxygen In fetal hemoglobin (HbF), there will be a poor binding of 2,3-DPG with the gamma chains in fetal Hb, resulting in greater oxygen affinity The oxygen dissociation curve will be shifted to the left, preventing oxygen release. The dissociation curve of oxygen&lt;/li&gt;&lt;li&gt;â€¢ The right shift of the oxygenâ€“hemoglobin dissociation curve (OHDC) will favor the release of oxygen from hemoglobin, thereby facilitating the oxygen delivery to the tissues&lt;/li&gt;&lt;li&gt;â€¢ The left shift of the curve will prevent the release of oxygen&lt;/li&gt;&lt;li&gt;â€¢ In fetal hemoglobin (HbF), there will be a poor binding of 2,3-DPG with the gamma chains in fetal Hb, resulting in greater oxygen affinity&lt;/li&gt;&lt;li&gt;â€¢ The oxygen dissociation curve will be shifted to the left, preventing oxygen release.&lt;/li&gt;&lt;li&gt;â€¢ The dissociation curve of oxygen&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize that fetal hemoglobin ( HbF ) has increased oxygen affinity and a leftward shift in its oxygen dissociation curve ( ODC ) compared to adult hemoglobin ( HbA ).&lt;/li&gt;&lt;li&gt;âž¤ Recognize that fetal hemoglobin ( HbF ) has increased oxygen affinity and a leftward shift in its oxygen dissociation curve ( ODC ) compared to adult hemoglobin ( HbA ).&lt;/li&gt;&lt;li&gt;âž¤ fetal hemoglobin&lt;/li&gt;&lt;li&gt;âž¤ HbF&lt;/li&gt;&lt;li&gt;âž¤ increased oxygen affinity&lt;/li&gt;&lt;li&gt;âž¤ leftward shift&lt;/li&gt;&lt;li&gt;âž¤ oxygen dissociation curve&lt;/li&gt;&lt;li&gt;âž¤ ODC&lt;/li&gt;&lt;li&gt;âž¤ adult hemoglobin&lt;/li&gt;&lt;li&gt;âž¤ HbA&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 641, 642)&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 641, 642)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male with a history of chronic obstructive pulmonary disease (COPD) presents to the emergency department with increased shortness of breath and a productive cough. On examination, his respiratory rate is 28 breaths per minute, oxygen saturation is 89% on room air, and auscultation reveals diffuse wheezes. Arterial blood gas analysis shows a PaO 2 of 60 mmHg and PaCO 2 of 50 mmHg. Considering the physiology of gas exchange, the diffusing capacity of oxygen (O 2 ) in the respiratory membrane is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;O 2 &amp;gt; CO 2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;O 2 &amp;lt; CO 2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;O 2 = CO 2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. O 2 &lt; CO 2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) O2&amp;lt; CO2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Incorrect . Oxygen (O 2 ) has a lower diffusing capacity compared to carbon dioxide ( CO 2 ) due to its lower solubility in blood .&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Oxygen&lt;/li&gt;&lt;li&gt;â€¢ lower diffusing capacity&lt;/li&gt;&lt;li&gt;â€¢ carbon dioxide&lt;/li&gt;&lt;li&gt;â€¢ CO 2&lt;/li&gt;&lt;li&gt;â€¢ lower solubility&lt;/li&gt;&lt;li&gt;â€¢ blood&lt;/li&gt;&lt;li&gt;â€¢ Option C: Incorrect . Oxygen and carbon dioxide do not have equal diffusing capacities, primarily due to differences in solubility .&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Oxygen&lt;/li&gt;&lt;li&gt;â€¢ differences&lt;/li&gt;&lt;li&gt;â€¢ solubility&lt;/li&gt;&lt;li&gt;â€¢ Option D: Incorrect , but less specific. Option B is true that O2&#x27;s diffusing capacity is less than CO 2 .&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ O2&#x27;s&lt;/li&gt;&lt;li&gt;â€¢ less than&lt;/li&gt;&lt;li&gt;â€¢ CO 2&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize that the diffusing capacity of oxygen ( O 2 ) in the respiratory membrane is less than that of carbon dioxide ( CO 2 ).&lt;/li&gt;&lt;li&gt;âž¤ Recognize that the diffusing capacity of oxygen ( O 2 ) in the respiratory membrane is less than that of carbon dioxide ( CO 2 ).&lt;/li&gt;&lt;li&gt;âž¤ diffusing capacity&lt;/li&gt;&lt;li&gt;âž¤ oxygen&lt;/li&gt;&lt;li&gt;âž¤ O 2&lt;/li&gt;&lt;li&gt;âž¤ respiratory membrane&lt;/li&gt;&lt;li&gt;âž¤ less than&lt;/li&gt;&lt;li&gt;âž¤ carbon dioxide&lt;/li&gt;&lt;li&gt;âž¤ CO 2&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg No: 635&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Ganongâ€™s Review of Medical Physiology, 25 th Edition, Pg No: 635&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old former miner with a long-standing history of cigarette smoking presents with progressively worsening shortness of breath and a persistent cough. A physical examination reveals diminished breath sounds, prolonged expiration, and a barrel chest. PFT show a markedly reduced FEV1/FVC ratio and a distinctive flattening of both the inspiratory and expiratory limbs of the Flow-Volume Loop. Which of the following additional findings is most consistent with the Suspected Diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reversibility of Obstruction with Bronchodilators&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Normal Diffusing Capacity of the Lungs for Carbon Monoxide (DLCO)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;An Increase in Residual Volume (RV) and Total Lung Capacity (TLC)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A Substantial Reduction in Both Static and Dynamic compliance of the Lung&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. An Increase in Residual Volume (RV) and Total Lung Capacity (TLC)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) An&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A . Reversibility of obstruction with bronchodilators is more indicative of asthma rather than Chronic Obstructive Pulmonary Disease (COPD).&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ asthma&lt;/li&gt;&lt;li&gt;â€¢ Chronic Obstructive Pulmonary Disease&lt;/li&gt;&lt;li&gt;â€¢ Option B . Normal DLCO is not typically seen in emphysema, a subtype of COPD , where DLCO is usually decreased due to alveolar destruction .&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ subtype&lt;/li&gt;&lt;li&gt;â€¢ COPD&lt;/li&gt;&lt;li&gt;â€¢ decreased&lt;/li&gt;&lt;li&gt;â€¢ alveolar destruction&lt;/li&gt;&lt;li&gt;â€¢ Option D . In emphysema , lung compliance is actually increased due to the loss of elastic recoil , not reduced.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ emphysema&lt;/li&gt;&lt;li&gt;â€¢ increased&lt;/li&gt;&lt;li&gt;â€¢ loss&lt;/li&gt;&lt;li&gt;â€¢ elastic recoil&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to identify the characteristic PFT findings in emphysema , particularly the changes in lung volumes and capacities , to differentiate it from other obstructive lung diseases .&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to identify the characteristic PFT findings in emphysema , particularly the changes in lung volumes and capacities , to differentiate it from other obstructive lung diseases .&lt;/li&gt;&lt;li&gt;âž¤ characteristic PFT findings&lt;/li&gt;&lt;li&gt;âž¤ emphysema&lt;/li&gt;&lt;li&gt;âž¤ changes&lt;/li&gt;&lt;li&gt;âž¤ lung volumes&lt;/li&gt;&lt;li&gt;âž¤ capacities&lt;/li&gt;&lt;li&gt;âž¤ obstructive lung diseases&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 641&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 641&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What pattern is suggested by the following Flow-Volume Loop?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Obstructive Lung Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Restrictive Lung Disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Emphysema&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Extrathoracic Airway Obstruction&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Restrictive Lung Disease&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/25.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/26.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/27.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Restrictive Lung Disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 76-year-old man has a Lung Tumor that is compressing an Airway, Obstructing Airflow to the Distal Alveoli partially. Given this scenario, identify which point on the O 2 -CO 2 diagram (V/Q line) corresponds to the Alveolar Gas in these Distal Alveoli.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Point A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Point B&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Point C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Point D&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Point B&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/28.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Point B&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Point A represents complete airway obstruction . In the case of an airway obstruction , there is a mismatch , leading to inadequate ventilation relative to perfusion . Point A would not correspond to partial distal obstruction.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ complete airway obstruction&lt;/li&gt;&lt;li&gt;â€¢ airway obstruction&lt;/li&gt;&lt;li&gt;â€¢ mismatch&lt;/li&gt;&lt;li&gt;â€¢ inadequate ventilation&lt;/li&gt;&lt;li&gt;â€¢ perfusion&lt;/li&gt;&lt;li&gt;â€¢ Option C. Point C usually indicates over-ventilated but under-perfused alveoli (but not complete obstruction of pulmonary capillaries), typical in conditions like pulmonary embolism . In the case presented, the problem is insufficient ventilation , not perfusion. Therefore, Point C does not represent the alveolar gas characteristics in the scenario of airway obstruction. Thus, Point C is not the correct Ans for this case.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ over-ventilated&lt;/li&gt;&lt;li&gt;â€¢ under-perfused alveoli&lt;/li&gt;&lt;li&gt;â€¢ pulmonary embolism&lt;/li&gt;&lt;li&gt;â€¢ insufficient ventilation&lt;/li&gt;&lt;li&gt;â€¢ Option D. Point D represents severely impaired perfusion ( complete obstruction of pulmonary capillaries ), seen in conditions like severe pneumonia or ARDS, pulmonary embolism. Point D is more indicative of widespread dysfunction of pulmonary capillaries , not localized airway obstruction. Hence, Point D is not applicable to this scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ severely impaired perfusion&lt;/li&gt;&lt;li&gt;â€¢ complete obstruction&lt;/li&gt;&lt;li&gt;â€¢ pulmonary capillaries&lt;/li&gt;&lt;li&gt;â€¢ indicative&lt;/li&gt;&lt;li&gt;â€¢ widespread dysfunction&lt;/li&gt;&lt;li&gt;â€¢ pulmonary capillaries&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective of this question is to understand the ventilation-perfusion (V/Q) relationship in the lungs and how various pathologies can alter this relationship .&lt;/li&gt;&lt;li&gt;âž¤ understand&lt;/li&gt;&lt;li&gt;âž¤ ventilation-perfusion&lt;/li&gt;&lt;li&gt;âž¤ relationship&lt;/li&gt;&lt;li&gt;âž¤ lungs&lt;/li&gt;&lt;li&gt;âž¤ alter&lt;/li&gt;&lt;li&gt;âž¤ relationship&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 642&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 642&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a respiratory clinic, a 45-year-old non-smoker presents a 6-month history of progressive dyspnoea and a nonproductive cough. Physical examination reveals digital clubbing and fine basilar inspiratory crackles. The resulting loop resembles the image provided. Given the patient&#x27;s symptoms and the flow-volume loop findings, what is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic Bronchitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Idiopathic Pulmonary Fibrosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Asthma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vocal Cord Dysfunction&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Idiopathic Pulmonary Fibrosis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/29.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/30.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Idiopathic Pulmonary Fibrosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A . Incorrect - Chronic Bronchitis would typically show an obstructive pattern with increased residual volume on the expiratory limb , not seen here.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ obstructive pattern&lt;/li&gt;&lt;li&gt;â€¢ increased residual volume&lt;/li&gt;&lt;li&gt;â€¢ expiratory limb&lt;/li&gt;&lt;li&gt;â€¢ Option C . Incorrect - Asthma would show an obstructive pattern , especially during an exacerbation , with a \&quot;scooped-out\&quot; expiratory curve .&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ obstructive pattern&lt;/li&gt;&lt;li&gt;â€¢ exacerbation&lt;/li&gt;&lt;li&gt;â€¢ \&quot;scooped-out\&quot;&lt;/li&gt;&lt;li&gt;â€¢ expiratory curve&lt;/li&gt;&lt;li&gt;â€¢ Option D . Incorrect - Vocal Cord Dysfunction would affect the inspiratory curve , showing a flattening , which is not depicted in this loop.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ affect&lt;/li&gt;&lt;li&gt;â€¢ inspiratory curve&lt;/li&gt;&lt;li&gt;â€¢ flattening&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ To correlate clinical findings and spirometry results, particularly the flow-volume loop , to diagnose respiratory conditions accurately .&lt;/li&gt;&lt;li&gt;âž¤ To correlate clinical findings and spirometry results, particularly the flow-volume loop , to diagnose respiratory conditions accurately .&lt;/li&gt;&lt;li&gt;âž¤ flow-volume loop&lt;/li&gt;&lt;li&gt;âž¤ accurately&lt;/li&gt;&lt;li&gt;âž¤ Ref: Guyton and Hall Textbook of Medical Physiology, 14 th Edition, Pg no: 542&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Guyton and Hall Textbook of Medical Physiology, 14 th Edition, Pg no: 542&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A cat undergoes a neurological procedure in which its apneustic centre is destroyed, and its vagus nerves are severed. Considering these specific alterations in the respiratory control system, which of the following statements correctly describes the expected change in the cat&#x27;s breathing pattern?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prolonged Inspiratory Spasm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prolonged Expiratory Spasm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Irregular and Shallow Respiration&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The Animal will Die&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Irregular and Shallow Respiration&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Irregular and Shallow Respiration&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A : Destroying the apneustic centre typically removes the stimulus for prolonged inspiratory drive , hence prolonged inspiratory spasms would not be expected.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ Destroying&lt;/li&gt;&lt;li&gt;â€¢ removes&lt;/li&gt;&lt;li&gt;â€¢ stimulus&lt;/li&gt;&lt;li&gt;â€¢ prolonged inspiratory drive&lt;/li&gt;&lt;li&gt;â€¢ Option B . The apneustic centre primarily affects inspiration , so its destruction would not cause prolonged expiratory spasm, which is more related to expiratory centres or pathways .&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ apneustic centre&lt;/li&gt;&lt;li&gt;â€¢ affects inspiration&lt;/li&gt;&lt;li&gt;â€¢ expiratory centres&lt;/li&gt;&lt;li&gt;â€¢ pathways&lt;/li&gt;&lt;li&gt;â€¢ Option D. Although severe, these specific alterations alone do not directly result in immediate death as respiratory control in the medulla are still intact .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ respiratory control&lt;/li&gt;&lt;li&gt;â€¢ medulla&lt;/li&gt;&lt;li&gt;â€¢ still intact&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective of this question is to understand the role of the apneustic center and the vagus nerve in regulating the respiratory rhythm .&lt;/li&gt;&lt;li&gt;âž¤ The educational objective of this question is to understand the role of the apneustic center and the vagus nerve in regulating the respiratory rhythm .&lt;/li&gt;&lt;li&gt;âž¤ The educational objective of this question is to understand the role of the apneustic center and the vagus nerve in regulating the respiratory rhythm .&lt;/li&gt;&lt;li&gt;âž¤ role&lt;/li&gt;&lt;li&gt;âž¤ apneustic center&lt;/li&gt;&lt;li&gt;âž¤ vagus nerve&lt;/li&gt;&lt;li&gt;âž¤ regulating&lt;/li&gt;&lt;li&gt;âž¤ respiratory rhythm&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 655&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 655&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with Chronic Hypoxia requires a Blood Transfusion. The Medical Team is deciding between using Blood stored in Citrate-Phosphate-Dextrose (CPD) solution and Blood stored in Acid-Citrate-Dextrose (ACD) solution. Considering the patient&#x27;s Hypoxic Condition, which of the following reasons makes CPD-stored Blood a more suitable option than ACD-Stored Blood?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Less Acidic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Less Decrease in 2,3-DPG&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It has Low P50&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Less Decrease in 2,3-DPG&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Less Decrease in 2, 3-DPG&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations&lt;/li&gt;&lt;li&gt;â€¢ Option A. Less acidic&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ While acidity is a consideration in stored blood , it is not the primary factor that makes CPD-stored blood more suitable for hypoxic patients. Both CPD and ACD solutions are designed to minimize acidity in stored blood , but it does not significantly affect the oxygen-carrying capacity of hemoglobin, in hypoxic conditions. Therefore, option A is not the most relevant factor in this context.&lt;/li&gt;&lt;li&gt;â€¢ While acidity is a consideration in stored blood , it is not the primary factor that makes CPD-stored blood more suitable for hypoxic patients.&lt;/li&gt;&lt;li&gt;â€¢ acidity&lt;/li&gt;&lt;li&gt;â€¢ stored blood&lt;/li&gt;&lt;li&gt;â€¢ Both CPD and ACD solutions are designed to minimize acidity in stored blood , but it does not significantly affect the oxygen-carrying capacity of hemoglobin, in hypoxic conditions.&lt;/li&gt;&lt;li&gt;â€¢ Both CPD&lt;/li&gt;&lt;li&gt;â€¢ ACD&lt;/li&gt;&lt;li&gt;â€¢ minimize acidity&lt;/li&gt;&lt;li&gt;â€¢ stored blood&lt;/li&gt;&lt;li&gt;â€¢ Therefore, option A is not the most relevant factor in this context.&lt;/li&gt;&lt;li&gt;â€¢ Option C. It has low P50&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ P50 is a measure of the oxygen affinity of hemoglobin ; however, a low P50 indicates higher oxygen affinity , which is not necessarily beneficial for hypoxic patients. In hypoxia, it&#x27;s more important for hemoglobin to release oxygen easily, which would correspond to a higher P50 . Therefore, option C does not provide the correct rationale for choosing CPD-stored blood.&lt;/li&gt;&lt;li&gt;â€¢ P50 is a measure of the oxygen affinity of hemoglobin ; however, a low P50 indicates higher oxygen affinity , which is not necessarily beneficial for hypoxic patients.&lt;/li&gt;&lt;li&gt;â€¢ oxygen affinity&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ low P50&lt;/li&gt;&lt;li&gt;â€¢ higher oxygen affinity&lt;/li&gt;&lt;li&gt;â€¢ In hypoxia, it&#x27;s more important for hemoglobin to release oxygen easily, which would correspond to a higher P50 . Therefore, option C does not provide the correct rationale for choosing CPD-stored blood.&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ release oxygen&lt;/li&gt;&lt;li&gt;â€¢ higher P50&lt;/li&gt;&lt;li&gt;â€¢ Option D. None of the above&lt;/li&gt;&lt;li&gt;â€¢ Option D. None of the above&lt;/li&gt;&lt;li&gt;â€¢ This option would be correct if none of the other options were valid .&lt;/li&gt;&lt;li&gt;â€¢ This option would be correct if none of the other options were valid .&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ valid&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Educational Objective of this question is to understand the importance of 2, 3-DPG levels in stored blood and its impact on oxygen delivery , especially in patients with hypoxia .&lt;/li&gt;&lt;li&gt;âž¤ The Educational Objective of this question is to understand the importance of 2, 3-DPG levels in stored blood and its impact on oxygen delivery , especially in patients with hypoxia .&lt;/li&gt;&lt;li&gt;âž¤ 2, 3-DPG levels&lt;/li&gt;&lt;li&gt;âž¤ blood&lt;/li&gt;&lt;li&gt;âž¤ oxygen delivery&lt;/li&gt;&lt;li&gt;âž¤ hypoxia&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 641&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 641&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man is undergoing a spirometry test. During the test, the doctor explains the role of various reflexes in respiratory mechanics. One specific reflex mentioned is the Hering-Breuer Deflation reflex. Identify the Primary Effect of this Reflex.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decrease in the Duration of Inspiration.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decrease in the Duration of Expiration.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increase in the Depth of Inspiration.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increase in the Depth of Expiration.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Decrease in the Duration of Expiration.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Decrease in the Duration of Expiration.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations&lt;/li&gt;&lt;li&gt;â€¢ Option A. The Hering-Breuer inflation reflex is actually associated with inhibiting inspiration when the lungs are inflated to prevent overexpansion, not the deflation reflex.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ inhibiting inspiration&lt;/li&gt;&lt;li&gt;â€¢ inflated&lt;/li&gt;&lt;li&gt;â€¢ prevent overexpansion,&lt;/li&gt;&lt;li&gt;â€¢ Option C . This is not the primary effect of the deflation reflex; it&#x27;s more related to the inflation reflex , which protects against lung overinflation .&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ inflation reflex&lt;/li&gt;&lt;li&gt;â€¢ against lung overinflation&lt;/li&gt;&lt;li&gt;â€¢ Option D . The deflation reflex does not typically cause an increase in the depth of expiration; it&#x27;s more involved in the timing of the breathing cycle .&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ timing&lt;/li&gt;&lt;li&gt;â€¢ breathing cycle&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ To comprehend the role and effects of the Hering-Breuer reflexes in respiratory physiology , particularly how the deflation reflex regulates the respiratory cycle .&lt;/li&gt;&lt;li&gt;âž¤ To comprehend the role and effects of the Hering-Breuer reflexes in respiratory physiology , particularly how the deflation reflex regulates the respiratory cycle .&lt;/li&gt;&lt;li&gt;âž¤ role&lt;/li&gt;&lt;li&gt;âž¤ effects&lt;/li&gt;&lt;li&gt;âž¤ Hering-Breuer&lt;/li&gt;&lt;li&gt;âž¤ reflexes&lt;/li&gt;&lt;li&gt;âž¤ respiratory physiology&lt;/li&gt;&lt;li&gt;âž¤ deflation&lt;/li&gt;&lt;li&gt;âž¤ reflex regulates&lt;/li&gt;&lt;li&gt;âž¤ respiratory cycle&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 658&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 658&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman is brought to the emergency department with symptoms of headache, dizziness, and nausea. She was found in a closed garage with a running vehicle. Her blood gases analysis indicates carbon monoxide poisoning. The incorrect statement regarding carbon monoxide poisoning is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oxygen Dissociation Curve is shifted to the Right.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oxygen Dissociation Curve is shifted to the Left.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Carboxyhaemoglobin (COHb) is formed.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hyperbaric Oxygen can be used in treatment.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Oxygen Dissociation Curve is shifted to the Right.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Oxygen Dissociation Curve is shifted to the Right.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations&lt;/li&gt;&lt;li&gt;â€¢ Option B. This statement is correct. Carbon monoxide binds to hemoglobin with a much higher affinity than oxygen , causing a leftward shift in the oxygen dissociation curve . This shift means that oxygen is more tightly bound to hemoglobin and is not readily released to the tissues, leading to tissue hypoxia despite normal oxygen levels in the blood .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Carbon monoxide&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ higher affinity&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ leftward shift&lt;/li&gt;&lt;li&gt;â€¢ oxygen dissociation curve&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ normal oxygen levels&lt;/li&gt;&lt;li&gt;â€¢ blood&lt;/li&gt;&lt;li&gt;â€¢ Option C. This is a true statement. In carbon monoxide poisoning, carbon monoxide binds to hemoglobin , forming carboxyhemoglobin (COHb) , which reduces the blood&#x27;s capacity to carry oxygen , leading to tissue hypoxia .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ carboxyhemoglobin (COHb)&lt;/li&gt;&lt;li&gt;â€¢ reduces&lt;/li&gt;&lt;li&gt;â€¢ blood&#x27;s capacity&lt;/li&gt;&lt;li&gt;â€¢ carry oxygen&lt;/li&gt;&lt;li&gt;â€¢ tissue hypoxia&lt;/li&gt;&lt;li&gt;â€¢ Option D. This is also true. Hyperbaric oxygen therapy is a treatment option for carbon monoxide poisoning . It involves breathing pure oxygen in a pressurized room , which can help to quickly reduce carboxyhemoglobin levels and restore the normal oxygen - carrying capacity of the blood .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ carbon monoxide poisoning&lt;/li&gt;&lt;li&gt;â€¢ breathing&lt;/li&gt;&lt;li&gt;â€¢ pressurized room&lt;/li&gt;&lt;li&gt;â€¢ reduce carboxyhemoglobin levels&lt;/li&gt;&lt;li&gt;â€¢ restore&lt;/li&gt;&lt;li&gt;â€¢ normal oxygen&lt;/li&gt;&lt;li&gt;â€¢ carrying capacity&lt;/li&gt;&lt;li&gt;â€¢ blood&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The objective is to understand the pathophysiological effects of carbon monoxide on oxygen transport and the principles of its treatment .&lt;/li&gt;&lt;li&gt;âž¤ The objective is to understand the pathophysiological effects of carbon monoxide on oxygen transport and the principles of its treatment .&lt;/li&gt;&lt;li&gt;âž¤ The objective is to understand the pathophysiological effects of carbon monoxide on oxygen transport and the principles of its treatment .&lt;/li&gt;&lt;li&gt;âž¤ pathophysiological effects&lt;/li&gt;&lt;li&gt;âž¤ carbon monoxide&lt;/li&gt;&lt;li&gt;âž¤ oxygen transport&lt;/li&gt;&lt;li&gt;âž¤ principles&lt;/li&gt;&lt;li&gt;âž¤ treatment&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 646&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 646&lt;/li&gt;&lt;li&gt;âž¤ Ganong, 25th ed/p.646&lt;/li&gt;&lt;li&gt;âž¤ Ganong, 25th ed/p.646&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old male with advanced heart failure presents with abnormal breathing patterns. Which pattern is characterized by increasing gradually and then decreasing tidal volumes gradually followed by a period of apnoea?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cheyne-Stokes Breathing&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Biot&#x27;s Respiration&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Kussmaul&#x27;s Breathing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Central Neurogenic Hyperventilation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cheyne-Stokes Breathing&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/35.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Cheyne-Stokes Breathing&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ A: Gradual increases / decreases in breath depth with apneic periods ; seen in heart failure . B: Irregular breathing with periods of apnea ; associated with brain damage . C: Deep , rapid breathing ; often linked to metabolic acidosis . D: Sustained hyperventilation ; typically due to central nervous system disorders.&lt;/li&gt;&lt;li&gt;â€¢ A: Gradual increases / decreases in breath depth with apneic periods ; seen in heart failure .&lt;/li&gt;&lt;li&gt;â€¢ A:&lt;/li&gt;&lt;li&gt;â€¢ increases&lt;/li&gt;&lt;li&gt;â€¢ decreases&lt;/li&gt;&lt;li&gt;â€¢ apneic periods&lt;/li&gt;&lt;li&gt;â€¢ heart failure&lt;/li&gt;&lt;li&gt;â€¢ B: Irregular breathing with periods of apnea ; associated with brain damage .&lt;/li&gt;&lt;li&gt;â€¢ B:&lt;/li&gt;&lt;li&gt;â€¢ Irregular breathing&lt;/li&gt;&lt;li&gt;â€¢ periods&lt;/li&gt;&lt;li&gt;â€¢ apnea&lt;/li&gt;&lt;li&gt;â€¢ brain damage&lt;/li&gt;&lt;li&gt;â€¢ C: Deep , rapid breathing ; often linked to metabolic acidosis .&lt;/li&gt;&lt;li&gt;â€¢ C:&lt;/li&gt;&lt;li&gt;â€¢ Deep&lt;/li&gt;&lt;li&gt;â€¢ rapid breathing&lt;/li&gt;&lt;li&gt;â€¢ metabolic acidosis&lt;/li&gt;&lt;li&gt;â€¢ D: Sustained hyperventilation ; typically due to central nervous system disorders.&lt;/li&gt;&lt;li&gt;â€¢ D:&lt;/li&gt;&lt;li&gt;â€¢ Sustained hyperventilation&lt;/li&gt;&lt;li&gt;â€¢ central nervous system&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Differentiate among periodic breathing patterns to aid in the diagnosis of underlying conditions .Top of Form&lt;/li&gt;&lt;li&gt;âž¤ Differentiate among periodic breathing patterns to aid in the diagnosis of underlying conditions .Top of Form&lt;/li&gt;&lt;li&gt;âž¤ breathing patterns&lt;/li&gt;&lt;li&gt;âž¤ aid&lt;/li&gt;&lt;li&gt;âž¤ diagnosis&lt;/li&gt;&lt;li&gt;âž¤ underlying conditions&lt;/li&gt;&lt;li&gt;âž¤ Ref: Guyton and Hall Textbook of Medical Physiology, 14 th Edition, Pg no: 538&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Guyton and Hall Textbook of Medical Physiology, 14 th Edition, Pg no: 538&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old woman presents to the clinic with a bluish tint to her skin, particularly noticeable on her lips and fingertips. She has no significant medical history and is not taking any medications. Laboratory tests reveal an elevated level of methemoglobin in her blood. What is the minimum concentration of methemoglobin required to cause cyanosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;5 gm/dL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;2 gm/dL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1.5 gm/dL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;12 gm/dL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 1.5 gm/dL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 1.5 gm/dL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ Option A. While 5 gm/dL of methemoglobin in the blood is certainly significant and can cause symptoms, it is not the minimum concentration at which cyanosis typically appears . Cyanosis can occur at lower levels , indicating that this is not the threshold value. Minimum concentration of 5 gm/dL of reduced Hb can cause cyanosis .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ appears&lt;/li&gt;&lt;li&gt;â€¢ lower levels&lt;/li&gt;&lt;li&gt;â€¢ cyanosis&lt;/li&gt;&lt;li&gt;â€¢ Option B. 2 gm/dL of methemoglobin in the blood may cause some concern , but it is usually not enough to cause cyanosis. Cyanosis generally appears at slightly higher concentrations of methemoglobin.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ some concern&lt;/li&gt;&lt;li&gt;â€¢ Cyanosis&lt;/li&gt;&lt;li&gt;â€¢ slightly higher&lt;/li&gt;&lt;li&gt;â€¢ Option D. A concentration of 12 gm/dL of methemoglobin is extremely high and would likely result in severe symptoms, including significant cyanosis . However, this is far above the threshold level at which cyanosis is typically seen .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ extremely high&lt;/li&gt;&lt;li&gt;â€¢ significant cyanosis&lt;/li&gt;&lt;li&gt;â€¢ above&lt;/li&gt;&lt;li&gt;â€¢ threshold level&lt;/li&gt;&lt;li&gt;â€¢ cyanosis&lt;/li&gt;&lt;li&gt;â€¢ seen&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The objective is to understand the pathophysiology of methemoglobinemia and recognize the methemoglobin level at which cyanosis becomes apparent .&lt;/li&gt;&lt;li&gt;âž¤ The objective is to understand the pathophysiology of methemoglobinemia and recognize the methemoglobin level at which cyanosis becomes apparent .&lt;/li&gt;&lt;li&gt;âž¤ pathophysiology&lt;/li&gt;&lt;li&gt;âž¤ methemoglobinemia&lt;/li&gt;&lt;li&gt;âž¤ recognize&lt;/li&gt;&lt;li&gt;âž¤ methemoglobin level&lt;/li&gt;&lt;li&gt;âž¤ cyanosis&lt;/li&gt;&lt;li&gt;âž¤ apparent&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 647&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 647&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a pulmonary clinic, a patient with chronic obstructive pulmonary disease (COPD) is undergoing treatment. The attending physician explains that due to the patient&#x27;s condition, there is an increased need for efficient oxygen delivery to tissues. What the does the Bohr Effect primarily facilitates from the blood towards tissues in the context of this patient with COPD?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Facilitates Oxygen Transport.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Facilitates CO 2 Transport.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Facilitates Chloride Transport.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Facilitates Oxygen Transport.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Facilitates Oxygen Transport.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ Option B. While CO 2 transport is essential in the body, the Bohr Effect specifically refers to the impact of CO 2 on the release of oxygen from hemoglobin , not the transport of CO 2 itself. CO 2 is primarily transported in the form of bicarbonate ions in the blood .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ impact&lt;/li&gt;&lt;li&gt;â€¢ CO 2&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ transported&lt;/li&gt;&lt;li&gt;â€¢ form&lt;/li&gt;&lt;li&gt;â€¢ bicarbonate ions&lt;/li&gt;&lt;li&gt;â€¢ blood&lt;/li&gt;&lt;li&gt;â€¢ Option C. The Bohr Effect does not directly involve chloride transport. The movement of chloride ions in and out of red blood cells is part of the chloride shift , which is a separate mechanism from the Bohr Effect .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ movement&lt;/li&gt;&lt;li&gt;â€¢ chloride ions&lt;/li&gt;&lt;li&gt;â€¢ in&lt;/li&gt;&lt;li&gt;â€¢ out&lt;/li&gt;&lt;li&gt;â€¢ red blood cells&lt;/li&gt;&lt;li&gt;â€¢ chloride shift&lt;/li&gt;&lt;li&gt;â€¢ separate mechanism&lt;/li&gt;&lt;li&gt;â€¢ Bohr Effect&lt;/li&gt;&lt;li&gt;â€¢ Option D. This option is incorrect as the Bohr Effect specifically relates to the facilitation of oxygen transport from hemoglobin to body tissues , especially under conditions of increased CO 2 and lowered pH .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ Bohr Effect&lt;/li&gt;&lt;li&gt;â€¢ facilitation&lt;/li&gt;&lt;li&gt;â€¢ oxygen transport&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ body tissues&lt;/li&gt;&lt;li&gt;â€¢ increased CO 2&lt;/li&gt;&lt;li&gt;â€¢ lowered pH&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the Bohr Effect and its significance in the physiological regulation of oxygen delivery to tissues .&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the Bohr Effect and its significance in the physiological regulation of oxygen delivery to tissues .&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the Bohr Effect and its significance in the physiological regulation of oxygen delivery to tissues .&lt;/li&gt;&lt;li&gt;âž¤ Bohr Effect&lt;/li&gt;&lt;li&gt;âž¤ significance&lt;/li&gt;&lt;li&gt;âž¤ physiological regulation&lt;/li&gt;&lt;li&gt;âž¤ oxygen&lt;/li&gt;&lt;li&gt;âž¤ delivery&lt;/li&gt;&lt;li&gt;âž¤ tissues&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 641&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 641&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;I n a pulmonary function testing session, a Respiratory Therapist evaluated different Lung Volumes in a patient of COPD. In Refence of the same, critical Closing Volume is defined as:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Volume at the end of Forceful Expiration.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Volume at the end of Forceful Inspiration.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Volume remaining after Functional Residual Capacity is measured.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Close to Residual Volume.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Volume at the end of Forceful Expiration.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Volume at the end of Forceful Expiration.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ Option B. This option is incorrect . It is not related to the volume at the end of forceful inspiration. During inspiration, lung volumes increase , and airways are held open by the higher transpulmonary pressure .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ lung volumes increase&lt;/li&gt;&lt;li&gt;â€¢ airways&lt;/li&gt;&lt;li&gt;â€¢ open&lt;/li&gt;&lt;li&gt;â€¢ higher transpulmonary pressure&lt;/li&gt;&lt;li&gt;â€¢ Option C. Incorrect . Functional Residual Capacity (FRC) is the volume of air remaining in the lungs after a normal exhalation , not specifically related to airway closure.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Functional Residual Capacity&lt;/li&gt;&lt;li&gt;â€¢ volume&lt;/li&gt;&lt;li&gt;â€¢ air&lt;/li&gt;&lt;li&gt;â€¢ lungs&lt;/li&gt;&lt;li&gt;â€¢ after&lt;/li&gt;&lt;li&gt;â€¢ normal exhalation&lt;/li&gt;&lt;li&gt;â€¢ Option D. Incorrect . While the critical closing volume may occur at low lung volumes , it is not synonymous with or specifically close to the residual volume, which is the volume of air remaining in the lungs after a maximal exhalation .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Incorrect&lt;/li&gt;&lt;li&gt;â€¢ low lung volumes&lt;/li&gt;&lt;li&gt;â€¢ volume&lt;/li&gt;&lt;li&gt;â€¢ air remaining&lt;/li&gt;&lt;li&gt;â€¢ lungs&lt;/li&gt;&lt;li&gt;â€¢ after&lt;/li&gt;&lt;li&gt;â€¢ maximal exhalation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The objective is to understand the concept of critical closing volume in pulmonary physiology and its relevance in the mechanics of breathing , especially during forced expiration .&lt;/li&gt;&lt;li&gt;âž¤ The objective is to understand the concept of critical closing volume in pulmonary physiology and its relevance in the mechanics of breathing , especially during forced expiration .&lt;/li&gt;&lt;li&gt;âž¤ concept&lt;/li&gt;&lt;li&gt;âž¤ critical closing volume&lt;/li&gt;&lt;li&gt;âž¤ pulmonary physiology&lt;/li&gt;&lt;li&gt;âž¤ mechanics&lt;/li&gt;&lt;li&gt;âž¤ breathing&lt;/li&gt;&lt;li&gt;âž¤ forced expiration&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 628&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 628&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The graph below represents the relationship of chest, lung and both together with respect to the Transmural Pressure.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A= Curve for chest wall; B= Curve for Lung; X= Residual Volume&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A= Curve for Lung; B= Curve for Chest wall; X= Residual Volume&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A= Curve for chest wall; B= Curve for Lung; X= Functional Residual Capacity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A= Curve for Lung; B= Curve for Chest wall; X= Functional Residual Capacity&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. A= Curve for chest wall; B= Curve for Lung; X= Functional Residual Capacity&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/36.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.Â  A= Curve for chest wall; B= Curve for Lung; X= Functional Residual Capacity&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Incorrect . This option inaccurately describes the curves and mislabels point X. The &#x27;Residual Volume&#x27; is not what point X represents.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Option B. Incorrect . This option swaps the compliance labels for the lung and chest wall. &#x27;Residual Volume&#x27; is incorrectly attributed to point X, it is FRC.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Option D. Incorrect . This option incorrectly labels curve A as lung compliance when it should represent chest wall compliance and curve B vice versa.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Incorrect&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ To understand the individual and combined effects of lung and chest wall mechanics on lung volumes, particularly the concept of Functional Residual Capacity (FRC).&lt;/li&gt;&lt;li&gt;âž¤ ( Ref: Ganong&#x27;s Review of Medical physiology, 25 th edition, pg no: 628)&lt;/li&gt;&lt;li&gt;âž¤ ( Ref: Ganong&#x27;s Review of Medical physiology, 25 th edition, pg no: 628)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a hospital&#x27;s pulmonary unit, a medical team is treating a patient with a severe pulmonary embolism. The patient&#x27;s condition leads to areas in the lung where blood flow is obstructed, but ventilation is unaffected. The concept of Ventilation-Perfusion Ratio (V/Q) is crucial for management in such cases. Which of the following is correct related to the affected areas of lung in given condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pressure of Oxygen in the Alveolar Air is less than Dead Space Air Volume.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Partial Pressure of Oxygen and Carbon Dioxide are Equal.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;When P A O 2 is 159 mm Hg and P A CO 2 is 46 mm Hg.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No Exchange of CO 2 and O 2 occurs.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. No Exchange of CO 2 and O 2 occurs.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) No Exchange of CO2and O2occurs.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ Option A. This statement is not correct . The pressure of oxygen in the alveolar air should be equal to (not less than) the dead space air volume , creating alveolar dead space ; directly relate to the ventilation - perfusion ratio being infinite .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ not correct&lt;/li&gt;&lt;li&gt;â€¢ pressure&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ alveolar air&lt;/li&gt;&lt;li&gt;â€¢ equal&lt;/li&gt;&lt;li&gt;â€¢ dead space air volume&lt;/li&gt;&lt;li&gt;â€¢ alveolar dead space&lt;/li&gt;&lt;li&gt;â€¢ ventilation&lt;/li&gt;&lt;li&gt;â€¢ perfusion ratio&lt;/li&gt;&lt;li&gt;â€¢ infinite&lt;/li&gt;&lt;li&gt;â€¢ Option B. This condition does not result in an infinite V/Q ratio . The partial pressures of oxygen and carbon dioxide are never equal .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ does not result&lt;/li&gt;&lt;li&gt;â€¢ infinite V/Q ratio&lt;/li&gt;&lt;li&gt;â€¢ partial pressures&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ carbon&lt;/li&gt;&lt;li&gt;â€¢ dioxide&lt;/li&gt;&lt;li&gt;â€¢ never equal&lt;/li&gt;&lt;li&gt;â€¢ Option C. These values represent normal alveolar gas pressures and do not lead to an infinite V/Q ratio. An infinite ratio is indicative of an extreme imbalance , not normal gas exchange.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ normal alveolar gas&lt;/li&gt;&lt;li&gt;â€¢ pressures&lt;/li&gt;&lt;li&gt;â€¢ extreme imbalance&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The objective is to understand the concept of ventilation-perfusion ratio (V/Q) and identify the conditions under which this ratio can become infinite, indicating a severe mismatch in lung ventilation and blood perfusion.&lt;/li&gt;&lt;li&gt;âž¤ understand&lt;/li&gt;&lt;li&gt;âž¤ concept&lt;/li&gt;&lt;li&gt;âž¤ ventilation-perfusion ratio (V/Q)&lt;/li&gt;&lt;li&gt;âž¤ ratio&lt;/li&gt;&lt;li&gt;âž¤ infinite,&lt;/li&gt;&lt;li&gt;âž¤ severe mismatch&lt;/li&gt;&lt;li&gt;âž¤ lung ventilation&lt;/li&gt;&lt;li&gt;âž¤ blood perfusion.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 636&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 636&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the Neurology Department, a patient with a confirmed Brainstem Lesion is being evaluated. The patient exhibits an unusual Respiratory Pattern, prompting the Evaluation of the Expected Respiratory Changes resulting from Damage to the Pneumotaxic center. What could the Type of Breathing associated with it?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Deep and Fast Respiration.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Deep and Slow Respiration.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Shallow and Fast Respiration.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Shallow and Slow Respiration.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Deep and Slow Respiration.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Deep and Slow Respiration.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ Option A. I ncorrect. Damage to the pneumotaxiccenter typically does not result in both deep and fast respiration. The pneumotaxiccenter primarily helps to regulate the rate and pattern of breathing , but its impairment usually leads to a slower respiratory rate .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Damage&lt;/li&gt;&lt;li&gt;â€¢ pneumotaxiccenter&lt;/li&gt;&lt;li&gt;â€¢ regulate&lt;/li&gt;&lt;li&gt;â€¢ rate&lt;/li&gt;&lt;li&gt;â€¢ pattern&lt;/li&gt;&lt;li&gt;â€¢ breathing&lt;/li&gt;&lt;li&gt;â€¢ slower respiratory rate&lt;/li&gt;&lt;li&gt;â€¢ Option C. This option is not accurate for pneumotaxiccenter damage. While fast respiration can occur in other respiratory conditions , the pattern associated with pneumotaxiccenter impairment is typically not characterized as shallow and fast.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ not accurate&lt;/li&gt;&lt;li&gt;â€¢ fast respiration&lt;/li&gt;&lt;li&gt;â€¢ other respiratory conditions&lt;/li&gt;&lt;li&gt;â€¢ Option D. Shallow and slow respiratory pattern is not characteristic of damage to the pneumotaxiccenter. Such a pattern might be observed in other neurological or respiratory conditions but is not indicative of pneumotaxiccenter impairment.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Shallow and slow&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the role of the pneumotaxiccenter in respiratory control and recognize the respiratory pattern resulting from its damage .&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the role of the pneumotaxiccenter in respiratory control and recognize the respiratory pattern resulting from its damage .&lt;/li&gt;&lt;li&gt;âž¤ understand&lt;/li&gt;&lt;li&gt;âž¤ role&lt;/li&gt;&lt;li&gt;âž¤ pneumotaxiccenter&lt;/li&gt;&lt;li&gt;âž¤ respiratory control&lt;/li&gt;&lt;li&gt;âž¤ recognize&lt;/li&gt;&lt;li&gt;âž¤ respiratory pattern&lt;/li&gt;&lt;li&gt;âž¤ damage&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 658&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 658&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a respiratory clinic, a patient with a chronic obstructive pulmonary disease (COPD) is being evaluated for uneven ventilation distribution in the lungs. The knowledge of distribution of ventilation and blood flow in the lungs is crucial in management of such cases. Which of the following statement pertaining to the case is true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;PaO 2 is Maximum at the Apex.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;V/Q is Maximum at the Base.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ventilation per unit Lung Volume is Maximum at the Apex.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Blood Circulation is Minimum at the Base.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ventilation per unit Lung Volume is Maximum at the Apex.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Ventilation per unit Lung Volume is Maximum at the Apex.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ Option A. This option is incorrect . While it&#x27;s true that PaO 2 ( partial pressure of oxygen in arterial blood ) can be higher in the apex due to lower blood flow compared to ventilation , this statement does not fully capture the relationship between ventilation and blood flow in different lung regions.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ PaO 2&lt;/li&gt;&lt;li&gt;â€¢ partial pressure&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ arterial blood&lt;/li&gt;&lt;li&gt;â€¢ higher&lt;/li&gt;&lt;li&gt;â€¢ apex&lt;/li&gt;&lt;li&gt;â€¢ lower blood flow&lt;/li&gt;&lt;li&gt;â€¢ ventilation&lt;/li&gt;&lt;li&gt;â€¢ Option B. This statement is not true . The ventilation-perfusion (V/Q) ratio is actually lower at the base of the lung because blood flow is greater there, compared to ventilation .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ not true&lt;/li&gt;&lt;li&gt;â€¢ actually lower&lt;/li&gt;&lt;li&gt;â€¢ base&lt;/li&gt;&lt;li&gt;â€¢ blood flow&lt;/li&gt;&lt;li&gt;â€¢ greater&lt;/li&gt;&lt;li&gt;â€¢ ventilation&lt;/li&gt;&lt;li&gt;â€¢ Option D. This statement is incorrect . Blood circulation is actually greater at the base of the lungs due to gravity . The lower parts of the lungs receive more blood flow compared to the apical regions .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ greater&lt;/li&gt;&lt;li&gt;â€¢ base&lt;/li&gt;&lt;li&gt;â€¢ lungs&lt;/li&gt;&lt;li&gt;â€¢ gravity&lt;/li&gt;&lt;li&gt;â€¢ lower parts&lt;/li&gt;&lt;li&gt;â€¢ lungs&lt;/li&gt;&lt;li&gt;â€¢ more blood flow&lt;/li&gt;&lt;li&gt;â€¢ apical regions&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the distribution of ventilation and blood flow in different regions of the lungs , particularly noting how gravity affects these distributions.&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the distribution of ventilation and blood flow in different regions of the lungs , particularly noting how gravity affects these distributions.&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the distribution of ventilation and blood flow in different regions of the lungs , particularly noting how gravity affects these distributions.&lt;/li&gt;&lt;li&gt;âž¤ understand&lt;/li&gt;&lt;li&gt;âž¤ distribution&lt;/li&gt;&lt;li&gt;âž¤ ventilation&lt;/li&gt;&lt;li&gt;âž¤ blood flow&lt;/li&gt;&lt;li&gt;âž¤ different regions&lt;/li&gt;&lt;li&gt;âž¤ lungs&lt;/li&gt;&lt;li&gt;âž¤ how gravity affects&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 638&lt;/li&gt;&lt;li&gt;âž¤ Ref : Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 638&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a critical care unit, a patient is being monitored for respiratory function. The attending physician is reviewing the patient&#x27;s respiratory parameters and asks a resident to calculate the Oxygen Saturation Index (OSI) using the following known parameters: FiO 2 - 0.6, PaO 2 : 85 mm Hg, SpO 2 : 90, and Mean airway pressure (MAP) - 12 cm H 2 O.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;8.5&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;5.5&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;7.5&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;10&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 8.5&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) 8.5&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ The Oxygen Saturation Index (OSI) is calculated using the formula: OSI = (FiO2 * MAP * 100) / PaO2. With the given values (FiO2 = 0.6, MAP = 12 cm H2O, PaO2 = 85 mm Hg), OSI = (0.6* 12* 100) / 85. the OSI is approximately 8.47, which rounds to 8.5 This index helps in assessing the severity of respiratory distress and the effectiveness of oxygen therapy.&lt;/li&gt;&lt;li&gt;â€¢ The Oxygen Saturation Index (OSI) is calculated using the formula: OSI = (FiO2 * MAP * 100) / PaO2. With the given values (FiO2 = 0.6, MAP = 12 cm H2O, PaO2 = 85 mm Hg), OSI = (0.6* 12* 100) / 85. the OSI is approximately 8.47, which rounds to 8.5&lt;/li&gt;&lt;li&gt;â€¢ Oxygen Saturation Index (OSI)&lt;/li&gt;&lt;li&gt;â€¢ OSI = (FiO2 * MAP * 100) / PaO2. With the given values (FiO2 = 0.6, MAP = 12 cm H2O, PaO2 = 85 mm Hg), OSI = (0.6* 12* 100) / 85. the OSI is approximately 8.47, which rounds to 8.5&lt;/li&gt;&lt;li&gt;â€¢ OSI = (FiO2 * MAP * 100) / PaO2.&lt;/li&gt;&lt;li&gt;â€¢ With the given values (FiO2 = 0.6, MAP = 12 cm H2O, PaO2 = 85 mm Hg),&lt;/li&gt;&lt;li&gt;â€¢ OSI = (0.6* 12* 100) / 85.&lt;/li&gt;&lt;li&gt;â€¢ the OSI is approximately 8.47, which rounds to 8.5&lt;/li&gt;&lt;li&gt;â€¢ This index helps in assessing the severity of respiratory distress and the effectiveness of oxygen therapy.&lt;/li&gt;&lt;li&gt;â€¢ assessing&lt;/li&gt;&lt;li&gt;â€¢ severity&lt;/li&gt;&lt;li&gt;â€¢ respiratory distress&lt;/li&gt;&lt;li&gt;â€¢ effectiveness&lt;/li&gt;&lt;li&gt;â€¢ oxygen therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand and apply the formula for calculating the oxygen saturation index (OSI) in a clinical setting, using known respiratory parameters .&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand and apply the formula for calculating the oxygen saturation index (OSI) in a clinical setting, using known respiratory parameters .&lt;/li&gt;&lt;li&gt;âž¤ understand&lt;/li&gt;&lt;li&gt;âž¤ apply&lt;/li&gt;&lt;li&gt;âž¤ formula&lt;/li&gt;&lt;li&gt;âž¤ calculating&lt;/li&gt;&lt;li&gt;âž¤ oxygen saturation index (OSI)&lt;/li&gt;&lt;li&gt;âž¤ respiratory parameters&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Pysiology, 25 th Edition, Pg No: 640&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Pysiology, 25 th Edition, Pg No: 640&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with a collapsed lung (pneumothorax) is being treated in pulmonary medicine ward. The understanding of the relationship between intrapleural pressure, transpulmonary pressure, and alveolar pressure, especially in the context of this patient&#x27;s condition is very essential. For understanding the mechanics of the pneumothorax and guiding appropriate treatment, which is the right formula?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Intrapleural Pressure = Alveolar Pressure x Transpulmonary Pressure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intrapleural Pressure = Transpulmonary Pressure - Alveolar Pressure.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intrapleural Pressure = Transmural Pressure + Alveolar Pressure.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Intrapleural Pressure = Alveolar Pressure - Transpulmonary Pressure.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Intrapleural Pressure = Alveolar Pressure - Transpulmonary Pressure.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ Option A. This option is incorrect . Transpulmonary pressure is the difference between alveolar pressure and intrapleural pressure . Incorrect because the formula suggests a multiplication, which does not represent the relationship between these pressures.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ Transpulmonary pressure&lt;/li&gt;&lt;li&gt;â€¢ difference&lt;/li&gt;&lt;li&gt;â€¢ alveolar pressure&lt;/li&gt;&lt;li&gt;â€¢ intrapleural&lt;/li&gt;&lt;li&gt;â€¢ pressure&lt;/li&gt;&lt;li&gt;â€¢ Option B. This option is also incorrect . Intrapleural pressure is not calculated by subtracting alveolar pressure from transpulmonary pressure. The transpulmonary pressure is actually the difference between alveolar and intrapleural pressures .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ transpulmonary pressure&lt;/li&gt;&lt;li&gt;â€¢ difference&lt;/li&gt;&lt;li&gt;â€¢ alveolar&lt;/li&gt;&lt;li&gt;â€¢ intrapleural pressures&lt;/li&gt;&lt;li&gt;â€¢ Option C. This statement is not correct . Intrapleural pressure is not the sum of transmural pressure and alveolar pressure. Transmural pressure is the pressure difference across the wall of the lung .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ not correct&lt;/li&gt;&lt;li&gt;â€¢ Transmural pressure&lt;/li&gt;&lt;li&gt;â€¢ across&lt;/li&gt;&lt;li&gt;â€¢ wall&lt;/li&gt;&lt;li&gt;â€¢ lung&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the relationship between intrapleural pressure , transpulmonary pressure , and alveolar pressure in pulmonary physiology .&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the relationship between intrapleural pressure , transpulmonary pressure , and alveolar pressure in pulmonary physiology .&lt;/li&gt;&lt;li&gt;âž¤ intrapleural pressure&lt;/li&gt;&lt;li&gt;âž¤ transpulmonary pressure&lt;/li&gt;&lt;li&gt;âž¤ alveolar pressure&lt;/li&gt;&lt;li&gt;âž¤ pulmonary physiology&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 62&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 62&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A respiratory therapist is assessing lung function of a patient Refred for chest physiotherapy. She provides data from a spirometry test for calculating the dead space ventilation. The data given are tidal volume is 500 ml, PECO 2 (Partial Pressure of CO 2 in expired air) is 30 mm Hg, and PACO 2 is 45 mm Hg. What is the Dead Space Volume in this Index Patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;150 ml&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;166 ml&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;175 ml&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;200 ml&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 166 ml&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 166 ml&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ Dead space ventilation is calculated using the formula: V d = TV * (PACO2 - PECO2) / PACO2. = 500 X (45- 30) / 45 = 166.6 Using the given values, the dead space ventilation is approximately 166.67 ml , which rounds to 166 ml .&lt;/li&gt;&lt;li&gt;â€¢ Dead space ventilation is calculated using the formula: V d = TV * (PACO2 - PECO2) / PACO2. = 500 X (45- 30) / 45 = 166.6&lt;/li&gt;&lt;li&gt;â€¢ Dead space ventilation&lt;/li&gt;&lt;li&gt;â€¢ V d = TV * (PACO2 - PECO2) / PACO2. = 500 X (45- 30) / 45 = 166.6&lt;/li&gt;&lt;li&gt;â€¢ V d = TV * (PACO2 - PECO2) / PACO2.&lt;/li&gt;&lt;li&gt;â€¢ = 500 X (45- 30) / 45&lt;/li&gt;&lt;li&gt;â€¢ = 166.6&lt;/li&gt;&lt;li&gt;â€¢ Using the given values, the dead space ventilation is approximately 166.67 ml , which rounds to 166 ml .&lt;/li&gt;&lt;li&gt;â€¢ dead space ventilation&lt;/li&gt;&lt;li&gt;â€¢ 166.67 ml&lt;/li&gt;&lt;li&gt;â€¢ 166 ml&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand and apply the concept of dead space ventilation in respiratory physiology , particularly in the context of interpreting spirometry data . â€‹&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand and apply the concept of dead space ventilation in respiratory physiology , particularly in the context of interpreting spirometry data . â€‹&lt;/li&gt;&lt;li&gt;âž¤ dead space&lt;/li&gt;&lt;li&gt;âž¤ ventilation&lt;/li&gt;&lt;li&gt;âž¤ respiratory physiology&lt;/li&gt;&lt;li&gt;âž¤ interpreting spirometry data&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 629&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 629&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a Neonatal Intensive Care Unit (NICU), a Premature Infant born at 28 Weeks is experiencing Respiratory difficulties shortly after Birth. Which specific type of Alveolar Cells are deficient in this premature infant, contributing to the development of the pathology in this Neonate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alveolar Capillary Endothelial Cells.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Type I Alveolar Cells.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Type II Alveolar Cells.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alveolar Macrophages.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Type II Alveolar Cells.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Type II Alveolar Cells.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alveolar capillary endothelial cells are not primarily deficient in premature infants with RDS. Alveolar capillary endothelial cells line the blood vessels in the lungs and are essential for gas exchange , but their deficiency is not the characteristic feature of RDS.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ line&lt;/li&gt;&lt;li&gt;â€¢ blood vessels&lt;/li&gt;&lt;li&gt;â€¢ lungs&lt;/li&gt;&lt;li&gt;â€¢ essential&lt;/li&gt;&lt;li&gt;â€¢ gas exchange&lt;/li&gt;&lt;li&gt;â€¢ Option B. While type I alveolar cells are crucial for gas exchange due to their thin structure facilitating diffusion , they are not the cells primarily deficient in RDS. RDS is more directly related to a deficiency in another type of alveolar cells .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ crucial&lt;/li&gt;&lt;li&gt;â€¢ gas exchange&lt;/li&gt;&lt;li&gt;â€¢ thin structure&lt;/li&gt;&lt;li&gt;â€¢ facilitating diffusion&lt;/li&gt;&lt;li&gt;â€¢ directly&lt;/li&gt;&lt;li&gt;â€¢ deficiency&lt;/li&gt;&lt;li&gt;â€¢ another type&lt;/li&gt;&lt;li&gt;â€¢ alveolar cells&lt;/li&gt;&lt;li&gt;â€¢ Option D. Alveolar macrophages are part of the immune defense in the lungs , helping to clear pathogens and debris . A deficiency of alveolar macrophages is not the primary concern in premature infants with RDS.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Alveolar macrophages&lt;/li&gt;&lt;li&gt;â€¢ immune defense&lt;/li&gt;&lt;li&gt;â€¢ lungs&lt;/li&gt;&lt;li&gt;â€¢ clear pathogens&lt;/li&gt;&lt;li&gt;â€¢ debris&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the pathophysiology of respiratory distress syndrome in premature infants , particularly the role of type II alveolar cells and surfactant deficiency .&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the pathophysiology of respiratory distress syndrome in premature infants , particularly the role of type II alveolar cells and surfactant deficiency .&lt;/li&gt;&lt;li&gt;âž¤ pathophysiology&lt;/li&gt;&lt;li&gt;âž¤ respiratory distress&lt;/li&gt;&lt;li&gt;âž¤ syndrome&lt;/li&gt;&lt;li&gt;âž¤ premature infants&lt;/li&gt;&lt;li&gt;âž¤ role&lt;/li&gt;&lt;li&gt;âž¤ type II alveolar cells&lt;/li&gt;&lt;li&gt;âž¤ surfactant deficiency&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 631&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 631&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a Respiratory Clinic, a patient presents with Acute Symptoms of Breathlessness and Tightness in the Chest after increase in Pulmonary Capillary Pressure . The Respiratory team suspects that the patient&#x27;s symptoms are being mediated by specific Pulmonary Receptors, potentially triggered by the Irritants. Given the Patient&#x27;s Clinical Presentation, what is the location of the Receptors which are likely involved in the patient&#x27;s Acute Respiratory Response?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pulmonary Interstitium.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alveolar Capillaries.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Terminal Bronchiole.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Respiratory Muscles.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Pulmonary Interstitium.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Pulmonary Interstitium.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ Option B. While J receptors are near alveolar capillaries , they are specifically located in the interstitial tissue of the lung and not within the capillaries themselves. Therefore, this option is not entirely accurate.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ near alveolar capillaries&lt;/li&gt;&lt;li&gt;â€¢ interstitial tissue&lt;/li&gt;&lt;li&gt;â€¢ lung&lt;/li&gt;&lt;li&gt;â€¢ Option C. J receptors are not located in the terminal bronchioles. Instead, other types of receptors like irritant receptors are found in the airway epithelium . Bronchioles are supplied with bronchial circulation not with Pulmonary capillaries.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ airway epithelium&lt;/li&gt;&lt;li&gt;â€¢ Bronchioles&lt;/li&gt;&lt;li&gt;â€¢ supplied&lt;/li&gt;&lt;li&gt;â€¢ bronchial circulation&lt;/li&gt;&lt;li&gt;â€¢ Option D. J receptors are not found in the respiratory muscles .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ not found&lt;/li&gt;&lt;li&gt;â€¢ respiratory muscles&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the location and function of J receptors in the respiratory system , emphasizing their role in responding to changes in pulmonary capillary pressure. Top of Form&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the location and function of J receptors in the respiratory system , emphasizing their role in responding to changes in pulmonary capillary pressure. Top of Form&lt;/li&gt;&lt;li&gt;âž¤ understand&lt;/li&gt;&lt;li&gt;âž¤ location&lt;/li&gt;&lt;li&gt;âž¤ function&lt;/li&gt;&lt;li&gt;âž¤ J receptors&lt;/li&gt;&lt;li&gt;âž¤ respiratory system&lt;/li&gt;&lt;li&gt;âž¤ role&lt;/li&gt;&lt;li&gt;âž¤ responding&lt;/li&gt;&lt;li&gt;âž¤ changes&lt;/li&gt;&lt;li&gt;âž¤ pulmonary capillary pressure.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 658&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 658&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old patient with a history of chronic bronchitis is undergoing spirometry. The patient is instructed to perform a forced expiratory maneuver. Which is the primary muscle group responsible for the patient&#x27;s ability to achieve maximum forced expiration during the test ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chest Wall Elasticity.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diaphragm Muscles.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Abdominal Muscles.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;External Intercostal Muscles.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Abdominal Muscles.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Abdominal Muscles.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ Option A. While chest wall elasticity plays a role in passive (quiet) expiration by recoiling to its original position , it is not the driver of maximum forced expiration. Forced expiration , especially at its maximum , requires active muscular effort beyond passive recoil .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ passive (quiet) expiration&lt;/li&gt;&lt;li&gt;â€¢ recoiling&lt;/li&gt;&lt;li&gt;â€¢ original position&lt;/li&gt;&lt;li&gt;â€¢ Forced expiration&lt;/li&gt;&lt;li&gt;â€¢ maximum&lt;/li&gt;&lt;li&gt;â€¢ active muscular effort&lt;/li&gt;&lt;li&gt;â€¢ beyond&lt;/li&gt;&lt;li&gt;â€¢ passive recoil&lt;/li&gt;&lt;li&gt;â€¢ Option B. The diaphragm is the primary muscle involved in inspiration , not forced expiration. During forced expiration , its role is less significant compared to the muscles that actively compress the thoracic cavity .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ primary muscle&lt;/li&gt;&lt;li&gt;â€¢ inspiration&lt;/li&gt;&lt;li&gt;â€¢ forced expiration&lt;/li&gt;&lt;li&gt;â€¢ less significant&lt;/li&gt;&lt;li&gt;â€¢ muscles&lt;/li&gt;&lt;li&gt;â€¢ actively compress&lt;/li&gt;&lt;li&gt;â€¢ thoracic cavity&lt;/li&gt;&lt;li&gt;â€¢ Option D. T he External Intercostal Muscles are involved in inspiration and not responsible for maximum forced expiration.&lt;/li&gt;&lt;li&gt;â€¢ Option D. T&lt;/li&gt;&lt;li&gt;â€¢ External Intercostal Muscles&lt;/li&gt;&lt;li&gt;â€¢ inspiration&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the role of various muscles and structural components in the process of forced expiration , particularly emphasizing the predominant role of the abdominal muscles in maximum forced expiration .&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the role of various muscles and structural components in the process of forced expiration , particularly emphasizing the predominant role of the abdominal muscles in maximum forced expiration .&lt;/li&gt;&lt;li&gt;âž¤ role&lt;/li&gt;&lt;li&gt;âž¤ various muscles&lt;/li&gt;&lt;li&gt;âž¤ structural components&lt;/li&gt;&lt;li&gt;âž¤ process&lt;/li&gt;&lt;li&gt;âž¤ forced expiration&lt;/li&gt;&lt;li&gt;âž¤ emphasizing&lt;/li&gt;&lt;li&gt;âž¤ predominant role&lt;/li&gt;&lt;li&gt;âž¤ abdominal muscles&lt;/li&gt;&lt;li&gt;âž¤ maximum forced expiration&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 628&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 628&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a Trauma Center, a 40-year-old male patient is brought in after a Severe Car Accident. He Exhibits Signs of Respiratory Distress, and the Medical Team notes the presence of Cyanosis. The significance of cyanosis in assessing the patient&#x27;s Oxygenation Status in a Trauma setting is very crucial. What does cyanosis signify in such a patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Early Sign of Hypoxia.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Late Sign of Hypoxia.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Absence of Cyanosis means Adequate Tissue Ventilation.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Absence of Cyanosis means Adequate Tissue Oxygenation.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Late Sign of Hypoxia.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Late Sign of Hypoxia.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ Option A. This option is not accurate . Cyanosis is not typically an early sign of hypoxia. It tends to occur when oxygen levels in the blood have significantly decreased , making it a later sign of inadequate oxygenation .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ not accurate&lt;/li&gt;&lt;li&gt;â€¢ oxygen levels&lt;/li&gt;&lt;li&gt;â€¢ blood&lt;/li&gt;&lt;li&gt;â€¢ significantly decreased&lt;/li&gt;&lt;li&gt;â€¢ later&lt;/li&gt;&lt;li&gt;â€¢ sign&lt;/li&gt;&lt;li&gt;â€¢ inadequate oxygenation&lt;/li&gt;&lt;li&gt;â€¢ Option C. This statement is not accurate . The absence of cyanosis does not necessarily indicate adequate tissue ventilation. Adequate tissue ventilation depends on multiple factors , including both oxygenation and ventilation .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ not accurate&lt;/li&gt;&lt;li&gt;â€¢ multiple factors&lt;/li&gt;&lt;li&gt;â€¢ both oxygenation&lt;/li&gt;&lt;li&gt;â€¢ ventilation&lt;/li&gt;&lt;li&gt;â€¢ Option D. This option is not entirely accurate . While the absence of cyanosis may suggest that tissue oxygenation is adequate , it does not provide a complete assessment of oxygenation status. Other clinical signs and measurements, such as oxygen saturation , should be considered for a comprehensive evaluation of tissue oxygenation .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ not entirely accurate&lt;/li&gt;&lt;li&gt;â€¢ absence&lt;/li&gt;&lt;li&gt;â€¢ cyanosis&lt;/li&gt;&lt;li&gt;â€¢ tissue oxygenation&lt;/li&gt;&lt;li&gt;â€¢ adequate&lt;/li&gt;&lt;li&gt;â€¢ oxygen saturation&lt;/li&gt;&lt;li&gt;â€¢ comprehensive evaluation&lt;/li&gt;&lt;li&gt;â€¢ tissue oxygenation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the clinical significance of cyanosis in trauma patients and recognize it as a late sign of hypoxia , indicating inadequate oxygenation.&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the clinical significance of cyanosis in trauma patients and recognize it as a late sign of hypoxia , indicating inadequate oxygenation.&lt;/li&gt;&lt;li&gt;âž¤ clinical significance&lt;/li&gt;&lt;li&gt;âž¤ cyanosis&lt;/li&gt;&lt;li&gt;âž¤ trauma patients&lt;/li&gt;&lt;li&gt;âž¤ recognize&lt;/li&gt;&lt;li&gt;âž¤ late sign&lt;/li&gt;&lt;li&gt;âž¤ hypoxia&lt;/li&gt;&lt;li&gt;âž¤ inadequate oxygenation.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 646&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 646&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male patient presents with symptoms of chronic obstructive pulmonary disease (COPD) and a recent history of respiratory failure. Patient has a respiratory rate of 30/min. Which is the specific channel through which Peripheral Chemoreceptors are Sensitive to Hypoxia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oxygen-Sensitive Sodium Channel.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oxygen-Sensitive Potassium Channel.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oxygen-Sensitive Chloride Channel.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ligand-Gated Channel.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Oxygen-Sensitive Potassium Channel.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Oxygen-Sensitive Potassium Channel.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Peripheral chemoreceptors are not sensitive to hypoxia via sodium channels. Sodium channels are involved in the generation of action potentials but are not directly related to the detection of oxygen levels.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Sodium channels&lt;/li&gt;&lt;li&gt;â€¢ generation&lt;/li&gt;&lt;li&gt;â€¢ action potentials&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chloride channels are not the channels through which peripheral chemoreceptors detect hypoxia. Their role is not directly related to oxygen sensing.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ Option D. While ligand-gated channels can be involved in various cellular processes , they are not the primary channels through which peripheral chemoreceptors sense hypoxia. Oxygen-sensitive potassium channels are more directly associated with this function .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ various cellular processes&lt;/li&gt;&lt;li&gt;â€¢ Oxygen-sensitive potassium channels&lt;/li&gt;&lt;li&gt;â€¢ directly&lt;/li&gt;&lt;li&gt;â€¢ function&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the mechanism by which peripheral chemoreceptors detect hypoxia , emphasizing the role of oxygen-sensitive potassium channels in this process.&lt;/li&gt;&lt;li&gt;âž¤ mechanism&lt;/li&gt;&lt;li&gt;âž¤ peripheral chemoreceptors&lt;/li&gt;&lt;li&gt;âž¤ detect&lt;/li&gt;&lt;li&gt;âž¤ hypoxia&lt;/li&gt;&lt;li&gt;âž¤ emphasizing&lt;/li&gt;&lt;li&gt;âž¤ role&lt;/li&gt;&lt;li&gt;âž¤ oxygen-sensitive potassium channels&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 657&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 657&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a Respiratory Diagnostics Workshop, a Pulmonary Function Test (PFT) technician discusses the measurement of Diffusing Capacity of the Lungs for Carbon Monoxide (DLCO). The Technician presents a scenario and asks the Attendees to identify the condition in which DLCO is NOT decreased.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pulmonary Hypertension.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Emphysema.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Interstitial Lung Disease (ILD).&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Polycythemia.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Polycythemia.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Polycythemia.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ Option A. DLCO is decreased in Pulmonary Hypertension due to reduced pulmonary capillary blood volume (decreased perfusion) and/or thickening of the alveolar-capillary membrane. This leads to impaired gas exchange, impacting the efficiency of oxygen transfer from the lungs to the blood.&lt;/li&gt;&lt;li&gt;â€¢ Option A. DLCO is decreased in Pulmonary Hypertension&lt;/li&gt;&lt;li&gt;â€¢ Option B. DLCO is decreased in emphysema because the destruction of alveolar walls reduces the surface area available for gas exchange .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ DLCO&lt;/li&gt;&lt;li&gt;â€¢ decreased&lt;/li&gt;&lt;li&gt;â€¢ emphysema&lt;/li&gt;&lt;li&gt;â€¢ destruction&lt;/li&gt;&lt;li&gt;â€¢ alveolar walls&lt;/li&gt;&lt;li&gt;â€¢ reduces&lt;/li&gt;&lt;li&gt;â€¢ gas exchange&lt;/li&gt;&lt;li&gt;â€¢ Option C. DLCO is decreased in ILD due to thickening of the alveolar-capillary membrane , which impairs gas diffusion .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ decreased&lt;/li&gt;&lt;li&gt;â€¢ ILD&lt;/li&gt;&lt;li&gt;â€¢ thickening&lt;/li&gt;&lt;li&gt;â€¢ alveolar-capillary membrane&lt;/li&gt;&lt;li&gt;â€¢ impairs&lt;/li&gt;&lt;li&gt;â€¢ diffusion&lt;/li&gt;&lt;li&gt;â€¢ Option D. DLCO is decreased in polycythemia because an increased number of red blood cells can cause reduced gas exchange efficiency in the lungs .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ decreased&lt;/li&gt;&lt;li&gt;â€¢ increased number&lt;/li&gt;&lt;li&gt;â€¢ red blood cells&lt;/li&gt;&lt;li&gt;â€¢ reduced gas exchange&lt;/li&gt;&lt;li&gt;â€¢ efficiency&lt;/li&gt;&lt;li&gt;â€¢ lungs&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the factors that affect DLCO measurements and recognize that DLCO is typically increased in Polycythemia, which is in contrast to conditions like emphysema, ILD, and pulmonary vascular diseases where DLCO is reduced.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 639&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 639&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a Hospital&#x27;s Neurology Ward, a 45-year-old patient with a Rare Neurological Disorder affecting Respiratory Control is being examined. The Medical Team is assessing the patient&#x27;s Breathing patterns to determine which Respiratory Centers might be Impacted by the Disorder. The patient exhibits Normal Breathing at Rest but experiences difficulties under Stress. Which of the following remains Inactive During Normal Respiration?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pre-Botzinger Complex.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dorsal Group of Neurons.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ventral Group of Neurons.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pneumotaxiccenter.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ventral Group of Neurons.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Ventral VRG Group of Neurons.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A (Pre-BÃ¶tzinger complex): This complex is active during normal respiration as it is critical for generating the rhythmic breathing pattern.&lt;/li&gt;&lt;li&gt;â€¢ Option A (Pre-BÃ¶tzinger complex):&lt;/li&gt;&lt;li&gt;â€¢ Option B (Dorsal group of neurons): Active during normal respiration, the dorsal group primarily controls inspiratory movements.&lt;/li&gt;&lt;li&gt;â€¢ Option B (Dorsal group of neurons):&lt;/li&gt;&lt;li&gt;â€¢ Option D (Pneumotaxiccenter): This center modulates the activity of the dorsal group to regulate the rate and pattern of breathing but is not necessarily inactive during normal respiration.&lt;/li&gt;&lt;li&gt;â€¢ Option D (Pneumotaxiccenter):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the functions of different respiratory centers in the brainstem and their roles in normal and stressed breathing conditions .&lt;/li&gt;&lt;li&gt;âž¤ Understand the functions of different respiratory centers in the brainstem and their roles in normal and stressed breathing conditions .&lt;/li&gt;&lt;li&gt;âž¤ different respiratory centers&lt;/li&gt;&lt;li&gt;âž¤ brainstem&lt;/li&gt;&lt;li&gt;âž¤ normal&lt;/li&gt;&lt;li&gt;âž¤ stressed breathing conditions&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 655)&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 655)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 46-year-old man presents to the emergency department with acute onset of confusion, lactic acidosis, and the smell of almonds on his breath. He works in an industrial plant that manufactures synthetic plastics, ABG reveals reduced arterio- venous difference. Which of the following is the most likely cause of his symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Methemoglobinemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cyanide Poisoning&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Carbon Monoxide Exposure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ethylene Glycol Poisoning&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Cyanide Poisoning&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Cyanide Poisoning&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Methemoglobinemia results from the presence of methemoglobin , which is hemoglobin with iron in the ferric state that cannot bind oxygen , leading to hypoxia . However, it does not typically present with an almond odor on the breath, nor is it commonly associated with plastic manufacturing.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ presence&lt;/li&gt;&lt;li&gt;â€¢ methemoglobin&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ iron&lt;/li&gt;&lt;li&gt;â€¢ ferric state&lt;/li&gt;&lt;li&gt;â€¢ cannot bind oxygen&lt;/li&gt;&lt;li&gt;â€¢ hypoxia&lt;/li&gt;&lt;li&gt;â€¢ Option C. CO binds to hemoglobin with greater affinity than oxygen , causing anemic hypoxia . It is characterized by cherry-red skin and may be found in environments with incomplete combustion ; however, it is not typically associated with the smell of almonds or with plastic manufacturing plants.&lt;/li&gt;&lt;li&gt;â€¢ Option C. CO&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ greater affinity&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ anemic hypoxia&lt;/li&gt;&lt;li&gt;â€¢ characterized&lt;/li&gt;&lt;li&gt;â€¢ cherry-red skin&lt;/li&gt;&lt;li&gt;â€¢ incomplete combustion&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ingestion of ethylene glycol , an antifreeze component, can lead to metabolic acidosis and renal failure . Although it can cause altered mental status , it does not result in histotoxic hypoxia or an almond odor on the breath.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ingestion&lt;/li&gt;&lt;li&gt;â€¢ ethylene glycol&lt;/li&gt;&lt;li&gt;â€¢ antifreeze&lt;/li&gt;&lt;li&gt;â€¢ metabolic acidosis&lt;/li&gt;&lt;li&gt;â€¢ renal failure&lt;/li&gt;&lt;li&gt;â€¢ altered mental status&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Identify the clinical presentation and causes of histotoxic hypoxia .&lt;/li&gt;&lt;li&gt;âž¤ Identify the clinical presentation and causes of histotoxic hypoxia .&lt;/li&gt;&lt;li&gt;âž¤ clinical presentation&lt;/li&gt;&lt;li&gt;âž¤ causes&lt;/li&gt;&lt;li&gt;âž¤ histotoxic hypoxia&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 647 Top of Form&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 647&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a neuroscience lecture on the neural control of respiration, the professor discusses various respiratory centers in the brainstem. The students are asked to identify which of these centers are inactive during normal respiration.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pre-Botzinger Complex.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dorsal Group of Neurons.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ventral Group of Neurons.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pneumotaxiccenter.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ventral Group of Neurons.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Ventral Group of Neurons.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pre-Botzinger complex is active in generating the respiratory rhythm , crucial even during normal respiration.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ active&lt;/li&gt;&lt;li&gt;â€¢ generating&lt;/li&gt;&lt;li&gt;â€¢ respiratory rhythm&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dorsal group of neurons i ntegrates sensory input and contributes to the regulation of breathing under normal conditions.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ sensory input&lt;/li&gt;&lt;li&gt;â€¢ regulation&lt;/li&gt;&lt;li&gt;â€¢ breathing&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pneumotaxiccenter, modulates the respiratory pattern but remains active to regulate the breath-holding capacity during normal breathing .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ modulates&lt;/li&gt;&lt;li&gt;â€¢ respiratory pattern&lt;/li&gt;&lt;li&gt;â€¢ active&lt;/li&gt;&lt;li&gt;â€¢ regulate&lt;/li&gt;&lt;li&gt;â€¢ breath-holding capacity&lt;/li&gt;&lt;li&gt;â€¢ normal breathing&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the role of different brainstem respiratory centers in regulating normal and increased respiratory demands .Top of Form&lt;/li&gt;&lt;li&gt;âž¤ Understand the role of different brainstem respiratory centers in regulating normal and increased respiratory demands .Top of Form&lt;/li&gt;&lt;li&gt;âž¤ brainstem respiratory centers&lt;/li&gt;&lt;li&gt;âž¤ regulating normal&lt;/li&gt;&lt;li&gt;âž¤ increased respiratory demands&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 655&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 655&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 76-year-old man has a Lung Tumor that pushes against an Airway, completely Obstructing Air Flow to the Distal Alveoli. Refer to the O 2 -CO 2 (Ventilation/Perfusion, V/Q) Diagram provided. Which point on the V/Q Line of the Diagram corresponds to the Alveolar Gas of these Distal Alveoli?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Point A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Point B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Point C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Point D&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Point A&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/37.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/38.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Point A&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Point B indicates a slightly reduced PO 2 with a normal PCO 2 , which would be consistent with a partial airway obstruction . In this situation, ventilation is reduced , but not absent, allowing for some oxygen to be absorbed and some carbon dioxide to be expelled , but not at optimal levels.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ slightly reduced&lt;/li&gt;&lt;li&gt;â€¢ PO 2&lt;/li&gt;&lt;li&gt;â€¢ normal PCO 2&lt;/li&gt;&lt;li&gt;â€¢ partial airway obstruction&lt;/li&gt;&lt;li&gt;â€¢ ventilation&lt;/li&gt;&lt;li&gt;â€¢ reduced&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ absorbed&lt;/li&gt;&lt;li&gt;â€¢ carbon dioxide&lt;/li&gt;&lt;li&gt;â€¢ expelled&lt;/li&gt;&lt;li&gt;â€¢ Option C. Point C is representing normal partial pressures of respiratory gases , but if it were, it would likely represent a different ratio of ventilation to perfusion , not consistent with complete airway obstruction.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ normal partial pressures&lt;/li&gt;&lt;li&gt;â€¢ respiratory gases&lt;/li&gt;&lt;li&gt;â€¢ different ratio&lt;/li&gt;&lt;li&gt;â€¢ ventilation&lt;/li&gt;&lt;li&gt;â€¢ perfusion&lt;/li&gt;&lt;li&gt;â€¢ Option D. Point D would indicate near normal ventilation and perfusion ( V/Q = 1 ), which is not consistent with an obstruction scenario, rather it can be due to partial obstruction in the perfusion .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ near normal ventilation&lt;/li&gt;&lt;li&gt;â€¢ perfusion&lt;/li&gt;&lt;li&gt;â€¢ V/Q = 1&lt;/li&gt;&lt;li&gt;â€¢ partial obstruction&lt;/li&gt;&lt;li&gt;â€¢ perfusion&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The objective is to understand the impact of airway obstruction on alveolar gas concentrations , as represented on a V/Q diagram , and to differentiate between different types of V/Q mismatches , such as those caused by obstructions versus those caused by vascular obstructions like pulmonary embolism .&lt;/li&gt;&lt;li&gt;âž¤ The objective is to understand the impact of airway obstruction on alveolar gas concentrations , as represented on a V/Q diagram , and to differentiate between different types of V/Q mismatches , such as those caused by obstructions versus those caused by vascular obstructions like pulmonary embolism .&lt;/li&gt;&lt;li&gt;âž¤ impact&lt;/li&gt;&lt;li&gt;âž¤ airway obstruction&lt;/li&gt;&lt;li&gt;âž¤ alveolar gas&lt;/li&gt;&lt;li&gt;âž¤ concentrations&lt;/li&gt;&lt;li&gt;âž¤ V/Q diagram&lt;/li&gt;&lt;li&gt;âž¤ different types&lt;/li&gt;&lt;li&gt;âž¤ V/Q mismatches&lt;/li&gt;&lt;li&gt;âž¤ obstructions&lt;/li&gt;&lt;li&gt;âž¤ vascular obstructions&lt;/li&gt;&lt;li&gt;âž¤ pulmonary embolism&lt;/li&gt;&lt;li&gt;âž¤ Ref: Guyton and Hall Textbook of Medical Physiology, 12 th Edition, Pg No: 500&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Guyton and Hall Textbook of Medical Physiology, 12 th Edition, Pg No: 500&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male, Chronic Smoker, came to the Emergency with Shortness of Breath. On examination, he was Tachypnoeic. An immediate Arterial Blood Gas Analysis revealed a Decreased PO 2 and Increased PCO 2 Levels. Which Area is most sensitive to CO 2 levels and primarily responsible for stimulating Increased Ventilation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Apneustic Center.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pneumotaxiccenter.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ventral Surface of the Medulla.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cerebral Cortex .&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ventral Surface of the Medulla.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Ventral Surface of the Medulla.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ Option A. The apneustic center, located in the pons , plays a role in promoting inspiration but is not responsible for the response to CO 2 levels in the blood.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ pons&lt;/li&gt;&lt;li&gt;â€¢ role&lt;/li&gt;&lt;li&gt;â€¢ promoting inspiration&lt;/li&gt;&lt;li&gt;â€¢ Option B. The pneumotaxiccenter, also located in the pons , regulates the rate and depth of breathing by modulating the activity of the inspiratory center but is not the site for CO 2 sensing.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ pons&lt;/li&gt;&lt;li&gt;â€¢ regulates&lt;/li&gt;&lt;li&gt;â€¢ rate&lt;/li&gt;&lt;li&gt;â€¢ depth&lt;/li&gt;&lt;li&gt;â€¢ breathing&lt;/li&gt;&lt;li&gt;â€¢ modulating&lt;/li&gt;&lt;li&gt;â€¢ activity&lt;/li&gt;&lt;li&gt;â€¢ inspiratory center&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cerebral cortex is not involved in the direct regulation of ventilation in response to CO 2 levels. It plays a role in oxygen transport in red blood cells .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ role&lt;/li&gt;&lt;li&gt;â€¢ oxygen transport&lt;/li&gt;&lt;li&gt;â€¢ red blood cells&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the central chemoreceptors&#x27; role in responding to changes in CO 2 levels in the cerebrospinal fluid and recognizing that an increase in CO 2 primarily affects the receptors on the ventral surface of the medulla to stimulate ventilation .&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the central chemoreceptors&#x27; role in responding to changes in CO 2 levels in the cerebrospinal fluid and recognizing that an increase in CO 2 primarily affects the receptors on the ventral surface of the medulla to stimulate ventilation .&lt;/li&gt;&lt;li&gt;âž¤ understand&lt;/li&gt;&lt;li&gt;âž¤ central chemoreceptors&#x27; role&lt;/li&gt;&lt;li&gt;âž¤ changes&lt;/li&gt;&lt;li&gt;âž¤ CO 2 levels&lt;/li&gt;&lt;li&gt;âž¤ cerebrospinal fluid&lt;/li&gt;&lt;li&gt;âž¤ increase&lt;/li&gt;&lt;li&gt;âž¤ affects&lt;/li&gt;&lt;li&gt;âž¤ receptors&lt;/li&gt;&lt;li&gt;âž¤ ventral surface&lt;/li&gt;&lt;li&gt;âž¤ medulla&lt;/li&gt;&lt;li&gt;âž¤ stimulate ventilation&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 657&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 657&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with a Lesion in the Midpontine Region and Bilateral Vagotomy presents with Respiratory Abnormalities. Which of the following best describes the Expected Respiratory Pattern in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Shallow and Rapid Breathing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Slow and Deep Breathing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Apneustic Pattern with Prolonged Inspiratory Gasping&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No Change in Respiratory Pattern&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Apneustic Pattern with Prolonged Inspiratory Gasping&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Apneustic Pattern with Prolonged Inspiratory Gasping.\&quot;&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Shallow and rapid breathing is unlikely because a lesion in the midpontine region and bilateral vagotomy would typically result in irregular and disrupted breathing patterns rather than shallow and rapid breathing .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ unlikely&lt;/li&gt;&lt;li&gt;â€¢ lesion&lt;/li&gt;&lt;li&gt;â€¢ midpontine region&lt;/li&gt;&lt;li&gt;â€¢ bilateral vagotomy&lt;/li&gt;&lt;li&gt;â€¢ result&lt;/li&gt;&lt;li&gt;â€¢ irregular&lt;/li&gt;&lt;li&gt;â€¢ disrupted breathing patterns&lt;/li&gt;&lt;li&gt;â€¢ shallow&lt;/li&gt;&lt;li&gt;â€¢ rapid breathing&lt;/li&gt;&lt;li&gt;â€¢ Option B. While Slow and deep breathing may seem plausible , if a lesion either in the midpontine region or bilateral vagotomy ; not it both as mentioned in the question.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ plausible&lt;/li&gt;&lt;li&gt;â€¢ either&lt;/li&gt;&lt;li&gt;â€¢ midpontine region&lt;/li&gt;&lt;li&gt;â€¢ bilateral vagotomy&lt;/li&gt;&lt;li&gt;â€¢ Option D. No change in respiratory pattern is unlikely because a lesion in the midpontine region and bilateral vagotomy are expected to have an impact on respiratory control , resulting in altered breathing patterns .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ unlikely&lt;/li&gt;&lt;li&gt;â€¢ lesion&lt;/li&gt;&lt;li&gt;â€¢ midpontine region&lt;/li&gt;&lt;li&gt;â€¢ bilateral vagotomy&lt;/li&gt;&lt;li&gt;â€¢ expected&lt;/li&gt;&lt;li&gt;â€¢ impact&lt;/li&gt;&lt;li&gt;â€¢ respiratory control&lt;/li&gt;&lt;li&gt;â€¢ resulting&lt;/li&gt;&lt;li&gt;â€¢ altered breathing patterns&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective of this question is to assess the understanding of the effects of specific brain lesions and vagotomy on respiratory patterns , emphasizing the potential development of an apneustic pattern in such cases.Top of Form&lt;/li&gt;&lt;li&gt;âž¤ The educational objective of this question is to assess the understanding of the effects of specific brain lesions and vagotomy on respiratory patterns , emphasizing the potential development of an apneustic pattern in such cases.Top of Form&lt;/li&gt;&lt;li&gt;âž¤ assess&lt;/li&gt;&lt;li&gt;âž¤ understanding&lt;/li&gt;&lt;li&gt;âž¤ effects&lt;/li&gt;&lt;li&gt;âž¤ specific brain lesions&lt;/li&gt;&lt;li&gt;âž¤ vagotomy&lt;/li&gt;&lt;li&gt;âž¤ respiratory patterns&lt;/li&gt;&lt;li&gt;âž¤ emphasizing&lt;/li&gt;&lt;li&gt;âž¤ potential development&lt;/li&gt;&lt;li&gt;âž¤ apneustic pattern&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 658&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 658&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a Clinical Medicine Seminar, the instructor discusses the Various Types of Hypoxia and their Clinical Manifestations, particularly the Presence or Absence of Cyanosis. The Students are asked to identify the Type of Hypoxia in which Cyanosis is NOT observed with Normal Arterial Content of Oxygen but Reduced Arteriovenous Difference of Oxygen.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypoxic Hypoxia.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stagnant Hypoxia.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Histotoxic Hypoxia.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anemic Hypoxia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Histotoxic Hypoxia.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Histotoxic Hypoxia.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypoxic hypoxia occurs when there is a reduced availability of oxygen in the inspired air or impaired oxygen diffusion in the lungs . It typically leads to cyanosis due to a decrease in oxygen saturation of hemoglobin in the blood .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ reduced availability&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ inspired air&lt;/li&gt;&lt;li&gt;â€¢ impaired oxygen&lt;/li&gt;&lt;li&gt;â€¢ diffusion&lt;/li&gt;&lt;li&gt;â€¢ lungs&lt;/li&gt;&lt;li&gt;â€¢ leads&lt;/li&gt;&lt;li&gt;â€¢ cyanosis&lt;/li&gt;&lt;li&gt;â€¢ decrease&lt;/li&gt;&lt;li&gt;â€¢ oxygen saturation&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ blood&lt;/li&gt;&lt;li&gt;â€¢ Option B. Stagnant hypoxia results from poor blood circulation or perfusion , leading to inadequate oxygen delivery to tissues . It often causes cyanosis due to reduced oxygen supply to the tissues .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ poor blood circulation&lt;/li&gt;&lt;li&gt;â€¢ perfusion&lt;/li&gt;&lt;li&gt;â€¢ inadequate oxygen delivery&lt;/li&gt;&lt;li&gt;â€¢ tissues&lt;/li&gt;&lt;li&gt;â€¢ cyanosis&lt;/li&gt;&lt;li&gt;â€¢ reduced oxygen supply&lt;/li&gt;&lt;li&gt;â€¢ tissues&lt;/li&gt;&lt;li&gt;â€¢ Option D . Cyanosis is typically not observed; it is characterized by reduced oxygen - carrying capacity of the blood due to low hemoglobin , although arterial oxygen content may be normal .&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ .&lt;/li&gt;&lt;li&gt;â€¢ characterized&lt;/li&gt;&lt;li&gt;â€¢ reduced oxygen&lt;/li&gt;&lt;li&gt;â€¢ carrying capacity&lt;/li&gt;&lt;li&gt;â€¢ blood&lt;/li&gt;&lt;li&gt;â€¢ low hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ arterial oxygen&lt;/li&gt;&lt;li&gt;â€¢ normal&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the different types of hypoxia and their clinical manifestations , particularly recognizing that cyanosis is not typically seen in histotoxic hypoxia because it involves impaired cellular utilization of oxygen despite adequate oxygen delivery .&lt;/li&gt;&lt;li&gt;âž¤ different types&lt;/li&gt;&lt;li&gt;âž¤ hypoxia&lt;/li&gt;&lt;li&gt;âž¤ clinical manifestations&lt;/li&gt;&lt;li&gt;âž¤ impaired cellular utilization&lt;/li&gt;&lt;li&gt;âž¤ oxygen&lt;/li&gt;&lt;li&gt;âž¤ adequate oxygen delivery&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 647&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 647&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a Medical Physiology Lecture, the Professor discusses the various types of Hypoxia and their Effects on Arterial Oxygen content. The students are asked to identify the Type of Hypoxia in which Arterial Oxygen content is reduced but Partial Pressure of Oxygen and Arterio-Venous Difference of Oxygen is Normal.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Stagnant Hhypoxia.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anemic Hypoxia.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Histotoxic Hypoxia.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypoxic Hypoxia.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Anemic Hypoxia.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Anemic Hypoxia.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Stagnant hypoxia is characterized by poor blood circulation , leading to inadequate oxygen delivery to tissues . While oxygen delivery may be reduced , it does not directly affect arterial oxygen content. The arterio-venous difference of Oxygen will increase .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ poor blood circulation&lt;/li&gt;&lt;li&gt;â€¢ inadequate oxygen&lt;/li&gt;&lt;li&gt;â€¢ tissues&lt;/li&gt;&lt;li&gt;â€¢ oxygen delivery&lt;/li&gt;&lt;li&gt;â€¢ reduced&lt;/li&gt;&lt;li&gt;â€¢ arterio-venous&lt;/li&gt;&lt;li&gt;â€¢ Oxygen&lt;/li&gt;&lt;li&gt;â€¢ increase&lt;/li&gt;&lt;li&gt;â€¢ Option C. Histotoxic hypoxia occurs when cells are unable to use oxygen despite it being delivered to them. It does not directly impact arterial oxygen content.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ cells&lt;/li&gt;&lt;li&gt;â€¢ unable&lt;/li&gt;&lt;li&gt;â€¢ use oxygen&lt;/li&gt;&lt;li&gt;â€¢ delivered&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ischemic hypoxia is caused by inadequate blood flow to tissues . While it can lead to reduced oxygen delivery , it does not directly affect arterial oxygen content.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ inadequate blood&lt;/li&gt;&lt;li&gt;â€¢ flow&lt;/li&gt;&lt;li&gt;â€¢ tissues&lt;/li&gt;&lt;li&gt;â€¢ lead&lt;/li&gt;&lt;li&gt;â€¢ reduced oxygen delivery&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the different types of hypoxia and their effects on arterial oxygen content , particularly recognizing that anemic hypoxia is associated with a reduction in arterial oxygen content due to a decrease in hemoglobin concentration .&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the different types of hypoxia and their effects on arterial oxygen content , particularly recognizing that anemic hypoxia is associated with a reduction in arterial oxygen content due to a decrease in hemoglobin concentration .&lt;/li&gt;&lt;li&gt;âž¤ understand&lt;/li&gt;&lt;li&gt;âž¤ different types&lt;/li&gt;&lt;li&gt;âž¤ hypoxia&lt;/li&gt;&lt;li&gt;âž¤ effects&lt;/li&gt;&lt;li&gt;âž¤ arterial oxygen content&lt;/li&gt;&lt;li&gt;âž¤ recognizing&lt;/li&gt;&lt;li&gt;âž¤ anemic hypoxia&lt;/li&gt;&lt;li&gt;âž¤ reduction&lt;/li&gt;&lt;li&gt;âž¤ arterial oxygen&lt;/li&gt;&lt;li&gt;âž¤ decrease&lt;/li&gt;&lt;li&gt;âž¤ hemoglobin concentration&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 646&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 646&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a Pulmonology Class, a Professor discusses techniques to measure the Effectiveness of Alveolar Ventilation. A patient case is presented where it&#x27;s crucial to ascertain how much of the Inspired Air actually Ventilates the Alveoli. Which method is used to Calculate the Volume of Inspired Air that Effectively Ventilates the Alveoli?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Single Breath N2 Method&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dalton&#x27;s Law&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bohr Equation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Boyle&#x27;s Law&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Single Breath N2 Method&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Single Breath N2 Method&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Incorrect . Dalton&#x27;s law relates to partial pressures of gases but is not directly used to measure alveolar ventilation.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Dalton&#x27;s law&lt;/li&gt;&lt;li&gt;â€¢ partial pressures&lt;/li&gt;&lt;li&gt;â€¢ gases&lt;/li&gt;&lt;li&gt;â€¢ Option C: Incorrect . The Bohr equation is used for calculating physiological dead space through calculating Alveolar dead space , not alveolar ventilation.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ physiological dead space&lt;/li&gt;&lt;li&gt;â€¢ Alveolar dead space&lt;/li&gt;&lt;li&gt;â€¢ Option D: Incorrect . Boyle&#x27;s law pertains to the relationship between pressure and volume of gases and is not specifically used to measure alveolar ventilation.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ pressure&lt;/li&gt;&lt;li&gt;â€¢ volume&lt;/li&gt;&lt;li&gt;â€¢ gases&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand various methods used to assess alveolar ventilation efficiency in respiratory physiology.&lt;/li&gt;&lt;li&gt;âž¤ Understand various methods used to assess alveolar ventilation efficiency in respiratory physiology.&lt;/li&gt;&lt;li&gt;âž¤ assess alveolar ventilation efficiency&lt;/li&gt;&lt;li&gt;âž¤ respiratory physiology.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 630&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 630&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Oxygen Therapy, or Supplemental Oxygen, can help people get enough Oxygen if they canâ€™t get it on their own. It can include Oxygen in Liquid or Gas Forms, among other types. In which of the following conditions, Oxygen Therapy is LEAST useful?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anemia.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ARDS (Acute Respiratory Distress Syndrome).&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alveolar Damage.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;COPD (Chronic Obstructive Pulmonary Disease).&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Anemia.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Anemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Oxygen therapy is commonly used in the management of ARDS to provide supplemental oxygen and improve oxygenation .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Oxygen therapy&lt;/li&gt;&lt;li&gt;â€¢ management&lt;/li&gt;&lt;li&gt;â€¢ ARDS&lt;/li&gt;&lt;li&gt;â€¢ supplemental oxygen&lt;/li&gt;&lt;li&gt;â€¢ improve oxygenation&lt;/li&gt;&lt;li&gt;â€¢ Option C. Oxygen therapy is often beneficial in cases of alveolar damage , such as in patients with pneumonia or acute lung injury , as it helps increase oxygen levels in the blood .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Oxygen therapy&lt;/li&gt;&lt;li&gt;â€¢ alveolar damage&lt;/li&gt;&lt;li&gt;â€¢ pneumonia&lt;/li&gt;&lt;li&gt;â€¢ acute lung injury&lt;/li&gt;&lt;li&gt;â€¢ increase oxygen levels&lt;/li&gt;&lt;li&gt;â€¢ blood&lt;/li&gt;&lt;li&gt;â€¢ Option D. Oxygen therapy is frequently prescribed for patients with COPD to alleviate hypoxemia and improve overall oxygenation .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ COPD&lt;/li&gt;&lt;li&gt;â€¢ alleviate hypoxemia&lt;/li&gt;&lt;li&gt;â€¢ improve overall oxygenation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ To understand that oxygen therapy may be least useful in the treatment of anemia because anemia primarily involves a decrease in the oxygen-carrying capacity of the blood , which oxygen therapy alone cannot fully address.&lt;/li&gt;&lt;li&gt;âž¤ oxygen therapy&lt;/li&gt;&lt;li&gt;âž¤ least&lt;/li&gt;&lt;li&gt;âž¤ treatment&lt;/li&gt;&lt;li&gt;âž¤ anemia&lt;/li&gt;&lt;li&gt;âž¤ anemia&lt;/li&gt;&lt;li&gt;âž¤ decrease&lt;/li&gt;&lt;li&gt;âž¤ oxygen-carrying capacity&lt;/li&gt;&lt;li&gt;âž¤ blood&lt;/li&gt;&lt;li&gt;âž¤ oxygen therapy&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 647&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 647&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a Medical Physiology Lecture, the Professor discusses the Concept of A-V (Arterial-Venous) Oxygen Difference and its variations in different types of Hypoxia. The students are asked to identify the Type of Hypoxia in which the least A-V Oxygen Difference is Observed.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypoxic Hypoxia.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anemic Hypoxia.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stagnant Hypoxia.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Histotoxic Hypoxia.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Histotoxic Hypoxia.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Histotoxic Hypoxia.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypoxic hypoxia is characterized by a reduced oxygen concentration in the inspired air or impaired oxygen diffusion in the lungs . It can lead to an increase in A-V oxygen difference as the body tries to extract more oxygen from the available blood .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ reduced oxygen concentration&lt;/li&gt;&lt;li&gt;â€¢ inspired air&lt;/li&gt;&lt;li&gt;â€¢ impaired oxygen diffusion&lt;/li&gt;&lt;li&gt;â€¢ lungs&lt;/li&gt;&lt;li&gt;â€¢ increase&lt;/li&gt;&lt;li&gt;â€¢ A-V oxygen difference&lt;/li&gt;&lt;li&gt;â€¢ body&lt;/li&gt;&lt;li&gt;â€¢ extract&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ available blood&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anemic hypoxia results from a decreased oxygen-carrying capacity of the blood , typically due to a decrease in hemoglobin concentration . This can lead to an increase in A-V oxygen difference as the blood carries less oxygen.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ decreased oxygen-carrying capacity&lt;/li&gt;&lt;li&gt;â€¢ blood&lt;/li&gt;&lt;li&gt;â€¢ decrease&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin concentration&lt;/li&gt;&lt;li&gt;â€¢ lead&lt;/li&gt;&lt;li&gt;â€¢ increase&lt;/li&gt;&lt;li&gt;â€¢ A-V oxygen&lt;/li&gt;&lt;li&gt;â€¢ blood&lt;/li&gt;&lt;li&gt;â€¢ less oxygen.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Stagnant hypoxia occurs when there is poor blood circulation or perfusion , leading to reduced oxygen delivery to tissues . It can result in an increase in A-V oxygen difference as oxygen extraction becomes more significant .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ poor blood circulation&lt;/li&gt;&lt;li&gt;â€¢ perfusion&lt;/li&gt;&lt;li&gt;â€¢ reduced oxygen delivery&lt;/li&gt;&lt;li&gt;â€¢ tissues&lt;/li&gt;&lt;li&gt;â€¢ result&lt;/li&gt;&lt;li&gt;â€¢ increase&lt;/li&gt;&lt;li&gt;â€¢ A-V oxygen difference&lt;/li&gt;&lt;li&gt;â€¢ oxygen extraction&lt;/li&gt;&lt;li&gt;â€¢ significant&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the concept of A-V oxygen difference in different types of hypoxia and recognize that the least A-V oxygen difference is observed in histotoxic hypoxia , where oxygen is present in the blood but cannot be utilized by the cells due to toxic factors.&lt;/li&gt;&lt;li&gt;âž¤ concept&lt;/li&gt;&lt;li&gt;âž¤ A-V oxygen&lt;/li&gt;&lt;li&gt;âž¤ different types&lt;/li&gt;&lt;li&gt;âž¤ hypoxia&lt;/li&gt;&lt;li&gt;âž¤ recognize&lt;/li&gt;&lt;li&gt;âž¤ least A-V oxygen difference&lt;/li&gt;&lt;li&gt;âž¤ histotoxic hypoxia&lt;/li&gt;&lt;li&gt;âž¤ oxygen&lt;/li&gt;&lt;li&gt;âž¤ blood&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 647&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 647&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a clinical round in the respiratory unit, the attending physician presents a patient case to the medical team. The patient is a 60-year-old male with chronic obstructive pulmonary disease (COPD) experiencing increased breathlessness. Arterial blood gas analysis reveals elevated CO 2 levels and a Decreased pH in the Cerebro-Spinal Fluid (CSF). Which factor is most directly stimulating the patientâ€™s Central Chemoreceptors, contributing to the Respiratory Symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decrease in PO 2 (Partial Pressure of Oxygen).&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decrease in pH of Cerebro-Spinal Fluid (CSF).&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypoxia.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increase in pH of CSF.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Decrease in pH of Cerebro-Spinal Fluid (CSF).&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Decrease in pH of&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ Option A. While peripheral chemoreceptors in the carotid bodies are primarily sensitive to changes in arterial PO 2 , central chemoreceptors are not directly stimulated by changes in PO 2 . Instead, they are more responsive to changes in pH .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ peripheral chemoreceptors&lt;/li&gt;&lt;li&gt;â€¢ carotid bodies&lt;/li&gt;&lt;li&gt;â€¢ sensitive&lt;/li&gt;&lt;li&gt;â€¢ arterial PO 2&lt;/li&gt;&lt;li&gt;â€¢ changes&lt;/li&gt;&lt;li&gt;â€¢ pH&lt;/li&gt;&lt;li&gt;â€¢ Option C. Central chemoreceptors are more sensitive to changes in pH than to changes in PO 2 . However, hypoxia can indirectly affect central chemoreceptor activity by altering CO 2 levels and pH .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Central chemoreceptors&lt;/li&gt;&lt;li&gt;â€¢ sensitive&lt;/li&gt;&lt;li&gt;â€¢ changes&lt;/li&gt;&lt;li&gt;â€¢ pH&lt;/li&gt;&lt;li&gt;â€¢ changes&lt;/li&gt;&lt;li&gt;â€¢ PO 2 .&lt;/li&gt;&lt;li&gt;â€¢ hypoxia&lt;/li&gt;&lt;li&gt;â€¢ indirectly&lt;/li&gt;&lt;li&gt;â€¢ affect&lt;/li&gt;&lt;li&gt;â€¢ altering CO 2 levels&lt;/li&gt;&lt;li&gt;â€¢ pH&lt;/li&gt;&lt;li&gt;â€¢ Option D. An increase in pH of the CSF would not typically stimulate central chemoreceptors. Central chemoreceptors are primarily responsive to a decrease in CSF pH (i.e., increased acidity ).&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ increase&lt;/li&gt;&lt;li&gt;â€¢ pH&lt;/li&gt;&lt;li&gt;â€¢ CSF&lt;/li&gt;&lt;li&gt;â€¢ Central chemoreceptors&lt;/li&gt;&lt;li&gt;â€¢ responsive&lt;/li&gt;&lt;li&gt;â€¢ decrease&lt;/li&gt;&lt;li&gt;â€¢ CSF pH&lt;/li&gt;&lt;li&gt;â€¢ increased acidity&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the factors that stimulate central chemoreceptors and recognize that a decrease in the pH of cerebrospinal fluid (CSF) is a direct stimulus for central chemoreceptors.&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the factors that stimulate central chemoreceptors and recognize that a decrease in the pH of cerebrospinal fluid (CSF) is a direct stimulus for central chemoreceptors.&lt;/li&gt;&lt;li&gt;âž¤ stimulate&lt;/li&gt;&lt;li&gt;âž¤ central chemoreceptors&lt;/li&gt;&lt;li&gt;âž¤ recognize&lt;/li&gt;&lt;li&gt;âž¤ decrease&lt;/li&gt;&lt;li&gt;âž¤ pH&lt;/li&gt;&lt;li&gt;âž¤ cerebrospinal fluid (CSF)&lt;/li&gt;&lt;li&gt;âž¤ direct stimulus&lt;/li&gt;&lt;li&gt;âž¤ central chemoreceptors.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 656&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 656&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a Neuroscience Class, the professor discusses the importance of communication between the Pons and Medulla in regulating respiration. The students are asked to predict the Effect on Respiration if a transaction is made between the Pons and Medulla.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Apnoea (Apnea).&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Irregular and Gasping.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;No Effect.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Slow and Deep.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Irregular and Gasping.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Irregular and Gasping.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ Option A . Transecting the pons and medulla disrupts the coordination of respiratory centers . Without this coordination, breathing regulation is compromised , leading to apnoea , which is the cessation of breathing .&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ Transecting&lt;/li&gt;&lt;li&gt;â€¢ pons&lt;/li&gt;&lt;li&gt;â€¢ medulla&lt;/li&gt;&lt;li&gt;â€¢ respiratory centers&lt;/li&gt;&lt;li&gt;â€¢ breathing regulation&lt;/li&gt;&lt;li&gt;â€¢ compromised&lt;/li&gt;&lt;li&gt;â€¢ apnoea&lt;/li&gt;&lt;li&gt;â€¢ cessation&lt;/li&gt;&lt;li&gt;â€¢ breathing&lt;/li&gt;&lt;li&gt;â€¢ Option C . This option is not correct . A transection between the pons and medulla significantly impacts respiration as these brain regions are vital for breathing regulation . No effect would not be an accurate outcome.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ not correct&lt;/li&gt;&lt;li&gt;â€¢ transection&lt;/li&gt;&lt;li&gt;â€¢ pons&lt;/li&gt;&lt;li&gt;â€¢ medulla&lt;/li&gt;&lt;li&gt;â€¢ respiration&lt;/li&gt;&lt;li&gt;â€¢ vital&lt;/li&gt;&lt;li&gt;â€¢ breathing regulation&lt;/li&gt;&lt;li&gt;â€¢ Option D . Midpontine lesion leads to Slow and deep breathing . Slow and deep breathing, however, is not the primary result of disrupting the communication between the pons and medulla, as it&#x27;s more likely to lead to irregular and erratic breathing.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Midpontine lesion&lt;/li&gt;&lt;li&gt;â€¢ Slow&lt;/li&gt;&lt;li&gt;â€¢ deep breathing&lt;/li&gt;&lt;li&gt;â€¢ Top of Form&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ To understand the role of the pons and medulla in regulating respiration and recognize that disruption in the transmission between these brainstem regions can lead to various effects on breathing , including apnoea , irregular gasping , or no significant effect.&lt;/li&gt;&lt;li&gt;âž¤ To understand the role of the pons and medulla in regulating respiration and recognize that disruption in the transmission between these brainstem regions can lead to various effects on breathing , including apnoea , irregular gasping , or no significant effect.&lt;/li&gt;&lt;li&gt;âž¤ To understand the role of the pons and medulla in regulating respiration and recognize that disruption in the transmission between these brainstem regions can lead to various effects on breathing , including apnoea , irregular gasping , or no significant effect.&lt;/li&gt;&lt;li&gt;âž¤ role&lt;/li&gt;&lt;li&gt;âž¤ pons&lt;/li&gt;&lt;li&gt;âž¤ medulla&lt;/li&gt;&lt;li&gt;âž¤ regulating respiration&lt;/li&gt;&lt;li&gt;âž¤ transmission&lt;/li&gt;&lt;li&gt;âž¤ brainstem regions&lt;/li&gt;&lt;li&gt;âž¤ various effects&lt;/li&gt;&lt;li&gt;âž¤ breathing&lt;/li&gt;&lt;li&gt;âž¤ including apnoea&lt;/li&gt;&lt;li&gt;âž¤ irregular gasping&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 656&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 656&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a Neurophysiology Class, the Professor discusses the Neural Control of Respiratory Rhythm and its initiation. The students are asked to identify the Specific Neural Structure where the Rhythm for Inspiration is Initiated.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pneumotaxic Centre.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Apneustic Centre.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;DRG (Dorsal Respiratory Group).&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pre-Botzinger Complex.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pre-Botzinger Complex.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Pre-Botzinger Complex.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ Option A. The pneumotaxic centre is located in the pons and plays a role in regulating the duration and depth of breaths by influencing the transition from inspiration to expiration . It does not initiate the rhythm for inspiration.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ pons&lt;/li&gt;&lt;li&gt;â€¢ regulating&lt;/li&gt;&lt;li&gt;â€¢ duration&lt;/li&gt;&lt;li&gt;â€¢ depth&lt;/li&gt;&lt;li&gt;â€¢ breaths&lt;/li&gt;&lt;li&gt;â€¢ influencing&lt;/li&gt;&lt;li&gt;â€¢ transition&lt;/li&gt;&lt;li&gt;â€¢ inspiration&lt;/li&gt;&lt;li&gt;â€¢ expiration&lt;/li&gt;&lt;li&gt;â€¢ Option B. The apneustic centre, also located in the pons , is involved in promoting prolonged inspiration . It can enhance the depth and prolongation of inspiration but does not initiate the rhythm.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ pons&lt;/li&gt;&lt;li&gt;â€¢ promoting&lt;/li&gt;&lt;li&gt;â€¢ inspiration&lt;/li&gt;&lt;li&gt;â€¢ enhance&lt;/li&gt;&lt;li&gt;â€¢ depth&lt;/li&gt;&lt;li&gt;â€¢ prolongation&lt;/li&gt;&lt;li&gt;â€¢ inspiration&lt;/li&gt;&lt;li&gt;â€¢ Option C. The DRG is part of the medulla and contributes to the basic rhythm of breathing . However, it does not initiate the respiratory rhythm but rather helps in coordinating the respiratory muscles during inspiration.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ part&lt;/li&gt;&lt;li&gt;â€¢ medulla&lt;/li&gt;&lt;li&gt;â€¢ basic rhythm&lt;/li&gt;&lt;li&gt;â€¢ breathing&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the neural structures involved in the control of respiratory rhythm and recognize that the rhythm for inspiration is initiated in the pre-Botzinger complex located in the medulla oblongata .&lt;/li&gt;&lt;li&gt;âž¤ neural structures&lt;/li&gt;&lt;li&gt;âž¤ control&lt;/li&gt;&lt;li&gt;âž¤ respiratory rhythm&lt;/li&gt;&lt;li&gt;âž¤ recognize&lt;/li&gt;&lt;li&gt;âž¤ rhythm&lt;/li&gt;&lt;li&gt;âž¤ inspiration&lt;/li&gt;&lt;li&gt;âž¤ initiated&lt;/li&gt;&lt;li&gt;âž¤ pre-Botzinger complex&lt;/li&gt;&lt;li&gt;âž¤ medulla oblongata&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 655&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg no: 655&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the following Diagram, the curve \&quot;X\&quot; represents the Normal Relationship of Alveolar Ventilation with PaCO 2 , when PaO 2 is 100 mmHg. If pH changed from 7.4 to 7.3, change in Alveolar Ventilation will shift to which of the Curve?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Curve B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Curve C&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Curve D&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Curve E&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Curve C&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/26/39.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Curve C&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ Option A : Incorrect . If the blood pH decreases (becomes more acidic ), alveolar ventilation typically increases to eliminate more CO 2 , which should shift the curve leftward , not to Curve B.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ blood pH&lt;/li&gt;&lt;li&gt;â€¢ decreases&lt;/li&gt;&lt;li&gt;â€¢ acidic&lt;/li&gt;&lt;li&gt;â€¢ alveolar ventilation&lt;/li&gt;&lt;li&gt;â€¢ increases&lt;/li&gt;&lt;li&gt;â€¢ eliminate&lt;/li&gt;&lt;li&gt;â€¢ CO 2&lt;/li&gt;&lt;li&gt;â€¢ leftward&lt;/li&gt;&lt;li&gt;â€¢ Option C: Incorrect . This curve does not represent the typical response to acidosis. Acidosis would increase ventilation , not decrease it.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ increase ventilation&lt;/li&gt;&lt;li&gt;â€¢ Option D: Incorrect . This curve does not align with the physiological response to a decrease in pH. Acidosis drives an increase in alveolar ventilation .&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ increase&lt;/li&gt;&lt;li&gt;â€¢ alveolar ventilation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The objective is to understand the physiological response of alveolar ventilation to changes in blood pH , particularly in relation to the regulation of arterial CO 2 levels .&lt;/li&gt;&lt;li&gt;âž¤ The objective is to understand the physiological response of alveolar ventilation to changes in blood pH , particularly in relation to the regulation of arterial CO 2 levels .&lt;/li&gt;&lt;li&gt;âž¤ physiological response&lt;/li&gt;&lt;li&gt;âž¤ alveolar ventilation&lt;/li&gt;&lt;li&gt;âž¤ blood pH&lt;/li&gt;&lt;li&gt;âž¤ regulation&lt;/li&gt;&lt;li&gt;âž¤ arterial CO 2 levels&lt;/li&gt;&lt;li&gt;âž¤ Ref Guyton, 13th Edition, p.544&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ Guyton, 13th Edition, p.544&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a Respiratory Physiology Seminar, the instructor discusses the Mechanisms that prevent Hyperinflation of the Lungs during the Breathing Cycle. The students are asked to identify the Specific Reflex that Plays a Role in Preventing Lung Hyperinflation.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hering Breuer Reflex.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Irritation Reflex.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cushing Reflex.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bainbridge Reflex.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Hering Breuer Reflex.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Hering Breuer Reflex.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ Option B. The irritation reflex, also known as the cough reflex , is primarily a protective mechanism to clear the airways in response to irritants or foreign particles . It does not play a direct role in preventing hyperinflation of the lungs.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ cough reflex&lt;/li&gt;&lt;li&gt;â€¢ protective mechanism&lt;/li&gt;&lt;li&gt;â€¢ clear&lt;/li&gt;&lt;li&gt;â€¢ airways&lt;/li&gt;&lt;li&gt;â€¢ irritants&lt;/li&gt;&lt;li&gt;â€¢ foreign particles&lt;/li&gt;&lt;li&gt;â€¢ Option C. The Cushing reflex is a physiological response to increased intracranial pressure . It involves increased blood pressure and decreased heart rate as a compensatory response . It is not related to lung inflation or hyperinflation.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ physiological response&lt;/li&gt;&lt;li&gt;â€¢ increased intracranial pressure&lt;/li&gt;&lt;li&gt;â€¢ increased blood pressure&lt;/li&gt;&lt;li&gt;â€¢ decreased heart rate&lt;/li&gt;&lt;li&gt;â€¢ compensatory response&lt;/li&gt;&lt;li&gt;â€¢ Option D. The Bainbridge reflex is a cardiovascular reflex that responds to changes in blood volume and pressure , primarily affecting heart rate . It does not play a role in lung inflation control.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ cardiovascular reflex&lt;/li&gt;&lt;li&gt;â€¢ changes&lt;/li&gt;&lt;li&gt;â€¢ blood volume&lt;/li&gt;&lt;li&gt;â€¢ pressure&lt;/li&gt;&lt;li&gt;â€¢ affecting&lt;/li&gt;&lt;li&gt;â€¢ heart rate&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ To understand the role of the Hering Breuer reflex in preventing hyperinflation of the lungs during the breathing cycle , particularly by inhibiting further inspiration in response to lung stretching .&lt;/li&gt;&lt;li&gt;âž¤ role&lt;/li&gt;&lt;li&gt;âž¤ Hering Breuer reflex&lt;/li&gt;&lt;li&gt;âž¤ preventing hyperinflation&lt;/li&gt;&lt;li&gt;âž¤ lungs&lt;/li&gt;&lt;li&gt;âž¤ breathing cycle&lt;/li&gt;&lt;li&gt;âž¤ inspiration&lt;/li&gt;&lt;li&gt;âž¤ lung stretching&lt;/li&gt;&lt;li&gt;âž¤ Ref: Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 65&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Ganong&#x27;s Review of Medical Physiology, 25 th Edition, Pg No: 65&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 112 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

</body>
</html>
